Citrus Sinensis ID: 012777
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 456 | 2.2.26 [Sep-21-2011] | |||||||
| P18160 | 2410 | Dual specificity protein | yes | no | 0.572 | 0.108 | 0.369 | 2e-38 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.491 | 0.173 | 0.412 | 1e-37 | |
| Q54N73 | 691 | Seven transmembrane domai | no | no | 0.631 | 0.416 | 0.370 | 3e-37 | |
| Q54Y55 | 506 | Dual specificity protein | no | no | 0.567 | 0.511 | 0.370 | 6e-37 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.510 | 0.283 | 0.383 | 8e-37 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.546 | 0.360 | 0.360 | 1e-36 | |
| Q54R58 | 918 | Probable tyrosine-protein | no | no | 0.576 | 0.286 | 0.371 | 3e-36 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.546 | 0.387 | 0.359 | 6e-36 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.578 | 0.288 | 0.335 | 7e-36 | |
| Q86HG9 | 1024 | Probable serine/threonine | no | no | 0.510 | 0.227 | 0.354 | 1e-35 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 160 bits (405), Expect = 2e-38, Method: Composition-based stats.
Identities = 110/298 (36%), Positives = 157/298 (52%), Gaps = 37/298 (12%)
Query: 144 EYEIDPKELDFSNSVEITKGTF---RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELAL 200
EYEID EL+F + I KG F + WR T VA+K + + F + + F +E+ +
Sbjct: 2107 EYEIDFNELEFGQT--IGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVMFQNEVGI 2164
Query: 201 LQKIRHPNVVQFLGAVTQSTP--MMIVTEYLPKGDLRAYLKQKGAL---KPTLAVKFALD 255
L K+RHPNVVQFLGA T IVTE++ G LR +L L P + +K ALD
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224
Query: 256 IARGMNYLHENRPEAIIHRDLEPSNILRDDS-------------GHLKVADFGLSKLLKF 302
IA+GMNYLH P I+HRDL NIL D + K++DFGLS+ LK
Sbjct: 2225 IAKGMNYLHGWTP-PILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSR-LKM 2282
Query: 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
+ + V C Y APEV+K + K DV+S+ ++L E++ P + K
Sbjct: 2283 EQASQMTQSVGCIP----YMAPEVFKGDSNSEKSDVYSYGMVLFELLTSDE--PQQDMKP 2336
Query: 363 VPKAYIA---NERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417
+ A++A + RPP T+ +E++ CW P RPTF+QI++ L ++ DQ
Sbjct: 2337 MKMAHLAAYESYRPPIPLTTSS---KWKEILTQCWDSNPDSRPTFKQIIVHLKEMEDQ 2391
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 2 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 157 bits (398), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 104/252 (41%), Positives = 137/252 (54%), Gaps = 28/252 (11%)
Query: 165 FRIASWRGTQVAVKTLGEEVFTDEDKVKAFID---ELALLQKIRHPNVVQFLGAVTQSTP 221
FR SWRGT+VAVK L F D +K D E+ LL K+RHPN+V F+GA T+ +
Sbjct: 866 FR-GSWRGTEVAVKML----FNDNVNLKLISDLRKEVDLLCKLRHPNIVLFMGACTEPSS 920
Query: 222 MMIVTEYLPKGDL-RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSN 280
IVTEYL +G L L + + L ++ D ARGM YLH P IIHRDL+ N
Sbjct: 921 PCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYLHSRNP-IIIHRDLKTDN 979
Query: 281 ILRDDSGHLKVADFGLS--KLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDV 338
+L DDS +KVADFGL+ K FA T+ C T W APEV E Y K DV
Sbjct: 980 LLVDDSWQVKVADFGLATVKSHTFAKTM-------CGTTGW--VAPEVLAEEGYTEKADV 1030
Query: 339 FSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRA--PTTHYAYGLRELIEDCWSE 396
+S+A++L E++ P+ K +V ++ ER P A P + A L+ CW
Sbjct: 1031 YSYAIVLWELLTRLIPYAGKNTMQVVRSIDRGERLPMPAWCPPKYAA-----LMNRCWET 1085
Query: 397 EPFRRPTFRQIL 408
+P RP+F +IL
Sbjct: 1086 DPTHRPSFPEIL 1097
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54N73|7TMK1_DICDI Seven transmembrane domain-containing tyrosine-protein kinase 1 OS=Dictyostelium discoideum GN=7tmk1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 156 bits (395), Expect = 3e-37, Method: Compositional matrix adjust.
Identities = 116/313 (37%), Positives = 159/313 (50%), Gaps = 25/313 (7%)
Query: 130 STAPMHVQNAREVPEYEIDPKELDFSNSV-EITKGTFRIASWRGTQVAVKTLGEEVFTDE 188
ST+ A ++ + I E F + E G R A W+G VAVK L F +
Sbjct: 341 STSGEGATTALQLSAFYIRFNEFKFGQVIGEGYFGEVRKAVWKGAVVAVKILHRNSFRNT 400
Query: 189 DKVK---AFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGAL- 244
D K F+ E+A+L +RHPNV+QFLG +++ IVTEY+ G L L + L
Sbjct: 401 DGNKEENVFLKEVAILSILRHPNVLQFLGVCSETNLNGIVTEYMGGGSLDRLLTDRYFLI 460
Query: 245 --KPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL-KVADFGLSKLLK 301
P LA A+ IARGM YLH+ +P I+HRDL NIL D+S + KVADFGLSK
Sbjct: 461 KQNPILAWNMAISIARGMFYLHDWKPNPILHRDLSTKNILLDESLTIAKVADFGLSK--- 517
Query: 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK 361
++ +T Y APEV+ E Y K DV+SF L++ +I G P + +
Sbjct: 518 -----EQGFEMTSTVGHLCYQAPEVFIGELYTPKADVYSFGLLVWCIITG--EQPNQNLQ 570
Query: 362 EVPKAYIA---NERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418
+ A++A N RPP P L +LIE CW + P RP+F I LD + +
Sbjct: 571 PLKMAHLAAYENYRPPMPQPMDPMWENLGKLIEMCWKKSPEERPSFSFI---LDFLEANV 627
Query: 419 SIKRHWKVGPLRC 431
I + V PL+C
Sbjct: 628 PISNTY-VPPLKC 639
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q54Y55|SHKC_DICDI Dual specificity protein kinase shkC OS=Dictyostelium discoideum GN=shkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 155 bits (392), Expect = 6e-37, Method: Compositional matrix adjust.
Identities = 102/275 (37%), Positives = 155/275 (56%), Gaps = 16/275 (5%)
Query: 146 EIDPKELDFSNSVEITKGTF-RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQ 202
EI P+E++F I G+F ++ R Q VAVK L ++ F D + AF E+ L+
Sbjct: 18 EIRPEEINFEEL--IGTGSFGKVYKGRCRQKAVAVKLLHKQNF-DAATLSAFRKEVHLMS 74
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLK-QKGALKPTLAVKFALDIARGMN 261
KI HPN+ F+GA T +IVTE +PKG+L L QK L L ++ A D A G+N
Sbjct: 75 KIYHPNICLFMGACTIPGRCVIVTELVPKGNLETLLHDQKIQLPLYLRMRMARDAALGIN 134
Query: 262 YLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRY 321
+LHE+ P +HRD++ SN+L D++ +K+ DFGLS L + +K+ + + + Y
Sbjct: 135 WLHESNP-VFVHRDIKSSNLLVDENMRVKICDFGLSALKQKHKMLKDQ---SSAKGTPLY 190
Query: 322 AAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPK--AYIANERPPFRAPT 379
APEV +E++ DV+SF ++L E++ PF +E E + + +ERPP
Sbjct: 191 MAPEVMMFKEFNESSDVYSFGIVLWEILTRKEPFSHHRELEKFREAVCVKHERPPIPNDC 250
Query: 380 THYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
LR LIE CW +EP RP+F++I+ LD +
Sbjct: 251 LD---SLRRLIEKCWDKEPISRPSFKEIISALDHV 282
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 155 bits (391), Expect = 8e-37, Method: Compositional matrix adjust.
Identities = 97/253 (38%), Positives = 137/253 (54%), Gaps = 20/253 (7%)
Query: 163 GTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222
GT A W G+ VAVK L E+ F E +V F+ E+A+++++RHPN+V F+GAVTQ +
Sbjct: 563 GTVHRAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 621
Query: 223 MIVTEYLPKGDLRAYLKQKGA---LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPS 279
IVTEYL +G L L + GA L + A D+A+GMNYLH NR I+HRDL+
Sbjct: 622 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRDLKSP 680
Query: 280 NILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVF 339
N+L D +KV DFGLS+L + T E + APEV ++E + K DV+
Sbjct: 681 NLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPE-----WMAPEVLRDEPSNEKSDVY 735
Query: 340 SFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR----ELIEDCWS 395
SF +IL E+ P+ +V A F+ L +IE CW+
Sbjct: 736 SFGVILWELATLQQPWGNLNPAQVVAAV------GFKCKRLEIPRNLNPQVAAIIEGCWT 789
Query: 396 EEPFRRPTFRQIL 408
EP++RP+F I+
Sbjct: 790 NEPWKRPSFATIM 802
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 154 bits (389), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 101/280 (36%), Positives = 151/280 (53%), Gaps = 31/280 (11%)
Query: 146 EIDPKELDFSNSVEITKGTF---RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
+ID +++ V I KG F + +WRG+QVAVK L +E+ +K F E+ L++
Sbjct: 385 DIDTQQIKIG--VRIGKGNFGEVYLGTWRGSQVAVKKLPAHNI-NENILKEFHREINLMK 441
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL-KQKGALKPTLAVKFALDIARGMN 261
+RHPNV+QFLG+ S + I TEY+P+G L + L +K + +L + +D A+G+
Sbjct: 442 NLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGII 501
Query: 262 YLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRY 321
YLH + P I+HRDL+ N+L D++ +KVADFGLS + + T+ C W
Sbjct: 502 YLHGSTP-VILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATM-----TACGTPCW-- 553
Query: 322 AAPEVYKNEEYDTKVDVFSFALILQEMIE------GCPPFPTKQEKEVPKAYIANERPPF 375
+PEV +++ Y K DV+SF +IL E G PPF + A R
Sbjct: 554 TSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPF---------QVIFAVGREGM 604
Query: 376 RAPTTHYA-YGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
R PT Y +L++DC +E P +RPT Q L L+ I
Sbjct: 605 RPPTPKYGPPKYIQLLKDCLNENPSQRPTMEQCLEILESI 644
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54R58|YTYK2_DICDI Probable tyrosine-protein kinase DDB_G0283397 OS=Dictyostelium discoideum GN=DDB_G0283397 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 153 bits (386), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 105/283 (37%), Positives = 152/283 (53%), Gaps = 20/283 (7%)
Query: 142 VPEYEIDPKELDFSNSVEITKGTF---RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDEL 198
+ ++EI +EL EI +G F A WRG VA+K + F D + + F E+
Sbjct: 167 LKKHEIPSRELTVEK--EIGQGFFGKVYKARWRGKSVALKKITLIKFRDLTETEIFDKEV 224
Query: 199 ALLQKIRHPNVVQFLGAVTQSTPM---MIVTEYLPKGDLRAYLKQKGA--LKPTLAVKFA 253
+++ K+ HP V F+GA + P I+ EY+ G LR L +K + L P+L + A
Sbjct: 225 SIMSKLCHPTCVMFIGACSLDGPSNDRSIIMEYMEGGSLRRLLDEKSSYHLPPSLQLSIA 284
Query: 254 LDIARGMNYLHENRPEA-IIHRDLEPSNILRDDSGHL-KVADFGLSKLLKFANTVKEDRP 311
DIA GMNYLH N E I+HRDL SNIL + S + K+ DFGLSK +K T
Sbjct: 285 RDIAEGMNYLHTNFKEGPIVHRDLTSSNILLNSSYTVAKINDFGLSKEMKPGPT-----E 339
Query: 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE 371
+T S + APE +K E Y KVDV+SFA+IL E++ P+ + + A++A+
Sbjct: 340 MTAAMGSLAWMAPECFKAENYTEKVDVYSFAIILWEIVTCRDPYNGMEPLRL--AFLASV 397
Query: 372 RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
+R P + ELI CW+ P RP+F++IL L+ I
Sbjct: 398 E-DYRLPLNGFPPYWVELISKCWNITPSLRPSFKEILQILNQI 439
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 152 bits (384), Expect = 6e-36, Method: Compositional matrix adjust.
Identities = 101/281 (35%), Positives = 147/281 (52%), Gaps = 32/281 (11%)
Query: 148 DPKELDFSN---SVEITKGTF---RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALL 201
D K++D V I KG + + +WRG+QVAVK L +E+ +K F E+ L+
Sbjct: 365 DGKDIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNI-NENILKEFHREINLM 423
Query: 202 QKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLK-QKGALKPTLAVKFALDIARGM 260
+ +RHPNV+QFLG+ + I TEY+P+G L + L Q L+ +L +K +D A+G+
Sbjct: 424 KNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGV 483
Query: 261 NYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWR 320
YLH + P I+HRDL+ N+L D++ +KVADFGLS + + T+ C W
Sbjct: 484 IYLHNSTP-VILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATM-----TACGTPCW- 536
Query: 321 YAAPEVYKNEEYDTKVDVFSFALILQEMIE------GCPPFPTKQEKEVPKAYIANERPP 374
+PEV +++ Y K DV+SF +IL E G PPF + A R
Sbjct: 537 -TSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPF---------QVIFAVGREG 586
Query: 375 FRAPTTHYA-YGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
R P +L+ DC +E P RPT Q L RL+ I
Sbjct: 587 MRPPVPQNGPPKYIQLLIDCLNENPSHRPTMEQCLERLESI 627
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 152 bits (383), Expect = 7e-36, Method: Compositional matrix adjust.
Identities = 95/283 (33%), Positives = 149/283 (52%), Gaps = 19/283 (6%)
Query: 137 QNAREVPEYEIDPKELDFSNSVEITKGTFRIAS---WRGTQVAVKTLGEEVFTDEDKVKA 193
Q + + EI EL S+ ++ +GTF + WRG+ VA+K + + ++
Sbjct: 647 QQQQYFSDIEISFSELKISS--KLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEE 704
Query: 194 FIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLR-AYLKQKGALKPTLAVKF 252
F EL +L ++RHPN+V + A T + +TEYLP G L A +K + L K
Sbjct: 705 FRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKL 764
Query: 253 ALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312
A+ IA+GMNYLH +IHRD++ N+L D+ ++K+ DFGLSKL + +
Sbjct: 765 AIQIAQGMNYLHL---SGVIHRDIKSLNLLLDEHMNVKICDFGLSKL------KSKSTEM 815
Query: 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE- 371
T S + +PE+ E+Y KVDV++F +IL E+ G P+ ++ A
Sbjct: 816 TKSIGSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSL 875
Query: 372 RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
RPP + Y L LI+ CW ++P +RP+F +IL L++I
Sbjct: 876 RPPI---PNAWPYQLSHLIQACWHQDPLKRPSFTEILNLLNEI 915
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q86HG9|Y9871_DICDI Probable serine/threonine-protein kinase DDB_G0271682 OS=Dictyostelium discoideum GN=DDB_G0271682 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 151 bits (381), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 89/251 (35%), Positives = 141/251 (56%), Gaps = 18/251 (7%)
Query: 170 WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229
W+GT VAVKT+ + + + K + E+++L+ +RHPNVV F+G + + I+TEYL
Sbjct: 379 WKGTPVAVKTIFKSLLRKDKKEEF-EKEVSILKCLRHPNVVLFMGTCLLNGNLAIITEYL 437
Query: 230 PKGDLRAYLK--QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
+G LR L K L ++ VK +D+A+GMNYLH P IIHRDL+ N+L D++
Sbjct: 438 NRGSLRDVLTTMNKSELSLSVKVKMLIDVAQGMNYLHTYSP-PIIHRDLKSLNLLVDNNF 496
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQE 347
++KV+DFGLS+ + + + C SW APEV+ Y TKVDV+SF ++L E
Sbjct: 497 NVKVSDFGLSRFI--SGGIGSSAKTFCGTLSW--IAPEVFNGSGYTTKVDVYSFGIVLWE 552
Query: 348 MIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQI 407
++ P + + + P P + +LI++C + P +RP F QI
Sbjct: 553 ILTHKQP-----SGNISATSLGHPELPSNCPQS-----FSDLIKECCNRNPDQRPNFSQI 602
Query: 408 LMRLDDISDQL 418
L++L + +Q+
Sbjct: 603 LLKLKLMYNQI 613
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 456 | ||||||
| 356499380 | 454 | PREDICTED: dual specificity protein kina | 0.986 | 0.991 | 0.781 | 0.0 | |
| 225443668 | 462 | PREDICTED: dual specificity protein kina | 0.969 | 0.956 | 0.769 | 0.0 | |
| 356553484 | 453 | PREDICTED: serine/threonine-protein kina | 0.991 | 0.997 | 0.757 | 0.0 | |
| 449450866 | 461 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.989 | 0.741 | 0.0 | |
| 255562560 | 466 | protein kinase, putative [Ricinus commun | 0.956 | 0.935 | 0.725 | 0.0 | |
| 356555470 | 456 | PREDICTED: probable serine/threonine-pro | 0.962 | 0.962 | 0.722 | 0.0 | |
| 357494353 | 554 | Protein kinase family protein [Medicago | 0.989 | 0.814 | 0.699 | 0.0 | |
| 356549162 | 455 | PREDICTED: probable serine/threonine-pro | 0.960 | 0.962 | 0.726 | 0.0 | |
| 224076914 | 423 | predicted protein [Populus trichocarpa] | 0.923 | 0.995 | 0.741 | 0.0 | |
| 297817188 | 474 | predicted protein [Arabidopsis lyrata su | 1.0 | 0.962 | 0.697 | 0.0 |
| >gi|356499380|ref|XP_003518519.1| PREDICTED: dual specificity protein kinase pyk1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 715 bits (1846), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/453 (78%), Positives = 393/453 (86%), Gaps = 3/453 (0%)
Query: 4 KSSARFTLGKQSSLAPDQPLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDV 63
K RF+LG+QSSLAP++ D SEA+DP VRLMY+ANEGD DGIKELLD+G+DV
Sbjct: 5 KLQPRFSLGRQSSLAPER---GGCGGDASEALDPAVRLMYLANEGDSDGIKELLDAGSDV 61
Query: 64 NFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLE 123
NF DID RTALHVAACQGRTDVV LLL RGADVDP+DRWGSTPL DA+YYK+HDV+KLLE
Sbjct: 62 NFTDIDGRTALHVAACQGRTDVVGLLLRRGADVDPQDRWGSTPLVDAMYYKNHDVVKLLE 121
Query: 124 EHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTFRIASWRGTQVAVKTLGEE 183
+HGA+P APMHVQNAREVPEYEIDP ELDF+NSV ITKGTFRIA WRGTQVAVKTLGEE
Sbjct: 122 KHGARPPMAPMHVQNAREVPEYEIDPSELDFTNSVCITKGTFRIALWRGTQVAVKTLGEE 181
Query: 184 VFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGA 243
+FTD+DKVKAF DEL LL+KIRHPNVVQFLGAVTQSTPMMIVTEYLP+GDLRAYLK+KGA
Sbjct: 182 LFTDDDKVKAFHDELTLLEKIRHPNVVQFLGAVTQSTPMMIVTEYLPQGDLRAYLKRKGA 241
Query: 244 LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303
LKP AVKFALDIARGMNYLHE++PEAIIHRDLEPSNILRDDSGHLKVADFG+SKLLK A
Sbjct: 242 LKPVTAVKFALDIARGMNYLHEHKPEAIIHRDLEPSNILRDDSGHLKVADFGVSKLLKVA 301
Query: 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV 363
TVKED+PVT +TSWRY APEVYKNEEYDTKVDVFSFALILQEMIEGCPPF K E EV
Sbjct: 302 KTVKEDKPVTSLDTSWRYVAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFYEKPENEV 361
Query: 364 PKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRH 423
PKAY+ NERPPFRA YAYGL++LIE+CW E+P+RRPTFRQI+ RL+DI L+ KR
Sbjct: 362 PKAYVENERPPFRASPKLYAYGLKQLIEECWDEKPYRRPTFRQIIGRLEDIYYHLAQKRR 421
Query: 424 WKVGPLRCFQSLAALWKKGHADPSSRSSRSTNR 456
WKV CFQ+L +++ +PSSRSSRST R
Sbjct: 422 WKVRAPGCFQNLEVIFRGNRTNPSSRSSRSTAR 454
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225443668|ref|XP_002263226.1| PREDICTED: dual specificity protein kinase shkB [Vitis vinifera] gi|297740576|emb|CBI30758.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 711 bits (1835), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/447 (76%), Positives = 384/447 (85%), Gaps = 5/447 (1%)
Query: 1 MESKSSARFTLGKQSSLAP----DQPLPADDDADGSEAIDPRVRLMYMANEGDLDGIKEL 56
+ESK++ RFTLGKQSSLAP D+ L + D E IDPRVRLMY+ANEGDL+G++EL
Sbjct: 3 VESKTAVRFTLGKQSSLAPERARDEALTEGEQGD-VEGIDPRVRLMYLANEGDLEGLREL 61
Query: 57 LDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHH 116
LDSG DVNFRDID RTALHVAACQG +DVV LL GA++D EDRWGSTPLADA++YK+H
Sbjct: 62 LDSGMDVNFRDIDNRTALHVAACQGFSDVVEFLLKNGAEIDLEDRWGSTPLADAIHYKNH 121
Query: 117 DVIKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTFRIASWRGTQVA 176
DVIKLLE+HGA+ APMHV NAREVPEYEIDPKELDF+NSV+ITKGT+RIASWRG QVA
Sbjct: 122 DVIKLLEKHGAQHLMAPMHVNNAREVPEYEIDPKELDFTNSVDITKGTYRIASWRGIQVA 181
Query: 177 VKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRA 236
VK LG+EV DEDKVKAF DELALLQKIRHPNVVQFLGAVTQS+PMMIVTEYLPKGDL A
Sbjct: 182 VKRLGDEVIIDEDKVKAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLHA 241
Query: 237 YLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGL 296
+LK+KGALK AVKFALDIARGMNYLHE+RPEAIIHRDLEPSNILRDDSGHLKVADFG+
Sbjct: 242 FLKRKGALKTATAVKFALDIARGMNYLHEHRPEAIIHRDLEPSNILRDDSGHLKVADFGV 301
Query: 297 SKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFP 356
SKLLK ANTVKED P+ C+ETS RY APEV+KNE YDTKVDVFSFALILQEMIEGCPPF
Sbjct: 302 SKLLKVANTVKEDYPLICQETSCRYLAPEVFKNEAYDTKVDVFSFALILQEMIEGCPPFS 361
Query: 357 TKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416
K E EVPK Y A ERPPFRAP+ Y++GL+ELIE+CW+E P +RPTF QIL RLD I +
Sbjct: 362 AKPENEVPKVYAAQERPPFRAPSKLYSHGLKELIEECWNENPTKRPTFGQILTRLDRIYN 421
Query: 417 QLSIKRHWKVGPLRCFQSLAALWKKGH 443
L KR WKV PL+CFQ+L A+WKK H
Sbjct: 422 HLGQKRRWKVRPLKCFQNLEAMWKKDH 448
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356553484|ref|XP_003545086.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 696 bits (1795), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 346/457 (75%), Positives = 389/457 (85%), Gaps = 5/457 (1%)
Query: 1 MESKS-SARFTLGKQSSLAPDQPLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDS 59
ME+K RF+LG+QSSLAP++ D SEA+DP VRLMY+ANEGD DGIKELLD+
Sbjct: 1 METKKLHPRFSLGRQSSLAPERA----GAGDSSEALDPAVRLMYLANEGDSDGIKELLDA 56
Query: 60 GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVI 119
G++VNF DID RT+LHVAACQGRTDVV LLL RGA VDP+DRWGSTPL DA+YYK+H V+
Sbjct: 57 GSNVNFTDIDGRTSLHVAACQGRTDVVDLLLRRGAHVDPQDRWGSTPLVDAMYYKNHQVV 116
Query: 120 KLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTFRIASWRGTQVAVKT 179
KLLE+HGA+P APMHVQNAREVPEYEIDP ELDF+NSV ITKGTFRIA WRG QVAVKT
Sbjct: 117 KLLEKHGARPPMAPMHVQNAREVPEYEIDPSELDFTNSVCITKGTFRIALWRGIQVAVKT 176
Query: 180 LGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLK 239
LGEE+FTD+DKVKAF EL LL+KIRHPNVVQFLGAVTQSTPMMIVTEYLP+GDL AYLK
Sbjct: 177 LGEELFTDDDKVKAFHYELTLLEKIRHPNVVQFLGAVTQSTPMMIVTEYLPQGDLGAYLK 236
Query: 240 QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKL 299
+KGALKP AVKFALDIARGMNYLHE++PEAIIHRDLEPSNILRDDSGHLKVADFG+SKL
Sbjct: 237 RKGALKPVTAVKFALDIARGMNYLHEHKPEAIIHRDLEPSNILRDDSGHLKVADFGVSKL 296
Query: 300 LKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQ 359
LK A VKED+PV +TSWRY APEVY+NEEYDT VDVFSFALILQEMIEGCPPF K
Sbjct: 297 LKVAKMVKEDKPVASLDTSWRYVAPEVYRNEEYDTNVDVFSFALILQEMIEGCPPFFAKP 356
Query: 360 EKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLS 419
E EVPKAY+ NERPPFRA YAYGL++LIE+CW E+P+RRPTFRQI+ RL+DI L+
Sbjct: 357 ENEVPKAYVENERPPFRASPKLYAYGLKQLIEECWDEKPYRRPTFRQIIGRLEDIYYHLA 416
Query: 420 IKRHWKVGPLRCFQSLAALWKKGHADPSSRSSRSTNR 456
KR WKV CFQ+L A+++ +PSSRSSRST R
Sbjct: 417 QKRGWKVRTPGCFQNLEAIFRGNRTNPSSRSSRSTAR 453
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450866|ref|XP_004143183.1| PREDICTED: serine/threonine-protein kinase TNNI3K-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 692 bits (1786), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/461 (74%), Positives = 385/461 (83%), Gaps = 5/461 (1%)
Query: 1 MESKSSARFTLGKQSSLAPDQ--PLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLD 58
M++ ARFTLGKQSSL P++ D+ D S AIDP ++LMY+AN+GDLDGIKELLD
Sbjct: 1 MDANVRARFTLGKQSSLNPEREDSHVVTDELDDSIAIDPGIKLMYLANDGDLDGIKELLD 60
Query: 59 SGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDV 118
S DVNF D D RT+LHVAACQGR DVV LLL RGA+VD +D+WGSTPLADA+YYK+HDV
Sbjct: 61 SAADVNFHDTDGRTSLHVAACQGRPDVVELLLERGAEVDVQDQWGSTPLADAIYYKNHDV 120
Query: 119 IKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTFRIASWRGTQVAVK 178
I LLE+HGAK APM VQNAREVPEYEI+P ELDFSNSV ITKGTFR ASWRG QVAVK
Sbjct: 121 INLLEKHGAKLPMAPMLVQNAREVPEYEINPNELDFSNSVNITKGTFRSASWRGIQVAVK 180
Query: 179 TLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL 238
TLGEE+FTDEDKVKAF DEL LLQKIRHPNVVQFLGAVTQS+PMMIVTEYLP+GDL A+L
Sbjct: 181 TLGEELFTDEDKVKAFRDELGLLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPQGDLHAFL 240
Query: 239 KQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK 298
K+KG LK VKFALDIARGMNYLHE++PEAIIHRDLEPSNILRDDSGHLKVADFG+SK
Sbjct: 241 KRKGFLKLATVVKFALDIARGMNYLHEHKPEAIIHRDLEPSNILRDDSGHLKVADFGVSK 300
Query: 299 LLKFANTVKEDRP--VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFP 356
LLKF+N VKEDRP VTC ETSWRYAAPEVYKNEEYDTKVDVFSF+LILQEMIEG PPFP
Sbjct: 301 LLKFSNRVKEDRPVAVTCLETSWRYAAPEVYKNEEYDTKVDVFSFSLILQEMIEGNPPFP 360
Query: 357 TKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416
T E EVPKAYIANERP F AP YA+G++ELI++CW E+P +RPTFRQI+ RL+DI+
Sbjct: 361 TMPENEVPKAYIANERPLFMAPPNRYAFGIQELIQECWDEKPQKRPTFRQIIRRLEDINT 420
Query: 417 QLSIKRHWKVGPL-RCFQSLAALWKKGHADPSSRSSRSTNR 456
+L R KV P CFQ+L AL+ +P SRSS S ++
Sbjct: 421 RLMQTRSLKVNPFCSCFQNLKALFTSERTNPGSRSSYSESK 461
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255562560|ref|XP_002522286.1| protein kinase, putative [Ricinus communis] gi|223538539|gb|EEF40144.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 676 bits (1745), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 330/455 (72%), Positives = 380/455 (83%), Gaps = 19/455 (4%)
Query: 1 MESKSSARFTLGKQSSLAPDQPLPAD---DDADGSEA-----------IDPRVRLMYMAN 46
ME KSS RFTLGKQSSLAP++ D D +GSE I P VRLMY +
Sbjct: 1 MEGKSSVRFTLGKQSSLAPERSREEDVSNDQEEGSEDMSNDPEEELEDIHPGVRLMYSCH 60
Query: 47 EGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTP 106
EGDLDGI+ELLDSG DVNFRDID RTALH+AACQG TDVV LLL+ GA+ DP+DRWGSTP
Sbjct: 61 EGDLDGIRELLDSGIDVNFRDIDNRTALHLAACQGYTDVVALLLNNGAETDPKDRWGSTP 120
Query: 107 LADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTFR 166
LADA+YYK+HDVIKLLE+ GAKP APMHV +AREVPEYEI+P ELDF+NSVEITKGTF
Sbjct: 121 LADAIYYKNHDVIKLLEKRGAKPLMAPMHVNHAREVPEYEINPHELDFTNSVEITKGTFH 180
Query: 167 IASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226
+ASWRG QVAVK LGE+V +DEDKV+AF DELALLQKIRHPNVVQFLGAVTQS+PMMIVT
Sbjct: 181 LASWRGIQVAVKKLGEDVISDEDKVRAFSDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 240
Query: 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286
EYL KGDLRA+LK+KGAL+P AV+F LDIARG+NYLHEN+P IIHRDLEPSNILRDDS
Sbjct: 241 EYLHKGDLRAFLKKKGALRPGTAVRFGLDIARGLNYLHENKP-PIIHRDLEPSNILRDDS 299
Query: 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQ 346
GHLKVADFG+SKLL TVKED+P+TC++TS RY APEV+K+EEYDTKVDVFSFALILQ
Sbjct: 300 GHLKVADFGVSKLL----TVKEDKPLTCQDTSCRYVAPEVFKHEEYDTKVDVFSFALILQ 355
Query: 347 EMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQ 406
EMIEGCPPF KQ+ EVPK+Y A ERPPFRAPT HY +GL++LI++CW+E P +RPTFRQ
Sbjct: 356 EMIEGCPPFSAKQDLEVPKSYAAKERPPFRAPTKHYPHGLKDLIQECWNENPAKRPTFRQ 415
Query: 407 ILMRLDDISDQLSIKRHWKVGPLRCFQSLAALWKK 441
I+ +L+ I + + KR WKV PL+CFQ+ A+ KK
Sbjct: 416 IITKLESIYNSIGHKRRWKVRPLKCFQNFEAMLKK 450
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555470|ref|XP_003546054.1| PREDICTED: probable serine/threonine-protein kinase drkB-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 671 bits (1730), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 320/443 (72%), Positives = 376/443 (84%), Gaps = 4/443 (0%)
Query: 1 MESKSSARFTLGKQSSLAPDQPLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSG 60
MESK+ ARFTLGKQSSLAP++ + EA+D VRLMY A EGD+DGI+E L+SG
Sbjct: 1 MESKNPARFTLGKQSSLAPERHNKEAELQKDGEAVDQGVRLMYSAFEGDVDGIREALESG 60
Query: 61 TDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIK 120
VN++DID RTALHVAAC+G TDVV LLL +GA+VDP+DRWGSTPLADA++YK +DVIK
Sbjct: 61 VSVNYKDIDNRTALHVAACEGFTDVVDLLLQKGAEVDPKDRWGSTPLADAIFYKKNDVIK 120
Query: 121 LLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTFRIASWRGTQVAVKTL 180
LLE+HGAKP APMHV +AREVPEYEI+PKELDF+NSVEITKGTF A WRGT+VAVK L
Sbjct: 121 LLEKHGAKPLMAPMHVNHAREVPEYEINPKELDFTNSVEITKGTFCSALWRGTKVAVKKL 180
Query: 181 GEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ 240
GE+V +DE+KVKAF DELAL QKIRHPNVVQFLGAVTQS+PMMIVTEYLPKGDLR ++K+
Sbjct: 181 GEDVISDEEKVKAFRDELALFQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRDFMKR 240
Query: 241 KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300
KGALKP+ AV+FALDIARG+ YLHEN+P IIHRDLEPSNILRDDSGHLKVADFG+SKLL
Sbjct: 241 KGALKPSTAVRFALDIARGVGYLHENKPSPIIHRDLEPSNILRDDSGHLKVADFGVSKLL 300
Query: 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE 360
VKED+P+TC++TS RY APEV++ EEYDTKVDVFSFALILQEMIEGCPPF KQ+
Sbjct: 301 ----AVKEDKPLTCQDTSCRYVAPEVFRQEEYDTKVDVFSFALILQEMIEGCPPFSAKQD 356
Query: 361 KEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSI 420
EVPK Y A ERPPF+AP Y++G+RELIE+CW+E P +RPTFRQI+ +L+ I + +
Sbjct: 357 DEVPKVYAAKERPPFQAPAKRYSHGIRELIEECWNENPAKRPTFRQIITKLESIYNTIGH 416
Query: 421 KRHWKVGPLRCFQSLAALWKKGH 443
KRHWKV PL+CFQ+L AL K+ H
Sbjct: 417 KRHWKVRPLKCFQNLEALLKRDH 439
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357494353|ref|XP_003617465.1| Protein kinase family protein [Medicago truncatula] gi|355518800|gb|AET00424.1| Protein kinase family protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 667 bits (1721), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/476 (69%), Positives = 379/476 (79%), Gaps = 25/476 (5%)
Query: 1 MESKS-SARFTLGKQSSLAPDQPLPADDDA------------DGSEAIDPRVRLMYMANE 47
ME+K +RF+LG+QSSLAPD A ++ ++ +DP VRLMY+ANE
Sbjct: 1 METKKLHSRFSLGRQSSLAPDHDGSATVNSLVTDSVTVTDSVTVTDLVDPTVRLMYLANE 60
Query: 48 GDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGST-- 105
GDL+GI ELLD G+DVNFRD D R+ALHVAACQGRTDVV LLL RGA+VD +DRW ST
Sbjct: 61 GDLEGITELLDDGSDVNFRDTDGRSALHVAACQGRTDVVELLLQRGAEVDVQDRWCSTVM 120
Query: 106 ----------PLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFS 155
PLADA+YYK+HDV+KLLE+HGAK APMHVQN+REVPEYEID ELDF+
Sbjct: 121 QCNAIFFVCFPLADALYYKNHDVVKLLEQHGAKLKVAPMHVQNSREVPEYEIDSSELDFT 180
Query: 156 NSVEITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGA 215
NSV ITKGTFR A WRG QVAVKTL E+VFTD+DKV AF DEL LLQK+RHPNVVQFLGA
Sbjct: 181 NSVCITKGTFRSAIWRGIQVAVKTLEEDVFTDDDKVWAFHDELTLLQKVRHPNVVQFLGA 240
Query: 216 VTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRD 275
VTQSTPMMIVTEYLP+GDL AYLK+KGALKP +AVKFALDIARGMNYLHE++PEAIIHRD
Sbjct: 241 VTQSTPMMIVTEYLPQGDLCAYLKRKGALKPIIAVKFALDIARGMNYLHEHKPEAIIHRD 300
Query: 276 LEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTK 335
LEPSNILRDDSGHLKVADFG+SK LK TVKED+PVTC++TSWRY APEVY+NEEYDTK
Sbjct: 301 LEPSNILRDDSGHLKVADFGVSKSLKITKTVKEDKPVTCQDTSWRYVAPEVYRNEEYDTK 360
Query: 336 VDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWS 395
VD FSFALILQEMIEGCPPF K E EVPKAY+ NERPPFRA Y YGL++LIE+CW
Sbjct: 361 VDAFSFALILQEMIEGCPPFYRKPESEVPKAYVENERPPFRALPKLYPYGLKDLIEECWD 420
Query: 396 EEPFRRPTFRQILMRLDDISDQLSIKRHWKVGPLRCFQSLAALWKKGHADPSSRSS 451
EP+RRPTFRQI+ RLD IS+ L+ KR WK C ++L L+K P SRS+
Sbjct: 421 GEPYRRPTFRQIIERLDKISNHLAQKRCWKALTPPCIRNLETLFKGYPTSPGSRSA 476
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549162|ref|XP_003542966.1| PREDICTED: probable serine/threonine-protein kinase drkA-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 667 bits (1721), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/443 (72%), Positives = 374/443 (84%), Gaps = 5/443 (1%)
Query: 1 MESKSSARFTLGKQSSLAPDQPLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSG 60
MESK+ ARFTLGKQSSLAP++ + + E +D VRLMY A EGD+DGI E L+ G
Sbjct: 1 MESKNPARFTLGKQSSLAPERHNKEAELQNDGEVVDQGVRLMYSAFEGDVDGICEALEFG 60
Query: 61 TDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIK 120
VN++DID RTALHVA C+G TDVV LLL +GA+VDP+DRWGSTPLADA++YK +DVIK
Sbjct: 61 VSVNYKDIDNRTALHVAVCEGFTDVVDLLLQKGAEVDPKDRWGSTPLADAIFYKKNDVIK 120
Query: 121 LLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTFRIASWRGTQVAVKTL 180
LLE+HGAK APMHV +AREVPEYEI+PKELDF+NSVEITKGTF IA WRGT+VAVK L
Sbjct: 121 LLEKHGAKLLMAPMHVNHAREVPEYEINPKELDFTNSVEITKGTFCIALWRGTEVAVKKL 180
Query: 181 GEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ 240
GE+V +DE+KVKAF DELAL QKIRHPNVVQFLGAVTQS+PMMIVTEYLPKGDLR +LK+
Sbjct: 181 GEDVISDEEKVKAFRDELALFQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRDFLKR 240
Query: 241 KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300
KGALKP+ AV+FALDIARG+ YLHEN+P IIHRDLEPSNILRDDSGHLKVADFG+SKLL
Sbjct: 241 KGALKPSTAVRFALDIARGVGYLHENKPSPIIHRDLEPSNILRDDSGHLKVADFGVSKLL 300
Query: 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE 360
VKED+P+TC +TS RY APEV++ +EYDTKVDVFSFALILQEMIEGCPPF KQ+
Sbjct: 301 ----AVKEDKPLTCHDTSCRYVAPEVFR-QEYDTKVDVFSFALILQEMIEGCPPFSAKQD 355
Query: 361 KEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSI 420
EVPK Y A ERPPFRAP HY+YG+RELIE+CW+E P +RPTFRQI+ RL+ I + +S
Sbjct: 356 NEVPKVYAAKERPPFRAPAKHYSYGIRELIEECWNENPAKRPTFRQIITRLESIYNTISH 415
Query: 421 KRHWKVGPLRCFQSLAALWKKGH 443
KRHWKV PL+CFQ+L AL K+ H
Sbjct: 416 KRHWKVRPLKCFQNLEALLKRDH 438
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076914|ref|XP_002305047.1| predicted protein [Populus trichocarpa] gi|222848011|gb|EEE85558.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 659 bits (1701), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 318/429 (74%), Positives = 365/429 (85%), Gaps = 8/429 (1%)
Query: 8 RFTLGKQSSLAPDQPLPADD-DADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFR 66
RFTLGKQSSLAP++ D D DG +DP VRLMY+ANEG+L+GIKEL++S DVNFR
Sbjct: 1 RFTLGKQSSLAPERDREESDVDMDG---VDPGVRLMYLANEGNLEGIKELVNSDVDVNFR 57
Query: 67 DIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHG 126
DID RTALH+A+CQG T VV LLL GA++DP+DRWGSTPLADA++YK+HDVIKLLE+ G
Sbjct: 58 DIDGRTALHIASCQGLTQVVDLLLDHGAEIDPKDRWGSTPLADAIFYKNHDVIKLLEKRG 117
Query: 127 AKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTFRIASWRGTQVAVKTLGEEVFT 186
AKP APMHV++AREVPEYEI+P ELDF+NSVE+TKGTF +A WRG QVAVK LGEEV +
Sbjct: 118 AKPLMAPMHVKHAREVPEYEINPDELDFTNSVELTKGTFCVALWRGIQVAVKKLGEEVLS 177
Query: 187 DEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKP 246
DEDKV+AF DELALLQKIRHPNVVQFLGAVTQS+PMMIVTE+LPKGD A+LK+KGALKP
Sbjct: 178 DEDKVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEFLPKGDFCAFLKRKGALKP 237
Query: 247 TLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306
AV+ ALDIARGMNYLHEN+P IIHRDLEPSNILRDDSGHLKVADFG+SKLL TV
Sbjct: 238 IAAVRLALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGHLKVADFGISKLL----TV 293
Query: 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKA 366
KE++P+ + SWRY APEV+KNEEYDTKVD+FSFALILQEMIEGCPPF KQE EVP A
Sbjct: 294 KEEKPLISLDNSWRYVAPEVFKNEEYDTKVDIFSFALILQEMIEGCPPFSAKQEHEVPSA 353
Query: 367 YIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKV 426
Y A ERPPFRAPT YA+GL+ELI++CW E P +RPTFRQIL RLD I + + KR WKV
Sbjct: 354 YAAKERPPFRAPTKSYAHGLKELIQECWHENPAKRPTFRQILTRLDAIQNSIGHKRRWKV 413
Query: 427 GPLRCFQSL 435
PL+CFQ+L
Sbjct: 414 RPLKCFQNL 422
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297817188|ref|XP_002876477.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297322315|gb|EFH52736.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 654 bits (1688), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 329/472 (69%), Positives = 379/472 (80%), Gaps = 16/472 (3%)
Query: 1 MESKSSARFTLGKQSSLAPD-----QPLPADDDADGSEA----IDPRVRLMYMANEGDLD 51
++ KS ARF LG+QSSLAP+ + L D+D + + A +DP +RLMY+ANEGD+D
Sbjct: 3 IKPKSPARFKLGRQSSLAPESRPPIETLTEDEDDELAAATAGIVDPTIRLMYLANEGDID 62
Query: 52 GIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAV 111
GI ++LDSGT+V++RDID RTALHVAACQGRTDVV LLLSRGA VD +DRWGSTPLADAV
Sbjct: 63 GINKMLDSGTNVDYRDIDGRTALHVAACQGRTDVVELLLSRGAKVDTKDRWGSTPLADAV 122
Query: 112 YYKHHDVIKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTFRIASWR 171
YYK+HDVIKLLE+HGAKP+ APMHV +EVPEYEI P ELDFSNSV+I+KGTF ASWR
Sbjct: 123 YYKNHDVIKLLEKHGAKPTIAPMHVLTDKEVPEYEIHPSELDFSNSVKISKGTFHKASWR 182
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G VAVKT GEE+FTDEDKV AF DELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK
Sbjct: 183 GIDVAVKTFGEEMFTDEDKVNAFRDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 242
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIAR------GMNYLHENRPEAIIHRDLEPSNILRDD 285
GDLR YL +KG L P AVKFAL+IAR GMNYLHE++PEAIIH DLEP NILRDD
Sbjct: 243 GDLRQYLDRKGPLMPAHAVKFALEIARLSGYFLGMNYLHEHKPEAIIHCDLEPPNILRDD 302
Query: 286 SGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALIL 345
SGHLKVADFG+SKLL TVK+DRP T ++SWRY APEVY+NEEYDTKVDVFSFALIL
Sbjct: 303 SGHLKVADFGVSKLLVVKKTVKKDRPATSLDSSWRYMAPEVYRNEEYDTKVDVFSFALIL 362
Query: 346 QEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFR 405
QEMIEGC PF +E EVPKAYI +ERPPF APT Y +GLRELI+DCW +E +RPTFR
Sbjct: 363 QEMIEGCEPFHEIEESEVPKAYIEDERPPFNAPTKSYPFGLRELIQDCWDKEASKRPTFR 422
Query: 406 QILMRLDDISDQLSIKRHWKVGPLRCFQSLAALWKKGHADP-SSRSSRSTNR 456
+I+ L+ ISD+ + KR WKV RC + K+ + +P S+RSSRS R
Sbjct: 423 EIISTLELISDRFASKRSWKVMLGRCIPRIRLFTKRDYVNPGSNRSSRSFAR 474
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 456 | ||||||
| TAIR|locus:2098999 | 471 | AT3G58760 [Arabidopsis thalian | 1.0 | 0.968 | 0.688 | 9.7e-167 | |
| TAIR|locus:2117129 | 459 | AT4G18950 [Arabidopsis thalian | 0.982 | 0.976 | 0.620 | 2.1e-148 | |
| TAIR|locus:2045258 | 476 | AT2G31800 [Arabidopsis thalian | 0.925 | 0.886 | 0.476 | 4.2e-102 | |
| TAIR|locus:2044034 | 479 | AT2G43850 [Arabidopsis thalian | 0.925 | 0.881 | 0.473 | 4.4e-100 | |
| TAIR|locus:2080517 | 477 | AT3G59830 [Arabidopsis thalian | 0.923 | 0.882 | 0.462 | 6.6e-97 | |
| TAIR|locus:2014849 | 438 | VIK "VH1-interacting kinase" [ | 0.918 | 0.956 | 0.454 | 1.4e-85 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.682 | 0.569 | 0.324 | 3.3e-40 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.622 | 0.498 | 0.350 | 3.3e-40 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.572 | 0.453 | 0.368 | 6.8e-40 | |
| WB|WBGene00016030 | 850 | C24A1.3 [Caenorhabditis elegan | 0.596 | 0.32 | 0.320 | 1.4e-38 |
| TAIR|locus:2098999 AT3G58760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1622 (576.0 bits), Expect = 9.7e-167, P = 9.7e-167
Identities = 323/469 (68%), Positives = 370/469 (78%)
Query: 1 MESKSSARFTLGKQSSXXXXXXXXXXX---------XXXGSEAI-DPRVRLMYMANEGDL 50
++ KS ARF LG+QSS + I DP +RLMY+ANEGD+
Sbjct: 3 IKPKSPARFKLGRQSSLAPESRTPIDTLTEDEDDDLAAAATAGIGDPTIRLMYLANEGDI 62
Query: 51 DGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110
DGI ++LDSGT+V++RDID RTALHVAACQGRTDVV LLLSRGA VD +DRWGSTPLADA
Sbjct: 63 DGINKMLDSGTNVDYRDIDARTALHVAACQGRTDVVELLLSRGAKVDTKDRWGSTPLADA 122
Query: 111 VYYKHHDVIKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTFRIASW 170
VYYK+HDVIKLLE+HGAKP+ APMHV +EVPEYEI P ELDFSNSV+I+KGTF ASW
Sbjct: 123 VYYKNHDVIKLLEKHGAKPTIAPMHVLTDKEVPEYEIHPTELDFSNSVKISKGTFNKASW 182
Query: 171 RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230
RG VAVKT GEE+FTDEDKV AF DELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP
Sbjct: 183 RGIDVAVKTFGEEMFTDEDKVNAFRDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 242
Query: 231 KGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290
KGDLR YL +KG L P AVKFAL+IARGMNYLHE++PEAIIH DLEP NILRDDSGHLK
Sbjct: 243 KGDLRQYLDRKGPLMPAHAVKFALEIARGMNYLHEHKPEAIIHCDLEPPNILRDDSGHLK 302
Query: 291 VADFGLSKLLKFANTVKEDRPV-TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI 349
VADFG+SKLL TVK+DRPV TC ++SWRY APEVY+NEEYDTKVDVFSFALILQEMI
Sbjct: 303 VADFGVSKLLVVKKTVKKDRPVVTCLDSSWRYMAPEVYRNEEYDTKVDVFSFALILQEMI 362
Query: 350 EGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILM 409
EGC PF +++EVPKAYI +ERPPF APT Y +GL+ELI+DCW +E +RPTFR I+
Sbjct: 363 EGCEPFHEIEDREVPKAYIEDERPPFNAPTKSYPFGLQELIQDCWDKEASKRPTFRVIIS 422
Query: 410 RLDDISDQLSIKRHWKVGPLRCFQSLAALWKKGHADP--SSRSSRSTNR 456
L+ ISD+++ KR WKV RC K+ + +P S+RSS S NR
Sbjct: 423 TLELISDRIARKRSWKVMLGRCLPRFRLFTKRDYVNPGGSNRSSGSFNR 471
|
|
| TAIR|locus:2117129 AT4G18950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1449 (515.1 bits), Expect = 2.1e-148, P = 2.1e-148
Identities = 284/458 (62%), Positives = 345/458 (75%)
Query: 2 ESKSSARFTLGKQSSXXXX-----XXXXXXXXXXGSEAIDPRVRLMYMANEGDLDGIKEL 56
E RFT+G+QSS E ID VRLMY+ANEGD++GIKEL
Sbjct: 3 EDYQQPRFTIGRQSSMAPEKIPEPSVHSEEEVFEDGEEIDGGVRLMYLANEGDIEGIKEL 62
Query: 57 LDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHH 116
+DSG D N+RDID RTALHVAACQG DVV LLL R A+VDP+DRWGSTP ADA++YK+
Sbjct: 63 IDSGIDANYRDIDDRTALHVAACQGLKDVVELLLDRKAEVDPKDRWGSTPFADAIFYKNI 122
Query: 117 DVIKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTFRIASWRGTQVA 176
DVIK+LE HGAK APMHV+ AREVPEYEI+P ELDF+ S EITKGT+ +A WRG QVA
Sbjct: 123 DVIKILEIHGAKHPMAPMHVKTAREVPEYEINPSELDFTQSKEITKGTYCMAMWRGIQVA 182
Query: 177 VKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRA 236
VK L +EV +D+D+V+ F DELALLQ++RHPN+VQFLGAVTQS PMMIVTEYLP+GDLR
Sbjct: 183 VKKLDDEVLSDDDQVRKFHDELALLQRLRHPNIVQFLGAVTQSNPMMIVTEYLPRGDLRE 242
Query: 237 YLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGL 296
LK+KG LKP AV++ALDIARGM+YLHE + + IIHRDLEPSNILRDDSGHLKVADFG+
Sbjct: 243 LLKRKGQLKPATAVRYALDIARGMSYLHEIKGDPIIHRDLEPSNILRDDSGHLKVADFGV 302
Query: 297 SKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFP 356
SKL+ TVKED+P TC++ S RY APEV+ +EEYDTK DVFSFALI+QEMIEG PF
Sbjct: 303 SKLV----TVKEDKPFTCQDISCRYIAPEVFTSEEYDTKADVFSFALIVQEMIEGRMPFA 358
Query: 357 TKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416
K++ E +AY RP F+AP+ +Y +GL+ LIE+CW E+P +RPTFR+I+ RL+ I
Sbjct: 359 EKEDSEASEAYAGKHRPLFKAPSKNYPHGLKTLIEECWHEKPAKRPTFREIIKRLESILH 418
Query: 417 QLSIKRHWKVGPLRCFQSLAALWKKGHADPSSRSSRST 454
+ KR W++ PL CFQ+ KK + D SS S+
Sbjct: 419 HMGHKRQWRMRPLTCFQNFEHK-KKHNWDLSSHDGSSS 455
|
|
| TAIR|locus:2045258 AT2G31800 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1012 (361.3 bits), Expect = 4.2e-102, P = 4.2e-102
Identities = 205/430 (47%), Positives = 279/430 (64%)
Query: 4 KSSARFTLGKQSSXXXXXXXXXXXXX---XGSEAIDPRVRLMYMANEGDLDGIKELLDSG 60
+++ RF+ G+QSS + +D ++L+++A GD++G+++LLD G
Sbjct: 39 RNNMRFSFGRQSSLDPIRRSPDGSNGPQLAVPDNLDATMQLLFVACRGDVEGVQDLLDEG 98
Query: 61 TDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIK 120
DVN D+D RTALH+AAC+G DVV+LLL+R A++D DRWGST ADA YY + DV
Sbjct: 99 IDVNSIDLDGRTALHIAACEGHVDVVKLLLTRKANIDARDRWGSTAAADAKYYGNMDVFN 158
Query: 121 LLEEHGAK-PST--APMHVQNAREVPEYEIDPKELDFSNSVEITKGTFRIASWRGTQVAV 177
+L+ GAK P T PM V N REVPEYE++P+EL + I+KG +++A W GT+V+V
Sbjct: 159 ILKARGAKVPKTKRTPMVVANPREVPEYELNPQELQVRKADGISKGIYQVAKWNGTKVSV 218
Query: 178 KTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAY 237
K L ++++ D D + AF EL L +K+RHPNVVQF+GAVTQ+ PMMIV+EY PKGDL +Y
Sbjct: 219 KILDKDLYKDSDTINAFKHELTLFEKVRHPNVVQFVGAVTQNVPMMIVSEYHPKGDLGSY 278
Query: 238 LKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLS 297
L++KG L P ++FALDIARGMNYLHE +PE +IH DL+P NI+ D GHLKVA FGL
Sbjct: 279 LQKKGRLSPAKVLRFALDIARGMNYLHECKPEPVIHCDLKPKNIMLDSGGHLKVAGFGLI 338
Query: 298 KLLKFANTVKEDRPVTCEETSWRYA-APEVYKNEEYDTKVDVFSFALILQEMIEGCPPFP 356
K ++ + Y APEVYK+E +D VD +SF ++L EMIEG PF
Sbjct: 339 SFAKLSSDKSKILNHGAHIDPSNYCMAPEVYKDEIFDRSVDSYSFGVVLYEMIEGVQPFH 398
Query: 357 TKQEKEVPKAY-IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415
K +E K + RP F+A + +RELIE+CW E F RPTF +I++RLD I
Sbjct: 399 PKPPEEAVKLMCLEGRRPSFKAKSKSCPQEMRELIEECWDTETFVRPTFSEIIVRLDKIF 458
Query: 416 DQLSIKRHWK 425
S + WK
Sbjct: 459 VHCSKQGWWK 468
|
|
| TAIR|locus:2044034 AT2G43850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 993 (354.6 bits), Expect = 4.4e-100, P = 4.4e-100
Identities = 205/433 (47%), Positives = 281/433 (64%)
Query: 4 KSSARFTLGKQSSXXXXXXXXXXXXXXGS------EAIDPRVRLMYMANEGDLDGIKELL 57
+++ RF+ G+QSS E +D ++L++MA++GD+ GI+ELL
Sbjct: 39 RTNMRFSFGRQSSLDPIRRSPDSSKSDDEPHMSVPENLDSTMQLLFMASKGDVRGIEELL 98
Query: 58 DSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHD 117
D G DVN D+D RTALH+AAC+G VV+ LLSR A++D DRWGST ADA YY + D
Sbjct: 99 DEGIDVNSIDLDGRTALHIAACEGHLGVVKALLSRRANIDARDRWGSTAAADAKYYGNLD 158
Query: 118 VIKLLEEHGAK-PST--APMHVQNAREVPEYEIDPKELDFSNSVEITKGTFRIASWRGTQ 174
V LL+ GAK P T PM V N REVPEYE++P E+ S I+KG +++A W GT+
Sbjct: 159 VYNLLKARGAKVPKTRKTPMTVSNPREVPEYELNPLEVQVRKSDGISKGAYQVAKWNGTR 218
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
V+VK L ++ ++D +++ AF EL LL+K+RHPNV+QF+GAVTQ+ PMMIV EY PKGDL
Sbjct: 219 VSVKILDKDSYSDPERINAFRHELTLLEKVRHPNVIQFVGAVTQNIPMMIVVEYNPKGDL 278
Query: 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294
YL++KG L P+ A++FALDIARGMNYLHE +P+ IIH DL+P NIL D G LK++ F
Sbjct: 279 SVYLQKKGRLSPSKALRFALDIARGMNYLHECKPDPIIHCDLKPKNILLDRGGQLKISGF 338
Query: 295 GLSKLLKFA-NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCP 353
G+ +L K + + K + S Y APEVYK+E +D +VD SF +IL E+ EG P
Sbjct: 339 GMIRLSKISQDKAKVANHKAHIDLSNYYIAPEVYKDEIFDLRVDAHSFGVILYEITEGVP 398
Query: 354 PFPTKQEKEVPKAY-IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412
F + +EV + + +RP F+ + Y ++ELIE CW E RPTF +I++RLD
Sbjct: 399 VFHPRPPEEVARMMCLEGKRPVFKTKSRSYPPDIKELIEKCWHPEAGIRPTFSEIIIRLD 458
Query: 413 DISDQLSIKRHWK 425
I S + WK
Sbjct: 459 KIVANCSKQGWWK 471
|
|
| TAIR|locus:2080517 AT3G59830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 963 (344.1 bits), Expect = 6.6e-97, P = 6.6e-97
Identities = 200/432 (46%), Positives = 282/432 (65%)
Query: 4 KSSARFTLGKQSSXXXXXXXXXXXX----XXGSEAIDPRVRLMYMANEGDLDGIKELLDS 59
+++ RF+ G+QSS E +D ++L++MA++GD++G++ELL+
Sbjct: 39 RNNMRFSFGRQSSLDPIRRSPESLSCEPHMSVPENLDSTMQLLFMASKGDVNGVEELLNE 98
Query: 60 GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVI 119
G DVN D+D RTALH+A+C+G DVV++LLSR A++D DRWGST DA YY + +V
Sbjct: 99 GIDVNSIDLDGRTALHIASCEGHYDVVKVLLSRRANIDARDRWGSTAAVDAKYYGNVEVY 158
Query: 120 KLLEEHGAK-PST--APMHVQNAREVPEYEIDPKELDFSNSVEITKGTFRIASWRGTQVA 176
LL+ GAK P T PM V N +EVPEYE++P EL I+KGT+++A W GT+V+
Sbjct: 159 NLLKARGAKAPKTRKTPMTVGNPKEVPEYELNPLELQVRKVDGISKGTYQVAKWNGTRVS 218
Query: 177 VKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRA 236
VK ++ ++D ++V AF +EL LL K RHPN+VQF+GAVTQ+ PMMIV E PKGDL
Sbjct: 219 VKIFDKDSYSDPERVNAFTNELTLLAKARHPNIVQFVGAVTQNLPMMIVVECNPKGDLSV 278
Query: 237 YLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGL 296
YL++KG L P+ A++FALDIARGMNYLHE +P+ IIH +L P NIL D G LK++ FGL
Sbjct: 279 YLQKKGRLSPSKALRFALDIARGMNYLHECKPDPIIHCELMPKNILLDRGGQLKISGFGL 338
Query: 297 SKLLKFA-NTVKE-DRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPP 354
KL K ++ K + +++++ Y APE+YK+E +D + DV SF +IL E+ EG
Sbjct: 339 IKLSKIGEDSAKVVNHEAQIDKSNY-YIAPEIYKDEVFDKRADVHSFGVILYELTEGVSL 397
Query: 355 FPTKQEKEVPKAY-IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDD 413
F K +EV ++ I +RP R + Y L+ELIE+CW E RP F +I++RLD
Sbjct: 398 FHPKPPEEVAESICIEGKRPTIRTKSKSYPPELKELIEECWHPEISVRPIFSEIIIRLDK 457
Query: 414 ISDQLSIKRHWK 425
I S + WK
Sbjct: 458 IVTNCSKQGWWK 469
|
|
| TAIR|locus:2014849 VIK "VH1-interacting kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 1.4e-85, P = 1.4e-85
Identities = 199/438 (45%), Positives = 260/438 (59%)
Query: 1 MESKSSARFTLGKQSSXXXXXXXXXXXXXXGSEAIDPRVRLMYMANEGDLDGIKELLDSG 60
M S S A G+Q++ + +++ A++ D +++LL+
Sbjct: 1 MSSDSPAAGDGGEQAAAGTSVPSPSYDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 60
Query: 61 -TDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVI 119
T V+ RD DKRT LHVA+ G DVV+ LL GADV+ +DRW +TPLADA + +I
Sbjct: 61 PTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQDRWKNTPLADAEGARKQKMI 120
Query: 120 KLLEEHGAKP-STAPMHVQNAREVP-------EYEIDPKELDFSNSVEITKGTF-RI--A 168
+LL+ HG H + + VP ++EI+P ELDFSN+ I KG+F I A
Sbjct: 121 ELLKSHGGLSYGQNGSHFE-PKPVPPPIPKKCDWEIEPAELDFSNAAMIGKGSFGEIVKA 179
Query: 169 SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228
WRGT VAVK + + D ++ F E+ LL K+RHPN+VQFLGAVT+ P+M++TEY
Sbjct: 180 YWRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITEY 239
Query: 229 LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG- 287
L GDL YLK+KG L PT AV FALDIARGM YLH N P IIHRDL+P N+L +S
Sbjct: 240 LRGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLH-NEPNVIIHRDLKPRNVLLVNSSA 298
Query: 288 -HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQ 346
HLKV DFGLSKL+K N+ + +T E S+RY APEV+K+ YD KVDVFSFA+IL
Sbjct: 299 DHLKVGDFGLSKLIKVQNS-HDVYKMTGETGSYRYMAPEVFKHRRYDKKVDVFSFAMILY 357
Query: 347 EMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQ 406
EM+EG PPF + E K RP FR+ LRELI CW + +RP+F
Sbjct: 358 EMLEGEPPFANHEPYEAAKHVSDGHRPTFRSKGC--TPDLRELIVKCWDADMNQRPSFLD 415
Query: 407 ILMRLDDISDQLSIKRHW 424
IL RL+ I + L HW
Sbjct: 416 ILKRLEKIKETLPSDHHW 433
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 428 (155.7 bits), Expect = 3.3e-40, P = 3.3e-40
Identities = 112/345 (32%), Positives = 189/345 (54%)
Query: 95 DVDPEDRWGSTP---LADAVYYKHHDVIKLLEEHGAKPSTAPM--HVQNARE-VP----- 143
DV D W L DA+ +++KL ++ G+K + H +++ E +P
Sbjct: 215 DVFVVDGWSQEETDGLRDAL---SKEILKLKDQPGSKQKSISFFEHDKSSNELIPACIEI 271
Query: 144 ------EYEIDPKELDFSNSVEI-TKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFID 196
E+EID +L V + G ++ +VA+K L + +E ++ F
Sbjct: 272 PTDGTDEWEIDVTQLKIEKKVASGSYGDLHRGTYCSQEVAIKFLKPDRVNNE-MLREFSQ 330
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL-KQKGALKPTLAVKFALD 255
E+ +++K+RH NVVQFLGA T+S + IVTE++ +G + +L KQK A K +K ALD
Sbjct: 331 EVFIMRKVRHKNVVQFLGACTRSPTLCIVTEFMARGSIYDFLHKQKCAFKLQTLLKVALD 390
Query: 256 IARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCE 315
+A+GM+YLH+N IIHRDL+ +N+L D+ G +KVADFG++++ E +T E
Sbjct: 391 VAKGMSYLHQNN---IIHRDLKTANLLMDEHGLVKVADFGVARVQI------ESGVMTAE 441
Query: 316 ETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPF 375
++R+ APEV +++ Y+ K DVFS+A++L E++ G P+ + + P
Sbjct: 442 TGTYRWMAPEVIEHKPYNHKADVFSYAIVLWELLTGDIPYAFLTPLQAAVGVVQKGLRPK 501
Query: 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSI 420
TH ++ L+E CW ++P +RP F +I+ L I ++++
Sbjct: 502 IPKKTHPK--VKGLLERCWHQDPEQRPLFEEIIEMLQQIMKEVNV 544
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 428 (155.7 bits), Expect = 3.3e-40, P = 3.3e-40
Identities = 106/302 (35%), Positives = 167/302 (55%)
Query: 144 EYEIDPKELDFSNSVEI-TKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
E+EID K+L V + G ++ +VA+K L E E ++ F E+ +++
Sbjct: 284 EWEIDMKQLKIEKKVACGSYGELFRGTYCSQEVAIKILKPERVNAE-MLREFSQEVYIMR 342
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL-KQKGALKPTLAVKFALDIARGMN 261
K+RH NVVQF+GA T+S + IVTE++ +G + +L K KG K +K ALD+++GMN
Sbjct: 343 KVRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKGMN 402
Query: 262 YLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRY 321
YLH+N IIHRDL+ +N+L D+ +KVADFG++++ T E +T E ++R+
Sbjct: 403 YLHQNN---IIHRDLKTANLLMDEHEVVKVADFGVARV----QT--ESGVMTAETGTYRW 453
Query: 322 AAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381
APEV +++ YD + DVFS+A++L E++ G P+ + + P TH
Sbjct: 454 MAPEVIEHKPYDHRADVFSYAIVLWELLTGELPYSYLTPLQAAVGVVQKGLRPKIPKETH 513
Query: 382 YAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVGPLRCFQSLAALWKK 441
L EL+E CW ++P RP F +I+ L+ + ++ K F L KK
Sbjct: 514 PK--LTELLEKCWQQDPALRPNFAEIIEMLNQLIREVGDDERHKDKHGGYFSGL----KK 567
Query: 442 GH 443
GH
Sbjct: 568 GH 569
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 425 (154.7 bits), Expect = 6.8e-40, P = 6.8e-40
Identities = 102/277 (36%), Positives = 161/277 (58%)
Query: 145 YEIDPKELDFSNSVEI-TKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQK 203
+EI+ K L F + + + G ++ +VA+K L E D D K F E+ +++K
Sbjct: 283 WEINLKHLKFGHKIASGSYGDLYKGTYCSQEVAIKVLKPERL-DSDLEKEFAQEVFIMRK 341
Query: 204 IRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL-KQKGALK-PTLAVKFALDIARGMN 261
+RH NVVQF+GA T+ + IVTE++P G + YL KQKG K PTL K A+DI +GM+
Sbjct: 342 VRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYLHKQKGVFKLPTL-FKVAIDICKGMS 400
Query: 262 YLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRY 321
YLH+N IIHRDL+ +N+L D++ +KVADFG++++ K V +T E ++R+
Sbjct: 401 YLHQNN---IIHRDLKAANLLMDENEVVKVADFGVARV-KAQTGV-----MTAETGTYRW 451
Query: 322 AAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381
APEV +++ YD K DVFS+ ++L E++ G P+ + + P TH
Sbjct: 452 MAPEVIEHKPYDHKADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQKGLRPTIPKNTH 511
Query: 382 YAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418
L EL+E W + +RP F +I+ +L +I+ ++
Sbjct: 512 PK--LAELLERLWEHDSTQRPDFSEIIEQLQEIAKEV 546
|
|
| WB|WBGene00016030 C24A1.3 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
Score = 340 (124.7 bits), Expect = 1.4e-38, Sum P(2) = 1.4e-38
Identities = 93/290 (32%), Positives = 148/290 (51%)
Query: 134 MHVQNAREVPEYEIDPKELDFSNSVEITKGTF-RI--ASWRGTQVAVKTLGEEVFTDEDK 190
+ +++A P + + E++F S I G+F ++ ++RG VAVK F + +
Sbjct: 499 LQLRSALPAP-FHLCLAEIEFQES--IGSGSFGKVYKGTYRGKLVAVKRYRAMAFGCKSE 555
Query: 191 VKAFIDELALLQKIRHPNVVQFLG-AVTQSTPMMIVTEYLPKGDL--RAYLKQKG--ALK 245
E+++L ++ HPNVV F+G ++ + I+TE++ G L R ++K +
Sbjct: 556 TDMLCREVSILSRLAHPNVVAFVGTSLDDPSQFAIITEFVENGSLFRRENGERKNYRVMD 615
Query: 246 PTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305
P ++ +LD+ARGM YLHE+ + +IHRDL NIL G VADFG S+ +
Sbjct: 616 PAFRLRISLDVARGMRYLHESAAKPVIHRDLNSHNILIHADGRSVVADFGESRFV----C 671
Query: 306 VKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFP-TKQEKEV 363
+ED +T + + R+ APEV+ +YD KVDVFSFAL++ E+ PF K
Sbjct: 672 QREDENLTKQPGNLRWMAPEVFSQSGKYDRKVDVFSFALVIWEIHTAELPFSHLKPAAAA 731
Query: 364 PKAYIANERPPF-RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412
+ RP PT + + LI W E RP F +I+ L+
Sbjct: 732 AEMTYKRGRPTLPNQPTAQFPAHILSLIPQAWHPESSSRPDFVEIVALLE 781
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 456 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-65 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-63 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-62 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-62 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-62 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-61 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-52 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-46 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-44 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-43 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-41 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-40 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-39 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-38 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-37 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-37 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-37 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-36 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-36 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-35 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-35 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-35 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-35 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-34 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-34 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-34 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-33 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-33 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-33 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-33 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-33 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-32 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-32 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-32 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-32 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-31 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-31 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-30 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-30 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-30 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-30 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-29 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-29 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-28 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-28 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-28 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-28 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-28 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-28 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-28 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-28 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-28 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-28 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-27 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-27 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-27 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-27 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-27 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 1e-26 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-26 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-26 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-26 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-26 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-26 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-26 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-25 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-25 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-25 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 4e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-25 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-25 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-25 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-25 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-24 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-24 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-24 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-24 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-24 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-24 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-24 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-24 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-23 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-23 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-23 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-23 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-23 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-23 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-22 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-22 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 3e-22 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-22 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-22 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-22 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-22 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-22 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-21 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-21 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-21 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-21 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-21 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-21 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-21 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-20 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-20 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-20 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-20 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-20 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-20 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-19 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-19 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-19 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-19 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-19 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-19 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-19 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-19 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-18 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-18 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-18 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-18 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-18 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-17 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-17 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-17 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-17 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-17 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-17 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 7e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-17 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-16 | |
| PTZ00322 | 664 | PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fruct | 1e-16 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-16 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-16 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-16 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-16 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-15 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 2e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-15 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-15 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-14 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-14 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-14 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-13 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-13 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-13 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-13 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-12 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-12 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-12 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-12 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 1e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-11 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-11 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-11 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 4e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-11 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 5e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-10 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 2e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-10 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 2e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-10 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 7e-10 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 7e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-10 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 9e-10 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 1e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-09 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 4e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-09 | |
| PLN03192 | 823 | PLN03192, PLN03192, Voltage-dependent potassium ch | 6e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-09 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 9e-09 | |
| PLN03192 | 823 | PLN03192, PLN03192, Voltage-dependent potassium ch | 2e-08 | |
| pfam00023 | 33 | pfam00023, Ank, Ankyrin repeat | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-08 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 7e-08 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 8e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 5e-07 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 6e-07 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 7e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-07 | |
| pfam13857 | 56 | pfam13857, Ank_5, Ankyrin repeats (many copies) | 1e-06 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 2e-06 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 3e-06 | |
| smart00248 | 30 | smart00248, ANK, ankyrin repeats | 3e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-06 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 4e-06 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 7e-06 | |
| PLN03192 | 823 | PLN03192, PLN03192, Voltage-dependent potassium ch | 9e-06 | |
| pfam13606 | 30 | pfam13606, Ank_3, Ankyrin repeat | 9e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-05 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 5e-05 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 5e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-05 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 6e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 7e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 2e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-04 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 8e-04 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 8e-04 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 8e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 9e-04 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 0.001 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 0.001 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 0.002 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 0.003 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 0.003 | |
| TIGR00870 | 743 | TIGR00870, trp, transient-receptor-potential calci | 0.003 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.003 | |
| PHA02798 | 489 | PHA02798, PHA02798, ankyrin-like protein; Provisio | 0.004 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.004 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 6e-65
Identities = 88/268 (32%), Positives = 135/268 (50%), Gaps = 29/268 (10%)
Query: 159 EITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ 218
E+ KG + + T+VAVKTL E E++ K F+ E +++K+ HPNVV+ LG T+
Sbjct: 10 EVYKGKLKGKDGKTTEVAVKTLKE--DASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE 67
Query: 219 STPMMIVTEYLPKGDLRAYLKQ---------KGALKPTLAVKFALDIARGMNYLHENRPE 269
P+ +V EY+ GDL YL++ K L + FA+ IA+GM YL +
Sbjct: 68 EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK-- 125
Query: 270 AIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEET--SWRYAAPEVY 327
+HRDL N L + +K++DFGLS+ + +D R+ APE
Sbjct: 126 -FVHRDLAARNCLVGEDLVVKISDFGLSR-----DVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 328 KNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPF--RAPTTHYAY 384
K+ + +K DV+SF ++L E+ G P+P +EV + R P P
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDE---- 235
Query: 385 GLRELIEDCWSEEPFRRPTFRQILMRLD 412
L EL+ CW +P RPTF +++ RL+
Sbjct: 236 -LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 6e-63
Identities = 91/258 (35%), Positives = 135/258 (52%), Gaps = 18/258 (6%)
Query: 160 ITKGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLG 214
+ G+F A +GT VAVK L ++ K + E+ +L+++ HPN+V+ +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKIL-KKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 215 AVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHR 274
A + +V EY GDL YL + G L A K AL I RG+ YLH N IIHR
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG---IIHR 122
Query: 275 DLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYK-NEEYD 333
DL+P NIL D++G +K+ADFGL+K L +++ T W Y APEV Y
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVG----TPW-YMAPEVLLGGNGYG 177
Query: 334 TKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG---LRELI 390
KVDV+S +IL E++ G PPF + + + PP ++ G ++LI
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 391 EDCWSEEPFRRPTFRQIL 408
+ C +++P +RPT +IL
Sbjct: 238 KKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 1e-62
Identities = 83/246 (33%), Positives = 133/246 (54%), Gaps = 21/246 (8%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
T+VAVKTL E E++ + F++E ++++K+ HPN+V+ LG TQ P+ IVTEY+P
Sbjct: 28 ETKVAVKTLKEG--ASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPG 85
Query: 232 GDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290
GDL +L++ G L ++ AL IA+GM YL +HRDL N L ++ +K
Sbjct: 86 GDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN---FVHRDLAARNCLVTENLVVK 142
Query: 291 VADFGLSKLLKFANTVKEDRPVTCEETSW--RYAAPEVYKNEEYDTKVDVFSFALILQEM 348
++DFGLS+ + ++D ++ APE K+ ++ +K DV+SF ++L E+
Sbjct: 143 ISDFGLSRDIY-----EDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEI 197
Query: 349 IEGC-PPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFR 405
P+P +EV + R P P L EL+ CW+ +P RPTF
Sbjct: 198 FTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDE-----LYELMLQCWAYDPEDRPTFS 252
Query: 406 QILMRL 411
+++ L
Sbjct: 253 ELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 1e-62
Identities = 89/262 (33%), Positives = 140/262 (53%), Gaps = 27/262 (10%)
Query: 159 EITKGTFRIAS-WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVT 217
E+ KG + + +VAVKTL E+ E +++ F+ E +++K+ HPNVV+ LG T
Sbjct: 14 EVYKGKLKGKGGKKKVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNVVKLLGVCT 71
Query: 218 QSTPMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDL 276
+ P+ IV EY+ GDL +YL++ + L + + FAL IARGM YL IHRDL
Sbjct: 72 EEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN---FIHRDL 128
Query: 277 EPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR---PVTCEETSWRYAAPEVYKNEEYD 333
N L ++ +K++DFGLS+ L + ++ P+ R+ APE K ++
Sbjct: 129 AARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI-------RWMAPESLKEGKFT 181
Query: 334 TKVDVFSFALILQEMIEGC-PPFPTKQEKEVPKAYIANE---RPPFRAPTTHYAYGLREL 389
+K DV+SF ++L E+ P+P +EV Y+ N P P L +L
Sbjct: 182 SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV-LEYLKNGYRLPQPPNCPP-----ELYDL 235
Query: 390 IEDCWSEEPFRRPTFRQILMRL 411
+ CW+E+P RPTF +++ L
Sbjct: 236 MLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 5e-62
Identities = 87/247 (35%), Positives = 133/247 (53%), Gaps = 25/247 (10%)
Query: 173 TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232
+VAVKTL E+ E +++ F+ E +++K+ HPN+V+ LG T+ P+MIV EY+P G
Sbjct: 29 VEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGG 86
Query: 233 DLRAYLKQKGALKPTLA--VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290
DL YL++ + +L+ + FAL IARGM YL IHRDL N L ++ +K
Sbjct: 87 DLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVK 143
Query: 291 VADFGLSKLLKFANTVK---EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQE 347
++DFGLS+ L + K P+ R+ APE K ++ +K DV+SF ++L E
Sbjct: 144 ISDFGLSRDLYDDDYYKVKGGKLPI-------RWMAPESLKEGKFTSKSDVWSFGVLLWE 196
Query: 348 MIEGC-PPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTF 404
+ P+P EV + R P P L +L+ CW+E+P RPTF
Sbjct: 197 IFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPP-----ELYKLMLQCWAEDPEDRPTF 251
Query: 405 RQILMRL 411
+++ L
Sbjct: 252 SELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 199 bits (509), Expect = 3e-61
Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 16/255 (6%)
Query: 159 EITKGTF---RIASWRGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
++ +G+F +A + T VA+K + + + + + E+ +L+K++HPN+V+
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVI--KKKKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIH 273
+ +V EY GDL LK++G L A + I + YLH I+H
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---IVH 120
Query: 274 RDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYD 333
RDL+P NIL D+ GH+K+ADFGL++ L K V T Y APEV + Y
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLD--PGEKLTTFVG---TPE-YMAPEVLLGKGYG 174
Query: 334 TKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDC 393
VD++S +IL E++ G PPFP + I +PPF P + ++LI
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 394 WSEEPFRRPTFRQIL 408
++P +R T + L
Sbjct: 235 LVKDPEKRLTAEEAL 249
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 2e-52
Identities = 72/240 (30%), Positives = 112/240 (46%), Gaps = 48/240 (20%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G +VA+K + +E ++ + E+ +L+K+ HPN+V+ G + +V EY
Sbjct: 18 GKKVAIKIIKKE--DSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEG 75
Query: 232 GDLRAYLKQKGA-LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL-RDDSGHL 289
G L+ LK+ L ++ L I G+ YLH N IIHRDL+P NIL D+G +
Sbjct: 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKV 132
Query: 290 KVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEM 348
K+ADFGLSKLL ++ + T Y APEV + Y K D++S +IL E+
Sbjct: 133 KLADFGLSKLLTSDKSLLKTIVGTP-----AYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
Query: 349 IEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
E L++LI ++P +RP+ ++IL
Sbjct: 188 PE-----------------------------------LKDLIRKMLQKDPEKRPSAKEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 8e-48
Identities = 99/281 (35%), Positives = 148/281 (52%), Gaps = 36/281 (12%)
Query: 145 YEIDPKELDFSNSVEITKGTF---RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALL 201
+ I+ KEL + I KG F + +RG +VAVK L ++ +AF+ E +++
Sbjct: 1 WAINSKELKLGAT--IGKGEFGDVMLGDYRGQKVAVKCLKDDSTA----AQAFLAEASVM 54
Query: 202 QKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLA--VKFALDIARG 259
+RHPN+VQ LG V Q P+ IVTEY+ KG L YL+ +G TLA + FALD+ G
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114
Query: 260 MNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR---PVTCEE 316
M YL E +HRDL N+L + KV+DFGL+K + +D PV
Sbjct: 115 MEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPV---- 163
Query: 317 TSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANER--P 373
++ APE + +++ TK DV+SF ++L E+ G P+P K+V R
Sbjct: 164 ---KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA 220
Query: 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
P P Y ++++DCW +P +RPTF+Q+ +L I
Sbjct: 221 PEGCPPEVY-----KVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 3e-46
Identities = 76/244 (31%), Positives = 121/244 (49%), Gaps = 20/244 (8%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM--IVTEYL 229
G +AVK++ E E++++A E+ +L ++HPN+V++ G+ I EY+
Sbjct: 25 GELMAVKSV-ELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83
Query: 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289
G L + LK+ G L + K+ I G+ YLH N I+HRD++ +NIL D G +
Sbjct: 84 SGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVV 140
Query: 290 KVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI 349
K+ADFG +K L T + V + + APEV + EEY D++S + EM
Sbjct: 141 KLADFGCAKRLGDIETGEGTGSVR---GTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMA 197
Query: 350 EGCPPFPTKQEKEVPKA---YIAN--ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTF 404
G PP+ E P A I + E P P H + ++ + C +P +RPT
Sbjct: 198 TGKPPWS---ELGNPMAALYKIGSSGEPPEI--P-EHLSEEAKDFLRKCLRRDPKKRPTA 251
Query: 405 RQIL 408
++L
Sbjct: 252 DELL 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 3e-45
Identities = 92/272 (33%), Positives = 140/272 (51%), Gaps = 30/272 (11%)
Query: 147 IDPKELDFSNSVEITKGTF---RIASWRGT-QVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
IDP EL F E+ G F + WRG VA+K + E +++D FI+E ++
Sbjct: 1 IDPSELTFLK--ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD----FIEEAKVMM 54
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMN 261
K+ HPN+VQ G T+ P+ IVTEY+ G L YL++ KG L + D+ M
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAME 114
Query: 262 YLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSW-- 319
YL N IHRDL N L + +KV+DFGL++ V +D+ + + T +
Sbjct: 115 YLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARY------VLDDQYTSSQGTKFPV 165
Query: 320 RYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANER--PPFR 376
++A PEV+ + +K DV+SF +++ E+ EG P+ EV ++ A R P
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKL 225
Query: 377 APTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
APT Y ++ CW E+P RP F+++L
Sbjct: 226 APTEVY-----TIMYSCWHEKPEDRPAFKKLL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 5e-44
Identities = 78/266 (29%), Positives = 129/266 (48%), Gaps = 27/266 (10%)
Query: 153 DFSNSVEITKGTFRI---ASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHP 207
F +I KG F A + T VA+K + E ++K+ I+E+ +L+K +HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI---INEIQILKKCKHP 57
Query: 208 NVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGA-LKPTLAVKFALDIARGMNYLHEN 266
N+V++ G+ + + IV E+ G L+ LK L + ++ +G+ YLH N
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 267 RPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEV 326
IIHRD++ +NIL G +K+ DFGLS + ++T + V + + APEV
Sbjct: 118 G---IIHRDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMVG----TPYWMAPEV 168
Query: 327 YKNEEYDTKVDVFSFALILQEMIEGCPPF----PTKQEKEVPKAYIANERPPFRAPTTHY 382
+ YD K D++S + E+ EG PP+ P K ++ N P R P
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT----NGPPGLRNPEKWS 224
Query: 383 AYGLRELIEDCWSEEPFRRPTFRQIL 408
++ ++ C + P +RPT Q+L
Sbjct: 225 DE-FKDFLKKCLQKNPEKRPTAEQLL 249
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 8e-43
Identities = 92/277 (33%), Positives = 143/277 (51%), Gaps = 32/277 (11%)
Query: 147 IDPKELDFSNSVEITKGTF---RIASWRGT-QVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
I+P EL F E+ G F + WR +VA+K + E ++ED FI+E ++
Sbjct: 1 INPSELTFMK--ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED----FIEEAKVMM 54
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMN 261
K+ HP +VQ G TQ P+ IVTE++ G L YL+Q+ G L + + D+ GM
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGME 114
Query: 262 YLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL---KFANTVKEDRPVTCEETS 318
YL N + IHRDL N L +G +KV+DFG+++ + ++ ++ PV
Sbjct: 115 YLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPV------ 165
Query: 319 WRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANER--PPF 375
+++ PEV+ +Y +K DV+SF +++ E+ EG PF K EV + R P
Sbjct: 166 -KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPK 224
Query: 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412
A T Y E++ CW E+P RPTF ++L +
Sbjct: 225 LASMTVY-----EVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-41
Identities = 87/277 (31%), Positives = 143/277 (51%), Gaps = 34/277 (12%)
Query: 147 IDPKELDFSNSVEITKGTFRIASWRG-----TQVAVKTLGEEVFTDEDKVKAFIDELALL 201
I P EL EI G F + W G +VA+KT+ E ++ED FI+E ++
Sbjct: 1 IHPSELTLV--QEIGSGQFGLV-WLGYWLEKRKVAIKTIREGAMSEED----FIEEAQVM 53
Query: 202 QKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLK-QKGALKPTLAVKFALDIARGM 260
K+ HP +VQ G T+ +P+ +V E++ G L YL+ Q+G + LD+ GM
Sbjct: 54 MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGM 113
Query: 261 NYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL---KFANTVKEDRPVTCEET 317
YL + +IHRDL N L ++ +KV+DFG+++ + ++ ++ PV
Sbjct: 114 AYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV----- 165
Query: 318 SWRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANER--PP 374
++++PEV+ +Y +K DV+SF +++ E+ EG P+ + EV + A R P
Sbjct: 166 --KWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP 223
Query: 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411
A + Y EL++ CW E P RP+F +L +L
Sbjct: 224 RLASQSVY-----ELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 6e-40
Identities = 86/280 (30%), Positives = 140/280 (50%), Gaps = 31/280 (11%)
Query: 147 IDPKELDFSNSV------EITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELAL 200
IDP + + E+ +G ++ + VA+KTL + +D+ ++ F+ E ++
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLD-FLTEASI 58
Query: 201 LQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARG 259
+ + HPN+++ G VT+S P+MI+TEY+ G L +L++ G V IA G
Sbjct: 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASG 118
Query: 260 MNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR----PVTCE 315
M YL E +HRDL NIL + + KV+DFGLS+ L+ + + P+
Sbjct: 119 MKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI--- 172
Query: 316 ETSWRYAAPEVYKNEEYDTKVDVFSFALILQE-MIEGCPPFPTKQEKEVPKAYIANER-- 372
R+ APE ++ + DV+SF +++ E M G P+ ++V KA R
Sbjct: 173 ----RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP 228
Query: 373 PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412
PP P+ Y +L+ DCW ++ RPTF QI+ LD
Sbjct: 229 PPMDCPSALY-----QLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 3e-39
Identities = 87/262 (33%), Positives = 128/262 (48%), Gaps = 27/262 (10%)
Query: 159 EITKGTFRIASWRG-TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVT 217
E+ GT W G T+VAVKTL + E AF+ E +++K+RH +VQ +
Sbjct: 21 EVWMGT-----WNGTTKVAVKTLKPGTMSPE----AFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 218 QSTPMMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRD 275
+ P+ IVTEY+ KG L +LK L+ V A IA GM YL IHRD
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRD 128
Query: 276 LEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSW--RYAAPEVYKNEEYD 333
L NIL ++ K+ADFGL++L+ ++D E + ++ APE +
Sbjct: 129 LAARNILVGENLVCKIADFGLARLI------EDDEYTAREGAKFPIKWTAPEAANYGRFT 182
Query: 334 TKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIED 392
K DV+SF ++L E++ G P+P +EV + R P P L +L+
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP--RPPNCPE-ELYDLMLQ 239
Query: 393 CWSEEPFRRPTFRQILMRLDDI 414
CW ++P RPTF + L+D
Sbjct: 240 CWDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 7e-38
Identities = 66/245 (26%), Positives = 121/245 (49%), Gaps = 24/245 (9%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G +K + +++++ A ++E+ +L+K+ HPN++++ + + + IV EY
Sbjct: 25 GKLYVLKEIDLSNMSEKEREDA-LNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83
Query: 232 GDLRAYLKQKGALKPTLAVKFALD----IARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
GDL +K++ + LD + + YLH + I+HRD++P NI +G
Sbjct: 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNG 140
Query: 288 HLKVADFGLSKLL----KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFAL 343
+K+ DFG+SK+L A TV T + Y +PE+ +N+ Y+ K D++S
Sbjct: 141 LVKLGDFGISKVLSSTVDLAKTV-------VG-TPY-YLSPELCQNKPYNYKSDIWSLGC 191
Query: 344 ILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPT 403
+L E+ PF + E+ + + PP + Y+ LR L+ ++P RP+
Sbjct: 192 VLYELCTLKHPFEGENLLELALKILKGQYPPIP---SQYSSELRNLVSSLLQKDPEERPS 248
Query: 404 FRQIL 408
QIL
Sbjct: 249 IAQIL 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 79/249 (31%), Positives = 125/249 (50%), Gaps = 18/249 (7%)
Query: 170 WRGT-QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228
W+ +VA+K L + D K + F E+ L+++RH +++ + P+ I+TE
Sbjct: 27 WKNRVRVAIKILKSD---DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83
Query: 229 LPKGDLRAYLK--QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286
+ KG L A+L+ + L + A +A GM YL E IHRDL NIL +
Sbjct: 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGED 140
Query: 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQ 346
KVADFGL++L+K + D+ + +++ APE + + TK DV+SF ++L
Sbjct: 141 LVCKVADFGLARLIKEDVYLSSDKKI-----PYKWTAPEAASHGTFSTKSDVWSFGILLY 195
Query: 347 EMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFR 405
EM G P+P EV A R P A Y +++ +CW+ EP RP+F+
Sbjct: 196 EMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIY---KIMLECWAAEPEDRPSFK 252
Query: 406 QILMRLDDI 414
+ LD+I
Sbjct: 253 ALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-37
Identities = 84/254 (33%), Positives = 121/254 (47%), Gaps = 26/254 (10%)
Query: 170 WRG-----TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224
W G T VAVKTL +D F+ E +++K+RHP ++Q T P+ I
Sbjct: 23 WEGLWNNTTPVAVKTLKPGTMDPKD----FLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78
Query: 225 VTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL 282
VTE + G L YL+ ALK + A +A GM YL + IHRDL N+L
Sbjct: 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVL 135
Query: 283 RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFA 342
++ KVADFGL++++K + E R W APE + K DV+SF
Sbjct: 136 VGENNICKVADFGLARVIK--EDIYEAREGAKFPIKW--TAPEAALYNRFSIKSDVWSFG 191
Query: 343 LILQEMIE-GCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPF 399
++L E++ G P+P EV + R P P Y +++ DCW E+P
Sbjct: 192 ILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELY-----DIMLDCWKEDPD 246
Query: 400 RRPTFRQILMRLDD 413
RPTF + +L+D
Sbjct: 247 DRPTFETLQWKLED 260
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 5e-37
Identities = 78/260 (30%), Positives = 129/260 (49%), Gaps = 34/260 (13%)
Query: 171 RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230
T+VA+KT+ E + +++ F++E +++++ +VV+ LG V+ P ++V E +
Sbjct: 35 PETRVAIKTVNENA-SMRERI-EFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMA 92
Query: 231 KGDLRAYLKQK--------GALKPTL--AVKFALDIARGMNYLHENRPEAIIHRDLEPSN 280
KGDL++YL+ + G PTL ++ A +IA GM YL + +HRDL N
Sbjct: 93 KGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARN 149
Query: 281 ILRDDSGHLKVADFGLSKLLKFANTVKEDR----PVTCEETSWRYAAPEVYKNEEYDTKV 336
+ + +K+ DFG+++ + + ++ PV R+ APE K+ + TK
Sbjct: 150 CMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV-------RWMAPESLKDGVFTTKS 202
Query: 337 DVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANE--RPPFRAPTTHYAYGLRELIEDC 393
DV+SF ++L EM P+ +EV K I P P L EL+ C
Sbjct: 203 DVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCP-----DKLLELMRMC 257
Query: 394 WSEEPFRRPTFRQILMRLDD 413
W P RPTF +I+ L D
Sbjct: 258 WQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 79/247 (31%), Positives = 133/247 (53%), Gaps = 27/247 (10%)
Query: 170 WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229
+ G +VAVK + +V +AF++E A++ K+ H N+V+ LG + + + IV E +
Sbjct: 27 YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELM 80
Query: 230 PKGDLRAYLKQKG-ALKPTLAV-KFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
KG+L +L+ +G AL + + +F+LD+A GM YL + ++HRDL NIL + G
Sbjct: 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDG 137
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQE 347
KV+DFGL+++ V + ++ APE K++++ +K DV+S+ ++L E
Sbjct: 138 VAKVSDFGLARV--------GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWE 189
Query: 348 MIE-GCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTF 404
+ G P+P KEV + R PP P Y L+ CW EP +RP+F
Sbjct: 190 VFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYV-----LMTSCWETEPKKRPSF 244
Query: 405 RQILMRL 411
++ +L
Sbjct: 245 HKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 7e-36
Identities = 88/273 (32%), Positives = 139/273 (50%), Gaps = 32/273 (11%)
Query: 147 IDPKELDFSNSVEITKGTF---RIASWRGT-QVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
IDPK+L F E+ G F + WRG VA+K + E ++++ FI+E ++
Sbjct: 1 IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMN 261
K+ H +VQ G T+ P+ IVTEY+ G L YL++ G +P+ ++ D+ GM
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMA 114
Query: 262 YLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL---KFANTVKEDRPVTCEETS 318
YL + IHRDL N L DD G +KV+DFGLS+ + ++ ++V PV
Sbjct: 115 YLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV------ 165
Query: 319 WRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANER--PPF 375
R++ PEV ++ +K DV++F +++ E+ G P+ E + R P
Sbjct: 166 -RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPH 224
Query: 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
A YA ++ CW E+ RPTF+Q+L
Sbjct: 225 LASEKVYA-----IMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 27/261 (10%)
Query: 159 EITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ 218
++ KG + T+VAVKT + + K K F+ E +L++ HPN+V+ +G Q
Sbjct: 10 DVYKGVLK----GNTEVAVKTCRSTLP-PDLKRK-FLQEAEILKQYDHPNIVKLIGVCVQ 63
Query: 219 STPMMIVTEYLPKGDLRAYL-KQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLE 277
P+ IV E +P G L +L K+K L ++ +LD A GM YL E++ IHRDL
Sbjct: 64 KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL-ESK--NCIHRDLA 120
Query: 278 PSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWR-----YAAPEVYKNEEY 332
N L ++ LK++DFG+S+ +E+ + + + APE Y
Sbjct: 121 ARNCLVGENNVLKISDFGMSR--------EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 333 DTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIE 391
++ DV+S+ ++L E G P+P ++ + + R P + L+
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP---APQLCPEEIYRLML 229
Query: 392 DCWSEEPFRRPTFRQILMRLD 412
CW+ +P RP+F +I L
Sbjct: 230 QCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 64/167 (38%), Positives = 92/167 (55%), Gaps = 13/167 (7%)
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALD 255
E++LL++++HPN+V+ L + + +V EY DL+ YL ++ G L P L
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQ 106
Query: 256 IARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCE 315
+ RG+ Y H +R I+HRDL+P NIL + G LK+ADFGL++ R T E
Sbjct: 107 LLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI-----PLRTYTHE 158
Query: 316 -ETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE 360
T W Y APE+ ++ Y T VD++S I EMI G P FP E
Sbjct: 159 VVTLW-YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 76/248 (30%), Positives = 122/248 (49%), Gaps = 27/248 (10%)
Query: 172 GTQVAVKTLGEEVFTDEDK--VKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229
G ++AVK + + + E K V A E+ LL+ ++H +VQ+ G + + I EY+
Sbjct: 27 GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86
Query: 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289
P G ++ LK GAL T+ K+ I G+ YLH N I+HRD++ +NILRD +G++
Sbjct: 87 PGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNV 143
Query: 290 KVADFGLSKLLKFANTVKEDRPVTCEETSWR-------YAAPEVYKNEEYDTKVDVFSFA 342
K+ DFG SK L+ + T + + +PEV E Y K DV+S
Sbjct: 144 KLGDFGASKRLQ---------TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVG 194
Query: 343 LILQEMIEGCPPFPTKQEKEVPKAY--IANERPPFRAPTTHYAYGLRELIEDCWSEEPFR 400
+ EM+ PP+ E E A IA + + P +H + R + + E +
Sbjct: 195 CTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPQLP-SHVSPDARNFLRRTFVENAKK 250
Query: 401 RPTFRQIL 408
RP+ ++L
Sbjct: 251 RPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 9e-35
Identities = 80/252 (31%), Positives = 125/252 (49%), Gaps = 33/252 (13%)
Query: 168 ASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225
W+ VAVKTL E+ +V+ F+ E A++++I+HPN+VQ LG T+ P I+
Sbjct: 25 GVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80
Query: 226 TEYLPKGDLRAYLKQ--KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR 283
TE++ G+L YL++ + + + + A I+ M YL + IHRDL N L
Sbjct: 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLV 137
Query: 284 DDSGHLKVADFGLSKLLK---FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFS 340
++ +KVADFGLS+L+ + P+ ++ APE ++ K DV++
Sbjct: 138 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-------KWTAPESLAYNKFSIKSDVWA 190
Query: 341 FALILQEMIE-GCPPFPTKQEKEV----PKAYIANERPPFRAPTTHYAYGLRELIEDCWS 395
F ++L E+ G P+P +V K Y ERP P Y EL+ CW
Sbjct: 191 FGVLLWEIATYGMSPYPGIDLSQVYELLEKGY-RMERPE-GCPPKVY-----ELMRACWQ 243
Query: 396 EEPFRRPTFRQI 407
P RP+F +I
Sbjct: 244 WNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 64/188 (34%), Positives = 97/188 (51%), Gaps = 8/188 (4%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLR 235
A+K L ++ +V+ + E +L +I HP +V+ A + +V EY P G+L
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81
Query: 236 AYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFG 295
++L ++G A +A +I + YLH II+RDL+P NIL D GH+K+ DFG
Sbjct: 82 SHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFG 138
Query: 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPF 355
L+K L + T E Y APEV + Y VD +S ++L EM+ G PPF
Sbjct: 139 LAKELSSEGSRTNTFCGTPE-----YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF 193
Query: 356 PTKQEKEV 363
+ KE+
Sbjct: 194 YAEDRKEI 201
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 77/269 (28%), Positives = 125/269 (46%), Gaps = 18/269 (6%)
Query: 150 KELDFSNSVEITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKA-FIDELALLQKIRHPN 208
KEL N + KG + + S + +VAVKTL +E K F+ E +++ ++ HP
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQE---HIAAGKKEFLREASVMAQLDHPC 57
Query: 209 VVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRP 268
+V+ +G V + P+M+V E P G L YLK++ + + + A +A GM YL
Sbjct: 58 IVRLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH- 115
Query: 269 EAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYK 328
+HRDL N+L + K++DFG+S+ L + R T ++ APE
Sbjct: 116 --FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD--YYRATTAGRWPLKWYAPECIN 171
Query: 329 NEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYG 385
++ +K DV+S+ + L E G P+ + EV + ER P P Y+
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYS-- 229
Query: 386 LRELIEDCWSEEPFRRPTFRQILMRLDDI 414
++ CW P RPTF ++
Sbjct: 230 ---IMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 7e-34
Identities = 87/267 (32%), Positives = 137/267 (51%), Gaps = 36/267 (13%)
Query: 160 ITKGTF---RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGA- 215
I KG F + +RG +VAVK + ++ +AF+ E +++ ++RH N+VQ LG
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 216 VTQSTPMMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIH 273
V + + IVTEY+ KG L YL+ +G L +KF+LD+ M YL N +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125
Query: 274 RDLEPSNILRDDSGHLKVADFGLSK-LLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEY 332
RDL N+L + KV+DFGL+K +T K PV ++ APE + +++
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK--LPV-------KWTAPEALREKKF 176
Query: 333 DTKVDVFSFALILQEMIE-GCPPFPTKQEKE----VPKAYIANERPPFRAPTTHYAYGLR 387
TK DV+SF ++L E+ G P+P K+ V K Y + P P Y
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA--PDGCPPVVY----- 229
Query: 388 ELIEDCWSEEPFRRPTFRQILMRLDDI 414
++++ CW + RP+F Q+ +L+ I
Sbjct: 230 DVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-33
Identities = 64/187 (34%), Positives = 97/187 (51%), Gaps = 12/187 (6%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
A+K + + +++V + E +L + + P VV+ + + +V EYLP GDL
Sbjct: 21 YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80
Query: 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294
+ L+ G+L +A + +I + YLH N IIHRDL+P NIL D +GHLK+ DF
Sbjct: 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDF 137
Query: 295 GLSKL------LKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEM 348
GLSK+ + + KED+ + Y APEV + + VD +S IL E
Sbjct: 138 GLSKVGLVRRQINLNDDEKEDKRIVGTPD---YIAPEVILGQGHSKTVDWWSLGCILYEF 194
Query: 349 IEGCPPF 355
+ G PPF
Sbjct: 195 LVGIPPF 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 76/242 (31%), Positives = 126/242 (52%), Gaps = 18/242 (7%)
Query: 174 QVAVKTLGEEVFTDEDKVKAFID----ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229
QV + ++ +D+ ++ +D E+ALL++++H N+VQ+LG+ + + I EY+
Sbjct: 32 QVELPSVSAS---SKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYV 88
Query: 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289
P G + A L GA + TL F I +G+NYLH NR IIHRD++ +NIL D+ G +
Sbjct: 89 PGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH-NR--GIIHRDIKGANILVDNKGGI 145
Query: 290 KVADFGLSKLLK---FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQ 346
K++DFG+SK L+ + RP W APEV K Y K D++S ++
Sbjct: 146 KISDFGISKKLEANSLSTKTNGARPSLQGSVFW--MAPEVVKQTSYTRKADIWSLGCLVV 203
Query: 347 EMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQ 406
EM+ G PFP + + N P ++ + + +E + + +RPT +
Sbjct: 204 EMLTGKHPFPDCTQLQAIFKIGENASP---EIPSNISSEAIDFLEKTFEIDHNKRPTAAE 260
Query: 407 IL 408
+L
Sbjct: 261 LL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-33
Identities = 85/265 (32%), Positives = 134/265 (50%), Gaps = 28/265 (10%)
Query: 159 EITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ 218
E+ +G ++ R VA+KTL + +T++ + + F+ E +++ + HPN++ G VT+
Sbjct: 19 EVCRGRLKLPGKREIFVAIKTL-KSGYTEKQR-RDFLSEASIMGQFDHPNIIHLEGVVTK 76
Query: 219 STPMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLE 277
S P+MI+TE++ G L ++L+Q G V IA GM YL E +HRDL
Sbjct: 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLA 133
Query: 278 PSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS-------WRYAAPEVYKNE 330
NIL + + KV+DFGLS+ L ED TS R+ APE
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRFL-------EDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 331 EYDTKVDVFSFALILQE-MIEGCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLR 387
++ + DV+S+ +++ E M G P+ ++V A + R PP PT L
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA-----LH 241
Query: 388 ELIEDCWSEEPFRRPTFRQILMRLD 412
+L+ DCW ++ RP F QI+ LD
Sbjct: 242 QLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 85/256 (33%), Positives = 129/256 (50%), Gaps = 31/256 (12%)
Query: 170 WRG-----TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224
W G T+VA+K+L + + E AF+ E L+++++HP +V+ VTQ P+ I
Sbjct: 23 WMGYYNGHTKVAIKSLKQGSMSPE----AFLAEANLMKQLQHPRLVRLYAVVTQE-PIYI 77
Query: 225 VTEYLPKGDLRAYLKQKGALKPTLA--VKFALDIARGMNYLHENRPEAIIHRDLEPSNIL 282
+TEY+ G L +LK +K T+ + A IA GM ++ IHRDL +NIL
Sbjct: 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANIL 134
Query: 283 RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS---WRYAAPEVYKNEEYDTKVDVF 339
++ K+ADFGL++L+ ED T E + ++ APE + K DV+
Sbjct: 135 VSETLCCKIADFGLARLI-------EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 340 SFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG-LRELIEDCWSEE 397
SF ++L E++ G P+P EV I N +R P L EL+ CW E+
Sbjct: 188 SFGILLTEIVTYGRIPYPGMTNPEV----IQNLERGYRMPRPDNCPEELYELMRLCWKEK 243
Query: 398 PFRRPTFRQILMRLDD 413
P RPTF + L+D
Sbjct: 244 PEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-33
Identities = 89/262 (33%), Positives = 136/262 (51%), Gaps = 34/262 (12%)
Query: 156 NSVEITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGA 215
N E+ KGT + T VAVKT E++ E K+K F+ E +L++ HPN+V+ +G
Sbjct: 7 NFGEVFKGTLK----DKTPVAVKTCKEDL-PQELKIK-FLSEARILKQYDHPNIVKLIGV 60
Query: 216 VTQSTPMMIVTEYLPKGDLRAYL-KQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHR 274
TQ P+ IV E +P GD ++L K+K LK VKFALD A GM YL IHR
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 275 DLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTC----EETSWRYAAPEVYKNE 330
DL N L ++ LK++DFG+S+ +ED + ++ ++ APE
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR--------QEDDGIYSSSGLKQIPIKWTAPEALNYG 169
Query: 331 EYDTKVDVFSFALILQEMIE-GCPPFP--TKQE--KEVPKAYIANERPPFRAPTTHYAYG 385
Y ++ DV+S+ ++L E G P+P T Q+ ++V K Y P + P Y
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY--RMSCPQKCPDDVY--- 224
Query: 386 LRELIEDCWSEEPFRRPTFRQI 407
++++ CW +P RP F ++
Sbjct: 225 --KVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 70/266 (26%), Positives = 128/266 (48%), Gaps = 25/266 (9%)
Query: 159 EITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ 218
++ +G + VAVKT T + F+ E ++++ HP++V+ +G +T+
Sbjct: 21 DVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78
Query: 219 STPMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLE 277
+ P+ IV E P G+LR+YL+ K +L + ++ ++ + YL R +HRD+
Sbjct: 79 N-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIA 134
Query: 278 PSNILRDDSGHLKVADFGLSKLLKFANTVKEDR---PVTCEETSWRYAAPEVYKNEEYDT 334
N+L +K+ DFGLS+ L+ + K + P+ ++ APE + +
Sbjct: 135 ARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPI-------KWMAPESINFRRFTS 187
Query: 335 KVDVFSFALILQE-MIEGCPPFPTKQEKEVPKAYIANERPPF--RAPTTHYAYGLRELIE 391
DV+ F + + E ++ G PF + +V ER P P T Y+ L+
Sbjct: 188 ASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS-----LMT 242
Query: 392 DCWSEEPFRRPTFRQILMRLDDISDQ 417
CW+ +P +RP F ++ +L DI +
Sbjct: 243 KCWAYDPSKRPRFTELKAQLSDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 4e-32
Identities = 85/265 (32%), Positives = 130/265 (49%), Gaps = 26/265 (9%)
Query: 159 EITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ 218
E+ G ++ R VA+KTL + E + + F+ E +++ + HPN++ G VT+
Sbjct: 19 EVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76
Query: 219 STPMMIVTEYLPKGDLRAYL-KQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLE 277
S P+MIVTEY+ G L A+L K G V IA GM YL + +HRDL
Sbjct: 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 133
Query: 278 PSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSW-----RYAAPEVYKNEEY 332
NIL + + KV+DFGLS++L ED P T R+ APE ++
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRVL-------EDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 333 DTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLREL 389
+ DV+S+ +++ E++ G P+ ++V KA R P P L +L
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPA-----ALHQL 241
Query: 390 IEDCWSEEPFRRPTFRQILMRLDDI 414
+ DCW ++ RP F QI+ LD +
Sbjct: 242 MLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 5e-32
Identities = 67/245 (27%), Positives = 112/245 (45%), Gaps = 16/245 (6%)
Query: 172 GTQVAVKTLGEEVFTDEDK--VKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229
G +AVK E D D +K DE+ +L+ ++HPN+V++ G + I EY
Sbjct: 25 GELMAVK---EIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81
Query: 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289
G L L+ L + + L + G+ YLH + I+HRD++P+NI D +G +
Sbjct: 82 SGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVI 138
Query: 290 KVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTK---VDVFSFALILQ 346
K+ DFG + LK T + + T Y APEV + D++S ++
Sbjct: 139 KLGDFGCAVKLKNNTTTMGEEVQSLAGTP-AYMAPEVITGGKGKGHGRAADIWSLGCVVL 197
Query: 347 EMIEGCPPFPTKQEKEVPKAY--IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTF 404
EM G P+ + + E + A +PP G ++ ++ C +P +RPT
Sbjct: 198 EMATGKRPWS-ELDNEFQIMFHVGAGHKPPIPDSLQLSPEG-KDFLDRCLESDPKKRPTA 255
Query: 405 RQILM 409
++L
Sbjct: 256 SELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 5e-32
Identities = 72/236 (30%), Positives = 116/236 (49%), Gaps = 16/236 (6%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
VA+K L EE T K +DE ++ + HP+VV+ LG + S+ + ++T+ +P G L
Sbjct: 39 VAIKVLREE--TSPKANKEILDEAYVMASVDHPHVVRLLG-ICLSSQVQLITQLMPLGCL 95
Query: 235 RAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293
Y++ K + + + + IA+GM+YL E R ++HRDL N+L H+K+ D
Sbjct: 96 LDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITD 152
Query: 294 FGLSKLLKFANTVKEDR-PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQE-MIEG 351
FGL+KLL V E + ++ A E + Y K DV+S+ + + E M G
Sbjct: 153 FGLAKLLD----VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFG 208
Query: 352 CPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQI 407
P+ E+P ER P T Y ++ CW + RPTF+++
Sbjct: 209 AKPYEGIPAVEIPDLLEKGERLPQPPICTIDVY---MVLVKCWMIDAESRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-32
Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 21/220 (9%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALK---PTLAV- 250
++E+ +L + HPN++ + A + IV EY P GDL + ++ + P +
Sbjct: 47 VNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW 106
Query: 251 KFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK--FANTVKE 308
+ + + RG+ LHE + I+HRDL+ +NIL + +K+ D G+SK+LK A T
Sbjct: 107 RIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI- 162
Query: 309 DRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYI 368
P Y APEV+K Y K D++S +L EM PPF + +++
Sbjct: 163 GTPH--------YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ 214
Query: 369 ANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
+ PP Y+ L+ I +P RP +IL
Sbjct: 215 RGKYPPIPP---IYSQDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 74/243 (30%), Positives = 122/243 (50%), Gaps = 20/243 (8%)
Query: 172 GTQVAVK--TLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229
G AVK +L ++ T ++ VK E+ALL K++HPN+VQ+LG + + I E +
Sbjct: 25 GDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV 84
Query: 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289
P G L LK+ G+ + + I G+ YLH+ +HRD++ +NIL D +G +
Sbjct: 85 PGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVV 141
Query: 290 KVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEM 348
K+ADFG++K + + K + + + + + APEV + Y D++S + EM
Sbjct: 142 KLADFGMAKQVVEFSFAK-----SFKGSPY-WMAPEVIAQQGGYGLAADIWSLGCTVLEM 195
Query: 349 IEGCPPFPTKQEKEVPKAY-IAN--ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFR 405
G PP+ Q + V + I E PP H + ++ I C +P RPT
Sbjct: 196 ATGKPPW--SQLEGVAAVFKIGRSKELPPI---PDHLSDEAKDFILKCLQRDPSLRPTAA 250
Query: 406 QIL 408
++L
Sbjct: 251 ELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 82/255 (32%), Positives = 126/255 (49%), Gaps = 23/255 (9%)
Query: 163 GTFRIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST 220
G R T +AVKT+ E+ +E K + EL +L K P +V F GA +
Sbjct: 15 GVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG 72
Query: 221 PMMIVTEYLPKGDLRAYLKQKGALKPTLAV-KFALDIARGMNYLHENRPEAIIHRDLEPS 279
+ I EY+ G L LK+ P + K A+ + +G+ YLHE IIHRD++PS
Sbjct: 73 DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHRDVKPS 130
Query: 280 NILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVF 339
NIL + G +K+ DFG+S L N++ + V Y APE + +Y K D++
Sbjct: 131 NILVNSRGQIKLCDFGVSGQL--VNSLAKTF-VGTSS----YMAPERIQGNDYSVKSDIW 183
Query: 340 SFALILQEMIEGCPPFPTKQEKEVPKA------YIANERPPFRAPTTHYAYGLRELIEDC 393
S L L E+ G FP E + P YI NE PP R P+ ++ ++ + C
Sbjct: 184 SLGLSLIELATG--RFPYPPENDPPDGIFELLQYIVNEPPP-RLPSGKFSPDFQDFVNLC 240
Query: 394 WSEEPFRRPTFRQIL 408
++P RP+++++L
Sbjct: 241 LIKDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 76/266 (28%), Positives = 123/266 (46%), Gaps = 42/266 (15%)
Query: 172 GTQVAVKTL----GEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP--MMIV 225
G QVAVK+L E+ +D F E+ +L+ + H N+V++ G + + ++
Sbjct: 33 GEQVAVKSLNHSGEEQHRSD------FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI 86
Query: 226 TEYLPKGDLRAYL-KQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD 284
EYLP G LR YL + + + + F+ I +GM+YL R IHRDL NIL +
Sbjct: 87 MEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVE 143
Query: 285 DSGHLKVADFGLSKLLKFAN---TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSF 341
+K++DFGL+K+L VKE E+ + APE + ++ + DV+SF
Sbjct: 144 SEDLVKISDFGLAKVLPEDKDYYYVKEPG-----ESPIFWYAPECLRTSKFSSASDVWSF 198
Query: 342 ALILQEMIEGCPPF---PTKQEKEVPKAYIA------------NERPPFRAPTTHYAYGL 386
+ L E+ P P + + + A ER P Y
Sbjct: 199 GVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVY-- 256
Query: 387 RELIEDCWSEEPFRRPTFRQILMRLD 412
+L++ CW EP RP+F +++ +D
Sbjct: 257 -DLMKLCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 6e-31
Identities = 66/252 (26%), Positives = 110/252 (43%), Gaps = 21/252 (8%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHP-NVVQFLGAVTQSTPMMIVTEYLPKGD 233
VA+K L +++ + +V+ F+ E+ +L + HP N+V+ + +V EY+ G
Sbjct: 25 VALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGS 84
Query: 234 LRAYLK---QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD-DSGHL 289
L LK +KG L + A+ I + YLH IIHRD++P NIL D D +
Sbjct: 85 LEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVV 141
Query: 290 KVADFGLSKLLKFANTVKEDRPVTCEET-SWRYAAPEVYK---NEEYDTKVDVFSFALIL 345
K+ DFGL+KLL + + + Y APEV + D++S + L
Sbjct: 142 KLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITL 201
Query: 346 QEMIEGCPPFPTKQEKEVPK---AYIANERPPFRAPTT------HYAYGLRELIEDCWSE 396
E++ G PPF ++ I P A + +L++ ++
Sbjct: 202 YELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAK 261
Query: 397 EPFRRPTFRQIL 408
+P R + L
Sbjct: 262 DPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 7e-31
Identities = 80/247 (32%), Positives = 124/247 (50%), Gaps = 23/247 (9%)
Query: 173 TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232
T+VAVKTL + V+AF++E L++ ++H +V+ VT+ P+ I+TEY+ KG
Sbjct: 31 TKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKG 86
Query: 233 DLRAYLKQKGALKPTL--AVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290
L +LK K L + F+ IA GM Y+ IHRDL +N+L +S K
Sbjct: 87 SLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCK 143
Query: 291 VADFGLSKLLKFANTVKEDRPVTCEETS---WRYAAPEVYKNEEYDTKVDVFSFALILQE 347
+ADFGL++++ ED T E + ++ APE + K DV+SF ++L E
Sbjct: 144 IADFGLARVI-------EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYE 196
Query: 348 MIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQ 406
++ G P+P +V A R P Y ++++ CW E+ RPTF
Sbjct: 197 IVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELY---DIMKTCWKEKAEERPTFDY 253
Query: 407 ILMRLDD 413
+ LDD
Sbjct: 254 LQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-31
Identities = 70/257 (27%), Positives = 125/257 (48%), Gaps = 39/257 (15%)
Query: 172 GTQVAVK--TLGEEVFTDEDKV-KAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228
GT +AVK T +++++V +A E+ L+ ++ HP++++ LGA + + + E+
Sbjct: 25 GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84
Query: 229 LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288
+ G + L + GA K + + + + RG++YLHEN+ IIHRD++ +N+L D +G
Sbjct: 85 MAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQ 141
Query: 289 -LKVADFGLSKLL------------KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTK 335
L++ADFG + L + T+ + APEV + E+Y
Sbjct: 142 RLRIADFGAAARLAAKGTGAGEFQGQLLGTIA-------------FMAPEVLRGEQYGRS 188
Query: 336 VDVFSFALILQEMIEGCPPFPTKQEKE----VPKAYIANERPPFRAPTTHYAYGLRELIE 391
DV+S ++ EM PP+ ++ + K A P H + GLR++
Sbjct: 189 CDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI---PEHLSPGLRDVTL 245
Query: 392 DCWSEEPFRRPTFRQIL 408
C +P RP R++L
Sbjct: 246 RCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 80/264 (30%), Positives = 127/264 (48%), Gaps = 41/264 (15%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGD 233
VAVK L ++ T++D + + E+ +++ I +H N++ LG TQ P+ +V EY G+
Sbjct: 45 VAVKMLKDDA-TEKD-LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGN 102
Query: 234 LRAYLKQK------------GALKPTLA----VKFALDIARGMNYLHENRPEAIIHRDLE 277
LR +L+ + + TL V FA +ARGM +L + IHRDL
Sbjct: 103 LRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLA 159
Query: 278 PSNILRDDSGHLKVADFGLSKLLK----FANTVKEDRPVTCEETSWRYAAPEVYKNEEYD 333
N+L + +K+ADFGL++ + + T PV ++ APE + Y
Sbjct: 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPV-------KWMAPEALFDRVYT 212
Query: 334 TKVDVFSFALILQE-MIEGCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELI 390
+ DV+SF ++L E G P+P +E+ K R P Y L+
Sbjct: 213 HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYH-----LM 267
Query: 391 EDCWSEEPFRRPTFRQILMRLDDI 414
DCW E P +RPTF+Q++ LD +
Sbjct: 268 RDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-30
Identities = 91/259 (35%), Positives = 134/259 (51%), Gaps = 27/259 (10%)
Query: 163 GTFRIASWRG-TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221
G + +W G T+VAVKTL + E +F++E +++K+RH +VQ L AV P
Sbjct: 20 GEVWMGTWNGNTKVAVKTLKPGTMSPE----SFLEEAQIMKKLRHDKLVQ-LYAVVSEEP 74
Query: 222 MMIVTEYLPKGDLRAYLK--QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPS 279
+ IVTEY+ KG L +LK + ALK V A +A GM Y+ IHRDL +
Sbjct: 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSA 131
Query: 280 NILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS---WRYAAPEVYKNEEYDTKV 336
NIL D K+ADFGL++L+ ED T + + ++ APE + K
Sbjct: 132 NILVGDGLVCKIADFGLARLI-------EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 337 DVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA-YGLRELIEDCW 394
DV+SF ++L E++ +G P+P +EV + ER +R P L EL+ CW
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMNNREVLEQV---ER-GYRMPCPQDCPISLHELMLQCW 240
Query: 395 SEEPFRRPTFRQILMRLDD 413
++P RPTF + L+D
Sbjct: 241 KKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 83/265 (31%), Positives = 129/265 (48%), Gaps = 26/265 (9%)
Query: 159 EITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ 218
E+ +G ++ + VA+KTL + +T++ + F+ E +++ + H N+++ G VT+
Sbjct: 20 EVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQD-FLSEASIMGQFSHHNIIRLEGVVTK 77
Query: 219 STPMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLE 277
P MI+TEY+ G L YL+ G V IA GM YL + +HRDL
Sbjct: 78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLA 134
Query: 278 PSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSW-----RYAAPEVYKNEEY 332
NIL + + KV+DFGLS++L ED P TS R+ APE ++
Sbjct: 135 ARNILVNSNLECKVSDFGLSRVL-------EDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 333 DTKVDVFSFALILQE-MIEGCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLREL 389
+ DV+SF +++ E M G P+ EV KA R P P+ Y +L
Sbjct: 188 TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY-----QL 242
Query: 390 IEDCWSEEPFRRPTFRQILMRLDDI 414
+ CW ++ RRP F I+ LD +
Sbjct: 243 MLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 70/241 (29%), Positives = 126/241 (52%), Gaps = 20/241 (8%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G VA+K + E E+ +K+ + E+ LL+ ++HPN+V+++G++ S + I+ EY
Sbjct: 25 GDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAEN 83
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
G LR +K+ G +L + + +G+ YLHE + +IHRD++ +NIL G +K+
Sbjct: 84 GSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKL 140
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG 351
ADFG++ K + K+D V + + APEV + T D++S + E++ G
Sbjct: 141 ADFGVA--TKLNDVSKDDASVVG---TPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195
Query: 352 CPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIED----CWSEEPFRRPTFRQI 407
PP+ + ++ PP P G+ ++D C+ ++P RPT +Q+
Sbjct: 196 NPPYYDLNPMAALFRIVQDDHPPL--PE-----GISPELKDFLMQCFQKDPNLRPTAKQL 248
Query: 408 L 408
L
Sbjct: 249 L 249
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-30
Identities = 88/258 (34%), Positives = 129/258 (50%), Gaps = 25/258 (9%)
Query: 163 GTFRIASWRGT-QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221
G + +W GT +VA+KTL + E AF+ E +++K+RH +VQ L AV P
Sbjct: 20 GEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-LYAVVSEEP 74
Query: 222 MMIVTEYLPKGDLRAYLKQKGA--LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPS 279
+ IVTEY+ KG L +LK + L+ V A IA GM Y+ +HRDL +
Sbjct: 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAA 131
Query: 280 NILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS---WRYAAPEVYKNEEYDTKV 336
NIL ++ KVADFGL++L+ ED T + + ++ APE + K
Sbjct: 132 NILVGENLVCKVADFGLARLI-------EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 337 DVFSFALILQEM-IEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWS 395
DV+SF ++L E+ +G P+P +EV R P P L +L+ CW
Sbjct: 185 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPECPE-SLHDLMCQCWR 241
Query: 396 EEPFRRPTFRQILMRLDD 413
+EP RPTF + L+D
Sbjct: 242 KEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 81/281 (28%), Positives = 137/281 (48%), Gaps = 48/281 (17%)
Query: 159 EITKGT-FRIASWRG-TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV 216
++ K T FR+ G T VAVK L E + E ++ + E LL+++ HP+V++ GA
Sbjct: 15 KVVKATAFRLKGRAGYTTVAVKMLKENASSSE--LRDLLSEFNLLKQVNHPHVIKLYGAC 72
Query: 217 TQSTPMMIVTEYLPKGDLRAYLKQKGALKPT------------------------LAVKF 252
+Q P++++ EY G LR++L++ + P+ + F
Sbjct: 73 SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISF 132
Query: 253 ALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312
A I+RGM YL E + ++HRDL N+L + +K++DFGLS+ + +ED V
Sbjct: 133 AWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSR-----DVYEEDSYV 184
Query: 313 --TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKE---VPKA 366
+ ++ A E + Y T+ DV+SF ++L E++ G P+P + + K
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT 244
Query: 367 YIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQI 407
ERP + + + L+ CW +EP +RPTF I
Sbjct: 245 GYRMERP------ENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 77/257 (29%), Positives = 125/257 (48%), Gaps = 34/257 (13%)
Query: 174 QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGD 233
QVAVKTL E +++D+ F+ E ++ K H N+V+ +G + P I+ E + GD
Sbjct: 38 QVAVKTL-PESCSEQDESD-FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGD 95
Query: 234 LRAYLKQK--GALKPTL-----AVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286
L+++L++ +P+ + A D+A+G YL EN IHRD+ N L
Sbjct: 96 LKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCK 152
Query: 287 GH---LKVADFGLSKLLKFANTV-KEDR---PVTCEETSWRYAAPEVYKNEEYDTKVDVF 339
G K+ADFG+++ + A+ K R P+ ++ PE + + + +K DV+
Sbjct: 153 GPGRVAKIADFGMARDIYRASYYRKGGRAMLPI-------KWMPPEAFLDGIFTSKTDVW 205
Query: 340 SFALILQEMIE-GCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSE 396
SF ++L E+ G P+P + +EV + R PP P Y ++ DCW
Sbjct: 206 SFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVY-----RIMTDCWQH 260
Query: 397 EPFRRPTFRQILMRLDD 413
P RP F IL R+
Sbjct: 261 TPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 9e-29
Identities = 88/258 (34%), Positives = 129/258 (50%), Gaps = 25/258 (9%)
Query: 163 GTFRIASWRGT-QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221
G + +W GT +VA+KTL E AF+ E +++K+RH +V L AV P
Sbjct: 20 GEVWMGTWNGTTKVAIKTLKPGTMMPE----AFLQEAQIMKKLRHDKLVP-LYAVVSEEP 74
Query: 222 MMIVTEYLPKGDLRAYLKQKGA--LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPS 279
+ IVTE++ KG L +LK+ LK V A IA GM Y+ IHRDL +
Sbjct: 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAA 131
Query: 280 NILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS---WRYAAPEVYKNEEYDTKV 336
NIL D+ K+ADFGL++L+ ED T + + ++ APE + K
Sbjct: 132 NILVGDNLVCKIADFGLARLI-------EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 337 DVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWS 395
DV+SF ++L E++ +G P+P +EV + R P L EL++ CW
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPE---SLHELMKLCWK 241
Query: 396 EEPFRRPTFRQILMRLDD 413
++P RPTF I L+D
Sbjct: 242 KDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 75/244 (30%), Positives = 116/244 (47%), Gaps = 18/244 (7%)
Query: 170 WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229
G A+K + V DE+ K + EL L+ P VV+ GA + + IV EY+
Sbjct: 24 PTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81
Query: 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289
G L LK+ G + + A I +G++YLH R IIHRD++PSN+L + G +
Sbjct: 82 DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR--HIIHRDIKPSNLLINSKGEV 139
Query: 290 KVADFGLSKLLKFANTVKEDRPVTCEETSW----RYAAPEVYKNEEYDTKVDVFSFALIL 345
K+ADFG+SK+L NT+ + ++ Y +PE + E Y D++S L L
Sbjct: 140 KIADFGISKVL--ENTLDQCN-------TFVGTVTYMSPERIQGESYSYAADIWSLGLTL 190
Query: 346 QEMIEG-CPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTF 404
E G P P Q + PP P ++ R+ I C ++P +RP+
Sbjct: 191 LECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSA 250
Query: 405 RQIL 408
++L
Sbjct: 251 AELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 73/258 (28%), Positives = 122/258 (47%), Gaps = 27/258 (10%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM------MIV 225
+VAVK L ++F+ D ++ F+ E A +++ HPNV++ +G +S M++
Sbjct: 27 FQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85
Query: 226 TEYLPKGDLRAYL------KQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPS 279
++ GDL +L ++ L V+F +DIA GM YL IHRDL
Sbjct: 86 LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAAR 142
Query: 280 NILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVF 339
N + +++ + VADFGLSK + + ++ + ++ A E + Y T DV+
Sbjct: 143 NCMLNENMTVCVADFGLSKKIYSGDYYRQG---CASKLPVKWLALESLADNVYTTHSDVW 199
Query: 340 SFALILQE-MIEGCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSE 396
+F + + E M G P+ + E+ I R P Y EL+ CWS
Sbjct: 200 AFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVY-----ELMCQCWSP 254
Query: 397 EPFRRPTFRQILMRLDDI 414
EP RP+F+ + +L+ I
Sbjct: 255 EPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 80/266 (30%), Positives = 121/266 (45%), Gaps = 48/266 (18%)
Query: 173 TQVAVKTLGE--EVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230
T VA+KTL E E ++ F E L+ ++HPN+V LG T+ P ++ EYL
Sbjct: 36 TSVAIKTLKENAEPKVQQE----FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLA 91
Query: 231 KGDLRAYL----------------KQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHR 274
GDL +L K +L + + A+ IA GM YL + +HR
Sbjct: 92 HGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHR 148
Query: 275 DLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR----PVTCEETSWRYAAPEVYKNE 330
DL N L + +K++DFGLS+ + A+ + PV R+ PE
Sbjct: 149 DLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV-------RWMPPEAILYG 201
Query: 331 EYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERP----PFRAPTTHYAYG 385
++ T+ D++SF ++L E+ G P+ +EV + R P P YA
Sbjct: 202 KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV--IEMIRSRQLLPCPEDCPARVYA-- 257
Query: 386 LRELIEDCWSEEPFRRPTFRQILMRL 411
L+ +CW+E P RRP F+ I RL
Sbjct: 258 ---LMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 81/265 (30%), Positives = 135/265 (50%), Gaps = 30/265 (11%)
Query: 163 GTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV--TQST 220
GT + + AVK+L TD ++V+ F+ E +++ HPNV+ LG ++ +
Sbjct: 14 GTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGS 71
Query: 221 PMMIVTEYLPKGDLRAYLKQKGALKPTLA--VKFALDIARGMNYLHENRPEAIIHRDLEP 278
P+ +V Y+ GDLR +++ + PT+ + F L +A+GM YL + +HRDL
Sbjct: 72 PL-VVLPYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAA 126
Query: 279 SNILRDDSGHLKVADFGLSK--LLKFANTVKEDR----PVTCEETSWRYAAPEVYKNEEY 332
N + D+S +KVADFGL++ K +V PV ++ A E + +++
Sbjct: 127 RNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV-------KWMALESLQTQKF 179
Query: 333 DTKVDVFSFALILQE-MIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG-LRELI 390
TK DV+SF ++L E M G PP+P ++ Y+ R R Y L E++
Sbjct: 180 TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITV-YLLQGR---RLLQPEYCPDPLYEVM 235
Query: 391 EDCWSEEPFRRPTFRQILMRLDDIS 415
CW +P RPTF +++ R++ I
Sbjct: 236 LSCWHPKPEMRPTFSELVSRIEQIF 260
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 59/234 (25%), Positives = 111/234 (47%), Gaps = 24/234 (10%)
Query: 187 DEDKVKAFIDELALLQKIRHPNVVQFLG--AVTQSTPMMIVTEYLPKGDLRAYLKQKGAL 244
E + + + E+ +L++++HPN+V++ + + IV EY GDL +++
Sbjct: 39 TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKE 98
Query: 245 KPTLAVKFALDI----ARGMNYLHENRP--EAIIHRDLEPSNILRDDSGHLKVADFGLSK 298
+ + +F I + H ++HRDL+P+NI D + ++K+ DFGL+K
Sbjct: 99 RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158
Query: 299 LL----KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPP 354
+L FA T T + Y +PE + YD K D++S ++ E+ PP
Sbjct: 159 ILGHDSSFAK--------TYVGTPY-YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
Query: 355 FPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
F + + ++ I FR Y+ L E+I+ + +P +RP+ ++L
Sbjct: 210 FTARNQLQLAS-KIK--EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 69/234 (29%), Positives = 113/234 (48%), Gaps = 17/234 (7%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRH---PNVVQFLGAVTQSTPMMIVTEY 228
G VA+K + + T +D V E+ALL ++R PN+ ++ G+ + + I+ EY
Sbjct: 26 GRVVALKIINLD--TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY 83
Query: 229 LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288
G +R +K G + ++ + Y+H+ +IHRD++ +NIL ++G+
Sbjct: 84 AEGGSVRTLMK-AGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGN 139
Query: 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQE 347
+K+ DFG++ LL N R W APEV + YDTK D++S + + E
Sbjct: 140 VKLCDFGVAALL---NQNSSKRSTFVGTPYW--MAPEVITEGKYYDTKADIWSLGITIYE 194
Query: 348 MIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRR 401
M G PP+ + + I +PP R Y+ LRE + C EEP R
Sbjct: 195 MATGNPPY-SDVDAFRAMMLIPKSKPP-RLEDNGYSKLLREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 160 ITKGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLG 214
I KG F I R T+ A+K + ++ ++ V+ ++E +LQ++ HP +V
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 215 AVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHR 274
+ M +V + L GDLR +L QK + +I + YLH IIHR
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHR 124
Query: 275 DLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDT 334
D++P NIL D+ GH+ + DF + A V D T + Y APEV + Y
Sbjct: 125 DIKPDNILLDEQGHVHITDFNI------ATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSV 178
Query: 335 KVDVFSFALILQEMIEGCPPFP 356
VD +S + E + G P+
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 72/272 (26%), Positives = 132/272 (48%), Gaps = 28/272 (10%)
Query: 148 DPKELDFSNSVEITKGTFRI---ASWRGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
DP+EL + N +I +G A+ R T +VA+K ++ + + I+E+ +++
Sbjct: 16 DPREL-YKNLEKIGEGASGEVYKATDRATGKEVAIK----KMRLRKQNKELIINEILIMK 70
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMN 261
+HPN+V + + + +V EY+ G L + Q + ++ +G+
Sbjct: 71 DCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLE 130
Query: 262 YLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS-WR 320
YLH +IHRD++ NIL G +K+ADFG + L T ++ + + T W
Sbjct: 131 YLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQL----TKEKSKRNSVVGTPYW- 182
Query: 321 YAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVP-KA--YIANERPPFRA 377
APEV K ++Y KVD++S ++ EM EG PP+ +E P +A I + P
Sbjct: 183 -MAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY----LREPPLRALFLITTKGIPPLK 237
Query: 378 PTTHYAYGLRELIEDCWSEEPFRRPTFRQILM 409
++ ++ + C ++P +RP+ ++L
Sbjct: 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 79/273 (28%), Positives = 114/273 (41%), Gaps = 47/273 (17%)
Query: 159 EITKGTFRIASWRGT---------QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNV 209
++ G+F + RG VAVK L + +D + F+ E A++ + H N+
Sbjct: 2 KLGDGSFGVV-RRGEWSTSGGKVIPVAVKCLKSDKLSD--IMDDFLKEAAIMHSLDHENL 58
Query: 210 VQFLGAVTQSTPMMIVTEYLPKGDLRAYLK--QKGALKPTLAVKFALDIARGMNYLHENR 267
++ G V P+M+VTE P G L L+ G + +A+ IA GM YL R
Sbjct: 59 IRLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 268 PEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYA--APE 325
IHRDL NIL +K+ DFGL + L ED V E +A APE
Sbjct: 118 ---FIHRDLAARNILLASDDKVKIGDFGLMRALP----QNEDHYVMEEHLKVPFAWCAPE 170
Query: 326 VYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE-----------KEVPKAYIANERPP 374
+ + DV+ F + L EM F +E K++ K ERP
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEM------FTYGEEPWAGLSGSQILKKIDKEGERLERPE 224
Query: 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQI 407
P Y ++ CW+ P RPTF +
Sbjct: 225 A-CPQDIY-----NVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-28
Identities = 71/258 (27%), Positives = 122/258 (47%), Gaps = 31/258 (12%)
Query: 174 QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM------MIVTE 227
+VAVKT+ ++ T + ++ F+ E A ++ HPNV++ +G +++ + M++
Sbjct: 29 KVAVKTMKLDIHTYSE-IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILP 87
Query: 228 YLPKGDLRAYL------KQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNI 281
++ GDL ++L L +KF +DIA GM YL IHRDL N
Sbjct: 88 FMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNC 144
Query: 282 LRDDSGHLKVADFGLSKLLKFANTVKEDR----PVTCEETSWRYAAPEVYKNEEYDTKVD 337
+ + + VADFGLSK + + ++ R PV ++ A E + Y +K D
Sbjct: 145 MLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV-------KWIAIESLADRVYTSKSD 197
Query: 338 VFSFALILQE-MIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSE 396
V++F + + E G P+P + E+ R + P L +L+ CW
Sbjct: 198 VWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR--LKQP-EDCLDELYDLMYSCWRA 254
Query: 397 EPFRRPTFRQILMRLDDI 414
+P RPTF ++ L++I
Sbjct: 255 DPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 7e-28
Identities = 82/262 (31%), Positives = 128/262 (48%), Gaps = 29/262 (11%)
Query: 171 RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYL 229
R T+VAVK L + E + I E+ +++ I +H N++ LGA TQ P+ ++ EY
Sbjct: 49 RVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 106
Query: 230 PKGDLRAYLKQKG------ALKPTLA----------VKFALDIARGMNYLHENRPEAIIH 273
KG+LR YL+ + PT V A +ARGM YL + IH
Sbjct: 107 SKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIH 163
Query: 274 RDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYD 333
RDL N+L + +K+ADFGL++ + + K+ T ++ APE + Y
Sbjct: 164 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK---TTNGRLPVKWMAPEALFDRIYT 220
Query: 334 TKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIED 392
+ DV+SF ++L E+ G P+P +E+ K R + T+ Y ++ D
Sbjct: 221 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELY---MMMRD 277
Query: 393 CWSEEPFRRPTFRQILMRLDDI 414
CW P +RPTF+Q++ LD I
Sbjct: 278 CWHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 56/162 (34%), Positives = 88/162 (54%), Gaps = 10/162 (6%)
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVK-FALD 255
E+ LQ +HP VV+ L + ++V EY+P DL L+ + P VK +
Sbjct: 49 EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRM 107
Query: 256 IARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCE 315
+ +G+ Y+H N I+HRDL+P+N+L G LK+ADFGL++L +E R + +
Sbjct: 108 LLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFS----EEEPRLYSHQ 160
Query: 316 ETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFP 356
+ Y APE+ Y +YD VD+++ I E++ G P FP
Sbjct: 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 74/263 (28%), Positives = 120/263 (45%), Gaps = 39/263 (14%)
Query: 173 TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232
VAVK L + ++ + F+ E+ +L ++ PN+ + LG T P+ ++ EY+ G
Sbjct: 47 VLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENG 104
Query: 233 DLRAYLKQKGALKPTLA-----------VKFALDIARGMNYLHENRPEAIIHRDLEPSNI 281
DL +L++ A LA + A IA GM YL +HRDL N
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC 161
Query: 282 LRDDSGHLKVADFGLSKLLKFANTVK-EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFS 340
L + +K+ADFG+S+ L ++ + + R R+ A E ++ TK DV++
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAP----LPIRWMAWESVLLGKFTTKSDVWA 217
Query: 341 FALILQEMIEGC--PPFPTKQEKEV----------PKAYIANERPPFRAPTTHYAYGLRE 388
F + L E++ C P+ +++V I RPP P Y E
Sbjct: 218 FGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPP-NCPKDIY-----E 271
Query: 389 LIEDCWSEEPFRRPTFRQILMRL 411
L+ +CW + RPTFR+I + L
Sbjct: 272 LMLECWRRDEEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 82/271 (30%), Positives = 129/271 (47%), Gaps = 37/271 (13%)
Query: 171 RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYL 229
+ VAVK L + TD+D + I E+ L++ I +H N++ LG TQ P+ ++ EY
Sbjct: 43 QTVTVAVKMLKDNA-TDKD-LADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYA 100
Query: 230 PKGDLRAYLKQKGALKPTLA----------------VKFALDIARGMNYLHENRPEAIIH 273
KG+LR +L+ + P V A +ARGM YL R IH
Sbjct: 101 AKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIH 157
Query: 274 RDLEPSNILRDDSGHLKVADFGLSKLLK----FANTVKEDRPVTCEETSWRYAAPEVYKN 329
RDL N+L + +K+ADFGL++ + + T PV ++ APE +
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPV-------KWMAPEALFD 210
Query: 330 EEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRE 388
Y + DV+SF +++ E+ G P+P +E+ K R + TH Y
Sbjct: 211 RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYM--- 267
Query: 389 LIEDCWSEEPFRRPTFRQILMRLDDISDQLS 419
L+ +CW P +RPTF+Q++ LD + +S
Sbjct: 268 LMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 78/254 (30%), Positives = 128/254 (50%), Gaps = 38/254 (14%)
Query: 174 QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGD 233
+VAVKTL + TD++K + F+ E L+ HPN+V+ LG + P I+ E + GD
Sbjct: 28 RVAVKTLRKGA-TDQEKKE-FLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGD 85
Query: 234 LRAYLKQKGALK---PTLAVK----FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286
L +YL+ + P L +K LD+A+G YL + IHRDL N L +
Sbjct: 86 LLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEK 142
Query: 287 GH-----LKVADFGLSKLLKFANTVKEDR-----PVTCEETSWRYAAPEVYKNEEYDTKV 336
G+ +K+ DFGL++ + + + PV R+ APE + ++ T+
Sbjct: 143 GYDADRVVKIGDFGLARDI-YKSDYYRKEGEGLLPV-------RWMAPESLLDGKFTTQS 194
Query: 337 DVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDC 393
DV+SF +++ E++ G P+P +EV + A R P P + +L+ +C
Sbjct: 195 DVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDK-----IYQLMTNC 249
Query: 394 WSEEPFRRPTFRQI 407
W+++P RPTF +I
Sbjct: 250 WAQDPSERPTFDRI 263
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 7e-27
Identities = 81/268 (30%), Positives = 130/268 (48%), Gaps = 41/268 (15%)
Query: 171 RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYL 229
+ VAVK L ++ TD+D + + E+ +++ I +H N++ LGA TQ P+ ++ EY
Sbjct: 43 KPVTVAVKMLKDDA-TDKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYA 100
Query: 230 PKGDLRAYLKQKGALKPTLAVKF------------------ALDIARGMNYLHENRPEAI 271
KG+LR YL+ + P + F A +ARGM YL +
Sbjct: 101 SKGNLREYLRARRP--PGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---C 155
Query: 272 IHRDLEPSNILRDDSGHLKVADFGLSK----LLKFANTVKEDRPVTCEETSWRYAAPEVY 327
IHRDL N+L + +K+ADFGL++ + + T PV ++ APE
Sbjct: 156 IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV-------KWMAPEAL 208
Query: 328 KNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386
+ Y + DV+SF ++L E+ G P+P +E+ K R A TH Y
Sbjct: 209 FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELY-- 266
Query: 387 RELIEDCWSEEPFRRPTFRQILMRLDDI 414
++ +CW P +RPTF+Q++ LD +
Sbjct: 267 -MIMRECWHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 7e-27
Identities = 76/255 (29%), Positives = 118/255 (46%), Gaps = 34/255 (13%)
Query: 172 GTQVAVKTLGEEVFTDE--DKVKAFIDELALLQKIRHPNVVQFLGAVT--QSTPMMIVTE 227
G A+KT + TD D K + EL + + + P +V++ GA S+ + I E
Sbjct: 26 GMIFALKT----ITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81
Query: 228 YLPKGDLRAYLK----QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR 283
Y G L + K + G + + K A + +G++YLH + IIHRD++PSNIL
Sbjct: 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILL 138
Query: 284 DDSGHLKVADFGLSKLL--KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSF 341
G +K+ DFG+S L A T TS+ Y APE + + Y DV+S
Sbjct: 139 TRKGQVKLCDFGVSGELVNSLAGTFT--------GTSF-YMAPERIQGKPYSITSDVWSL 189
Query: 342 ALILQEMIEGCPPFPTKQEKEVPK----AYIANERPPF----RAPTTHYAYGLRELIEDC 393
L L E+ + PFP + E + +YI N P ++ ++ I+ C
Sbjct: 190 GLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQC 249
Query: 394 WSEEPFRRPTFRQIL 408
++P RRPT +L
Sbjct: 250 LEKDPTRRPTPWDML 264
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-26
Identities = 42/90 (46%), Positives = 60/90 (66%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A+ G L+ +K LL++G DVN +D D RT LH+AA G ++V+LLL +GADV+ D
Sbjct: 11 LHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNARD 70
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKPS 130
+ G+TPL A + DV+KLL +HGA +
Sbjct: 71 KDGNTPLHLAARNGNLDVVKLLLKHGADVN 100
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 79/262 (30%), Positives = 129/262 (49%), Gaps = 37/262 (14%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGD 233
VAVK L ++ E + + E+ +++ I +H N++ LGA TQ P+ ++ EY KG+
Sbjct: 50 VAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 107
Query: 234 LRAYLKQKGALKPTLAVKFALDI--------------------ARGMNYLHENRPEAIIH 273
LR YL+ A +P ++++ DI ARGM YL + IH
Sbjct: 108 LREYLR---ARRP-PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIH 160
Query: 274 RDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYD 333
RDL N+L ++ +K+ADFGL++ + N + + T ++ APE + Y
Sbjct: 161 RDLAARNVLVTENNVMKIADFGLARDV---NNIDYYKKTTNGRLPVKWMAPEALFDRVYT 217
Query: 334 TKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIED 392
+ DV+SF +++ E+ G P+P +E+ K R A T+ Y ++ D
Sbjct: 218 HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY---MMMRD 274
Query: 393 CWSEEPFRRPTFRQILMRLDDI 414
CW P RPTF+Q++ LD I
Sbjct: 275 CWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 2e-26
Identities = 80/247 (32%), Positives = 122/247 (49%), Gaps = 24/247 (9%)
Query: 173 TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232
T+VAVKT+ + V+AF+ E +++ ++H +V+ L AV P+ I+TE++ KG
Sbjct: 31 TKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKG 85
Query: 233 DLRAYLKQKGALKPTLA--VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290
L +LK K L + F+ IA GM ++ + IHRDL +NIL S K
Sbjct: 86 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCK 142
Query: 291 VADFGLSKLLKFANTVKEDRPVTCEETS---WRYAAPEVYKNEEYDTKVDVFSFALILQE 347
+ADFGL++++ ED T E + ++ APE + K DV+SF ++L E
Sbjct: 143 IADFGLARVI-------EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLME 195
Query: 348 MIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQ 406
++ G P+P EV +A R P + L ++ CW P RPTF
Sbjct: 196 IVTYGRIPYPGMSNPEVIRALERGYRMP---RPENCPEELYNIMMRCWKNRPEERPTFEY 252
Query: 407 ILMRLDD 413
I LDD
Sbjct: 253 IQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 27/204 (13%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAF-IDELALLQKIR---HPNVVQFLG-----AVTQSTPM 222
G VA+K + V E+ + + E+ALL+++ HPN+V+ L + +
Sbjct: 24 GRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81
Query: 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIA----RGMNYLHENRPEAIIHRDLEP 278
+V E++ + DL YL + KP L + D+ RG+++LH +R I+HRDL+P
Sbjct: 82 TLVFEHVDQ-DLATYLSK--CPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKP 135
Query: 279 SNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDV 338
NIL G +K+ADFGL+++ F E + T W Y APEV Y T VD+
Sbjct: 136 QNILVTSDGQVKIADFGLARIYSF-----EMALTSVVVTLW-YRAPEVLLQSSYATPVDM 189
Query: 339 FSFALILQEMIEGCPPFPTKQEKE 362
+S I E+ P F E +
Sbjct: 190 WSVGCIFAELFRRRPLFRGTSEAD 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 64/241 (26%), Positives = 113/241 (46%), Gaps = 21/241 (8%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
VA+K + E ED+++ E+ L + R P + ++ G+ + + + I+ EY
Sbjct: 26 NQVVAIKVIDLE--EAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG 83
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
G LK + +A ++ G+ YLHE IHRD++ +NIL + G +K+
Sbjct: 84 GSCLDLLKPGKLDETYIAF-ILREVLLGLEYLHEEGK---IHRDIKAANILLSEEGDVKL 139
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG 351
ADFG+S L K + V T + + APEV K YD K D++S + E+ +G
Sbjct: 140 ADFGVSGQLTS-TMSKRNTFVG---TPF-WMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
Query: 352 CPPF----PTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQI 407
PP P + +PK P ++ ++ + C +++P RP+ +++
Sbjct: 195 EPPLSDLHPMRVLFLIPK------NNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKEL 248
Query: 408 L 408
L
Sbjct: 249 L 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 78/248 (31%), Positives = 128/248 (51%), Gaps = 34/248 (13%)
Query: 174 QVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKG 232
+VAVK L + E + A + EL ++ + H N+V LGA T P++++TEY G
Sbjct: 67 KVAVKMLKPTAHSSERE--ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYG 124
Query: 233 DLRAYLKQKGALKPTLA--VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL- 289
DL +L++K TL + F+ +A+GM +L + IHRDL N+L G +
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLL-THGKIV 180
Query: 290 KVADFGLSK-LLKFANTVKEDR---PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALIL 345
K+ DFGL++ ++ +N V + PV ++ APE N Y + DV+S+ ++L
Sbjct: 181 KICDFGLARDIMNDSNYVVKGNARLPV-------KWMAPESIFNCVYTFESDVWSYGILL 233
Query: 346 QEMIE-GCPPFP-----TKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPF 399
E+ G P+P +K K + + Y + P AP Y ++++ CW +P
Sbjct: 234 WEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ--PEHAPAEIY-----DIMKTCWDADPL 286
Query: 400 RRPTFRQI 407
+RPTF+QI
Sbjct: 287 KRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-26
Identities = 73/244 (29%), Positives = 116/244 (47%), Gaps = 27/244 (11%)
Query: 173 TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232
T VAVK+ E + K K F+ E +L++ HPN+V+ +G TQ P+ IV E + G
Sbjct: 21 TPVAVKSC-RETLPPDLKAK-FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78
Query: 233 DLRAYLKQKGA-LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
D +L+ +G LK ++ + A GM YL + IHRDL N L + LK+
Sbjct: 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKI 135
Query: 292 ADFGLSKLLKFANTVKEDRPVTC-----EETSWRYAAPEVYKNEEYDTKVDVFSFALILQ 346
+DFG+S+ +E+ V ++ ++ APE Y ++ DV+SF ++L
Sbjct: 136 SDFGMSR--------EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLW 187
Query: 347 EMIE-GCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPT 403
E G P+ ++ +A R P P Y L+E CW +P +RP+
Sbjct: 188 EAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVY-----RLMERCWEYDPGQRPS 242
Query: 404 FRQI 407
F +
Sbjct: 243 FSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 156 NSVEITK----GTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQKIRH 206
+ E K G+F + +G+ A+K L + +V+ ++E +LQ IRH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 207 PNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHEN 266
P +V G+ + + +V EY+P G+L ++L++ G +A +A + + YLH
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 267 RPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTC---EETSWRYAA 323
I++RDL+P N+L D G++K+ DFG FA VK C E Y A
Sbjct: 121 ---DIVYRDLKPENLLLDSDGYIKITDFG------FAKRVKGRTYTLCGTPE-----YLA 166
Query: 324 PEVYKNEEYDTKVDVFSFALILQEMIEGCPPF 355
PE+ ++ Y VD ++ +++ EM+ G PPF
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 172 GTQVAVKTLGEEVFTDEDKVK-AFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230
+ A+K L + E KVK I++ L + HP +++ + V EY P
Sbjct: 26 NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85
Query: 231 KGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290
G+L Y+++ G+L +A +I + YLH IIHRDL+P NIL D H+K
Sbjct: 86 NGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIK 142
Query: 291 VADFGLSKLL-----------KFANTVKEDRPVTCEETSW----RYAAPEVYKNEEYDTK 335
+ DFG +K+L N + S+ Y +PE+ +
Sbjct: 143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS 202
Query: 336 VDVFSFALILQEMIEGCPPFPTKQEKEV 363
D+++ I+ +M+ G PPF E
Sbjct: 203 SDLWALGCIIYQMLTGKPPFRGSNEYLT 230
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 73/265 (27%), Positives = 123/265 (46%), Gaps = 31/265 (11%)
Query: 160 ITKGTFR-----IASWRGTQVAVKTLGEEVFTDEDKVKA---FIDELALLQKIRHPNVVQ 211
I KG F I G VA+K + ++F D KA + E+ LL+++ HPNV++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKV--QIFEMMDA-KARQDCLKEIDLLKQLDHPNVIK 66
Query: 212 FLGAVTQSTPMMIVTEYLPKGDLR---AYLKQKGALKPTLAV-KFALDIARGMNYLHENR 267
+L + ++ + IV E GDL + K++ L P + K+ + + + ++H R
Sbjct: 67 YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126
Query: 268 PEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVY 327
I+HRD++P+N+ +G +K+ D GL + T T Y +PE
Sbjct: 127 ---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP-----YYMSPERI 178
Query: 328 KNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK----EVPKAYIANERPPFRAPTTHYA 383
Y+ K D++S +L EM PF +K + K + PP P HY+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLYSLCKKIEKCDYPPL--PADHYS 234
Query: 384 YGLRELIEDCWSEEPFRRPTFRQIL 408
LR+L+ C + +P +RP +L
Sbjct: 235 EELRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 82/283 (28%), Positives = 133/283 (46%), Gaps = 34/283 (12%)
Query: 150 KELDFSNSVEITKGTFRIASWRGTQ-VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPN 208
+EL +I KG + Q VA+KTL + + + F E +L+ ++ HPN
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--INNPQQWGEFQQEASLMAELHHPN 68
Query: 209 VVQFLGAVTQSTPMMIVTEYLPKGDLRAYL-------------KQKGALKPTLA----VK 251
+V LG VTQ P+ ++ EYL +GDL +L + G +K +L +
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 252 FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311
A+ IA GM YL + +H+DL NIL + H+K++D GLS+ + A+ + +P
Sbjct: 129 IAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV-QP 184
Query: 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIAN 370
+ W PE ++ + D++SF ++L E+ G P+ +EV +
Sbjct: 185 KSLLPIRW--MPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR 242
Query: 371 ERPPFR--APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411
+ P P Y+ L+ +CW E P RRP F+ I RL
Sbjct: 243 QLLPCSEDCPPRMYS-----LMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 83/275 (30%), Positives = 129/275 (46%), Gaps = 32/275 (11%)
Query: 151 ELDFSNS---VEITKGTFRI---ASWRGTQV--AVKTLGEEVFTDEDKVKAFIDELALLQ 202
E ++ + V + KGT+ I A TQV A+K + E D V+ +E+AL
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPE---RDSRYVQPLHEEIALHS 60
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQK-GALK---PTLAVKFALDIAR 258
++H N+VQ+LG+ +++ I E +P G L A L+ K G LK T+ + I
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIF-YTKQILE 119
Query: 259 GMNYLHENRPEAIIHRDLEPSNILRDD-SGHLKVADFGLSKLLKFANTVKEDRPVTCEET 317
G+ YLH+N+ I+HRD++ N+L + SG +K++DFG SK L N E T +
Sbjct: 120 GLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQ-- 174
Query: 318 SWRYAAPEVYKN--EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVP--KAYIANERP 373
Y APEV Y D++S + EM G PPF E + K + P
Sbjct: 175 ---YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP 231
Query: 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
+ A + I C+ +P +R + +L
Sbjct: 232 EIPESLSAEA---KNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 60/171 (35%), Positives = 95/171 (55%), Gaps = 23/171 (13%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLK---QKGALKPTLAVK 251
I E++L+++++H N+V+ + +M+V EY+ K DL+ Y+ +GAL P
Sbjct: 46 IREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKS 104
Query: 252 FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL-----KFANTV 306
F + +G+ + HENR ++HRDL+P N+L + G LK+ADFGL++ F+N V
Sbjct: 105 FTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEV 161
Query: 307 KEDRPVTCEETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFP 356
T W Y AP+V + Y T +D++S I+ EMI G P FP
Sbjct: 162 V---------TLW-YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP 202
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 71/251 (28%), Positives = 118/251 (47%), Gaps = 41/251 (16%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G VA+K + V D ++ I E+++L++ P +V++ G+ ++T + IV EY
Sbjct: 28 GQVVAIKVV--PVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82
Query: 232 GDLRAYLKQKGALKPTLA---VKFAL-DIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
G + +K TL + L +G+ YLH N+ IHRD++ NIL ++ G
Sbjct: 83 GSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEG 136
Query: 288 HLKVADFGLSKLL----KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFAL 343
K+ADFG+S L NTV P + APEV + Y+ K D++S +
Sbjct: 137 QAKLADFGVSGQLTDTMAKRNTVI-GTPF--------WMAPEVIQEIGYNNKADIWSLGI 187
Query: 344 ILQEMIEGCPPF----PTKQEKEVPKAYIANERPP--FRAPTTHYAYGLRELIEDCWSEE 397
EM EG PP+ P + +P +PP P ++ + ++ C ++
Sbjct: 188 TAIEMAEGKPPYSDIHPMRAIFMIPN------KPPPTLSDP-EKWSPEFNDFVKKCLVKD 240
Query: 398 PFRRPTFRQIL 408
P RP+ Q+L
Sbjct: 241 PEERPSAIQLL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 68/248 (27%), Positives = 111/248 (44%), Gaps = 20/248 (8%)
Query: 171 RGTQVAVKTLGEEVFTDEDKVKAFIDEL----ALLQKIRHPNVVQFLGAVTQSTPMMIVT 226
+VA+K + D +K + +DEL + + HPNVV++ + + +V
Sbjct: 25 NNEKVAIKRI------DLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78
Query: 227 EYLPKGDLRAYLKQK---GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR 283
YL G L +K G L + ++ +G+ YLH N IHRD++ NIL
Sbjct: 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILL 135
Query: 284 DDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEE-YDTKVDVFSFA 342
+ G +K+ADFG+S L T T + APEV + YD K D++SF
Sbjct: 136 GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC-WMAPEVMEQVHGYDFKADIWSFG 194
Query: 343 LILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG--LRELIEDCWSEEPFR 400
+ E+ G P+ +V + N+ P + Y R++I C ++P +
Sbjct: 195 ITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSK 254
Query: 401 RPTFRQIL 408
RPT ++L
Sbjct: 255 RPTAEELL 262
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 76/260 (29%), Positives = 120/260 (46%), Gaps = 39/260 (15%)
Query: 173 TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232
T V VK L + DE+ F EL + +K+ H NVV+ LG ++ P ++ EY G
Sbjct: 36 TLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLG 93
Query: 233 DLRAYL-----KQKGALKPTLAVK----FALDIARGMNYLHENRPEAIIHRDLEPSNILR 283
DL+ +L K + P L+ K IA GM++L R +HRDL N L
Sbjct: 94 DLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLV 150
Query: 284 DDSGHLKVADFGLSK------LLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVD 337
+KV+ LSK K N + P+ R+ APE + +++ TK D
Sbjct: 151 SSQREVKVSLLSLSKDVYNSEYYKLRNALI---PL-------RWLAPEAVQEDDFSTKSD 200
Query: 338 VFSFALILQEMI-EGCPPFPTKQEKEV---PKAYIANERPPFRAPTTHYAYGLRELIEDC 393
V+SF +++ E+ +G PF ++EV +A P P+ L +L+ C
Sbjct: 201 VWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSR-----LYKLMTRC 255
Query: 394 WSEEPFRRPTFRQILMRLDD 413
W+ P RP+F +++ L +
Sbjct: 256 WAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 68/203 (33%), Positives = 97/203 (47%), Gaps = 29/203 (14%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP--MMIVTEYL 229
G VA+K + E + + A I E+ LLQK+RHPN+V+ VT + +V EY+
Sbjct: 24 GELVALKKIRMENEKEGFPITA-IREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82
Query: 230 PKGDLRAYLKQKGALKPTLAVKFALD--------IARGMNYLHENRPEAIIHRDLEPSNI 281
DL L VKF + G+ YLH N I+HRD++ SNI
Sbjct: 83 DH-DLTGLLDSPE-------VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNI 131
Query: 282 LRDDSGHLKVADFGLSKLLKFANTVK-EDRPVTCEETSWRYAAPEVYKNEE-YDTKVDVF 339
L ++ G LK+ADFGL++ N+ +R +T W Y PE+ Y +VD++
Sbjct: 132 LINNDGVLKLADFGLARPYTKRNSADYTNRVITL----W-YRPPELLLGATRYGPEVDMW 186
Query: 340 SFALILQEMIEGCPPFPTKQEKE 362
S IL E+ G P F E E
Sbjct: 187 SVGCILAELFLGKPIFQGSTELE 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 4e-25
Identities = 39/90 (43%), Positives = 56/90 (62%), Gaps = 2/90 (2%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G+L+ +K LL+ G DVN D TALH+AA G ++V+LLL GADV+ +D
Sbjct: 1 LHLAAKNGNLELVKLLLEKGADVNLGD--TDTALHLAARNGNLEIVKLLLEHGADVNAKD 58
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKPS 130
+ G+T L A + +++KLL EHGA +
Sbjct: 59 KDGNTALHLAARNGNLEIVKLLLEHGADIN 88
|
Length = 91 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 66/224 (29%), Positives = 112/224 (50%), Gaps = 10/224 (4%)
Query: 189 DKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTL 248
D VKA E+ L+ + H N+VQ+LG T + I EY+P G + + L+ G + L
Sbjct: 50 DMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL 109
Query: 249 AVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKE 308
F + G+ YLH + I+HRDL+ N+L D G K++DFG+SK K +
Sbjct: 110 VRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDN 164
Query: 309 DRPVTCEETSWRYAAPEVYKNEE--YDTKVDVFSFALILQEMIEGCPPFPTKQE-KEVPK 365
D+ ++ + + + + APEV + Y KVD++S ++ EM G P+ ++ + K
Sbjct: 165 DQNMSMQGSVF-WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223
Query: 366 AYIANERPPFRAPTT-HYAYGLRELIEDCWSEEPFRRPTFRQIL 408
PP + + + + + C++ P RPT R++L
Sbjct: 224 LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 78/268 (29%), Positives = 126/268 (47%), Gaps = 42/268 (15%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST---PMMIVTEY 228
G VAVK L + + ++ F E+ +L+ ++H N+V++ G V S + +V EY
Sbjct: 33 GEVVAVKKLQH---STAEHLRDFEREIEILKSLQHDNIVKYKG-VCYSAGRRNLRLVMEY 88
Query: 229 LPKGDLRAYL-KQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
LP G LR YL K + L + +A I +GM YL R +HRDL NIL +
Sbjct: 89 LPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESEN 145
Query: 288 HLKVADFGLSKLL---KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALI 344
+K+ DFGL+K+L K V+E E+ + APE ++ DV+SF ++
Sbjct: 146 RVKIGDFGLTKVLPQDKEYYKVREP-----GESPIFWYAPESLTESKFSVASDVWSFGVV 200
Query: 345 LQEMIEGC-----PP--FPTKQEKEVPKAYIA---------NER--PPFRAPTTHYAYGL 386
L E+ PP F + I N R P P YA
Sbjct: 201 LYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYA--- 257
Query: 387 RELIEDCWSEEPFRRPTFRQILMRLDDI 414
++++CW+ +P +RP+F ++ ++++ I
Sbjct: 258 --IMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 61/182 (33%), Positives = 93/182 (51%), Gaps = 13/182 (7%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
VA+K + + + ++V+ + E +L + +V+ L A + + EY+P GD
Sbjct: 29 VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF 88
Query: 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294
R L G L A + ++ ++ LHE IHRDL+P N L D SGH+K+ DF
Sbjct: 89 RTLLNNLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDF 145
Query: 295 GLSK-LLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCP 353
GLSK ++ +AN+V S Y APEV + + YD VD +S +L E + G P
Sbjct: 146 GLSKGIVTYANSVV---------GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196
Query: 354 PF 355
PF
Sbjct: 197 PF 198
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 13/214 (6%)
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL-KQKGALKPTLAV-KFAL 254
E+A+L ++HPN+VQ+ + ++ + IV +Y GDL + Q+G L P + + +
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108
Query: 255 DIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTC 314
I + ++H+ + I+HRD++ NI G +K+ DFG++++L +TV+ R TC
Sbjct: 109 QICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLN--STVELAR--TC 161
Query: 315 EETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPP 374
T + Y +PE+ +N Y+ K D+++ +L EM F K + I PP
Sbjct: 162 IGTPY-YLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP 220
Query: 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
++HY+Y LR L+ + P RP+ IL
Sbjct: 221 V---SSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 60/169 (35%), Positives = 91/169 (53%), Gaps = 12/169 (7%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKF 252
I E++LL+++ HPN+V+ L V + +V E+L DL+ Y+ L P L +
Sbjct: 46 IREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSY 104
Query: 253 ALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312
+ +G+ Y H +R ++HRDL+P N+L D G LK+ADFGL++ F V R
Sbjct: 105 LYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPV---RTY 156
Query: 313 TCEETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE 360
T E + Y APE+ + +Y T VD++S I EM+ P FP E
Sbjct: 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 62/170 (36%), Positives = 85/170 (50%), Gaps = 13/170 (7%)
Query: 197 ELALLQKIRHPNVVQFLGAVT--QSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVK-FA 253
E+ LL +RHPN+V+ V + +V EY + DL + L VK
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLM 114
Query: 254 LDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT 313
L + RG+ YLHEN IIHRDL+ SN+L D G LK+ADFGL++ + K P
Sbjct: 115 LQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART--YGLPAKPMTPKV 169
Query: 314 CEETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
T W Y APE+ Y T +D+++ IL E++ P P K E E
Sbjct: 170 V--TLW-YRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 2e-24
Identities = 80/266 (30%), Positives = 132/266 (49%), Gaps = 20/266 (7%)
Query: 148 DPKELDFSNSVEITKGTFR-----IASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
DP+EL F+ +I KG+F I + VA+K + E ED+++ E+ +L
Sbjct: 1 DPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE--EAEDEIEDIQQEITVLS 57
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNY 262
+ P V ++ G+ + T + I+ EYL G L + G L T +I +G++Y
Sbjct: 58 QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDY 116
Query: 263 LHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYA 322
LH E IHRD++ +N+L + G +K+ADFG++ L +K + V +
Sbjct: 117 LHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTP----FWM 168
Query: 323 APEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382
APEV K YD+K D++S + E+ +G PP +V N P +Y
Sbjct: 169 APEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEG---NY 225
Query: 383 AYGLRELIEDCWSEEPFRRPTFRQIL 408
+ L+E +E C ++EP RPT +++L
Sbjct: 226 SKPLKEFVEACLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 73/267 (27%), Positives = 126/267 (47%), Gaps = 27/267 (10%)
Query: 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHP 207
DF +I KG+F + A+K + ++ +A IDE +L K+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEA-IDEARVLAKLDSS 59
Query: 208 NVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLK-QKGALKPTLAV-KFALDIARGMNYLHE 265
++++ + + IV EY GDL LK Q+G P V +F + I G+ +LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 266 NRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK----FANTVKEDRPVTCEETSWRY 321
+ I+HRD++ N+ D ++K+ D G++KLL FANT+ T + Y
Sbjct: 120 KK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV--------GTPY-Y 167
Query: 322 AAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381
+PE+ +++ Y+ K DV++ ++L E G PF + + I PP
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQM--- 224
Query: 382 YAYGLRELIEDCWSEEPFRRPTFRQIL 408
Y+ L +LI+ C +++ +RP Q+L
Sbjct: 225 YSQQLAQLIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 78/264 (29%), Positives = 112/264 (42%), Gaps = 46/264 (17%)
Query: 173 TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232
T VAVK L EE D F E AL+ + HPN+V+ LG PM ++ EY+ G
Sbjct: 36 TMVAVKMLKEEASADMQA--DFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYG 93
Query: 233 DLRAYLKQ----------------------KGALKPTLAVKFALDIARGMNYLHENRPEA 270
DL +L+ L T + A +A GM YL E +
Sbjct: 94 DLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--- 150
Query: 271 IIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE 330
+HRDL N L ++ +K+ADFGLS+ + A+ K + R+ PE
Sbjct: 151 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN---DAIPIRWMPPESIFYN 207
Query: 331 EYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERP------PFRAPTTHYA 383
Y T+ DV+++ ++L E+ G P+ +EV I R P P Y
Sbjct: 208 RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV----IYYVRDGNVLSCPDNCPLELYN 263
Query: 384 YGLRELIEDCWSEEPFRRPTFRQI 407
L+ CWS+ P RP+F I
Sbjct: 264 -----LMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 58/190 (30%), Positives = 93/190 (48%), Gaps = 15/190 (7%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
VA+K +E DED K + E+ +L+++RH N+V A + + +V EY+ + L
Sbjct: 29 VAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLL 87
Query: 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294
G L P + + + + Y H + IIHRD++P NIL +SG LK+ DF
Sbjct: 88 ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDF 144
Query: 295 GLSKLLKFANTVKEDRPVTCEE---TSWRYAAPEVY-KNEEYDTKVDVFSFALILQEMIE 350
G FA ++ + T W Y APE+ + Y VDV++ I+ E+++
Sbjct: 145 G------FARALRARPASPLTDYVATRW-YRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197
Query: 351 GCPPFPTKQE 360
G P FP +
Sbjct: 198 GEPLFPGDSD 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 69/246 (28%), Positives = 117/246 (47%), Gaps = 22/246 (8%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
GT +A K + + K + EL ++ + R P +V F GA + + E++
Sbjct: 30 GTVMAKKVV--HIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDC 87
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
G L K+ G + + K A+ + G+ YL+ I+HRD++PSNIL + G +K+
Sbjct: 88 GSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKL 145
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG 351
DFG+S L N++ + T TS Y +PE + +Y K DV+S + + E+ G
Sbjct: 146 CDFGVSGEL--INSIAD----TFVGTS-TYMSPERIQGGKYTVKSDVWSLGISIIELALG 198
Query: 352 CPPFPTKQEKEVPKA----------YIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRR 401
PF + + I E PP R P++ + LR+ ++ C ++P R
Sbjct: 199 KFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP-RLPSSDFPEDLRDFVDACLLKDPTER 257
Query: 402 PTFRQI 407
PT +Q+
Sbjct: 258 PTPQQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 73/219 (33%), Positives = 112/219 (51%), Gaps = 18/219 (8%)
Query: 153 DFSNSVEITKGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDE---LALLQKI 204
DF+ + + KG+F +A +GT A+K L ++V +D V+ + E LAL K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK- 59
Query: 205 RHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLH 264
P + Q + V EY+ GDL +++Q G K AV +A +IA G+ +LH
Sbjct: 60 -PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118
Query: 265 ENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAP 324
+ II+RDL+ N++ D GH+K+ADFG+ K N T T Y AP
Sbjct: 119 S---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK----ENIFGGKTTRTFCGTP-DYIAP 170
Query: 325 EVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV 363
E+ + Y VD ++F ++L EM+ G PPF + E E+
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 3e-24
Identities = 81/259 (31%), Positives = 123/259 (47%), Gaps = 42/259 (16%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
A+K L E F E+ + F EL +L K+ HPN++ LGA + I EY P G+L
Sbjct: 33 AIKMLKE--FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNL 90
Query: 235 RAYLKQKGALK--PTLA--------------VKFALDIARGMNYLHENRPEAIIHRDLEP 278
+L++ L+ P A ++FA D+A GM YL E + IHRDL
Sbjct: 91 LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAA 147
Query: 279 SNILRDDSGHLKVADFGLSKLLK-FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVD 337
N+L ++ K+ADFGLS+ + + PV R+ A E Y TK D
Sbjct: 148 RNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPV-------RWMAIESLNYSVYTTKSD 200
Query: 338 VFSFALILQEMIE-GCPPFP----TKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIED 392
V+SF ++L E++ G P+ + +++P+ Y + P Y EL+
Sbjct: 201 VWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK--PRNCDDEVY-----ELMRQ 253
Query: 393 CWSEEPFRRPTFRQILMRL 411
CW + P+ RP F QI ++L
Sbjct: 254 CWRDRPYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 79/266 (29%), Positives = 130/266 (48%), Gaps = 20/266 (7%)
Query: 148 DPKELDFSNSVEITKGTFR-----IASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
DP+EL F+ I KG+F I + VA+K + E ED+++ E+ +L
Sbjct: 1 DPEEL-FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE--EAEDEIEDIQQEITVLS 57
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNY 262
+ P + ++ G+ + T + I+ EYL G LK G L+ T +I +G++Y
Sbjct: 58 QCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDY 116
Query: 263 LHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYA 322
LH R IHRD++ +N+L + G +K+ADFG++ L T + + T T + +
Sbjct: 117 LHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQL----TDTQIKRNTFVGTPF-WM 168
Query: 323 APEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382
APEV K YD K D++S + E+ +G PP V N P Y
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEG---QY 225
Query: 383 AYGLRELIEDCWSEEPFRRPTFRQIL 408
+ +E +E C +++P RPT +++L
Sbjct: 226 SKPFKEFVEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 14/210 (6%)
Query: 160 ITKGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALL-QKIRHPNVVQFL 213
+ KG+F +A +GT AVK L ++V +D V+ + E +L +HP + Q
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIH 273
+ V EY+ GDL ++++ G A +A +I G+ +LHE II+
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE---RGIIY 119
Query: 274 RDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYD 333
RDL+ N+L D GH+K+ADFG+ K + T T Y APE+ + Y
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMCK----EGILGGVTTSTFCGTP-DYIAPEILSYQPYG 174
Query: 334 TKVDVFSFALILQEMIEGCPPFPTKQEKEV 363
VD ++ ++L EM+ G PF E E+
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 14/192 (7%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G VA+K + ++ A + E+ LL+++ HPN+++ L + +V E++
Sbjct: 24 GEIVAIKKIKLRFESEGIPKTA-LREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-D 81
Query: 232 GDLRAYLKQKGALKPTLAVK-FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290
DL +K + P +K + + +G+ + H + I+HRDL+P N+L + G LK
Sbjct: 82 TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLK 138
Query: 291 VADFGLSKLLKFANTVKEDRPVTCE-ETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEM 348
+ADFGL++ RP T T W Y APE+ ++ Y T VD++S I E+
Sbjct: 139 LADFGLARSFGSPV-----RPYTHYVVTRW-YRAPELLLGDKGYSTPVDIWSVGCIFAEL 192
Query: 349 IEGCPPFPTKQE 360
+ P FP K E
Sbjct: 193 LSRRPLFPGKSE 204
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 78/265 (29%), Positives = 129/265 (48%), Gaps = 42/265 (15%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
A+K + E + +D + F EL +L K+ HPN++ LGA + + EY P G+L
Sbjct: 38 AIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 95
Query: 235 RAYLKQKGALK--PTLAV--------------KFALDIARGMNYLHENRPEAIIHRDLEP 278
+L++ L+ P A+ FA D+ARGM+YL + + IHRDL
Sbjct: 96 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAA 152
Query: 279 SNILRDDSGHLKVADFGLSKLLK-FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVD 337
NIL ++ K+ADFGLS+ + + PV R+ A E Y T D
Sbjct: 153 RNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV-------RWMAIESLNYSVYTTNSD 205
Query: 338 VFSFALILQEMIE-GCPPFP----TKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIED 392
V+S+ ++L E++ G P+ + +++P+ Y + P Y +L+
Sbjct: 206 VWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK--PLNCDDEVY-----DLMRQ 258
Query: 393 CWSEEPFRRPTFRQILMRLDDISDQ 417
CW E+P+ RP+F QIL+ L+ + ++
Sbjct: 259 CWREKPYERPSFAQILVSLNRMLEE 283
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 7e-24
Identities = 60/237 (25%), Positives = 110/237 (46%), Gaps = 9/237 (3%)
Query: 174 QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGD 233
QV + T V E + + +E+ LL+ ++H N+VQ+LG + I E++P G
Sbjct: 31 QVELDT--SNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGS 88
Query: 234 LRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293
+ + L + G L + K+ I G+ YLH N ++HRD++ +N++ +G +K+ D
Sbjct: 89 ISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLID 145
Query: 294 FGLSKLLKF--ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG 351
FG ++ L + + + + T + + APEV Y K D++S + EM G
Sbjct: 146 FGCARRLAWVGLHGTHSNMLKSMHGTPY-WMAPEVINESGYGRKSDIWSIGCTVFEMATG 204
Query: 352 CPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
PP ++ YI R ++ + + C + + RP+ Q+L
Sbjct: 205 KPPL-ASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 8e-24
Identities = 71/223 (31%), Positives = 111/223 (49%), Gaps = 14/223 (6%)
Query: 190 KVKAFIDELALLQKIRHPNVVQFLGAVTQ--STPMMIVTEYLPKGDLRAYLKQKGALKPT 247
+V A E+ LL+ ++H +VQ+ G + + I EY+P G ++ LK GAL +
Sbjct: 47 EVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTES 106
Query: 248 LAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK-FANTV 306
+ K+ I GM+YLH N I+HRD++ +NILRD +G++K+ DFG SK L+ +
Sbjct: 107 VTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSG 163
Query: 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKA 366
R VT + + +PEV E Y K DV+S + EM+ PP+ E E A
Sbjct: 164 TGIRSVT---GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAA 217
Query: 367 YIANERPPFRAP-TTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
P +H + R+ + C E RP+ ++L
Sbjct: 218 IFKIATQPTNPQLPSHISEHARDFLG-CIFVEARHRPSAEELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 72/220 (32%), Positives = 112/220 (50%), Gaps = 15/220 (6%)
Query: 162 KGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKA-FIDELALLQKIRHPNVVQFLGA 215
KG+F +A +GT A+K L ++V ++D V+ ++ L HP +
Sbjct: 5 KGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCT 64
Query: 216 VTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRD 275
+ V EYL GDL +++ G A +A +I G+ +LH+ II+RD
Sbjct: 65 FQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRD 121
Query: 276 LEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTK 335
L+ N+L D GH+K+ADFG+ K N E + T T Y APE+ K ++Y+
Sbjct: 122 LKLDNVLLDKDGHIKIADFGMCKE----NMNGEGKASTFCGTP-DYIAPEILKGQKYNES 176
Query: 336 VDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPF 375
VD +SF ++L EM+ G PF + E E+ + I N+RP F
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGEDEDELFDS-ILNDRPHF 215
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 1e-23
Identities = 80/265 (30%), Positives = 118/265 (44%), Gaps = 44/265 (16%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS--TPMMIVTEYL 229
G VAVKTL E + + E+ +L+ + H N+V++ G ++ + ++ EY+
Sbjct: 33 GEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90
Query: 230 PKGDLRAYL-KQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288
P G LR YL K K L L FA I GM YLH IHRDL N+L D+
Sbjct: 91 PLGSLRDYLPKHKLNLAQLLL--FAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRL 145
Query: 289 LKVADFGLSKLLKFANT---VKE--DRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFAL 343
+K+ DFGL+K + + V+E D PV + A E K ++ DV+SF +
Sbjct: 146 VKIGDFGLAKAVPEGHEYYRVREDGDSPVF-------WYAVECLKENKFSYASDVWSFGV 198
Query: 344 ILQEMIEGCPPF---PTKQEKEV-PKAYIANERP-------------PFRAPTTHYAYGL 386
L E++ C P K E+ + PK P P +
Sbjct: 199 TLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQE-----V 253
Query: 387 RELIEDCWSEEPFRRPTFRQILMRL 411
L+++CW E RPTFR ++ L
Sbjct: 254 YILMKNCWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 52/174 (29%), Positives = 94/174 (54%), Gaps = 11/174 (6%)
Query: 196 DELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALD 255
+E +L+++ HP +++ + ++ EY+P G+L +YL+ G + + +A +
Sbjct: 50 NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109
Query: 256 IARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCE 315
I + YLH + I++RDL+P NIL D GH+K+ DFG +K L+ DR T
Sbjct: 110 IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-------DRTWTLC 159
Query: 316 ETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIA 369
T Y APEV +++ ++ VD ++ +++ EM+ G PPF + + +A
Sbjct: 160 GTP-EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA 212
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-23
Identities = 74/260 (28%), Positives = 121/260 (46%), Gaps = 33/260 (12%)
Query: 174 QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST-------PMMIVT 226
+VAVKT+ + T +++ F+ E +++ HPNV++ +G Q+ P++I+
Sbjct: 28 KVAVKTMKIAICT-RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILP 86
Query: 227 EYLPKGDLRAYL------KQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSN 280
++ GDL ++L L + VKF DIA GM YL IHRDL N
Sbjct: 87 -FMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARN 142
Query: 281 ILRDDSGHLKVADFGLSKLLKFANTVKEDR----PVTCEETSWRYAAPEVYKNEEYDTKV 336
+ +++ ++ VADFGLSK + + ++ R PV ++ A E + Y TK
Sbjct: 143 CMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV-------KWIAIESLADRVYTTKS 195
Query: 337 DVFSFALILQEM-IEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWS 395
DV+SF + + E+ G P+P + E+ R + P GL L+ CW
Sbjct: 196 DVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR--LKQPPDCLD-GLYSLMSSCWL 252
Query: 396 EEPFRRPTFRQILMRLDDIS 415
P RP+F + L+
Sbjct: 253 LNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 2e-23
Identities = 78/259 (30%), Positives = 125/259 (48%), Gaps = 42/259 (16%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
A+K + E + +D + F EL +L K+ HPN++ LGA + + EY P G+L
Sbjct: 26 AIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 83
Query: 235 RAYLKQKGALK--PTLA--------------VKFALDIARGMNYLHENRPEAIIHRDLEP 278
+L++ L+ P A + FA D+ARGM+YL + + IHRDL
Sbjct: 84 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAA 140
Query: 279 SNILRDDSGHLKVADFGLSKLLK-FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVD 337
NIL ++ K+ADFGLS+ + + PV R+ A E Y T D
Sbjct: 141 RNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV-------RWMAIESLNYSVYTTNSD 193
Query: 338 VFSFALILQEMIE-GCPPF----PTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIED 392
V+S+ ++L E++ G P+ + +++P+ Y + P Y +L+
Sbjct: 194 VWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK--PLNCDDEVY-----DLMRQ 246
Query: 393 CWSEEPFRRPTFRQILMRL 411
CW E+P+ RP+F QIL+ L
Sbjct: 247 CWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 75/266 (28%), Positives = 122/266 (45%), Gaps = 31/266 (11%)
Query: 159 EITKGTF-------RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQ 211
I GT+ IA+ G VA+K + D + E+++L++ RHPN+V
Sbjct: 10 RIGSGTYGDVYKARDIAT--GELVAIKVIK---LEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 212 FLGAVTQSTPMMIVTEYLPKGDLR-AYLKQKGALKPTLAVKFALDIARGMNYLHENRPEA 270
+ G+ + + IV EY G L+ Y +G L + +G+ YLHE
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--- 121
Query: 271 IIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE 330
IHRD++ +NIL + G +K+ADFG+S L T+ + R W APEV E
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLT--ATIAK-RKSFIGTPYW--MAPEVAAVE 176
Query: 331 E---YDTKVDVFSFALILQEMIEGCPPF----PTKQEKEVPKAYIANERPPFRAPTTHYA 383
YD K D+++ + E+ E PP P + + K +N PP ++
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK---SNFPPPKLKDKEKWS 233
Query: 384 YGLRELIEDCWSEEPFRRPTFRQILM 409
+ I+ C +++P +RPT ++L
Sbjct: 234 PVFHDFIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 5e-23
Identities = 61/188 (32%), Positives = 100/188 (53%), Gaps = 9/188 (4%)
Query: 172 GTQVAVKTLGEEVFTDE--DKVKAFIDELALLQKIRHPNVVQFLGAVTQST--PMMIVTE 227
G ++AVK + + + E +V A E+ LL+ +RH +VQ+ G + + I E
Sbjct: 27 GRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86
Query: 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
Y+P G ++ LK GAL + ++ I +G++YLH N I+HRD++ +NILRD +G
Sbjct: 87 YMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAG 143
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQE 347
++K+ DFG SK + + + + +PEV E Y K DV+S A + E
Sbjct: 144 NVKLGDFGASK--RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVE 201
Query: 348 MIEGCPPF 355
M+ PP+
Sbjct: 202 MLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 5e-23
Identities = 52/219 (23%), Positives = 105/219 (47%), Gaps = 13/219 (5%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL-RAYLKQKGALKPT-LAVKF 252
++E+ +L ++HPN++ + ++I EY G L ++QKG L + + +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 253 ALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312
I ++Y+H+ I+HRD++ NI +G +K+ DFG+SK+L ++ E
Sbjct: 107 LFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE---- 159
Query: 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER 372
T T + Y +PE+ + +Y+ K D+++ +L E++ F + +
Sbjct: 160 TVVGTPY-YMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY 218
Query: 373 PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411
P + Y+ L L+ ++P +RPT ++L +
Sbjct: 219 TPVVSV---YSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 6e-23
Identities = 75/273 (27%), Positives = 120/273 (43%), Gaps = 26/273 (9%)
Query: 146 EIDPKELDFSNSV------EITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELA 199
E+D K + + E+ +G ++ S R VA+ TL + + + F+ E
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG--CSDKQRRGFLAEAL 58
Query: 200 LLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL-KQKGALKPTLAVKFALDIAR 258
L + H N+V+ G +T+ MMIVTEY+ G L ++L K +G L + +A
Sbjct: 59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLAS 118
Query: 259 GMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGL---SKLLKFANTVKEDRPVTCE 315
GM YL E +H+ L +L + K++ F K T+ PV
Sbjct: 119 GMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-- 173
Query: 316 ETSWRYAAPEVYKNEEYDTKVDVFSFALILQE-MIEGCPPFPTKQEKEVPKAYIANERPP 374
+AAPE + + + DV+SF +++ E M G P+ ++V KA R P
Sbjct: 174 -----WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP 228
Query: 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQI 407
+ L +L+ DCW +E RP F QI
Sbjct: 229 ---APRNCPNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 8e-23
Identities = 68/236 (28%), Positives = 113/236 (47%), Gaps = 21/236 (8%)
Query: 171 RGTQVAVKTLGEEVFTDEDKVK-AFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229
+G AVK L ++V +D V+ +++ L +P + + V E+L
Sbjct: 19 KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78
Query: 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289
GDL +++ KG A +A +I G+ +LH II+RDL+ N++ D GH+
Sbjct: 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHI 135
Query: 290 KVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI 349
K+ADFG+ K N ++R T T Y APE+ + +Y VD +SF ++L EM+
Sbjct: 136 KIADFGMCK----ENVFGDNRASTFCGTP-DYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
Query: 350 EGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL----RELIEDCWSEEPFRR 401
G PF E E+ ++ R T HY + ++++E + +P RR
Sbjct: 191 IGQSPFHGDDEDELFES--------IRVDTPHYPRWITKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 9e-23
Identities = 64/191 (33%), Positives = 101/191 (52%), Gaps = 17/191 (8%)
Query: 172 GTQVAVKT--LGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229
G VA+K LGE + + E+ LLQ+++HPN++ L + + +V E++
Sbjct: 25 GRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM 84
Query: 230 PKGDLRAYLKQKGALKPTLA-VK-FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
DL +K K ++ T A +K + L RG+ YLH N I+HRDL+P+N+L G
Sbjct: 85 E-TDLEKVIKDK-SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDG 139
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEE-TSWRYAAPEV-YKNEEYDTKVDVFSFALIL 345
LK+ADFGL++ F + +R +T + T W Y APE+ + Y VD++S I
Sbjct: 140 VLKLADFGLAR--SFGSP---NRKMTHQVVTRW-YRAPELLFGARHYGVGVDMWSVGCIF 193
Query: 346 QEMIEGCPPFP 356
E++ P P
Sbjct: 194 AELLLRVPFLP 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 19/219 (8%)
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLK-QKGALKPT-LAVKFAL 254
E LL K++HPN+V F + + IV EY GDL +K Q+G L P +++ +
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 255 DIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTC 314
+ G+ ++HE R ++HRD++ NI +G +K+ DFG ++LL P
Sbjct: 108 QMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT--------SPGAY 156
Query: 315 EET---SWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE 371
T + Y PE+++N Y+ K D++S IL E+ PF K +
Sbjct: 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS 216
Query: 372 RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410
P +HY+Y LR LI+ + P RP+ IL R
Sbjct: 217 YKPL---PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 75/261 (28%), Positives = 114/261 (43%), Gaps = 40/261 (15%)
Query: 173 TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232
VAVKTL E D K F E LL +H N+V+F G T+ P ++V EY+ G
Sbjct: 36 ELVAVKTLKET--ASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHG 93
Query: 233 DLRAYLK--------------QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEP 278
DL +L+ G L + ++ A+ IA GM YL +HRDL
Sbjct: 94 DLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLAT 150
Query: 279 SNILRDDSGHLKVADFGLSKLLKFAN--TVKEDR--PVTCEETSWRYAAPEVYKNEEYDT 334
N L +K+ DFG+S+ + + V P+ R+ PE ++ T
Sbjct: 151 RNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI-------RWMPPESIMYRKFTT 203
Query: 335 KVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANER---PPFRAPTTHYAYGLRELI 390
+ DV+SF ++L E+ G P+ +EV + I R P P+ Y +++
Sbjct: 204 ESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE-CITQGRLLQRPRTCPSEVY-----DIM 257
Query: 391 EDCWSEEPFRRPTFRQILMRL 411
CW +P +R + I RL
Sbjct: 258 LGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 62/190 (32%), Positives = 98/190 (51%), Gaps = 16/190 (8%)
Query: 171 RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGA-VTQSTPMMIVTEYL 229
G VA+K + + F+ K EL LL+ +RH N++ ++ + VTE L
Sbjct: 34 TGQNVAIKKIMKP-FSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL 92
Query: 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289
DL L + L+ F I RG+ Y+H ++HRDL+PSNIL +++ L
Sbjct: 93 GT-DLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDL 147
Query: 290 KVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEM 348
K+ DFGL+++ +D +T ++ Y APE+ ++YD +VD++S I EM
Sbjct: 148 KICDFGLARI--------QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEM 199
Query: 349 IEGCPPFPTK 358
+EG P FP K
Sbjct: 200 LEGKPLFPGK 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-22
Identities = 41/82 (50%), Positives = 50/82 (60%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G L+ +K LL+ G DVN RD D T LH+AA G DVV+LLL GADV+ D
Sbjct: 44 LHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAARNGNLDVVKLLLKHGADVNARD 103
Query: 101 RWGSTPLADAVYYKHHDVIKLL 122
+ G TPL A H +V+KLL
Sbjct: 104 KDGRTPLHLAAKNGHLEVVKLL 125
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-22
Identities = 65/222 (29%), Positives = 96/222 (43%), Gaps = 30/222 (13%)
Query: 159 EITKGTF---RIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRH-PNVVQF 212
I+KG F +A R G A+K L + +++V E A++ P V +
Sbjct: 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 213 LGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAII 272
+ + +V EYL GD + +K G L A ++ ++ G+ LH+ II
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GII 119
Query: 273 HRDLEPSNILRDDSGHLKVADFGLSKLL----KFANTVKEDRPVTCEETSWRYAAPEVYK 328
HRD++P N+L D +GHLK+ DFGLS+ KF T Y APE
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD-------------YLAPETIL 166
Query: 329 NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN 370
D D +S ++ E + G PPF E P A N
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPPF----HAETPDAVFDN 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 3e-22
Identities = 74/268 (27%), Positives = 129/268 (48%), Gaps = 24/268 (8%)
Query: 148 DPKELDFSNSVEITKGTFR-----IASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
DP+EL F+ I KG+F I + VA+K + E ED+++ E+ +L
Sbjct: 1 DPEEL-FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEITVLS 57
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNY 262
+ P V ++ G+ + T + I+ EYL G L+ G +I +G++Y
Sbjct: 58 QCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDY 116
Query: 263 LHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYA 322
LH E IHRD++ +N+L + G +K+ADFG++ L + T T + +
Sbjct: 117 LHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN----TFVGTPF-WM 168
Query: 323 APEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTT-- 380
APEV + YD+K D++S + E+ +G PP ++ + P PT
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPP-----NSDMHPMRVLFLIPKNNPPTLTG 223
Query: 381 HYAYGLRELIEDCWSEEPFRRPTFRQIL 408
++ +E I+ C +++P RPT +++L
Sbjct: 224 EFSKPFKEFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 66/251 (26%), Positives = 105/251 (41%), Gaps = 49/251 (19%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFAL 254
I EL +L + P +V F GA + I E++ G L LK+ G + + K ++
Sbjct: 47 IRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISI 106
Query: 255 DIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL--KFANTVKEDRPV 312
+ RG+ YL E I+HRD++PSNIL + G +K+ DFG+S L AN+ R
Sbjct: 107 AVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-- 162
Query: 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPK------- 365
Y +PE + Y + D++S L L EM G P P KE+
Sbjct: 163 -------SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVS 215
Query: 366 ----------------------------AYIANERPPFRAPTTHYAYGLRELIEDCWSEE 397
YI NE PP + P+ ++ ++ ++ C +
Sbjct: 216 EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPP-KLPSGAFSDEFQDFVDKCLKKN 274
Query: 398 PFRRPTFRQIL 408
P R +++
Sbjct: 275 PKERADLKELT 285
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 4e-22
Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 14/217 (6%)
Query: 153 DFSNSVEITKGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVK-AFIDELALLQKIRH 206
DF+ + + KG+F +A +GT A+K L ++V +D V+ +++ L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 207 PNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHEN 266
P + Q + V EY+ GDL +++Q G K AV +A +I+ G+ +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR- 119
Query: 267 RPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEV 326
II+RDL+ N++ D GH+K+ADFG+ K T + Y APE+
Sbjct: 120 --RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD-----YIAPEI 172
Query: 327 YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV 363
+ Y VD +++ ++L EM+ G PPF + E E+
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 5e-22
Identities = 60/188 (31%), Positives = 95/188 (50%), Gaps = 9/188 (4%)
Query: 172 GTQVAVKTLGEEVFTDE--DKVKAFIDELALLQKIRHPNVVQFLGAV--TQSTPMMIVTE 227
G ++AVK + + + E +V A E+ LL+ + H +VQ+ G + + I E
Sbjct: 27 GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86
Query: 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
++P G ++ LK GAL + K+ I G++YLH N I+HRD++ +NILRD G
Sbjct: 87 HMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVG 143
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQE 347
++K+ DFG SK L+ W +PEV E Y K D++S + E
Sbjct: 144 NVKLGDFGASKRLQTICLSGTGMKSVTGTPYW--MSPEVISGEGYGRKADIWSVGCTVVE 201
Query: 348 MIEGCPPF 355
M+ PP+
Sbjct: 202 MLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 7e-22
Identities = 60/170 (35%), Positives = 89/170 (52%), Gaps = 11/170 (6%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVK-FA 253
I E++LL+ ++H N+V + + +V EYL DL+ YL G L VK F
Sbjct: 51 IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFM 109
Query: 254 LDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT 313
+ RG++Y H+ + I+HRDL+P N+L ++ G LK+ADFGL++ + VT
Sbjct: 110 FQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVT 166
Query: 314 CEETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
W Y P+V + EY T +D++ IL EM G P FP KE
Sbjct: 167 L----W-YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 16/208 (7%)
Query: 153 DFSNSVEITKGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHP 207
DF + G+F RIA +GT A+K L + +V+ E ++L ++ HP
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 208 NVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENR 267
+V + + + + E++ G+L +L++ G +A + ++ YLH
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS-- 136
Query: 268 PEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVY 327
+ II+RDL+P N+L D+ GH+KV DFG FA V DR T T Y APEV
Sbjct: 137 -KDIIYRDLKPENLLLDNKGHVKVTDFG------FAKKVP-DRTFTLCGTP-EYLAPEVI 187
Query: 328 KNEEYDTKVDVFSFALILQEMIEGCPPF 355
+++ + VD ++ ++L E I G PPF
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-21
Identities = 62/221 (28%), Positives = 112/221 (50%), Gaps = 22/221 (9%)
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL-KQKGAL-KPTLAVKFAL 254
E+ LL K++HPN+V F + ++ + IV EY GDL + +Q+G L + + +
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 255 DIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL-KVADFGLSKLLKFANTVKEDRPVT 313
I+ G+ ++H+ + I+HRD++ NI +G + K+ DFG+++ L ++++ T
Sbjct: 109 QISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAY--T 161
Query: 314 CEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE----VPKAYIA 369
C T + Y +PE+ +N Y+ K D++S +L E+ PF + + + Y A
Sbjct: 162 CVGTPY-YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA 220
Query: 370 NERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410
P +++ LR LI + P RP+ IL R
Sbjct: 221 PISP-------NFSRDLRSLISQLFKVSPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 37/263 (14%)
Query: 174 QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ-STPMMIVTEYLPKG 232
+V VKT+ + E +V + E LL + H N++ L + P ++ Y+ G
Sbjct: 37 EVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWG 94
Query: 233 DLRAYLKQ--------KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD 284
+L+ +L+Q AL V A+ IA GM+YLH+ +IH+D+ N + D
Sbjct: 95 NLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVID 151
Query: 285 DSGHLKVADFGLSKLLKFANTV-----KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVF 339
+ +K+ D LS+ L F E+RPV ++ A E N+EY + DV+
Sbjct: 152 EELQVKITDNALSRDL-FPMDYHCLGDNENRPV-------KWMALESLVNKEYSSASDVW 203
Query: 340 SFALILQEMIE-GCPPFPTKQEKEVPKAYIANER---PPFRAPTTHYAYGLRELIEDCWS 395
SF ++L E++ G P+ E+ AY+ + P P +A ++ CW+
Sbjct: 204 SFGVLLWELMTLGQTPYVEIDPFEM-AAYLKDGYRLAQPINCPDELFA-----VMACCWA 257
Query: 396 EEPFRRPTFRQILMRLDDISDQL 418
+P RP+F Q++ L D QL
Sbjct: 258 LDPEERPSFSQLVQCLTDFHAQL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 65/195 (33%), Positives = 93/195 (47%), Gaps = 21/195 (10%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM-----MIVT 226
G +VA+K + VF D K + E+ LL+ +RH N++ L + +P IVT
Sbjct: 25 GRKVAIKKI-SNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT 83
Query: 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEA-IIHRDLEPSNILRDD 285
E + DL +K L F I RG+ YLH A +IHRDL+PSNIL +
Sbjct: 84 ELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS----ANVIHRDLKPSNILVNS 138
Query: 286 SGHLKVADFGLSKLLKFANTVKEDRPVTCEE---TSWRYAAPEVYKN-EEYDTKVDVFSF 341
+ LK+ DFGL++ ED E T W Y APE+ + Y +D++S
Sbjct: 139 NCDLKICDFGLAR----GVDPDEDEKGFLTEYVVTRW-YRAPELLLSSSRYTKAIDIWSV 193
Query: 342 ALILQEMIEGCPPFP 356
I E++ P FP
Sbjct: 194 GCIFAELLTRKPLFP 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-21
Identities = 67/252 (26%), Positives = 122/252 (48%), Gaps = 31/252 (12%)
Query: 185 FTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ--KG 242
E++++ F+ E+ +L + +HPN+V A + I+ E+ G L + + + +G
Sbjct: 40 IESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG 99
Query: 243 ALKPTLAV--KFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300
+P + + L+ +N+LH ++ +IHRDL+ NIL G +K+ADFG+S
Sbjct: 100 LTEPQIRYVCRQMLE---ALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKN 153
Query: 301 KFANTVKEDRPVTCEETSWRYAAPEV-----YKNEEYDTKVDVFSFALILQEMIEGCPPF 355
K + + R W APEV +K+ YD K D++S + L E+ + PP
Sbjct: 154 K---STLQKRDTFIGTPYW--MAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPH 208
Query: 356 ----PTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR- 410
P + ++ K+ E P P + ++ + ++ C ++P RPT ++L
Sbjct: 209 HELNPMRVLLKILKS----EPPTLDQP-SKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP 263
Query: 411 -LDDISDQLSIK 421
+ D SD +IK
Sbjct: 264 FVSDQSDNKAIK 275
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 4e-21
Identities = 76/262 (29%), Positives = 124/262 (47%), Gaps = 42/262 (16%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS--TPMMIVTEYL 229
G QVAVK+L E + + + E+ +L+ + H N+V++ G T+ + ++ E+L
Sbjct: 33 GEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90
Query: 230 PKGDLRAYL---KQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286
P G L+ YL K K LK L K+A+ I +GM+YL + +HRDL N+L +
Sbjct: 91 PSGSLKEYLPRNKNKINLKQQL--KYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESE 145
Query: 287 GHLKVADFGLSKLLKFAN---TVKEDR--PVTCEETSWRYAAPEVYKNEEYDTKVDVFSF 341
+K+ DFGL+K ++ TVK+D PV + APE ++ DV+SF
Sbjct: 146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF-------WYAPECLIQSKFYIASDVWSF 198
Query: 342 ALILQEMIEGC----PPF--------PTKQEKEVP---KAYIANERPPFRAPTTHYAYGL 386
+ L E++ C P PT + V + +R P Y
Sbjct: 199 GVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVY-- 256
Query: 387 RELIEDCWSEEPFRRPTFRQIL 408
+L+ CW +P +R TF+ ++
Sbjct: 257 -QLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 4e-21
Identities = 62/237 (26%), Positives = 114/237 (48%), Gaps = 16/237 (6%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
V +K + E T +D+ A +E +L+ + HPN++++ + +MIV EY P G L
Sbjct: 28 VIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTL 86
Query: 235 RAYLKQKGA--LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH-LKV 291
Y++++ L + F + I ++++H + I+HRDL+ NIL D +K+
Sbjct: 87 AEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKI 143
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG 351
DFG+SK+L + C Y +PE+ + + Y+ K D+++ +L E+
Sbjct: 144 GDFGISKILSSKSKAYTVVGTPC------YISPELCEGKPYNQKSDIWALGCVLYELASL 197
Query: 352 CPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
F + +P + F + Y+ LR+LI + +P +RP QI+
Sbjct: 198 KRAF---EAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 59/189 (31%), Positives = 94/189 (49%), Gaps = 9/189 (4%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDEL-ALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
AVK L ++ + + K + E LL+ ++HP +V + + + V +Y+ G+L
Sbjct: 24 AVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGEL 83
Query: 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294
+L+++ + A +A +IA + YLH II+RDL+P NIL D GH+ + DF
Sbjct: 84 FFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDF 140
Query: 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPP 354
GL K T T Y APEV + + YD VD + +L EM+ G PP
Sbjct: 141 GLCK----EGIEHSKTTSTFCGTP-EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
Query: 355 FPTKQEKEV 363
F ++ E+
Sbjct: 196 FYSRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 69/229 (30%), Positives = 111/229 (48%), Gaps = 38/229 (16%)
Query: 153 DFSNSVEITKGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHP 207
DF+ + + KG+F +A +GT A+K L ++V +D V+ + E +L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 208 NVVQFLGAVTQSTP-MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHEN 266
+ L + Q+ + V EY+ GDL ++Q G K AV +A +IA G+ +LH
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS- 119
Query: 267 RPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSW------- 319
+ II+RDL+ N++ D GH+K+ADFG+ C+E W
Sbjct: 120 --KGIIYRDLKLDNVMLDSEGHIKIADFGM-----------------CKENMWDGVTTKT 160
Query: 320 -----RYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV 363
Y APE+ + Y VD ++F ++L EM+ G PF + E E+
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 4e-21
Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 28/254 (11%)
Query: 171 RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230
+V VK L DE + F+ E+ +++ HPNV+Q LG +S P ++V E+ P
Sbjct: 21 SKARVVVKELRASATPDEQLL--FLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78
Query: 231 KGDLRAYLKQ-----KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD 285
GDL+ YL+ + + + A ++A G+ +LH+ IH DL N
Sbjct: 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTA 135
Query: 286 SGHLKVADFGLSKLLKFANTVKEDRPVT--CEETSWRYAAPEVYKNEEYDTKV------- 336
+K+ D+GL+ L ++ ED +T C R+ APE+ + D
Sbjct: 136 DLSVKIGDYGLA-LEQY----PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKS 190
Query: 337 DVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR--ELIEDC 393
+++S + + E+ P+P +++V K + + P Y R E+++ C
Sbjct: 191 NIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFC 250
Query: 394 WSEEPFRRPTFRQI 407
W +P RPT ++
Sbjct: 251 WL-DPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 13/203 (6%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALLQ---KIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232
A+K L + D+V++ + E + + RHP +V + V EY G
Sbjct: 28 AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG 87
Query: 233 DLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVA 292
DL ++ +P AV +A + G+ YLHEN+ I++RDL+ N+L D G +K+A
Sbjct: 88 DLMMHIHTDVFSEPR-AVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIA 143
Query: 293 DFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGC 352
DFGL K DR T T + APEV Y VD + +++ EM+ G
Sbjct: 144 DFGLCK----EGMGFGDRTSTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGE 198
Query: 353 PPFPTKQEKEVPKAYIANERPPF 375
PFP E+EV + I N+ +
Sbjct: 199 SPFPGDDEEEVFDS-IVNDEVRY 220
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 5e-21
Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 11/167 (6%)
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFAL 254
E +L+K+ +V A + +V + GDL+ ++ G A+ +A
Sbjct: 43 EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102
Query: 255 DIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTC 314
I G+ +LH+ R I++RDL+P N+L DD G+++++D GL A +K + +
Sbjct: 103 QIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGL------AVELKGGKKIKG 153
Query: 315 EETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK 361
+ Y APEV + E YD VD F+ L EMI G PF ++EK
Sbjct: 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 8e-21
Identities = 70/261 (26%), Positives = 118/261 (45%), Gaps = 46/261 (17%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
VAVK L +V + F+ E+ ++ ++++PN+++ LG P+ ++TEY+ GDL
Sbjct: 47 VAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 235 RAYLKQKGALKPTLAVK-------------FALDIARGMNYLHENRPEAIIHRDLEPSNI 281
+L Q+ ++ T A+ IA GM YL +HRDL N
Sbjct: 105 NQFLSQR-EIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160
Query: 282 LRDDSGHLKVADFGLSKLLKFANTVK-EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFS 340
L + +K+ADFG+S+ L + + + R V R+ A E ++ T DV++
Sbjct: 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAV----LPIRWMAWESILLGKFTTASDVWA 216
Query: 341 FALILQEMIEGCPPFPTKQEKEVPKAYIANE--------------RPPFRAPTTHYAYGL 386
F + L EM C KE P + +++E R + + T +
Sbjct: 217 FGVTLWEMFTLC--------KEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPV 268
Query: 387 RELIEDCWSEEPFRRPTFRQI 407
+L+ CWS + RPTF +I
Sbjct: 269 FKLMMRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 8e-21
Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 16/214 (7%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLR---AYLKQKGALKPTLAV- 250
+ E+ LL+++ HPNV+++L + + + IV E GDL Y K++ L P V
Sbjct: 50 VKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW 109
Query: 251 KFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR 310
K+ + + + ++H R ++HRD++P+N+ +G +K+ D GL + T
Sbjct: 110 KYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 166
Query: 311 PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK--EVPKAYI 368
T Y +PE Y+ K D++S +L EM PF + + +
Sbjct: 167 VGTP-----YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE 221
Query: 369 ANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRP 402
+ PP PT HY+ LREL+ C +P +RP
Sbjct: 222 QCDYPPL--PTEHYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 8e-21
Identities = 55/169 (32%), Positives = 84/169 (49%), Gaps = 11/169 (6%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKF 252
++E +L+K+ VV A + +V + GDL+ ++ G AV +
Sbjct: 48 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY 107
Query: 253 ALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312
A +I G+ LH R I++RDL+P NIL DD GH++++D GL A + E +
Sbjct: 108 AAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGL------AVEIPEGETI 158
Query: 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK 361
+ Y APEV KNE Y D + ++ EMIEG PF ++EK
Sbjct: 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 9e-21
Identities = 67/267 (25%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 148 DPKELDFSNSVEI---TKGTFRIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
DP+ N V+I + G IA+ + G QVAVK + + + + +E+ +++
Sbjct: 16 DPRS-YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMR 71
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNY 262
+HPN+V+ + + +V E+L G L + + +A L + + +++
Sbjct: 72 DYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLAVLKALSF 130
Query: 263 LHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRY- 321
LH + +IHRD++ +IL G +K++DFG F V ++ P Y
Sbjct: 131 LHA---QGVIHRDIKSDSILLTSDGRVKLSDFG------FCAQVSKEVPRRKSLVGTPYW 181
Query: 322 AAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381
APEV Y T+VD++S +++ EM++G PP+ + + K I + PP
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR-IRDNLPPKLKNLHK 240
Query: 382 YAYGLRELIEDCWSEEPFRRPTFRQIL 408
+ LR ++ +P +R T ++L
Sbjct: 241 VSPRLRSFLDRMLVRDPAQRATAAELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 9e-21
Identities = 61/188 (32%), Positives = 96/188 (51%), Gaps = 14/188 (7%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G VA+K + E +E I E++LL++++HPN+V + Q + + ++ E+L
Sbjct: 25 GQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSM 83
Query: 232 GDLRAYLKQKGA---LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288
DL+ YL + L + I +G+ + H R ++HRDL+P N+L D+ G
Sbjct: 84 -DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGV 139
Query: 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEV-YKNEEYDTKVDVFSFALILQE 347
+K+ADFGL++ F V R T E + Y APEV + Y T VD++S I E
Sbjct: 140 IKLADFGLAR--AFGIPV---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAE 194
Query: 348 MIEGCPPF 355
M P F
Sbjct: 195 MATKKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 151 ELDFSNSVEITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVV 210
E+ + + F + R VAVK L + +++ F+ E+ +L +++ PN++
Sbjct: 25 EVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD--ANKNARNDFLKEVKILSRLKDPNII 82
Query: 211 QFLGAVTQSTPMMIVTEYLPKGDLRAYLKQK-------------GALKPTLAVKF----- 252
+ LG P+ ++TEY+ GDL +L A+ +
Sbjct: 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLH 142
Query: 253 -ALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK-EDR 310
AL IA GM YL +HRDL N L ++ +K+ADFG+S+ L + + + R
Sbjct: 143 VALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGR 199
Query: 311 PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGC--PPFPTKQEKEVPKAYI 368
V R+ A E ++ T DV++F + L E++ C P+ +++V I
Sbjct: 200 AV----LPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQV----I 251
Query: 369 ANERPPFRAPTTHY--------AYGLRELIEDCWSEEPFRRPTFRQI 407
N FR GL EL+ CWS + RP+F I
Sbjct: 252 ENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 54/163 (33%), Positives = 75/163 (46%), Gaps = 29/163 (17%)
Query: 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR 283
+V EY+P GDL L +K A + ++ ++ +H+ IHRD++P NIL
Sbjct: 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILI 134
Query: 284 DDSGHLKVADFGLSK-----------------LLKFAN-----TVKEDRPVTCEET--SW 319
D GH+K+ADFGL K LL N + R V T +
Sbjct: 135 DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTP 194
Query: 320 RYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPF--PTKQE 360
Y APEV + Y + D +S +IL EM+ G PPF T QE
Sbjct: 195 DYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 68/258 (26%), Positives = 129/258 (50%), Gaps = 34/258 (13%)
Query: 173 TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232
T+VA+KT+ E E +++ F++E +++++ +VV+ LG V+Q P +++ E + +G
Sbjct: 37 TRVAIKTVNEAASMRE-RIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRG 94
Query: 233 DLRAYLK--------QKGALKPTLA--VKFALDIARGMNYLHENRPEAIIHRDLEPSNIL 282
DL++YL+ P+L ++ A +IA GM YL+ N+ +HRDL N +
Sbjct: 95 DLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM 151
Query: 283 RDDSGHLKVADFGLSKLLKFANTVKED----RPVTCEETSWRYAAPEVYKNEEYDTKVDV 338
+ +K+ DFG+++ + + ++ PV R+ +PE K+ + T DV
Sbjct: 152 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-------RWMSPESLKDGVFTTYSDV 204
Query: 339 FSFALILQEMIE-GCPPFPTKQEKEVPKAYIANE--RPPFRAPTTHYAYGLRELIEDCWS 395
+SF ++L E+ P+ ++V + + P P L EL+ CW
Sbjct: 205 WSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDM-----LFELMRMCWQ 259
Query: 396 EEPFRRPTFRQILMRLDD 413
P RP+F +I+ + +
Sbjct: 260 YNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 52/169 (30%), Positives = 89/169 (52%), Gaps = 12/169 (7%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLK--QKGALKPTLAVKF 252
I E++LL+++ HPN+V+ L + + +V E+L + DL+ ++ + L +
Sbjct: 47 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSY 105
Query: 253 ALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312
+ +G+ + H +R ++HRDL+P N+L + G +K+ADFGL++ F V R
Sbjct: 106 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPV---RTY 157
Query: 313 TCEETSWRYAAPEVYKNEE-YDTKVDVFSFALILQEMIEGCPPFPTKQE 360
T E + Y APE+ + Y T VD++S I EM+ FP E
Sbjct: 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 66/236 (27%), Positives = 114/236 (48%), Gaps = 14/236 (5%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
VA+K L E T K +DE ++ + P V + LG ST + +VT+ +P G L
Sbjct: 39 VAIKVLREN--TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTST-VQLVTQLMPYGCL 95
Query: 235 RAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293
Y+++ K + + + + IA+GM+YL E R ++HRDL N+L H+K+ D
Sbjct: 96 LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITD 152
Query: 294 FGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GC 352
FGL++LL T + + ++ A E + + + DV+S+ + + E++ G
Sbjct: 153 FGLARLLDIDET---EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGA 209
Query: 353 PPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
P+ +E+P ER P T Y ++ CW + RP FR+++
Sbjct: 210 KPYDGIPAREIPDLLEKGERLPQPPICTIDVY---MIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 3e-20
Identities = 63/237 (26%), Positives = 113/237 (47%), Gaps = 18/237 (7%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
VA+KT+ + + + D + + + H +V+ LG + + +VT+ P G L
Sbjct: 39 VAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLG-ICPGASLQLVTQLSPLGSL 95
Query: 235 RAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293
+++Q + +L P + + + IA+GM YL E+R ++HR+L NIL +++AD
Sbjct: 96 LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIAD 152
Query: 294 FGLSKLLKFANTVKEDRPVTCEE--TSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE- 350
FG++ LL +D+ E T ++ A E Y + DV+S+ + + EM+
Sbjct: 153 FGVADLL-----YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSY 207
Query: 351 GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQI 407
G P+ + EVP ER T Y ++ CW + RPTF+++
Sbjct: 208 GAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVY---MVMVKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-20
Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 16/237 (6%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G VA+K + D I E+ LL+++ HPNV+++ + + + IV E
Sbjct: 27 GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 86
Query: 232 GDL----RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
GDL + + KQK + K+ + + + ++H R ++HRD++P+N+ +G
Sbjct: 87 GDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATG 143
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQE 347
+K+ D GL + T T Y +PE Y+ K D++S +L E
Sbjct: 144 VVKLGDLGLGRFFSSKTTAAHSLVGTP-----YYMSPERIHENGYNFKSDIWSLGCLLYE 198
Query: 348 MIEGCPPFPTKQEK--EVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRP 402
M PF + + K + PP P+ HY+ LR+L+ C + +P +RP
Sbjct: 199 MAALQSPFYGDKMNLYSLCKKIEQCDYPPL--PSDHYSEELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 4e-20
Identities = 67/234 (28%), Positives = 110/234 (47%), Gaps = 22/234 (9%)
Query: 187 DEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAY----LKQKG 242
DE K I EL +L K P +V F GA + + EY+ G L + +G
Sbjct: 39 DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEG 98
Query: 243 ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302
+ L + + +G+ +L E IIHRD++P+N+L + +G +K+ DFG+S L
Sbjct: 99 IPEDVLR-RITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV- 154
Query: 303 ANTVKEDRPVTCEETSWRYAAPEVYKNE------EYDTKVDVFSFALILQEMIEGCPPFP 356
A+ K + + C+ Y APE K+ Y + DV+S L + EM G P+P
Sbjct: 155 ASLAKTN--IGCQS----YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208
Query: 357 TKQEKEVPKAYIA-NERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILM 409
+ + A + P P+ Y+ ++ + C ++ P RRPT+ Q+L
Sbjct: 209 PETYANIFAQLSAIVDGDPPTLPSG-YSDDAQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 5e-20
Identities = 68/250 (27%), Positives = 116/250 (46%), Gaps = 29/250 (11%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY--- 228
GT +AVK + V + E K + +D ++ + P V F GA+ + + I E
Sbjct: 26 GTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDT 84
Query: 229 -LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
L K + Y K + L K A+ I + + YLH ++IHRD++PSN+L + +G
Sbjct: 85 SLDKFYKKVYDKGLTIPEDILG-KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNG 141
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVY----KNEEYDTKVDVFSFAL 343
+K+ DFG+S L ++V + C+ Y APE + YD K DV+S +
Sbjct: 142 QVKLCDFGISGYL--VDSVAKTIDAGCKP----YMAPERINPELNQKGYDVKSDVWSLGI 195
Query: 344 ILQEMIEGCPPF-----PTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEP 398
+ E+ G P+ P +Q K+V E P + P ++ ++ + C +
Sbjct: 196 TMIELATGRFPYDSWKTPFQQLKQVV------EEPSPQLPAEKFSPEFQDFVNKCLKKNY 249
Query: 399 FRRPTFRQIL 408
RP + ++L
Sbjct: 250 KERPNYPELL 259
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 5e-20
Identities = 72/240 (30%), Positives = 116/240 (48%), Gaps = 15/240 (6%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM-IVTEYLP 230
G Q +K L + ++ KA E LL +++HPN+V + + ++ IV +
Sbjct: 25 GKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83
Query: 231 KGDLRAYLK-QKGALKP-TLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288
GDL LK QKG L P V++ + IA + YLHE + I+HRDL+ N+ +
Sbjct: 84 GGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNI 140
Query: 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEM 348
+KV D G++++L+ D T T + Y +PE++ N+ Y+ K DV++ + EM
Sbjct: 141 IKVGDLGIARVLENQC----DMASTLIGTPY-YMSPELFSNKPYNYKSDVWALGCCVYEM 195
Query: 349 IEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
F K + I + PP Y+ L ELI S+ P +RP+ + IL
Sbjct: 196 ATLKHAFNAKDMNSLVYRIIEGKLPPM---PKDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 67/236 (28%), Positives = 114/236 (48%), Gaps = 14/236 (5%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
VA+K L E T K +DE ++ + +P+V + LG ST + ++T+ +P G L
Sbjct: 39 VAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCL 95
Query: 235 RAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293
Y+++ K + + + + IA+GMNYL E R ++HRDL N+L H+K+ D
Sbjct: 96 LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITD 152
Query: 294 FGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQE-MIEGC 352
FGL+KLL +++ + ++ A E + Y + DV+S+ + + E M G
Sbjct: 153 FGLAKLL---GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 209
Query: 353 PPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
P+ E+ ER P T Y ++ CW + RP FR+++
Sbjct: 210 KPYDGIPASEISSILEKGERLPQPPICTIDVY---MIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-20
Identities = 56/170 (32%), Positives = 88/170 (51%), Gaps = 11/170 (6%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVK-FA 253
I E++LL+ ++H N+V + + +V EYL K DL+ YL G VK F
Sbjct: 52 IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL 110
Query: 254 LDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT 313
+ RG+NY H + ++HRDL+P N+L ++ G LK+ADFGL++ + VT
Sbjct: 111 FQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVT 167
Query: 314 CEETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
W Y P++ + +Y T++D++ I EM G P FP +E
Sbjct: 168 L----W-YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 6e-20
Identities = 57/185 (30%), Positives = 93/185 (50%), Gaps = 9/185 (4%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDEL-ALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230
G+ AVK L ++ + + + E LL+ ++HP +V + + + V +Y+
Sbjct: 20 GSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79
Query: 231 KGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290
G+L +L+++ A +A ++A + YLH II+RDL+P NIL D GH+
Sbjct: 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVV 136
Query: 291 VADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE 350
+ DFGL K V+ + + + Y APEV + E YD VD + +L EM+
Sbjct: 137 LTDFGLCK-----EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLY 191
Query: 351 GCPPF 355
G PPF
Sbjct: 192 GLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 6e-20
Identities = 78/262 (29%), Positives = 127/262 (48%), Gaps = 28/262 (10%)
Query: 162 KGTFR---IASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQ-KIRHPNVVQFLGA 215
KG+F +A +GT A+K L ++V +D V+ + E +L HP +
Sbjct: 5 KGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCT 64
Query: 216 VTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRD 275
+ V EYL GDL +++ A +A +I G+ +LH + I++RD
Sbjct: 65 FQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS---KGIVYRD 121
Query: 276 LEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTK 335
L+ NIL D GH+K+ADFG+ K N + + + T T Y APE+ ++Y+T
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCK----ENMLGDAKTCTFCGTP-DYIAPEILLGQKYNTS 176
Query: 336 VDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWS 395
VD +SF ++L EM+ G PF E+E+ ++ I + P + T A ++++ +
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGHDEEELFQS-IRMDNPCYPRWLTREA---KDILVKLFV 232
Query: 396 EEPFRR----------PTFRQI 407
EP RR P FR+I
Sbjct: 233 REPERRLGVKGDIRQHPFFREI 254
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 9e-20
Identities = 58/233 (24%), Positives = 110/233 (47%), Gaps = 16/233 (6%)
Query: 187 DEDK-VKAFIDELALL-QKIRHPNVVQFLGAVTQSTPMMIVTEYL---PKGDLRAYLKQK 241
+ DK + + E+ ++ +++RHPN+V++ ++ + IV + + P G+ LK+K
Sbjct: 47 ERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEK 106
Query: 242 GALKPTLAV-KFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300
+ + + + YLH+ + I+HRDL P+NI+ + + + DFGL+K
Sbjct: 107 KQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAK-- 162
Query: 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE 360
+ + +T + Y+ PE+ KNE Y K DV++F IL +M PPF +
Sbjct: 163 ----QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM 218
Query: 361 KEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDD 413
+ + P P Y+ + ++I C + + RP Q+ + D
Sbjct: 219 LSLATKIVEAVYEPL--PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-19
Identities = 54/188 (28%), Positives = 78/188 (41%), Gaps = 9/188 (4%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL-GAVTQSTPMMIVTEYLP 230
G +VA+K L + +E + F E AL ++ HPN+V L + V EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 231 KGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL---RDDSG 287
LR L GAL + L + + H I+HRDL+P NI+
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRP 119
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEET--SWRYAAPEVYKNEEYDTKVDVFSFALIL 345
H KV DFG+ LL E + Y APE + E D++++ LI
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 346 QEMIEGCP 353
E + G
Sbjct: 180 LECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 57/164 (34%), Positives = 86/164 (52%), Gaps = 11/164 (6%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVK-FA 253
I E++LL+ ++H N+V V + +V EYL K DL+ Y+ G + VK F
Sbjct: 52 IREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL 110
Query: 254 LDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT 313
I RG+ Y H + ++HRDL+P N+L ++ G LK+ADFGL++ + VT
Sbjct: 111 YQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVT 167
Query: 314 CEETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFP 356
W Y P+V + EY T++D++ I EM G P FP
Sbjct: 168 L----W-YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 70/257 (27%), Positives = 114/257 (44%), Gaps = 37/257 (14%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTP------MMI 224
G VA+K + ED+ + +E +L+K HPN+ F GA + P + +
Sbjct: 31 GQLVAIKIMD----IIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWL 86
Query: 225 VTEYLPKG---DL-RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSN 280
V E G DL + K+ LK + RG+ YLHEN+ +IHRD++ N
Sbjct: 87 VMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQN 143
Query: 281 ILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEE-----YDTK 335
IL + +K+ DFG+S L R T T + + APEV +E YD +
Sbjct: 144 ILLTKNAEVKLVDFGVSAQLDSTLG----RRNTFIGTPY-WMAPEVIACDEQPDASYDAR 198
Query: 336 VDVFSFALILQEMIEGCPPF----PTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIE 391
DV+S + E+ +G PP P + ++P+ PP +++ + I
Sbjct: 199 SDVWSLGITAIELADGKPPLCDMHPMRALFKIPR-----NPPPTLKSPENWSKKFNDFIS 253
Query: 392 DCWSEEPFRRPTFRQIL 408
+C + +RP ++L
Sbjct: 254 ECLIKNYEQRPFMEELL 270
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 68/247 (27%), Positives = 114/247 (46%), Gaps = 20/247 (8%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRH-PNVVQFLGAVTQSTPMMIVTEY-- 228
GT +AVK + V DE + K + +L ++ + P +V+F GA+ + I E
Sbjct: 29 GTIMAVKRIRSTV--DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86
Query: 229 --LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286
L K Y K + + K A+ + +NYL E IIHRD++PSNIL D +
Sbjct: 87 ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRN 144
Query: 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPE---VYKNEEYDTKVDVFSFAL 343
G++K+ DFG+S L +++ + R C Y APE + YD + DV+S +
Sbjct: 145 GNIKLCDFGISGQL--VDSIAKTRDAGCRP----YMAPERIDPSARDGYDVRSDVWSLGI 198
Query: 344 ILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPT--THYAYGLRELIEDCWSEEPFRR 401
L E+ G P+P + PP + + ++ I C ++ +R
Sbjct: 199 TLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKR 258
Query: 402 PTFRQIL 408
P ++++L
Sbjct: 259 PKYKELL 265
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 71/259 (27%), Positives = 126/259 (48%), Gaps = 36/259 (13%)
Query: 173 TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232
T+VAVKT+ E E +++ F++E ++++ +VV+ LG V++ P ++V E + G
Sbjct: 37 TRVAVKTVNESASLRE-RIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 94
Query: 233 DLRAYLK--------QKGALKPTLA--VKFALDIARGMNYLHENRPEAIIHRDLEPSNIL 282
DL++YL+ G PTL ++ A +IA GM YL+ + +HRDL N +
Sbjct: 95 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 151
Query: 283 RDDSGHLKVADFGLSKLLKFANTVKED----RPVTCEETSWRYAAPEVYKNEEYDTKVDV 338
+K+ DFG+++ + + ++ PV R+ APE K+ + T D+
Sbjct: 152 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-------RWMAPESLKDGVFTTSSDM 204
Query: 339 FSFALILQEMIE-GCPPFPTKQEKEVPKAYIAN---ERPPFRAPTTHYAYGLRELIEDCW 394
+SF ++L E+ P+ ++V K + ++P +L+ CW
Sbjct: 205 WSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVT------DLMRMCW 258
Query: 395 SEEPFRRPTFRQILMRLDD 413
P RPTF +I+ L D
Sbjct: 259 QFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 55/169 (32%), Positives = 87/169 (51%), Gaps = 11/169 (6%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKF 252
++E +L+K+ VV A + +V + GDL+ ++ G + AV +
Sbjct: 48 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFY 107
Query: 253 ALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312
A +I G+ LH+ R I++RDL+P NIL DD GH++++D GL A V E + +
Sbjct: 108 AAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGL------AVHVPEGQTI 158
Query: 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK 361
+ Y APEV KNE Y D ++ +L EMI G PF +++K
Sbjct: 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 69/239 (28%), Positives = 116/239 (48%), Gaps = 22/239 (9%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
VA+K L E T F+DE ++ + HP++V+ LG V S + +VT+ +P G L
Sbjct: 39 VAIKILNET--TGPKANVEFMDEALIMASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCL 95
Query: 235 RAYL-KQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293
Y+ + K + L + + + IA+GM YL E R ++HRDL N+L H+K+ D
Sbjct: 96 LDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITD 152
Query: 294 FGLSKLL----KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI 349
FGL++LL K N P+ ++ A E ++ + DV+S+ + + E++
Sbjct: 153 FGLARLLEGDEKEYNADGGKMPI-------KWMALECIHYRKFTHQSDVWSYGVTIWELM 205
Query: 350 E-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQI 407
G P+ +E+P ER P T Y ++ CW + RP F+++
Sbjct: 206 TFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY---MVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 51/164 (31%), Positives = 80/164 (48%), Gaps = 9/164 (5%)
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDI 256
E +L++ HP +V+ + ++ EY G+L L+ +G A + +
Sbjct: 43 EKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACV 102
Query: 257 ARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEE 316
YLH II+RDL+P N+L D +G++K+ DFG +K LK + T
Sbjct: 103 VLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-----KTWTFCG 154
Query: 317 TSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE 360
T Y APE+ N+ YD VD +S ++L E++ G PPF E
Sbjct: 155 TP-EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE 197
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 24/275 (8%)
Query: 145 YEIDPKELDFSNSV------EITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDEL 198
Y D +L+ + ++ K F+ G +AVK + +E+K + +D
Sbjct: 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKT---GHVMAVKQMRRTGNKEENK-RILMDLD 65
Query: 199 ALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIAR 258
+L+ P +V+ G + + I E + + + +G + + K + I +
Sbjct: 66 VVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVK 125
Query: 259 GMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS 318
++YL E +IHRD++PSNIL D SG++K+ DFG+S L ++ + R C
Sbjct: 126 ALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRSAGCAA-- 179
Query: 319 WRYAAPEVY----KNEEYDTKVDVFSFALILQEMIEGCPPFP-TKQEKEVPKAYIANERP 373
Y APE N +YD + DV+S + L E+ G P+ K E EV I E P
Sbjct: 180 --YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV-LTKILQEEP 236
Query: 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
P P ++ ++ C +++ +RP +R++L
Sbjct: 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELL 271
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 3e-19
Identities = 76/261 (29%), Positives = 125/261 (47%), Gaps = 38/261 (14%)
Query: 173 TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232
QV VK L E F++E + ++H N++Q LG T+ TP ++V E+ P G
Sbjct: 23 AQVVVKELRVSASVQEQM--KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80
Query: 233 DLRAYLKQKGALK-----PTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
DL+ YL+ + PT + A +IA G+ +LH+N IH DL N L
Sbjct: 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADL 137
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSW---RYAAP----EVYKN---EEYDTKVD 337
+K+ D+GLS N KED VT ++ W R+ AP EV+ N + + +
Sbjct: 138 TVKIGDYGLSH-----NKYKEDYYVTPDQL-WVPLRWIAPELVDEVHGNLLVVDQTKESN 191
Query: 338 VFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANE------RPPFRAPTTHYAYGLRELI 390
V+S + + E+ E G P+ +++V Y E +P + P + Y E++
Sbjct: 192 VWSLGVTIWELFELGSQPYRHLSDEQV-LTYTVREQQLKLPKPRLKLPLSDRWY---EVM 247
Query: 391 EDCWSEEPFRRPTFRQILMRL 411
+ CW +P +RP+ ++ + L
Sbjct: 248 QFCWL-QPEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 29/196 (14%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM------IV 225
G +VA+K L + + + EL LL+ + H NV+ L T ++ + +V
Sbjct: 40 GRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98
Query: 226 TEYLPKGDLRAYLKQKGALKPTLA---VKFAL-DIARGMNYLHENRPEAIIHRDLEPSNI 281
T L DL +K + L+ ++F + I RG+ Y+H IIHRDL+PSNI
Sbjct: 99 TH-LMGADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNI 149
Query: 282 LRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFS 340
++ LK+ DFGL++ +D T W Y APE+ N Y+ VD++S
Sbjct: 150 AVNEDCELKILDFGLARH-------TDDEMTGYVATRW-YRAPEIMLNWMHYNQTVDIWS 201
Query: 341 FALILQEMIEGCPPFP 356
I+ E++ G FP
Sbjct: 202 VGCIMAELLTGKTLFP 217
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 4e-19
Identities = 69/261 (26%), Positives = 118/261 (45%), Gaps = 42/261 (16%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
VA+KTL ++ + + F E + +++HPN+V LG VT+ P+ ++ Y DL
Sbjct: 38 VAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 235 RAYLKQ----------------KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEP 278
+L K L+P V IA GM +L + ++H+DL
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLAT 152
Query: 279 SNILRDDSGHLKVADFGLSKLLKFANTVK----EDRPVTCEETSWRYAAPEVYKNEEYDT 334
N+L D ++K++D GL + + A+ K P+ R+ +PE ++
Sbjct: 153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI-------RWMSPEAIMYGKFSI 205
Query: 335 KVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERP---PFRAPTTHYAYGLRELI 390
D++S+ ++L E+ G P+ ++V + I N + P P Y L+
Sbjct: 206 DSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM-IRNRQVLPCPDDCPAWVYT-----LM 259
Query: 391 EDCWSEEPFRRPTFRQILMRL 411
+CW+E P RRP F+ I RL
Sbjct: 260 LECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-19
Identities = 69/271 (25%), Positives = 124/271 (45%), Gaps = 28/271 (10%)
Query: 150 KELDFSNSVEITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDEL----ALLQKIR 205
EL N + KG ++ + + KT+ ++ +++ A DEL ++Q++
Sbjct: 1 GELGSGNFGTVKKGMYK------MKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD 54
Query: 206 HPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHE 265
+P +V+ +G + ++ M+V E G L +L++ + + ++ GM YL E
Sbjct: 55 NPYIVRMIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE 113
Query: 266 NRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSW--RYAA 323
+HRDL N+L + K++DFGLSK L E+ W ++ A
Sbjct: 114 TN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL----GADENYYKAKTHGKWPVKWYA 166
Query: 324 PEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANER--PPFRAPTT 380
PE ++ +K DV+SF +++ E G P+ + EV + + ER P R P
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPE 226
Query: 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411
Y +L++ CW+ RP F + +RL
Sbjct: 227 MY-----DLMKLCWTYGVDERPGFAVVELRL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 65/252 (25%), Positives = 106/252 (42%), Gaps = 31/252 (12%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLR 235
A+K L ++ +KVK + E +L + HP + + T + +V +Y P G+L
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89
Query: 236 AYL-KQKGALKPTLAVKF-ALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293
L +Q G +F A ++ + YLH I++RDL+P NIL +SGH+ ++D
Sbjct: 90 RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSD 146
Query: 294 FGLSKLLKFANTVKED---------------RPVTCEETSWR---------YAAPEVYKN 329
F LSK EE S+R Y APEV
Sbjct: 147 FDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG 206
Query: 330 EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLREL 389
+ + + VD ++ ++L EM+ G PF E + E F + + R+L
Sbjct: 207 DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKE-VTF-PGSPPVSSSARDL 264
Query: 390 IEDCWSEEPFRR 401
I ++P +R
Sbjct: 265 IRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 5e-19
Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 150 KELDFSNSVEITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNV 209
++L + + KG RI G VA+K + + T+E I E +LL+ ++H N+
Sbjct: 11 EKLGEGSYATVYKGISRI---NGQLVALKVISMK--TEEGVPFTAIREASLLKGLKHANI 65
Query: 210 VQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRP 268
V + + V EY+ DL Y+ Q G L P F + RG+ Y+H
Sbjct: 66 VLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH- 123
Query: 269 EAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEV-Y 327
I+HRDL+P N+L G LK+ADFGL++ + VT W Y P+V
Sbjct: 124 --ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTL----W-YRPPDVLL 176
Query: 328 KNEEYDTKVDVFSFALILQEMIEGCPPFP 356
+Y + +D++ I EM++G P FP
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQPAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 54/164 (32%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFA 253
I E +LL+ ++H N+V + + +V EYL DL+ Y+ G L F
Sbjct: 51 IREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFL 109
Query: 254 LDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT 313
+ RG+ Y H+ R ++HRDL+P N+L + G LK+ADFGL++ + + VT
Sbjct: 110 FQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVT 166
Query: 314 CEETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFP 356
W Y P+V + EY T +D++ I EM G P FP
Sbjct: 167 L----W-YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 160 ITKGTF---RIASWRGTQV--AVKTLGEEVFTDEDKVKAFIDEL-ALLQKIRHPNVVQFL 213
I KG+F +A + + AVK L ++ + + K + E LL+ ++HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIH 273
+ + + V +Y+ G+L +L+++ A +A +IA + YLH I++
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVY 119
Query: 274 RDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYD 333
RDL+P NIL D GH+ + DFGL K ++ + + + Y APEV + YD
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCK-----ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 334 TKVDVFSFALILQEMIEGCPPFPTKQEKEV 363
VD + +L EM+ G PPF ++ E+
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 6e-19
Identities = 60/237 (25%), Positives = 114/237 (48%), Gaps = 13/237 (5%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G +VA+K + + K + I+E+ ++++ +HPN+V +L + + +V EYL
Sbjct: 44 GQEVAIKQMN---LQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
G L + + + +A + + + +LH N+ +IHRD++ NIL G +K+
Sbjct: 101 GSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 156
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG 351
DFG + T ++ + T T + + APEV + Y KVD++S ++ EM+EG
Sbjct: 157 TDFGFCAQI----TPEQSKRSTMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
Query: 352 CPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
PP+ + N P + P A R+ + C + +R + +++L
Sbjct: 212 EPPYLNENPLRALYLIATNGTPELQNPEKLSAI-FRDFLNRCLEMDVEKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 7e-19
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 192 KAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVK 251
K + EL +L K P ++ F GA + I TE++ G L Y K + L +
Sbjct: 44 KQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIP---EHVLG-R 99
Query: 252 FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311
A+ + +G+ YL + I+HRD++PSN+L + G +K+ DFG+S L N++ +
Sbjct: 100 IAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTYV 154
Query: 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE---VPKAY- 367
T Y APE E+Y DV+S + E+ G P+P Q+ + +P
Sbjct: 155 GTNA-----YMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL 209
Query: 368 --IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPT 403
I +E PP P ++ I C ++P RP
Sbjct: 210 QCIVDEDPP-VLPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-19
Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 9/193 (4%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDEL-ALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230
G AVK L +++ + + K + E LL+ ++HP +V + + + V +++
Sbjct: 20 GKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79
Query: 231 KGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290
G+L +L+++ + A +A +IA + YLH I++RDL+P NIL D GH+
Sbjct: 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVV 136
Query: 291 VADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE 350
+ DFGL K + D T T Y APEV + + YD VD + +L EM+
Sbjct: 137 LTDFGLCK----EGIAQSDTTTTFCGTP-EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY 191
Query: 351 GCPPFPTKQEKEV 363
G PPF + E+
Sbjct: 192 GLPPFYCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 9e-19
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 162 KGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDE---LALLQKIRHPNVVQFL 213
KG+F +A +GT A+K L ++V +D V + E LAL K HP +
Sbjct: 5 KGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFLTALH 62
Query: 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIH 273
+ V EY+ GDL +++ + +A ++ + +LH + +I+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIY 119
Query: 274 RDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYD 333
RDL+ NIL D GH K+ADFG+ K + T + Y APE+ + EY
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCK-----EGILNGVTTTTFCGTPDYIAPEILQELEYG 174
Query: 334 TKVDVFSFALILQEMIEGCPPFPTKQEKEV 363
VD ++ +++ EM+ G PPF E ++
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 68/260 (26%), Positives = 107/260 (41%), Gaps = 57/260 (21%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFAL 254
I EL +L + P +V F GA + I E++ G L LK+ G + + K ++
Sbjct: 51 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 110
Query: 255 DIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL--KFANTVKEDRPV 312
+ +G+ YL E I+HRD++PSNIL + G +K+ DFG+S L AN+ R
Sbjct: 111 AVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-- 166
Query: 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV--------- 363
Y +PE + Y + D++S L L EM G P P KE+
Sbjct: 167 -------SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVE 219
Query: 364 ----------------------------PKA------YIANERPPFRAPTTHYAYGLREL 389
P A YI NE PP + P+ + ++
Sbjct: 220 GDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPP-KLPSGVFGAEFQDF 278
Query: 390 IEDCWSEEPFRRPTFRQILM 409
+ C + P R +Q+++
Sbjct: 279 VNKCLIKNPAERADLKQLMV 298
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 57/172 (33%), Positives = 93/172 (54%), Gaps = 21/172 (12%)
Query: 197 ELALLQKIRHPNVVQFLGAVTQST--PMMIVTEYLPKGDLRAYLKQKGALKPTLA---VK 251
E+ +L K++HPN+V V S + +V EY+ + DL++ ++ K VK
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV-EHDLKSLMETM---KQPFLQSEVK 109
Query: 252 -FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKE-D 309
L + G+ +LH+N I+HRDL+ SN+L ++ G LK+ DFGL++ ++ + +K
Sbjct: 110 CLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYT 164
Query: 310 RPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQE 360
+ V T W Y APE+ EY T +D++S I E++ P FP K E
Sbjct: 165 QLVV---TLW-YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-18
Identities = 72/303 (23%), Positives = 141/303 (46%), Gaps = 27/303 (8%)
Query: 120 KLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITK-------GTFRIASWRG 172
+ E++ A P + ++PE E P+ + + + T + RG
Sbjct: 32 EAFEKYCA--DLDPEAYKKCVDLPEGEEVPESNNPREHMYVLTTLVGRNPTTAAFVATRG 89
Query: 173 TQVAVKTLGEEVFTDEDKVKAFI-DELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
+ K + + V ++++ A+ EL L H +V+ ++++ EY
Sbjct: 90 SDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149
Query: 232 GDLRAYLKQKGALKPTLAVK------FALDIARGMNYLHENRPEAIIHRDLEPSNILRDD 285
GDL +KQ+ LK L + I ++ +H + ++HRDL+ +NI
Sbjct: 150 GDLNKQIKQR--LKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMP 204
Query: 286 SGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALIL 345
+G +K+ DFG SK +++++V D + T + Y APE+++ + Y K D++S +IL
Sbjct: 205 TGIIKLGDFGFSK--QYSDSVSLDVASSFCGTPY-YLAPELWERKRYSKKADMWSLGVIL 261
Query: 346 QEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFR 405
E++ PF ++E+ + + + PF P + G++ L++ S+ P RPT +
Sbjct: 262 YELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSS---GMKALLDPLLSKNPALRPTTQ 318
Query: 406 QIL 408
Q+L
Sbjct: 319 QLL 321
|
Length = 478 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 50/167 (29%), Positives = 85/167 (50%), Gaps = 20/167 (11%)
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFALD 255
E+ LL++++H N+V+ + + +V EY + DL+ Y G + P + F
Sbjct: 49 EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQ 107
Query: 256 IARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCE 315
+ +G+ + H + ++HRDL+P N+L + +G LK+ADFGL++ PV C
Sbjct: 108 LLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI--------PVRCY 156
Query: 316 E----TSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIE-GCPPFP 356
T W Y P+V + + Y T +D++S I E+ G P FP
Sbjct: 157 SAEVVTLW-YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 33/231 (14%)
Query: 154 FSNSVEITKGTF-------RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRH 206
+ I +GT+ R G + A+K + ++ E+ALL++++H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 207 PNVVQFLGAVTQSTPMMI--VTEYLPKGDLRAYLK----QKGALKPTLAVKFAL-DIARG 259
NVV + + + + +Y + DL +K K P VK L I G
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 260 MNYLHENRPEAIIHRDLEPSNIL----RDDSGHLKVADFGLSKLLKFANTVK----EDRP 311
++YLH N ++HRDL+P+NIL + G +K+ D GL++L F +K D
Sbjct: 121 VHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARL--FNAPLKPLADLDPV 175
Query: 312 VTCEETSWRYAAPEVYKNEEYDTK-VDVFSFALILQEMIEGCPPFPTKQEK 361
V T W Y APE+ + TK +D+++ I E++ P F ++ K
Sbjct: 176 VV---TIW-YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 63/200 (31%), Positives = 96/200 (48%), Gaps = 27/200 (13%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G A+K L + D+V+ + E +L ++ HP +V+ A + ++ ++L
Sbjct: 24 GQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRG 82
Query: 232 GDLRAYLKQKGALKPTLAVKFAL-DIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290
GDL L K + VKF L ++A +++LH II+RDL+P NIL D+ GH+K
Sbjct: 83 GDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIK 138
Query: 291 VADFGLSK--------LLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFA 342
+ DFGLSK F TV+ Y APEV + D +SF
Sbjct: 139 LTDFGLSKESIDHEKKAYSFCGTVE-------------YMAPEVVNRRGHTQSADWWSFG 185
Query: 343 LILQEMIEGCPPFPTKQEKE 362
+++ EM+ G PF K KE
Sbjct: 186 VLMFEMLTGSLPFQGKDRKE 205
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 56/164 (34%), Positives = 86/164 (52%), Gaps = 11/164 (6%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL-KQKGALKPTLAVKFA 253
I E +LL+ ++H N+V + + +V EY+ DL Y+ K G L P F
Sbjct: 51 IREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL 109
Query: 254 LDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT 313
+ RG++Y+H+ I+HRDL+P N+L D+G LK+ADFGL++ + + VT
Sbjct: 110 FQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVT 166
Query: 314 CEETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFP 356
W Y P+V + EY T +D++ I EMI+G FP
Sbjct: 167 L----W-YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 76/293 (25%), Positives = 128/293 (43%), Gaps = 25/293 (8%)
Query: 129 PSTAPMHVQNAREVPE--YEIDPKELDFSNSVEITKGTFRIASW----RGTQV-AVKTLG 181
PST+ E+ E ++ DP++L F++ EI G+F + R +V A+K +
Sbjct: 1 PSTSRAGSLKDPEIAELFFKEDPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMS 59
Query: 182 EEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQK 241
+K + I E+ LQ+I+HPN +++ G + +V EY K
Sbjct: 60 YSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHK 119
Query: 242 GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301
L+ +G+ YLH + +IHRD++ NIL + G +K+ADFG + +
Sbjct: 120 KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176
Query: 302 FANTVKEDRPVTCEETSWRYAAPEV---YKNEEYDTKVDVFSFALILQEMIEGCPPFPTK 358
AN+ + + APEV +YD KVDV+S + E+ E PP
Sbjct: 177 PANSFV---------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227
Query: 359 QEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411
NE P + + ++ R ++ C + P RPT ++L +
Sbjct: 228 NAMSALYHIAQNESPTLQ--SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 11/192 (5%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G A K L ++ + K + E +L+K+ P +V A T + +V +
Sbjct: 18 GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77
Query: 232 GDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289
GDL+ ++ G L+ + ++ I G+ +LH I++RD++P N+L DD G+
Sbjct: 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNC 134
Query: 290 KVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI 349
+++D GL A +K+ + +T + Y APE+ K E Y VD F+ + EM+
Sbjct: 135 RLSDLGL------AVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMV 188
Query: 350 EGCPPFPTKQEK 361
G PF +EK
Sbjct: 189 AGRTPFKDHKEK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 23/206 (11%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP--------MM 223
G VA+K + D + A E+ +L+K++HPNVV + + +
Sbjct: 33 GRVVALKKILMHNEKDGFPITAL-REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY 91
Query: 224 IVTEYLPKGDLRAYLK-QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL 282
+VT Y+ DL L+ L + + L + G+NYLHEN I+HRD++ +NIL
Sbjct: 92 MVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANIL 147
Query: 283 RDDSGHLKVADFGLSKL-------LKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDT 334
D+ G LK+ADFGL++ K + T W Y PE+ E Y T
Sbjct: 148 IDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRW-YRPPELLLGERRYTT 206
Query: 335 KVDVFSFALILQEMIEGCPPFPTKQE 360
VD++ + EM P K +
Sbjct: 207 AVDIWGIGCVFAEMFTRRPILQGKSD 232
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 65/242 (26%), Positives = 109/242 (45%), Gaps = 20/242 (8%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G A K L ++ + + E +L K+ +V A T + +V +
Sbjct: 18 GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG 77
Query: 232 GDLRAYLKQKGALKPTL----AVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
GDLR ++ P A + I G+ +LH+ R II+RDL+P N+L D+ G
Sbjct: 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDG 134
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQE 347
+++++D GL+ LK + + T + APE+ + EEYD VD F+ + L E
Sbjct: 135 NVRISDLGLAVELKDGQSKTKGYAGTPG-----FMAPELLQGEEYDFSVDYFALGVTLYE 189
Query: 348 MIEGCPPFPTKQE----KEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPT 403
MI PF + E KE+ K I N+ + ++ + E +++P +R
Sbjct: 190 MIAARGPFRARGEKVENKEL-KQRILNDSVTY---PDKFSPASKSFCEALLAKDPEKRLG 245
Query: 404 FR 405
FR
Sbjct: 246 FR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 55/192 (28%), Positives = 89/192 (46%), Gaps = 11/192 (5%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G A K L ++ ++E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84
Query: 232 GDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289
GDL+ ++ G + A+ +A +I G+ LH E ++RDL+P NIL DD GH+
Sbjct: 85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHI 141
Query: 290 KVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI 349
+++D GL A + E + + Y APEV N+ Y D + ++ EMI
Sbjct: 142 RISDLGL------AVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMI 195
Query: 350 EGCPPFPTKQEK 361
EG PF ++EK
Sbjct: 196 EGQSPFRGRKEK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 13/193 (6%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI---VTEY 228
G +VA+K + F K + EL +L+ +H N++ + V
Sbjct: 30 GKKVAIKKIPH-AFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88
Query: 229 LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288
L + DL + L F + RG+ Y+H +IHRDL+PSN+L ++
Sbjct: 89 LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCE 145
Query: 289 LKVADFGLSKLLKFANTVKEDRPVTCE--ETSWRYAAPEV-YKNEEYDTKVDVFSFALIL 345
L++ DFG+++ L +++ E + E T W Y APE+ EY T +D++S I
Sbjct: 146 LRIGDFGMARGL--SSSPTEHKYFMTEYVATRW-YRAPELLLSLPEYTTAIDMWSVGCIF 202
Query: 346 QEMIEGCPPFPTK 358
EM+ FP K
Sbjct: 203 AEMLGRRQLFPGK 215
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 14/187 (7%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLR 235
A+K + + V ++ V F +E +L P + Q A + +V EY P GDL
Sbjct: 30 AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL 89
Query: 236 AYL-KQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294
+ L + + +A + ++ ++ +H+ +HRD++P N+L D +GH+K+ADF
Sbjct: 90 SLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADF 146
Query: 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEV------YKNEEYDTKVDVFSFALILQEM 348
G + L V PV + Y APEV Y + D +S +I EM
Sbjct: 147 GSAARLTANKMVNSKLPVGTPD----YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEM 202
Query: 349 IEGCPPF 355
I G PF
Sbjct: 203 IYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 6e-18
Identities = 60/237 (25%), Positives = 115/237 (48%), Gaps = 13/237 (5%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G +VA+K + + K + I+E+ ++++ ++PN+V +L + + +V EYL
Sbjct: 44 GQEVAIKQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
G L + + + +A + + +++LH N+ +IHRD++ NIL G +K+
Sbjct: 101 GSLTDVVTETCMDEGQIAA-VCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKL 156
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG 351
DFG + T ++ + T T + + APEV + Y KVD++S ++ EM+EG
Sbjct: 157 TDFGFCAQI----TPEQSKRSTMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
Query: 352 CPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
PP+ + N P + P A R+ + C + RR + +++L
Sbjct: 212 EPPYLNENPLRALYLIATNGTPELQNPERLSAV-FRDFLNRCLEMDVDRRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 67/197 (34%), Positives = 103/197 (52%), Gaps = 27/197 (13%)
Query: 172 GTQVAVKTLGEEVFTDEDKVK-AFIDELALLQKIR---HPNVVQFLGAVT-----QSTPM 222
G VA+K++ V T+ED + + + E+ALL+++ HPN+V+ + + T +
Sbjct: 25 GHFVALKSV--RVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV 82
Query: 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIAR----GMNYLHENRPEAIIHRDLEP 278
+V E++ + DLR YL + P L + D+ R G+++LH N I+HRDL+P
Sbjct: 83 TLVFEHVDQ-DLRTYLDK--VPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKP 136
Query: 279 SNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDV 338
NIL G +K+ADFGL+++ + PV T W Y APEV Y T VD+
Sbjct: 137 ENILVTSGGQVKLADFGLARIYSCQMALT---PVVV--TLW-YRAPEVLLQSTYATPVDM 190
Query: 339 FSFALILQEMIEGCPPF 355
+S I EM P F
Sbjct: 191 WSVGCIFAEMFRRKPLF 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 7e-18
Identities = 52/166 (31%), Positives = 86/166 (51%), Gaps = 8/166 (4%)
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDI 256
E +L+ ++HP +V + A + ++ EYL G+L +L+++G A + +I
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEI 109
Query: 257 ARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEE 316
+ + +LH+ + II+RDL+P NIL D GH+K+ DFGL K TV T E
Sbjct: 110 SLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIE- 165
Query: 317 TSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
Y APE+ + VD +S ++ +M+ G PPF + K+
Sbjct: 166 ----YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK 207
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 9e-18
Identities = 58/237 (24%), Positives = 115/237 (48%), Gaps = 13/237 (5%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G +VA+K + + K + I+E+ +++++++PN+V FL + + +V EYL
Sbjct: 44 GQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
G L + + + +A + + + +LH N+ +IHRD++ N+L G +K+
Sbjct: 101 GSLTDVVTETCMDEAQIAA-VCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKL 156
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG 351
DFG + T ++ + T T + + APEV + Y KVD++S ++ EM+EG
Sbjct: 157 TDFGFCAQI----TPEQSKRSTMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
Query: 352 CPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
PP+ + N P + P + R+ + C + +R + +++L
Sbjct: 212 EPPYLNENPLRALYLIATNGTPELQNPEK-LSPIFRDFLNRCLEMDVEKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 9e-18
Identities = 74/269 (27%), Positives = 118/269 (43%), Gaps = 23/269 (8%)
Query: 148 DPKELDFSNSVEITKGTFRIASW----RGTQV-AVKTLGEEVFTDEDKVKAFIDELALLQ 202
DP++L FS+ EI G+F + R ++V A+K + +K + I E+ LQ
Sbjct: 12 DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNY 262
K+RHPN +Q+ G + +V EY K L+ +G+ Y
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 263 LHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYA 322
LH + +IHRD++ NIL + G +K+ DFG + ++ AN + +
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV---------GTPYWM 178
Query: 323 APEV---YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPT 379
APEV +YD KVDV+S + E+ E PP NE P + +
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--S 236
Query: 380 THYAYGLRELIEDCWSEEPFRRPTFRQIL 408
H++ R ++ C + P RPT +L
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 61/178 (34%), Positives = 91/178 (51%), Gaps = 13/178 (7%)
Query: 187 DEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG--AL 244
DE I E++LL++++H N+V+ V + +V EYL DL+ ++ A
Sbjct: 41 DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAK 99
Query: 245 KPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH-LKVADFGLSKLLKFA 303
P L + I RG+ Y H +R ++HRDL+P N+L D + LK+ADFGL++ F
Sbjct: 100 NPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLAR--AFG 154
Query: 304 NTVKEDRPVTCEETSWRYAAPEVY-KNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE 360
V R T E + Y APE+ + Y T VD++S I EM+ P FP E
Sbjct: 155 IPV---RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE 209
|
Length = 294 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 9/197 (4%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
AVK L ++V +D V+ + E +L R HP + Q + V E++ GDL
Sbjct: 24 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL 83
Query: 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294
++++ A +A +I + +LH+ + II+RDL+ N+L D GH K+ADF
Sbjct: 84 MFHIQKSRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADF 140
Query: 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPP 354
G+ K + + + + Y APE+ + Y VD ++ ++L EM+ G P
Sbjct: 141 GMCK-----EGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
Query: 355 FPTKQEKEVPKAYIANE 371
F + E ++ +A + +E
Sbjct: 196 FEAENEDDLFEAILNDE 212
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 33/230 (14%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFAL 254
I EL +L + P +V F GA + I E++ G L LK+ + + K ++
Sbjct: 51 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSI 110
Query: 255 DIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL--KFANTVKEDRPV 312
+ RG+ YL E I+HRD++PSNIL + G +K+ DFG+S L AN+ R
Sbjct: 111 AVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-- 166
Query: 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV--------- 363
Y +PE + Y + D++S L L E+ G P P KE+
Sbjct: 167 -------SYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVV 219
Query: 364 ------PKAYIANERPPFRAPTTH-----YAYGLRELIEDCWSEEPFRRP 402
P + RPP R + H A + EL++ +E P + P
Sbjct: 220 DGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP 269
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 59/189 (31%), Positives = 85/189 (44%), Gaps = 33/189 (17%)
Query: 182 EEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQK 241
++VF + D +L +P VV + + +V EY+ GD LK
Sbjct: 46 QQVFVERD----------ILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI 95
Query: 242 GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK--L 299
GAL +A + + + YLH I+HRDL+P N+L GH+K+ DFGLSK L
Sbjct: 96 GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152
Query: 300 LKFANTVKE-----------DRPV--TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQ 346
+ + E D+ V T E Y APEV + Y VD ++ +IL
Sbjct: 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPE-----YIAPEVILRQGYGKPVDWWAMGIILY 207
Query: 347 EMIEGCPPF 355
E + GC PF
Sbjct: 208 EFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 18/217 (8%)
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL----RAYLKQKGALKPTLAVKF 252
E LL K+ HP +V+F + + I+TEY DL L ++
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 253 ALDIARGMNYLHENRPEAIIHRDLEPSNI-LRDDSGHLKVADFGLSKLLKFANTVKEDRP 311
+ + G++Y+H+ R I+HRDL+ NI L+++ LK+ DFG+S+LL + D
Sbjct: 112 FIQLLLGVHYMHQRR---ILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSC----DLA 162
Query: 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE 371
T T + Y +PE K++ YD+K D++S IL EM F + V +
Sbjct: 163 TTFTGTPY-YMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP 221
Query: 372 RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
P P T Y+ L +++ +++P RP+ +IL
Sbjct: 222 TPSL--PET-YSRQLNSIMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 75/274 (27%), Positives = 122/274 (44%), Gaps = 33/274 (12%)
Query: 148 DPKELDFSNSVEITKGTFRIASW-----RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
DP++L F++ EI G+F + VA+K + +K + I E+ LQ
Sbjct: 12 DPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYL--PKGDLRAYLKQKGALKPTLAVKFA---LDIA 257
++RHPN +++ G + +V EY D+ K KP V+ A
Sbjct: 71 QLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHK-----KPLQEVEIAAICHGAL 125
Query: 258 RGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEET 317
+G+ YLH + IHRD++ NIL + G +K+ADFG + L+ AN+ T
Sbjct: 126 QGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV--------GT 174
Query: 318 SWRYAAPEV---YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPP 374
+ + APEV +YD KVDV+S + E+ E PP +IA P
Sbjct: 175 PY-WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNDSP 232
Query: 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
+ ++ R ++ C + P RP+ ++L
Sbjct: 233 -TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 10/181 (5%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLR 235
A+K L +EV +D+V + E +LQ RHP + + + V EY G+L
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 236 AYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFG 295
+L ++ A + +I + YLH +++RDL+ N++ D GH+K+ DFG
Sbjct: 84 FHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFG 140
Query: 296 LSKL-LKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPP 354
L K + T+K C + Y APEV ++ +Y VD + +++ EM+ G P
Sbjct: 141 LCKEGISDGATMK----TFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
Query: 355 F 355
F
Sbjct: 195 F 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 67/254 (26%), Positives = 112/254 (44%), Gaps = 21/254 (8%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLR 235
A+KT+ + +V + E +L ++ P +V + + +V ++ G+L
Sbjct: 22 ALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELF 81
Query: 236 AYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFG 295
+L+++G + A + ++ + LH+ +I+RDL+P NIL D GH+ + DFG
Sbjct: 82 HHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFG 138
Query: 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPF 355
L KL N +D+ T T Y APE+ Y VD ++ ++L EM+ G PPF
Sbjct: 139 LCKL----NMKDDDKTNTFCGTP-EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPF 193
Query: 356 PTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415
++ V + Y + P R P G +D R PT R +I
Sbjct: 194 ---YDENVNEMYRKILQEPLRFPD-----GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245
Query: 416 -----DQLSIKRHW 424
QLS K+
Sbjct: 246 NHPFFSQLSWKKLL 259
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 160 ITKGTF-RIASWR----GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI---RHPNVVQ 211
I KGTF ++ R A+K L ++ + +V I E +L + P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 212 FLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAI 271
+ + + +VT+Y+ G+L +L+++G A + ++ + +LH+ I
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---I 117
Query: 272 IHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT-CEETSWRYAAPEVYKNE 330
++RDL+P NIL D +GH+ + DFGLSK AN T C T Y APEV +E
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSK----ANLTDNKTTNTFCGTT--EYLAPEVLLDE 171
Query: 331 E-YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPK 365
+ Y VD +S +++ EM G PF + +++ +
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR 207
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 50/181 (27%), Positives = 90/181 (49%), Gaps = 9/181 (4%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALL-QKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
A+K + +E+ D++ + E + HP +V + + V E++ GDL
Sbjct: 24 AMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL 83
Query: 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294
+++++ L A ++ +I+ +N+LHE II+RDL+ N+L D GH+K+ D+
Sbjct: 84 MFHMQRQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDY 140
Query: 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPP 354
G+ K D T T Y APE+ + E+Y VD ++ +++ EM+ G P
Sbjct: 141 GMCK----EGIRPGDTTSTFCGTP-NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
Query: 355 F 355
F
Sbjct: 196 F 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 57/188 (30%), Positives = 95/188 (50%), Gaps = 14/188 (7%)
Query: 172 GTQVAVKTLGEEVFTDEDKV--KAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229
G VA+K E +++DK+ K + E+ +L+++RH N+V + + + +V E++
Sbjct: 26 GQIVAIKKFLE---SEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82
Query: 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289
L K L + K+ I RG+ + H + IIHRD++P NIL SG +
Sbjct: 83 DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVV 139
Query: 290 KVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPE-VYKNEEYDTKVDVFSFALILQEM 348
K+ DFG ++ L V D T W Y APE + + +Y VD+++ ++ EM
Sbjct: 140 KLCDFGFARTLAAPGEVYTDYVA----TRW-YRAPELLVGDTKYGRAVDIWAVGCLVTEM 194
Query: 349 IEGCPPFP 356
+ G P FP
Sbjct: 195 LTGEPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 66/231 (28%), Positives = 109/231 (47%), Gaps = 21/231 (9%)
Query: 187 DEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ--KGAL 244
E++++ ++ E+ +L HP +V+ LGA + I+ E+ P G + A + + +G
Sbjct: 49 SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT 108
Query: 245 KPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304
+P + V + + YLH + IIHRDL+ N+L G +K+ADFG+S A
Sbjct: 109 EPQIQV-ICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVS-----AK 159
Query: 305 TVK--EDRPVTCEETSWRYAAPEV-----YKNEEYDTKVDVFSFALILQEMIEGCPPFPT 357
VK + R W APEV K+ YD K D++S + L EM + PP
Sbjct: 160 NVKTLQRRDSFIGTPYW--MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217
Query: 358 KQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
V IA PP + + ++ R+ ++ + P RP+ Q+L
Sbjct: 218 LNPMRV-LLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 6e-17
Identities = 68/268 (25%), Positives = 122/268 (45%), Gaps = 24/268 (8%)
Query: 151 ELDFSNSVEITKGTFRIASWRGTQVAVKTL---GEEVFTDEDKVKAFIDELALLQKIRHP 207
EL N + KG +++ + VA+K L E+ DE + E ++ ++ +P
Sbjct: 2 ELGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNENEKSVRDE-----MMREAEIMHQLDNP 55
Query: 208 NVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTL-AVKFALDIARGMNYLHEN 266
+V+ +G V ++ +M+V E G L +L K V+ ++ GM YL
Sbjct: 56 YIVRMIG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK 114
Query: 267 RPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEV 326
+HRDL N+L + + K++DFGLSK L ++ + R + + ++ APE
Sbjct: 115 N---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR--SAGKWPLKWYAPEC 169
Query: 327 YKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERP--PFRAPTTHYA 383
++ ++ DV+S+ + + E G P+ + EV +R P P YA
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYA 229
Query: 384 YGLRELIEDCWSEEPFRRPTFRQILMRL 411
L++DCW + RP F ++ R+
Sbjct: 230 -----LMKDCWIYKWEDRPNFAKVEERM 252
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 7e-17
Identities = 28/60 (46%), Positives = 40/60 (66%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G+L+ +K LL+ G DVN +D D TALH+AA G ++V+LLL GAD++ +D
Sbjct: 32 LHLAARNGNLEIVKLLLEHGADVNAKDKDGNTALHLAARNGNLEIVKLLLEHGADINLKD 91
|
Length = 91 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-17
Identities = 61/171 (35%), Positives = 89/171 (52%), Gaps = 20/171 (11%)
Query: 195 IDELALLQKIR---HPNVVQFLGAVTQS-----TPMMIVTEYLPKGDLRAYL-KQKGALK 245
I E+A+L+ + HPNVV+ T S T + +V E++ + DL YL K
Sbjct: 49 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV 107
Query: 246 PTLAVK-FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304
PT +K + RG+++LH +R ++HRDL+P NIL SG +K+ADFGL+++ F
Sbjct: 108 PTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 164
Query: 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPF 355
+ + T W Y APEV Y T VD++S I EM P F
Sbjct: 165 ALT-----SVVVTLW-YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-17
Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 11/169 (6%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKF 252
++E +L+K+ VV A + +V + GDL+ ++ G A+ +
Sbjct: 48 LNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY 107
Query: 253 ALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312
A ++ G+ L R I++RDL+P NIL DD GH++++D GL A + E V
Sbjct: 108 AAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGL------AVQIPEGETV 158
Query: 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK 361
+ Y APEV NE+Y D + ++ EMI+G PF ++E+
Sbjct: 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 8e-17
Identities = 52/202 (25%), Positives = 101/202 (50%), Gaps = 18/202 (8%)
Query: 161 TKGTFRIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVT 217
T G+ +A + G VA+K + ++ ++ E+ + + E+ L+K+ HPN+V+
Sbjct: 11 TFGSVYLARNKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNEHPNIVKLKEVFR 68
Query: 218 QSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFAL-DIARGMNYLHENRPEAIIHRDL 276
++ + V EY+ + +KG ++ + I +G+ ++H++ HRDL
Sbjct: 69 ENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDL 125
Query: 277 EPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWR-YAAPEVY-KNEEYDT 334
+P N+L +K+ADFGL++ + RP + S R Y APE+ ++ Y +
Sbjct: 126 KPENLLVSGPEVVKIADFGLAREI-------RSRPPYTDYVSTRWYRAPEILLRSTSYSS 178
Query: 335 KVDVFSFALILQEMIEGCPPFP 356
VD+++ I+ E+ P FP
Sbjct: 179 PVDIWALGCIMAELYTLRPLFP 200
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.2 bits (197), Expect = 9e-17
Identities = 58/238 (24%), Positives = 110/238 (46%), Gaps = 15/238 (6%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G +VA++ + + K + I+E+ ++++ ++PN+V +L + + +V EYL
Sbjct: 45 GQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
G L + + + +A + + + +LH N+ +IHRD++ NIL G +K+
Sbjct: 102 GSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRY-AAPEVYKNEEYDTKVDVFSFALILQEMIE 350
DFG F + ++ Y APEV + Y KVD++S ++ EMIE
Sbjct: 158 TDFG------FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 211
Query: 351 GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
G PP+ + N P + P A R+ + C + +R + +++L
Sbjct: 212 GEPPYLNENPLRALYLIATNGTPELQNPEKLSAI-FRDFLNRCLDMDVEKRGSAKELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 69/259 (26%), Positives = 113/259 (43%), Gaps = 34/259 (13%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
VAVKTL + ++ K F E LL ++H ++V+F G + P+++V EY+ GDL
Sbjct: 38 VAVKTLKD---ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDL 94
Query: 235 RAYLKQKGA-------------LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNI 281
+L+ G L + + A IA GM YL + +HRDL N
Sbjct: 95 NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNC 151
Query: 282 LRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSW--RYAAPEVYKNEEYDTKVDVF 339
L ++ +K+ DFG+S+ + D T R+ PE ++ T+ DV+
Sbjct: 152 LVGENLLVKIGDFGMSR-----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVW 206
Query: 340 SFALILQEMIE-GCPPFPTKQEKEVPKAYIANE--RPPFRAPTTHYAYGLRELIEDCWSE 396
S ++L E+ G P+ EV + + P P Y +L+ CW
Sbjct: 207 SLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVY-----DLMLGCWQR 261
Query: 397 EPFRRPTFRQILMRLDDIS 415
EP R ++I L +++
Sbjct: 262 EPHMRLNIKEIHSLLQNLA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 70/230 (30%), Positives = 112/230 (48%), Gaps = 21/230 (9%)
Query: 188 EDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ--KGALK 245
E++++ ++ E+ +L HPN+V+ L A + I+ E+ G + A + + + +
Sbjct: 43 EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE 102
Query: 246 PTLAV--KFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303
P + V K L+ +NYLHEN+ IIHRDL+ NIL G +K+ADFG+S
Sbjct: 103 PQIRVVCKQTLE---ALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSA----K 152
Query: 304 NTVKEDRPVTCEETSWRYAAPEVY-----KNEEYDTKVDVFSFALILQEMIEGCPPFPTK 358
NT R + T + + APEV K+ YD K DV+S + L EM + PP
Sbjct: 153 NTRTIQRRDSFIGTPY-WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211
Query: 359 QEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
V IA PP A + ++ ++ ++ C + R T Q+L
Sbjct: 212 NPMRV-LLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|140343 PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-16
Identities = 47/139 (33%), Positives = 59/139 (42%), Gaps = 6/139 (4%)
Query: 19 PDQPLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAA 78
PD L ++ D A V L +A GD G + LL G D N RD D RT LH+A
Sbjct: 64 PDHNLTTEEVIDPVVAHMLTVELCQLAASGDAVGARILLTGGADPNCRDYDGRTPLHIAC 123
Query: 79 CQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQN 138
G VVR+LL GAD D+ G TPL A +V++LL H
Sbjct: 124 ANGHVQVVRVLLEFGADPTLLDKDGKTPLELAEENGFREVVQLLSRHSQCHFEL-----G 178
Query: 139 AREVPEYEIDPKELDFSNS 157
A P+ K +S
Sbjct: 179 ANAKPD-SFTGKPPSLEDS 196
|
Length = 664 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 7/184 (3%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G A+K L +EV +D+V + E +LQ RHP + + + V EY
Sbjct: 20 GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
G+L +L ++ A + +I ++YLH + +++RDL+ N++ D GH+K+
Sbjct: 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKI 137
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG 351
DFGL K +K+ + + Y APEV ++ +Y VD + +++ EM+ G
Sbjct: 138 TDFGLCK-----EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 192
Query: 352 CPPF 355
PF
Sbjct: 193 RLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 67/267 (25%), Positives = 124/267 (46%), Gaps = 21/267 (7%)
Query: 148 DPKELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
DP+ L N ++I +G+ I G QVAVK + + + + +E+ +++
Sbjct: 18 DPRSL-LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMR 73
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNY 262
+H NVV+ + + ++ E+L G L + Q + +A + + + Y
Sbjct: 74 DYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIAT-VCESVLQALCY 132
Query: 263 LHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRY- 321
LH + +IHRD++ +IL G +K++DFG F + +D P Y
Sbjct: 133 LHS---QGVIHRDIKSDSILLTLDGRVKLSDFG------FCAQISKDVPKRKSLVGTPYW 183
Query: 322 AAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381
APEV Y T+VD++S +++ EM++G PP+ + + K + + PP
Sbjct: 184 MAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRDSPPPKLKNAHK 242
Query: 382 YAYGLRELIEDCWSEEPFRRPTFRQIL 408
+ LR+ +E + EP R T +++L
Sbjct: 243 ISPVLRDFLERMLTREPQERATAQELL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 50/181 (27%), Positives = 92/181 (50%), Gaps = 9/181 (4%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALL-QKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
A+K + +E+ D++ + E + Q HP +V + + V EY+ GDL
Sbjct: 24 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83
Query: 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294
+++++ L A ++ +I+ +NYLHE II+RDL+ N+L D GH+K+ D+
Sbjct: 84 MFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDY 140
Query: 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPP 354
G+ K ++ + + Y APE+ + E+Y VD ++ +++ EM+ G P
Sbjct: 141 GMCK-----EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
Query: 355 F 355
F
Sbjct: 196 F 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 66/268 (24%), Positives = 119/268 (44%), Gaps = 53/268 (19%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
VAVK L E+ +++ F+ E+ ++ +++ PN+++ L S P+ ++TEY+ GDL
Sbjct: 49 VAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 235 RAYL-----KQKGALKPTLAVKF------ALDIARGMNYLHENRPEAIIHRDLEPSNILR 283
+L ++ + + + A IA GM YL +HRDL N L
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLV 163
Query: 284 DDSGHLKVADFGLSKLLKFANTVK-EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFA 342
+ +K+ADFG+S+ L + + + R V R+ + E ++ T DV++F
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAV----LPIRWMSWESILLGKFTTASDVWAFG 219
Query: 343 LILQEMIEGCPPFPTKQEKEVPKAYIANER-------------------PPFRAPTTHYA 383
+ L E++ C KE P + +++E+ P P + Y
Sbjct: 220 VTLWEILTLC--------KEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLY- 270
Query: 384 YGLRELIEDCWSEEPFRRPTFRQILMRL 411
+L+ CW RP+F++I L
Sbjct: 271 ----KLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 51/184 (27%), Positives = 87/184 (47%), Gaps = 8/184 (4%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G A+K L +EV +D+V + E +LQ RHP + A + V EY
Sbjct: 20 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
G+L +L ++ A + +I + YLH +++RD++ N++ D GH+K+
Sbjct: 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKI 136
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG 351
DFGL K + + + + Y APEV ++ +Y VD + +++ EM+ G
Sbjct: 137 TDFGLCK-----EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191
Query: 352 CPPF 355
PF
Sbjct: 192 RLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 70/272 (25%), Positives = 113/272 (41%), Gaps = 23/272 (8%)
Query: 145 YEIDPKELDFSNSVEITKGTF-----RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELA 199
Y+ DP+E+ F EI G+F S VAVK + +K + I E+
Sbjct: 15 YKDDPEEI-FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK 73
Query: 200 LLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARG 259
LQ+++HPN +++ G + +V EY K L+ +G
Sbjct: 74 FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 133
Query: 260 MNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSW 319
+ YLH + +IHRD++ NIL + G +K+ADFG + AN+ +
Sbjct: 134 LAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV---------GTP 181
Query: 320 RYAAPEV---YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFR 376
+ APEV +YD KVDV+S + E+ E PP N+ P +
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQ 241
Query: 377 APTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
+ + R ++ C + P RP ++L
Sbjct: 242 --SNEWTDSFRGFVDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 5e-16
Identities = 54/193 (27%), Positives = 96/193 (49%), Gaps = 10/193 (5%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G A+K L +EV +D+V + E +L+ RHP + + + V EY+
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
G+L +L ++ + +I ++YLH + I++RDL+ N++ D GH+K+
Sbjct: 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKI 136
Query: 292 ADFGLSKL-LKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE 350
DFGL K + A T+K C + Y APEV ++ +Y VD + +++ EM+
Sbjct: 137 TDFGLCKEGITDAATMK----TFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 190
Query: 351 GCPPFPTKQEKEV 363
G PF + +++
Sbjct: 191 GRLPFYNQDHEKL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 70/266 (26%), Positives = 123/266 (46%), Gaps = 19/266 (7%)
Query: 148 DPKEL--DFSNSVEITKGTFRIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQK 203
DP+E F E + G IA+ + G QVAVK + + + + +E+ +++
Sbjct: 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRD 75
Query: 204 IRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYL 263
H NVV + + +V E+L G L + + +A L + R ++YL
Sbjct: 76 YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLSVLRALSYL 134
Query: 264 HENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRY-A 322
H + +IHRD++ +IL G +K++DFG F V ++ P Y
Sbjct: 135 HN---QGVIHRDIKSDSILLTSDGRIKLSDFG------FCAQVSKEVPKRKSLVGTPYWM 185
Query: 323 APEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382
APEV Y T+VD++S +++ EMI+G PP+ + + + I + PP +
Sbjct: 186 APEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-IRDNLPPRVKDSHKV 244
Query: 383 AYGLRELIEDCWSEEPFRRPTFRQIL 408
+ LR ++ EP +R T +++L
Sbjct: 245 SSVLRGFLDLMLVREPSQRATAQELL 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 6e-16
Identities = 61/251 (24%), Positives = 102/251 (40%), Gaps = 35/251 (13%)
Query: 173 TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232
V +K LG + AF + +L+ ++ H ++V+ G V ++V EY+ G
Sbjct: 31 VSVVLKVLGSDHRDSL----AFFETASLMSQLSHKHLVKLYG-VCVRDENIMVEEYVKFG 85
Query: 233 DLRAYLKQKGALKPTLAVKF--ALDIARGMNYLHENRPEAIIHRDLEPSNIL--RDDSGH 288
L +L ++ +L K A +A ++YL + + ++H ++ NIL R
Sbjct: 86 PLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNE 141
Query: 289 -----LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEE--YDTKVDVFSF 341
+K++D G+ + E P + APE +N + D +SF
Sbjct: 142 GYVPFIKLSDPGIPITVLSREERVERIP---------WIAPECIRNGQASLTIAADKWSF 192
Query: 342 ALILQEMIEGCP-PFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFR 400
L E+ P T E + Y R P L LI CW+ +P +
Sbjct: 193 GTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAE-----LANLINQCWTYDPTK 247
Query: 401 RPTFRQILMRL 411
RP+FR IL L
Sbjct: 248 RPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 18/176 (10%)
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDI 256
EL ++ +I+H N++ + + + +V + + DL+ + +K L + L I
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQI 128
Query: 257 ARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEE 316
G+N LH+ +HRDL P+NI + G K+ADFGL++ ++ D E
Sbjct: 129 LNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLAR--RYGYPPYSDTLSKDET 183
Query: 317 TSWR-----------YAAPE-VYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE 360
R Y APE + E+Y VD++S I E++ G P FP + E
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239
|
Length = 335 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 48/181 (26%), Positives = 83/181 (45%), Gaps = 11/181 (6%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
VA+K + + +V E +L I HP V G+ + + +V E++ G+
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118
Query: 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294
+L++ + +A I YL I++RDL+P N+L D G +K+ DF
Sbjct: 119 FTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDF 175
Query: 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPP 354
G +K++ + R T T Y APE+ N + D ++ + + E++ GCPP
Sbjct: 176 GFAKVV-------DTRTYTLCGTP-EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
Query: 355 F 355
F
Sbjct: 228 F 228
|
Length = 340 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 53/186 (28%), Positives = 91/186 (48%), Gaps = 15/186 (8%)
Query: 197 ELALLQKIRH-PNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALD 255
E +L+ +R P +V A T + ++ +Y+ G+L +L Q+ + + +
Sbjct: 54 ERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAE 113
Query: 256 IARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCE 315
I +++LH+ II+RD++ NIL D GH+ + DFGLSK +E+R +
Sbjct: 114 IVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL---AEEEERAYSFC 167
Query: 316 ETSWRYAAPEVYKNEE--YDTKVDVFSFALILQEMIEGCPPFPTKQEK----EVPKAYIA 369
T Y APEV + +D VD +S ++ E++ G PF E+ E+ + I
Sbjct: 168 GTI-EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR-IL 225
Query: 370 NERPPF 375
+PPF
Sbjct: 226 KSKPPF 231
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 74/273 (27%), Positives = 118/273 (43%), Gaps = 41/273 (15%)
Query: 160 ITKGTF----RIASWR-GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFL 213
I KGT+ ++ + + G+ AVK L DE+ ++A E +LQ + HPNVV+F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE-IEA---EYNILQSLPNHPNVVKFY 85
Query: 214 GAVTQST-----PMMIVTEYLPKGD----LRAYLKQKGALKPTLAVKFALDIARGMNYLH 264
G ++ + +V E G ++ L L + G+ +LH
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145
Query: 265 ENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAP 324
NR IIHRD++ +NIL G +K+ DFG+S L + + R + W AP
Sbjct: 146 NNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQL---TSTRLRRNTSVGTPFW--MAP 197
Query: 325 EVYKNEE-----YDTKVDVFSFALILQEMIEGCPPF----PTKQEKEVPKAYIANERPPF 375
EV E+ YD + DV+S + E+ +G PP P K ++P+ N P
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR----NPPPTL 253
Query: 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
P + I C ++ RP+ +L
Sbjct: 254 LHP-EKWCRSFNHFISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-15
Identities = 33/64 (51%), Positives = 41/64 (64%)
Query: 64 NFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLE 123
N RD D RT LH+AA G +VV+LLL GADV+ +D G TPL A H +++KLL
Sbjct: 1 NARDEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLL 60
Query: 124 EHGA 127
E GA
Sbjct: 61 EKGA 64
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 70/257 (27%), Positives = 110/257 (42%), Gaps = 43/257 (16%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
VAVK L + K F E LL ++H ++V+F G P+++V EY+ GDL
Sbjct: 38 VAVKALKDPTLAAR---KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL 94
Query: 235 RAYLK----------------QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEP 278
+L+ KG L + + A IA GM YL + +HRDL
Sbjct: 95 NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLAT 151
Query: 279 SNILRDDSGHLKVADFGLSKLLKFANTVKED----RPVTCEETSWRYAAPEVYKNEEYDT 334
N L + +K+ DFG+S+ + + + P+ R+ PE ++ T
Sbjct: 152 RNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI-------RWMPPESIMYRKFTT 204
Query: 335 KVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIAN---ERPPFRAPTTHYAYGLRELI 390
+ DV+SF +IL E+ G P+ EV + ERP P Y +++
Sbjct: 205 ESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV-CPKEVY-----DIM 258
Query: 391 EDCWSEEPFRRPTFRQI 407
CW EP +R ++I
Sbjct: 259 LGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 73/263 (27%), Positives = 112/263 (42%), Gaps = 44/263 (16%)
Query: 173 TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232
VAVK L E E + F E LL ++H ++V+F G T+ P+++V EY+ G
Sbjct: 36 MLVAVKALKE---ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHG 92
Query: 233 DLRAYLKQKGALKPTLA---------------VKFALDIARGMNYLHENRPEAIIHRDLE 277
DL +L+ G LA + A IA GM YL +HRDL
Sbjct: 93 DLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLA 149
Query: 278 PSNILRDDSGHLKVADFGLSKLLKFANTVKED----RPVTCEETSWRYAAPEVYKNEEYD 333
N L +K+ DFG+S+ + + + P+ R+ PE ++
Sbjct: 150 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI-------RWMPPESILYRKFT 202
Query: 334 TKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIAN---ERPPFRA-PTTHYAYGLRE 388
T+ D++SF ++L E+ G P+ E + ERP R P YA
Sbjct: 203 TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERP--RTCPPEVYA----- 255
Query: 389 LIEDCWSEEPFRRPTFRQILMRL 411
+++ CW EP +R + I RL
Sbjct: 256 IMQGCWQREPQQRMVIKDIHSRL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 55/177 (31%), Positives = 83/177 (46%), Gaps = 22/177 (12%)
Query: 197 ELALLQKIRH-PNVVQFLGA--VTQSTP---MMIVTEYLPKGDLRAYLKQKG-----ALK 245
E++LLQ + +V+ L V + + +V EYL DL+ ++ G L
Sbjct: 50 EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLP 108
Query: 246 PTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS-GHLKVADFGLSKLLKFAN 304
F + +G+ + H++ ++HRDL+P N+L D G LK+AD GL + F+
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR--AFSI 163
Query: 305 TVKEDRPVTCEETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE 360
VK T E + Y APEV + Y T VD++S I EM P FP E
Sbjct: 164 PVKS---YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE 217
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 66/243 (27%), Positives = 114/243 (46%), Gaps = 41/243 (16%)
Query: 187 DEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTP------MMIVTEYLPKGDLRAYLK 239
+E+++K E+ +L+K H N+ + GA + +P + +V E+ G + +K
Sbjct: 55 EEEEIKL---EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVK 111
Query: 240 Q-KG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLS 297
KG ALK +I RG+ +LH ++ +IHRD++ N+L ++ +K+ DFG+S
Sbjct: 112 NTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 168
Query: 298 KLLKFANTVKEDRPVTCEET---SWRYAAPEVYKNEE-----YDTKVDVFSFALILQEMI 349
L DR V T + + APEV +E YD + D++S + EM
Sbjct: 169 AQL--------DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMA 220
Query: 350 EGCPPF----PTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFR 405
EG PP P + +P+ PP + + ++ + IE C + RP+
Sbjct: 221 EGAPPLCDMHPMRALFLIPR------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTE 274
Query: 406 QIL 408
Q+L
Sbjct: 275 QLL 277
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 52/184 (28%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALL-QKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
A+K + +E+ D++ + E + Q +P +V ++ + +V EY+ GDL
Sbjct: 24 AMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL 83
Query: 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294
+++++ L A +A +I +N+LHE II+RDL+ N+L D GH+K+ D+
Sbjct: 84 MFHMQRQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDY 140
Query: 295 GLSKLLKFANTVKEDRPVTCEET---SWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG 351
G+ K + P T + Y APE+ + EEY VD ++ +++ EM+ G
Sbjct: 141 GMCK--------EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 192
Query: 352 CPPF 355
PF
Sbjct: 193 RSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 66/243 (27%), Positives = 114/243 (46%), Gaps = 41/243 (16%)
Query: 187 DEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTP------MMIVTEYLPKGDLRAYLK 239
+E+++K E+ +L+K H N+ + GA + P + +V E+ G + +K
Sbjct: 45 EEEEIK---QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 101
Query: 240 Q-KG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLS 297
KG LK +I RG+++LH+++ +IHRD++ N+L ++ +K+ DFG+S
Sbjct: 102 NTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158
Query: 298 KLLKFANTVKEDRPVTCEET---SWRYAAPEVYKNEE-----YDTKVDVFSFALILQEMI 349
L DR V T + + APEV +E YD K D++S + EM
Sbjct: 159 AQL--------DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 210
Query: 350 EGCPPF----PTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFR 405
EG PP P + +P+ P R + ++ + IE C + +RPT
Sbjct: 211 EGAPPLCDMHPMRALFLIPR------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTE 264
Query: 406 QIL 408
Q++
Sbjct: 265 QLM 267
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 41/207 (19%)
Query: 171 RGTQVAVKTLGEEVFTDEDKVKAF---------IDELALLQKIRHPNVVQFLGAVTQST- 220
G +VA+K K+ F + E+ +L++ +H N++ L + +
Sbjct: 29 TGVKVAIK-----------KISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF 77
Query: 221 ----PMMIVTEYLPKGDLRAYLK-QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRD 275
+ IV E + DL +K Q L F I RG+ Y+H ++HRD
Sbjct: 78 ESFNDVYIVQELMET-DLYKLIKTQH--LSNDHIQYFLYQILRGLKYIHSAN---VLHRD 131
Query: 276 LEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEE---TSWRYAAPEVYKN-EE 331
L+PSN+L + + LK+ DFGL+++ + D E T W Y APE+ N +
Sbjct: 132 LKPSNLLLNTNCDLKICDFGLARI----ADPEHDHTGFLTEYVATRW-YRAPEIMLNSKG 186
Query: 332 YDTKVDVFSFALILQEMIEGCPPFPTK 358
Y +D++S IL EM+ P FP K
Sbjct: 187 YTKAIDIWSVGCILAEMLSNRPLFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 56/189 (29%), Positives = 89/189 (47%), Gaps = 21/189 (11%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP--------MM 223
G +VA+K + VF + K EL +L +H NV L A+ P +
Sbjct: 25 GKRVALKKM-PNVFQNLVSCKRVFRELKMLCFFKHDNV---LSALDILQPPHIDPFEEIY 80
Query: 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR 283
+VTE L + DL + L F I RG+ YLH I+HRD++P N+L
Sbjct: 81 VVTE-LMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLV 136
Query: 284 DDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYK-NEEYDTKVDVFSFA 342
+ + LK+ DFGL+++ + E + +T E + Y APE+ + Y + VD++S
Sbjct: 137 NSNCVLKICDFGLARVEEP----DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVG 192
Query: 343 LILQEMIEG 351
I E++
Sbjct: 193 CIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 61/284 (21%), Positives = 121/284 (42%), Gaps = 41/284 (14%)
Query: 147 IDPKELDFSNSVEITKG-TFRI--ASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQK 203
I+ ++D SV I + I + +V ++T + + + +E+ L++
Sbjct: 15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRR 74
Query: 204 IRHPNVVQFLG---AVTQSTP-MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARG 259
I N+++ G + P + ++ EY +G LR L ++ L + A+D +G
Sbjct: 75 IDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKG 134
Query: 260 MNYLHE--NRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL-----KFANTVKEDRPV 312
+ L++ N+P +++L + L ++ LK+ GL K+L K N +
Sbjct: 135 LYNLYKYTNKP----YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----- 185
Query: 313 TCEETSWRYAAPEVYKN--EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN 370
Y + ++ + EY K D++S ++L E+ G PF KE+ I
Sbjct: 186 --------YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK 237
Query: 371 ---ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411
+ P P ++ ++E C S + +RP ++IL L
Sbjct: 238 NNSLKLPLDCPLE-----IKCIVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 54/201 (26%), Positives = 84/201 (41%), Gaps = 24/201 (11%)
Query: 167 IASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIV 225
+ VA+K + VF+ + K + EL LL+ R H N+ M IV
Sbjct: 22 AETSEEETVAIKKI-TNVFSKKILAKRALRELKLLRHFRGHKNITCLYD-------MDIV 73
Query: 226 T----------EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRD 275
E L + DL ++ L F I G+ Y+H ++HRD
Sbjct: 74 FPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRD 130
Query: 276 LEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVY-KNEEYDT 334
L+P N+L + LK+ DFGL++ N + +T + Y APE+ + Y
Sbjct: 131 LKPGNLLVNADCELKICDFGLARGFS-ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTK 189
Query: 335 KVDVFSFALILQEMIEGCPPF 355
+DV+S IL E++ P F
Sbjct: 190 AIDVWSVGCILAELLGRKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-14
Identities = 57/241 (23%), Positives = 111/241 (46%), Gaps = 15/241 (6%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G A+K + E D V+ E+ +++ +H N+V + G+ + + I E+
Sbjct: 34 GELAAIKVIKLEPGEDFAVVQ---QEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG 90
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
G L+ G L + + + +G+ YLH + +HRD++ +NIL D+GH+K+
Sbjct: 91 GSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKL 147
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEE---YDTKVDVFSFALILQEM 348
ADFG+S + T+ + + + + APEV E Y+ D+++ + E+
Sbjct: 148 ADFGVSA--QITATIAKRKSFI---GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
Query: 349 IEGCPP-FPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQI 407
E PP F + + +N +PP ++ ++ ++ P +RPT ++
Sbjct: 203 AELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKL 262
Query: 408 L 408
L
Sbjct: 263 L 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 8/186 (4%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
VA+K + +E K + + EL +L+ ++ N+V+ A + + +V EY+ K L
Sbjct: 29 VAIKKFKDSEENEEVK-ETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNML 87
Query: 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294
+ + P + + + +++ H+N I+HRD++P N+L + LK+ DF
Sbjct: 88 ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDF 144
Query: 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPP 354
G ++ L + V T W Y +PE+ Y VD++S IL E+ +G P
Sbjct: 145 GFARNLSEGSNANYTEYVA---TRW-YRSPELLLGAPYGKAVDMWSVGCILGELSDGQPL 200
Query: 355 FPTKQE 360
FP + E
Sbjct: 201 FPGESE 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 69/235 (29%), Positives = 109/235 (46%), Gaps = 52/235 (22%)
Query: 140 REVPEYEIDPKELDFSNSVEITKGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKAF 194
EV +YE +I +GTF A + T+ VA+K +V + +K + F
Sbjct: 9 DEVSKYE---------KLAKIGQGTFGEVFKARHKKTKQIVALK----KVLMENEK-EGF 54
Query: 195 ----IDELALLQKIRHPNVVQFLGAV-TQSTP-------MMIVTEYLPKGDLRAYLKQKG 242
+ E+ +LQ ++H NVV + T++TP +V E+ DL L K
Sbjct: 55 PITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNK- 112
Query: 243 ALKPTLAVKFAL-DIAR-------GMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294
VKF L +I + G+ Y+H N+ I+HRD++ +NIL G LK+ADF
Sbjct: 113 ------NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163
Query: 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEM 348
GL++ + K +R T W Y PE+ E +Y +D++ I+ EM
Sbjct: 164 GLARAFSLSKNSKPNRYTNRVVTLW-YRPPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 58/193 (30%), Positives = 89/193 (46%), Gaps = 16/193 (8%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVT-----QSTPMMIVT 226
+VA+K + F + K + E+ LL+ + H NV+ + + IV
Sbjct: 30 NEKVAIKKIAN-AFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88
Query: 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286
E L DL ++ L F + RG+ Y+H ++HRDL+PSN+L + +
Sbjct: 89 E-LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNAN 144
Query: 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALIL 345
LK+ DFGL++ + K D T W Y APE+ N EY T +DV+S I
Sbjct: 145 CDLKICDFGLAR----TTSEKGDFMTEYVVTRW-YRAPELLLNCSEYTTAIDVWSVGCIF 199
Query: 346 QEMIEGCPPFPTK 358
E++ P FP K
Sbjct: 200 AELLGRKPLFPGK 212
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 54/191 (28%), Positives = 97/191 (50%), Gaps = 13/191 (6%)
Query: 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFA----LDIARGMNYLHENRPEAIIHRDLE 277
+ +V +Y GDLR +K + T A + + ++++H +IHRD++
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIK 170
Query: 278 PSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVD 337
+NIL +G +K+ DFG SK+ +A TV +D T T + Y APE+++ + Y K D
Sbjct: 171 SANILLCSNGLVKLGDFGFSKM--YAATVSDDVGRTFCGTPY-YVAPEIWRRKPYSKKAD 227
Query: 338 VFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEE 397
+FS ++L E++ PF + +EV +A P + ++E++ S +
Sbjct: 228 MFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPE---MQEIVTALLSSD 284
Query: 398 PFRRPTFRQIL 408
P RRP+ ++L
Sbjct: 285 PKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 55/168 (32%), Positives = 91/168 (54%), Gaps = 17/168 (10%)
Query: 197 ELALLQKIR-HPNVVQFLGAVTQS---TPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKF 252
E+ LQ++ HPN+V+ L V ++ + +V EY+ + DL A ++ L+ + ++
Sbjct: 56 EIMFLQELGDHPNIVKLL-NVIKAENDKDIYLVFEYM-ETDLHAVIR-ANILED-VHKRY 111
Query: 253 AL-DIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311
+ + + + Y+H +IHRDL+PSNIL + +K+ADFGL++ L + P
Sbjct: 112 IMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLS-ELEENPENP 167
Query: 312 VTCE--ETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFP 356
V + T W Y APE+ + Y VD++S IL EM+ G P FP
Sbjct: 168 VLTDYVATRW-YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 32/234 (13%)
Query: 188 EDKVKAFI-DELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLR-AYLKQKGALK 245
ED V+ I E+ +L+ + HPNVV+ + + ++ E++ G L ++ + L
Sbjct: 112 EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA 171
Query: 246 PTLAVKFALDIAR----GMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301
D+AR G+ YLH I+HRD++PSN+L + + ++K+ADFG+S++L
Sbjct: 172 ---------DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRIL- 218
Query: 302 FANTVKEDRPVTCEETSWRYAAPEVYKNE----EYDTKV-DVFSFALILQEMIEGCPPFP 356
A T+ P + Y +PE + YD D++S + + E G PF
Sbjct: 219 -AQTMD---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274
Query: 357 TKQEKEVPK--AYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
++ + I +PP AP T R I C EP +R + Q+L
Sbjct: 275 VGRQGDWASLMCAICMSQPP-EAPATASR-EFRHFISCCLQREPAKRWSAMQLL 326
|
Length = 353 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 51/168 (30%), Positives = 87/168 (51%), Gaps = 17/168 (10%)
Query: 252 FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK-LLKFANTVKEDR 310
++ +A+GM +L + IHRDL NIL ++ +K+ DFGL++ + K + V++
Sbjct: 184 YSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 311 PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFP-TKQEKEVPKAYI 368
++ APE + Y + DV+SF ++L E+ G P+P K ++E +
Sbjct: 241 A----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 296
Query: 369 ANERPPFRAP--TTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
R RAP TT Y + + DCW EP +RPTF +++ L ++
Sbjct: 297 EGTR--MRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 174 QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQF--------------LGAVTQS 219
+VAVK + V TD VK + E+ +++++ H N+V+ +G++T+
Sbjct: 32 RVAVKKI---VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88
Query: 220 TPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPS 279
+ IV EY+ + DL L+Q G L A F + RG+ Y+H ++HRDL+P+
Sbjct: 89 NSVYIVQEYM-ETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 143
Query: 280 NIL-RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPE-VYKNEEYDTKVD 337
N+ + LK+ DFGL++++ + K T W Y +P + Y +D
Sbjct: 144 NVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL-VTKW-YRSPRLLLSPNNYTKAID 201
Query: 338 VFSFALILQEMIEGCPPFPTKQEKE 362
+++ I EM+ G P F E E
Sbjct: 202 MWAAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 8e-14
Identities = 41/110 (37%), Positives = 66/110 (60%), Gaps = 6/110 (5%)
Query: 190 KVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLA 249
+V+A D LAL + P +V ++ + + +V EYL GD+++ L G +A
Sbjct: 50 QVQAERDALAL---SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA 106
Query: 250 VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKL 299
VK+ ++A ++YLH + IIHRDL+P N+L + GH+K+ DFGLSK+
Sbjct: 107 VKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 14/194 (7%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP-----MMIVT 226
G +VA+K + +VF + E+ LL+ +RHP++V+ + + + +V
Sbjct: 25 GEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83
Query: 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286
E L + DL +K L P F + R + Y+H + HRDL+P NIL +
Sbjct: 84 E-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANAD 139
Query: 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN--EEYDTKVDVFSFALI 344
LK+ DFGL++ + F +T T W Y APE+ + +Y +D++S I
Sbjct: 140 CKLKICDFGLAR-VAFNDTPTAIFWTDYVATRW-YRAPELCGSFFSKYTPAIDIWSIGCI 197
Query: 345 LQEMIEGCPPFPTK 358
E++ G P FP K
Sbjct: 198 FAEVLTGKPLFPGK 211
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 14/192 (7%)
Query: 172 GTQVAVKTLGEEVFTDEDKV--KAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229
G VA+K E +++D V K + E+ +L++++HPN+V + + + +V EY
Sbjct: 26 GQIVAIKKFVE---SEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82
Query: 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289
L K + L K + +N+ H++ IHRD++P NIL G +
Sbjct: 83 DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQI 139
Query: 290 KVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEM 348
K+ DFG +++L T D T W Y APE+ + +Y VDV++ + E+
Sbjct: 140 KLCDFGFARIL----TGPGDDYTDYVATRW-YRAPELLVGDTQYGPPVDVWAIGCVFAEL 194
Query: 349 IEGCPPFPTKQE 360
+ G P +P K +
Sbjct: 195 LTGQPLWPGKSD 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 52/158 (32%), Positives = 73/158 (46%), Gaps = 22/158 (13%)
Query: 207 PNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLK-----QKGALKPTLAVKFALDIARGMN 261
+VQ A + +V EY+P GDL + +K A T V ALD M
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG 162
Query: 262 YLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRY 321
+ IHRD++P N+L D SGHLK+ADFG + V+ D V + Y
Sbjct: 163 F---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPD----Y 209
Query: 322 AAPEVYKNE----EYDTKVDVFSFALILQEMIEGCPPF 355
+PEV K++ Y + D +S + L EM+ G PF
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 47/172 (27%), Positives = 71/172 (41%), Gaps = 50/172 (29%)
Query: 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKF-------ALDIARGMNYLHENRPEAIIHRDL 276
++ EYLP GD+ L +K +F A+D + Y IHRD+
Sbjct: 78 LIMEYLPGGDMMTLLMKKDTFTEEET-RFYIAETILAIDSIHKLGY---------IHRDI 127
Query: 277 EPSNILRDDSGHLKVADFGLSKLLK------FANTVKEDRPVTCEET------------S 318
+P N+L D GH+K++DFGL LK F + P + +
Sbjct: 128 KPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAET 187
Query: 319 WR---------------YAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPF 355
W+ Y APEV+ Y+ + D +S +I+ EM+ G PPF
Sbjct: 188 WKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 29/163 (17%)
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP--KGDLRAYL-KQKGALKPTLAVKFA 253
E LLQ + HP+V++ + +V LP DL YL K+ L A+
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 254 LDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKL-------LKFANTV 306
I G+ YLH R IIHRD++ NI +D + + D G ++ L A TV
Sbjct: 164 KQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTV 220
Query: 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI 349
ET+ APEV ++Y++K D++S ++L EM+
Sbjct: 221 ---------ETN----APEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 79/289 (27%), Positives = 128/289 (44%), Gaps = 55/289 (19%)
Query: 153 DFSNSVEIT----KGT----FRIASWR-GTQVAVKTLG------EEVFTDEDKVKAFIDE 197
D S++ EI KGT F++ + + G++ AVK L EE+ + + +KA D
Sbjct: 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSD- 73
Query: 198 LALLQKIRHPNVVQFLGA-----VTQSTPMMIVTEYLPKG---DLRAYLKQKGALKPTLA 249
HPNVV+F G V + +V E G DL ++G
Sbjct: 74 --------HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI 125
Query: 250 VKFALDIA-RGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKE 308
+ + L A G+ +LH N+ IHRD++ +NIL G +K+ DFG+S L + +
Sbjct: 126 IAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQL---TSTRL 179
Query: 309 DRPVTCEETSWRYAAPEVYKNEE-----YDTKVDVFSFALILQEMIEGCPPF----PTKQ 359
R + W APEV E+ YD + DV+S + E+ +G PP P +
Sbjct: 180 RRNTSVGTPFW--MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237
Query: 360 EKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
++P+ N P P ++ + I C +++ +RPT +L
Sbjct: 238 LFKIPR----NPPPTLHQPEL-WSNEFNDFIRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 13/166 (7%)
Query: 252 FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK-LLKFANTVKEDR 310
++ +ARGM +L + IHRDL NIL ++ +K+ DFGL++ + K + V++
Sbjct: 179 YSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235
Query: 311 PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQ-EKEVPKAYI 368
++ APE ++ Y T+ DV+SF ++L E+ G P+P Q +E +
Sbjct: 236 A----RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK 291
Query: 369 ANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
R RAP + ++ CW +P RPTF ++ L D+
Sbjct: 292 DGTR--MRAPENATP-EIYRIMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 43/212 (20%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAF----IDELALLQKIRHPNVVQFLGAVTQSTPMM---- 223
G VA+K +V D +K + F I E+ +L+++ H N+V VT +
Sbjct: 32 GELVALK----KVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86
Query: 224 ------IVTEYLPKGDLRAYLKQKGALKPTLAVKFALD--------IARGMNYLHENRPE 269
+V EY+ DL L+ V F+ D + G+NY H+ +
Sbjct: 87 DKGAFYLVFEYMDH-DLMGLLESG-------LVHFSEDHIKSFMKQLLEGLNYCHK---K 135
Query: 270 AIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN 329
+HRD++ SNIL ++ G +K+ADFGL++L +E RP T + + Y PE+
Sbjct: 136 NFLHRDIKCSNILLNNKGQIKLADFGLARLYN----SEESRPYTNKVITLWYRPPELLLG 191
Query: 330 EE-YDTKVDVFSFALILQEMIEGCPPFPTKQE 360
EE Y +DV+S IL E+ P F QE
Sbjct: 192 EERYGPAIDVWSCGCILGELFTKKPIFQANQE 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 56/171 (32%), Positives = 79/171 (46%), Gaps = 22/171 (12%)
Query: 194 FIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLK-----QKGALKPTL 248
F +E ++ P VVQ A + +V EY+P GDL + +K A T
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 149
Query: 249 AVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKE 308
V ALD M + IHRD++P N+L D SGHLK+ADFG + V+
Sbjct: 150 EVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 200
Query: 309 DRPVTCEETSWRYAAPEVYKNE----EYDTKVDVFSFALILQEMIEGCPPF 355
D V + Y +PEV K++ Y + D +S + L EM+ G PF
Sbjct: 201 DTAVGTPD----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 62/245 (25%), Positives = 107/245 (43%), Gaps = 38/245 (15%)
Query: 153 DFSNSVEITKGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHP 207
DF + I +G F R+ + T A+K L + ++++V E +L +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 208 NVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENR 267
VV+ + + ++ E+LP GD+ L +K L + + ++ +H+
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ-- 119
Query: 268 PEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS--------- 318
IHRD++P N+L D GH+K++DFGL LK A+ + R +T S
Sbjct: 120 -LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 319 ------WR---------------YAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPT 357
W+ Y APEV+ Y+ D +S +I+ EM+ G PPF +
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 358 KQEKE 362
+ +E
Sbjct: 239 ETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 44/132 (33%), Positives = 69/132 (52%), Gaps = 11/132 (8%)
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
GDL +L Q G +A +I G+ ++H NR +++RDL+P+NIL D+ GH+++
Sbjct: 82 GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH-NR--FVVYRDLKPANILLDEHGHVRI 138
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVY-KNEEYDTKVDVFSFALILQEMIE 350
+D GL A + +P T Y APEV K YD+ D FS +L +++
Sbjct: 139 SDLGL------ACDFSKKKPHASVGTH-GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 191
Query: 351 GCPPFPTKQEKE 362
G PF + K+
Sbjct: 192 GHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 57/212 (26%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 197 ELALLQKIRH-PNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALD 255
E +L+ IR P +V A T + ++ +Y+ G+L +L Q+ K ++ +
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGE 113
Query: 256 IARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCE 315
I + +LH+ II+RD++ NIL D +GH+ + DFGLSK +F E C
Sbjct: 114 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK--EFHEDEVERAYSFC- 167
Query: 316 ETSWRYAAPEVYKNEE--YDTKVDVFSFALILQEMIEGCPPFPTKQEK----EVPKAYIA 369
+ Y AP++ + + +D VD +S +++ E++ G PF EK E+ + +
Sbjct: 168 -GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK 226
Query: 370 NERPPFRAPTTHYAYGLRELIEDCWSEEPFRR 401
+E PP+ + A +++I+ ++P +R
Sbjct: 227 SE-PPYPQEMSALA---KDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 61/197 (30%), Positives = 82/197 (41%), Gaps = 29/197 (14%)
Query: 171 RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVT-QSTPMMIVTEYL 229
G VA+K L F + K EL L++ + H N++ L T Q + YL
Sbjct: 40 TGQNVAIKKLSRP-FQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL 98
Query: 230 PKGDLRAYLKQKGALKPTLAVKFALDIAR----------GMNYLHENRPEAIIHRDLEPS 279
+ A L Q ++ LD R G+ +LH IIHRDL+PS
Sbjct: 99 VMELMDANLCQ--------VIQMDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPS 147
Query: 280 NILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVF 339
NI+ LK+ DFGL A T +T + Y APEV Y VD++
Sbjct: 148 NIVVKSDCTLKILDFGL------ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 201
Query: 340 SFALILQEMIEGCPPFP 356
S I+ EMI G FP
Sbjct: 202 SVGCIMGEMIRGTVLFP 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 7e-13
Identities = 51/172 (29%), Positives = 84/172 (48%), Gaps = 14/172 (8%)
Query: 198 LALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIA 257
L+L+ P +V A + + + + GDL +L Q G +A +I
Sbjct: 48 LSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII 107
Query: 258 RGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEET 317
G+ ++H NR +++RDL+P+NIL D+ GH++++D GL A + +P T
Sbjct: 108 LGLEHMH-NR--FVVYRDLKPANILLDEHGHVRISDLGL------ACDFSKKKPHASVGT 158
Query: 318 SWRYAAPEVY-KNEEYDTKVDVFSFALILQEMIEGCPPF---PTKQEKEVPK 365
Y APEV K YD+ D FS +L +++ G PF TK + E+ +
Sbjct: 159 H-GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 60/192 (31%), Positives = 91/192 (47%), Gaps = 21/192 (10%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM-----MIVT 226
G +VAVK L F K EL LL+ ++H NV+ L T + + + +
Sbjct: 42 GLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100
Query: 227 EYLPKGDLRAYLKQKGALKPTLAVKFAL-DIARGMNYLHENRPEAIIHRDLEPSNILRDD 285
+L DL +K + V+F + I RG+ Y+H IIHRDL+PSN+ ++
Sbjct: 101 THLMGADLNNIVKCQKLTDD--HVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNE 155
Query: 286 SGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALI 344
LK+ DFGL++ +D T W Y APE+ N Y+ VD++S I
Sbjct: 156 DCELKILDFGLARH-------TDDEMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCI 207
Query: 345 LQEMIEGCPPFP 356
+ E++ G FP
Sbjct: 208 MAELLTGRTLFP 219
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 61/248 (24%), Positives = 108/248 (43%), Gaps = 38/248 (15%)
Query: 153 DFSNSVEITKGTF---RIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHP 207
DF + I +G F R+ + G A+K L + ++++V E +L +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 208 NVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENR 267
VV+ + + ++ E+LP GD+ L +K L + + ++ +H+
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ-- 119
Query: 268 PEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTC------------- 314
IHRD++P N+L D GH+K++DFGL LK A+ + R +
Sbjct: 120 -LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 315 --EETSWR---------------YAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPT 357
+ +W+ Y APEV+ Y+ D +S +I+ EM+ G PPF +
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 358 KQEKEVPK 365
+ +E K
Sbjct: 239 ETPQETYK 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 55/171 (32%), Positives = 78/171 (45%), Gaps = 22/171 (12%)
Query: 194 FIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLK-----QKGALKPTL 248
F +E ++ P VVQ A + +V EY+P GDL + +K A T
Sbjct: 90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA 149
Query: 249 AVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKE 308
V ALD M +IHRD++P N+L D GHLK+ADFG + V+
Sbjct: 150 EVVLALDAIHSM---------GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC 200
Query: 309 DRPVTCEETSWRYAAPEVYKNE----EYDTKVDVFSFALILQEMIEGCPPF 355
D V + Y +PEV K++ Y + D +S + L EM+ G PF
Sbjct: 201 DTAVGTPD----YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 9e-13
Identities = 54/219 (24%), Positives = 102/219 (46%), Gaps = 12/219 (5%)
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDI 256
E+ ++++ +H N+V + G+ + I EY G L+ G L +
Sbjct: 56 EIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRET 115
Query: 257 ARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEE 316
+G+ YLH + +HRD++ +NIL D+G +K+ADFG++ K T+ + +
Sbjct: 116 LQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFI--- 167
Query: 317 TSWRYAAPEVY---KNEEYDTKVDVFSFALILQEMIEGCPP-FPTKQEKEVPKAYIANER 372
+ + APEV KN Y+ D+++ + E+ E PP F + + +N +
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ 227
Query: 373 PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411
PP T ++ ++ ++ P +RPT ++L L
Sbjct: 228 PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 47/232 (20%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLR 235
A+KTL ++ + ++V E +L + + VV+ + + V +Y+P GD+
Sbjct: 30 AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 236 AYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFG 295
+ L + LA + ++ + +H+ IHRD++P NIL D GH+K+ DFG
Sbjct: 90 SLLIRMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFG 146
Query: 296 L---------SKLLKFANTVKE------------------DRPVTCEETSWR-------- 320
L SK + + +++ DR T E+ + +
Sbjct: 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206
Query: 321 -------YAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPF--PTKQEKEV 363
Y APEV + Y D +S +IL EM+ G PPF PT E ++
Sbjct: 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQL 258
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 52/170 (30%), Positives = 87/170 (51%), Gaps = 17/170 (10%)
Query: 250 VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK-LLKFANTVKE 308
+ ++ +ARGM +L + IHRDL NIL ++ +K+ DFGL++ + K + V++
Sbjct: 176 ISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 232
Query: 309 DRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQ-EKEVPKA 366
++ APE ++ Y T+ DV+SF ++L E+ G P+P Q ++E +
Sbjct: 233 GDA----RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR 288
Query: 367 YIANERPPFRAP--TTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
R RAP T Y ++ DCW P RPTF +++ L D+
Sbjct: 289 LKEGTR--MRAPEYATPEIY---SIMLDCWHNNPEDRPTFSELVEILGDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 65/262 (24%), Positives = 115/262 (43%), Gaps = 41/262 (15%)
Query: 178 KTLGEEVFTDEDKVKAFIDELA----------LLQK------IRHPNVVQFLGAVTQSTP 221
K L E++TD + + EL LQ+ ++HPN++Q LG ++ P
Sbjct: 10 KVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIP 69
Query: 222 MMIVTEYLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLE 277
++V EY GDL++YL Q + + L + A +IA G+ ++H++ +H DL
Sbjct: 70 YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLA 126
Query: 278 PSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEE--TSWRYAAPEVYKN------ 329
N +KV D+G+ + KED T ++ R+ APE+
Sbjct: 127 LRNCFLTSDLTVKVGDYGIG----PSR-YKEDYIETEDDKCVPLRWLAPELVGEFHGGLI 181
Query: 330 -EEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387
E +V++ + L E+ E P+ ++EV I +++ P Y R
Sbjct: 182 TAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSER 241
Query: 388 --ELIEDCWSEEPFRRPTFRQI 407
E+++ CW P +R T ++
Sbjct: 242 WYEVLQFCWL-SPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 48/169 (28%), Positives = 71/169 (42%), Gaps = 41/169 (24%)
Query: 225 VTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD 284
V +Y+P GD+ + L + G + LA + ++ + +H+ IHRD++P NIL D
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILID 135
Query: 285 DSGHLKVADFGL---------SKLLKFANTVKED--------------RPVTCEETSWR- 320
GH+K+ DFGL SK + + ++D R E R
Sbjct: 136 RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQ 195
Query: 321 --------------YAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPF 355
Y APEV Y D +S +IL EM+ G PPF
Sbjct: 196 HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 57/190 (30%), Positives = 87/190 (45%), Gaps = 19/190 (10%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY--- 228
G +VA+K L F E K EL LL+ ++H NV+ L T + ++
Sbjct: 40 GAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98
Query: 229 LP--KGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286
+P DL +K + L + +G+ Y+H IIHRDL+P N+ ++
Sbjct: 99 MPFMGTDLGKLMKHE-KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNED 154
Query: 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALIL 345
LK+ DFGL++ + D +T + Y APEV N Y VD++S I+
Sbjct: 155 CELKILDFGLAR--------QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIM 206
Query: 346 QEMIEGCPPF 355
EM+ G P F
Sbjct: 207 AEMLTGKPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 51/173 (29%), Positives = 87/173 (50%), Gaps = 27/173 (15%)
Query: 250 VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF-ANTVKE 308
+ F+ +A+GM++L IHRDL NIL K+ DFGL++ ++ +N V +
Sbjct: 217 LSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273
Query: 309 DR---PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFP-----TKQ 359
PV ++ APE N Y + DV+S+ ++L E+ G P+P +K
Sbjct: 274 GNARLPV-------KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF 326
Query: 360 EKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412
K + + Y P AP+ Y ++++ CW +P +RPTF+QI+ ++
Sbjct: 327 YKMIKEGY-RMLSPEC-APSEMY-----DIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 27/168 (16%)
Query: 250 VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK-LLKFANTVKE 308
++F+ +A+GM++L IHRD+ N+L D K+ DFGL++ ++ +N V +
Sbjct: 215 LRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271
Query: 309 DR---PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFP-----TKQ 359
PV ++ APE + Y + DV+S+ ++L E+ G P+P +K
Sbjct: 272 GNARLPV-------KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF 324
Query: 360 EKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQI 407
K V + Y RP F AP Y+ +++ CW+ EP RPTF QI
Sbjct: 325 YKMVKRGY-QMSRPDF-APPEIYS-----IMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 67/297 (22%), Positives = 118/297 (39%), Gaps = 59/297 (19%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
T VAVK + + ++ +K E+ ++++HPN++ ++ + + + +V+ +
Sbjct: 25 NTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83
Query: 232 GDLRAYLKQ--KGALKPTLAVKFAL-DIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288
G LK L P LA+ F L D+ ++Y+H IHR ++ S+IL G
Sbjct: 84 GSCEDLLKTHFPEGL-PELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGK 139
Query: 289 LKVADFGLSKLLKFANTVKEDRPVTCEETS------WRYAAPEV-YKN-EEYDTKVDVFS 340
+ ++ GL + K R V S W +PEV +N + Y+ K D++S
Sbjct: 140 VVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW--LSPEVLQQNLQGYNEKSDIYS 195
Query: 341 FALILQEMIEGCPPF----PTKQ--EK-------------------EVPKAYIANERPPF 375
+ E+ G PF T+ EK + ++ +NE P
Sbjct: 196 VGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNN 255
Query: 376 RAPTTHYAYGL-----RELIEDCWSEEPFRRPT---------FRQILMRLDDISDQL 418
R H + +E C +P RP+ F+Q R + D L
Sbjct: 256 RDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTSLLDLL 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 37/91 (40%), Positives = 53/91 (58%), Gaps = 6/91 (6%)
Query: 43 YMANEGD--LDGIKELLDSGTDVNFRDIDKRTALHV---AACQGRTDVVRLLLSRGADVD 97
Y+ N + ++ ++ LL +G DVNFR +T LH+ + + D+VRLLL GADV+
Sbjct: 18 YLLNASNVTVEEVRRLLAAGADVNFRGEYGKTPLHLYLHYSSEKVKDIVRLLLEAGADVN 77
Query: 98 PEDRWGSTPLADAVYYKHH-DVIKLLEEHGA 127
+R G TPL +Y DVIKLL + GA
Sbjct: 78 APERCGFTPLHLYLYNATTLDVIKLLIKAGA 108
|
Length = 471 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 54/211 (25%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 197 ELALLQKIRH-PNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALD 255
E +L+ +R P +V A + ++ +Y+ G++ +L Q+ ++ +
Sbjct: 54 ERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGE 113
Query: 256 IARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCE 315
I + +LH+ I++RD++ NIL D GH+ + DFGLSK +F + KE C
Sbjct: 114 IILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSK--EFLSEEKERTYSFCG 168
Query: 316 ETSWRYAAPEVYKNEEYDTK-VDVFSFALILQEMIEGCPPFPTKQEK----EVPKAYIAN 370
Y APE+ + + K VD +S +++ E++ G PF + E+ EV + +
Sbjct: 169 TI--EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC 226
Query: 371 ERPPFRAPTTHYAYGLRELIEDCWSEEPFRR 401
+ PPF + A ++L+ ++P +R
Sbjct: 227 D-PPFPSFIGPEA---QDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 56/189 (29%), Positives = 88/189 (46%), Gaps = 19/189 (10%)
Query: 174 QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY----- 228
+VAVK L F + EL LL+ ++H NV+ L T +T + E
Sbjct: 42 KVAVKKLSRP-FQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN 100
Query: 229 LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288
L DL +K + L + RG+ Y+H IIHRDL+PSN+ ++
Sbjct: 101 LMGADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCE 156
Query: 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQE 347
L++ DFGL++ + D +T + Y APE+ N Y+ VD++S I+ E
Sbjct: 157 LRILDFGLAR--------QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208
Query: 348 MIEGCPPFP 356
+++G FP
Sbjct: 209 LLKGKALFP 217
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 61/257 (23%), Positives = 115/257 (44%), Gaps = 25/257 (9%)
Query: 159 EITKGTFRIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV 216
E + G IA+ + G VAVK + + + + +E+ +++ +H NVV+ +
Sbjct: 30 EGSTGIVCIATVKSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 217 TQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDL 276
+ +V E+L G L + + +A L + + ++ LH + +IHRD+
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-VCLAVLKALSVLHA---QGVIHRDI 142
Query: 277 EPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRY-AAPEVYKNEEYDTK 335
+ +IL G +K++DFG F V ++ P Y APE+ Y +
Sbjct: 143 KSDSILLTHDGRVKLSDFG------FCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 336 VDVFSFALILQEMIEGCPPF----PTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIE 391
VD++S +++ EM++G PP+ P K K I + PP + L+ ++
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-----MIRDNLPPKLKNLHKVSPSLKGFLD 251
Query: 392 DCWSEEPFRRPTFRQIL 408
+P +R T ++L
Sbjct: 252 RLLVRDPAQRATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 11/167 (6%)
Query: 250 VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK-LLKFANTVKE 308
V F+ +A GM +L +HRDL N+L + +K+ DFGL++ +++ +N + +
Sbjct: 242 VGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK 298
Query: 309 DRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAY 367
++ APE N Y T DV+SF ++L E+ G P+P E + Y
Sbjct: 299 GSTF----LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--QFY 352
Query: 368 IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
A +R A H + + E+++ CW E+ RP F Q++ + D+
Sbjct: 353 NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 58/222 (26%), Positives = 92/222 (41%), Gaps = 45/222 (20%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLR 235
A+KTL ++ ++V E +L + + VV+ + + V +Y+P GD+
Sbjct: 30 AMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 236 AYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFG 295
+ L + G LA + ++ + +H+ IHRD++P NIL D GH+K+ DFG
Sbjct: 90 SLLIRMGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFG 146
Query: 296 L---------SKLLKFANTVKEDR---------PVTC------EETSWR----------- 320
L SK + + V++D P C + R
Sbjct: 147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAH 206
Query: 321 -------YAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPF 355
Y APEV Y D +S +IL EM+ G PPF
Sbjct: 207 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 59/191 (30%), Positives = 82/191 (42%), Gaps = 29/191 (15%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVT-QSTPMMIVTEYLP 230
G VAVK L F ++ K EL LL+ + H N++ L T Q + YL
Sbjct: 46 GINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104
Query: 231 KGDLRAYLKQKGALKPTLAVKFALDIAR----------GMNYLHENRPEAIIHRDLEPSN 280
+ A L Q + LD R G+ +LH IIHRDL+PSN
Sbjct: 105 MELMDANLCQ--------VIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSN 153
Query: 281 ILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFS 340
I+ LK+ DFGL A T + +T + Y APEV Y VD++S
Sbjct: 154 IVVKSDCTLKILDFGL------ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 207
Query: 341 FALILQEMIEG 351
I+ E+++G
Sbjct: 208 VGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 41/114 (35%), Positives = 61/114 (53%), Gaps = 8/114 (7%)
Query: 51 DGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110
D IK +LD G DVN +D + +T LH A +G + +++L GADV+ ED G P+ A
Sbjct: 105 DMIKTILDCGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIA 164
Query: 111 VYYKHHDVIKLLEEHGAKPST------APMHVQNAREVPEYEIDPKELDFSNSV 158
+ + D+IKLL E GA + +P+H NA E +Y +D N +
Sbjct: 165 IKHNFFDIIKLLLEKGAYANVKDNNGESPLH--NAAEYGDYACIKLLIDHGNHI 216
|
Length = 434 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 28/165 (16%)
Query: 197 ELALLQKIRHPNVVQFLGAVT-QSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALD 255
E +L+ I HP+++Q G T +I+ Y K DL YL K + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAAKRNIAICDILAIERS 190
Query: 256 IARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLS---------KLLKFANTV 306
+ R + YLHENR IIHRD++ NI + G + + DFG + K +A T+
Sbjct: 191 VLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247
Query: 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG 351
+ APE+ + Y VD++S ++L EM
Sbjct: 248 ATN-------------APELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 6/101 (5%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L Y +GDL+ IK L + G DVN D + +H+A D+++LLL +GA + +D
Sbjct: 128 LHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKD 187
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA------KPSTAPMH 135
G +PL +A Y + IKLL +HG K P+H
Sbjct: 188 NNGESPLHNAAEYGDYACIKLLIDHGNHIMNKCKNGFTPLH 228
|
Length = 434 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 48/187 (25%), Positives = 85/187 (45%), Gaps = 21/187 (11%)
Query: 229 LPKGDLRAYLKQKGALKPTL--AVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286
+++ L G+ T + F +ARGM +L +HRDL N+L
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQG 273
Query: 287 GHLKVADFGLSK-LLKFANTVKEDR---PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFA 342
+K+ DFGL++ ++ +N V + PV ++ APE + Y T DV+S+
Sbjct: 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPV-------KWMAPESIFDNLYTTLSDVWSYG 326
Query: 343 LILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFR-APTTHYAYGLRELIEDCWSEEPFR 400
++L E+ G P+P V + + +R A H + +++ CW+ EP +
Sbjct: 327 ILLWEIFSLGGTPYPGMI---VDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEK 383
Query: 401 RPTFRQI 407
RP+F +
Sbjct: 384 RPSFLHL 390
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 52/175 (29%), Positives = 87/175 (49%), Gaps = 28/175 (16%)
Query: 197 ELALLQKIRHPNVV--------QFLGAVTQSTPMMIVTEYLPK---GDLRAYLKQKGALK 245
EL +++ + H N++ + ++ + +V E++P+ ++ Y + AL
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHAL- 167
Query: 246 PTLAVK-FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH-LKVADFGLSKLLKFA 303
P VK ++ + R + Y+H + I HRDL+P N+L D + H LK+ DFG +K
Sbjct: 168 PLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK----- 219
Query: 304 NTVKEDRPVT--CEETSWRYAAPEVY-KNEEYDTKVDVFSFALILQEMIEGCPPF 355
N + R V+ C S Y APE+ Y T +D++S I+ EMI G P F
Sbjct: 220 NLLAGQRSVSYIC---SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 38/97 (39%), Positives = 52/97 (53%), Gaps = 8/97 (8%)
Query: 42 MYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTD--VVRLLLSRGADVDPE 99
+Y+ N LD IK L+ +G DVN +D RT LHV + V+RLLL +GADV+
Sbjct: 89 LYLYNATTLDVIKLLIKAGADVNAKDKVGRTPLHVYLSGFNINPKVIRLLLRKGADVNAL 148
Query: 100 DRWGSTPLADAVYYKHHDV----IKLLEEHGAKPSTA 132
D +G TPL AV K + ++LL + GA
Sbjct: 149 DLYGMTPL--AVLLKSRNANVELLRLLIDAGADVYAV 183
|
Length = 471 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 24/195 (12%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM------MIV 225
G +VA+K L F E K EL LL+ ++H NV+ L T + +V
Sbjct: 40 GEKVAIKKLSRP-FQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98
Query: 226 TEYLPKGDLRAYLKQKGALKPTLAVKFAL-DIARGMNYLHENRPEAIIHRDLEPSNILRD 284
Y+ + DL+ K G V++ + + G+ Y+H IIHRDL+P N+ +
Sbjct: 99 MPYM-QTDLQ---KIMGHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVN 151
Query: 285 DSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFAL 343
+ LK+ DFGL++ D +T + Y APEV N Y+ VD++S
Sbjct: 152 EDCELKILDFGLAR--------HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGC 203
Query: 344 ILQEMIEGCPPFPTK 358
I+ EM+ G F K
Sbjct: 204 IMAEMLTGKTLFKGK 218
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 58/194 (29%), Positives = 83/194 (42%), Gaps = 29/194 (14%)
Query: 174 QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE-YLPKG 232
VA+K L F ++ K EL L++ + H N++ L T + + Y+
Sbjct: 51 NVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 233 DLRAYLKQKGALKPTLAVKFALDIAR----------GMNYLHENRPEAIIHRDLEPSNIL 282
+ A L Q ++ LD R G+ +LH IIHRDL+PSNI+
Sbjct: 110 LMDANLCQ--------VIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIV 158
Query: 283 RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFA 342
LK+ DFGL A T +T + Y APEV Y VD++S
Sbjct: 159 VKSDCTLKILDFGL------ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 212
Query: 343 LILQEMIEGCPPFP 356
I+ EMI+G FP
Sbjct: 213 CIMGEMIKGGVLFP 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 40/134 (29%), Positives = 58/134 (43%), Gaps = 13/134 (9%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L Y D + LL G +VN D + LH A +V +LL GA D D
Sbjct: 172 LHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARD 231
Query: 101 RWGSTPLADAV-YYKHHDVIKLLEEHG----AKPST---APMHV-----QNAREVPEYEI 147
+ G+TPL +V Y K +D++KLL EHG AK +H + + + EY
Sbjct: 232 KCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSYILGLTALHSSIKSERKLKLLLEYGA 291
Query: 148 DPKELDFSNSVEIT 161
D L+ ++
Sbjct: 292 DINSLNSYKLTPLS 305
|
Length = 477 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 49/192 (25%), Positives = 88/192 (45%), Gaps = 14/192 (7%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
GT V V+ E T+E +KA +E+ L RHPN++ T + + +++ ++
Sbjct: 25 GTLVTVRITDLENCTEE-HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83
Query: 232 GDLRAYLKQ--KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289
G + LK + L RG+NYLH+N IHR+++ S+IL G +
Sbjct: 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLV 140
Query: 290 KVADFGLSKLLKFANTVKEDRPV----TCEETSWRYAAPEVYKNE--EYDTKVDVFSFAL 343
++ GLS L ++ + V + + +PE+ + + Y+ K D++S +
Sbjct: 141 SLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI 198
Query: 344 ILQEMIEGCPPF 355
E+ G PF
Sbjct: 199 TACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 52/195 (26%), Positives = 93/195 (47%), Gaps = 20/195 (10%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTP--MMIVTEY 228
G A+K + ++ F ++V E+ L+++ HPN+++ + + + +V E
Sbjct: 24 GKYYAIKCM-KKHFKSLEQVNNL-REIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE- 80
Query: 229 LPKGDLRAYLKQKGALKPTLAVK-FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
L +L +K + P VK + + + ++++H N I HRD++P NIL D
Sbjct: 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-D 136
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSWR-YAAPE-VYKNEEYDTKVDVFSFALIL 345
LK+ADFG + + P T E S R Y APE + + Y K+D+++ +
Sbjct: 137 ILKLADFGSCR------GIYSKPPYT-EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVF 189
Query: 346 QEMIEGCPPFPTKQE 360
E++ P FP E
Sbjct: 190 FEILSLFPLFPGTNE 204
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 7e-10
Identities = 27/50 (54%), Positives = 32/50 (64%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLL 90
L A G+LD +K LL G DVN RD D RT LH+AA G +VV+LLL
Sbjct: 77 LHLAARNGNLDVVKLLLKHGADVNARDKDGRTPLHLAAKNGHLEVVKLLL 126
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 53 IKELLDSGTDVNFRDIDK-RTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAV 111
K LL G D+N +D K TALH A + LLLS GA+V+ D+ ++PL AV
Sbjct: 150 TKLLLSYGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAV 209
Query: 112 YYKHHDVIKLLEEHGA------KPSTAPMHVQNAREVPEYEI 147
+ + ++ +L E+GA K P+H+ +Y+I
Sbjct: 210 KHYNKPIVHILLENGASTDARDKCGNTPLHISVGY-CKDYDI 250
|
Length = 477 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 7e-10
Identities = 58/195 (29%), Positives = 82/195 (42%), Gaps = 29/195 (14%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVT-QSTPMMIVTEYLPKGD 233
VA+K L F ++ K EL L++ + H N++ L T Q + YL
Sbjct: 45 VAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 103
Query: 234 LRAYLKQKGALKPTLAVKFALDIAR----------GMNYLHENRPEAIIHRDLEPSNILR 283
+ A L Q ++ LD R G+ +LH IIHRDL+PSNI+
Sbjct: 104 MDANLCQ--------VIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVV 152
Query: 284 DDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFAL 343
LK+ DFGL A T +T + Y APEV Y VD++S
Sbjct: 153 KSDCTLKILDFGL------ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 206
Query: 344 ILQEMIEGCPPFPTK 358
I+ EM+ FP +
Sbjct: 207 IMGEMVRHKILFPGR 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 58.3 bits (140), Expect = 9e-10
Identities = 47/134 (35%), Positives = 62/134 (46%), Gaps = 15/134 (11%)
Query: 6 SARFTLGKQSSLAPDQPLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNF 65
A L D+ L A D L A++GD +K LL SG DVN
Sbjct: 49 PAASLSELLLKLIVDRHLAARDLDGRLP-------LHSAASKGDDKIVKLLLASGADVNA 101
Query: 66 RDIDKRTALHVAACQGRT-----DVVRLLLSRGADVD---PEDRWGSTPLADAVYYKHHD 117
+D D T LH+AA G +V +LLL GAD+D D G+TPL A D
Sbjct: 102 KDADGDTPLHLAALNGNPPEGNIEVAKLLLEAGADLDVNNLRDEDGNTPLHWAALNGDAD 161
Query: 118 VIKLLEEHGAKPST 131
+++LL E GA P++
Sbjct: 162 IVELLLEAGADPNS 175
|
Length = 235 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 29/136 (21%), Positives = 56/136 (41%), Gaps = 23/136 (16%)
Query: 48 GDLDGIKELLDSGTDVNFRDIDKRTALHVAA--CQGRTDVVRLLLSRGADVDPEDR---- 101
++ LLD+G +VN ++ D LH+ + +++LL+ +G D++ ++R
Sbjct: 119 NSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKNRVNYL 178
Query: 102 ------------WGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNAREVP-EYEID 148
+G TPL AVY + + +K L + GA P+ V + P I
Sbjct: 179 LSYGVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNL----VNKYGDTPLHIAIL 234
Query: 149 PKELDFSNSVEITKGT 164
+ + +
Sbjct: 235 NNNKEIFKLLLNNGPS 250
|
Length = 422 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 20/179 (11%)
Query: 197 ELALLQKIRHPNVVQ----FLGAVTQSTPMMI-VTEYLPKGDLRAYLKQKGALKPT---- 247
E+ALL++++HPNV+ FL + ++ E+ ++ + K KP
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107
Query: 248 -LAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL----RDDSGHLKVADFGLSKLLKF 302
+ I G++YLH N ++HRDL+P+NIL + G +K+AD G ++L F
Sbjct: 108 GMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL--F 162
Query: 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTK-VDVFSFALILQEMIEGCPPFPTKQE 360
+ +K + ++ Y APE+ + TK +D+++ I E++ P F +QE
Sbjct: 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 70/286 (24%), Positives = 114/286 (39%), Gaps = 52/286 (18%)
Query: 153 DFSNSVEITKGTF---RIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHP 207
DF I KG F R+ + G A+KTL + +D++ E +L + P
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 208 NVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENR 267
VV + + + ++ E+LP GDL L + + + + + +H+
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK-- 119
Query: 268 PEAIIHRDLEPSNILRDDSGHLKVADFGLS-------------KLLK---FANTVKEDRP 311
IHRD++P NIL D GH+K++DFGLS KLL+ N +
Sbjct: 120 -LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178
Query: 312 VTCEETS-----------WR---------------YAAPEVYKNEEYDTKVDVFSFALIL 345
V + + W+ Y APE++ + Y + D +S I+
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238
Query: 346 QEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPT-THYAYGLRELI 390
E + G PPF ++ E + I N R P H + +LI
Sbjct: 239 FECLIGWPPFCSENSHETYRK-IINWRETLYFPDDIHLSVEAEDLI 283
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 7/94 (7%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRT-DVVRLLLSRGADVDPE 99
++ ++E D ++ LL++G DVN + T LH+ T DV++LL+ GADV+ +
Sbjct: 54 YLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAK 113
Query: 100 DRWGSTPLADAVYYK----HHDVIKLLEEHGAKP 129
D+ G TPL VY + VI+LL GA
Sbjct: 114 DKVGRTPL--HVYLSGFNINPKVIRLLLRKGADV 145
|
Length = 471 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 49/179 (27%), Positives = 89/179 (49%), Gaps = 20/179 (11%)
Query: 197 ELALLQKIRHPNVVQ----FLGAVTQSTPMMI-VTEYLPKGDLRAYLKQKGALKP----- 246
E+ALL++++HPNV+ FL + ++ E+ ++ + K KP
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107
Query: 247 TLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL----RDDSGHLKVADFGLSKLLKF 302
++ I G++YLH N ++HRDL+P+NIL + G +K+AD G ++L F
Sbjct: 108 SMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL--F 162
Query: 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTK-VDVFSFALILQEMIEGCPPFPTKQE 360
+ +K + ++ Y APE+ + TK +D+++ I E++ P F +QE
Sbjct: 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 28/79 (35%), Positives = 41/79 (51%), Gaps = 3/79 (3%)
Query: 44 MANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWG 103
N L+ ELL + D + D RT LH+AA +G D V +LL +V D G
Sbjct: 535 TGNAALLE---ELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANG 591
Query: 104 STPLADAVYYKHHDVIKLL 122
+T L +A+ KHH + ++L
Sbjct: 592 NTALWNAISAKHHKIFRIL 610
|
Length = 823 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-09
Identities = 37/146 (25%), Positives = 62/146 (42%), Gaps = 13/146 (8%)
Query: 207 PNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHEN 266
PN+V + + +V ++ G L +++ + + ++A ++ ++ LH
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHR- 103
Query: 267 RPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWR-YAAPE 325
E I+ RDL P+NIL DD GH+++ F E E Y APE
Sbjct: 104 --EGIVCRDLNPNNILLDDRGHIQLTYFS---------RWSEVEDSCDGEAVENMYCAPE 152
Query: 326 VYKNEEYDTKVDVFSFALILQEMIEG 351
V E D +S IL E++ G
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 28/70 (40%), Positives = 42/70 (60%), Gaps = 3/70 (4%)
Query: 173 TQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPK 231
+VAVK L TDE +A + EL +L + +H N+V LGA T P++++TEY
Sbjct: 69 LRVAVKMLKASAHTDE--REALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCY 126
Query: 232 GDLRAYLKQK 241
GDL +L++K
Sbjct: 127 GDLLNFLRKK 136
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 55.6 bits (133), Expect = 9e-09
Identities = 33/84 (39%), Positives = 46/84 (54%), Gaps = 3/84 (3%)
Query: 46 NEGDLDGIKELLDSG--TDVNFR-DIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRW 102
EG+++ K LL++G DVN D D T LH AA G D+V LLL GAD + + +
Sbjct: 120 PEGNIEVAKLLLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADPNSRNSY 179
Query: 103 GSTPLADAVYYKHHDVIKLLEEHG 126
G T L A +++KLL + G
Sbjct: 180 GVTALDPAAKNGRIELVKLLLDKG 203
|
Length = 235 |
| >gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 26/57 (45%), Positives = 32/57 (56%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVD 97
L A DL +KELL G +V+ D TAL VA + D+VRLL+ GADVD
Sbjct: 626 LCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVD 682
|
Length = 823 |
| >gnl|CDD|200936 pfam00023, Ank, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 2e-08
Identities = 17/33 (51%), Positives = 22/33 (66%)
Query: 69 DKRTALHVAACQGRTDVVRLLLSRGADVDPEDR 101
D T LH+AA G +VV+LLL GADV+ D+
Sbjct: 1 DGNTPLHLAARNGHLEVVKLLLEAGADVNARDK 33
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Repeats 13-24 are especially active, with known sites of interaction for the Na/K ATPase, Cl/HCO(3) anion exchanger, voltage-gated sodium channel, clathrin heavy chain and L1 family cell adhesion molecules. The ANK repeats are found to form a contiguous spiral stack such that ion transporters like the anion exchanger associate in a large central cavity formed by the ANK repeat spiral, while clathrin and cell adhesion molecules associate with specific regions outside this cavity. Length = 33 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 66/252 (26%), Positives = 103/252 (40%), Gaps = 52/252 (20%)
Query: 197 ELALLQKIRHPNVVQFLGAVT-QSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALD 255
E+ +L+ I H ++ + A +ST M++ +Y K DL Y+ + G L ++ A+
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKY--KCDLFTYVDRSGPL----PLEQAIT 189
Query: 256 IARGM----NYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLS-KLLKFANTVKEDR 310
I R + YLH IIHRD++ NI D+ + + DFG + KL +T +
Sbjct: 190 IQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 311 PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK--------- 361
ET+ +PE+ + Y K D++S L+L EM KQ K
Sbjct: 247 WSGTLETN----SPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSI 302
Query: 362 ---------EVP-----------KAYIANERPPFRAPTTHYAYGL----RELIEDCWSEE 397
E P K Y RPP+ P YG+ LI + +
Sbjct: 303 IRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFD 362
Query: 398 PFRRPTFRQILM 409
RP+ + IL
Sbjct: 363 QEFRPSAQDILS 374
|
Length = 392 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 49/176 (27%), Positives = 81/176 (46%), Gaps = 14/176 (7%)
Query: 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFAL-DIARGMNYLHENRPEAIIHRDLEPSN 280
+ +V +Y GDL L + P +F L ++ ++ +H+ +HRD++P N
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDN 132
Query: 281 ILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEE-----YDTK 335
IL D +GH+++ADFG L TV+ V + Y +PE+ + E Y +
Sbjct: 133 ILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD----YISPEILQAMEDGKGKYGPE 188
Query: 336 VDVFSFALILQEMIEGCPPFPTKQEKEV-PKAYIANERPPFRAPTTHYAYGLRELI 390
D +S + + EM+ G PF + E K ER F A T + ++LI
Sbjct: 189 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLI 244
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 7e-08
Identities = 41/158 (25%), Positives = 77/158 (48%), Gaps = 13/158 (8%)
Query: 206 HPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHE 265
+PN ++ +VT +++ +Y+ GDL LK++G L K + +N LH+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 266 NRPEAIIHRDLEPSNILRDDS-GHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAP 324
+ IIH D++ N+L D + + + D+GL K+ P +C + + Y +P
Sbjct: 128 HN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI--------IGTP-SCYDGTLDYFSP 175
Query: 325 EVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
E K YD D ++ ++ E++ G PF +++E
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 14/164 (8%)
Query: 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFAL-DIARGMNYLHENRPEAIIHRDLEPSN 280
+ +V +Y GDL L + P +F + ++ ++ +H+ +HRD++P N
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDN 132
Query: 281 ILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEE-----YDTK 335
+L D +GH+++ADFG + TV+ V + Y +PE+ + E Y +
Sbjct: 133 VLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD----YISPEILQAMEDGMGKYGPE 188
Query: 336 VDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPT 379
D +S + + EM+ G PF + E I N F+ P+
Sbjct: 189 CDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHEERFQFPS 231
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 39/138 (28%), Positives = 68/138 (49%), Gaps = 13/138 (9%)
Query: 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFAL-DIARGMNYLHENRPEAIIHRDLEPSNIL 282
+V +Y GDL L + P +F L ++ ++ +H+ +HRD++P N+L
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVL 134
Query: 283 RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEE-----YDTKVD 337
D +GH+++ADFG L TV+ + V + Y +PE+ + E Y + D
Sbjct: 135 LDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD----YISPEILQAMEDGKGRYGPECD 190
Query: 338 VFSFALILQEMIEGCPPF 355
+S + + EM+ G PF
Sbjct: 191 WWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 27/81 (33%), Positives = 40/81 (49%)
Query: 49 DLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLA 108
LD +K L+ G D + + DK + LH+A G + LL+ A +D ED G TPL
Sbjct: 114 KLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLI 173
Query: 109 DAVYYKHHDVIKLLEEHGAKP 129
A+ + K+L + GA
Sbjct: 174 IAMAKGDIAICKMLLDSGANI 194
|
Length = 413 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 8e-08
Identities = 23/52 (44%), Positives = 33/52 (63%)
Query: 71 RTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLL 122
RTALH AA GR ++V+ LL +G D++ D G+T L A + +V+KLL
Sbjct: 2 RTALHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLL 53
|
Length = 54 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 17/160 (10%)
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDI 256
E+A + K++HPN+V+ +G ++ EY+ +L L+ L K A+ I
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGI 789
Query: 257 ARGMNYLHENRPEAIIHRDLEPSNILRD--DSGHLKVADFGLSKLLKFANTVKEDRPVTC 314
A+ + +LH A++ +L P I+ D D HL++ L LL C
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRL---SLPGLLCTDTK--------C 838
Query: 315 EETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPP 354
+S Y APE + ++ K D++ F LIL E++ G P
Sbjct: 839 FISS-AYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 27/236 (11%)
Query: 186 TDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL-KQKGAL 244
+ D AF + +L+ ++ H ++ G + + ++V E++ G L L K+KG +
Sbjct: 55 SHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV 114
Query: 245 KPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG-------HLKVADFGLS 297
+ A +A ++YL + + ++H ++ NIL G +K++D G+S
Sbjct: 115 PVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS 171
Query: 298 KLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEM-IEGCPPF 355
F +E+R E W APE T D +SF L E+ +G P
Sbjct: 172 ----FTALSREER---VERIPW--IAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPL 222
Query: 356 PTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411
+ E + Y R P P+ L LI C + EP +RP+FR IL L
Sbjct: 223 KERTPSEKERFYEKKHRLP--EPSCK---ELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 5e-07
Identities = 23/50 (46%), Positives = 31/50 (62%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLL 90
L A G L+ +K LL+ G D+N D D TALH+AA G +V++LLL
Sbjct: 5 LHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLLL 54
|
Length = 54 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 49.8 bits (118), Expect = 6e-07
Identities = 36/136 (26%), Positives = 56/136 (41%), Gaps = 10/136 (7%)
Query: 1 MESKSSARFTLGKQSSLAPDQ--PLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLD 58
+ + +A L + +D + + L+ A+ +L +
Sbjct: 5 LSALLLINKCFLDLLLVALLLLLSLDLSNPSDKKLNLYLELALLPAASLSELLLKLIVDR 64
Query: 59 SGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKH--- 115
RD+D R LH AA +G +V+LLL+ GADV+ +D G TPL A +
Sbjct: 65 HL---AARDLDGRLPLHSAASKGDDKIVKLLLASGADVNAKDADGDTPLHLAALNGNPPE 121
Query: 116 --HDVIKLLEEHGAKP 129
+V KLL E GA
Sbjct: 122 GNIEVAKLLLEAGADL 137
|
Length = 235 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 32/84 (38%), Positives = 48/84 (57%), Gaps = 5/84 (5%)
Query: 47 EGDLDGIKELLDSGT---DVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWG 103
EGD+ ++ELLD G DV ++D T LH+A + D+++LL++RGAD D +
Sbjct: 78 EGDVKAVEELLDLGKFADDVFYKD--GMTPLHLATILKKLDIMKLLIARGADPDIPNTDK 135
Query: 104 STPLADAVYYKHHDVIKLLEEHGA 127
+PL AV I+LL +H A
Sbjct: 136 FSPLHLAVMMGDIKGIELLIDHKA 159
|
Length = 413 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (123), Expect = 7e-07
Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 39/199 (19%)
Query: 188 EDKVKAFIDELALLQKIRHPNVVQ----FLGAVTQSTPMMIVTEYLPKGDLRAYL----K 239
E + + E+ ++++++H N+V+ FL Q + I+ E+ GDL + K
Sbjct: 53 EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK--LYILMEFCDAGDLSRNIQKCYK 110
Query: 240 QKGALKPTLAVKFALDIARGMNYLHENRP----EAIIHRDLEPSNI-LRDDSGHL----- 289
G ++ V + + Y H + E ++HRDL+P NI L H+
Sbjct: 111 MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170
Query: 290 -----------KVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEV--YKNEEYDTKV 336
K+ DFGLSK N E +C T + Y +PE+ ++ + YD K
Sbjct: 171 QANNLNGRPIAKIGDFGLSK-----NIGIESMAHSCVGTPY-YWSPELLLHETKSYDDKS 224
Query: 337 DVFSFALILQEMIEGCPPF 355
D+++ I+ E+ G PF
Sbjct: 225 DMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|206028 pfam13857, Ank_5, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-06
Identities = 18/46 (39%), Positives = 26/46 (56%)
Query: 62 DVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPL 107
D+N D + T LH+AA G ++V+ LL G D++ D G T L
Sbjct: 8 DLNATDGNGNTPLHLAAKYGALELVQWLLKPGVDLNLRDSDGLTAL 53
|
Length = 56 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 38/112 (33%), Positives = 56/112 (50%), Gaps = 3/112 (2%)
Query: 56 LLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKH 115
LL+ G DVN +DI T +H AA +G +V LLLS GADV+ + L AV K+
Sbjct: 164 LLEGGADVNAKDIYCITPIHYAAERGNAKMVNLLLSYGADVNIIALDDLSVLECAVDSKN 223
Query: 116 HDVIKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELD--FS-NSVEITKGT 164
D IK + ++ + + + + A + E D FS NS++ K T
Sbjct: 224 IDTIKAIIDNRSNINKNDLSLLKAIRNEDLETSLLLYDAGFSVNSIDDCKNT 275
|
Length = 682 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 42 MYMANEG-DLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRT-----DVVRLLLSRGAD 95
+Y+A E ++D +K LLD+G D+N + T LH + ++V+LLL GA+
Sbjct: 39 LYLAKEARNIDVVKILLDNGADINSSTKNNSTPLHYLSNIKYNLTDVKEIVKLLLEYGAN 98
Query: 96 VDPEDRWGSTPLADAVYYK--HHDVIKLLEEHGAK 128
V+ D G TPL A+ K + +++ L ++GA
Sbjct: 99 VNAPDNNGITPLLYAISKKSNSYSIVEYLLDNGAN 133
|
Length = 422 |
| >gnl|CDD|197603 smart00248, ANK, ankyrin repeats | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 3e-06
Identities = 16/29 (55%), Positives = 22/29 (75%)
Query: 69 DKRTALHVAACQGRTDVVRLLLSRGADVD 97
D RT LH+AA G +VV+LLL +GAD++
Sbjct: 1 DGRTPLHLAAENGNLEVVKLLLDKGADIN 29
|
Ankyrin repeats are about 33 amino acids long and occur in at least four consecutive copies. They are involved in protein-protein interactions. The core of the repeat seems to be an helix-loop-helix structure. Length = 30 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 56/265 (21%), Positives = 100/265 (37%), Gaps = 50/265 (18%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
+VA+K + E++ + K F+ E + + HP +V + P+ Y+
Sbjct: 27 SRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG 86
Query: 232 GDLRAYLK---QKGALKPTLAVKFAL--------DIARGMNYLHENRPEAIIHRDLEPSN 280
L++ LK QK +L LA K ++ I + Y+H + ++HRDL+P N
Sbjct: 87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDN 143
Query: 281 ILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWR-------------YAAPEVY 327
IL G + + D+G + K D V + Y APE
Sbjct: 144 ILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL 203
Query: 328 KNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387
D+++ +IL +M+ P+ K+ +++ R
Sbjct: 204 LGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS---------------------YR 242
Query: 388 ELIEDCWSEEPFRR--PTFRQILMR 410
++I P+R P QI M+
Sbjct: 243 DVILSPIEVAPYREIPPFLSQIAMK 267
|
Length = 932 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 30/71 (42%), Positives = 38/71 (53%), Gaps = 4/71 (5%)
Query: 173 TQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQST-PMMIVTEYLP 230
VAVK L E E K A + EL +L I H NVV LGA T+ P+M++ EY
Sbjct: 38 RTVAVKMLKEGATASEYK--ALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCK 95
Query: 231 KGDLRAYLKQK 241
G+L YL+ K
Sbjct: 96 FGNLSNYLRSK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 29/77 (37%), Positives = 44/77 (57%), Gaps = 2/77 (2%)
Query: 53 IKELLDSGTDVNFRDIDKRTALHVAACQG-RTDVVRLLLSRGADVDPEDRWGSTPLADA- 110
+ +LL+ G DVN ++I T L++ A G T+ +R L+ GADV+ DR TPL A
Sbjct: 290 VPKLLERGADVNAKNIKGETPLYLMAKNGYDTENIRTLIMLGADVNAADRLYITPLHQAS 349
Query: 111 VYYKHHDVIKLLEEHGA 127
++ D++ L E GA
Sbjct: 350 TLDRNKDIVITLLELGA 366
|
Length = 682 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 20/65 (30%), Positives = 33/65 (50%)
Query: 56 LLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKH 115
LL +G +N R+ +T LH AA R L++ GAD++ G+TPL+ V +
Sbjct: 243 LLIAGISINARNRYGQTPLHYAAVFNNPRACRRLIALGADINAVSSDGNTPLSLMVRNNN 302
Query: 116 HDVIK 120
++
Sbjct: 303 GRAVR 307
|
Length = 471 |
| >gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 38/147 (25%), Positives = 59/147 (40%), Gaps = 32/147 (21%)
Query: 20 DQPLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTAL----- 74
++ L A D D ++ R L A++G D + LL +V+ RD + TAL
Sbjct: 542 EELLKAKLDPDIGDS-KGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAIS 600
Query: 75 --H------------------------VAACQGRTDVVRLLLSRGADVDPEDRWGSTPLA 108
H AA + ++ LL +G +VD ED G+T L
Sbjct: 601 AKHHKIFRILYHFASISDPHAAGDLLCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQ 660
Query: 109 DAVYYKHHDVIKLLEEHGAKPSTAPMH 135
A+ H D+++LL +GA A
Sbjct: 661 VAMAEDHVDMVRLLIMNGADVDKANTD 687
|
Length = 823 |
| >gnl|CDD|205784 pfam13606, Ank_3, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 9e-06
Identities = 14/29 (48%), Positives = 20/29 (68%)
Query: 69 DKRTALHVAACQGRTDVVRLLLSRGADVD 97
D T LH+AA G ++V+LLL GAD++
Sbjct: 1 DGNTPLHLAARNGNLELVKLLLEHGADIN 29
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Length = 30 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 26/231 (11%)
Query: 192 KAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTL-AV 250
++F + +++ ++ H ++V G ++V EY+ G L YLK+ L +
Sbjct: 44 ESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKL 103
Query: 251 KFALDIARGMNYLHENRPEAIIHRDLEPSNIL-----RDDSGH---LKVADFGLSKLLKF 302
+ A +A +++L + + H ++ N+L +G+ +K++D G+S
Sbjct: 104 EVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI---- 156
Query: 303 ANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEK 361
TV + + E W PE +N + D +SF L E+ G P
Sbjct: 157 --TVLP-KEILLERIPW--VPPECIENPQNLSLAADKWSFGTTLWEIFSGGD-KPLSALD 210
Query: 362 EVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412
K +R AP L LI C EP RP+FR I+ L+
Sbjct: 211 SQKKLQFYEDRHQLPAPKWTE---LANLINQCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 19/63 (30%), Positives = 31/63 (49%), Gaps = 2/63 (3%)
Query: 53 IKELLDSGTDVNFRDIDKRTALHVAA--CQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110
++EL+ +G D D+ T LH A + +V LL G ++ +R+G TPL A
Sbjct: 205 VRELIRAGCDPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARNRYGQTPLHYA 264
Query: 111 VYY 113
+
Sbjct: 265 AVF 267
|
Length = 471 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 28/78 (35%), Positives = 45/78 (57%), Gaps = 5/78 (6%)
Query: 53 IKELLDSGTDVNFRDIDKRTALHVAACQG--RTDVVRLLLSRGADVDPEDRWGSTPLADA 110
+K L+D G +VN ++ D T LH AC+ + DV+ +LL GADV+ + PL A
Sbjct: 425 VKTLIDRGANVNSKNKDLSTPLHY-ACKKNCKLDVIEMLLDNGADVNAINIQNQYPLLIA 483
Query: 111 VYYKHHDVIKLLEEHGAK 128
+ Y H ++ +L +GA+
Sbjct: 484 LEY--HGIVNILLHYGAE 499
|
Length = 682 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 28/69 (40%), Positives = 38/69 (55%), Gaps = 4/69 (5%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQ-STPMMIVTEYLPKG 232
VAVK L E E + A + EL +L I H NVV LGA T+ P+M++ E+ G
Sbjct: 40 VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 97
Query: 233 DLRAYLKQK 241
+L YL+ K
Sbjct: 98 NLSNYLRSK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 25/91 (27%), Positives = 40/91 (43%), Gaps = 5/91 (5%)
Query: 43 YMANEGD-LDGIKELLDSGTDVNFRDIDKRTALHVAACQ--GRTDVVRLLLSRGADVDPE 99
N D + +K LL+ G +VN D + T L A + +V LL GA+V+ +
Sbjct: 78 IKYNLTDVKEIVKLLLEYGANVNAPDNNGITPLLYAISKKSNSYSIVEYLLDNGANVNIK 137
Query: 100 DRWGSTPLADAVYYKHHD--VIKLLEEHGAK 128
+ G L + D ++KLL + G
Sbjct: 138 NSDGENLLHLYLESNKIDLKILKLLIDKGVD 168
|
Length = 422 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 25/91 (27%), Positives = 42/91 (46%), Gaps = 12/91 (13%)
Query: 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNI 281
+IV EY+ L+ + G + L+ + + + LH IIH DL SN+
Sbjct: 74 FIIVMEYIEGEPLKDLINSNGMEELELSREIGRLVGK----LHSAG---IIHGDLTTSNM 126
Query: 282 LRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312
+ + + DFGL+ +F+ + EDR V
Sbjct: 127 ILSGGK-IYLIDFGLA---EFSKDL-EDRAV 152
|
Length = 211 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 28/69 (40%), Positives = 38/69 (55%), Gaps = 4/69 (5%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQST-PMMIVTEYLPKG 232
VAVK L E E K A + EL +L I H NVV LGA T+ P+M++ E+ G
Sbjct: 40 VAVKMLKEGATASEHK--ALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYG 97
Query: 233 DLRAYLKQK 241
+L +L+ K
Sbjct: 98 NLSNFLRAK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 27/68 (39%), Positives = 39/68 (57%), Gaps = 3/68 (4%)
Query: 174 QVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKG 232
+VAVK L + E + A + EL ++ + H N+V LGA T+S P+ I+TEY G
Sbjct: 69 KVAVKMLKPTARSSEKQ--ALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYG 126
Query: 233 DLRAYLKQ 240
DL YL +
Sbjct: 127 DLVNYLHK 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 26/68 (38%), Positives = 37/68 (54%), Gaps = 3/68 (4%)
Query: 175 VAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGD 233
VAVK L E + A + EL +L + H N+V LGA T P +++TEY GD
Sbjct: 68 VAVKMLKPSAHLTERE--ALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGD 125
Query: 234 LRAYLKQK 241
L +L++K
Sbjct: 126 LLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 26/66 (39%), Positives = 37/66 (56%), Gaps = 3/66 (4%)
Query: 174 QVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKG 232
+VAVK L + E + A + EL ++ + H N+V LGA T+ P+ I+TEY G
Sbjct: 69 KVAVKMLKSTARSSEKQ--ALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYG 126
Query: 233 DLRAYL 238
DL YL
Sbjct: 127 DLVDYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 32/90 (35%), Positives = 44/90 (48%), Gaps = 2/90 (2%)
Query: 41 LMYMANEG-DLDGIKELLDSGTDVNFRDIDKRTALHVAACQGR-TDVVRLLLSRGADVDP 98
L MA G D + I+ L+ G DVN D T LH A+ R D+V LL GA+V+
Sbjct: 311 LYLMAKNGYDTENIRTLIMLGADVNAADRLYITPLHQASTLDRNKDIVITLLELGANVNA 370
Query: 99 EDRWGSTPLADAVYYKHHDVIKLLEEHGAK 128
D TP+ A + +I L ++GA
Sbjct: 371 RDYCDKTPIHYAAVRNNVVIINTLLDYGAD 400
|
Length = 682 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 34/162 (20%), Positives = 50/162 (30%), Gaps = 27/162 (16%)
Query: 253 ALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312
L + LH NIL G LK+ G S K + D
Sbjct: 23 CLQCLGALRELHRQAKSG---------NILLTWDGLLKL--DG-SVAFKTPEQSRPDPYF 70
Query: 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPP----FPTKQEKEVPKAYI 368
APEV + + Y K D++S + L E ++ P E+ +
Sbjct: 71 M---------APEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM 121
Query: 369 ANERPPFRAPTTHY--AYGLRELIEDCWSEEPFRRPTFRQIL 408
+ P R+ A + + C S P RR L
Sbjct: 122 PADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYL 163
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 24/81 (29%), Positives = 37/81 (45%), Gaps = 5/81 (6%)
Query: 49 DLDGIKELLDSGTDVNFRDIDKRTALHVAA--CQGRTDVVRLLLSRGADVDPEDRWGSTP 106
+++ ++ L+D+G DV D R+ LH + R +VR L+ G D D G+TP
Sbjct: 166 NVELLRLLIDAGADVYAVDDRFRSLLHHHLQSFKPRARIVRELIRAGCDPAATDMLGNTP 225
Query: 107 LADAVYY---KHHDVIKLLEE 124
L K V+ LL
Sbjct: 226 LHSMATGSSCKRSLVLPLLIA 246
|
Length = 471 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 40.6 bits (94), Expect = 8e-04
Identities = 23/57 (40%), Positives = 34/57 (59%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVD 97
L + A GD D ++ LL++G D N R+ TAL AA GR ++V+LLL +G +
Sbjct: 151 LHWAALNGDADIVELLLEAGADPNSRNSYGVTALDPAAKNGRIELVKLLLDKGLHLS 207
|
Length = 235 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 21/58 (36%), Positives = 31/58 (53%), Gaps = 5/58 (8%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKR---TALHVAACQGRTDVVRLLLSRGAD 95
L+ +GD+ K LLDSG ++++ K AL A + D+VRL + RGAD
Sbjct: 172 LIIAMAKGDIAICKMLLDSGANIDY--FGKNGCVAALCYAIENNKIDIVRLFIKRGAD 227
|
Length = 413 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 9e-04
Identities = 27/92 (29%), Positives = 44/92 (47%), Gaps = 17/92 (18%)
Query: 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSN- 280
IV EY+ L+ +++ L + + + LH+ I+H DL SN
Sbjct: 72 KTIVMEYIEGKPLKDVIEEGN---DELLREIGRLVGK----LHKAG---IVHGDLTTSNI 121
Query: 281 ILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312
I+RDD L + DFGL K+++ + ED+ V
Sbjct: 122 IVRDDK--LYLIDFGLG---KYSDEI-EDKAV 147
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 25/64 (39%), Positives = 36/64 (56%), Gaps = 3/64 (4%)
Query: 49 DLDGIKELLDSGTDVNFRD-IDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPL 107
D D +K LL+ G DVN + I TALH + ++LLL GAD++ + + TPL
Sbjct: 247 DYDILKLLLEHGVDVNAKSYILGLTALHSSI--KSERKLKLLLEYGADINSLNSYKLTPL 304
Query: 108 ADAV 111
+ AV
Sbjct: 305 SSAV 308
|
Length = 477 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 16/61 (26%), Positives = 27/61 (44%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L Y + + +K LLD G + N + T LH+A ++ +LLL+ G +
Sbjct: 196 LHYAVYNNNPEFVKYLLDLGANPNLVNKYGDTPLHIAILNNNKEIFKLLLNNGPSIKTII 255
Query: 101 R 101
Sbjct: 256 E 256
|
Length = 422 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 25/88 (28%), Positives = 45/88 (51%), Gaps = 1/88 (1%)
Query: 48 GDLDGIKELLDSGTD-VNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTP 106
GD++ I++++ + + +N + T L A G +V L + GAD++ + P
Sbjct: 12 GDIEAIEKIIKNKGNCINISVDETTTPLIDAIRSGDAKIVELFIKHGADINHINTKIPHP 71
Query: 107 LADAVYYKHHDVIKLLEEHGAKPSTAPM 134
L A+ HD+IKLL ++G S P+
Sbjct: 72 LLTAIKIGAHDIIKLLIDNGVDTSILPI 99
|
Length = 434 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 29/104 (27%), Positives = 50/104 (48%), Gaps = 4/104 (3%)
Query: 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTD 84
AD D ++ P + L M GD+ GI+ L+D ++ D T L +A +G
Sbjct: 126 ADPDIPNTDKFSP-LHLAVMM--GDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIA 182
Query: 85 VVRLLLSRGADVDPEDRWGS-TPLADAVYYKHHDVIKLLEEHGA 127
+ ++LL GA++D + G L A+ D+++L + GA
Sbjct: 183 ICKMLLDSGANIDYFGKNGCVAALCYAIENNKIDIVRLFIKRGA 226
|
Length = 413 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.002
Identities = 26/93 (27%), Positives = 43/93 (46%), Gaps = 15/93 (16%)
Query: 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNI 281
+IV EY+ L+ L++ +P L + + + LH+ I+H DL SNI
Sbjct: 74 GLIVMEYIEGELLKDALEEA---RPDLLREVGRLVGK----LHKA---GIVHGDLTTSNI 123
Query: 282 LRDDSGHLKVADFGLSKLLKFANTVKEDRPVTC 314
+ + DFGL +F++ V ED+ V
Sbjct: 124 ILSGGR-IYFIDFGLG---EFSDEV-EDKAVDL 151
|
Length = 204 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 32/97 (32%), Positives = 44/97 (45%), Gaps = 11/97 (11%)
Query: 49 DLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGA---DVDPEDRWGST 105
D + IK L+ G + + D + LH A +G V LL G DV +D G T
Sbjct: 47 DSEAIKLLMKHGAIPDVKYPDIESELHDAVEEGDVKAVEELLDLGKFADDVFYKD--GMT 104
Query: 106 PLADAVYYKHHDVIKLLEEHGAKPS------TAPMHV 136
PL A K D++KLL GA P +P+H+
Sbjct: 105 PLHLATILKKLDIMKLLIARGADPDIPNTDKFSPLHL 141
|
Length = 413 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 2/87 (2%)
Query: 43 YMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDV-VRLLLSRGADVDPEDR 101
Y A ++ I LLD G D+ TALH A C + V+ L+ RGA+V+ +++
Sbjct: 381 YAAVRNNVVIINTLLDYGADIEALSQKIGTALHFALCGTNPYMSVKTLIDRGANVNSKNK 440
Query: 102 WGSTPLADAVYYK-HHDVIKLLEEHGA 127
STPL A DVI++L ++GA
Sbjct: 441 DLSTPLHYACKKNCKLDVIEMLLDNGA 467
|
Length = 682 |
| >gnl|CDD|233161 TIGR00870, trp, transient-receptor-potential calcium channel protein | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 26/89 (29%), Positives = 37/89 (41%), Gaps = 17/89 (19%)
Query: 58 DSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPE---DRWGSTPLADAVYYK 114
D T I TALH+AA + ++V+LLL RGA V D + + D+ Y+
Sbjct: 119 DQYTSEFTPGI---TALHLAAHRQNYEIVKLLLERGASVPARACGDFFVKSQGVDSFYHG 175
Query: 115 HH-----------DVIKLLEEHGAKPSTA 132
++ LL E A TA
Sbjct: 176 ESPLNAAACLGSPSIVALLSEDPADILTA 204
|
The Transient Receptor Potential Ca2+ Channel (TRP-CC) Family (TC. 1.A.4)The TRP-CC family has also been called the store-operated calcium channel (SOC) family. The prototypical members include the Drosophila retinal proteinsTRP and TRPL (Montell and Rubin, 1989; Hardie and Minke, 1993). SOC members of the family mediate the entry of extracellular Ca2+ into cells in responseto depletion of intracellular Ca2+ stores (Clapham, 1996) and agonist stimulated production of inositol-1,4,5 trisphosphate (IP3). One member of the TRP-CCfamily, mammalian Htrp3, has been shown to form a tight complex with the IP3 receptor (TC #1.A.3.2.1). This interaction is apparently required for IP3 tostimulate Ca2+ release via Htrp3. The vanilloid receptor subtype 1 (VR1), which is the receptor for capsaicin (the ?hot? ingredient in chili peppers) and servesas a heat-activated ion channel in the pain pathway (Caterina et al., 1997), is also a member of this family. The stretch-inhibitable non-selective cation channel(SIC) is identical to the vanilloid receptor throughout all of its first 700 residues, but it exhibits a different sequence in its last 100 residues. VR1 and SICtransport monovalent cations as well as Ca2+. VR1 is about 10x more permeable to Ca2+ than to monovalent ions. Ca2+ overload probably causes cell deathafter chronic exposure to capsaicin. (McCleskey and Gold, 1999) [Transport and binding proteins, Cations and iron carrying compounds]. Length = 743 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 27/226 (11%)
Query: 193 AFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPT-LAVK 251
AF + ++++++ H ++V G + ++V E++ G L ++ +K + T K
Sbjct: 50 AFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK 109
Query: 252 FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG-------HLKVADFGLSKLLKFAN 304
A +A ++YL + ++H ++ NIL G +K++D G+
Sbjct: 110 VAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI------ 160
Query: 305 TVKEDRPVTCEETSWRYAAPE-VYKNEEYDTKVDVFSFALILQEM-IEGCPPFPTKQEKE 362
TV R E W APE V ++ D +SF L E+ G P K E
Sbjct: 161 TVLS-RQECVERIPW--IAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217
Query: 363 VPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
+ Y T L +L+ C + +P +RP FR I+
Sbjct: 218 KERFYEGQCML-----VTPSCKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|222931 PHA02798, PHA02798, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 22/87 (25%), Positives = 45/87 (51%), Gaps = 8/87 (9%)
Query: 50 LDGIKELLDSGTDVNFRDIDKRTAL-----HVAACQGRTDVVRLLLSRGADVDPEDRWGS 104
D +K ++ G +VN D + T L ++ + D+V++L+ GAD++ ++ G
Sbjct: 51 TDIVKLFINLGANVNGLDNEYSTPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGE 110
Query: 105 TPLADAV---YYKHHDVIKLLEEHGAK 128
TPL + Y + +++ + E+GA
Sbjct: 111 TPLYCLLSNGYINNLEILLFMIENGAD 137
|
Length = 489 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 50/205 (24%), Positives = 86/205 (41%), Gaps = 22/205 (10%)
Query: 164 TFRIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221
T +A ++ G V V+ + E T+ + V EL + + HPN+V +
Sbjct: 15 TVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 73
Query: 222 MMIVTEYLPKG---DLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEP 278
+ +VT ++ G DL G + +A + + ++Y+H +HR ++
Sbjct: 74 LWVVTSFMAYGSAKDLICTHFMDGMSELAIAY-ILQGVLKALDYIHH---MGYVHRSVKA 129
Query: 279 SNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV------TCEETSWRYAAPEVYKN--E 330
S+IL G KV GL L N + R V + + W +PEV + +
Sbjct: 130 SHILISVDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPW--LSPEVLQQNLQ 185
Query: 331 EYDTKVDVFSFALILQEMIEGCPPF 355
YD K D++S + E+ G PF
Sbjct: 186 GYDAKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 456 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| KOG4412 | 226 | consensus 26S proteasome regulatory complex, subun | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG4412 | 226 | consensus 26S proteasome regulatory complex, subun | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.76 | |
| KOG0512 | 228 | consensus Fetal globin-inducing factor (contains a | 99.76 | |
| PF12796 | 89 | Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02 | 99.75 | |
| PHA02743 | 166 | Viral ankyrin protein; Provisional | 99.74 | |
| KOG0509 | 600 | consensus Ankyrin repeat and DHHC-type Zn-finger d | 99.72 | |
| PHA02859 | 209 | ankyrin repeat protein; Provisional | 99.71 | |
| PHA02791 | 284 | ankyrin-like protein; Provisional | 99.7 | |
| PHA02875 | 413 | ankyrin repeat protein; Provisional | 99.7 | |
| KOG0512 | 228 | consensus Fetal globin-inducing factor (contains a | 99.69 | |
| PHA02736 | 154 | Viral ankyrin protein; Provisional | 99.69 | |
| KOG0509 | 600 | consensus Ankyrin repeat and DHHC-type Zn-finger d | 99.69 | |
| PHA02741 | 169 | hypothetical protein; Provisional | 99.68 | |
| PHA02878 | 477 | ankyrin repeat protein; Provisional | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| PHA02791 | 284 | ankyrin-like protein; Provisional | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| PHA02859 | 209 | ankyrin repeat protein; Provisional | 99.66 | |
| KOG0508 | 615 | consensus Ankyrin repeat protein [General function | 99.66 | |
| KOG0502 | 296 | consensus Integral membrane ankyrin-repeat protein | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| PHA02741 | 169 | hypothetical protein; Provisional | 99.66 | |
| PHA02874 | 434 | ankyrin repeat protein; Provisional | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.64 | |
| PLN03192 | 823 | Voltage-dependent potassium channel; Provisional | 99.64 | |
| PHA02884 | 300 | ankyrin repeat protein; Provisional | 99.63 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| PHA02884 | 300 | ankyrin repeat protein; Provisional | 99.62 | |
| PHA02946 | 446 | ankyin-like protein; Provisional | 99.62 | |
| KOG0508 | 615 | consensus Ankyrin repeat protein [General function | 99.62 | |
| PHA02875 | 413 | ankyrin repeat protein; Provisional | 99.62 | |
| PHA02878 | 477 | ankyrin repeat protein; Provisional | 99.61 | |
| PHA03095 | 471 | ankyrin-like protein; Provisional | 99.61 | |
| PHA02716 | 764 | CPXV016; CPX019; EVM010; Provisional | 99.61 | |
| KOG0514 | 452 | consensus Ankyrin repeat protein [General function | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| PHA02798 | 489 | ankyrin-like protein; Provisional | 99.6 | |
| PHA02795 | 437 | ankyrin-like protein; Provisional | 99.6 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.6 | |
| PHA03100 | 480 | ankyrin repeat protein; Provisional | 99.6 | |
| PHA02716 | 764 | CPXV016; CPX019; EVM010; Provisional | 99.6 | |
| PHA02743 | 166 | Viral ankyrin protein; Provisional | 99.59 | |
| PHA03100 | 480 | ankyrin repeat protein; Provisional | 99.59 | |
| KOG0514 | 452 | consensus Ankyrin repeat protein [General function | 99.59 | |
| PHA02736 | 154 | Viral ankyrin protein; Provisional | 99.57 | |
| PHA02798 | 489 | ankyrin-like protein; Provisional | 99.57 | |
| PHA02874 | 434 | ankyrin repeat protein; Provisional | 99.56 | |
| KOG4177 | 1143 | consensus Ankyrin [Cell wall/membrane/envelope bio | 99.56 | |
| PHA03095 | 471 | ankyrin-like protein; Provisional | 99.56 | |
| KOG4214 | 117 | consensus Myotrophin and similar proteins [Transcr | 99.55 | |
| PHA02989 | 494 | ankyrin repeat protein; Provisional | 99.55 | |
| PHA02730 | 672 | ankyrin-like protein; Provisional | 99.54 | |
| PHA02946 | 446 | ankyin-like protein; Provisional | 99.54 | |
| KOG0510 | 929 | consensus Ankyrin repeat protein [General function | 99.53 | |
| PHA02917 | 661 | ankyrin-like protein; Provisional | 99.53 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| PHA02795 | 437 | ankyrin-like protein; Provisional | 99.53 | |
| PHA02876 | 682 | ankyrin repeat protein; Provisional | 99.53 | |
| PF12796 | 89 | Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02 | 99.51 | |
| PF13637 | 54 | Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A | 99.51 | |
| PHA02989 | 494 | ankyrin repeat protein; Provisional | 99.51 | |
| PHA02730 | 672 | ankyrin-like protein; Provisional | 99.5 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| KOG4177 | 1143 | consensus Ankyrin [Cell wall/membrane/envelope bio | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| PF13857 | 56 | Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A | 99.47 | |
| PLN03192 | 823 | Voltage-dependent potassium channel; Provisional | 99.47 | |
| cd00204 | 126 | ANK ankyrin repeats; ankyrin repeats mediate prote | 99.47 | |
| PHA02917 | 661 | ankyrin-like protein; Provisional | 99.46 | |
| KOG4214 | 117 | consensus Myotrophin and similar proteins [Transcr | 99.45 | |
| PTZ00322 | 664 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatas | 99.45 | |
| PHA02876 | 682 | ankyrin repeat protein; Provisional | 99.44 | |
| KOG0510 | 929 | consensus Ankyrin repeat protein [General function | 99.44 | |
| KOG0515 | 752 | consensus p53-interacting protein 53BP/ASPP, conta | 99.41 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.4 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-51 Score=379.94 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=220.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCH----HHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDE----DKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM 223 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 223 (456)
.|.+.+.||+|.||.| +.+|+.||||++.+...... .......+|+++|++++|||||+++++|..++..|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 4677899999999987 45899999999987654431 23345679999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC---CCEEEeccCCcccc
Q 012777 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS---GHLKVADFGLSKLL 300 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~---~~vkl~Dfgls~~~ 300 (456)
+||||++||.|.+.+..++.+.+.....+++|++.|+.|||++| |+||||||+|||+..+ ..+||+|||+|+..
T Consensus 253 mVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred EEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 99999999999999999999999999999999999999999999 9999999999999866 67999999999987
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCC---CchhHHHHHHHHHHHHcCCCCCCCCCccc-hHHHHHhcCCCCCC
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYD---TKVDVFSFALILQEMIEGCPPFPTKQEKE-VPKAYIANERPPFR 376 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~ 376 (456)
+ +.....+.+|||.|.|||++.+..+. .++|+||+||++|-+++|.+||.+..... +..+|..+.....+
T Consensus 330 g------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p 403 (475)
T KOG0615|consen 330 G------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP 403 (475)
T ss_pred c------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence 3 45566778999999999999776432 37899999999999999999999887766 78888776665555
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 377 APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 377 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
..+..++.+..+||.+||..||++|||++|+|++=.
T Consensus 404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 404 LQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 667899999999999999999999999999998843
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=387.27 Aligned_cols=258 Identities=29% Similarity=0.470 Sum_probs=234.4
Q ss_pred CCCccccCccccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeE
Q 012777 141 EVPEYEIDPKELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGA 215 (456)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 215 (456)
.+|+...++....|...+.||+|+|+.+ ..+|+.||+|++.+.........+.+.+|+++.+.++|||||+++++
T Consensus 7 ~ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~ 86 (592)
T KOG0575|consen 7 EIPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF 86 (592)
T ss_pred CCCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE
Confidence 4666667777788999999999999755 36899999999999888888888999999999999999999999999
Q ss_pred EEeCCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccC
Q 012777 216 VTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFG 295 (456)
Q Consensus 216 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfg 295 (456)
|++.+.+|||+|+|..++|..+++.+++++|.+++.++.||+.||.|||+++ |+|||||..|+|++++.+|||+|||
T Consensus 87 FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 87 FEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred eecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccc
Confidence 9999999999999999999999998899999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCC
Q 012777 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPF 375 (456)
Q Consensus 296 ls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 375 (456)
||..+... .....+.+|||.|.|||++.+...+.-+||||+|||||.|+.|++||...+-.+.+..|+....
T Consensus 164 LAt~le~~-----~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y--- 235 (592)
T KOG0575|consen 164 LATQLEYD-----GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY--- 235 (592)
T ss_pred eeeeecCc-----ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc---
Confidence 99988422 2334467899999999999999999999999999999999999999999988888888865542
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 376 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..+..++.+.++||.++|..||.+|||+++++.+
T Consensus 236 -~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 -SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2246899999999999999999999999999987
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=368.05 Aligned_cols=244 Identities=29% Similarity=0.476 Sum_probs=215.3
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc-eEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP-MMIVT 226 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~-~~lv~ 226 (456)
+.+....||+|..|.| +.+++.+|+|++..+ .++...+++.+|+++++.++||+||++|++|..+.. ++|+|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 4566778999998876 457999999999654 567788999999999999999999999999999985 99999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHE-NRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
||+++|||.+++...+.+++.....|+.++++||.|||+ ++ ||||||||+|+|++..|.|||||||.+..+..
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn--- 231 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVN--- 231 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhh---
Confidence 999999999999988999999999999999999999996 77 99999999999999999999999999997732
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC-----CccchHHHHHhcCCCCCCCCCC
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTK-----QEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
.....+.||..|||||.+.+..|+.++||||||++++|+.+|+.||... ...++...|..+..|.++ ..
T Consensus 232 ----S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP--~~ 305 (364)
T KOG0581|consen 232 ----SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLP--EG 305 (364)
T ss_pred ----hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCC--cc
Confidence 1445678999999999999999999999999999999999999999875 334555666544444442 23
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++++|++||..||++||.+|||++|+++|
T Consensus 306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 599999999999999999999999999998
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-50 Score=358.27 Aligned_cols=252 Identities=27% Similarity=0.477 Sum_probs=218.0
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeee-EEEeCCc-eEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLG-AVTQSTP-MMIV 225 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~-~~~~~~~-~~lv 225 (456)
+|++.++||+|+||.+ .++|..||.|.+.-. ..+....+++..|+.+|++++|||||++++ .|.++.. ++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 6899999999999865 568999999999854 356778899999999999999999999998 5665555 9999
Q ss_pred EEccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 226 TEYLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHENRPE-AIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~~~-~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
||||.+|+|.++++. +..+++..+|+++.|++.||.+||++-++ .|+||||||.||+++.+|.|||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999864 34599999999999999999999994222 4999999999999999999999999999988
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
.. ....-..++|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.+.+-.++..+|..+..++. +..
T Consensus 179 ~s-----~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~--p~~ 251 (375)
T KOG0591|consen 179 SS-----KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPL--PDE 251 (375)
T ss_pred cc-----hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCC--cHH
Confidence 42 23345568999999999999999999999999999999999999999999988888888866655544 237
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
.||.++..||..|+..||+.||+...++..+.
T Consensus 252 ~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 252 HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 89999999999999999999999655554443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=362.65 Aligned_cols=248 Identities=29% Similarity=0.451 Sum_probs=221.8
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|...+.||+|+||.| +.+++.||+|++++..+......+....|..+|..++||+||+++-.|++...+|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 36899999999999976 4578999999999988877778899999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||+.||.|.-+|++.+.+++..++.++.+|+.||.|||++| ||||||||+|||+|.+|.++|+|||+++....
T Consensus 105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~---- 177 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK---- 177 (357)
T ss_pred eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc----
Confidence 99999999999999999999999999999999999999999 99999999999999999999999999985422
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
........+||+.|||||++.+..++..+|+||||+++|+|++|.+||.+.+...+.+.+.....+. .+...+.+.
T Consensus 178 -~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~---~p~~ls~~a 253 (357)
T KOG0598|consen 178 -DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL---PPGYLSEEA 253 (357)
T ss_pred -CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC---CCccCCHHH
Confidence 2223334789999999999999999999999999999999999999999999888888886555233 356689999
Q ss_pred HHHHHHhcccCCCCCC----CHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRP----TFRQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rp----t~~ell~~ 410 (456)
++++.++|..||++|. ++.++.+|
T Consensus 254 rdll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 254 RDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred HHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 9999999999999995 55554443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=364.89 Aligned_cols=271 Identities=43% Similarity=0.738 Sum_probs=231.7
Q ss_pred CCCccccCccccccccceeeeccEEEEE---eEcCcE-EEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEE
Q 012777 141 EVPEYEIDPKELDFSNSVEITKGTFRIA---SWRGTQ-VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV 216 (456)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~lg~G~fg~~---~~~g~~-vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 216 (456)
..+.+++++.++.+.. .||+|+||.| .|.|+. ||+|++......... .+.|.+|+.+|.+++|||||+++|++
T Consensus 32 ~~~~~~i~~~~l~~~~--~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~ 108 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEE--VLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGAC 108 (362)
T ss_pred cccceecChHHhhhhh--hcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 4466667766654443 5999999865 788999 999999877654444 78999999999999999999999999
Q ss_pred EeCC-ceEEEEEccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-CEEEe
Q 012777 217 TQST-PMMIVTEYLPKGDLRAYLKQ--KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG-HLKVA 292 (456)
Q Consensus 217 ~~~~-~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~-~vkl~ 292 (456)
.++. .+++||||+++|+|.+++.. +..++...+..++.||+.||+|||++++ ||||||||+|||++.++ .+||+
T Consensus 109 ~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~ 186 (362)
T KOG0192|consen 109 TSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIA 186 (362)
T ss_pred cCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEEC
Confidence 9887 79999999999999999988 5679999999999999999999999984 89999999999999997 99999
Q ss_pred ccCCcccccccccccCCCCcccCCCCcccccccccC--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc
Q 012777 293 DFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYK--NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN 370 (456)
Q Consensus 293 Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 370 (456)
|||+++...... .......||+.|||||+++ +..++.++||||||+++|||+||+.||.+..+......+...
T Consensus 187 DFGlsr~~~~~~-----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~ 261 (362)
T KOG0192|consen 187 DFGLSREKVISK-----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG 261 (362)
T ss_pred CCccceeecccc-----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 999998663211 2333468999999999999 569999999999999999999999999999886666555544
Q ss_pred C-CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhcccccc
Q 012777 371 E-RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHW 424 (456)
Q Consensus 371 ~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~ 424 (456)
. ++.. +..++..+..++.+||..||..||++.+++..|+.+..+.......
T Consensus 262 ~~Rp~~---p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~ 313 (362)
T KOG0192|consen 262 GLRPPI---PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPE 313 (362)
T ss_pred CCCCCC---CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCcc
Confidence 4 5554 3448899999999999999999999999999999999887654443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=354.57 Aligned_cols=247 Identities=32% Similarity=0.548 Sum_probs=214.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||+|+|++| +.++..||||.+.+... ..+..+.+..|+.+|+.++|||||.+++++..++.+|+|||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 5777788999999876 45789999999988753 66778889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC------CCEEEeccCCccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS------GHLKVADFGLSKLLK 301 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~------~~vkl~Dfgls~~~~ 301 (456)
||.||+|.++++..+.+++..++.++.||+.||++||+++ ||||||||+|||++.. -.+||+|||+|+.+.
T Consensus 90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999999999999999999999999999999999999999 9999999999999964 468999999999884
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (456)
+........|+|.|||||+++...|+.|+|+||+|+++|++++|+.||...++.++...+.+.. ...+..+..
T Consensus 167 ------~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~-~~~~~~~~~ 239 (429)
T KOG0595|consen 167 ------PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN-EIVPVLPAE 239 (429)
T ss_pred ------chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc-cccCchhhh
Confidence 2333445789999999999999999999999999999999999999999999999888664443 222233455
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+....+++...+..+|..|-+..+...+
T Consensus 240 ~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 240 LSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred ccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 55567788899999999888877665443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=362.01 Aligned_cols=254 Identities=29% Similarity=0.457 Sum_probs=226.9
Q ss_pred cccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceE
Q 012777 150 KELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMM 223 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~ 223 (456)
...+|...+.||.|+|..| ..+++.||||++.+..+..+...+.+..|-.+|.+| .||.|++|+-.|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3457999999999999866 457999999999999888888889999999999999 7999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
+|+||+++|+|.++|++-+.+++.-++.++.||+.||+|||++| ||||||||+|||+|.++.+||+|||.++.+...
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999999999999999999999999999999999999999 999999999999999999999999999988543
Q ss_pred ccc------c--CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCC
Q 012777 304 NTV------K--EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPF 375 (456)
Q Consensus 304 ~~~------~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 375 (456)
... . .......++||..|.+||++.....++++|||+|||++|+|+.|.+||.+.+...+.+.|.....
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y--- 304 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY--- 304 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc---
Confidence 222 1 11122558899999999999999999999999999999999999999999998888777754332
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 376 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++.++++.+.+||+++|..||.+|+|.++|-+|
T Consensus 305 -~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 305 -EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 2367888999999999999999999999887766
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=333.51 Aligned_cols=234 Identities=26% Similarity=0.511 Sum_probs=216.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||.|+||+| +.+|..||+|++.+.....-...++..+|..+|+.+.||+++++++.|.+...+|+|||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 6888999999999987 45799999999998887788888999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|++||.|..++.+.+++++..++.++.||+.||+|||+++ |++||+||+|||+|.+|.+||+|||+|+.+.
T Consensus 125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~------ 195 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS------ 195 (355)
T ss_pred ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec------
Confidence 9999999999999999999999999999999999999999 9999999999999999999999999999772
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
. .....+|||.|+|||+++..+++.++|.||||+++|||+.|.+||.+.++..++.+|.... -.+ +..++.+++
T Consensus 196 -~-rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~-v~f---P~~fs~~~k 269 (355)
T KOG0616|consen 196 -G-RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK-VKF---PSYFSSDAK 269 (355)
T ss_pred -C-cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc-ccC---CcccCHHHH
Confidence 1 2345789999999999999999999999999999999999999999999988888885544 222 577889999
Q ss_pred HHHHHhcccCCCCC
Q 012777 388 ELIEDCWSEEPFRR 401 (456)
Q Consensus 388 ~li~~~l~~dp~~R 401 (456)
+||.++|+.|-.+|
T Consensus 270 dLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 270 DLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHHhhhhHhh
Confidence 99999999999999
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=357.18 Aligned_cols=260 Identities=35% Similarity=0.601 Sum_probs=225.4
Q ss_pred CCccccCccccccccceeeeccEEEEE---eEcCc-EEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE
Q 012777 142 VPEYEIDPKELDFSNSVEITKGTFRIA---SWRGT-QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVT 217 (456)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~lg~G~fg~~---~~~g~-~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 217 (456)
...++++... +...+.||+|-||.| .++|. .||+|.++..... .+.|.+|+++|++++|++||+++++|.
T Consensus 198 ~d~wei~r~~--l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 198 RDPWEIPREE--LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred cCCeeecHHH--HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 3445556555 445568999999976 67877 9999999865332 257889999999999999999999999
Q ss_pred eCCceEEEEEccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccC
Q 012777 218 QSTPMMIVTEYLPKGDLRAYLKQ--KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFG 295 (456)
Q Consensus 218 ~~~~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfg 295 (456)
.++.++|||||++.|+|.++|+. ++.+...+.+.++.||++|++||++++ +|||||...||||+++..+||+|||
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFG 348 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFG 348 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccc
Confidence 99999999999999999999987 345999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCC
Q 012777 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPP 374 (456)
Q Consensus 296 ls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 374 (456)
+++...+. .........-++.|.|||.+..+.++.+|||||||++|+||+| |+.||.+++..+....+..+.+.+
T Consensus 349 LAr~~~d~----~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp 424 (468)
T KOG0197|consen 349 LARLIGDD----EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP 424 (468)
T ss_pred cccccCCC----ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC
Confidence 99954322 1122222334567999999999999999999999999999999 999999999999999997777776
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 375 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
- +..+|.++.+++..||..+|++|||++.+...|++++..
T Consensus 425 ~---P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 425 R---PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred C---CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 5 678999999999999999999999999999999988754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=353.28 Aligned_cols=271 Identities=27% Similarity=0.453 Sum_probs=240.4
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
...|+....||+|+||.| ..+++.||+|++..+. .++.++++.+|+.+|..++++||.++|+++..+..++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 446888899999999976 4578899999999874 455678999999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
||||.||++.+.++.++.+++..+..++++++.||.|||.++ .+|||||+.|||+..+|.|||+|||++..+...
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~-- 164 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT-- 164 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech--
Confidence 999999999999998777899999999999999999999999 999999999999999999999999999877432
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
......+.|||.|||||++.+..|+.++||||||++.+||.+|.+||.+..+......|-+...|.+ ..++++.
T Consensus 165 ---~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L---~~~~S~~ 238 (467)
T KOG0201|consen 165 ---VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRL---DGDFSPP 238 (467)
T ss_pred ---hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcc---ccccCHH
Confidence 2222568899999999999998999999999999999999999999999999776665644444444 3589999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccccccCcchhhHHHHHhhhc
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVGPLRCFQSLAALWKK 441 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (456)
+++|+..||.+||+.||++.+++++ +| +++.+++.++.......++|+.
T Consensus 239 ~kEFV~~CL~k~P~~RpsA~~LLKh------~F-Ik~a~k~s~L~~~i~r~~~~~~ 287 (467)
T KOG0201|consen 239 FKEFVEACLDKNPEFRPSAKELLKH------KF-IKRAKKTSELKELIDRYKRWRV 287 (467)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhh------HH-HHhcCCchHHHHHHHHHHHHhh
Confidence 9999999999999999999999998 55 3347889999999999999997
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=342.17 Aligned_cols=248 Identities=27% Similarity=0.456 Sum_probs=225.6
Q ss_pred ccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
..+|++.+.||+|+||.|+ ..|+.||||.+.++.+.+++..-.+.+|+++++.++||||+.+|.+|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3478899999999999884 57999999999999999999999999999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|||..+|.|+||+.+++.+++.++..+++||.+|+.|||.++ ++|||||.+|||+|.++++||+|||++..+
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly----- 203 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLY----- 203 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhh-----
Confidence 999999999999999999999999999999999999999999 999999999999999999999999999877
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYD-TKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
....+...++|+|.|.+||++.+.+|. +.+|.||||++||.|+.|..||++.+-..+.++|..+... .+.-|.
T Consensus 204 -~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr-----EP~~PS 277 (668)
T KOG0611|consen 204 -ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR-----EPETPS 277 (668)
T ss_pred -ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc-----CCCCCc
Confidence 344567778999999999999998876 5799999999999999999999999988888888655422 133455
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
...-||++||..||++|.|++++.+|-.
T Consensus 278 dA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 278 DASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred hHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 6889999999999999999999988743
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=330.84 Aligned_cols=248 Identities=23% Similarity=0.423 Sum_probs=205.9
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|+...++|+|+||.| +.+|+.||||++.... .++...+-.++|+.+|++++|||+|.++++|.....+++|+|
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 3677789999999988 4579999999997543 445566667899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQKGA-LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~-l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||+ .++.+-+...+. ++.+.+..+++|++.|+.|||+++ +|||||||+|||++.+|.+||||||+|+.+..+
T Consensus 82 ~~d-hTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--- 154 (396)
T KOG0593|consen 82 YCD-HTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP--- 154 (396)
T ss_pred ecc-hHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC---
Confidence 995 577777766543 999999999999999999999999 999999999999999999999999999988432
Q ss_pred cCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC-------------
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER------------- 372 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------------- 372 (456)
...++.++.|..|+|||.+.+ -+|.+.+||||+||++.||++|.+.|++....+....|.....
T Consensus 155 --gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 155 --GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred --cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 233455678889999999988 4899999999999999999999999999876554333322110
Q ss_pred C--------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 373 P--------------PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 373 ~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+ +++......+.-+.+|++.||.+||++|++.++++.+
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 0 0111124555668899999999999999999999976
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=341.45 Aligned_cols=255 Identities=27% Similarity=0.465 Sum_probs=209.1
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC--ceE
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST--PMM 223 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~--~~~ 223 (456)
..++...+.||+|+||.| ..+|+..|||.+.... ... .+.+.+|+.+|++++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 456888899999999977 2347899999997652 222 677899999999999999999999854444 699
Q ss_pred EEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-CCCEEEeccCCccccc
Q 012777 224 IVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD-SGHLKVADFGLSKLLK 301 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~-~~~vkl~Dfgls~~~~ 301 (456)
++|||+++|+|.+++...+ .+++..++.+++|+++||.|||++| |+||||||+|||++. ++.+||+|||++....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999999876 7999999999999999999999999 999999999999999 7999999999988763
Q ss_pred ccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCC-CccchHHHHHhcCCCCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTK-QEKEVPKAYIANERPPFRAPT 379 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~ 379 (456)
. ............||+.|||||++..+ ...+++|||||||++.||+||++||... ........+.... ..+..+
T Consensus 170 ~--~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--~~P~ip 245 (313)
T KOG0198|consen 170 S--KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--SLPEIP 245 (313)
T ss_pred c--ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--CCCCCC
Confidence 2 11122233457799999999999953 3445999999999999999999999883 3333333333333 223457
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 380 THYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
..++.+.++||.+|+..||++|||+++++++.-.-.
T Consensus 246 ~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 246 DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 789999999999999999999999999999854433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=336.91 Aligned_cols=275 Identities=25% Similarity=0.390 Sum_probs=228.8
Q ss_pred CCccccCccccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEE
Q 012777 142 VPEYEIDPKELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV 216 (456)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 216 (456)
.+..+......+|+....||.|.-+.| .-.++.||||++..+...++ .+.+.+|++.++.++||||++++.+|
T Consensus 16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sF 93 (516)
T KOG0582|consen 16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSF 93 (516)
T ss_pred cccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEE
Confidence 345556666778999999999976544 44689999999998765443 78899999999999999999999999
Q ss_pred EeCCceEEEEEccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEecc
Q 012777 217 TQSTPMMIVTEYLPKGDLRAYLKQKGA--LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294 (456)
Q Consensus 217 ~~~~~~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Df 294 (456)
..+..+|+||.|+.+||+.++++..-+ +++..+..|++++++||.|||.+| .||||||+.|||++.+|.|||+||
T Consensus 94 vv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadF 170 (516)
T KOG0582|consen 94 VVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADF 170 (516)
T ss_pred EecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCc
Confidence 999999999999999999999987432 999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccccccCCCCcccCCCCcccccccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC
Q 012777 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE--EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER 372 (456)
Q Consensus 295 gls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 372 (456)
|.+..+...+.....++ ..+.||+.|||||++.+. .|+.|+||||||++..||.+|..||....+..+......+..
T Consensus 171 gvsa~l~~~G~R~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~p 249 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDP 249 (516)
T ss_pred eeeeeecccCceeeEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCC
Confidence 99887755442222222 678899999999997554 799999999999999999999999999988877665544443
Q ss_pred CCCC------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhcccccc
Q 012777 373 PPFR------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHW 424 (456)
Q Consensus 373 ~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~ 424 (456)
|... .....++++|+.+|..||.+||++|||+++++++ .++++..-+.+.
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh--~FFk~~k~~~~~ 305 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH--AFFKKAKSKEYL 305 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc--HHHhhccchhhc
Confidence 3111 1235677889999999999999999999999987 556665444443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=320.55 Aligned_cols=366 Identities=27% Similarity=0.423 Sum_probs=294.9
Q ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccc
Q 012777 33 EAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVY 112 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~ 112 (456)
-|..|.+||||||..|+..+++.|+.+|+.+|+.+.-..||||+|+..||-++|+.||++.+|+|..|..|.|||||||.
T Consensus 30 gddhgfsplhwaakegh~aivemll~rgarvn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehgntplhyacf 109 (448)
T KOG0195|consen 30 GDDHGFSPLHWAAKEGHVAIVEMLLSRGARVNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGNTPLHYACF 109 (448)
T ss_pred ccccCcchhhhhhhcccHHHHHHHHhcccccccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCCCchhhhhh
Confidence 34569999999999999999999999999999999989999999999999999999999999999999999999999999
Q ss_pred cccchhhhhhhhcCCCCCCCccc-----------------------cccccCCCccccC--------------------c
Q 012777 113 YKHHDVIKLLEEHGAKPSTAPMH-----------------------VQNAREVPEYEID--------------------P 149 (456)
Q Consensus 113 ~~~~~~~~~L~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~--------------------~ 149 (456)
+|+..+++-|+..|+.++....+ .++...+|..+.. .
T Consensus 110 wgydqiaedli~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~nripfkdt~wkgtktr~rdatlsr~~gid~ 189 (448)
T KOG0195|consen 110 WGYDQIAEDLISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRIPFKDTTWKGTKTRTRDATLSRYTGIDV 189 (448)
T ss_pred hcHHHHHHHHHhccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCCcccccccccccccccccccccccccCcch
Confidence 99999999999999998764322 1222333322211 1
Q ss_pred ccccccc-ceeeeccEEEEEeEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 150 KELDFSN-SVEITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 150 ~~~~~~~-~~~lg~G~fg~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
..+++.. ...--+|..+++.|.|..+++|+++..... ...-.+|..|.-.|+.+.||||+.+++.|..+..+.++..|
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 1111111 011124556678899999999999765432 33346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEe--ccCCcccccccc
Q 012777 229 LPKGDLRAYLKQKGA--LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVA--DFGLSKLLKFAN 304 (456)
Q Consensus 229 ~~~~sL~~~l~~~~~--l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~--Dfgls~~~~~~~ 304 (456)
++.|||+.++.+... .+..++.+++.+++.++.|||+..+ .|.---+....|++|++...+|. |--++...
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsfqe---- 343 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSFQE---- 343 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeeeec----
Confidence 999999999987543 7888999999999999999999862 23344688999999988766653 43332211
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCC---CchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCCCCCC
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYD---TKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRAPTT 380 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~ 380 (456)
......|.|++||.++..+-+ .++|+|||.+++|||.|...||.+..+.+.--++...+ +... ++
T Consensus 344 --------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~i---pp 412 (448)
T KOG0195|consen 344 --------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHI---PP 412 (448)
T ss_pred --------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccC---CC
Confidence 122345789999999877544 47999999999999999999999999988776665555 4443 57
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
..+..+..++.-|++.||.+||.++.++-.|+.+.
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 88888999999999999999999999999998764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=347.26 Aligned_cols=247 Identities=31% Similarity=0.477 Sum_probs=212.9
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCH--HHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDE--DKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMM 223 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~--~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~ 223 (456)
-.|...+.||+|+||.| ..+|+.||+|++........ ...+.+.+|+.+++++. ||||+++++++.....++
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 36888899999999987 34689999998876532211 23456778999999998 999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC-CCEEEeccCCcccccc
Q 012777 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS-GHLKVADFGLSKLLKF 302 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~-~~vkl~Dfgls~~~~~ 302 (456)
+|||||.||+|.+++.+.+++.+..+..+++|+++|+.|||++| |+||||||+|+|++.+ +++||+|||++....
T Consensus 97 ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred EEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 99999999999999999889999999999999999999999999 9999999999999999 999999999998662
Q ss_pred cccccCCCCcccCCCCcccccccccCCCC-CC-CchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEE-YD-TKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
..........||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||.+.+...+...+.... ..+ +.
T Consensus 173 ----~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~-~~~---p~ 244 (370)
T KOG0583|consen 173 ----GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE-FKI---PS 244 (370)
T ss_pred ----CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC-ccC---CC
Confidence 2334555678999999999999977 87 58999999999999999999999988777777764332 222 34
Q ss_pred CC-cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 381 HY-AYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 381 ~~-~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+ +.++..++.+||..||.+|+|+.+++.+
T Consensus 245 ~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 245 YLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred CcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 44 8999999999999999999999999933
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=350.03 Aligned_cols=245 Identities=22% Similarity=0.433 Sum_probs=218.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|..-.+||+|.-|.+ ..+++.||||.+....... .+-+.+|+.+|+..+|+|||++++.|...+.+++|||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 4777788999988754 4578899999998764333 3678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|++||+|.|++.+. .+++.++..|++++++||+|||.+| |+|||||.+|||++.+|.+||+|||++..+...
T Consensus 351 ym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~---- 422 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE---- 422 (550)
T ss_pred ecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccc----
Confidence 99999999999764 4999999999999999999999999 999999999999999999999999999877432
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
.......+|||.|||||++....|+++.||||||++++||+-|++||-+.++......|...+.+.+.. +..++..|+
T Consensus 423 -~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~-~~klS~~~k 500 (550)
T KOG0578|consen 423 -QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKN-PEKLSPELK 500 (550)
T ss_pred -cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCC-ccccCHHHH
Confidence 113445789999999999999999999999999999999999999999988888888887777777654 678999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+|+.+||+.|+++|++++|||+|
T Consensus 501 dFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 501 DFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHHhhcchhcCCCHHHHhcC
Confidence 99999999999999999999987
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=350.20 Aligned_cols=245 Identities=27% Similarity=0.423 Sum_probs=219.3
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
|..++.||.|+.|.| ..+|+.+|||++.+.....+.....+.+|+-+|+.+.|||++++|++++....+|+|+||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 667789999999876 468999999999887555566667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccC
Q 012777 229 LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKE 308 (456)
Q Consensus 229 ~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~ 308 (456)
++||-|++++..+|++++.++.++++||+.|+.|||..+ |+|||+||+|+|+|..+++||+|||+|... .+
T Consensus 94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe------~~ 164 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE------VP 164 (786)
T ss_pred cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc------cC
Confidence 999999999999999999999999999999999999999 999999999999999999999999999865 33
Q ss_pred CCCcccCCCCcccccccccCCCCCCC-chhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 309 DRPVTCEETSWRYAAPEVYKNEEYDT-KVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
.....+.+|+|.|.+||++++.+|+- ++||||.|+|||.|++|++||++.+...+..++..+. |.. +..++.+.+
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~---f~M-Ps~Is~eaQ 240 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV---FEM-PSNISSEAQ 240 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc---ccC-CCcCCHHHH
Confidence 44555678999999999999999885 8999999999999999999999888777776664443 222 478999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
+||.+|+..||.+|.|.++|++|-
T Consensus 241 dLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 241 DLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred HHHHHHhccCccccccHHHHhhCc
Confidence 999999999999999999999884
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=342.30 Aligned_cols=255 Identities=26% Similarity=0.396 Sum_probs=218.5
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
-.+|.....||+|+||.| +.+|+.||+|++++.......+++.+..|..+|....+|.||+++-+|.+...+|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 347999999999999977 458999999999998888888899999999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc-
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN- 304 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~- 304 (456)
|||++||++..+|...+.|++..++.++.+++.|++.+|..| +|||||||+|+|||..|.+||+||||+.-+....
T Consensus 220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 999999999999999999999999999999999999999999 9999999999999999999999999986432100
Q ss_pred ---------------c-ccCCCC-------------------------cccCCCCcccccccccCCCCCCCchhHHHHHH
Q 012777 305 ---------------T-VKEDRP-------------------------VTCEETSWRYAAPEVYKNEEYDTKVDVFSFAL 343 (456)
Q Consensus 305 ---------------~-~~~~~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 343 (456)
. ...... ....+|||-|+|||++.+..|+...|+|||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 0 000000 01357999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCccchHHHHHhcCCCCCC-CCCCCCcHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 012777 344 ILQEMIEGCPPFPTKQEKEVPKAYIANERPPFR-APTTHYAYGLRELIEDCWSEEPFRRPT---FRQILMR 410 (456)
Q Consensus 344 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rpt---~~ell~~ 410 (456)
|||||+.|.+||...++.+.++.|..-. ..+. ......+++..+||.+||+ ||++|.. ++||-+|
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr-~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWR-ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHh-hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 9999999999999999999988874332 1111 1235667899999999999 9999975 6665544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=345.43 Aligned_cols=244 Identities=29% Similarity=0.506 Sum_probs=218.2
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.| +++.+.||+|.+.+.. ..++..+.+.+|+++++.++||||+.+++.|+....+++|+|
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5777889999999876 4567889999998865 456678899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
||.| +|..++.+.+.++++.+..++.+++.||.|||+.+ |+|||+||.|||++..+.+|+||||+++....+
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~---- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN---- 153 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC----
Confidence 9965 99999999999999999999999999999999999 999999999999999999999999999977432
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
........|||.|||||++.+.+|+..+|+|||||++||++.|++||......++.+.|......+ +...+..+.
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~----p~~~S~~f~ 228 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP----PSTASSSFV 228 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC----cccccHHHH
Confidence 223344679999999999999999999999999999999999999999888777777775443222 458889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+|++.+|.+||..|.|..+++.|
T Consensus 229 nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 229 NFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHHHhhcChhhcccHHHHhcC
Confidence 99999999999999999999876
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=328.13 Aligned_cols=257 Identities=21% Similarity=0.322 Sum_probs=215.8
Q ss_pred ccCccccccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe----
Q 012777 146 EIDPKELDFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ---- 218 (456)
Q Consensus 146 ~~~~~~~~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---- 218 (456)
.+++.+++......||+|+++.+ ..+|+.||||.+...........+.+.+|+.+|++++||||+++++++.+
T Consensus 14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~ 93 (283)
T PHA02988 14 CIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93 (283)
T ss_pred ecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccC
Confidence 34555555665578899888754 77899999999987654455556788999999999999999999999876
Q ss_pred CCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEeCCCCCEEEeccCCc
Q 012777 219 STPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHEN-RPEAIIHRDLEPSNILRDDSGHLKVADFGLS 297 (456)
Q Consensus 219 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls 297 (456)
...+++||||+++|+|.+++.+.+.+++.....++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~ 170 (283)
T PHA02988 94 LPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLE 170 (283)
T ss_pred CCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchH
Confidence 357899999999999999998888899999999999999999999985 7 889999999999999999999999998
Q ss_pred ccccccccccCCCCcccCCCCcccccccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCC
Q 012777 298 KLLKFANTVKEDRPVTCEETSWRYAAPEVYKN--EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPP 374 (456)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~ 374 (456)
...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.... +++
T Consensus 171 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 242 (283)
T PHA02988 171 KILSSP--------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK 242 (283)
T ss_pred hhhccc--------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 765211 112357788999999876 678999999999999999999999999887766666554333 322
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 012777 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416 (456)
Q Consensus 375 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~ 416 (456)
. +...+..+.+++.+||+.||++|||++++++.|+.+..
T Consensus 243 ~---~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 243 L---PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred C---CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 2 34678899999999999999999999999999998864
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=346.74 Aligned_cols=242 Identities=26% Similarity=0.409 Sum_probs=215.7
Q ss_pred cccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceE
Q 012777 150 KELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMM 223 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~ 223 (456)
...+|...+.||+|+||+| +.+++.||||++++..+...+.++..+.|.+++... +||+++.++.+|...+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3347899999999999987 457889999999999988888999999999999998 5999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
+||||+.||++. ++++.+.+++..+..++..++.||.|||++| |||||||.+|||+|.+|.+||+|||+++....
T Consensus 446 fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~- 520 (694)
T KOG0694|consen 446 FVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG- 520 (694)
T ss_pred EEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC-
Confidence 999999999944 3444577999999999999999999999999 99999999999999999999999999985521
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
......++.|||.|+|||++.+..|+.++|+|||||+||||+.|+.||.+.+.+++...|. ...+.+ +..++
T Consensus 521 ----~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~-~d~~~y---P~~ls 592 (694)
T KOG0694|consen 521 ----QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV-NDEVRY---PRFLS 592 (694)
T ss_pred ----CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-cCCCCC---CCccc
Confidence 2223446789999999999999999999999999999999999999999999999998884 333433 67899
Q ss_pred HHHHHHHHHhcccCCCCCCCH
Q 012777 384 YGLRELIEDCWSEEPFRRPTF 404 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~ 404 (456)
.+..+|++++|.+||++|..+
T Consensus 593 ~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 593 KEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHHHHhccCcccccCC
Confidence 999999999999999999855
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=333.93 Aligned_cols=250 Identities=27% Similarity=0.423 Sum_probs=211.1
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS--TPMMI 224 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~l 224 (456)
..|+..++||+|+||.| ..+|+.||+|++..+.. .+.......+|+.+|+++.||||++|.+...+. ..+|+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 36888899999999866 45799999999987653 344556778999999999999999999998876 68999
Q ss_pred EEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 225 VTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
|+||+ ..+|.-++...+ .+++.++..++.||+.||+|||++| |+|||||.+|||+|.+|.+||+|||||+++..
T Consensus 196 VFeYM-dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~- 270 (560)
T KOG0600|consen 196 VFEYM-DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP- 270 (560)
T ss_pred EEecc-cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC-
Confidence 99999 569999887644 5999999999999999999999999 99999999999999999999999999998743
Q ss_pred ccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCC--CC---
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPP--FR--- 376 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~--~~--- 376 (456)
.....++..+.|..|.|||++.+. .|+++.|+||.||||.||++|++.|.+.+..+....|.+.+ .|. ++
T Consensus 271 ---~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 271 ---SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred ---CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 233346667789999999999886 79999999999999999999999999988776665554433 111 00
Q ss_pred -------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 377 -------------------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 377 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.....++....+|+..+|..||++|.|+.+.++.
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0125677788999999999999999999998875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=335.00 Aligned_cols=246 Identities=25% Similarity=0.402 Sum_probs=208.6
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCC-ceEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQST-PMMIV 225 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~-~~~lv 225 (456)
+|...++||.|+||-| ..+|+.||||.+++.....++ ..=.+|+..|++++ ||||+++.+++.+.+ .+|+|
T Consensus 11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee--~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE--CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH--HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 6888999999999966 457889999999987654332 23368999999998 999999999999887 99999
Q ss_pred EEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 226 TEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
|||+ ..+|+++++.+. .+++..+..|+.||++||.|+|.+| +.|||+||+|||+..+..+||+|||+|+.+
T Consensus 89 fE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev---- 160 (538)
T KOG0661|consen 89 FEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV---- 160 (538)
T ss_pred HHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc----
Confidence 9999 679999998864 4999999999999999999999999 999999999999998889999999999976
Q ss_pred cccCCCCcccCCCCccccccccc-CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCC------
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVY-KNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFR------ 376 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~------ 376 (456)
....+++.++.|..|+|||++ +.+.|+.+.|+|++|||++|+.+-++.|++.+..+...+|.... .|...
T Consensus 161 --~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 161 --RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred --ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 344567778899999999986 45679999999999999999999999999987665554443321 22111
Q ss_pred -------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 377 -------------------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 377 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
....+.+.++.++|.+|+..||++|||+++.+++
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0124578889999999999999999999999987
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=333.23 Aligned_cols=247 Identities=28% Similarity=0.463 Sum_probs=220.3
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc-eEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP-MMIV 225 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~-~~lv 225 (456)
.+|...+.+|+|.||.+ +.++..|++|.+....... .......+|+.++++++|||||.+++.|..++. ++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~-~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE-PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc-hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 35788899999999954 5678899999998876444 445588999999999999999999999999888 9999
Q ss_pred EEccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 226 TEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
|+||+||+|.+.+.+.. .++++.++.|+.|++.|+.|||+.. |+|||||+.||+++.++.|+|+|||+|+.+..
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~- 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP- 158 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC-
Confidence 99999999999997644 4999999999999999999999998 99999999999999999999999999998742
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
.........|||.|++||.+.+.+|+.++|||||||++|||++-+++|...+...+..++......+. +..++
T Consensus 159 ----~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl---p~~ys 231 (426)
T KOG0589|consen 159 ----EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL---PSMYS 231 (426)
T ss_pred ----chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC---Ccccc
Confidence 22244567899999999999999999999999999999999999999999998888888866653443 68999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+++.+|..|+..+|..||++.+++.+
T Consensus 232 ~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 232 SELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 999999999999999999999999998
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=308.29 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=217.5
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|++.+.||+|.|..| .-+|+.+|+|++....+... ..+.+.+|+++-+.++||||+++++.+.+....|+|+|
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 5777789999999865 56899999999987665443 55788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---CCCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD---SGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~---~~~vkl~Dfgls~~~~~~~ 304 (456)
+++|++|..-+.++-.+++..+..+++||++||.|||.++ |||||+||.|+++-+ ..-+||+|||++..+.
T Consensus 91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--- 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--- 164 (355)
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC---
Confidence 9999999877766667999999999999999999999999 999999999999863 3359999999999874
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.........|||.|||||+++..+|+..+|||+-|++||-|+.|++||.+.+...++.+|+.+...--...+.++++
T Consensus 165 ---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~ 241 (355)
T KOG0033|consen 165 ---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTP 241 (355)
T ss_pred ---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCH
Confidence 22344567899999999999999999999999999999999999999999999999999977653222224689999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.++|+.+||..||.+|.|+.|.|+|
T Consensus 242 ~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 242 EAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHHHHHHHhccChhhhccHHHHhCC
Confidence 99999999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=330.91 Aligned_cols=256 Identities=29% Similarity=0.482 Sum_probs=205.3
Q ss_pred cccccceeeeccEEEEEe----------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC-
Q 012777 152 LDFSNSVEITKGTFRIAS----------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQS- 219 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~----------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~- 219 (456)
.+|.+.+.||+|+||.|. .+++.||+|++... ........+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG--ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc--cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 357888999999999762 23467999999754 2344457789999999999 899999999988764
Q ss_pred CceEEEEEccCCCCHHHHHHHc----------------------------------------------------------
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQK---------------------------------------------------------- 241 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~---------------------------------------------------------- 241 (456)
..++++|||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4689999999999999998753
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCC
Q 012777 242 ----GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEET 317 (456)
Q Consensus 242 ----~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~g 317 (456)
.++++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......... .......+
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~ 238 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---VRKGSARL 238 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcch---hcccCCCC
Confidence 23677888999999999999999999 999999999999999999999999998765221110 11122345
Q ss_pred CcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhccc
Q 012777 318 SWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSE 396 (456)
Q Consensus 318 t~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 396 (456)
++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+............ ..+..++.++.+++.+||..
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~ 316 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM--RAPENATPEIYRIMLACWQG 316 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHccC
Confidence 678999999998899999999999999999997 999998766544333332222111 12457788999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHH
Q 012777 397 EPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 397 dp~~Rpt~~ell~~L~~~~~~ 417 (456)
||++|||+.++++.|+.+..+
T Consensus 317 dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 317 DPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred ChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=328.62 Aligned_cols=243 Identities=25% Similarity=0.421 Sum_probs=208.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.+ ..+|+.||+|++...........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5778899999999866 23588999999975433333455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~----- 153 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----- 153 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC-----
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999876521
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.... ..+ +..++..+.
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~---~~~~~~~~~ 226 (291)
T cd05612 154 ---RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEF---PRHLDLYAK 226 (291)
T ss_pred ---CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCC---CccCCHHHH
Confidence 1122458889999999999889999999999999999999999998877766666654332 222 456788999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPT-----FRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt-----~~ell~~ 410 (456)
++|.+||..||.+||+ +++++++
T Consensus 227 ~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 227 DLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 9999999999999995 8888877
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=333.33 Aligned_cols=241 Identities=24% Similarity=0.379 Sum_probs=205.8
Q ss_pred eeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCC
Q 012777 158 VEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232 (456)
Q Consensus 158 ~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~ 232 (456)
+.||+|+||.| ..+|+.||+|++.............+.+|+.++++++||||+++++++...+.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36899999876 2468899999998654444555677889999999999999999999999999999999999999
Q ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCc
Q 012777 233 DLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312 (456)
Q Consensus 233 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~ 312 (456)
+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-----~~~~~ 152 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-----DGATM 152 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc-----CCCcc
Confidence 99999988888999999999999999999999999 99999999999999999999999999875321 11122
Q ss_pred ccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q 012777 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIED 392 (456)
Q Consensus 313 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 392 (456)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+... ... .+..++.++.++|.+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-~~~---~p~~~~~~~~~li~~ 228 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIR---FPRTLSPEAKSLLAG 228 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-CCC---CCCCCCHHHHHHHHH
Confidence 3356899999999999999999999999999999999999999887665555544322 222 246788999999999
Q ss_pred hcccCCCCCC-----CHHHHHHH
Q 012777 393 CWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 393 ~l~~dp~~Rp-----t~~ell~~ 410 (456)
||..||++|| ++++++++
T Consensus 229 ~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 229 LLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HccCCHHHcCCCCCCCHHHHHcC
Confidence 9999999999 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=324.00 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=204.3
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
|+..+.||+|+||.| ..+|+.||+|.+.............+.+|+.++++++|++|+++++++...+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667789999999976 346899999998765433333445678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 229 LPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 229 ~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 155 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--- 155 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---
Confidence 9999999888653 35899999999999999999999999 999999999999999999999999998765211
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...........+..++..+
T Consensus 156 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 232 (285)
T cd05631 156 ---ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDA 232 (285)
T ss_pred ---CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHH
Confidence 11223468899999999999999999999999999999999999998766543333332222222222356788999
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPT-----FRQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt-----~~ell~~ 410 (456)
.+||.+||..||++||+ +++++++
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 233 KSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 99999999999999997 7888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=333.91 Aligned_cols=243 Identities=25% Similarity=0.421 Sum_probs=209.3
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.+ ..+|+.||+|++...........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 6888899999999866 23688999999976543344456778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---- 171 (329)
T PTZ00263 99 FVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---- 171 (329)
T ss_pred CCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC----
Confidence 9999999999998888999999999999999999999999 999999999999999999999999998765211
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+... ...+ +..++..+.
T Consensus 172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~~---p~~~~~~~~ 243 (329)
T PTZ00263 172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG-RLKF---PNWFDGRAR 243 (329)
T ss_pred ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-CcCC---CCCCCHHHH
Confidence 12346889999999999999999999999999999999999999887766666555332 2222 355788899
Q ss_pred HHHHHhcccCCCCCCC-----HHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPT-----FRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt-----~~ell~~ 410 (456)
++|.+||+.||.+||+ ++++++|
T Consensus 244 ~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 244 DLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999996 6888876
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=302.66 Aligned_cols=246 Identities=25% Similarity=0.412 Sum_probs=219.6
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|.||.| +.++-.||+|++.++.+.......++.+|+++.+.++||||+++|++|.+....|+++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 6889999999999976 45788999999988776666667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLK--QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|.++|+|+..++ ....+++..+..++.|++.||.|||.++ |+||||||+|+|++..+.+|++|||-+...+
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---- 175 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 175 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC----
Confidence 999999999998 4456999999999999999999999999 9999999999999999999999999887542
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.......+||.-|.|||...+...+..+|+|++|++.||++.|.+||......+.+..|.... ..+ +..++.+
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~-~~~---p~~is~~ 248 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD-LKF---PSTISGG 248 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc-ccC---CcccChh
Confidence 233445679999999999999999999999999999999999999999988778887774433 222 4789999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
.+++|.+|+.++|.+|.+..|++.+-.
T Consensus 249 a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 249 AADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred HHHHHHHHhccCccccccHHHHhhhHH
Confidence 999999999999999999999988743
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=327.07 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=205.6
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCC-----------HHHHHHHHHHHHHHhcCCCCcceeeeeEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTD-----------EDKVKAFIDELALLQKIRHPNVVQFLGAV 216 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 216 (456)
+|+..+.||+|.||.|+ .+++.||||++.+..... ....+...+|+.+|+++.|||||+|+.+.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 68899999999999884 368899999997643211 11235788999999999999999999998
Q ss_pred EeC--CceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEecc
Q 012777 217 TQS--TPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294 (456)
Q Consensus 217 ~~~--~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Df 294 (456)
.+. +.+|||+|||..|.+...=-.+..+++.+++.++++++.||+|||.+| ||||||||+|+|++++|.|||+||
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred cCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeecc
Confidence 654 679999999998877543222223999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccccccCCCCcccCCCCcccccccccCCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc
Q 012777 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEE----YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN 370 (456)
Q Consensus 295 gls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 370 (456)
|.+.....+.............|||.|+|||....+. .+.+.||||+|++||.|+.|+.||-+....++..+|+..
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~ 334 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND 334 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence 9998663332222222233468999999999987642 335789999999999999999999998888888888543
Q ss_pred CCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 371 ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
...++. .+.+...++++|.+||.+||+.|.+..+|..|..
T Consensus 335 -pL~fP~-~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 335 -PLEFPE-NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred -cccCCC-cccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 223322 2346778999999999999999999999877654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=317.87 Aligned_cols=253 Identities=24% Similarity=0.374 Sum_probs=216.3
Q ss_pred ccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|...+.||.|..|.| . .++..+|+|++.++.....+...+...|.++|+.+.||.++.||..|+.+...|++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 5788889999998876 2 3458999999999887777888889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
||+||+|..+++++. .+++..++.++.+++-||+|||..| ||+|||||+||||.++|.|.|.||.|+........
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999998754 3999999999999999999999999 99999999999999999999999999775522100
Q ss_pred cc------------------------------C---------------------CCCcccCCCCcccccccccCCCCCCC
Q 012777 306 VK------------------------------E---------------------DRPVTCEETSWRYAAPEVYKNEEYDT 334 (456)
Q Consensus 306 ~~------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 334 (456)
.. . ......++||-.|+|||++++...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 00 0 01112367999999999999999999
Q ss_pred chhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 012777 335 KVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPT----FRQILMR 410 (456)
Q Consensus 335 ~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt----~~ell~~ 410 (456)
++|+|+||+++|||+.|..||.+.+..+....+.. ..+.++.. ...+..+++||+++|.+||.+|.. ++||-+|
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~-~~l~Fp~~-~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG-QPLKFPEE-PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc-CCCcCCCC-CcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 99999999999999999999999999998888843 33444332 367789999999999999999998 7776554
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=334.51 Aligned_cols=254 Identities=34% Similarity=0.529 Sum_probs=213.0
Q ss_pred CCccccCccccccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe
Q 012777 142 VPEYEIDPKELDFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ 218 (456)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 218 (456)
...|+|..++ ....+.||+|.-|.| ...++.||||+++.- -..++..|++|+||||+.+.++|..
T Consensus 116 ~e~WeiPFe~--IsELeWlGSGaQGAVF~Grl~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 116 EELWEIPFEE--ISELEWLGSGAQGAVFLGRLHNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred hhhccCCHHH--hhhhhhhccCcccceeeeeccCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecC
Confidence 3445555444 234457999988865 678999999987532 1357889999999999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 219 STPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 219 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
.-.+|||||||..|-|..+|+...++.......|..+|+.+++|||.++ |||||||.-||||+.+..|||+|||-++
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred CceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchH
Confidence 9999999999999999999999999999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCC
Q 012777 299 LLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAP 378 (456)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 378 (456)
... .......+.||..|||||++++.+++.|+||||||||||||+||..||.+.+..-++.-+-.+ ...+ .-
T Consensus 261 e~~------~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsN-sL~L-pv 332 (904)
T KOG4721|consen 261 ELS------DKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSN-SLHL-PV 332 (904)
T ss_pred hhh------hhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCC-cccc-cC
Confidence 763 224455678999999999999999999999999999999999999999887754433222000 1111 12
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 379 TTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 379 ~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
+..+|+.|.-||++||+..|..||++.+++.||+-+.-.+
T Consensus 333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 5788999999999999999999999999999998765443
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=330.41 Aligned_cols=247 Identities=28% Similarity=0.430 Sum_probs=210.7
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.+ ..+++.||+|++.............+.+|+.+++.++||||+++++++......++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5788899999999866 23588999999976543334456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 9999999999988888999999999999999999999999 99999999999999999999999999875521
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC----CCCCCCCCCCCc
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE----RPPFRAPTTHYA 383 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 383 (456)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.... .+........++
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s 230 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS 230 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccC
Confidence 2233568899999999999999999999999999999999999998877766655543221 111111123668
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++.++|.+||..+|++||++++++++
T Consensus 231 ~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 231 DEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 899999999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=327.63 Aligned_cols=241 Identities=24% Similarity=0.384 Sum_probs=205.5
Q ss_pred eeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCC
Q 012777 158 VEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232 (456)
Q Consensus 158 ~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~ 232 (456)
+.||+|+||.| ..+|..||+|++.............+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36899999976 2468899999998654444555677889999999999999999999999999999999999999
Q ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCc
Q 012777 233 DLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312 (456)
Q Consensus 233 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~ 312 (456)
+|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~-----~~~~~ 152 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-----DGATM 152 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccC-----CCCcc
Confidence 99999988888999999999999999999999999 99999999999999999999999998774311 11122
Q ss_pred ccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q 012777 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIED 392 (456)
Q Consensus 313 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 392 (456)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.... .. .+..+++++.++|.+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-~~---~p~~~~~~~~~li~~ 228 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IR---FPRTLSPEAKSLLAG 228 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CC---CCCCCCHHHHHHHHH
Confidence 23568899999999999999999999999999999999999998877666555553222 12 245788999999999
Q ss_pred hcccCCCCCC-----CHHHHHHH
Q 012777 393 CWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 393 ~l~~dp~~Rp-----t~~ell~~ 410 (456)
||..||++|| ++.+++++
T Consensus 229 ~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 229 LLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HccCCHHHhCCCCCCCHHHHHcC
Confidence 9999999998 89998876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=298.86 Aligned_cols=248 Identities=26% Similarity=0.485 Sum_probs=205.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||+|.||.| ..+|+.||||+++..... +.......+|+..|+.++|+||+.++++|.....+.+|+|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 5777889999999976 458999999999875432 2223567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|++ .+|..+++... .++...+..++.++++||.|||++. |+||||||.|+|++++|.+||+|||+++.+......
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 994 69999998654 4999999999999999999999999 999999999999999999999999999987543222
Q ss_pred cCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CC-----------
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RP----------- 373 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~----------- 373 (456)
....+.|..|+|||.+.+. .|+...|+||.||++.||+.|.+-|.+.+.-+....+.... .|
T Consensus 158 -----~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 158 -----QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred -----cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 2223567789999988765 79999999999999999999999998877655444443221 11
Q ss_pred ------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 ------------PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 ------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+........+++..+|+.+|+..||.+|++++|.+++
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111234566778999999999999999999999987
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=303.76 Aligned_cols=248 Identities=24% Similarity=0.419 Sum_probs=213.0
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCC-----CCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCce
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVF-----TDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~-----~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 222 (456)
|.-.+.||.|..+.+ +.+|..+|+|++..... ......+.-.+|+.+|+++ .||+|+++.++|+.+..+
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 555567898887644 56899999999863221 1223345567899999998 699999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
++|+|.++.|.|.|++...-.++++....|++|++++++|||.++ ||||||||+|||++++.++||+|||+++.+..
T Consensus 99 FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCC
Confidence 999999999999999999888999999999999999999999999 99999999999999999999999999998843
Q ss_pred cccccCCCCcccCCCCcccccccccCC------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKN------EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFR 376 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 376 (456)
+ ......+|||+|+|||.+.. ..|+...|+|++|++||.|+.|++||......-+.+.|..+....-.
T Consensus 176 G------ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s 249 (411)
T KOG0599|consen 176 G------EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS 249 (411)
T ss_pred c------hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC
Confidence 3 23345689999999998854 35777899999999999999999999988877777877666654444
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 377 APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 377 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..+.+++...+++|.+||+.||.+|.|++|.|.|
T Consensus 250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 250 PEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 5578999999999999999999999999999987
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=329.92 Aligned_cols=292 Identities=27% Similarity=0.509 Sum_probs=242.7
Q ss_pred hhhhhhhhcCCCCCCCccccccccCCCccccCccccccccceeeeccEEEEE-----eEc-C---cEEEEEEeCCCCCCC
Q 012777 117 DVIKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTFRIA-----SWR-G---TQVAVKTLGEEVFTD 187 (456)
Q Consensus 117 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~~-----~~~-g---~~vAvK~~~~~~~~~ 187 (456)
+++.+.......+......+..+-..+.|++..+++.+. ++||+|.||.| ... + ..||+|..+.+....
T Consensus 124 ~li~~~~~~~~~~~~~~~~L~~PI~r~~Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~ 201 (474)
T KOG0194|consen 124 ELVNYYKFSKLEITGKNFFLKRPIPRQKWELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELT 201 (474)
T ss_pred HHHHHHHhcccceeccceeecccccccccEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeeccccccc
Confidence 344444444444444555566666667788888887777 89999999876 222 2 238999998755567
Q ss_pred HHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhC
Q 012777 188 EDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGA-LKPTLAVKFALDIARGMNYLHEN 266 (456)
Q Consensus 188 ~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~ql~~aL~~LH~~ 266 (456)
.+.+..+++|++++++++||||+++||+.....++++|||+|.||+|.++|++.+. ++..+...++.+.+.||+|||++
T Consensus 202 ~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k 281 (474)
T KOG0194|consen 202 KEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK 281 (474)
T ss_pred HHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC
Confidence 88899999999999999999999999999999999999999999999999999875 99999999999999999999999
Q ss_pred CCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHH
Q 012777 267 RPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQ 346 (456)
Q Consensus 267 ~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 346 (456)
+ ++||||-..|+|++.++.+||+|||+++..... . .......-+.+|+|||.+....++.++||||||+++|
T Consensus 282 ~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~---~--~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~ 353 (474)
T KOG0194|consen 282 N---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY---V--MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLW 353 (474)
T ss_pred C---CcchhHhHHHheecCCCeEEeCccccccCCcce---e--eccccccCcceecChhhhccCccccccchhheeeeEE
Confidence 9 999999999999999999999999998755210 0 0110113457899999999999999999999999999
Q ss_pred HHHc-CCCCCCCCCccchHHHHHhcC-CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccc
Q 012777 347 EMIE-GCPPFPTKQEKEVPKAYIANE-RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIK 421 (456)
Q Consensus 347 ~l~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~ 421 (456)
|+++ |..||.+....+....+.... +.+. +...|..+..++.+||..||++|||+.++.+.|+.+.......
T Consensus 354 Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~---~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 354 EIFENGAEPYPGMKNYEVKAKIVKNGYRMPI---PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred eeeccCCCCCCCCCHHHHHHHHHhcCccCCC---CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 9998 899999999998888885544 4443 4577888999999999999999999999999999999887653
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=327.13 Aligned_cols=241 Identities=24% Similarity=0.396 Sum_probs=205.4
Q ss_pred eeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCC
Q 012777 158 VEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232 (456)
Q Consensus 158 ~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~ 232 (456)
+.||+|+||.+ ..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999876 2468899999998665445556678899999999999999999999999999999999999999
Q ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCc
Q 012777 233 DLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312 (456)
Q Consensus 233 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~ 312 (456)
+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~-----~~~~~ 152 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT-----DAATM 152 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCC-----ccccc
Confidence 99999988788999999999999999999999999 99999999999999999999999999875321 11122
Q ss_pred ccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q 012777 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIED 392 (456)
Q Consensus 313 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 392 (456)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.. .... .+..++.++.++|.+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~-~~~~---~p~~~~~~~~~li~~ 228 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-EDIK---FPRTLSADAKSLLSG 228 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-CCcc---CCCCCCHHHHHHHHH
Confidence 235689999999999998999999999999999999999999987766555444422 2222 246788999999999
Q ss_pred hcccCCCCCC-----CHHHHHHH
Q 012777 393 CWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 393 ~l~~dp~~Rp-----t~~ell~~ 410 (456)
||..||++|| ++.+++++
T Consensus 229 ~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 229 LLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HcCCCHHHcCCCCCCCHHHHhcC
Confidence 9999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=328.28 Aligned_cols=244 Identities=21% Similarity=0.375 Sum_probs=208.7
Q ss_pred cccccceeeeccEEEEE---eE--c-CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 152 LDFSNSVEITKGTFRIA---SW--R-GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~~--~-g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
.+|.+.+.||+|+||.+ .. . +..||+|++...........+.+.+|+.+++.++||||+++++++.....+++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 36888899999999966 22 2 257999998765434445567788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|||+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~--- 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--- 183 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC---
Confidence 999999999999998888999999999999999999999999 99999999999999999999999999876521
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
......||+.|+|||++.+..++.++|+|||||++|+|++|..||...++......+.... .. .+..++..
T Consensus 184 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-~~---~p~~~~~~ 254 (340)
T PTZ00426 184 -----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-IY---FPKFLDNN 254 (340)
T ss_pred -----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CC---CCCCCCHH
Confidence 1123468899999999998889999999999999999999999998877665555553322 22 24567889
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rp-----t~~ell~~ 410 (456)
+.++|.+||+.||++|+ ++++++++
T Consensus 255 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 255 CKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 99999999999999995 89998876
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=330.50 Aligned_cols=264 Identities=28% Similarity=0.517 Sum_probs=216.7
Q ss_pred CccccCccccccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC
Q 012777 143 PEYEIDPKELDFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS 219 (456)
Q Consensus 143 ~~~~~~~~~~~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 219 (456)
.+++|.+++ +.....||+|+||+| .|-| .||||++..+.. .++..+.|++|+.+|++-+|.||+-+.|+|..+
T Consensus 385 ~~WeIp~~e--v~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEE--VLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHH--hhccceeccccccceeeccccc-ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 345555444 566679999999977 4455 699999998764 455889999999999999999999999999988
Q ss_pred CceEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
.. .||+.+|+|-+|+.++.-. ..+...+.+.|++|+++|+.|||.++ |||+|||..||++.+++.|||+|||++.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 76 9999999999999999653 34999999999999999999999999 9999999999999999999999999987
Q ss_pred cccccccccCCCCcccCCCCcccccccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCC
Q 012777 299 LLKFANTVKEDRPVTCEETSWRYAAPEVYKNE---EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPP 374 (456)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~ 374 (456)
.-..- ..........|...|||||+++.+ +|+..+||||||+|+|||++|..||.....+.++..+-.+. .+.
T Consensus 537 vk~~w---~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd 613 (678)
T KOG0193|consen 537 VKTRW---SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD 613 (678)
T ss_pred eeeee---ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc
Confidence 43211 112222334577789999999754 78899999999999999999999999655554444332221 344
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 375 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
......+.+.++.+|+..||..++++||.+.+|+..|+.+..+
T Consensus 614 ~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 614 LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 4445678888999999999999999999999999999988874
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=332.38 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=208.6
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|++.+.||+|+||.| ..+|+.||||++.............+.+|+.+++.++||||+++++++.....+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 5788899999999976 23688999999976433344455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++..+.......
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999999999988888999999999999999999999999 9999999999999999999999999987542211000
Q ss_pred CC---------------------------------CCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCC
Q 012777 308 ED---------------------------------RPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPP 354 (456)
Q Consensus 308 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p 354 (456)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 00 001123589999999999999999999999999999999999999
Q ss_pred CCCCCccchHHHHHhcCCCCCCC-CCCCCcHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 012777 355 FPTKQEKEVPKAYIANERPPFRA-PTTHYAYGLRELIEDCWSEEPFRRPT---FRQILMR 410 (456)
Q Consensus 355 f~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rpt---~~ell~~ 410 (456)
|...+..+....+.... ..+.. ....++.++.++|.+|+. +|.+|++ +++++++
T Consensus 239 f~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 239 FCSDNPQETYRKIINWK-ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCHHHHHHHHHcCC-CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 98887766555553322 22111 123578899999999996 9999998 9998886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=329.73 Aligned_cols=253 Identities=26% Similarity=0.388 Sum_probs=206.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||+|+||.| ..+++.||+|++.+...........+.+|+.++..++||+|+++++.+.+...+++|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 5788899999999976 23688999999976433344455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999999998888999999999999999999999999 9999999999999999999999999987542210000
Q ss_pred ------------------------------CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 012777 308 ------------------------------EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPT 357 (456)
Q Consensus 308 ------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 357 (456)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 00011234689999999999999999999999999999999999999998
Q ss_pred CCccchHHHHHhcC-CCCCCCCCCCCcHHHHHHHHHhcccCCC---CCCCHHHHHHH
Q 012777 358 KQEKEVPKAYIANE-RPPFRAPTTHYAYGLRELIEDCWSEEPF---RRPTFRQILMR 410 (456)
Q Consensus 358 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~---~Rpt~~ell~~ 410 (456)
.+..+....+.... ...++ ....++.++.++|.+++. +|+ .||++++++++
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 239 ETPQETYKKVMNWKETLIFP-PEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCHHHHHHHHHcCcCcccCC-CcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 87766666654322 12221 123578889999998765 444 45899999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=311.79 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=209.0
Q ss_pred cccccceeeeccEEEEE---e-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012777 152 LDFSNSVEITKGTFRIA---S-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM 223 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 223 (456)
.+|++.+.||+|+||.| . ..+..||+|.++... .......+.+|+.++++++||||+++++++......+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 35788889999999976 1 235689999998653 3444577899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 224 IVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++++|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999764 46899999999999999999999999 99999999999999999999999998764321
Q ss_pred cccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (456)
.. ........++..|+|||.+.+..++.++|||||||++|++++ |..||......+....+......+ .+..
T Consensus 160 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 232 (266)
T cd05064 160 EA----IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP---APRN 232 (266)
T ss_pred cc----hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCC
Confidence 11 011112234567999999999999999999999999999875 999998877766666554333322 2567
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
++..+.+++.+||+.+|++||+++++++.|..+
T Consensus 233 ~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 233 CPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 888999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=342.07 Aligned_cols=253 Identities=29% Similarity=0.511 Sum_probs=216.7
Q ss_pred ccccceeeeccEEEEEe----------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 153 DFSNSVEITKGTFRIAS----------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~----------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
+....+.||+|.||+|. .....||||.++.. .+.+...+|.+|++++..++|||||+|+|.|.+.+.+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 44555689999999872 34567999999876 4566789999999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC
Q 012777 223 MIVTEYLPKGDLRAYLKQK--------------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~--------------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~ 288 (456)
++|+||+..|+|.++|... ++++..+.+.|+.||+.|+.||-++. +|||||.+.|+||+++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 9999999999999999642 22788899999999999999999999 999999999999999999
Q ss_pred EEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHH
Q 012777 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAY 367 (456)
Q Consensus 289 vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~ 367 (456)
|||+|||+++..=... ..+......-+++|||||.|..++|+++|||||+||+|||+++ |..||.+....+.+..+
T Consensus 642 VKIsDfGLsRdiYssD---YYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSD---YYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred EEecccccchhhhhhh---hhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 9999999998541110 1111112234678999999999999999999999999999998 99999999999998888
Q ss_pred HhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 012777 368 IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416 (456)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~ 416 (456)
..+.- + ..+.++|.++.+|+..||+.+|++||+++||-..|+....
T Consensus 719 ~~g~l--L-~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 719 RAGQL--L-SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HcCCc--c-cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 55443 2 2368999999999999999999999999999999988754
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=324.20 Aligned_cols=239 Identities=25% Similarity=0.380 Sum_probs=201.7
Q ss_pred eeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012777 160 ITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234 (456)
Q Consensus 160 lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~sL 234 (456)
||+|+||.+ ..+++.||+|++.............+.+|+.++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 689999866 235789999999765434455567788999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCccc
Q 012777 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTC 314 (456)
Q Consensus 235 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~ 314 (456)
.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-----~~~~~~ 152 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-----DDKTNT 152 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC-----CCcccc
Confidence 999988888999999999999999999999999 999999999999999999999999998753211 111223
Q ss_pred CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhc
Q 012777 315 EETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCW 394 (456)
Q Consensus 315 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 394 (456)
..||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... ... .+..++.++.++|.+||
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~li~~~L 228 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-PLR---FPDGFDRDAKDLLIGLL 228 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CCC---CCCcCCHHHHHHHHHHc
Confidence 46889999999999999999999999999999999999999887766655555322 222 24678889999999999
Q ss_pred ccCCCCCCC---HHHHHHH
Q 012777 395 SEEPFRRPT---FRQILMR 410 (456)
Q Consensus 395 ~~dp~~Rpt---~~ell~~ 410 (456)
..||++||+ +.+++++
T Consensus 229 ~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 229 SRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCCHHHcCCCCCHHHHHcC
Confidence 999999975 5666655
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=320.87 Aligned_cols=247 Identities=26% Similarity=0.439 Sum_probs=205.1
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|++.+.||+|+||.+ ..+|..||+|++..+ ........+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 46888899999999966 236889999999764 24455678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||+++++|.+++.....+++..+..++.|++.||.|||+++ +|+||||||+|||++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 99999999999988888999999999999999999999853 2999999999999999999999999998755211
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHH------------------
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYI------------------ 368 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~------------------ 368 (456)
......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.
T Consensus 158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence 1223468889999999999899999999999999999999999997655433221110
Q ss_pred ----------------------------hcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 369 ----------------------------ANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 369 ----------------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
....+. .....++.++.+||.+||..||++|||+++++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPK--LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcC--CCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000111 11235788999999999999999999999999873
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=330.79 Aligned_cols=254 Identities=25% Similarity=0.353 Sum_probs=206.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|...+.||+|+||.| ..+++.||+|++.............+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 4778899999999976 23688999999976544455566789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc-
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV- 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~- 306 (456)
|+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 9999999999988888999999999999999999999999 999999999999999999999999997533110000
Q ss_pred -----------------------------------------cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHH
Q 012777 307 -----------------------------------------KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALIL 345 (456)
Q Consensus 307 -----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 345 (456)
..........||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 000001234689999999999988899999999999999
Q ss_pred HHHHcCCCCCCCCCccchHHHHHhcC-CCCCCCCCCCCcHHHHHHHHHhc--ccCCCCCCCHHHHHHH
Q 012777 346 QEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRAPTTHYAYGLRELIEDCW--SEEPFRRPTFRQILMR 410 (456)
Q Consensus 346 ~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l--~~dp~~Rpt~~ell~~ 410 (456)
|+|++|..||...+..+....+.... .... .....++.++.++|.+|+ ..+|..||++++++++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHI-PPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccCC-CCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999998877655554443222 1111 123467889999999955 4455569999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=319.08 Aligned_cols=243 Identities=26% Similarity=0.524 Sum_probs=212.3
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
|...+.||+|-|..| .++|+.||||++.+... +.-...++.+|++.|+.++|||||++|.+...+..+|+|+|+
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 667789999999876 47899999999998764 445567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe-CCCCCEEEeccCCcccccccccc
Q 012777 229 LPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR-DDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 229 ~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~-~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
-++|+|+||+.+.. -+.++.+.+++.||+.|+.|||... +|||||||+||++ ..-|.|||.|||++..+.
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~----- 170 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ----- 170 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC-----
Confidence 99999999998754 3999999999999999999999999 9999999999865 478999999999987663
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCC-chhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDT-KVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
+.......+|+..|-|||++.+..|+. ++||||||+|||.|++|++||...+..+..-.|.... + ..+.+++.+
T Consensus 171 -PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK---Y-tvPshvS~e 245 (864)
T KOG4717|consen 171 -PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK---Y-TVPSHVSKE 245 (864)
T ss_pred -CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc---c-cCchhhhHH
Confidence 333445567999999999999999985 7999999999999999999999988887766663221 1 236789999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++||..||..||++|.+.++|...
T Consensus 246 CrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 246 CRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHHHHHHHHhcCchhhccHHHHhcc
Confidence 9999999999999999999998765
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=323.32 Aligned_cols=249 Identities=27% Similarity=0.428 Sum_probs=221.4
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv 225 (456)
..|...+.||+|.||.+ ..+|+.+|+|++.+...........+.+|+.+|++++ ||||+.++++|+....+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 35777789999999976 3469999999999877665556678999999999997 99999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC----CCEEEeccCCccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS----GHLKVADFGLSKLLK 301 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~----~~vkl~Dfgls~~~~ 301 (456)
||+|.||.|.+.+.+. .+++..+..++.|++.++.|||+.| |+||||||+|+|+... +.+|++|||++....
T Consensus 115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999876 4999999999999999999999999 9999999999999733 479999999999873
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (456)
. ........||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+.......+...........+..
T Consensus 191 ~------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~ 264 (382)
T KOG0032|consen 191 P------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDD 264 (382)
T ss_pred C------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccc
Confidence 2 3345567899999999999999999999999999999999999999999998887777766554333455788
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++..+.++|..|+..||.+|+|+.++++|
T Consensus 265 is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 265 ISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred cCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 89999999999999999999999999997
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=310.19 Aligned_cols=256 Identities=29% Similarity=0.442 Sum_probs=211.6
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe-----CCceE
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ-----STPMM 223 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-----~~~~~ 223 (456)
|...+.||+|.||.| ..+|+.||||++... +.+.-..+...+|+.+|+.++|+||+.+++.+.- -+.+|
T Consensus 24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred ecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 444678999999976 457899999999754 3566677889999999999999999999999865 35699
Q ss_pred EEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
+|+|++ +-+|.+.++.+..+++..+..++.|++.||+|+|+.+ |+|||+||.|++++.+..+||+|||+|+.....
T Consensus 103 iV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 103 LVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred EehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecccc
Confidence 999999 6799999998878999999999999999999999999 999999999999999999999999999977432
Q ss_pred ccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-----------
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE----------- 371 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----------- 371 (456)
......+.++.|..|.|||++.. ..|+.+.||||+||++.||++|++.|.+.+..+-...+....
T Consensus 179 ---~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 179 ---FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred ---CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 33445577888999999998644 589999999999999999999999998876544332221111
Q ss_pred ----------------CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 012777 372 ----------------RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLS 419 (456)
Q Consensus 372 ----------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~ 419 (456)
+.++....++.++...+|+++||..||.+|+|++|.+.| .++..+.
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h--PYl~~~h 317 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH--PYLAPYH 317 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC--hhhhhhc
Confidence 112222246888899999999999999999999999987 4444443
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=331.41 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=206.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.| ..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 5778899999999976 34788999999876433344556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc--
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT-- 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~-- 305 (456)
|+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999999988888999999999999999999999999 99999999999999999999999999863311000
Q ss_pred ----------ccCC------------------------------CCcccCCCCcccccccccCCCCCCCchhHHHHHHHH
Q 012777 306 ----------VKED------------------------------RPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALIL 345 (456)
Q Consensus 306 ----------~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 345 (456)
.... .......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 0000 000124589999999999998999999999999999
Q ss_pred HHHHcCCCCCCCCCccchHHHHHhcCCCCCCC-CCCCCcHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 012777 346 QEMIEGCPPFPTKQEKEVPKAYIANERPPFRA-PTTHYAYGLRELIEDCWSEEPFRR---PTFRQILMR 410 (456)
Q Consensus 346 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~R---pt~~ell~~ 410 (456)
|+|++|.+||...+..+....+.... ..... ....++.++.++|.+||. +|.+| +++.+++++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWR-ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccC-CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999998877666555553221 11111 123578899999999997 77765 599999887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=325.54 Aligned_cols=241 Identities=25% Similarity=0.385 Sum_probs=204.3
Q ss_pred eeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCC
Q 012777 158 VEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232 (456)
Q Consensus 158 ~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~ 232 (456)
+.||+|+||.|. .+|..||+|++.............+.+|+.+++.++||||+++++++.....+++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 368999999762 468899999998654444555677889999999999999999999999999999999999999
Q ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCC
Q 012777 233 DLRAYLKQKGALKPTLAVKFALDIARGMNYLHE-NRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311 (456)
Q Consensus 233 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~ 311 (456)
+|.+++...+.+++..+..++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~-----~~~~ 152 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-----DGAT 152 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCC-----CCcc
Confidence 999999887889999999999999999999997 78 99999999999999999999999999874321 1112
Q ss_pred cccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q 012777 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIE 391 (456)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 391 (456)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. .... .+..++.++.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-~~~~---~p~~~~~~~~~li~ 228 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-EEIR---FPRTLSPEAKSLLS 228 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc-CCCC---CCCCCCHHHHHHHH
Confidence 2234689999999999998999999999999999999999999988766555544422 2222 24568899999999
Q ss_pred HhcccCCCCCC-----CHHHHHHH
Q 012777 392 DCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 392 ~~l~~dp~~Rp-----t~~ell~~ 410 (456)
+||+.||++|+ ++.+++++
T Consensus 229 ~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 229 GLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHhhcCHHHhCCCCCCCHHHHhcC
Confidence 99999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=328.73 Aligned_cols=253 Identities=27% Similarity=0.412 Sum_probs=210.5
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.+ ..+|+.||+|++.............+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 5788899999999876 23589999999976543333456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc--
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT-- 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~-- 305 (456)
|+++++|.+++.+.+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 9999999999988888999999999999999999999999 99999999999999999999999999886533210
Q ss_pred ----------------------ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccch
Q 012777 306 ----------------------VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV 363 (456)
Q Consensus 306 ----------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 363 (456)
...........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 0001122335689999999999999999999999999999999999999988876665
Q ss_pred HHHHHhcC-CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 012777 364 PKAYIANE-RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPT-FRQILMR 410 (456)
Q Consensus 364 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-~~ell~~ 410 (456)
...+.... ...++ ....++.++.++|.+||. ||.+||+ +++++++
T Consensus 239 ~~~i~~~~~~~~~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 239 YNKIINWKESLRFP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHhccCCcccCC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 55554311 11111 123478999999999997 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=322.69 Aligned_cols=266 Identities=33% Similarity=0.522 Sum_probs=210.8
Q ss_pred CCCccccCccccccccceeeeccEEEEEe----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEE
Q 012777 141 EVPEYEIDPKELDFSNSVEITKGTFRIAS----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV 216 (456)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~lg~G~fg~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 216 (456)
..+..++...+.+|.....||+|+||.+. .+|..||||.+....... ...|.+|+.++.+++|||+++|+|+|
T Consensus 64 ~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 64 SFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred eeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34555677777899999999999998763 345899999887653221 34599999999999999999999999
Q ss_pred EeCC-ceEEEEEccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEec
Q 012777 217 TQST-PMMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293 (456)
Q Consensus 217 ~~~~-~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~D 293 (456)
.+.+ ..+||+||+++|+|.+++.... ++++..+.+|+.+++.||.|||+...++||||||||+|||+|++..+||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 4999999999999999998754 799999999999999999999998877899999999999999999999999
Q ss_pred cCCcccccccccccCCCCcccC-CCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc---cchHHH---
Q 012777 294 FGLSKLLKFANTVKEDRPVTCE-ETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE---KEVPKA--- 366 (456)
Q Consensus 294 fgls~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~--- 366 (456)
||+++..+.. ....... .||.+|++||++..+..+.++||||||++|.||++|+.|.+...+ ......
T Consensus 221 FGLa~~~~~~-----~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 221 FGLAKLGPEG-----DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred ccCcccCCcc-----ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 9999655210 1111112 789999999999999999999999999999999999988875431 112221
Q ss_pred HHhcC------CCCCCCCCCCCc--H---HHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 012777 367 YIANE------RPPFRAPTTHYA--Y---GLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416 (456)
Q Consensus 367 ~~~~~------~~~~~~~~~~~~--~---~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~ 416 (456)
..... .+.+. ...++ . .+..+..+|++.+|++||++.++++.|+.+..
T Consensus 296 ~~~~~~~~eiiD~~l~--~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLK--EGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHCcchhheeCCCcc--CCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 11111 11111 02333 2 25677889999999999999999888855543
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=322.41 Aligned_cols=241 Identities=26% Similarity=0.407 Sum_probs=202.5
Q ss_pred eeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 158 VEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 158 ~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
+.||+|+||.| ..+++.||+|++.+.....+.....+..|..+++.+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999876 235889999999765433444566778898888876 699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCC
Q 012777 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311 (456)
Q Consensus 232 ~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~ 311 (456)
++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-----~~~ 152 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-----GKT 152 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-----CCc
Confidence 999999988888999999999999999999999999 999999999999999999999999998753211 112
Q ss_pred cccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q 012777 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIE 391 (456)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 391 (456)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... ... .+..++.++.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~-~~~---~~~~~~~~~~~li~ 228 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-EVV---YPTWLSQDAVDILK 228 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-CCC---CCCCCCHHHHHHHH
Confidence 22356899999999999989999999999999999999999999988776666665332 222 24568889999999
Q ss_pred HhcccCCCCCCCH------HHHHHH
Q 012777 392 DCWSEEPFRRPTF------RQILMR 410 (456)
Q Consensus 392 ~~l~~dp~~Rpt~------~ell~~ 410 (456)
+||..||++||++ ++++++
T Consensus 229 ~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 229 AFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHcccCHHHCCCCCCCCCHHHHHcC
Confidence 9999999999998 666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=325.31 Aligned_cols=253 Identities=27% Similarity=0.448 Sum_probs=205.9
Q ss_pred cccccceeeeccEEEEEeE----------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCC
Q 012777 152 LDFSNSVEITKGTFRIASW----------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQST 220 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~~----------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~ 220 (456)
.+|.+.+.||+|+||.|.. ++..||+|++.... ..+....+.+|+.+++.+ +||||+++++++....
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3688889999999997621 23479999997653 344567789999999999 8999999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHcC----------------------------------------------------------
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKG---------------------------------------------------------- 242 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~---------------------------------------------------------- 242 (456)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999986421
Q ss_pred ------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCC
Q 012777 243 ------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR 310 (456)
Q Consensus 243 ------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~ 310 (456)
++++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~---~~ 269 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN---YV 269 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc---ee
Confidence 3677889999999999999999999 99999999999999999999999999876532111 11
Q ss_pred CcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcC-CCCCCCCCCCCcHHHHH
Q 012777 311 PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANE-RPPFRAPTTHYAYGLRE 388 (456)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~ 388 (456)
......+++.|+|||++.+..++.++|||||||++|+|++ |+.||................ .+. .+..++.++.+
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~ 346 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS---RPDFAPPEIYS 346 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc---CCCCCCHHHHH
Confidence 1122335567999999988899999999999999999997 999998766544433333332 222 23456889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 389 LIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 389 li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
++.+||+.||++|||+.++++.|++++
T Consensus 347 li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 347 IMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=329.53 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=206.5
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|...+.||+|+||.| ..+++.||+|++.+...........+.+|+.++++++||+|+++++++.....+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 4788899999999976 23688999999976543344556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc-
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV- 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~- 306 (456)
|+++++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999999988788999999999999999999999999 999999999999999999999999997532110000
Q ss_pred -----------------------------------------cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHH
Q 012777 307 -----------------------------------------KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALIL 345 (456)
Q Consensus 307 -----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 345 (456)
..........||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 000011224689999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 012777 346 QEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPT---FRQILMR 410 (456)
Q Consensus 346 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt---~~ell~~ 410 (456)
|+|++|++||...++.+....+..............+++++.++|.+|+ .+|.+|++ ++++++|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 9999999999887766555555332211111123567889999999976 69999987 8888775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=320.50 Aligned_cols=246 Identities=28% Similarity=0.428 Sum_probs=205.9
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCC-CcceeeeeEEEeCCceEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRH-PNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~~~~~~~~lv~ 226 (456)
+|.+.+.||+|+||.+ ..+++.||+|++.+.........+.+..|..++..+.| ++|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999976 23567899999986544344556778899999999965 56888999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~---- 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF---- 153 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC----
Confidence 99999999999988888999999999999999999999999 99999999999999999999999999864311
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
.........||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+.. .... .+..++.++
T Consensus 154 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~-~~~~---~~~~~~~~~ 228 (324)
T cd05587 154 -GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME-HNVS---YPKSLSKEA 228 (324)
T ss_pred -CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCC---CCCCCCHHH
Confidence 11122234688999999999999999999999999999999999999988777666665533 2222 246788899
Q ss_pred HHHHHHhcccCCCCCCCH-----HHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTF-----RQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~-----~ell~~ 410 (456)
.+++.+||..||.+|++. ++++++
T Consensus 229 ~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 229 VSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 999999999999999976 566654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=320.20 Aligned_cols=240 Identities=28% Similarity=0.459 Sum_probs=199.8
Q ss_pred eeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 158 VEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 158 ~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
+.||+|+||.| ..+++.||+|+++......+...+.+..|..++... +||||+++++++.....+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999976 235778999999865433344455667777777655 899999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCC
Q 012777 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311 (456)
Q Consensus 232 ~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~ 311 (456)
++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~-----~~~ 152 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG-----EGK 152 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCC-----CCc
Confidence 999999988888999999999999999999999999 999999999999999999999999998754211 112
Q ss_pred cccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q 012777 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIE 391 (456)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 391 (456)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. ...+. .+..++.++.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~-~~~~~---~~~~~~~~~~~ll~ 228 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL-NDRPH---FPRWISKEAKDCLS 228 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCC---CCCCCCHHHHHHHH
Confidence 233468999999999999899999999999999999999999999877666655553 22332 24668889999999
Q ss_pred HhcccCCCCCCCHH-HHHH
Q 012777 392 DCWSEEPFRRPTFR-QILM 409 (456)
Q Consensus 392 ~~l~~dp~~Rpt~~-ell~ 409 (456)
+||..||++||++. ++++
T Consensus 229 ~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 229 KLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHccCCHHHcCCChHHHHc
Confidence 99999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=323.43 Aligned_cols=251 Identities=29% Similarity=0.483 Sum_probs=203.6
Q ss_pred ccccceeeeccEEEEEe----------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCc
Q 012777 153 DFSNSVEITKGTFRIAS----------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~----------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~ 221 (456)
+|+..+.||+|+||.|. .++..||||+++... .....+.+.+|+.+++.+ +||||+++++++.....
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 58888999999999772 135589999997543 233456789999999999 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC-----------------------------------------------------------
Q 012777 222 MMIVTEYLPKGDLRAYLKQKG----------------------------------------------------------- 242 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~----------------------------------------------------------- 242 (456)
.++||||+++|+|.+++.+..
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986432
Q ss_pred ----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 243 ----------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 243 ----------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 3677889999999999999999999 999999999999999999999999998865322111
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcC-CCCCCCCCCCCcH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANE-RPPFRAPTTHYAY 384 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 384 (456)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||................ ++. .+...+.
T Consensus 271 ---~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 344 (375)
T cd05104 271 ---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML---SPECAPS 344 (375)
T ss_pred ---cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC---CCCCCCH
Confidence 11112334567999999999999999999999999999998 899998765443333332332 222 2345678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
++.++|.+||+.||++|||++++++.|+..
T Consensus 345 ~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 345 EMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=320.07 Aligned_cols=241 Identities=24% Similarity=0.386 Sum_probs=202.5
Q ss_pred eeeeccEEEEEe--------EcCcEEEEEEeCCCCC-CCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 158 VEITKGTFRIAS--------WRGTQVAVKTLGEEVF-TDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 158 ~~lg~G~fg~~~--------~~g~~vAvK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
+.||+|+||.+. .+++.||+|++..... ........+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 579999999762 2578999999875322 1223345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccC
Q 012777 229 LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKE 308 (456)
Q Consensus 229 ~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~ 308 (456)
+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----- 153 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE----- 153 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC-----
Confidence 999999999988888999999999999999999999999 999999999999999999999999998743211
Q ss_pred CCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHH
Q 012777 309 DRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRE 388 (456)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 388 (456)
........|++.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+... ... .+..++.++.+
T Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~ 229 (323)
T cd05584 154 GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-KLN---LPPYLTPEARD 229 (323)
T ss_pred CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCC---CCCCCCHHHHH
Confidence 11222346889999999999988999999999999999999999999887765555555332 222 24567889999
Q ss_pred HHHHhcccCCCCCC-----CHHHHHHH
Q 012777 389 LIEDCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 389 li~~~l~~dp~~Rp-----t~~ell~~ 410 (456)
+|.+||+.||++|| ++++++++
T Consensus 230 li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 230 LLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 99999999999999 89998875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=313.89 Aligned_cols=249 Identities=25% Similarity=0.369 Sum_probs=204.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|++.+.||+|+||.+ ..+++.||+|++.............+.+|+.+++.++||+|+++++.+.....+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3777889999999876 23688999999976543333444567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-- 155 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC--
Confidence 99999999888653 35999999999999999999999999 999999999999999999999999998765221
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.......|++.|+|||++.+..++.++||||+|+++|+|++|..||.+.........+...........+..++..
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd05605 156 ----ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEA 231 (285)
T ss_pred ----CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHH
Confidence 1112345788999999999888999999999999999999999999876554333332221111112234568899
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rp-----t~~ell~~ 410 (456)
+.++|.+||..||++|| ++++++++
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 232 ARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 99999999999999999 88898776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=321.44 Aligned_cols=248 Identities=21% Similarity=0.341 Sum_probs=202.1
Q ss_pred ccccceeeeccEEEEEe--------EcCcEEEEEEeCCCCC-CCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCce
Q 012777 153 DFSNSVEITKGTFRIAS--------WRGTQVAVKTLGEEVF-TDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~--------~~g~~vAvK~~~~~~~-~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 222 (456)
+|++.+.||+|+||.|. .++..||+|++.+... ......+.+..|+.+++.+ +||+|+++++++.....+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 47788999999999762 2578999999875322 2233456788899999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
++||||+++++|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999999999988888999999999999999999999999 99999999999999999999999999875422
Q ss_pred cccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHH---HhcCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAY---IANERPPFRAP 378 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~ 378 (456)
.. ........||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+ .....++ .
T Consensus 158 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~ 230 (332)
T cd05614 158 EE----KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP---F 230 (332)
T ss_pred cC----CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC---C
Confidence 11 1112234689999999998765 4788999999999999999999999754433222221 1222222 2
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 012777 379 TTHYAYGLRELIEDCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 379 ~~~~~~~l~~li~~~l~~dp~~Rp-----t~~ell~~ 410 (456)
+..++..+.++|.+||..||++|| ++++++++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 231 PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 456888999999999999999999 78888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=330.34 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=206.5
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|++.+.||+|+||.| ..+++.||+|++.+...........+.+|+.+++.++||||+++++.+...+.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5888899999999976 34688999999975433333445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc--
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT-- 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~-- 305 (456)
|+++++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 9999999999988888999999999999999999999999 99999999999999999999999999753210000
Q ss_pred ------------------------------------ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHH
Q 012777 306 ------------------------------------VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI 349 (456)
Q Consensus 306 ------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 349 (456)
...........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 00000112346899999999999999999999999999999999
Q ss_pred cCCCCCCCCCccchHHHHHhcCCCCCCC-CCCCCcHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 012777 350 EGCPPFPTKQEKEVPKAYIANERPPFRA-PTTHYAYGLRELIEDCWSEEPFRRP---TFRQILMR 410 (456)
Q Consensus 350 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rp---t~~ell~~ 410 (456)
+|+.||...+..+....+.... ..... ....++.++.++|.+|+ .+|.+|+ ++.+++++
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWE-TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccC-ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999998877665554443221 11111 23467889999999976 5999999 89999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=315.04 Aligned_cols=250 Identities=23% Similarity=0.359 Sum_probs=199.7
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.+ ..+++.||+|++..... .+...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4788899999999865 23578999999976532 33445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|++++.+..+......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 154 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS--- 154 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc---
Confidence 9988766655544556999999999999999999999999 9999999999999999999999999988653211
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-------------CCC
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-------------RPP 374 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------------~~~ 374 (456)
........+++.|+|||++.+..++.++|+|||||++|+|++|++||...+.......+.... .+.
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 -NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred -cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 111223457889999999998889999999999999999999999998765433222211100 000
Q ss_pred -----CC----------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 -----FR----------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 -----~~----------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+ .....++.++.+||.+||..||++|||++++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 0012467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=310.17 Aligned_cols=250 Identities=30% Similarity=0.510 Sum_probs=208.5
Q ss_pred ccccceeeeccEEEEEe---E-------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 153 DFSNSVEITKGTFRIAS---W-------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~---~-------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
+|++.+.||+|+||.+. . ....||+|.+... ........+.+|+.++++++||||+++++++......
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN--AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC--CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 57788899999998652 1 1257999998754 2445567789999999999999999999999998999
Q ss_pred EEEEEccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC
Q 012777 223 MIVTEYLPKGDLRAYLKQK----------------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~ 286 (456)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence 9999999999999999764 34788899999999999999999999 9999999999999999
Q ss_pred CCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHH
Q 012777 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPK 365 (456)
Q Consensus 287 ~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~ 365 (456)
+.++|+|||++........ ........+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+....+...
T Consensus 161 ~~~~L~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 161 LTVKISDFGLSRDIYSADY---YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred CcEEECCCcceeecccccc---ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999875422111 111122345678999999988899999999999999999998 999998877776666
Q ss_pred HHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 012777 366 AYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDD 413 (456)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~ 413 (456)
.+.....++ .+..++.++.+|+.+||+.||++||++++++++|+.
T Consensus 238 ~i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 MIRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 654333332 256789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=320.93 Aligned_cols=240 Identities=24% Similarity=0.384 Sum_probs=203.6
Q ss_pred eeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCCC
Q 012777 159 EITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKG 232 (456)
Q Consensus 159 ~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~e~~~~~ 232 (456)
.||+|+||.+ ..+++.||+|++.............+..|..++..+ +||+|+++++++...+.+++||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 6899999866 235789999999865444455567788899998876 7999999999999999999999999999
Q ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCc
Q 012777 233 DLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312 (456)
Q Consensus 233 sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~ 312 (456)
+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-----~~~~ 153 (321)
T cd05591 82 DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-----GVTT 153 (321)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC-----Cccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998754211 1122
Q ss_pred ccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q 012777 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIED 392 (456)
Q Consensus 313 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 392 (456)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.... .. .+..++.++.++|.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~-~~---~p~~~~~~~~~ll~~ 229 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD-VL---YPVWLSKEAVSILKA 229 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC---CCCCCCHHHHHHHHH
Confidence 33568899999999999899999999999999999999999999887766666654332 22 234578899999999
Q ss_pred hcccCCCCCC-------CHHHHHHH
Q 012777 393 CWSEEPFRRP-------TFRQILMR 410 (456)
Q Consensus 393 ~l~~dp~~Rp-------t~~ell~~ 410 (456)
||..||++|| ++++++++
T Consensus 230 ~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 230 FMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HhccCHHHcCCCCCCCCCHHHHhcC
Confidence 9999999999 78888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=323.97 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=207.4
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.+ ..+|+.||+|++.............+.+|+.+++.++||+|+++++++......++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 5788899999999976 24688999999986544344556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|+++++|.+++.+. +.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999999876 67999999999999999999999999 999999999999999999999999999865322111
Q ss_pred cCCCCcccCCCCcccccccccC------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC-CCCCCCC
Q 012777 307 KEDRPVTCEETSWRYAAPEVYK------NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER-PPFRAPT 379 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~ 379 (456)
......+|+.|+|||++. ...++.++|||||||++|+|++|..||...+.......+..... ..++ ..
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~ 233 (330)
T cd05601 159 ----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP-ED 233 (330)
T ss_pred ----eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCC-CC
Confidence 122346888999999986 45677899999999999999999999988776655555533321 1111 13
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 380 THYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..++.++.++|.+||. +|.+|||+++++++
T Consensus 234 ~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 234 PKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 4678899999999997 99999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=319.27 Aligned_cols=246 Identities=27% Similarity=0.410 Sum_probs=206.3
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
+|.+.+.||+|+||.| ..+++.||+|++.+...........+..|..++..+ .|++|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778889999999976 235779999999865443444556677888888887 5899999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~--- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--- 154 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC---
Confidence 99999999999988888999999999999999999999999 999999999999999999999999998753211
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
........||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+.... .. .+..++.++
T Consensus 155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~---~p~~~s~~~ 228 (323)
T cd05616 155 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VA---YPKSMSKEA 228 (323)
T ss_pred --CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CC---CCCcCCHHH
Confidence 112233568899999999999999999999999999999999999999887766666654322 22 245788999
Q ss_pred HHHHHHhcccCCCCCCCH-----HHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTF-----RQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~-----~ell~~ 410 (456)
.+++.+||+.||++|++. ++++++
T Consensus 229 ~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 229 VAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 999999999999999985 566544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=320.04 Aligned_cols=242 Identities=23% Similarity=0.376 Sum_probs=199.1
Q ss_pred eeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 158 VEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 158 ~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
+.||+|+||.| ..+++.||+|++++...........+..|..+++.+ +||||+++++++.....+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999876 236889999999876544555567788999999998 799999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCC
Q 012777 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311 (456)
Q Consensus 232 ~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~ 311 (456)
++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-----~~~~ 152 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-----PGDT 152 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc-----CCCc
Confidence 999999988888999999999999999999999999 99999999999999999999999999864311 1112
Q ss_pred cccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc--------chHHHHHhcCCCCCCCCCCCCc
Q 012777 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK--------EVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
.....||+.|+|||++.+..++.++|+|||||++|+|++|+.||...... ............. .+..++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~p~~~~ 229 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR---IPRSLS 229 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC---CCCCCC
Confidence 22356889999999999999999999999999999999999999642211 1112222222222 245678
Q ss_pred HHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPT------FRQILMR 410 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt------~~ell~~ 410 (456)
.++.++|.+||+.||.+||+ +.+++++
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 89999999999999999997 5677655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=325.25 Aligned_cols=250 Identities=24% Similarity=0.337 Sum_probs=206.3
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|++.+.||+|+||.+ ..+++.||+|++.+...........+.+|+.+++.++||||+++++++.....+++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 46888899999999976 2368899999997543333344466789999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||+++++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 123 Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-- 196 (370)
T cd05596 123 EYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-- 196 (370)
T ss_pred cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCC--
Confidence 99999999999865 46899999999999999999999999 9999999999999999999999999987653211
Q ss_pred cCCCCcccCCCCcccccccccCCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC-CCCCCCCCC
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNE----EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER-PPFRAPTTH 381 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~ 381 (456)
........||+.|+|||++.+. .++.++|+|||||++|+|++|+.||...+.......+..... ..++ ....
T Consensus 197 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~ 273 (370)
T cd05596 197 --MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFP-DDIE 273 (370)
T ss_pred --cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCC-CcCC
Confidence 1112235689999999998653 478899999999999999999999988776666666543321 1111 1236
Q ss_pred CcHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFR--RPTFRQILMR 410 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~--Rpt~~ell~~ 410 (456)
++.++.++|.+||..+|++ ||++++++++
T Consensus 274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 7899999999999999988 9999999887
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=318.86 Aligned_cols=244 Identities=26% Similarity=0.396 Sum_probs=201.9
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHH---hcCCCCcceeeeeEEEeCCceEEE
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALL---QKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l---~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
|.+.+.||+|+||.+ ..+|+.||||++.+.........+.+.+|+.++ +.++||||+++++++......|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999876 236889999999765433444556777777665 456799999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|||+++++|..++.. +.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--- 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--- 153 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC---
Confidence 999999999988764 56999999999999999999999999 99999999999999999999999999864321
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.........|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+.... .. .+..++..
T Consensus 154 --~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~---~p~~~~~~ 227 (324)
T cd05589 154 --FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE-VR---YPRFLSRE 227 (324)
T ss_pred --CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CC---CCCCCCHH
Confidence 1112234568899999999999999999999999999999999999998877666655553332 22 24678899
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rp-----t~~ell~~ 410 (456)
+.++|.+||..||++|| ++.+++++
T Consensus 228 ~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 228 AISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 99999999999999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=329.15 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=207.3
Q ss_pred ccccccceeeeccEEEEEe-----Ec-CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WR-GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~-g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
...|...+.||+|+||.+. .+ +..||+|.+... .......+.+|+.+++.++||||+++++++...+..|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 3458888999999998652 23 678999987543 44555677889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 225 VTEYLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
||||+++++|.+++.+ ..++++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 9999999999988754 346899999999999999999999999 999999999999999999999999999865
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
.... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......+. +.
T Consensus 220 ~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~ 293 (478)
T PTZ00267 220 SDSV---SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PC 293 (478)
T ss_pred CCcc---ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---Cc
Confidence 3211 11112335689999999999999999999999999999999999999988776666666544433332 45
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++.++.++|.+||..||++||++.+++.+
T Consensus 294 ~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 294 PVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 688899999999999999999999999764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=311.30 Aligned_cols=252 Identities=28% Similarity=0.460 Sum_probs=201.9
Q ss_pred ccccceeeeccEEEEEeE---------------------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCccee
Q 012777 153 DFSNSVEITKGTFRIASW---------------------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQ 211 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~~---------------------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 211 (456)
+|...+.||+|+||.|.. .+..||+|.+.... .......+.+|+.++.+++||||++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 577888999999997621 23479999987642 3455678999999999999999999
Q ss_pred eeeEEEeCCceEEEEEccCCCCHHHHHHHcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 012777 212 FLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG-------------------ALKPTLAVKFALDIARGMNYLHENRPEAII 272 (456)
Q Consensus 212 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~iv 272 (456)
+++++......+++|||+++++|.+++.... .++...+..++.|++.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999986532 2567788999999999999999999 99
Q ss_pred ecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc--
Q 012777 273 HRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-- 350 (456)
Q Consensus 273 H~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-- 350 (456)
||||||+|||++.++.+||+|||++......... .......++..|+|||++....++.++||||||+++|+|++
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCcee---EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 9999999999999999999999998755321110 11122345678999999988899999999999999999986
Q ss_pred CCCCCCCCCccchHHHHHhc----CCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 351 GCPPFPTKQEKEVPKAYIAN----ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 351 g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
+..||...+.......+... ........+..++..+.+++.+||..||++|||+.++.+.|+
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 56788776655544333211 111112224567889999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=313.03 Aligned_cols=247 Identities=28% Similarity=0.438 Sum_probs=198.6
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||.|+||.| ..++..||+|++..... ......+.+|+.++++++||||+++++++......++|||
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 5888899999999876 23688999999975432 2223567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|++ ++|.+++...+ .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--- 156 (288)
T cd07871 84 YLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP--- 156 (288)
T ss_pred CCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC---
Confidence 996 59999887654 4889999999999999999999999 999999999999999999999999998754211
Q ss_pred cCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCC-----------
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPP----------- 374 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------- 374 (456)
........+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+......+
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 157 --TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred --CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 112223457889999998865 468899999999999999999999998876554443332211000
Q ss_pred -------CC--------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 -------FR--------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 -------~~--------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++ ......+.++.++|.+||..||.+|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0113467789999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=319.56 Aligned_cols=251 Identities=25% Similarity=0.429 Sum_probs=197.9
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----Cce
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS-----TPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~~ 222 (456)
+|++.+.||+|+||.+ ..+|..||+|.+.... ........+.+|+.++++++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 4778899999999865 3468999999987542 2233346788999999999999999999988543 248
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
|+||||+ +++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999999 5799999988888999999999999999999999999 99999999999999999999999999875422
Q ss_pred cccccCCCCcccCCCCcccccccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHh-----------
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKN--EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIA----------- 369 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~----------- 369 (456)
... .........+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 156 ~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 156 DTP--TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccC--ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 111 1111233568899999999866 5788999999999999999999999977553222111100
Q ss_pred ----------------cCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 370 ----------------NERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 370 ----------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
....++......++..+.++|.+||..||++|||+++++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00011111124567789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=317.50 Aligned_cols=241 Identities=28% Similarity=0.439 Sum_probs=199.5
Q ss_pred eeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 158 VEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 158 ~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
+.||+|+||.| ..+|+.||+|++.......+.....+..|..++... +||+|+++++++...+.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36899999876 236889999999765332233445677788888765 899999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCC
Q 012777 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311 (456)
Q Consensus 232 ~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~ 311 (456)
++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++...... ...
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~ 152 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-----DNR 152 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC-----CCc
Confidence 999999988888999999999999999999999999 999999999999999999999999998643111 112
Q ss_pred cccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q 012777 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIE 391 (456)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 391 (456)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+... .+. .+..++.++.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~li~ 228 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-TPH---YPRWITKESKDILE 228 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCC---CCCCCCHHHHHHHH
Confidence 23456899999999999999999999999999999999999999887766655555322 222 24567889999999
Q ss_pred HhcccCCCCCCCHH-HHHHH
Q 012777 392 DCWSEEPFRRPTFR-QILMR 410 (456)
Q Consensus 392 ~~l~~dp~~Rpt~~-ell~~ 410 (456)
+||..||++||++. +++++
T Consensus 229 ~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 229 KLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred HHccCCHHHcCCChHHHHcC
Confidence 99999999999984 66543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=317.46 Aligned_cols=241 Identities=26% Similarity=0.421 Sum_probs=202.7
Q ss_pred eeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 158 VEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 158 ~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
+.||+|+||.+ ..+++.||+|++.+...........+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999866 235789999999865434445567778899999888 699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCC
Q 012777 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311 (456)
Q Consensus 232 ~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~ 311 (456)
++|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... ...
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-----~~~ 152 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-----GVT 152 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC-----CCc
Confidence 999999988888999999999999999999999999 999999999999999999999999998643111 111
Q ss_pred cccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q 012777 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIE 391 (456)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 391 (456)
.....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+... ... .+..++..+.++|.
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-~~~---~~~~~~~~~~~li~ 228 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-EVR---YPRWLSKEAKSILK 228 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCC---CCCcCCHHHHHHHH
Confidence 22345788999999999999999999999999999999999999887765555555322 222 24568899999999
Q ss_pred HhcccCCCCCCCH-----HHHHHH
Q 012777 392 DCWSEEPFRRPTF-----RQILMR 410 (456)
Q Consensus 392 ~~l~~dp~~Rpt~-----~ell~~ 410 (456)
+||..||++||++ .+++++
T Consensus 229 ~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 229 SFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHccCCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=314.67 Aligned_cols=250 Identities=26% Similarity=0.479 Sum_probs=204.6
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|++.+.||+|+||.+ ..++..+|+|.+.... .......+.+|+++++.++||||+++++++...+.+++||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 46888899999999866 2367889999987642 4455678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHEN-RPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
||+++++|.+++...+.+++..+..++.|++.||.|||+. + ++|+||||+|||++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 9999999999998888899999999999999999999975 6 999999999999999999999999998755221
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHH------------------
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAY------------------ 367 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~------------------ 367 (456)
......+++.|+|||++.+..++.++|+|||||++|+|++|+.||...........+
T Consensus 158 -----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 158 -----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred -----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 112346788999999999888999999999999999999999999765432221110
Q ss_pred --------------------------HhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 368 --------------------------IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 368 --------------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
.....+.. ....++.++.+||.+||+.||++|||+++++.+ .+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h--~~~~~ 304 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH--AFIKR 304 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccC--CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC--HHHhc
Confidence 00001111 112467889999999999999999999999876 44443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=303.52 Aligned_cols=249 Identities=30% Similarity=0.519 Sum_probs=207.4
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||+|+||.+ ..+++.||+|.+..+ ......+.+|+.+++.++||+|+++++++..+...+++||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 4777789999999865 335889999998743 2234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|+++++|.+++.... .+++..+..++.|++.+|.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999997643 4899999999999999999999999 99999999999999999999999999886532211
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.....+. .+..++.
T Consensus 160 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 232 (263)
T cd05052 160 T----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME---RPEGCPP 232 (263)
T ss_pred e----ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC---CCCCCCH
Confidence 1 1111233567999999988899999999999999999998 999998877666555553332322 2467889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
++.+++.+||..||++|||+.++++.|+.++
T Consensus 233 ~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 233 KVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 9999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=318.43 Aligned_cols=236 Identities=28% Similarity=0.425 Sum_probs=195.9
Q ss_pred eeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHH-HHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 158 VEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELA-LLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 158 ~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
+.||+|+||.+ ..+|+.||+|++.............+..|.. +++.++||||+++++.+......++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999866 2368899999997643333333455566655 55778999999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCC
Q 012777 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311 (456)
Q Consensus 232 ~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~ 311 (456)
++|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~-----~~~~ 152 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-----HSKT 152 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc-----CCCc
Confidence 999999988888999999999999999999999999 99999999999999999999999999874311 1112
Q ss_pred cccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q 012777 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIE 391 (456)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 391 (456)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.... .. .+..++..+.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~---~~~~~~~~~~~li~ 228 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-LR---LKPNISVSARHLLE 228 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CC---CCCCCCHHHHHHHH
Confidence 233468899999999999999999999999999999999999998877666665554332 22 23567889999999
Q ss_pred HhcccCCCCCCCHH
Q 012777 392 DCWSEEPFRRPTFR 405 (456)
Q Consensus 392 ~~l~~dp~~Rpt~~ 405 (456)
+||+.||++||++.
T Consensus 229 ~~l~~~p~~R~~~~ 242 (323)
T cd05575 229 GLLQKDRTKRLGAK 242 (323)
T ss_pred HHhhcCHHhCCCCC
Confidence 99999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=309.67 Aligned_cols=243 Identities=25% Similarity=0.358 Sum_probs=197.1
Q ss_pred eeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012777 160 ITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234 (456)
Q Consensus 160 lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~sL 234 (456)
||+|+||.+ ..+|+.||+|.+...........+.+..|+.+++.++||+|+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 688999866 346889999999765433444456778899999999999999999999999999999999999999
Q ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCC
Q 012777 235 RAYLKQ----KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR 310 (456)
Q Consensus 235 ~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~ 310 (456)
.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-----~ 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-----S 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC-----c
Confidence 988743 345999999999999999999999999 9999999999999999999999999987653211 1
Q ss_pred CcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHH
Q 012777 311 PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELI 390 (456)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 390 (456)
......|++.|+|||++.+..++.++|+||||+++|+|++|+.||.......................+..++..+.+++
T Consensus 153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 232 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFC 232 (280)
T ss_pred cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHH
Confidence 12234688899999999999999999999999999999999999976543322222211111111122456889999999
Q ss_pred HHhcccCCCCCC-----CHHHHHHH
Q 012777 391 EDCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 391 ~~~l~~dp~~Rp-----t~~ell~~ 410 (456)
.+||+.||++|| ++++++++
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 999999999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=306.78 Aligned_cols=255 Identities=27% Similarity=0.451 Sum_probs=212.1
Q ss_pred cccccceeeeccEEEEEe----------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012777 152 LDFSNSVEITKGTFRIAS----------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~----------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 221 (456)
.+|.+.+.||+|+||.+. .++..+|+|.+... .......+.+|+.++++++||+|+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 467888899999998662 12456999988653 34456789999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC
Q 012777 222 MMIVTEYLPKGDLRAYLKQKG-------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~-------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~ 288 (456)
.+++|||+++++|.+++...+ .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999999997543 3899999999999999999999999 999999999999999999
Q ss_pred EEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHH
Q 012777 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAY 367 (456)
Q Consensus 289 vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~ 367 (456)
++|+|||++....... .........+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||......+....+
T Consensus 159 ~kl~dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i 235 (288)
T cd05093 159 VKIGDFGMSRDVYSTD---YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235 (288)
T ss_pred EEeccCCccccccCCc---eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999987552211 1111122345678999999998889999999999999999998 99999887766666666
Q ss_pred HhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 368 IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
....... .+..++.++.+++.+||+.||.+|||++++++.|+.+.+..
T Consensus 236 ~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 236 TQGRVLQ---RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred HcCCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 4433222 24567889999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=291.71 Aligned_cols=262 Identities=23% Similarity=0.364 Sum_probs=207.1
Q ss_pred CccccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC--
Q 012777 148 DPKELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST-- 220 (456)
Q Consensus 148 ~~~~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-- 220 (456)
...+.+|++.+.||+|+|..+ ..+++.||+|++... ..+..+..++|++..++++|||+++++++...+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 344668999999999999865 357889999999865 3456788999999999999999999999875543
Q ss_pred ---ceEEEEEccCCCCHHHHHHHc---C-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEec
Q 012777 221 ---PMMIVTEYLPKGDLRAYLKQK---G-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293 (456)
Q Consensus 221 ---~~~lv~e~~~~~sL~~~l~~~---~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~D 293 (456)
..|++++|...|+|.+.++.. + .+++.+++.|+.++++||++||+.. .++.||||||.|||+++.+.++|.|
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEe
Confidence 499999999999999998753 3 4999999999999999999999986 3799999999999999999999999
Q ss_pred cCCcccccccccc----cCCCCcccCCCCcccccccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCcc--chH
Q 012777 294 FGLSKLLKFANTV----KEDRPVTCEETSWRYAAPEVYKNE---EYDTKVDVFSFALILQEMIEGCPPFPTKQEK--EVP 364 (456)
Q Consensus 294 fgls~~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~ 364 (456)
||.+......-.. ..-+......+|..|+|||.+.-. -.+.++|||||||++|.|+.|..||...... .+.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 9998755321100 011122234578889999998543 5667999999999999999999999654321 111
Q ss_pred HHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 365 KAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
..+ ......++. ...+|..+.++|++||+.||.+||++.+++.+++.+.
T Consensus 253 LAv-~n~q~s~P~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 LAV-QNAQISIPN-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred Eee-eccccccCC-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111 111222222 2348999999999999999999999999999998763
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=329.38 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=210.6
Q ss_pred CccccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC--
Q 012777 148 DPKELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST-- 220 (456)
Q Consensus 148 ~~~~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-- 220 (456)
.....+|.+.+.||+|+||.| ..+|+.||||++..... .+.....+.+|+.++..++|++|+++++.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344558999999999999976 33689999999976543 4555677889999999999999999988775432
Q ss_pred ------ceEEEEEccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEE
Q 012777 221 ------PMMIVTEYLPKGDLRAYLKQK----GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290 (456)
Q Consensus 221 ------~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vk 290 (456)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 368999999999999998653 35899999999999999999999999 99999999999999999999
Q ss_pred EeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc
Q 012777 291 VADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN 370 (456)
Q Consensus 291 l~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 370 (456)
|+|||+++.+.... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+...
T Consensus 184 L~DFGls~~~~~~~---~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~ 260 (496)
T PTZ00283 184 LGDFGFSKMYAATV---SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260 (496)
T ss_pred EEecccCeeccccc---cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 99999988653211 111123356899999999999999999999999999999999999999887766665555444
Q ss_pred CCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 371 ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
...+ .+..++.++.+++.+||..||++||++.+++++
T Consensus 261 ~~~~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RYDP---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 3333 356788999999999999999999999999875
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=302.63 Aligned_cols=252 Identities=25% Similarity=0.450 Sum_probs=208.0
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|++.+.||+|+||.+ ..+++.||+|.+.............+.+|+.+++.++||||+++++++...+..++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 5788899999999865 34789999999876444556666788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 228 YLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 228 ~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
|+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999988853 234899999999999999999999999 999999999999999999999999998765321
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc--chHHHHHhcCCCCCCCCCCC
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK--EVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~ 381 (456)
. .......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... .....+.....++. ....
T Consensus 160 ~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 232 (267)
T cd08228 160 T-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL--PTEH 232 (267)
T ss_pred h-----HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC--Chhh
Confidence 1 1112345778899999998888999999999999999999999999665432 22333322222222 2346
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
++..+.+++.+||..+|++||+++++++.++.+
T Consensus 233 ~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 233 YSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred cCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 778899999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=315.87 Aligned_cols=240 Identities=28% Similarity=0.423 Sum_probs=199.1
Q ss_pred eeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 158 VEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 158 ~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
+.||+|+||.| ..+++.||+|++.......+.....+..|..+++.. +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999876 235789999999765332233445677788888765 899999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCC
Q 012777 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311 (456)
Q Consensus 232 ~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~ 311 (456)
++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~ 152 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-----DAK 152 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC-----CCc
Confidence 999999988778999999999999999999999999 999999999999999999999999998743111 111
Q ss_pred cccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q 012777 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIE 391 (456)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 391 (456)
.....||+.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+... .+. .+..++.++.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-~~~---~~~~~~~~~~~li~ 228 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-NPC---YPRWLTREAKDILV 228 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCC---CCccCCHHHHHHHH
Confidence 22346889999999999989999999999999999999999999887766655555322 222 23567889999999
Q ss_pred HhcccCCCCCCCHH-HHHH
Q 012777 392 DCWSEEPFRRPTFR-QILM 409 (456)
Q Consensus 392 ~~l~~dp~~Rpt~~-ell~ 409 (456)
+||..||++||++. ++++
T Consensus 229 ~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 229 KLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHhccCHhhcCCChHHHHc
Confidence 99999999999997 5554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.99 Aligned_cols=244 Identities=27% Similarity=0.466 Sum_probs=217.2
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
..|+..+.||.|+||.| ..+.+.||||++.-......+...+|+.|+..|.+++|||++.+-+||..+...++||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 35888899999999977 3468899999998877777888899999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|||- ||-.|++.- +.++.+.++..|+.+.+.||.|||+.+ .||||||..|||+++.|.|||+|||.+....
T Consensus 106 EYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---- 177 (948)
T KOG0577|consen 106 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA---- 177 (948)
T ss_pred HHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC----
Confidence 9994 688888753 457999999999999999999999999 9999999999999999999999999987652
Q ss_pred ccCCCCcccCCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCC
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYK---NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (456)
+-..++|||.|||||++. .+.|+-++||||||+++.||.-.++|+-+++......-|..+..|.+. ...-
T Consensus 178 -----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq--s~eW 250 (948)
T KOG0577|consen 178 -----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--SNEW 250 (948)
T ss_pred -----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC--Cchh
Confidence 233578999999999884 568999999999999999999999999999988877778777777664 4667
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.|.+|++.||++=|++|||.++++.|
T Consensus 251 S~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 251 SDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 7889999999999999999999998875
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=316.81 Aligned_cols=242 Identities=23% Similarity=0.368 Sum_probs=198.1
Q ss_pred eeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 158 VEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 158 ~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
+.||+|+||.| ..+++.||+|++.+...........+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36899999976 346789999999876545555667788899988877 799999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCC
Q 012777 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311 (456)
Q Consensus 232 ~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~ 311 (456)
++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-----~~~ 152 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-----GDT 152 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC-----CCc
Confidence 999999988888999999999999999999999999 999999999999999999999999998743111 111
Q ss_pred cccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc--------chHHHHHhcCCCCCCCCCCCCc
Q 012777 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK--------EVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
.....||+.|+|||++.+..++.++|+|||||++|+|++|+.||...... ............. .+..++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---~p~~~~ 229 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---IPRSLS 229 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC---CCCCCC
Confidence 22356889999999999999999999999999999999999999532111 1111111222222 246788
Q ss_pred HHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTF------RQILMR 410 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~------~ell~~ 410 (456)
..+.++|.+||+.||++||++ .+++++
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 899999999999999999984 676655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.06 Aligned_cols=247 Identities=26% Similarity=0.428 Sum_probs=204.2
Q ss_pred eeeccEEEEEe-------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 159 EITKGTFRIAS-------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 159 ~lg~G~fg~~~-------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
.||+|+||.+. .++..||+|++.... .+....+.+.+|+.+++.+.||||+++++++.. ...++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 58999998652 256889999987553 345566789999999999999999999998854 567899999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCC
Q 012777 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311 (456)
Q Consensus 232 ~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~ 311 (456)
++|.+++.....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~ 154 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY--KA 154 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCee--ee
Confidence 999999988778999999999999999999999999 9999999999999999999999999988653221111 01
Q ss_pred cccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHH
Q 012777 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELI 390 (456)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 390 (456)
.....++..|+|||.+....++.++|+||||+++|+|++ |..||......+....+.....++ .+..++.++.++|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li 231 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERME---CPQRCPPEMYDLM 231 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC---CCCCCCHHHHHHH
Confidence 112234568999999988889999999999999999998 999998877666666554433333 2457889999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 391 EDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 391 ~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
.+||+.||++||++.+|...|+.++
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 232 KLCWTYGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred HHHhccCchhCcCHHHHHHHHhccc
Confidence 9999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=322.18 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=204.9
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
..+|++.+.||+|+||.| ..+++.||+|++.+...........+.+|+.+++.++||||+++++++..+..+++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 346888999999999976 235789999999754333344456688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|||+++++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 122 ~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~- 196 (370)
T cd05621 122 MEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG- 196 (370)
T ss_pred EcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCC-
Confidence 999999999999875 46899999999999999999999999 9999999999999999999999999988653211
Q ss_pred ccCCCCcccCCCCcccccccccCCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC-CCCCCCCC
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNE----EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER-PPFRAPTT 380 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 380 (456)
........||+.|+|||++.+. .++.++|+|||||++|+|++|+.||...+.......+..... ..++ ...
T Consensus 197 ---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~ 272 (370)
T cd05621 197 ---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP-EDV 272 (370)
T ss_pred ---ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCC-Ccc
Confidence 1112345689999999998654 377899999999999999999999988776666665543321 2221 124
Q ss_pred CCcHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFR--RPTFRQILMR 410 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~--Rpt~~ell~~ 410 (456)
.++..+.+++..|+..++.+ |+++++++++
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 57888999999999865544 8899999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=323.20 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=206.6
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||+|+||.| ..+++.||+|++.............+.+|+.++..++||+|+++++.+...+.+++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 4778899999999976 23688999999975433344556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++..........
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 9999999999988888999999999999999999999999 9999999999999999999999999987542210000
Q ss_pred ------------------------------CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 012777 308 ------------------------------EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPT 357 (456)
Q Consensus 308 ------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 357 (456)
.........||+.|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 00011234689999999999999999999999999999999999999998
Q ss_pred CCccchHHHHHhcC-CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 012777 358 KQEKEVPKAYIANE-RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPT---FRQILMR 410 (456)
Q Consensus 358 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt---~~ell~~ 410 (456)
.++......+.... ...++ ....++.++.++|.+++ .||.+|++ +.++++|
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 239 ETPQETYRKVMNWKETLVFP-PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCHHHHHHHHHcCCCceecC-CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 88776665553322 11111 12347888999999977 59999985 6777766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=315.48 Aligned_cols=240 Identities=27% Similarity=0.414 Sum_probs=201.4
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv~ 226 (456)
+|...+.||+|+||.| ..+|+.||+|++.+.........+.+..|..++..+. |++|+++++++...+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677789999999976 2368899999998654333445567888999998885 678889999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~--- 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--- 154 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC---
Confidence 99999999999988888999999999999999999999999 999999999999999999999999998753211
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
........||+.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+.... .. .+..++.++
T Consensus 155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~---~p~~~~~~~ 228 (323)
T cd05615 155 --GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VS---YPKSLSKEA 228 (323)
T ss_pred --CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CC---CCccCCHHH
Confidence 111223458899999999999899999999999999999999999998877666666554322 22 245678899
Q ss_pred HHHHHHhcccCCCCCCCH
Q 012777 387 RELIEDCWSEEPFRRPTF 404 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~ 404 (456)
.+++.+||..+|.+|++.
T Consensus 229 ~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 229 VSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHHHcccCHhhCCCC
Confidence 999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=306.51 Aligned_cols=242 Identities=25% Similarity=0.378 Sum_probs=193.8
Q ss_pred eeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012777 160 ITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234 (456)
Q Consensus 160 lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~sL 234 (456)
||+|+||.+ ..+|+.||+|.+.............+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 689999866 346899999999754333323334566799999999999999999999999999999999999999
Q ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCc
Q 012777 235 RAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312 (456)
Q Consensus 235 ~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~ 312 (456)
.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...... ...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~------~~~ 151 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG------KTI 151 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC------cee
Confidence 98886543 4888999999999999999999999 999999999999999999999999998765321 112
Q ss_pred ccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCCCCCCCCcHHHHHHHH
Q 012777 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRAPTTHYAYGLRELIE 391 (456)
Q Consensus 313 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~ 391 (456)
....++..|+|||++.+..++.++|+|||||++|+|++|..||...........+.... ..........++.++.++|.
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 231 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICR 231 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHH
Confidence 23457889999999998889999999999999999999999997654322111111111 11222223578899999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 012777 392 DCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 392 ~~l~~dp~~Rpt~~ell~~ 410 (456)
+||+.||++||++.|+++.
T Consensus 232 ~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 232 LFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HHhccCHhhCCCCccchhh
Confidence 9999999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=300.02 Aligned_cols=245 Identities=31% Similarity=0.589 Sum_probs=203.1
Q ss_pred ccccceeeeccEEEEE---eE-cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 153 DFSNSVEITKGTFRIA---SW-RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~-~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
+|.+.+.||+|+||.+ .+ .+..+|+|.+..... ....+.+|+.++++++||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 4677789999999865 22 456899999864422 235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 229 LPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 229 ~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
+++++|.+++... +.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 9999999998753 46899999999999999999999999 999999999999999999999999998765221111
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+.....+.. +...+..+
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~ 230 (256)
T cd05114 157 ---SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---PKLASMTV 230 (256)
T ss_pred ---ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCCHHH
Confidence 1112234567999999988889999999999999999999 9999988877666666644433322 34567889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
.+++.+||+.+|++||+++++++.|
T Consensus 231 ~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 231 YEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhh
Confidence 9999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=304.56 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=203.7
Q ss_pred cccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----
Q 012777 150 KELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS----- 219 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 219 (456)
..+.|...+.+|+|+||.| ..+++.||||.+-.+.- .-.+|+++|+.+.|||||+++-+|...
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 3456888899999999976 34688999999865431 224799999999999999999888643
Q ss_pred CceEEEEEccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-CCCEEEecc
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD-SGHLKVADF 294 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~-~~~vkl~Df 294 (456)
-.+.+||||++ .+|.++++. +..++...+.-+.+||+.||.|||+.+ |+||||||+|+|+|. .|.+|||||
T Consensus 95 ~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDF 170 (364)
T KOG0658|consen 95 VYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDF 170 (364)
T ss_pred hHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccC
Confidence 24678999996 599999885 466999999999999999999999999 999999999999995 599999999
Q ss_pred CCcccccccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-C
Q 012777 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-R 372 (456)
Q Consensus 295 gls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~ 372 (456)
|.|+.+..+ .+...+.+|..|+|||.+.+. .|+.+.||||.||++.||+.|++-|.+.+..+....|.... .
T Consensus 171 GSAK~L~~~------epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 171 GSAKVLVKG------EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT 244 (364)
T ss_pred CcceeeccC------CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence 999988432 233445677789999998776 79999999999999999999999999977655433332211 1
Q ss_pred C----------C-------------C-CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccc
Q 012777 373 P----------P-------------F-RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIK 421 (456)
Q Consensus 373 ~----------~-------------~-~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~ 421 (456)
| . + .......+.+..+|+.++|..+|.+|.++-|++.+ .+++.+...
T Consensus 245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h--~fFdelr~~ 315 (364)
T KOG0658|consen 245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH--PFFDELRDP 315 (364)
T ss_pred CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc--hhhHHhhCc
Confidence 1 0 0 11346788899999999999999999999999876 666666544
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=303.33 Aligned_cols=252 Identities=26% Similarity=0.458 Sum_probs=204.7
Q ss_pred ccccccceeeeccEEEEEe----------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012777 151 ELDFSNSVEITKGTFRIAS----------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST 220 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~----------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 220 (456)
..+|+..+.||+|+||.+. ..+..||+|++... ........+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3468888999999998652 13467999998643 23344567889999999999999999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEE
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKG----------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vk 290 (456)
..++||||+++++|.+++.+.. .++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 9999999999999999987532 2567788999999999999999999 99999999999999999999
Q ss_pred EeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHh
Q 012777 291 VADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIA 369 (456)
Q Consensus 291 l~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~ 369 (456)
|+|||++.......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+..
T Consensus 160 l~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 160 IGDFGMTRDIYETDYYR---KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred ECCCCCccccCCcceee---cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999987552211111 1112234678999999998889999999999999999998 7899988776655554433
Q ss_pred cCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 012777 370 NERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDD 413 (456)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~ 413 (456)
...+. .+...+..+.+++.+||+.||++|||+.++++.|++
T Consensus 237 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 GGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 33222 246678899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=319.74 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=205.3
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
..+|++.+.||+|+||.+ ..+++.||+|++.+...........+.+|+.+++.++||||+++++++.....+++|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 457999999999999976 346889999998754333344456678999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|||+++++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 122 ~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~- 196 (371)
T cd05622 122 MEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG- 196 (371)
T ss_pred EcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-
Confidence 999999999999875 45899999999999999999999999 9999999999999999999999999988653211
Q ss_pred ccCCCCcccCCCCcccccccccCCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCCCCCC
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEE----YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRAPTT 380 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~ 380 (456)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+.... ...++ ...
T Consensus 197 ---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~ 272 (371)
T cd05622 197 ---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP-DDN 272 (371)
T ss_pred ---cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCC-CcC
Confidence 11122356899999999987543 7789999999999999999999998877666666664332 12221 235
Q ss_pred CCcHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFR--RPTFRQILMRL 411 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~--Rpt~~ell~~L 411 (456)
.++..+.++|.+||..++.+ |+++++++++.
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 78899999999999844433 78999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=300.83 Aligned_cols=249 Identities=31% Similarity=0.532 Sum_probs=207.3
Q ss_pred cccccceeeeccEEEEE----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 152 LDFSNSVEITKGTFRIA----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.+|++.++||+|+||.+ ..++..||+|.+.... ...+.+.+|+.+++.++||||+++++.+......+++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 35888899999999865 2356789999986532 234688999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|+++++|.+++... ..++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999999753 45888999999999999999999999 99999999999999999999999999886532111
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.......++..|+|||++.+..++.++|+||||+++|+|++ |..||...........+......+ ....++.
T Consensus 159 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 231 (261)
T cd05072 159 ----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP---RMENCPD 231 (261)
T ss_pred ----eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCH
Confidence 11112335667999999988889999999999999999998 999998877666665554333322 2356888
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
++.+++.+||..+|++||+++++++.|+.+
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 232 ELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=317.53 Aligned_cols=236 Identities=25% Similarity=0.339 Sum_probs=198.4
Q ss_pred eeeeccEEEEEe--------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEcc
Q 012777 158 VEITKGTFRIAS--------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229 (456)
Q Consensus 158 ~~lg~G~fg~~~--------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~ 229 (456)
+.||+|+||.+. .+|+.||+|++..... .......+.+|+.++++++||||+++++++......|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 579999998662 3678999999976432 2223456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCC
Q 012777 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKED 309 (456)
Q Consensus 230 ~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~ 309 (456)
++++|.+++.+...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-----~ 152 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-----E 152 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC-----C
Confidence 99999999988788999999999999999999999999 999999999999999999999999998754221 1
Q ss_pred CCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHH
Q 012777 310 RPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLREL 389 (456)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 389 (456)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+.... .. .+..++..+.++
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~---~p~~~~~~~~~l 228 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LG---MPQFLSPEAQSL 228 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CC---CCCCCCHHHHHH
Confidence 12223568899999999998889999999999999999999999998877666555553322 22 245678899999
Q ss_pred HHHhcccCCCCCCCHHH
Q 012777 390 IEDCWSEEPFRRPTFRQ 406 (456)
Q Consensus 390 i~~~l~~dp~~Rpt~~e 406 (456)
|.+||+.||++||++.+
T Consensus 229 i~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 229 LRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHhhcCHhHcCCCCC
Confidence 99999999999999444
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=314.43 Aligned_cols=242 Identities=23% Similarity=0.365 Sum_probs=199.3
Q ss_pred eeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 158 VEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 158 ~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
+.||+|+||.| ..+++.||+|++.+...........+..|..++.++ +||+|+++++++.....+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36899999866 246789999999876555556667788999999888 699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCC
Q 012777 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311 (456)
Q Consensus 232 ~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~ 311 (456)
++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~-----~~~~ 152 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG-----PGDT 152 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC-----CCCc
Confidence 999999988788999999999999999999999999 99999999999999999999999999874311 1112
Q ss_pred cccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc------chHHHHHhcCCCCCCCCCCCCcHH
Q 012777 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK------EVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...... +............ .+..++..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~p~~~~~~ 229 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR---IPRFLSVK 229 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC---CCCCCCHH
Confidence 23356899999999999999999999999999999999999999643221 1122222222222 24567889
Q ss_pred HHHHHHHhcccCCCCCCCH------HHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTF------RQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~------~ell~~ 410 (456)
+.++|.+||..||++|+++ ++++++
T Consensus 230 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 9999999999999999984 566655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=310.24 Aligned_cols=248 Identities=27% Similarity=0.456 Sum_probs=194.6
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|.+.+.||+|+||.+ ..+++.||+|++..... ......+.+|+.+++.++||||+++++++......++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 35888899999999866 23688999999975432 222346778999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
||+. ++|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-- 156 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP-- 156 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC--
Confidence 9994 6888887654 46899999999999999999999999 999999999999999999999999998754211
Q ss_pred ccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc-hHHHHHhc-CCCC--------
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE-VPKAYIAN-ERPP-------- 374 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~-~~~~-------- 374 (456)
........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....+... ..+.
T Consensus 157 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 157 ---SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred ---CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 112223457889999998865 457889999999999999999999998754321 11111110 0000
Q ss_pred ----C-----C----------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 ----F-----R----------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 ----~-----~----------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+ . .....++..+.+++.+||+.||++|||++++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0 0 0011345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=316.53 Aligned_cols=244 Identities=23% Similarity=0.367 Sum_probs=195.5
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||+|+||.+ ..+|+.||||++... ........+.+|+.+++.++|+||+++++++...+.+++|||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN--HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC--CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 5777889999999876 235889999999654 244556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+.+++|.+. ...++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~---- 221 (353)
T PLN00034 153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT---- 221 (353)
T ss_pred cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc----
Confidence 9999998643 34677888899999999999999999 999999999999999999999999998865321
Q ss_pred CCCCcccCCCCcccccccccCCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCC
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNE-----EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (456)
........||..|+|||++... ..+.++|||||||++|+|++|+.||..........................+
T Consensus 222 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (353)
T PLN00034 222 -MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATA 300 (353)
T ss_pred -cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCcc
Confidence 1112234688999999987432 3346899999999999999999999854433322222111111112234678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.++.+||.+||..||++|||++|++++
T Consensus 301 ~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 301 SREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 8899999999999999999999999986
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=307.68 Aligned_cols=247 Identities=28% Similarity=0.436 Sum_probs=195.1
Q ss_pred ccccceeeeccEEEEEe------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC---CCCcceeeeeEEEe-----
Q 012777 153 DFSNSVEITKGTFRIAS------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI---RHPNVVQFLGAVTQ----- 218 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~----- 218 (456)
+|++.+.||+|+||.+. .++..||+|.+....... .....+.+|+.+++.+ +||||+++++++..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 57888899999999762 236789999987543222 2234556777777665 69999999998852
Q ss_pred CCceEEEEEccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCC
Q 012777 219 STPMMIVTEYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGL 296 (456)
Q Consensus 219 ~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgl 296 (456)
...+++||||+. ++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 356899999995 6999998764 34899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCC-
Q 012777 297 SKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPF- 375 (456)
Q Consensus 297 s~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~- 375 (456)
+...... .......+++.|+|||.+.+..++.++|||||||++|+|++|++||.+.+..+....+......+.
T Consensus 157 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~ 230 (290)
T cd07862 157 ARIYSFQ------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 230 (290)
T ss_pred eEeccCC------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 8765321 122334678899999999888999999999999999999999999988776555444432211000
Q ss_pred ----------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 376 ----------------------RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 376 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
......++..+.+++.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00123567789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=316.16 Aligned_cols=238 Identities=27% Similarity=0.402 Sum_probs=195.7
Q ss_pred eeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHH-HHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 158 VEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELA-LLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 158 ~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
+.||+|+||.| ..+++.||+|++.............+..|.. +++.++||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36899999866 2357789999997543222233344555544 56778999999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCC
Q 012777 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311 (456)
Q Consensus 232 ~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~ 311 (456)
++|.+++...+.+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~-----~~~~ 152 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE-----HNGT 152 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc-----CCCC
Confidence 999999988888999999999999999999999999 99999999999999999999999999875321 1112
Q ss_pred cccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q 012777 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIE 391 (456)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 391 (456)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.... .. ....++..+.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~---~~~~~~~~~~~li~ 228 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQ---LKPNITNSARHLLE 228 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-cC---CCCCCCHHHHHHHH
Confidence 234568999999999999999999999999999999999999998877666655553322 11 23578899999999
Q ss_pred HhcccCCCCCCCHHHH
Q 012777 392 DCWSEEPFRRPTFRQI 407 (456)
Q Consensus 392 ~~l~~dp~~Rpt~~el 407 (456)
+||+.||.+||++.+.
T Consensus 229 ~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 229 GLLQKDRTKRLGAKDD 244 (325)
T ss_pred HHcccCHHHCCCCCCC
Confidence 9999999999988743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=299.23 Aligned_cols=249 Identities=32% Similarity=0.520 Sum_probs=206.8
Q ss_pred cccccceeeeccEEEEE----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 152 LDFSNSVEITKGTFRIA----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.+|++.+.||+|+||.+ ..+++.||+|.+..... ..+.+.+|+.++++++||||+++++++...+..+++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 35788899999999865 23567899999875432 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|+++++|.+++.... .+++..+..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999997654 5899999999999999999999999 99999999999999999999999999886632111
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
. .......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+.......+......+ .+...+.
T Consensus 159 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 231 (261)
T cd05068 159 E----AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP---CPPGCPK 231 (261)
T ss_pred c----ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCcCCH
Confidence 0 1111223457999999998889999999999999999999 999998877666665554333322 2456788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
.+.+++.+||+.+|++||+++++++.|+++
T Consensus 232 ~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 232 ELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=303.17 Aligned_cols=249 Identities=29% Similarity=0.462 Sum_probs=207.3
Q ss_pred ccccceeeeccEEEEEe----------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 153 DFSNSVEITKGTFRIAS----------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~----------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
+|.+.+.||+|+||.+. .++..||+|.+... ...+....+.+|+++++.++||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc--CCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 57778899999998662 22468999998764 2344567899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC
Q 012777 223 MIVTEYLPKGDLRAYLKQKG--------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~--------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~ 288 (456)
+++|||+++++|.+++...+ .+++..+..++.|++.||.+||+++ ++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997643 3788899999999999999999999 999999999999999999
Q ss_pred EEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHH
Q 012777 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAY 367 (456)
Q Consensus 289 vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~ 367 (456)
++|+|||++........ ........+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+
T Consensus 161 ~kl~d~g~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDY---YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred EEECCcccceecccCcc---eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 99999999875421110 011122335678999999999999999999999999999998 99999887776666665
Q ss_pred HhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 368 IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
....... .+..++..+.+++.+||+.||++|||++|+++.|+
T Consensus 238 ~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 TQGRLLQ---RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HcCCcCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 4333222 24578899999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=306.18 Aligned_cols=245 Identities=37% Similarity=0.698 Sum_probs=199.3
Q ss_pred cceeeeccEEEEE---eEc------CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 156 NSVEITKGTFRIA---SWR------GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 156 ~~~~lg~G~fg~~---~~~------g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
..+.||.|.||.+ .+. +..|+||.++.. ...+..+.+.+|++.+++++||||+++++++......++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence 3568999999965 344 678999999653 45556789999999999999999999999999888899999
Q ss_pred EccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 227 EYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 227 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
||+++++|.+++... ..++...+..|+.|++.||.|||+++ ++|++|+++||+++.++.+||+|||++.......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999999886 56999999999999999999999999 9999999999999999999999999987652111
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
.. ...........|+|||.+....++.++||||||+++||+++ |+.||.+.+..+....+....+.+ .+..++
T Consensus 158 ~~---~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 231 (259)
T PF07714_consen 158 KY---KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP---IPDNCP 231 (259)
T ss_dssp SE---EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT---SBTTSB
T ss_pred cc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccce---eccchh
Confidence 11 11112235567999999988889999999999999999999 789998887777666664443433 256789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
..+.++|.+||..||++|||+.++++.|
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 9999999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=297.84 Aligned_cols=243 Identities=30% Similarity=0.514 Sum_probs=200.4
Q ss_pred eeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCC
Q 012777 159 EITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGD 233 (456)
Q Consensus 159 ~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~s 233 (456)
.||+|+||.+ ..+++.||+|.+... ...+....+.+|++++++++||||+++++++......++||||+++++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 6899999865 337889999998654 245556789999999999999999999999999999999999999999
Q ss_pred HHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCc
Q 012777 234 LRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312 (456)
Q Consensus 234 L~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~ 312 (456)
|.+++...+ .+++..++.++.|+++||.|||+++ ++|+||||+||+++.++.+||+|||++........ ....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~ 153 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY---ASTG 153 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccc---cccC
Confidence 999997644 5899999999999999999999999 99999999999999999999999999875432100 0001
Q ss_pred ccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q 012777 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIE 391 (456)
Q Consensus 313 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 391 (456)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+....... .+..++..+.+++.
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~ 230 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP---CPELCPDAVYRLME 230 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC---CcccCCHHHHHHHH
Confidence 11123456999999998889999999999999999997 999998766655444443332322 24567889999999
Q ss_pred HhcccCCCCCCCHHHHHHHHH
Q 012777 392 DCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 392 ~~l~~dp~~Rpt~~ell~~L~ 412 (456)
+||+.+|++|||+.++++.|+
T Consensus 231 ~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 231 RCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHcCCChhhCcCHHHHHHHHh
Confidence 999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=299.83 Aligned_cols=246 Identities=26% Similarity=0.394 Sum_probs=219.2
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||+|+||+| +.+|+.||+|+++++.+...+++.+-..|-++|+..+||.+..+.-+|+..+.+|+|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 6778889999999987 45799999999999999888999999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|..||.|.-++.....+++..++.+..+|+.||.|||+++ ||+||+|.+|.|+|.+|.+||.|||+.+... .
T Consensus 249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-----~ 320 (516)
T KOG0690|consen 249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-----K 320 (516)
T ss_pred EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-----c
Confidence 9999999999998888999999999999999999999999 9999999999999999999999999988542 2
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
.......++|||.|+|||++....|+.+.|+|.+|++||||++|++||.+.+...+...|.... .. ++..++++..
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed-~k---FPr~ls~eAk 396 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED-LK---FPRTLSPEAK 396 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh-cc---CCccCCHHHH
Confidence 2334456889999999999999999999999999999999999999999988777666664332 22 2578899999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rp-----t~~ell~~ 410 (456)
.|+..+|.+||.+|. +++|+.++
T Consensus 397 tLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 397 TLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 999999999999994 56666654
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=298.41 Aligned_cols=251 Identities=31% Similarity=0.529 Sum_probs=208.9
Q ss_pred ccccceeeeccEEEEEe---E-----cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 153 DFSNSVEITKGTFRIAS---W-----RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~---~-----~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
+|...+.||+|+||.+. + ....||+|.+.... .......+..|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 57888999999998662 2 24579999987542 44456778999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 225 VTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
+|||+++++|.+++... +.+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999764 46899999999999999999999999 999999999999999999999999999876311
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCC
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (456)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+......+. +..+
T Consensus 160 ~~~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 233 (266)
T cd05033 160 EATY---TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP---PMDC 233 (266)
T ss_pred ccce---eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC---CCCC
Confidence 1100 1112234567999999998899999999999999999998 9999987776666655543333222 4567
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
+..+.+++.+||+.+|++||++++++++|+.+
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 88999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=313.48 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=203.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.| ..+++.||+|++.+.........+.+.+|+.+++.++|++|+++++++.....+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 5778899999999976 33688999999975433334455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|+++++|.+++.+ ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 157 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT- 157 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-
Confidence 9999999999976 456999999999999999999999999 99999999999999999999999999875532111
Q ss_pred cCCCCcccCCCCcccccccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCCCCCC
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKN-----EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRAPTT 380 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~ 380 (456)
.......||+.|+|||++.. ..++.++|||||||++|+|++|+.||...+..+....+.... ...+.....
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 234 (331)
T cd05597 158 ---VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVT 234 (331)
T ss_pred ---ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccC
Confidence 11122458999999999863 457789999999999999999999998877666555553322 222222335
Q ss_pred CCcHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFR--RPTFRQILMR 410 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~--Rpt~~ell~~ 410 (456)
.++.++.++|.+||..++++ ||++++++++
T Consensus 235 ~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 235 DVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 58899999999988764444 7899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=300.76 Aligned_cols=253 Identities=25% Similarity=0.457 Sum_probs=208.0
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.+ ..++..||||.+.............+.+|+.+++.++||||+++++++...+..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 4777889999999865 24789999998876544455566788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 228 YLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 228 ~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
|+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999998864 345899999999999999999999999 999999999999999999999999998765321
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc--chHHHHHhcCCCCCCCCCCC
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK--EVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~ 381 (456)
. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .....+.....++ .....
T Consensus 160 ~-----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 232 (267)
T cd08229 160 T-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP--LPSDH 232 (267)
T ss_pred C-----cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCC--CCccc
Confidence 1 1122345778899999998888999999999999999999999999765432 2222221111222 12356
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
++..+.+++.+||..||++|||++++++.+.++.
T Consensus 233 ~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 233 YSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 7889999999999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=295.42 Aligned_cols=248 Identities=29% Similarity=0.418 Sum_probs=204.0
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS--TPMMIV 225 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~lv 225 (456)
+|+....|++|+||.| +.+++.||+|+++.+.. .+..--..++|+.+|.+++|||||.+-.+.+.. +.+|+|
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 5777789999999977 45789999999987642 221123457999999999999999999887654 679999
Q ss_pred EEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 226 TEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
||||+ .+|..++..-+ ++...++..++.|++.|++|||.+. |+||||||+|+|++..|.+|++|||+|+.+..
T Consensus 156 Me~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs-- 229 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS-- 229 (419)
T ss_pred HHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC--
Confidence 99995 69999997755 6999999999999999999999999 99999999999999999999999999998743
Q ss_pred cccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCC------CC
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPP------FR 376 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~------~~ 376 (456)
.....+..+.|..|+|||.+.+. .|+++.|+||+|||+.||+++++.|.+....+....|.... .|. +.
T Consensus 230 ---p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 230 ---PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred ---CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 33455667788999999998876 68999999999999999999999999877665555553321 111 00
Q ss_pred ---------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 377 ---------------------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 377 ---------------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+....++..-.+|+..+|..||.+|.|+++.|++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0012256778899999999999999999999887
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=305.07 Aligned_cols=264 Identities=31% Similarity=0.553 Sum_probs=212.8
Q ss_pred CCccccCccccccccceeeeccEEEEEeE------------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCc
Q 012777 142 VPEYEIDPKELDFSNSVEITKGTFRIASW------------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPN 208 (456)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~lg~G~fg~~~~------------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~ 208 (456)
.|.+++.. .+|.+.+.||+|+||.+.. ++..||+|.+..+. .......+.+|+.+++.+ +|||
T Consensus 10 ~~~~~~~~--~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~ 85 (307)
T cd05098 10 DPRWEVPR--DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKN 85 (307)
T ss_pred CCcceeeh--HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCC
Confidence 34444443 3688999999999997621 23469999997642 344456788999999999 7999
Q ss_pred ceeeeeEEEeCCceEEEEEccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 012777 209 VVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG----------------ALKPTLAVKFALDIARGMNYLHENRPEAII 272 (456)
Q Consensus 209 iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~iv 272 (456)
|+++++++......++||||+++++|.+++...+ .++..+++.++.|++.||.|||+++ ++
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~ 162 (307)
T cd05098 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CI 162 (307)
T ss_pred EeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999999997642 3788899999999999999999999 99
Q ss_pred ecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-C
Q 012777 273 HRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-G 351 (456)
Q Consensus 273 H~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g 351 (456)
|+||||+||+++.++.+||+|||++......... .......+++.|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus 163 H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g 239 (307)
T cd05098 163 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 239 (307)
T ss_pred cccccHHheEEcCCCcEEECCCcccccccccchh---hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCC
Confidence 9999999999999999999999998755321100 01111234467999999988889999999999999999998 8
Q ss_pred CCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 352 CPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 352 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
..||......+....+....... .+...+.++.+++.+||..+|++|||++++++.|++++...
T Consensus 240 ~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 240 GSPYPGVPVEELFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred CCCCCcCCHHHHHHHHHcCCCCC---CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 99998766555555443332222 24567889999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=301.65 Aligned_cols=250 Identities=30% Similarity=0.496 Sum_probs=205.2
Q ss_pred ccccceeeeccEEEEEe---------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012777 153 DFSNSVEITKGTFRIAS---------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM 223 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~---------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 223 (456)
+|++.+.||+|+||.+. ..+..||+|.+... ........+.+|+.++++++||||+++++++......+
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 47777899999998662 14578999999754 33445577899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC
Q 012777 224 IVTEYLPKGDLRAYLKQK-----------------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~-----------------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~ 286 (456)
++|||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+|||++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence 999999999999998632 23788889999999999999999999 9999999999999999
Q ss_pred CCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHH
Q 012777 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPK 365 (456)
Q Consensus 287 ~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~ 365 (456)
+.+||+|||++......... .......++..|+|||++.+..++.++|+||||+++|+|++ |..||.+....+...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 161 LHVKISDLGLSREIYSADYY---RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred CcEEeccccccccccCCcce---ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999998765322111 11122335667999999988889999999999999999998 999998776555555
Q ss_pred HHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 012777 366 AYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDD 413 (456)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~ 413 (456)
.+.....++ .+..++..+.+++.+||+.||++||++.+++++|..
T Consensus 238 ~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 MVRKRQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 443333222 246788999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=304.89 Aligned_cols=245 Identities=27% Similarity=0.405 Sum_probs=201.9
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
|+..+.||+|+||.+ ..+++.||+|.+.............+.+|+.++++++|++|+++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999876 336889999998765444444456678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 229 LPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 229 ~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
+++++|.+++...+ .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 155 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--- 155 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC---
Confidence 99999999986543 4899999999999999999999999 999999999999999999999999998754221
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchH---HHHHhcCCCCCCCCCCCCc
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVP---KAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 383 (456)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||......... ......... ..+..++
T Consensus 156 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 229 (285)
T cd05630 156 ---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE---EYSEKFS 229 (285)
T ss_pred ---ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh---hcCccCC
Confidence 1112346888999999999989999999999999999999999999875432221 111111111 1346788
Q ss_pred HHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPT-----FRQILMR 410 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt-----~~ell~~ 410 (456)
.++.+++.+||+.||++||| +++++++
T Consensus 230 ~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 230 PDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 89999999999999999999 8899886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=297.59 Aligned_cols=246 Identities=26% Similarity=0.440 Sum_probs=207.9
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||+|+||.+ ..+++.|++|.+..... .......+.+|+.+++.++||||+++++++......+++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 3677789999999755 23688999999875433 34556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~- 155 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT- 155 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc-
Confidence 99999999999774 46899999999999999999999999 9999999999999999999999999987653211
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.......+++.|+|||++.+..++.++|+||||+++++|++|+.||...+.......+.....++. ...++.+
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 228 (256)
T cd08529 156 ----NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV---SQMYSQQ 228 (256)
T ss_pred ----chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---ccccCHH
Confidence 112234577889999999998899999999999999999999999988776555555544433333 3478889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.+++.+||+.+|++||++.+++++
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 229 LAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHhhC
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=304.33 Aligned_cols=248 Identities=23% Similarity=0.355 Sum_probs=203.2
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
|+..+.||+|+||.+ ..+++.||+|.+.............+.+|++++++++|++|+++++++...+..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 666788999999866 236889999999765444444456678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 229 LPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 229 ~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
+++++|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--- 155 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--- 155 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC---
Confidence 99999998886543 5999999999999999999999999 999999999999999999999999998754211
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||...........+..............++.++
T Consensus 156 ---~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd05632 156 ---ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEA 232 (285)
T ss_pred ---CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHH
Confidence 11123467899999999998899999999999999999999999998765544333332222221122346788899
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPT-----FRQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt-----~~ell~~ 410 (456)
.+|+.+||..||++||+ +++++.+
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 233 KSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 99999999999999999 6677665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=315.44 Aligned_cols=255 Identities=27% Similarity=0.446 Sum_probs=205.8
Q ss_pred ccccccceeeeccEEEEEeE----------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeC
Q 012777 151 ELDFSNSVEITKGTFRIASW----------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQS 219 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~~----------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~ 219 (456)
..+|.+.+.||+|+||.|.. .+..||||++... ......+.+.+|+.+++++. ||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT--ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 44678888999999997721 1246999999754 23445578999999999995 99999999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHc----------------------------------------------------------
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQK---------------------------------------------------------- 241 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~---------------------------------------------------------- 241 (456)
...++|||||++|+|.+++.++
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999999988642
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe
Q 012777 242 --------------------------------------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR 283 (456)
Q Consensus 242 --------------------------------------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~ 283 (456)
..+++..+..++.|++.||.|||+.+ |+|+||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 13677788899999999999999999 9999999999999
Q ss_pred CCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccc
Q 012777 284 DDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKE 362 (456)
Q Consensus 284 ~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~ 362 (456)
+.++.+||+|||++........ ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSN---YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred eCCCEEEEEeCCcceecccccc---ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 9999999999999886532111 111122345678999999988889999999999999999997 999998765443
Q ss_pred hH-HHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 012777 363 VP-KAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416 (456)
Q Consensus 363 ~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~ 416 (456)
.. ..+.....+. .+..++..+.+++.+||+.||++|||+.++.+.|+.++.
T Consensus 348 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 TFYNKIKSGYRMA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHhcCCCCC---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 33 2232222222 245778899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=301.99 Aligned_cols=253 Identities=29% Similarity=0.520 Sum_probs=207.5
Q ss_pred ccccceeeeccEEEEEeE----------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 153 DFSNSVEITKGTFRIASW----------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~~----------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
+|++.+.||+|+||.+.. ....+|+|.+.... .......+.+|+.+++.++||||+++++.+......
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 367778999999986521 22469999887553 344457889999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 012777 223 MIVTEYLPKGDLRAYLKQK------------------------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEP 278 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~------------------------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp 278 (456)
++++||+.+++|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhh
Confidence 9999999999999998642 23778899999999999999999999 99999999
Q ss_pred CCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 012777 279 SNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPT 357 (456)
Q Consensus 279 ~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~ 357 (456)
+||++++++.+||+|||++.......... ......++..|+|||.+.+..++.++||||||+++++|++ |..||.+
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYV---KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchh---cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999987552221110 1112334567999999988889999999999999999998 9999988
Q ss_pred CCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 012777 358 KQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416 (456)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~ 416 (456)
..+......+......+ .+..++.++.+++.+||+.+|++||+++++++.|+.++.
T Consensus 233 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 233 IAPERLFNLLKTGYRME---RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCHHHHHHHHhCCCCCC---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 77666555443332222 246678899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=318.04 Aligned_cols=243 Identities=25% Similarity=0.309 Sum_probs=194.3
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
..+|.+.+.||+|+||.| ..+++.||+|.... ..+.+|++++++++||||+++++++......+++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 346999999999999976 34688999997532 3467899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
+|++ +++|.+++.....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 162 ~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-- 235 (391)
T PHA03212 162 LPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-- 235 (391)
T ss_pred EecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc--
Confidence 9999 5799999988778999999999999999999999999 999999999999999999999999998754211
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc-------chHHHHHhc-CC-----
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK-------EVPKAYIAN-ER----- 372 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~-~~----- 372 (456)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+... +.
T Consensus 236 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 236 --NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred --cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 111223456899999999999999999999999999999999999876432210 011111000 00
Q ss_pred ---------------------CCC-C---CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 373 ---------------------PPF-R---APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 373 ---------------------~~~-~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+. . ......+.++.++|.+||+.||.+|||++|++++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 0 0012346679999999999999999999999975
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=315.18 Aligned_cols=237 Identities=27% Similarity=0.413 Sum_probs=196.8
Q ss_pred eeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHH-HHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 158 VEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELA-LLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 158 ~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
+.||+|+||.| ..+|+.||+|++.+...........+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36899999876 2368899999997654333444456666665 46678999999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCC
Q 012777 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311 (456)
Q Consensus 232 ~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~ 311 (456)
++|.+++...+.+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~-----~~~~ 152 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-----QSDT 152 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCC-----CCCC
Confidence 999999988888999999999999999999999999 99999999999999999999999999874311 1112
Q ss_pred cccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q 012777 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIE 391 (456)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 391 (456)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.... .. .....+..+.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~ll~ 228 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP-LV---LRPGASLTAWSILE 228 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-cc---CCCCCCHHHHHHHH
Confidence 234568899999999999999999999999999999999999998877666665553322 22 13467888999999
Q ss_pred HhcccCCCCCCCHHH
Q 012777 392 DCWSEEPFRRPTFRQ 406 (456)
Q Consensus 392 ~~l~~dp~~Rpt~~e 406 (456)
+||..||.+||++.+
T Consensus 229 ~ll~~~p~~R~~~~~ 243 (325)
T cd05604 229 ELLEKDRQRRLGAKE 243 (325)
T ss_pred HHhccCHHhcCCCCC
Confidence 999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=297.14 Aligned_cols=251 Identities=27% Similarity=0.462 Sum_probs=206.9
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCC--HHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTD--EDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
+|...+.||+|+||.+ ..+++.||+|.+....... ......+.+|+.++++++||||+++++++..+...+++
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 4788899999999865 2468899999987543221 22346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
+||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 999999999999988888999999999999999999999999 99999999999999999999999999876532110
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.........++..|+|||++.+..++.++||||||+++|+|++|+.||...+............ .....+..++..
T Consensus 160 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (263)
T cd06625 160 --SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP--TNPQLPSHVSPD 235 (263)
T ss_pred --ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC--CCCCCCccCCHH
Confidence 1111123456778999999999889999999999999999999999998766554444332222 112235678889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.++|.+||..+|++|||+.+++++
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhC
Confidence 9999999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=302.14 Aligned_cols=253 Identities=27% Similarity=0.438 Sum_probs=209.1
Q ss_pred ccccceeeeccEEEEEe----------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 153 DFSNSVEITKGTFRIAS----------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~----------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
+|...+.||+|+||.+. .++..+++|.+... .......+.+|+.++++++||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 46777899999998652 13456999998643 334456788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC
Q 012777 223 MIVTEYLPKGDLRAYLKQKG----------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~ 286 (456)
++||||+++++|.+++...+ .+++..++.++.|++.||.|||+++ ++|+||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 99999999999999997643 3788999999999999999999999 9999999999999999
Q ss_pred CCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHH
Q 012777 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPK 365 (456)
Q Consensus 287 ~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~ 365 (456)
+.++|+|||++........ ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+...
T Consensus 160 ~~~~l~dfg~a~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDY---YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred CcEEECCCCcccccCCCce---eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999875532111 111122345678999999998899999999999999999998 999998877766655
Q ss_pred HHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 366 AYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
.+.....+. .....+..+.+++.+||+.+|++|||++++++.|+.+.+.
T Consensus 237 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 CITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHhCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 553333222 2456788999999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=301.55 Aligned_cols=249 Identities=23% Similarity=0.369 Sum_probs=202.0
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|++.+.||+|+||.+ ..+++.||+|++.... ......+.+|+.++++++||||+++++++......++||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 36889999999999865 2367899999997542 223456789999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||+++++|.+++...+.+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--- 159 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITAT--- 159 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccc---
Confidence 99999999999988788999999999999999999999999 999999999999999999999999998865321
Q ss_pred cCCCCcccCCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCCCCCCCC
Q 012777 307 KEDRPVTCEETSWRYAAPEVYK---NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRAPTTHY 382 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 382 (456)
........+++.|+|||.+. ...++.++|+||+||++|+|++|..||....+.+....+.... .++.......+
T Consensus 160 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06646 160 --IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW 237 (267)
T ss_pred --ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcccccc
Confidence 11112345778899999874 3457789999999999999999999997665443322221111 11111123457
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
+..+.++|.+||..+|++|||+++++++|
T Consensus 238 ~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 238 SSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 88999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=297.48 Aligned_cols=245 Identities=27% Similarity=0.453 Sum_probs=205.7
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|++.+.||.|+||.+ ..++..||+|.+.... .....+.+.+|+.+++.++||||+++++++.....++++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4677889999999865 3468899999986542 23455778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|+++++|.+++... ..+++..+..++.|++.||.+||+++ ++|+||||+||+++.++.++++|||++......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 153 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-- 153 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc--
Confidence 99999999988653 34899999999999999999999999 999999999999999999999999998755321
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
........+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+......+ .+..++..
T Consensus 154 ---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 227 (255)
T cd08219 154 ---GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP---LPSHYSYE 227 (255)
T ss_pred ---ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC---CCcccCHH
Confidence 111223457888999999998889999999999999999999999998776655555443333332 24567888
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.++|.+||+.||++|||+++++..
T Consensus 228 ~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 228 LRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHHhCCcccCCCHHHHhhc
Confidence 9999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=297.20 Aligned_cols=246 Identities=30% Similarity=0.559 Sum_probs=202.7
Q ss_pred cccccceeeeccEEEEEe---E-cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 152 LDFSNSVEITKGTFRIAS---W-RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~---~-~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.+|+..+.||+|+||.+. . .+..+|+|++..... . ...+.+|+.++++++||||+++++++......++|||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-S---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-C---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 357788899999998662 2 456899999875432 1 2467889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|+++++|.+++... +.+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~- 155 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY- 155 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-
Confidence 99999999999764 46899999999999999999999999 99999999999999999999999999875532110
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+........ +..++..
T Consensus 156 ---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 229 (256)
T cd05059 156 ---TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR---PKLAPTE 229 (256)
T ss_pred ---cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCC---CCCCCHH
Confidence 01111223457999999998899999999999999999999 8999987776666655543333222 3568899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
+.+++.+||..+|++|||+.++++.|
T Consensus 230 ~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 230 VYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 99999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=297.69 Aligned_cols=246 Identities=30% Similarity=0.552 Sum_probs=202.5
Q ss_pred ccccceeeeccEEEEE---eEc-CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 153 DFSNSVEITKGTFRIA---SWR-GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~~-g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
+|...+.||+|+||.+ .+. +..||+|.+..... ....+.+|+.++++++||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 4677789999999865 333 34699999875432 235688999999999999999999999998999999999
Q ss_pred cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 229 LPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 229 ~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
+.+++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-- 155 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce--
Confidence 9999999999764 35899999999999999999999999 99999999999999999999999999875532111
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+....... .+...+..+
T Consensus 156 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 230 (256)
T cd05113 156 --TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY---RPHLASEKV 230 (256)
T ss_pred --eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC---CCCCCCHHH
Confidence 01112235567999999988889999999999999999998 999998777665555554333322 234568899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
.+++.+||..||++|||+.+++..|+
T Consensus 231 ~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 231 YAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=297.74 Aligned_cols=251 Identities=31% Similarity=0.506 Sum_probs=206.2
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCH------HHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDE------DKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~------~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
|.....||+|+||.+ ..+++.||+|.+........ ...+.+.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 667789999999865 23678999999875433221 2346788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
++++||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 999999999999999988888999999999999999999999999 99999999999999999999999999886642
Q ss_pred cccc-cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCC
Q 012777 303 ANTV-KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 303 ~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (456)
.... ..........++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.....+. .+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 235 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPE---IPSN 235 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCc---CCcc
Confidence 2111 11111223457788999999998889999999999999999999999998765544443333322222 3467
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++..+.++|.+||+.||++||++.+++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 236 ISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred cCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 88899999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=306.10 Aligned_cols=256 Identities=27% Similarity=0.522 Sum_probs=206.9
Q ss_pred ccccccceeeeccEEEEEe---E--cCc----EEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012777 151 ELDFSNSVEITKGTFRIAS---W--RGT----QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~---~--~g~----~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 221 (456)
..+|+..+.||+|+||.+. + +++ .||+|++... ......+.+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 3468899999999998762 1 333 4899998753 3445567889999999999999999999998764 5
Q ss_pred eEEEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
.++++||+++|+|.+++.+.. .++...++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 789999999999999998743 5889999999999999999999999 999999999999999999999999999866
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCC
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPT 379 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 379 (456)
...... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+......+. +
T Consensus 160 ~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~ 233 (316)
T cd05108 160 GADEKE---YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---P 233 (316)
T ss_pred cCCCcc---eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCC---C
Confidence 322111 01111234567999999999999999999999999999997 9999987765554433322222222 3
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 380 THYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
..++.++.+++.+||..+|++||++.+++..|..+.+.-
T Consensus 234 ~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 234 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 567788999999999999999999999999988886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=313.05 Aligned_cols=236 Identities=27% Similarity=0.396 Sum_probs=194.3
Q ss_pred eeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHH-HHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 158 VEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELA-LLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 158 ~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
+.||+|+||.+ ..+|+.||+|++.+...........+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999876 2368899999997643333333455566654 57788999999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCC
Q 012777 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311 (456)
Q Consensus 232 ~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~ 311 (456)
++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..... ....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~-----~~~~ 152 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE-----PEET 152 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCC-----CCCc
Confidence 999999988778999999999999999999999999 99999999999999999999999999874311 1112
Q ss_pred cccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q 012777 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIE 391 (456)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 391 (456)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+... ... .+...+..+.++|.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~---~~~~~~~~~~~li~ 228 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-PLQ---LPGGKTVAACDLLV 228 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCC---CCCCCCHHHHHHHH
Confidence 22346889999999999989999999999999999999999999887765555555322 222 24567888999999
Q ss_pred HhcccCCCCCCCHH
Q 012777 392 DCWSEEPFRRPTFR 405 (456)
Q Consensus 392 ~~l~~dp~~Rpt~~ 405 (456)
+||+.||.+||++.
T Consensus 229 ~~l~~~p~~R~~~~ 242 (321)
T cd05603 229 GLLHKDQRRRLGAK 242 (321)
T ss_pred HHccCCHhhcCCCC
Confidence 99999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=305.54 Aligned_cols=252 Identities=31% Similarity=0.532 Sum_probs=204.0
Q ss_pred ccccceeeeccEEEEE---e--EcCc--EEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEE
Q 012777 153 DFSNSVEITKGTFRIA---S--WRGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~--~~g~--~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~l 224 (456)
+|++.+.||+|+||.+ . .++. .+|+|.+... ........+.+|+.++.++ +||||+++++++...+..++
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 5788889999999866 2 2444 4577776542 3445567888999999999 89999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC
Q 012777 225 VTEYLPKGDLRAYLKQKG----------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~ 288 (456)
+|||+++++|.+++...+ .+++..++.++.|++.||.|||+++ ++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999997542 4788999999999999999999999 999999999999999999
Q ss_pred EEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHH
Q 012777 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAY 367 (456)
Q Consensus 289 vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~ 367 (456)
+||+|||++...... . .......+..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+
T Consensus 163 ~kl~dfg~~~~~~~~----~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 163 AKIADFGLSRGQEVY----V--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred EEeCccccCcccchh----h--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 999999998633110 0 0111223557999999988888999999999999999998 99999877665555444
Q ss_pred HhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 368 IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
....... .+...+.++.+++.+||+.+|++||++++++..|+.+...-
T Consensus 237 ~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 237 PQGYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred hcCCcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 3222222 23457888999999999999999999999999998876444
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=327.69 Aligned_cols=264 Identities=20% Similarity=0.347 Sum_probs=211.3
Q ss_pred cCccccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeE-EEe-
Q 012777 147 IDPKELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGA-VTQ- 218 (456)
Q Consensus 147 ~~~~~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~-~~~- 218 (456)
+.....++++.+.|.+|+|+.|. ..|..||+|++-.. ++...+.+.+|+++|++|+ |+|||.|+|. ...
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 44556678899999999998762 23489999998753 7788899999999999996 9999999994 221
Q ss_pred -----CCceEEEEEccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEE
Q 012777 219 -----STPMMIVTEYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291 (456)
Q Consensus 219 -----~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl 291 (456)
.-.++|.||||.||.|.|+++++ ..|++.++++|+.++++|+.+||... .+|||||||-+|||++.+|..||
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEe
Confidence 13578999999999999999864 34999999999999999999999996 68999999999999999999999
Q ss_pred eccCCcccccccccccCCC----CcccCCCCccccccccc---CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchH
Q 012777 292 ADFGLSKLLKFANTVKEDR----PVTCEETSWRYAAPEVY---KNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVP 364 (456)
Q Consensus 292 ~Dfgls~~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 364 (456)
||||.+............. .......|+.|+|||++ ++.+.+.|+|||+|||+||-|+....||.......+.
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl 267 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL 267 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE
Confidence 9999988442221100000 01123478899999976 6778999999999999999999999999886543322
Q ss_pred HHHHhcCCCCCCCC-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccc
Q 012777 365 KAYIANERPPFRAP-TTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIK 421 (456)
Q Consensus 365 ~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~ 421 (456)
.. .|..+ ...|+..+.+||..||+.||++||++-+++..+-++..+-...
T Consensus 268 ----ng---~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~ 318 (738)
T KOG1989|consen 268 ----NG---NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI 318 (738)
T ss_pred ----ec---cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc
Confidence 11 12222 2689999999999999999999999999999998887654333
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=308.16 Aligned_cols=253 Identities=30% Similarity=0.505 Sum_probs=204.1
Q ss_pred ccccceeeeccEEEEEeE----------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC-C
Q 012777 153 DFSNSVEITKGTFRIASW----------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQS-T 220 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~~----------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~ 220 (456)
+|++.+.||+|+||.+.. +++.||+|++.... .......+..|+.++.++ +||||+++++++... .
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 588889999999997731 24689999987542 334456788999999999 799999999987654 5
Q ss_pred ceEEEEEccCCCCHHHHHHHc-----------------------------------------------------------
Q 012777 221 PMMIVTEYLPKGDLRAYLKQK----------------------------------------------------------- 241 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~----------------------------------------------------------- 241 (456)
.+++++||+++++|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999998642
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCc
Q 012777 242 --GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSW 319 (456)
Q Consensus 242 --~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~ 319 (456)
..+++..+..++.|++.||.|||+++ |+||||||.|||++.++.++|+|||++..+...... .......++.
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~---~~~~~~~~~~ 239 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---VRKGDARLPL 239 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcch---hhccCCCCCc
Confidence 25788899999999999999999999 999999999999999999999999999865322111 1112234566
Q ss_pred ccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcC-CCCCCCCCCCCcHHHHHHHHHhcccC
Q 012777 320 RYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANE-RPPFRAPTTHYAYGLRELIEDCWSEE 397 (456)
Q Consensus 320 ~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~d 397 (456)
.|+|||++.+..++.++|||||||++|+|++ |..||......+......... .+. .+...+.++.+++.+||+.+
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~cl~~~ 316 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR---APEYATPEIYSIMLDCWHNN 316 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC---CCccCCHHHHHHHHHHccCC
Confidence 7999999999999999999999999999997 999998755444332322222 222 23567788999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHH
Q 012777 398 PFRRPTFRQILMRLDDISD 416 (456)
Q Consensus 398 p~~Rpt~~ell~~L~~~~~ 416 (456)
|++||++.+++++|+.++.
T Consensus 317 p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 317 PEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred hhhCcCHHHHHHHHHHHHh
Confidence 9999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=296.08 Aligned_cols=246 Identities=24% Similarity=0.447 Sum_probs=201.1
Q ss_pred eeeccEEEEEe---E----cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 159 EITKGTFRIAS---W----RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 159 ~lg~G~fg~~~---~----~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
.||+|+||.+. + .+..||+|++... ......+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc--cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 48999998652 2 3456999998754 234455779999999999999999999998854 578999999999
Q ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCC
Q 012777 232 GDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR 310 (456)
Q Consensus 232 ~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~ 310 (456)
++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++...........
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~-- 153 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK-- 153 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcccee--
Confidence 999999875 346999999999999999999999999 99999999999999999999999999875532211111
Q ss_pred CcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHH
Q 012777 311 PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLREL 389 (456)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 389 (456)
......+++.|+|||.+....++.++|+||||+++|++++ |..||...........+.....+.. +...+.++.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l 230 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC---PAECPPEMYAL 230 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC---CCCCCHHHHHH
Confidence 1112233568999999988889999999999999999996 9999988776666555544333332 45678899999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 390 IEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 390 i~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
|.+||..+|++||++.++.+.|+.++
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=302.74 Aligned_cols=256 Identities=29% Similarity=0.542 Sum_probs=210.2
Q ss_pred ccccccceeeeccEEEEEeE------------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEE
Q 012777 151 ELDFSNSVEITKGTFRIASW------------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVT 217 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~~------------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~ 217 (456)
..+|.+.+.||+|+||.+.. .+..||+|.+.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 45678889999999986621 23479999987542 344567889999999999 7999999999999
Q ss_pred eCCceEEEEEccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 012777 218 QSTPMMIVTEYLPKGDLRAYLKQKG----------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNI 281 (456)
Q Consensus 218 ~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Ni 281 (456)
.....+++|||+++++|.+++.... .++...+..++.|++.||.|||+++ ++|+||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 9999999999999999999997642 3677888999999999999999999 99999999999
Q ss_pred EeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 012777 282 LRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQE 360 (456)
Q Consensus 282 l~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~ 360 (456)
+++.++.+||+|||++......... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+.
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred EEcCCCcEEECCCccceeccccccc---ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9999999999999998866322111 11122335567999999988889999999999999999998 8899988776
Q ss_pred cchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 361 KEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
.+....+....... .+..++..+.+++.+||..+|++|||+.++++.|+++..-
T Consensus 246 ~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 EELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 66665554333322 2457888999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=302.42 Aligned_cols=252 Identities=32% Similarity=0.511 Sum_probs=206.7
Q ss_pred ccccceeeeccEEEEEe-----EcCc--EEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~--~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~l 224 (456)
+|++.+.||+|+||.+. .++. .+++|.++.. ......+.+.+|+.++.++ +||||+++++++......++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 57788899999998662 2333 4788887642 2344557789999999999 79999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC
Q 012777 225 VTEYLPKGDLRAYLKQKG----------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~ 288 (456)
++||+++++|.+++.+.+ .+++..++.++.|++.||.|||+++ ++|+||||+|||++.++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCe
Confidence 999999999999997532 3788899999999999999999999 999999999999999999
Q ss_pred EEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHH
Q 012777 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAY 367 (456)
Q Consensus 289 vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~ 367 (456)
+||+|||++...... ........+..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+
T Consensus 158 ~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~ 231 (297)
T cd05089 158 SKIADFGLSRGEEVY------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231 (297)
T ss_pred EEECCcCCCccccce------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999998643110 00111223456999999988889999999999999999997 99999887776665555
Q ss_pred HhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 368 IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
....... .+..++.++.+|+.+||..+|.+|||++++++.|+.+....
T Consensus 232 ~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 232 PQGYRME---KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred hcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 3332222 24568889999999999999999999999999999998766
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=298.53 Aligned_cols=250 Identities=31% Similarity=0.527 Sum_probs=210.2
Q ss_pred ccccccceeeeccEEEEE----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 151 ELDFSNSVEITKGTFRIA----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
..+|+..+.||.|+||.+ ...+..+|+|++.... ......+..|+.+++.++||||+++++++......+++|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 346888899999999865 2347889999987642 334567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 227 EYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 227 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
||+++++|.+++... ..++...+..++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999999763 35899999999999999999999999 9999999999999999999999999987653211
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+......+. +..++
T Consensus 159 -----~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 230 (261)
T cd05148 159 -----YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC---PAKCP 230 (261)
T ss_pred -----ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCC---CCCCC
Confidence 11112335667999999988889999999999999999998 8999988777666666654333332 46788
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
.++.+++.+||..||++|||++++++.|+.+
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 231 QEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 8999999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=311.72 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=204.6
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.| ..+++.||+|++.+...........+.+|+.++..++|++|+++++++.....+++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 5778899999999966 23577899999975332333444568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|+++++|.+++.+ ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-- 156 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-- 156 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC--
Confidence 9999999999977 456999999999999999999999999 9999999999999999999999999987542211
Q ss_pred cCCCCcccCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCCCCCC
Q 012777 307 KEDRPVTCEETSWRYAAPEVYK-----NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRAPTT 380 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~ 380 (456)
........||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..+....+.... ...++....
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 234 (332)
T cd05623 157 --TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVT 234 (332)
T ss_pred --cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccc
Confidence 11112346899999999986 3467889999999999999999999998877666666654332 223333345
Q ss_pred CCcHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFR--RPTFRQILMR 410 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~--Rpt~~ell~~ 410 (456)
.++.++.++|.+|+..++++ |+++++++++
T Consensus 235 ~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 235 DVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 68899999999999765554 6899999888
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=318.81 Aligned_cols=246 Identities=25% Similarity=0.392 Sum_probs=213.7
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|.+...||.|.||.|. .++-..|.|++.. ..++..++++-|+++|..+.||+|++|++.|..++.++|+.|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 37888999999999772 3445577788864 357788999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||+||-+..++-+- ..+.+.++..+++|++.||+|||+++ |||||||..|||++-+|.++|+|||.+....
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~----- 181 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK----- 181 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch-----
Confidence 99999999887664 56999999999999999999999999 9999999999999999999999999986542
Q ss_pred cCCCCcccCCCCcccccccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCC
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKN-----EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (456)
........+.|||.|||||+... .+|+.++||||||++|.+|..+.+|....++..+...+.+...|. -..+..
T Consensus 182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPT-LlqPS~ 260 (1187)
T KOG0579|consen 182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LLQPSH 260 (1187)
T ss_pred hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCc-ccCcch
Confidence 22233446789999999998744 589999999999999999999999999999988888885554444 345677
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
-+..|.+|+.+||.+||..||++.++++|
T Consensus 261 Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 261 WSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred hhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 88899999999999999999999999986
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=301.23 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=207.1
Q ss_pred ccccccceeeeccEEEEEe----------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC
Q 012777 151 ELDFSNSVEITKGTFRIAS----------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQS 219 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~----------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~ 219 (456)
..+|...+.||+|+||.+. ..+..||+|.+.... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 4468888999999998662 124479999987542 344557889999999999 799999999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCc
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQKGA--LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLS 297 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls 297 (456)
+..+++|||+++++|.+++..... +++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999999976432 899999999999999999999999 999999999999999999999999998
Q ss_pred ccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCC
Q 012777 298 KLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFR 376 (456)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 376 (456)
......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...................
T Consensus 189 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-- 263 (302)
T cd05055 189 RDIMNDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-- 263 (302)
T ss_pred ccccCCCce---eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC--
Confidence 765322110 11112345678999999999889999999999999999998 999998766544433332222111
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 377 APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 377 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
..+...+..+.+++.+||..+|++|||+.++++.|+++
T Consensus 264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 12456788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=299.54 Aligned_cols=244 Identities=24% Similarity=0.418 Sum_probs=212.2
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
-|.+.++||+|+||-| +.+|+.+|||.+..+ ...+.+..|+.++++++.|++|++|+.|.....+++|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 4888899999999965 678999999998754 335789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||..|++.|++..+ .++++.++..+++..+++|+|||... -+|||||..|||++.+|.+||+|||.+-.+.+..
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-- 183 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-- 183 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--
Confidence 99999999998754 56999999999999999999999998 8999999999999999999999999998774322
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
.......|||.|||||++..-.|+.++||||||++..||.-|++||.+..+....-.+-.+..|.+.. +..-+++|
T Consensus 184 ---AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~K-PE~WS~~F 259 (502)
T KOG0574|consen 184 ---AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKK-PEEWSSEF 259 (502)
T ss_pred ---HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCC-hHhhhhHH
Confidence 12234679999999999999999999999999999999999999999988876655453333444432 45567889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+|+++||.++|++|-|+.++++|
T Consensus 260 ~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 260 NDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HHHHHHHhcCCHHHHHHHHHHhhh
Confidence 999999999999999999998876
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=301.08 Aligned_cols=253 Identities=27% Similarity=0.448 Sum_probs=205.6
Q ss_pred cccccceeeeccEEEEEeE---------------------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcce
Q 012777 152 LDFSNSVEITKGTFRIASW---------------------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVV 210 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~~---------------------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv 210 (456)
.+|.+.+.||+|+||.+.. .+..||+|.+.... .....+.+.+|++++++++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3678889999999986631 23568999987652 345567899999999999999999
Q ss_pred eeeeEEEeCCceEEEEEccCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 012777 211 QFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG-----------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPS 279 (456)
Q Consensus 211 ~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~ 279 (456)
++++++......+++|||+++++|.+++.... .+++..++.++.|++.||.|||+++ ++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence 99999999999999999999999999997765 6899999999999999999999999 999999999
Q ss_pred CeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCC
Q 012777 280 NILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE--GCPPFPT 357 (456)
Q Consensus 280 Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~ 357 (456)
||+++.++.++|+|||++........ ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDY---YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred ceeecCCCceEEccccceeecccCcc---eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999875422110 111122345678999999988889999999999999999998 7788877
Q ss_pred CCccchHHHHHhc----CCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 358 KQEKEVPKAYIAN----ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 358 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
.+........... ........+..++.++.+++.+||+.||++|||+.++++.|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 237 LTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred cChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 6655544444322 111111224567789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=294.00 Aligned_cols=247 Identities=28% Similarity=0.509 Sum_probs=202.9
Q ss_pred eeeeccEEEEEe---E-----cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEcc
Q 012777 158 VEITKGTFRIAS---W-----RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229 (456)
Q Consensus 158 ~~lg~G~fg~~~---~-----~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~ 229 (456)
+.||+|+||.+. + .+..||+|.+...... ...+.+.+|+.+++.+.||||+++++++. ....+++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 368999998662 2 2368999999866432 44578899999999999999999999876 45689999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCC
Q 012777 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKED 309 (456)
Q Consensus 230 ~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~ 309 (456)
++++|.+++...+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++..........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~-- 152 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY-- 152 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc--
Confidence 99999999988778999999999999999999999999 9999999999999999999999999988663322111
Q ss_pred CCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHH
Q 012777 310 RPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRE 388 (456)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 388 (456)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...+..+....+......+ .+..++..+.+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~ 229 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLP---RPEECPQEIYS 229 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCC---CCCCCCHHHHH
Confidence 11111223457999999998899999999999999999998 999998877655555553332222 34678889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 389 LIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 389 li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
+|.+||..+|++||++.++++.|+.+.
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=297.26 Aligned_cols=252 Identities=28% Similarity=0.470 Sum_probs=199.6
Q ss_pred cccceeeeccEEEEEe---------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--Cce
Q 012777 154 FSNSVEITKGTFRIAS---------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS--TPM 222 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~~---------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~ 222 (456)
|...+.||+|+||.+. .++..||+|.+.... .......+.+|+++++.++||||+++++++... ..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 3677899999999762 257789999997642 334456788999999999999999999988653 458
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
+++|||+++++|.+++.. ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999999976 45999999999999999999999999 99999999999999999999999999886632
Q ss_pred cccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc--hH------------HHHH
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE--VP------------KAYI 368 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~------------~~~~ 368 (456)
..... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... .. ....
T Consensus 160 ~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 160 GHEYY--RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred cchhh--ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 21111 11112234567999999988889999999999999999999999986543211 00 0000
Q ss_pred hcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 369 ANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
... .....+..++.++.+++.+||+.+|++|||++++++.|+++.
T Consensus 238 ~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERG--MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcC--CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000 011124567889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=301.98 Aligned_cols=254 Identities=31% Similarity=0.563 Sum_probs=208.5
Q ss_pred ccccccceeeeccEEEEEe---E-------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC
Q 012777 151 ELDFSNSVEITKGTFRIAS---W-------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQS 219 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~---~-------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~ 219 (456)
..+|+..+.||+|+||.+. . ....+|+|.+.... .......+.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 3457888899999998652 1 23579999987642 344557789999999999 799999999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQK----------------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR 283 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~ 283 (456)
..++++|||+++++|.+++... +.+++..+..++.|++.||.|||+.+ |+|+||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999999642 34888999999999999999999999 9999999999999
Q ss_pred CCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccc
Q 012777 284 DDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKE 362 (456)
Q Consensus 284 ~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~ 362 (456)
+.++.+||+|||++..+...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYY---RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred cCCCeEEeCccccccccccccce---eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 99999999999998865322110 11111234567999999988889999999999999999997 999998877666
Q ss_pred hHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 363 VPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
....+....... .+...+..+.+++.+||..||++|||++++++.|+.+.
T Consensus 243 ~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLLKEGYRME---KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 665554333322 24567889999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=296.03 Aligned_cols=251 Identities=27% Similarity=0.479 Sum_probs=204.3
Q ss_pred cccceeeeccEEEEEe---E-----cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc----
Q 012777 154 FSNSVEITKGTFRIAS---W-----RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP---- 221 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~~---~-----~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~---- 221 (456)
|...+.||+|+||.+. . .+..||+|.+..+. ........+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 4566789999998662 1 23679999998653 234456789999999999999999999998866543
Q ss_pred --eEEEEEccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEec
Q 012777 222 --MMIVTEYLPKGDLRAYLKQK------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293 (456)
Q Consensus 222 --~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~D 293 (456)
.++++||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECC
Confidence 79999999999999988542 24899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCC
Q 012777 294 FGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANER 372 (456)
Q Consensus 294 fgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 372 (456)
||++.......... .......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus 157 fg~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05035 157 FGLSKKIYSGDYYR---QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR 233 (273)
T ss_pred ccceeecccccccc---ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99988653221111 1111234567999999988889999999999999999999 8999988776666555543333
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 373 PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 373 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
.. .+..++.++.+++.+||+.||++|||+.++++.|+++
T Consensus 234 ~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 LK---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 32 2467888999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=298.92 Aligned_cols=247 Identities=23% Similarity=0.383 Sum_probs=202.3
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.+ ..+++.||+|+++... ......+.+|+.+++.++||||+++++++...+..+++||
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 6888889999999865 2368899999987542 2334567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++...+.+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~---- 159 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT---- 159 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc----
Confidence 9999999999988888999999999999999999999999 999999999999999999999999998755221
Q ss_pred CCCCcccCCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCCCCCCCCc
Q 012777 308 EDRPVTCEETSWRYAAPEVYK---NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRAPTTHYA 383 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 383 (456)
........+++.|+|||++. ...++.++|+|||||++|+|++|..||....+........... .++.......++
T Consensus 160 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06645 160 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWS 238 (267)
T ss_pred -ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCC
Confidence 11122346788999999874 4568889999999999999999999997665544333222222 122111223577
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..+.++|.+||..+|++|||+++++++
T Consensus 239 ~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 239 NSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 889999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=314.38 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=200.7
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC-----ce
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST-----PM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-----~~ 222 (456)
+|+..+.||+|+||.+ ..+|+.||+|.+.... .+......+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4778889999999976 2468999999987542 33445567889999999999999999999998776 78
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
++|+||+. ++|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99999995 689998887778999999999999999999999999 99999999999999999999999999876532
Q ss_pred cccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc-----------
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN----------- 370 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~----------- 370 (456)
. .........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...++......+...
T Consensus 156 ~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 156 D----ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred C----ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 1 11122234578889999998774 4788999999999999999999999877654433322110
Q ss_pred -----------C--CCCC----CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 371 -----------E--RPPF----RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 371 -----------~--~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
. .++. .......+.++.++|.+||+.||++|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 0100 01124457889999999999999999999999887
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=314.89 Aligned_cols=240 Identities=25% Similarity=0.384 Sum_probs=196.4
Q ss_pred eeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC---CCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 160 ITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI---RHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 160 lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
||+|+||.+ ..+|+.||+|++.+..............|..++... .||+|+++++.+......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 689999876 336889999999754433334445566677777665 699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCC
Q 012777 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311 (456)
Q Consensus 232 ~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~ 311 (456)
++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++...... ...
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-----~~~ 152 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD-----NKT 152 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-----CCC
Confidence 999999988888999999999999999999999999 999999999999999999999999998753211 112
Q ss_pred cccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHH
Q 012777 312 VTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELI 390 (456)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 390 (456)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.... . ......++.++.++|
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~--~~~~~~~~~~~~~li 229 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK-V--RFPKNVLSDEGRQFV 229 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC-C--CCCCccCCHHHHHHH
Confidence 2335689999999998764 47899999999999999999999998877666655553332 1 222345788999999
Q ss_pred HHhcccCCCCCC----CHHHHHHH
Q 012777 391 EDCWSEEPFRRP----TFRQILMR 410 (456)
Q Consensus 391 ~~~l~~dp~~Rp----t~~ell~~ 410 (456)
.+||..||++|| ++.+++++
T Consensus 230 ~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 230 KGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HHHcCCCHHHCCCCCCCHHHHhcC
Confidence 999999999998 57777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=333.67 Aligned_cols=260 Identities=32% Similarity=0.519 Sum_probs=221.6
Q ss_pred ccccceeeeccEEEEEe------EcC----cEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 153 DFSNSVEITKGTFRIAS------WRG----TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~------~~g----~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
.....+.||+|.||.|. ..| ..||+|.+... .+.+....|.+|..+|+.++||||++++|++.+....
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 34556789999999762 123 34899988764 5788889999999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccC
Q 012777 223 MIVTEYLPKGDLRAYLKQK-------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFG 295 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfg 295 (456)
+|++||+++|+|..+|.+. ..++..+.+.++.+++.|++||++++ +|||||...|+|++....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999875 23899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCC
Q 012777 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPP 374 (456)
Q Consensus 296 ls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 374 (456)
+|+..-...... ......-+..|||||.+..+.++.++|||||||+|||+++ |..||.+.+..++...+..+++.+
T Consensus 848 lArDiy~~~yyr---~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~ 924 (1025)
T KOG1095|consen 848 LARDIYDKDYYR---KHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLD 924 (1025)
T ss_pred hhHhhhhchhee---ccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccC
Confidence 999442211111 1111244568999999999999999999999999999999 999999999988887676666554
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccc
Q 012777 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRH 423 (456)
Q Consensus 375 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~ 423 (456)
. +..+|+.+.++|..||+.+|++||++..|++++..+...+.-...
T Consensus 925 ~---P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~ 970 (1025)
T KOG1095|consen 925 P---PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIY 970 (1025)
T ss_pred C---CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcc
Confidence 3 678999999999999999999999999999999998877644443
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=293.65 Aligned_cols=244 Identities=35% Similarity=0.626 Sum_probs=207.0
Q ss_pred cccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 152 LDFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
.+|+..+.||.|+||.+ ...|+.||+|.+.... ...+.+.+|+.+++.++|+||+++++++......++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEEeccch----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 35777889999999865 5678999999997542 1457889999999999999999999999988999999999
Q ss_pred cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 229 LPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 229 ~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
+++++|.+++.... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 99999999998765 6999999999999999999999999 9999999999999999999999999988652111
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.....+..|+|||.+....++.++|+||||+++++|++ |..||......+....+....... .+..++..
T Consensus 157 ------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 227 (256)
T cd05039 157 ------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRME---APEGCPPE 227 (256)
T ss_pred ------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC---CccCCCHH
Confidence 11233557999999988889999999999999999997 999998776655554443322222 24567889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMRLDD 413 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~L~~ 413 (456)
+.++|.+||..+|++|||++++++.|+.
T Consensus 228 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 228 VYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=295.23 Aligned_cols=244 Identities=35% Similarity=0.602 Sum_probs=205.9
Q ss_pred eeeeccEEEEE---eE--c---CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEcc
Q 012777 158 VEITKGTFRIA---SW--R---GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229 (456)
Q Consensus 158 ~~lg~G~fg~~---~~--~---g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~ 229 (456)
+.||+|+||.+ .. . +..||+|.+..... ......+.+|+..++.++|++|+++++++......+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 36899999865 22 2 78999999986532 225678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 230 PKGDLRAYLKQK---------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 230 ~~~sL~~~l~~~---------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
++++|.+++... ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccc
Confidence 999999999875 67999999999999999999999999 999999999999999999999999999866
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCC
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPT 379 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 379 (456)
..... ........+++.|+|||.+....++.++|+||||+++|+|++ |..||......+....+....... .+
T Consensus 156 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 229 (262)
T cd00192 156 YDDDY---YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP---KP 229 (262)
T ss_pred ccccc---cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CC
Confidence 43211 111223456778999999988889999999999999999999 699999887766666664433322 24
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 380 THYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
..++.++.+++.+||..+|++|||+++++++|+
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 230 EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 667889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=311.24 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=204.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.| ..+++.||+|++.+...........+.+|..++..++|++|+++++++...+..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5788899999999865 34678899999975433334445668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|+++++|.+++.+ ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 157 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT- 157 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-
Confidence 9999999999987 456999999999999999999999999 99999999999999999999999999876532111
Q ss_pred cCCCCcccCCCCcccccccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCCCCCC
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKN-----EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRAPTT 380 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~ 380 (456)
.......|++.|+|||++.+ ..++.++|+||||+++|+|++|+.||...+..+....+.... +.+++....
T Consensus 158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 234 (331)
T cd05624 158 ---VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHIT 234 (331)
T ss_pred ---eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccc
Confidence 11123458999999999875 467889999999999999999999998877666555554322 233333345
Q ss_pred CCcHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFR--RPTFRQILMR 410 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~--Rpt~~ell~~ 410 (456)
.++.++.++|.+|+..++++ |+++++++++
T Consensus 235 ~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 67899999999999876654 4688888776
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=296.31 Aligned_cols=254 Identities=31% Similarity=0.517 Sum_probs=205.8
Q ss_pred ccccceeeeccEEEEEe-----EcC---cEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRG---TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g---~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
.|.+.+.||+|+||.+. .++ ..||+|.+... ..+.....+..|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 36778899999998652 223 36999998754 245566789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 225 VTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
||||+++++|.+++... +.++...+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999999764 45899999999999999999999999 999999999999999999999999998765322
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCC
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (456)
..............+..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+......+. +..+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~ 236 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP---PMDC 236 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC---cccC
Confidence 11111001111112457999999998899999999999999999886 9999987776655555533222221 3567
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
+..+.+++.+||..+|++||++++++..|+.+
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 237 PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 88999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=301.76 Aligned_cols=258 Identities=29% Similarity=0.531 Sum_probs=210.5
Q ss_pred cccccceeeeccEEEEEeE------------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEe
Q 012777 152 LDFSNSVEITKGTFRIASW------------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQ 218 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~~------------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~ 218 (456)
.+|.+.+.||+|+||.+.. ....||+|.+.... .......+..|+.+++++ .||||+++++++..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 4678889999999986521 23469999987542 344567788999999999 69999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeE
Q 012777 219 STPMMIVTEYLPKGDLRAYLKQK----------------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL 282 (456)
Q Consensus 219 ~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil 282 (456)
....+++|||+++++|.+++... ..++..++..++.|++.||.|||+++ ++|+||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 89999999999999999999763 23788899999999999999999999 999999999999
Q ss_pred eCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 012777 283 RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEK 361 (456)
Q Consensus 283 ~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~ 361 (456)
++.++.+||+|||++......... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYY---KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred EcCCCcEEEccccccccccccccc---cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999998765321110 01111223457999999988889999999999999999999 89999887766
Q ss_pred chHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhcc
Q 012777 362 EVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSI 420 (456)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~ 420 (456)
+....+....... .+..++.++.+++.+||..+|++|||+.++++.|+.+...+..
T Consensus 244 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 244 ELFKLLREGHRMD---KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred HHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 6555553332222 2457788999999999999999999999999999999876643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=295.82 Aligned_cols=254 Identities=24% Similarity=0.445 Sum_probs=207.3
Q ss_pred ccccceeeeccEEEEE----eEcCcEEEEEEeCCCCCC---CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 153 DFSNSVEITKGTFRIA----SWRGTQVAVKTLGEEVFT---DEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~----~~~g~~vAvK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
+|...+.||.|+||.+ ..+|+.+|+|.+...... .......+.+|++++++++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677889999999865 236889999998754321 233456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc-
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN- 304 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~- 304 (456)
+||+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999999999988788999999999999999999999999 9999999999999999999999999987653211
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
............++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+... ....+..+..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 236 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH-RGLMPRLPDSFSA 236 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc-cCCCCCCCCCCCH
Confidence 111111223345788999999999888999999999999999999999999876544333333222 1222234567889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.++|.+||..+|++||++.+++++
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=297.46 Aligned_cols=258 Identities=27% Similarity=0.407 Sum_probs=210.4
Q ss_pred ccccccccceeeeccEEEEE---eE-c-----CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe-
Q 012777 149 PKELDFSNSVEITKGTFRIA---SW-R-----GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ- 218 (456)
Q Consensus 149 ~~~~~~~~~~~lg~G~fg~~---~~-~-----g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 218 (456)
....+|...+.||+|+||.+ .. . +..|++|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 34456888899999999866 22 2 578999998743 355667888999999999999999999998765
Q ss_pred CCceEEEEEccCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEE
Q 012777 219 STPMMIVTEYLPKGDLRAYLKQK--------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290 (456)
Q Consensus 219 ~~~~~lv~e~~~~~sL~~~l~~~--------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vk 290 (456)
....++++||+++++|.+++... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEE
Confidence 46789999999999999998763 34889999999999999999999999 99999999999999999999
Q ss_pred EeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHh
Q 012777 291 VADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIA 369 (456)
Q Consensus 291 l~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~ 369 (456)
|+|||+++.+....... ......++..|+|||++.+..++.++||||||+++|++++ |+.||...++.+....+..
T Consensus 158 l~d~g~~~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 234 (280)
T cd05043 158 ITDNALSRDLFPMDYHC---LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD 234 (280)
T ss_pred ECCCCCcccccCCceEE---eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc
Confidence 99999987552211100 1112235667999999988889999999999999999998 9999988776665544433
Q ss_pred cCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 370 NERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
..... ....++.++.+++.+||..||++|||+.++++.|+++.++
T Consensus 235 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 235 GYRLA---QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 22222 2356788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=298.03 Aligned_cols=250 Identities=30% Similarity=0.503 Sum_probs=203.7
Q ss_pred cccccceeeeccEEEEE---eE-------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012777 152 LDFSNSVEITKGTFRIA---SW-------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 221 (456)
.+|.+.+.||+|+||.+ .. .+..||+|.+... ........+.+|+.+++.++|+||+++++++.+...
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35788889999999755 22 4567999988654 234445678999999999999999999999998889
Q ss_pred eEEEEEccCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC---CEEE
Q 012777 222 MMIVTEYLPKGDLRAYLKQKG-------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG---HLKV 291 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~---~vkl 291 (456)
.+++|||+++++|.+++...+ .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 999999999999999997653 4888999999999999999999999 99999999999998654 5999
Q ss_pred eccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhc
Q 012777 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIAN 370 (456)
Q Consensus 292 ~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~ 370 (456)
+|||++......... ........+..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 161 ~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 161 ADFGMARDIYRASYY---RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred ccCccccccCCccce---ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999998865211100 01111223457999999998899999999999999999997 99999887766655554333
Q ss_pred CCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 371 ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
.... .+..++..+.+++.+||+.+|++|||+.+++++|+
T Consensus 238 ~~~~---~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GRLD---PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 3322 24677889999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=295.68 Aligned_cols=250 Identities=28% Similarity=0.494 Sum_probs=201.7
Q ss_pred ccceeeeccEEEEEe---E--cCc--EEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------Cc
Q 012777 155 SNSVEITKGTFRIAS---W--RGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS------TP 221 (456)
Q Consensus 155 ~~~~~lg~G~fg~~~---~--~g~--~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------~~ 221 (456)
.+.+.||+|+||.+. . ++. .||+|.++... ......+.+.+|+.+++.++||||+++++.+... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 456789999998762 2 232 69999987653 3455678899999999999999999999987432 34
Q ss_pred eEEEEEccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccC
Q 012777 222 MMIVTEYLPKGDLRAYLKQK------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFG 295 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfg 295 (456)
.+++|||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 78999999999999887431 23889999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCC
Q 012777 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPP 374 (456)
Q Consensus 296 ls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 374 (456)
++......... .......+++.|++||.+.+..++.++|+||||+++|+|++ |..||......+....+......+
T Consensus 158 ~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd05075 158 LSKKIYNGDYY---RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK 234 (272)
T ss_pred cccccCcccce---ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 98865322111 11112335668999999999899999999999999999999 899998876666555554433322
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 375 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
.+..++..+.++|.+||+.||++|||+.++++.|+.+
T Consensus 235 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 235 ---QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2456788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=310.84 Aligned_cols=246 Identities=26% Similarity=0.371 Sum_probs=195.2
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC------
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST------ 220 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~------ 220 (456)
.+|++.+.||+|+||.+ ..+|..||+|++.... ........+.+|+.+++.++||||+++++++....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 36888999999999976 3468899999997653 33444567889999999999999999999986543
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
.+++||||++ ++|.+.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 100 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMD-ANLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCC-cCHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 4799999995 57777664 35889999999999999999999999 999999999999999999999999998754
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc----------
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN---------- 370 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~---------- 370 (456)
.. ........+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 174 ~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 174 CT------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cc------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 21 11223356788999999999999999999999999999999999999876543221111100
Q ss_pred -----------CCCCCC-----------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 371 -----------ERPPFR-----------------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 371 -----------~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..+.+. ......+..+.++|.+||..||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 011100 0112345678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=293.98 Aligned_cols=253 Identities=26% Similarity=0.489 Sum_probs=207.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||+|+||.+ ..+|+.||+|.+......+....+.+.+|+.++++++|++|+++++++...+..+++||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 5788889999999865 23689999999875444455556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 228 YLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 228 ~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999999864 234899999999999999999999999 999999999999999999999999998755321
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc--chHHHHHhcCCCCCCCCCCC
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK--EVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~ 381 (456)
. .......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... .....+.....++. +...
T Consensus 160 ~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 232 (267)
T cd08224 160 T-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL--PADH 232 (267)
T ss_pred C-----cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCC--Chhh
Confidence 1 1112235677899999998888999999999999999999999999654422 22222222222222 2236
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
++..+.++|.+||..+|++|||+.++++.|+.+.
T Consensus 233 ~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 233 YSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 7889999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=300.60 Aligned_cols=250 Identities=26% Similarity=0.451 Sum_probs=205.8
Q ss_pred ccccceeeeccEEEEEeE----------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 153 DFSNSVEITKGTFRIASW----------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~~----------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
+|.+.+.||+|+||.+.. .+..||+|++.... .....+.+.+|+.+++.++||||+++++++......
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 467778999999986521 24689999997542 344557788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC
Q 012777 223 MIVTEYLPKGDLRAYLKQK----------------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~ 286 (456)
++++||+.+++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.+
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence 9999999999999998532 24788889999999999999999999 9999999999999999
Q ss_pred CCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHH
Q 012777 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPK 365 (456)
Q Consensus 287 ~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~ 365 (456)
+.+||+|||++........ ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+...
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05091 161 LNVKISDLGLFREVYAADY---YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE 237 (283)
T ss_pred CceEecccccccccccchh---eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999875532111 111122345678999999988889999999999999999998 889998877666666
Q ss_pred HHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 012777 366 AYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDD 413 (456)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~ 413 (456)
.+......+ .+..++..+.+++.+||+.+|++||++++++..|+.
T Consensus 238 ~i~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIRNRQVLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHcCCcCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 554433322 356788999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=294.40 Aligned_cols=252 Identities=31% Similarity=0.515 Sum_probs=207.6
Q ss_pred ccccceeeeccEEEEEe-----EcC---cEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRG---TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g---~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
+|+..+.||+|+||.+. .++ ..+|+|.+.... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 57778899999998652 223 379999987542 34456788999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 225 VTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
||||+++++|.+++... +.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999764 56899999999999999999999999 999999999999999999999999998765322
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCC
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (456)
.... ........++.|+|||++.+..++.++|+||||+++|+|++ |..||...+..+....+......+. ...+
T Consensus 161 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~ 235 (268)
T cd05063 161 PEGT--YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA---PMDC 235 (268)
T ss_pred cccc--eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC---CCCC
Confidence 1111 11111223457999999988889999999999999999997 9999987776666666644333222 3567
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
+.++.+++.+||..+|++||++.++++.|+++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 88999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=294.82 Aligned_cols=248 Identities=33% Similarity=0.560 Sum_probs=203.7
Q ss_pred ccccceeeeccEEEEE---eE-cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 153 DFSNSVEITKGTFRIA---SW-RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~-~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
+|++.++||+|+||.+ .. ....||+|++..... . .+.+.+|+.++++++||||+++++.+.. ...+++|||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-C---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 5888899999999855 22 345799999975432 2 2568899999999999999999998754 568999999
Q ss_pred cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 229 LPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 229 ~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~- 157 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 157 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc-
Confidence 9999999999763 34889999999999999999999999 99999999999999999999999999876532211
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.......++..|+|||+..+..++.++|+||||+++|+|++ |..||...........+......+. ...++..
T Consensus 158 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 231 (262)
T cd05071 158 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPES 231 (262)
T ss_pred ---ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC---ccccCHH
Confidence 11112345667999999988889999999999999999999 8999988776665555533322222 4568889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
+.+++.+|++.||++||+++++++.|+.++
T Consensus 232 l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 232 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=297.06 Aligned_cols=249 Identities=29% Similarity=0.490 Sum_probs=205.6
Q ss_pred ccccceeeeccEEEEEe---E-------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 153 DFSNSVEITKGTFRIAS---W-------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~---~-------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
+|.+.+.||+|+||.+. . .+..||+|.+... ........+.+|+.+++.++||||+++++++......
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc--cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 57788899999998662 1 2367999998654 2334456788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEe
Q 012777 223 MIVTEYLPKGDLRAYLKQKG----------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVA 292 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~ 292 (456)
+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999996532 3677889999999999999999999 9999999999999999999999
Q ss_pred ccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcC
Q 012777 293 DFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANE 371 (456)
Q Consensus 293 Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~ 371 (456)
|||++......... .......++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+....
T Consensus 162 dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 162 DFGMTRDIYETDYY---RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238 (277)
T ss_pred CcccchhhccCccc---ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence 99998765322111 11122345678999999988889999999999999999998 999998877766666554333
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 372 RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 372 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
.+.. +..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 239 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 HLDL---PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 3332 4557889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=297.41 Aligned_cols=249 Identities=28% Similarity=0.452 Sum_probs=205.4
Q ss_pred cccccceeeeccEEEEEeE----------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012777 152 LDFSNSVEITKGTFRIASW----------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~~----------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 221 (456)
.++...+.||+|+||.+.. ++..+|+|.+... .......+.+|+++++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 3567788999999986621 3568999988643 34556789999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC
Q 012777 222 MMIVTEYLPKGDLRAYLKQKG---------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~---------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~ 286 (456)
.+++|||+++++|.+++...+ .+++..+..++.|++.||.|||+++ ++|+||||+|||++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCC
Confidence 999999999999999987643 3788999999999999999999999 9999999999999999
Q ss_pred CCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHH
Q 012777 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPK 365 (456)
Q Consensus 287 ~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~ 365 (456)
+.+||+|||++........ ........+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+...
T Consensus 159 ~~~kL~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDY---YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235 (280)
T ss_pred CCEEECCCCceeEcCCCce---eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 9999999999875422110 011112234678999999998899999999999999999998 999998777666555
Q ss_pred HHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 366 AYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
.+....... .+..++..+.++|.+||+.||++||+++++++.|+
T Consensus 236 ~~~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 CITQGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHcCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 553333222 24578889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=294.40 Aligned_cols=248 Identities=30% Similarity=0.485 Sum_probs=203.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCc-ceeeeeEEEeCC------
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPN-VVQFLGAVTQST------ 220 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~l~~~~~~~~------ 220 (456)
.|...++||+|+||.| ..+|+.||+|++..+... +..-....+|+.+|+.++|+| |+++++++...+
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4677778999999866 567999999999876421 223356789999999999999 999999998877
Q ss_pred ceEEEEEccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCC
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKG----ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGL 296 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgl 296 (456)
.+++|+||+ .-+|.+++...+ .++...++.+++||+.||.|||+++ |+||||||+|+|++++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 899999999 569999998755 3788899999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCC
Q 012777 297 SKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPP 374 (456)
Q Consensus 297 s~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~ 374 (456)
|+.... +........+|..|+|||++.+. .|++..||||+||+++||+++++.|++....+....|.... .|+
T Consensus 167 Ara~~i-----p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 167 ARAFSI-----PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN 241 (323)
T ss_pred HHHhcC-----CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence 995532 33345567788899999999887 79999999999999999999999999887755554443322 221
Q ss_pred ------------CC----CC---------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 ------------FR----AP---------TTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 ------------~~----~~---------~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+. .. ......+..+++.+||+.+|.+|.|++..+.|
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00 00 12223468899999999999999999999987
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=293.66 Aligned_cols=243 Identities=32% Similarity=0.582 Sum_probs=202.5
Q ss_pred ccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE-eCCceEEEEEc
Q 012777 153 DFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVT-QSTPMMIVTEY 228 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~~lv~e~ 228 (456)
+|.+.+.||+|+||.+ ...|..||+|.+.... ..+.+.+|+.++++++|++++++++++. .....++++||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 5778889999999754 5678999999986432 2457889999999999999999999764 45678999999
Q ss_pred cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 229 LPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 229 ~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
+++++|.+++.+.+ .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--- 155 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 155 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc---
Confidence 99999999997654 3889999999999999999999999 999999999999999999999999998754211
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.....++..|+|||++.+..++.++|||||||++|+|++ |+.||......+....+.....+. ....++..
T Consensus 156 -----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 227 (256)
T cd05082 156 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---APDGCPPV 227 (256)
T ss_pred -----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---CCCCCCHH
Confidence 112234567999999998889999999999999999997 999998776655555553332222 24677889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
+.+++.+||..+|++|||++++++.|+.+
T Consensus 228 ~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 228 VYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 99999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=294.05 Aligned_cols=246 Identities=31% Similarity=0.529 Sum_probs=203.5
Q ss_pred ccccceeeeccEEEEE----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 153 DFSNSVEITKGTFRIA----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
+|.+.++||+|+||.+ ..+++.||+|.+..... ....+.+|+.++++++||||+++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred HceeeeeeccCccceEEeeecCCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 5778899999999866 23678999999875432 2357889999999999999999999874 4678999999
Q ss_pred cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 229 LPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 229 ~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
+.+++|.+++... ..++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence 9999999998753 35899999999999999999999999 99999999999999999999999999876532111
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.......++..|+|||++....++.++|+||||+++|+|++ |++||...+..+....+......+ .+...+.+
T Consensus 158 ---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (260)
T cd05067 158 ---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP---RPDNCPEE 231 (260)
T ss_pred ---ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC---CCCCCCHH
Confidence 11112335668999999988889999999999999999998 999998877666655553332322 24567889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMRLDD 413 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~L~~ 413 (456)
+.+++.+||..+|++|||++++++.|+.
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 232 LYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=301.00 Aligned_cols=247 Identities=27% Similarity=0.469 Sum_probs=202.2
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|++.+.||+|+||.+ ..++..||+|.+... ........+.+|++++++++||||+++++++..++.++++||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 5888899999999866 236788999998754 245556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHE-NRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|+++++|.+++...+.+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 99999999999888889999999999999999999997 57 999999999999999999999999998754211
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC--------------
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER-------------- 372 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------- 372 (456)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.....
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 ----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 11234578899999999888899999999999999999999999976543332221110000
Q ss_pred --------------------CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 373 --------------------PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 373 --------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
.+...+...++.++.+++.+||..||++|||+++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000011124678899999999999999999999999883
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=294.61 Aligned_cols=252 Identities=25% Similarity=0.484 Sum_probs=203.3
Q ss_pred ccccceeeeccEEEEE---eE--cCc----EEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012777 153 DFSNSVEITKGTFRIA---SW--RGT----QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM 223 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~--~g~----~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 223 (456)
+|++.+.||+|+||.+ .+ +|+ .|++|.+... ........+..|+..++++.||||+++++++.. ...+
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 5777789999999866 22 344 4788887543 233445678888889999999999999998764 4578
Q ss_pred EEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 224 IVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
+++||+++++|.+++... +.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 899999999999999764 46899999999999999999999999 99999999999999999999999999986532
Q ss_pred cccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (456)
.. .........++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+.....++. +..
T Consensus 162 ~~---~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 235 (279)
T cd05111 162 DD---KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ---PQI 235 (279)
T ss_pred CC---cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---CCC
Confidence 11 1111223446678999999988899999999999999999998 9999988766555444433323222 345
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~ 416 (456)
++.++.+++.+||..||++|||+.++++.|..+.+
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 236 CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 67789999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=328.44 Aligned_cols=260 Identities=19% Similarity=0.269 Sum_probs=207.9
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.| ..+|+.||+|++..+....+...+.+.+|+.+++.++||||+++++++...+..+++||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 5788899999999976 23588999999987654555566789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCC
Q 012777 228 YLPKGDLRAYLKQK-----------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGL 296 (456)
Q Consensus 228 ~~~~~sL~~~l~~~-----------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgl 296 (456)
|++|++|.+++... ..++...+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999998641 12456678899999999999999999 99999999999999999999999999
Q ss_pred cccccccccc-------------cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccch
Q 012777 297 SKLLKFANTV-------------KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV 363 (456)
Q Consensus 297 s~~~~~~~~~-------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 363 (456)
+......... ..........||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 9865211000 000111224689999999999999999999999999999999999999987554433
Q ss_pred HHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHH
Q 012777 364 PKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRP-TFRQILMRLDDISD 416 (456)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-t~~ell~~L~~~~~ 416 (456)
...... ..+........++..+.+++.+||..||++|| +++++++.|+.+..
T Consensus 240 ~~~~~i-~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 240 SYRDVI-LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhhc-cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 222111 11111122357888999999999999999996 67788888887765
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=294.85 Aligned_cols=254 Identities=25% Similarity=0.490 Sum_probs=206.0
Q ss_pred cccccceeeeccEEEEEe-----EcCc----EEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGT----QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~----~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
.+|...+.||+|+||.+. .+|+ .||+|++... ........+.+|+.+++.++||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC--CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 357888999999998662 2444 4899998754 344556788899999999999999999999875 457
Q ss_pred EEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
++++||+++|+|.+++.+. +.+++..+..++.|++.||.|||+++ ++|+||||+|||++.++.+||+|||++....
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 8999999999999999764 46999999999999999999999999 9999999999999999999999999988663
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
..... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+.....++. +.
T Consensus 161 ~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 234 (279)
T cd05109 161 IDETE---YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ---PP 234 (279)
T ss_pred cccce---eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---Cc
Confidence 21111 01112234567999999988889999999999999999998 9999987766555544433323222 45
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
.++.++.+++.+||..||++||++.++++.|+.+...
T Consensus 235 ~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 235 ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 6788999999999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=293.11 Aligned_cols=246 Identities=33% Similarity=0.555 Sum_probs=203.2
Q ss_pred ccccceeeeccEEEEE---e-EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 153 DFSNSVEITKGTFRIA---S-WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~-~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
+|++.+.||+|+||.+ . ..+..||+|.+..... . .+.+.+|+.++++++||+++++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-S---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-C---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 5778889999999865 2 3567899999976432 2 246889999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 229 LPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 229 ~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~-- 156 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-- 156 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc--
Confidence 9999999999763 34899999999999999999999999 9999999999999999999999999987653211
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
........++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+......+. +...+..
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 231 (260)
T cd05070 157 --YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC---PQDCPIS 231 (260)
T ss_pred --cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCHH
Confidence 111112234567999999988889999999999999999999 8999988776666666644333332 4577889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMRLDD 413 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~L~~ 413 (456)
+.+++.+||..+|++|||+.++.+.|+.
T Consensus 232 ~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 232 LHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=288.97 Aligned_cols=242 Identities=31% Similarity=0.537 Sum_probs=199.6
Q ss_pred eeeccEEEEE----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012777 159 EITKGTFRIA----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234 (456)
Q Consensus 159 ~lg~G~fg~~----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~sL 234 (456)
.||+|+||.+ ..++..||+|.+.... .......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 6899999865 2357789999987542 344456789999999999999999999999999999999999999999
Q ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcc
Q 012777 235 RAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT 313 (456)
Q Consensus 235 ~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~ 313 (456)
.+++... ..+++..+..++.|++.+|.|||+++ ++|+||||+||+++.++.+||+|||++........ ....
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~----~~~~ 152 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY----SSSG 152 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc----ccCC
Confidence 9998754 45899999999999999999999999 99999999999999999999999999875422111 0111
Q ss_pred cCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q 012777 314 CEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIED 392 (456)
Q Consensus 314 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 392 (456)
...++..|+|||++....++.++|+||||+++|++++ |..||...........+....+.. .+..++..+.+++.+
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~ 229 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMS---CPQKCPDDVYKVMQR 229 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHH
Confidence 1233567999999988889999999999999999998 999998876655555443332222 245678899999999
Q ss_pred hcccCCCCCCCHHHHHHHHH
Q 012777 393 CWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 393 ~l~~dp~~Rpt~~ell~~L~ 412 (456)
|+..+|++||++.++++.|.
T Consensus 230 ~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 230 CWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HcccCcccCCCHHHHHHHhc
Confidence 99999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=292.92 Aligned_cols=252 Identities=32% Similarity=0.535 Sum_probs=206.8
Q ss_pred ccccceeeeccEEEEEe---E-----cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 153 DFSNSVEITKGTFRIAS---W-----RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~---~-----~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
+|.+.+.||+|.||.+. . .+..+|+|.+.... .......+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57778899999998652 1 23379999987542 34456788999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 225 VTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
+|||+++++|.+++... +.++..++..++.|++.||.+||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999765 45899999999999999999999999 999999999999999999999999998866322
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCC
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (456)
.... .......++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+....+.+. +..+
T Consensus 160 ~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 234 (267)
T cd05066 160 PEAA--YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA---PMDC 234 (267)
T ss_pred ccee--eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCC---CCCC
Confidence 1110 01111223457999999998889999999999999999886 9999988776665555543333222 3567
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 88999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=296.41 Aligned_cols=253 Identities=25% Similarity=0.490 Sum_probs=201.3
Q ss_pred cccccceeeeccEEEEEe---------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--C
Q 012777 152 LDFSNSVEITKGTFRIAS---------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS--T 220 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~---------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~ 220 (456)
..|.+.+.||+|+||.+. .++..||+|.+... ........+.+|+.++++++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 347888999999999762 35788999998754 2345567899999999999999999999998775 5
Q ss_pred ceEEEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKL 299 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~ 299 (456)
..+++|||+++++|.+++.+.. .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 6899999999999999997653 5899999999999999999999999 99999999999999999999999999886
Q ss_pred ccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc-----------cc----hH
Q 012777 300 LKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE-----------KE----VP 364 (456)
Q Consensus 300 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----------~~----~~ 364 (456)
....... ........++..|+|||.+.+..++.++||||||+++|+|++++.|+..... .. ..
T Consensus 159 ~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 159 IETDKEY--YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccCccc--eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 6322111 1111234466679999999888899999999999999999998766432110 00 01
Q ss_pred HHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 365 KAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
..+......+ .+..++..+.+|+.+||+.||++|||++++++.|+.+
T Consensus 237 ~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRLP---RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111111111 2456888999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=296.07 Aligned_cols=253 Identities=26% Similarity=0.437 Sum_probs=204.1
Q ss_pred cccccceeeeccEEEEEeE----------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012777 152 LDFSNSVEITKGTFRIASW----------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~~----------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 221 (456)
.+|++.+.||+|+||.+.. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4688889999999986631 24479999987542 33344568899999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEE
Q 012777 222 MMIVTEYLPKGDLRAYLKQKG----------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl 291 (456)
.++||||+++++|.+++...+ ..+...+..++.|++.||.|||+++ |+||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997532 2456788899999999999999999 999999999999999999999
Q ss_pred eccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhc
Q 012777 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIAN 370 (456)
Q Consensus 292 ~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~ 370 (456)
+|||++......... .......++..|+|||.+.+..++.++|+|||||++|+|++ |..||......+....+...
T Consensus 161 ~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (288)
T cd05061 161 GDFGMTRDIYETDYY---RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237 (288)
T ss_pred CcCCccccccccccc---cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 999998754221110 11112234567999999998889999999999999999998 79999887666555544333
Q ss_pred CCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 371 ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
.... .+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus 238 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 238 GYLD---QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 3222 24566788999999999999999999999998887764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=290.93 Aligned_cols=247 Identities=21% Similarity=0.396 Sum_probs=208.7
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||.|.||.+ ..+++.+++|.+..... .......+.+|+.++++++|+||+++++++.+...++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 4778889999999843 45688999999875532 34456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|+++++|.+++... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~- 155 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY- 155 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc-
Confidence 99999999999765 45899999999999999999999999 9999999999999999999999999987653221
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.......+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+......+ ....++..
T Consensus 156 ----~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 228 (256)
T cd08221 156 ----SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP---VVSVYSSE 228 (256)
T ss_pred ----ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---CccccCHH
Confidence 11223457889999999988888899999999999999999999998877666666654333222 24677889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
+.++|.+||..+|++||+++++++++
T Consensus 229 ~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 229 LISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHHHHHHcccCcccCCCHHHHhhCc
Confidence 99999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=290.99 Aligned_cols=246 Identities=27% Similarity=0.427 Sum_probs=203.3
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe-CCceEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ-STPMMIVT 226 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~~lv~ 226 (456)
+|++.+.||+|+||.+ ..+++.||+|.+.... ......+.+.+|+.++++++|||++++++.+.. ...++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh-cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 3778889999999855 3467899999997543 234455678999999999999999999998764 44689999
Q ss_pred EccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 227 EYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 227 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
||+++++|.+++... ..+++.+++.++.|++.+|.+||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999999763 35899999999999999999999999 9999999999999999999999999987653211
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.......+++.|+|||++.+..++.++|+||||+++++|++|+.||...+.......+.....+. .+..++.
T Consensus 157 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 228 (257)
T cd08223 157 -----DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSP 228 (257)
T ss_pred -----CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCH
Confidence 12223457888999999999889999999999999999999999998766555444443333222 2467889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+.+++.+||+.||++|||+.+++++
T Consensus 229 ~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 229 ELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHHHHHhccCcccCCCHHHHhcC
Confidence 99999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=296.83 Aligned_cols=251 Identities=31% Similarity=0.477 Sum_probs=205.4
Q ss_pred cccccceeeeccEEEEEeE----------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012777 152 LDFSNSVEITKGTFRIASW----------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~~----------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 221 (456)
.+|+..+.||+|+||.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 4688889999999986521 46789999987542 34455778999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 012777 222 MMIVTEYLPKGDLRAYLKQKG----------------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPS 279 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~----------------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~ 279 (456)
.++++||+++++|.+++.... .+++..++.++.|++.||.|||+++ ++|+||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999997532 3678888999999999999999999 999999999
Q ss_pred CeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 012777 280 NILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTK 358 (456)
Q Consensus 280 Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~ 358 (456)
||+++.++.++|+|||++..+...... ........+..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYY---KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred heEecCCCceEECccccceecccCccc---cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999998754211110 01111234567999999988899999999999999999997 88999877
Q ss_pred CccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 012777 359 QEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDD 413 (456)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~ 413 (456)
...+....+......+ .+..++.++.++|.+||+.+|++|||+.|+++.|++
T Consensus 237 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 AHEEVIYYVRDGNVLS---CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 7666655554333222 245678899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=317.50 Aligned_cols=243 Identities=25% Similarity=0.370 Sum_probs=191.2
Q ss_pred ccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS------ 219 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------ 219 (456)
..+|...+.||+|+||.|. .+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 3468999999999999762 368899999986431 2335799999999999999999887432
Q ss_pred --CceEEEEEccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-CEEEe
Q 012777 220 --TPMMIVTEYLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG-HLKVA 292 (456)
Q Consensus 220 --~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~-~vkl~ 292 (456)
..+++||||++ ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeee
Confidence 24779999996 578777653 456999999999999999999999999 99999999999999654 79999
Q ss_pred ccCCcccccccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC
Q 012777 293 DFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE 371 (456)
Q Consensus 293 Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 371 (456)
|||+++.+... .......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+....+....
T Consensus 214 DFGla~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 287 (440)
T PTZ00036 214 DFGSAKNLLAG------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL 287 (440)
T ss_pred ccccchhccCC------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999865321 122235678899999988664 68999999999999999999999998876544433332211
Q ss_pred -CCC----------C-----C---------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 -RPP----------F-----R---------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 -~~~----------~-----~---------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+. + + ..+...+.++.+||.+||..||.+|||+.+++++
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 100 0 0 1123567889999999999999999999999977
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=298.96 Aligned_cols=243 Identities=26% Similarity=0.471 Sum_probs=207.5
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||+|+||.+ ..+++.||+|++.............+.+|++++++++||||+++++++......++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 4778889999999865 23689999999976544445556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999999999988888999999999999999999999999 999999999999999999999999998765221
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
.....+++.|+|||.+.+...+.++|+||||+++|+|++|..||...+.......+. .....+ +..++..+.
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~---~~~~~~~l~ 226 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL-EGKVRF---PSFFSPDAK 226 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCccC---CccCCHHHH
Confidence 223457888999999988888899999999999999999999998777554444443 222222 456788999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rp-----t~~ell~~ 410 (456)
++|.+||..||++|+ ++++++++
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 227 DLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 999999999999999 78888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=292.71 Aligned_cols=248 Identities=27% Similarity=0.434 Sum_probs=204.7
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|...+.||.|+||.+ ..+++.+|+|++.... ....+.+.+|+.++++++||||+++++++.....++++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 35788889999999865 2357889999997542 235578899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
||+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 999999999999776 67999999999999999999999999 9999999999999999999999999987653211
Q ss_pred ccCCCCcccCCCCcccccccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCCCCCCC
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNE---EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRAPTTH 381 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~ 381 (456)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||....+......+.... .+........
T Consensus 156 ----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (262)
T cd06613 156 ----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK 231 (262)
T ss_pred ----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhh
Confidence 111234577789999998776 78899999999999999999999998776555444333321 2221122345
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.++.+++.+||..+|.+|||+++++.+
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred hhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 67889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=297.75 Aligned_cols=253 Identities=27% Similarity=0.442 Sum_probs=202.7
Q ss_pred cccccceeeeccEEEEEeE-----------------c--CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceee
Q 012777 152 LDFSNSVEITKGTFRIASW-----------------R--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQF 212 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~~-----------------~--g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l 212 (456)
.+|++.+.||+|+||.+.. + ...||+|.+.... .......+.+|++++++++|||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 3578888999999987631 1 2359999997642 34556789999999999999999999
Q ss_pred eeEEEeCCceEEEEEccCCCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 012777 213 LGAVTQSTPMMIVTEYLPKGDLRAYLKQKG------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSN 280 (456)
Q Consensus 213 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~N 280 (456)
++++......++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ ++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence 999999999999999999999999986532 3678889999999999999999999 9999999999
Q ss_pred eEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCCC
Q 012777 281 ILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE--GCPPFPTK 358 (456)
Q Consensus 281 il~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~~ 358 (456)
|+++.++.+||+|||++........ ........++..|+|||.+.+..++.++|+||||+++|+|++ |..||...
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDY---YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred EEEcCCCcEEecccccccccccCcc---eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999999875532110 111122344678999999988889999999999999999998 67888776
Q ss_pred CccchHHHHHh----cCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 359 QEKEVPKAYIA----NERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 359 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
........+.. .....+...+...+..+.+|+.+||..||++|||++++++.|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 237 SDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 65554433321 1122222234567889999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=299.47 Aligned_cols=247 Identities=28% Similarity=0.444 Sum_probs=192.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC---CCCcceeeeeEEEeC-----
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI---RHPNVVQFLGAVTQS----- 219 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~~----- 219 (456)
+|++.+.||+|+||.+ ..+|+.||+|.+....... .....+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 4778899999999876 3368899999987543221 1123455677777665 699999999988642
Q ss_pred CceEEEEEccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCc
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLS 297 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls 297 (456)
...++++||+. ++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 45899999996 58998887643 4899999999999999999999999 999999999999999999999999998
Q ss_pred ccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CC---
Q 012777 298 KLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RP--- 373 (456)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~--- 373 (456)
...... .......+++.|+|||++.+..++.++|||||||++|+|++|.+||...........+.... .+
T Consensus 156 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 156 RIYSCQ------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229 (288)
T ss_pred ccccCc------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence 765311 11223457888999999998899999999999999999999999997765543332222110 00
Q ss_pred -------------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 -------------------PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 -------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.......++..+.++|.+||+.||++|||+++++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0001123567889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=306.39 Aligned_cols=249 Identities=30% Similarity=0.551 Sum_probs=214.5
Q ss_pred ccceeeeccEEEEE---eE----cCc--EEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 155 SNSVEITKGTFRIA---SW----RGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 155 ~~~~~lg~G~fg~~---~~----~g~--~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
...+.||.|.||.| .+ .|+ -||||.-+.+. ..+..+.|+.|..+++.+.||||++++|.|.+ .+.+||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 34567999999865 22 232 58999988764 45557899999999999999999999999976 578999
Q ss_pred EEccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGA-LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
||+++-|.|..+++.+.. ++......++.||+.||.|||+.. +|||||...||||....-|||+|||+++.+.+..
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 999999999999998764 999999999999999999999999 9999999999999999999999999999886543
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
....+. ..-++-|||||.+.-..++.++|||.||++|||++. |..||.+....+..-.+..+.+.+. +.++|
T Consensus 546 yYkaS~----~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~---P~nCP 618 (974)
T KOG4257|consen 546 YYKASR----GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPC---PPNCP 618 (974)
T ss_pred hhhccc----cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCC---CCCCC
Confidence 332221 123456999999999999999999999999999986 9999999888777766756667765 68899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~ 416 (456)
+.+..++.+||+.+|.+||+++++...|.++..
T Consensus 619 p~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 619 PALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred hHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 999999999999999999999999999999986
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=309.03 Aligned_cols=246 Identities=26% Similarity=0.371 Sum_probs=196.7
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------C
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS------T 220 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------~ 220 (456)
.+|...+.||+|+||.+ ...++.||||++.... ........+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 36888999999999976 3468899999997653 2344456788999999999999999999987543 3
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
..|+||||++ ++|.+.+.. .++...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 5799999995 588887753 4889999999999999999999999 999999999999999999999999998755
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC---------
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE--------- 371 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------- 371 (456)
.. ........+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+....
T Consensus 177 ~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 177 GT------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred CC------CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 21 112233567889999999999999999999999999999999999998766544433332211
Q ss_pred ------------CCCCC-----------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 ------------RPPFR-----------------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 ------------~~~~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.+. ......+..+.++|.+||..||++|||+++++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11100 0011234678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=300.87 Aligned_cols=263 Identities=29% Similarity=0.548 Sum_probs=212.4
Q ss_pred CccccCccccccccceeeeccEEEEEe---E---------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcc
Q 012777 143 PEYEIDPKELDFSNSVEITKGTFRIAS---W---------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNV 209 (456)
Q Consensus 143 ~~~~~~~~~~~~~~~~~lg~G~fg~~~---~---------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i 209 (456)
|.+++. ..+|.+.+.||+|+||.+. . .+..||+|.+... ......+.+.+|+.+++++ +||||
T Consensus 5 ~~~~~~--~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i 80 (334)
T cd05100 5 PKWELS--RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNI 80 (334)
T ss_pred cccccC--HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCe
Confidence 445444 3458888999999998652 1 1236999988754 2345567899999999999 79999
Q ss_pred eeeeeEEEeCCceEEEEEccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 012777 210 VQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG----------------ALKPTLAVKFALDIARGMNYLHENRPEAIIH 273 (456)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH 273 (456)
+++++++......++++||+++++|.+++.+.. .++..++..++.|++.||.|||+++ ++|
T Consensus 81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH 157 (334)
T cd05100 81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIH 157 (334)
T ss_pred eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 999999999999999999999999999997532 3677888999999999999999999 999
Q ss_pred cCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CC
Q 012777 274 RDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GC 352 (456)
Q Consensus 274 ~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~ 352 (456)
|||||+||+++.++.+||+|||++........ ........++..|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 234 (334)
T cd05100 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 234 (334)
T ss_pred cccccceEEEcCCCcEEECCcccceecccccc---cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCC
Confidence 99999999999999999999999875532111 111112234467999999999899999999999999999998 89
Q ss_pred CCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 353 PPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 353 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
.||...+..+....+....... .+..++..+.+++.+||+.+|++|||+.++++.|+.+....
T Consensus 235 ~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 235 SPYPGIPVEELFKLLKEGHRMD---KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred CCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 9998877666655554333322 24567889999999999999999999999999999998544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=312.13 Aligned_cols=242 Identities=31% Similarity=0.415 Sum_probs=198.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-C-----CcceeeeeEEEeCCc
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-H-----PNVVQFLGAVTQSTP 221 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----p~iv~l~~~~~~~~~ 221 (456)
+|.+.+.||+|+||.| ..+++.||||+++.. .....+...|+.+|..++ | -|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 6788999999999976 347999999999854 455677788999999995 4 389999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC--CEEEeccCCc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG--HLKVADFGLS 297 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~--~vkl~Dfgls 297 (456)
+|||+|.+ ..+|+++++++. .++...++.++.||+.||.+||+.+ |||+||||+|||+...+ .||++|||+|
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 99999999 679999999865 3899999999999999999999999 99999999999998443 7999999999
Q ss_pred ccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCC--
Q 012777 298 KLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPP-- 374 (456)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~-- 374 (456)
++... ....+..+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+.+..+....|.... .|+
T Consensus 339 c~~~q--------~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~ 410 (586)
T KOG0667|consen 339 CFESQ--------RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK 410 (586)
T ss_pred cccCC--------cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence 97631 2224566778999999999999999999999999999999999998876655443332211 000
Q ss_pred -----------CC-----------------------------------CC----------CCCCcHHHHHHHHHhcccCC
Q 012777 375 -----------FR-----------------------------------AP----------TTHYAYGLRELIEDCWSEEP 398 (456)
Q Consensus 375 -----------~~-----------------------------------~~----------~~~~~~~l~~li~~~l~~dp 398 (456)
+. .+ ...-...|.+||++||..||
T Consensus 411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP 490 (586)
T KOG0667|consen 411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP 490 (586)
T ss_pred HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence 00 00 01222358999999999999
Q ss_pred CCCCCHHHHHHH
Q 012777 399 FRRPTFRQILMR 410 (456)
Q Consensus 399 ~~Rpt~~ell~~ 410 (456)
.+|+|..+.++|
T Consensus 491 ~~R~tp~qal~H 502 (586)
T KOG0667|consen 491 AERITPAQALNH 502 (586)
T ss_pred hhcCCHHHHhcC
Confidence 999999999887
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=291.20 Aligned_cols=253 Identities=27% Similarity=0.507 Sum_probs=206.9
Q ss_pred cccccceeeeccEEEEEe---E-c----CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012777 152 LDFSNSVEITKGTFRIAS---W-R----GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM 223 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~---~-~----g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 223 (456)
.+|...+.||.|+||.+. . . ...||+|..... ......+.+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc--CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 357778899999998662 1 1 236899988654 235566789999999999999999999998875 4578
Q ss_pred EEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 224 IVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
++|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999999998754 4899999999999999999999999 99999999999999999999999999876532
Q ss_pred cccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (456)
.... ......++..|+|||.+....++.++|+||||+++|+|++ |..||......+....+......+ .+..
T Consensus 160 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~ 232 (270)
T cd05056 160 ESYY----KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP---MPPN 232 (270)
T ss_pred ccce----ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC---CCCC
Confidence 2111 1112234567999999988889999999999999999986 999998877666555554333333 2467
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
++..+.++|.+|+..+|++|||+.+++..|+.+..+
T Consensus 233 ~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 233 CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 788999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=291.17 Aligned_cols=246 Identities=34% Similarity=0.563 Sum_probs=201.3
Q ss_pred ccccceeeeccEEEEE---eE-cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 153 DFSNSVEITKGTFRIA---SW-RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~-~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
+|.+.+.||+|+||.+ .. .+..+|+|.+..... ..+.+.+|+.++++++||+++++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 4777889999999865 22 345799998865422 2356889999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 229 LPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 229 ~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-
Confidence 99999999997643 3889999999999999999999999 99999999999999999999999999876532211
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.......++..|+|||...+..++.++|+||||+++|+|++ |..||.+....+....+......+ .+...+..
T Consensus 158 ---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (260)
T cd05069 158 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP---CPQGCPES 231 (260)
T ss_pred ---cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCcccCHH
Confidence 11112335667999999988889999999999999999999 999998877666665554333322 24578889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMRLDD 413 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~L~~ 413 (456)
+.+++.+||..||++||+++++++.|+.
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 232 LHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=291.77 Aligned_cols=249 Identities=32% Similarity=0.526 Sum_probs=206.0
Q ss_pred ccccccceeeeccEEEEE----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 151 ELDFSNSVEITKGTFRIA----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
..+|.+.+.||+|+||.+ ...+..||+|.+..... ..+.+.+|+.++++++||||+++++++......+++|
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 346888899999999865 23457899999875432 2357889999999999999999999999889999999
Q ss_pred EccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 227 EYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
||+++++|.+++.+.. .++...+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999997643 5899999999999999999999999 9999999999999999999999999987653211
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
.........+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+.......+......+. +...+
T Consensus 158 ----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 230 (261)
T cd05034 158 ----YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR---PPNCP 230 (261)
T ss_pred ----hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCC
Confidence 001112224567999999998889999999999999999998 9999988776666655543332222 34568
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMRLDD 413 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~L~~ 413 (456)
..+.+++.+||..+|++||+++++++.|+.
T Consensus 231 ~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 231 EELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=294.64 Aligned_cols=244 Identities=27% Similarity=0.474 Sum_probs=204.5
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|+..+.||.|+||.+ ..++..||+|++.... .......+.+|+.+++++.||+|+++++++......++|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 4777789999999865 2357899999987542 34456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++.. +++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc---
Confidence 9999999999865 56899999999999999999999999 9999999999999999999999999987653211
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||....+......+.....+. ....++..+.
T Consensus 156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 230 (277)
T cd06640 156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPT---LTGEFSKPFK 230 (277)
T ss_pred --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCC---CchhhhHHHH
Confidence 11223456778999999988889999999999999999999999998776555444332222222 2456788899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+++.+||..+|++||++++++++
T Consensus 231 ~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 231 EFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHcccCcccCcCHHHHHhC
Confidence 99999999999999999999888
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=302.72 Aligned_cols=247 Identities=26% Similarity=0.442 Sum_probs=197.2
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||+|+||.+ ..+++.||+|.+..... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 5888899999999876 23678899999875432 2223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|++ ++|.+++...+ .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--- 157 (309)
T cd07872 85 YLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVP--- 157 (309)
T ss_pred CCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCC---
Confidence 996 58888887654 4899999999999999999999999 999999999999999999999999998754221
Q ss_pred cCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC-------------
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER------------- 372 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------------- 372 (456)
........+++.|+|||.+.+ ..++.++||||||+++|+|++|++||...+..+....+.....
T Consensus 158 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 158 --TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred --ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence 111223456788999998865 4678899999999999999999999987765444333221110
Q ss_pred --------CCCC-----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 373 --------PPFR-----APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 373 --------~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+... .....++.++.++|.+||..||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000 0113567889999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=307.88 Aligned_cols=246 Identities=26% Similarity=0.371 Sum_probs=195.5
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------C
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS------T 220 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------~ 220 (456)
.+|...+.||+|+||.| ...++.||+|.+.... ........+.+|+.+++.++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 36888899999999976 2468899999997653 3344557788999999999999999999988643 3
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
..+++|||++ ++|.+.+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 96 ~~~lv~e~~~-~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhc-ccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 4799999995 577777653 5889999999999999999999999 999999999999999999999999998755
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc----------
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN---------- 370 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~---------- 370 (456)
.. ........+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 170 ~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 170 GT------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred CC------ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 21 11223356788999999999989999999999999999999999999876543222111110
Q ss_pred -----------CCCCC-----------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 371 -----------ERPPF-----------------RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 371 -----------~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..+.+ .......+..+.++|.+||..||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000 00112345678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=293.73 Aligned_cols=267 Identities=26% Similarity=0.428 Sum_probs=216.6
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||.|+||.+ ..+++.||+|.+.... .......+.+|+.+++.++||||+++++++..+...++|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 4677788999999865 3368899999997542 23445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++... ++++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 152 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--- 152 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc---
Confidence 99999999999764 7999999999999999999999999 9999999999999999999999999988763221
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...++......+.....+... ...++.++.
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 228 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GNKFSKPFK 228 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--ccccCHHHH
Confidence 1122345778899999999888999999999999999999999999877655544444333332221 122888999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccccccCcchhhHHHHHhh
Q 012777 388 ELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVGPLRCFQSLAALW 439 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (456)
+++.+||..+|++|||+++++++ .++. .....++++.+....++|
T Consensus 229 ~~l~~~l~~~p~~Rpt~~~il~~--~~~~-----~~~~~~~~~~~~~~~~~~ 273 (274)
T cd06609 229 DFVSLCLNKDPKERPSAKELLKH--KFIK-----KAKKTSYLTLLIERIKKW 273 (274)
T ss_pred HHHHHHhhCChhhCcCHHHHhhC--hhhc-----CCCcccHHHHHHHHHHhc
Confidence 99999999999999999999885 2222 233446666666666665
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=296.95 Aligned_cols=246 Identities=27% Similarity=0.452 Sum_probs=200.7
Q ss_pred ccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||+|+||.+ . .+|..||+|.+... ..+.....+.+|+.++++++||||+++++++...+..++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 4777889999999865 2 35899999998754 244456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 228 YLPKGDLRAYLKQK---GALKPTLAVKFALDIARGMNYLHE-NRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 228 ~~~~~sL~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~-~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
|+++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999988763 369999999999999999999997 47 999999999999999999999999998755211
Q ss_pred ccccCCCCcccCCCCcccccccccCCCC------CCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCC
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEE------YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRA 377 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 377 (456)
......+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...........+..........
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd06622 157 -------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT 229 (286)
T ss_pred -------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCC
Confidence 112235677899999985543 4779999999999999999999997765544443332211111122
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 378 PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 378 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+..++.++.++|.+||..+|++||++++++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 230 LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 345688999999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=298.94 Aligned_cols=257 Identities=25% Similarity=0.389 Sum_probs=207.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||+|+||.+ ..+++.||+|.+.............+.+|+.+++.++||||+++++.+..+...++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778889999999865 34578999999876543334455778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc-
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV- 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~- 306 (456)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999999988888999999999999999999999999 999999999999999999999999988642110000
Q ss_pred ---------cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCC
Q 012777 307 ---------KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRA 377 (456)
Q Consensus 307 ---------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 377 (456)
..........++..|+|||.+.+..++.++|+||||+++|+|++|..||.+....+....+.... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~ 237 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-IEWPE 237 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCCCC
Confidence 00001112356778999999988889999999999999999999999998877666555543332 22222
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 012777 378 PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDD 413 (456)
Q Consensus 378 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~ 413 (456)
....++.++.++|.+||+.||++||+..++.+.|+.
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 234688899999999999999999996555555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=294.47 Aligned_cols=245 Identities=27% Similarity=0.399 Sum_probs=201.6
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
|++.+.||+|+||.+ ..++..+++|.+... .......+.+|+.+++.++||||+++++++......++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 567788999999866 225778999998653 345567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 229 LPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 229 ~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
+++++|..++.. .+++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~---- 156 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---- 156 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc----
Confidence 999999988765 456999999999999999999999999 999999999999999999999999998754211
Q ss_pred CCCCcccCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCC
Q 012777 308 EDRPVTCEETSWRYAAPEVYK-----NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (456)
........+++.|+|||++. +..++.++|+|||||++|+|++|.+||...+..+....+.....+. ...+..+
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 234 (282)
T cd06643 157 -IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRW 234 (282)
T ss_pred -ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-CCCcccc
Confidence 11122345788999999874 3457789999999999999999999998876655544443332222 2234568
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.++.++|.+||..||++||++++++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 235 SSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 8899999999999999999999998876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=290.20 Aligned_cols=249 Identities=29% Similarity=0.523 Sum_probs=197.6
Q ss_pred eeeccEEEEEe---E-----cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE-eCCceEEEEEcc
Q 012777 159 EITKGTFRIAS---W-----RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVT-QSTPMMIVTEYL 229 (456)
Q Consensus 159 ~lg~G~fg~~~---~-----~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~~lv~e~~ 229 (456)
.||+|+||.+. . .+..||+|.+... ......+.+.+|+.+++.++||||+++++++. .+...+++|||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 58999998662 1 2357999998543 34455678899999999999999999999765 455689999999
Q ss_pred CCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccC
Q 012777 230 PKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKE 308 (456)
Q Consensus 230 ~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~ 308 (456)
.+++|.+++.... ..+...+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++..........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~- 155 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS- 155 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee-
Confidence 9999999997643 4677888899999999999999999 9999999999999999999999999987542211000
Q ss_pred CCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 309 DRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
........++..|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+.....+. .+...+..+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLL---QPEYCPDPLY 232 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC---CCCcCCHHHH
Confidence 011112335667999999988889999999999999999999 577887766655554443332222 2345688999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPTFRQILMRLDDISD 416 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt~~ell~~L~~~~~ 416 (456)
+++.+||..+|++||++.++++.|+.++.
T Consensus 233 ~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 233 EVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 99999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=307.34 Aligned_cols=252 Identities=29% Similarity=0.473 Sum_probs=204.1
Q ss_pred ccccceeeeccEEEEEe---E-------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCc
Q 012777 153 DFSNSVEITKGTFRIAS---W-------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTP 221 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~---~-------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~ 221 (456)
+|.+.+.||+|+||.|. + .+..||+|++.... .....+.+.+|+.+|.++. ||||+++++++.....
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 46677899999999762 2 23579999997653 3334567899999999997 9999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC-----------------------------------------------------------
Q 012777 222 MMIVTEYLPKGDLRAYLKQKG----------------------------------------------------------- 242 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~----------------------------------------------------------- 242 (456)
.++||||+.+|+|.+++...+
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999986532
Q ss_pred ---------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe
Q 012777 243 ---------------------------------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR 283 (456)
Q Consensus 243 ---------------------------------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~ 283 (456)
.++...+..++.|++.||.|||+.+ ++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 2566678889999999999999999 9999999999999
Q ss_pred CCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccc
Q 012777 284 DDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKE 362 (456)
Q Consensus 284 ~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~ 362 (456)
+.++.+||+|||++......... .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNY---ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred eCCCEEEEEecCcceeccccccc---ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 99999999999998765221111 11112345778999999998889999999999999999998 899998766554
Q ss_pred hHHHHHhcC-CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 363 VPKAYIANE-RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 363 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
......... ++. .+..++.++.+++.+||..+|.+||++++|++.|+.++
T Consensus 350 ~~~~~~~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 QFYNAIKRGYRMA---KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 433332322 222 24567889999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=280.65 Aligned_cols=246 Identities=27% Similarity=0.479 Sum_probs=203.4
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEE
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv~e 227 (456)
......||+|+-|.| ..+|...|||-+... .+.++.+.+++.+.+..... +|+||+.+++|..+...++.||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 445568999988865 457899999999876 56777889999998888774 9999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
.+ .-.+..++.. .+++++..+-++..-++.||.||.++. +|+|||+||+|||+|+.|++||||||.+-++.
T Consensus 172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv----- 243 (391)
T KOG0983|consen 172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV----- 243 (391)
T ss_pred HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee-----
Confidence 98 4455666554 467999999999999999999999765 49999999999999999999999999988773
Q ss_pred cCCCCcccCCCCcccccccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKN---EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
.+.......|.+.|||||.+.- ..|+.++||||||++++||.||+.||.+.+.+...........|+.-.....++
T Consensus 244 -dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFS 322 (391)
T KOG0983|consen 244 -DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFS 322 (391)
T ss_pred -cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcC
Confidence 3333444567788999998853 478899999999999999999999999977654444443445444433345699
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..|++|++.||.+|+.+||.+.++++|
T Consensus 323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 323 PDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 999999999999999999999999987
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=301.61 Aligned_cols=253 Identities=28% Similarity=0.491 Sum_probs=202.2
Q ss_pred ccccceeeeccEEEEEe----------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC-C
Q 012777 153 DFSNSVEITKGTFRIAS----------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQS-T 220 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~----------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~ 220 (456)
+|.+.+.||+|+||.|. .+++.||||++.... .......+.+|+.++.++ +||||+++++++... .
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 68889999999999762 346789999997543 334456788999999999 689999999987654 5
Q ss_pred ceEEEEEccCCCCHHHHHHHcC----------------------------------------------------------
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKG---------------------------------------------------------- 242 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~---------------------------------------------------------- 242 (456)
..+++|||+++++|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6899999999999999986531
Q ss_pred ---------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcc
Q 012777 243 ---------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT 313 (456)
Q Consensus 243 ---------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~ 313 (456)
.++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~ 239 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---VRKG 239 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcch---hhcC
Confidence 2577788899999999999999999 999999999999999999999999998765221110 1111
Q ss_pred cCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchH-HHHHhcCCCCCCCCCCCCcHHHHHHHH
Q 012777 314 CEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVP-KAYIANERPPFRAPTTHYAYGLRELIE 391 (456)
Q Consensus 314 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~ 391 (456)
...+++.|+|||.+.+..++.++||||||+++|+|++ |..||......... ..+........ +...+.++.+++.
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 316 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTML 316 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC---CCCCCHHHHHHHH
Confidence 2335567999999988889999999999999999996 99999876543322 22222222222 3346778999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHHHH
Q 012777 392 DCWSEEPFRRPTFRQILMRLDDISD 416 (456)
Q Consensus 392 ~~l~~dp~~Rpt~~ell~~L~~~~~ 416 (456)
+||+.||++|||+.+++++|+.+++
T Consensus 317 ~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 317 DCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=292.65 Aligned_cols=240 Identities=25% Similarity=0.457 Sum_probs=197.0
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||+|+||.+ ..++..||+|++.... .......+.+|+.++++++||||+++++++...+..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 4677789999999865 3468899999987542 34455678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|..+ ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence 9999998654 35788999999999999999999999 999999999999999999999999998755211
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc-------hHHHHHhcCCCCCCCCCC
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE-------VPKAYIANERPPFRAPTT 380 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~~ 380 (456)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ....+.....+ .....
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 223 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP--VLPVG 223 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC--CCCCC
Confidence 1223467889999999998889999999999999999999999997543221 11111111111 11234
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++.++.+++.+||+.+|++||++++++++
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 578889999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=291.90 Aligned_cols=254 Identities=28% Similarity=0.487 Sum_probs=204.6
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCC---HHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTD---EDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
+|+..+.||+|+||.+ ..+++.||+|++....... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4777889999999865 3478899999997543211 2345788999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-CEEEeccCCccccccc
Q 012777 225 VTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG-HLKVADFGLSKLLKFA 303 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~-~vkl~Dfgls~~~~~~ 303 (456)
|+||+++++|.+++.+.+++++..+..++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999999988788999999999999999999999999 99999999999998765 5999999998766432
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCCCCCCCC
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRAPTTHY 382 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 382 (456)
... .........++..|+|||.+.+..++.++|+||||+++++|++|..||...........+.... .......+..+
T Consensus 158 ~~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd06630 158 GTG-AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236 (268)
T ss_pred ccc-CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhh
Confidence 111 1111223457788999999988889999999999999999999999997655433322221111 11112234567
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.++.+++.+||..+|++|||+.+++++
T Consensus 237 ~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 237 SPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 8899999999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=294.58 Aligned_cols=252 Identities=25% Similarity=0.448 Sum_probs=201.6
Q ss_pred ccccceeeeccEEEEEeE---------------------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCccee
Q 012777 153 DFSNSVEITKGTFRIASW---------------------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQ 211 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~~---------------------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 211 (456)
+|++.+.||+|+||.+.. ++..||+|++... ........+.+|+.+++.++||||++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 588889999999987632 2346999998754 23455678999999999999999999
Q ss_pred eeeEEEeCCceEEEEEccCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 012777 212 FLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG-----------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSN 280 (456)
Q Consensus 212 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~N 280 (456)
+++++......+++|||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999997642 2667789999999999999999999 9999999999
Q ss_pred eEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCCC
Q 012777 281 ILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE--GCPPFPTK 358 (456)
Q Consensus 281 il~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~~ 358 (456)
|+++.++.++|+|||++..+...... .......+++.|++||...++.++.++|+|||||++|+|++ |..||...
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcce---eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999998755221110 11112234567999999888889999999999999999998 77899776
Q ss_pred CccchHHHHHh----cCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 359 QEKEVPKAYIA----NERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 359 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
+..+....... .........+..++..+.+++.+||..||++||++.++++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 65444332211 1111111224567789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=290.93 Aligned_cols=243 Identities=32% Similarity=0.549 Sum_probs=197.4
Q ss_pred eeeccEEEEE---e--EcCc--EEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccC
Q 012777 159 EITKGTFRIA---S--WRGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLP 230 (456)
Q Consensus 159 ~lg~G~fg~~---~--~~g~--~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~e~~~ 230 (456)
.||+|+||.+ . .++. .+|+|.+... ........+.+|+.+++++ +||||+++++++......+++|||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 5899999865 2 2333 4688888743 2344557889999999999 79999999999999999999999999
Q ss_pred CCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEecc
Q 012777 231 KGDLRAYLKQKG----------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294 (456)
Q Consensus 231 ~~sL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Df 294 (456)
+++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence 999999997543 3788899999999999999999999 999999999999999999999999
Q ss_pred CCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCC
Q 012777 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERP 373 (456)
Q Consensus 295 gls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 373 (456)
|++...... . .......+..|+|||++....++.++|+||||+++|+|++ |..||...+.......+......
T Consensus 157 gl~~~~~~~----~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 230 (270)
T cd05047 157 GLSRGQEVY----V--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 230 (270)
T ss_pred CCccccchh----h--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCC
Confidence 997532110 0 0111223557999999988889999999999999999997 99999877665555554332222
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 374 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
. .+...+.++.+++.+||..||.+|||+.+++..|+.++
T Consensus 231 ~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 231 E---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C---CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 2 23457788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=298.88 Aligned_cols=248 Identities=30% Similarity=0.535 Sum_probs=198.8
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
|+..+.||+|+||.+ ..+++.||+|++..... .........+|+.++++++||||+++++++......+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI-EEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH-HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc-cccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 566789999999976 23566899999987532 222233446699999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccC
Q 012777 229 LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKE 308 (456)
Q Consensus 229 ~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~ 308 (456)
+.+++|.+++...+.+++..+..++.|+++||.+||+++ ++|+||||+||+++.++.++|+|||.+.... ..
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-----~~ 151 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-----EN 151 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-----ST
T ss_pred ccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-----cc
Confidence 988899999997788999999999999999999999999 9999999999999999999999999987531 11
Q ss_pred CCCcccCCCCcccccccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCC---CCCCCCCcH
Q 012777 309 DRPVTCEETSWRYAAPEVYK-NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPF---RAPTTHYAY 384 (456)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 384 (456)
........+++.|+|||++. +..++.++|+||||+++++|++|..||...........+........ .......+.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSE 231 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHH
Confidence 22333456788999999998 78899999999999999999999999988732222222211111000 000122247
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+.++|.+||..||++|||+++++++
T Consensus 232 ~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 232 ELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 89999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=307.36 Aligned_cols=248 Identities=27% Similarity=0.454 Sum_probs=216.6
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
.-.|.+...||+|.|+.| ..++..||||.+.+... +......+.+|+++++.++|||||+++++...+..+|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 346888899999999977 34799999999988764 445556699999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|||+.+|.+++++.+.+.+.+..+..++.|+..|++|||+++ |+|||||+.|+|++.+.++||+|||++.++.
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD---- 206 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec----
Confidence 999999999999999999999999999999999999999999 9999999999999999999999999999874
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCCCCCCCCc
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYD-TKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRAPTTHYA 383 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 383 (456)
.......+.|++.|.|||++.+.+++ +.+|+||+|+++|.|+.|.+||++.+-.+.......+. +.+ ...+
T Consensus 207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp-----~~ms 279 (596)
T KOG0586|consen 207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIP-----FYMS 279 (596)
T ss_pred --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccc-----ceee
Confidence 23344567899999999999988766 58999999999999999999999988777666554443 333 3456
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMRLDD 413 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~L~~ 413 (456)
.+..++|+++|.++|.+|++.+++.++-..
T Consensus 280 ~dce~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 280 CDCEDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred chhHHHHHHhhccCccccCCHHHhhhhccc
Confidence 678999999999999999999999887443
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=290.67 Aligned_cols=253 Identities=26% Similarity=0.516 Sum_probs=208.4
Q ss_pred cccccceeeeccEEEEEe-----EcCc----EEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGT----QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~----~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
.+|+..+.||+|+||.+. .+|. .||+|.+.... .......+.+|+.++++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 457788899999998652 1233 69999987653 34556788999999999999999999999887 788
Q ss_pred EEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
++++||+++++|.+++.+. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999999774 45999999999999999999999999 9999999999999999999999999998663
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
...... ......++..|+|||.+....++.++|+||||+++|++++ |..||......+....+......+ .+.
T Consensus 161 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~ 234 (279)
T cd05057 161 VDEKEY---HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLP---QPP 234 (279)
T ss_pred Ccccce---ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC---CCC
Confidence 221111 1111223567999999988889999999999999999998 999998887766665554332222 234
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~ 416 (456)
..+..+.+++.+||..||++||++.++++.|.++.+
T Consensus 235 ~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 235 ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 577889999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=288.18 Aligned_cols=247 Identities=30% Similarity=0.510 Sum_probs=203.3
Q ss_pred cccccceeeeccEEEEEe----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 152 LDFSNSVEITKGTFRIAS----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
-+|...+.||+|+||.+. ..+..+|+|.+... ....+.+.+|+.+++.++|+||+++++++.. ...+++||
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 357888999999998662 34567999988643 3345778999999999999999999999887 77899999
Q ss_pred ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|+++++|.+++... ..++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999763 34788899999999999999999999 99999999999999999999999999876532111
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.......++..|+|||++....++.++|+||||+++|++++ |..||...+.......+......+ .....+.
T Consensus 158 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 230 (260)
T cd05073 158 ----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP---RPENCPE 230 (260)
T ss_pred ----ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC---CcccCCH
Confidence 11112234567999999988889999999999999999998 999998876655555553332222 2457888
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMRLDD 413 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~L~~ 413 (456)
++.+++.+||+.+|++||+++++++.|+.
T Consensus 231 ~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 231 ELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 99999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=293.41 Aligned_cols=246 Identities=25% Similarity=0.404 Sum_probs=202.3
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|++.+.||.|+||.+ ..++..||+|.+... .......+.+|+.+++.++||||+++++++..+...++|||
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 4888899999999865 235889999998753 45566788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|+++++|..++.+ ...+++..+..++.|++.+|.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--- 163 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--- 163 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc---
Confidence 9999999988765 456999999999999999999999999 999999999999999999999999987654211
Q ss_pred cCCCCcccCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCC
Q 012777 307 KEDRPVTCEETSWRYAAPEVYK-----NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (456)
........+++.|+|||++. ...++.++|+|||||++|+|++|..||...+.......+.....+. ...+..
T Consensus 164 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 240 (292)
T cd06644 164 --LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LSQPSK 240 (292)
T ss_pred --ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc-CCCCcc
Confidence 11112345778899999884 3456789999999999999999999998766554444443222222 223456
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.++.++|.+||..||++||++++++++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 241 WSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 78889999999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=288.62 Aligned_cols=246 Identities=25% Similarity=0.472 Sum_probs=207.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||+|+||.+ ..+|+.||+|.+..... .......+.+|+.++++++||||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 4778899999999864 23688999999875432 33445688999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 999999999987643 4889999999999999999999999 9999999999999999999999999987653211
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.......+++.|+|||++.+..++.++|+||||+++++|++|..||...+..+....+.....+. .+..++.+
T Consensus 156 ----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 228 (256)
T cd08218 156 ----ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP---VSSHYSYD 228 (256)
T ss_pred ----hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC---CcccCCHH
Confidence 11122346788999999988888999999999999999999999998777666665554444333 24677889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.++|.+||+.+|++||++.+++++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 229 LRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhhC
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=288.46 Aligned_cols=240 Identities=32% Similarity=0.631 Sum_probs=201.4
Q ss_pred ccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEcc
Q 012777 153 DFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~ 229 (456)
+|.+.+.||+|+||.+ ..+++.||+|.+.... ....+.+|+.++++++||||+++++++... ..+++|||+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HceeeeeeccCCCCceEecccCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 5778889999999865 5578899999986531 235788999999999999999999998765 479999999
Q ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 230 PKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 230 ~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 9999999997654 4889999999999999999999999 999999999999999999999999998754211
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+.....+. ....++..+
T Consensus 154 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 226 (254)
T cd05083 154 ----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME---PPEGCPADV 226 (254)
T ss_pred ----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC---CCCcCCHHH
Confidence 111233457999999988899999999999999999997 999998877666655554333222 245788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
.+++.+||+.+|++||++++++..|+
T Consensus 227 ~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 227 YVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=295.04 Aligned_cols=247 Identities=22% Similarity=0.421 Sum_probs=204.1
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
..+|+..+.||+|+||.+ ..++..||+|.+..... .....+.+|+.+++.+.||||+++++.+......++|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 347888899999999865 24688999999876432 2346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|||+++++|.+++.+ ..+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~-- 169 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccc--
Confidence 999999999999865 46899999999999999999999999 999999999999999999999999988754221
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
........+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...++............+.. ..+..++..
T Consensus 170 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 245 (296)
T cd06654 170 ---QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSAI 245 (296)
T ss_pred ---ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCC-CCccccCHH
Confidence 1112234577889999999888889999999999999999999999987765443333322222222 224567888
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.++|.+||..+|++||++++++++
T Consensus 246 l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 246 FRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHHHHHCcCCcccCcCHHHHhhC
Confidence 9999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=295.40 Aligned_cols=244 Identities=29% Similarity=0.484 Sum_probs=203.2
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|+..+.||+|+||.+ ..++..||+|.+.... .....+.+.+|+.++++++||||+++++++......++|+|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 3666778999999865 2357899999987542 34456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++.. +.+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc---
Confidence 9999999998864 56899999999999999999999999 9999999999999999999999999987653211
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
.......++..|+|||++.+..++.++|+||||+++|+|++|..||....+......+.....+. ....++.++.
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 230 (277)
T cd06642 156 --IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT---LEGQYSKPFK 230 (277)
T ss_pred --hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCC---CCcccCHHHH
Confidence 11122356778999999998889999999999999999999999998766555444332222222 2356788899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++|.+||..+|++||++.+++++
T Consensus 231 ~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 231 EFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=288.98 Aligned_cols=252 Identities=27% Similarity=0.460 Sum_probs=207.5
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|++.+.||.|+||.+ ..++..+|+|++...... .....+.+|+..++.++|+||+++++.+......++++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 5788889999999865 236789999999765322 256789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQK---GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
++++++|.+++... ..+++..+..++.|++.||.+||+++ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999999764 35899999999999999999999999 9999999999999999999999999988664322
Q ss_pred cccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCC--CCC
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAP--TTH 381 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~ 381 (456)
.... .......++..|+|||.+... .++.++|+||||+++++|++|+.||...+.............+.+... ...
T Consensus 157 ~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06610 157 DRTR-KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235 (267)
T ss_pred cccc-cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccc
Confidence 1110 112334578889999998776 788899999999999999999999988776555544433333322222 247
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++..+.+++.+||..||++|||+++++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 78899999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=293.94 Aligned_cols=246 Identities=25% Similarity=0.409 Sum_probs=204.7
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|++.+.||.|+||.+ ..++..||+|.+... .....+.+..|+.++++++||||+++++.+..+...++|||
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 5888889999999865 235889999998643 45566789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|+++++|.+++.+. ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--- 156 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--- 156 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc---
Confidence 99999999998764 46999999999999999999999999 999999999999999999999999987755221
Q ss_pred cCCCCcccCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCC
Q 012777 307 KEDRPVTCEETSWRYAAPEVYK-----NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (456)
........+++.|+|||.+. ...++.++|+||||+++|+|++|..||...+.......+.....+.+ ..+..
T Consensus 157 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 233 (280)
T cd06611 157 --LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQPSK 233 (280)
T ss_pred --ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CCccc
Confidence 11122345788899999874 34577799999999999999999999988766555544433322222 22456
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.++.++|.+||..+|++||++++++++
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 234 WSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 78899999999999999999999999886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=288.38 Aligned_cols=244 Identities=28% Similarity=0.522 Sum_probs=201.0
Q ss_pred eeeccEEEEE---eE---cCc--EEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccC
Q 012777 159 EITKGTFRIA---SW---RGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230 (456)
Q Consensus 159 ~lg~G~fg~~---~~---~g~--~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~ 230 (456)
.||+|+||.+ .+ +++ .||+|.+...... ...+.+.+|+.++++++||||+++++.+.. ...++++||++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 5899999865 21 222 6999999876432 566889999999999999999999999988 88999999999
Q ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccC
Q 012777 231 KGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKE 308 (456)
Q Consensus 231 ~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~ 308 (456)
+++|.+++.+.. .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++..........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~- 154 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY- 154 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce-
Confidence 999999998754 5899999999999999999999999 9999999999999999999999999998764321111
Q ss_pred CCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 309 DRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
.......++..|+|||.+....++.++|+|||||++|+|++ |..||...+..+....+.... ... ..+..++..+.
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~ 231 (257)
T cd05040 155 -VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG-ERL-ERPEACPQDIY 231 (257)
T ss_pred -ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-CcC-CCCccCCHHHH
Confidence 11112446678999999988889999999999999999998 999998777666555553322 111 12356788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
+++.+||+.+|++||++.++++.|.
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHHHhc
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=286.80 Aligned_cols=245 Identities=30% Similarity=0.569 Sum_probs=202.5
Q ss_pred ccccceeeeccEEEEEe----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 153 DFSNSVEITKGTFRIAS----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
+|+..+.||.|+||.+. .++..+|+|.+...... ...+.+|++++++++||+++++++++......++++||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 46677899999998652 24788999998754322 24688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 229 LPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 229 ~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
+++++|.+++... +.+++..++.++.|++.+|.+||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 154 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ--- 154 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc---
Confidence 9999999998764 46899999999999999999999999 9999999999999999999999999987552211
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
........++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+....... .+...+..+
T Consensus 155 -~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 230 (256)
T cd05112 155 -YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY---KPRLASQSV 230 (256)
T ss_pred -ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC---CCCCCCHHH
Confidence 111112234568999999998889999999999999999998 999998777666555554332222 234568899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
.+++.+||+.+|++|||++++++.|
T Consensus 231 ~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 231 YELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHHHcccChhhCCCHHHHHHhh
Confidence 9999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=309.20 Aligned_cols=244 Identities=24% Similarity=0.318 Sum_probs=196.8
Q ss_pred cccccceeeeccEEEEEe-------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 152 LDFSNSVEITKGTFRIAS-------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
.+|.+.+.||+|+||.|. ..+..||+|.+... ....+|+.++++++||||+++++++......++
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 468999999999999762 13568999988643 234589999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 225 VTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
+||++ +++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.......
T Consensus 164 v~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 164 VMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred Eehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 99999 5789999977778999999999999999999999999 9999999999999999999999999987653221
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccch---HHHHHh------------
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV---PKAYIA------------ 369 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~------------ 369 (456)
.........||+.|+|||++....++.++|||||||++|+|++|+.||.+...... ...+..
T Consensus 240 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 240 ---DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred ---ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 11112245689999999999999999999999999999999999999976543211 111110
Q ss_pred --------------cCCCCCCCC----CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 370 --------------NERPPFRAP----TTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 370 --------------~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..++++... ...++.++.++|.+||..||++|||+.+++.+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 001111110 13456788999999999999999999999988
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=297.71 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=206.6
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||+|+||.+ ..+++.||+|.+...........+.+..|+.+++.++||+|+++++.+......+++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5778889999999865 23578999999987654444566788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|+.+++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999998764 45899999999999999999999999 99999999999999999999999999875532111
Q ss_pred ccC------------------------CCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 012777 306 VKE------------------------DRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK 361 (456)
Q Consensus 306 ~~~------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 361 (456)
... ........|+..|+|||++.+..++.++||||||+++|+|++|..||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 000 00111245788899999999888999999999999999999999999877765
Q ss_pred chHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 012777 362 EVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPT----FRQILMR 410 (456)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt----~~ell~~ 410 (456)
.....+.... ..+. ....++..+.++|.+||..||++||+ +++++++
T Consensus 239 ~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 239 ETFSNILKKE-VTFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHhcCC-ccCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 5554443222 2221 12337889999999999999999999 8888775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=298.62 Aligned_cols=250 Identities=17% Similarity=0.322 Sum_probs=192.2
Q ss_pred ceeeecc--EEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEcc
Q 012777 157 SVEITKG--TFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229 (456)
Q Consensus 157 ~~~lg~G--~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~ 229 (456)
...||+| +|+.+ ..+|+.||+|.+..+.. .......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 4578999 44443 35689999999976542 3445567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc-c
Q 012777 230 PKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT-V 306 (456)
Q Consensus 230 ~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~-~ 306 (456)
++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+++.||+........+. .
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999753 34899999999999999999999999 99999999999999999999999986553321110 0
Q ss_pred c-CCCCcccCCCCcccccccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCC---------
Q 012777 307 K-EDRPVTCEETSWRYAAPEVYKN--EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPP--------- 374 (456)
Q Consensus 307 ~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 374 (456)
. .........++..|+|||++.+ ..++.++|||||||++|+|++|..||.................+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 0 0011122345677999999876 468899999999999999999999997654333222211111000
Q ss_pred ---------------------------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 ---------------------------------FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 ---------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.......++..+.++|.+||+.||++|||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000122456789999999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=286.66 Aligned_cols=245 Identities=25% Similarity=0.443 Sum_probs=205.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||+|+||.+ ..+++.+|+|.+..... .......+.+|+.+++.++||||+++++.+......++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 4777889999999855 34788999999976543 33456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC-CCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS-GHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~-~~vkl~Dfgls~~~~~~~ 304 (456)
|+++++|.+++.+. ..+++..+..++.|++.+|.|||+++ ++|+||+|.||+++.+ +.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~- 155 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK- 155 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC-
Confidence 99999999999764 34899999999999999999999999 9999999999999854 46899999998866322
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+......+ .+..++.
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 227 (256)
T cd08220 156 -----SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP---ISDRYSP 227 (256)
T ss_pred -----ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC---CCCCcCH
Confidence 11122457788999999998888999999999999999999999998877665555554333322 2456788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.+++.+||..+|++|||+.+++++
T Consensus 228 ~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 228 DLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhC
Confidence 99999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=288.79 Aligned_cols=251 Identities=27% Similarity=0.468 Sum_probs=201.9
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCC--CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--CCce
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFT--DEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ--STPM 222 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~ 222 (456)
++|...+.||+|+||.+ ..++..||+|.+...... .......+.+|+.++++++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999865 246889999998754322 23345678899999999999999999998865 3678
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
++++||+++++|.+++...+.+++...+.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 899999999999999988778999999999999999999999999 99999999999999999999999999875532
Q ss_pred cccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (456)
.. ..........++..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+.... .....+..+
T Consensus 159 ~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~ 234 (266)
T cd06651 159 IC--MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP--TNPQLPSHI 234 (266)
T ss_pred cc--ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC--CCCCCchhc
Confidence 11 01111122447788999999998889999999999999999999999998765544333332211 112224567
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+..+.+++ +||..+|++||++++++++
T Consensus 235 ~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 235 SEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 78888998 7888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=293.58 Aligned_cols=250 Identities=22% Similarity=0.428 Sum_probs=207.1
Q ss_pred CccccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 148 DPKELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 148 ~~~~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
.....+|+..+.||.|+||.+ ..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++......
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 333456889999999999865 24788999999875432 2346788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
++|+||+++++|.+++.. ..+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 999999999999998865 46899999999999999999999999 99999999999999999999999999875532
Q ss_pred cccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (456)
.. .......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...++......+.....+.. ..+..+
T Consensus 168 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~ 241 (296)
T cd06655 168 EQ-----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL-QNPEKL 241 (296)
T ss_pred cc-----ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCccc-CCcccC
Confidence 11 111224577889999999988899999999999999999999999988776544443432222222 234678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+..+.++|.+||..||++||++.+++.+
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 8899999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=326.08 Aligned_cols=248 Identities=22% Similarity=0.366 Sum_probs=198.3
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS--TPMMIV 225 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~lv 225 (456)
+|.+.+.||+|+||.| ..++..||+|++..... .......+..|+.++++++||||++++++|... ..+|+|
T Consensus 14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV 92 (1021)
T PTZ00266 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL 92 (1021)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence 6889999999999976 23677899999976543 445567899999999999999999999988653 568999
Q ss_pred EEccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCCeEeCC------------
Q 012777 226 TEYLPKGDLRAYLKQK----GALKPTLAVKFALDIARGMNYLHENRP----EAIIHRDLEPSNILRDD------------ 285 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~~----~~ivH~Dikp~Nil~~~------------ 285 (456)
|||+++++|.+++... +.+++..++.|+.||+.||.|||+.+. .+|+|+||||+|||++.
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 9999999999998752 569999999999999999999998431 23999999999999964
Q ss_pred -----CCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 012777 286 -----SGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN--EEYDTKVDVFSFALILQEMIEGCPPFPTK 358 (456)
Q Consensus 286 -----~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~ 358 (456)
.+.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIE------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccCCCCceEEccCCcccccccc------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 235899999998765221 11223468999999999854 45888999999999999999999999765
Q ss_pred CccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 359 QEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+........... .+.+ +...++.++.+||..||..+|.+||++.+++.+
T Consensus 247 ~~~~qli~~lk~-~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 247 NNFSQLISELKR-GPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CcHHHHHHHHhc-CCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 543332222222 1222 235678899999999999999999999999864
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=292.00 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=205.4
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||.|+||.+ ..++..||+|++.+.........+.+.+|++++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778889999999754 33589999999987654455567889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+.+++|.+++....++++..+..++.|+++||.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--- 154 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--- 154 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc---
Confidence 9999999999988778999999999999999999999999 9999999999999999999999999987653211
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc--chHHHHHhcCCCCCCCCCCCCcHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK--EVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
......++..|+|||.+....++.++|+||||+++|+|++|..||...... ......... .....+...+..
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 228 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---ADVLYPATWSTE 228 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---ccccCcccCcHH
Confidence 222345777899999998888999999999999999999999999877642 222222111 222234667889
Q ss_pred HHHHHHHhcccCCCCCCCH--HHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTF--RQILM 409 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~--~ell~ 409 (456)
+.++|.+||..||++||+. +++++
T Consensus 229 ~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 229 AIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHHHHHHHccCChhHcCCccHHHHhc
Confidence 9999999999999999999 77654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=296.70 Aligned_cols=247 Identities=25% Similarity=0.423 Sum_probs=196.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||+|+||.+ ..+++.||+|.+..... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 5888899999999866 23678999999875432 2223467789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|++ ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--- 157 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP--- 157 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCC---
Confidence 996 6999988764 45899999999999999999999999 999999999999999999999999998754221
Q ss_pred cCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC-------------
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER------------- 372 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------------- 372 (456)
........+++.|+|||.+.+. .++.++||||||+++|+|++|++||...+..+....+.....
T Consensus 158 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 158 --TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred --CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 1112233467889999987654 578899999999999999999999987665433322211100
Q ss_pred -----CCCC--------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 373 -----PPFR--------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 373 -----~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..++ .....++..+.++|.+||..||.+|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 0123577889999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=288.97 Aligned_cols=254 Identities=26% Similarity=0.491 Sum_probs=199.1
Q ss_pred ccccccceeeeccEEEEEe---------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--C
Q 012777 151 ELDFSNSVEITKGTFRIAS---------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ--S 219 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~---------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~ 219 (456)
+.+|++.+.||+|+||.+. .++..||+|.+... .....+.+.+|++++++++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 4468888999999998762 25789999998753 34556788999999999999999999998754 3
Q ss_pred CceEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
..+++|+||+++++|.+++.+. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 4689999999999999999764 45899999999999999999999999 9999999999999999999999999988
Q ss_pred cccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc------------hHH-
Q 012777 299 LLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE------------VPK- 365 (456)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------------~~~- 365 (456)
.......... ......++..|+|||++.+..++.++|+||||+++|+|++|..|+....... ...
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 157 VLPQDKEYYK--VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred cccCCCccee--ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence 6632211100 0111223445999999988889999999999999999999877764332110 000
Q ss_pred --HHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 366 --AYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 366 --~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
...... ........++.++.+++.+||..+|++|||++++++.|+.+
T Consensus 235 ~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNN--GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcC--CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 011111 11112456788999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=288.73 Aligned_cols=245 Identities=26% Similarity=0.460 Sum_probs=192.7
Q ss_pred eeeccEEEEEe----E---cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 159 EITKGTFRIAS----W---RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 159 ~lg~G~fg~~~----~---~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
.||+|+||.+. . ....+|+|.+... ........+.+|+.+++.++||||+++++.+......++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc--CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 58999998662 2 2346888887644 2344556788999999999999999999999999999999999999
Q ss_pred CCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 232 GDLRAYLKQKGA-----LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 232 ~sL~~~l~~~~~-----l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
++|.+++..... .++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999976432 467788899999999999999999 999999999999999999999999998644211100
Q ss_pred cCCCCcccCCCCcccccccccCC-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCC--C
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKN-------EEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPF--R 376 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~--~ 376 (456)
. ......+++.|+|||++.. ..++.++|||||||++|+|++ |..||......+............. +
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 157 I---TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred e---ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 0 1122345677999998743 356779999999999999999 8899987766555554444432222 2
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 377 APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 377 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
.....++..+.+++..|+ .||++|||++++++.|.
T Consensus 234 ~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 234578888999999999 59999999999998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=285.99 Aligned_cols=245 Identities=36% Similarity=0.628 Sum_probs=203.3
Q ss_pred ccceeeeccEEEEE---eEc------CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 155 SNSVEITKGTFRIA---SWR------GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 155 ~~~~~lg~G~fg~~---~~~------g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
++.+.||.|+||.+ ... +..||+|.+.... .......+.+|+.+++.++|+||+++++++...+..+++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 45678999999855 222 3889999997552 333567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGA--LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
|||+++++|.+++..... +++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999976544 999999999999999999999999 999999999999999999999999998866432
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCC
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (456)
..... ....+++.|+|||.+.+..++.++|+||||+++++|++ |.+||...+.......+....... .+..+
T Consensus 157 ~~~~~----~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 229 (258)
T smart00219 157 DYYKK----KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLP---KPENC 229 (258)
T ss_pred ccccc----ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---CCCcC
Confidence 11111 01236678999999988889999999999999999998 899998766666555554333332 24558
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
+..+.+++.+||..||++|||+.++++.|
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 230 PPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 89999999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=286.97 Aligned_cols=246 Identities=24% Similarity=0.455 Sum_probs=204.7
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--CCceEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ--STPMMIV 225 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~~lv 225 (456)
+|.+...||.|+||.+ ..+|..||+|.+..... .....+.+..|+.+++.++||||+++++++.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 3677789999999865 34678999999976543 45556788999999999999999999998764 3568999
Q ss_pred EEccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCCeEeCCCCCEEEeccCC
Q 012777 226 TEYLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLH-----ENRPEAIIHRDLEPSNILRDDSGHLKVADFGL 296 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH-----~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgl 296 (456)
|||+++++|.+++.. ..++++..++.++.|++.||.||| +.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccc
Confidence 999999999999876 356999999999999999999999 777 99999999999999999999999999
Q ss_pred cccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCC
Q 012777 297 SKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFR 376 (456)
Q Consensus 297 s~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 376 (456)
+....... .......+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+.......+..... +
T Consensus 157 ~~~~~~~~-----~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~ 228 (265)
T cd08217 157 AKILGHDS-----SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF---R 228 (265)
T ss_pred cccccCCc-----ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC---C
Confidence 88663221 112234578889999999888899999999999999999999999988775555444433322 2
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 377 APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 377 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..+..++..+.+++.+||..+|++|||+++++++
T Consensus 229 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 2356788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=286.27 Aligned_cols=252 Identities=26% Similarity=0.464 Sum_probs=204.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||+|+||.+ ..++..||+|.+..... .+.....+.+|+.+++.++|+||+++++.+.....+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 4777889999999855 23688999999986543 24567889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999999988777999999999999999999999999 9999999999999999999999999988663322111
Q ss_pred CCCCcccCCCCcccccccccCCCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCCCCCCCCc
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEE---YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRAPTTHYA 383 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 383 (456)
........+++.|+|||++.... ++.++|+||||++++++++|+.||................ .+.++ ....++
T Consensus 157 -~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 234 (264)
T cd06626 157 -GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIP-DSLQLS 234 (264)
T ss_pred -cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCC-cccccC
Confidence 11012245778899999998766 7889999999999999999999997654322222221222 22221 223458
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..+.++|.+||+.+|++|||+.+++.+
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 889999999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=284.37 Aligned_cols=243 Identities=30% Similarity=0.531 Sum_probs=199.7
Q ss_pred eeeccEEEEE---e-EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012777 159 EITKGTFRIA---S-WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234 (456)
Q Consensus 159 ~lg~G~fg~~---~-~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~sL 234 (456)
.||.|+||.+ . ..++.||+|.+.... .......+.+|+.++++++||+|+++++++......+++|||+++++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTL--PPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 6888888754 2 238999999987653 234567899999999999999999999999999999999999999999
Q ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcc
Q 012777 235 RAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT 313 (456)
Q Consensus 235 ~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~ 313 (456)
.+++... ..++...+..++.+++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++.......... ...
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~---~~~ 153 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV---SDG 153 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCccee---ccc
Confidence 9999664 45899999999999999999999999 9999999999999999999999999987553211100 001
Q ss_pred cCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q 012777 314 CEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIED 392 (456)
Q Consensus 314 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 392 (456)
....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+....... .+...+..+.+++.+
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~ 230 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP---APQLCPEEIYRLMLQ 230 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC---CCccCCHHHHHHHHH
Confidence 1223456999999988889999999999999999998 899998877655555443322222 245678899999999
Q ss_pred hcccCCCCCCCHHHHHHHHH
Q 012777 393 CWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 393 ~l~~dp~~Rpt~~ell~~L~ 412 (456)
||..+|++|||+.++++.|+
T Consensus 231 ~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 231 CWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HhccChhhCcCHHHHHHHhh
Confidence 99999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=308.04 Aligned_cols=251 Identities=27% Similarity=0.485 Sum_probs=204.4
Q ss_pred ccCccccccccceeeeccEEEEE-----eEcCcEEE---EEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE
Q 012777 146 EIDPKELDFSNSVEITKGTFRIA-----SWRGTQVA---VKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVT 217 (456)
Q Consensus 146 ~~~~~~~~~~~~~~lg~G~fg~~-----~~~g~~vA---vK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 217 (456)
+.++...=......||+|.|-.| ...|..|| ||.-. ...++...+.|..|+.+|+.|+||||+++|++|.
T Consensus 34 e~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d--~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~ 111 (632)
T KOG0584|consen 34 EKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRD--VTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWV 111 (632)
T ss_pred ccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHH--hhcChHHHHHHHHHHHHHccCCCCceeeeeehee
Confidence 34444433345568999999765 33555555 33322 2245667789999999999999999999999998
Q ss_pred eCCc--eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-CCCCEEEecc
Q 012777 218 QSTP--MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD-DSGHLKVADF 294 (456)
Q Consensus 218 ~~~~--~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~-~~~~vkl~Df 294 (456)
+... +.+|+|++..|+|..|+++.+.++.+.+..|++||++||.|||++. ++|||||||++||+|+ ..|.|||+|+
T Consensus 112 d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDL 190 (632)
T KOG0584|consen 112 DTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDL 190 (632)
T ss_pred cCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecch
Confidence 7655 8899999999999999999999999999999999999999999997 5899999999999998 6789999999
Q ss_pred CCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc-cchHHHHHhcCCC
Q 012777 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE-KEVPKAYIANERP 373 (456)
Q Consensus 295 gls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~ 373 (456)
|||.... ........|||.|||||++. ..|+..+||||||++|.||+|+..||..... -.+++++..+..|
T Consensus 191 GLAtl~r-------~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP 262 (632)
T KOG0584|consen 191 GLATLLR-------KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP 262 (632)
T ss_pred hHHHHhh-------ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH
Confidence 9998762 22333468999999999988 5799999999999999999999999987764 4666666555444
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.- +..--.+++++||.+||.. ..+|||+.|||.+
T Consensus 263 ~s--l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 263 AA--LSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HH--hhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 21 1222356799999999999 9999999999976
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=314.69 Aligned_cols=245 Identities=19% Similarity=0.220 Sum_probs=188.9
Q ss_pred cccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC------CCcceeeeeEEEe
Q 012777 150 KELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR------HPNVVQFLGAVTQ 218 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~l~~~~~~ 218 (456)
...+|.+.+.||+|+||.| ..+++.||||++... ......+..|+.+++.++ |++++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3457999999999999977 235788999999642 122234556776666654 4568899998876
Q ss_pred C-CceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCC---------
Q 012777 219 S-TPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHE-NRPEAIIHRDLEPSNILRDDSG--------- 287 (456)
Q Consensus 219 ~-~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~~~~ivH~Dikp~Nil~~~~~--------- 287 (456)
. ..+++|||++ +++|.+++.+.+.+++..+..|+.||+.||.|||+ .+ |+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccccc
Confidence 4 5689999998 78999999888889999999999999999999998 58 99999999999998765
Q ss_pred -------CEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc
Q 012777 288 -------HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE 360 (456)
Q Consensus 288 -------~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 360 (456)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|++||...+.
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~--------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDER--------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred ccCCCCceEEECCCCccccCc--------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 49999999875431 112345689999999999999999999999999999999999999987665
Q ss_pred cchHHHHHhcC-CC-------------------------CCC------------CCCCCCcHHHHHHHHHhcccCCCCCC
Q 012777 361 KEVPKAYIANE-RP-------------------------PFR------------APTTHYAYGLRELIEDCWSEEPFRRP 402 (456)
Q Consensus 361 ~~~~~~~~~~~-~~-------------------------~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rp 402 (456)
.+....+.... .. ... .........+.+||.+||+.||++||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 43332221110 00 000 00001234578999999999999999
Q ss_pred CHHHHHHH
Q 012777 403 TFRQILMR 410 (456)
Q Consensus 403 t~~ell~~ 410 (456)
|++|+++|
T Consensus 431 ta~e~L~H 438 (467)
T PTZ00284 431 NARQMTTH 438 (467)
T ss_pred CHHHHhcC
Confidence 99999986
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=287.64 Aligned_cols=245 Identities=27% Similarity=0.415 Sum_probs=190.7
Q ss_pred eeeccEEEEEe---E----cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 159 EITKGTFRIAS---W----RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 159 ~lg~G~fg~~~---~----~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
.||+|+||.+. . ++..+|+|.+.... .......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 58999998652 1 34579999987653 233445788999999999999999999999998999999999999
Q ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 232 GDLRAYLKQKG-----ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 232 ~sL~~~l~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
++|.+++.... ..+...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~- 155 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY- 155 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce-
Confidence 99999997532 3566778899999999999999999 99999999999999999999999999864421111
Q ss_pred cCCCCcccCCCCcccccccccCCC-------CCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCC--C
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNE-------EYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPF--R 376 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~--~ 376 (456)
........++..|+|||++.+. .++.++|+||||+++|+|++ |..||......+............. +
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 156 --YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred --eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 0111223467789999988643 35779999999999999996 9999987765554333222222211 1
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 377 APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 377 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
......++.+.+++.+|+ .+|++|||+++|+..|+
T Consensus 234 ~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 223456788999999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=288.63 Aligned_cols=250 Identities=29% Similarity=0.466 Sum_probs=204.6
Q ss_pred cccccceeeeccEEEEEe----------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012777 152 LDFSNSVEITKGTFRIAS----------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~----------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 221 (456)
.+|+....||+|+||.+. .....|++|.+... ........+.+|++++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc--cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 357888899999998662 13467999988654 233456789999999999999999999999998899
Q ss_pred eEEEEEccCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEe
Q 012777 222 MMIVTEYLPKGDLRAYLKQKG---------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVA 292 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~---------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~ 292 (456)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEc
Confidence 999999999999999998755 6899999999999999999999999 9999999999999999999999
Q ss_pred ccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcC
Q 012777 293 DFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANE 371 (456)
Q Consensus 293 Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~ 371 (456)
|||++...... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+...
T Consensus 160 ~~~~~~~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~- 234 (275)
T cd05046 160 LLSLSKDVYNS----EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG- 234 (275)
T ss_pred ccccccccCcc----cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC-
Confidence 99998644211 1111122345667999999988888999999999999999998 88999776655554444322
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 372 RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 372 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
...+. ....++..+.+++.+||..+|++|||+.+++..|.
T Consensus 235 ~~~~~-~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLELP-VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 22221 24568889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=287.77 Aligned_cols=267 Identities=28% Similarity=0.466 Sum_probs=212.9
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
|...+.||+|+||.+ ..+++.||+|.+.... .......+.+|+.++++++||||+++++++......++||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 667789999999866 2367899999986542 334457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccC
Q 012777 229 LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKE 308 (456)
Q Consensus 229 ~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~ 308 (456)
+++++|.+++.. +.+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~---- 155 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---- 155 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch----
Confidence 999999998864 56899999999999999999999999 9999999999999999999999999987553211
Q ss_pred CCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHH
Q 012777 309 DRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRE 388 (456)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 388 (456)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.....+. ....++.++.+
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 231 (277)
T cd06641 156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSKPLKE 231 (277)
T ss_pred -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC---CCcccCHHHHH
Confidence 11122456778999999988888999999999999999999999998766554444442222222 24567889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccccccCcchhhHHHHHhhh
Q 012777 389 LIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVGPLRCFQSLAALWK 440 (456)
Q Consensus 389 li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (456)
++.+||..+|++||++.+++++ .++.+. .-+...++.....-++|+
T Consensus 232 ~i~~~l~~~p~~Rp~~~~~l~~--~~~~~~----~~~~~~~~~~~~~~~~~~ 277 (277)
T cd06641 232 FVEACLNKEPSFRPTAKELLKH--KFIVRF----AKKTSYLTELIDRYKRWK 277 (277)
T ss_pred HHHHHccCChhhCcCHHHHHhC--HHHhhh----hhccchHHHHHHHhhccC
Confidence 9999999999999999999996 233322 222334444444445553
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=286.98 Aligned_cols=245 Identities=25% Similarity=0.443 Sum_probs=202.9
Q ss_pred cccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|+..+.||+|.||.+ . .++..|++|.+... ...+.+.+|+.++++++||||+++++.+.....+++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 35888889999999854 2 24789999998643 12578999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~- 153 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM- 153 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc-
Confidence 99999999999976 346899999999999999999999999 9999999999999999999999999988663221
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.......++..|+|||++.+..++.++||||||+++|+|++|+.||....+......+.....+.+ ..+..++..
T Consensus 154 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 228 (256)
T cd06612 154 ----AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTL-SDPEKWSPE 228 (256)
T ss_pred ----cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCC-CchhhcCHH
Confidence 112234467789999999888899999999999999999999999987665444333322222221 123467788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.++|.+||+.||++|||+++++.+
T Consensus 229 ~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 229 FNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHHHHHHHHhcChhhCcCHHHHhcC
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=286.20 Aligned_cols=250 Identities=27% Similarity=0.437 Sum_probs=201.4
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCC--CCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEV--FTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS--TPMM 223 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~ 223 (456)
+|.+.+.||+|+||.+ ..+|..||+|.+.... .........+.+|+.+++++.||||+++++++.+. ..++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 5788899999999866 2358899999986432 12234567889999999999999999999998764 5688
Q ss_pred EEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
++|||+++++|.+++...+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 99999999999999988778999999999999999999999999 999999999999999999999999998755321
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
.. .........++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.. .+.....+..++
T Consensus 160 ~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (265)
T cd06652 160 CL--SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT--QPTNPVLPPHVS 235 (265)
T ss_pred cc--cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc--CCCCCCCchhhC
Confidence 10 01112223577889999999888899999999999999999999999987654443333322 122222355677
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..+.++|.+|+. +|++||++++++++
T Consensus 236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 236 DHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 889999999994 99999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=302.40 Aligned_cols=244 Identities=25% Similarity=0.384 Sum_probs=194.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------Cc
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS------TP 221 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------~~ 221 (456)
+|.+.+.||+|+||.| ..++..||+|++.... ........+.+|+.++++++||||+++++++... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 6888899999999976 3467899999997643 2223345678899999999999999999987543 45
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
.+++++++ +++|.+++.. +.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 95 ~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred EEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecC
Confidence 78999998 7899888754 56999999999999999999999999 9999999999999999999999999987652
Q ss_pred ccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-C-------
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-R------- 372 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~------- 372 (456)
. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.... .
T Consensus 170 ~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 170 D--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred C--------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 1 1223467889999999877 468889999999999999999999997755433222221100 0
Q ss_pred --------------CCC-----CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 373 --------------PPF-----RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 373 --------------~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.. .......++.+.++|.+||..||++|||+++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00112456678899999999999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=290.21 Aligned_cols=242 Identities=26% Similarity=0.396 Sum_probs=196.4
Q ss_pred eeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012777 160 ITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234 (456)
Q Consensus 160 lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~sL 234 (456)
||+|+||.+ ..+|+.||+|.+.............+.+|+.++++++||+|+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 588888865 236889999999765433334456678899999999999999999999999999999999999999
Q ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCc
Q 012777 235 RAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312 (456)
Q Consensus 235 ~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~ 312 (456)
.+++...+ .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+..... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~------~~~~ 151 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG------GKKI 151 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc------CCcc
Confidence 99997755 6999999999999999999999999 99999999999999999999999999876532 1112
Q ss_pred ccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHH
Q 012777 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIED 392 (456)
Q Consensus 313 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 392 (456)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+...........+..++..+.++|.+
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 231 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEA 231 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHH
Confidence 23456778999999988889999999999999999999999997765432222222222111112345678899999999
Q ss_pred hcccCCCCCC-----CHHHHHHH
Q 012777 393 CWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 393 ~l~~dp~~Rp-----t~~ell~~ 410 (456)
||+.||++|| ++.+++++
T Consensus 232 ~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 232 LLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred HccCChhHccCCCcccHHHHHhC
Confidence 9999999999 77777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=286.75 Aligned_cols=239 Identities=25% Similarity=0.412 Sum_probs=199.4
Q ss_pred eeccEEEEE---eE--cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012777 160 ITKGTFRIA---SW--RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234 (456)
Q Consensus 160 lg~G~fg~~---~~--~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~sL 234 (456)
||.|+||.+ .. +++.||+|++...........+.+.+|+.+++.++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 577877644 33 4889999999876544555667899999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCccc
Q 012777 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTC 314 (456)
Q Consensus 235 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~ 314 (456)
.+++.+...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------~~~~ 151 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------KTWT 151 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc------cccc
Confidence 999988778999999999999999999999999 9999999999999999999999999988663221 1123
Q ss_pred CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC--ccchHHHHHh-cCCCCCCCCCCCCcHHHHHHHH
Q 012777 315 EETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQ--EKEVPKAYIA-NERPPFRAPTTHYAYGLRELIE 391 (456)
Q Consensus 315 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~ 391 (456)
..+++.|++||.+....++.++|+||||+++|+|++|..||.... +.+....+.. ..... .+...+.++.++|.
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~ 228 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE---FPNYIDKAAKDLIK 228 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCC---CCcccCHHHHHHHH
Confidence 457788999999988889999999999999999999999998776 3334444432 11222 23455889999999
Q ss_pred HhcccCCCCCCC-----HHHHHHH
Q 012777 392 DCWSEEPFRRPT-----FRQILMR 410 (456)
Q Consensus 392 ~~l~~dp~~Rpt-----~~ell~~ 410 (456)
+||..+|++||+ ++|++++
T Consensus 229 ~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 229 QLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred HHccCChhhCcCCcccCHHHHhcC
Confidence 999999999999 8888774
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=292.28 Aligned_cols=246 Identities=26% Similarity=0.456 Sum_probs=203.1
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|++.+.||+|+||.+ ..+|..||+|++.... .......+.+|+++++.++||||+++++++.....+++||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 35788899999999866 2358899999987542 3445678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHE-NRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
||+++++|.+++.+.+.+++..+..++.+++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 999999999999887889999999999999999999997 57 999999999999999999999999987654211
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc-----------chHHHHHhcCCCC
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK-----------EVPKAYIANERPP 374 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----------~~~~~~~~~~~~~ 374 (456)
......++..|+|||++.+..++.++|+|||||++|+|++|+.||...... +....+.....+.
T Consensus 158 -----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd06620 158 -----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR 232 (284)
T ss_pred -----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCC
Confidence 112346788999999998888999999999999999999999999865542 1122222211121
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 375 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
. ....++..+.+++.+||..||++|||++|++++.
T Consensus 233 ~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 233 L--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred C--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1 1234778899999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=291.64 Aligned_cols=248 Identities=28% Similarity=0.468 Sum_probs=195.3
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.+ ..++..||+|.+.... ..+.....+.+|+.+++.++||||+++++++..+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 4777889999999865 2368899999987543 222334667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQK---GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
|++ ++|.+++... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 154 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP- 154 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC-
Confidence 996 6898888653 45899999999999999999999999 999999999999999999999999998754221
Q ss_pred cccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC------------
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE------------ 371 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------------ 371 (456)
........+++.|+|||.+.+. .++.++|+||||+++|+|++|++||...........+....
T Consensus 155 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 155 ----VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred ----cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence 1112223467789999988654 57889999999999999999999998654332211111000
Q ss_pred -------------CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 -------------RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 -------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..........++.++.++|.+||..||++|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000011134578889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=294.03 Aligned_cols=247 Identities=23% Similarity=0.424 Sum_probs=204.3
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
..+|+..+.||+|+||.+ ..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++......++|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 357888999999999865 24689999999975432 2346688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++.......
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~- 169 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 169 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc-
Confidence 999999999999865 45899999999999999999999999 9999999999999999999999999987542211
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...++......+.....+.. ..+..++..
T Consensus 170 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 244 (297)
T cd06656 170 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL-QNPERLSAV 244 (297)
T ss_pred ----cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCC-CCccccCHH
Confidence 111234577889999999988899999999999999999999999977665433322222222221 234567888
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.+++.+||..+|++||++++++++
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 245 FRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=307.83 Aligned_cols=239 Identities=31% Similarity=0.541 Sum_probs=199.8
Q ss_pred eeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCC
Q 012777 158 VEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232 (456)
Q Consensus 158 ~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~ 232 (456)
..||+|+||.| ..+...+|||-+... +....+.+.+|+.+-++++|.|||+++|++.+++.+-|.||-++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 36899999977 345668999998754 3345578899999999999999999999999999999999999999
Q ss_pred CHHHHHHH-cCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-CCCCEEEeccCCcccccccccccC
Q 012777 233 DLRAYLKQ-KGAL--KPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD-DSGHLKVADFGLSKLLKFANTVKE 308 (456)
Q Consensus 233 sL~~~l~~-~~~l--~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~-~~~~vkl~Dfgls~~~~~~~~~~~ 308 (456)
||.+++.. .|++ .+.++-.+.+||++||.|||++. |||||||-+||||+ -.|.+||.|||-++.+.- .
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-----i 729 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-----I 729 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc-----C
Confidence 99999975 5887 78889999999999999999999 99999999999998 688999999999998731 1
Q ss_pred CCCcccCCCCcccccccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchH--HHHHhcCCCCCCCCCCCCcH
Q 012777 309 DRPVTCEETSWRYAAPEVYKNE--EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVP--KAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 384 (456)
......+.||..|||||++..+ .|.+++|||||||++.||.||++||......... +.-..+..|+. +..++.
T Consensus 730 nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~i---Peelsa 806 (1226)
T KOG4279|consen 730 NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPI---PEELSA 806 (1226)
T ss_pred CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCC---cHHHHH
Confidence 1223356799999999999876 5888999999999999999999999776543321 11111223443 678888
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.++||.+|+.+||.+||++++++..
T Consensus 807 eak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 807 EAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHcCCCcccCccHHHhccC
Confidence 99999999999999999999998764
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=284.57 Aligned_cols=247 Identities=28% Similarity=0.442 Sum_probs=204.7
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCC--CCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVF--TDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
+|+..+.||+|+||.+ ..+++.|++|.+..... ...+..+.+.+|+.+++.++||||+++++++.....++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3666788999999865 23688999999865321 2244567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
+||+++++|.+++...+.+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 999999999999988778999999999999999999999999 9999999999999999999999999987653211
Q ss_pred ccCCCCcccCCCCcccccccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEE-YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
......+++.|++||.+.... ++.++|+||||+++|+|++|..||...........+... ......+..++.
T Consensus 157 -----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 229 (258)
T cd06632 157 -----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS--KELPPIPDHLSD 229 (258)
T ss_pred -----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc--ccCCCcCCCcCH
Confidence 122345778899999987766 889999999999999999999999776644433333221 122233567888
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+.+++.+||..+|++||++.+++.+
T Consensus 230 ~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 230 EAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 99999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=287.20 Aligned_cols=219 Identities=25% Similarity=0.424 Sum_probs=177.7
Q ss_pred cEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCHHHHHHH-cCCCCHHHHHH
Q 012777 173 TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVK 251 (456)
Q Consensus 173 ~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~ 251 (456)
..||+|++... .......+.+|+.+++.++||||+++++++......++||||+++++|..++.. .+.+++..+..
T Consensus 45 ~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~ 121 (274)
T cd05076 45 LRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT 121 (274)
T ss_pred eeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHH
Confidence 35899998653 233456788899999999999999999999999999999999999999999865 45689999999
Q ss_pred HHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-------CEEEeccCCcccccccccccCCCCcccCCCCcccccc
Q 012777 252 FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG-------HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAP 324 (456)
Q Consensus 252 i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~-------~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aP 324 (456)
++.|++.||.|||+++ |+||||||+|||++..+ .+|++|||++...... ....++..|+||
T Consensus 122 i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---------~~~~~~~~~~aP 189 (274)
T cd05076 122 VAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---------EERVERIPWIAP 189 (274)
T ss_pred HHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc---------cccccCCcccCc
Confidence 9999999999999999 99999999999998643 4899999987643110 112456779999
Q ss_pred cccCC-CCCCCchhHHHHHHHHHHHH-cCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCC
Q 012777 325 EVYKN-EEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRP 402 (456)
Q Consensus 325 E~~~~-~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 402 (456)
|.+.+ ..++.++|+||||+++|+|+ +|..||....+.+......... .. +...+..+.++|.+||+.+|++||
T Consensus 190 e~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~---~~~~~~~~~~li~~cl~~~p~~Rp 264 (274)
T cd05076 190 ECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKH--RL---PEPSCKELATLISQCLTYEPTQRP 264 (274)
T ss_pred hhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhcc--CC---CCCCChHHHHHHHHHcccChhhCc
Confidence 98866 46889999999999999995 6999998776554433322111 11 233456799999999999999999
Q ss_pred CHHHHHHHH
Q 012777 403 TFRQILMRL 411 (456)
Q Consensus 403 t~~ell~~L 411 (456)
|++++++.|
T Consensus 265 s~~~il~~L 273 (274)
T cd05076 265 SFRTILRDL 273 (274)
T ss_pred CHHHHHHhh
Confidence 999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=288.09 Aligned_cols=244 Identities=30% Similarity=0.532 Sum_probs=197.3
Q ss_pred eeeccEEEEEe---E--------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 159 EITKGTFRIAS---W--------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 159 ~lg~G~fg~~~---~--------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.||+|+||.+. . .+..||+|.+... ........+.+|+.+++.++||||+++++++......+++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG--ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcc--cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 58999998652 1 1257999988654 223445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-----CEEEeccC
Q 012777 228 YLPKGDLRAYLKQK-------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG-----HLKVADFG 295 (456)
Q Consensus 228 ~~~~~sL~~~l~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~-----~vkl~Dfg 295 (456)
|+++++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999642 23788999999999999999999999 99999999999999877 89999999
Q ss_pred CcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCC
Q 012777 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPP 374 (456)
Q Consensus 296 ls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 374 (456)
++......... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.......
T Consensus 157 ~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05044 157 LARDIYKSDYY---RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQ 233 (269)
T ss_pred ccccccccccc---ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccC
Confidence 98755321111 11112345678999999999999999999999999999998 999998766655544443222222
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 012777 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDD 413 (456)
Q Consensus 375 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~ 413 (456)
.+..++..+.++|.+||..+|++||+++++++.|++
T Consensus 234 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 234 ---KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 245678899999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=291.35 Aligned_cols=255 Identities=25% Similarity=0.498 Sum_probs=204.6
Q ss_pred cccccceeeeccEEEEEe-----EcCc----EEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGT----QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~----~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
.+|+..+.||+|+||.+. .+|. .||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 357788899999998652 2344 57999887542 344445788999999999999999999998654 46
Q ss_pred EEEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
++++||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 78999999999999997754 5899999999999999999999999 9999999999999999999999999998653
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
..... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+......+. +.
T Consensus 161 ~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 234 (303)
T cd05110 161 GDEKE---YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ---PP 234 (303)
T ss_pred Ccccc---cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC---CC
Confidence 21111 11112334668999999998899999999999999999997 9999987665554444433322222 35
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
.++..+.+++.+||..+|++||+++++++.|..+.+.-
T Consensus 235 ~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 235 ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 57788999999999999999999999999999886443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=284.02 Aligned_cols=245 Identities=29% Similarity=0.487 Sum_probs=205.6
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|++|.+ ..+++.||+|++.... .......+.+|+..+++++||||+++++++......++++|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG--DEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCc--chHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 4777789999999754 3358999999997653 22556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHE-NRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|+++++|.+++.....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~-- 154 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL-- 154 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC--
Confidence 99999999999887889999999999999999999999 99 9999999999999999999999999988653211
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc---cchHHHHHhcCCCCCCCCCCC-C
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE---KEVPKAYIANERPPFRAPTTH-Y 382 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~-~ 382 (456)
.......++..|+|||.+....++.++|+||||+++|+|++|..||..... .+....+.....+. .... +
T Consensus 155 ---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 228 (264)
T cd06623 155 ---DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS---LPAEEF 228 (264)
T ss_pred ---CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC---CCcccC
Confidence 111234567889999999988899999999999999999999999987752 23333333222222 2344 8
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+..+.++|.+||..+|++||++.+++++
T Consensus 229 ~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 229 SPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 8999999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=290.87 Aligned_cols=249 Identities=23% Similarity=0.405 Sum_probs=198.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||+|+||.+ ..+|+.||+|++.... ......+.+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE-DDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecc-cCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4777889999999865 2358899999987543 122233567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|..++.....+++..+..++.|++.+|.|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-- 155 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence 9998888887766667999999999999999999999999 99999999999999999999999999886632211
Q ss_pred CCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC---------------
Q 012777 308 EDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE--------------- 371 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------------- 371 (456)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....+....+....
T Consensus 156 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 ---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred ---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1223456778999999876 457889999999999999999999998766543322221100
Q ss_pred ------CCCC------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 ------RPPF------RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 ------~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+.. ......++..+.+||.+||..+|++|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000 00123567889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=286.81 Aligned_cols=252 Identities=29% Similarity=0.460 Sum_probs=201.6
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCC-------HHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTD-------EDKVKAFIDELALLQKIRHPNVVQFLGAVTQST 220 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 220 (456)
+|...+.||.|+||.+ ..+|+.||+|.+....... ....+.+..|+.+++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677789999999866 2368899999886432111 112456788999999999999999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
..++||||+++++|.+++.+.+.+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 99999999999999999988788999999999999999999999999 999999999999999999999999998754
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCC-
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEE--YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFR- 376 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~- 376 (456)
... ..........++..|+|||.+.... ++.++|+||||++++++++|..||......+....+.... .+.+.
T Consensus 159 ~~~---~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd06629 159 DDI---YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP 235 (272)
T ss_pred ccc---ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCc
Confidence 211 1111122345778899999987654 7889999999999999999999997655443333222221 22221
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 377 APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 377 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.....++.++.++|.+||..+|++|||+++++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1234678899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=299.53 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=199.1
Q ss_pred cCccccccccceeeeccEEEEE----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCc
Q 012777 147 IDPKELDFSNSVEITKGTFRIA----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 147 ~~~~~~~~~~~~~lg~G~fg~~----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~ 221 (456)
|......|++.+.||+|+-..| ..+.+.||+|++.... .++.....|.+|+..|.++ .|.+|++|||+-..++.
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 4455668999999999987655 2345678888887654 4677889999999999999 49999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKGA-LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
+|+||||- ..+|..+|++... .+.-.+..++.||+.|++++|..| |||.||||.|+|+-. |.+||+|||.|...
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred EEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 99999976 7899999988765 444588899999999999999999 999999999999875 68999999999876
Q ss_pred cccccccCCCCcccCCCCcccccccccCCC-----------CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHh
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNE-----------EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIA 369 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 369 (456)
.... ..-....-.||+.||+||.+... +.++++|||||||+||+|+.|+.||.... ..+..+..
T Consensus 510 ~~DT---TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~a 584 (677)
T KOG0596|consen 510 QPDT---TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHA 584 (677)
T ss_pred Cccc---cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHh
Confidence 4332 11122335799999999998543 25678999999999999999999997643 12223322
Q ss_pred cCCCCCC--CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 370 NERPPFR--APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 370 ~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
...|+.. .+...-..++.++++.||+.||++||+..+||++
T Consensus 585 I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 585 ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2333221 1112222348999999999999999999999986
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=288.24 Aligned_cols=246 Identities=25% Similarity=0.410 Sum_probs=197.2
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC-----
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQS----- 219 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~----- 219 (456)
+-.|+..+.||+|+||.+ ..+++.||+|.+.... .....+.+|+.+++++ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 335778889999999866 2367899999987542 1235678999999998 699999999998753
Q ss_pred -CceEEEEEccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCC
Q 012777 220 -TPMMIVTEYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGL 296 (456)
Q Consensus 220 -~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgl 296 (456)
..++++|||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4589999999999999999864 35899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccCCCCcccCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC
Q 012777 297 SKLLKFANTVKEDRPVTCEETSWRYAAPEVYK-----NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE 371 (456)
Q Consensus 297 s~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 371 (456)
+...... ........+++.|+|||++. ...++.++|+|||||++|+|++|..||....+...........
T Consensus 158 ~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~ 232 (272)
T cd06637 158 SAQLDRT-----VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 232 (272)
T ss_pred ceecccc-----cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC
Confidence 8755221 11222345788899999986 3357789999999999999999999997665544333332222
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+ ......++.++.+++.+||..||.+|||+++++.+
T Consensus 233 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 233 AP--RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CC--CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 11 12245678899999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=311.87 Aligned_cols=254 Identities=32% Similarity=0.536 Sum_probs=223.5
Q ss_pred cccceeeeccEEEEEe--------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 154 FSNSVEITKGTFRIAS--------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~~--------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
..+++.||.|.||.|- .....||||.++.- ..+....+|+.|+.+|-++.||||++|-|+.......+||
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 4667899999999762 33457999999865 4677889999999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 226 TEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
+||+++|+|+.+|.++ +.++..++..+++.|+.|++||.+.+ +|||||...||||+.+-..|++|||+++.+.++.
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999999999764 56999999999999999999999999 9999999999999999999999999999875433
Q ss_pred cccCCCCcccC--CCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCC
Q 012777 305 TVKEDRPVTCE--ETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 305 ~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (456)
...+.+. --+++|.|||.+...+++.++||||+|++|||.++ |..||.++...+.+..+..+.+.+- +-+
T Consensus 786 ----~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp---PmD 858 (996)
T KOG0196|consen 786 ----EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP---PMD 858 (996)
T ss_pred ----CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC---CCC
Confidence 1111111 22468999999999999999999999999999987 9999999999999999877665553 678
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLS 419 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~ 419 (456)
+|..+.+|+..||++|-.+||.+.+|+..|+.+.++-+
T Consensus 859 CP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 859 CPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred CcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 99999999999999999999999999999999987654
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=283.09 Aligned_cols=247 Identities=28% Similarity=0.463 Sum_probs=195.9
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.++.....||+|+||.+ ..++..||+|.+... .....+.+.+|+.++++++|+||+++++++......++++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34555568999999866 235778999998754 3344578899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-CCCEEEeccCCcccccc
Q 012777 227 EYLPKGDLRAYLKQK-GAL--KPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD-SGHLKVADFGLSKLLKF 302 (456)
Q Consensus 227 e~~~~~sL~~~l~~~-~~l--~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~-~~~vkl~Dfgls~~~~~ 302 (456)
||+++++|.+++... ..+ ++..+..++.|++.||.|||+++ |+|+||||+||+++. ++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999999999999764 445 88889999999999999999999 999999999999986 67999999999875521
Q ss_pred cccccCCCCcccCCCCcccccccccCCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEE--YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
. ........+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||............ ..........+.
T Consensus 162 ~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~ 235 (268)
T cd06624 162 I-----NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEIPE 235 (268)
T ss_pred C-----CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCCCCCc
Confidence 1 11122345788899999986643 778999999999999999999999765432221111 111111112245
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++.++.+++.+||..+|++|||+++++.+
T Consensus 236 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 236 SLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 678899999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=288.69 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=199.0
Q ss_pred CccccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEe---
Q 012777 148 DPKELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQ--- 218 (456)
Q Consensus 148 ~~~~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~--- 218 (456)
....-.|++.+.||.|+||.+ ..+++.||+|++... ......+..|+.+++++ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred cChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 334457888899999999865 236889999998643 23446788999999998 69999999999853
Q ss_pred ---CCceEEEEEccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEec
Q 012777 219 ---STPMMIVTEYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293 (456)
Q Consensus 219 ---~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~D 293 (456)
....+++|||+++++|.+++... ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~d 164 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVD 164 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEee
Confidence 45789999999999999999763 34888899999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccccccCCCCcccCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHH
Q 012777 294 FGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYK-----NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYI 368 (456)
Q Consensus 294 fgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 368 (456)
||++...... ........+++.|+|||.+. ...++.++|+||||+++|+|++|..||....+......+.
T Consensus 165 fg~~~~~~~~-----~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 239 (282)
T cd06636 165 FGVSAQLDRT-----VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP 239 (282)
T ss_pred Ccchhhhhcc-----ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh
Confidence 9998755211 11122345788899999876 3457789999999999999999999997765444333332
Q ss_pred hcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 369 ANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
... ........++.++.++|.+||..||.+|||+.+++++
T Consensus 240 ~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 240 RNP--PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hCC--CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 221 2222345688999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.31 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=214.3
Q ss_pred cCccccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012777 147 IDPKELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 147 ~~~~~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 221 (456)
+.....+++....||.|.||.| ..+|+..|+|-++..... ......+.+|+.+|..++|||+|+++++=.+.+.
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence 3344557888899999999977 357999999999865433 4556778999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
.+|.||||.+|+|.+++...+..++.-...+..|++.|+.|||++| ||||||||.||+++.+|.+|++|||.|..+.
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence 9999999999999999998877888889999999999999999999 9999999999999999999999999999875
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCccc-hHHHHHhcCCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEE---YDTKVDVFSFALILQEMIEGCPPFPTKQEKE-VPKAYIANERPPFRA 377 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~ 377 (456)
... ...........||+.|||||++.+.. -..++||||||||+.||+||+.||...+.+- +...+..+..|.+
T Consensus 1386 ~~~-~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~-- 1462 (1509)
T KOG4645|consen 1386 NNA-QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI-- 1462 (1509)
T ss_pred Cch-hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC--
Confidence 431 11223345678999999999997753 4468999999999999999999998876432 2222322335554
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 378 PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 378 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+..++.+-.+||++||..||++|.++.|++++
T Consensus 1463 -P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1463 -PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 45599999999999999999999999988876
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=299.27 Aligned_cols=258 Identities=30% Similarity=0.490 Sum_probs=221.0
Q ss_pred cccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 150 KELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
+..+.....+||-|.||.| +...-.||||.++. +...++.|+.|..+|+.++|||+|+|+++|..+-.+||
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE----DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhh----cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 3445677789999999865 33456899999974 34567899999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 225 VTEYLPKGDLRAYLKQKGA--LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
|+||+..|+|.+|+.++.. ++.-..+.++.||.+|+.||..++ +|||||...|+||.++..||++|||+++.+.-
T Consensus 341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 9999999999999988654 888888999999999999999999 99999999999999999999999999998732
Q ss_pred cccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (456)
. ........-.++-|.|||.+-...++.++|||+||++|||+.| |..||.+.+....+..+..+.+..- +..
T Consensus 418 D----TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~---PeG 490 (1157)
T KOG4278|consen 418 D----TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDG---PEG 490 (1157)
T ss_pred C----ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccC---CCC
Confidence 2 1222222334567999999999999999999999999999998 9999999988777776655545543 578
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccc
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIK 421 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~ 421 (456)
+|+.+.+|+..||+.+|.+||++.|+.+.++.++..-++.
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSis 530 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSIS 530 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccccc
Confidence 9999999999999999999999999999999998655443
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=287.20 Aligned_cols=244 Identities=30% Similarity=0.556 Sum_probs=200.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||+|+||.+ ..+++.||+|.+.... .......+.+|++++++++||||+++++.+......++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 4667788999999855 2358899999987653 34556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHE-NRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~-~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|+++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999999876 679999999999999999999999 88 99999999999999999999999999875532111
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc--c---chHHHHHhcCCCCCCCCCC
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE--K---EVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~---~~~~~~~~~~~~~~~~~~~ 380 (456)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... . +....+.....+.. ...
T Consensus 157 -------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 227 (265)
T cd06605 157 -------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRL--PSG 227 (265)
T ss_pred -------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCC--Chh
Confidence 114577789999999888999999999999999999999999976531 1 12222222222222 122
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++.++.++|.+||..||++|||+.+++.+
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 228 KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 388899999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=286.84 Aligned_cols=245 Identities=24% Similarity=0.431 Sum_probs=203.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|...+.||+|++|.+ ..+++.|++|.+... .....+.+.+|+.+++.++||||+++++++...+..++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 3555679999999865 246789999998643 33345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++.. +.+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||.+......
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~---- 168 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE---- 168 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccC----
Confidence 9999999999887 67999999999999999999999999 999999999999999999999999987654211
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
........+++.|+|||.+.+..++.++|+||||+++|+|++|..||...++.+....+.... ++.......++..+.
T Consensus 169 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~ 246 (285)
T cd06648 169 -VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PPKLKNLHKVSPRLR 246 (285)
T ss_pred -CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CCCCcccccCCHHHH
Confidence 111123457888999999988889999999999999999999999998877665555553332 222222344788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+++.+||..+|++|||+++++++
T Consensus 247 ~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 247 SFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHHHHcccChhhCcCHHHHccC
Confidence 99999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=286.62 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=199.1
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCC----
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQST---- 220 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~---- 220 (456)
.-+|++.+.||+|+||.+ ..+++.|++|++.... ...+.+.+|+.+++++ .||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 457888999999998755 2367899999987542 2346789999999999 6999999999997654
Q ss_pred --ceEEEEEccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEecc
Q 012777 221 --PMMIVTEYLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294 (456)
Q Consensus 221 --~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Df 294 (456)
.++++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCC
Confidence 48999999999999998865 246999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccccccCCCCcccCCCCcccccccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHh
Q 012777 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-----EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIA 369 (456)
Q Consensus 295 gls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 369 (456)
|++....... .......++..|+|||.+.. ..++.++||||||+++|+|++|..||...........+..
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 232 (275)
T cd06608 158 GVSAQLDSTL-----GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR 232 (275)
T ss_pred ccceecccch-----hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc
Confidence 9987553211 11223457888999998754 2467789999999999999999999987665554444433
Q ss_pred cCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 370 NERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
...+... ....++.++.++|.+||..||++|||+++++++
T Consensus 233 ~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 233 NPPPTLK-SPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred cCCCCCC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 3322221 233477899999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=287.50 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=198.1
Q ss_pred CccccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEE----
Q 012777 148 DPKELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVT---- 217 (456)
Q Consensus 148 ~~~~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~---- 217 (456)
.....+|++.+.||+|+||.+ ..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 334557899999999999866 3368899999886431 1225677899999999 6999999999874
Q ss_pred -eCCceEEEEEccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEe
Q 012777 218 -QSTPMMIVTEYLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVA 292 (456)
Q Consensus 218 -~~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~ 292 (456)
.....++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 34568999999999999998753 245889999999999999999999999 9999999999999999999999
Q ss_pred ccCCcccccccccccCCCCcccCCCCcccccccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHH
Q 012777 293 DFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-----EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAY 367 (456)
Q Consensus 293 Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 367 (456)
|||++...... ........+++.|+|||++.. ..++.++|+|||||++|+|++|+.||...........+
T Consensus 167 dfg~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~ 241 (286)
T cd06638 167 DFGVSAQLTST-----RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241 (286)
T ss_pred cCCceeecccC-----CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc
Confidence 99998765321 111223457889999998753 34788999999999999999999999876654433332
Q ss_pred HhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 368 IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
... .++....+..++..+.++|.+||+.||++|||+++++++.
T Consensus 242 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 242 PRN-PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccc-CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 222 1111122345678899999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=291.34 Aligned_cols=248 Identities=24% Similarity=0.436 Sum_probs=193.2
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||+|+||.+ ..+|+.||+|.+..... .......+.+|+.++++++||||+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 3677789999999865 23688999999975432 22233567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|++ ++|.+++.. .+.+++..++.++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--- 152 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP--- 152 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCC---
Confidence 995 588888765 456999999999999999999999999 999999999999999999999999998755321
Q ss_pred cCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCC-CCccchHHHHHhcC-------------
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPT-KQEKEVPKAYIANE------------- 371 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~------------- 371 (456)
........+++.|+|||++.+. .++.++||||||+++|+|++|..|+.. .+..+....+....
T Consensus 153 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 153 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred --CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 1112234567889999998765 468899999999999999998887533 33222222211100
Q ss_pred ---C---CCC------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 ---R---PPF------RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 ---~---~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
. +.. ......++.++.++|.+||..||.+|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 000 01123567889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=281.61 Aligned_cols=241 Identities=25% Similarity=0.372 Sum_probs=199.0
Q ss_pred ccccc-eeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC----Cc
Q 012777 153 DFSNS-VEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQS----TP 221 (456)
Q Consensus 153 ~~~~~-~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~----~~ 221 (456)
+|++. ..||-|-.|.| +.+|+.+|+|++... ....+|+++--.. .|||||.++++|... ..
T Consensus 62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45554 46788888866 568999999998642 3456788776666 699999999998653 55
Q ss_pred eEEEEEccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC---CCCCEEEeccCC
Q 012777 222 MMIVTEYLPKGDLRAYLKQKGA--LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD---DSGHLKVADFGL 296 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~---~~~~vkl~Dfgl 296 (456)
+.+|||.++||.|...+++++. +++.++..|+.||..|+.|||+.+ |.||||||+|+|.. .+..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 8899999999999999998876 999999999999999999999999 99999999999998 455799999999
Q ss_pred cccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc----chHHHHHhcCC
Q 012777 297 SKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK----EVPKAYIANER 372 (456)
Q Consensus 297 s~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~ 372 (456)
++... ..........||.|.|||++....|+.+.|+||+|++||-|++|.+||...... .+...|..+..
T Consensus 211 AK~t~------~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 211 AKETQ------EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred ccccC------CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 98653 233445567899999999999999999999999999999999999999776543 33455544332
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 373 PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 373 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..-...+..+|+..+++|+.+|..+|.+|.|+++++++
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 22223357888999999999999999999999999887
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=282.96 Aligned_cols=233 Identities=23% Similarity=0.385 Sum_probs=185.9
Q ss_pred eeeccEEEEEeE-----------------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012777 159 EITKGTFRIASW-----------------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 159 ~lg~G~fg~~~~-----------------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 221 (456)
.||+|+||.+.. ....||+|++... .......+.+|+.+++.++||||+++++++.....
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 578888875521 1235899987653 23345678889999999999999999999999889
Q ss_pred eEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC-------EEEec
Q 012777 222 MMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH-------LKVAD 293 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~-------vkl~D 293 (456)
.+++|||+++++|..++... ..+++..++.++.|+++||.|||+++ |+||||||+|||++.++. ++++|
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999999888753 46999999999999999999999999 999999999999987664 89999
Q ss_pred cCCcccccccccccCCCCcccCCCCcccccccccC-CCCCCCchhHHHHHHHHHHHH-cCCCCCCCCCccchHHHHHhcC
Q 012777 294 FGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYK-NEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANE 371 (456)
Q Consensus 294 fgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~ 371 (456)
||++..... .....++..|+|||.+. +..++.++|||||||++|+|+ .|..||......+..... ...
T Consensus 156 ~g~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~~ 225 (262)
T cd05077 156 PGIPITVLS---------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-EGQ 225 (262)
T ss_pred CCCCccccC---------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-hcC
Confidence 998865421 11234677899999886 456888999999999999998 588998776544332211 111
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 372 RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 372 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
. . .....+.++.++|.+||+.||++||+++++++.+
T Consensus 226 ~-~---~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 226 C-M---LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred c-c---CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1 1 1233467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=290.03 Aligned_cols=244 Identities=27% Similarity=0.448 Sum_probs=201.4
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
..|...+.||+|+||.+ ..+|+.||+|++........+....+.+|+.+++.++||||+++++++......++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 35888889999999865 2368999999987554445556678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
||+. ++|.+++.. .+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~--- 167 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP--- 167 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC---
Confidence 9995 688777754 456999999999999999999999999 99999999999999999999999998875421
Q ss_pred ccCCCCcccCCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCC
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYK---NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (456)
.....+++.|+|||++. ...++.++||||||+++|+|++|..||.+.+.......+.....+.. ....+
T Consensus 168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 239 (307)
T cd06607 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL--SSNDW 239 (307)
T ss_pred ------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC--Cchhh
Confidence 11235677899999874 45688899999999999999999999987765554444433222222 23457
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+..+.++|.+||..||++||++.+++.+
T Consensus 240 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 240 SDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 7889999999999999999999999886
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=295.80 Aligned_cols=240 Identities=28% Similarity=0.436 Sum_probs=207.6
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
..|+.-+.||+|+||.| ..+|+.||.|.+.+..+.........++|..+|.+++.++||.+--+|+..+.+|+|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 36888899999999854 6789999999998877666666677889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 227 EYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
..+.||+|.-+|.+.+ .+++..++.++.+|+.+|++||+.+ ||+||+||+|||+|+.|.|.|+|+|+|..+..
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~-- 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE-- 339 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC--
Confidence 9999999998888765 5999999999999999999999999 99999999999999999999999999997742
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc---chHHHHHhcCCCCCCCCCCC
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK---EVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~ 381 (456)
.......+||.+|||||++.++.|+.+.|+|||||++|+|+.|+.||...... +..++........ .+..
T Consensus 340 ----g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~e---y~~k 412 (591)
T KOG0986|consen 340 ----GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEE---YSDK 412 (591)
T ss_pred ----CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhh---cccc
Confidence 33444458999999999999999999999999999999999999999764432 2233333333333 3588
Q ss_pred CcHHHHHHHHHhcccCCCCCCC
Q 012777 382 YAYGLRELIEDCWSEEPFRRPT 403 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt 403 (456)
+|++.++|++.+|++||.+|..
T Consensus 413 FS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 413 FSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred cCHHHHHHHHHHHccCHHHhcc
Confidence 9999999999999999999964
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=293.83 Aligned_cols=242 Identities=23% Similarity=0.396 Sum_probs=182.3
Q ss_pred eeeeccEEEEEe-------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--CCceEEEEEc
Q 012777 158 VEITKGTFRIAS-------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ--STPMMIVTEY 228 (456)
Q Consensus 158 ~~lg~G~fg~~~-------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~~lv~e~ 228 (456)
.+||+|+||.|. .++..||+|.+..... ...+.+|+.++++++||||+++++++.. +..+++++||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 589999999762 2457899999875432 1356789999999999999999999854 4568999999
Q ss_pred cCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe----CCCCCEEEeccC
Q 012777 229 LPKGDLRAYLKQK---------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR----DDSGHLKVADFG 295 (456)
Q Consensus 229 ~~~~sL~~~l~~~---------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~----~~~~~vkl~Dfg 295 (456)
+ +++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||+ +..+.+||+|||
T Consensus 82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 A-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred c-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 9 56898887532 24889999999999999999999999 9999999999999 456789999999
Q ss_pred CcccccccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccc---------hHH
Q 012777 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKE---------VPK 365 (456)
Q Consensus 296 ls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---------~~~ 365 (456)
++....... ..........+|+.|+|||++.+. .++.++||||+||++|+|++|++||....... ...
T Consensus 158 ~a~~~~~~~--~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07868 158 FARLFNSPL--KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 235 (317)
T ss_pred ceeccCCCC--ccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHH
Confidence 998653211 111122345678899999998764 58889999999999999999999996543210 011
Q ss_pred HHHhc-CCC------------------------CC---------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 366 AYIAN-ERP------------------------PF---------RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 366 ~~~~~-~~~------------------------~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+... +.+ .. .......+..+.++|.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 236 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11000 000 00 00011234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=291.45 Aligned_cols=244 Identities=24% Similarity=0.430 Sum_probs=200.2
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
|.....||.|+||.+ ..++..||||.+... .....+.+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 333457999999865 236889999998643 334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccC
Q 012777 229 LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKE 308 (456)
Q Consensus 229 ~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~ 308 (456)
+++++|.+++.. +.+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 101 ~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----- 171 (292)
T cd06658 101 LEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE----- 171 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccc-----
Confidence 999999998854 56899999999999999999999999 999999999999999999999999998754221
Q ss_pred CCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHH
Q 012777 309 DRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRE 388 (456)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 388 (456)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.....+.. .....++..+.+
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 250 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV-KDSHKVSSVLRG 250 (292)
T ss_pred cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc-ccccccCHHHHH
Confidence 1111224578889999999888899999999999999999999999987665544444322222221 123457888999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 012777 389 LIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 389 li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.+||..||.+|||+++++++
T Consensus 251 li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 251 FLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHccCChhHCcCHHHHhhC
Confidence 9999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=298.26 Aligned_cols=240 Identities=23% Similarity=0.334 Sum_probs=187.6
Q ss_pred cccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|.+.+.||+|+||.| . .+++.||+|+.... ....|+.++++++||||+++++++......++|+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 46999999999999876 2 25678999986432 2346899999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|++ .++|.+++... ..+++..+..|+.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 137 e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--- 209 (357)
T PHA03209 137 PHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV--- 209 (357)
T ss_pred Ecc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc---
Confidence 999 56888888654 56999999999999999999999999 99999999999999999999999999875321
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCC-CCCCCCCcc----------chHHHHHhcC-CC
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGC-PPFPTKQEK----------EVPKAYIANE-RP 373 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~----------~~~~~~~~~~-~~ 373 (456)
........||+.|+|||++.+..++.++|||||||++|+|+++. .+|...... .+...+.... .+
T Consensus 210 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 286 (357)
T PHA03209 210 ---APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP 286 (357)
T ss_pred ---CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence 11222356889999999999999999999999999999999854 444432211 0001010000 00
Q ss_pred -CCC---------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 -PFR---------------------------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 -~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+. .....++.++.++|.+||+.||.+|||++|++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 287 EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred hhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 000 0012456678889999999999999999999986
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=283.83 Aligned_cols=240 Identities=25% Similarity=0.344 Sum_probs=192.0
Q ss_pred eeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHh-cCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 158 VEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQ-KIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 158 ~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
+.||+|+||.+ ..+|+.||+|++.+...........+..|..++. ..+|||++++++++...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999865 2368899999987543222333344555655444 45899999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCC
Q 012777 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311 (456)
Q Consensus 232 ~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~ 311 (456)
++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--------- 149 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--------- 149 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc---------
Confidence 999999988888999999999999999999999999 99999999999999999999999998875421
Q ss_pred cccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q 012777 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIE 391 (456)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 391 (456)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..............++..+.++|.
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 229 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLIN 229 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHH
Confidence 12234677899999998888899999999999999999999999877766555544332211111123467889999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 012777 392 DCWSEEPFRRPTFRQILM 409 (456)
Q Consensus 392 ~~l~~dp~~Rpt~~ell~ 409 (456)
+||..+|++||++.++.+
T Consensus 230 ~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 230 RLLCMDPAKRLGANGYQE 247 (260)
T ss_pred HHccCCHHHccCCCcHHH
Confidence 999999999997654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=291.62 Aligned_cols=244 Identities=25% Similarity=0.427 Sum_probs=201.0
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
|.....||+|+||.+ ..+++.||+|++.... ......+.+|+.+++.+.||||+++++++...+..++++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 444557999999865 3368899999986532 22346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccC
Q 012777 229 LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKE 308 (456)
Q Consensus 229 ~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~ 308 (456)
+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~---- 171 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV---- 171 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc----
Confidence 999999998765 56899999999999999999999999 9999999999999999999999999986542211
Q ss_pred CCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHH
Q 012777 309 DRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRE 388 (456)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 388 (456)
.......++..|+|||++.+..++.++|+||||+++|+|++|..||....+.+....+.... .........++..+.+
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ 249 (297)
T cd06659 172 -PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNAHKISPVLRD 249 (297)
T ss_pred -ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CCCccccCCCCHHHHH
Confidence 11123457889999999998889999999999999999999999998766555444442222 2222234567888999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 012777 389 LIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 389 li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+|.+||+.+|++||++++++++
T Consensus 250 ~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 250 FLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHhcCCcccCcCHHHHhhC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=282.75 Aligned_cols=251 Identities=29% Similarity=0.488 Sum_probs=201.0
Q ss_pred cccceeeeccEEEEEe--------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC-----
Q 012777 154 FSNSVEITKGTFRIAS--------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST----- 220 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~~--------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~----- 220 (456)
|.+.+.||+|+||.+. .++..||+|++..+. ......+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 4566789999998552 136789999997654 34455678899999999999999999999886532
Q ss_pred -ceEEEEEccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEec
Q 012777 221 -PMMIVTEYLPKGDLRAYLKQK------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293 (456)
Q Consensus 221 -~~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~D 293 (456)
..+++++|+.+++|.+++... ..++...+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECc
Confidence 347889999999999887532 14788999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCC
Q 012777 294 FGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANER 372 (456)
Q Consensus 294 fgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 372 (456)
||++.......... ......+++.|++||.+....++.++||||||+++|+|++ |.+||...+..+....+.....
T Consensus 157 fg~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05074 157 FGLSKKIYSGDYYR---QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233 (273)
T ss_pred ccccccccCCccee---cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99988653221111 1112234567999999988889999999999999999999 8999987766555555543332
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 373 PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 373 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
.. .....+..+.+++.+||+.+|++||++.+++..|+.+
T Consensus 234 ~~---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 LK---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 22 2346778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=288.74 Aligned_cols=284 Identities=25% Similarity=0.357 Sum_probs=231.6
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
+|.....||+|+||.|. -+.+.||||+++++.+..++.++--+.|-++|... +-|.+++++.+|..-+.+|+||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 67777899999999873 34668999999998876666666777888888877 5789999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||+.||+|--++++-+.+.+..+..++.+|+-||-+||++| |++||||.+|||++.+|.+||+|||+++.-.
T Consensus 430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni----- 501 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI----- 501 (683)
T ss_pred EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc-----
Confidence 99999999999999999999999999999999999999999 9999999999999999999999999987432
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
........+.|||-|+|||++...+|+.++|+||+|++||||+.|++||++.+..++...|.... - .++.++|.+.
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn-v---syPKslSkEA 577 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN-V---SYPKSLSKEA 577 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-C---cCcccccHHH
Confidence 23334456789999999999999999999999999999999999999999999999888885433 1 2368899999
Q ss_pred HHHHHHhcccCCCCCCC----HHHHHHHHHHHHHHhcccc------ccccC----cchhhHHHHHhhhcCCCCCCCC
Q 012777 387 RELIEDCWSEEPFRRPT----FRQILMRLDDISDQLSIKR------HWKVG----PLRCFQSLAALWKKGHADPSSR 449 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt----~~ell~~L~~~~~~~~~~~------~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 449 (456)
.++++..|.+.|.+|.. .++=+. ...+++.++-++ .-|.+ -.+..+++...|....++-+++
T Consensus 578 v~ickg~ltK~P~kRLGcg~~ge~di~-~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~~lTPp 653 (683)
T KOG0696|consen 578 VAICKGLLTKHPGKRLGCGPEGERDIR-EHPFFRRIDWEKLERREIQPPFKPKIKCGRDAENFDKFFTREPTDLTPP 653 (683)
T ss_pred HHHHHHHhhcCCccccCCCCccccchh-hCcchhhccHHHHhhccCCCCCCCccccCCchhhhhHHHhcCCCCCCCc
Confidence 99999999999999952 222111 123333332111 11222 2356788888888777665543
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=281.37 Aligned_cols=251 Identities=28% Similarity=0.468 Sum_probs=204.2
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCC--CCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--Cce
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEV--FTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS--TPM 222 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~ 222 (456)
.+|.+.+.||+|+||.+ ..++..||+|.+.... .........+.+|+.++++++||||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 36888899999999865 3468899999875431 12344567889999999999999999999998764 458
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
++++||+++++|.+++...+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 899999999999999988778999999999999999999999999 99999999999999999999999999886532
Q ss_pred cccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (456)
.. ..........++..|+|||.+.+..++.++|+||||+++|+|++|+.||..........++.. .+.....+..+
T Consensus 159 ~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~p~~~ 234 (264)
T cd06653 159 IC--MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTKPMLPDGV 234 (264)
T ss_pred cc--ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc--CCCCCCCCccc
Confidence 11 011111234578889999999888889999999999999999999999987655444443322 22223346788
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.+.++|.+||. +|.+||++.+++.+
T Consensus 235 ~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 235 SDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 8999999999998 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=286.04 Aligned_cols=239 Identities=23% Similarity=0.352 Sum_probs=189.4
Q ss_pred eeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhc---CCCCcceeeeeEEEeCCceEEEEEccC
Q 012777 159 EITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQK---IRHPNVVQFLGAVTQSTPMMIVTEYLP 230 (456)
Q Consensus 159 ~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~---l~hp~iv~l~~~~~~~~~~~lv~e~~~ 230 (456)
.||+|+||.+ ..+++.||+|.+.............+.+|..+++. ..||+|+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3789999866 23588999999976543333323334455544443 479999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCC
Q 012777 231 KGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR 310 (456)
Q Consensus 231 ~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~ 310 (456)
+++|.+++...+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~------- 150 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK------- 150 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc-------
Confidence 9999999988888999999999999999999999999 999999999999999999999999998754211
Q ss_pred CcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchH--HHHHhcCCCCCCCCCCCCcHHHH
Q 012777 311 PVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVP--KAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
......+++.|+|||.+.. ..++.++|+||+||++|+|++|..||......... ......... ..+..++.++.
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 227 (279)
T cd05633 151 KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNV---ELPDSFSPELK 227 (279)
T ss_pred CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCc---CCccccCHHHH
Confidence 1122457889999998864 56889999999999999999999999765433222 111111111 12456888999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rp-----t~~ell~~ 410 (456)
++|.+||..||++|| |+++++++
T Consensus 228 ~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 228 SLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 999999999999999 59888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=285.59 Aligned_cols=251 Identities=26% Similarity=0.381 Sum_probs=199.8
Q ss_pred cCccccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC-
Q 012777 147 IDPKELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQS- 219 (456)
Q Consensus 147 ~~~~~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~- 219 (456)
+.....+|.+.+.||+|+||.+ ..+++.+|+|++.... .....+.+|+.++.++ +|||++++++++...
T Consensus 17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3344567999999999999865 2368899999986532 2235677899999998 799999999998754
Q ss_pred ----CceEEEEEccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEE
Q 012777 220 ----TPMMIVTEYLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291 (456)
Q Consensus 220 ----~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl 291 (456)
...++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence 358999999999999998863 346899999999999999999999999 999999999999999999999
Q ss_pred eccCCcccccccccccCCCCcccCCCCcccccccccCCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHH
Q 012777 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-----EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKA 366 (456)
Q Consensus 292 ~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 366 (456)
+|||++....... .......++..|+|||.+... .++.++|+|||||++|+|++|++||...........
T Consensus 170 ~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~ 244 (291)
T cd06639 170 VDFGVSAQLTSTR-----LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244 (291)
T ss_pred eecccchhccccc-----ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH
Confidence 9999987653211 111223577889999987643 367899999999999999999999987765444444
Q ss_pred HHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 367 YIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.....+... .+..++..+.++|.+||+.+|++||++.+++++
T Consensus 245 ~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 IPRNPPPTLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HhcCCCCCCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 4333222221 234567789999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=297.04 Aligned_cols=255 Identities=28% Similarity=0.453 Sum_probs=210.8
Q ss_pred ccccceeeeccEEEEEe----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 153 DFSNSVEITKGTFRIAS----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
...+.++||+|.||.+. ..+..||+|.++... .......|..|+.+|.+++||||++++++|..++.+++|+||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34567799999999773 345899999998763 445568999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 229 LPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 229 ~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
++.|+|.+++.+. +.+..+....|+.||++|+.||.+.+ +|||||.+.|+|++.++.+||+|||+++-+=.+.
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~-- 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD-- 691 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC--
Confidence 9999999999876 33566778889999999999999999 9999999999999999999999999998542111
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCccchHHHHHhc----CCCCCCCCCC
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE--GCPPFPTKQEKEVPKAYIAN----ERPPFRAPTT 380 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~ 380 (456)
........+-+++|||||.+.-+++++++|+|+||+++||+++ ...||...+.+...+..-.- ...-....+.
T Consensus 692 -yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~ 770 (807)
T KOG1094|consen 692 -YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP 770 (807)
T ss_pred -ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence 1111222345678999999999999999999999999999986 67899988876655443111 1122233467
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
-+|.++.+++.+||..+..+||+++++...|++..
T Consensus 771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 771 ACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred cCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 88899999999999999999999999999988653
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=285.17 Aligned_cols=244 Identities=27% Similarity=0.485 Sum_probs=199.6
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC---CCcceeeeeEEEeCCceEEE
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR---HPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~l~~~~~~~~~~~lv 225 (456)
|+..+.||+|+||.+ ..++..||+|.+.... .......+.+|+.+++.++ |||++++++++......+++
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 667788999999855 3468899999987542 3344567889999999986 99999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|||+++++|.+++.. +.+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 81 MEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred EecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 999999999999865 47999999999999999999999999 9999999999999999999999999988663221
Q ss_pred ccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.......++..|+|||.+.++ .++.++|+||||+++|+|++|..||...........+.....+.+ ....++.
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 229 (277)
T cd06917 156 ----SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRL--EDNGYSK 229 (277)
T ss_pred ----cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCC--CcccCCH
Confidence 112234578889999988654 568899999999999999999999987665443332211111221 2234788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.+++.+||..||++||++.+++.+
T Consensus 230 ~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 230 LLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 99999999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=286.03 Aligned_cols=249 Identities=26% Similarity=0.449 Sum_probs=199.7
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.+ ..+|+.||+|++..... .......+.+|+.++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 4777889999999865 23688999999976532 23345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|+ +++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 99 99999998653 56999999999999999999999999 99999999999999999999999999886632211
Q ss_pred cCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC-C-----------
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER-P----------- 373 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~----------- 373 (456)
.......++..|+|||.+.+. .++.++||||||+++++|++|.+||...........+..... +
T Consensus 155 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 ---RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred ---CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence 122334678889999998654 468899999999999999999988877654433322221110 0
Q ss_pred --------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 --------------PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 --------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+.......+..+.++|.+||..+|++|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000113567889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=288.71 Aligned_cols=249 Identities=28% Similarity=0.463 Sum_probs=198.2
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCC--CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFT--DEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
+|...+.||+|+||.+ ..+|+.||+|.+...... .......+..|+.++++++|+||+++++++......++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3667788999999865 235889999999765432 122345677899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 226 TEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
|||+ +++|.+++.... .+++..+..++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 899999998765 7999999999999999999999999 9999999999999999999999999988663221
Q ss_pred cccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC-C---------
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER-P--------- 373 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~--------- 373 (456)
.......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||...+..+....+..... +
T Consensus 157 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 157 -----RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred -----ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 11222345678999998855 4578899999999999999999888877665443333221110 0
Q ss_pred --------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 --------------PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 --------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+........+..+.++|.+||..||++|||+++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0001123456789999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=287.56 Aligned_cols=247 Identities=27% Similarity=0.453 Sum_probs=204.5
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
|...+.||+|+||.+ ..++..||+|.+........+....+.+|+.++++++|||++++++++..+...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 778889999999865 236889999999765444555667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 229 LPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 229 ~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
+. ++|.+++.. ..++++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 96 578777754 456999999999999999999999999 99999999999999999999999998764421
Q ss_pred CCCCcccCCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 308 EDRPVTCEETSWRYAAPEVYK---NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.....+++.|+|||.+. ...++.++|+||||+++|+|++|..||...+.......+.....+.. ....++.
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 251 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSNEWSD 251 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--CCccccH
Confidence 12235677899999873 45688899999999999999999999987765555555544333322 2356778
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
.+.+++.+||+.+|++||++.++++++.-+.
T Consensus 252 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 252 YFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 8999999999999999999999998865443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=283.65 Aligned_cols=253 Identities=27% Similarity=0.498 Sum_probs=200.8
Q ss_pred ccccceeeeccEEEEE---eE------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--CCc
Q 012777 153 DFSNSVEITKGTFRIA---SW------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ--STP 221 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~ 221 (456)
.|...+.||+|+||.+ .. ++..||+|++..... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--EQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc--hHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 4677789999999865 22 367899999986532 2456789999999999999999999999877 557
Q ss_pred eEEEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
.+++|||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 899999999999999997654 5999999999999999999999999 999999999999999999999999998866
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccch-----------HHH---
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV-----------PKA--- 366 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-----------~~~--- 366 (456)
....... .......++..|++||.+....++.++|+||||+++++|++|..|+........ ...
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 160 PEDKDYY--YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccCCcce--eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 4211110 111112345569999999888899999999999999999999999865432210 111
Q ss_pred HHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 367 YIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
..... ... ..+..++.++.+++.+||..+|++|||+.++++.|+.+
T Consensus 238 ~~~~~-~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEG-ERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcC-CcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111 111 12356678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=278.73 Aligned_cols=246 Identities=26% Similarity=0.486 Sum_probs=207.6
Q ss_pred ccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||.|+||.+ . .++..||+|++..... .......+.+|+++++.++|||++++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 4677889999999855 2 3588999999976542 34556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 228 YLPKGDLRAYLKQK----GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 228 ~~~~~sL~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
|+++++|.+++... ..+++..+..++.+++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999999764 56999999999999999999999999 999999999999999999999999998765322
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
. .......+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+.............+. .+..++
T Consensus 157 ~-----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 228 (258)
T cd08215 157 V-----DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP---IPSQYS 228 (258)
T ss_pred c-----ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC---CCCCCC
Confidence 1 11223457788999999988889999999999999999999999998877655555543333222 345788
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..+.+++.+||..+|++|||+.+++++
T Consensus 229 ~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 229 SELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=302.31 Aligned_cols=244 Identities=20% Similarity=0.258 Sum_probs=190.4
Q ss_pred ccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
...|.+.+.||+|+||.|. ..++.||||.... ..+.+|++++++++||||+++++++......++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 3468999999999999762 3578899996432 2456899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 226 TEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
||++ .++|.+++... ..+++..++.|+.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 239 ~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 239 LPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 9999 57898888764 46999999999999999999999999 9999999999999999999999999998653211
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-c-------cchHHHHHhcCC--CC
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQ-E-------KEVPKAYIANER--PP 374 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~-------~~~~~~~~~~~~--~~ 374 (456)
.........||+.|+|||++.+..++.++|||||||++|||++|..|+-... . ..+...+..... ..
T Consensus 315 ---~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 315 ---STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred ---ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 1111223568999999999999999999999999999999999876542211 1 111111111110 00
Q ss_pred CC------------------------C----CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 FR------------------------A----PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 ~~------------------------~----~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+. . ....++.++.+||.+||..||.+|||+.|++++
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 0 001345578999999999999999999999986
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=277.38 Aligned_cols=246 Identities=28% Similarity=0.540 Sum_probs=207.6
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||+|.+|.+ ..+++.||+|.+..... .+.....+.+|++++++++||+++++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 3677889999999865 23678999999987643 34566789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++...+.+++..++.++.|++.+|.+||+.+ ++|+||+|.||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-- 154 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc--
Confidence 9999999999988888999999999999999999999999 99999999999999999999999999886633211
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
......++..|+|||.+.+..++.++|+||||+++++|++|..||.................+. .+..++..+.
T Consensus 155 ---~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 228 (254)
T cd06627 155 ---DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP---LPEGISPELK 228 (254)
T ss_pred ---cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCC---CCCCCCHHHH
Confidence 1223456788999999988888899999999999999999999998766544444443232222 3567788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+++.+||..+|++|||+.+++.+
T Consensus 229 ~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 229 DFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHHHHHHhCChhhCcCHHHHhcC
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=287.02 Aligned_cols=250 Identities=26% Similarity=0.453 Sum_probs=199.4
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||+|+||.+ ..+++.||+|++.... ........+.+|++++++++|+||+++++++...+..++++|
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4778889999999855 2357899999987543 233445788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|++++.+..+..+...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-- 155 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--
Confidence 9988777666666666999999999999999999999999 99999999999999999999999999886632211
Q ss_pred CCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-------------CC
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-------------RP 373 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------------~~ 373 (456)
.......++..|+|||++.+. .++.++|+||||+++|+|++|++||......+....+.... ..
T Consensus 156 --~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 156 --SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred --ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 122334567889999999888 78899999999999999999999998665433222211100 00
Q ss_pred --------CCC-------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 --------PFR-------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 --------~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.. ..+..++.++.++|.+||..+|++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 0123357889999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=284.10 Aligned_cols=247 Identities=24% Similarity=0.467 Sum_probs=205.8
Q ss_pred ccccccceeeeccEEEEE---eE--cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIA---SW--RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~---~~--~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
...|+....||+|+||.+ .. ++..||+|++..... ....+.+|+++++.++|+||+++++++......+++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 345788889999998754 22 588999999975421 456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 226 TEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
+||+++++|.+++...+ .++...+..++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999999998876 7999999999999999999999999 9999999999999999999999999887553211
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...++......+.....+... ....++.
T Consensus 171 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 244 (286)
T cd06614 171 -----SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLK-NPEKWSP 244 (286)
T ss_pred -----hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc-chhhCCH
Confidence 1112234677899999998888999999999999999999999999877665554444333322221 2344788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+.++|.+||+.+|.+|||+.+++.+
T Consensus 245 ~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 245 EFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhhC
Confidence 99999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=287.24 Aligned_cols=246 Identities=23% Similarity=0.437 Sum_probs=202.9
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|.+.+.||+|+||.+ ..++..||+|.+... .....+.+.+|+.+++.++||||+++++++......++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 46888899999999865 236789999998643 2233467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||+++++|.+++.+ ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-- 169 (293)
T cd06647 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 169 (293)
T ss_pred ecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc--
Confidence 99999999999875 45889999999999999999999999 9999999999999999999999999887553211
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
.......+++.|++||.+.+..++.++|+||||+++|++++|+.||...+.......+.....+.+. .+..++..+
T Consensus 170 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l 245 (293)
T cd06647 170 ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ-NPEKLSAIF 245 (293)
T ss_pred ---cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCC-CccccCHHH
Confidence 1122345778899999998888899999999999999999999999876654433323222222221 244577889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++|.+||..+|++||++++++.+
T Consensus 246 ~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 246 RDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=279.65 Aligned_cols=244 Identities=25% Similarity=0.410 Sum_probs=188.7
Q ss_pred eeeccEEEEEe----EcC---cEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 159 EITKGTFRIAS----WRG---TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 159 ~lg~G~fg~~~----~~g---~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
.||+|+||.+. .++ ..+++|.+.... .......+.+|+.+++.++||||+++++.+......++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 58999998662 222 246677765442 334567899999999999999999999999999999999999999
Q ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 232 GDLRAYLKQK----GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 232 ~sL~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
++|.+++.+. ...+...+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~-- 154 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-- 154 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh--
Confidence 9999999764 23667788899999999999999999 99999999999999999999999998764311100
Q ss_pred CCCCcccCCCCcccccccccCC-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCC--CCC
Q 012777 308 EDRPVTCEETSWRYAAPEVYKN-------EEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPP--FRA 377 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~--~~~ 377 (456)
........++..|+|||++.. ..++.++||||||+++|+|++ |..||......+....+....... .+.
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 155 -IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred -hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc
Confidence 011123456788999998753 245678999999999999997 678997766655554443332211 122
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 378 PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 378 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
....+++.+.+++..|| .+|++||+++++++.|
T Consensus 234 ~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 234 LELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 23457888999999999 7899999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=283.56 Aligned_cols=247 Identities=28% Similarity=0.460 Sum_probs=196.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS--TPMMIV 225 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~lv 225 (456)
+|...+.||.|.+|.+ ..+++.||+|.+.... .......+.+|++++++++||||+++++++... ..+++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 4677889999999865 2368899999997542 334557789999999999999999999998654 468999
Q ss_pred EEccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 226 TEYLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999988753 345899999999999999999999999 9999999999999999999999999987542
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc-----cchHHHHHhcCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE-----KEVPKAYIANERPPFR 376 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~ 376 (456)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .+....+.....+...
T Consensus 157 ~~-------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd06621 157 NS-------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229 (287)
T ss_pred cc-------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc
Confidence 11 11123467789999999988999999999999999999999999976632 2222222211111111
Q ss_pred CC---CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 377 AP---TTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 377 ~~---~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
.. ....+..+.++|.+||..+|.+|||+.|++.+-
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 230 DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 11 134567899999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=295.40 Aligned_cols=246 Identities=27% Similarity=0.390 Sum_probs=195.4
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------C
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS------T 220 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------~ 220 (456)
.+|+..+.||+|+||.+ ..+|+.||+|.+.... ........+.+|+.++++++||||+++++++... .
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 36888899999999866 3478899999987543 2344456778899999999999999999988644 3
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
..++||||+. ++|.+.+... +++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++...
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 5799999994 6898888643 899999999999999999999999 999999999999999999999999998765
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC---------
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE--------- 371 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------- 371 (456)
... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 169 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 169 GTS------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred CCC------CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 321 11223456788999999999999999999999999999999999998665432222221100
Q ss_pred ------------CCCCC------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 ------------RPPFR------------------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 ------------~~~~~------------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++... ......+..+.++|.+||+.||++|||+++++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0012346678999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=288.10 Aligned_cols=249 Identities=26% Similarity=0.431 Sum_probs=198.3
Q ss_pred ccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||+|+||.+ . .+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++......++|+|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4777889999999865 2 2588999999876432 22345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.++......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--- 154 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--- 154 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc---
Confidence 9999888887766667999999999999999999999999 9999999999999999999999999987653221
Q ss_pred CCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc----------------
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN---------------- 370 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~---------------- 370 (456)
.......++..|+|||++.+. .++.++||||||+++|+|++|.+||......+....+...
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 122234567889999988753 4678899999999999999999999765543222221110
Q ss_pred ----C-CCCC------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 371 ----E-RPPF------RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 371 ----~-~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
. .+.. ......++..+.+++.+||..+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0 0000 00124667889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=283.16 Aligned_cols=244 Identities=25% Similarity=0.482 Sum_probs=192.0
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHH-HhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELAL-LQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
+|++.+.||+|+||.+ ..+|+.||+|.+...... . ....+..|+.. ++..+||||+++++++..+...+++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-Q-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-H-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 5788889999999866 236899999999765322 2 23455566665 55568999999999999999999999
Q ss_pred EccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 227 EYLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHEN-RPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 227 e~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~-~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
||++ ++|.+++.. ...+++..++.++.|++.||.|||++ + ++|+||||+||+++.++.+||+|||++....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9995 688888764 23589999999999999999999997 8 9999999999999999999999999987652
Q ss_pred ccccccCCCCcccCCCCcccccccccCC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc-cchHHHHHhcCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKN----EEYDTKVDVFSFALILQEMIEGCPPFPTKQE-KEVPKAYIANERPPFR 376 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~ 376 (456)
.. .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..... .+..........+..
T Consensus 156 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 228 (283)
T cd06617 156 DS------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQL- 228 (283)
T ss_pred cc------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCC-
Confidence 21 11122356778999998865 3567899999999999999999999975432 222223322222222
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 377 APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 377 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+...++.++.++|.+||..+|++||++++++++
T Consensus 229 -~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 229 -PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 234678899999999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=275.92 Aligned_cols=245 Identities=30% Similarity=0.518 Sum_probs=204.1
Q ss_pred ccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||+|++|.+ . .++..+++|++..... .....+.+|++.+++++||+++++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 3677789999998755 2 2588999999976532 355788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|+++++|.+++... ..+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999999999875 57999999999999999999999999 99999999999999999999999999876632211
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
.....++..|+|||.+.+..++.++|+||||+++++|++|..||...+.............+... ....++..+
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 227 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR-NPEKWSDEF 227 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcC-cccccCHHH
Confidence 22345778899999998888899999999999999999999999887655444444332222221 123347889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++|.+||..||++|||+.+++++
T Consensus 228 ~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 228 KDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHHccCChhhCCCHHHHhcC
Confidence 999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=277.57 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=201.8
Q ss_pred ceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccC
Q 012777 157 SVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLP 230 (456)
Q Consensus 157 ~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~e~~~ 230 (456)
.+.||+|.|+.| ..+|..||||++.+. .......+.+|++++.++ .|+||++++++|+++..+|+|||-+.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 467999999866 568999999999875 344568899999999999 59999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC---CEEEeccCCcccccccccc-
Q 012777 231 KGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG---HLKVADFGLSKLLKFANTV- 306 (456)
Q Consensus 231 ~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~---~vkl~Dfgls~~~~~~~~~- 306 (456)
||+|..+++++..+++.++..+..+|+.||.|||.+| |.|||+||+|||-...+ -||||||.+..-....+..
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 9999999999889999999999999999999999999 99999999999987554 4899999887654332221
Q ss_pred -cCCCCcccCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc-------cch--------HH
Q 012777 307 -KEDRPVTCEETSWRYAAPEVYK-----NEEYDTKVDVFSFALILQEMIEGCPPFPTKQE-------KEV--------PK 365 (456)
Q Consensus 307 -~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-------~~~--------~~ 365 (456)
........+.|+..|||||+.. .-.|+.+.|.||||+|+|-|+.|.+||.+.-. .+. ..
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 1222334567889999999762 23688999999999999999999999965322 221 23
Q ss_pred HHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 366 AYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.|..+....-...+.+++.+..++|..++..|+..|.++.+++++
T Consensus 317 sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 317 SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 332222211123367899999999999999999999999998884
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=279.13 Aligned_cols=232 Identities=25% Similarity=0.458 Sum_probs=186.4
Q ss_pred eeeeccEEEEE---eE--cC----------cEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 158 VEITKGTFRIA---SW--RG----------TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 158 ~~lg~G~fg~~---~~--~g----------~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
+.||+|+||.+ .. ++ ..|++|.+.... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999865 22 22 248888776432 115788999999999999999999999987 778
Q ss_pred EEEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-------CEEEecc
Q 012777 223 MIVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG-------HLKVADF 294 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~-------~vkl~Df 294 (456)
++||||+++++|.+++...+ .++...+..++.|++.||.|||+++ |+|+||||+|||++.++ .+||+||
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999999998766 6999999999999999999999999 99999999999999887 7999999
Q ss_pred CCcccccccccccCCCCcccCCCCcccccccccCCC--CCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcC
Q 012777 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE--EYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANE 371 (456)
Q Consensus 295 gls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~ 371 (456)
|++..... .....++..|+|||++... .++.++|+||||+++|+|++ |..||......+....+....
T Consensus 153 g~a~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~ 223 (259)
T cd05037 153 GIPITVLS---------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH 223 (259)
T ss_pred Cccccccc---------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC
Confidence 99886521 1123355679999998876 78889999999999999999 688887765443333332111
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 372 RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 372 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
.. +......+.++|.+||..+|++|||+.++++.|
T Consensus 224 ~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 224 RL-----PMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CC-----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11 112236799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=283.05 Aligned_cols=234 Identities=23% Similarity=0.385 Sum_probs=186.9
Q ss_pred eeeccEEEEEe---E---------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 159 EITKGTFRIAS---W---------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 159 ~lg~G~fg~~~---~---------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.||+|+||.|. . ....||+|.+... .....+.+.+|+.+++.++||||+++++++......++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 58999997552 1 2335888887543 2334567889999999999999999999999988999999
Q ss_pred EccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC--------EEEeccCCc
Q 012777 227 EYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH--------LKVADFGLS 297 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~--------vkl~Dfgls 297 (456)
||+++++|.+++..++ .+++..+..++.|++.||.|||+++ |+||||||+||+++.++. ++++|||++
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999997654 4899999999999999999999999 999999999999987665 699999987
Q ss_pred ccccccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcC-CCCCCCCCccchHHHHHhcCCCCC
Q 012777 298 KLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEG-CPPFPTKQEKEVPKAYIANERPPF 375 (456)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~ 375 (456)
..... .....+++.|+|||++.+. .++.++|+||||+++|+|++| ..||...+........ .....+
T Consensus 156 ~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~--~~~~~~ 224 (258)
T cd05078 156 ITVLP---------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY--EDRHQL 224 (258)
T ss_pred cccCC---------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH--HccccC
Confidence 64421 1123467789999998764 578899999999999999998 5777665544332222 122222
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 376 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
+...+.++.+++.+||+.||++|||++++++.|+
T Consensus 225 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 225 ---PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 3455678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=279.54 Aligned_cols=244 Identities=27% Similarity=0.465 Sum_probs=205.9
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|++.+.||.|+||.+ ..+++.+|+|.+..... .......+.+|+.+++.++||||+++++++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 4677889999998754 23678999999976543 34456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 228 YLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 228 ~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
|+++++|.+++.+ ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999999876 345899999999999999999999999 999999999999999999999999998866322
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
......+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+..+....+.....+. .+..++
T Consensus 157 -------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 226 (256)
T cd08530 157 -------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP---IPPIYS 226 (256)
T ss_pred -------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC---CchhhC
Confidence 1122346778999999998889999999999999999999999998877665555553333333 245788
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++.+++.+||..+|++|||+.+++++
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 227 QDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=285.41 Aligned_cols=248 Identities=27% Similarity=0.488 Sum_probs=195.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||.|+||.+ ..+|+.||||.+..+.. .......+.+|++++++++||||+++++++......+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 4778889999999865 23688999999875432 23334578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~-- 153 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-- 153 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccC--
Confidence 995 6899988653 45899999999999999999999999 999999999999999999999999998755321
Q ss_pred ccCCCCcccCCCCcccccccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCC----------
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEE-YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPP---------- 374 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 374 (456)
........+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+......+
T Consensus 154 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 154 ---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred ---ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH
Confidence 11122334677899999886644 5788999999999999999999997765433322221111000
Q ss_pred -------C--------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 -------F--------RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 -------~--------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+ ......++.++.++|.+||..||++|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0 00123467789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=275.48 Aligned_cols=249 Identities=28% Similarity=0.470 Sum_probs=205.2
Q ss_pred ccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceEEE
Q 012777 153 DFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS--TPMMIV 225 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~lv 225 (456)
+|...+.||+|++|.+ . .++..|++|++..... .....+.+.+|+.++++++||||+++++.+... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 3677789999999865 2 2588999999976542 245668899999999999999999999999988 889999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
+||+++++|.+++.+...+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999999999988778999999999999999999999999 99999999999999999999999999886633211
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc-chHHHHHhcCCCCCCCCCCCCcH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK-EVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
. .......++..|+|||.+.....+.++|+||||+++++|++|..||...... .....+ .........+...+.
T Consensus 157 ~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 231 (260)
T cd06606 157 G---EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI--GSSGEPPEIPEHLSE 231 (260)
T ss_pred c---ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhc--cccCCCcCCCcccCH
Confidence 0 0122345778899999998888999999999999999999999999876621 111111 111222233566788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+.++|.+|+..||++||++.+++.+
T Consensus 232 ~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 232 EAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 99999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=280.12 Aligned_cols=246 Identities=24% Similarity=0.415 Sum_probs=202.3
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||+|+||.+ ..+|..||+|.+..... .....+.+.+|+.+++.++||||+++++.+......++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 4677889999999755 33678999999876432 22344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-CEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG-HLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~-~vkl~Dfgls~~~~~~~ 304 (456)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++ .++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999987643 4789999999999999999999999 99999999999999875 46999999987653211
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.......+++.|+|||.+.+..++.++|+||||+++++|++|..||...+.......+...... .....++.
T Consensus 157 -----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 228 (257)
T cd08225 157 -----ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA---PISPNFSR 228 (257)
T ss_pred -----ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC---CCCCCCCH
Confidence 1112245788899999998888999999999999999999999999876655555444332222 22456788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.++|.+||..+|++|||+++++++
T Consensus 229 ~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 229 DLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhhC
Confidence 99999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=279.73 Aligned_cols=249 Identities=23% Similarity=0.449 Sum_probs=202.4
Q ss_pred ccccceeeeccEEEEE---eE---cCcEEEEEEeCCCC-------CCCHHHHHHHHHHHHHHhc-CCCCcceeeeeEEEe
Q 012777 153 DFSNSVEITKGTFRIA---SW---RGTQVAVKTLGEEV-------FTDEDKVKAFIDELALLQK-IRHPNVVQFLGAVTQ 218 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~---~g~~vAvK~~~~~~-------~~~~~~~~~~~~E~~~l~~-l~hp~iv~l~~~~~~ 218 (456)
+|++.+.||+|+||.+ .. .++.+|+|.+.... .........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 3777889999999855 22 46789999886432 1234455677889988875 699999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCCCEEEec
Q 012777 219 STPMMIVTEYLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHE-NRPEAIIHRDLEPSNILRDDSGHLKVAD 293 (456)
Q Consensus 219 ~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~-~~~~~ivH~Dikp~Nil~~~~~~vkl~D 293 (456)
.+..+++|||+++++|.+++.. ...+++..++.++.|++.+|.|||+ .+ ++|+||+|.||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988743 3458999999999999999999996 66 99999999999999999999999
Q ss_pred cCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCC
Q 012777 294 FGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERP 373 (456)
Q Consensus 294 fgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 373 (456)
||++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+......
T Consensus 158 fg~~~~~~~~~------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd08528 158 FGLAKQKQPES------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231 (269)
T ss_pred ccceeeccccc------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence 99987653211 223345788899999999888999999999999999999999999876655544444333222
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 374 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
+. ....++.++.++|.+||+.||++||++.|+..++.
T Consensus 232 ~~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 PL--PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cC--CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 21 23467889999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=284.32 Aligned_cols=246 Identities=28% Similarity=0.489 Sum_probs=193.2
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv~ 226 (456)
+|...+.||+|+||.+ ..+++.||+|.+.... .......+.+|+.++.++. ||||+++++++..+...+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV--DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc--ChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 4566678999999866 3368899999987653 2345567889999999995 999999999999999999999
Q ss_pred EccCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 227 EYLPKGDLRAYLK-----QKGALKPTLAVKFALDIARGMNYLHEN-RPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 227 e~~~~~sL~~~l~-----~~~~l~~~~~~~i~~ql~~aL~~LH~~-~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
||+. .++.++.. ....+++..+..++.|++.||.|||+. + ++||||||+||+++.++.++|+|||++...
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 9984 56655432 235699999999999999999999975 7 999999999999999999999999998755
Q ss_pred cccccccCCCCcccCCCCcccccccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCcc-chHHHHHhcCCCCCC
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNE---EYDTKVDVFSFALILQEMIEGCPPFPTKQEK-EVPKAYIANERPPFR 376 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~ 376 (456)
... .......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...... +....+.....+...
T Consensus 159 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd06616 159 VDS------IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS 232 (288)
T ss_pred ccC------CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCC
Confidence 221 111223567889999998776 6888999999999999999999999765421 111222111122221
Q ss_pred -CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 377 -APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 377 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.....++.++.+||.+||..||++|||+++++.+
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1124578899999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=280.68 Aligned_cols=246 Identities=29% Similarity=0.459 Sum_probs=199.2
Q ss_pred eeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012777 160 ITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234 (456)
Q Consensus 160 lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~sL 234 (456)
||.|+||.+ . .+|+.||+|++.............+.+|++++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 577777754 2 25899999999765444445667899999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc---cCCCC
Q 012777 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV---KEDRP 311 (456)
Q Consensus 235 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~---~~~~~ 311 (456)
.+++...+.+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999988778999999999999999999999999 999999999999999999999999998754322110 00112
Q ss_pred cccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q 012777 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIE 391 (456)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 391 (456)
.....++..|++||.+.....+.++|+||||+++|+|++|..||......+....+.... ..... ...++..+.+++.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~i~ 235 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK-IEWPE-DVEVSDEAIDLIS 235 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-cCCCc-cccCCHHHHHHHH
Confidence 223456778999999988888999999999999999999999998877666655553322 22211 1234889999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 012777 392 DCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 392 ~~l~~dp~~Rpt~~ell~~ 410 (456)
+||+.+|++|||+.++.+.
T Consensus 236 ~~l~~~p~~Rpt~~~~~~~ 254 (265)
T cd05579 236 KLLVPDPEKRLGAKSIEEI 254 (265)
T ss_pred HHhcCCHhhcCCCccHHHH
Confidence 9999999999999444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=283.27 Aligned_cols=251 Identities=26% Similarity=0.444 Sum_probs=208.7
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv~ 226 (456)
+|...+.||+|+||.+ ..+|..||+|++.............+.+|..+++++. ||||+++++++......+++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 5777889999999865 2378999999998755445555678899999999998 999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||+++++|.+++.+.+.+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999999999998888999999999999999999999999 999999999999999999999999998866332110
Q ss_pred cC---------------CCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC
Q 012777 307 KE---------------DRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE 371 (456)
Q Consensus 307 ~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 371 (456)
.. ........++..|+|||.+....++.++|+||||++++++++|..||...........+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence 00 012233457788999999988888999999999999999999999998876544444443221
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 012777 372 RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTF----RQILMR 410 (456)
Q Consensus 372 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~----~ell~~ 410 (456)
. ..+..++..+.++|.+||..+|++||++ ++++++
T Consensus 239 -~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 239 -Y---SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred -C---CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1 1245678899999999999999999999 787764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=280.71 Aligned_cols=239 Identities=23% Similarity=0.355 Sum_probs=188.8
Q ss_pred eeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHH---HHhcCCCCcceeeeeEEEeCCceEEEEEccC
Q 012777 159 EITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELA---LLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230 (456)
Q Consensus 159 ~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~---~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~ 230 (456)
.||+|+||.+ ..+++.||+|.+.+...........+..|.. .++...||+|+++++++......++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3789999865 2468899999987654332222223344443 3444579999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCC
Q 012777 231 KGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR 310 (456)
Q Consensus 231 ~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~ 310 (456)
+++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~------- 150 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK------- 150 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc-------
Confidence 9999999988788999999999999999999999999 999999999999999999999999998754211
Q ss_pred CcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchH--HHHHhcCCCCCCCCCCCCcHHHH
Q 012777 311 PVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVP--KAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
......|+..|+|||.+.++ .++.++|+||+|+++|+|++|..||......... ........+. .+..++..+.
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~s~~~~ 227 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE---LPDSFSPELR 227 (278)
T ss_pred CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC---CCCcCCHHHH
Confidence 11224578899999998754 6889999999999999999999999876432221 1111122222 2445788999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rp-----t~~ell~~ 410 (456)
+++.+||..+|.+|| ++++++++
T Consensus 228 ~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 228 SLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=298.00 Aligned_cols=247 Identities=27% Similarity=0.518 Sum_probs=208.9
Q ss_pred ccccceeeeccEEEEEe---Ec---C--cEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 153 DFSNSVEITKGTFRIAS---WR---G--TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~---~~---g--~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
+....+.||+|+||.|. |+ | ..||||++...... ....+|++|+.+|.+++|||+++|||...+ ....+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 35566789999999773 32 2 36999999876432 267899999999999999999999999987 68899
Q ss_pred EEEccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 225 VTEYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
|+|+++.|||.+.|.+. ..|.....+.++.||+.||.||.+++ +|||||...|+|+-....|||+|||+.+-+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999999999872 34889999999999999999999999 99999999999999988999999999997754
Q ss_pred cccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (456)
+....... ....-++.|+|||.++...++.++|+|++||++|||++ |+.||.+.....+...+..+.+.+- +..
T Consensus 265 ned~Yvm~--p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpR---Pk~ 339 (1039)
T KOG0199|consen 265 NEDMYVMA--PQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPR---PKY 339 (1039)
T ss_pred CCcceEec--CCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCC---CCC
Confidence 43222211 11223457999999999999999999999999999998 8999999998888887764444433 578
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.++.+++..||..+|++|||+..|.+.
T Consensus 340 csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 89999999999999999999999999744
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=279.32 Aligned_cols=230 Identities=21% Similarity=0.395 Sum_probs=185.0
Q ss_pred eeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCCCC
Q 012777 160 ITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGD 233 (456)
Q Consensus 160 lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~e~~~~~s 233 (456)
||+|+||.+ ..++..+|+|.+....... .|+.....+ +||||+++++.+...+..++||||+++++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 95 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGD 95 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCc
Confidence 599999865 3468899999987543211 122222222 79999999999999999999999999999
Q ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-CEEEeccCCcccccccccccCCCCc
Q 012777 234 LRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG-HLKVADFGLSKLLKFANTVKEDRPV 312 (456)
Q Consensus 234 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~-~vkl~Dfgls~~~~~~~~~~~~~~~ 312 (456)
|.+++.....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||++..... .
T Consensus 96 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~---------~ 163 (267)
T PHA03390 96 LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT---------P 163 (267)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCC---------C
Confidence 9999988778999999999999999999999999 99999999999999888 999999999875521 1
Q ss_pred ccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchH-HHHHhcCCCCCCCCCCCCcHHHHHHHH
Q 012777 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVP-KAYIANERPPFRAPTTHYAYGLRELIE 391 (456)
Q Consensus 313 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~ 391 (456)
....++..|+|||++.+..++.++|+||||+++|+|++|..||......... ..+....... ......++..+.++|.
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 242 (267)
T PHA03390 164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK-LPFIKNVSKNANDFVQ 242 (267)
T ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhccc-CCcccccCHHHHHHHH
Confidence 1235778899999999889999999999999999999999999865443321 1221112111 1224578899999999
Q ss_pred HhcccCCCCCCC-HHHHHHH
Q 012777 392 DCWSEEPFRRPT-FRQILMR 410 (456)
Q Consensus 392 ~~l~~dp~~Rpt-~~ell~~ 410 (456)
+||+.+|.+||+ +++++++
T Consensus 243 ~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 243 SMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHhccChhhCCchHHHHhcC
Confidence 999999999996 6998864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=295.06 Aligned_cols=240 Identities=23% Similarity=0.358 Sum_probs=216.8
Q ss_pred ccccceeeeccEEEEE---eEcCcE--EEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA---SWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~~g~~--vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
++.+...||-|+||+| ..+++. +|+|++++..+.+....+++..|.++|..+.+|.||++|-.|.++.++|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 6777888999999976 445554 89999999888888888999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
-|-||.|...+..++.+++..+..++.-+++|++|||+++ ||+|||||+|.|++.+|.+||.|||+++.+..
T Consensus 501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~----- 572 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS----- 572 (732)
T ss_pred hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc-----
Confidence 9999999999999999999999999999999999999999 99999999999999999999999999998843
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
....-.++|||.|.|||++.+...+.++|.||||+++|||++|.+||.+.++...+..|..+... -..+..++....
T Consensus 573 -g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~--i~~Pr~I~k~a~ 649 (732)
T KOG0614|consen 573 -GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK--IEFPRRITKTAT 649 (732)
T ss_pred -CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh--hhcccccchhHH
Confidence 23334578999999999999999999999999999999999999999999999888888655421 123578899999
Q ss_pred HHHHHhcccCCCCCCC
Q 012777 388 ELIEDCWSEEPFRRPT 403 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt 403 (456)
++|+++...+|.+|..
T Consensus 650 ~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 650 DLIKKLCRDNPTERLG 665 (732)
T ss_pred HHHHHHHhcCcHhhhc
Confidence 9999999999999975
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=282.77 Aligned_cols=247 Identities=30% Similarity=0.510 Sum_probs=196.4
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
|++.+.||.|.+|.+ ..+|..||+|++..+.. .......+.+|+.+++.++||+++++++++......++++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 566788999999865 23789999999976532 222335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 229 LPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 229 ~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
+ +++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--- 152 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVP--- 152 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCC---
Confidence 9 569999997765 6899999999999999999999999 999999999999999999999999998755221
Q ss_pred cCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC--------------
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-------------- 371 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------------- 371 (456)
........+++.|+|||++.+. .++.++|+||||+++|+|++|++||...+.......+....
T Consensus 153 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 153 --VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred --ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc
Confidence 1111223457789999987654 56889999999999999999999997765433222211110
Q ss_pred -----------CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 -----------RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 -----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..........++..+.++|.+||+.||++|||+++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011111235677889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=286.87 Aligned_cols=248 Identities=30% Similarity=0.457 Sum_probs=195.7
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS--TPMMIV 225 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~lv 225 (456)
+|.+.+.||.|+||.+ ..+|+.||+|.+...... ......+.+|+.++++++|+||+++++++... +.+++|
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 6888899999999865 346889999998754322 22223466899999999999999999998765 568999
Q ss_pred EEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 226 TEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
|||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 87 ~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 87 MEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99995 5898888763 56999999999999999999999999 9999999999999999999999999988663211
Q ss_pred cccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCC---------
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPP--------- 374 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 374 (456)
.......+++.|+|||.+.+ ..++.++|+||||+++|+|++|++||...+..+....+......+
T Consensus 163 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 163 -----KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred -----CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 11222335677999999865 457889999999999999999999998877655544443211100
Q ss_pred -------CCC----------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 -------FRA----------PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 -------~~~----------~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.. .....+.++.++|.+||..||++|||+++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 012357789999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=283.14 Aligned_cols=242 Identities=28% Similarity=0.464 Sum_probs=199.8
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
|.....||+|+||.+ ..+|+.||+|++.............+.+|+++++.++|||++++++++......+++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999865 236889999999765444555667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 229 LPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 229 ~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
+. ++|.+++.. ..++++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~------ 172 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS------ 172 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC------
Confidence 95 588887765 456999999999999999999999999 9999999999999999999999999876431
Q ss_pred CCCCcccCCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 308 EDRPVTCEETSWRYAAPEVYK---NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
......++..|+|||++. ...++.++|+||||+++|+|++|..||...+.......+.....+.. ....++.
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 247 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL--QSNEWTD 247 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CccccCH
Confidence 112345778899999984 45688899999999999999999999988766555444433332222 2345778
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+.+++.+||+.+|.+||++.+++.+
T Consensus 248 ~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 248 SFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=285.73 Aligned_cols=259 Identities=18% Similarity=0.291 Sum_probs=198.1
Q ss_pred cccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccC
Q 012777 154 FSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~ 230 (456)
+.+.+.+|.|+++.+ ..+++.||+|++.... ........+.+|+.+++.++||||+++++++......+++|||++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 444556666666533 4579999999997653 234566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc--
Q 012777 231 KGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV-- 306 (456)
Q Consensus 231 ~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~-- 306 (456)
+++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999999764 35899999999999999999999999 999999999999999999999999988755322111
Q ss_pred cCCCCcccCCCCcccccccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCC----------
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNE--EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPP---------- 374 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 374 (456)
..........++..|+|||++.+. .++.++|+||||+++|+|++|..||.................+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 011111233466789999998763 57889999999999999999999998765433221111111000
Q ss_pred --------------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 375 --------------------FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 375 --------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
.......++.++.+++.+||..||++|||+++++++ .+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~--p~~~~~ 301 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH--SFFKQC 301 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC--chHhhh
Confidence 000112345678899999999999999999999996 344444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=282.12 Aligned_cols=247 Identities=28% Similarity=0.499 Sum_probs=196.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||.|++|.+ ..+|..||+|++..... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 4778889999999855 23688999999976532 2234567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQKG---ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
|++ ++|.+++...+ .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 996 58998887643 5899999999999999999999999 9999999999999999999999999987552211
Q ss_pred cccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCC---------
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPP--------- 374 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 374 (456)
.......++..|++||.+.+. .++.++|+||||+++|+|++|..||.+.+..+....+......+
T Consensus 155 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 155 -----NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred -----cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 111223467789999988664 56889999999999999999999998776554433332211000
Q ss_pred ----C----C--------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 ----F----R--------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 ----~----~--------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+ . .....++..+.+++.+||+.||.+||++++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 0 0012456778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=282.95 Aligned_cols=247 Identities=26% Similarity=0.454 Sum_probs=190.7
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||+|+||.+ ..+++.||+|.+...... .....+.+|++++++++||||+++++++......++|||
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 5788899999999865 236889999998754321 122456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|+. ++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 84 YLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 996 5999988764 45899999999999999999999999 9999999999999999999999999987542111
Q ss_pred cCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc-cchHHHHHhcC-CC----------
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQE-KEVPKAYIANE-RP---------- 373 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~-~~---------- 373 (456)
.......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||..... .+....+.... .+
T Consensus 158 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 158 ---KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred ---ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 11112235678999998865 4578899999999999999999999976542 11111111000 00
Q ss_pred -------CCC--------CCCCCCc--HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 -------PFR--------APTTHYA--YGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 -------~~~--------~~~~~~~--~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
... ......+ .++.+++.+||+.+|++|||+++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 0011233 678899999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=284.80 Aligned_cols=248 Identities=27% Similarity=0.415 Sum_probs=196.3
Q ss_pred ccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceEEE
Q 012777 153 DFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS--TPMMIV 225 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~lv 225 (456)
+|+..+.||+|+||.+ . .+++.||+|.++..... +.....+.+|+.++++++||||+++++++... ...++|
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5788889999999865 2 25889999999755322 23334677899999999999999999999877 889999
Q ss_pred EEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 226 TEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
+||+. ++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99996 59999987644 4999999999999999999999999 9999999999999999999999999988653221
Q ss_pred cccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCC----------
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERP---------- 373 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------- 373 (456)
.......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||...........+......
T Consensus 161 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 161 -----KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred -----cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 122234567789999998764 4688999999999999999999999876654433332211100
Q ss_pred -------------C---C-CCCCCC-CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 -------------P---F-RAPTTH-YAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 -------------~---~-~~~~~~-~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
. . ...+.. ++..+.++|.+||+.||++|||++|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0 001111 57889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=286.06 Aligned_cols=242 Identities=24% Similarity=0.397 Sum_probs=181.0
Q ss_pred eeeeccEEEEEe-------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--CCceEEEEEc
Q 012777 158 VEITKGTFRIAS-------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ--STPMMIVTEY 228 (456)
Q Consensus 158 ~~lg~G~fg~~~-------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~~lv~e~ 228 (456)
.+||+|+||.|. ..+..||+|.+..... ...+.+|+.+++.++||||+++++++.. +...++++||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999762 1346899999875432 2357789999999999999999999854 4678999999
Q ss_pred cCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe----CCCCCEEEeccC
Q 012777 229 LPKGDLRAYLKQK---------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR----DDSGHLKVADFG 295 (456)
Q Consensus 229 ~~~~sL~~~l~~~---------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~----~~~~~vkl~Dfg 295 (456)
++ ++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 95 5888877531 23888999999999999999999999 9999999999999 466789999999
Q ss_pred CcccccccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccch---------HH
Q 012777 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV---------PK 365 (456)
Q Consensus 296 ls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---------~~ 365 (456)
++....... ..........+|+.|+|||++.+. .++.++|||||||++|+|++|.+||........ ..
T Consensus 158 ~a~~~~~~~--~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07867 158 FARLFNSPL--KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235 (317)
T ss_pred ceeccCCCc--ccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHH
Confidence 998653221 111122335678899999998764 578899999999999999999999965432100 00
Q ss_pred HHHhc-C------------CCCC---------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 366 AYIAN-E------------RPPF---------------------RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 366 ~~~~~-~------------~~~~---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+... . .+.+ .......+..+.++|.+||..||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000 0 0000 00012334568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=282.12 Aligned_cols=246 Identities=28% Similarity=0.494 Sum_probs=193.9
Q ss_pred cccccceeeeccEEEEE---eE--cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEE
Q 012777 152 LDFSNSVEITKGTFRIA---SW--RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~~--~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv 225 (456)
.+|.+.+.||+|+||.+ .. +++.||||.+.... .......+..|+.++.+. .||||+++++++......+++
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 35788899999999865 33 38899999997643 233445667787777776 599999999999999999999
Q ss_pred EEccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 226 TEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHE-NRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~-~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
|||+ +++|.+++.. ...+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 93 ~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 93 MELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9998 4588887765 3569999999999999999999997 57 999999999999999999999999998765321
Q ss_pred ccccCCCCcccCCCCcccccccccCCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCcc-chHHHHHhcCCCCCCCC
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEE----YDTKVDVFSFALILQEMIEGCPPFPTKQEK-EVPKAYIANERPPFRAP 378 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 378 (456)
.......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...... +....+.....+.. ..
T Consensus 169 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 241 (296)
T cd06618 169 ------KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PP 241 (296)
T ss_pred ------CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CC
Confidence 1112234677899999987553 788999999999999999999999764432 22333322222222 12
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 379 TTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 379 ~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
...++.++.+++.+||..||++||++++++.+
T Consensus 242 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 23578899999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=280.65 Aligned_cols=244 Identities=22% Similarity=0.336 Sum_probs=190.9
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeC--CceEEE
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQS--TPMMIV 225 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~--~~~~lv 225 (456)
|.+.+.||+|+||.+ ..++..||+|.++.... .... .....|+.++.++. ||||+++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 456788999999855 33688999999876432 2222 23457888888884 99999999999887 889999
Q ss_pred EEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 226 TEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
|||++ ++|.+.+... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++. +.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~- 152 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK- 152 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC-
Confidence 99996 5888888763 46899999999999999999999999 999999999999999 99999999998765321
Q ss_pred cccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC------------
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE------------ 371 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------------ 371 (456)
.......++..|+|||.+.. ..++.++|+|||||++|+|++|.+||...+..+....+....
T Consensus 153 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 -----PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred -----CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence 11122456788999997644 457889999999999999999999998776544333322110
Q ss_pred ---CCCCCC----------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 ---RPPFRA----------PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 ---~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
...+.. ....++.++.++|.+||..+|++||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000100 123567899999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=283.98 Aligned_cols=245 Identities=29% Similarity=0.448 Sum_probs=201.2
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|...+.||+|+||.+ ..++..||+|.+.............+.+|+.+++.++|+|++++++++......++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4777789999999865 33678999999875433445556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 995 688887754 446899999999999999999999999 99999999999999999999999999875521
Q ss_pred cCCCCcccCCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 307 KEDRPVTCEETSWRYAAPEVYK---NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
.....+++.|+|||.+. ...++.++|||||||++|+|++|..||...+..+....+.....+.. ....++
T Consensus 168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 240 (308)
T cd06634 168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWS 240 (308)
T ss_pred -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc--Cccccc
Confidence 11235677899999874 34678899999999999999999999987665554444433333322 235678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
..+.++|.+||..+|++||++++++++..
T Consensus 241 ~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 88999999999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=282.25 Aligned_cols=248 Identities=26% Similarity=0.448 Sum_probs=190.9
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|.+.+.||+|+||.+ ..+|..||+|++..... ......+.+|+.+++.++|+||+++++++......++|+
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 46888899999999866 23688999999975432 222245678999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS- 157 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence 9995 6787776543 45888899999999999999999999 9999999999999999999999999987542211
Q ss_pred ccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCcc-chHHHHHhc-C-----------
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEK-EVPKAYIAN-E----------- 371 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~-~----------- 371 (456)
.......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...... +....+... .
T Consensus 158 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 158 ----QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred ----CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 111223467889999998764 5788999999999999999999999765432 111111000 0
Q ss_pred -CCC-------------CCC--CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 -RPP-------------FRA--PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 -~~~-------------~~~--~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+. ... .....+.++.+++.+|+..||.+|||+++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000 000 011235678999999999999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=280.58 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=198.1
Q ss_pred ccccceeeeccEEEEEe--------EcCcEEEEEEeCCCCCC-CHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCce
Q 012777 153 DFSNSVEITKGTFRIAS--------WRGTQVAVKTLGEEVFT-DEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~--------~~g~~vAvK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 222 (456)
+|++.+.||.|+||.+. .+|..||+|++...... .....+.+.+|+.+++++ +|++|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 36778899999998552 26889999998754221 122346778899999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
++|+||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 999999999999999988888999999999999999999999999 99999999999999999999999999876532
Q ss_pred cccccCCCCcccCCCCcccccccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHh---cCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNE--EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIA---NERPPFRA 377 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~ 377 (456)
.. ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.. ...+++
T Consensus 158 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 231 (290)
T cd05613 158 DE----VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY-- 231 (290)
T ss_pred cc----ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC--
Confidence 11 1112234577889999998753 467899999999999999999999975433222222211 122222
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 012777 378 PTTHYAYGLRELIEDCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 378 ~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~ell~~ 410 (456)
+..++..+.+++.+||..||++|| ++++++.+
T Consensus 232 -~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 232 -PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 456788899999999999999997 77777665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=291.18 Aligned_cols=253 Identities=24% Similarity=0.379 Sum_probs=198.9
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe----CCce
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ----STPM 222 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----~~~~ 222 (456)
.+|+..+.||.|+||.+ ..+|..||+|++..... .......+.+|+.++++++||||+++++++.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 46888889999999865 34689999999976432 22345677889999999999999999998753 3568
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
++|+||+. ++|.+++...+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 99999995 699999987777999999999999999999999999 99999999999999999999999999876533
Q ss_pred cccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc-C---------
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN-E--------- 371 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~--------- 371 (456)
.... .........++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+... +
T Consensus 160 ~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 160 SPTE-HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred cCcC-CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 2111 1112223467888999998865 46888999999999999999999999776543222111110 0
Q ss_pred ---------------CCCC--CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 ---------------RPPF--RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 ---------------~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.... .......+.++.++|.+||+.+|++|||+++++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000 00124568889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=281.04 Aligned_cols=248 Identities=29% Similarity=0.462 Sum_probs=194.6
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||+|.+|.+ ..+|+.||+|.+..... .......+.+|+.++++++||||+++++++......++|||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4778889999999865 23688999999875432 22334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-CCCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQKGA--LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD-SGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~--l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~-~~~vkl~Dfgls~~~~~~~ 304 (456)
|++ ++|.+++..... +++..+..++.|++.||.|||+++ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~- 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP- 156 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence 995 688888865443 578888999999999999999999 999999999999985 567999999998754221
Q ss_pred cccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc-CCC---------
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN-ERP--------- 373 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~--------- 373 (456)
........+++.|+|||.+.+. .++.++|+||||+++|+|++|++||...+..+....+... ..+
T Consensus 157 ----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 ----VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred ----ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 1112234567889999988664 5788999999999999999999999876554433332111 000
Q ss_pred ----------CCC-----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 ----------PFR-----APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 ----------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+. .....++..+.+++.+||+.+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0124567889999999999999999999999975
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=274.29 Aligned_cols=239 Identities=30% Similarity=0.460 Sum_probs=200.4
Q ss_pred eeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012777 160 ITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234 (456)
Q Consensus 160 lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~sL 234 (456)
||.|+||.+ . .+++.||+|.+.............+..|+.++++++||||+++++.+......+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 578888754 2 25889999999876555555677899999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCccc
Q 012777 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTC 314 (456)
Q Consensus 235 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~ 314 (456)
.+++...+.+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~ 152 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-----SRTNT 152 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-----CcccC
Confidence 999988778999999999999999999999999 9999999999999999999999999987653211 12233
Q ss_pred CCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhc
Q 012777 315 EETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCW 394 (456)
Q Consensus 315 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 394 (456)
..++..|+|||.+.+...+.++|+||||+++|+|++|..||...+.......+.. ...+ .+...+..+.+++.+||
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~---~~~~~~~~l~~~i~~~l 228 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLR---FPEFLSPEARDLISGLL 228 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCC---CCCCCCHHHHHHHHHHh
Confidence 4577789999999888888999999999999999999999977665444444433 2222 24556889999999999
Q ss_pred ccCCCCCCCH---HHHHHH
Q 012777 395 SEEPFRRPTF---RQILMR 410 (456)
Q Consensus 395 ~~dp~~Rpt~---~ell~~ 410 (456)
..||++||++ ++++++
T Consensus 229 ~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 229 QKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred cCCHhhCCCcccHHHHHhC
Confidence 9999999999 565543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=282.89 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=191.9
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC-------
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST------- 220 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~------- 220 (456)
+|...+.||+|+||.+ ..+++.||+|.+..... .+.....+.+|+.++++++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 6888999999999865 23688999999865432 2222345678999999999999999999986653
Q ss_pred -ceEEEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 221 -PMMIVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 221 -~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
..++||||+. ++|.+++.... .+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 3599999995 58888887643 6899999999999999999999999 9999999999999999999999999988
Q ss_pred cccccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-C--CC
Q 012777 299 LLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-R--PP 374 (456)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~--~~ 374 (456)
......... ........++..|+|||.+.+. .++.++|+||||+++|+|++|++||...+.......+.... . +.
T Consensus 168 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 168 AFSLSKNSK-PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred cccCCcccC-CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 653321111 1122234567789999988664 46889999999999999999999997765433322221110 0 00
Q ss_pred ---------------CC----------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 ---------------FR----------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 ---------------~~----------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+. ......+..+.++|.+||..||++|||+++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00 0011234568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=280.97 Aligned_cols=241 Identities=22% Similarity=0.402 Sum_probs=198.9
Q ss_pred ceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 157 SVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 157 ~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
...||+|+||.+ ..+|+.||+|.+... .......+.+|+.+++.++||||+++++.+...+..+++|||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 457999999855 236889999998643 334456789999999999999999999999999999999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCC
Q 012777 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311 (456)
Q Consensus 232 ~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~ 311 (456)
++|.+++.. +.+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 102 ~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-----~~ 172 (292)
T cd06657 102 GALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-----PR 172 (292)
T ss_pred CcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-----cc
Confidence 999998754 56899999999999999999999999 9999999999999999999999999877552211 11
Q ss_pred cccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q 012777 312 VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIE 391 (456)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 391 (456)
.....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...........+.....+.+. ....++..+.+++.
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~ 251 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLK-NLHKVSPSLKGFLD 251 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccC-CcccCCHHHHHHHH
Confidence 12345778899999998888899999999999999999999999876655444444322222221 23567888999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 012777 392 DCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 392 ~~l~~dp~~Rpt~~ell~~ 410 (456)
+||..+|.+||++.+++.+
T Consensus 252 ~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 252 RLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHhCCcccCcCHHHHhcC
Confidence 9999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=279.26 Aligned_cols=256 Identities=15% Similarity=0.146 Sum_probs=187.3
Q ss_pred ccccccceeeeccEEEEEe---E--c---CcEEEEEEeCCCCCCC--HHH------HHHHHHHHHHHhcCCCCcceeeee
Q 012777 151 ELDFSNSVEITKGTFRIAS---W--R---GTQVAVKTLGEEVFTD--EDK------VKAFIDELALLQKIRHPNVVQFLG 214 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~---~--~---g~~vAvK~~~~~~~~~--~~~------~~~~~~E~~~l~~l~hp~iv~l~~ 214 (456)
..+|.+.+.||+|+||.|. . + +..+|+|+........ +.. ......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3468999999999999762 2 2 4467777654322111 100 011223444556678999999999
Q ss_pred EEEeCC----ceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEE
Q 012777 215 AVTQST----PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290 (456)
Q Consensus 215 ~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vk 290 (456)
++.... ..+++++++ ..++.+.+......++..+..++.|++.||.|||+++ |+||||||+|||++.++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEE
Confidence 876543 357888888 4588888776556788899999999999999999999 99999999999999999999
Q ss_pred EeccCCccccccccccc--CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc-chHHHH
Q 012777 291 VADFGLSKLLKFANTVK--EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK-EVPKAY 367 (456)
Q Consensus 291 l~Dfgls~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~ 367 (456)
|+|||++.......... .........||+.|+|||++.+..++.++|||||||++|+|++|..||...... +.....
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 99999998663221111 111122346899999999999999999999999999999999999999877432 221111
Q ss_pred H----hcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 368 I----ANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 368 ~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
. ...... .......++.+.+++..|+..+|++||+++++++.|
T Consensus 247 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 247 KCDFIKRLHEG-KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHHhhhh-hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1 111100 112356688899999999999999999999999876
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=280.99 Aligned_cols=248 Identities=26% Similarity=0.410 Sum_probs=192.7
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCc-----
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTP----- 221 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~----- 221 (456)
+|+..+.||+|+||.+ ..+|+.||+|.+.... ........+.+|+.+++.+. ||||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4778889999999865 2368899999987543 22223356788999999994 6999999999987665
Q ss_pred eEEEEEccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-CCCEEEeccC
Q 012777 222 MMIVTEYLPKGDLRAYLKQK-----GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD-SGHLKVADFG 295 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~-~~~vkl~Dfg 295 (456)
.+++|||+++ +|.+++... ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 898887642 24799999999999999999999999 999999999999998 8899999999
Q ss_pred CcccccccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CC
Q 012777 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RP 373 (456)
Q Consensus 296 ls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~ 373 (456)
++...... ........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.... .+
T Consensus 157 ~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIP-----VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP 231 (295)
T ss_pred cceecCCC-----ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 98755221 111122345778999998865 457889999999999999999999998765544332221110 00
Q ss_pred C-----------------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 P-----------------------FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 ~-----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
. .......++.++.++|.+||..||++||++++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 001124578889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=280.67 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=199.4
Q ss_pred ccccceeeeccEEEEEe--------EcCcEEEEEEeCCCCCC-CHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCce
Q 012777 153 DFSNSVEITKGTFRIAS--------WRGTQVAVKTLGEEVFT-DEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~--------~~g~~vAvK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 222 (456)
+|++.+.||+|+||.+. .+++.||+|++...... .......+.+|+.++.++ +||+|+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 36777899999998652 25678999998753221 223346788999999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
++||||+++++|.+++.....+++..+..++.|++.+|.|||+.+ ++|+||+|.||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 999999999999999987777999999999999999999999999 99999999999999999999999999876532
Q ss_pred cccccCCCCcccCCCCcccccccccCCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHH---HhcCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEE--YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAY---IANERPPFRA 377 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~ 377 (456)
.. ........++..|++||.+.+.. .+.++|+||||+++|+|++|..||...........+ .....++
T Consensus 158 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 230 (288)
T cd05583 158 EE----EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP--- 230 (288)
T ss_pred cc----ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC---
Confidence 11 11112235778899999987654 678999999999999999999999654332211111 1122222
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 378 PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 378 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
.+..++..+.+++.+||+.||++|||+.++...|+..
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 231 FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 2456788999999999999999999987776665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=288.29 Aligned_cols=250 Identities=25% Similarity=0.424 Sum_probs=194.0
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----Cc
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS-----TP 221 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~ 221 (456)
.+|.+.+.||+|+||.+ ..+|+.||+|.+... ........+.+|+.++++++||||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 36888999999999865 346889999998643 2334456788999999999999999999987544 35
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
.++++||++ ++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 799999995 588888754 56999999999999999999999999 9999999999999999999999999987653
Q ss_pred ccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC---------
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE--------- 371 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------- 371 (456)
.... .........+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+....
T Consensus 158 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 158 PEHD--HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred cccc--ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 2211 1112233467888999998654 468889999999999999999999997654322111110000
Q ss_pred ------------------CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 ------------------RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 ------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..++......++..+.++|.+||+.+|++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000123467789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=288.56 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=197.9
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----Cc
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS-----TP 221 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~ 221 (456)
.+|.+.+.||+|+||.+ ..+++.||+|.+..... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 36888899999999865 34688999999875432 233345678899999999999999999987644 34
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
.++++||+ +++|.+++...+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCC-CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 89999999 4799999988888999999999999999999999999 9999999999999999999999999988653
Q ss_pred ccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC---------
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE--------- 371 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------- 371 (456)
... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|++||.+.+..+....+....
T Consensus 160 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 160 EKG-----DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred CCc-----ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 211 12223456778999998765 468899999999999999999999997654322221111000
Q ss_pred ------------------CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 ------------------RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 ------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+.+......++.++.++|.+||+.+|++|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 011111234678889999999999999999999999998
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.48 Aligned_cols=251 Identities=25% Similarity=0.344 Sum_probs=215.8
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
.-+|.+.+.||+|.||.| +.+++.||+|++.+...........|..|..+|.....+=|+.++-+|.+++++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 346999999999999965 457899999999875544444557899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|||++||+|..++.+..+++++-++.++.+|+.||.-||+.| +|||||||+|||+|..|.+||+|||.+-.+...+.
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence 999999999999998888999999999999999999999999 99999999999999999999999999887754433
Q ss_pred ccCCCCcccCCCCcccccccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCCCCC
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKN-----EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRAPT 379 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~ 379 (456)
.. ....+|||-|.+||+++. +.|++..|+||+|+++|||+.|..||....-.+.+..|.... ...|+ ..
T Consensus 231 V~----s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP-~~ 305 (1317)
T KOG0612|consen 231 VR----SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP-DE 305 (1317)
T ss_pred EE----eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC-cc
Confidence 32 234689999999999843 578899999999999999999999999988888888775443 33333 24
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 012777 380 THYAYGLRELIEDCWSEEPFRRPT---FRQILMR 410 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~Rpt---~~ell~~ 410 (456)
..+|.+.++||.+.+ -+|+.|.. ++++-.|
T Consensus 306 ~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 306 TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred cccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 669999999999988 57888987 8887665
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=278.70 Aligned_cols=248 Identities=29% Similarity=0.414 Sum_probs=196.3
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceEEEE
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS--TPMMIVT 226 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~lv~ 226 (456)
|.+.+.||+|+||.+ ..+|+.||+|.+.... ........+.+|+.+++.++|||++++++++... ...++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 456788999999865 2357899999998653 2334456788999999999999999999999888 8899999
Q ss_pred EccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
||++ ++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9996 5899988765 46999999999999999999999999 99999999999999999999999999886633211
Q ss_pred ccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC-CCCC-------
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER-PPFR------- 376 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~------- 376 (456)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+..... +...
T Consensus 156 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 156 ----ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred ----ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence 11222345678999998765 3578899999999999999999999987665444333322111 0000
Q ss_pred -------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 377 -------------------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 377 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.....++..+.+++.+||..+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0011137889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=283.20 Aligned_cols=252 Identities=22% Similarity=0.355 Sum_probs=193.1
Q ss_pred ccccceeeeccEEEEE---e--E--cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceE
Q 012777 153 DFSNSVEITKGTFRIA---S--W--RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS--TPMM 223 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~--~--~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~ 223 (456)
.|.+.+.||+|+||.+ . . .+..||+|.+.............+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999865 2 2 5789999999874322233346678899999999999999999999888 7899
Q ss_pred EEEEccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC----CCCEEEecc
Q 012777 224 IVTEYLPKGDLRAYLKQK-----GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD----SGHLKVADF 294 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~----~~~vkl~Df 294 (456)
+||||++ ++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999995 5787776532 25899999999999999999999999 999999999999999 899999999
Q ss_pred CCcccccccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccc---------hH
Q 012777 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKE---------VP 364 (456)
Q Consensus 295 gls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---------~~ 364 (456)
|++........ .........+++.|+|||.+.+. .++.++|+||||+++++|++|++||....... ..
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd07842 157 GLARLFNAPLK--PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234 (316)
T ss_pred ccccccCCCcc--cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence 99886533211 11112234567889999987664 57889999999999999999999997655432 00
Q ss_pred HHHH-------------------------hcCCCCCCC--------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 365 KAYI-------------------------ANERPPFRA--------PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 365 ~~~~-------------------------~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..+. ......+.. .....+..+.+++.+||..||++|||+.+++++
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 000011100 001566789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=272.26 Aligned_cols=239 Identities=23% Similarity=0.383 Sum_probs=205.4
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
+|...+.||+|+|.+| +.+.+.||+|+++++.+.+++.+.-...|-.+..+. +||.+|.++.+|..+..+++|.
T Consensus 251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 6888899999999865 567889999999999888888888888999999888 6999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||++||+|--++++..+++++.+..+..+|..||+|||++| |++||||.+|||++..|.+||.|+|+.+.--
T Consensus 331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l----- 402 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL----- 402 (593)
T ss_pred EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC-----
Confidence 99999999999998889999999999999999999999999 9999999999999999999999999987431
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC---c----cchHHHHHhcCCCCCCCCC
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQ---E----KEVPKAYIANERPPFRAPT 379 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~----~~~~~~~~~~~~~~~~~~~ 379 (456)
........+.|||.|.|||++++..|..+.|+|+||++|+||+.|+.||+... + ++-.-++....+... +
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri---p 479 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI---P 479 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc---c
Confidence 22233445789999999999999999999999999999999999999996422 1 222333333332222 4
Q ss_pred CCCcHHHHHHHHHhcccCCCCCC
Q 012777 380 THYAYGLRELIEDCWSEEPFRRP 402 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~Rp 402 (456)
..++.....+++..|++||.+|.
T Consensus 480 rslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 480 RSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ceeehhhHHHHHHhhcCCcHHhc
Confidence 67777888999999999999995
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=301.17 Aligned_cols=251 Identities=16% Similarity=0.215 Sum_probs=184.2
Q ss_pred cccccceeeeccEEEEEeE------cCcEEEEE--------------EeCCCCCCCHHHHHHHHHHHHHHhcCCCCccee
Q 012777 152 LDFSNSVEITKGTFRIASW------RGTQVAVK--------------TLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQ 211 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~~------~g~~vAvK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 211 (456)
.+|.+.+.||+|+||.|.. .+..++.| ++.+...........+.+|+.+|++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 3689999999999996631 11122222 111111123334567889999999999999999
Q ss_pred eeeEEEeCCceEEEEEccCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC
Q 012777 212 FLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG-----ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286 (456)
Q Consensus 212 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~ 286 (456)
+++++...+..|++++++ +++|.+++.... ......+..++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 999999999999999999 568888775422 2345678889999999999999999 9999999999999999
Q ss_pred CCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCC-CCCCCCcc--ch
Q 012777 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCP-PFPTKQEK--EV 363 (456)
Q Consensus 287 ~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~-pf~~~~~~--~~ 363 (456)
+.+||+|||++..+.... ........||+.|+|||++.+..++.++|||||||++|+|++|.. ||...... ..
T Consensus 304 ~~vkL~DFGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKER----EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCEEEEeCCCceecCccc----ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 999999999998663211 111223568999999999999999999999999999999999875 44432211 11
Q ss_pred HHHHHhcCC---CCCC-------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 364 PKAYIANER---PPFR-------------------------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 364 ~~~~~~~~~---~~~~-------------------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
...+..... ..++ ......+.++.++|.+||..||++|||+.|++.+
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111111000 0000 0112456678888999999999999999999875
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=285.72 Aligned_cols=252 Identities=26% Similarity=0.421 Sum_probs=197.4
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC--CceEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQS--TPMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~--~~~~l 224 (456)
+|++.+.||+|+||.+ ..+|+.||+|++.... ........+..|+.+++++ +||||+++++++... ...++
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 5888889999999865 2367899999986543 2333445677899999999 999999999998654 36899
Q ss_pred EEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 225 VTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
||||+. ++|.+++... .+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 87 v~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 87 VFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred Eecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 999996 6999988765 7889999999999999999999999 9999999999999999999999999988664322
Q ss_pred cccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC------------
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE------------ 371 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------------ 371 (456)
............++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......+....+....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 1111122233567889999998755 457889999999999999999999997765443322221110
Q ss_pred ---------------CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 ---------------RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 ---------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..+.......++.++.++|.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 111111224478899999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=282.34 Aligned_cols=250 Identities=22% Similarity=0.393 Sum_probs=190.2
Q ss_pred eeeecc--EEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccC
Q 012777 158 VEITKG--TFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230 (456)
Q Consensus 158 ~~lg~G--~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~ 230 (456)
..||+| +|+.+ ..+|+.||+|++.... ......+.+.+|+.+++.++||||++++++|......++++||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN-CTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 356666 66544 3478999999997653 234556788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccC
Q 012777 231 KGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKE 308 (456)
Q Consensus 231 ~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~ 308 (456)
+++|.+++.+.. .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++++||+.+...........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999999988643 4899999999999999999999999 99999999999999999999999976543311110000
Q ss_pred --CCCcccCCCCcccccccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCC---------
Q 012777 309 --DRPVTCEETSWRYAAPEVYKNE--EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPP--------- 374 (456)
Q Consensus 309 --~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~--------- 374 (456)
........++..|+|||++.+. .++.++|||||||++|+|++|..||................ ..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 0001112345679999998764 47889999999999999999999997765433222221110 000
Q ss_pred --------------------------------C-CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 375 --------------------------------F-RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 375 --------------------------------~-~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
. ......++..+.+||.+||+.||++|||+++++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 0 001234567899999999999999999999998763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=285.33 Aligned_cols=251 Identities=26% Similarity=0.414 Sum_probs=202.3
Q ss_pred ccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC-----ce
Q 012777 153 DFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST-----PM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-----~~ 222 (456)
+|.+.+.||.|+||.+ . .+++.||+|.+.... ......+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 4778889999999865 2 357899999997643 22444577899999999999999999999987765 78
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
|++|||++ ++|.+++.....+++..++.++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999996 589999987778999999999999999999999999 99999999999999999999999999987643
Q ss_pred cccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCC--------
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERP-------- 373 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 373 (456)
.... ........++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...+..+....+......
T Consensus 156 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 156 DEDE--KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccc--cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 2110 0112234567889999999887 7889999999999999999999999877654443333221110
Q ss_pred -------------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 -------------------PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 -------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++......++..+.++|.+||+.+|++||++++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0001123467889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=276.24 Aligned_cols=247 Identities=27% Similarity=0.463 Sum_probs=198.3
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
|.+.+.||+|++|.+ ..+|+.+++|.+..... .+.....+.+|+.++++++||+|+++++++......++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 456678999998755 23688999999876542 223456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 229 LPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 229 ~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
++ ++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 80 MD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred cC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 96 5888888764 57999999999999999999999999 9999999999999999999999999987663221
Q ss_pred CCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCC------------
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPP------------ 374 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 374 (456)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+......+
T Consensus 153 --~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 153 --RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred --ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence 122234567789999998776 78889999999999999999999998766544433332211100
Q ss_pred --------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 --------------FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 --------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.......++.++.++|.+||..||.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000123467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=282.35 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=195.1
Q ss_pred ccccceeeeccEEEEE---eE--c--CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC----C
Q 012777 153 DFSNSVEITKGTFRIA---SW--R--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQS----T 220 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~--~--g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~----~ 220 (456)
+|...+.||+|+||.+ .. . +..||+|.+.... ......+.+.+|+.+++++ +||||+++++.+... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 3677889999999865 22 3 6789999987542 2333456788999999999 599999999875432 4
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
..++++||+ +++|.+++.....+++..++.++.|++.||.|||+++ ++|+||||+|||++.++.++|+|||++...
T Consensus 80 ~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred cEEEEEecc-cCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 578999998 4799999987778999999999999999999999999 999999999999999999999999999866
Q ss_pred cccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC--------
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-------- 371 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------- 371 (456)
...... .........++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+.......+....
T Consensus 156 ~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGE-NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccc-ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 432111 1111233567889999998765 468899999999999999999999998765433222111100
Q ss_pred -------------------CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 -------------------RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 -------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
...+.......+..+.+++.+||+.||++|||+++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 011111223467889999999999999999999999866
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=274.24 Aligned_cols=246 Identities=28% Similarity=0.458 Sum_probs=193.3
Q ss_pred cccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC---CCCcceeeeeEEEeCCc----
Q 012777 154 FSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI---RHPNVVQFLGAVTQSTP---- 221 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~~~~---- 221 (456)
|.+.+.||+|+||.+ . .+++.||+|++..... .......+.+|+.+++++ .||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 456788999999865 2 2588999999976532 223335566788777766 59999999999988776
Q ss_pred -eEEEEEccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 222 -MMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 222 -~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
.+++|||+. ++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 999999996 58999887643 4899999999999999999999999 9999999999999999999999999987
Q ss_pred cccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCC-----
Q 012777 299 LLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERP----- 373 (456)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----- 373 (456)
..... .......++..|+|||.+.+..++.++|+||||+++|+|++|++||......+....+......
T Consensus 156 ~~~~~------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFE------MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred eccCC------cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence 65322 1112234677899999999888999999999999999999999999877655444333221100
Q ss_pred ------------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 ------------------PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 ------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.........+..+.++|.+||+.||++||++++++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000112455678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=285.51 Aligned_cols=241 Identities=24% Similarity=0.389 Sum_probs=208.3
Q ss_pred ceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 157 SVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 157 ~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
.+.||+|.||.| ..+|+.||||++.+..+....+ .++.+|+.+|+.+.||.||.+---|+..+.+++|||-+ .
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-H 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-c
Confidence 468999999976 5789999999999988766544 78999999999999999999999999999999999999 6
Q ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC---CCEEEeccCCcccccccccc
Q 012777 232 GDLRAYLK--QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS---GHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 232 ~sL~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~---~~vkl~Dfgls~~~~~~~~~ 306 (456)
|++.+++- +.+.+++.....+..||+.||.|||-++ |+|+||||+|||+.+. -++||||||+++..
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiI------ 717 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARII------ 717 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeec------
Confidence 67777763 4678999999999999999999999999 9999999999999854 37999999999987
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
.+..+....+|||.|+|||++++..|..+-|+||.|+++|--+.|..||... +++.++|......--+.++..++...
T Consensus 718 gEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~A 795 (888)
T KOG4236|consen 718 GEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEA 795 (888)
T ss_pred chhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHH
Confidence 3455666789999999999999999999999999999999999999999553 45566664443332234568899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+||..+|+..=.+|-|+++.+.+
T Consensus 796 idlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 796 IDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred HHHHHHHHHHHHHHhcchHhhccc
Confidence 999999999999999999987765
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=267.30 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=198.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
+.+....||.|.||.| +.+|+..|||.+.... .+....++..|.+...+- +.|+||++||+...++.+++.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n--~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN--IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc--chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 4556678999999987 5689999999998764 456678899999876665 6999999999999999999999
Q ss_pred EccCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 227 EYLPKGDLRAYLK-----QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 227 e~~~~~sL~~~l~-----~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
|++ ..||..+.+ ++..+++..+-.|..-.+.||+||-+.- .|||||+||+|||++..|.|||||||.+-.+.
T Consensus 143 ELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 999 678876543 3456999999999999999999998643 39999999999999999999999999987763
Q ss_pred ccccccCCCCcccCCCCcccccccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCC-
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNE--EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAP- 378 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 378 (456)
. +...+.-.|...|||||.+... .|+.+||+||||++|||+.||+.||..++...........+.++.-.+
T Consensus 220 ~------SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 220 D------SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD 293 (361)
T ss_pred H------HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc
Confidence 2 2222233466679999988543 589999999999999999999999998876433333334444433222
Q ss_pred --CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 379 --TTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 379 --~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..+++..+..+|..|+.+|-..||.++++.+.
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 34689999999999999999999999998765
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=281.14 Aligned_cols=254 Identities=22% Similarity=0.391 Sum_probs=197.2
Q ss_pred ccc-cceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHH-----------HHHHHHHHHHHHhcCCCCcceeeeeE
Q 012777 153 DFS-NSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDED-----------KVKAFIDELALLQKIRHPNVVQFLGA 215 (456)
Q Consensus 153 ~~~-~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~hp~iv~l~~~ 215 (456)
+|. ..+.||.|+||.+ ..+++.||+|++......... ....+.+|+.+++.++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 344 3467999999866 246889999998754322110 01247789999999999999999999
Q ss_pred EEeCCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccC
Q 012777 216 VTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFG 295 (456)
Q Consensus 216 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfg 295 (456)
+......+++|||+. ++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCcc
Confidence 999999999999995 699999988778999999999999999999999999 9999999999999999999999999
Q ss_pred Ccccccccccc---------cCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHH
Q 012777 296 LSKLLKFANTV---------KEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPK 365 (456)
Q Consensus 296 ls~~~~~~~~~---------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 365 (456)
++......... ..........+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||...+..+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 98765311100 011112223467789999998764 46889999999999999999999998877654443
Q ss_pred HHHhcCC-CC---C--------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 366 AYIANER-PP---F--------------------RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 366 ~~~~~~~-~~---~--------------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+..... +. + .......+..+.++|.+||..+|++|||+++++.+
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 3322110 00 0 00123557789999999999999999999999975
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=277.50 Aligned_cols=249 Identities=28% Similarity=0.419 Sum_probs=193.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC-------
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST------- 220 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~------- 220 (456)
+|++.+.||+|+||.+ ..+|+.||+|.+..... .+.....+.+|+.++++++||||+++++++....
T Consensus 8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 5788889999999865 23588999999975432 2223356778999999999999999999987654
Q ss_pred ---ceEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCC
Q 012777 221 ---PMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGL 296 (456)
Q Consensus 221 ---~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgl 296 (456)
.+++++||+++ ++.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccc
Confidence 78999999965 787777654 35999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CC-
Q 012777 297 SKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RP- 373 (456)
Q Consensus 297 s~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~- 373 (456)
+........ .......++..|+|||.+.+. .++.++|||||||++++|++|++||...+.......+.... .+
T Consensus 163 ~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 163 ARLYNSEES----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccccCCcc----cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 886532211 111222356679999988653 56889999999999999999999998765544333332211 00
Q ss_pred C-----C-------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 P-----F-------------------RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 ~-----~-------------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+ . ......++..+.+++.+||..||++||++++++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0 00123468899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=301.58 Aligned_cols=144 Identities=31% Similarity=0.527 Sum_probs=130.9
Q ss_pred cccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|.+.+.||.|+||.| . .+++.||||++.............+..|+.+++.++||||+++++++.....+|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 36888899999999876 2 258899999998655555666778899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999988778999999999999999999999999 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=303.50 Aligned_cols=247 Identities=29% Similarity=0.453 Sum_probs=190.2
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe---------
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ--------- 218 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--------- 218 (456)
+|+..+.||+|+||.| +.+|+.||||++.... .......+.+|+.+|.+++|||||+|+.++.+
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 5778889999999966 4589999999998764 56777899999999999999999999943310
Q ss_pred --------------------------------------------------------------------------------
Q 012777 219 -------------------------------------------------------------------------------- 218 (456)
Q Consensus 219 -------------------------------------------------------------------------------- 218 (456)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------C--------CceEEEEEccCCCCHHHHHHHcCCC-CHHHHHHHHHHHHHHHHHHHhCC
Q 012777 219 ----------------------S--------TPMMIVTEYLPKGDLRAYLKQKGAL-KPTLAVKFALDIARGMNYLHENR 267 (456)
Q Consensus 219 ----------------------~--------~~~~lv~e~~~~~sL~~~l~~~~~l-~~~~~~~i~~ql~~aL~~LH~~~ 267 (456)
+ ..+||-||||+..+|.+++..+... ....+|+++++|++||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 2368899999887777777655443 57889999999999999999999
Q ss_pred CCCeEecCCCCCCeEeCCCCCEEEeccCCccccc----c---------cccccCCCCcccCCCCcccccccccCCCC---
Q 012777 268 PEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK----F---------ANTVKEDRPVTCEETSWRYAAPEVYKNEE--- 331 (456)
Q Consensus 268 ~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~----~---------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--- 331 (456)
+|||||||.||++++++.|||+|||++.... . ..........+...||.-|+|||++.+..
T Consensus 718 ---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 718 ---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred ---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999731 0 01112223455678999999999997654
Q ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCC---CCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 012777 332 YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAP---TTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408 (456)
Q Consensus 332 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rpt~~ell 408 (456)
|+.|+|+||||++++||+. ||... .+....+..-..+.++.+ ...--+.-..+|.+|++.||.+|||+.|+|
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 9999999999999999983 35332 222222221123333322 222233467899999999999999999998
Q ss_pred H
Q 012777 409 M 409 (456)
Q Consensus 409 ~ 409 (456)
+
T Consensus 870 ~ 870 (1351)
T KOG1035|consen 870 N 870 (1351)
T ss_pred h
Confidence 6
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=270.24 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=195.7
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCC--CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFT--DEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
+|.+.+.||+|+||.+. ..+..+++|+++..... .......+..|+.+++.++||||+++++++......+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 36778899999998662 23455667766542211 222334567899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 226 TEYLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
+||+++++|.+++.+ ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 345999999999999999999999999 999999999999975 579999999987653
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (456)
... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+..... +..+..
T Consensus 157 ~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 228 (260)
T cd08222 157 GSC-----DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT---PSLPET 228 (260)
T ss_pred CCc-----ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCC---CCCcch
Confidence 211 112234567889999999888889999999999999999999999976554444444322222 223567
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.++.++|.+||..||++||++.+++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 229 YSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred hcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 88899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=272.06 Aligned_cols=245 Identities=25% Similarity=0.424 Sum_probs=192.7
Q ss_pred cccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEE
Q 012777 154 FSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv~e 227 (456)
|.+.+.||.|+||.+ . .+++.||+|.+...... .......+|+..+++++ ||||+++++++..+...++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 556788999999865 2 35788999998765322 12234567999999998 9999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|+ +++|.+++.... .+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-- 152 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-- 152 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCC--
Confidence 99 789999987754 6899999999999999999999999 999999999999999999999999998765321
Q ss_pred ccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCC----------
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPP---------- 374 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 374 (456)
.......++..|+|||.+.+ ..++.++|+||||+++++|++|++||...........+......+
T Consensus 153 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 153 ----PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred ----CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 12223456778999998754 457889999999999999999999997765443322221110000
Q ss_pred ----------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 ----------------FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 ----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
........+..+.++|.+||+.||++|||++|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000112336789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=296.89 Aligned_cols=261 Identities=30% Similarity=0.523 Sum_probs=214.7
Q ss_pred ccccCccccccccceeeeccEEEEEeE------------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcce
Q 012777 144 EYEIDPKELDFSNSVEITKGTFRIASW------------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVV 210 (456)
Q Consensus 144 ~~~~~~~~~~~~~~~~lg~G~fg~~~~------------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv 210 (456)
.+|++...+.+. +.||+|.||.+.. ....||||.++.... ....+.+..|+.+++.+ +||||+
T Consensus 290 ~~e~~~~~l~~~--~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv 365 (609)
T KOG0200|consen 290 KWEIPRENLKLG--KYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIV 365 (609)
T ss_pred ceeechhhcccc--ceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchh
Confidence 566666665444 4999999986521 145799999987643 36678999999999999 699999
Q ss_pred eeeeEEEeCCceEEEEEccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 012777 211 QFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG----------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHR 274 (456)
Q Consensus 211 ~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~ 274 (456)
.+++++.....+++|+||+..|+|.+++.+++ .++....+.++.||+.|++||++.. +|||
T Consensus 366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHR 442 (609)
T KOG0200|consen 366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHR 442 (609)
T ss_pred hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccch
Confidence 99999999999999999999999999998766 3888999999999999999999999 9999
Q ss_pred CCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCC
Q 012777 275 DLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCP 353 (456)
Q Consensus 275 Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~ 353 (456)
||-..|||++.+..+|++|||+++............... . -+..|||||.+....|+.++||||+|++|||+++ |..
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~-~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~ 520 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAG-T-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT 520 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCC-c-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence 999999999999999999999998653221111110000 0 2346999999999999999999999999999998 999
Q ss_pred CCCCCC-ccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 012777 354 PFPTKQ-EKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416 (456)
Q Consensus 354 pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~ 416 (456)
||.+.. ..++...+..+.+... +..++.++.+++..||+.+|++||++.++.+.++.+..
T Consensus 521 PYp~~~~~~~l~~~l~~G~r~~~---P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 521 PYPGIPPTEELLEFLKEGNRMEQ---PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCCCCcHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 999866 4455554544445443 57779999999999999999999999999999999654
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=272.94 Aligned_cols=247 Identities=30% Similarity=0.520 Sum_probs=196.5
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
|+..+.||+|.||.+ ..+++.||+|++.... ..+.....+..|+.+++.++||+|+++++++......++|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 445678999988755 2358999999998653 2333446778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 229 LPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 229 ~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
++ ++|.+++.+. ..+++..+..++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 152 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--- 152 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc---
Confidence 96 6999999876 57999999999999999999999999 9999999999999999999999999987653211
Q ss_pred CCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC---------------
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE--------------- 371 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------------- 371 (456)
.......++..|+|||.+.+. .++.++|+||||+++++|++|.+||...+.......+....
T Consensus 153 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 153 --RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred --cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 112223456679999998776 78899999999999999999999998765443332221110
Q ss_pred -----CCCC-----CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 -----RPPF-----RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 -----~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+.+ ......++..+.++|.+||..||++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000 01123457789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=280.10 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=197.6
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC------c
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST------P 221 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~------~ 221 (456)
+|.+.+.||+|.||.+ ..+|..||+|.+.... ........+.+|+.++++++||||+++++++.... .
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 5888899999999866 3368899999986543 33444567889999999999999999999987553 3
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
.++||||+ +++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 95 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 58999999 7799988864 56999999999999999999999999 9999999999999999999999999987552
Q ss_pred ccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC--------
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER-------- 372 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------- 372 (456)
. ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.....
T Consensus 170 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 170 S--------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred c--------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 1 1122356778999998876 3578899999999999999999999987654332222211100
Q ss_pred -------------------CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 373 -------------------PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 373 -------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
..+......++..+.++|.+|++.||++|||+.+++.+ .+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~--~~~~~~ 304 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH--PYFEEF 304 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC--ccHhhh
Confidence 00111124677789999999999999999999999964 444444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=279.43 Aligned_cols=254 Identities=27% Similarity=0.364 Sum_probs=197.6
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------C
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS------T 220 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------~ 220 (456)
.+|.+.+.||+|+||.+ ..+|+.||+|++.... ......+.+.+|+.++++++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 46888899999999865 3468899999997642 2233346788899999999999999999988643 3
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
..+++++++ +++|.+++.. ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++...
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred cEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccccc
Confidence 478888887 7899888764 46999999999999999999999999 999999999999999999999999998754
Q ss_pred cccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC--------
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-------- 371 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------- 371 (456)
.. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+....
T Consensus 171 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T cd07877 171 DD--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 242 (345)
T ss_pred cc--------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 21 1123456788999998866 467889999999999999999999997655433222221110
Q ss_pred -------------------CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccc
Q 012777 372 -------------------RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIK 421 (456)
Q Consensus 372 -------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~ 421 (456)
...+.......+..+.++|.+||+.||++||++.+++.+ ..+.+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h--~~f~~~~~~ 309 (345)
T cd07877 243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--AYFAQYHDP 309 (345)
T ss_pred hhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC--hhhhhcCCC
Confidence 001111122467789999999999999999999999988 344444333
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=276.64 Aligned_cols=246 Identities=28% Similarity=0.442 Sum_probs=194.3
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe-CCceEE
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ-STPMMI 224 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~~l 224 (456)
..+|++.+.||.|+||.+ ..+|+.||+|.+.+... .....+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 446888999999999866 33788999999875432 23345678899999999999999999999865 467899
Q ss_pred EEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 225 VTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
++||+ +++|.+++.. .++++..+..++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-- 160 (328)
T cd07856 88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP-- 160 (328)
T ss_pred Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCC--
Confidence 99999 6799988864 46889999999999999999999999 99999999999999999999999999874421
Q ss_pred cccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHh--------------
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIA-------------- 369 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-------------- 369 (456)
......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+..
T Consensus 161 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 161 ------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred ------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 1122356778999998765 5688999999999999999999999976553221111100
Q ss_pred ---------cC----CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 370 ---------NE----RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 370 ---------~~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.. ..+.......++.++.++|.+||+.+|++|||+++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 001111124577889999999999999999999999877
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=280.71 Aligned_cols=248 Identities=26% Similarity=0.399 Sum_probs=193.9
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC------
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST------ 220 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~------ 220 (456)
.+|.....||+|+||.+ ..+|+.||+|++.... ..+.....+.+|+.+++.++||||+++++++....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36888899999999865 2368999999987643 22333456889999999999999999999986543
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
..++++||+. .+|.+++ ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 4699999995 5777765 246899999999999999999999999 999999999999999999999999998754
Q ss_pred cccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC-------
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER------- 372 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------- 372 (456)
.. ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+.....
T Consensus 168 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 168 DA--------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CC--------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 21 1123456778999999876 4688899999999999999999999987654333322221110
Q ss_pred ---------------C-----CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHH
Q 012777 373 ---------------P-----PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR--LDDI 414 (456)
Q Consensus 373 ---------------~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~--L~~~ 414 (456)
+ .+.......+..+.++|.+||+.||++||++++++.+ ++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0 0001123567789999999999999999999999976 4444
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=276.83 Aligned_cols=254 Identities=27% Similarity=0.403 Sum_probs=192.5
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-------
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS------- 219 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------- 219 (456)
.+|++.+.||+|+||.+ ..+++.||+|.+......+ .....+.+|+++++.++||||+++++.+...
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46888999999999865 2368899999986543222 1224567899999999999999999987543
Q ss_pred -CceEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCc
Q 012777 220 -TPMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLS 297 (456)
Q Consensus 220 -~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls 297 (456)
..+++++||+. ++|.+.+... ..+++..+..++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccc
Confidence 34699999995 5787777653 46999999999999999999999999 999999999999999999999999998
Q ss_pred ccccccccccC------CCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc
Q 012777 298 KLLKFANTVKE------DRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN 370 (456)
Q Consensus 298 ~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 370 (456)
........... ........+++.|+|||.+.+. .++.++||||||+++|+|++|++||.+.+.......+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 86532211111 1111233567789999987654 5788999999999999999999999876654433332221
Q ss_pred CCCC--------------------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 371 ERPP--------------------------FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 371 ~~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
...+ .......++..+.++|.+||..||++|||+.+++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1000 000012344678899999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=280.73 Aligned_cols=249 Identities=24% Similarity=0.405 Sum_probs=192.7
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-------
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS------- 219 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------- 219 (456)
.+|.+.+.||.|+||.+ ..+|..||+|.+..... ...+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 57889999999999866 24688999999875432 3456788999999999999999999876543
Q ss_pred -------CceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-CCCCEEE
Q 012777 220 -------TPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD-DSGHLKV 291 (456)
Q Consensus 220 -------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~-~~~~vkl 291 (456)
...++++||++ ++|.+++.. +.+++..++.++.|+++||.|||+.+ ++||||||+||+++ .++.++|
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999996 699888864 46999999999999999999999999 99999999999998 4567899
Q ss_pred eccCCcccccccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc
Q 012777 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN 370 (456)
Q Consensus 292 ~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 370 (456)
+|||++........ .........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...++......+...
T Consensus 157 ~dfg~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 157 GDFGLARIVDPHYS--HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred CCcccceecCCccc--cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999876522111 1111122346778999997654 46788999999999999999999999876654333322111
Q ss_pred CC--------------------------CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 371 ER--------------------------PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 371 ~~--------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.. .+.......++.++.++|.+||+.||++|||+++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 10 00001123577889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=281.27 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=196.2
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc-----
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP----- 221 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~----- 221 (456)
.+|.+.+.||+|+||.+ ..++..||+|++.... ........+.+|+.++++++||||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 36888899999999865 2357899999987543 233344667889999999999999999998866554
Q ss_pred -eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 222 -MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 222 -~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 6799998875 56999999999999999999999999 999999999999999999999999998765
Q ss_pred cccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC-------
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER------- 372 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------- 372 (456)
... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+.....
T Consensus 169 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 169 DDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred ccc--------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 211 223356778999998765 3678899999999999999999999987665444333322111
Q ss_pred --------------------CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 373 --------------------PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 373 --------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.+......++..+.++|.+||+.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00111123468889999999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=282.62 Aligned_cols=233 Identities=26% Similarity=0.429 Sum_probs=192.6
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.|.....+|.|+|+.+ ..+++..++|++.+... +-.+|+.++... +||||+++++.+.+....|+||
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4556667999998765 34688999999987622 224566666666 7999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe-CCCCCEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR-DDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~-~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|++.|+-|.+.+...+... ..+..|+.+|+.|+.|||++| ||||||||+|||+ +..+.++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999998888877655454 788889999999999999999 9999999999999 68899999999998866321
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc-chHHHHHhcCCCCCCCCCCCCcH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK-EVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.....-|..|.|||++....++.++||||||++||+|++|+.||..-... ++...+ ..+++ ...+|.
T Consensus 470 ------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i---~~~~~---s~~vS~ 537 (612)
T KOG0603|consen 470 ------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI---QMPKF---SECVSD 537 (612)
T ss_pred ------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh---cCCcc---ccccCH
Confidence 33345677899999999999999999999999999999999999765544 333322 23333 378899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+++||.+||+.||.+||+++++..+
T Consensus 538 ~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 538 EAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HHHHHHHHhccCChhhCcChhhhccC
Confidence 99999999999999999999999887
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=260.98 Aligned_cols=209 Identities=20% Similarity=0.250 Sum_probs=170.2
Q ss_pred eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCHHHHHHHcCCCCHHH
Q 012777 169 SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTL 248 (456)
Q Consensus 169 ~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~ 248 (456)
..+++.||+|.+.... .+.+|...+....||||+++++++......+++|||+++++|.+++.+...+++..
T Consensus 15 ~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~ 86 (237)
T cd05576 15 TRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEEC 86 (237)
T ss_pred ccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHH
Confidence 4578999999997542 22345555555679999999999999999999999999999999998877899999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccC
Q 012777 249 AVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYK 328 (456)
Q Consensus 249 ~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 328 (456)
+..++.|++.||.|||+++ ++|+||||+||+++.++.++++|||.+...... .....++..|+|||.+.
T Consensus 87 ~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--------~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 87 VKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--------CDGEAVENMYCAPEVGG 155 (237)
T ss_pred HHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc--------cccCCcCccccCCcccC
Confidence 9999999999999999999 999999999999999999999999987654211 11223456799999998
Q ss_pred CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH
Q 012777 329 NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTF 404 (456)
Q Consensus 329 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~ 404 (456)
+..++.++|+||+|+++|+|++|..|+...... +.... .+ ..+..++..+.++|.+||+.||++||++
T Consensus 156 ~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~--~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 156 ISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHT--TL-NIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----ccccc--cc-CCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 888899999999999999999999887543211 10000 11 1235678899999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=260.02 Aligned_cols=252 Identities=24% Similarity=0.380 Sum_probs=193.6
Q ss_pred ccccceeeeccEEEEEeEc---------CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe-CCce
Q 012777 153 DFSNSVEITKGTFRIASWR---------GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ-STPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~~~---------g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 222 (456)
.|..+..||+|+||.|... ...+|+|.++.+.... ..-....+|+.+++.++|||++.+..+|.. +..+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 5888899999999977221 3479999998763211 122456799999999999999999999987 7889
Q ss_pred EEEEEccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC----CCEEEec
Q 012777 223 MIVTEYLPKGDLRAYLKQK-----GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS----GHLKVAD 293 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~----~~vkl~D 293 (456)
++++||.+ .+|.+++... ..++...+..|++||+.++.|||++- |+||||||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 99999995 6999988643 34899999999999999999999998 9999999999999977 8999999
Q ss_pred cCCcccccccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCcc---------ch
Q 012777 294 FGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEK---------EV 363 (456)
Q Consensus 294 fgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---------~~ 363 (456)
||+++.+... ..+-......+.|..|+|||.+.+. .|+++.|+|++||+..||++-.+.|.+.... +-
T Consensus 180 lGlaR~~~~p--lkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 180 LGLARLFNNP--LKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ccHHHHhhcc--ccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 9999977432 2222233445678899999998876 6899999999999999999998888653221 11
Q ss_pred HHHHHh-cCCCCC---------CC-----------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 364 PKAYIA-NERPPF---------RA-----------------------PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 364 ~~~~~~-~~~~~~---------~~-----------------------~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
...|.. -+.|.- +. ....-++...+|+.++|..||.+|.|+++.+++
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 112211 111110 00 012234457899999999999999999999887
Q ss_pred H
Q 012777 411 L 411 (456)
Q Consensus 411 L 411 (456)
.
T Consensus 338 ~ 338 (438)
T KOG0666|consen 338 P 338 (438)
T ss_pred c
Confidence 3
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=237.87 Aligned_cols=248 Identities=26% Similarity=0.468 Sum_probs=201.3
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...++||+|+||.| ..+++.||+|.+..+. .++..-....+|+-+|+.++|.||+++++....++.+.+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 3556678999999977 3468899999998653 344455778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|| ..+|..+... ++.++.+.+..++.|++.+|.+||+++ ++|||+||+|.|++.+|.+||+|||+++-.+.
T Consensus 82 ~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi---- 153 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI---- 153 (292)
T ss_pred Hh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC----
Confidence 99 5688888765 577999999999999999999999999 99999999999999999999999999986632
Q ss_pred cCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcC-CCC---------
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANE-RPP--------- 374 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~-~~~--------- 374 (456)
+-+.+.....|..|.+|.++.+. -|+++.|+||.||++.|+.. |++.|++.+..+....|.... .+.
T Consensus 154 -pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 154 -PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred -ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 22334445678899999998776 58889999999999999996 899999887766555543321 111
Q ss_pred ------CCCC---------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 ------FRAP---------TTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 ------~~~~---------~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.+ .+.++..-++++.+++.-+|..|.++++.+++
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111 12344456789999999999999999988765
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=282.36 Aligned_cols=245 Identities=25% Similarity=0.385 Sum_probs=205.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEe-----CCc
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQ-----STP 221 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-----~~~ 221 (456)
.|++.+.||.|.+|.| ..+++..|+|+....... .+.+..|.++|+.+ .|||++.++++|.. ++.
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 5888899999999865 568999999998765422 25677899999998 59999999999854 478
Q ss_pred eEEEEEccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQ--KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKL 299 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~ 299 (456)
++||||||.+||..|+++. ...+.+..+..|+..++.|+.|||.+. ++|||||-.|||++.++.|||+|||++..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeee
Confidence 9999999999999999976 345999999999999999999999999 99999999999999999999999999998
Q ss_pred ccccccccCCCCcccCCCCcccccccccCCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCC
Q 012777 300 LKFANTVKEDRPVTCEETSWRYAAPEVYKNE-----EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPP 374 (456)
Q Consensus 300 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 374 (456)
+... ........|||.|||||++... .|+.++|+||||++..||--|.+|+.++.+....-.|..+.+|.
T Consensus 173 ldsT-----~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk 247 (953)
T KOG0587|consen 173 LDST-----VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 247 (953)
T ss_pred eecc-----cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence 7432 1223346799999999998554 46678999999999999999999999998876665553332222
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
...+..-+.+|.++|..||.+|..+||++.+++++
T Consensus 248 -Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 248 -LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -ccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 23356677889999999999999999999999865
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=281.26 Aligned_cols=254 Identities=28% Similarity=0.440 Sum_probs=200.2
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------Cc
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS------TP 221 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------~~ 221 (456)
.|...+.||+|+||.| +.+|+.||||.+.... .....+...+|+++|++++|||||++.++-... ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 4667789999999866 5689999999998764 334467889999999999999999999875443 45
Q ss_pred eEEEEEccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC--CCC--CEEEecc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKG---ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD--DSG--HLKVADF 294 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~--~~~--~vkl~Df 294 (456)
..++||||.+|||..++++.. -+++.+.+.++..+..||.|||++| |+||||||.||++- .+| .-||+||
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecc
Confidence 789999999999999997632 3999999999999999999999999 99999999999875 333 5899999
Q ss_pred CCcccccccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc----chHHHHHh
Q 012777 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEK----EVPKAYIA 369 (456)
Q Consensus 295 gls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~ 369 (456)
|.|+.+.. ........||..|++||++.+ ..|+..+|.|||||++|+..||..||...... ++...+..
T Consensus 169 G~Arel~d------~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t 242 (732)
T KOG4250|consen 169 GAARELDD------NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT 242 (732)
T ss_pred cccccCCC------CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc
Confidence 99997743 335667889999999999984 78999999999999999999999999654332 23333322
Q ss_pred cCCC------------C------CCCCCCCCcHH----HHHHHHHhcccCCCCCC--CHHHHHHHHHHHHHHh
Q 012777 370 NERP------------P------FRAPTTHYAYG----LRELIEDCWSEEPFRRP--TFRQILMRLDDISDQL 418 (456)
Q Consensus 370 ~~~~------------~------~~~~~~~~~~~----l~~li~~~l~~dp~~Rp--t~~ell~~L~~~~~~~ 418 (456)
+... + ++ .+-+++.. +...+..+|.-+|.+|. ...+....+..+.+..
T Consensus 243 kkp~~v~i~~~~~eNgpv~~s~~lP-~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 243 KKPSGVAIGAQEEENGPVEWSSTLP-QPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred cCCCceeEeeecccCCceeeeccCC-CcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 2110 0 11 12333333 45667889999999999 8888888888876543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=273.56 Aligned_cols=246 Identities=25% Similarity=0.350 Sum_probs=204.3
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.-|...+.||-|.||.| ..+...||+|.+.+........+...+.|..+|....++-||+||-.|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 34778889999999976 2356689999998876677777888999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc----
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF---- 302 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~---- 302 (456)
+|++||++-.+|.+-+.++++.++.++.++..|+++.|..| +|||||||+|||||.+|.+||.||||+.-+..
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccc
Confidence 99999999999999999999999999999999999999999 99999999999999999999999999763311
Q ss_pred -----cccccCCC----------------------------CcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHH
Q 012777 303 -----ANTVKEDR----------------------------PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI 349 (456)
Q Consensus 303 -----~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 349 (456)
+.....+. .-...+||+.|+|||++....++...|+||.|+|||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 10000000 002357999999999999999999999999999999999
Q ss_pred cCCCCCCCCCccchHHHHHhcCCCCCCC-CCCCCcHHHHHHHHHhcccCCCCCC
Q 012777 350 EGCPPFPTKQEKEVPKAYIANERPPFRA-PTTHYAYGLRELIEDCWSEEPFRRP 402 (456)
Q Consensus 350 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rp 402 (456)
.|++||...++.+....+ .+++..+.. ...+++++..++|.++. -+++.|.
T Consensus 866 ~g~~pf~~~tp~~tq~kv-~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKV-INWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred hCCCCccCCCCCcceeee-eehhhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 999999998887765444 233333222 24788999999988765 5677775
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=260.99 Aligned_cols=256 Identities=30% Similarity=0.481 Sum_probs=200.6
Q ss_pred ccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC--CCCcceeeeeEEEeC----CceE
Q 012777 153 DFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI--RHPNVVQFLGAVTQS----TPMM 223 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~l~~~~~~~----~~~~ 223 (456)
+....+.||+|.||.| .|.|+.||||++..- ++ ..+.+|.++++.. +|+||+.++++-..+ .+++
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr---dE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR---DE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred eeEEEEEecCccccceeeccccCCceEEEEeccc---ch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 4667789999999854 899999999999642 22 5677888888774 999999999876543 4699
Q ss_pred EEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHE-----NRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~-----~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
||++|.+.|||+|+|+. ..++.+..++++..++.||.|||. +|++.|.|||||..||||..++..-|+|+|||.
T Consensus 286 LvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred EeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 99999999999999987 679999999999999999999996 567789999999999999999999999999998
Q ss_pred cccccccccCCCCcccCCCCcccccccccCCCC----CC--CchhHHHHHHHHHHHHcC----------CCCCCCCCcc-
Q 012777 299 LLKFANTVKEDRPVTCEETSWRYAAPEVYKNEE----YD--TKVDVFSFALILQEMIEG----------CPPFPTKQEK- 361 (456)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~--~~~DiwslG~il~~l~~g----------~~pf~~~~~~- 361 (456)
...... ...+......+||.+|||||++...- +. ..+||||||.++||+... ++||.+..+.
T Consensus 365 ~h~~~t-~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 365 RHDSDT-DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EecccC-CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 764432 22233344568999999999986642 11 358999999999999842 5788765443
Q ss_pred ----chHHHHHhc-CCCCCCCCCCCCc--HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 012777 362 ----EVPKAYIAN-ERPPFRAPTTHYA--YGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416 (456)
Q Consensus 362 ----~~~~~~~~~-~~~~~~~~~~~~~--~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~ 416 (456)
++.+-+... .+|+.+..+...+ ..+.++++.||..||..|.|+=.+-+.|.++.+
T Consensus 444 Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 444 PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 222222222 2555554444433 346788999999999999999888888887764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=279.15 Aligned_cols=254 Identities=26% Similarity=0.479 Sum_probs=216.1
Q ss_pred cccccceeeeccEEEEEeE---------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 152 LDFSNSVEITKGTFRIASW---------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~~---------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
......+.||+|.||.|.. -.-+||+|++... ...+.-..+..|+-+|.++.|||++++++++..+. +
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 3456678999999997621 2458999999765 34445578999999999999999999999998765 8
Q ss_pred EEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
.||++|++.|+|.|+++.+ +++.....+.|..||++||.|||++. ++||||-..||||..-..||+.|||+++.+.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 8999999999999999875 46999999999999999999999999 9999999999999999999999999999774
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
..... .........+.|||-|.++...++.++||||+||++||++| |..||.+....++.+.+.++.+.+ .+.
T Consensus 850 ~d~~e---y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLs---qPp 923 (1177)
T KOG1025|consen 850 PDEKE---YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLS---QPP 923 (1177)
T ss_pred ccccc---ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCC---CCC
Confidence 33211 12222334567999999999999999999999999999998 999999999988888776665533 367
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
..+-++.-++.+||..|++.||+++++...+.++.+.
T Consensus 924 iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 924 ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred CccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 8889999999999999999999999999999888654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=248.51 Aligned_cols=229 Identities=35% Similarity=0.580 Sum_probs=189.2
Q ss_pred cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCHHHHHHHcCCCCHHHHH
Q 012777 171 RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAV 250 (456)
Q Consensus 171 ~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~ 250 (456)
+|+.+|+|++....... ..+.+.+|++.+++++|++|+++++++......++++||+++++|.+++.....++...++
T Consensus 13 ~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~ 90 (244)
T smart00220 13 TGKLVAIKVIKKEKIKK--KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEAR 90 (244)
T ss_pred CCcEEEEEEeccccccc--HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHH
Confidence 57999999997653222 1578999999999999999999999999989999999999888999999876669999999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCC
Q 012777 251 KFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE 330 (456)
Q Consensus 251 ~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 330 (456)
.++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.+.+.
T Consensus 91 ~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~~~~pE~~~~~ 161 (244)
T smart00220 91 FYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG------LLTTFVGTPEYMAPEVLLGK 161 (244)
T ss_pred HHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc------ccccccCCcCCCCHHHHccC
Confidence 99999999999999999 9999999999999999999999999988763221 22234567789999999888
Q ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 331 EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 331 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++.++|+||||+++++|++|..||......+...................++.++.+++.+|+..+|++||++.+++++
T Consensus 162 ~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 162 GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 88999999999999999999999998743333332232333222222122288899999999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=252.95 Aligned_cols=252 Identities=24% Similarity=0.376 Sum_probs=193.5
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--------C
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ--------S 219 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--------~ 219 (456)
.|....+||+|.||.| ..+|+.||+|++-.+. ..+..-....+|+.+|..++|+|++.+++.|.. .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 5677788999999854 5678889998875432 122222456889999999999999999987743 2
Q ss_pred CceEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
..+|+|+++|+ .+|.-++... ..++..++.+++.++..+|.|+|... |+|||+||.|+||+.+|.+||+|||+++
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence 35899999995 6999988765 45999999999999999999999999 9999999999999999999999999997
Q ss_pred cccccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC---C--
Q 012777 299 LLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE---R-- 372 (456)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---~-- 372 (456)
.+....+.... .++..+.|..|++||.+.+. .++++.|||..||+|.+|++|.+.+.+.+.......|..-+ .
T Consensus 173 ~fs~~~n~~kp-rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 173 AFSTSKNVVKP-RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred ceecccccCCC-CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 65433222222 24556678899999998776 79999999999999999999999877655433222221100 0
Q ss_pred --C--------------CCC----------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 373 --P--------------PFR----------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 373 --~--------------~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
| ++. ..+..-.++..++++++|..||.+|+++++++++
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 0 000 0011223468899999999999999999999876
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=298.70 Aligned_cols=245 Identities=24% Similarity=0.355 Sum_probs=186.5
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.+.....||+|+||.| ..+|..||+|.+...... ...|++.+++++||||+++++++......++|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 4566678999999876 246889999998653211 1246788999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++. .+++..+..++.|++.||.|||.....+|+||||||+||+++.++.+++. ||......
T Consensus 764 y~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~------ 833 (968)
T PLN00113 764 YIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------ 833 (968)
T ss_pred CCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc------
Confidence 999999999996 38899999999999999999994422339999999999999998888775 55443221
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc--chHHHHHh---cC------CCCCC
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK--EVPKAYIA---NE------RPPFR 376 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~---~~------~~~~~ 376 (456)
......+++.|+|||++.+..++.++|||||||++|||++|+.||...... ........ .. .+...
T Consensus 834 ---~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 834 ---TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ---cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcccc
Confidence 011225678999999999999999999999999999999999999543221 11111100 00 01110
Q ss_pred C---CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 377 A---PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 377 ~---~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
. .......++.+++.+||+.||++|||++++++.|+.+.+.
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 0 0111223577889999999999999999999999988653
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=257.45 Aligned_cols=256 Identities=24% Similarity=0.345 Sum_probs=201.4
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHH----HHHHHHHHHHHhcCCCCcceeeeeEEEe-CCce
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDK----VKAFIDELALLQKIRHPNVVQFLGAVTQ-STPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 222 (456)
+|.....||+|+|..| ....+.||+|+-..+....++. .+...+|..+-+.+.||.||++|++|.- .+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 5777888999999744 4568899999977655444433 3456789999999999999999999964 4678
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC---CCCCEEEeccCCccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD---DSGHLKVADFGLSKL 299 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~---~~~~vkl~Dfgls~~ 299 (456)
|-|+|||+|.+|.-+++++.-++++++..|+.||+.||.||.+.. .+|||-||||.|||+- .-|.+||.|||+++.
T Consensus 544 CTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred eeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 999999999999999999888999999999999999999999886 6899999999999986 457899999999998
Q ss_pred ccccccccCC--CCcccCCCCcccccccccCCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHH---HHHhc
Q 012777 300 LKFANTVKED--RPVTCEETSWRYAAPEVYKNE----EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPK---AYIAN 370 (456)
Q Consensus 300 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~ 370 (456)
.......... .......||..|+|||.+.-+ ..+.++||||+|+++|..+.|+.||.......-+. .|...
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA 702 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA 702 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence 7543222111 112235799999999987543 56779999999999999999999997754332211 12222
Q ss_pred CCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 371 ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
....|+. .+.++.+..+||++||+.--++|.++.++..+
T Consensus 703 tEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 703 TEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred eeccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 2222222 35678899999999999999999998887654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=231.27 Aligned_cols=211 Identities=26% Similarity=0.447 Sum_probs=171.9
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
+......||+|.||.+ ..+|...|+|.+.... +.+..++..+|+.+..+. .+|.+|.+|+........++.|
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 4455678999999966 5689999999998763 456678889999988887 6999999999999999999999
Q ss_pred EccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 227 EYLPKGDLRAYLK----QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 227 e~~~~~sL~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
|.+ .-||..+-. +.+.+++..+-+|+..+..||.|||++= .++|||+||+|||++.+|+||+||||.+-.+.+
T Consensus 125 E~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 999 568876543 4567999999999999999999999875 399999999999999999999999999887743
Q ss_pred cccccCCCCcccCCCCcccccccccCC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc-cchHHHHHhcCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKN----EEYDTKVDVFSFALILQEMIEGCPPFPTKQE-KEVPKAYIANERPP 374 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~ 374 (456)
. -..+.-.|...|||||.+.. ..|+.++||||||++++||.+++.||+.... .+...++.....|.
T Consensus 202 S------iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~ 272 (282)
T KOG0984|consen 202 S------IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ 272 (282)
T ss_pred h------hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence 2 12222345567999998744 3688899999999999999999999987654 45556664444333
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=249.88 Aligned_cols=256 Identities=28% Similarity=0.423 Sum_probs=198.6
Q ss_pred ccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC--CCCcceeeeeEEEeCC----ceE
Q 012777 153 DFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI--RHPNVVQFLGAVTQST----PMM 223 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~l~~~~~~~~----~~~ 223 (456)
.....+.||+|+||.| ...++.||||++. .+..+.|.+|.++++.. +|+||++++++-.... .++
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred chhhHHHhhcCccceeehhhccCceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 3445568999999976 6689999999985 45568899999999886 7999999998876544 799
Q ss_pred EEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCCeEeCCCCCEEEeccCCc
Q 012777 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENR------PEAIIHRDLEPSNILRDDSGHLKVADFGLS 297 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~------~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls 297 (456)
||++|.+.|+|.++|+. ..+++....+|+..++.||.|||+-- +.+|+|||||..||||..++...|+|||+|
T Consensus 285 LVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 99999999999999986 46999999999999999999999743 346999999999999999999999999999
Q ss_pred ccccccccccCCCCcccCCCCcccccccccCCC-CCC-----CchhHHHHHHHHHHHHcCCCCC------------CC--
Q 012777 298 KLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYD-----TKVDVFSFALILQEMIEGCPPF------------PT-- 357 (456)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DiwslG~il~~l~~g~~pf------------~~-- 357 (456)
..+..+ ........-+||.+|||||++.+. .+. .+.||||+|.+||||++.+.-+ ..
T Consensus 364 l~~~p~---~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 364 LRLEPG---KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred EEecCC---CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 988532 222233346899999999999765 222 2689999999999999865433 20
Q ss_pred ---CCccchHHHHHhc-CCCCCCCCCC--CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 358 ---KQEKEVPKAYIAN-ERPPFRAPTT--HYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 358 ---~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
...+++...+... .+|.++..+. .....+.+.++.||..||+.|.|+.=+-+.+.++....
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 1112223333222 3555543322 23345889999999999999999998888877776444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=277.03 Aligned_cols=267 Identities=25% Similarity=0.371 Sum_probs=201.6
Q ss_pred ccccceeeeccEEEE----EeEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRI----ASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~----~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
-|...+.+|.|+-|. +.+.|+.||||.+-.+. .....+|+..|+.- .||||+++++.-.++...||..|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 456667788887764 46789999999986432 34567999999998 69999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---C--CCEEEeccCCcc
Q 012777 228 YLPKGDLRAYLKQKGA----LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD---S--GHLKVADFGLSK 298 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~----l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~---~--~~vkl~Dfgls~ 298 (456)
.| ..+|.+++...+. ......+.+..|+++||.|||+.+ ||||||||+||||+. + .+++|+|||+++
T Consensus 584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 99 6799999987421 112456789999999999999999 999999999999985 2 479999999999
Q ss_pred cccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCC
Q 012777 299 LLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRA 377 (456)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 377 (456)
.+..+.... +......||.+|+|||++.....+.++|||||||++|+.++ |..||.+.-..+. .|..+.......
T Consensus 660 kl~~~~sS~--~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L 735 (903)
T KOG1027|consen 660 KLAGGKSSF--SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHL 735 (903)
T ss_pred ccCCCcchh--hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeee
Confidence 885443222 22456789999999999999988889999999999999998 5999987543322 222222111111
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH------------HHHHHHHhccccc-cccCcchhhHH
Q 012777 378 PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR------------LDDISDQLSIKRH-WKVGPLRCFQS 434 (456)
Q Consensus 378 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~------------L~~~~~~~~~~~~-~~~~~~~~~~~ 434 (456)
...-..+..+||.+|++++|+.||++.+++.| |.++.+++.++.- ++-..++.+|.
T Consensus 736 -~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e~r~~~s~lL~~le~ 804 (903)
T KOG1027|consen 736 -EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKENRDSPSELLRALEA 804 (903)
T ss_pred -ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhhhccCchHHHHhhcc
Confidence 11111178999999999999999999999754 6666666665543 34434444443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=254.65 Aligned_cols=244 Identities=25% Similarity=0.309 Sum_probs=191.2
Q ss_pred ccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC--CC----cceeeeeEEEeC
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR--HP----NVVQFLGAVTQS 219 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp----~iv~l~~~~~~~ 219 (456)
.-+|.+...+|+|+||.|. .++..||||+++.- ....+..+-|+++|.++. -| -++.+.++|...
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 3478888999999999772 35789999999743 344566788999999993 23 378888899999
Q ss_pred CceEEEEEccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC------------
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD------------ 285 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~------------ 285 (456)
+..|||+|.+ |-|+.+++.+++ +++...++.+++|+++++++||+.+ ++|-||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999 779999998765 4999999999999999999999999 999999999999753
Q ss_pred --------CCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 012777 286 --------SGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPT 357 (456)
Q Consensus 286 --------~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 357 (456)
+-.|+++|||.+.+.. ......+.|-.|.|||++.+-.++..+||||+||||+||.+|...|..
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~--------e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDH--------EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cceeccCCCcceEEEecCCcceec--------cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 2248999999988652 122345678889999999999999999999999999999999998876
Q ss_pred CCccc---hHHHHH-----------------hcCCCCCCC-------------------C---CCCCcHHHHHHHHHhcc
Q 012777 358 KQEKE---VPKAYI-----------------ANERPPFRA-------------------P---TTHYAYGLRELIEDCWS 395 (456)
Q Consensus 358 ~~~~~---~~~~~~-----------------~~~~~~~~~-------------------~---~~~~~~~l~~li~~~l~ 395 (456)
-+..+ +...+. ..++..++. . ....-..+.+||++||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 55443 111110 000111000 0 01111248899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 012777 396 EEPFRRPTFRQILMR 410 (456)
Q Consensus 396 ~dp~~Rpt~~ell~~ 410 (456)
.||.+|+|+.|++.+
T Consensus 392 fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 392 FDPARRITLREALSH 406 (415)
T ss_pred cCccccccHHHHhcC
Confidence 999999999999876
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=260.89 Aligned_cols=245 Identities=25% Similarity=0.380 Sum_probs=196.4
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC------CCcceeeeeEEEeC
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR------HPNVVQFLGAVTQS 219 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~l~~~~~~~ 219 (456)
+..|.+....|+|.|+.| ...|..||||+|..+ +--.+.=+.|+++|++|. --++++|+..|...
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN----E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN----EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc----hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 347888999999999866 345779999999854 222345578999999994 24799999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-CCCEEEeccC
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQKGA---LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD-SGHLKVADFG 295 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~-~~~vkl~Dfg 295 (456)
+++|||+|.+ .-+|.+++++-|. |....+..++.|++.||..|-..+ |+|.||||+||||++ ...+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 9999999999 6799999998664 888999999999999999999999 999999999999995 4579999999
Q ss_pred CcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHh-cC-CC
Q 012777 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIA-NE-RP 373 (456)
Q Consensus 296 ls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~-~~ 373 (456)
.|.....+ ..+.+..+-.|.|||++.+-+|+...|+||+||+||||.||+..|++.+...+...... .+ .|
T Consensus 583 SA~~~~en-------eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 583 SASFASEN-------EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred cccccccc-------cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 99876321 22333445569999999999999999999999999999999999999887766543321 11 11
Q ss_pred C----------------CCC---------------------C----------CCCCcH-------HHHHHHHHhcccCCC
Q 012777 374 P----------------FRA---------------------P----------TTHYAY-------GLRELIEDCWSEEPF 399 (456)
Q Consensus 374 ~----------------~~~---------------------~----------~~~~~~-------~l~~li~~~l~~dp~ 399 (456)
. +.+ + ...++. .|.+|+.+||..||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 0 000 0 012332 388999999999999
Q ss_pred CCCCHHHHHHH
Q 012777 400 RRPTFRQILMR 410 (456)
Q Consensus 400 ~Rpt~~ell~~ 410 (456)
+|.|..+.|.|
T Consensus 736 KRit~nqAL~H 746 (752)
T KOG0670|consen 736 KRITVNQALKH 746 (752)
T ss_pred hcCCHHHHhcC
Confidence 99999998875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=241.89 Aligned_cols=254 Identities=25% Similarity=0.382 Sum_probs=211.4
Q ss_pred cccceeeeccEEEEEe---E-------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-Cce
Q 012777 154 FSNSVEITKGTFRIAS---W-------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS-TPM 222 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~~---~-------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 222 (456)
++..-.+-+|+||++. | +.+.|-+|.++.. .++-....+..|...+..+.|||+..+.+++.++ ...
T Consensus 286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 4445556789998652 1 2346778888765 3556678889999999999999999999987654 567
Q ss_pred EEEEEccCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEecc
Q 012777 223 MIVTEYLPKGDLRAYLKQK--------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~--------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Df 294 (456)
++++.+..-|+|..++..+ ..++..+...++.|++.|+.|||+++ |||.||...|++|++.-+|||+|=
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccc
Confidence 8888999899999999842 23777888899999999999999999 999999999999999999999999
Q ss_pred CCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCC
Q 012777 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERP 373 (456)
Q Consensus 295 gls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 373 (456)
.+++.+-.. ..........++..||+||.+.+..|+.++|+||||++||||+| |+.||...++.++...++.+.+.
T Consensus 441 aLSRDLFP~---DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl 517 (563)
T KOG1024|consen 441 ALSRDLFPG---DYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL 517 (563)
T ss_pred hhccccCcc---cccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee
Confidence 999876321 11112223346678999999999999999999999999999998 99999999999998888776654
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 374 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
.- +.++|+++..++.-||+..|++||+++++..-|.++..++
T Consensus 518 aQ---P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 518 AQ---PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred cC---CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 43 5789999999999999999999999999999999987765
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=225.57 Aligned_cols=240 Identities=20% Similarity=0.367 Sum_probs=184.3
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeC--CceEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQS--TPMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~--~~~~l 224 (456)
+|++.+++|+|.|+.| ..+++.++||+++.- ..+.+.+|+.+|..+. ||||+++++...++ ....+
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 6889999999998543 567899999998743 3478999999999995 99999999998765 56789
Q ss_pred EEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-CCCCEEEeccCCccccccc
Q 012777 225 VTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD-DSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~-~~~~vkl~Dfgls~~~~~~ 303 (456)
|+||+.+.+...+. +.++...+..++.+++.||.|||++| |.|||+||.|+|++ ....++|+|+|++.++..+
T Consensus 113 iFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred HhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 99999776655543 45888999999999999999999999 99999999999999 4557999999999988543
Q ss_pred ccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCC-CCCCccchHHHHHhc-----------
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPF-PTKQEKEVPKAYIAN----------- 370 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~----------- 370 (456)
...+ -.+.+..|--||.+-. ..|+.+-|+|||||++..|+..+.|| .+.+..+..-.|...
T Consensus 187 ~eYn------VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 187 KEYN------VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred ceee------eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 2221 1233445788998754 46889999999999999999988887 333332221111110
Q ss_pred -----CCC------------CCC-----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 371 -----ERP------------PFR-----APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 371 -----~~~------------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..+ ++. ....-++++..+|+.++|..|-++|||++|.+.|
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 001 110 0123445889999999999999999999998876
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=265.61 Aligned_cols=244 Identities=19% Similarity=0.233 Sum_probs=161.4
Q ss_pred cccccceeeeccEEEEEe-----Ec----CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeE------E
Q 012777 152 LDFSNSVEITKGTFRIAS-----WR----GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGA------V 216 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~----g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~------~ 216 (456)
.+|...+.||+|+||.|. .+ +..||+|.+.... . .+...+| .+....+.++..++.. .
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---A--VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---h--hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 468889999999999772 23 7899999976432 1 1112222 1122222223222222 2
Q ss_pred EeCCceEEEEEccCCCCHHHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 012777 217 TQSTPMMIVTEYLPKGDLRAYLKQKGA--------------------LKPTLAVKFALDIARGMNYLHENRPEAIIHRDL 276 (456)
Q Consensus 217 ~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Di 276 (456)
......++|+||+++++|.+++..... .....+..++.|++.||.|||+++ |+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 345679999999999999999875321 123446689999999999999999 999999
Q ss_pred CCCCeEeCC-CCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCC----------------------CCC
Q 012777 277 EPSNILRDD-SGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE----------------------EYD 333 (456)
Q Consensus 277 kp~Nil~~~-~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~ 333 (456)
||+|||++. ++.+||+|||++..+.... ........+++.|+|||.+... .++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~----~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGI----NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccc----ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 999999995 5799999999998653221 1122345678899999965332 233
Q ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC----------CCCCCC-------CCCCCcHHHHHHHHHhccc
Q 012777 334 TKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE----------RPPFRA-------PTTHYAYGLRELIEDCWSE 396 (456)
Q Consensus 334 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~~~~-------~~~~~~~~l~~li~~~l~~ 396 (456)
.++|||||||++|+|+++..|+.... ......+.... .+.... ..........+||.+||+.
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 45699999999999999776654321 01111111100 000000 0011122355899999999
Q ss_pred CCCCCCCHHHHHHH
Q 012777 397 EPFRRPTFRQILMR 410 (456)
Q Consensus 397 dp~~Rpt~~ell~~ 410 (456)
||++|||++++++|
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999997
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=253.14 Aligned_cols=195 Identities=23% Similarity=0.379 Sum_probs=172.4
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHH-----HHHHHHHHhcCC---CCcceeeeeEEEeC
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKA-----FIDELALLQKIR---HPNVVQFLGAVTQS 219 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~-----~~~E~~~l~~l~---hp~iv~l~~~~~~~ 219 (456)
+|+..+.+|+|.||.| +.+...|+||.+.++++.-+.++++ +-.|+++|..++ |+||+|++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 6888999999999987 4467799999999887665544433 467999999996 99999999999999
Q ss_pred CceEEEEEcc-CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 220 TPMMIVTEYL-PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 220 ~~~~lv~e~~-~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
+.+||+||.- ++.+|.+++..++.+++.++..|++|++.|+++||++| |||||||-+||.++.+|-+||+|||.+.
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchh
Confidence 9999999985 56699999998889999999999999999999999999 9999999999999999999999999988
Q ss_pred cccccccccCCCCcccCCCCcccccccccCCCCCCC-chhHHHHHHHHHHHHcCCCCCCC
Q 012777 299 LLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDT-KVDVFSFALILQEMIEGCPPFPT 357 (456)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~l~~g~~pf~~ 357 (456)
... +.+...+.||..|.|||++.+.+|-- .-|||+||+++|.++....||.+
T Consensus 719 ~~k-------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YTK-------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhc-------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 663 33455678999999999999988765 47999999999999999999865
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=249.54 Aligned_cols=249 Identities=18% Similarity=0.196 Sum_probs=176.0
Q ss_pred ccccccceeeeccEEEEEe---------------------EcCcEEEEEEeCCCCCCCHHHHH--------------HHH
Q 012777 151 ELDFSNSVEITKGTFRIAS---------------------WRGTQVAVKTLGEEVFTDEDKVK--------------AFI 195 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~---------------------~~g~~vAvK~~~~~~~~~~~~~~--------------~~~ 195 (456)
.-+|.+.++||+|+||.|. ..++.||||.+.... ....+ ...
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~---~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR---QGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc---hhhHHHHHhhhhhhhcccchhH
Confidence 4479999999999999763 235679999986532 11122 233
Q ss_pred HHHHHHhcCCCCc-----ceeeeeEEEe--------CCceEEEEEccCCCCHHHHHHHcC--------------------
Q 012777 196 DELALLQKIRHPN-----VVQFLGAVTQ--------STPMMIVTEYLPKGDLRAYLKQKG-------------------- 242 (456)
Q Consensus 196 ~E~~~l~~l~hp~-----iv~l~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~-------------------- 242 (456)
.|+.++.+++|.+ +++++++|.. ....++|+||+++++|.+++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 4666677775544 4677777653 356899999999999999886421
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCC
Q 012777 243 ----ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS 318 (456)
Q Consensus 243 ----~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt 318 (456)
.+++..+..++.|++.+|.|||+++ |+||||||+|||++.++.+||+|||++....... ........++
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~----~~~~~~g~~t 373 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI----NFNPLYGMLD 373 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCC----ccCccccCCC
Confidence 1355678889999999999999999 9999999999999999999999999987542211 1111123357
Q ss_pred cccccccccCCCCC----------------------CCchhHHHHHHHHHHHHcCCC-CCCCCCccch--------HH--
Q 012777 319 WRYAAPEVYKNEEY----------------------DTKVDVFSFALILQEMIEGCP-PFPTKQEKEV--------PK-- 365 (456)
Q Consensus 319 ~~y~aPE~~~~~~~----------------------~~~~DiwslG~il~~l~~g~~-pf~~~~~~~~--------~~-- 365 (456)
+.|+|||.+..... ..+.|+||+||++++|++|.. ||........ ..
T Consensus 374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~ 453 (507)
T PLN03224 374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW 453 (507)
T ss_pred cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH
Confidence 89999998754321 124699999999999999875 7754321110 00
Q ss_pred HHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 012777 366 AYIANERPPFRAPTTHYAYGLRELIEDCWSEEP---FRRPTFRQILMR 410 (456)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp---~~Rpt~~ell~~ 410 (456)
.........+. .....+....+++.+||..+| .+|+|++|+++|
T Consensus 454 r~~~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 454 RMYKGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HhhcccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 01111122222 234567889999999999876 689999999986
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-31 Score=258.47 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=209.0
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.....+|+|+||.+ +.+++..|+|+++.+. .+..+-+.+|+-+++.++||||+.|++.+...+.++++||
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 4777789999999855 5679999999998764 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
||.||+|++.-.-.+++++.++..++++.+++|+|||++| -+|||||-.||++++.|.||+.|||.+-.+...-
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati--- 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI--- 166 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh---
Confidence 9999999998877789999999999999999999999999 8999999999999999999999999988664321
Q ss_pred CCCCcccCCCCccccccccc---CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCCCCCCCCc
Q 012777 308 EDRPVTCEETSWRYAAPEVY---KNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRAPTTHYA 383 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 383 (456)
.....+.||+.|||||+- +.+.|...+|||++|+...|+---++|--+..+........+.. .++.......-+
T Consensus 167 --~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws 244 (829)
T KOG0576|consen 167 --AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS 244 (829)
T ss_pred --hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence 122346799999999975 56688999999999999999988888876666655554444444 444444455667
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..|.+|++.++.++|++||+++.++.|
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheec
Confidence 789999999999999999999998873
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-31 Score=235.62 Aligned_cols=252 Identities=25% Similarity=0.415 Sum_probs=197.8
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----Cc
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS-----TP 221 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~ 221 (456)
.+.+-.+.||.|.||.| -.+|+.||+|++..- +.+--..+.+.+|+.+|+.++|.|++..++...-. ..
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 34555679999999966 246999999998753 35556678899999999999999999988876533 34
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
+|+++|++ ..+|..++.....++.+.+.-+..||+.+|+|||+.+ |+||||||.|.|++.+..+||||||+++...
T Consensus 132 iYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 132 LYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 78889998 6789999888888999999999999999999999999 9999999999999999999999999999763
Q ss_pred ccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-C-------
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-R------- 372 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~------- 372 (456)
. ......+..+.|-.|.|||++.+. .|+.+.||||.||++.||+..+..|...++.+....|..-. .
T Consensus 208 ~----d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr 283 (449)
T KOG0664|consen 208 Q----RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMK 283 (449)
T ss_pred h----hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHH
Confidence 2 222333344556679999999886 68999999999999999999988887766654333322110 1
Q ss_pred -----------------CCCCC-----CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 373 -----------------PPFRA-----PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 373 -----------------~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
|.+.. .+.+-..+...++.+++..||++|.+.++.+.++.
T Consensus 284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11110 11233445778899999999999999999887754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=232.93 Aligned_cols=246 Identities=26% Similarity=0.364 Sum_probs=191.9
Q ss_pred cccccceeeeccEEEEE----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------Cc
Q 012777 152 LDFSNSVEITKGTFRIA----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS------TP 221 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------~~ 221 (456)
.+|...+.+|.|.-..+ ...+++||+|++..+ +.+..-.+...+|..+++.++|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQIVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCceEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666666776655222 457899999999877 34444557788999999999999999999998533 45
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
.|+|||++ ..+|...+. -.++-+++..++.|++.|++|||+.+ |+||||||+||++..++.+|+.|||++....
T Consensus 96 ~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccC
Confidence 89999999 679988887 34777899999999999999999999 9999999999999999999999999998652
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-C--------
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-R-------- 372 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~-------- 372 (456)
.....+.+..+..|.|||++.+-.+...+||||+||++.||++|...|.+.+.-.-+.++.... .
T Consensus 170 ------~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 170 ------TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ------cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 2234556677888999999999889999999999999999999999888654322221111110 0
Q ss_pred ------------C------------CCC-----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 373 ------------P------------PFR-----APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 373 ------------~------------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+ ... .....-+..+++++.+||..||++|-+++++|+|
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 000 0011223458899999999999999999999987
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=221.53 Aligned_cols=271 Identities=15% Similarity=0.222 Sum_probs=229.3
Q ss_pred CccccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCc
Q 012777 148 DPKELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 148 ~~~~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~ 221 (456)
......|.+.++||+|+||.. ..++++||||.-.... ...++..|.+.++.| ..++|...|-+..+..+
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~ 98 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY 98 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccch
Confidence 455678999999999999854 5689999999976542 234678899999998 58999999999888888
Q ss_pred eEEEEEccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC-----CCEEEeccC
Q 012777 222 MMIVTEYLPKGDLRAYLKQKGA-LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS-----GHLKVADFG 295 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~-----~~vkl~Dfg 295 (456)
-.+|+|++ |.||.|++.-++. ++.+++..++.|++.-++++|++. +|.|||||+|+||+.. +.|.++|||
T Consensus 99 NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 99 NILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred hhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEecc
Confidence 89999999 8999999977654 999999999999999999999999 9999999999999843 469999999
Q ss_pred Ccccccccc--cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC--
Q 012777 296 LSKLLKFAN--TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-- 371 (456)
Q Consensus 296 ls~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-- 371 (456)
+++.+.+.. ...+.+......||.+||+-..+.+...+.+.|+-|||-++.+.+-|.+||.+.........+.+.+
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 999885532 3334455567789999999999999999999999999999999999999999877665544443322
Q ss_pred --CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccccccC
Q 012777 372 --RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVG 427 (456)
Q Consensus 372 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~ 427 (456)
..+......++|.++...+...-..+-++-|+++-+...+.++++......+..+|
T Consensus 255 Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yD 312 (449)
T KOG1165|consen 255 KRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYD 312 (449)
T ss_pred cccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccc
Confidence 12333345789999999999999999999999999999999999999999998888
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-27 Score=215.63 Aligned_cols=207 Identities=36% Similarity=0.626 Sum_probs=176.0
Q ss_pred eeccEEEEE---eEc--CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012777 160 ITKGTFRIA---SWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234 (456)
Q Consensus 160 lg~G~fg~~---~~~--g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~sL 234 (456)
||+|.+|.+ ... ++.+++|++...... ...+.+.+|+..++.++|++|+++++++......++++|++++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS--SLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccch--hHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 467777643 333 899999999865321 1357889999999999999999999999998999999999988999
Q ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-CCCEEEeccCCcccccccccccCCCCc
Q 012777 235 RAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD-SGHLKVADFGLSKLLKFANTVKEDRPV 312 (456)
Q Consensus 235 ~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~-~~~vkl~Dfgls~~~~~~~~~~~~~~~ 312 (456)
.+++... ..++...++.++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ..
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-----~~ 150 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-----LL 150 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-----hh
Confidence 9999875 46999999999999999999999999 999999999999999 89999999999876532211 12
Q ss_pred ccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHH
Q 012777 313 TCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIE 391 (456)
Q Consensus 313 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 391 (456)
....+...|++||.+... ..+.++|+|++|+++++| ..+.+++.
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~ 195 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIR 195 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHH
Confidence 224466789999998887 788899999999999999 46899999
Q ss_pred HhcccCCCCCCCHHHHHHHH
Q 012777 392 DCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 392 ~~l~~dp~~Rpt~~ell~~L 411 (456)
+|+..+|++||++.++++++
T Consensus 196 ~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 196 KMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHhhCCcccCcCHHHHhhCC
Confidence 99999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=218.97 Aligned_cols=245 Identities=20% Similarity=0.347 Sum_probs=187.0
Q ss_pred CCccccCcccc--ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeee
Q 012777 142 VPEYEIDPKEL--DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFL 213 (456)
Q Consensus 142 ~~~~~~~~~~~--~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~ 213 (456)
+|..++...++ .|.+.+.||+|.||.. ..+.+.+++|.+..+ .-...+|.+|..---.+ .|.||+.-|
T Consensus 12 I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY 87 (378)
T KOG1345|consen 12 IPMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTY 87 (378)
T ss_pred cccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHH
Confidence 45555554443 6889999999999965 346789999999865 34567899998766666 489999877
Q ss_pred eE-EEeCCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC--CCCCEE
Q 012777 214 GA-VTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD--DSGHLK 290 (456)
Q Consensus 214 ~~-~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~--~~~~vk 290 (456)
+. |+..+.+++++||++.|+|.+-+...| +-+.....++.|+++||.|+|+++ +||||||.+||||- +..+||
T Consensus 88 ~vaFqt~d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvK 163 (378)
T KOG1345|consen 88 EVAFQTSDAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVK 163 (378)
T ss_pred HHHhhcCceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEE
Confidence 64 777788999999999999998776533 888889999999999999999999 99999999999985 334899
Q ss_pred EeccCCcccccccccccCCCCcccCCCCcccccccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc---
Q 012777 291 VADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-----EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE--- 362 (456)
Q Consensus 291 l~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--- 362 (456)
|||||++...+.. ....-.+..|.+||.... ....+.+|+|.||+++|..++|++||.......
T Consensus 164 lcDFG~t~k~g~t--------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y 235 (378)
T KOG1345|consen 164 LCDFGLTRKVGTT--------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY 235 (378)
T ss_pred eeecccccccCce--------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH
Confidence 9999998755321 111223345889996532 246788999999999999999999997543322
Q ss_pred -hHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCC
Q 012777 363 -VPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRP 402 (456)
Q Consensus 363 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 402 (456)
...++..+..+..+.....+++.+..+.++-|..++++|=
T Consensus 236 ~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drc 276 (378)
T KOG1345|consen 236 WEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRC 276 (378)
T ss_pred HHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccc
Confidence 2233333333444444577888899999999999999993
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=204.18 Aligned_cols=276 Identities=16% Similarity=0.181 Sum_probs=223.7
Q ss_pred ccccceeeeccEEEE-----EeEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEE
Q 012777 153 DFSNSVEITKGTFRI-----ASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~-----~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.|...++||+|+||. ...+|+.||||+-..... ..++..|..++..++ ...|..+..++.+...-.+||
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 688899999999973 356899999999865532 246788999999995 578888888999999999999
Q ss_pred EccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---CCCEEEeccCCcccccc
Q 012777 227 EYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD---SGHLKVADFGLSKLLKF 302 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~---~~~vkl~Dfgls~~~~~ 302 (456)
+++ |.||.++++-+. .++.++++.++-|++.-++|+|.++ ++||||||+|+|..- -..+.|+|||+|+.+-+
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 999 899999998654 4999999999999999999999999 999999999999983 34799999999997643
Q ss_pred c--ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchH---HHHHhcC-CCCCC
Q 012777 303 A--NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVP---KAYIANE-RPPFR 376 (456)
Q Consensus 303 ~--~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~-~~~~~ 376 (456)
. ....+.+......||.+|.+-..+.+-..+.+.|+-|+|++|.++--|.+||.+..+..-. ..|.... ..+..
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie 246 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE 246 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence 2 2223344455678999999999988888899999999999999999999999987664433 3332222 22223
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccccccCcchhhHHHHHhhhc
Q 012777 377 APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVGPLRCFQSLAALWKK 441 (456)
Q Consensus 377 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (456)
.....+|.+|.-.+..|-..--++-|++.-+-+.+..++..++..-+.-+| |-++....++
T Consensus 247 ~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyD----W~~lkqk~~q 307 (341)
T KOG1163|consen 247 VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYD----WTMLKQKSQQ 307 (341)
T ss_pred HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEee----HHHHHHHhhc
Confidence 346889999999999999999999999999999999999999655555555 6666655443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=212.72 Aligned_cols=207 Identities=32% Similarity=0.538 Sum_probs=171.1
Q ss_pred cccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 154 FSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
|.....||.|+++.+ . .+++.+|+|.+...... ...+.+.+|+..+++++|++++++++++......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 455678999988754 2 24789999999865322 2467889999999999999999999999998999999999
Q ss_pred cCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 229 LPKGDLRAYLKQKGA-LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 229 ~~~~sL~~~l~~~~~-l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
+++++|.+++..... +++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~--- 152 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL--- 152 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc---
Confidence 998899999987666 899999999999999999999999 9999999999999999999999999988763321
Q ss_pred CCCCcccCCCCccccccccc-CCCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCcc-chHHHHHh
Q 012777 308 EDRPVTCEETSWRYAAPEVY-KNEEYDTKVDVFSFALILQEMIEGCPPFPT-KQEK-EVPKAYIA 369 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~-~~~~-~~~~~~~~ 369 (456)
........++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .++. .+...+..
T Consensus 153 -~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 153 -AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred -cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 0012233466779999998 666788899999999999999999999977 4444 45555533
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=221.40 Aligned_cols=268 Identities=20% Similarity=0.273 Sum_probs=211.4
Q ss_pred ccccceeeeccEEEEE---eE-c--CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC----CCcceeeeeEE-EeCCc
Q 012777 153 DFSNSVEITKGTFRIA---SW-R--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR----HPNVVQFLGAV-TQSTP 221 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~-~--g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~----hp~iv~l~~~~-~~~~~ 221 (456)
+|.+.+.||+|+||.+ .. . ...+|+|+......... ..+..|..++..+. .+++..+++.+ .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 6999999999999966 21 1 24799999876422211 25778888888886 36899999999 57788
Q ss_pred eEEEEEccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC-----CCEEEecc
Q 012777 222 MMIVTEYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS-----GHLKVADF 294 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~-----~~vkl~Df 294 (456)
.++||+.+ |.+|.++.... +.++..++..|+.|++.+|+++|+.| ++||||||+|++++.. ..+.|.||
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence 99999999 88999988654 45999999999999999999999999 9999999999999854 46999999
Q ss_pred CCcccccc--cccc--cCCCC-cccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHh
Q 012777 295 GLSKLLKF--ANTV--KEDRP-VTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIA 369 (456)
Q Consensus 295 gls~~~~~--~~~~--~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 369 (456)
|+++.... .... ...+. .....||.+|+++.++.+...+++.|+|||++++.+++.|.+||...........+..
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~ 251 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK 251 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence 99984321 1111 12222 2346699999999999999999999999999999999999999987765444333322
Q ss_pred cCCCCCCC-CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccccccC
Q 012777 370 NERPPFRA-PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVG 427 (456)
Q Consensus 370 ~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~ 427 (456)
........ .....+..+.++...+-..+...+|.+..+...|...+.........+.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~d 310 (322)
T KOG1164|consen 252 DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFD 310 (322)
T ss_pred HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCc
Confidence 22111111 23456678999999999999999999999999999999988778778888
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=221.02 Aligned_cols=126 Identities=28% Similarity=0.406 Sum_probs=106.9
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-----C---CcceeeeeEEEe
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-----H---PNVVQFLGAVTQ 218 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---p~iv~l~~~~~~ 218 (456)
-+|.++++||=|-|.+| ..+.+.||+|+.+. .+...+..+.|+.+|+++. | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS----AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS----AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh----hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 46889999999999876 45678999999974 3445577789999999983 2 379999999975
Q ss_pred C----CceEEEEEccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC
Q 012777 219 S----TPMMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD 284 (456)
Q Consensus 219 ~----~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~ 284 (456)
. .++|+|+|++ |.+|..+|+... -++...+..|++|++.||.|||... +|||-||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 4 5799999999 889999998753 3999999999999999999999876 599999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=204.15 Aligned_cols=165 Identities=20% Similarity=0.264 Sum_probs=130.2
Q ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCC
Q 012777 232 GDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR 310 (456)
Q Consensus 232 ~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~ 310 (456)
|+|.+++... ..+++.+++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-------
Confidence 6899999874 45999999999999999999999885 999999999999999 9998765321
Q ss_pred CcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc-hHHHHHhcCCCCC---CCCCCCCcH--
Q 012777 311 PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE-VPKAYIANERPPF---RAPTTHYAY-- 384 (456)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~-- 384 (456)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+........ ......++.
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAAR 139 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhh
Confidence 1247889999999999999999999999999999999999997654432 2222222211111 011223333
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
.+.++|.+||..||++||++.++++++..+..+
T Consensus 140 ~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 140 SFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred hHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 599999999999999999999999999877643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=256.36 Aligned_cols=198 Identities=17% Similarity=0.181 Sum_probs=142.1
Q ss_pred CCC-CcceeeeeEE-------EeCCceEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 012777 204 IRH-PNVVQFLGAV-------TQSTPMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHR 274 (456)
Q Consensus 204 l~h-p~iv~l~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~ 274 (456)
++| +||++++++| .....++.++|++ +++|.+++... ..+++.++..++.||+.||.|||++| |+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 345 5788888877 3335677888988 67999999753 45999999999999999999999999 9999
Q ss_pred CCCCCCeEeCCCC-------------------CEEEeccCCccccccccc-----ccC------CCCcccCCCCcccccc
Q 012777 275 DLEPSNILRDDSG-------------------HLKVADFGLSKLLKFANT-----VKE------DRPVTCEETSWRYAAP 324 (456)
Q Consensus 275 Dikp~Nil~~~~~-------------------~vkl~Dfgls~~~~~~~~-----~~~------~~~~~~~~gt~~y~aP 324 (456)
||||+|||++..+ .+|++|||+++....... ... ........+|+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 9999999996544 455566666543210000 000 0001124578889999
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH
Q 012777 325 EVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTF 404 (456)
Q Consensus 325 E~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~ 404 (456)
|++.+..++.++|||||||+||||++|.+|+..... ....+.....++. .........+++.+||.++|.+||++
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQ---ILLNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChh---hhhcCHHHHHHHHHhCCCChhhCcCh
Confidence 999999999999999999999999999988754321 1222211111111 11123456789999999999999999
Q ss_pred HHHHHH
Q 012777 405 RQILMR 410 (456)
Q Consensus 405 ~ell~~ 410 (456)
.+++++
T Consensus 260 ~eil~h 265 (793)
T PLN00181 260 SELLQS 265 (793)
T ss_pred HHHhhc
Confidence 999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=217.40 Aligned_cols=248 Identities=21% Similarity=0.330 Sum_probs=188.0
Q ss_pred cccccceeeeccEEEEE-----eE---cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCce
Q 012777 152 LDFSNSVEITKGTFRIA-----SW---RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~---~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 222 (456)
..|....+||.|+|+.| .. .++.||+|.+.... .+ ..+.+|+++|..+ .+.||+++.+++...+..
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SP---SRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--Cc---hHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 35778889999999866 22 57789999997543 22 5689999999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-CCCCEEEeccCCccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD-DSGHLKVADFGLSKLLK 301 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~-~~~~vkl~Dfgls~~~~ 301 (456)
.+|+||++...-.++... ++...+..+++.++.||.++|.+| ||||||||+|+|++ ..+.-.|+|||++....
T Consensus 111 ~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred EEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999999888887753 778999999999999999999999 99999999999999 56788999999998321
Q ss_pred ccc------c-----ccC----------------------------CCCcccCCCCcccccccccCC-CCCCCchhHHHH
Q 012777 302 FAN------T-----VKE----------------------------DRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSF 341 (456)
Q Consensus 302 ~~~------~-----~~~----------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diwsl 341 (456)
... . ... ........||++|.|||++.+ +..++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 100 0 000 000012459999999998755 467889999999
Q ss_pred HHHHHHHHcCCCCCCCCCccc-h-------------HHHHHhcCC------CC-------------C-------------
Q 012777 342 ALILQEMIEGCPPFPTKQEKE-V-------------PKAYIANER------PP-------------F------------- 375 (456)
Q Consensus 342 G~il~~l~~g~~pf~~~~~~~-~-------------~~~~~~~~~------~~-------------~------------- 375 (456)
|+++..+++++.||-.....- . ......-++ .+ .
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 999999999999985422210 0 000000000 00 0
Q ss_pred --CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 376 --RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 376 --~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
......++..+.+++++|+..||.+|.|+++.|+|
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00113344568899999999999999999999876
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-25 Score=228.75 Aligned_cols=248 Identities=20% Similarity=0.244 Sum_probs=178.8
Q ss_pred ccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHH--HhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELAL--LQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~--l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
++...+.||++.|-++ +...-.|+||++-+.. +.-..+.|.+++.- ...+++||++++.-.-..++..|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~--p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQD--PTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccC--CCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4777889999999644 3344459999997653 22223344443333 444589999999888888888999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcc--ccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK--LLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~--~~~~~~~ 305 (456)
|+ ..+|+|.+..++-+...+...|+.|++.||.-||+.| |+|||||.+||||+..+.+.|+||..-+ +++..+.
T Consensus 102 yv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99 5699999988777999999999999999999999999 9999999999999999999999998765 2222222
Q ss_pred ccCCCCcccCCCCcccccccccCCC----------C-CCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCC
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNE----------E-YDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERP 373 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 373 (456)
.....+..+......|.|||.+-.. + .+++.||||+||+++||++ |++||.-.. .-.+..+...
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~~~~~ 253 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRSGNAD 253 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhccCcc
Confidence 2222222222334469999987431 2 6678999999999999998 899984311 0011011000
Q ss_pred CCC-CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 PFR-APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 ~~~-~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
... ....--+..++++|..|++.||.+|.+++++|+.
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 000 0011122358999999999999999999999998
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.8e-22 Score=190.06 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=198.9
Q ss_pred cccceeeeccEEEEEe--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCC-cceeeeeEEEeCCceEEEEEccC
Q 012777 154 FSNSVEITKGTFRIAS--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHP-NVVQFLGAVTQSTPMMIVTEYLP 230 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~l~~~~~~~~~~~lv~e~~~ 230 (456)
|.....||.|.|+.+. .....+++|.+.............+.+|..++..+.|+ +++++++.+......+++++++.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 5667789999997652 22378999999877654444578899999999999887 79999999977777899999999
Q ss_pred CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-CEEEeccCCcccccccccc
Q 012777 231 KGDLRAYLKQKG---ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG-HLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 231 ~~sL~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~-~vkl~Dfgls~~~~~~~~~ 306 (456)
++++.+++.... .++......++.|++.++.++|+.+ ++|||+||+||+++..+ .++++|||.+.........
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999998877664 7999999999999999999999999 99999999999999888 7999999998855322111
Q ss_pred cCC-CCcccCCCCcccccccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc----cchHHHHHhcCCC-CCCC
Q 012777 307 KED-RPVTCEETSWRYAAPEVYKN---EEYDTKVDVFSFALILQEMIEGCPPFPTKQE----KEVPKAYIANERP-PFRA 377 (456)
Q Consensus 307 ~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~-~~~~ 377 (456)
... .......++..|++||.+.+ .......|+|++|++++++++|..||..... ......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 110 13355678999999999987 5788899999999999999999999877664 2333333322222 1111
Q ss_pred CCCCC----cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 378 PTTHY----AYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 378 ~~~~~----~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..... ...+.+++..++..+|..|.+..+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11111 2578999999999999999998887776
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=194.12 Aligned_cols=174 Identities=21% Similarity=0.242 Sum_probs=129.5
Q ss_pred CccccCccccccccceeeeccEEEEEe---E---cCcEEEEEEeCCCCC--CCHHHHHHHHHHHHHHhcCCCCccee-ee
Q 012777 143 PEYEIDPKELDFSNSVEITKGTFRIAS---W---RGTQVAVKTLGEEVF--TDEDKVKAFIDELALLQKIRHPNVVQ-FL 213 (456)
Q Consensus 143 ~~~~~~~~~~~~~~~~~lg~G~fg~~~---~---~g~~vAvK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~-l~ 213 (456)
|...+.+....|...+.||+|+||.|. . +++.||||++..... ......+.+.+|+++|++++|+++++ ++
T Consensus 9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~ 88 (365)
T PRK09188 9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL 88 (365)
T ss_pred cccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence 334455566679999999999999772 1 467789998763311 13344567999999999999999985 54
Q ss_pred eEEEeCCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCeEeCCCCCEEEe
Q 012777 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDL-EPSNILRDDSGHLKVA 292 (456)
Q Consensus 214 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Di-kp~Nil~~~~~~vkl~ 292 (456)
+. +..++||||++|++|... . ... ...++.|++++|.|||++| |+|||| ||+|||++.++.+||+
T Consensus 89 ~~----~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 89 AT----GKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred Ec----CCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEE
Confidence 42 457999999999999732 1 111 1467899999999999999 999999 9999999999999999
Q ss_pred ccCCcccccccccccC---CCCcccCCCCcccccccccCCC
Q 012777 293 DFGLSKLLKFANTVKE---DRPVTCEETSWRYAAPEVYKNE 330 (456)
Q Consensus 293 Dfgls~~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~ 330 (456)
|||+++.+...+.... ........+++.|++||.+...
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9999997643321111 1122355677889999988554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-23 Score=217.52 Aligned_cols=250 Identities=25% Similarity=0.332 Sum_probs=184.1
Q ss_pred cceeeeccEEEEE----e-EcCcEEEEEEeCC---CCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 156 NSVEITKGTFRIA----S-WRGTQVAVKTLGE---EVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 156 ~~~~lg~G~fg~~----~-~~g~~vAvK~~~~---~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
..+.+|.|.+|.+ . .....++.|.... ...........+..|+-+-..++|||++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4567788888722 1 1233344443321 111122222236677777888899999888777766555555599
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
||++ +|..++...+.+...++..++.|++.|++|+|+.| +.|||+|++|+++..+|.+||+|||.+.........
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~- 476 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK- 476 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcch-
Confidence 9998 99999998778999999999999999999999999 999999999999999999999999998866432211
Q ss_pred CCCCcccCCCCcccccccccCCCCCCC-chhHHHHHHHHHHHHcCCCCCCCCCccchH-HHHHhcC----CCCCCCCCCC
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDT-KVDVFSFALILQEMIEGCPPFPTKQEKEVP-KAYIANE----RPPFRAPTTH 381 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~----~~~~~~~~~~ 381 (456)
.........|+..|+|||.+.+..|++ ..||||.|++++.|.+|+.||......... ....... ..........
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL 556 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence 113344567888999999999999998 489999999999999999999765544322 1111111 1111112356
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++..-+.+|.+||+.||.+|-|+++|++.
T Consensus 557 lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 557 LPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred chhhHHHHHHHHccCChhheecHHHHhhC
Confidence 67778999999999999999999999875
|
|
| >KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-22 Score=169.78 Aligned_cols=116 Identities=28% Similarity=0.324 Sum_probs=99.9
Q ss_pred CCCCCCCCCCC-CCCCchHHHHHHHcCCHHHHHHHH-HcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhC-CCCCCCC
Q 012777 23 LPADDDADGSE-AIDPRVRLMYMANEGDLDGIKELL-DSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSR-GADVDPE 99 (456)
Q Consensus 23 ~~~~~~~~~~~-~~~g~t~Lh~a~~~~~~~~~~~Ll-~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~-ga~~~~~ 99 (456)
++..+++-..+ |-||+|||||||..|+.+++.+|+ +.++.+|.+|..||||||+||..|+.++|+.|+.+ |+|+|..
T Consensus 23 ~~s~~kSL~~r~dqD~Rt~LHwa~S~g~~eiv~fLlsq~nv~~ddkDdaGWtPlhia~s~g~~evVk~Ll~r~~advna~ 102 (226)
T KOG4412|consen 23 IQSDPKSLNARDDQDGRTPLHWACSFGHVEIVYFLLSQPNVKPDDKDDAGWTPLHIAASNGNDEVVKELLNRSGADVNAT 102 (226)
T ss_pred HhcChhhhhccccccCCceeeeeeecCchhHHHHHHhcCCCCCCCccccCCchhhhhhhcCcHHHHHHHhcCCCCCccee
Confidence 44445443444 449999999999999999999999 56788999999999999999999999999999998 9999999
Q ss_pred CCCCCcccccccccccchhhhhhhhcCCCCCCCcccccc
Q 012777 100 DRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQN 138 (456)
Q Consensus 100 ~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~ 138 (456)
++.|.||||||+..|+.||+++|+..|+.+++++-+.++
T Consensus 103 tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~~qt 141 (226)
T KOG4412|consen 103 TNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQGQT 141 (226)
T ss_pred cCCCcceehhhhcCChhhHHHHHHhcCCCCcccccccCc
Confidence 999999999999999999999999999998887666543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=201.57 Aligned_cols=230 Identities=22% Similarity=0.300 Sum_probs=188.7
Q ss_pred eeccEEEEE--------eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEEccC
Q 012777 160 ITKGTFRIA--------SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIVTEYLP 230 (456)
Q Consensus 160 lg~G~fg~~--------~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv~e~~~ 230 (456)
+|.|.||.+ ...|..+|+|+.++......... ....|..++...+ ||.+++++-.+..+..+++++++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 678888754 45678899999987654333222 6677888888886 9999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCC
Q 012777 231 KGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR 310 (456)
Q Consensus 231 ~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~ 310 (456)
|+.|...+.+...+.+.....+...++-+++++|+.+ ++|||+|++||+++.+|.+++.|||+++..-...
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------ 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------ 151 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh------
Confidence 9999999988788999999999999999999999999 9999999999999999999999999998653211
Q ss_pred CcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHH
Q 012777 311 PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELI 390 (456)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 390 (456)
...||..|||||++. ....++|.||+|+++++|++|..||.. +....|.... .. .+...+..+++++
T Consensus 152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-~~---~p~~l~~~a~~~~ 218 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-LE---MPRELSAEARSLF 218 (612)
T ss_pred ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-cC---CchhhhHHHHHHH
Confidence 116899999999988 567899999999999999999999988 4444453322 22 2567788899999
Q ss_pred HHhcccCCCCCCCH--HHHHHHHH
Q 012777 391 EDCWSEEPFRRPTF--RQILMRLD 412 (456)
Q Consensus 391 ~~~l~~dp~~Rpt~--~ell~~L~ 412 (456)
..++..+|.+|.-. ..+.+..+
T Consensus 219 ~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 219 RQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred HHHHhhCHHHHhccCcchhHHHhc
Confidence 99999999999755 34444433
|
|
| >KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4e-21 Score=160.91 Aligned_cols=117 Identities=31% Similarity=0.362 Sum_probs=107.5
Q ss_pred CCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHc-CCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCC
Q 012777 24 PADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDS-GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRW 102 (456)
Q Consensus 24 ~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~-g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 102 (456)
..|-..++. |..|+||||+||..|+.++|+.|+.+ |+|+|+.+..|.||||+|+..|..+|+++|+++|+.++.+|..
T Consensus 60 q~nv~~ddk-DdaGWtPlhia~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~ 138 (226)
T KOG4412|consen 60 QPNVKPDDK-DDAGWTPLHIAASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQ 138 (226)
T ss_pred cCCCCCCCc-cccCCchhhhhhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCcccccc
Confidence 344445555 66799999999999999999999988 9999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccchhhhhhhhcCCCCCCCccccccccC
Q 012777 103 GSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNARE 141 (456)
Q Consensus 103 g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~~~~ 141 (456)
|.||||-|+.-|+.+++++|+..|+.+|.++-+..++..
T Consensus 139 ~qtplHRAAavGklkvie~Li~~~a~~n~qDk~G~TpL~ 177 (226)
T KOG4412|consen 139 GQTPLHRAAAVGKLKVIEYLISQGAPLNTQDKYGFTPLH 177 (226)
T ss_pred cCchhHHHHhccchhhHHHHHhcCCCCCcccccCccHHH
Confidence 999999999999999999999999999999888776544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=7e-21 Score=172.86 Aligned_cols=169 Identities=11% Similarity=0.164 Sum_probs=131.1
Q ss_pred cccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHH------HHHHHHHHhcCCCCcceeeeeEEEeC---
Q 012777 152 LDFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKA------FIDELALLQKIRHPNVVQFLGAVTQS--- 219 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~------~~~E~~~l~~l~hp~iv~l~~~~~~~--- 219 (456)
-+|...+.+|.|+||.| ..++..+|+|++..+....+..... +.+|+..+.++.||+|..+.+++...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~ 110 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERK 110 (232)
T ss_pred CceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccc
Confidence 36888999999999866 3357789999998765555554444 57899999999999999999886643
Q ss_pred -----CceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEecc
Q 012777 220 -----TPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294 (456)
Q Consensus 220 -----~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Df 294 (456)
...+++|||++|.+|.++. .+++ ....+++.+|..||+.| ++|||+||+||+++.+| ++|+||
T Consensus 111 ~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 111 TLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred cccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEEC
Confidence 3578999999999998873 2333 34669999999999999 99999999999999988 999999
Q ss_pred CCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHH
Q 012777 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI 349 (456)
Q Consensus 295 gls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 349 (456)
|....... .... ..++....++.++|+|+||+++..+.
T Consensus 179 g~~~~~~e------~~a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQ------RKAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccc------hhhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 98764411 1110 11344455778999999999987664
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=176.25 Aligned_cols=229 Identities=19% Similarity=0.284 Sum_probs=147.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC----------CCcceeeeeEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR----------HPNVVQFLGAVT 217 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------hp~iv~l~~~~~ 217 (456)
.+.....||.|+++.+ ..+|+.+|+|++..........++.+.+|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4566778999988765 3468999999997665444556778887775555532 212222233221
Q ss_pred ---------eC---C-----ceEEEEEccCCCCHHHHHHH---cCC----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 012777 218 ---------QS---T-----PMMIVTEYLPKGDLRAYLKQ---KGA----LKPTLAVKFALDIARGMNYLHENRPEAIIH 273 (456)
Q Consensus 218 ---------~~---~-----~~~lv~e~~~~~sL~~~l~~---~~~----l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH 273 (456)
.. . ..+++|+-. .++|.+++.- ... +.......+..|++..+.+||.+| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11 1 246777777 5788887642 222 222334556799999999999999 999
Q ss_pred cCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCC--------CCCCCchhHHHHHHHH
Q 012777 274 RDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN--------EEYDTKVDVFSFALIL 345 (456)
Q Consensus 274 ~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il 345 (456)
+||+|+|++++.+|.++|+||+.....+.. ..+...+..|.|||.... -.++.+.|.|+||+++
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~--------~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR--------YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEE--------EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCce--------eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 999999999999999999999876654321 111233467999997633 2467789999999999
Q ss_pred HHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCC
Q 012777 346 QEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRR 401 (456)
Q Consensus 346 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 401 (456)
|.|++|..||....+...... .+.... ++|..++.||..+|+.||.+|
T Consensus 241 y~lWC~~lPf~~~~~~~~~~~-------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEADPEW-------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHSS-STCCCGGGSTSGG-------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHccCCCCCCCccccccc-------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999999987654332221 222233 889999999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.7e-20 Score=164.72 Aligned_cols=138 Identities=19% Similarity=0.204 Sum_probs=105.0
Q ss_pred ceeeeccEEEEE----eEcCcEEEEEEeCCCCCCCHH-----------------------HHHHHHHHHHHHhcCCCCcc
Q 012777 157 SVEITKGTFRIA----SWRGTQVAVKTLGEEVFTDED-----------------------KVKAFIDELALLQKIRHPNV 209 (456)
Q Consensus 157 ~~~lg~G~fg~~----~~~g~~vAvK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~hp~i 209 (456)
...||+|+||.| ..+|+.||||+++........ .......|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 357999999866 126899999999764321111 01223459999999987776
Q ss_pred eeeeeEEEeCCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCeEeCCCCC
Q 012777 210 VQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYL-HENRPEAIIHRDLEPSNILRDDSGH 288 (456)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~L-H~~~~~~ivH~Dikp~Nil~~~~~~ 288 (456)
........ ...++||||++++++.......+.++...+..++.|++.+|.++ |+.| |+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCc
Confidence 44333222 23389999998877766544556799999999999999999999 7999 99999999999998 478
Q ss_pred EEEeccCCcccc
Q 012777 289 LKVADFGLSKLL 300 (456)
Q Consensus 289 vkl~Dfgls~~~ 300 (456)
++|+|||++...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=159.33 Aligned_cols=190 Identities=14% Similarity=0.039 Sum_probs=135.0
Q ss_pred ccceeeeccEEEEEeE---cCcEEEEEEeCCCCCCCHH-HHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEEcc
Q 012777 155 SNSVEITKGTFRIASW---RGTQVAVKTLGEEVFTDED-KVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIVTEYL 229 (456)
Q Consensus 155 ~~~~~lg~G~fg~~~~---~g~~vAvK~~~~~~~~~~~-~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv~e~~ 229 (456)
.+...|++|+||.+.. .+.+++.+.+......... ....+.+|+++|+++. |+++++++++ ...+++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 3456899999997743 5677887777654321111 1225789999999995 6889999886 3469999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCeEeCCCCCEEEeccCCcccccccccc--
Q 012777 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDL-EPSNILRDDSGHLKVADFGLSKLLKFANTV-- 306 (456)
Q Consensus 230 ~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Di-kp~Nil~~~~~~vkl~Dfgls~~~~~~~~~-- 306 (456)
.|.+|.+.... ....++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 81 AGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred cCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99998764321 12357889999999999999 999999 799999999999999999999855322110
Q ss_pred --c-CCC---CcccCCCCcccccccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 012777 307 --K-EDR---PVTCEETSWRYAAPEVYKN--EEYDTKVDVFSFALILQEMIEGCPPFPTK 358 (456)
Q Consensus 307 --~-~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~ 358 (456)
. .+. .......++.+++|+.-.- ..--.+.+.++.|+.+|.++|+..+....
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 000 0011224566777774322 22225689999999999999998886543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=178.41 Aligned_cols=212 Identities=30% Similarity=0.486 Sum_probs=164.7
Q ss_pred HhcCCCCcceeeeeEEEeCCceEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EecCCCC
Q 012777 201 LQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAI-IHRDLEP 278 (456)
Q Consensus 201 l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~i-vH~Dikp 278 (456)
|+.+.|.|+.++++.+..+...++|.+||..|+|.|.+... ..++......+.++++.+|.|+|... | .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeecc
Confidence 35678999999999999999999999999999999999873 45888899999999999999999886 4 9999999
Q ss_pred CCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCC---C----CCCchhHHHHHHHHHHHHcC
Q 012777 279 SNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE---E----YDTKVDVFSFALILQEMIEG 351 (456)
Q Consensus 279 ~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~~~~~DiwslG~il~~l~~g 351 (456)
.|++++....+||.|||+....... .............-|.|||.++.. . .+.+.|+||+|++++|+++.
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~---~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEET---AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred ccceeeeeEEEEechhhhccccccc---ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999997765320 001111111123459999999774 1 35579999999999999999
Q ss_pred CCCCCCCCcc----chHHHHHhcCCCCCCCC---CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 352 CPPFPTKQEK----EVPKAYIANERPPFRAP---TTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 352 ~~pf~~~~~~----~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
..||+..... ++...+......++... ....++.+..++..||..+|.+||+++++-..++.+...-
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred cCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 9999874432 34444433232222211 1145557999999999999999999999999988887643
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.3e-19 Score=165.15 Aligned_cols=202 Identities=21% Similarity=0.283 Sum_probs=149.4
Q ss_pred CCCcceeeeeEEEe---------------------------CCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHH
Q 012777 205 RHPNVVQFLGAVTQ---------------------------STPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIA 257 (456)
Q Consensus 205 ~hp~iv~l~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~ 257 (456)
+|||||++..+|.+ ...+|+||... ..+|.+++-.+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 69999999988753 24689999988 56999998654 466677778999999
Q ss_pred HHHHHHHhCCCCCeEecCCCCCCeEeC--CCC--CEEEeccCCcccccc-cccccCCCCcccCCCCcccccccccCCCC-
Q 012777 258 RGMNYLHENRPEAIIHRDLEPSNILRD--DSG--HLKVADFGLSKLLKF-ANTVKEDRPVTCEETSWRYAAPEVYKNEE- 331 (456)
Q Consensus 258 ~aL~~LH~~~~~~ivH~Dikp~Nil~~--~~~--~vkl~Dfgls~~~~~-~~~~~~~~~~~~~~gt~~y~aPE~~~~~~- 331 (456)
+|+.|||.+| |.|||+|.+|||+. +++ .+.++|||.+---.. +-.....+......|.-..||||+....+
T Consensus 352 Eav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 9999999999 99999999999986 333 477899997542211 11122222333455777799999875432
Q ss_pred ----CC-CchhHHHHHHHHHHHHcCCCCCCCCCccchH-HHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 012777 332 ----YD-TKVDVFSFALILQEMIEGCPPFPTKQEKEVP-KAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFR 405 (456)
Q Consensus 332 ----~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ 405 (456)
.+ .++|.|+.|.+.||+++...||.......+- +.+ ....++..+..+++.+++++..+|+.||.+|++..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y---qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY---QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh---hhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 11 3799999999999999999999885433221 122 22233445788999999999999999999999887
Q ss_pred HHHHHHHHH
Q 012777 406 QILMRLDDI 414 (456)
Q Consensus 406 ell~~L~~~ 414 (456)
=..+.|+=.
T Consensus 506 iAANvl~Ls 514 (598)
T KOG4158|consen 506 IAANVLNLS 514 (598)
T ss_pred HHHhHHHHH
Confidence 766666533
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.6e-19 Score=186.06 Aligned_cols=258 Identities=19% Similarity=0.238 Sum_probs=189.1
Q ss_pred ccCCCccccCccccccccceeeeccEEEEE----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC---CCccee
Q 012777 139 AREVPEYEIDPKELDFSNSVEITKGTFRIA----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR---HPNVVQ 211 (456)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~lg~G~fg~~----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~ 211 (456)
+..-|.-++......|.+.+.||+|+||.| ..+|+.||+|+-+......=. -=.+++.+|+ -+.|..
T Consensus 685 ~~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY------I~~q~~~RLk~~~~~~~~~ 758 (974)
T KOG1166|consen 685 PKLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY------ICLQVMERLKPQMLPSIMH 758 (974)
T ss_pred cccCccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee------ehHHHHHhhchhhhcchHH
Confidence 333455556666778999999999999965 346999999998766433211 1123334443 456777
Q ss_pred eeeEEEeCCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC------
Q 012777 212 FLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD------ 285 (456)
Q Consensus 212 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~------ 285 (456)
+..++...+..++|+||.+.|+|.++++..+.+++..+..++.|++..+++||..+ |||+||||+|+|+..
T Consensus 759 ~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~ 835 (974)
T KOG1166|consen 759 ISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADS 835 (974)
T ss_pred HHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCC
Confidence 77788888889999999999999999998888999999999999999999999999 999999999999862
Q ss_pred -CCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCC-CCCCccch
Q 012777 286 -SGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPF-PTKQEKEV 363 (456)
Q Consensus 286 -~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~ 363 (456)
.--++|+|||.+..+..-.. ........+|-.+-.+|+..+.+++...|.|.|..+++-|+.|+.-- .+.....
T Consensus 836 ~~~~l~lIDfG~siDm~lfp~---~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~~- 911 (974)
T KOG1166|consen 836 DSKGLYLIDFGRSIDMKLFPD---GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSWM- 911 (974)
T ss_pred cccceEEEecccceeeeEcCC---CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCccee-
Confidence 23589999999986632211 11233345677899999999999999999999999999999986431 1111000
Q ss_pred HHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 364 PKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
+ ...+ .+.---+-..+|+..+|+.|-..=|...+|...++.++.+.
T Consensus 912 ---~----~~~~--~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 912 ---V----KTNF--PRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred ---c----cccc--hhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 0 0000 00000122567888888866556688999999999888665
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=156.52 Aligned_cols=138 Identities=18% Similarity=0.135 Sum_probs=106.2
Q ss_pred ceeeeccEEEEE---e-EcCcEEEEEEeCCCCCCC---------------------H--HHHHHHHHHHHHHhcCCCCcc
Q 012777 157 SVEITKGTFRIA---S-WRGTQVAVKTLGEEVFTD---------------------E--DKVKAFIDELALLQKIRHPNV 209 (456)
Q Consensus 157 ~~~lg~G~fg~~---~-~~g~~vAvK~~~~~~~~~---------------------~--~~~~~~~~E~~~l~~l~hp~i 209 (456)
.+.||+|+||.+ . .+|+.||||++....... . .....+..|...+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999876 2 269999999998652110 0 012234678999999998887
Q ss_pred eeeeeEEEeCCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCCC
Q 012777 210 VQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHE-NRPEAIIHRDLEPSNILRDDSGH 288 (456)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~~~~ivH~Dikp~Nil~~~~~~ 288 (456)
.....+... ..++||||++|+++.........++...+..++.|++.++.++|. .| |+||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCC
Confidence 544443333 248999999887654443344568889999999999999999999 98 99999999999999 789
Q ss_pred EEEeccCCcccc
Q 012777 289 LKVADFGLSKLL 300 (456)
Q Consensus 289 vkl~Dfgls~~~ 300 (456)
++|+|||++...
T Consensus 156 ~~liDFG~a~~~ 167 (190)
T cd05145 156 PYIIDVSQAVEL 167 (190)
T ss_pred EEEEEcccceec
Confidence 999999998765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.2e-18 Score=154.93 Aligned_cols=134 Identities=19% Similarity=0.270 Sum_probs=103.5
Q ss_pred ccccceeeeccEEEEEeE---cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-----CCCcceeeeeEEEeCC---c
Q 012777 153 DFSNSVEITKGTFRIASW---RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-----RHPNVVQFLGAVTQST---P 221 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~~---~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~l~~~~~~~~---~ 221 (456)
+......||+|+|+.+.. ++.. +||++.... ....+.+.+|+.+++.+ .||||+++++++.++. .
T Consensus 3 ~L~~~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 3 RLSEQSPLGTGRHRKCYAHPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred ecCCcceecCCCceEEEECCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 345567899999998743 2333 688876542 22346789999999999 5799999999998873 3
Q ss_pred eE-EEEEc--cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCCeEeCC----CCCEEEec
Q 012777 222 MM-IVTEY--LPKGDLRAYLKQKGALKPTLAVKFALDIARGM-NYLHENRPEAIIHRDLEPSNILRDD----SGHLKVAD 293 (456)
Q Consensus 222 ~~-lv~e~--~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL-~~LH~~~~~~ivH~Dikp~Nil~~~----~~~vkl~D 293 (456)
++ +|+|| +.+++|.+++++. .+++. ..++.|++.++ +|||+++ |+||||||+|||++. ++.++|+|
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 33 78999 5579999999763 46655 35678888777 9999999 999999999999974 33799999
Q ss_pred cCC
Q 012777 294 FGL 296 (456)
Q Consensus 294 fgl 296 (456)
|+.
T Consensus 153 g~G 155 (210)
T PRK10345 153 NIG 155 (210)
T ss_pred CCC
Confidence 543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.2e-19 Score=182.18 Aligned_cols=229 Identities=28% Similarity=0.410 Sum_probs=166.7
Q ss_pred ccCccccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012777 146 EIDPKELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST 220 (456)
Q Consensus 146 ~~~~~~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 220 (456)
.-.+.+.+|..++.|-.|.||.+. .+-+++|+|+ .++. .+.+ .++....+|.+|
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~--------lilR--nilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN--------LILR--NILTFAGNPFVV---------- 135 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhcc-cccc--------hhhh--ccccccCCccee----------
Confidence 456677889999999999998663 3466788843 3221 1111 033333455554
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
|+-...++.-++++..- +.+++|||+.+ |+|||+||+|.+|+.-|.+|+.|||+++..
T Consensus 136 -----------gDc~tllk~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 -----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred -----------chhhhhcccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 45555665555666543 78999999999 999999999999999999999999998855
Q ss_pred cccc--cccCC--------CCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc
Q 012777 301 KFAN--TVKED--------RPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN 370 (456)
Q Consensus 301 ~~~~--~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 370 (456)
.... ...+. ......+|||.|.|||++....|...+|+|++|+++|+.+-|+.||.+.+++++..+++..
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd 273 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 273 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh
Confidence 2211 11100 1112357999999999999999999999999999999999999999999999988777443
Q ss_pred CCCCCCCCCCCCcHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHHHh
Q 012777 371 ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRP-TFRQILMRLDDISDQL 418 (456)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-t~~ell~~L~~~~~~~ 418 (456)
. ..+......++.+++++|.++|..+|..|. |..++.-.=+.++..+
T Consensus 274 ~-i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 274 D-IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred h-ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 3 233333577888999999999999999996 4444444444555554
|
|
| >KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.7e-19 Score=146.90 Aligned_cols=96 Identities=28% Similarity=0.277 Sum_probs=67.7
Q ss_pred CCCCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCC
Q 012777 21 QPLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100 (456)
Q Consensus 21 ~~~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~ 100 (456)
++|++.+|....+|.||+||||-|+++|+++|++.|+..|+|++++-..||||||-||..++.+|+-.||.+|+|+|.+.
T Consensus 81 ~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~va~~LLqhgaDVnA~t 160 (228)
T KOG0512|consen 81 RLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEVAGRLLQHGADVNAQT 160 (228)
T ss_pred HHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhHHHHHHhccCcccccc
Confidence 35666777777777777777777777777777777777777777777777777777777777777777777777777776
Q ss_pred CCCCcccccccccccc
Q 012777 101 RWGSTPLADAVYYKHH 116 (456)
Q Consensus 101 ~~g~t~l~~A~~~~~~ 116 (456)
...+||||+|+...+.
T Consensus 161 ~g~ltpLhlaa~~rn~ 176 (228)
T KOG0512|consen 161 KGLLTPLHLAAGNRNS 176 (228)
T ss_pred cccchhhHHhhcccch
Confidence 6667777777665543
|
|
| >PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.7e-18 Score=133.55 Aligned_cols=89 Identities=40% Similarity=0.604 Sum_probs=83.4
Q ss_pred HHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccccchhhh
Q 012777 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIK 120 (456)
Q Consensus 41 Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~ 120 (456)
||+||..|+.+++++|++.+.+++. |.||||+|+..|+.+++++|+++|++++.+|..|+||+|+|+..|+.++++
T Consensus 1 L~~A~~~~~~~~~~~ll~~~~~~~~----~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~ 76 (89)
T PF12796_consen 1 LHIAAQNGNLEILKFLLEKGADINL----GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVK 76 (89)
T ss_dssp HHHHHHTTTHHHHHHHHHTTSTTTS----SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHH
T ss_pred CHHHHHcCCHHHHHHHHHCcCCCCC----CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHH
Confidence 7999999999999999999998887 999999999999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCc
Q 012777 121 LLEEHGAKPSTAP 133 (456)
Q Consensus 121 ~L~~~~~~~~~~~ 133 (456)
+|+++|++++.++
T Consensus 77 ~Ll~~g~~~~~~n 89 (89)
T PF12796_consen 77 LLLEHGADVNIRN 89 (89)
T ss_dssp HHHHTTT-TTSS-
T ss_pred HHHHcCCCCCCcC
Confidence 9999999998763
|
These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B .... |
| >PHA02743 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.8e-18 Score=148.02 Aligned_cols=104 Identities=19% Similarity=0.186 Sum_probs=95.6
Q ss_pred CCCCCCchHHHHHHHcCCHHH---HHHHHHcCCCCCccc-cCcchHHHHHHHcCCHHHHHHHHh-CCCCCCCCCCCCCcc
Q 012777 32 SEAIDPRVRLMYMANEGDLDG---IKELLDSGTDVNFRD-IDKRTALHVAACQGRTDVVRLLLS-RGADVDPEDRWGSTP 106 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~---~~~Ll~~g~~in~~d-~~g~T~Lh~A~~~~~~~~v~~Ll~-~ga~~~~~~~~g~t~ 106 (456)
..+.+|+||||+||..|+.+. +++|++.|+++|.+| ..|.||||+|+..|+.+++++|++ .|++++.+|..|.||
T Consensus 52 ~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~tp 131 (166)
T PHA02743 52 RYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINARELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAINYQHETA 131 (166)
T ss_pred ccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCcCCCCCCH
Confidence 557789999999999988654 899999999999998 589999999999999999999995 799999999999999
Q ss_pred cccccccccchhhhhhhhcCCCCCCCccc
Q 012777 107 LADAVYYKHHDVIKLLEEHGAKPSTAPMH 135 (456)
Q Consensus 107 l~~A~~~~~~~~~~~L~~~~~~~~~~~~~ 135 (456)
+|+|+..++.+++++|+.+|++++.++..
T Consensus 132 L~~A~~~~~~~iv~~Ll~~ga~~~~~~~~ 160 (166)
T PHA02743 132 YHIAYKMRDRRMMEILRANGAVCDDPLSI 160 (166)
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCCCcccC
Confidence 99999999999999999999999877544
|
|
| >KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.6e-18 Score=166.44 Aligned_cols=116 Identities=28% Similarity=0.324 Sum_probs=105.0
Q ss_pred CCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccc-cCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCC
Q 012777 26 DDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRD-IDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGS 104 (456)
Q Consensus 26 ~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d-~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 104 (456)
+.+++. .|.+|.|+|||||.+++++++++|+++|+|+|..+ .-|.||||+|+++|++.+|.+|+++|||++.+|.+|.
T Consensus 68 g~~v~~-~D~~g~tlLHWAAiNNrl~v~r~li~~gadvn~~gG~l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G~ 146 (600)
T KOG0509|consen 68 GESVNN-PDREGVTLLHWAAINNRLDVARYLISHGADVNAIGGVLGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQGL 146 (600)
T ss_pred CcCCCC-CCcCCccceeHHHHcCcHHHHHHHHHcCCCccccCCCCCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCCC
Confidence 444444 45599999999999999999999999999999998 4589999999999999999999999999999999999
Q ss_pred cccccccccccchhhhhhhhcCCCCCCCccccccccCC
Q 012777 105 TPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNAREV 142 (456)
Q Consensus 105 t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~~~~~ 142 (456)
+|+|+|+..|+.-+|-+|+..+++++.+|....++..-
T Consensus 147 ~~lHla~~~~~~~~vayll~~~~d~d~~D~~grTpLmw 184 (600)
T KOG0509|consen 147 TPLHLAAQFGHTALVAYLLSKGADIDLRDNNGRTPLMW 184 (600)
T ss_pred cHHHHHHHhCchHHHHHHHHhcccCCCcCCCCCCHHHH
Confidence 99999999999999999999999999998887765443
|
|
| >PHA02859 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=3e-17 Score=149.50 Aligned_cols=102 Identities=22% Similarity=0.289 Sum_probs=56.9
Q ss_pred CCCCCchHHHHHHHcC--CHHHHHHHHHcCCCCCccc-cCcchHHHHHHHc---CCHHHHHHHHhCCCCCCCCCCCCCcc
Q 012777 33 EAIDPRVRLMYMANEG--DLDGIKELLDSGTDVNFRD-IDKRTALHVAACQ---GRTDVVRLLLSRGADVDPEDRWGSTP 106 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~--~~~~~~~Ll~~g~~in~~d-~~g~T~Lh~A~~~---~~~~~v~~Ll~~ga~~~~~~~~g~t~ 106 (456)
.+..|.||||+|+..+ +.+++++|+++|+|+|.++ ..|.||||+|+.. ++.+++++|+++|++++.+|.+|.||
T Consensus 47 ~~~~g~TpLh~a~~~~~~~~eiv~~Ll~~gadvn~~~~~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G~Tp 126 (209)
T PHA02859 47 CNDLYETPIFSCLEKDKVNVEILKFLIENGADVNFKTRDNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDGKNL 126 (209)
T ss_pred cCccCCCHHHHHHHcCCCCHHHHHHHHHCCCCCCccCCCCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCCCCH
Confidence 3445566666655533 5566666666666666554 3556666655432 24556666666666666666666666
Q ss_pred cccccc--cccchhhhhhhhcCCCCCCCcc
Q 012777 107 LADAVY--YKHHDVIKLLEEHGAKPSTAPM 134 (456)
Q Consensus 107 l~~A~~--~~~~~~~~~L~~~~~~~~~~~~ 134 (456)
||+|+. .++.+++++|++.|++++.++.
T Consensus 127 Lh~a~~~~~~~~~iv~~Li~~gadin~~d~ 156 (209)
T PHA02859 127 LHMYMCNFNVRINVIKLLIDSGVSFLNKDF 156 (209)
T ss_pred HHHHHHhccCCHHHHHHHHHcCCCcccccC
Confidence 665543 2355566666666666555443
|
|
| >PHA02791 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.9e-17 Score=154.59 Aligned_cols=100 Identities=24% Similarity=0.264 Sum_probs=94.4
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccccc
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAV 111 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~ 111 (456)
..|.+|.||||+||..|+.+++++|++.|++++..+ |+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+
T Consensus 25 ~~D~~G~TpLh~Aa~~g~~eiv~~Ll~~ga~~n~~d--~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh~Aa 102 (284)
T PHA02791 25 KADVHGHSALYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALYYAV 102 (284)
T ss_pred CCCCCCCcHHHHHHHcCCHHHHHHHHHCcCCCcCCC--CCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence 467889999999999999999999999999998875 799999999999999999999999999999999999999999
Q ss_pred ccccchhhhhhhhcCCCCCCCc
Q 012777 112 YYKHHDVIKLLEEHGAKPSTAP 133 (456)
Q Consensus 112 ~~~~~~~~~~L~~~~~~~~~~~ 133 (456)
..|+.+++++|+..|++++.++
T Consensus 103 ~~g~~eivk~Ll~~gadin~~~ 124 (284)
T PHA02791 103 DSGNMQTVKLFVKKNWRLMFYG 124 (284)
T ss_pred HcCCHHHHHHHHHCCCCcCccC
Confidence 9999999999999999987653
|
|
| >PHA02875 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.2e-17 Score=164.75 Aligned_cols=111 Identities=28% Similarity=0.259 Sum_probs=101.9
Q ss_pred CCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCC
Q 012777 24 PADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWG 103 (456)
Q Consensus 24 ~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 103 (456)
+.+++.+...+.+|.||||+||..|+.+++++|+++|+|++.++..|.||||+|+..|+.+++++|+++|++++.+|..|
T Consensus 89 ~~~~~~~~~~~~~g~tpL~~A~~~~~~~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g 168 (413)
T PHA02875 89 DLGKFADDVFYKDGMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCG 168 (413)
T ss_pred HcCCcccccccCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCC
Confidence 34455556667789999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccchhhhhhhhcCCCCCCCcc
Q 012777 104 STPLADAVYYKHHDVIKLLEEHGAKPSTAPM 134 (456)
Q Consensus 104 ~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~ 134 (456)
.||||+|+..|+.+++++|++.|++++..+.
T Consensus 169 ~TpL~~A~~~g~~eiv~~Ll~~ga~~n~~~~ 199 (413)
T PHA02875 169 CTPLIIAMAKGDIAICKMLLDSGANIDYFGK 199 (413)
T ss_pred CCHHHHHHHcCCHHHHHHHHhCCCCCCcCCC
Confidence 9999999999999999999999999986543
|
|
| >KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.7e-17 Score=135.54 Aligned_cols=99 Identities=34% Similarity=0.482 Sum_probs=92.0
Q ss_pred CCchHHHHHHHcCCHHHHHHHHHcCCC-CCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccc
Q 012777 36 DPRVRLMYMANEGDLDGIKELLDSGTD-VNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYK 114 (456)
Q Consensus 36 ~g~t~Lh~a~~~~~~~~~~~Ll~~g~~-in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~ 114 (456)
|..-.+.+|+..+.+..|+.|++-.++ +|.+|.+|+||||.|+++|+++||+.|+..||+++.+...||||||-||.++
T Consensus 62 dp~rl~lwaae~nrl~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWn 141 (228)
T KOG0512|consen 62 DPIRLLLWAAEKNRLTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWN 141 (228)
T ss_pred CHHHHHHHHHhhccHHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhccc
Confidence 444567899999999999999977665 9999999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhhhcCCCCCCCcc
Q 012777 115 HHDVIKLLEEHGAKPSTAPM 134 (456)
Q Consensus 115 ~~~~~~~L~~~~~~~~~~~~ 134 (456)
+.+++-.|+++|+|||+...
T Consensus 142 N~~va~~LLqhgaDVnA~t~ 161 (228)
T KOG0512|consen 142 NFEVAGRLLQHGADVNAQTK 161 (228)
T ss_pred chhHHHHHHhccCccccccc
Confidence 99999999999999998633
|
|
| >PHA02736 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.6e-17 Score=142.72 Aligned_cols=99 Identities=18% Similarity=0.239 Sum_probs=90.9
Q ss_pred CCCCCCchHHHHHHHcCCH---HHHHHHHHcCCCCCccc-cCcchHHHHHHHcCCHHHHHHHHh-CCCCCCCCCCCCCcc
Q 012777 32 SEAIDPRVRLMYMANEGDL---DGIKELLDSGTDVNFRD-IDKRTALHVAACQGRTDVVRLLLS-RGADVDPEDRWGSTP 106 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~---~~~~~Ll~~g~~in~~d-~~g~T~Lh~A~~~~~~~~v~~Ll~-~ga~~~~~~~~g~t~ 106 (456)
..|.+|.||||+||..|+. +++++|++.|+++|.+| ..|+||||+|+..|+.+++++|+. .|++++.+|..|.||
T Consensus 50 ~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~tp 129 (154)
T PHA02736 50 EYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKTP 129 (154)
T ss_pred HhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCccccCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCCCH
Confidence 3577899999999999886 46889999999999998 589999999999999999999998 499999999999999
Q ss_pred cccccccccchhhhhhhhcCCCCC
Q 012777 107 LADAVYYKHHDVIKLLEEHGAKPS 130 (456)
Q Consensus 107 l~~A~~~~~~~~~~~L~~~~~~~~ 130 (456)
+|+|+..|+.+++++|+..|++++
T Consensus 130 L~~A~~~~~~~i~~~Ll~~ga~~~ 153 (154)
T PHA02736 130 YYVACERHDAKMMNILRAKGAQCK 153 (154)
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCC
Confidence 999999999999999999998865
|
|
| >KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.5e-17 Score=161.36 Aligned_cols=112 Identities=30% Similarity=0.394 Sum_probs=107.0
Q ss_pred CCCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCC
Q 012777 22 PLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDR 101 (456)
Q Consensus 22 ~~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~ 101 (456)
.++.++|+|+....-+.|||||||++|++.++..|+++|||++.+|.+|.||||+|+..|+.-.|.|||..|+++|.+|+
T Consensus 97 li~~gadvn~~gG~l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G~~~lHla~~~~~~~~vayll~~~~d~d~~D~ 176 (600)
T KOG0509|consen 97 LISHGADVNAIGGVLGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQGLTPLHLAAQFGHTALVAYLLSKGADIDLRDN 176 (600)
T ss_pred HHHcCCCccccCCCCCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCCCcHHHHHHHhCchHHHHHHHHhcccCCCcCC
Confidence 36778999999988899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcccccccccccchhhhhhhhcCCCCCCCc
Q 012777 102 WGSTPLADAVYYKHHDVIKLLEEHGAKPSTAP 133 (456)
Q Consensus 102 ~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~ 133 (456)
+|.|||++|+.+|....+..|+..|+.++.++
T Consensus 177 ~grTpLmwAaykg~~~~v~~LL~f~a~~~~~d 208 (600)
T KOG0509|consen 177 NGRTPLMWAAYKGFALFVRRLLKFGASLLLTD 208 (600)
T ss_pred CCCCHHHHHHHhcccHHHHHHHHhcccccccc
Confidence 99999999999999888999999999998876
|
|
| >PHA02741 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=9e-17 Score=141.48 Aligned_cols=106 Identities=20% Similarity=0.224 Sum_probs=88.8
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHHHHH------cCCCCCccccCcchHHHHHHHcCC----HHHHHHHHhCCCCCCCCCC
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKELLD------SGTDVNFRDIDKRTALHVAACQGR----TDVVRLLLSRGADVDPEDR 101 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~Ll~------~g~~in~~d~~g~T~Lh~A~~~~~----~~~v~~Ll~~ga~~~~~~~ 101 (456)
.++.+|.|+||+||..|+.++++.|+. .|++++.+|..|+||||+|+..|+ .+++++|+++|++++.++.
T Consensus 16 ~~~~~g~t~Lh~Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~~~ 95 (169)
T PHA02741 16 EKNSEGENFFHEAARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQEM 95 (169)
T ss_pred ccccCCCCHHHHHHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCCCc
Confidence 456779999999999999999998753 368889999999999999999888 5888999999999998885
Q ss_pred -CCCcccccccccccchhhhhhhh-cCCCCCCCccccc
Q 012777 102 -WGSTPLADAVYYKHHDVIKLLEE-HGAKPSTAPMHVQ 137 (456)
Q Consensus 102 -~g~t~l~~A~~~~~~~~~~~L~~-~~~~~~~~~~~~~ 137 (456)
.|.||||+|+..++.+++++|+. .|++++.++....
T Consensus 96 ~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~~g~ 133 (169)
T PHA02741 96 LEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCNADNK 133 (169)
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCC
Confidence 89999999999999999999986 5888877655443
|
|
| >PHA02878 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=9.9e-17 Score=164.91 Aligned_cols=111 Identities=32% Similarity=0.439 Sum_probs=102.4
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCC
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRW 102 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 102 (456)
++.++|++......|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..
T Consensus 154 l~~gadin~~~~~~g~tpLh~A~~~~~~~iv~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~ 233 (477)
T PHA02878 154 LSYGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKC 233 (477)
T ss_pred HHcCCCCCccCCCCCCCHHHHHHhCCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCC
Confidence 44567777665555999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccccccccc-ccchhhhhhhhcCCCCCCCc
Q 012777 103 GSTPLADAVYY-KHHDVIKLLEEHGAKPSTAP 133 (456)
Q Consensus 103 g~t~l~~A~~~-~~~~~~~~L~~~~~~~~~~~ 133 (456)
|.||||+|+.. ++.+++++|++.|++++.++
T Consensus 234 g~TpLh~A~~~~~~~~iv~~Ll~~gadvn~~~ 265 (477)
T PHA02878 234 GNTPLHISVGYCKDYDILKLLLEHGVDVNAKS 265 (477)
T ss_pred CCCHHHHHHHhcCCHHHHHHHHHcCCCCCccC
Confidence 99999999975 68999999999999998764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=7.5e-16 Score=140.82 Aligned_cols=134 Identities=22% Similarity=0.346 Sum_probs=110.7
Q ss_pred eeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHH-----HHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEcc
Q 012777 158 VEITKGTFRIA---SWRGTQVAVKTLGEEVFTDED-----KVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229 (456)
Q Consensus 158 ~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~ 229 (456)
+.||+|++|.+ .+.|..|++|+........+. ....+.+|+.++..+.|+++.....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 46899999865 567899999987654322221 2345788999999999998887777777777889999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccc
Q 012777 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKL 299 (456)
Q Consensus 230 ~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~ 299 (456)
+|++|.+++..... ....++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++++|||.+..
T Consensus 82 ~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999875432 78899999999999999999 99999999999999 78899999998653
|
|
| >PHA02791 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.6e-16 Score=150.34 Aligned_cols=110 Identities=15% Similarity=0.104 Sum_probs=90.1
Q ss_pred CCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcc-hHHHHHHHcCCHHHHHHHHhCCCCCCCCC-C
Q 012777 24 PADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKR-TALHVAACQGRTDVVRLLLSRGADVDPED-R 101 (456)
Q Consensus 24 ~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~-T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~-~ 101 (456)
+.+++++. +|.+|+||||+||..|+.+++++|+++|++++.++..|+ ||||+|+..|+.+++++|++++.+. .| .
T Consensus 82 ~~Gadvn~-~d~~G~TpLh~Aa~~g~~eivk~Ll~~gadin~~~~~g~~TpL~~Aa~~g~~eivk~LL~~~~~~--~d~~ 158 (284)
T PHA02791 82 FSGMDDSQ-FDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPST--FDLA 158 (284)
T ss_pred HCCCCCCC-CCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCccCCCCCcHHHHHHHHcCCHHHHHHHHhcCCcc--cccc
Confidence 44555543 567899999999999999999999999999998888885 8999999999999999999886543 22 2
Q ss_pred CCCcccccccccccchhhhhhhhcCCCCCCCcccc
Q 012777 102 WGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHV 136 (456)
Q Consensus 102 ~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~ 136 (456)
.|.||||+|+..|+.+++++|+++|++++.++...
T Consensus 159 ~g~TpLh~Aa~~g~~eiv~lLL~~gAd~n~~d~~g 193 (284)
T PHA02791 159 ILLSCIHITIKNGHVDMMILLLDYMTSTNTNNSLL 193 (284)
T ss_pred cCccHHHHHHHcCCHHHHHHHHHCCCCCCcccCCC
Confidence 47899999999999999999999999888776543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.9e-17 Score=160.38 Aligned_cols=175 Identities=27% Similarity=0.404 Sum_probs=129.8
Q ss_pred CceEEEEEccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCC
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQKGA---LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGL 296 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgl 296 (456)
..+||.|++|...+|.+++..+.. .+......++.|++.+++| ++ .+|+|+||.||++..+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 358999999999999999975443 6777889999999999999 77 99999999999999999999999999
Q ss_pred cccccccccc-cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCC
Q 012777 297 SKLLKFANTV-KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPP 374 (456)
Q Consensus 297 s~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 374 (456)
.......... ......+...||..||+||.+.+..|+.++||||||++++||+. -..++.-... ...+..+..|+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t---~~d~r~g~ip~ 479 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT---LTDIRDGIIPP 479 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh---hhhhhcCCCCh
Confidence 8765332211 11223445679999999999999999999999999999999996 2223211111 11111111221
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHH
Q 012777 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQ 406 (456)
Q Consensus 375 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~e 406 (456)
....++|. -..|+.+++.+.|.+||++.+
T Consensus 480 --~~~~d~p~-e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 480 --EFLQDYPE-EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred --HHhhcCcH-HHHHHHHhcCCCcccCchHHH
Confidence 12344553 458999999999999994433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=3e-16 Score=145.45 Aligned_cols=143 Identities=20% Similarity=0.108 Sum_probs=108.6
Q ss_pred ccccccceeeeccEEEEE---e---EcCcEEEEEEeCCCCCCC-------------------H--HHHHHHHHHHHHHhc
Q 012777 151 ELDFSNSVEITKGTFRIA---S---WRGTQVAVKTLGEEVFTD-------------------E--DKVKAFIDELALLQK 203 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~---~---~~g~~vAvK~~~~~~~~~-------------------~--~~~~~~~~E~~~l~~ 203 (456)
...|.+.+.||+|+||.+ . .+|+.||+|++....... . .....+..|+..+++
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 334777889999999865 2 478999999987542110 0 012345689999999
Q ss_pred CCC--CcceeeeeEEEeCCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 012777 204 IRH--PNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNI 281 (456)
Q Consensus 204 l~h--p~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Ni 281 (456)
+.+ ..++++++. ...++||||+++.+|.........+....+..++.|++.++.+||+++ .++|+||||+||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NI 180 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNI 180 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhE
Confidence 965 334444443 235899999998888776544456777778899999999999999987 499999999999
Q ss_pred EeCCCCCEEEeccCCcccc
Q 012777 282 LRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 282 l~~~~~~vkl~Dfgls~~~ 300 (456)
+++ ++.++|+|||.+...
T Consensus 181 li~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEE-CCCEEEEEChhhhcc
Confidence 999 789999999987644
|
|
| >PHA02859 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.4e-16 Score=143.56 Aligned_cols=118 Identities=19% Similarity=0.230 Sum_probs=100.4
Q ss_pred CCCCCCCCCCCCCCCCchHHHHHHHc---CCHHHHHHHHHcCCCCCccccCcchHHHHHHH--cCCHHHHHHHHhCCCCC
Q 012777 22 PLPADDDADGSEAIDPRVRLMYMANE---GDLDGIKELLDSGTDVNFRDIDKRTALHVAAC--QGRTDVVRLLLSRGADV 96 (456)
Q Consensus 22 ~~~~~~~~~~~~~~~g~t~Lh~a~~~---~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~--~~~~~~v~~Ll~~ga~~ 96 (456)
.++.++|++...+.+|.||||+|+.. ++.+++++|+++|+|+|.+|..|.||||.|+. .++.+++++|+++|+++
T Consensus 72 Ll~~gadvn~~~~~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G~TpLh~a~~~~~~~~~iv~~Li~~gadi 151 (209)
T PHA02859 72 LIENGADVNFKTRDNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDGKNLLHMYMCNFNVRINVIKLLIDSGVSF 151 (209)
T ss_pred HHHCCCCCCccCCCCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCc
Confidence 45678888877667899999998764 47899999999999999999999999999876 46899999999999999
Q ss_pred CCCCCCCCccccc-ccccccchhhhhhhhcCCCCCCCccccccc
Q 012777 97 DPEDRWGSTPLAD-AVYYKHHDVIKLLEEHGAKPSTAPMHVQNA 139 (456)
Q Consensus 97 ~~~~~~g~t~l~~-A~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 139 (456)
+.+|..|.||+|. |+..++.+++++|++.|++++.++....++
T Consensus 152 n~~d~~g~t~Lh~~a~~~~~~~iv~~Ll~~Gadi~~~d~~g~tp 195 (209)
T PHA02859 152 LNKDFDNNNILYSYILFHSDKKIFDFLTSLGIDINETNKSGYNC 195 (209)
T ss_pred ccccCCCCcHHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCCH
Confidence 9999999999995 566788999999999999998876655443
|
|
| >KOG0508 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.7e-17 Score=155.67 Aligned_cols=104 Identities=28% Similarity=0.425 Sum_probs=74.6
Q ss_pred CCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCC
Q 012777 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGS 104 (456)
Q Consensus 25 ~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 104 (456)
.++++|..... .-|||.-||..|+++++++|+++|+|++..|..|.|.||+||++||.+|+++|++.|||+|.++..|.
T Consensus 106 ~ga~VN~tT~T-NStPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~qyLle~gADvn~ks~kGN 184 (615)
T KOG0508|consen 106 RGASVNDTTRT-NSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQYLLEQGADVNAKSYKGN 184 (615)
T ss_pred hcCcccccccc-CCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHHHHHHHHhCCCcchhcccCc
Confidence 34555555443 35777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred cccccccccccchhhhhhhhcCCCC
Q 012777 105 TPLADAVYYKHHDVIKLLEEHGAKP 129 (456)
Q Consensus 105 t~l~~A~~~~~~~~~~~L~~~~~~~ 129 (456)
|+||.|+..|+.+++++|+++|+.+
T Consensus 185 TALH~caEsG~vdivq~Ll~~ga~i 209 (615)
T KOG0508|consen 185 TALHDCAESGSVDIVQLLLKHGAKI 209 (615)
T ss_pred hHHHhhhhcccHHHHHHHHhCCcee
Confidence 7777777777777777777776654
|
|
| >KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.3e-16 Score=137.94 Aligned_cols=112 Identities=29% Similarity=0.291 Sum_probs=104.8
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCC
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRW 102 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 102 (456)
+....+....-|+.|.|||+||+..|++..|++|++.|+|+++.-+...|||.+|+..|-.++|++||+++.|+|.-|.+
T Consensus 146 ~~~~~n~VN~~De~GfTpLiWAaa~G~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwN 225 (296)
T KOG0502|consen 146 DLLVNNKVNACDEFGFTPLIWAAAKGHIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWN 225 (296)
T ss_pred HHHhhccccCccccCchHhHHHHhcCchHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccC
Confidence 34456677788899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccchhhhhhhhcCCCCCCCcc
Q 012777 103 GSTPLADAVYYKHHDVIKLLEEHGAKPSTAPM 134 (456)
Q Consensus 103 g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~ 134 (456)
|.|||-+|+..|+.+||+.|+..||++++.+-
T Consensus 226 GgTpLlyAvrgnhvkcve~Ll~sGAd~t~e~d 257 (296)
T KOG0502|consen 226 GGTPLLYAVRGNHVKCVESLLNSGADVTQEDD 257 (296)
T ss_pred CCceeeeeecCChHHHHHHHHhcCCCcccccc
Confidence 99999999999999999999999999987643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=1e-15 Score=138.61 Aligned_cols=129 Identities=26% Similarity=0.353 Sum_probs=103.6
Q ss_pred eeccEEEEE---eEcCcEEEEEEeCCCCCCCH-----HHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 160 ITKGTFRIA---SWRGTQVAVKTLGEEVFTDE-----DKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 160 lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
||+|+||.+ .++|..|++|.........+ .....+.+|+.++..+.|+++....-++......+++|||++|
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g 81 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG 81 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence 789999865 56888999999764332221 1236678899999999887765555555566678999999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccc
Q 012777 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKL 299 (456)
Q Consensus 232 ~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~ 299 (456)
++|.+++..... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 82 ~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 82 KPLKDVIEEGND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999998765321 78999999999999999 99999999999999 78999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PHA02741 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.3e-16 Score=138.90 Aligned_cols=102 Identities=21% Similarity=0.288 Sum_probs=93.1
Q ss_pred CCCCCCCCCCCCchHHHHHHHcCC----HHHHHHHHHcCCCCCcccc-CcchHHHHHHHcCCHHHHHHHHh-CCCCCCCC
Q 012777 26 DDDADGSEAIDPRVRLMYMANEGD----LDGIKELLDSGTDVNFRDI-DKRTALHVAACQGRTDVVRLLLS-RGADVDPE 99 (456)
Q Consensus 26 ~~~~~~~~~~~g~t~Lh~a~~~~~----~~~~~~Ll~~g~~in~~d~-~g~T~Lh~A~~~~~~~~v~~Ll~-~ga~~~~~ 99 (456)
+++++ .+|..|+||||+||..|+ .+++++|++.|+++|.+|. .|+||||+|+..++.+++++|++ .|++++.+
T Consensus 50 ga~in-~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~ 128 (169)
T PHA02741 50 AAALN-ATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQEMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFC 128 (169)
T ss_pred hhhhh-ccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCCCcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcC
Confidence 34444 556789999999999998 5899999999999999985 89999999999999999999998 59999999
Q ss_pred CCCCCcccccccccccchhhhhhhhcCCC
Q 012777 100 DRWGSTPLADAVYYKHHDVIKLLEEHGAK 128 (456)
Q Consensus 100 ~~~g~t~l~~A~~~~~~~~~~~L~~~~~~ 128 (456)
|.+|.|||++|+..++.+++++|+++++.
T Consensus 129 n~~g~tpL~~A~~~~~~~iv~~L~~~~~~ 157 (169)
T PHA02741 129 NADNKSPFELAIDNEDVAMMQILREIVAT 157 (169)
T ss_pred CCCCCCHHHHHHHCCCHHHHHHHHHHHHH
Confidence 99999999999999999999999988765
|
|
| >PHA02874 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.2e-16 Score=159.25 Aligned_cols=110 Identities=31% Similarity=0.452 Sum_probs=101.4
Q ss_pred CCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCC
Q 012777 24 PADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWG 103 (456)
Q Consensus 24 ~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 103 (456)
+.+.|++. ++.+|.||||+||..|+.+++++|++.|+++|.+|.+|.||||+|+..|+.+++++|+++|++++.++..|
T Consensus 112 ~~g~d~n~-~~~~g~T~Lh~A~~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~g 190 (434)
T PHA02874 112 DCGIDVNI-KDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNG 190 (434)
T ss_pred HCcCCCCC-CCCCCccHHHHHHHCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCC
Confidence 34455554 46789999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccchhhhhhhhcCCCCCCCcc
Q 012777 104 STPLADAVYYKHHDVIKLLEEHGAKPSTAPM 134 (456)
Q Consensus 104 ~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~ 134 (456)
.||||+|+..|+.+++++|++.|++++.++.
T Consensus 191 ~tpL~~A~~~g~~~iv~~Ll~~g~~i~~~~~ 221 (434)
T PHA02874 191 ESPLHNAAEYGDYACIKLLIDHGNHIMNKCK 221 (434)
T ss_pred CCHHHHHHHcCCHHHHHHHHhCCCCCcCCCC
Confidence 9999999999999999999999999876643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.3e-17 Score=171.35 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=196.2
Q ss_pred ccccccceeeeccEEEEE------eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceE
Q 012777 151 ELDFSNSVEITKGTFRIA------SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMM 223 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~------~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~ 223 (456)
...|...+.||+|.|+-+ ......+|.|.+.... ........+..|..+-+.+. |+|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 445777778999999854 2234467777776543 34445566777888888886 999999999999999999
Q ss_pred EEEEccCCCCHHHHH-HHcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCeEeCCCC-CEEEeccCCccc
Q 012777 224 IVTEYLPKGDLRAYL-KQKG-ALKPTLAVKFALDIARGMNYLH-ENRPEAIIHRDLEPSNILRDDSG-HLKVADFGLSKL 299 (456)
Q Consensus 224 lv~e~~~~~sL~~~l-~~~~-~l~~~~~~~i~~ql~~aL~~LH-~~~~~~ivH~Dikp~Nil~~~~~-~vkl~Dfgls~~ 299 (456)
++++|..++++.+-+ .... ..+...+..++.|+..++.|+| ..+ +.|+|+||+|.+++..+ ..++.|||++..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999999888 4443 4778888999999999999999 888 99999999999999999 999999999987
Q ss_pred ccccccccCCCCcccCCC-CcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchH-HHHHhcCCCCCC
Q 012777 300 LKFANTVKEDRPVTCEET-SWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVP-KAYIANERPPFR 376 (456)
Q Consensus 300 ~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~ 376 (456)
+... ...........| ++.|+|||...+. ...+..|+||.|+++..+++|..||......... ............
T Consensus 175 ~~~~--~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (601)
T KOG0590|consen 175 YRNK--NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQ 252 (601)
T ss_pred cccc--CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccccc
Confidence 7441 112222333455 8899999998884 5567899999999999999999999776544322 111122112123
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 377 APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 377 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..+...+....+++.+++..+|..|.+.+++-..
T Consensus 253 ~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 253 LPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred CccccCChhhhhcccccccCCchhcccccccccc
Confidence 3457788889999999999999999998886544
|
|
| >PLN03192 Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.2e-16 Score=169.03 Aligned_cols=113 Identities=33% Similarity=0.361 Sum_probs=99.1
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHH-------------------------
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVA------------------------- 77 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A------------------------- 77 (456)
++.+.|.+. .|.+|+||||+||..|+.++++.|+++|+|+|.+|.+|+||||.|
T Consensus 545 l~~G~d~n~-~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~g~~~iv~~L~~~~~~~~~~~~~ 623 (823)
T PLN03192 545 LKAKLDPDI-GDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAKHHKIFRILYHFASISDPHAAG 623 (823)
T ss_pred HHCCCCCCC-CCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHhcCcccCcccCc
Confidence 455666654 567899999999999999999999999999999999999998855
Q ss_pred ------HHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccccchhhhhhhhcCCCCCCCcccc
Q 012777 78 ------ACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHV 136 (456)
Q Consensus 78 ------~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~ 136 (456)
+..|+.+++++|+++|+++|.+|.+|.||||+|+..|+.+++++|+.+|++++..+.+.
T Consensus 624 ~~L~~Aa~~g~~~~v~~Ll~~Gadin~~d~~G~TpLh~A~~~g~~~iv~~Ll~~GAdv~~~~~~g 688 (823)
T PLN03192 624 DLLCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVDKANTDD 688 (823)
T ss_pred hHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCCCCCC
Confidence 45556667777889999999999999999999999999999999999999998876544
|
|
| >PHA02884 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=8.7e-16 Score=145.42 Aligned_cols=106 Identities=22% Similarity=0.119 Sum_probs=91.6
Q ss_pred CCCCCch-HHHHHHHcCCHHHHHHHHHcCCCCCccc----cCcchHHHHHHHcCCHHHHHHHHhCCCCCCCC-CCCCCcc
Q 012777 33 EAIDPRV-RLMYMANEGDLDGIKELLDSGTDVNFRD----IDKRTALHVAACQGRTDVVRLLLSRGADVDPE-DRWGSTP 106 (456)
Q Consensus 33 ~~~~g~t-~Lh~a~~~~~~~~~~~Ll~~g~~in~~d----~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~-~~~g~t~ 106 (456)
.|.+|.| +||.|+..|+.+++++|+++|+|+|.++ ..|.||||+|+..++.+++++|+++||+++.+ +..|.||
T Consensus 28 ~d~~~~~~lL~~A~~~~~~eivk~LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~Tp 107 (300)
T PHA02884 28 KNKICIANILYSSIKFHYTDIIDAILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITP 107 (300)
T ss_pred cCcCCCCHHHHHHHHcCCHHHHHHHHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCH
Confidence 3455555 5566777789999999999999999874 58999999999999999999999999999986 4579999
Q ss_pred cccccccccchhhhhhhhcCCCCCCCcccccc
Q 012777 107 LADAVYYKHHDVIKLLEEHGAKPSTAPMHVQN 138 (456)
Q Consensus 107 l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~ 138 (456)
||+|+..|+.+++++|+..|++++.++....+
T Consensus 108 Lh~Aa~~~~~eivklLL~~GAdin~kd~~G~T 139 (300)
T PHA02884 108 LYISVLHGCLKCLEILLSYGADINIQTNDMVT 139 (300)
T ss_pred HHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Confidence 99999999999999999999999987655443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.4e-15 Score=154.46 Aligned_cols=135 Identities=23% Similarity=0.251 Sum_probs=108.5
Q ss_pred ccccceeeeccEEEEEe---EcCcEEEEEEeCCCCCCC-----HHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 153 DFSNSVEITKGTFRIAS---WRGTQVAVKTLGEEVFTD-----EDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~---~~g~~vAvK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
.|...+.||+|+||.|. +.+..+++|+........ ....+.+.+|+++++.++|++++..+.++......++
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 34567889999999774 356666666543222111 1223568899999999999999888777777778899
Q ss_pred EEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccc
Q 012777 225 VTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKL 299 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~ 299 (456)
||||+++++|.+++. ....++.+++.+|.+||+.+ ++||||||+|||+ .++.++|+|||++..
T Consensus 414 v~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 414 VMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999999885 34679999999999999999 9999999999999 577899999998764
|
|
| >PHA02884 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.6e-16 Score=145.14 Aligned_cols=102 Identities=24% Similarity=0.257 Sum_probs=91.9
Q ss_pred CCCCCCCCCCC---CCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCcc-ccCcchHHHHHHHcCCHHHHHHHHhCCCCCC
Q 012777 22 PLPADDDADGS---EAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFR-DIDKRTALHVAACQGRTDVVRLLLSRGADVD 97 (456)
Q Consensus 22 ~~~~~~~~~~~---~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~-d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~ 97 (456)
.++.++|.+.. .+.+|.||||+||..++.+++++|+++|+|+|.+ +..|.||||+|+..|+.+++++|+++|++++
T Consensus 52 LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~~~~eivklLL~~GAdin 131 (300)
T PHA02884 52 ILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLHGCLKCLEILLSYGADIN 131 (300)
T ss_pred HHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCC
Confidence 35667777765 3568999999999999999999999999999996 4679999999999999999999999999999
Q ss_pred CCCCCCCcccccccccccchhhhhhh
Q 012777 98 PEDRWGSTPLADAVYYKHHDVIKLLE 123 (456)
Q Consensus 98 ~~~~~g~t~l~~A~~~~~~~~~~~L~ 123 (456)
.+|..|.||+|+|+..++.+++.++.
T Consensus 132 ~kd~~G~TpL~~A~~~~~~~~~~~~~ 157 (300)
T PHA02884 132 IQTNDMVTPIELALMICNNFLAFMIC 157 (300)
T ss_pred CCCCCCCCHHHHHHHhCChhHHHHhc
Confidence 99999999999999988888876665
|
|
| >PHA02946 ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.1e-15 Score=154.68 Aligned_cols=113 Identities=20% Similarity=0.183 Sum_probs=92.9
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcC--CHHHHHHHHhCCCCCCC-C
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQG--RTDVVRLLLSRGADVDP-E 99 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~--~~~~v~~Ll~~ga~~~~-~ 99 (456)
++.++|++. .|.+|.||||+||..|+.+++++|+++|+|+|.+|.+|.||||+|+..+ +.+++++|+++|++++. .
T Consensus 59 l~~Gadvn~-~d~~G~TpLh~Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~ 137 (446)
T PHA02946 59 LHRGYSPNE-TDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSV 137 (446)
T ss_pred HHCcCCCCc-cCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCccccc
Confidence 345666654 4677999999999999999999999999999999999999999988765 47889999999999885 6
Q ss_pred CCCCCcccccccccccchhhhhhhhcCCCCCCCccccc
Q 012777 100 DRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 100 ~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
|..|.|||+ |+..|+.+++++|+..|++++.++....
T Consensus 138 d~~g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~~G~ 174 (446)
T PHA02946 138 DEEGCGPLL-ACTDPSERVFKKIMSIGFEARIVDKFGK 174 (446)
T ss_pred CCCCCcHHH-HHHCCChHHHHHHHhccccccccCCCCC
Confidence 788899996 6667888999999999988887765543
|
|
| >KOG0508 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.9e-16 Score=146.06 Aligned_cols=108 Identities=31% Similarity=0.405 Sum_probs=101.4
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccccc
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAV 111 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~ 111 (456)
..+++|-+||-.|+..|++++|+.|+.+|+++|-......|||.-||.-|++++|+||+++|+|++..|..|.|.|++||
T Consensus 79 ge~IegappLWaAsaAGHl~vVk~L~~~ga~VN~tT~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ 158 (615)
T KOG0508|consen 79 GETIEGAPPLWAASAAGHLEVVKLLLRRGASVNDTTRTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIAC 158 (615)
T ss_pred CcccCCCchhhHHhccCcHHHHHHHHHhcCccccccccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeee
Confidence 34678999999999999999999999999999988888899999999999999999999999999999999999999999
Q ss_pred ccccchhhhhhhhcCCCCCCCccccccc
Q 012777 112 YYKHHDVIKLLEEHGAKPSTAPMHVQNA 139 (456)
Q Consensus 112 ~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 139 (456)
+.|+.+|+++|++.|+|+|.++....+.
T Consensus 159 ykGh~~I~qyLle~gADvn~ks~kGNTA 186 (615)
T KOG0508|consen 159 YKGHVDIAQYLLEQGADVNAKSYKGNTA 186 (615)
T ss_pred ccCchHHHHHHHHhCCCcchhcccCchH
Confidence 9999999999999999999998776543
|
|
| >PHA02875 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.2e-15 Score=154.18 Aligned_cols=108 Identities=25% Similarity=0.351 Sum_probs=98.9
Q ss_pred CCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCC
Q 012777 24 PADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWG 103 (456)
Q Consensus 24 ~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 103 (456)
+.++|.+. ++.+|.||||+||..|+.++++.|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++..+..|
T Consensus 123 ~~gad~~~-~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~~eiv~~Ll~~ga~~n~~~~~~ 201 (413)
T PHA02875 123 ARGADPDI-PNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSGANIDYFGKNG 201 (413)
T ss_pred hCCCCCCC-CCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCC
Confidence 44555544 45789999999999999999999999999999999999999999999999999999999999999998887
Q ss_pred C-cccccccccccchhhhhhhhcCCCCCCC
Q 012777 104 S-TPLADAVYYKHHDVIKLLEEHGAKPSTA 132 (456)
Q Consensus 104 ~-t~l~~A~~~~~~~~~~~L~~~~~~~~~~ 132 (456)
. ||+|+|+..|+.+++++|+++|++++..
T Consensus 202 ~~t~l~~A~~~~~~~iv~~Ll~~gad~n~~ 231 (413)
T PHA02875 202 CVAALCYAIENNKIDIVRLFIKRGADCNIM 231 (413)
T ss_pred CchHHHHHHHcCCHHHHHHHHHCCcCcchH
Confidence 5 7899999999999999999999999864
|
|
| >PHA02878 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.5e-15 Score=156.12 Aligned_cols=113 Identities=24% Similarity=0.267 Sum_probs=100.8
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHc-CCHHHHHHHHhCCCCCCCCCC
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQ-GRTDVVRLLLSRGADVDPEDR 101 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~-~~~~~v~~Ll~~ga~~~~~~~ 101 (456)
++.++|++. .+.+|.||||.|+..|+.++++.|++.|+++|.+|..|.||||+|+.. ++.+++++|+++|++++.++.
T Consensus 188 l~~gad~n~-~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g~TpLh~A~~~~~~~~iv~~Ll~~gadvn~~~~ 266 (477)
T PHA02878 188 LSYGANVNI-PDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSY 266 (477)
T ss_pred HHCCCCCCC-cCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhcCCHHHHHHHHHcCCCCCccCC
Confidence 345666654 567899999999999999999999999999999999999999999976 799999999999999999886
Q ss_pred -CCCcccccccccccchhhhhhhhcCCCCCCCcccccc
Q 012777 102 -WGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQN 138 (456)
Q Consensus 102 -~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~ 138 (456)
.|.||||+| .++.+++++|+.+|++++..+....+
T Consensus 267 ~~g~TpLh~A--~~~~~~v~~Ll~~gadin~~d~~g~T 302 (477)
T PHA02878 267 ILGLTALHSS--IKSERKLKLLLEYGADINSLNSYKLT 302 (477)
T ss_pred CCCCCHHHHH--ccCHHHHHHHHHCCCCCCCcCCCCCC
Confidence 799999999 56789999999999999988665543
|
|
| >PHA03095 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.5e-15 Score=156.11 Aligned_cols=115 Identities=29% Similarity=0.347 Sum_probs=103.5
Q ss_pred CCCCCCCCCCCCCCCCchHHHHHHHcC---CHHHHHHHHHcCCCCCccccCcchHHHHHHHcC-CHHHHHHHHhCCCCCC
Q 012777 22 PLPADDDADGSEAIDPRVRLMYMANEG---DLDGIKELLDSGTDVNFRDIDKRTALHVAACQG-RTDVVRLLLSRGADVD 97 (456)
Q Consensus 22 ~~~~~~~~~~~~~~~g~t~Lh~a~~~~---~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~-~~~~v~~Ll~~ga~~~ 97 (456)
.++.+.|++. .+..|.||||+|+..+ +.++++.|++.|+|+|.+|..|.||||+|+..| +.+++++|+++|++++
T Consensus 33 Ll~~ga~vn~-~~~~g~t~Lh~a~~~~~~~~~~iv~~Ll~~Gadin~~~~~g~TpLh~A~~~~~~~~iv~lLl~~ga~in 111 (471)
T PHA03095 33 LLAAGADVNF-RGEYGKTPLHLYLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVN 111 (471)
T ss_pred HHHcCCCccc-CCCCCCCHHHHHHHhcCCChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCcHHHHHHHHHcCCCCC
Confidence 3456677764 4677999999999999 999999999999999999999999999999999 5999999999999999
Q ss_pred CCCCCCCccccccc--ccccchhhhhhhhcCCCCCCCccccc
Q 012777 98 PEDRWGSTPLADAV--YYKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 98 ~~~~~g~t~l~~A~--~~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
.+|..|.||||+|+ ..++.+++++|++.|++++..+....
T Consensus 112 ~~~~~g~tpLh~a~~~~~~~~~iv~~Ll~~gad~~~~d~~g~ 153 (471)
T PHA03095 112 AKDKVGRTPLHVYLSGFNINPKVIRLLLRKGADVNALDLYGM 153 (471)
T ss_pred CCCCCCCCHHHHHhhCCcCCHHHHHHHHHcCCCCCccCCCCC
Confidence 99999999999999 55688999999999999988765543
|
|
| >PHA02716 CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.4e-15 Score=159.51 Aligned_cols=83 Identities=20% Similarity=0.217 Sum_probs=42.9
Q ss_pred CCCCCCCCCCCchHHHHHHH--cCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCC--HHHHHHHHhCCCCCCCCCCC
Q 012777 27 DDADGSEAIDPRVRLMYMAN--EGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGR--TDVVRLLLSRGADVDPEDRW 102 (456)
Q Consensus 27 ~~~~~~~~~~g~t~Lh~a~~--~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~--~~~v~~Ll~~ga~~~~~~~~ 102 (456)
+|++...+..|.||||+|+. +++.+++++|+++|+|+|.+|..|.||||+|+..|+ .++|++|+++||++|.+|..
T Consensus 167 ADIN~~~d~~G~TpLH~A~~n~~~~~eIVklLLe~GADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~kD~~ 246 (764)
T PHA02716 167 VNLNYVCKKTGYGILHAYLGNMYVDIDILEWLCNNGVNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGGDMDMKCVN 246 (764)
T ss_pred CCcccccCCCCCcHHHHHHHhccCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 44444434445555555433 234555555555555555555555555555555553 24555555555555555555
Q ss_pred CCccccc
Q 012777 103 GSTPLAD 109 (456)
Q Consensus 103 g~t~l~~ 109 (456)
|.||||+
T Consensus 247 G~TPLh~ 253 (764)
T PHA02716 247 GMSPIMT 253 (764)
T ss_pred CCCHHHH
Confidence 5555553
|
|
| >KOG0514 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.5e-16 Score=144.67 Aligned_cols=110 Identities=33% Similarity=0.410 Sum_probs=80.9
Q ss_pred CCCCCCCCchHHHHHHHcCCHHHHHHHHHcC-CCCCcccc--------------------------------------Cc
Q 012777 30 DGSEAIDPRVRLMYMANEGDLDGIKELLDSG-TDVNFRDI--------------------------------------DK 70 (456)
Q Consensus 30 ~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g-~~in~~d~--------------------------------------~g 70 (456)
....|.+|+|+||+|+.++|+++|+.|++.| +|++.+|. .|
T Consensus 261 VNlaDsNGNTALHYsVSHaNF~VV~~LLDSgvC~VD~qNrAGYtpiMLaALA~lk~~~d~~vV~~LF~mgnVNaKAsQ~g 340 (452)
T KOG0514|consen 261 VNLADSNGNTALHYAVSHANFDVVSILLDSGVCDVDQQNRAGYTPVMLAALAKLKQPADRTVVERLFKMGDVNAKASQHG 340 (452)
T ss_pred hhhhcCCCCeeeeeeecccchHHHHHHhccCcccccccccccccHHHHHHHHhhcchhhHHHHHHHHhccCcchhhhhhc
Confidence 3345677888888888888888888888766 34444433 46
Q ss_pred chHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccccchhhhhhhh-cCCCCCCCccccccc
Q 012777 71 RTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEE-HGAKPSTAPMHVQNA 139 (456)
Q Consensus 71 ~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~-~~~~~~~~~~~~~~~ 139 (456)
.||||+|+.+|+.++|+.||..|||+|.+|.+|.|+|+.||.+||.||+++|+. .++++...+...++.
T Consensus 341 QTALMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~DgSTA 410 (452)
T KOG0514|consen 341 QTALMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDGSTA 410 (452)
T ss_pred chhhhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCCchh
Confidence 667777788888888888888888888888888888888888888888888874 356665555554443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-14 Score=135.24 Aligned_cols=136 Identities=20% Similarity=0.226 Sum_probs=104.3
Q ss_pred cceeeeccEEEEEeEcCcEEEEEEeCCCCC----------CCHHHHHHHHHHHHHHhcCCCCcc--eeeeeEEEeC-C--
Q 012777 156 NSVEITKGTFRIASWRGTQVAVKTLGEEVF----------TDEDKVKAFIDELALLQKIRHPNV--VQFLGAVTQS-T-- 220 (456)
Q Consensus 156 ~~~~lg~G~fg~~~~~g~~vAvK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~hp~i--v~l~~~~~~~-~-- 220 (456)
+.+..|.|+++.+...+..++||.+..... ........+.+|+.++.++.|++| ++.+++.... .
T Consensus 39 lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~ 118 (239)
T PRK01723 39 VGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLF 118 (239)
T ss_pred eecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcc
Confidence 334667888888888899999998853211 111234567889999999988774 6777764432 2
Q ss_pred -ceEEEEEccCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 221 -PMMIVTEYLPK-GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 221 -~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
..++|||+++| .+|.+++.. .++++.. +.+++.+|.+||+.| |+|+||||.|||++.++.++|+|||.+.
T Consensus 119 ~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 119 YRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred eeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 23599999987 699988865 4455543 578999999999999 9999999999999998899999999876
Q ss_pred c
Q 012777 299 L 299 (456)
Q Consensus 299 ~ 299 (456)
.
T Consensus 191 ~ 191 (239)
T PRK01723 191 L 191 (239)
T ss_pred c
Confidence 4
|
|
| >PHA02798 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.4e-15 Score=156.82 Aligned_cols=110 Identities=25% Similarity=0.340 Sum_probs=99.9
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHc-----CCHHHHHHHHHcCCCCCccccCcchHHHHHHHcC---CHHHHHHHHhCCC
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANE-----GDLDGIKELLDSGTDVNFRDIDKRTALHVAACQG---RTDVVRLLLSRGA 94 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~-----~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~---~~~~v~~Ll~~ga 94 (456)
++.++|++. .+.+|.||||.|+.+ +..+++++|+++|+|+|.+|.+|.||||+|+..+ +.+++++|+++|+
T Consensus 58 l~~Gadvn~-~d~~g~TpL~~~~~n~~~~~~~~~iv~~Ll~~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Ga 136 (489)
T PHA02798 58 INLGANVNG-LDNEYSTPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGETPLYCLLSNGYINNLEILLFMIENGA 136 (489)
T ss_pred HHCCCCCCC-CCCCCCChHHHHHHhHHhHHhHHHHHHHHHHCCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCC
Confidence 567788775 458899999999864 6799999999999999999999999999999875 7899999999999
Q ss_pred CCCCCCCCCCccccccccccc---chhhhhhhhcCCCCCCCc
Q 012777 95 DVDPEDRWGSTPLADAVYYKH---HDVIKLLEEHGAKPSTAP 133 (456)
Q Consensus 95 ~~~~~~~~g~t~l~~A~~~~~---~~~~~~L~~~~~~~~~~~ 133 (456)
+++.+|..|.||||+|+..++ .+++++|++.|++++.++
T Consensus 137 dvn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~~~ 178 (489)
T PHA02798 137 DTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTHN 178 (489)
T ss_pred CccccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCccccc
Confidence 999999999999999999887 899999999999998764
|
|
| >PHA02795 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.5e-15 Score=149.57 Aligned_cols=98 Identities=26% Similarity=0.170 Sum_probs=87.8
Q ss_pred CCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccc
Q 012777 35 IDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYK 114 (456)
Q Consensus 35 ~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~ 114 (456)
..|.|++|.|+..++.+++++|+++|+|+|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|
T Consensus 186 ~~~~t~l~~a~~~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~TpLh~Aa~~g 265 (437)
T PHA02795 186 IIQYTRGFLVDEPTVLEIYKLCIPYIEDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYTCLDVAVDRG 265 (437)
T ss_pred hhccchhHHHHhcCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcC
Confidence 45788999999999999999999999999999999999999999999999999999999999999999999999999888
Q ss_pred c--------chhhhhhhhcCCCCCCC
Q 012777 115 H--------HDVIKLLEEHGAKPSTA 132 (456)
Q Consensus 115 ~--------~~~~~~L~~~~~~~~~~ 132 (456)
+ .+++++|++.|++++..
T Consensus 266 ~~~~~~~~~~eIvelLL~~gadI~~~ 291 (437)
T PHA02795 266 SVIARRETHLKILEILLREPLSIDCI 291 (437)
T ss_pred CcccccccHHHHHHHHHhCCCCCCch
Confidence 4 58999999999888764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.4e-15 Score=135.15 Aligned_cols=135 Identities=21% Similarity=0.083 Sum_probs=102.4
Q ss_pred ccccceeeeccEEEEE----eEcCcEEEEEEeCCCCCCCH-------------------HHHHHHHHHHHHHhcCCCC--
Q 012777 153 DFSNSVEITKGTFRIA----SWRGTQVAVKTLGEEVFTDE-------------------DKVKAFIDELALLQKIRHP-- 207 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~----~~~g~~vAvK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~hp-- 207 (456)
.|...+.||+|+||.+ ..+|+.||||++........ ........|...+..+.++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 4666788999999866 23689999999765321000 0112356788888888776
Q ss_pred cceeeeeEEEeCCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC
Q 012777 208 NVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287 (456)
Q Consensus 208 ~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~ 287 (456)
.+++.++. ...+++|||++|++|.++... .....++.+++.++.++|..+ ++|+||||.||+++.++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCC
Confidence 44444432 345899999999998765431 345678899999999999999 99999999999999999
Q ss_pred CEEEeccCCcccc
Q 012777 288 HLKVADFGLSKLL 300 (456)
Q Consensus 288 ~vkl~Dfgls~~~ 300 (456)
.++|+|||.+...
T Consensus 163 ~~~liDfg~~~~~ 175 (198)
T cd05144 163 KIYIIDWPQMVST 175 (198)
T ss_pred cEEEEECCccccC
Confidence 9999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PHA03100 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.2e-15 Score=155.22 Aligned_cols=99 Identities=38% Similarity=0.579 Sum_probs=55.1
Q ss_pred CCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCc------chHHHHHHHcCC--HHHHHHHHhCCCCCCCCCCCCCccc
Q 012777 36 DPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDK------RTALHVAACQGR--TDVVRLLLSRGADVDPEDRWGSTPL 107 (456)
Q Consensus 36 ~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g------~T~Lh~A~~~~~--~~~v~~Ll~~ga~~~~~~~~g~t~l 107 (456)
+|.||||+|+..|+.+++++|+++|++++..+..| .||||.|+..|+ .+++++|+++|++++.+|..|.|||
T Consensus 175 ~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~~t~l~~a~~~~~~~~~iv~~Ll~~g~din~~d~~g~TpL 254 (480)
T PHA03100 175 YGYTPLHIAVEKGNIDVIKFLLDNGADINAGDIETLLFTIFETPLHIAACYNEITLEVVNYLLSYGVPINIKDVYGFTPL 254 (480)
T ss_pred CCCCHHHHHHHhCCHHHHHHHHHcCCCccCCCCCCCcHHHHHhHHHHHHHhCcCcHHHHHHHHHcCCCCCCCCCCCCCHH
Confidence 45555555555555555555555555555555555 555555555555 5555555555555555555555555
Q ss_pred ccccccccchhhhhhhhcCCCCCCCcc
Q 012777 108 ADAVYYKHHDVIKLLEEHGAKPSTAPM 134 (456)
Q Consensus 108 ~~A~~~~~~~~~~~L~~~~~~~~~~~~ 134 (456)
|+|+..|+.+++++|++.|++++.++.
T Consensus 255 ~~A~~~~~~~iv~~Ll~~gad~n~~d~ 281 (480)
T PHA03100 255 HYAVYNNNPEFVKYLLDLGANPNLVNK 281 (480)
T ss_pred HHHHHcCCHHHHHHHHHcCCCCCccCC
Confidence 555555555555555555555554433
|
|
| >PHA02716 CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=2e-15 Score=158.34 Aligned_cols=91 Identities=24% Similarity=0.260 Sum_probs=67.4
Q ss_pred HcCCHHHHHHHHHcC-CCCCcc-ccCcchHHHHHHH--cCCHHHHHHHHhCCCCCCCCCCCCCccccccccccc--chhh
Q 012777 46 NEGDLDGIKELLDSG-TDVNFR-DIDKRTALHVAAC--QGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKH--HDVI 119 (456)
Q Consensus 46 ~~~~~~~~~~Ll~~g-~~in~~-d~~g~T~Lh~A~~--~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~--~~~~ 119 (456)
..++.+++++|+++| +|+|.+ |..|.||||.|+. .++.+++++|+++|++++.+|..|.||||+|+..|+ .++|
T Consensus 151 ~~v~leiVk~LLe~G~ADIN~~~d~~G~TpLH~A~~n~~~~~eIVklLLe~GADVN~kD~~G~TPLH~Aa~~g~~~~eIV 230 (764)
T PHA02716 151 RGIDLDLIKYMVDVGIVNLNYVCKKTGYGILHAYLGNMYVDIDILEWLCNNGVNVNLQNNHLITPLHTYLITGNVCASVI 230 (764)
T ss_pred cCCCHHHHHHHHHCCCCCcccccCCCCCcHHHHHHHhccCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCCCHHHH
Confidence 357778888888877 788777 7778888887654 356778888888888888877788888888877774 3778
Q ss_pred hhhhhcCCCCCCCcccc
Q 012777 120 KLLEEHGAKPSTAPMHV 136 (456)
Q Consensus 120 ~~L~~~~~~~~~~~~~~ 136 (456)
++|++.||+++.++...
T Consensus 231 klLLe~GADVN~kD~~G 247 (764)
T PHA02716 231 KKIIELGGDMDMKCVNG 247 (764)
T ss_pred HHHHHcCCCCCCCCCCC
Confidence 88888888877665443
|
|
| >PHA02743 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.2e-15 Score=132.15 Aligned_cols=103 Identities=19% Similarity=0.268 Sum_probs=91.3
Q ss_pred CCCchHHHHHHHcCCH----HHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHH---HHHHHhCCCCCCCCC-CCCCcc
Q 012777 35 IDPRVRLMYMANEGDL----DGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDV---VRLLLSRGADVDPED-RWGSTP 106 (456)
Q Consensus 35 ~~g~t~Lh~a~~~~~~----~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~---v~~Ll~~ga~~~~~~-~~g~t~ 106 (456)
.++.++||.||..|++ +++++|++.|++++.+|..|+||||+|+..|+.+. +++|+++|++++.++ ..|.||
T Consensus 18 ~~~~~~l~~a~~~g~~~~l~~~~~~l~~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g~Tp 97 (166)
T PHA02743 18 EDEQNTFLRICRTGNIYELMEVAPFISGDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINARELGTGNTL 97 (166)
T ss_pred cCCCcHHHHHHHcCCHHHHHHHHHHHhhcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCCCCCCCCCcH
Confidence 5678899999999998 66778889999999999999999999999987654 899999999999998 589999
Q ss_pred cccccccccchhhhhhhh-cCCCCCCCccccc
Q 012777 107 LADAVYYKHHDVIKLLEE-HGAKPSTAPMHVQ 137 (456)
Q Consensus 107 l~~A~~~~~~~~~~~L~~-~~~~~~~~~~~~~ 137 (456)
||+|+..++.+++++|+. .|++++.++....
T Consensus 98 Lh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~ 129 (166)
T PHA02743 98 LHIAASTKNYELAEWLCRQLGVNLGAINYQHE 129 (166)
T ss_pred HHHHHHhCCHHHHHHHHhccCCCccCcCCCCC
Confidence 999999999999999994 8999987765443
|
|
| >PHA03100 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=2e-15 Score=155.61 Aligned_cols=110 Identities=27% Similarity=0.450 Sum_probs=85.0
Q ss_pred CCCCCCCCCCCCCCCchHHHHHH--HcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcC--CHHHHHHHHhCCCCCCC
Q 012777 23 LPADDDADGSEAIDPRVRLMYMA--NEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQG--RTDVVRLLLSRGADVDP 98 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~--~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~--~~~~v~~Ll~~ga~~~~ 98 (456)
++.++++ ...+..|.||||+|+ ..|+.+++++|+++|++++..|..|.||||+|+..| +.+++++|+++|++++.
T Consensus 93 l~~ga~i-~~~d~~g~tpL~~A~~~~~~~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~iv~~Ll~~g~din~ 171 (480)
T PHA03100 93 LEYGANV-NAPDNNGITPLLYAISKKSNSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINA 171 (480)
T ss_pred HHCCCCC-CCCCCCCCchhhHHHhcccChHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCChHHHHHHHHHCCCCccc
Confidence 3445666 455667788888888 788888888888888888888888888888888887 78888888888888887
Q ss_pred CCCCCCcccccccccccchhhhhhhhcCCCCCCCc
Q 012777 99 EDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAP 133 (456)
Q Consensus 99 ~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~ 133 (456)
++..|.||||+|+..|+.+++++|++.|++++..+
T Consensus 172 ~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~ 206 (480)
T PHA03100 172 KNRYGYTPLHIAVEKGNIDVIKFLLDNGADINAGD 206 (480)
T ss_pred ccCCCCCHHHHHHHhCCHHHHHHHHHcCCCccCCC
Confidence 77788888888888888888888888887776553
|
|
| >KOG0514 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-15 Score=140.73 Aligned_cols=99 Identities=33% Similarity=0.445 Sum_probs=93.6
Q ss_pred CCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhC-CCCCCCCCCCC
Q 012777 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSR-GADVDPEDRWG 103 (456)
Q Consensus 25 ~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~-ga~~~~~~~~g 103 (456)
..-|+|+...-.|+|+||+|+.+|+.++++.|+..|+|||.+|.+|.||||.||.+||.+++++||.. ++|+...|.+|
T Consensus 328 ~mgnVNaKAsQ~gQTALMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~Dg 407 (452)
T KOG0514|consen 328 KMGDVNAKASQHGQTALMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDG 407 (452)
T ss_pred hccCcchhhhhhcchhhhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCC
Confidence 35678888888999999999999999999999999999999999999999999999999999999975 99999999999
Q ss_pred Ccccccccccccchhhhhhh
Q 012777 104 STPLADAVYYKHHDVIKLLE 123 (456)
Q Consensus 104 ~t~l~~A~~~~~~~~~~~L~ 123 (456)
.|+|.+|...|+.||.-+|-
T Consensus 408 STAl~IAleagh~eIa~mlY 427 (452)
T KOG0514|consen 408 STALSIALEAGHREIAVMLY 427 (452)
T ss_pred chhhhhHHhcCchHHHHHHH
Confidence 99999999999999998774
|
|
| >PHA02736 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.2e-15 Score=132.28 Aligned_cols=111 Identities=21% Similarity=0.329 Sum_probs=89.9
Q ss_pred CCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCC--C-----CCccccCcchHHHHHHHcCCH---HHHHHHHhCCC
Q 012777 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGT--D-----VNFRDIDKRTALHVAACQGRT---DVVRLLLSRGA 94 (456)
Q Consensus 25 ~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~--~-----in~~d~~g~T~Lh~A~~~~~~---~~v~~Ll~~ga 94 (456)
++..+....|.+|.||||+||..|+. +..+...+. + ++.+|.+|.||||+|+..|+. +++++|+++|+
T Consensus 5 ~~~~~~~~~d~~g~tpLh~A~~~g~~--~~l~~~~~~~~~~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~ga 82 (154)
T PHA02736 5 EEIIFASEPDIEGENILHYLCRNGGV--TDLLAFKNAISDENRYLVLEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGA 82 (154)
T ss_pred chhhHHHhcCCCCCCHHHHHHHhCCH--HHHHHHHHHhcchhHHHHHHhcCCCCEEEEeecccCchhHHHHHHHHHHcCC
Confidence 44556667788999999999999984 333332222 2 345789999999999999987 46889999999
Q ss_pred CCCCCCC-CCCcccccccccccchhhhhhhh-cCCCCCCCccccc
Q 012777 95 DVDPEDR-WGSTPLADAVYYKHHDVIKLLEE-HGAKPSTAPMHVQ 137 (456)
Q Consensus 95 ~~~~~~~-~g~t~l~~A~~~~~~~~~~~L~~-~~~~~~~~~~~~~ 137 (456)
+++.++. .|.||||+|+..|+.+++++|+. .|++++.++....
T Consensus 83 din~~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~ 127 (154)
T PHA02736 83 DINGKERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFK 127 (154)
T ss_pred CccccCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCC
Confidence 9999984 89999999999999999999997 5999987765544
|
|
| >PHA02798 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=5.6e-15 Score=152.32 Aligned_cols=108 Identities=21% Similarity=0.364 Sum_probs=84.5
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHcC---CHHHHHHHHHcCCCCCccccCcchHHHHHHHcCC---HHHHHHHHhCCCCC
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANEG---DLDGIKELLDSGTDVNFRDIDKRTALHVAACQGR---TDVVRLLLSRGADV 96 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~~---~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~---~~~v~~Ll~~ga~~ 96 (456)
++.++|++. .+.+|+||||+|+..+ +.+++++|+++|+|+|.+|.+|.||||+|+..++ .+++++|+++|+++
T Consensus 96 l~~GadiN~-~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadi 174 (489)
T PHA02798 96 IENGADINK-KNSDGETPLYCLLSNGYINNLEILLFMIENGADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDI 174 (489)
T ss_pred HHCCCCCCC-CCCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCccccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCc
Confidence 456777665 4567999999999875 7899999999999999999999999999999887 89999999998888
Q ss_pred CCCC-CCCCccccccccc----ccchhhhhhhhcCCCCCC
Q 012777 97 DPED-RWGSTPLADAVYY----KHHDVIKLLEEHGAKPST 131 (456)
Q Consensus 97 ~~~~-~~g~t~l~~A~~~----~~~~~~~~L~~~~~~~~~ 131 (456)
+.++ ..|.||+|.++.. ++.+++++|+++|++++.
T Consensus 175 n~~~~~~~~t~Lh~~~~~~~~~~~~~ivk~Li~~Ga~i~~ 214 (489)
T PHA02798 175 NTHNNKEKYDTLHCYFKYNIDRIDADILKLFVDNGFIINK 214 (489)
T ss_pred ccccCcCCCcHHHHHHHhccccCCHHHHHHHHHCCCCccc
Confidence 7764 3566777665443 356666776666666554
|
|
| >PHA02874 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=8.1e-15 Score=148.98 Aligned_cols=112 Identities=22% Similarity=0.243 Sum_probs=96.5
Q ss_pred CCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCC----------
Q 012777 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGA---------- 94 (456)
Q Consensus 25 ~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga---------- 94 (456)
.+.......+.+|.||||.|+..|+.+++++|++.|+++|..+..|.||||.|+..|+.+++++|+++|+
T Consensus 23 ~~~~~~n~~~~~~~tpL~~A~~~g~~~iv~~Ll~~Ga~~n~~~~~~~t~L~~A~~~~~~~iv~~Ll~~g~~~~~~~~~~~ 102 (434)
T PHA02874 23 NKGNCINISVDETTTPLIDAIRSGDAKIVELFIKHGADINHINTKIPHPLLTAIKIGAHDIIKLLIDNGVDTSILPIPCI 102 (434)
T ss_pred cCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcchhccC
Confidence 3344344566789999999999999999999999999999999999999999999999999999987664
Q ss_pred -------------CCCCCCCCCCcccccccccccchhhhhhhhcCCCCCCCcccc
Q 012777 95 -------------DVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHV 136 (456)
Q Consensus 95 -------------~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~ 136 (456)
+++.++..|.||||+|+..|+.+++++|+..|++++.++...
T Consensus 103 ~~~~i~~ll~~g~d~n~~~~~g~T~Lh~A~~~~~~~~v~~Ll~~gad~n~~d~~g 157 (434)
T PHA02874 103 EKDMIKTILDCGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNG 157 (434)
T ss_pred CHHHHHHHHHCcCCCCCCCCCCccHHHHHHHCCCHHHHHHHHhCCCCCCCcCCCC
Confidence 567788899999999999999999999999999988765443
|
|
| >KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis] | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.2e-15 Score=159.06 Aligned_cols=99 Identities=38% Similarity=0.415 Sum_probs=89.6
Q ss_pred CCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 31 GSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 31 ~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
..++.+|.||||.||..|++++|++|+++|+|++++++.|+||||.||..|+.+|+.+|+++||++|..|.+|.|||++|
T Consensus 534 ~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~~~i~~LLlk~GA~vna~d~~g~TpL~iA 613 (1143)
T KOG4177|consen 534 DLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPLHQAAQQGHNDIAELLLKHGASVNAADLDGFTPLHIA 613 (1143)
T ss_pred ehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChhhHHHHcChHHHHHHHHHcCCCCCcccccCcchhHHH
Confidence 34567789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccchhhhhhhhcCCCC
Q 012777 111 VYYKHHDVIKLLEEHGAKP 129 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~~~~ 129 (456)
...|+.+++++|+..++++
T Consensus 614 ~~lg~~~~~k~l~~~~~~~ 632 (1143)
T KOG4177|consen 614 VRLGYLSVVKLLKVVTATP 632 (1143)
T ss_pred HHhcccchhhHHHhccCcc
Confidence 9999999999999888884
|
|
| >PHA03095 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=9.4e-15 Score=150.20 Aligned_cols=114 Identities=23% Similarity=0.253 Sum_probs=96.2
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHc--CCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCH--HHHHHHHhCCCCCCC
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANE--GDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRT--DVVRLLLSRGADVDP 98 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~--~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~--~~v~~Ll~~ga~~~~ 98 (456)
++.+++.+.. +..|+||||+|+.. ++.++++.|++.|++++.+|..|.||||+|+..|+. .+++.|++.|+++|.
T Consensus 174 l~~g~~~~~~-d~~g~t~Lh~~~~~~~~~~~i~~~Ll~~g~~~~~~d~~g~tpLh~Aa~~~~~~~~~v~~ll~~g~din~ 252 (471)
T PHA03095 174 IDAGADVYAV-DDRFRSLLHHHLQSFKPRARIVRELIRAGCDPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINA 252 (471)
T ss_pred HHcCCCCccc-CCCCCCHHHHHHHHCCCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHhcCCchHHHHHHHHHcCCCCCC
Confidence 4456666665 77899999988875 678899999999999999999999999999988864 578888999999999
Q ss_pred CCCCCCcccccccccccchhhhhhhhcCCCCCCCccccc
Q 012777 99 EDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 99 ~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
+|..|.||||+|+..|+.+++++|++.|++++.++....
T Consensus 253 ~d~~g~TpLh~A~~~~~~~~v~~LL~~gad~n~~~~~g~ 291 (471)
T PHA03095 253 RNRYGQTPLHYAAVFNNPRACRRLIALGADINAVSSDGN 291 (471)
T ss_pred cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCC
Confidence 999999999999999999999999999999887765544
|
|
| >KOG4214 consensus Myotrophin and similar proteins [Transcription] | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.8e-15 Score=111.10 Aligned_cols=95 Identities=33% Similarity=0.556 Sum_probs=86.7
Q ss_pred CchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccccc
Q 012777 37 PRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHH 116 (456)
Q Consensus 37 g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~ 116 (456)
|...+.|++.+|.++.|+..+..|.|+|..- .|+||||+|+-.|+++++++|+.-||+++.+|..|-|||--|++.||.
T Consensus 2 ~d~~~~W~vkNG~~DeVk~~v~~g~nVn~~~-ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~ 80 (117)
T KOG4214|consen 2 GDMSVAWNVKNGEIDEVKQSVNEGLNVNEIY-GGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHR 80 (117)
T ss_pred cchhHhhhhccCcHHHHHHHHHccccHHHHh-CCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhH
Confidence 3467889999999999999999998888775 899999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhhcCCCCCCC
Q 012777 117 DVIKLLEEHGAKPSTA 132 (456)
Q Consensus 117 ~~~~~L~~~~~~~~~~ 132 (456)
.||++|++.||+-...
T Consensus 81 ~cVklLL~~GAdrt~~ 96 (117)
T KOG4214|consen 81 DCVKLLLQNGADRTIH 96 (117)
T ss_pred HHHHHHHHcCccccee
Confidence 9999999999986543
|
|
| >PHA02989 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=9.9e-15 Score=150.66 Aligned_cols=110 Identities=22% Similarity=0.284 Sum_probs=82.2
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHc---CCHHHHHHHHHcCCCC-CccccCcchHHHHHHHc--CCHHHHHHHHhCCCCC
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANE---GDLDGIKELLDSGTDV-NFRDIDKRTALHVAACQ--GRTDVVRLLLSRGADV 96 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~---~~~~~~~~Ll~~g~~i-n~~d~~g~T~Lh~A~~~--~~~~~v~~Ll~~ga~~ 96 (456)
++.++|++.. +.+|.||||.|+.. ++.+++++|+++|+|+ +.+|..|+||||+|+.. ++.+++++|+++|+++
T Consensus 95 l~~Gadin~~-d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi 173 (494)
T PHA02989 95 LKFGADINLK-TFNGVSPIVCFIYNSNINNCDMLRFLLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNL 173 (494)
T ss_pred HHCCCCCCCC-CCCCCcHHHHHHHhcccCcHHHHHHHHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCc
Confidence 4667776654 46688888877655 5678888888888888 67888888888887653 5778888888888888
Q ss_pred CC-CCCCCCccccccccc----ccchhhhhhhhcCCCCCCCc
Q 012777 97 DP-EDRWGSTPLADAVYY----KHHDVIKLLEEHGAKPSTAP 133 (456)
Q Consensus 97 ~~-~~~~g~t~l~~A~~~----~~~~~~~~L~~~~~~~~~~~ 133 (456)
+. .+..|.||+|+|+.. ++.+++++|++.|++++..+
T Consensus 174 ~~~~~~~g~tpL~~a~~~~~~~~~~~iv~~Ll~~Ga~vn~~~ 215 (494)
T PHA02989 174 FEKTSLYGLTPMNIYLRNDIDVISIKVIKYLIKKGVNIETNN 215 (494)
T ss_pred cccccccCCChHHHHHhcccccccHHHHHHHHhCCCCccccC
Confidence 77 566788888777654 37788888888887776554
|
|
| >PHA02730 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.1e-14 Score=150.11 Aligned_cols=110 Identities=19% Similarity=0.153 Sum_probs=96.2
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHcCC----HHHHHHHHHcCC--CCCccccCcchHHHH---HHHcC---------CHH
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANEGD----LDGIKELLDSGT--DVNFRDIDKRTALHV---AACQG---------RTD 84 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~~~----~~~~~~Ll~~g~--~in~~d~~g~T~Lh~---A~~~~---------~~~ 84 (456)
++.++|++.. .+|.||||+|+..++ .+++++|+++|+ ++|.+|..|.||||. |...+ ..+
T Consensus 366 Is~GAdIN~k--~~G~TpLH~Aa~~nnn~i~~eIvelLIs~Ga~~dIN~kd~~G~T~Lh~~i~a~~~n~~~~~~e~~~~~ 443 (672)
T PHA02730 366 LDNGATMDKT--TDNNYPLHDYFVNNNNIVDVNVVRFIVENNGHMAINHVSNNGRLCMYGLILSRFNNCGYHCYETILID 443 (672)
T ss_pred HHCCCCCCcC--CCCCcHHHHHHHHcCCcchHHHHHHHHHcCCCccccccccCCCchHhHHHHHHhccccccccchhHHH
Confidence 4567888863 689999999998875 899999999997 699999999999994 33332 235
Q ss_pred HHHHHHhCCCCCCCCCCCCCcccccccccccchhhhhhhhcCCCCCCCcc
Q 012777 85 VVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPM 134 (456)
Q Consensus 85 ~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~ 134 (456)
++++|+.+||++|.+|..|.||||+|+..++.+++++|+.+||+++..+.
T Consensus 444 ivk~LIs~GADINakD~~G~TPLh~Aa~~~~~eive~LI~~GAdIN~~d~ 493 (672)
T PHA02730 444 VFDILSKYMDDIDMIDNENKTLLYYAVDVNNIQFARRLLEYGASVNTTSR 493 (672)
T ss_pred HHHHHHhcccchhccCCCCCCHHHHHHHhCCHHHHHHHHHCCCCCCCCCC
Confidence 79999999999999999999999999999999999999999999998874
|
|
| >PHA02946 ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.4e-14 Score=146.86 Aligned_cols=109 Identities=15% Similarity=0.171 Sum_probs=52.1
Q ss_pred CCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcC--CHHHHHHHHhCCCCCCCCCC
Q 012777 24 PADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQG--RTDVVRLLLSRGADVDPEDR 101 (456)
Q Consensus 24 ~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~--~~~~v~~Ll~~ga~~~~~~~ 101 (456)
+.+++++...+.+|.|||| ||..++.++++.|++.|++++.+|..|+||||+|+..+ +.+++++|+++|++++.+|.
T Consensus 128 ~~Gadin~~~d~~g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~~G~t~Lh~A~~~~~~~~~~v~~Ll~~Gadin~~d~ 206 (446)
T PHA02946 128 QYGAKINNSVDEEGCGPLL-ACTDPSERVFKKIMSIGFEARIVDKFGKNHIHRHLMSDNPKASTISWMMKLGISPSKPDH 206 (446)
T ss_pred HcCCCcccccCCCCCcHHH-HHHCCChHHHHHHHhccccccccCCCCCCHHHHHHHhcCCCHHHHHHHHHcCCCCcccCC
Confidence 3344444444444455554 33344445555555555555555555555555544432 23455555555555555555
Q ss_pred CCCcccccccccc--cchhhhhhhhcCCCCCCCcc
Q 012777 102 WGSTPLADAVYYK--HHDVIKLLEEHGAKPSTAPM 134 (456)
Q Consensus 102 ~g~t~l~~A~~~~--~~~~~~~L~~~~~~~~~~~~ 134 (456)
+|.||||+|+..+ +.+++++|+. |++++.++.
T Consensus 207 ~G~TpLH~Aa~~~~~~~~iv~lLl~-gadin~~d~ 240 (446)
T PHA02946 207 DGNTPLHIVCSKTVKNVDIINLLLP-STDVNKQNK 240 (446)
T ss_pred CCCCHHHHHHHcCCCcHHHHHHHHc-CCCCCCCCC
Confidence 5555555555443 3445554442 455444433
|
|
| >KOG0510 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.4e-15 Score=148.27 Aligned_cols=116 Identities=28% Similarity=0.329 Sum_probs=96.9
Q ss_pred CCCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHH-cC-CCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCC--
Q 012777 22 PLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLD-SG-TDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVD-- 97 (456)
Q Consensus 22 ~~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~-~g-~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~-- 97 (456)
++..|++++... .|+.||||.||..|++++|+.|++ .| ..+|..|..|.||||+|+..||..+++.||+.||+..
T Consensus 292 Ll~~Ga~I~~kn-~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLHlaa~~gH~~v~qlLl~~GA~~~~~ 370 (929)
T KOG0510|consen 292 LLGFGASINSKN-KDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLHLAAKSGHDRVVQLLLNKGALFLNM 370 (929)
T ss_pred HHHcCCcccccC-CCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchhhhhhcCHHHHHHHHHhcChhhhcc
Confidence 345566666544 888999999999999999999997 54 4678889999999999999999999999999999877
Q ss_pred -CCCCCCCcccccccccccchhhhhhhhcCCCCCCCcccccc
Q 012777 98 -PEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQN 138 (456)
Q Consensus 98 -~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~ 138 (456)
..|.+|.||||+|+..|+..+|++|+.+||++...+....+
T Consensus 371 ~e~D~dg~TaLH~Aa~~g~~~av~~Li~~Ga~I~~~n~~g~S 412 (929)
T KOG0510|consen 371 SEADSDGNTALHLAAKYGNTSAVQKLISHGADIGVKNKKGKS 412 (929)
T ss_pred cccccCCchhhhHHHHhccHHHHHHHHHcCCceeeccccccc
Confidence 56889999999999999999999999999998775555444
|
|
| >PHA02917 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.5e-14 Score=150.76 Aligned_cols=104 Identities=17% Similarity=0.189 Sum_probs=91.4
Q ss_pred CCCCCCCCchHHHHHHHc---CCHHHHHHHHHcCCCCCccccCcchHHHHHHHcC-------------------------
Q 012777 30 DGSEAIDPRVRLMYMANE---GDLDGIKELLDSGTDVNFRDIDKRTALHVAACQG------------------------- 81 (456)
Q Consensus 30 ~~~~~~~g~t~Lh~a~~~---~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~------------------------- 81 (456)
+...|.+|+||||+||.. |+.++++.|++.|+|++.+|.+|+||||.|+..|
T Consensus 25 ~~~~d~~g~t~Lh~a~~~~~~~~~~~v~~Ll~~ga~v~~~~~~g~TpL~~Aa~~g~~~v~~~~~~~Ll~~~~~~n~~~~~ 104 (661)
T PHA02917 25 NDTRNQFKNNALHAYLFNEHCNNVEVVKLLLDSGTNPLHKNWRQLTPLEEYTNSRHVKVNKDIAMALLEATGYSNINDFN 104 (661)
T ss_pred ccccCCCCCcHHHHHHHhhhcCcHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCChhHHHHHHHHHHhccCCCCCCCcc
Confidence 356688999999998665 8899999999999999999999999999877533
Q ss_pred ----------CHHHHHHHHhCCCCCCCCCCCCCcccccc--cccccchhhhhhhhcCCCCCCCc
Q 012777 82 ----------RTDVVRLLLSRGADVDPEDRWGSTPLADA--VYYKHHDVIKLLEEHGAKPSTAP 133 (456)
Q Consensus 82 ----------~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A--~~~~~~~~~~~L~~~~~~~~~~~ 133 (456)
+.++|++|+++|+++|.+|..|.||||+| +..|+.+++++|+++|++++.++
T Consensus 105 ~~~~~a~~~~~~e~vk~Ll~~Gadin~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga~vn~~d 168 (661)
T PHA02917 105 IFSYMKSKNVDVDLIKVLVEHGFDLSVKCENHRSVIENYVMTDDPVPEIIDLFIENGCSVLYED 168 (661)
T ss_pred hHHHHHhhcCCHHHHHHHHHcCCCCCccCCCCccHHHHHHHccCCCHHHHHHHHHcCCCccccc
Confidence 56889999999999999999999999954 45789999999999999998654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.9e-14 Score=126.22 Aligned_cols=134 Identities=21% Similarity=0.189 Sum_probs=92.2
Q ss_pred ceeeeccEEEEE----eEcCcEEEEEEeCCCCCCCHHHHHH---------------------HHHHHHHHhcCCCC--cc
Q 012777 157 SVEITKGTFRIA----SWRGTQVAVKTLGEEVFTDEDKVKA---------------------FIDELALLQKIRHP--NV 209 (456)
Q Consensus 157 ~~~lg~G~fg~~----~~~g~~vAvK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~hp--~i 209 (456)
.+.||+|+||.+ ..+|+.||||++............. ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 357999999865 2268999999987543222111111 13456666665332 34
Q ss_pred eeeeeEEEeCCceEEEEEccCCCCHHH-HHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCC
Q 012777 210 VQFLGAVTQSTPMMIVTEYLPKGDLRA-YLKQKGALKPTLAVKFALDIARGMNYLHE-NRPEAIIHRDLEPSNILRDDSG 287 (456)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~~~~ivH~Dikp~Nil~~~~~ 287 (456)
.+.+++ ...+++|||++++.+.. .+.... .. ..+..++.+++.++.++|. .+ |+|+||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CC
Confidence 444443 24589999998843321 111111 11 6678899999999999999 88 99999999999999 88
Q ss_pred CEEEeccCCcccc
Q 012777 288 HLKVADFGLSKLL 300 (456)
Q Consensus 288 ~vkl~Dfgls~~~ 300 (456)
.++|+|||.+...
T Consensus 152 ~~~liDfg~a~~~ 164 (187)
T cd05119 152 KVYIIDVPQAVEI 164 (187)
T ss_pred cEEEEECcccccc
Confidence 9999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PHA02795 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.9e-14 Score=141.72 Aligned_cols=113 Identities=16% Similarity=0.088 Sum_probs=91.5
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCcc------ccCcchHHHHHHHcCCHHHHHHHHhCCCCC
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFR------DIDKRTALHVAACQGRTDVVRLLLSRGADV 96 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~------d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~ 96 (456)
++-|+|++. .++.||||.|+..++.+++++|+.+|++.+.. +..|.|++|.|+..++.+++++|+++||++
T Consensus 138 I~~GADIn~---~~~~t~lh~A~~~~~~eIVk~Lls~Ga~~~n~~~~~l~~~~~~t~l~~a~~~~~~eIve~LIs~GADI 214 (437)
T PHA02795 138 VDHGAVIYK---IECLNAYFRGICKKESSVVEFILNCGIPDENDVKLDLYKIIQYTRGFLVDEPTVLEIYKLCIPYIEDI 214 (437)
T ss_pred HHCCCCCCC---CCCCCHHHHHHHcCcHHHHHHHHhcCCcccccccchhhhhhccchhHHHHhcCHHHHHHHHHhCcCCc
Confidence 345666655 34578888888888888888888888743322 134778888888888999999999999999
Q ss_pred CCCCCCCCcccccccccccchhhhhhhhcCCCCCCCcccccc
Q 012777 97 DPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQN 138 (456)
Q Consensus 97 ~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~ 138 (456)
|.+|..|.||||+|+..|+.+++++|++.|++++.++....+
T Consensus 215 N~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~T 256 (437)
T PHA02795 215 NQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYT 256 (437)
T ss_pred CcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCC
Confidence 999999999999999999999999999999999888665443
|
|
| >PHA02876 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.3e-14 Score=153.86 Aligned_cols=114 Identities=28% Similarity=0.360 Sum_probs=92.4
Q ss_pred CCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCC-HHHHHHHHhCCCCCCCCCCC
Q 012777 24 PADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGR-TDVVRLLLSRGADVDPEDRW 102 (456)
Q Consensus 24 ~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~-~~~v~~Ll~~ga~~~~~~~~ 102 (456)
+.+.+.+ .+|.+|.||||+|+..|+.++++.|++.|++++..+..|.||||+|+..++ ..++++|+++|+++|.+|.+
T Consensus 363 ~~gadin-~~d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~~~g~T~Lh~A~~~~~~~~~vk~Ll~~gadin~~d~~ 441 (682)
T PHA02876 363 ELGANVN-ARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTALHFALCGTNPYMSVKTLIDRGANVNSKNKD 441 (682)
T ss_pred HcCCCCc-cCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCccccCCCCCchHHHHHHcCCHHHHHHHHHhCCCCCCcCCCC
Confidence 3444544 346778888888888888888888888888888888888888888887554 56788888999999999999
Q ss_pred CCcccccccccc-cchhhhhhhhcCCCCCCCcccccc
Q 012777 103 GSTPLADAVYYK-HHDVIKLLEEHGAKPSTAPMHVQN 138 (456)
Q Consensus 103 g~t~l~~A~~~~-~~~~~~~L~~~~~~~~~~~~~~~~ 138 (456)
|.||||+|+..| +.+++++|++.|++++..+....+
T Consensus 442 G~TpLh~Aa~~~~~~~iv~lLl~~Gad~n~~d~~g~t 478 (682)
T PHA02876 442 LSTPLHYACKKNCKLDVIEMLLDNGADVNAINIQNQY 478 (682)
T ss_pred CChHHHHHHHhCCcHHHHHHHHHCCCCCCCCCCCCCC
Confidence 999999998876 678999999999998887655443
|
|
| >PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.3e-14 Score=111.04 Aligned_cols=64 Identities=42% Similarity=0.654 Sum_probs=59.9
Q ss_pred CchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCC
Q 012777 37 PRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100 (456)
Q Consensus 37 g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~ 100 (456)
|+||||+||..|+.+++++|++.|++++.+|.+|+||||+|+..|+.+++++|+++|++++.+|
T Consensus 26 ~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~n 89 (89)
T PF12796_consen 26 GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVKLLLEHGADVNIRN 89 (89)
T ss_dssp SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHHHHHHTTT-TTSS-
T ss_pred CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcC
Confidence 8999999999999999999999999999999999999999999999999999999999999875
|
These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B .... |
| >PF13637 Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A 3B7B_A 3F6Q_A 2KBX_A 3IXE_A 2DWZ_C 2DVW_A 3AJI_A 1S70_B 2HE0_A | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.8e-14 Score=99.42 Aligned_cols=54 Identities=44% Similarity=0.674 Sum_probs=46.3
Q ss_pred CchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHH
Q 012777 37 PRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLL 90 (456)
Q Consensus 37 g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll 90 (456)
|+||||+||..|+.+++++|+++|+|+|.+|.+|.||||+|+..|+.+++++||
T Consensus 1 g~t~lh~A~~~g~~~~~~~Ll~~~~din~~d~~g~t~lh~A~~~g~~~~~~~Ll 54 (54)
T PF13637_consen 1 GRTPLHWAARSGNLEIVKLLLEHGADINAQDEDGRTPLHYAAKNGNIDIVKFLL 54 (54)
T ss_dssp SSBHHHHHHHTT-HHHHHHHHHTTSGTT-B-TTS--HHHHHHHTT-HHHHHHHH
T ss_pred CChHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHccCHHHHHHHC
Confidence 789999999999999999999999999999999999999999999999999986
|
... |
| >PHA02989 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=4e-14 Score=146.13 Aligned_cols=109 Identities=22% Similarity=0.250 Sum_probs=96.9
Q ss_pred CCCCCCCCCCCCCCCCCchHHHHHHH------cCCHHHHHHHHHcCCCCCccccCcchHHHHHHHc---CCHHHHHHHHh
Q 012777 21 QPLPADDDADGSEAIDPRVRLMYMAN------EGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQ---GRTDVVRLLLS 91 (456)
Q Consensus 21 ~~~~~~~~~~~~~~~~g~t~Lh~a~~------~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~---~~~~~v~~Ll~ 91 (456)
..++.++|++... .+.||||.|+. .+..+++++|+++|+|+|.+|.+|.||||.|+.. |+.+++++|++
T Consensus 55 ~Ll~~GAdvn~~~--~~~tpL~~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~ 132 (494)
T PHA02989 55 LLIDNGADVNYKG--YIETPLCAVLRNREITSNKIKKIVKLLLKFGADINLKTFNGVSPIVCFIYNSNINNCDMLRFLLS 132 (494)
T ss_pred HHHHcCCCccCCC--CCCCcHHHHHhccCcchhhHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHhcccCcHHHHHHHHH
Confidence 3467888888653 57999999875 5789999999999999999999999999998765 68999999999
Q ss_pred CCCCC-CCCCCCCCccccccccc--ccchhhhhhhhcCCCCCC
Q 012777 92 RGADV-DPEDRWGSTPLADAVYY--KHHDVIKLLEEHGAKPST 131 (456)
Q Consensus 92 ~ga~~-~~~~~~g~t~l~~A~~~--~~~~~~~~L~~~~~~~~~ 131 (456)
+||++ +.+|..|.||||+|+.. ++.+++++|+++|++++.
T Consensus 133 ~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~ 175 (494)
T PHA02989 133 KGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFE 175 (494)
T ss_pred CCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccc
Confidence 99999 89999999999998754 688999999999999987
|
|
| >PHA02730 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.4e-14 Score=147.69 Aligned_cols=106 Identities=17% Similarity=0.163 Sum_probs=93.0
Q ss_pred CCCCCCCCCCCchHHHHHHHcC---CHHHHHHHHHcCCCCCccccCcchHHHHHHHcC--CHHHHHHHHhCCC--CCCCC
Q 012777 27 DDADGSEAIDPRVRLMYMANEG---DLDGIKELLDSGTDVNFRDIDKRTALHVAACQG--RTDVVRLLLSRGA--DVDPE 99 (456)
Q Consensus 27 ~~~~~~~~~~g~t~Lh~a~~~~---~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~--~~~~v~~Ll~~ga--~~~~~ 99 (456)
.+++...|.+|+||||+|+..| +.+++++|+++|||++++|..|+||||+|+..+ +.++|++|++.|+ +++..
T Consensus 31 ~~in~~kd~~G~TaLh~A~~~~~~~~~eivklLLs~GAdin~kD~~G~TPLh~Aa~~~~~~~eIv~~Ll~~~~~~~~~~~ 110 (672)
T PHA02730 31 HNLSKHIDRRGNNALHCYVSNKCDTDIKIVRLLLSRGVERLCRNNEGLTPLGVYSKRKYVKSQIVHLLISSYSNASNELT 110 (672)
T ss_pred cchhhhcCCCCCcHHHHHHHcCCcCcHHHHHHHHhCCCCCcccCCCCCChHHHHHHcCCCcHHHHHHHHhcCCCCCcccc
Confidence 4677778889999999999997 599999999999999999999999999999976 7999999999955 45777
Q ss_pred CCCCCcccccccc--cccchhhhhhhh-cCCCCCCC
Q 012777 100 DRWGSTPLADAVY--YKHHDVIKLLEE-HGAKPSTA 132 (456)
Q Consensus 100 ~~~g~t~l~~A~~--~~~~~~~~~L~~-~~~~~~~~ 132 (456)
++-+.+|++.++. .++.+++++|+. .+++++..
T Consensus 111 ~~~~d~~l~~y~~s~n~~~~~vk~Li~~~~~~~~~~ 146 (672)
T PHA02730 111 SNINDFDLYSYMSSDNIDLRLLKYLIVDKRIRPSKN 146 (672)
T ss_pred cccCCchHHHHHHhcCCcHHHHHHHHHhcCCChhhh
Confidence 7778899888887 889999999996 77787654
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.7e-13 Score=117.52 Aligned_cols=131 Identities=19% Similarity=0.161 Sum_probs=106.6
Q ss_pred ceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCC--CcceeeeeEEEeCCceEEEEEccCC
Q 012777 157 SVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRH--PNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 157 ~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
.+.||+|.++.+ ...+..+++|....... ...+..|+..+..+++ +.+++++.++...+..++++||+.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 467888888644 55667999999875432 3578899999999975 5899999888877889999999988
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccc
Q 012777 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKL 299 (456)
Q Consensus 232 ~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~ 299 (456)
..+..+ +......++.+++.++..+|.....+++|+|++|.||+++..+.+++.|||.+..
T Consensus 78 ~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777644 5566677899999999999986333499999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.8e-14 Score=152.84 Aligned_cols=111 Identities=35% Similarity=0.487 Sum_probs=103.7
Q ss_pred CCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccc
Q 012777 29 ADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLA 108 (456)
Q Consensus 29 ~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~ 108 (456)
........|-|+||.|+..+....++.++++|++++.++..|.||||.||..|+.++|++||++|++++.+++.|+||||
T Consensus 499 ~~~~~~~~~l~~lhla~~~~~v~~~~~l~~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH 578 (1143)
T KOG4177|consen 499 NDNLDAKKGLTPLHLAADEDTVKVAKILLEHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPLH 578 (1143)
T ss_pred ccCccchhccchhhhhhhhhhHHHHHHHhhcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChhh
Confidence 33444566999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchhhhhhhhcCCCCCCCccccccc
Q 012777 109 DAVYYKHHDVIKLLEEHGAKPSTAPMHVQNA 139 (456)
Q Consensus 109 ~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 139 (456)
.||..|+.+|+.+|+++|+.+|.++....++
T Consensus 579 ~Aa~~G~~~i~~LLlk~GA~vna~d~~g~Tp 609 (1143)
T KOG4177|consen 579 QAAQQGHNDIAELLLKHGASVNAADLDGFTP 609 (1143)
T ss_pred HHHHcChHHHHHHHHHcCCCCCcccccCcch
Confidence 9999999999999999999999998877654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.8e-14 Score=142.24 Aligned_cols=252 Identities=23% Similarity=0.197 Sum_probs=185.5
Q ss_pred cccccccceeeec--cEEEEE-------eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC
Q 012777 150 KELDFSNSVEITK--GTFRIA-------SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQS 219 (456)
Q Consensus 150 ~~~~~~~~~~lg~--G~fg~~-------~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~ 219 (456)
.+..|.....+|+ |.+|-+ ..++..+|+|.-+... ..+.....-.+|+.-.+.+ .|++.++.+..+...
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccC
Confidence 3445677778898 888744 4567889999865443 2222233445677666666 599999999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCCeEeCCC-CCEEEec
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQKGA-LKPTLAVKFALDIAR----GMNYLHENRPEAIIHRDLEPSNILRDDS-GHLKVAD 293 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~ql~~----aL~~LH~~~~~~ivH~Dikp~Nil~~~~-~~vkl~D 293 (456)
+.+++-+|+| +.+|.++...... ++...++.++.+... ||.++|+.+ ++|-|+||.||+...+ ...+++|
T Consensus 191 ~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 191 GILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred Ccceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 9999999999 6899999887666 899999999999999 999999999 9999999999999998 8899999
Q ss_pred cCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCC
Q 012777 294 FGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERP 373 (456)
Q Consensus 294 fgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 373 (456)
||+...+..+.............+...|++||...+ -++.++|+|++|.+..+..++..+........ +.++ .....
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W~~~-r~~~i 343 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS-WSQL-RQGYI 343 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC-cccc-ccccC
Confidence 999887765543333322233356667999998766 57889999999999999998765443221000 0111 11111
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+. .+....+.++...+.+++..+|-.|++...+.++
T Consensus 344 p~-e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 344 PL-EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ch-hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 11 1234555667779999999999999988776554
|
|
| >PF13857 Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A 3EHR_B 3EHQ_A | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.8e-14 Score=100.70 Aligned_cols=55 Identities=51% Similarity=0.678 Sum_probs=29.7
Q ss_pred HHHcC-CCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 56 LLDSG-TDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 56 Ll~~g-~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
|+++| +++|.+|..|.||||+||..|+.+++++|++.|++++.+|.+|+||+|+|
T Consensus 1 LL~~~~~~~n~~d~~G~T~LH~A~~~g~~~~v~~Ll~~g~d~~~~d~~G~Tpl~~A 56 (56)
T PF13857_consen 1 LLEHGPADVNAQDKYGNTPLHWAARYGHSEVVRLLLQNGADPNAKDKDGQTPLHYA 56 (56)
T ss_dssp -----T--TT---TTS--HHHHHHHHT-HHHHHHHHHCT--TT---TTS--HHHH-
T ss_pred CCccCcCCCcCcCCCCCcHHHHHHHcCcHHHHHHHHHCcCCCCCCcCCCCCHHHhC
Confidence 56667 78888888888888888888888888888888888888888888888876
|
|
| >PLN03192 Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=1e-13 Score=151.09 Aligned_cols=97 Identities=30% Similarity=0.432 Sum_probs=88.9
Q ss_pred CCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccccccc
Q 012777 34 AIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYY 113 (456)
Q Consensus 34 ~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~ 113 (456)
+.++.++||.||..|+.++++.|++.|+|+|..|.+|.||||+|+..|+.+++++|+++|++++.+|.+|.||||+|+..
T Consensus 522 ~~~~~~~L~~Aa~~g~~~~l~~Ll~~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~ 601 (823)
T PLN03192 522 DPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISA 601 (823)
T ss_pred CccchhHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHh
Confidence 34578999999999999999999999999999999999999999999999999999999999999999999999999888
Q ss_pred ccchhhhhhhhcCCCCC
Q 012777 114 KHHDVIKLLEEHGAKPS 130 (456)
Q Consensus 114 ~~~~~~~~L~~~~~~~~ 130 (456)
|+.+++++|+..++..+
T Consensus 602 g~~~iv~~L~~~~~~~~ 618 (823)
T PLN03192 602 KHHKIFRILYHFASISD 618 (823)
T ss_pred CCHHHHHHHHhcCcccC
Confidence 88888888776665443
|
|
| >cd00204 ANK ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.5e-13 Score=112.35 Aligned_cols=101 Identities=44% Similarity=0.611 Sum_probs=94.8
Q ss_pred CCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccccccc
Q 012777 34 AIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYY 113 (456)
Q Consensus 34 ~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~ 113 (456)
+.+|.||||.|+..++.++++.|++.|.+++.++..|.||+|.|+..++.+++++|++.|++++..+..|.||+|+|+..
T Consensus 4 ~~~g~t~l~~a~~~~~~~~i~~li~~~~~~~~~~~~g~~~l~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~l~~a~~~ 83 (126)
T cd00204 4 DEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAARN 83 (126)
T ss_pred CcCCCCHHHHHHHcCcHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHHHc
Confidence 46799999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhhhhcCCCCCCCcc
Q 012777 114 KHHDVIKLLEEHGAKPSTAPM 134 (456)
Q Consensus 114 ~~~~~~~~L~~~~~~~~~~~~ 134 (456)
++.+++++|++.+.+++..+.
T Consensus 84 ~~~~~~~~L~~~~~~~~~~~~ 104 (126)
T cd00204 84 GNLDVVKLLLKHGADVNARDK 104 (126)
T ss_pred CcHHHHHHHHHcCCCCcccCC
Confidence 999999999999877666543
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. |
| >PHA02917 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.4e-13 Score=145.06 Aligned_cols=106 Identities=25% Similarity=0.267 Sum_probs=94.3
Q ss_pred CCCCCCCCCCCCCchHHHHHHHcC-----------------------CHHHHHHHHHcCCCCCccccCcchHHHHHHHcC
Q 012777 25 ADDDADGSEAIDPRVRLMYMANEG-----------------------DLDGIKELLDSGTDVNFRDIDKRTALHVAACQG 81 (456)
Q Consensus 25 ~~~~~~~~~~~~g~t~Lh~a~~~~-----------------------~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~ 81 (456)
.+.+.+...+ +|.||||.||..+ ..++++.|+.+|+|+|.+|..|+||||+|+..+
T Consensus 385 ~ga~~~~~~~-~G~TpL~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~Ll~~GAdIN~kd~~G~TpLh~Aa~~~ 463 (661)
T PHA02917 385 EGGDAVNHLD-DGEIPIGHLCKSNYGCYNFYTYTYKKGLCDMSYACPILSTINICLPYLKDINMIDKRGETLLHKAVRYN 463 (661)
T ss_pred cCCCccccCC-CCCChhHHHHHhcccchhhhhhhhhhccchhhhhhhhHHHHHHHHHCCCCCCCCCCCCcCHHHHHHHcC
Confidence 4566565544 6999999998543 356889999999999999999999999999999
Q ss_pred CHHHHHHHHhCCCCCCCCCCCCCcccccccc-cccchhhhhhhhcCCCCCC
Q 012777 82 RTDVVRLLLSRGADVDPEDRWGSTPLADAVY-YKHHDVIKLLEEHGAKPST 131 (456)
Q Consensus 82 ~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~-~~~~~~~~~L~~~~~~~~~ 131 (456)
+.+++++|+++|++++.++..|.|||++|+. .++.+++++|+.+|++++.
T Consensus 464 ~~~~v~~Ll~~GAdin~~d~~G~T~L~~A~~~~~~~~iv~~LL~~ga~i~~ 514 (661)
T PHA02917 464 KQSLVSLLLESGSDVNIRSNNGYTCIAIAINESRNIELLKMLLCHKPTLDC 514 (661)
T ss_pred CHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHhCCCHHHHHHHHHcCCChhH
Confidence 9999999999999999999999999999996 6789999999999998763
|
|
| >KOG4214 consensus Myotrophin and similar proteins [Transcription] | Back alignment and domain information |
|---|
Probab=99.45 E-value=8.4e-14 Score=104.00 Aligned_cols=81 Identities=28% Similarity=0.358 Sum_probs=73.4
Q ss_pred CCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccc
Q 012777 30 DGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLAD 109 (456)
Q Consensus 30 ~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~ 109 (456)
+..+...|+||||+||-.|.++++++|+..|++++.+|+.|.|||.-|+..||.+||++||.+||+-..+..+|.+.+..
T Consensus 27 nVn~~~ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cVklLL~~GAdrt~~~PdG~~~~ea 106 (117)
T KOG4214|consen 27 NVNEIYGGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCVKLLLQNGADRTIHAPDGTALIEA 106 (117)
T ss_pred cHHHHhCCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHHHHHHHcCcccceeCCCchhHHhh
Confidence 33344579999999999999999999999999999999999999999999999999999999999998888888877664
Q ss_pred c
Q 012777 110 A 110 (456)
Q Consensus 110 A 110 (456)
+
T Consensus 107 t 107 (117)
T KOG4214|consen 107 T 107 (117)
T ss_pred c
Confidence 3
|
|
| >PTZ00322 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.7e-13 Score=143.73 Aligned_cols=96 Identities=42% Similarity=0.581 Sum_probs=90.9
Q ss_pred hHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccccchh
Q 012777 39 VRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDV 118 (456)
Q Consensus 39 t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~ 118 (456)
+.||.||..|+.++++.|++.|+|+|.+|.+|+||||+||..|+.+++++|+++|++++.+|..|.||||+|+..|+.++
T Consensus 84 ~~L~~aa~~G~~~~vk~LL~~Gadin~~d~~G~TpLh~Aa~~g~~eiv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~i 163 (664)
T PTZ00322 84 VELCQLAASGDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDGKTPLELAEENGFREV 163 (664)
T ss_pred HHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHH
Confidence 46899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhc-------CCCCCCCcc
Q 012777 119 IKLLEEH-------GAKPSTAPM 134 (456)
Q Consensus 119 ~~~L~~~-------~~~~~~~~~ 134 (456)
+++|+.+ |++++....
T Consensus 164 v~~Ll~~~~~~~~~ga~~~~~~~ 186 (664)
T PTZ00322 164 VQLLSRHSQCHFELGANAKPDSF 186 (664)
T ss_pred HHHHHhCCCcccccCCCCCcccc
Confidence 9999998 777766554
|
|
| >PHA02876 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.2e-13 Score=146.18 Aligned_cols=101 Identities=32% Similarity=0.375 Sum_probs=68.9
Q ss_pred CCCCCchHHHHHHHcC-CHHHHHHHHHcCCCCCccccCcchHHHHHHHc-CCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 33 EAIDPRVRLMYMANEG-DLDGIKELLDSGTDVNFRDIDKRTALHVAACQ-GRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~-~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~-~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
.+.+|.||||+|+..| +.++++.|+..|+++|.+|..|.||||+|+.. ++.+++++|++.|++++.+|..|.||||+|
T Consensus 303 ~d~~g~TpLh~Aa~~g~~~~~v~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~iv~lLl~~gadin~~d~~G~TpLh~A 382 (682)
T PHA02876 303 KNIKGETPLYLMAKNGYDTENIRTLIMLGADVNAADRLYITPLHQASTLDRNKDIVITLLELGANVNARDYCDKTPIHYA 382 (682)
T ss_pred cCCCCCCHHHHHHHhCCCHHHHHHHHHcCCCCCCcccCCCcHHHHHHHhCCcHHHHHHHHHcCCCCccCCCCCCCHHHHH
Confidence 3455666666666666 46666666666666666666667777766664 356667777777777777777777777777
Q ss_pred cccccchhhhhhhhcCCCCCCCc
Q 012777 111 VYYKHHDVIKLLEEHGAKPSTAP 133 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~~~~~~~~ 133 (456)
+..|+.+++++|++.|++++..+
T Consensus 383 a~~~~~~iv~~Ll~~gad~~~~~ 405 (682)
T PHA02876 383 AVRNNVVIINTLLDYGADIEALS 405 (682)
T ss_pred HHcCCHHHHHHHHHCCCCccccC
Confidence 77777777777777777766543
|
|
| >KOG0510 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.5e-13 Score=139.41 Aligned_cols=102 Identities=31% Similarity=0.397 Sum_probs=94.8
Q ss_pred CCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHh-C-CCCCCCCCCCCCccc
Q 012777 30 DGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLS-R-GADVDPEDRWGSTPL 107 (456)
Q Consensus 30 ~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~-~-ga~~~~~~~~g~t~l 107 (456)
....|.||.||||+||.+|+.+++..|+..|+++|.++.++.||||.|+..|++++|+-||+ . -..+|..|..|.||+
T Consensus 266 v~~~d~dg~tpLH~a~r~G~~~svd~Ll~~Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpL 345 (929)
T KOG0510|consen 266 VNDEDNDGCTPLHYAARQGGPESVDNLLGFGASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPL 345 (929)
T ss_pred hhcccccCCchHHHHHHcCChhHHHHHHHcCCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCch
Confidence 34567899999999999999999999999999999999999999999999999999999998 4 455788999999999
Q ss_pred ccccccccchhhhhhhhcCCCCCC
Q 012777 108 ADAVYYKHHDVIKLLEEHGAKPST 131 (456)
Q Consensus 108 ~~A~~~~~~~~~~~L~~~~~~~~~ 131 (456)
|+|+..||..++++|++.||....
T Consensus 346 Hlaa~~gH~~v~qlLl~~GA~~~~ 369 (929)
T KOG0510|consen 346 HLAAKSGHDRVVQLLLNKGALFLN 369 (929)
T ss_pred hhhhhcCHHHHHHHHHhcChhhhc
Confidence 999999999999999999998763
|
|
| >KOG0515 consensus p53-interacting protein 53BP/ASPP, contains ankyrin and SH3 domains [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.1e-13 Score=130.47 Aligned_cols=98 Identities=33% Similarity=0.418 Sum_probs=91.2
Q ss_pred CCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccc
Q 012777 35 IDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYK 114 (456)
Q Consensus 35 ~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~ 114 (456)
.+.-..|..|+..|-+++|+.++..-.|+...|.+|.||||.|+..||++||++||+.|+++|..|.+||||||.|+.-+
T Consensus 548 fnPLaLLLDaaLeGEldlVq~~i~ev~DpSqpNdEGITaLHNAiCaghyeIVkFLi~~ganVNa~DSdGWTPLHCAASCN 627 (752)
T KOG0515|consen 548 FNPLALLLDAALEGELDLVQRIIYEVTDPSQPNDEGITALHNAICAGHYEIVKFLIEFGANVNAADSDGWTPLHCAASCN 627 (752)
T ss_pred cchHHHHHhhhhcchHHHHHHHHHhhcCCCCCCccchhHHhhhhhcchhHHHHHHHhcCCcccCccCCCCchhhhhhhcC
Confidence 45556788999999999999999888899999999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhhhcCCCCCCC
Q 012777 115 HHDVIKLLEEHGAKPSTA 132 (456)
Q Consensus 115 ~~~~~~~L~~~~~~~~~~ 132 (456)
+..||+.|+..|+-|.+.
T Consensus 628 nv~~ckqLVe~GaavfAs 645 (752)
T KOG0515|consen 628 NVPMCKQLVESGAAVFAS 645 (752)
T ss_pred chHHHHHHHhccceEEee
Confidence 999999999999877543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.5e-12 Score=126.67 Aligned_cols=169 Identities=18% Similarity=0.312 Sum_probs=130.2
Q ss_pred EEEeEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCHHHHHHHcCCCC
Q 012777 166 RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALK 245 (456)
Q Consensus 166 g~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~ 245 (456)
|..+.++.+|.|.+.+... ........+-+..|+.++||||+++++.++.++.+|+|+|-+. .|..++++.+
T Consensus 31 ~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~--- 102 (690)
T KOG1243|consen 31 GTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG--- 102 (690)
T ss_pred cceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---
Confidence 4567789999999987642 2455677888899999999999999999999999999999983 7788887644
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCccccccc
Q 012777 246 PTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPE 325 (456)
Q Consensus 246 ~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE 325 (456)
.......++||+.||.|||..+ .++|++|.-+.|+|+..|..||++|.+.......+. ......--..|..|+
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-----~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-----PAKSLYLIESFDDPE 175 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-----ccccchhhhcccChh
Confidence 7778888999999999998555 399999999999999999999999988764421110 001111111356666
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHcC
Q 012777 326 VYKNEEYDTKVDVFSFALILQEMIEG 351 (456)
Q Consensus 326 ~~~~~~~~~~~DiwslG~il~~l~~g 351 (456)
.+.... -..|.|.|||++++++.|
T Consensus 176 ~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCccc--cchhhhhHHHHHHHHhCc
Confidence 543322 457999999999999998
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 456 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-38 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-38 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-32 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-32 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-32 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-32 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-31 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-31 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-29 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-29 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-29 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-29 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-29 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-29 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-29 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-29 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-29 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-28 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-28 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-28 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-28 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-28 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-28 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-28 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-28 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-28 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-28 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-28 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-28 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-27 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-27 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-27 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-27 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-27 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-27 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-27 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-27 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-27 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-27 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-26 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-26 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-26 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-26 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-26 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-26 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-26 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-26 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-26 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-26 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-26 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-26 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-26 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-26 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-26 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-26 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-26 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-26 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-25 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-25 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-25 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-25 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-25 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-25 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-25 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-25 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-25 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-25 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-25 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-25 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-25 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-25 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-25 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-25 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-25 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-25 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-25 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-25 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-25 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-25 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-25 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-25 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-25 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-25 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-25 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-25 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-25 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-25 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-25 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-25 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-25 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-25 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-25 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-25 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-25 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-25 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-25 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-25 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-25 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-25 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-24 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-24 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-24 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-24 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-24 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-24 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-24 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-24 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-24 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-24 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-24 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-24 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-24 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-24 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-24 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-24 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-24 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-24 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-24 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-24 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-24 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-24 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-24 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-24 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-24 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-24 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-24 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-24 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-24 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-24 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-24 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-24 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-24 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-24 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-24 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-24 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-24 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-24 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-24 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-24 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-24 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-24 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-24 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-24 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-24 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-24 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-24 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-24 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-23 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-23 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-23 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-22 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-22 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-22 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-22 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-22 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-22 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-22 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-22 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-22 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-22 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-22 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-22 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-22 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-22 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-22 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-22 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-22 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-22 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-22 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-22 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-22 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-22 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-22 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-22 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-22 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-22 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-22 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-22 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-22 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-22 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-21 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-21 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-21 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-21 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-21 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-21 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-21 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-21 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-20 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-20 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-20 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-20 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-20 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-20 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-20 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-20 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-20 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-20 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-20 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-20 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-20 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-20 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-20 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-20 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-20 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-20 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-20 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-20 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-20 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-20 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-20 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-20 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-20 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-20 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-20 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-20 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-20 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-20 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-20 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-20 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-20 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-20 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-20 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-20 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-19 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-19 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-19 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-19 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-19 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-19 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-19 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-19 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-19 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-19 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-19 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-19 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-19 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-19 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-19 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-19 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-19 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-19 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-19 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-19 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-19 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-19 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-19 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-19 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-19 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-19 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-19 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-19 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-19 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-19 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-19 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-19 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-19 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-19 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-19 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-19 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-19 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-18 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-18 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-18 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-18 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-18 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-18 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-18 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-18 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-18 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-18 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-18 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-18 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-18 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-18 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-18 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-18 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-18 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-18 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-18 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-18 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-18 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-18 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-18 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-18 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-18 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-18 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-18 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-18 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-18 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-18 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-18 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-18 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-18 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-18 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-18 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-18 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-18 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-17 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-17 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-17 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-17 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-17 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-17 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-17 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-17 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-17 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-17 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-17 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-17 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-17 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-17 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-17 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-17 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-17 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-17 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-17 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-17 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-17 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-17 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-17 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-16 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-16 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-16 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-16 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-16 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-16 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-16 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-16 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-16 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-16 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-16 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-16 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-16 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-16 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-16 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-16 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-16 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-16 | ||
| 4gmr_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 9e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-15 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-15 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-15 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-15 | ||
| 4hqd_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 4e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-15 | ||
| 4gpm_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 5e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-15 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-15 | ||
| 1n0r_A | 126 | 4ank: A Designed Ankyrin Repeat Protein With Four I | 9e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-14 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-14 | ||
| 1n0q_A | 93 | 3ank: A Designed Ankyrin Repeat Protein With Three | 2e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-14 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-14 | ||
| 4hb5_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 2e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-14 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-14 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-14 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-14 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-14 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-14 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-14 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-13 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-12 | ||
| 2l6b_A | 115 | Nrc Consensus Ankyrin Repeat Protein Solution Struc | 1e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-12 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-12 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-12 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-12 | ||
| 4dui_A | 169 | Darpin D1 Binding To Tubulin Beta Chain (not In Com | 6e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-11 | ||
| 3zuv_B | 136 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-11 | ||
| 4drx_E | 169 | Gtp-Tubulin In Complex With A Darpin Length = 169 | 1e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-11 | ||
| 4f6r_D | 169 | Tubulin:stathmin-Like Domain Complex Length = 169 | 1e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-11 | ||
| 3twu_A | 167 | Crystal Structure Of Arc4 From Human Tankyrase 2 In | 1e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-11 | ||
| 3twq_A | 175 | Crystal Structure Of Arc4 From Human Tankyrase 2 (A | 1e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 3twr_A | 165 | Crystal Structure Of Arc4 From Human Tankyrase 2 In | 2e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-11 | ||
| 3q9u_C | 158 | In Silico And In Vitro Co-Evolution Of A High Affin | 2e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-11 | ||
| 4atz_D | 154 | Ad5 Knob In Complex With A Designed Ankyrin Repeat | 2e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-11 | ||
| 2xeh_A | 157 | Structural Determinants For Improved Thermal Stabil | 2e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-11 | ||
| 1mj0_A | 166 | Sank E3_5: An Artificial Ankyrin Repeat Protein Len | 3e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-11 | ||
| 2xzt_G | 136 | Caspase-3 In Complex With Darpin-3.4_i78s Length = | 3e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-11 | ||
| 1svx_A | 169 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-11 | ||
| 2xzd_G | 136 | Caspase-3 In Complex With An Inhibitory Darpin-3.4 | 4e-11 | ||
| 2y0b_G | 136 | Caspase-3 In Complex With An Inhibitory Darpin-3.4_ | 5e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-10 | ||
| 2v4h_C | 136 | Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 13 | 1e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-10 | ||
| 2j8s_D | 169 | Drug Export Pathway Of Multidrug Exporter Acrb Reve | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-10 | ||
| 3b7b_A | 237 | Euhmt1 (Glp) Ankyrin Repeat Domain (Structure 1) Le | 2e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-10 | ||
| 2xee_A | 157 | Structural Determinants For Improved Thermal Stabil | 2e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-10 | ||
| 2qyj_A | 166 | Crystal Structure Of A Designed Full Consensus Anky | 3e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-10 | ||
| 3zu7_B | 169 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-10 | ||
| 3v2o_A | 183 | Crystal Structure Of The Peptide Bound Complex Of T | 3e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-10 | ||
| 3v2x_A | 167 | Crystal Structure Of The Peptide Bound Complex Of T | 4e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-10 | ||
| 3so8_A | 162 | Crystal Structure Of Ankra Length = 162 | 4e-10 | ||
| 3noc_D | 169 | Designed Ankyrin Repeat Protein (Darpin) Binders To | 4e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-10 | ||
| 2v5q_C | 167 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-10 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-10 | ||
| 3hg0_D | 136 | Crystal Structure Of A Darpin In Complex With Orf49 | 6e-10 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4GMR|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or266. Length = 169 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4HQD|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or265. Length = 169 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4GPM|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or264. Length = 169 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1N0R|A Chain A, 4ank: A Designed Ankyrin Repeat Protein With Four Identical Consensus Repeats Length = 126 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1N0Q|A Chain A, 3ank: A Designed Ankyrin Repeat Protein With Three Identical Consensus Repeats Length = 93 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4HB5|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or267. Length = 169 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2L6B|A Chain A, Nrc Consensus Ankyrin Repeat Protein Solution Structure Length = 115 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4DUI|A Chain A, Darpin D1 Binding To Tubulin Beta Chain (not In Complex) Length = 169 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ZUV|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 136 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4DRX|E Chain E, Gtp-Tubulin In Complex With A Darpin Length = 169 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4F6R|D Chain D, Tubulin:stathmin-Like Domain Complex Length = 169 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3TWU|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 In Complex With Peptide From Human Mcl1 Length = 167 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TWQ|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 (Apo Form) Length = 175 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3TWR|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 In Complex With Peptide From Human 3bp2 Length = 165 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3Q9U|C Chain C, In Silico And In Vitro Co-Evolution Of A High Affinity Complementary Protein-Protein Interface Length = 158 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4ATZ|D Chain D, Ad5 Knob In Complex With A Designed Ankyrin Repeat Protein Length = 154 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2XEH|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1MJ0|A Chain A, Sank E3_5: An Artificial Ankyrin Repeat Protein Length = 166 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XZT|G Chain G, Caspase-3 In Complex With Darpin-3.4_i78s Length = 136 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SVX|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Maltose Binding Protein Length = 169 | Back alignment and structure |
|
| >pdb|2XZD|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4 Length = 136 | Back alignment and structure |
|
| >pdb|2Y0B|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4_s76r Length = 136 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2V4H|C Chain C, Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 136 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J8S|D Chain D, Drug Export Pathway Of Multidrug Exporter Acrb Revealed By Darpin Inhibitors Length = 169 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3B7B|A Chain A, Euhmt1 (Glp) Ankyrin Repeat Domain (Structure 1) Length = 237 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XEE|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2QYJ|A Chain A, Crystal Structure Of A Designed Full Consensus Ankyrin Length = 166 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3ZU7|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 169 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3V2O|A Chain A, Crystal Structure Of The Peptide Bound Complex Of The Ankyrin Repeat Domains Of Human Ankra2 Length = 183 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3V2X|A Chain A, Crystal Structure Of The Peptide Bound Complex Of The Ankyrin Repeat Domains Of Human Ankra2 Length = 167 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3SO8|A Chain A, Crystal Structure Of Ankra Length = 162 | Back alignment and structure |
|
| >pdb|3NOC|D Chain D, Designed Ankyrin Repeat Protein (Darpin) Binders To Acrb: Plasticity Of The Interface Length = 169 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|C Chain C, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 167 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3HG0|D Chain D, Crystal Structure Of A Darpin In Complex With Orf49 From Lactococcal Phage Tp901-1 Length = 136 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 2e-95
Identities = 92/326 (28%), Positives = 141/326 (43%), Gaps = 44/326 (13%)
Query: 144 EYEIDPKELDFSNSVEITKGTF---RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELAL 200
+ ID KE++ + +G F A WR VA+K E + KAFI EL
Sbjct: 2 LHMIDYKEIEVEE--VVGRGAFGVVCKAKWRAKDVAIK-----QIESESERKAFIVELRQ 54
Query: 201 LQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL---KQKGALKPTLAVKFALDIA 257
L ++ HPN+V+ GA P+ +V EY G L L + A+ + L +
Sbjct: 55 LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 258 RGMNYLHENRPEAIIHRDLEPSNILRDDSG-HLKVADFGLSKLLKFANTVKEDRPVTCEE 316
+G+ YLH +P+A+IHRDL+P N+L G LK+ DFG + ++ +T +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--------MTNNK 164
Query: 317 TSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFP--TKQEKEVPKAYIANERPP 374
S + APEV++ Y K DVFS+ +IL E+I PF + A RPP
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP 224
Query: 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD---------------QLS 419
+ L+ CWS++P +RP+ +I+ + + L
Sbjct: 225 LIKNLPK---PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLP 281
Query: 420 IKRHWKVGPLRCFQSLAALWKKGHAD 445
+V P F LW H +
Sbjct: 282 PGEDGRVEPYVDFAEFYRLWSVDHGE 307
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 9e-95
Identities = 104/317 (32%), Positives = 164/317 (51%), Gaps = 20/317 (6%)
Query: 114 KHHDVIKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTF---RIASW 170
KHH + ++ P+T ++ Q A + + +I +L+ +I G+F A W
Sbjct: 2 KHHHHHHPMSDY-DIPTTENLYFQGAMDGDDMDIPWCDLNIKE--KIGAGSFGTVHRAEW 58
Query: 171 RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230
G+ VAVK L E+ F ++V F+ E+A+++++RHPN+V F+GAVTQ + IVTEYL
Sbjct: 59 HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS 117
Query: 231 KGDLRAYLKQKGA---LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
+G L L + GA L + A D+A+GMNYLH P I+HR+L+ N+L D
Sbjct: 118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKY 176
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQE 347
+KV DFGLS+L A+T + + + APEV ++E + K DV+SF +IL E
Sbjct: 177 TVKVCDFGLSRLK--ASTFLSSKSAAG---TPEWMAPEVLRDEPSNEKSDVYSFGVILWE 231
Query: 348 MIEGCPPFPTKQEKEVPKAYI-ANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQ 406
+ P+ +V A +R + +IE CW+ EP++RP+F
Sbjct: 232 LATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP---QVAAIIEGCWTNEPWKRPSFAT 288
Query: 407 ILMRLDDISDQLSIKRH 423
I+ L + +
Sbjct: 289 IMDLLRPLIKSAVPPPN 305
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 4e-90
Identities = 84/281 (29%), Positives = 123/281 (43%), Gaps = 24/281 (8%)
Query: 146 EIDPKELDFSNSVEITKGTF---RIASWRGTQVAVKTLGEEVFTD-EDKVKAFIDELALL 201
EID EL I G F A W G +VAVK + D ++ E L
Sbjct: 3 EIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 202 QKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMN 261
++HPN++ G + + +V E+ G L L K + P + V +A+ IARGMN
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMN 119
Query: 262 YLHENRPEAIIHRDLEPSNILRDDSGH--------LKVADFGLSKLLKFANTVKEDRPVT 313
YLH+ IIHRDL+ SNIL LK+ DFGL++
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-------EWHRTTKM 172
Query: 314 CEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERP 373
++ + APEV + + DV+S+ ++L E++ G PF V N+
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232
Query: 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
T +L+EDCW+ +P RP+F IL +L I
Sbjct: 233 LPIPSTCPEP--FAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 7e-86
Identities = 70/292 (23%), Positives = 125/292 (42%), Gaps = 25/292 (8%)
Query: 137 QNAREVPEYEIDPKELDFSNSVEITKGTF----RIASWRGTQVAVKTLGEEVFTDEDKVK 192
Q + + E++I ++L+ I KG F W G VA++ + E ED++K
Sbjct: 20 QTSIFLQEWDIPFEQLEIGE--LIGKGRFGQVYH-GRWHGE-VAIRLIDIERDN-EDQLK 74
Query: 193 AFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL-KQKGALKPTLAVK 251
AF E+ ++ RH NVV F+GA + I+T L + + K L +
Sbjct: 75 AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQ 134
Query: 252 FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRP 311
A +I +GM YLH I+H+DL+ N+ D+ G + + DFGL + + +
Sbjct: 135 IAQEIVKGMGYLHAK---GILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDK 190
Query: 312 VTCEETSWRYAAPEVYKNEE---------YDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
+ + + APE+ + + DVF+ I E+ PF T+ +
Sbjct: 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA 250
Query: 363 VPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
+ +P + +++ CW+ E RPTF +++ L+ +
Sbjct: 251 IIWQMGTGMKPNLSQIGMGKE--ISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 2e-85
Identities = 80/291 (27%), Positives = 129/291 (44%), Gaps = 36/291 (12%)
Query: 144 EYEIDPKELDFSNSVEITKGTF---RIASW--RGTQVAVKTLGEEVFTDE----DKVKAF 194
+ E+++ +I KG F + VA+K+L E +K + F
Sbjct: 13 LPTLADNEIEYEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL-KQKGALKPTLAVKFA 253
E+ ++ + HPN+V+ G + P +V E++P GDL L + +K ++ ++
Sbjct: 71 QREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128
Query: 254 LDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG-----HLKVADFGLSKLLKFANTVKE 308
LDIA G+ Y+ P I+HRDL NI KVADFGLS+
Sbjct: 129 LDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--------S 179
Query: 309 DRPVTCEETSWRYAAPEVY--KNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKA 366
V+ ++++ APE + E Y K D +SFA+IL ++ G PF ++
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239
Query: 367 YIA---NERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
+ RP LR +IE CWS +P +RP F I+ L ++
Sbjct: 240 NMIREEGLRPTIPEDCPP---RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 3e-83
Identities = 78/296 (26%), Positives = 129/296 (43%), Gaps = 30/296 (10%)
Query: 142 VPEYEIDPKELDFSNSVEITKGTF----RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFI 195
+P P +L + KG F + + R T + +K L DE+ + F+
Sbjct: 2 MPHRIFRPSDLIHGE--VLGKGCFGQAIK-VTHRETGEVMVMKELIRF---DEETQRTFL 55
Query: 196 DELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL-KQKGALKPTLAVKFAL 254
E+ +++ + HPNV++F+G + + + +TEY+ G LR + + V FA
Sbjct: 56 KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAK 115
Query: 255 DIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTC 314
DIA GM YLH IIHRDL N L ++ ++ VADFGL++L+ T E
Sbjct: 116 DIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 315 EET---------SWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFP--TKQEKEV 363
+ + + APE+ YD KVDVFSF ++L E+I P + +
Sbjct: 173 KPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232
Query: 364 PKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLS 419
P + + C +P +RP+F ++ L+ + L+
Sbjct: 233 GLNVRGFLDRY-CPPNCPPS--FFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 8e-83
Identities = 72/286 (25%), Positives = 127/286 (44%), Gaps = 30/286 (10%)
Query: 144 EYEIDPKELDFSNSVEITKGTF---RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELAL 200
ID K+L+F ++ + W+G + VK L ++ K + F +E
Sbjct: 4 HSGIDFKQLNFLT--KLNENHSGELWKGRWQGNDIVVKVLKVRDWS-TRKSRDFNEECPR 60
Query: 201 LQKIRHPNVVQFLGAVTQ--STPMMIVTEYLPKGDLRAYL--KQKGALKPTLAVKFALDI 256
L+ HPNV+ LGA + ++T ++P G L L + + AVKFALD+
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 257 ARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEE 316
ARGM +LH P I L +++ D+ +++ + + +
Sbjct: 121 ARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM---------- 169
Query: 317 TSWRYAAPEVYKNEEYDT---KVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-- 371
+ + APE + + DT D++SFA++L E++ PF E+ +A E
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK-VALEGL 228
Query: 372 RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417
RP P + +L++ C +E+P +RP F I+ L+ + D+
Sbjct: 229 RPTI-PPGISPH--VSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 4e-80
Identities = 72/285 (25%), Positives = 134/285 (47%), Gaps = 28/285 (9%)
Query: 144 EYEIDPKELDFSNSVEITKGTF----RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELA 199
++EI ++ I G+F + W G VAVK L T +++AF +E+
Sbjct: 18 DWEIPDGQITVGQ--RIGSGSFGTVYK-GKWHGD-VAVKMLNVTAPT-PQQLQAFKNEVG 72
Query: 200 LLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL-KQKGALKPTLAVKFALDIAR 258
+L+K RH N++ F+G T + IVT++ L +L + + + A AR
Sbjct: 73 VLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 259 GMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS 318
GM+YLH IIHRDL+ +NI + +K+ DFGL+ S
Sbjct: 132 GMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS---RWSGSHQFEQLSGS 185
Query: 319 WRYAAPEVYKNEE---YDTKVDVFSFALILQEMIEGCPPFPTKQEKE-----VPKAYIAN 370
+ APEV + ++ Y + DV++F ++L E++ G P+ ++ V + ++
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP 245
Query: 371 ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415
+ R+ ++ L+ +C ++ RP+F +IL +++++
Sbjct: 246 DLSKVRSNCPK---RMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 7e-77
Identities = 78/316 (24%), Positives = 127/316 (40%), Gaps = 48/316 (15%)
Query: 144 EYEIDPKELDFSNSVEITKGTF---RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELA- 199
K++ +I KG + + WRG +VAVK VF ++ ++ E
Sbjct: 31 VQRTIAKQIQMVK--QIGKGRYGEVWMGKWRGEKVAVK-----VFFTTEE-ASWFRETEI 82
Query: 200 -LLQKIRHPNVVQFLGAVTQS----TPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFAL 254
+RH N++ F+ A + T + ++T+Y G L YLK L +K A
Sbjct: 83 YQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAY 141
Query: 255 DIARGMNYLHENRPE-----AIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKED 309
G+ +LH AI HRDL+ NIL +G +AD GL+ ++T + D
Sbjct: 142 SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI-SDTNEVD 200
Query: 310 RPVTCEETSWRYAAPEV------YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV 363
P + RY PEV + + D++SF LIL E+ C +E ++
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260
Query: 364 PKAYIA----------------NERPPFRAPTTHYAY--GLRELIEDCWSEEPFRRPTFR 405
P + RP F + + +L+ +CW+ P R T
Sbjct: 261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320
Query: 406 QILMRLDDISDQLSIK 421
++ L +S+ IK
Sbjct: 321 RVKKTLAKMSESQDIK 336
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 3e-73
Identities = 73/316 (23%), Positives = 125/316 (39%), Gaps = 48/316 (15%)
Query: 144 EYEIDPKELDFSNSVEITKGTF---RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDE--L 198
+ + I KG F WRG +VAVK +F+ ++ +++ E +
Sbjct: 36 VQRTIARTIVLQE--SIGKGRFGEVWRGKWRGEEVAVK-----IFSSREE-RSWFREAEI 87
Query: 199 ALLQKIRHPNVVQFLGAVTQ----STPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFAL 254
+RH N++ F+ A + T + +V++Y G L YL + + +K AL
Sbjct: 88 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLAL 146
Query: 255 DIARGMNYLHENRPE-----AIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKED 309
A G+ +LH AI HRDL+ NIL +G +AD GL+ + T D
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD-SATDTID 205
Query: 310 RPVTCEETSWRYAAPEV------YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV 363
+ RY APEV K+ E + D+++ L+ E+ C ++ ++
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265
Query: 364 P--------------KAYIANE--RPPFRAPTTHYAY--GLRELIEDCWSEEPFRRPTFR 405
P + + + RP + +++ +CW R T
Sbjct: 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325
Query: 406 QILMRLDDISDQLSIK 421
+I L +S Q IK
Sbjct: 326 RIKKTLSQLSQQEGIK 341
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 6e-72
Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 46/302 (15%)
Query: 150 KELDFSNSVEITKGTF---RIASWRGTQVAVKTLGEEVFTDEDKVKAFID-ELALLQKIR 205
+++ + KG + SW+G VAVK +F+ D+ F + EL +R
Sbjct: 8 RDITLLE--CVGKGRYGEVWRGSWQGENVAVK-----IFSSRDEKSWFRETELYNTVMLR 60
Query: 206 HPNVVQFLGAVT----QSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMN 261
H N++ F+ + ST + ++T Y G L YL+ L ++ L IA G+
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLA 119
Query: 262 YLHENRPE-----AIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEE 316
+LH AI HRDL+ NIL +G +AD GL+ + +T + D
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ-STNQLDVGNNPRV 178
Query: 317 TSWRYAAPEVYKNE------EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIA- 369
+ RY APEV + +VD+++F L+L E+ ++ + P +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 370 ---------------NERPPFRAPTTHYAY--GLRELIEDCWSEEPFRRPTFRQILMRLD 412
+RP L +L+++CW + P R T +I L
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
Query: 413 DI 414
I
Sbjct: 299 KI 300
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-66
Identities = 66/316 (20%), Positives = 115/316 (36%), Gaps = 48/316 (15%)
Query: 143 PEYEIDPKELDFSNSVEITKGTFRI---ASWRGTQVAVKTLGEEVFTDEDKVKAFIDELA 199
L +G F A VAVK + + E+
Sbjct: 17 ENLYFQSMPLQLLE--VKARGRFGCVWKAQLLNEYVAVKIF----PIQDKQSWQNEYEVY 70
Query: 200 LLQKIRHPNVVQFLGAVTQS----TPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALD 255
L ++H N++QF+GA + + ++T + KG L +LK + A
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAET 129
Query: 256 IARGMNYLHENRPE-------AIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKE 308
+ARG+ YLHE+ P AI HRD++ N+L ++ +ADFGL+ + + +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 309 DRPVTCEETSWRYAAPEV-----YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV 363
+ RY APEV + ++D+++ L+L E+ C ++ +
Sbjct: 190 THGQV---GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 364 PKAYIA-----------------NERPPFRA--PTTHYAYGLRELIEDCWSEEPFRRPTF 404
+RP R L E IE+CW + R +
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 405 RQILMRLDDISDQLSI 420
+ R+ + +I
Sbjct: 307 GCVGERITQMQRLTNI 322
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 9e-65
Identities = 81/327 (24%), Positives = 125/327 (38%), Gaps = 59/327 (18%)
Query: 141 EVPEYEIDPKELDFSNSVEITKGTF----RIASWRGTQVAVKTLGEEVFTDEDKVKAFID 196
E +D L I +G + + S VAVK VF+ ++ + FI+
Sbjct: 4 AASEPSLDLDNLKLLEL--IGRGRYGAVYK-GSLDERPVAVK-----VFSFANR-QNFIN 54
Query: 197 ELA--LLQKIRHPNVVQFLGA-----VTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLA 249
E + + H N+ +F+ ++V EY P G L YL +
Sbjct: 55 EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSS 113
Query: 250 VKFALDIARGMNYLHENRPE------AIIHRDLEPSNILRDDSGHLKVADFGLSKLL--- 300
+ A + RG+ YLH P AI HRDL N+L + G ++DFGLS L
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 301 KFANTVKEDRPVTCEETSWRYAAPEVYKN-------EEYDTKVDVFSFALILQEMIEGC- 352
+ +ED E + RY APEV + E +VD+++ LI E+ C
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 353 PPFPTKQEKEVPKAYIA------------------NERPPFRAPTTHYAYGLR---ELIE 391
FP + E A+ +RP F + +R E IE
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 392 DCWSEEPFRRPTFRQILMRLDDISDQL 418
DCW ++ R T + R+ ++
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIW 320
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 7e-63
Identities = 82/319 (25%), Positives = 144/319 (45%), Gaps = 28/319 (8%)
Query: 112 YYKHHDVIKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTF---RIA 168
+ D + + A P + ++E++ ++ + ++ G +
Sbjct: 182 HSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKH--KLGGGQYGEVYEG 239
Query: 169 SWRG--TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226
W+ VAVKTL E+ E+ F+ E A++++I+HPN+VQ LG T+ P I+T
Sbjct: 240 VWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295
Query: 227 EYLPKGDLRAYLKQKGALKPTLA--VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD 284
E++ G+L YL++ + + + A I+ M YL + IHR+L N L
Sbjct: 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVG 352
Query: 285 DSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALI 344
++ +KVADFGLS+L+ + ++ APE ++ K DV++F ++
Sbjct: 353 ENHLVKVADFGLSRLMT----GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 408
Query: 345 LQEMI-EGCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRR 401
L E+ G P+P +V + + R P P Y EL+ CW P R
Sbjct: 409 LWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSDR 463
Query: 402 PTFRQILMRLDDISDQLSI 420
P+F +I + + + SI
Sbjct: 464 PSFAEIHQAFETMFQESSI 482
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 3e-62
Identities = 86/321 (26%), Positives = 134/321 (41%), Gaps = 44/321 (13%)
Query: 112 YYKHHDVIKLLEEHGAKPSTAPMHVQNAREVP--EYEIDPKELDFSNSVEITKGTF---R 166
+ +P T V R VP ++ ++ ++L +I +G F
Sbjct: 84 HLLST----------QQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGE--QIGRGNFGEVF 131
Query: 167 IASWRG--TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224
R T VAVK+ E D F+ E +L++ HPN+V+ +G TQ P+ I
Sbjct: 132 SGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189
Query: 225 VTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR 283
V E + GD +L+ +G L+ ++ D A GM YL IHRDL N L
Sbjct: 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLV 246
Query: 284 DDSGHLKVADFGLSKLLKFANTVKEDR----PVTCEETSWRYAAPEVYKNEEYDTKVDVF 339
+ LK++DFG+S+ PV ++ APE Y ++ DV+
Sbjct: 247 TEKNVLKISDFGMSREEADGVYAASGGLRQVPV-------KWTAPEALNYGRYSSESDVW 299
Query: 340 SFALILQEMIE-GCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSE 396
SF ++L E G P+P ++ + R P P + L+E CW+
Sbjct: 300 SFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVF-----RLMEQCWAY 354
Query: 397 EPFRRPTFRQILMRLDDISDQ 417
EP +RP+F I L I +
Sbjct: 355 EPGQRPSFSTIYQELQSIRKR 375
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 4e-62
Identities = 84/323 (26%), Positives = 138/323 (42%), Gaps = 34/323 (10%)
Query: 112 YYKHH-DVIKLLEEHGAKPSTAPMHVQNAREVPEY-------EIDPKELDFSNSV----- 158
++ HH + L G P + E P EI+ + +
Sbjct: 3 HHHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDS 62
Query: 159 -EITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVT 217
E+ G R+ R VA+K L E + + F+ E +++ + HPN+++ G VT
Sbjct: 63 GEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNIIRLEGVVT 120
Query: 218 QSTPMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDL 276
+ MIVTEY+ G L +L+ G V + GM YL + +HRDL
Sbjct: 121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDL 177
Query: 277 EPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSW--RYAAPEVYKNEEYDT 334
N+L D + KV+DFGLS++L+ D T R+ APE + +
Sbjct: 178 AARNVLVDSNLVCKVSDFGLSRVLED----DPDAAYTTTGGKIPIRWTAPEAIAFRTFSS 233
Query: 335 KVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIE 391
DV+SF +++ E++ G P+ ++V + R P P + +L+
Sbjct: 234 ASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALH-----QLML 288
Query: 392 DCWSEEPFRRPTFRQILMRLDDI 414
DCW ++ +RP F QI+ LD +
Sbjct: 289 DCWHKDRAQRPRFSQIVSVLDAL 311
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 5e-62
Identities = 86/288 (29%), Positives = 138/288 (47%), Gaps = 46/288 (15%)
Query: 143 PEYEIDPKELDFSNSVEITKGTF---RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELA 199
+ ++ KEL I KG F + +RG +VAVK + + T + F+ E +
Sbjct: 14 SGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCIKNDA-TAQA----FLAEAS 66
Query: 200 LLQKIRHPNVVQFLGAVTQSTP-MMIVTEYLPKGDLRAYLKQKGALKPTLA--VKFALDI 256
++ ++RH N+VQ LG + + + IVTEY+ KG L YL+ +G +KF+LD+
Sbjct: 67 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126
Query: 257 ARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL-------KFANTVKED 309
M YL N +HRDL N+L + KV+DFGL+K K
Sbjct: 127 CEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------- 176
Query: 310 RPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYI 368
PV ++ APE + +++ TK DV+SF ++L E+ G P+P K+V
Sbjct: 177 -PV-------KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
Query: 369 ANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
+ P P Y E++++CW + RP+F Q+ +L+ I
Sbjct: 229 KGYKMDAPDGCPPAVY-----EVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 8e-62
Identities = 89/281 (31%), Positives = 143/281 (50%), Gaps = 30/281 (10%)
Query: 144 EYEIDPKELDFSNSVEITKGTF---RIASWRG-TQVAVKTLGEEVFTDEDKVKAFIDELA 199
++ IDP EL F EI G F + W +VA+KT+ E ++ED FI+E
Sbjct: 2 KWVIDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAE 55
Query: 200 LLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIAR 258
++ K+ HP +VQ G + P+ +VTE++ G L YL+ +G + LD+
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115
Query: 259 GMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS 318
GM YL E +IHRDL N L ++ +KV+DFG+++ V +D+ + T
Sbjct: 116 GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF------VLDDQYTSSTGTK 166
Query: 319 W--RYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANER--P 373
+ ++A+PEV+ Y +K DV+SF +++ E+ EG P+ + EV + R
Sbjct: 167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 226
Query: 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
P A T Y +++ CW E P RP F ++L +L +I
Sbjct: 227 PRLASTHVY-----QIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-61
Identities = 81/291 (27%), Positives = 138/291 (47%), Gaps = 34/291 (11%)
Query: 143 PEYEIDPKELDFSNSVEITKGTF---RIASWRG--TQVAVKTLGEEVFTDEDKVKAFIDE 197
++E++ ++ + ++ G + W+ VAVKTL E+ E+ F+ E
Sbjct: 6 DKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKE 59
Query: 198 LALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLA--VKFALD 255
A++++I+HPN+VQ LG T+ P I+TE++ G+L YL++ + + + A
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 256 IARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR---PV 312
I+ M YL + IHRDL N L ++ +KVADFGLS+L+ P+
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANE 371
++ APE ++ K DV++F ++L E+ G P+P +V + +
Sbjct: 177 -------KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 229
Query: 372 R--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSI 420
R P P Y EL+ CW P RP+F +I + + + SI
Sbjct: 230 RMERPEGCPEKVY-----ELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 1e-61
Identities = 90/317 (28%), Positives = 152/317 (47%), Gaps = 42/317 (13%)
Query: 112 YYKHHD---VIKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTF--- 165
+Y +L++ K + Q+ + ++ KEL I KG F
Sbjct: 155 HYTTDADGLCTRLIK---PKVMEGTVAAQDEFYRSGWALNMKELKLLQ--TIGKGEFGDV 209
Query: 166 RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP-MMI 224
+ +RG +VAVK + + T + F+ E +++ ++RH N+VQ LG + + + I
Sbjct: 210 MLGDYRGNKVAVKCIKNDA-TAQA----FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264
Query: 225 VTEYLPKGDLRAYLKQKGALKPTLA--VKFALDIARGMNYLHENRPEAIIHRDLEPSNIL 282
VTEY+ KG L YL+ +G +KF+LD+ M YL N +HRDL N+L
Sbjct: 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVL 321
Query: 283 RDDSGHLKVADFGLSKLLKFANTVKEDR--PVTCEETSWRYAAPEVYKNEEYDTKVDVFS 340
+ KV+DFGL+ K A++ ++ PV ++ APE + +++ TK DV+S
Sbjct: 322 VSEDNVAKVSDFGLT---KEASSTQDTGKLPV-------KWTAPEALREKKFSTKSDVWS 371
Query: 341 FALILQEMI-EGCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEE 397
F ++L E+ G P+P K+V + P P Y +++++CW +
Sbjct: 372 FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY-----DVMKNCWHLD 426
Query: 398 PFRRPTFRQILMRLDDI 414
RPTF Q+ +L+ I
Sbjct: 427 AATRPTFLQLREQLEHI 443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 3e-61
Identities = 83/282 (29%), Positives = 145/282 (51%), Gaps = 30/282 (10%)
Query: 146 EIDPKELDFSNSVEITKGTF---RIASWRG-TQVAVKTLGEEVFTDEDKVKAFIDELALL 201
E+ +E+ E+ G F ++ W+G VAVK + E ++++ F E +
Sbjct: 4 ELKREEITLLK--ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE----FFQEAQTM 57
Query: 202 QKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGM 260
K+ HP +V+F G ++ P+ IVTEY+ G L YL+ G L+P+ ++ D+ GM
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 261 NYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSW- 319
+L ++ IHRDL N L D +KV+DFG+++ V +D+ V+ T +
Sbjct: 118 AFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRY------VLDDQYVSSVGTKFP 168
Query: 320 -RYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANER--PPF 375
+++APEV+ +Y +K DV++F +++ E+ G P+ EV R P
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH 228
Query: 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417
A T Y +++ CW E P +RPTF+Q+L ++ + ++
Sbjct: 229 LASDTIY-----QIMYSCWHELPEKRPTFQQLLSSIEPLREK 265
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 6e-61
Identities = 75/294 (25%), Positives = 119/294 (40%), Gaps = 26/294 (8%)
Query: 137 QNAREVPEYEIDPKELDFSNSV------EITKGTFRIASWRGTQVAVKTLGEEVFTDEDK 190
+ + I K+L + + +G + S + VAVK L +V + +
Sbjct: 5 EGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA 64
Query: 191 VKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ-KGALKPTLA 249
+ FI E+ + + H N+++ G V PM +VTE P G L L++ +G
Sbjct: 65 MDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTL 123
Query: 250 VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKED 309
++A+ +A GM YL R IHRDL N+L +K+ DFGL + L +D
Sbjct: 124 SRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN----DD 176
Query: 310 RPVTCEETSW--RYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKA 366
V E + APE K + D + F + L EM G P+ ++
Sbjct: 177 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 236
Query: 367 -YIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417
ER P P Y ++ CW+ +P RPTF + L +
Sbjct: 237 IDKEGERLPRPEDCPQDIY-----NVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 6e-61
Identities = 85/302 (28%), Positives = 144/302 (47%), Gaps = 36/302 (11%)
Query: 128 KPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTF---RIASWRG-TQVAVKTLGEE 183
PSTA + +EIDPK+L F E+ G F + WRG VA+K + E
Sbjct: 8 APSTAGL------GYGSWEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEG 59
Query: 184 VFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ-KG 242
++++ FI+E ++ + H +VQ G T+ P+ I+TEY+ G L YL++ +
Sbjct: 60 SMSEDE----FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH 115
Query: 243 ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302
+ ++ D+ M YL + +HRDL N L +D G +KV+DFGLS+
Sbjct: 116 RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRY--- 169
Query: 303 ANTVKEDRPVTCEETSW--RYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQ 359
V +D + + + R++ PEV ++ +K D+++F +++ E+ G P+
Sbjct: 170 ---VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226
Query: 360 EKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417
E + R P A Y ++ CW E+ RPTF+ +L + D+ D+
Sbjct: 227 NSETAEHIAQGLRLYRPHLASEKVY-----TIMYSCWHEKADERPTFKILLSNILDVMDE 281
Query: 418 LS 419
S
Sbjct: 282 ES 283
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 8e-61
Identities = 76/292 (26%), Positives = 126/292 (43%), Gaps = 27/292 (9%)
Query: 144 EYEIDPKELDFSNSVEITKGTF---RIASWRG----TQVAVKTLGEEVFTDEDKVKAFID 196
E +D K L + E+ G F + ++ VAVK L E D +
Sbjct: 10 EVYLDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLA 67
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDI 256
E ++Q++ +P +V+ +G M+V E G L YL+Q +K ++ +
Sbjct: 68 EANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126
Query: 257 ARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEE 316
+ GM YL E+ +HRDL N+L + K++DFGLSK L+ E+
Sbjct: 127 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR----ADENYYKAQTH 179
Query: 317 TSW--RYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANER- 372
W ++ APE ++ +K DV+SF +++ E G P+ + EV ER
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 239
Query: 373 -PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRH 423
P P Y +L+ CW+ + RP F + +RL + + + H
Sbjct: 240 GCPAGCPREMY-----DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 286
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 9e-61
Identities = 67/260 (25%), Positives = 119/260 (45%), Gaps = 23/260 (8%)
Query: 162 KGTFRIASWRG-TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST 220
KG + + VA+K L E T K +DE ++ + +P+V + LG S
Sbjct: 33 KGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89
Query: 221 PMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPS 279
+ ++T+ +P G L Y+++ K + + + + IA+GMNYL + R ++HRDL
Sbjct: 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR 146
Query: 280 NILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSW--RYAAPEVYKNEEYDTKVD 337
N+L H+K+ DFGL+KLL E++ E ++ A E + Y + D
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLG-----AEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 201
Query: 338 VFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCW 394
V+S+ + + E++ G P+ E+ ER P Y ++ CW
Sbjct: 202 VWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY-----MIMRKCW 256
Query: 395 SEEPFRRPTFRQILMRLDDI 414
+ RP FR++++ +
Sbjct: 257 MIDADSRPKFRELIIEFSKM 276
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-60
Identities = 69/287 (24%), Positives = 133/287 (46%), Gaps = 31/287 (10%)
Query: 141 EVPEYEIDPKELDFSNSV------EITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAF 194
+YEI + ++ + ++ +G + VA+KT T + + F
Sbjct: 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKF 63
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFA 253
+ E +++ HP++V+ +G +T++ P+ I+ E G+LR++L+ K +L + +A
Sbjct: 64 LQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 254 LDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR--- 310
++ + YL R +HRD+ N+L + +K+ DFGLS+ ++ + K +
Sbjct: 123 YQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 179
Query: 311 PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIA 369
P+ ++ APE + + DV+ F + + E++ G PF + +V
Sbjct: 180 PI-------KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 232
Query: 370 NER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
ER P P T Y L+ CW+ +P RRP F ++ +L I
Sbjct: 233 GERLPMPPNCPPTLY-----SLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 4e-60
Identities = 74/285 (25%), Positives = 132/285 (46%), Gaps = 31/285 (10%)
Query: 143 PEYEIDPKELDFSNSV------EITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFID 196
P+Y I +++ + + E+ +G + VAVKT ++ D + F+
Sbjct: 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMS 62
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFALD 255
E +++ + HP++V+ +G + + P I+ E P G+L YL++ K +LK V ++L
Sbjct: 63 EAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121
Query: 256 IARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR---PV 312
I + M YL +HRD+ NIL +K+ DFGLS+ ++ + K P+
Sbjct: 122 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI 178
Query: 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANE 371
++ +PE + T DV+ FA+ + E++ G PF + K+V +
Sbjct: 179 -------KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD 231
Query: 372 R--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
R P P Y L+ CW +P RP F +++ L D+
Sbjct: 232 RLPKPDLCPPVLY-----TLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 4e-60
Identities = 86/347 (24%), Positives = 147/347 (42%), Gaps = 62/347 (17%)
Query: 111 VYYKHHDVIKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSV---EITKGTF-- 165
Y+ HH P+T ++ Q A + DP + + + ++ KG F
Sbjct: 3 YYHHHH------HHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGS 56
Query: 166 -RIASWRG------TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ 218
+ + VAVK L E+ ++ F E+ +L+ ++H N+V++ G
Sbjct: 57 VEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113
Query: 219 ST--PMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRD 275
+ + ++ EYLP G LR YL++ K + +++ I +GM YL R IHRD
Sbjct: 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRD 170
Query: 276 LEPSNILRDDSGHLKVADFGLSKLLKFAN---TVKEDR--PVTCEETSWRYAAPEVYKNE 330
L NIL ++ +K+ DFGL+K+L VKE P+ + APE
Sbjct: 171 LATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI-------FWYAPESLTES 223
Query: 331 EYDTKVDVFSFALILQEMI----------------EGCPPFPTKQEKEVPKAYIANER-- 372
++ DV+SF ++L E+ G + + N R
Sbjct: 224 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 283
Query: 373 PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLS 419
P P Y ++ +CW+ +RP+FR + +R+D I DQ++
Sbjct: 284 RPDGCPDEIY-----MIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 3e-59
Identities = 95/331 (28%), Positives = 147/331 (44%), Gaps = 51/331 (15%)
Query: 110 AVYYKHHDVIKLLEEHGAKPSTAPMHVQNAR-EVP-------EYEIDPKELDFSNSV--- 158
+ Y+ HH P+T ++ Q A P EI P + +
Sbjct: 2 SYYHHHH------HHDYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAG 55
Query: 159 ---EITKGTFRIASWRG-TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLG 214
E+ KG + +S + VA+KTL T++ +V F+ E ++ + H N+++ G
Sbjct: 56 EFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVD-FLGEAGIMGQFSHHNIIRLEG 113
Query: 215 AVTQSTPMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIH 273
+++ PMMI+TEY+ G L +L++ G V IA GM YL +H
Sbjct: 114 VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVH 170
Query: 274 RDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS-------WRYAAPEV 326
RDL NIL + + KV+DFGLS++L ED P TS W APE
Sbjct: 171 RDLAARNILVNSNLVCKVSDFGLSRVL-------EDDPEATYTTSGGKIPIRW--TAPEA 221
Query: 327 YKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYA 383
++ + DV+SF +++ E++ G P+ EV KA R P P+ Y
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY- 280
Query: 384 YGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
+L+ CW +E RRP F I+ LD +
Sbjct: 281 ----QLMMQCWQQERARRPKFADIVSILDKL 307
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 9e-59
Identities = 89/314 (28%), Positives = 141/314 (44%), Gaps = 34/314 (10%)
Query: 112 YYKHHDVIKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTF---RIA 168
YY H L +EI + L ++ +G F +
Sbjct: 148 YYSKH--ADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEV--KLGQGCFGEVWMG 203
Query: 169 SWRG-TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227
+W G T+VA+KTL + E F+ E +++K+RH +VQ V++ P+ IVTE
Sbjct: 204 TWNGTTRVAIKTLKPGTMSPEA----FLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTE 258
Query: 228 YLPKGDLRAYLKQKGALKPTLA--VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD 285
Y+ KG L +LK + L V A IA GM Y+ +HRDL +NIL +
Sbjct: 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGE 315
Query: 286 SGHLKVADFGLSKLLKFANTVKEDRPVTCEETSW--RYAAPEVYKNEEYDTKVDVFSFAL 343
+ KVADFGL++L ++++ + + ++ APE + K DV+SF +
Sbjct: 316 NLVCKVADFGLARL------IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 369
Query: 344 ILQEMI-EGCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFR 400
+L E+ +G P+P +EV R P P + + +L+ CW +EP
Sbjct: 370 LLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH-----DLMCQCWRKEPEE 424
Query: 401 RPTFRQILMRLDDI 414
RPTF + L+D
Sbjct: 425 RPTFEYLQAFLEDY 438
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-58
Identities = 69/282 (24%), Positives = 126/282 (44%), Gaps = 29/282 (10%)
Query: 146 EIDPKELDFSNSV------EITKGTFRIASWRG-TQVAVKTLGEEVFTDEDKVKAFIDEL 198
EL + + KG + V +K + ++ + +A D +
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTDHM 66
Query: 199 ALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIA 257
+ + H ++V+ LG S + +VT+YLP G L +++Q +GAL P L + + + IA
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 258 RGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEET 317
+GM YL E+ ++HR+L N+L ++VADFG++ LL +D+ + E
Sbjct: 126 KGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP-----PDDKQLLYSEA 177
Query: 318 SW--RYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANER-- 372
++ A E +Y + DV+S+ + + E++ G P+ + EVP ER
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA 237
Query: 373 PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
P Y ++ CW + RPTF+++ +
Sbjct: 238 QPQICTIDVY-----MVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-58
Identities = 86/284 (30%), Positives = 137/284 (48%), Gaps = 34/284 (11%)
Query: 143 PEYEIDPKELDFSNSVEITKGTF---RIASWRG-TQVAVKTLGEEVFTDEDKVKAFIDEL 198
E+E+ + L + G F + + G T+VAVK+L + + + F+ E
Sbjct: 6 DEWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA----FLAEA 59
Query: 199 ALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLA--VKFALDI 256
L+++++H +V+ VTQ P+ I+TEY+ G L +LK +K T+ + A I
Sbjct: 60 NLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 257 ARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN-TVKEDR--PVT 313
A GM ++ E IHRDL +NIL D+ K+ADFGL++L++ T +E P+
Sbjct: 119 AEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI- 174
Query: 314 CEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANER 372
++ APE + K DV+SF ++L E++ G P+P EV + R
Sbjct: 175 ------KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR 228
Query: 373 --PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
P P Y +L+ CW E P RPTF + L+D
Sbjct: 229 MVRPDNCPEELY-----QLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-58
Identities = 78/311 (25%), Positives = 134/311 (43%), Gaps = 55/311 (17%)
Query: 144 EYEIDPKELDFSNSVEITKGTF---RIASWRG------TQVAVKTLGEEVFTDEDKVKAF 194
+ + + L F ++ KG F + + VAVK L E+ ++ F
Sbjct: 4 PTQFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDF 58
Query: 195 IDELALLQKIRHPNVVQFLGAVTQST--PMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVK 251
E+ +L+ ++H N+V++ G + + ++ EYLP G LR YL++ K + ++
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 252 FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN---TVKE 308
+ I +GM YL R IHRDL NIL ++ +K+ DFGL+K+L VKE
Sbjct: 119 YTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175
Query: 309 DR--PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI----------------E 350
P+ + APE ++ DV+SF ++L E+
Sbjct: 176 PGESPI-------FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228
Query: 351 GCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
G + + N R P P Y ++ +CW+ +RP+FR +
Sbjct: 229 GNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIY-----MIMTECWNNNVNQRPSFRDLA 283
Query: 409 MRLDDISDQLS 419
+R+D I D ++
Sbjct: 284 LRVDQIRDNMA 294
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-58
Identities = 82/281 (29%), Positives = 135/281 (48%), Gaps = 26/281 (9%)
Query: 146 EIDPKELDFSNSV------EITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELA 199
E+D + V E+ G ++ S + VA+KTL E + + F+ E +
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEAS 98
Query: 200 LLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIAR 258
++ + HPN+++ G VT+S P+MIVTEY+ G L ++L++ V IA
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 259 GMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS 318
GM YL + +HRDL NIL + + KV+DFGL ++L+ + T
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED----DPEAAYTTRGGK 211
Query: 319 W--RYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANER--P 373
R+ +PE ++ + DV+S+ ++L E++ G P+ ++V KA R P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
P P Y +L+ DCW ++ RP F QI+ LD +
Sbjct: 272 PMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 1e-57
Identities = 65/290 (22%), Positives = 121/290 (41%), Gaps = 29/290 (10%)
Query: 143 PEYEIDPKELDFSNSVEITKGTF---RIASWRG----TQVAVKTLGEEVFTDEDKVKAFI 195
+ + L ++ +E+ G F R +R VA+K L + T++ + +
Sbjct: 2 KKLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMM 58
Query: 196 DELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFAL 254
E ++ ++ +P +V+ +G +M+V E G L +L + + + +
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 117
Query: 255 DIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTC 314
++ GM YL E +HRDL N+L + + K++DFGLSK L +
Sbjct: 118 QVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG----ADDSYYTAR 170
Query: 315 EETSW--RYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANE 371
W ++ APE ++ ++ DV+S+ + + E + G P+ + EV +
Sbjct: 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 230
Query: 372 R--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLS 419
R P P Y L+ DCW + RP F + R+ L+
Sbjct: 231 RMECPPECPPELY-----ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 4e-57
Identities = 85/282 (30%), Positives = 137/282 (48%), Gaps = 32/282 (11%)
Query: 144 EYEIDPKELDFSNSVEITKGTF---RIASWRG-TQVAVKTLGEEVFTDEDKVKAFIDELA 199
+EI + L ++ +G F + +W G T+VA+KTL + E F+ E
Sbjct: 261 AWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQ 314
Query: 200 LLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLA--VKFALDIA 257
+++K+RH +VQ V++ P+ IVTEY+ KG L +LK + L V A IA
Sbjct: 315 VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 373
Query: 258 RGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEET 317
GM Y+ +HRDL +NIL ++ KVADFGL++L ++++ +
Sbjct: 374 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL------IEDNEYTARQGA 424
Query: 318 SW--RYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANER-- 372
+ ++ APE + K DV+SF ++L E+ +G P+P +EV R
Sbjct: 425 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 484
Query: 373 PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
P P + + +L+ CW +EP RPTF + L+D
Sbjct: 485 CPPECPESLH-----DLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 5e-57
Identities = 67/260 (25%), Positives = 119/260 (45%), Gaps = 23/260 (8%)
Query: 162 KGTFRIASWRG-TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST 220
KG + + VA+K L E T K +DE ++ + +P+V + LG S
Sbjct: 33 KGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89
Query: 221 PMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPS 279
+ ++T+ +P G L Y+++ K + + + + IA+GMNYL + R ++HRDL
Sbjct: 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR 146
Query: 280 NILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSW--RYAAPEVYKNEEYDTKVD 337
N+L H+K+ DFGL+KLL E++ E ++ A E + Y + D
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLG-----AEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 201
Query: 338 VFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCW 394
V+S+ + + E++ G P+ E+ ER P Y ++ CW
Sbjct: 202 VWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY-----MIMVKCW 256
Query: 395 SEEPFRRPTFRQILMRLDDI 414
+ RP FR++++ +
Sbjct: 257 MIDADSRPKFRELIIEFSKM 276
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 9e-57
Identities = 63/302 (20%), Positives = 122/302 (40%), Gaps = 45/302 (14%)
Query: 145 YEIDPKELDFSNSVEITKGTF------------RIASWRGTQVAVKTLGEEVFTDEDKVK 192
++I ++L F+ + +GTF T+V +K L + + +
Sbjct: 3 HKIRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK---AHRNYSE 57
Query: 193 AFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVK 251
+F + +++ K+ H ++V G ++V E++ G L YLK+ K + ++
Sbjct: 58 SFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE 117
Query: 252 FALDIARGMNYLHENRPEAIIHRDLEPSNIL--------RDDSGHLKVADFGLSKLLKFA 303
A +A M++L EN +IH ++ NIL + +K++D G+S +
Sbjct: 118 VAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 304 NTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMI-EGCPPFPTKQEK 361
+ ++E + + PE +N + + D +SF L E+ G P +
Sbjct: 175 DILQE--RI-------PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ 225
Query: 362 EVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIK 421
+ Y + P LI +C EP RP+FR I+ L+ + +
Sbjct: 226 RKLQFYEDRHQLPAPKAAELA-----NLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280
Query: 422 RH 423
R
Sbjct: 281 RG 282
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-56
Identities = 84/293 (28%), Positives = 135/293 (46%), Gaps = 32/293 (10%)
Query: 133 PMHVQNAREVPEYEIDPKELDFSNSVEITKGTF---RIASWRG-TQVAVKTLGEEVFTDE 188
Q E +EI + L ++ G F +A++ T+VAVKT+ + E
Sbjct: 171 SSKPQKPWEKDAWEIPRESLKLEK--KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE 228
Query: 189 DKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTL 248
F+ E +++ ++H +V+ VT+ P+ I+TE++ KG L +LK K L
Sbjct: 229 A----FLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPL 283
Query: 249 A--VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306
+ F+ IA GM ++ + IHRDL +NIL S K+ADFGL+++ +
Sbjct: 284 PKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV------I 334
Query: 307 KEDRPVTCEETSW--RYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEV 363
+++ E + ++ APE + K DV+SF ++L E++ G P+P EV
Sbjct: 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV 394
Query: 364 PKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
+A R P P Y ++ CW P RPTF I LDD
Sbjct: 395 IRALERGYRMPRPENCPEELY-----NIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 6e-56
Identities = 69/292 (23%), Positives = 137/292 (46%), Gaps = 31/292 (10%)
Query: 143 PEYEIDPKELDFSNSV------EITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFID 196
+YEI + ++ + ++ +G + VA+KT T + + F+
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQ 440
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFALD 255
E +++ HP++V+ +G +T++ P+ I+ E G+LR++L+ K +L + +A
Sbjct: 441 EALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 256 IARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR---PV 312
++ + YL R +HRD+ N+L + +K+ DFGLS+ ++ + K + P+
Sbjct: 500 LSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANE 371
++ APE + + DV+ F + + E++ G PF + +V E
Sbjct: 557 -------KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 609
Query: 372 R--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIK 421
R P P T Y L+ CW+ +P RRP F ++ +L I ++ ++
Sbjct: 610 RLPMPPNCPPTLY-----SLMTKCWAYDPSRRPRFTELKAQLSTILEEEKLQ 656
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-55
Identities = 77/298 (25%), Positives = 133/298 (44%), Gaps = 36/298 (12%)
Query: 141 EVPEYEIDPKELDFSNSVEITKGTF--------RIASWRGTQVAVKTLGEEVFTDEDKVK 192
V I P L + I +G F + AVK+L TD +V
Sbjct: 14 AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVS 71
Query: 193 AFIDELALLQKIRHPNVVQFLGAVTQS-TPMMIVTEYLPKGDLRAYLKQKGALKPTLA-- 249
F+ E +++ HPNV+ LG +S ++V Y+ GDLR +++ + PT+
Sbjct: 72 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDL 130
Query: 250 VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKED 309
+ F L +A+GM YL + +HRDL N + D+ +KVADFGL++ + +
Sbjct: 131 IGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD------MYDK 181
Query: 310 RPVTCEETSW-----RYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEV 363
+ + ++ A E + +++ TK DV+SF ++L E++ G PP+P ++
Sbjct: 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 241
Query: 364 PKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLS 419
+ R P P Y E++ CW + RP+F +++ R+ I
Sbjct: 242 TVYLLQGRRLLQPEYCPDPLY-----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 2e-55
Identities = 73/305 (23%), Positives = 131/305 (42%), Gaps = 41/305 (13%)
Query: 141 EVPEYEIDPKELDFSNSV------EITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAF 194
++ + I ++ + + + + +VAVK L ++ D ++ F
Sbjct: 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD-IEEF 72
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTP------MMIVTEYLPKGDLRAYLK------QKG 242
+ E A +++ HP+V + +G +S M++ ++ GDL A+L
Sbjct: 73 LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132
Query: 243 ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302
L V+F +DIA GM YL IHRDL N + + + VADFGLS+ +
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189
Query: 303 ANTVKEDR----PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPT 357
+ ++ PV ++ A E + Y DV++F + + E++ G P+
Sbjct: 190 GDYYRQGCASKLPV-------KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG 242
Query: 358 KQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415
+ E+ I R P Y +L+ CWS +P +RP+F + M L++I
Sbjct: 243 IENAEIYNYLIGGNRLKQPPECMEEVY-----DLMYQCWSADPKQRPSFTCLRMELENIL 297
Query: 416 DQLSI 420
LS+
Sbjct: 298 GHLSV 302
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 3e-55
Identities = 77/316 (24%), Positives = 129/316 (40%), Gaps = 54/316 (17%)
Query: 133 PMHVQNAREVPEYEIDPKELDFSNSVEITKGTF---------RIASWRGTQVAVKTLGEE 183
H Q + + L + + ++ KG F + G VAVK L
Sbjct: 6 HHHAQLYACQDPTIFEERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS 63
Query: 184 VFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST--PMMIVTEYLPKGDLRAYL-KQ 240
D+ + F E+ +L+ + +V++ G + +V EYLP G LR +L +
Sbjct: 64 ---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH 120
Query: 241 KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300
+ L + + ++ I +GM YL R +HRDL NIL + H+K+ADFGL+KLL
Sbjct: 121 RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177
Query: 301 KFAN---TVKEDR--PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPP 354
V+E P+ + APE + + + DV+SF ++L E+
Sbjct: 178 PLDKDYYVVREPGQSPI-------FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
Query: 355 FPTKQE--------------KEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEP 398
E + + +R P P + EL++ CW+ P
Sbjct: 231 CSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVH-----ELMKLCWAPSP 285
Query: 399 FRRPTFRQILMRLDDI 414
RP+F + +LD +
Sbjct: 286 QDRPSFSALGPQLDML 301
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-55
Identities = 74/308 (24%), Positives = 133/308 (43%), Gaps = 53/308 (17%)
Query: 141 EVPEYEIDPKELDFSNSVEITKGTF---RIASWR------GTQVAVKTLGEEVFTDEDKV 191
EV + + L ++ +G F + + G QVAVK+L E + + +
Sbjct: 12 EVDPTHFEKRFLKRIR--DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHI 67
Query: 192 KAFIDELALLQKIRHPNVVQFLGAVTQST--PMMIVTEYLPKGDLRAYLKQ-KGALKPTL 248
E+ +L+ + H N+V++ G T+ + ++ E+LP G L+ YL + K +
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 249 AVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN---T 305
+K+A+ I +GM+YL + +HRDL N+L + +K+ DFGL+K ++ T
Sbjct: 128 QLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 184
Query: 306 VKEDR--PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI-------------- 349
VK+DR PV + APE ++ DV+SF + L E++
Sbjct: 185 VKDDRDSPV-------FWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFL 237
Query: 350 -EGCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQ 406
P + +R P P Y +L+ CW +P R +F+
Sbjct: 238 KMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVY-----QLMRKCWEFQPSNRTSFQN 292
Query: 407 ILMRLDDI 414
++ + +
Sbjct: 293 LIEGFEAL 300
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 5e-55
Identities = 78/303 (25%), Positives = 132/303 (43%), Gaps = 40/303 (13%)
Query: 141 EVPEYEIDPKELDFSNSV------EITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAF 194
++ + ID L + + +G + +VAVKT+ + + + + F
Sbjct: 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREI-EEF 83
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPM-----MIVTEYLPKGDLRAYLKQK----GALK 245
+ E A ++ HPNV++ LG + + M++ ++ GDL YL G
Sbjct: 84 LSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH 143
Query: 246 PTLA--VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303
L +KF +DIA GM YL +HRDL N + D + VADFGLSK +
Sbjct: 144 IPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG 200
Query: 304 NTVKEDR----PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTK 358
+ ++ R PV ++ A E + Y +K DV++F + + E+ G P+P
Sbjct: 201 DYYRQGRIAKMPV-------KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253
Query: 359 QEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416
Q E+ + R P Y E++ CW +P RPTF + ++L+ + +
Sbjct: 254 QNHEMYDYLLHGHRLKQPEDCLDELY-----EIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308
Query: 417 QLS 419
L
Sbjct: 309 SLP 311
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 5e-55
Identities = 73/307 (23%), Positives = 122/307 (39%), Gaps = 53/307 (17%)
Query: 146 EIDPKELDFSNSVEITKGTF---RIASWRG------TQVAVKTLGEEVFTDEDKVKAFID 196
+ L ++ +G F + + VAVK L + +
Sbjct: 27 VFHKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQ 82
Query: 197 ELALLQKIRHPNVVQFLGAVTQST--PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFAL 254
E+ +L+ + H +++++ G + + +V EY+P G LR YL + L + FA
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-LLFAQ 141
Query: 255 DIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN---TVKEDR- 310
I GM YLH IHRDL N+L D+ +K+ DFGL+K + + V+ED
Sbjct: 142 QICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 311 -PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI---------------EGCPP 354
PV + APE K ++ DV+SF + L E++
Sbjct: 199 SPV-------FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251
Query: 355 FPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412
+ + ER P + P Y L+++CW E RPTF ++ L
Sbjct: 252 QGQMTVLRLTELLERGERLPRPDKCPAEVY-----HLMKNCWETEASFRPTFENLIPILK 306
Query: 413 DISDQLS 419
+ ++
Sbjct: 307 TVHEKYQ 313
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-54
Identities = 80/299 (26%), Positives = 137/299 (45%), Gaps = 38/299 (12%)
Query: 141 EVPEYEIDPKELDFSNSVEITKGTF---RIASWRG-----TQVAVKTLGEEVFTDEDKVK 192
EV + I + + + I KG F + Q A+K+L T+ +V+
Sbjct: 10 EVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVE 67
Query: 193 AFIDELALLQKIRHPNVVQFLGAVTQSTPM-MIVTEYLPKGDLRAYLKQKGALKPTLA-- 249
AF+ E L++ + HPNV+ +G + + ++ Y+ GDL +++ PT+
Sbjct: 68 AFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR-NPTVKDL 126
Query: 250 VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL------KFA 303
+ F L +ARGM YL E + +HRDL N + D+S +KVADFGL++ +
Sbjct: 127 ISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ 183
Query: 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKE 362
PV ++ A E + + TK DV+SF ++L E++ G PP+ +
Sbjct: 184 QHRHARLPV-------KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236
Query: 363 VPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLS 419
+ R P P + Y ++++ CW +P RPTFR ++ ++ I L
Sbjct: 237 LTHFLAQGRRLPQPEYCPDSLY-----QVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-54
Identities = 76/320 (23%), Positives = 140/320 (43%), Gaps = 36/320 (11%)
Query: 119 IKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTF--------RIASW 170
+ + + ++ + + V I P L + I +G F
Sbjct: 56 LYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDG 115
Query: 171 RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS-TPMMIVTEYL 229
+ AVK+L TD +V F+ E +++ HPNV+ LG +S ++V Y+
Sbjct: 116 KKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173
Query: 230 PKGDLRAYLKQKGALKPTLA--VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
GDLR +++ + PT+ + F L +A+GM +L + +HRDL N + D+
Sbjct: 174 KHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKF 229
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSW-----RYAAPEVYKNEEYDTKVDVFSFA 342
+KVADFGL++ + + + + ++ A E + +++ TK DV+SF
Sbjct: 230 TVKVADFGLARD------MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFG 283
Query: 343 LILQEMIE-GCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPF 399
++L E++ G PP+P ++ + R P P Y E++ CW +
Sbjct: 284 VLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKCWHPKAE 338
Query: 400 RRPTFRQILMRLDDISDQLS 419
RP+F +++ R+ I
Sbjct: 339 MRPSFSELVSRISAIFSTFI 358
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-53
Identities = 84/297 (28%), Positives = 134/297 (45%), Gaps = 47/297 (15%)
Query: 146 EIDPKELDFSNSVEITKGTF---RIASWRG----TQVAVKTLGEEVFTDEDKVKAFIDEL 198
+D ++ F + I +G F A + A+K + E + +D + F EL
Sbjct: 21 VLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDH-RDFAGEL 76
Query: 199 ALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLA-------- 249
+L K+ HPN++ LGA + + EY P G+L +L++ L+ A
Sbjct: 77 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 250 --------VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301
+ FA D+ARGM+YL + + IHRDL NIL ++ K+ADFGLS+ +
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQE 193
Query: 302 FANTVKEDR-PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQ 359
R PV R+ A E Y T DV+S+ ++L E++ G P+
Sbjct: 194 VYVKKTMGRLPV-------RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246
Query: 360 EKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
E+ + R P Y +L+ CW E+P+ RP+F QIL+ L+ +
Sbjct: 247 CAELYEKLPQGYRLEKPLNCDDEVY-----DLMRQCWREKPYERPSFAQILVSLNRM 298
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 8e-53
Identities = 73/299 (24%), Positives = 144/299 (48%), Gaps = 46/299 (15%)
Query: 143 PEYEIDPKELDFSNSVEITKGTF---RIASWRG-------TQVAVKTLGEEVFTDEDKVK 192
E+E+ +++ S E+ +G+F +G T+VA+KT+ E + ++
Sbjct: 18 DEWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRER-I 73
Query: 193 AFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL--------KQKGAL 244
F++E +++++ +VV+ LG V+Q P +++ E + +GDL++YL
Sbjct: 74 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 245 KPTLA--VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302
P+L+ ++ A +IA GM YL+ N+ +HRDL N + + +K+ DFG+++ +
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 303 ANTVKEDR----PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPT 357
+ ++ PV R+ +PE K+ + T DV+SF ++L E+ P+
Sbjct: 191 TDYYRKGGKGLLPV-------RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 243
Query: 358 KQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
++V + + P P + EL+ CW P RP+F +I+ + +
Sbjct: 244 LSNEQVLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIISSIKEE 297
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-52
Identities = 93/339 (27%), Positives = 146/339 (43%), Gaps = 55/339 (16%)
Query: 112 YYKHHDVIKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTF---RIA 168
++ H I E + A + E P +E+ L + +G F +A
Sbjct: 31 HHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGK--PLGEGAFGQVVLA 88
Query: 169 SWRG---------TQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQ 218
G T+VAVK L + E + I E+ +++ I +H N++ LGA TQ
Sbjct: 89 EAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146
Query: 219 STPMMIVTEYLPKGDLRAYLKQK----------------GALKPTLAVKFALDIARGMNY 262
P+ ++ EY KG+LR YL+ + L V A +ARGM Y
Sbjct: 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206
Query: 263 LHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR----PVTCEETS 318
L + IHRDL N+L + +K+ADFGL++ + + K+ PV
Sbjct: 207 LASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV------ 257
Query: 319 WRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANER--PPF 375
++ APE + Y + DV+SF ++L E+ G P+P +E+ K R P
Sbjct: 258 -KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS 316
Query: 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
Y ++ DCW P +RPTF+Q++ LD I
Sbjct: 317 NCTNELY-----MMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-52
Identities = 84/300 (28%), Positives = 135/300 (45%), Gaps = 46/300 (15%)
Query: 144 EYEIDPKELDFSNSVEITKGTF---RIASWRG-------TQVAVKTLGEEVFTDEDKVKA 193
E+ K + + G F G QVAVKTL EV +++D++
Sbjct: 24 LKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELD- 79
Query: 194 FIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLK-------QKGALKP 246
F+ E ++ K H N+V+ +G QS P I+ E + GDL+++L+ Q +L
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 247 TLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH---LKVADFGLSKLLKFA 303
+ A DIA G YL EN IHRD+ N L G K+ DFG+++ + A
Sbjct: 140 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 304 NTVKEDR----PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTK 358
+ ++ PV ++ PE + + +K D +SF ++L E+ G P+P+K
Sbjct: 197 SYYRKGGCAMLPV-------KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
Query: 359 QEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416
+EV + + R PP P Y ++ CW +P RP F IL R++ +
Sbjct: 250 SNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRPNFAIILERIEYCTQ 304
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 3e-52
Identities = 84/310 (27%), Positives = 129/310 (41%), Gaps = 58/310 (18%)
Query: 143 PEYEIDPKELDFSNSVEITKGTF---RIASWRG-------TQVAVKTLGEEVFTDEDKVK 192
++E L F + G F A+ G VAVK L + +
Sbjct: 16 HKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTERE 71
Query: 193 AFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQK---------- 241
A + EL +L + H N+V LGA T P +++TEY GDL +L++K
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 242 --------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293
AL + F+ +A+GM +L IHRDL NIL K+ D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 188
Query: 294 FGLSKLLKFAN--TVKEDR--PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI 349
FGL++ +K + VK + PV ++ APE N Y + DV+S+ + L E+
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPV-------KWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 350 E-GCPPFPTKQEKEVPKAYIAN----ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTF 404
G P+P I P AP Y ++++ CW +P +RPTF
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEH-APAEMY-----DIMKTCWDADPLKRPTF 295
Query: 405 RQILMRLDDI 414
+QI+ ++
Sbjct: 296 KQIVQLIEKQ 305
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 5e-52
Identities = 85/325 (26%), Positives = 143/325 (44%), Gaps = 59/325 (18%)
Query: 128 KPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTF---RIASWRG---------TQV 175
P A + E P++E +L + +G F +A G V
Sbjct: 13 DPMLAGVSEYELPEDPKWEFPRDKLTLGK--PLGEGAFGQVVMAEAVGIDKDKPKEAVTV 70
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
AVK L ++ E + + E+ +++ I +H N++ LGA TQ P+ ++ EY KG+L
Sbjct: 71 AVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 235 RAYLKQK----------------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEP 278
R YL+ + + V +ARGM YL + IHRDL
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAA 185
Query: 279 SNILRDDSGHLKVADFGLSKLLKFANTVKEDR----PVTCEETSWRYAAPEVYKNEEYDT 334
N+L ++ +K+ADFGL++ + + K+ PV ++ APE + Y
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV-------KWMAPEALFDRVYTH 238
Query: 335 KVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIAN----ERPPFRAPTTHYAYGLREL 389
+ DV+SF +++ E+ G P+P +E+ K + ++P Y +
Sbjct: 239 QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPAN-CTNELY-----MM 291
Query: 390 IEDCWSEEPFRRPTFRQILMRLDDI 414
+ DCW P +RPTF+Q++ LD I
Sbjct: 292 MRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 6e-52
Identities = 80/315 (25%), Positives = 137/315 (43%), Gaps = 64/315 (20%)
Query: 143 PEYEIDPKELDFSNSVEITKGTF---RIASWRG-------TQVAVKTLGEEVFTDEDKVK 192
P++E K L + +G F A+ T VAVK L E + + +
Sbjct: 16 PKWEFPRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSEL-R 71
Query: 193 AFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLA--- 249
+ E +L+++ HP+V++ GA +Q P++++ EY G LR +L++ + P
Sbjct: 72 DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 250 ---------------------VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288
+ FA I++GM YL E + ++HRDL NIL +
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRK 188
Query: 289 LKVADFGLSKLLKFAN--TVKEDR--PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALI 344
+K++DFGLS+ + + + PV ++ A E + Y T+ DV+SF ++
Sbjct: 189 MKISDFGLSRDVYEEDSYVKRSQGRIPV-------KWMAIESLFDHIYTTQSDVWSFGVL 241
Query: 345 LQEMIE-GCPPFPTKQEKEVPKAYIAN----ERPPFRAPTTHYAYGLRELIEDCWSEEPF 399
L E++ G P+P + + + ERP Y L+ CW +EP
Sbjct: 242 LWEIVTLGGNPYPGIPPERLFN-LLKTGHRMERPDN-CSEEMY-----RLMLQCWKQEPD 294
Query: 400 RRPTFRQILMRLDDI 414
+RP F I L+ +
Sbjct: 295 KRPVFADISKDLEKM 309
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 3e-51
Identities = 86/325 (26%), Positives = 137/325 (42%), Gaps = 49/325 (15%)
Query: 122 LEEHGAKPSTAPMHVQNAREVP---EYEIDPKELDFSNSVEITKGTF---RIASWRG--- 172
L P + + E+ K + + G F G
Sbjct: 40 LRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPN 97
Query: 173 ----TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228
QVAVKTL EV +++D+ F+ E ++ K H N+V+ +G QS P I+ E
Sbjct: 98 DPSPLQVAVKTL-PEVCSEQDE-LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 155
Query: 229 LPKGDLRAYLK-------QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNI 281
+ GDL+++L+ Q +L + A DIA G YL EN IHRD+ N
Sbjct: 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNC 212
Query: 282 LRDDSGH---LKVADFGLSKLLKFANTVKEDR----PVTCEETSWRYAAPEVYKNEEYDT 334
L G K+ DFG+++ + A ++ PV ++ PE + + +
Sbjct: 213 LLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV-------KWMPPEAFMEGIFTS 265
Query: 335 KVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIE 391
K D +SF ++L E+ G P+P+K +EV + + R PP P Y ++
Sbjct: 266 KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMT 320
Query: 392 DCWSEEPFRRPTFRQILMRLDDISD 416
CW +P RP F IL R++ +
Sbjct: 321 QCWQHQPEDRPNFAIILERIEYCTQ 345
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 182 bits (462), Expect = 3e-51
Identities = 65/307 (21%), Positives = 123/307 (40%), Gaps = 31/307 (10%)
Query: 123 EEHGAKPSTAPMHVQNAREVP--EYEIDPKELDFSNSVEITKGTF---RIASWRG----T 173
S + E+ + + L ++ +E+ G F R +R
Sbjct: 306 RPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQI 364
Query: 174 QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGD 233
VA+K L + T++ + + E ++ ++ +P +V+ +G +M+V E G
Sbjct: 365 DVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGP 421
Query: 234 LRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVA 292
L +L + + + + ++ GM YL E +HR+L N+L + + K++
Sbjct: 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKIS 478
Query: 293 DFGLSKLLKFANTVKEDRPVTCEETSW--RYAAPEVYKNEEYDTKVDVFSFALILQEMI- 349
DFGLSK L + W ++ APE ++ ++ DV+S+ + + E +
Sbjct: 479 DFGLSKALG----ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
Query: 350 EGCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQI 407
G P+ + EV +R P P Y L+ DCW + RP F +
Sbjct: 535 YGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY-----ALMSDCWIYKWEDRPDFLTV 589
Query: 408 LMRLDDI 414
R+
Sbjct: 590 EQRMRAC 596
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 4e-51
Identities = 82/314 (26%), Positives = 137/314 (43%), Gaps = 55/314 (17%)
Query: 143 PEYEIDPKELDFSNSVEITKGTF---RIASWRG---------TQVAVKTLGEEVFTDEDK 190
P++E +L + +G F +A G VAVK L ++ E
Sbjct: 74 PKWEFPRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKD 129
Query: 191 VKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQK-------- 241
+ + E+ +++ I +H N++ LGA TQ P+ ++ EY KG+LR YL+ +
Sbjct: 130 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 189
Query: 242 --------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293
+ V +ARGM YL + IHRDL N+L ++ +K+AD
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIAD 246
Query: 294 FGLSKLLKFAN--TVKEDR--PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI 349
FGL++ + + + PV ++ APE + Y + DV+SF +++ E+
Sbjct: 247 FGLARDINNIDYYKKTTNGRLPV-------KWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299
Query: 350 E-GCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQ 406
G P+P +E+ K R P Y ++ DCW P +RPTF+Q
Sbjct: 300 TLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY-----MMMRDCWHAVPSQRPTFKQ 354
Query: 407 ILMRLDDISDQLSI 420
++ LD I +
Sbjct: 355 LVEDLDRILTLTTN 368
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 7e-51
Identities = 75/304 (24%), Positives = 122/304 (40%), Gaps = 53/304 (17%)
Query: 146 EIDPKELDFSNSVEITKGTF---RIASWRG-------TQVAVKTLGEEVFTDEDKVKAFI 195
I +++ E+ +G F +A VAVK L + T + K F
Sbjct: 11 HIKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAAR-KDFQ 65
Query: 196 DELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLK---------------- 239
E LL ++H ++V+F G P+++V EY+ GDL +L+
Sbjct: 66 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 240 QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKL 299
KG L + + A IA GM YL +HRDL N L + +K+ DFG+S+
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRD 182
Query: 300 LKFANTVKEDR----PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPP 354
+ + + P+ R+ PE ++ T+ DV+SF +IL E+ G P
Sbjct: 183 VYSTDYYRVGGHTMLPI-------RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
Query: 355 FPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412
+ EV + P P Y +++ CW EP +R ++I L
Sbjct: 236 WFQLSNTEVIECITQGRVLERPRVCPKEVY-----DVMLGCWQREPQQRLNIKEIYKILH 290
Query: 413 DISD 416
+
Sbjct: 291 ALGK 294
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 1e-50
Identities = 79/310 (25%), Positives = 135/310 (43%), Gaps = 56/310 (18%)
Query: 143 PEYEIDPKELDFSNSVEITKGTF---------RIASWRG-TQVAVKTLGEEVFTDEDKVK 192
++E L F + G F + +VAVK L D+ +
Sbjct: 39 EKWEFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKE 94
Query: 193 AFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG--------- 242
A + EL ++ + +H N+V LGA T P++++TEY GDL +L++K
Sbjct: 95 ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154
Query: 243 -----ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLS 297
+ F+ +A+GM +L IHRD+ N+L + K+ DFGL+
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 298 KLLKFAN--TVKEDR--PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GC 352
+ + + VK + PV ++ APE + Y + DV+S+ ++L E+ G
Sbjct: 212 RDIMNDSNYIVKGNARLPV-------KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 264
Query: 353 PPFPTKQ-EKEVPKAYIAN----ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQI 407
P+P + K + + +P F AP Y +++ CW+ EP RPTF+QI
Sbjct: 265 NPYPGILVNSKFYK-LVKDGYQMAQPAF-APKNIY-----SIMQACWALEPTHRPTFQQI 317
Query: 408 LMRLDDISDQ 417
L + + +
Sbjct: 318 CSFLQEQAQE 327
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-50
Identities = 77/332 (23%), Positives = 130/332 (39%), Gaps = 62/332 (18%)
Query: 128 KPSTAPMHVQNAREVPEY-------EIDPKELDFSNSVEITKGTF---RIASWRG----- 172
K S H+ E P+Y I +++ E+ +G F +A
Sbjct: 15 KGSGLQGHII---ENPQYFSDACVHHIKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQ 69
Query: 173 --TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230
VAVK L E ++ + + F E LL ++H ++V+F G T+ P+++V EY+
Sbjct: 70 DKMLVAVKALKEA--SESAR-QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMR 126
Query: 231 KGDLRAYLK---------------QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRD 275
GDL +L+ G L + A +A GM YL +HRD
Sbjct: 127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRD 183
Query: 276 LEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR----PVTCEETSWRYAAPEVYKNEE 331
L N L +K+ DFG+S+ + + + P+ R+ PE +
Sbjct: 184 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI-------RWMPPESILYRK 236
Query: 332 YDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRE 388
+ T+ DV+SF ++L E+ G P+ E P P Y
Sbjct: 237 FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVY-----A 291
Query: 389 LIEDCWSEEPFRRPTFRQILMRLDDISDQLSI 420
++ CW EP +R + + + RL ++ +
Sbjct: 292 IMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-50
Identities = 84/341 (24%), Positives = 135/341 (39%), Gaps = 60/341 (17%)
Query: 121 LLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTF---RIASWRG----- 172
LL+ P M + ++ E +++ +I +G F A G
Sbjct: 18 LLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYE 75
Query: 173 --TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230
T VAVK L EE + + + F E AL+ + +PN+V+ LG PM ++ EY+
Sbjct: 76 PFTMVAVKMLKEEA-SADMQ-ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMA 133
Query: 231 KGDLRAYLK------------------------QKGALKPTLAVKFALDIARGMNYLHEN 266
GDL +L+ L + A +A GM YL E
Sbjct: 134 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193
Query: 267 RPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT-VKEDR---PVTCEETSWRYA 322
+ +HRDL N L ++ +K+ADFGLS+ + A+ + P+ R+
Sbjct: 194 K---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPI-------RWM 243
Query: 323 APEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANER--PPFRAPT 379
PE Y T+ DV+++ ++L E+ G P+ +EV P P
Sbjct: 244 PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPL 303
Query: 380 THYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSI 420
Y L+ CWS+ P RP+F I L + ++
Sbjct: 304 ELY-----NLMRLCWSKLPADRPSFCSIHRILQRMCERAEG 339
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 4e-50
Identities = 80/315 (25%), Positives = 132/315 (41%), Gaps = 63/315 (20%)
Query: 143 PEYEIDPKELDFSNSVEITKGTF---RIASWRG-------TQVAVKTLGEEVFTDEDKVK 192
++E + L+F + G F A+ G QVAVK L E+ D + +
Sbjct: 38 LKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSERE 93
Query: 193 AFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQK---------- 241
A + EL ++ ++ H N+V LGA T S P+ ++ EY GDL YL+ K
Sbjct: 94 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 153
Query: 242 -------------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288
L + FA +A+GM +L +HRDL N+L
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKV 210
Query: 289 LKVADFGLSKLLKFAN--TVKEDR--PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALI 344
+K+ DFGL++ + + V+ + PV ++ APE Y K DV+S+ ++
Sbjct: 211 VKICDFGLARDIMSDSNYVVRGNARLPV-------KWMAPESLFEGIYTIKSDVWSYGIL 263
Query: 345 LQEMIE-GCPPFPTKQEKEVPKAYIAN----ERPPFRAPTTHYAYGLRELIEDCWSEEPF 399
L E+ G P+P I N ++P + A Y +++ CW+ +
Sbjct: 264 LWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFY-ATEEIY-----IIMQSCWAFDSR 317
Query: 400 RRPTFRQILMRLDDI 414
+RP+F + L
Sbjct: 318 KRPSFPNLTSFLGCQ 332
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 9e-50
Identities = 78/304 (25%), Positives = 129/304 (42%), Gaps = 52/304 (17%)
Query: 146 EIDPKELDFSNSVEITKGTF---RIASWRG-------TQVAVKTLGEEVFTDEDKVKAFI 195
EI + F E+ + F G VA+KTL ++ + + F
Sbjct: 5 EISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLR-EEFR 60
Query: 196 DELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ--------------- 240
E L +++HPNVV LG VT+ P+ ++ Y GDL +L
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 241 -KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKL 299
K AL+P V IA GM YL + ++H+DL N+L D ++K++D GL +
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 300 LKFAN--TVKEDR--PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPP 354
+ A+ + + P+ R+ APE ++ D++S+ ++L E+ G P
Sbjct: 178 VYAADYYKLLGNSLLPI-------RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
Query: 355 FPTKQEKEVPKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412
+ ++V + + P P Y L+ +CW+E P RRP F+ I RL
Sbjct: 231 YCGYSNQDVVEMIRNRQVLPCPDDCPAWVY-----ALMIECWNEFPSRRPRFKDIHSRLR 285
Query: 413 DISD 416
+
Sbjct: 286 AWGN 289
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 5e-49
Identities = 79/309 (25%), Positives = 130/309 (42%), Gaps = 59/309 (19%)
Query: 144 EYEIDPKELDFSNSVEITKGTF---RIASWRG-------TQVAVKTLGEEVFTDEDKVKA 193
++E L + +G F A G VAVK L E + +A
Sbjct: 21 KWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRA 76
Query: 194 FIDELALLQKI-RHPNVVQFLGAVTQS-TPMMIVTEYLPKGDLRAYLK------------ 239
+ EL +L I H NVV LGA T+ P+M++ E+ G+L YL+
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 240 ----QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFG 295
K L + ++ +A+GM +L + IHRDL NIL + +K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFG 193
Query: 296 LSKLLKFANTVKEDR----PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE- 350
L++ + P+ ++ APE + Y + DV+SF ++L E+
Sbjct: 194 LARDIYKDPDYVRKGDARLPL-------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246
Query: 351 GCPPFPT-KQEKEVPKAYIAN----ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFR 405
G P+P K ++E + + P + Y + + DCW EP +RPTF
Sbjct: 247 GASPYPGVKIDEEFCR-RLKEGTRMRAPDY-TTPEMY-----QTMLDCWHGEPSQRPTFS 299
Query: 406 QILMRLDDI 414
+++ L ++
Sbjct: 300 ELVEHLGNL 308
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-47
Identities = 62/259 (23%), Positives = 102/259 (39%), Gaps = 32/259 (12%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGA------------VTQS 219
A+K + + E + + E+ L K+ HP +V++ A +
Sbjct: 30 DCNYAIKRI--RLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87
Query: 220 TPMMIVTEYLPKGDLRAYLKQKGALKPT---LAVKFALDIARGMNYLHENRPEAIIHRDL 276
+ I + K +L+ ++ + ++ + + L IA + +LH ++HRDL
Sbjct: 88 VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDL 144
Query: 277 EPSNILRDDSGHLKVADFGLSKLLK---FANTVKEDRPVTCEETSW----RYAAPEVYKN 329
+PSNI +KV DFGL + TV P T Y +PE
Sbjct: 145 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204
Query: 330 EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLREL 389
Y KVD+FS LIL E+ PF T+ E+ + N + P T +
Sbjct: 205 NSYSHKVDIFSLGLILFEL---LYPFSTQMERVRTLTDVRNLKFP-PLF-TQKYPCEYVM 259
Query: 390 IEDCWSEEPFRRPTFRQIL 408
++D S P RP I+
Sbjct: 260 VQDMLSPSPMERPEAINII 278
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-46
Identities = 65/288 (22%), Positives = 131/288 (45%), Gaps = 32/288 (11%)
Query: 135 HVQNAREVPEYEIDPKELD-FSNSVEITKGTF-------RIASWRGTQVAVKTLGEEVFT 186
H + ++ + + ++ + +I +G+F G Q +K + +
Sbjct: 6 HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTED--GRQYVIKEINISRMS 63
Query: 187 DEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLK-QKGALK 245
+++ ++ E+A+L ++HPN+VQ+ + ++ + IV +Y GDL + QKG L
Sbjct: 64 SKEREES-RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLF 122
Query: 246 P-TLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK--- 301
+ + + I + ++H+ + I+HRD++ NI G +++ DFG++++L
Sbjct: 123 QEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179
Query: 302 -FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE 360
A T + Y +PE+ +N+ Y+ K D+++ +L E+ F
Sbjct: 180 ELARACI--------GTPY-YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM 230
Query: 361 KEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
K + I+ PP HY+Y LR L+ + P RP+ IL
Sbjct: 231 KNLVLKIISGSFPPV--S-LHYSYDLRSLVSQLFKRNPRDRPSVNSIL 275
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-46
Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 27/277 (9%)
Query: 146 EIDPKELDFSNSVEITKGTFR-----IASWRGTQVAVKTLGEEVFTDEDKVKAFIDELAL 200
+ +EI +G+F+ + + +VA L + T + + F +E +
Sbjct: 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE-RQRFKEEAEM 78
Query: 201 LQKIRHPNVVQFLGA----VTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDI 256
L+ ++HPN+V+F + V +++VTE + G L+ YLK+ +K + + I
Sbjct: 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 138
Query: 257 ARGMNYLHENRPEAIIHRDLEPSNILRD-DSGHLKVADFGLSKLLK--FANTVKEDRPVT 313
+G+ +LH P IIHRDL+ NI +G +K+ D GL+ L + FA V T
Sbjct: 139 LKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIG----T 193
Query: 314 CEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAY-IANER 372
E + APE+Y+ E+YD VDV++F + + EM P+ + + + Y
Sbjct: 194 PE-----FMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYS--ECQNAAQIYRRVTSG 245
Query: 373 PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILM 409
+ ++E+IE C + R + + +L
Sbjct: 246 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-46
Identities = 60/245 (24%), Positives = 113/245 (46%), Gaps = 17/245 (6%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV--TQSTPMMIVTEYL 229
G + K L T+ +K + E+ LL++++HPN+V++ + +T + IV EY
Sbjct: 31 GKILVWKELDYGSMTEAEKQML-VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 230 PKGDLRAYLKQKGALKPTL----AVKFALDIARGMNYLHENRPEA--IIHRDLEPSNILR 283
GDL + + + + L ++ + + H ++HRDL+P+N+
Sbjct: 90 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149
Query: 284 DDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFAL 343
D ++K+ DFGL+++L + + T T + Y +PE Y+ K D++S
Sbjct: 150 DGKQNVKLGDFGLARILNHDTSFAK----TFVGTPY-YMSPEQMNRMSYNEKSDIWSLGC 204
Query: 344 ILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPT 403
+L E+ PPF +KE+ + P Y+ L E+I + + + RP+
Sbjct: 205 LLYELCALMPPFTAFSQKELAGKIREGKFRRI--P-YRYSDELNEIITRMLNLKDYHRPS 261
Query: 404 FRQIL 408
+IL
Sbjct: 262 VEEIL 266
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 9e-46
Identities = 60/243 (24%), Positives = 108/243 (44%), Gaps = 16/243 (6%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G VA+K + D I E+ LL+++ HPNV+++ + + + IV E
Sbjct: 57 GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 116
Query: 232 GDLRAYLKQKGALKPTLA----VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
GDL +K K + K+ + + + ++H R ++HRD++P+N+ +G
Sbjct: 117 GDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATG 173
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQE 347
+K+ D GL + + K + T + Y +PE Y+ K D++S +L E
Sbjct: 174 VVKLGDLGLGRFF----SSKTTAAHSLVGTPY-YMSPERIHENGYNFKSDIWSLGCLLYE 228
Query: 348 MIEGCPPFPTKQEKEVPKAY--IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFR 405
M PF + + I P P+ HY+ LR+L+ C + +P +RP
Sbjct: 229 MAALQSPF-YGDKMNLYSLCKKIEQCDYP-PLPSDHYSEELRQLVNMCINPDPEKRPDVT 286
Query: 406 QIL 408
+
Sbjct: 287 YVY 289
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-45
Identities = 59/262 (22%), Positives = 106/262 (40%), Gaps = 35/262 (13%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGA-------------VTQ 218
A+K ++ E+K+ + E+ LL + H VV++ A V +
Sbjct: 31 SRYYAIK----KIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKK 86
Query: 219 STPMMIVTEYLPKGDLRAYLKQKGALKP-TLAVKFALDIARGMNYLHENRPEAIIHRDLE 277
+ + I EY G L + + + + I ++Y+H IIHRDL+
Sbjct: 87 KSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLK 143
Query: 278 PSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWR---------YAAPEVYK 328
P NI D+S ++K+ DFGL+K + + + + +S Y A EV
Sbjct: 144 PMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD 203
Query: 329 NE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAP-TTHYAYGL 386
Y+ K+D++S +I EMI P + + K + + F +
Sbjct: 204 GTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKK-LRSVSIEFPPDFDDNKMKVE 260
Query: 387 RELIEDCWSEEPFRRPTFRQIL 408
+++I +P +RP R +L
Sbjct: 261 KKIIRLLIDHDPNKRPGARTLL 282
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 6e-45
Identities = 67/295 (22%), Positives = 120/295 (40%), Gaps = 60/295 (20%)
Query: 144 EYEIDPKEL-DFSNSVEITKGTF-------RIASWRGTQVAVKTLGEEVFTDEDKVKAFI 195
+ +D + DF I G F G +K V + +K +
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRID--GKTYVIK----RVKYNNEKAE--- 52
Query: 196 DELALLQKIRHPNVVQFLGA----------------VTQSTPMMIVTEYLPKGDLRAYLK 239
E+ L K+ H N+V + G +++ + I E+ KG L +++
Sbjct: 53 REVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 112
Query: 240 QKGA--LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLS 297
++ L LA++ I +G++Y+H + +I+RDL+PSNI D+ +K+ DFGL
Sbjct: 113 KRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLV 169
Query: 298 KLLKFANTVKEDRPVTCEETSW----RYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCP 353
LK + T RY +PE +++Y +VD+++ LIL E++ C
Sbjct: 170 TSLKN----------DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
Query: 354 PFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
E K + + + L++ S++P RP +IL
Sbjct: 220 TAF-----ETSKFFTDLRDGII--S-DIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 8e-44
Identities = 54/238 (22%), Positives = 88/238 (36%), Gaps = 17/238 (7%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G AVK +D+ + + + + +HP V+ A + + + TE
Sbjct: 82 GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G 140
Query: 232 GDLRAYLKQKGA-LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290
L+ + + GA L + D + +LH ++H D++P+NI G K
Sbjct: 141 PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCK 197
Query: 291 VADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE 350
+ DFGL L A + E RY APE+ Y T DVFS L + E+
Sbjct: 198 LGDFGLLVELGTAGAGE-----VQEGDP-RYMAPELL-QGSYGTAADVFSLGLTILEVAC 250
Query: 351 GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
+ + P F T + LR ++ +P R T +L
Sbjct: 251 NMELP--HGGEGWQQLRQGYLPPEF---TAGLSSELRSVLVMMLEPDPKLRATAEALL 303
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-43
Identities = 48/258 (18%), Positives = 97/258 (37%), Gaps = 22/258 (8%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM----IVTE 227
G A+K + + ++ + E + + HPN+++ + + ++
Sbjct: 54 GHFYALKRI---LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110
Query: 228 YLPKGDLRAYLKQKGALKPTL----AVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR 283
+ +G L +++ L + L I RG+ +H HRDL+P+NIL
Sbjct: 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILL 167
Query: 284 DDSGHLKVADFGLSKLLKFANTVKEDRPVTCEE----TSWRYAAPEV---YKNEEYDTKV 336
D G + D G + + Y APE+ + D +
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT 227
Query: 337 DVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSE 396
DV+S +L M+ G P+ +K A + + ++ L +L+ +
Sbjct: 228 DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIP-QSPRHSSALWQLLNSMMTV 286
Query: 397 EPFRRPTFRQILMRLDDI 414
+P +RP +L +L+ +
Sbjct: 287 DPHQRPHIPLLLSQLEAL 304
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 7e-43
Identities = 75/276 (27%), Positives = 124/276 (44%), Gaps = 18/276 (6%)
Query: 139 AREVPEYEIDPKEL-DFSNSVEITKGTF---RIASWRGT--QVAVKTLGEEVFTDEDKVK 192
A+E+PE +DP+ + + KG F S T A K + + + + +
Sbjct: 1 AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 193 AFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKF 252
E+++ + + H +VV F G + + +V E + L K++ AL A +
Sbjct: 61 KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 120
Query: 253 ALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312
I G YLH NR +IHRDL+ N+ ++ +K+ DFGL+ +++ E + V
Sbjct: 121 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG---ERKKV 174
Query: 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER 372
C + Y APEV + + +VDV+S I+ ++ G PPF T KE NE
Sbjct: 175 LC--GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE- 231
Query: 373 PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
+ P H LI+ +P RPT ++L
Sbjct: 232 --YSIP-KHINPVAASLIQKMLQTDPTARPTINELL 264
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-43
Identities = 54/253 (21%), Positives = 106/253 (41%), Gaps = 29/253 (11%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPN--VVQFLGAVTQSTPMMIVTEYL 229
A+K + E D + ++ +E+A L K++ + +++ + +V E
Sbjct: 33 KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 90
Query: 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289
DL ++LK+K ++ P + ++ ++ +H++ I+H DL+P+N L D G L
Sbjct: 91 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 146
Query: 290 KVADFGLSKLLKFANTVKEDRPVTCEET---SWRYAAPEV-----------YKNEEYDTK 335
K+ DFG AN ++ D +++ + Y PE + K
Sbjct: 147 KLIDFG------IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 200
Query: 336 VDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWS 395
DV+S IL M G PF + I + P L+++++ C
Sbjct: 201 SDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP-DIPEKDLQDVLKCCLK 259
Query: 396 EEPFRRPTFRQIL 408
+P +R + ++L
Sbjct: 260 RDPKQRISIPELL 272
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 68/239 (28%), Positives = 101/239 (42%), Gaps = 15/239 (6%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G Q AVK + EVF E EL + P +V GAV + + I E L
Sbjct: 83 GFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG-HLK 290
G L +KQ G L A+ + G+ YLH R I+H D++ N+L G
Sbjct: 135 GSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAA 191
Query: 291 VADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE 350
+ DFG + L+ K + + APEV + D KVD++S ++ M+
Sbjct: 192 LCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN 251
Query: 351 GCPPFPTKQEKEVPKAY-IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
GC P+ Q P IA+E PP R A + I++ +EP R + ++
Sbjct: 252 GCHPWT--QYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELR 308
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-42
Identities = 77/288 (26%), Positives = 126/288 (43%), Gaps = 18/288 (6%)
Query: 127 AKPSTAPMHVQNAREVPEYEIDPKEL-DFSNSVEITKGTF---RIASWRGT--QVAVKTL 180
AP A+E+PE +DP+ + + KG F S T A K +
Sbjct: 15 VAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIV 74
Query: 181 GEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ 240
+ + + + E+++ + + H +VV F G + + +V E + L K+
Sbjct: 75 PKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR 134
Query: 241 KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300
+ AL A + I G YLH NR +IHRDL+ N+ ++ +K+ DFGL+ +
Sbjct: 135 RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191
Query: 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE 360
++ E + V C + Y APEV + + +VDV+S I+ ++ G PPF T
Sbjct: 192 EYDG---ERKKVLC--GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 246
Query: 361 KEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
KE NE + P H LI+ +P RPT ++L
Sbjct: 247 KETYLRIKKNE---YSIP-KHINPVAASLIQKMLQTDPTARPTINELL 290
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-42
Identities = 55/254 (21%), Positives = 109/254 (42%), Gaps = 31/254 (12%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPN--VVQFLGAVTQSTPMMIVTEYL 229
A+K + E D + ++ +E+A L K++ + +++ + +V E
Sbjct: 52 KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 109
Query: 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289
DL ++LK+K ++ P + ++ ++ +H++ I+H DL+P+N L D G L
Sbjct: 110 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 165
Query: 290 KVADFGLSKLLKFANTVKEDRPVTCEET---SWRYAAPEV-----------YKNEEYDTK 335
K+ DFG AN ++ D +++ + Y PE + K
Sbjct: 166 KLIDFG------IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 219
Query: 336 VDVFSFALILQEMIEGCPPFPTKQEKEVPKAY-IANERPPFRAPTTHYAYGLRELIEDCW 394
DV+S IL M G PF ++ K + I + P L+++++ C
Sbjct: 220 SDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIIDPNHEIEFP-DIPEKDLQDVLKCCL 277
Query: 395 SEEPFRRPTFRQIL 408
+P +R + ++L
Sbjct: 278 KRDPKQRISIPELL 291
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-41
Identities = 64/315 (20%), Positives = 123/315 (39%), Gaps = 33/315 (10%)
Query: 114 KHHDVIKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTF----RIAS 169
K K +H P A I K +S +I G ++ +
Sbjct: 18 KETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN 77
Query: 170 WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPN--VVQFLGAVTQSTPMMIVTE 227
+ A+K + E D + ++ +E+A L K++ + +++ + +V E
Sbjct: 78 EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136
Query: 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
DL ++LK+K ++ P + ++ ++ +H++ I+H DL+P+N L D G
Sbjct: 137 C-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-G 191
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEET---SWRYAAPEV-----------YKNEEYD 333
LK+ DFG AN ++ D +++ + Y PE +
Sbjct: 192 MLKLIDFG------IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKIS 245
Query: 334 TKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDC 393
K DV+S IL M G PF + I + P L+++++ C
Sbjct: 246 PKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP-DIPEKDLQDVLKCC 304
Query: 394 WSEEPFRRPTFRQIL 408
+P +R + ++L
Sbjct: 305 LKRDPKQRISIPELL 319
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 50/262 (19%), Positives = 91/262 (34%), Gaps = 44/262 (16%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G A+K + + D+ A + A +H +VV++ A + M+I EY
Sbjct: 36 GCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG 95
Query: 232 GDLRAYLKQKGALKPTL----AVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
G L + + + L + RG+ Y+H ++H D++PSNI +
Sbjct: 96 GSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTS 152
Query: 288 HL-------------------KVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYK 328
K+ D G + + D R+ A EV +
Sbjct: 153 IPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGD-S--------RFLANEVLQ 203
Query: 329 -NEEYDTKVDVFSFALILQEMIEGCPPFPTKQE-KEVPKAYIANERPPFRAPTTHYAYGL 386
N + K D+F+ AL + P + E+ + P +
Sbjct: 204 ENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ----GRLPRI---PQVLSQEF 256
Query: 387 RELIEDCWSEEPFRRPTFRQIL 408
EL++ +P RRP+ ++
Sbjct: 257 TELLKVMIHPDPERRPSAMALV 278
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 14/237 (5%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
+A+K L + E+ + +RHPN+++ G +T + ++ EY P
Sbjct: 34 KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
G + L++ + ++A ++Y H R +IHRD++P N+L +G LK+
Sbjct: 94 GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKI 150
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG 351
ADFG S R C + Y PE+ + +D KVD++S ++ E + G
Sbjct: 151 ADFGWSVHAPS-----SRRTDLC--GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
Query: 352 CPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
PPF + + Y R F P G R+LI P +RP R++L
Sbjct: 204 KPPF---EANTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRPMLREVL 256
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 4e-39
Identities = 56/235 (23%), Positives = 92/235 (39%), Gaps = 20/235 (8%)
Query: 185 FTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGAL 244
+ + A ++ + N V L + + I + K +L+ ++ ++ +L
Sbjct: 99 LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158
Query: 245 KP---TLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301
+ + + + IA + +LH ++HRDL+PSNI +KV DFGL +
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 215
Query: 302 FAN---TVKEDRPVTCEETSW----RYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPP 354
TV P T Y +PE Y KVD+FS LIL E+
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL---LYS 272
Query: 355 FPTKQEKEVPKAYIANER-PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
F T+ E+ I + R F T +++D S P RP I+
Sbjct: 273 FSTQMER---VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDII 324
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-39
Identities = 59/252 (23%), Positives = 110/252 (43%), Gaps = 19/252 (7%)
Query: 162 KGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV 216
KG F +A + + +A+K L + E E+ + +RHPN+++
Sbjct: 24 KGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83
Query: 217 TQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDL 276
+ ++ E+ P+G+L L++ G + F ++A ++Y HE + +IHRD+
Sbjct: 84 HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDI 140
Query: 277 EPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKV 336
+P N+L G LK+ADFG S R C + Y PE+ + + +D KV
Sbjct: 141 KPENLLMGYKGELKIADFGWSVH-----APSLRRRTMC--GTLDYLPPEMIEGKTHDEKV 193
Query: 337 DVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSE 396
D++ ++ E + G PPF + + + P + G ++LI
Sbjct: 194 DLWCAGVLCYEFLVGMPPF---DSPSHTETHRRIVNVDLKFP-PFLSDGSKDLISKLLRY 249
Query: 397 EPFRRPTFRQIL 408
P +R + ++
Sbjct: 250 HPPQRLPLKGVM 261
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 71/246 (28%), Positives = 114/246 (46%), Gaps = 24/246 (9%)
Query: 172 GTQVAVKTLGEEV-FTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230
++A+K E+ D + +E+AL + ++H N+VQ+LG+ +++ + I E +P
Sbjct: 47 QVRIAIK----EIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102
Query: 231 KGDLRAYLKQK-GALKPTLAV--KFALDIARGMNYLHENRPEAIIHRDLEPSNILRD-DS 286
G L A L+ K G LK + I G+ YLH+N+ I+HRD++ N+L + S
Sbjct: 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYS 159
Query: 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEE--YDTKVDVFSFALI 344
G LK++DFG SK L N E T T Y APE+ Y D++S
Sbjct: 160 GVLKISDFGTSKRLAGINPCTE----TFTGTLQ-YMAPEIIDKGPRGYGKAADIWSLGCT 214
Query: 345 LQEMIEGCPPFPTKQEKEVPKA--YIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRP 402
+ EM G PPF + E A + + P + + I C+ +P +R
Sbjct: 215 IIEMATGKPPFY--ELGEPQAAMFKVGMFKVHPEIP-ESMSAEAKAFILKCFEPDPDKRA 271
Query: 403 TFRQIL 408
+L
Sbjct: 272 CANDLL 277
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-38
Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 13/238 (5%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G +VA+K + ++ V+ +E+ + +++HP++++ S + +V E
Sbjct: 36 GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95
Query: 232 GDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290
G++ YLK + A F I GM YLH + I+HRDL SN+L + ++K
Sbjct: 96 GEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIK 152
Query: 291 VADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE 350
+ADFGL+ LK + E C + Y +PE+ + + DV+S + ++
Sbjct: 153 IADFGLATQLKMPH---EKHYTLC--GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLI 207
Query: 351 GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
G PPF V + P + + ++LI P R + +L
Sbjct: 208 GRPPF---DTDTVKNTLNKVVLADYEMP-SFLSIEAKDLIHQLLRRNPADRLSLSSVL 261
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-38
Identities = 58/292 (19%), Positives = 104/292 (35%), Gaps = 61/292 (20%)
Query: 172 GTQVAVKTLG-EEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI--VTEY 228
G A+K D E +L+K+ H N+V+ ++T + E+
Sbjct: 34 GDLFAIKVFNNISFLRPVDVQMR---EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90
Query: 229 LPKGDLRAYLKQKG---ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR-- 283
P G L L++ L + + D+ GMN+L EN I+HR+++P NI+R
Sbjct: 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVI 147
Query: 284 --DDSGHLKVADFGLSKLLK---FANTVKEDRPVTCEETSWRYAAPEVYK--------NE 330
D K+ DFG ++ L+ ++ + Y P++Y+ +
Sbjct: 148 GEDGQSVYKLTDFGAARELEDDEQFVSL-------Y--GTEEYLHPDMYERAVLRKDHQK 198
Query: 331 EYDTKVDVFSFALILQEMIEGCPPFPT------------KQEKEVPKAYIANERPPFRAP 378
+Y VD++S + G PF K P I+ + P
Sbjct: 199 KYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGP 258
Query: 379 ---------TTHYAYGLRELIEDCWS----EEPFRRPTFRQILMRLDDISDQ 417
+ + GL+ L+ + + + F Q DI +
Sbjct: 259 IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-38
Identities = 69/257 (26%), Positives = 119/257 (46%), Gaps = 24/257 (9%)
Query: 160 ITKGTF---RIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLG 214
I KG F ++A G +VA+K + + K F E+ +++ + HPN+V+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 215 AVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHR 274
+ + ++ EY G++ YL G +K A I + Y H+ R I+HR
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHR 138
Query: 275 DLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV--TCEETSWRYAAPEVYKNEEY 332
DL+ N+L D ++K+ADFG S N + C + YAAPE+++ ++Y
Sbjct: 139 DLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDAFCG--APPYAAPELFQGKKY 190
Query: 333 D-TKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIE 391
D +VDV+S +IL ++ G PF + + + R +R P + + L++
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPF---DGQNLKELRERVLRGKYRIP-FYMSTDCENLLK 246
Query: 392 DCWSEEPFRRPTFRQIL 408
P +R T QI+
Sbjct: 247 RFLVLNPIKRGTLEQIM 263
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-38
Identities = 58/299 (19%), Positives = 106/299 (35%), Gaps = 50/299 (16%)
Query: 172 GTQVAVKTLG-EEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI--VTEY 228
G A+K D E +L+K+ H N+V+ ++T + E+
Sbjct: 34 GDLFAIKVFNNISFLRPVDVQMR---EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90
Query: 229 LPKGDLRAYLKQKG---ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR-- 283
P G L L++ L + + D+ GMN+L EN I+HR+++P NI+R
Sbjct: 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVI 147
Query: 284 --DDSGHLKVADFGLSKLLK---FANTVKEDRPVTCEETSWRYAAPEVYK--------NE 330
D K+ DFG ++ L+ ++ + Y P++Y+ +
Sbjct: 148 GEDGQSVYKLTDFGAARELEDDEQFVSL-------Y--GTEEYLHPDMYERAVLRKDHQK 198
Query: 331 EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPK---AYIANERPPFRAPTTHYAYGLR 387
+Y VD++S + G PF + K I +P A
Sbjct: 199 KYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG-------AISGV 251
Query: 388 ELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVGPLRCF---QSLAALWKKGH 443
+ E+ + P + L + + + + +C+ Q A H
Sbjct: 252 QKAENGPIDWSGDMPVSCSLSRGLQVLLTPV-LANILEADQEKCWGFDQFFAETSDILH 309
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-37
Identities = 67/271 (24%), Positives = 114/271 (42%), Gaps = 33/271 (12%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMM------- 223
G + A+K L + +E+K +A I E+ ++K+ HPN+VQF A +
Sbjct: 53 GREYALKRL---LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109
Query: 224 IVTEYLPKGDLRAYLKQ---KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSN 280
++ L KG L +LK+ +G L +K R + ++H +P IIHRDL+ N
Sbjct: 110 LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVEN 168
Query: 281 ILRDDSGHLKVADFGLSKLLK--FANTVKEDRPVTCEE-----TSWRYAAPEV---YKNE 330
+L + G +K+ DFG + + + R EE T+ Y PE+ Y N
Sbjct: 169 LLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNF 228
Query: 331 EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPT-THYAYGLREL 389
K D+++ IL + PF E I N + + P L
Sbjct: 229 PIGEKQDIWALGCILYLLCFRQHPF----EDGAKLR-IVNGK--YSIPPHDTQYTVFHSL 281
Query: 390 IEDCWSEEPFRRPTFRQILMRLDDISDQLSI 420
I P R + +++ +L +I+ ++
Sbjct: 282 IRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 72/312 (23%), Positives = 120/312 (38%), Gaps = 64/312 (20%)
Query: 145 YEIDPKELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELA 199
E+ + + + E+ G + G +A K + + I EL
Sbjct: 28 GELKDDDFEKIS--ELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQ 83
Query: 200 LLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARG 259
+L + P +V F GA + I E++ G L LK+ G + + K ++ + +G
Sbjct: 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 143
Query: 260 MNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK--FANTVKEDRPVTCEET 317
+ YL E I+HRD++PSNIL + G +K+ DFG+S L AN+ R
Sbjct: 144 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS------ 195
Query: 318 SWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKA----------- 366
Y +PE + Y + D++S L L EM G P P KE+
Sbjct: 196 ---YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252
Query: 367 ------------------------------YIANERPPFRAPTTHYAYGLRELIEDCWSE 396
YI NE PP + P+ ++ ++ + C +
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIK 311
Query: 397 EPFRRPTFRQIL 408
P R +Q++
Sbjct: 312 NPAERADLKQLM 323
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 72/301 (23%), Positives = 111/301 (36%), Gaps = 38/301 (12%)
Query: 126 GAKPSTAPMHVQ---NAREVPEYEIDPKELDFSNSVEITKGTF----RIASWRGTQVAVK 178
G+ PS + V + PK+ + G + VAVK
Sbjct: 2 GSSPSLEQDDGDEETSVVIVGKISFCPKD-------VLGHGAEGTIVYRGMFDNRDVAVK 54
Query: 179 TLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAY 237
+ E F+ D+ E+ LL++ HPNV+++ I E L+ Y
Sbjct: 55 RILPECFSFADR------EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEY 107
Query: 238 LKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH-----LKV 291
++QK A + G+ +LH I+HRDL+P NIL +
Sbjct: 108 VEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMI 164
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYK---NEEYDTKVDVFSFALILQEM 348
+DFGL K L R W APE+ E VD+FS + +
Sbjct: 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWI--APEMLSEDCKENPTYTVDIFSAGCVFYYV 222
Query: 349 I-EGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQI 407
I EG PF +++ + P H RELIE + +P +RP+ + +
Sbjct: 223 ISEGSHPFGKSLQRQA-NILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
Query: 408 L 408
L
Sbjct: 282 L 282
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 5e-36
Identities = 67/273 (24%), Positives = 101/273 (36%), Gaps = 51/273 (18%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL------GAVTQSTPMMIV 225
G QVA+K +E+ + + E+ +++K+ HPNVV + + ++
Sbjct: 39 GEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96
Query: 226 TEYLPKGDLRAYLKQKG---ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL 282
EY GDLR YL Q LK DI+ + YLHENR IIHRDL+P NI+
Sbjct: 97 MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIV 153
Query: 283 RDDSGH---LKVADFGLSKLLK---FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKV 336
K+ D G +K L + +Y APE+ + ++Y V
Sbjct: 154 LQPGPQRLIHKIIDLGYAKELDQGELCTEF-------V--GTLQYLAPELLEQKKYTVTV 204
Query: 337 DVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN----------------ERPPFRAPTT 380
D +SF + E I G PF + + +
Sbjct: 205 DYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPN 264
Query: 381 HYAYGLRELIEDCW-----SEEPFRRPTFRQIL 408
H + L +E W +R T Q
Sbjct: 265 HLSGILAGKLER-WLQCMLMWHQRQRGTDPQNP 296
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-36
Identities = 59/277 (21%), Positives = 117/277 (42%), Gaps = 26/277 (9%)
Query: 145 YEIDPKELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELA 199
E+ +L+ E+ +G + + G +AVK + V + + K + +L
Sbjct: 2 MEVKADDLEPIM--ELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLD 57
Query: 200 -LLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG---DLRAYLKQKGALKPTLAVKFALD 255
++ + P V F GA+ + + I E + + + + + + K A+
Sbjct: 58 ISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVS 117
Query: 256 IARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCE 315
I + + +LH ++IHRD++PSN+L + G +K+ DFG+S L + V +D C+
Sbjct: 118 IVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCK 173
Query: 316 ETSWRYAAPEVYKNEE----YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE 371
Y APE E Y K D++S + + E+ P+ + + E
Sbjct: 174 ----PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE 229
Query: 372 RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
P + P ++ + C + RPT+ +++
Sbjct: 230 PSP-QLPADKFSAEFVDFTSQCLKKNSKERPTYPELM 265
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 8e-36
Identities = 66/276 (23%), Positives = 122/276 (44%), Gaps = 23/276 (8%)
Query: 144 EYEIDPKELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDEL 198
Y+ + +L+ E+ GT G +AVK + ++++ K + +L
Sbjct: 19 RYQAEINDLENLG--EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRILMDL 74
Query: 199 ALLQK-IRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIA 257
++ K P +VQ G +T + I E + + + +G + + K + I
Sbjct: 75 DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIV 134
Query: 258 RGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEET 317
+ + YL E +IHRD++PSNIL D+ G +K+ DFG+S L + +DR C
Sbjct: 135 KALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCA-- 188
Query: 318 SWRYAAPEV-----YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER 372
Y APE +YD + DV+S + L E+ G P+ + + E
Sbjct: 189 --AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE 246
Query: 373 PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
PP ++ + ++DC +++ +RP + ++L
Sbjct: 247 PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-35
Identities = 70/255 (27%), Positives = 120/255 (47%), Gaps = 19/255 (7%)
Query: 160 ITKGTF---RIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLG 214
+ GTF +I + G +VAVK L + D V E+ L+ RHP++++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 215 AVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHR 274
++ T +V EY+ G+L Y+ + G ++ A + I ++Y H + ++HR
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHR 135
Query: 275 DLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYD- 333
DL+P N+L D + K+ADFGLS ++ ++ +C S YAAPEV Y
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR----TSC--GSPNYAAPEVISGRLYAG 189
Query: 334 TKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDC 393
+VD++S +IL ++ G PF ++ VP + F P + + L+
Sbjct: 190 PEVDIWSCGVILYALLCGTLPF---DDEHVPTLFKKIRGGVFYIP-EYLNRSVATLLMHM 245
Query: 394 WSEEPFRRPTFRQIL 408
+P +R T + I
Sbjct: 246 LQVDPLKRATIKDIR 260
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-34
Identities = 61/266 (22%), Positives = 109/266 (40%), Gaps = 38/266 (14%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G +VA+K E ++ F E+ L RHP++V +G + M+++ +Y+
Sbjct: 63 GAKVALKRRTPE---SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119
Query: 232 GDLRAYLKQKGALKPTLA----VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
G+L+ +L +++ ++ + ARG++YLH AIIHRD++ NIL D++
Sbjct: 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENF 176
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEET----SWRYAAPEVYKNEEYDTKVDVFSFAL 343
K+ DFG+SK T + ++ T + Y PE + K DV+SF +
Sbjct: 177 VPKITDFGISKK----GTELDQTHLS---TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229
Query: 344 ILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRA--------PTTHYAYGLRELI---- 390
+L E++ +E +A P L
Sbjct: 230 VLFEVLCARSAIVQSLPRE--MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGD 287
Query: 391 --EDCWSEEPFRRPTFRQILMRLDDI 414
C + RP+ +L +L+
Sbjct: 288 TAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-34
Identities = 49/279 (17%), Positives = 98/279 (35%), Gaps = 42/279 (15%)
Query: 162 KGTF---RIASWRGTQVAVKTL--------------GEEVFTDEDKVKAFIDELALLQKI 204
+G F + A+K + + + K F +EL ++ I
Sbjct: 41 QGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100
Query: 205 RHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIAR------ 258
++ + G +T + I+ EY+ + + + L + + +
Sbjct: 101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSV 160
Query: 259 --GMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEE 316
+Y+H + I HRD++PSNIL D +G +K++DFG S+ + + +
Sbjct: 161 LNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMV-----DKKIKGSR-- 211
Query: 317 TSWRYAAPEVYKNEE--YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAY--IANER 372
++ + PE + NE KVD++S + L M PF + + + + I +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF--SLKISLVELFNNIRTK- 268
Query: 373 PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411
P + + F L
Sbjct: 269 -NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF 306
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-34
Identities = 59/245 (24%), Positives = 100/245 (40%), Gaps = 24/245 (9%)
Query: 172 GTQVAVKTLG-EEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230
VAVK + + + +K E+ + + + H NVV+F G + + EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 231 KGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290
G+L ++ + A +F + G+ YLH I HRD++P N+L D+ +LK
Sbjct: 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLK 145
Query: 291 VADFGLSKLLKFANTVKEDRPVTCEET---SWRYAAPEVYKNEEYD-TKVDVFSFALILQ 346
++DFGL+ + + + Y APE+ K E+ VDV+S ++L
Sbjct: 146 ISDFGLA------TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 347 EMIEGCPPFPTKQEKEVPKAY---IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPT 403
M+ G P+ Q + + Y + + P L+ E P R T
Sbjct: 200 AMLAGELPWD--QPSDSCQEYSDWKEKKT--YLNPWKKIDSAPLALLHKILVENPSARIT 255
Query: 404 FRQIL 408
I
Sbjct: 256 IPDIK 260
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 69/281 (24%), Positives = 122/281 (43%), Gaps = 28/281 (9%)
Query: 144 EYEIDPKELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDEL 198
++ ++L EI +G + + G +AVK + DE + K + +L
Sbjct: 16 HWDFTAEDLKDLG--EIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDL 71
Query: 199 A-LLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAV----KFA 253
+++ P +VQF GA+ + I E + + Y L + K
Sbjct: 72 DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT 131
Query: 254 LDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT 313
L + +N+L EN IIHRD++PSNIL D SG++K+ DFG+S L +++ + R
Sbjct: 132 LATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAG 187
Query: 314 CEETSWRYAAPEV----YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIA 369
C Y APE + YD + DV+S + L E+ G P+P +
Sbjct: 188 CR----PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV 243
Query: 370 NERPP--FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
PP + ++ + C +++ +RP ++++L
Sbjct: 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 71/258 (27%), Positives = 129/258 (50%), Gaps = 26/258 (10%)
Query: 160 ITKGTF---RIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLG 214
+ +G+F ++A+ +VA+K + ++ D E++ L+ +RHP++++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 215 AVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHR 274
+T T +++V EY G+L Y+ +K + +F I + Y H ++ I+HR
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHR 132
Query: 275 DLEPSNILRDDSGHLKVADFGLSKLLK---FANTVKEDRPVTCEETSWRYAAPEVYKNEE 331
DL+P N+L DD+ ++K+ADFGLS ++ F T +C S YAAPEV +
Sbjct: 133 DLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-------SC--GSPNYAAPEVINGKL 183
Query: 332 YD-TKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELI 390
Y +VDV+S ++L M+ G PF ++ +P + + P + G + LI
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPF---DDEFIPNLFKKVNSCVYVMP-DFLSPGAQSLI 239
Query: 391 EDCWSEEPFRRPTFRQIL 408
+P +R T ++I
Sbjct: 240 RRMIVADPMQRITIQEIR 257
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 58/171 (33%), Positives = 94/171 (54%), Gaps = 13/171 (7%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVK-FA 253
I E++LL+++ HPN+V + + + +V E++ K DL+ L + +K +
Sbjct: 67 IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYL 125
Query: 254 LDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT 313
+ RG+ + H++R I+HRDL+P N+L + G LK+ADFGL++ F R T
Sbjct: 126 YQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARA--FGI---PVRSYT 177
Query: 314 CE-ETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
E T W Y AP+V +++Y T VD++S I EMI G P FP + +
Sbjct: 178 HEVVTLW-YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-33
Identities = 59/245 (24%), Positives = 100/245 (40%), Gaps = 24/245 (9%)
Query: 172 GTQVAVKTLG-EEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230
VAVK + + + +K E+ + + + H NVV+F G + + EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 231 KGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290
G+L ++ + A +F + G+ YLH I HRD++P N+L D+ +LK
Sbjct: 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLK 145
Query: 291 VADFGLSKLLKFANTVKEDRPVTCEET---SWRYAAPEVYKNEEYD-TKVDVFSFALILQ 346
++DFGL+ + + + Y APE+ K E+ VDV+S ++L
Sbjct: 146 ISDFGLA------TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 347 EMIEGCPPFPTKQEKEVPKAY---IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPT 403
M+ G P+ Q + + Y + + P L+ E P R T
Sbjct: 200 AMLAGELPWD--QPSDSCQEYSDWKEKKT--YLNPWKKIDSAPLALLHKILVENPSARIT 255
Query: 404 FRQIL 408
I
Sbjct: 256 IPDIK 260
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 7e-33
Identities = 55/171 (32%), Positives = 93/171 (54%), Gaps = 13/171 (7%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVK-FA 253
I E+++L++++H N+V+ + +++V E+L + DL+ L ++ K F
Sbjct: 48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFL 106
Query: 254 LDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT 313
L + G+ Y H+ R ++HRDL+P N+L + G LK+ADFGL++ R T
Sbjct: 107 LQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI-----PVRKYT 158
Query: 314 CE-ETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
E T W Y AP+V +++Y T +D++S I EM+ G P FP E +
Sbjct: 159 HEIVTLW-YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-33
Identities = 61/245 (24%), Positives = 110/245 (44%), Gaps = 28/245 (11%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFID---ELALLQKIRH--PNVVQFLGAVTQSTPMMIVT 226
VA+K + ++ +D ++ E+ LL+K+ V++ L + +++
Sbjct: 68 NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127
Query: 227 EY-LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD- 284
E P DL ++ ++GAL+ LA F + + + H ++HRD++ NIL D
Sbjct: 128 ERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDL 184
Query: 285 DSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYD-TKVDVFSFAL 343
+ G LK+ DFG LLK D T + + Y+ PE + Y V+S +
Sbjct: 185 NRGELKLIDFGSGALLK-------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 237
Query: 344 ILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPT 403
+L +M+ G PF + ++E+ + + R + + LI C + P RPT
Sbjct: 238 LLYDMVCGDIPF--EHDEEIIRGQV---FFRQRVSS-----ECQHLIRWCLALRPSDRPT 287
Query: 404 FRQIL 408
F +I
Sbjct: 288 FEEIQ 292
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 83/281 (29%), Positives = 138/281 (49%), Gaps = 34/281 (12%)
Query: 140 REVPEYEIDPKELDFSNSVEITKGTF-----RIASWRGTQVAVKTLGEEVFTDEDKVKAF 194
+ + DP+EL F+ +I KG+F I + VA+K + E ED+++
Sbjct: 11 PGMQNLKADPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE--EAEDEIEDI 67
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFAL 254
E+ +L + P V ++ G+ + T + I+ EYL G L+ + +A
Sbjct: 68 QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-ILR 126
Query: 255 DIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTC 314
+I +G++YLH + IHRD++ +N+L + G +K+ADFG++ L T + + T
Sbjct: 127 EILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL----TDTQIKRNTF 179
Query: 315 EETS-WRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPF----PTKQEKEVPKAYIA 369
T W APEV K YD+K D++S + E+ G PP P K +PK
Sbjct: 180 VGTPFW--MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK---- 233
Query: 370 NERPPFRAPT--THYAYGLRELIEDCWSEEPFRRPTFRQIL 408
P PT +Y+ L+E +E C ++EP RPT +++L
Sbjct: 234 --NNP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELL 269
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 53/246 (21%), Positives = 101/246 (41%), Gaps = 30/246 (12%)
Query: 172 GTQVAVK-----TLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226
+V VK + E+ + ++ K+ E+A+L ++ H N+++ L +V
Sbjct: 49 NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108
Query: 227 E-YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD 285
E + DL A++ + L LA + + YL IIHRD++ NI+ +
Sbjct: 109 EKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAE 165
Query: 286 SGHLKVADFGLSKLLKFANTVKEDRP--VTCEETSWRYAAPEVYKNEEYD-TKVDVFSFA 342
+K+ DFG + ++ + C + Y APEV Y +++++S
Sbjct: 166 DFTIKLIDFGSA------AYLERGKLFYTFC--GTIEYCAPEVLMGNPYRGPELEMWSLG 217
Query: 343 LILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRP 402
+ L ++ PF E+ + A PP+ + L L+ P RR
Sbjct: 218 VTLYTLVFEENPF-----CELEETVEAAIHPPY-----LVSKELMSLVSGLLQPVPERRT 267
Query: 403 TFRQIL 408
T +++
Sbjct: 268 TLEKLV 273
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 71/256 (27%), Positives = 119/256 (46%), Gaps = 25/256 (9%)
Query: 162 KGTF---RIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV 216
GTF ++ G +VAVK L + D V E+ L+ RHP++++ +
Sbjct: 26 VGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85
Query: 217 TQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDL 276
+ + + +V EY+ G+L Y+ + G L + + I G++Y H + ++HRDL
Sbjct: 86 STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDL 142
Query: 277 EPSNILRDDSGHLKVADFGLSKLLK---FANTVKEDRPVTCEETSWRYAAPEVYKNEEYD 333
+P N+L D + K+ADFGLS ++ F T +C S YAAPEV Y
Sbjct: 143 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-------SC--GSPNYAAPEVISGRLYA 193
Query: 334 -TKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIED 392
+VD++S +IL ++ G PF + VP + F P + + L++
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPF---DDDHVPTLFKKICDGIFYTP-QYLNPSVISLLKH 249
Query: 393 CWSEEPFRRPTFRQIL 408
+P +R T + I
Sbjct: 250 MLQVDPMKRATIKDIR 265
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 54/169 (31%), Positives = 93/169 (55%), Gaps = 13/169 (7%)
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVK-FALD 255
E+ LLQ++ HPN++ L A + + +V +++ DL +K + +K + L
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 256 IARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCE 315
+G+ YLH++ I+HRDL+P+N+L D++G LK+ADFGL+K F + +R T +
Sbjct: 121 TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK--SFGS---PNRAYTHQ 172
Query: 316 -ETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
T W Y APE+ + Y VD+++ IL E++ P P + +
Sbjct: 173 VVTRW-YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 65/271 (23%), Positives = 127/271 (46%), Gaps = 29/271 (10%)
Query: 148 DPKELDFSNSVEITKGTFR-----IASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
DPK+ ++ +I +G + G +VA++ + + + K + I+E+ +++
Sbjct: 17 DPKKK-YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKKELIINEILVMR 72
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNY 262
+ ++PN+V +L + + +V EYL G L + + + +A + + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEF 131
Query: 263 LHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS-WRY 321
LH N+ +IHRD++ NIL G +K+ DFG + T ++ + T T W
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYW-- 182
Query: 322 AAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPF----PTKQEKEVPKAYIANERPPFRA 377
APEV + Y KVD++S ++ EMIEG PP+ P + + N P +
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT----NGTPELQN 238
Query: 378 PTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
P + R+ + C + +R + +++L
Sbjct: 239 P-EKLSAIFRDFLNRCLEMDVEKRGSAKELL 268
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 55/171 (32%), Positives = 89/171 (52%), Gaps = 13/171 (7%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVK-FA 253
I E++LL+ ++H N+V + + +V EYL K DL+ YL G + VK F
Sbjct: 48 IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFL 106
Query: 254 LDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT 313
+ RG+ Y H + ++HRDL+P N+L ++ G LK+ADFGL++ + +
Sbjct: 107 FQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARA--KSI---PTKTYD 158
Query: 314 CE-ETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
E T W Y P++ + +Y T++D++ I EM G P FP +E
Sbjct: 159 NEVVTLW-YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 14/192 (7%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G VA+K E K A + E+ +L++++HPN+V L + + +V EY
Sbjct: 28 GQIVAIKKFLESEDDPVIKKIA-LREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH 86
Query: 232 GDLRAYLKQKGALKPTLAVK-FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290
+ L + P VK + +N+ H++ IHRD++P NIL +K
Sbjct: 87 -TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIK 142
Query: 291 VADFGLSKLLKFANTVKEDRPVTCE-ETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEM 348
+ DFG ++LL E T W Y +PE+ + +Y VDV++ + E+
Sbjct: 143 LCDFGFARLLTG-----PSDYYDDEVATRW-YRSPELLVGDTQYGPPVDVWAIGCVFAEL 196
Query: 349 IEGCPPFPTKQE 360
+ G P +P K +
Sbjct: 197 LSGVPLWPGKSD 208
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 77/295 (26%), Positives = 119/295 (40%), Gaps = 42/295 (14%)
Query: 129 PSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTF---RIA--SWRGTQVAVKTLGEE 183
+T P+ + + Y+ +I G F R+ VAVK +
Sbjct: 6 VTTGPLDMPIMHDSDRYDFVK---------DIGSGNFGVARLMRDKLTKELVAVKYIERG 56
Query: 184 VFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGA 243
DE V+ E+ + +RHPN+V+F + T + I+ EY G+L + G
Sbjct: 57 AAIDE-NVQR---EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR 112
Query: 244 LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS--GHLKVADFGLSKLLK 301
A F + G++Y H + I HRDL+ N L D S LK+ DFG SK
Sbjct: 113 FSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169
Query: 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYD-TKVDVFSFALILQEMIEGCPPFPTKQE 360
+ K T + Y APEV +EYD DV+S + L M+ G PF ++
Sbjct: 170 LHSQPK----STVG--TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF---ED 220
Query: 361 KEVPKAY------IANERPPFRAP-TTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
E P+ Y I + + + P + LI + +P R + +I
Sbjct: 221 PEEPRDYRKTIQRILSVK--YSIPDDIRISPECCHLISRIFVADPATRISIPEIK 273
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-32
Identities = 76/304 (25%), Positives = 118/304 (38%), Gaps = 54/304 (17%)
Query: 125 HGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTF-------RIASWRGTQVAV 177
P+ P EY + P + KG F R+ QVA+
Sbjct: 13 PPGTPTPPPGGKDREAFEAEYRLGP---------LLGKGGFGTVFAGHRLTD--RLQVAI 61
Query: 178 KTLG----EEVFTDEDKVKAFIDELALLQKIR----HPNVVQFLGAVTQSTPMMIVTEY- 228
K + D V + E+ALL K+ HP V++ L M+V E
Sbjct: 62 KVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERP 120
Query: 229 LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD-DSG 287
LP DL Y+ +KG L + F + + + H ++HRD++ NIL D G
Sbjct: 121 LPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRG 177
Query: 288 HLKVADFGLSKLLKFANTVKEDRP--VTCEETSWRYAAPEVYKNEEYD-TKVDVFSFALI 344
K+ DFG LL D P + Y+ PE +Y V+S ++
Sbjct: 178 CAKLIDFGSGALLH-------DEPYTDFD--GTRVYSPPEWISRHQYHALPATVWSLGIL 228
Query: 345 LQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTF 404
L +M+ G PF ++++E+ +A P H + LI C + +P RP+
Sbjct: 229 LYDMVCGDIPF--ERDQEILEA-------ELHFP-AHVSPDCCALIRRCLAPKPSSRPSL 278
Query: 405 RQIL 408
+IL
Sbjct: 279 EEIL 282
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 63/259 (24%), Positives = 117/259 (45%), Gaps = 20/259 (7%)
Query: 159 EITKGTF---RIASWRGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
+ KG+F + + T + AVK + + + ++ + E+ LL+++ HPN+++
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIH 273
+V E G+L + + A + + G+ Y+H+N+ I+H
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVH 149
Query: 274 RDLEPSNIL---RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE 330
RDL+P N+L + ++++ DFGLS + + + + + Y APEV
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTH------FEASKKMKDKIGTAYYIAPEVLH-G 202
Query: 331 EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPT-THYAYGLREL 389
YD K DV+S +IL ++ GCPPF E ++ K + + F P + ++L
Sbjct: 203 TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKK-VEKGKYTFELPQWKKVSESAKDL 261
Query: 390 IEDCWSEEPFRRPTFRQIL 408
I + P R + R L
Sbjct: 262 IRKMLTYVPSMRISARDAL 280
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-32
Identities = 48/170 (28%), Positives = 84/170 (49%), Gaps = 14/170 (8%)
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVK-FALD 255
E+ LL++++H N+V+ + + +V E+ + DL+ Y VK F
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 256 IARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCE 315
+ +G+ + H ++HRDL+P N+L + +G LK+A+FGL++ F R + E
Sbjct: 110 LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA--FGI---PVRCYSAE 161
Query: 316 -ETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKE 362
T W Y P+V + + Y T +D++S I E+ G P FP +
Sbjct: 162 VVTLW-YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 74/330 (22%), Positives = 125/330 (37%), Gaps = 64/330 (19%)
Query: 140 REVPEYEIDPKELDFSNSVEITKGTF----RIASWRGTQVAVKTLGEEVFTDEDKVKAFI 195
+P +E K L S + + G+ S++G VAVK + D +
Sbjct: 4 ANIPNFEQSLKNLVVSEKI-LGYGSSGTVVFQGSFQGRPVAVKRM------LIDFCDIAL 56
Query: 196 DELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTL------ 248
E+ LL + HPNV+++ + T + I E +L+ ++ K L
Sbjct: 57 MEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEY 115
Query: 249 -AVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL-------------RDDSGHLKVADF 294
+ IA G+ +LH + IIHRDL+P NIL ++ + ++DF
Sbjct: 116 NPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172
Query: 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEV-------YKNEEYDTKVDVFSFALILQE 347
GL K L + TS + APE+ +D+FS +
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPSGTSG-WRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY 231
Query: 348 MI-EGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL----RELIEDCWSEEPFRRP 402
++ +G PF K +E + I + L +LI +P +RP
Sbjct: 232 ILSKGKHPFGDKYSRE---SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP 288
Query: 403 TFRQIL---------MRLD---DISDQLSI 420
T ++L +L+ +SD+L I
Sbjct: 289 TAMKVLRHPLFWPKSKKLEFLLKVSDRLEI 318
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 63/239 (26%), Positives = 104/239 (43%), Gaps = 26/239 (10%)
Query: 174 QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGD 233
+VA+K + E+ +K F E+ ++ H N+V + + +V EY+
Sbjct: 38 KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97
Query: 234 LRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293
L Y++ G L A+ F I G+ + H+ R I+HRD++P NIL D + LK+ D
Sbjct: 98 LSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFD 154
Query: 294 FGLSKLLKFANTVKEDRPVTCEET---SWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE 350
FG++K L + +T + +Y +PE K E D D++S ++L EM+
Sbjct: 155 FGIAKAL-------SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV 207
Query: 351 GCPPFPTKQEKEVPKAYIA----NERPPFRAPTTHYA---YGLRELIEDCWSEEPFRRP 402
G PPF E + IA + P T L +I ++ R
Sbjct: 208 GEPPF----NGETAVS-IAIKHIQDSVP-NVTTDVRKDIPQSLSNVILRATEKDKANRY 260
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 54/176 (30%), Positives = 91/176 (51%), Gaps = 18/176 (10%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ------KGALKPTL 248
I E++L+++++H N+V+ + + +V E++ DL+ Y+ L+ L
Sbjct: 51 IREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNL 109
Query: 249 AVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKE 308
F + +G+ + HEN+ I+HRDL+P N+L + G LK+ DFGL++
Sbjct: 110 VKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-----P 161
Query: 309 DRPVTCE-ETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
+ E T W Y AP+V + Y T +D++S IL EMI G P FP ++E
Sbjct: 162 VNTFSSEVVTLW-YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE 216
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 66/271 (24%), Positives = 110/271 (40%), Gaps = 44/271 (16%)
Query: 172 GTQVAVKTLGEEVFTDEDK-VKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230
T VAVK L V ++ + F E+ ++ K +H N+V+ LG + + +V Y+P
Sbjct: 54 NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113
Query: 231 KGDLRAYLKQKGALKP---TLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
G L L P + K A A G+N+LHE IHRD++ +NIL D++
Sbjct: 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAF 170
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSWR------YAAPEVYKNEEYDTKVDVFSF 341
K++DFGL++ +T + R Y APE E K D++SF
Sbjct: 171 TAKISDFGLARAS----EKFAQTVMT---S--RIVGTTAYMAPE-ALRGEITPKSDIYSF 220
Query: 342 ALILQEMIEGCPPFPTKQEKE--VPKAYIANERPPFRAPTTHYA--------YGLRELIE 391
++L E+I G P +E + + T +
Sbjct: 221 GVVLLEIITGLPAVDEHREPQLLLDIK-----EEIEDEEKTIEDYIDKKMNDADSTSVEA 275
Query: 392 ------DCWSEEPFRRPTFRQILMRLDDISD 416
C E+ +RP +++ L +++
Sbjct: 276 MYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 51/175 (29%), Positives = 87/175 (49%), Gaps = 17/175 (9%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFAL 254
I E++LL++++H N+++ + + + ++ EY DL+ Y+ + + + F
Sbjct: 81 IREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLY 139
Query: 255 DIARGMNYLHENRPEAIIHRDLEPSNIL-----RDDSGHLKVADFGLSKLLKFANTVKED 309
+ G+N+ H R +HRDL+P N+L ++ LK+ DFGL++ F
Sbjct: 140 QLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGI---PI 191
Query: 310 RPVTCE-ETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
R T E T W Y PE+ + Y T VD++S A I EM+ P FP E +
Sbjct: 192 RQFTHEIITLW-YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID 245
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 63/271 (23%), Positives = 121/271 (44%), Gaps = 29/271 (10%)
Query: 148 DPKELDFSNSVEITKGTFR-----IASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
DP+ L + V+I +G+ G QVAVK + + + + +E+ +++
Sbjct: 42 DPRLL-LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR---KQQRRELLFNEVVIMR 97
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNY 262
+H NVV+ + + ++ E+L G L + Q + +A + + + Y
Sbjct: 98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT-VCEAVLQALAY 156
Query: 263 LHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS-WRY 321
LH +IHRD++ +IL G +K++DFG + + + + T W
Sbjct: 157 LHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI----SKDVPKRKSLVGTPYW-- 207
Query: 322 AAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPF----PTKQEKEVPKAYIANERPPFRA 377
APEV Y T+VD++S +++ EM++G PP+ P + K + + P +
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD----SPPPKLKN 263
Query: 378 PTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
+ LR+ +E +P R T +++L
Sbjct: 264 S-HKVSPVLRDFLERMLVRDPQERATAQELL 293
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-31
Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 14/192 (7%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G VA+K E K A + E+ LL+++RH N+V L + +V E++
Sbjct: 50 GRIVAIKKFLESDDDKMVKKIA-MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH 108
Query: 232 GDLRAYLKQKGALKPTLAVK-FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290
+ L+ V+ + I G+ + H + IIHRD++P NIL SG +K
Sbjct: 109 -TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVK 164
Query: 291 VADFGLSKLLKFANTVKEDRPVTCE-ETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEM 348
+ DFG ++ L E T W Y APE+ + +Y VDV++ ++ EM
Sbjct: 165 LCDFGFARTLA-----APGEVYDDEVATRW-YRAPELLVGDVKYGKAVDVWAIGCLVTEM 218
Query: 349 IEGCPPFPTKQE 360
G P FP +
Sbjct: 219 FMGEPLFPGDSD 230
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 42/186 (22%), Positives = 73/186 (39%), Gaps = 13/186 (6%)
Query: 174 QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGD 233
VA+K + E + +D E +++ P+VV + + + D
Sbjct: 61 IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120
Query: 234 LRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293
L A L+++G L P AV I ++ H HRD++P NIL + D
Sbjct: 121 LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVD 177
Query: 294 FGLSKLLKFANTVKEDRPVTCEET---SWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE 350
FG++ D +T + Y APE + + D+++ +L E +
Sbjct: 178 FGIASAT-------TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLT 230
Query: 351 GCPPFP 356
G PP+
Sbjct: 231 GSPPYQ 236
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 57/253 (22%), Positives = 101/253 (39%), Gaps = 30/253 (11%)
Query: 172 GTQVAVKT-----LGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226
+VA++ + D E+ +L+K+ HP +++ + IV
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 218
Query: 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL---R 283
E + G+L + LK + + + YLHEN IIHRDL+P N+L +
Sbjct: 219 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQ 275
Query: 284 DDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEV---YKNEEYDTKVDVFS 340
++ +K+ DFG SK+L + ++ C + Y APEV Y+ VD +S
Sbjct: 276 EEDCLIKITDFGHSKILGETSLMRT----LC--GTPTYLAPEVLVSVGTAGYNRAVDCWS 329
Query: 341 FALILQEMIEGCPPF-----PTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWS 395
+IL + G PPF + ++ + + +L++
Sbjct: 330 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS----EKALDLVKKLLV 385
Query: 396 EEPFRRPTFRQIL 408
+P R T + L
Sbjct: 386 VDPKARFTTEEAL 398
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 67/316 (21%), Positives = 128/316 (40%), Gaps = 41/316 (12%)
Query: 122 LEEHGAKPSTAPMHVQNAREVPE---YEIDPKELDFSNSVEITKGTF---RIASWRGTQ- 174
++ A+P +Q+A+ P+ + DF + +G+F +A T
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRPE----DFKFGKILGEGSFSTVVLARELATSR 56
Query: 175 -VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGD 233
A+K L + E+KV E ++ ++ HP V+ + Y G+
Sbjct: 57 EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 116
Query: 234 LRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293
L Y+++ G+ T + +I + YLH IIHRDL+P NIL ++ H+++ D
Sbjct: 117 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITD 173
Query: 294 FGLSKLLKFANTVKEDRPVTCEETSW------RYAAPEVYKNEEYDTKVDVFSFALILQE 347
FG +K+L P + + + +Y +PE+ + D+++ I+ +
Sbjct: 174 FGTAKVLS---------PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 224
Query: 348 MIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQI 407
++ G PPF E + + I F A R+L+E + +R ++
Sbjct: 225 LVAGLPPFRAGNEYLIFQK-IIKLEYDFPEKFFPKA---RDLVEKLLVLDATKRLGCEEM 280
Query: 408 LMRLDDISDQLSIKRH 423
+ +K H
Sbjct: 281 ----EGYGP---LKAH 289
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 64/263 (24%), Positives = 107/263 (40%), Gaps = 40/263 (15%)
Query: 171 RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230
+ +VA+K + E + + + E+ + + HPN+V + + + +V + L
Sbjct: 39 KKEKVAIKRINLE--KCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS 96
Query: 231 KGDLRAYLKQKGALKPTLAVKFA-LDIA-------RGMNYLHENRPEAIIHRDLEPSNIL 282
G + +K A + IA G+ YLH+N IHRD++ NIL
Sbjct: 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNIL 153
Query: 283 RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS------WRYAAPEVYK-NEEYDTK 335
+ G +++ADFG+S L D + W APEV + YD K
Sbjct: 154 LGEDGSVQIADFGVSAFL----ATGGDITRNKVRKTFVGTPCW--MAPEVMEQVRGYDFK 207
Query: 336 VDVFSFALILQEMIEGCPPFPTKQEKEVP-KA--YIANERPP-------FRAPTTHYAYG 385
D++SF + E+ G P+ K P K PP + Y
Sbjct: 208 ADIWSFGITAIELATGAAPY----HKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKS 263
Query: 386 LRELIEDCWSEEPFRRPTFRQIL 408
R++I C ++P +RPT ++L
Sbjct: 264 FRKMISLCLQKDPEKRPTAAELL 286
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 60/259 (23%), Positives = 122/259 (47%), Gaps = 21/259 (8%)
Query: 159 EITKGTF---RIASWRGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
++ G + + + T + A+K + + + ++E+A+L+ + HPN+++
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN-SKLLEEVAVLKLLDHPNIMKLY 102
Query: 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIH 273
+V E G+L + + A + G+ YLH++ I+H
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVH 159
Query: 274 RDLEPSNIL---RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE 330
RDL+P N+L ++ +K+ DFGLS + + + + + Y APEV + +
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAV------FENQKKMKERLGTAYYIAPEVLR-K 212
Query: 331 EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPT-THYAYGLREL 389
+YD K DV+S +IL ++ G PPF + ++E+ + + + F +P + + G ++L
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK-VEKGKYTFDSPEWKNVSEGAKDL 271
Query: 390 IEDCWSEEPFRRPTFRQIL 408
I+ + RR + +Q L
Sbjct: 272 IKQMLQFDSQRRISAQQAL 290
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-30
Identities = 61/269 (22%), Positives = 112/269 (41%), Gaps = 40/269 (14%)
Query: 159 EITKGTF---RIASWRGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
E+ KG F R + T + A K + + + D + E + +K++HPN+V+
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLH 71
Query: 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIH 273
++ + + +V + + G+L + + A I + Y H N I+H
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVH 128
Query: 274 RDLEPSNIL---RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWR-------YAA 323
R+L+P N+L + +K+ADFGL+ + + +W Y +
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVN-------------DSEAWHGFAGTPGYLS 175
Query: 324 PEVYKNEEYDTKVDVFSFALILQEMIEGCPPF--PTKQE--KEVPKAYIANERPPFRAPT 379
PEV K + Y VD+++ +IL ++ G PPF + ++ P +
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT-V 234
Query: 380 THYAYGLRELIEDCWSEEPFRRPTFRQIL 408
T A + LI+ + P +R T Q L
Sbjct: 235 TPEA---KSLIDSMLTVNPKKRITADQAL 260
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 8e-30
Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 19/238 (7%)
Query: 174 QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL--GAVTQSTPMM--IVTEYL 229
VAVK L ++ D F E + HP +V G + IV EY+
Sbjct: 39 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289
LR + +G + P A++ D + +N+ H+N IIHRD++P+NI+ + +
Sbjct: 99 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAV 155
Query: 290 KVADFGLSKLLKFANTVKEDRPVTCEET---SWRYAAPEVYKNEEYDTKVDVFSFALILQ 346
KV DFG+++ + + VT + +Y +PE + + D + DV+S +L
Sbjct: 156 KVMDFGIARAIADSGN-----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY 210
Query: 347 EMIEGCPPFPTKQEKEVPKAY--IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRP 402
E++ G PPF + V AY + + P A + L ++ ++ P R
Sbjct: 211 EVLTGEPPF--TGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY 266
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-30
Identities = 75/273 (27%), Positives = 117/273 (42%), Gaps = 31/273 (11%)
Query: 148 DPKELDFSNSVEITKGTF-----RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
DP++L FS+ EI G+F VA+K + +K + I E+ LQ
Sbjct: 51 DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNY 262
K+RHPN +Q+ G + +V EY K L+ +G+ Y
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 263 LHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYA 322
LH + +IHRD++ NIL + G +K+ DFG + ++ AN+ P W
Sbjct: 170 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT-PY------W--M 217
Query: 323 APEV---YKNEEYDTKVDVFSFALILQEMIEGCPPF----PTKQEKEVPKAYIANERPPF 375
APEV +YD KVDV+S + E+ E PP + + NE P
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NESPAL 273
Query: 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
++ H++ R ++ C + P RPT +L
Sbjct: 274 QSG--HWSEYFRNFVDSCLQKIPQDRPTSEVLL 304
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 66/311 (21%), Positives = 130/311 (41%), Gaps = 34/311 (10%)
Query: 121 LLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITK----GTF---RIASWRGT 173
+ H ++ Q P + KE S + G + + +
Sbjct: 1 MHHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNG 60
Query: 174 --QVAVKTL----------GEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221
+ A+K + ++ E + +E++LL+ + HPN+++
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNI 281
+VTE+ G+L + + A I G+ YLH++ I+HRD++P NI
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENI 177
Query: 282 L---RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDV 338
L ++ ++K+ DFGLS +D + + Y APEV K ++Y+ K DV
Sbjct: 178 LLENKNSLLNIKIVDFGLSSF------FSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDV 230
Query: 339 FSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPT-THYAYGLRELIEDCWSEE 397
+S +I+ ++ G PPF + ++++ K + + F + + +ELI+ + +
Sbjct: 231 WSCGVIMYILLCGYPPFGGQNDQDIIKK-VEKGKYYFDFNDWKNISDEAKELIKLMLTYD 289
Query: 398 PFRRPTFRQIL 408
+R T + L
Sbjct: 290 YNKRCTAEEAL 300
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-30
Identities = 73/272 (26%), Positives = 123/272 (45%), Gaps = 31/272 (11%)
Query: 148 DPKELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
P+E+ F ++ +G++ G VA+K E ++ I E++++Q
Sbjct: 26 QPEEV-FDVLEKLGEGSYGSVYKAIHKETGQIVAIK-----QVPVESDLQEIIKEISIMQ 79
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMN 261
+ P+VV++ G+ ++T + IV EY G + ++ L +G+
Sbjct: 80 QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE 139
Query: 262 YLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEET-SWR 320
YLH R IHRD++ NIL + GH K+ADFG++ L T + T T W
Sbjct: 140 YLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQL----TDTMAKRNTVIGTPFW- 191
Query: 321 YAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPF----PTKQEKEVPKAYIANERPPFR 376
APEV + Y+ D++S + EM EG PP+ P + +P N P FR
Sbjct: 192 -MAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT----NPPPTFR 246
Query: 377 APTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
P ++ + ++ C + P +R T Q+L
Sbjct: 247 KP-ELWSDNFTDFVKQCLVKSPEQRATATQLL 277
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-30
Identities = 68/283 (24%), Positives = 123/283 (43%), Gaps = 42/283 (14%)
Query: 146 EIDPKELDFSNSVEITKGTF-----RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELAL 200
++DP E+ + E+ G F G A K + + E++++ +I E+ +
Sbjct: 14 DLDPNEV-WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEI 69
Query: 201 LQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFAL-DIARG 259
L HP +V+ LGA + I+ E+ P G + A + + ++ +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129
Query: 260 MNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS- 318
+N+LH R IIHRDL+ N+L G +++ADFG+S + ++
Sbjct: 130 LNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR--------DSFI 178
Query: 319 ----WRYAAPEV-----YKNEEYDTKVDVFSFALILQEMIEGCPPF----PTKQEKEVPK 365
W APEV K+ YD K D++S + L EM + PP P + ++ K
Sbjct: 179 GTPYW--MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 236
Query: 366 AYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
++ P P + ++ R+ ++ + P RP+ Q+L
Sbjct: 237 ----SDPPTLLTP-SKWSVEFRDFLKIALDKNPETRPSAAQLL 274
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 64/262 (24%), Positives = 115/262 (43%), Gaps = 29/262 (11%)
Query: 159 EITKGTF---RIASWRGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
+ G F + R T A+K + + + ++ +E+A+L+KI+H N+V
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIVTLE 72
Query: 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIH 273
+T +V + + G+L + ++G A + + YLHEN I+H
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVH 129
Query: 274 RDLEPSNIL---RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE 330
RDL+P N+L +++ + + DFGLSK+ + C + Y APEV +
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST-----AC--GTPGYVAPEVLAQK 182
Query: 331 EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAP----TTHYAYGL 386
Y VD +S +I ++ G PPF + E ++ + I F +P + A
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEK-IKEGYYEFESPFWDDISESA--- 238
Query: 387 RELIEDCWSEEPFRRPTFRQIL 408
++ I ++P R T + L
Sbjct: 239 KDFICHLLEKDPNERYTCEKAL 260
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 42/304 (13%), Positives = 93/304 (30%), Gaps = 63/304 (20%)
Query: 144 EYEIDPKELDFSNSVEITKGTF---RIASWRGTQ-------VAVKTLGEEVFTDEDKVKA 193
E+++ K + + + +G F A+ +K + +
Sbjct: 59 EFQLGSKLVYVHH--LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYI 113
Query: 194 FIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGA-----LKPTL 248
+ L+ ++F A ++V E G L + + L
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173
Query: 249 AVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL-----------RDDSGHLKVADFGLS 297
+ FA+ + + +H+ IIH D++P N + D S L + D G S
Sbjct: 174 VISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 298 KLLKFANTVKEDRPVTCEETSWR---YAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPP 354
+K T + E+ N+ ++ ++D F A + M+ G
Sbjct: 231 IDMKL------FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
Query: 355 FPTKQE-----KEVPKAY------------IANERPPFRAPTTHYAYGLRELIEDCWSEE 397
+ + + + + N P+ LR+ ++ + +
Sbjct: 285 KVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLD---LLRQKLKKVFQQH 341
Query: 398 PFRR 401
+
Sbjct: 342 YTNK 345
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 29/276 (10%), Positives = 58/276 (21%), Gaps = 50/276 (18%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT----- 226
A+K +++ + ++ + + P V
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 227 --------------------EYLPKGDL-------RAYLKQKGALKPTLAVKFALDIARG 259
DL +G + R
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 260 MNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSW 319
L ++H P N+ G L + D K
Sbjct: 207 AANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL--------WKVGTRGPASSVPV 255
Query: 320 RYAAPEVYKNEE--YDTKVDVFSFALILQEMIEGCPPF-----PTKQEKEVPKAYIANER 372
YA E + ++ + L + + PF K + P +
Sbjct: 256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD 315
Query: 373 PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
T ++ LI + + RR + +
Sbjct: 316 SLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 62/251 (24%), Positives = 110/251 (43%), Gaps = 30/251 (11%)
Query: 172 GTQVAVKTL------GEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225
G + A K + ++++ E+++L+++ H NV+ T ++++
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVSREEIE---REVSILRQVLHHNVITLHDVYENRTDVVLI 93
Query: 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL--- 282
E + G+L +L QK +L A F I G+NYLH + I H DL+P NI+
Sbjct: 94 LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLD 150
Query: 283 -RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSF 341
H+K+ DFGL+ ++ K + T E + APE+ E + D++S
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFK-NIFGTPE-----FVAPEIVNYEPLGLEADMWSI 204
Query: 342 ALILQEMIEGCPPF--PTKQE--KEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEE 397
+I ++ G PF TKQE + + F T+ A ++ I +E
Sbjct: 205 GVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH-TSELA---KDFIRKLLVKE 260
Query: 398 PFRRPTFRQIL 408
+R T ++ L
Sbjct: 261 TRKRLTIQEAL 271
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 70/259 (27%), Positives = 120/259 (46%), Gaps = 21/259 (8%)
Query: 159 EITKGTF---RIASWRGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
+ KG+F R T + AVK + + ++D + E+ LL+K+ HPN+++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLF 87
Query: 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIH 273
+ S+ IV E G+L + ++ A + + G+ Y+H++ I+H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVH 144
Query: 274 RDLEPSNIL---RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE 330
RDL+P NIL ++ +K+ DFGLS +++ + + Y APEV +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTC------FQQNTKMKDRIGTAYYIAPEVLR-G 197
Query: 331 EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPT-THYAYGLREL 389
YD K DV+S +IL ++ G PPF K E ++ K + + F P + ++L
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR-VETGKYAFDLPQWRTISDDAKDL 256
Query: 390 IEDCWSEEPFRRPTFRQIL 408
I + P R T Q L
Sbjct: 257 IRKMLTFHPSLRITATQCL 275
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 22/223 (9%)
Query: 162 KGTFR---IASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV 216
KGTF + + T A+K L +EV +D+V + E +LQ RHP + A
Sbjct: 15 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74
Query: 217 TQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDL 276
+ V EY G+L +L ++ A + +I + YLH +++RD+
Sbjct: 75 QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDI 131
Query: 277 EPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT-C---EETSWRYAAPEVYKNEEY 332
+ N++ D GH+K+ DFGL K T C E Y APEV ++ +Y
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKE----GISDGATMKTFCGTPE-----YLAPEVLEDNDY 182
Query: 333 DTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPF 375
VD + +++ EM+ G PF + + + + I E F
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-ILMEEIRF 224
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 3e-29
Identities = 63/254 (24%), Positives = 111/254 (43%), Gaps = 36/254 (14%)
Query: 172 GTQVAVKTL------GEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225
G + A K + ++++ E+ +L++IRHPN++ T ++++
Sbjct: 30 GKEYAAKFIKKRRLSSSRRGVSREEIE---REVNILREIRHPNIITLHDIFENKTDVVLI 86
Query: 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL--- 282
E + G+L +L +K +L A +F I G++YLH R I H DL+P NI+
Sbjct: 87 LELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLD 143
Query: 283 -RDDSGHLKVADFGLSKLLKFANTVKEDRPVTC---EETSWRYAAPEVYKNEEYDTKVDV 338
+ +K+ DFG++ ++ N K E + APE+ E + D+
Sbjct: 144 KNVPNPRIKLIDFGIAHKIEAGNEFKN----IFGTPE-----FVAPEIVNYEPLGLEADM 194
Query: 339 FSFALILQEMIEGCPPF--PTKQE--KEVPKAYIANERPPFRAPTTHYAYGLRELIEDCW 394
+S +I ++ G PF TKQE + + F T+ A ++ I
Sbjct: 195 WSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN-TSELA---KDFIRRLL 250
Query: 395 SEEPFRRPTFRQIL 408
++P RR T Q L
Sbjct: 251 VKDPKRRMTIAQSL 264
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-29
Identities = 34/89 (38%), Positives = 47/89 (52%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
M+ GDLD +K+ + G DVN R LH AA G+ +++ LL +GAD++ D
Sbjct: 11 FMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPD 70
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+ TPL AVY H +KLL GA
Sbjct: 71 KHHITPLLSAVYEGHVSCVKLLLSKGADK 99
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 90.5 bits (226), Expect = 3e-22
Identities = 25/80 (31%), Positives = 37/80 (46%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L Y A+ G L+ ++ LL G D+N D T L A +G V+LLLS+GAD +
Sbjct: 44 LHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKG 103
Query: 101 RWGSTPLADAVYYKHHDVIK 120
G T +++
Sbjct: 104 PDGLTAFEATDNQAIKALLQ 123
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 79.4 bits (197), Expect = 3e-18
Identities = 14/59 (23%), Positives = 23/59 (38%)
Query: 69 DKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
A G D V+ +++G DV+ G PL A ++++ L GA
Sbjct: 6 MCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGA 64
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
GT VAVK L EE + F E+ ++ H N+++ G T ++V Y+
Sbjct: 54 GTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 111
Query: 232 GDLRAYLKQKGALKPTLA----VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
G + + L+++ +P L + AL ARG+ YLH++ IIHRD++ +NIL D+
Sbjct: 112 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSWR----YAAPEVYKNEEYDT-KVDVFSFA 342
V DFGL+KL+ + +T VT T+ R + APE Y + + K DVF +
Sbjct: 172 EAVVGDFGLAKLMDYKDT-----HVT---TAVRGTIGHIAPE-YLSTGKSSEKTDVFGYG 222
Query: 343 LILQEMIEGCPPFPTKQEKEVPKAYI 368
++L E+I G F + +
Sbjct: 223 VMLLELITGQRAFDLARLANDDDVML 248
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 28/223 (12%)
Query: 197 ELALLQKIRHPNVVQF---LGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFA 253
E+A+L+K+ HPNVV+ L + + +V E + +G + L A +
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDH-LYMVFELVNQGPVMEVPT-LKPLSEDQARFYF 143
Query: 254 LDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK----FANTVKED 309
D+ +G+ YLH + IIHRD++PSN+L + GH+K+ADFG+S K +
Sbjct: 144 QDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN---- 196
Query: 310 RPVTCEETSWRYAAPEVYKNE--EYD-TKVDVFSFALILQEMIEGCPPFPTKQEKEVPKA 366
T + + APE + +DV++ + L + G PF ++ +
Sbjct: 197 ---TV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF---MDERIMCL 248
Query: 367 YIANERPPFRAPT-THYAYGLRELIEDCWSEEPFRRPTFRQIL 408
+ + P A L++LI + P R +I
Sbjct: 249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 21/225 (9%)
Query: 162 KGTF---RIASWRGTQV--AVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV 216
KG+F I T+ A+K + ++ + ++V+ EL ++Q + HP +V +
Sbjct: 25 KGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF 84
Query: 217 TQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKF-ALDIARGMNYLHENRPEAIIHRD 275
M +V + L GDLR +L+Q VK ++ ++YL R IIHRD
Sbjct: 85 QDEEDMFMVVDLLLGGDLRYHLQQNVHF-KEETVKLFICELVMALDYLQNQR---IIHRD 140
Query: 276 LEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEE---Y 332
++P NIL D+ GH+ + DF ++ +L +E + T T Y APE++ + + Y
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAAMLP-----RETQITTMAGTK-PYMAPEMFSSRKGAGY 194
Query: 333 DTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAY--IANERPPF 375
VD +S + E++ G P+ + + +
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY 239
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 61/262 (23%), Positives = 111/262 (42%), Gaps = 29/262 (11%)
Query: 159 EITKGTF---RIASWRGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
I +G++ +IA +GT + A K + + D D+ K E+ +++ + HPN+++
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDHPNIIRLY 72
Query: 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIH 273
+T + +V E G+L + K + + A + D+ + Y H+ + H
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAH 129
Query: 274 RDLEPSNIL---RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE 330
RDL+P N L LK+ DFGL+ K ++ + Y +P+V +
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT----KV--GTPYYVSPQVLEG- 182
Query: 331 EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAP----TTHYAYGL 386
Y + D +S +++ ++ G PPF + EV I F + A
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK-IREGTFTFPEKDWLNVSPQA--- 238
Query: 387 RELIEDCWSEEPFRRPTFRQIL 408
LI ++ P +R T Q L
Sbjct: 239 ESLIRRLLTKSPKQRITSLQAL 260
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 66/251 (26%), Positives = 111/251 (44%), Gaps = 30/251 (11%)
Query: 172 GTQVAVKTL------GEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225
G Q A K + + ++ E+++L++I+HPNV+ T ++++
Sbjct: 36 GLQYAAKFIKKRRTKSSRRGVSREDIE---REVSILKEIQHPNVITLHEVYENKTDVILI 92
Query: 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL--- 282
E + G+L +L +K +L A +F I G+ YLH + I H DL+P NI+
Sbjct: 93 LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLD 149
Query: 283 -RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSF 341
+K+ DFGL+ + F N K + T E + APE+ E + D++S
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFK-NIFGTPE-----FVAPEIVNYEPLGLEADMWSI 203
Query: 342 ALILQEMIEGCPPF--PTKQE--KEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEE 397
+I ++ G PF TKQE V E F T+ A ++ I ++
Sbjct: 204 GVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN-TSALA---KDFIRRLLVKD 259
Query: 398 PFRRPTFRQIL 408
P +R T + L
Sbjct: 260 PKKRMTIQDSL 270
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 65/303 (21%), Positives = 122/303 (40%), Gaps = 44/303 (14%)
Query: 129 PSTAPMHVQNAREVPEYEIDPKELDFSNSVEITK----GTF---RIASWRGT--QVAVKT 179
P A M + FS++ ++ + G F R + T + A K
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 180 LGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLK 239
+ + + D + E + +K++HPN+V+ ++ + + +V + + G+L +
Sbjct: 62 INTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 240 QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL---RDDSGHLKVADFGL 296
+ A I + Y H N I+HR+L+P N+L + +K+ADFGL
Sbjct: 121 AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 177
Query: 297 SKLLKFANTVKEDRPVTCEETSWR-------YAAPEVYKNEEYDTKVDVFSFALILQEMI 349
+ + + +W Y +PEV K + Y VD+++ +IL ++
Sbjct: 178 AIEVN-------------DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224
Query: 350 EGCPPFPTKQEKEVPKAYIANERPPFRAP----TTHYAYGLRELIEDCWSEEPFRRPTFR 405
G PPF + + + I + +P T A + LI+ + P +R T
Sbjct: 225 VGYPPFWDEDQHRLYAQ-IKAGAYDYPSPEWDTVTPEA---KSLIDSMLTVNPKKRITAD 280
Query: 406 QIL 408
Q L
Sbjct: 281 QAL 283
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-29
Identities = 53/195 (27%), Positives = 86/195 (44%), Gaps = 21/195 (10%)
Query: 172 GTQVAVKT-----LGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226
+VA+K + D E+ +L+K+ HP +++ + IV
Sbjct: 35 CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 93
Query: 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL---R 283
E + G+L + LK + + + YLHEN IIHRDL+P N+L +
Sbjct: 94 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQ 150
Query: 284 DDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEV---YKNEEYDTKVDVFS 340
++ +K+ DFG SK+L + ++ C + Y APEV Y+ VD +S
Sbjct: 151 EEDCLIKITDFGHSKILGETSLMRT----LC--GTPTYLAPEVLVSVGTAGYNRAVDCWS 204
Query: 341 FALILQEMIEGCPPF 355
+IL + G PPF
Sbjct: 205 LGVILFICLSGYPPF 219
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 68/247 (27%), Positives = 112/247 (45%), Gaps = 37/247 (14%)
Query: 128 KPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTFRI---ASWRGT-QVAVKTLGEE 183
P P V + +E+ ++N I G+F + A + +VA+K +
Sbjct: 16 NPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIK----K 71
Query: 184 VFTD-EDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM------IVTEYLPKGDL-- 234
V D K + EL +++ ++HPNVV + +V EY+P+ +
Sbjct: 72 VLQDKRFKNR----ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYR 126
Query: 235 --RAYLKQKGALKPTLAVK-FALDIARGMNYLHENRPEAIIHRDLEPSNILRD-DSGHLK 290
R Y K K + P L +K + + R + Y+H I HRD++P N+L D SG LK
Sbjct: 127 ASRHYAKLKQTM-PMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLK 182
Query: 291 VADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMI 349
+ DFG +K+L P S Y APE+ + Y T +D++S ++ E++
Sbjct: 183 LIDFGSAKILI------AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236
Query: 350 EGCPPFP 356
+G P FP
Sbjct: 237 QGQPLFP 243
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 67/293 (22%), Positives = 119/293 (40%), Gaps = 44/293 (15%)
Query: 172 GTQVAVKTL------GEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225
G + A K + ++++ E+++L+++ HPN++ T ++++
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVCREEIE---REVSILRQVLHPNIITLHDVYENRTDVVLI 93
Query: 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL--- 282
E + G+L +L QK +L A F I G+NYLH + I H DL+P NI+
Sbjct: 94 LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLD 150
Query: 283 -RDDSGHLKVADFGLSKLLKFANTVKEDRPVTC---EETSWRYAAPEVYKNEEYDTKVDV 338
H+K+ DFGL+ ++ K E + APE+ E + D+
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKN----IFGTPE-----FVAPEIVNYEPLGLEADM 201
Query: 339 FSFALILQEMIEGCPPF--PTKQE--KEVPKAYIANERPPFRAPTTHYAYGLRELIEDCW 394
+S +I ++ G PF TKQE + + F T+ A ++ I
Sbjct: 202 WSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ-TSELA---KDFIRKLL 257
Query: 395 SEEPFRRPTFRQIL----MRLDDISDQLSIKRHWKVGPLRCFQSLAAL--WKK 441
+E +R T ++ L + D + + V L F+ WK
Sbjct: 258 VKETRKRLTIQEALRHPWITPVDTQQAMVRRES--VVNLENFKKQYVRRRWKL 308
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 70/247 (28%), Positives = 110/247 (44%), Gaps = 27/247 (10%)
Query: 122 LEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSV-----EITKGTF---RIASWRGT 173
L TA A VP+Y ID D + E+ +G +GT
Sbjct: 18 LYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGT 77
Query: 174 --QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
A+K L + V D+ V+ E+ +L ++ HPN+++ T + +V E +
Sbjct: 78 QKPYALKVLKKTV--DKKIVR---TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL---RDDSGH 288
G+L + +KG A I + YLHEN I+HRDL+P N+L
Sbjct: 133 GELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAP 189
Query: 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEM 348
LK+ADFGLSK+++ +K C + Y APE+ + Y +VD++S +I +
Sbjct: 190 LKIADFGLSKIVEHQVLMKT----VC--GTPGYCAPEILRGCAYGPEVDMWSVGIITYIL 243
Query: 349 IEGCPPF 355
+ G PF
Sbjct: 244 LCGFEPF 250
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 57/263 (21%), Positives = 112/263 (42%), Gaps = 27/263 (10%)
Query: 159 EITKGTF---RIASWRGT--QVAVKTLG-EEVFTDEDKVKAFIDELALLQKIRHPNVVQF 212
++ G F + R + + +KT+ + ++++ E+ +L+ + HPN+++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE---AEIEVLKSLDHPNIIKI 85
Query: 213 LGAVTQSTPMMIVTEYLPKGDL----RAYLKQKGALKPTLAVKFALDIARGMNYLHENRP 268
M IV E G+L + + AL + + + Y H
Sbjct: 86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH- 144
Query: 269 EAIIHRDLEPSNIL---RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPE 325
++H+DL+P NIL +K+ DFGL++L K + Y APE
Sbjct: 145 --VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN----AAG--TALYMAPE 196
Query: 326 VYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385
V+K + K D++S +++ ++ GC PF +EV + + P +
Sbjct: 197 VFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK-ATYKEPNYAVECRPLTPQ 254
Query: 386 LRELIEDCWSEEPFRRPTFRQIL 408
+L++ +++P RRP+ Q+L
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVL 277
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 59/188 (31%), Positives = 91/188 (48%), Gaps = 11/188 (5%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLR 235
A K L ++ ++E +L+K+ VV A + +V + GDL+
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272
Query: 236 AYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293
++ G AV +A +I G+ LH R I++RDL+P NIL DD GH++++D
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISD 329
Query: 294 FGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCP 353
GL+ + T+K R T Y APEV KNE Y D ++ +L EMI G
Sbjct: 330 LGLAVHVPEGQTIKG-RVGTVG-----YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
Query: 354 PFPTKQEK 361
PF +++K
Sbjct: 384 PFQQRKKK 391
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 57/176 (32%), Positives = 78/176 (44%), Gaps = 19/176 (10%)
Query: 195 IDELALLQKIRHPNVVQFLGAVTQSTP-----MMIVTEYLPKGDLRAYLKQKGA--LKPT 247
+ L L+ HPNVV+ + S + +V E++ + DLR YL + L
Sbjct: 62 VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAE 120
Query: 248 LAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307
RG+++LH N I+HRDL+P NIL G +K+ADFGL A
Sbjct: 121 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL------ARIYS 171
Query: 308 EDRPVTCE-ETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
+T T W Y APEV Y T VD++S I EM P F E +
Sbjct: 172 YQMALTPVVVTLW-YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 226
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 55/247 (22%), Positives = 103/247 (41%), Gaps = 24/247 (9%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFID-ELALLQKIRHPNVVQFLGAVTQSTPMMI--VTEY 228
+ AVK L ++ +A + E+ LL+++RH NV+Q + + + V EY
Sbjct: 30 LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY 89
Query: 229 LPKG--DLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286
G ++ + +K A + + G+ YLH I+H+D++P N+L
Sbjct: 90 CVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTG 145
Query: 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEET---SWRYAAPEVYKNEE-YD-TKVDVFSF 341
G LK++ G++ + T S + PE+ + + KVD++S
Sbjct: 146 GTLKISALGVA------EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSA 199
Query: 342 ALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRR 401
+ L + G PF + + K + + + P L +L++ EP +R
Sbjct: 200 GVTLYNITTGLYPF---EGDNIYKLFENIGKGSYAIP-GDCGPPLSDLLKGMLEYEPAKR 255
Query: 402 PTFRQIL 408
+ RQI
Sbjct: 256 FSIRQIR 262
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 21/223 (9%)
Query: 162 KGTFR---IASWRGTQV--AVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV 216
KGTF + + T A+K L +EV +D+V + E +LQ RHP + +
Sbjct: 158 KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF 217
Query: 217 TQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDL 276
+ V EY G+L +L ++ A + +I ++YLH + +++RDL
Sbjct: 218 QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK--NVVYRDL 275
Query: 277 EPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT-C---EETSWRYAAPEVYKNEEY 332
+ N++ D GH+K+ DFGL K T C E Y APEV ++ +Y
Sbjct: 276 KLENLMLDKDGHIKITDFGLCKE----GIKDGATMKTFCGTPE-----YLAPEVLEDNDY 326
Query: 333 DTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPF 375
VD + +++ EM+ G PF + +++ + I E F
Sbjct: 327 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-ILMEEIRF 368
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 55/173 (31%), Positives = 79/173 (45%), Gaps = 19/173 (10%)
Query: 198 LALLQKIRHPNVVQFLGAVTQSTP-----MMIVTEYLPKGDLRAYLKQKGA--LKPTLAV 250
L L+ HPNVV+ T S + +V E++ + DL YL + +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK 123
Query: 251 KFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR 310
+ RG+++LH +R ++HRDL+P NIL SG +K+ADFGL A
Sbjct: 124 DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL------ARIYSFQM 174
Query: 311 PVTCE-ETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
+T T W Y APEV Y T VD++S I EM P F + +
Sbjct: 175 ALTSVVVTLW-YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 226
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-28
Identities = 63/254 (24%), Positives = 115/254 (45%), Gaps = 30/254 (11%)
Query: 172 GTQVAVKTL------GEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMI 224
+ AVK + ++ +A + E+ +L+K+ HPN++Q +T +
Sbjct: 42 CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101
Query: 225 VTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD 284
V + + KG+L YL +K L K + + LH+ I+HRDL+P NIL D
Sbjct: 102 VFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLD 158
Query: 285 DSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEE------YDTKVDV 338
D ++K+ DFG S L ++E C + Y APE+ + Y +VD+
Sbjct: 159 DDMNIKLTDFGFSCQLDPGEKLRE----VC--GTPSYLAPEIIECSMNDNHPGYGKEVDM 212
Query: 339 FSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAP----TTHYAYGLRELIEDCW 394
+S +I+ ++ G PPF +++ + + I + F +P + ++L+
Sbjct: 213 WSTGVIMYTLLAGSPPFWHRKQMLMLRM-IMSGNYQFGSPEWDDYSDTV---KDLVSRFL 268
Query: 395 SEEPFRRPTFRQIL 408
+P +R T + L
Sbjct: 269 VVQPQKRYTAEEAL 282
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-28
Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 19/213 (8%)
Query: 159 EITKGTF---RIASWRGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
+ KG+F R T + AVK + + ++D + E+ LL+K+ HPN+++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLF 87
Query: 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIH 273
+ S+ IV E G+L + ++ A + + G+ Y+H++ I+H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVH 144
Query: 274 RDLEPSNIL---RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE 330
RDL+P NIL ++ +K+ DFGLS +++ + + Y APEV +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTC------FQQNTKMKDRIGTAYYIAPEVLR-G 197
Query: 331 EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV 363
YD K DV+S +IL ++ G PPF K E ++
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI 230
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 61/341 (17%), Positives = 112/341 (32%), Gaps = 45/341 (13%)
Query: 135 HVQNAREVPEYEIDPKELDFSNSVEITKGTFRIAS-------WRGTQVAVKTLGEEVFTD 187
H++N P+ + I KG + + G V V+ + E ++
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 188 EDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG---DLRAYLKQKGAL 244
E V EL + + HPN+V + + +VT ++ G DL G
Sbjct: 68 EM-VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN 126
Query: 245 KPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304
+ +A + + ++Y+H +HR ++ S+IL G + ++ + + +
Sbjct: 127 ELAIAY-ILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM--IS 180
Query: 305 TVKEDRPVTCEETS------WRYAAPEVYK--NEEYDTKVDVFSFALILQEMIEGCPPF- 355
+ R V W +PEV + + YD K D++S + E+ G PF
Sbjct: 181 HGQRQRVVHDFPKYSVKVLPW--LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238
Query: 356 ---PTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412
T+ E P +T A L + +
Sbjct: 239 DMPATQMLLEKLN----GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSN 294
Query: 413 DISDQLSIKRHWKVGPLRCFQSLAA--LWKKGHADPSSRSS 451
S R + F L + +P +R S
Sbjct: 295 GDSPSHPYHRTFS----PHFHHFVEQCLQR----NPDARPS 327
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-28
Identities = 32/89 (35%), Positives = 45/89 (50%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L + +GD+ ++ LL +G+D N +D T LH A G VV LLL A V+
Sbjct: 14 LHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTG 73
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+PL DA H D++KLL +GA
Sbjct: 74 YQNDSPLHDAAKNGHVDIVKLLLSYGASR 102
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 3e-27
Identities = 25/91 (27%), Positives = 41/91 (45%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L N G L ++ LL VN + LH AA G D+V+LLLS GA + +
Sbjct: 47 LHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVN 106
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKPST 131
+G P+ ++ L E++ + ++
Sbjct: 107 IFGLRPVDYTDDESMKSLLLLPEKNESSSAS 137
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 87.1 bits (217), Expect = 9e-21
Identities = 24/68 (35%), Positives = 36/68 (52%), Gaps = 1/68 (1%)
Query: 60 GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVI 119
G D + T LH+A+ +G V LL G+D + +D G TPL +A + H V+
Sbjct: 1 GIDPF-TNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVV 59
Query: 120 KLLEEHGA 127
+LL +H A
Sbjct: 60 ELLLQHKA 67
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 39.3 bits (93), Expect = 5e-04
Identities = 9/37 (24%), Positives = 15/37 (40%), Gaps = 1/37 (2%)
Query: 93 GADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
G D + G T L A ++ L ++G+ P
Sbjct: 1 GIDPF-TNHRGETLLHIASIKGDIPSVEYLLQNGSDP 36
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 55/190 (28%), Positives = 88/190 (46%), Gaps = 12/190 (6%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLR 235
A K L ++ + + E +L K+ +V A T + +V + GD+R
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273
Query: 236 AYLKQKGALKPTL----AVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
++ P A+ + I G+ +LH+ II+RDL+P N+L DD G++++
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRI 330
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG 351
+D GL+ LK T + T + APE+ EEYD VD F+ + L EMI
Sbjct: 331 SDLGLAVELKAGQTKTKGYAGTPG-----FMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385
Query: 352 CPPFPTKQEK 361
PF + EK
Sbjct: 386 RGPFRARGEK 395
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALLQK-IRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
A+K L ++V +D V+ + E +L HP + + V EYL GDL
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL 105
Query: 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294
+++ + A +A +I G+ +LH I++RDL+ NIL D GH+K+ADF
Sbjct: 106 MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADF 162
Query: 295 GLSKLLKFANTVKEDRPVT-C---EETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE 350
G+ K N + + + T C + Y APE+ ++Y+ VD +SF ++L EM+
Sbjct: 163 GMCKE----NMLGDAKTNTFCGTPD-----YIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213
Query: 351 GCPPFPTKQEKEVPKAYIANERPPF 375
G PF + E+E+ + I + P +
Sbjct: 214 GQSPFHGQDEEELFHS-IRMDNPFY 237
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 54/262 (20%), Positives = 110/262 (41%), Gaps = 25/262 (9%)
Query: 159 EITKGTF---RIASWRGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
E+ KG F R + A + + + D + E + + ++HPN+V+
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHPNIVRLH 76
Query: 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIH 273
++++ ++ + + G+L + + A I + + H+ ++H
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVH 133
Query: 274 RDLEPSNIL---RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE 330
R+L+P N+L + +K+ADFGL+ ++ T Y +PEV + +
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG-----YLSPEVLRKD 188
Query: 331 EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAP----TTHYAYGL 386
Y VD+++ +IL ++ G PPF + + + + I F +P T A
Sbjct: 189 PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ-IKAGAYDFPSPEWDTVTPEA--- 244
Query: 387 RELIEDCWSEEPFRRPTFRQIL 408
++LI + P +R T + L
Sbjct: 245 KDLINKMLTINPSKRITAAEAL 266
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 107 bits (271), Expect = 8e-28
Identities = 28/89 (31%), Positives = 40/89 (44%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L + G D + LL+ D+N D + T L A V LL+RGAD+ E
Sbjct: 73 LSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGNHVKCVEALLARGADLTTEA 132
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
G TP+ AV + V +++E H K
Sbjct: 133 DSGYTPMDLAVALGYRKVQQVIENHILKL 161
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 29/87 (33%), Positives = 49/87 (56%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L++ + G+++ ++ LL+ G D + ++ +AL +A+ G TD+V LLL R D++ D
Sbjct: 40 LIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYD 99
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
G TPL AV H ++ L GA
Sbjct: 100 WNGGTPLLYAVRGNHVKCVEALLARGA 126
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-26
Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 1/90 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTD-VNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPE 99
+ +A +G+LD +KE L G + VN D T L A+ G + VR LL GAD
Sbjct: 6 IHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGADPHIL 65
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+ + L+ A + D++ LL E
Sbjct: 66 AKERESALSLASTGGYTDIVGLLLERDVDI 95
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 82.1 bits (204), Expect = 1e-18
Identities = 11/66 (16%), Positives = 25/66 (37%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L+Y + ++ LL G D+ T + +A G V +++ + + +
Sbjct: 106 LLYAVRGNHVKCVEALLARGADLTTEADSGYTPMDLAVALGYRKVQQVIENHILKLFQSN 165
Query: 101 RWGSTP 106
+ P
Sbjct: 166 LVPADP 171
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 75.5 bits (187), Expect = 2e-16
Identities = 19/60 (31%), Positives = 30/60 (50%), Gaps = 1/60 (1%)
Query: 71 RTALHVAACQGRTDVVRLLLSRGAD-VDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
++H A QG D ++ L +G + V+ D G TPL A + + ++ L E GA P
Sbjct: 3 SLSIHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGADP 62
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-28
Identities = 29/88 (32%), Positives = 40/88 (45%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L ++G D +K LLD G DVN D + T L A V++LL GAD E
Sbjct: 73 LSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGADPTIET 132
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAK 128
G + AV + V +++E H K
Sbjct: 133 DSGYNSMDLAVALGYRSVQQVIESHLLK 160
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 22/87 (25%), Positives = 41/87 (47%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
+ +A +G++ + ++ +N D + T L AA G+ VV LL GAD
Sbjct: 7 VHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLG 66
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ + L+ A + D++K+L + G
Sbjct: 67 KGRESALSLACSKGYTDIVKMLLDCGV 93
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 33/87 (37%), Positives = 49/87 (56%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
LM+ A G + ++ LL +G D + +AL +A +G TD+V++LL G DV+ D
Sbjct: 40 LMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYD 99
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
G TPL AV+ H +K+L E GA
Sbjct: 100 WNGGTPLLYAVHGNHVKCVKMLLESGA 126
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 81.3 bits (202), Expect = 2e-18
Identities = 15/59 (25%), Positives = 27/59 (45%)
Query: 71 RTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
++H A QG + + + ++ D G TPL A + V++ L ++GA P
Sbjct: 4 SLSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADP 62
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 72.4 bits (179), Expect = 3e-15
Identities = 12/61 (19%), Positives = 25/61 (40%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L+Y + + +K LL+SG D ++ +A G V +++ S +
Sbjct: 106 LLYAVHGNHVKCVKMLLESGADPTIETDSGYNSMDLAVALGYRSVQQVIESHLLKLLQNI 165
Query: 101 R 101
+
Sbjct: 166 K 166
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-27
Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 23/224 (10%)
Query: 162 KGTFR---IASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDE-LALLQKIRHPNVVQFLGA 215
KG+F ++ +GT AVK L ++V +D V+ + E L + P + Q
Sbjct: 351 KGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 410
Query: 216 VTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRD 275
+ V EY+ GDL +++Q G K AV +A +IA G+ +L II+RD
Sbjct: 411 FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRD 467
Query: 276 LEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT-C---EETSWRYAAPEVYKNEE 331
L+ N++ D GH+K+ADFG+ K N T C + Y APE+ +
Sbjct: 468 LKLDNVMLDSEGHIKIADFGMCKE----NIWDGVTTKTFCGTPD-----YIAPEIIAYQP 518
Query: 332 YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPF 375
Y VD ++F ++L EM+ G PF + E E+ ++ I +
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS-IMEHNVAY 561
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 69/286 (24%), Positives = 118/286 (41%), Gaps = 46/286 (16%)
Query: 148 DPKELDFSNSVEITKGTF-----RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
DP + F + GT+ G A+K + D+ + E+ +L+
Sbjct: 21 DPAGI-FELVELVGNGTYGQVYKGRHVKTGQLAAIK----VMDVTGDEEEEIKQEINMLK 75
Query: 203 KI-RHPNVVQFLGA------VTQSTPMMIVTEYLPKG---DLRAYLKQKGALKPTLAVKF 252
K H N+ + GA + +V E+ G DL K + +A
Sbjct: 76 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-I 134
Query: 253 ALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312
+I RG+++LH+++ +IHRD++ N+L ++ +K+ DFG+S L +
Sbjct: 135 CREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN---- 187
Query: 313 TCEET-SWRYAAPEVYKNEE-----YDTKVDVFSFALILQEMIEGCPPF----PTKQEKE 362
T T W APEV +E YD K D++S + EM EG PP P +
Sbjct: 188 TFIGTPYW--MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 245
Query: 363 VPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
+P+ P R + ++ + IE C + +RP Q++
Sbjct: 246 IPR------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLM 285
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDE---LALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKG 232
A+K L ++ + ++E L+L+ P +V A + + + + G
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 233 DLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVA 292
DL +L Q G +A +I G+ ++H +++RDL+P+NIL D+ GH++++
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS 334
Query: 293 DFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEG 351
D GL+ + +P T Y APEV K YD+ D FS +L +++ G
Sbjct: 335 DLGLACD------FSKKKPHASVGTH-GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387
Query: 352 CPPFPTKQEKEVPKAY--IANERPPF 375
PF + K+ +
Sbjct: 388 HSPFRQHKTKDKHEIDRMTLTMAVEL 413
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 66/270 (24%), Positives = 112/270 (41%), Gaps = 35/270 (12%)
Query: 159 EITKGTF---RIASWRGT--QVAVKT-----LGEEVFTDEDKVKAFIDELALLQKIRHPN 208
I KG F R R T Q AVK + +K E ++ ++HP+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK---REASICHMLKHPH 87
Query: 209 VVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTL----AVKFALDIARGMNYLH 264
+V+ L + + +V E++ DL + ++ A + I + Y H
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 265 ENRPEAIIHRDLEPSNIL---RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRY 321
+N IIHRD++P +L +++S +K+ FG++ L + V R T +
Sbjct: 148 DNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPH-----F 199
Query: 322 AAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPF-PTKQE--KEVPKAYIANERPPFRAP 378
APEV K E Y VDV+ +IL ++ GC PF TK+ + + K +
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSH- 258
Query: 379 TTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
+ A ++L+ +P R T + L
Sbjct: 259 ISESA---KDLVRRMLMLDPAERITVYEAL 285
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
AVK L ++V +D V+ + E +L + P + Q + V EY+ GDL
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 108
Query: 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294
+++Q G K AV +A +IA G+ +L II+RDL+ N++ D GH+K+ADF
Sbjct: 109 MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADF 165
Query: 295 GLSKLLKFANTVKEDRPVT-C---EETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE 350
G+ K N T C + Y APE+ + Y VD ++F ++L EM+
Sbjct: 166 GMCKE----NIWDGVTTKTFCGTPD-----YIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216
Query: 351 GCPPFPTKQEKEVPKAYIANERPPF 375
G PF + E E+ ++ I +
Sbjct: 217 GQAPFEGEDEDELFQS-IMEHNVAY 240
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 66/333 (19%), Positives = 113/333 (33%), Gaps = 67/333 (20%)
Query: 135 HVQNAREVPEYEIDPKELDFSNSVEITK----GTF---RIASWRGT--QVAVKT-----L 180
H ++ Y L+ + G++ R+A T A+K +
Sbjct: 5 HHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKI 64
Query: 181 GEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ 240
+ D +++K E+ L++K+ HPN+ + + +V E G L L
Sbjct: 65 RQINPKDVERIK---TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNV 121
Query: 241 KGALKPTL----------------------------------------AVKFALDIARGM 260
I +
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 261 NYLHENRPEAIIHRDLEPSNIL--RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS 318
+YLH I HRD++P N L + S +K+ DFGLSK N + T T
Sbjct: 182 HYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238
Query: 319 WRYAAPEV--YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFR 376
+ + APEV NE Y K D +S ++L ++ G PFP + + + N++ F
Sbjct: 239 Y-FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQ-VLNKKLCFE 296
Query: 377 APT-THYAYGLRELIEDCWSEEPFRRPTFRQIL 408
P + R+L+ + + R + L
Sbjct: 297 NPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-27
Identities = 37/87 (42%), Positives = 53/87 (60%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G + +K+LL G DVN R D T LH+AA G ++V+LLL++GADV+
Sbjct: 13 LHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARS 72
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ G+TP A HH+++KLL+ GA
Sbjct: 73 KDGNTPEHLAKKNGHHEIVKLLDAKGA 99
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 81.7 bits (203), Expect = 4e-19
Identities = 27/68 (39%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 60 GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVI 119
G D T LH AA G + V+ LLS+GADV+ + G+TPL A H +++
Sbjct: 1 GHMWG--SKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIV 58
Query: 120 KLLEEHGA 127
KLL GA
Sbjct: 59 KLLLAKGA 66
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 78.6 bits (195), Expect = 5e-18
Identities = 24/67 (35%), Positives = 33/67 (49%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G + +K LL G DVN R D T H+A G ++V+LL ++GADV+
Sbjct: 46 LHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKKNGHHEIVKLLDAKGADVNARS 105
Query: 101 RWGSTPL 107
S
Sbjct: 106 WGSSHHH 112
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-27
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 1/95 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L + A ++D LL +G + + ++ + T L +AA +G + ++LL A+ D D
Sbjct: 129 LHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRDITD 188
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMH 135
P A HHD+++LL+E+ S +H
Sbjct: 189 HMDRLPRDIAQERMHHDIVRLLDEYNLVRSPQ-LH 222
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 98.3 bits (246), Expect = 8e-24
Identities = 27/87 (31%), Positives = 43/87 (49%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L+ A +++L++S DVN D ++ALH AA D +LL GA+ D ++
Sbjct: 96 LILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN 155
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
TPL A ++ K+L +H A
Sbjct: 156 NREETPLFLAAREGSYETAKVLLDHFA 182
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 93.2 bits (233), Expect = 5e-22
Identities = 26/90 (28%), Positives = 37/90 (41%), Gaps = 1/90 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGA-DVDPE 99
L A D K LL++ D N +D RT LH A V ++L+ A D+D
Sbjct: 29 LHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDAR 88
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
G+TPL A +++ L A
Sbjct: 89 MHDGTTPLILAARLAVEGMLEDLINSHADV 118
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 90.2 bits (225), Expect = 5e-21
Identities = 26/77 (33%), Positives = 37/77 (48%), Gaps = 1/77 (1%)
Query: 53 IKELLDSGTDV-NFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAV 111
I + + G + N D TALH+AA R+D + LL AD + +D G TPL AV
Sbjct: 7 ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 66
Query: 112 YYKHHDVIKLLEEHGAK 128
V ++L + A
Sbjct: 67 SADAQGVFQILIRNRAT 83
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 89.4 bits (223), Expect = 1e-20
Identities = 22/88 (25%), Positives = 39/88 (44%), Gaps = 1/88 (1%)
Query: 41 LMYMANEGDLDGIKELLDSG-TDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPE 99
L + + L+ + TD++ R D T L +AA ++ L++ ADV+
Sbjct: 62 LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAV 121
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGA 127
D G + L A + D +L ++GA
Sbjct: 122 DDLGKSALHWAAAVNNVDAAVVLLKNGA 149
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 53.6 bits (130), Expect = 2e-08
Identities = 15/48 (31%), Positives = 20/48 (41%), Gaps = 1/48 (2%)
Query: 81 GRTDVVRLLLSRGADVDPE-DRWGSTPLADAVYYKHHDVIKLLEEHGA 127
V+ + +GA + + DR G T L A Y D K L E A
Sbjct: 2 DAPAVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASA 49
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 66/313 (21%), Positives = 122/313 (38%), Gaps = 47/313 (15%)
Query: 115 HHDVIKLLEEHGAKPSTAPMHVQNAREVPE-YEIDPKELDFSNSVEITKGTF---RIASW 170
HH G T ++ Q+ Y + KEL +G F R
Sbjct: 2 HHHHHH---SSGVDLGTENLYFQSMENFNNFYILTSKELG--------RGKFAVVRQCIS 50
Query: 171 RGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRH-PNVVQFLGAVTQSTPMMIVTE 227
+ T + A K L + + + + E+A+L+ + P V+ ++ ++++ E
Sbjct: 51 KSTGQEYAAKFLKKRRRGQDCR-AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILE 109
Query: 228 YLPKGDL--RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL--- 282
Y G++ + + ++ I G+ YLH+N I+H DL+P NIL
Sbjct: 110 YAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSS 166
Query: 283 RDDSGHLKVADFGLSKLLKFANTVKEDRPVTC---EETSWRYAAPEVYKNEEYDTKVDVF 339
G +K+ DFG+S+ + A ++E E Y APE+ + T D++
Sbjct: 167 IYPLGDIKIVDFGMSRKIGHACELRE----IMGTPE-----YLAPEILNYDPITTATDMW 217
Query: 340 SFALILQEMIEGCPPF--PTKQE--KEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWS 395
+ +I ++ PF QE + + + F + + A + I+
Sbjct: 218 NIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS-VSQLA---TDFIQSLLV 273
Query: 396 EEPFRRPTFRQIL 408
+ P +RPT L
Sbjct: 274 KNPEKRPTAEICL 286
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-27
Identities = 42/87 (48%), Positives = 56/87 (64%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G L+ +K LL++G DVN +D + RT LH+AA G +VV+LLL GADV+ +D
Sbjct: 6 LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKD 65
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ G TPL A H +V+KLL E GA
Sbjct: 66 KNGRTPLHLAARNGHLEVVKLLLEAGA 92
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 80.9 bits (201), Expect = 5e-19
Identities = 30/59 (50%), Positives = 39/59 (66%)
Query: 69 DKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ RT LH+AA G +VV+LLL GADV+ +D+ G TPL A H +V+KLL E GA
Sbjct: 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 59
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-27
Identities = 27/89 (30%), Positives = 38/89 (42%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
+ A G ++ L+ G VN D + LH A G V++LL GA V+
Sbjct: 63 MHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVT 122
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
TPL +A D + LL +HGA
Sbjct: 123 ADWHTPLFNACVSGSWDCVNLLLQHGASV 151
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 1e-23
Identities = 21/89 (23%), Positives = 41/89 (46%), Gaps = 1/89 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
+ A G ++ + L+ G +++ + T L++A + V+ LL GADV+ +
Sbjct: 161 IHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVN-QG 219
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+ +PL V ++ LL + GA
Sbjct: 220 KGQDSPLHAVVRTASEELACLLMDFGADT 248
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 9e-23
Identities = 29/89 (32%), Positives = 37/89 (41%), Gaps = 1/89 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L G L +K LL G VN D T L A G D V LLL GA V PE
Sbjct: 96 LHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGSWDCVNLLLQHGASVQPES 155
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
++P+ +A H + + L +G
Sbjct: 156 D-LASPIHEAARRGHVECVNSLIAYGGNI 183
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 4e-21
Identities = 25/89 (28%), Positives = 38/89 (42%), Gaps = 1/89 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L G D + LL G V + D + +H AA +G + V L++ G ++D +
Sbjct: 129 LFNACVSGSWDCVNLLLQHGASVQ-PESDLASPIHEAARRGHVECVNSLIAYGGNIDHKI 187
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
TPL A + +K L E GA
Sbjct: 188 SHLGTPLYLACENQQRACVKKLLESGADV 216
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-20
Identities = 22/93 (23%), Positives = 35/93 (37%), Gaps = 2/93 (2%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L +K+LL+SG DVN + + + LH ++ LL+ GAD ++
Sbjct: 194 LYLACENQQRACVKKLLESGADVN-QGKGQDSPLHAVVRTASEELACLLMDFGADTQAKN 252
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAP 133
G P+ + LE GA
Sbjct: 253 AEGKRPVELVPPESPLAQL-FLEREGASLPKPK 284
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 87.5 bits (218), Expect = 1e-19
Identities = 18/77 (23%), Positives = 33/77 (42%)
Query: 53 IKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVY 112
+ + + + +H AA G +R L+S+G V+ +PL +A
Sbjct: 42 FPGIRLLSNPLMGDAVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACL 101
Query: 113 YKHHDVIKLLEEHGAKP 129
H +K+L +HGA+
Sbjct: 102 GGHLSCVKILLKHGAQV 118
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 4e-11
Identities = 14/88 (15%), Positives = 26/88 (29%), Gaps = 12/88 (13%)
Query: 45 ANEGDLDGIKELLDSGTDVNFRD-----IDKRTALHVAACQGRTDVVRLLLSRGADVDPE 99
++ L+ G+ + D +D G LLS D
Sbjct: 3 SSHHHHHHSSGLVPRGSHMASMDGKQGGMDGSKPAGPRDFPG-----IRLLSNPLMGDAV 57
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+P+ +A + H ++ L G
Sbjct: 58 S--DWSPMHEAAIHGHQLSLRNLISQGW 83
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 18/188 (9%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
+ AVK + D+ K + LL+ +HPN++ + +VTE +
Sbjct: 47 NMEFAVKII------DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL----RDDSG 287
G+L + ++ A I + + YLH ++HRDL+PSNIL +
Sbjct: 101 GELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPE 157
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQE 347
+++ DFG +K L+ N + C + + APEV + + YD D++S ++L
Sbjct: 158 SIRICDFGFAKQLRAENGLLMTP---C--YTANFVAPEVLERQGYDAACDIWSLGVLLYT 212
Query: 348 MIEGCPPF 355
M+ G PF
Sbjct: 213 MLTGYTPF 220
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 56/234 (23%), Positives = 91/234 (38%), Gaps = 23/234 (9%)
Query: 160 ITKGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLG 214
I +G F + + T A+K + + +V F +E +L + Q
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 215 AVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKF-ALDIARGMNYLHENRPEAIIH 273
A + +V EY GDL L + G P +F +I ++ +H +H
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVH 185
Query: 274 RDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV-TCEETSWRYAAPEV------ 326
RD++P NIL D GH+++ADFG L+ TV+ V T + Y +PE+
Sbjct: 186 RDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD-----YLSPEILQAVGG 240
Query: 327 -YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPT 379
Y + D ++ + EM G PF E I + + P
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK-IVHYKEHLSLPL 293
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-27
Identities = 28/103 (27%), Positives = 47/103 (45%)
Query: 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTD 84
++P V L+ A G+L+ +++ + D + + + TALH A C
Sbjct: 9 GSPRKARRARLNPLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYS 68
Query: 85 VVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+V L++ GA+V+ D G TPL A + L +HGA
Sbjct: 69 IVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGA 111
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 20/91 (21%), Positives = 32/91 (35%), Gaps = 3/91 (3%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L + + L+ +G +VN D T LH AA T + L+ GA +
Sbjct: 58 LHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATT 117
Query: 101 R-WGSTPLADAVYYK--HHDVIKLLEEHGAK 128
G+T Y+ + D L +
Sbjct: 118 LSDGATAFEKCDPYREGYADCATYLADVEQS 148
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-15
Identities = 15/90 (16%), Positives = 24/90 (26%), Gaps = 4/90 (4%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDI-DKRTALHVAAC--QGRTDVVRLLLSRGADVD 97
L A+ D L+ G + + D TA +G D L +
Sbjct: 91 LHCAASCNDTVICMALVQHGAAIFATTLSDGATAFEKCDPYREGYADCATYLADVEQSMG 150
Query: 98 PEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ L D + D + E
Sbjct: 151 LMNSGAVYALWDYS-AEFGDELSFREGESV 179
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-10
Identities = 12/75 (16%), Positives = 19/75 (25%), Gaps = 1/75 (1%)
Query: 45 ANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGS 104
EG D L D + + AL + + D + V D
Sbjct: 131 YREGYADCATYLADVEQSMGLMNSGAVYALWDYSAEF-GDELSFREGESVTVLRRDGPEE 189
Query: 105 TPLADAVYYKHHDVI 119
T A + +
Sbjct: 190 TDWWWAALHGQEGYV 204
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 6e-07
Identities = 9/50 (18%), Positives = 16/50 (32%), Gaps = 3/50 (6%)
Query: 86 VRLLLSRGADVDPEDRW---GSTPLADAVYYKHHDVIKLLEEHGAKPSTA 132
+R +L + R L DA +V++ + PS
Sbjct: 1 MRSVLRKAGSPRKARRARLNPLVLLLDAALTGELEVVQQAVKEMNDPSQP 50
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 6e-07
Identities = 12/66 (18%), Positives = 18/66 (27%), Gaps = 1/66 (1%)
Query: 43 YMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVV-RLLLSRGADVDPEDR 101
+ + D + V RD + T AA G+ V R V P+
Sbjct: 161 WDYSAEFGDELSFREGESVTVLRRDGPEETDWWWAALHGQEGYVPRNYFGLFPRVKPQRS 220
Query: 102 WGSTPL 107
Sbjct: 221 KVKHHH 226
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-27
Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 18/188 (9%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIVTEYLP 230
AVK + + E+ L+ HPN+V+ +V E L
Sbjct: 36 NQAFAVKII------SKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89
Query: 231 KGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL---RDDSG 287
G+L +K+K T A + ++++H+ ++HRDL+P N+L +D+
Sbjct: 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNL 146
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQE 347
+K+ DFG ++L N + T YAAPE+ YD D++S +IL
Sbjct: 147 EIKIIDFGFARLKPPDNQPLKTPCFTLH-----YAAPELLNQNGYDESCDLWSLGVILYT 201
Query: 348 MIEGCPPF 355
M+ G PF
Sbjct: 202 MLSGQVPF 209
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 44/178 (24%), Positives = 75/178 (42%), Gaps = 19/178 (10%)
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTP--------MMIVTEYLPKGDLRAYLKQKGALKPTL 248
E+ +LQ ++H NVV + + +V ++ DL L
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124
Query: 249 AVK-FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307
+K + G+ Y+H N+ I+HRD++ +N+L G LK+ADFGL++ F+
Sbjct: 125 EIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA--FSLAKN 179
Query: 308 -EDRPVTCE-ETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
+ T T W Y PE+ +Y +D++ I+ EM P E+
Sbjct: 180 SQPNRYTNRVVTLW-YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 236
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
AVK L ++V +D V+ + E +L HP + Q + V E++ GDL
Sbjct: 52 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL 111
Query: 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294
++++ A +A +I + +LH+ II+RDL+ N+L D GH K+ADF
Sbjct: 112 MFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF 168
Query: 295 GLSKLLKFANTVKEDRPVT-C---EETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE 350
G+ K T C + Y APE+ + Y VD ++ ++L EM+
Sbjct: 169 GMCKE----GICNGVTTATFCGTPD-----YIAPEILQEMLYGPAVDWWAMGVLLYEMLC 219
Query: 351 GCPPFPTKQEKEVPKAYIANERPPF 375
G PF + E ++ +A I N+ +
Sbjct: 220 GHAPFEAENEDDLFEA-ILNDEVVY 243
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 36/117 (30%), Positives = 48/117 (41%), Gaps = 9/117 (7%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A + ++ LL G DV+ +D LH A G +V LLL GA V+ D
Sbjct: 62 LHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMD 121
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKPSTA------PMHV---QNAREVPEYEID 148
W TPL +A +V LL HGA P+ + + RE YE
Sbjct: 122 LWQFTPLHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEFK 178
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 34/88 (38%), Positives = 50/88 (56%), Gaps = 1/88 (1%)
Query: 41 LMYMANEGDLDGIKELLDS-GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPE 99
L+ A G+ + + LL + + D K T LH+AA R +V+LLL GADV +
Sbjct: 28 LLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAK 87
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGA 127
D+ G PL +A Y H++V +LL +HGA
Sbjct: 88 DKGGLVPLHNACSYGHYEVTELLLKHGA 115
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 24/87 (27%), Positives = 39/87 (44%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L + G + + LL G VN D+ + T LH AA + R +V LLLS GAD +
Sbjct: 95 LHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAASKNRVEVCSLLLSHGADPTLVN 154
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
G + + A + + + + +
Sbjct: 155 CHGKSAVDMAPTPELRERLTYEFKGHS 181
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 30/116 (25%), Positives = 45/116 (38%), Gaps = 11/116 (9%)
Query: 41 LMYMANEGDLDGI---KELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVD 97
L + LL G +VN ++ D T LHVAA + DV+ +L GA ++
Sbjct: 215 LHCAVASLHPKRKQVAELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMN 274
Query: 98 PEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTA------PMHVQNAREVPEYEI 147
D G T L A H +LL +G+ PS + E + +
Sbjct: 275 ALDSLGQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQM--GNEAVQQIL 328
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 2e-22
Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQG---RTDVVRLLLSRGADVD 97
L+ A E DL +K+ L + TALH A R V LLL +GA+V+
Sbjct: 182 LLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVAELLLRKGANVN 241
Query: 98 PEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+++ TPL A H+DV+++L +HGAK
Sbjct: 242 EKNKDFMTPLHVAAERAHNDVMEVLHKHGAKM 273
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 2e-19
Identities = 21/76 (27%), Positives = 30/76 (39%), Gaps = 1/76 (1%)
Query: 53 IKELLDSGTDVNFRDIDKRTALHVAACQG-RTDVVRLLLSRGADVDPEDRWGSTPLADAV 111
+L D K+ L AA G ++ LL + D STPL A
Sbjct: 7 ALDLADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAA 66
Query: 112 YYKHHDVIKLLEEHGA 127
Y +++LL +HGA
Sbjct: 67 GYNRVRIVQLLLQHGA 82
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 2e-19
Identities = 23/89 (25%), Positives = 33/89 (37%), Gaps = 5/89 (5%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A D ++ L G +N D +TALH AA G RLLLS G+D
Sbjct: 251 LHVAAERAHNDVMEVLHKHGAKMNALDSLGQTALHRAALAGHLQTCRLLLSYGSDPSIIS 310
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
G T ++ ++ +
Sbjct: 311 LQGFTAAQMG-----NEAVQQILSESTPM 334
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 19/113 (16%), Positives = 37/113 (32%), Gaps = 24/113 (21%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVA---------------------AC 79
L A++ ++ LL G D + ++A+ +A A
Sbjct: 128 LHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEFKGHSLLQAAR 187
Query: 80 QGRTDVVRLLLSRGADVDPEDRWGSTPL---ADAVYYKHHDVIKLLEEHGAKP 129
+ V+ L+ + + T L +++ K V +LL GA
Sbjct: 188 EADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVAELLLRKGANV 240
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 15/68 (22%), Positives = 24/68 (35%), Gaps = 5/68 (7%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G L + LL G+D + + TA + + V+ +LS + D
Sbjct: 284 LHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMGN-----EAVQQILSESTPMRTSD 338
Query: 101 RWGSTPLA 108
A
Sbjct: 339 VDYRLLEA 346
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 45.9 bits (110), Expect = 1e-05
Identities = 7/48 (14%), Positives = 15/48 (31%), Gaps = 3/48 (6%)
Query: 81 GRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHD-VIKLLEEHGA 127
G++ L A + L +A + + ++ LL
Sbjct: 4 GKS--ALDLADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNV 49
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 47/206 (22%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFID------ELALLQKIRHPNVVQFLGAVTQSTPMM-- 223
G VA+K K D EL +++K+ H N+V+ S
Sbjct: 79 GELVAIK-------------KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125
Query: 224 ----IVTEYLPKGDLRAYLKQKGALK---PTLAVK-FALDIARGMNYLHENRPEAIIHRD 275
+V +Y+P+ + + K P + VK + + R + Y+H I HRD
Sbjct: 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRD 181
Query: 276 LEPSNILRD-DSGHLKVADFGLSKLLKFANTVKEDRPVT---CEETSWRYAAPEV-YKNE 330
++P N+L D D+ LK+ DFG +K L P C + + Y APE+ +
Sbjct: 182 IKPQNLLLDPDTAVLKLCDFGSAKQLV------RGEPNVSYIC--SRY-YRAPELIFGAT 232
Query: 331 EYDTKVDVFSFALILQEMIEGCPPFP 356
+Y + +DV+S +L E++ G P FP
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQPIFP 258
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 57/227 (25%), Positives = 100/227 (44%), Gaps = 26/227 (11%)
Query: 162 KGTF------RIASWRGTQV--AVKTLG-EEVFTDEDKVKAFIDELALLQKIRHPNVVQF 212
KG + R + T A+K L + + E +L++++HP +V
Sbjct: 27 KGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDL 86
Query: 213 LGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAII 272
+ A + ++ EYL G+L L+++G A + +I+ + +LH+ II
Sbjct: 87 IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GII 143
Query: 273 HRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT-C---EETSWRYAAPEVYK 328
+RDL+P NI+ + GH+K+ DFGL K + T C E Y APE+
Sbjct: 144 YRDLKPENIMLNHQGHVKLTDFGLCKE----SIHDGTVTHTFCGTIE-----YMAPEILM 194
Query: 329 NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPF 375
++ VD +S ++ +M+ G PPF + K+ I +
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK-ILKCKLNL 240
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 73/253 (28%), Positives = 115/253 (45%), Gaps = 30/253 (11%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDE-LALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
AVK L ++ + + K + E LL+ ++HP +V + + + V +Y+ G+L
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126
Query: 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294
+L+++ A +A +IA + YLH I++RDL+P NIL D GH+ + DF
Sbjct: 127 FYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDF 183
Query: 295 GLSKLLKFANTVKEDRPVT-C---EETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE 350
GL K N T C E Y APEV + YD VD + +L EM+
Sbjct: 184 GLCKE----NIEHNSTTSTFCGTPE-----YLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 234
Query: 351 GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410
G PPF ++ E+ I N+ + T+ A R L+E ++ + R
Sbjct: 235 GLPPFYSRNTAEMYDN-ILNKPLQLKPNITNSA---RHLLEGLLQKDRTK---------R 281
Query: 411 LDDISDQLSIKRH 423
L D + IK H
Sbjct: 282 LGAKDDFMEIKSH 294
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 1/90 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
++ G + +EL+++G DV D + T LH AA R D+V+ +S+GA VD
Sbjct: 13 IVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLG 72
Query: 101 R-WGSTPLADAVYYKHHDVIKLLEEHGAKP 129
STPL A H ++ L ++GA P
Sbjct: 73 GDLNSTPLHWATRQGHLSMVVQLMKYGADP 102
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 98.7 bits (247), Expect = 7e-24
Identities = 32/90 (35%), Positives = 43/90 (47%), Gaps = 2/90 (2%)
Query: 41 LMYMANEG-DLDGIKELLDSGTDVNFRD-IDKRTALHVAACQGRTDVVRLLLSRGADVDP 98
LM+ A +D + LL VN D K TALH A G T V+ LLL GA+VD
Sbjct: 146 LMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGANVDA 205
Query: 99 EDRWGSTPLADAVYYKHHDVIKLLEEHGAK 128
++ G + L A K+ +I L+E
Sbjct: 206 QNIKGESALDLAKQRKNVWMINHLQEARQA 235
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 96.7 bits (242), Expect = 4e-23
Identities = 24/88 (27%), Positives = 36/88 (40%), Gaps = 1/88 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDK-RTALHVAACQGRTDVVRLLLSRGADVDPE 99
L + A +D +K + G V+ D T LH A QG +V L+ GAD
Sbjct: 46 LHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLI 105
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGA 127
D G + + A + H ++ L G
Sbjct: 106 DGEGCSCIHLAAQFGHTSIVAYLIAKGQ 133
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 96.3 bits (241), Expect = 5e-23
Identities = 29/88 (32%), Positives = 45/88 (51%), Gaps = 1/88 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L + +G L + +L+ G D + D + + +H+AA G T +V L+++G DVD D
Sbjct: 80 LHWATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMD 139
Query: 101 RWGSTPLADAVYYKHH-DVIKLLEEHGA 127
+ G TPL A Y H D +LL
Sbjct: 140 QNGMTPLMWAAYRTHSVDPTRLLLTFNV 167
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 84.0 bits (209), Expect = 1e-18
Identities = 16/65 (24%), Positives = 23/65 (35%)
Query: 63 VNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLL 122
+ D + A G + R L+ G DV D+ T L A D++K
Sbjct: 2 MTHIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYY 61
Query: 123 EEHGA 127
GA
Sbjct: 62 ISKGA 66
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 62.8 bits (154), Expect = 2e-11
Identities = 14/71 (19%), Positives = 28/71 (39%), Gaps = 6/71 (8%)
Query: 27 DDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVV 86
D + A L + G+ I LL++G +V+ ++I +AL +A + ++
Sbjct: 173 DKYHKNTA------LHWAVLAGNTTVISLLLEAGANVDAQNIKGESALDLAKQRKNVWMI 226
Query: 87 RLLLSRGADVD 97
L
Sbjct: 227 NHLQEARQAKG 237
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 29/206 (14%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI--VTEYL 229
A+K + + E+ALL++++HPNV+ + + +Y
Sbjct: 48 DKDYALKQIEGTGISMSA-----CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 102
Query: 230 PKGDLRAYLKQKGALKPTLA--------VK-FALDIARGMNYLHENRPEAIIHRDLEPSN 280
DL +K A K VK I G++YLH N ++HRDL+P+N
Sbjct: 103 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPAN 158
Query: 281 IL----RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCE-ETSWRYAAPEV-YKNEEYDT 334
IL + G +K+AD G ++L F + +K + T W Y APE+ Y
Sbjct: 159 ILVMGEGPERGRVKIADMGFARL--FNSPLKPLADLDPVVVTFW-YRAPELLLGARHYTK 215
Query: 335 KVDVFSFALILQEMIEGCPPFPTKQE 360
+D+++ I E++ P F +QE
Sbjct: 216 AIDIWAIGCIFAELLTSEPIFHCRQE 241
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-26
Identities = 35/106 (33%), Positives = 46/106 (43%), Gaps = 8/106 (7%)
Query: 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTD 84
AD ++ A + D + +LL DV+ D + RTAL A G
Sbjct: 38 ADVVSEYETP------WWTAARKADEQALSQLL-EDRDVDAVDENGRTALLFVAGLGSDK 90
Query: 85 VVRLLLSRGADVDPED-RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
VRLL GAD+D D R G T L A Y +V++ L E GA
Sbjct: 91 CVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADI 136
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 5e-24
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 1/89 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDI-DKRTALHVAACQGRTDVVRLLLSRGADVDPE 99
L+++A G ++ L ++G D++ RD+ TALH+AA R +VV L+ GAD++ E
Sbjct: 80 LLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVE 139
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGAK 128
D G T L A + G +
Sbjct: 140 DERGLTALELAREILKTTPKGNPMQFGRR 168
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 87.9 bits (219), Expect = 1e-20
Identities = 20/87 (22%), Positives = 26/87 (29%), Gaps = 4/87 (4%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
+ +G DV T AA + + LL DVD D
Sbjct: 18 YLIEWKDGHSPSWVPSSYIAADVVSEY---ETPWWTAARKADEQALSQLLE-DRDVDAVD 73
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
G T L ++LL E GA
Sbjct: 74 ENGRTALLFVAGLGSDKCVRLLAEAGA 100
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 2e-15
Identities = 16/85 (18%), Positives = 27/85 (31%), Gaps = 17/85 (20%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A + ++ L++ G D+ D TAL +A +T + G +
Sbjct: 114 LHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIG--- 170
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEH 125
VI +LE
Sbjct: 171 --------------LEKVINVLEGQ 181
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 4e-11
Identities = 9/59 (15%), Positives = 13/59 (22%), Gaps = 4/59 (6%)
Query: 69 DKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ + G + ADV E TP A + L
Sbjct: 13 EGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPWWTAARKADEQALSQL-LEDR 67
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 159 EITKGTF---RIASWRGT--QVAVKT-----LGEEVFTDEDKVKAFIDELALLQKIR-HP 207
I +G R R T + AVK E+ +A E +L+++ HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 208 NVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENR 267
+++ + + S+ M +V + + KG+L YL +K AL + +++LH N
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN 220
Query: 268 PEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEV- 326
I+HRDL+P NIL DD+ ++++DFG S L+ ++E C + Y APE+
Sbjct: 221 ---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE----LC--GTPGYLAPEIL 271
Query: 327 -----YKNEEYDTKVDVFSFALILQEMIEGCPPF 355
+ Y +VD+++ +IL ++ G PPF
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-26
Identities = 28/88 (31%), Positives = 43/88 (48%), Gaps = 2/88 (2%)
Query: 41 LMYMANEGDLDGIKELLDS-GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPE 99
L A GD+ ++ LL + + +TAL V G T + LL +GA + +
Sbjct: 6 LSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASPNVQ 64
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGA 127
D G++P+ DA D +K+L EHGA
Sbjct: 65 DTSGTSPVHDAARTGFLDTLKVLVEHGA 92
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 97.1 bits (243), Expect = 4e-24
Identities = 27/85 (31%), Positives = 38/85 (44%), Gaps = 1/85 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L M G ELL G N +D + +H AA G D +++L+ GADV+ D
Sbjct: 40 LQVMMF-GSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPD 98
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEH 125
G+ P+ AV H V+ L
Sbjct: 99 GTGALPIHLAVQEGHTAVVSFLAAE 123
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 94.0 bits (235), Expect = 4e-23
Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 1/85 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
+ A G LD +K L++ G DVN D +H+A +G T VV L + +D+ D
Sbjct: 72 VHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLAA-ESDLHRRD 130
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEH 125
G TPL A+ D++ +L+ H
Sbjct: 131 ARGLTPLELALQRGAQDLVDILQGH 155
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 67.1 bits (165), Expect = 2e-13
Identities = 17/59 (28%), Positives = 24/59 (40%), Gaps = 2/59 (3%)
Query: 72 TALHVAACQGRTDVVR-LLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
L AA +G VR LL D +R+G T L + + + L + GA P
Sbjct: 4 DRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASP 61
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 100 bits (253), Expect = 6e-26
Identities = 42/87 (48%), Positives = 56/87 (64%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G L+ +K LL++G DVN +D + RT LH+AA G +VV+LLL GADV+ +D
Sbjct: 6 LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKD 65
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ G TPL A H +V+KLL E GA
Sbjct: 66 KNGRTPLHLAARNGHLEVVKLLLEAGA 92
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 99.0 bits (248), Expect = 3e-25
Identities = 42/87 (48%), Positives = 56/87 (64%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G L+ +K LL++G DVN +D + RT LH+AA G +VV+LLL GADV+ +D
Sbjct: 39 LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKD 98
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ G TPL A H +V+KLL E GA
Sbjct: 99 KNGRTPLHLAARNGHLEVVKLLLEAGA 125
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 80.5 bits (200), Expect = 1e-18
Identities = 30/59 (50%), Positives = 39/59 (66%)
Query: 69 DKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ RT LH+AA G +VV+LLL GADV+ +D+ G TPL A H +V+KLL E GA
Sbjct: 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 59
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-26
Identities = 32/142 (22%), Positives = 56/142 (39%), Gaps = 16/142 (11%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L + EG ++ L+ G +N + T LH+AA G D+V+ LL AD++ +
Sbjct: 43 LHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVN 102
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKPSTA------PMHV---QNAREVPEYEIDPKE 151
G+ PL A ++ V + L +GA S P+ + E
Sbjct: 103 EHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPVDKAKAPLRELLRERAE---- 158
Query: 152 LDFSNSVEITKGTFRIASWRGT 173
+ + ++ W+GT
Sbjct: 159 ---KMGQNLNRIPYKDTFWKGT 177
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 100 bits (253), Expect = 3e-25
Identities = 27/103 (26%), Positives = 49/103 (47%), Gaps = 7/103 (6%)
Query: 28 DADGSEAIDPRVRLMYMANEGDLDGIKELLDSG-TDVNFRDIDKRTALHVAACQGRTDVV 86
+ + + EG+ ++ LD+ D+N D + LH A +GR+ VV
Sbjct: 2 SPEFMDD------IFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVV 55
Query: 87 RLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+L+ RGA ++ +R TPL A + H D+++ L ++ A
Sbjct: 56 EMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADI 98
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 71/336 (21%), Positives = 133/336 (39%), Gaps = 44/336 (13%)
Query: 91 SRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNAREVP---EYEI 147
SR + ++ W + L + + K L + A P+ + A++ Y +
Sbjct: 32 SRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTV 91
Query: 148 DPKELDFSNSVEITKGTF---RIASWRGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
E + G F T ++A K + D+++VK +E++++
Sbjct: 92 SKTE-------ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMN 141
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMN 261
++ H N++Q A +++V EY+ G+L + + L + F I G+
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIR 201
Query: 262 YLHENRPEAIIHRDLEPSNIL--RDDSGHLKVADFGLSKLLKFANTVKEDRPVTC---EE 316
++H+ I+H DL+P NIL D+ +K+ DFGL++ K +K V E
Sbjct: 202 HMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK----VNFGTPE- 253
Query: 317 TSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPF--PTKQE--KEVPKAYIANER 372
+ APEV + D++S +I ++ G PF E + E
Sbjct: 254 ----FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED 309
Query: 373 PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
F+ + A +E I +E R + + L
Sbjct: 310 EEFQD-ISEEA---KEFISKLLIKEKSWRISASEAL 341
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-26
Identities = 27/109 (24%), Positives = 43/109 (39%), Gaps = 6/109 (5%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRT-ALHVAACQGRTDVVRLLLSRGADVDPE 99
+ M G + LL G + N D T +H AA +G D + +L GA +D
Sbjct: 49 IQVMMM-GSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVR 107
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTA-PMHV---QNAREVPE 144
D WG P+ A H DV + L + + + ++P+
Sbjct: 108 DAWGRLPVDLAEELGHRDVARYLRAAAGGTRGSNHARIDAAEGPSDIPD 156
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 5e-24
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 2/90 (2%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G ++ ++ LL++G + N + R + V G V LLL GA+ + D
Sbjct: 16 LATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCAD 74
Query: 101 RWGST-PLADAVYYKHHDVIKLLEEHGAKP 129
T P+ DA D + +L GA+
Sbjct: 75 PATLTRPVHDAAREGFLDTLVVLHRAGARL 104
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 2e-19
Identities = 23/87 (26%), Positives = 37/87 (42%), Gaps = 10/87 (11%)
Query: 57 LDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHH 116
++ + L AA +GR + VR LL GA+ + + +G P+ +
Sbjct: 1 MEPAAGSS--MEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSA 57
Query: 117 DVIKLLEEHGAKP-------STAPMHV 136
V +LL HGA+P T P+H
Sbjct: 58 RVAELLLLHGAEPNCADPATLTRPVHD 84
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 162 KGTF------RIASWRGTQV--AVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
+G+F + S + A+K L + D+V+ + E +L ++ HP +V+
Sbjct: 34 QGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVNHPFIVKLH 92
Query: 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIH 273
A + ++ ++L GDL L ++ + ++A +++LH II+
Sbjct: 93 YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIY 149
Query: 274 RDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT-C---EETSWRYAAPEVYKN 329
RDL+P NIL D+ GH+K+ DFGLSK + E + + C E Y APEV
Sbjct: 150 RDLKPENILLDEEGHIKLTDFGLSKE----SIDHEKKAYSFCGTVE-----YMAPEVVNR 200
Query: 330 EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPF 375
+ D +SF +++ EM+ G PF K KE I +
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM-ILKAKLGM 245
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 50/244 (20%), Positives = 104/244 (42%), Gaps = 23/244 (9%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G K + D+ VK +E++++ ++ HP ++ A M+++ E+L
Sbjct: 76 GRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 232 GDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL--RDDSGH 288
G+L + + + + + G+ ++HE+ I+H D++P NI+ +
Sbjct: 133 GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASS 189
Query: 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEM 348
+K+ DFGL+ L D V + +AAPE+ E D+++ ++ +
Sbjct: 190 VKIIDFGLATKL------NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVL 243
Query: 349 IEGCPPF--PTKQE--KEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTF 404
+ G PF E + V + + F + + A ++ I++ +EP +R T
Sbjct: 244 LSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS-VSPEA---KDFIKNLLQKEPRKRLTV 299
Query: 405 RQIL 408
L
Sbjct: 300 HDAL 303
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 162 KGTFR---IASWRGTQV--AVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGA 215
+G++ + + T A+K + +E+ D++ + E + ++ HP +V
Sbjct: 19 RGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 78
Query: 216 VTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRD 275
+ + V EY+ GDL +++++ L A ++ +I+ +NYLHE II+RD
Sbjct: 79 FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRD 135
Query: 276 LEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT-C---EETSWRYAAPEVYKNEE 331
L+ N+L D GH+K+ D+G+ K D T C Y APE+ + E+
Sbjct: 136 LKLDNVLLDSEGHIKLTDYGMCKE----GLRPGDTTSTFCGTPN-----YIAPEILRGED 186
Query: 332 YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKA 366
Y VD ++ +++ EM+ G PF + P
Sbjct: 187 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 55/252 (21%), Positives = 110/252 (43%), Gaps = 32/252 (12%)
Query: 122 LEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVEITKGTF---RIASWRGTQ--VA 176
++E AK + ++D F + G+F + + + A
Sbjct: 15 VKEFLAKAKEDFLKKWETPSQNTAQLD----QFDRIKTLGTGSFGRVMLVKHKESGNHYA 70
Query: 177 VKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRA 236
+K L ++ +++ ++E +LQ + P +V+ + ++ + +V EY+ G++ +
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 237 YLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGL 296
+L++ G A +A I YLH +I+RDL+P N+L D G+++V DFG
Sbjct: 131 HLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 297 SKLLKFANTVKEDRPVTCEETSW------RYAAPEVYKNEEYDTKVDVFSFALILQEMIE 350
+K + +W APE+ ++ Y+ VD ++ +++ EM
Sbjct: 188 AK--------------RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 351 GCPPFPTKQEKE 362
G PPF Q +
Sbjct: 234 GYPPFFADQPIQ 245
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-26
Identities = 58/244 (23%), Positives = 104/244 (42%), Gaps = 23/244 (9%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G A K + +D++ V+ E+ + +RHP +V A M+++ E++
Sbjct: 182 GNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238
Query: 232 GDL-RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL--RDDSGH 288
G+L + + AV++ + +G+ ++HEN +H DL+P NI+ S
Sbjct: 239 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNE 295
Query: 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEM 348
LK+ DFGL+ L +VK VT + +AAPEV + + D++S ++ +
Sbjct: 296 LKLIDFGLTAHLDPKQSVK----VTT--GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 349
Query: 349 IEGCPPF--PTKQE--KEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTF 404
+ G PF E + V + F + ++ I +P R T
Sbjct: 350 LSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG-ISEDG---KDFIRKLLLADPNTRMTI 405
Query: 405 RQIL 408
Q L
Sbjct: 406 HQAL 409
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 60/232 (25%), Positives = 97/232 (41%), Gaps = 18/232 (7%)
Query: 160 ITKGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLG 214
I +G F ++ + T+ A+K L + F +E ++ P VVQ
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 215 AVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHR 274
A + +V EY+P GDL + + A + ++ ++ +H IHR
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSM---GFIHR 192
Query: 275 DLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE---- 330
D++P N+L D SGHLK+ADFG + V+ D V + Y +PEV K++
Sbjct: 193 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD----YISPEVLKSQGGDG 248
Query: 331 EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382
Y + D +S + L EM+ G PF I N + P +
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK-IMNHKNSLTFPDDND 299
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-25
Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 6/101 (5%)
Query: 27 DDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVV 86
+D + L+ A G D ++ L+ +G DVN D T LH+AA G ++V
Sbjct: 10 HGSDLGKK------LLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIV 63
Query: 87 RLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+LL GADV+ D G TPL A + H +++++L ++GA
Sbjct: 64 EVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGA 104
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-25
Identities = 33/87 (37%), Positives = 50/87 (57%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G L+ ++ LL +G DVN D T L +AA G ++V +LL GADV+ D
Sbjct: 51 LHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNAND 110
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
G TPL A + H +++++L ++GA
Sbjct: 111 MEGHTPLHLAAMFGHLEIVEVLLKNGA 137
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 98.6 bits (247), Expect = 1e-24
Identities = 29/85 (34%), Positives = 51/85 (60%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G L+ ++ LL +G DVN D++ T LH+AA G ++V +LL GADV+ +D
Sbjct: 84 LRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQD 143
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEH 125
++G T ++ + D+ ++L++
Sbjct: 144 KFGKTAFDISIDNGNEDLAEILQKL 168
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 29/88 (32%), Positives = 45/88 (51%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G +D L+ +G +++ D+RT L AA + V+ L+ GA VDP+D
Sbjct: 15 LHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKD 74
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAK 128
GST L A H++V++ L +G
Sbjct: 75 AEGSTCLHLAAKKGHYEVVQYLLSNGQM 102
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 98.6 bits (247), Expect = 7e-24
Identities = 24/87 (27%), Positives = 42/87 (48%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
+++ +D +K LL G+D+N RD ++ LH AA G D+ +LL+ D+ +
Sbjct: 115 MIWATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVN 174
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
G +PL A +D + L +
Sbjct: 175 IHGDSPLHIAARENRYDCVVLFLSRDS 201
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 98.3 bits (246), Expect = 1e-23
Identities = 25/90 (27%), Positives = 43/90 (47%), Gaps = 1/90 (1%)
Query: 41 LMYMANEGDLDGIKELLDSG-TDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPE 99
L A +G + ++ LL +G DVN +D T + A D+V+LLLS+G+D++
Sbjct: 81 LHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIR 140
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
D + L A + D+ ++L
Sbjct: 141 DNEENICLHWAAFSGCVDIAEILLAAKCDL 170
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 97.9 bits (245), Expect = 1e-23
Identities = 26/87 (29%), Positives = 42/87 (48%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L + A G +D + LL + D++ +I + LH+AA + R D V L LSR +DV ++
Sbjct: 148 LHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLHIAARENRYDCVVLFLSRDSDVTLKN 207
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ G TPL A + +
Sbjct: 208 KEGETPLQCASLNSQVWSALQMSKALQ 234
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 92.5 bits (231), Expect = 1e-21
Identities = 21/66 (31%), Positives = 33/66 (50%)
Query: 62 DVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKL 121
+ +KR+ LH AA G D+ +L+ GA++D TPL +A H + +K
Sbjct: 3 NFKMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKY 62
Query: 122 LEEHGA 127
L + GA
Sbjct: 63 LIKAGA 68
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 61.3 bits (150), Expect = 6e-11
Identities = 11/55 (20%), Positives = 19/55 (34%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGAD 95
L A E D + L +DV ++ + T L A+ + + D
Sbjct: 181 LHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASLNSQVWSALQMSKALQD 235
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 41.2 bits (98), Expect = 3e-04
Identities = 9/34 (26%), Positives = 15/34 (44%)
Query: 94 ADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ E + +PL A H D+ +L + GA
Sbjct: 2 MNFKMEHQNKRSPLHAAAEAGHVDICHMLVQAGA 35
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 31/122 (25%), Positives = 58/122 (47%), Gaps = 9/122 (7%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
+ + GD + + LL+ G D+N+ ++D TALH A D+V+ L+ GA+++ D
Sbjct: 44 FLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPD 103
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKPSTA------PMHV---QNAREVPEYEIDPKE 151
G PL A + D+ + L GA P+ + + E+ + E++ +
Sbjct: 104 NEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVNRQG 163
Query: 152 LD 153
+D
Sbjct: 164 VD 165
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 8e-22
Identities = 26/102 (25%), Positives = 41/102 (40%), Gaps = 6/102 (5%)
Query: 28 DADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVR 87
D A D + L + TALHVAA +G T+V++
Sbjct: 163 GVDIEAA------RKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLK 216
Query: 88 LLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
LL+ DV+ +D G TPL A ++ + ++L E+
Sbjct: 217 LLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDM 258
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 93.3 bits (233), Expect = 2e-21
Identities = 23/88 (26%), Positives = 41/88 (46%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A +G + +K L+ + DVN +D D T LH AA G+ + R+L+ D++ +
Sbjct: 203 LHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVN 262
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAK 128
+ G T A + +L ++
Sbjct: 263 KVGQTAFDVADEDILGYLEELQKKQNLL 290
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 85.2 bits (212), Expect = 1e-18
Identities = 24/100 (24%), Positives = 36/100 (36%), Gaps = 7/100 (7%)
Query: 28 DADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVR 87
DA G ++ + + D A G T+ V
Sbjct: 5 DAKQKRN------EQLKRWIGSETDLEPPVVKRKKTKVKF-DDGAVFLAACSSGDTEEVL 57
Query: 88 LLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
LL RGAD++ + G T L A + D++K L E+GA
Sbjct: 58 RLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGA 97
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 5e-16
Identities = 15/87 (17%), Positives = 28/87 (32%), Gaps = 6/87 (6%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L E + ++ ++ +D A D + L S +
Sbjct: 143 LDIAEEEAMEELLQNEVNRQ------GVDIEAARKEEERIMLRDARQWLNSGHINDVRHA 196
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ G T L A + +V+KLL +
Sbjct: 197 KSGGTALHVAAAKGYTEVLKLLIQARY 223
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 69.8 bits (172), Expect = 1e-13
Identities = 10/67 (14%), Positives = 21/67 (31%), Gaps = 1/67 (1%)
Query: 63 VNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLL 122
+ D ++ + G + + + + G+ LA A + + L
Sbjct: 1 MKMADAKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFLA-ACSSGDTEEVLRL 59
Query: 123 EEHGAKP 129
E GA
Sbjct: 60 LERGADI 66
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 6e-07
Identities = 13/69 (18%), Positives = 24/69 (34%), Gaps = 6/69 (8%)
Query: 28 DADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVR 87
D DG L A+ G + + L+++ D+ + +TA VA +
Sbjct: 229 DYDGWTP------LHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADEDILGYLEE 282
Query: 88 LLLSRGADV 96
L +
Sbjct: 283 LQKKQNLLH 291
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-25
Identities = 25/88 (28%), Positives = 36/88 (40%), Gaps = 2/88 (2%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRT-ALHVAACQGRTDVVRLLLSRGADVDPE 99
+ M G + LL G + N D T +H AA +G D + +L GA +D
Sbjct: 49 IQVMMM-GSAQVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVC 107
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGA 127
D WG P+ A H D+ + L
Sbjct: 108 DAWGRLPVDLAEEQGHRDIARYLHAATG 135
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 98.7 bits (247), Expect = 6e-25
Identities = 26/88 (29%), Positives = 40/88 (45%), Gaps = 2/88 (2%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G ++ +++LL++G D N + R + V G V LLL GA+ + D
Sbjct: 16 LATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMM-MGSAQVAELLLLHGAEPNCAD 74
Query: 101 RWGST-PLADAVYYKHHDVIKLLEEHGA 127
T P+ DA D + +L GA
Sbjct: 75 PATLTRPVHDAAREGFLDTLVVLHRAGA 102
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 92.5 bits (231), Expect = 1e-22
Identities = 24/84 (28%), Positives = 37/84 (44%), Gaps = 8/84 (9%)
Query: 60 GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVI 119
++ L AA +G+ + VR LL GAD + +R+G P+ + V
Sbjct: 2 SPGIHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMM-MGSAQVA 60
Query: 120 KLLEEHGAKP-------STAPMHV 136
+LL HGA+P T P+H
Sbjct: 61 ELLLLHGAEPNCADPATLTRPVHD 84
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 69.0 bits (170), Expect = 2e-14
Identities = 16/55 (29%), Positives = 25/55 (45%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGAD 95
+ A EG LD + L +G ++ D R + +A QG D+ R L + D
Sbjct: 82 VHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLAEEQGHRDIARYLHAATGD 136
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-25
Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 29 ADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRL 88
+D + L+ A G D ++ L+ +G DVN +D T L++A G ++V +
Sbjct: 12 SDLGKK------LLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEV 65
Query: 89 LLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
LL GADV+ D G TPL A + H ++ ++L +HGA
Sbjct: 66 LLKNGADVNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGA 104
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 92.4 bits (231), Expect = 1e-22
Identities = 27/85 (31%), Positives = 47/85 (55%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L G L+ ++ LL +G DVN D T LH+AA G ++ +LL GADV+ +D
Sbjct: 51 LYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQD 110
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEH 125
++G T ++ + D+ ++L++
Sbjct: 111 KFGKTAFDISIGNGNEDLAEILQKL 135
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 55/201 (27%), Positives = 85/201 (42%), Gaps = 31/201 (15%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAF--IDELALLQKIRHPNVVQFLGAVTQSTP-------M 222
G VA+K +V +D + + L + HPN+VQ +
Sbjct: 48 GMSVAIK----KVI--QDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101
Query: 223 MIVTEYLPKGDLRAYLKQKGALK---PTLAVKFAL-DIARGMNYLHENRPEAIIHRDLEP 278
+V EY+P L + + P + +K L + R + LH + HRD++P
Sbjct: 102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKP 159
Query: 279 SNILRD-DSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS-WRYAAPEV-YKNEEYDTK 335
N+L + G LK+ DFG +K L P S + Y APE+ + N+ Y T
Sbjct: 160 HNVLVNEADGTLKLCDFGSAKKLS------PSEPNVAYICSRY-YRAPELIFGNQHYTTA 212
Query: 336 VDVFSFALILQEMIEGCPPFP 356
VD++S I EM+ G P F
Sbjct: 213 VDIWSVGCIFAEMMLGEPIFR 233
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 57/232 (24%), Positives = 98/232 (42%), Gaps = 21/232 (9%)
Query: 160 ITKGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLG 214
I +G F + + A+K L + + F +E +L +
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 215 AVTQSTPMMIVTEYLPKGDLRAYL-KQKGALKPTLAVKFALDIARGMNYLHENRPEAIIH 273
A + +V +Y GDL L K + L +A + ++ ++ +H+ +H
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVH 198
Query: 274 RDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV-TCEETSWRYAAPEVYKNEE- 331
RD++P NIL D +GH+++ADFG L TV+ V T + Y +PE+ + E
Sbjct: 199 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD-----YISPEILQAMEG 253
Query: 332 ----YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPT 379
Y + D +S + + EM+ G PF + E I N + F+ PT
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK-IMNHKERFQFPT 304
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 56/300 (18%), Positives = 116/300 (38%), Gaps = 40/300 (13%)
Query: 159 EITKGTF---RIASWRGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
++ +G F + K + + TD+ VK E+++L RH N++
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVK---KEISILNIARHRNILHLH 67
Query: 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQKGA-LKPTLAVKFALDIARGMNYLHENRPEAII 272
+ ++++ E++ D+ + L V + + + +LH + I
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IG 124
Query: 273 HRDLEPSNIL--RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE 330
H D+ P NI+ S +K+ +FG ++ L K T+ Y APEV++++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQL------KPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 331 EYDTKVDVFSFALILQEMIEGCPPF--PTKQE--KEVPKAYIANERPPFRAPTTHYAYGL 386
T D++S ++ ++ G PF T Q+ + + A + F+ + A
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE-ISIEA--- 234
Query: 387 RELIEDCWSEEPFRRPTFRQIL-----MRLDDISDQLSIKRHWKVGPLRCFQSLAALWKK 441
+ ++ +E R T + L + + I+ L+ + L KK
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT------LKHRRYYHTLIKK 288
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 31/89 (34%), Positives = 43/89 (48%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A EG ++ + LL+ T LHVAA G+ V LLL R A +
Sbjct: 117 LHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAG 176
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+ G TPL AV++ + D++KLL G P
Sbjct: 177 KNGLTPLHVAVHHNNLDIVKLLLPRGGSP 205
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 31/89 (34%), Positives = 45/89 (50%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L + G L +K LL G N ++ T LH+AA G T+V + LL A V+ +
Sbjct: 18 LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKA 77
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+ TPL A H +++KLL E+ A P
Sbjct: 78 KDDQTPLHCAARIGHTNMVKLLLENNANP 106
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 28/89 (31%), Positives = 41/89 (46%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A EG + + LL + N + T LH+ A +G V +L+ G VD
Sbjct: 249 LHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATT 308
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
R G TPL A +Y + ++K L +H A
Sbjct: 309 RMGYTPLHVASHYGNIKLVKFLLQHQADV 337
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 33/111 (29%), Positives = 52/111 (46%), Gaps = 3/111 (2%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L ++ G++ +K LL DVN + + LH AA QG TD+V LLL GA +
Sbjct: 315 LHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVS 374
Query: 101 RWGSTPLADAVYYKHHDVIKLLE---EHGAKPSTAPMHVQNAREVPEYEID 148
G+TPLA A + V +L+ + + + H + E + +D
Sbjct: 375 SDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSDKHRMSFPETVDEILD 425
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 28/89 (31%), Positives = 40/89 (44%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L + +LD +K LL G + + T LH+AA Q + +V R LL G + E
Sbjct: 183 LHVAVHHNNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSANAES 242
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
G TPL A H +++ LL A
Sbjct: 243 VQGVTPLHLAAQEGHAEMVALLLSKQANG 271
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 30/89 (33%), Positives = 45/89 (50%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L +A EG + L+ G V+ T LHVA+ G +V+ LL ADV+ +
Sbjct: 282 LHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKT 341
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+ G +PL A H D++ LL ++GA P
Sbjct: 342 KLGYSPLHQAAQQGHTDIVTLLLKNGASP 370
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 9e-25
Identities = 29/89 (32%), Positives = 40/89 (44%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G + +K LL++ + N T LH+AA +G + V LL + A
Sbjct: 84 LHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMT 143
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+ G TPL A Y V +LL E A P
Sbjct: 144 KKGFTPLHVAAKYGKVRVAELLLERDAHP 172
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 26/89 (29%), Positives = 36/89 (40%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G + + LL+ N + T LHVA D+V+LLL RG
Sbjct: 150 LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPA 209
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
G TPL A +V + L ++G
Sbjct: 210 WNGYTPLHIAAKQNQVEVARSLLQYGGSA 238
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 30/89 (33%), Positives = 41/89 (46%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G + K LL + VN + D +T LH AA G T++V+LLL A+ +
Sbjct: 51 LHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLAT 110
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
G TPL A H + + L E A
Sbjct: 111 TAGHTPLHIAAREGHVETVLALLEKEASQ 139
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 27/89 (30%), Positives = 43/89 (48%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A + ++ + LL G N + T LH+AA +G ++V LLLS+ A+ + +
Sbjct: 216 LHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGN 275
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+ G TPL H V +L +HG
Sbjct: 276 KSGLTPLHLVAQEGHVPVADVLIKHGVMV 304
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 23/70 (32%), Positives = 31/70 (44%)
Query: 60 GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVI 119
G T LHVA+ G +V+ LL RGA + + TPL A H +V
Sbjct: 4 GISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVA 63
Query: 120 KLLEEHGAKP 129
K L ++ AK
Sbjct: 64 KYLLQNKAKV 73
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 48.6 bits (117), Expect = 2e-06
Identities = 13/39 (33%), Positives = 17/39 (43%)
Query: 91 SRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
S G G TPL A + H ++K L + GA P
Sbjct: 2 SPGISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASP 40
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 52/196 (26%), Positives = 94/196 (47%), Gaps = 17/196 (8%)
Query: 176 AVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234
A++ + +E+ D++ + E + ++ HP +V + + V EY+ GDL
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140
Query: 235 RAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294
+++++ L A ++ +I+ +NYLHE II+RDL+ N+L D GH+K+ D+
Sbjct: 141 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 197
Query: 295 GLSKLLKFANTVKEDRPVT-C---EETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE 350
G+ K D T C Y APE+ + E+Y VD ++ +++ EM+
Sbjct: 198 GMCKE----GLRPGDTTSTFCGTPN-----YIAPEILRGEDYGFSVDWWALGVLMFEMMA 248
Query: 351 GCPPFPTKQEKEVPKA 366
G PF + P
Sbjct: 249 GRSPFDIVGSSDNPDQ 264
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 57/254 (22%), Positives = 105/254 (41%), Gaps = 38/254 (14%)
Query: 133 PMHVQNAREVPEYEIDPKELDFSNSVEITK-----GTF---RIASWRGT--QVAVKTLGE 182
H + EV +PK+ ++ +++K G R T + A+K L
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-- 62
Query: 183 EVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGA----VTQSTPMMIVTEYLPKGDLRAY 237
E+ + P++V L ++I+ E + G+L +
Sbjct: 63 ------YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSR 116
Query: 238 LKQKGALKPT--LAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL---RDDSGHLKVA 292
++++G T A + DI + +LH + I HRD++P N+L ++ LK+
Sbjct: 117 IQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLT 173
Query: 293 DFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGC 352
DFG +K N ++ C + Y APEV E+YD D++S +I+ ++ G
Sbjct: 174 DFGFAKETT-QNALQT----PC--YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF 226
Query: 353 PPFPTKQEKEVPKA 366
PPF + + +
Sbjct: 227 PPFYSNTGQAISPG 240
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 46/173 (26%), Positives = 83/173 (47%), Gaps = 23/173 (13%)
Query: 250 VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT-VKE 308
+ ++ +A+GM +L + IHRDL NIL + +K+ DFGL++ + V++
Sbjct: 196 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 309 DR---PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQ-EKEV 363
P+ ++ APE + Y + DV+SF ++L E+ G P+P + ++E
Sbjct: 253 GDARLPL-------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305
Query: 364 PKAYIANER--PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
+ R P Y + + DCW EP +RPTF +++ L ++
Sbjct: 306 CRRLKEGTRMRAPDYTTPEMY-----QTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 42/173 (24%), Positives = 62/173 (35%), Gaps = 23/173 (13%)
Query: 144 EYEIDPKELDFSNSVEITKGTF---RIASWRG-------TQVAVKTLGEEVFTDEDKVKA 193
++E L + +G F A G VAVK L E + +A
Sbjct: 16 KWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRA 71
Query: 194 FIDELALLQKI-RHPNVVQFLGAVTQ-STPMMIVTEYLPKGDLRAYLKQKGALKPTLAVK 251
+ EL +L I H NVV LGA T+ P+M++ E+ G+L YL+ K +
Sbjct: 72 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-------RNE 124
Query: 252 FALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304
F +G + I DL+ S + F K L
Sbjct: 125 FVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 162 KGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV 216
G+F + R A+K L +E+ +V+ DE +L + HP +++ G
Sbjct: 16 TGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF 75
Query: 217 TQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDL 276
+ + ++ +Y+ G+L + L++ +A +A ++ + YLH II+RDL
Sbjct: 76 QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDL 132
Query: 277 EPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT-C---EETSWRYAAPEVYKNEEY 332
+P NIL D +GH+K+ DFG +K + D T C + Y APEV + Y
Sbjct: 133 KPENILLDKNGHIKITDFGFAKYV-------PDVTYTLCGTPD-----YIAPEVVSTKPY 180
Query: 333 DTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
+ +D +SF +++ EM+ G PF +
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 17/195 (8%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIVTEYLP 230
+ AVK + ++ +V E+ +L + + H NV++ + + +V E +
Sbjct: 38 SQEYAVKIIEKQPGHIRSRVF---REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
Query: 231 KGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL---RDDSG 287
G + +++ ++ A D+A +++LH I HRDL+P NIL +
Sbjct: 95 GGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVS 151
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEET--SWRYAAPEV-----YKNEEYDTKVDVFS 340
+K+ DF L +K S Y APEV + YD + D++S
Sbjct: 152 PVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWS 211
Query: 341 FALILQEMIEGCPPF 355
+IL ++ G PPF
Sbjct: 212 LGVILYILLSGYPPF 226
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 27/87 (31%), Positives = 40/87 (45%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L D ++ LL G D R + T +AA G +++L LS+GADV+ D
Sbjct: 43 LHNAVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECD 102
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
+G T +A Y +K L + GA
Sbjct: 103 FYGFTAFMEAAVYGKVKALKFLYKRGA 129
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 102 bits (258), Expect = 5e-25
Identities = 30/88 (34%), Positives = 45/88 (51%), Gaps = 1/88 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDID-KRTALHVAACQGRTDVVRLLLSRGADVDPE 99
L+ D+D +++LL+ G +VNF++ + T LH A R D+V LLL GAD
Sbjct: 9 LIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLR 68
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ G+TP A ++KL GA
Sbjct: 69 KKNGATPFLLAAIAGSVKLLKLFLSKGA 96
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 97.9 bits (245), Expect = 4e-23
Identities = 27/94 (28%), Positives = 43/94 (45%), Gaps = 5/94 (5%)
Query: 41 LMYMANEGDLDGIKE----LLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSR-GAD 95
L++ D ++ LLD G DVN R +T L +A + +V+ LL + +
Sbjct: 186 LIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIE 245
Query: 96 VDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
++ D G T L AV K + +LL + GA
Sbjct: 246 INDTDSDGKTALLLAVELKLKKIAELLCKRGAST 279
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 5e-21
Identities = 32/98 (32%), Positives = 45/98 (45%), Gaps = 11/98 (11%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
+ A G + +K L G DVN D TA AA G+ ++ L RGA+V+
Sbjct: 76 FLLAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLRR 135
Query: 101 ----------RWGSTPLADAVYYKHHDVIK-LLEEHGA 127
+ G+T L DA H +V+K LL+E GA
Sbjct: 136 KTKEDQERLRKGGATALMDAAEKGHVEVLKILLDEMGA 173
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 90.2 bits (225), Expect = 2e-20
Identities = 35/93 (37%), Positives = 45/93 (48%), Gaps = 6/93 (6%)
Query: 41 LMYMANEGDLDGIKELLD-SGTDVNFRDIDKRTALHVAACQGRTD----VVRLLLSRGAD 95
LM A +G ++ +K LLD G DVN D R AL A + LLL GAD
Sbjct: 152 LMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGAD 211
Query: 96 VDPEDRWGSTPLADAVYYKHHDVIK-LLEEHGA 127
V+ G TPL AV KH +++ LLE+
Sbjct: 212 VNVRGERGKTPLILAVEKKHLGLVQRLLEQEHI 244
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 4e-17
Identities = 21/62 (33%), Positives = 33/62 (53%), Gaps = 1/62 (1%)
Query: 67 DIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDR-WGSTPLADAVYYKHHDVIKLLEEH 125
++ L A D+V+ LL GA+V+ ++ G TPL +AV D+++LL H
Sbjct: 2 AVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRH 61
Query: 126 GA 127
GA
Sbjct: 62 GA 63
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 71.7 bits (177), Expect = 3e-14
Identities = 18/61 (29%), Positives = 28/61 (45%), Gaps = 1/61 (1%)
Query: 41 LMYMANEGDLDGIKELLDS-GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPE 99
L+ + L ++ LL+ ++N D D +TAL +A + LL RGA D
Sbjct: 223 LILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCG 282
Query: 100 D 100
D
Sbjct: 283 D 283
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-25
Identities = 35/106 (33%), Positives = 46/106 (43%), Gaps = 8/106 (7%)
Query: 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTD 84
AD ++ A + D + +LL DV+ D + RTAL A G
Sbjct: 39 ADVVSEYETP------WWTAARKADEQALSQLL-EDRDVDAVDENGRTALLFVAGLGSDK 91
Query: 85 VVRLLLSRGADVDPED-RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
VRLL GAD+D D R G T L A Y +V++ L E GA
Sbjct: 92 CVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADI 137
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-24
Identities = 33/121 (27%), Positives = 52/121 (42%), Gaps = 10/121 (8%)
Query: 28 DADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDI-DKRTALHVAACQGRTDVV 86
D +G A L+++A G ++ L ++G D++ RD+ TALH+AA R +VV
Sbjct: 74 DENGRTA------LLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVV 127
Query: 87 RLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP---STAPMHVQNAREVP 143
L+ GAD++ ED G T L A + G + + E
Sbjct: 128 EALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEKVINVLEGQVFEYA 187
Query: 144 E 144
E
Sbjct: 188 E 188
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 9/61 (14%), Positives = 13/61 (21%), Gaps = 4/61 (6%)
Query: 69 DKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAK 128
+ + G + ADV E TP A + L
Sbjct: 14 EGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPWWTAARKADEQALSQL-LEDRD 69
Query: 129 P 129
Sbjct: 70 V 70
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 9/88 (10%), Positives = 19/88 (21%), Gaps = 11/88 (12%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L + G + + + +V ++ RG
Sbjct: 148 LELAREILKTTPKGNPMQFGRRIGLEKV---INVLEGQVFEYAEVDEIVEKRGK------ 198
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAK 128
G + D + H A+
Sbjct: 199 --GKDVEYLVRWKDGGDCEWVKGVHVAE 224
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-25
Identities = 29/87 (33%), Positives = 46/87 (52%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L+ + EG+ D ++ ++ D + + + TALH A C G T++V+ L+ G +V+ D
Sbjct: 41 LLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAAD 100
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
G TPL A + V K L E GA
Sbjct: 101 SDGWTPLHCAASCNNVQVCKFLVESGA 127
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-23
Identities = 29/135 (21%), Positives = 44/135 (32%), Gaps = 12/135 (8%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADV---D 97
L G + +K L+ G +VN D D T LH AA V + L+ GA V
Sbjct: 74 LHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMT 133
Query: 98 PEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP-------STAPMH--VQNAREVPEYEID 148
D + + + + + L K A QN E+P E D
Sbjct: 134 YSDMQTAADKCEEMEEGYTQCSQFLYGVQEKMGIMNKGVIYALWDYEPQNDDELPMKEGD 193
Query: 149 PKELDFSNSVEITKG 163
+ + +
Sbjct: 194 CMTIIHREDEDEIEW 208
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 5e-22
Identities = 20/100 (20%), Positives = 36/100 (36%), Gaps = 7/100 (7%)
Query: 28 DADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVR 87
+ G + L E + G V F L ++ +G D+V+
Sbjct: 2 EITGQVS------LPPGKRTNLRKTGSERIAHGMRVKFNP-LPLALLLDSSLEGEFDLVQ 54
Query: 88 LLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
++ D + G T L +AV H +++K L + G
Sbjct: 55 RIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGV 94
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-15
Identities = 9/66 (13%), Positives = 20/66 (30%), Gaps = 1/66 (1%)
Query: 67 DIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHG 126
+I + +L ++ G V + L D+ D+++ +
Sbjct: 2 EITGQVSLPPGKRTNLRKTGSERIAHGMRVK-FNPLPLALLLDSSLEGEFDLVQRIIYEV 60
Query: 127 AKPSTA 132
PS
Sbjct: 61 DDPSLP 66
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-25
Identities = 23/87 (26%), Positives = 42/87 (48%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L + A ++D LL +G + + ++ + T L +AA +G + ++LL A+ D D
Sbjct: 161 LHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRDITD 220
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
P A HHD+++LL+
Sbjct: 221 HMDRLPRDIAQERMHHDIVRLLDLEHH 247
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 99.8 bits (250), Expect = 4e-24
Identities = 27/87 (31%), Positives = 43/87 (49%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L+ A +++L++S DVN D ++ALH AA D +LL GA+ D ++
Sbjct: 128 LILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN 187
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
TPL A ++ K+L +H A
Sbjct: 188 NREETPLFLAAREGSYETAKVLLDHFA 214
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 3e-22
Identities = 22/88 (25%), Positives = 39/88 (44%), Gaps = 1/88 (1%)
Query: 41 LMYMANEGDLDGIKELLDSG-TDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPE 99
L + + L+ + TD++ R D T L +AA ++ L++ ADV+
Sbjct: 94 LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAV 153
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGA 127
D G + L A + D +L ++GA
Sbjct: 154 DDLGKSALHWAAAVNNVDAAVVLLKNGA 181
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 89.4 bits (223), Expect = 2e-20
Identities = 27/89 (30%), Positives = 38/89 (42%), Gaps = 1/89 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDV-NFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPE 99
E I + + G + N D TALH+AA R+D + LL AD + +
Sbjct: 27 GNSEEEEDAPAVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQ 86
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGAK 128
D G TPL AV V ++L + A
Sbjct: 87 DNMGRTPLHAAVSADAQGVFQILIRNRAT 115
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 8e-16
Identities = 25/82 (30%), Positives = 32/82 (39%), Gaps = 14/82 (17%)
Query: 62 DVNFRDIDKRTALHVAACQG-------------RTDVVRLLLSRGADVDPE-DRWGSTPL 107
DVN R D T L +A+C G V+ + +GA + + DR G T L
Sbjct: 2 DVNVRGPDGFTPLMIASCSGGGLETGNSEEEEDAPAVISDFIYQGASLHNQTDRTGETAL 61
Query: 108 ADAVYYKHHDVIKLLEEHGAKP 129
A Y D K L E A
Sbjct: 62 HLAARYSRSDAAKRLLEASADA 83
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 62.1 bits (152), Expect = 5e-11
Identities = 16/55 (29%), Positives = 22/55 (40%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGAD 95
L A EG + K LLD + + D R +A + D+VRLL
Sbjct: 194 LFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDLEHHH 248
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 43/234 (18%), Positives = 83/234 (35%), Gaps = 33/234 (14%)
Query: 174 QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM-----IVTEY 228
V +K L D + + E L ++ HP++VQ V + IV EY
Sbjct: 108 PVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY 165
Query: 229 LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288
+ L+ L A+ + L+I ++YLH +++ DL+P NI+ +
Sbjct: 166 VGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEEQ- 219
Query: 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEM 348
LK+ D G + + + + APE+ + D+++ L +
Sbjct: 220 LKLIDLGAVSRINSFGYLY---------GTPGFQAPEIVRTGP-TVATDIYTVGRTLAAL 269
Query: 349 IEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRP 402
P + +P+ + P + L+ +P +R
Sbjct: 270 TLDLPTRNGRYVDGLPE-----DDPVLKTYD-----SYGRLLRRAIDPDPRQRF 313
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 98.6 bits (247), Expect = 1e-24
Identities = 28/87 (32%), Positives = 42/87 (48%), Gaps = 1/87 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L M G+ + + LL G + + +D +H AA G D ++ LL ADV+ ED
Sbjct: 42 LQVMKL-GNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIED 100
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
G+ PL A H V++ L +H A
Sbjct: 101 NEGNLPLHLAAKEGHLRVVEFLVKHTA 127
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 97.5 bits (244), Expect = 3e-24
Identities = 31/87 (35%), Positives = 44/87 (50%), Gaps = 1/87 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A GDL+ + LL + +VN ++ RTAL V G ++ R LL RGA+ D +D
Sbjct: 9 LASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKD 67
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
R G + DA D ++ L E A
Sbjct: 68 RTGFAVIHDAARAGFLDTLQTLLEFQA 94
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 97.1 bits (243), Expect = 4e-24
Identities = 28/88 (31%), Positives = 44/88 (50%), Gaps = 1/88 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGA-DVDPE 99
+ A G LD ++ LL+ DVN D + LH+AA +G VV L+ A +V
Sbjct: 74 IHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHR 133
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ G T A Y ++V+ L++ +GA
Sbjct: 134 NHKGDTACDLARLYGRNEVVSLMQANGA 161
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 73.6 bits (182), Expect = 1e-15
Identities = 14/61 (22%), Positives = 26/61 (42%), Gaps = 1/61 (1%)
Query: 69 DKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAK 128
L AA +G + + LL +V+ ++ +G T L + ++ + L GA
Sbjct: 4 PWGNELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGAN 62
Query: 129 P 129
P
Sbjct: 63 P 63
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 98.2 bits (246), Expect = 1e-24
Identities = 31/87 (35%), Positives = 47/87 (54%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G + LL +G + R RT LH+AA +G ++V +LL GADV+ +D
Sbjct: 38 LHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKD 97
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
T L A + H +V++LL ++GA
Sbjct: 98 MLKMTALHWATEHNHQEVVELLIKYGA 124
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 95.5 bits (239), Expect = 1e-23
Identities = 25/87 (28%), Positives = 40/87 (45%), Gaps = 1/87 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L+ A G D ++ L+ +G D + LH+AA G +LL G D
Sbjct: 6 LLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDART 64
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ TPL A H +++++L +HGA
Sbjct: 65 KVDRTPLHMAASEGHANIVEVLLKHGA 91
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 93.6 bits (234), Expect = 7e-23
Identities = 28/83 (33%), Positives = 46/83 (55%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A+EG + ++ LL G DVN +D+ K TALH A +VV LL+ GADV +
Sbjct: 71 LHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQS 130
Query: 101 RWGSTPLADAVYYKHHDVIKLLE 123
++ T ++ + D+ ++L+
Sbjct: 131 KFCKTAFDISIDNGNEDLAEILQ 153
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 75.1 bits (186), Expect = 2e-16
Identities = 20/59 (33%), Positives = 28/59 (47%), Gaps = 1/59 (1%)
Query: 69 DKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
D L AA G+ D VR+L++ GA D G++PL A Y H ++L G
Sbjct: 1 DLGKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGV 58
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 99.4 bits (249), Expect = 2e-24
Identities = 16/87 (18%), Positives = 36/87 (41%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L + L D+ V+ D + T L++A ++ + L+ RGAD++ ++
Sbjct: 10 LEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQN 69
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
+P A +++ + +H
Sbjct: 70 SISDSPYLYAGAQGRTEILAYMLKHAT 96
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 2e-21
Identities = 28/91 (30%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 41 LMYMANEGDLDGIKELLDSGT-DVNFRDIDKRTALHVAAC-----QGRTDVVRLLLSRGA 94
L+ A +G +D +K LL+ G D++F++ TAL A Q D+V+LL+ GA
Sbjct: 110 LIPAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEAVGLREGNQLYQDIVKLLMENGA 169
Query: 95 DVDPEDRWGSTPLADAVYYKHHDVIKLLEEH 125
D +D G T + A + ++ K+L ++
Sbjct: 170 DQSIKDNSGRTAMDYANQKGYTEISKILAQY 200
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 89.0 bits (222), Expect = 9e-21
Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 41 LMYMANEGDLDGIKELLDSG-TDVNFRDIDKRTALHVAACQGRTDVVRLLLSRG-ADVDP 98
+Y +G + + +L D+N + AL AA +G D V+LLL G D+D
Sbjct: 76 YLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDF 135
Query: 99 EDRWGSTPLADAVYYK-----HHDVIKLLEEHGA 127
++ +G T L +AV + + D++KLL E+GA
Sbjct: 136 QNDFGYTALIEAVGLREGNQLYQDIVKLLMENGA 169
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 6e-18
Identities = 17/62 (27%), Positives = 26/62 (41%)
Query: 66 RDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEH 125
+ + L A + V +L VD D G+TPL AV+ ++ K L +
Sbjct: 2 KTYEVGALLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDR 61
Query: 126 GA 127
GA
Sbjct: 62 GA 63
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 54/194 (27%), Positives = 86/194 (44%), Gaps = 26/194 (13%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM------IV 225
G +VA+K L F E K EL LL+ ++H NV+ L T ++ + +V
Sbjct: 49 GEKVAIKKLSR-PFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107
Query: 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD 285
++ DL+ + K + +G+ Y+H ++HRDL+P N+ ++
Sbjct: 108 MPFMQT-DLQKIMGLK--FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNE 161
Query: 286 SGHLKVADFGLSKLLKFANT--VKEDRPVTCEETSWRYAAPEV-YKNEEYDTKVDVFSFA 342
LK+ DFGL++ T V T W Y APEV Y+ VD++S
Sbjct: 162 DCELKILDFGLARHADAEMTGYV---------VTRW-YRAPEVILSWMHYNQTVDIWSVG 211
Query: 343 LILQEMIEGCPPFP 356
I+ EM+ G F
Sbjct: 212 CIMAEMLTGKTLFK 225
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 98.2 bits (246), Expect = 2e-24
Identities = 31/89 (34%), Positives = 45/89 (50%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L + A + ++ LL G DV+ +D LH A G +V LL+ GA V+ D
Sbjct: 46 LHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVAD 105
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
W TPL +A +++ KLL +HGA P
Sbjct: 106 LWKFTPLHEAAAKGKYEICKLLLQHGADP 134
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 95.9 bits (240), Expect = 1e-23
Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 7/104 (6%)
Query: 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDS-GTDVNFRDIDKRTALHVAACQGRT 83
A +++ L+ A GD++ +K+L + + + T LH AA R
Sbjct: 2 AMGNSEADRQ------LLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRV 55
Query: 84 DVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
VV LL GADV +D+ G PL +A Y H++V +LL +HGA
Sbjct: 56 SVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGA 99
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 93.2 bits (233), Expect = 1e-22
Identities = 31/87 (35%), Positives = 45/87 (51%), Gaps = 1/87 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L + G + + L+ G VN D+ K T LH AA +G+ ++ +LLL GAD ++
Sbjct: 79 LHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKN 138
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
R G+TPL D V D+ LL A
Sbjct: 139 RDGNTPL-DLVKDGDTDIQDLLRGDAA 164
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 22/93 (23%), Positives = 34/93 (36%), Gaps = 3/93 (3%)
Query: 41 LMYMANEGDLDGIKELLDSGTD---VNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVD 97
L + LL ++ ++ +TALH+AA G V L + GA V
Sbjct: 13 LHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVL 72
Query: 98 PEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPS 130
+R G T L A + H +L +
Sbjct: 73 VAERGGHTALHLACRVRAHTCACVLLQPRPSHP 105
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 29/90 (32%), Positives = 41/90 (45%), Gaps = 1/90 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDK-RTALHVAACQGRTDVVRLLLSRGADVDPE 99
L D + ++ L D+G D+N + RT LH+A V+ LLL GAD
Sbjct: 162 LHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTAR 221
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
G TPL A+ + + +LL HGA
Sbjct: 222 MYGGRTPLGSALLRPNPILARLLRAHGAPE 251
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 4e-22
Identities = 27/96 (28%), Positives = 41/96 (42%), Gaps = 2/96 (2%)
Query: 36 DPRVRLMYMANEGDLDGIKELLDS-GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGA 94
+ + + + + + D T LHVA ++VRLL GA
Sbjct: 123 TSHAPAAVDSQPNPENEEEPRDEDWRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGA 182
Query: 95 DVD-PEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
D++ PE G TPL AV + V++LL + GA P
Sbjct: 183 DLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADP 218
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 4e-21
Identities = 18/86 (20%), Positives = 30/86 (34%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L ++ LL +G D R RT L A + + RLL + GA +
Sbjct: 196 LHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPEDG 255
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHG 126
+P + + D +E+
Sbjct: 256 GDKLSPCSSSGSDSDSDNRDEGDEYD 281
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 1e-17
Identities = 14/101 (13%), Positives = 28/101 (27%), Gaps = 14/101 (13%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G+ +++L +G V + TALH+A +LL +
Sbjct: 49 LHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDA 108
Query: 101 RWGSTPLAD--------------AVYYKHHDVIKLLEEHGA 127
+ + ++ E+
Sbjct: 109 SDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRDEDWRL 149
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 8e-17
Identities = 17/70 (24%), Positives = 25/70 (35%), Gaps = 3/70 (4%)
Query: 63 VNFRDIDKRTALHVAACQGRTDVVRLLLSRGAD---VDPEDRWGSTPLADAVYYKHHDVI 119
+ D TALH+A + LL A +D ++ G T L A +
Sbjct: 2 FGYVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTV 61
Query: 120 KLLEEHGAKP 129
+ L GA
Sbjct: 62 EKLYAAGAGV 71
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 56/191 (29%), Positives = 82/191 (42%), Gaps = 19/191 (9%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM------IV 225
VA+K L F ++ K EL L++ + H N++ L T + IV
Sbjct: 50 ERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108
Query: 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD 285
E + +L ++ + L + G+ +LH IIHRDL+PSNI+
Sbjct: 109 MELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 162
Query: 286 SGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALIL 345
LK+ DFGL A T +T + Y APEV Y VD++S I+
Sbjct: 163 DCTLKILDFGL------ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 216
Query: 346 QEMIEGCPPFP 356
EMI+G FP
Sbjct: 217 GEMIKGGVLFP 227
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 30/126 (23%), Positives = 48/126 (38%), Gaps = 11/126 (8%)
Query: 28 DADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVR 87
D + E + A +G D ++ L+++G ++ TALH+A G D +
Sbjct: 17 DDENMEK------IHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLACKFGCVDTAK 70
Query: 88 LLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHV---QNAREVPE 144
L S G G P+ AV D++ L E + P + + REV E
Sbjct: 71 YLASVGEVHSLWH--GQKPIHLAVMANKTDLVVALVEGAKERGQMPESLLNECDEREVNE 128
Query: 145 YEIDPK 150
K
Sbjct: 129 IGSHVK 134
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 20/107 (18%), Positives = 37/107 (34%), Gaps = 5/107 (4%)
Query: 41 LMYMANEGDLDGIKELLDS-----GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGAD 95
LM + + + ++D+ +++ + + LH A DV + G D
Sbjct: 177 LMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAILINWEDVAMRFVEMGID 236
Query: 96 VDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNAREV 142
V+ ED + PL +V + K L + N V
Sbjct: 237 VNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVFLIQACPYHNGTTV 283
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 17/102 (16%), Positives = 30/102 (29%), Gaps = 13/102 (12%)
Query: 41 LMYMANEGDLDGIKELLD-------------SGTDVNFRDIDKRTALHVAACQGRTDVVR 87
L + KELL +GT V + + AA + +V++
Sbjct: 248 LYLSVRAAMVLLTKELLQKTDVFLIQACPYHNGTTVLPDRVVWLDFVPAAADPSKQEVLQ 307
Query: 88 LLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
LL + +V G+ V ++ A
Sbjct: 308 LLQEKLDEVVRSLNTGAGGAVKRKKKAAPAVKRMKLAPSAPV 349
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 23/78 (29%), Positives = 34/78 (43%), Gaps = 1/78 (1%)
Query: 52 GIKELLD-SGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110
G + D + D + +HVAA +G+TD VR L+ G ++R+G T L A
Sbjct: 1 GPGSMTDFPKLNRIKSDDENMEKIHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLA 60
Query: 111 VYYKHHDVIKLLEEHGAK 128
+ D K L G
Sbjct: 61 CKFGCVDTAKYLASVGEV 78
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 18/121 (14%), Positives = 44/121 (36%), Gaps = 23/121 (19%)
Query: 41 LMYMANEGDLDGIKELLDSGTD---------------------VNFRDIDKRTALHVAAC 79
+ D + L++ + + + +TALH
Sbjct: 88 IHLAVMANKTDLVVALVEGAKERGQMPESLLNECDEREVNEIGSHVKHCKGQTALHWCVG 147
Query: 80 QG--RTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQ 137
G +++++L+ GA +D+ TPL A+ +++ + + L+ + S+ +
Sbjct: 148 LGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYA 207
Query: 138 N 138
N
Sbjct: 208 N 208
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 4e-15
Identities = 10/77 (12%), Positives = 23/77 (29%)
Query: 32 SEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLS 91
+ + + A+ + ++ L + +V + V R+ L+
Sbjct: 285 PDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSLNTGAGGAVKRKKKAAPAVKRMKLA 344
Query: 92 RGADVDPEDRWGSTPLA 108
A V R + A
Sbjct: 345 PSAPVRTRSRSRARSSA 361
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 2e-04
Identities = 7/42 (16%), Positives = 12/42 (28%)
Query: 88 LLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+ + D + A D ++ L E G P
Sbjct: 5 MTDFPKLNRIKSDDENMEKIHVAARKGQTDEVRRLIETGVSP 46
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 7e-04
Identities = 4/37 (10%), Positives = 10/37 (27%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVA 77
+ + + L V R + + V+
Sbjct: 327 AVKRKKKAAPAVKRMKLAPSAPVRTRSRSRARSSAVS 363
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 5e-24
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTD 84
+ +D + L+ A G D ++ L+ +G DV +D + T LH+AA G +
Sbjct: 18 SHMGSDLGKK------LLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLE 71
Query: 85 VVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLE 123
VV+LLL GADV +D++G T ++ + D+ ++L+
Sbjct: 72 VVKLLLEAGADVXAQDKFGKTAFDISIDNGNEDLAEILQ 110
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 8e-24
Identities = 30/83 (36%), Positives = 43/83 (51%), Gaps = 3/83 (3%)
Query: 45 ANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGS 104
++ L+ G+ + D L AA G+ D VR+L++ GADV +D+ GS
Sbjct: 2 SSHHHHHHSSGLVPRGSHMG---SDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGS 58
Query: 105 TPLADAVYYKHHDVIKLLEEHGA 127
TPL A H +V+KLL E GA
Sbjct: 59 TPLHLAARNGHLEVVKLLLEAGA 81
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 5e-12
Identities = 10/51 (19%), Positives = 19/51 (37%), Gaps = 3/51 (5%)
Query: 77 AACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ L+ RG+ + D L +A D +++L +GA
Sbjct: 1 GSSHHHHHHSSGLVPRGSHMG-SD--LGKKLLEAARAGQDDEVRILMANGA 48
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 5e-24
Identities = 31/234 (13%), Positives = 67/234 (28%), Gaps = 39/234 (16%)
Query: 194 FIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY-LPKGD-------LRAYLKQKGALK 245
FI L++ + +++ + Y + + L ++ +L
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 204
Query: 246 PTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305
++ L + R + LH ++H L P +I+ D G + + F
Sbjct: 205 HHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL-------- 253
Query: 306 VKEDRPVTCEETSWRYAAPEVYKNEE-----------YDTKVDVFSFALILQEMIEGCPP 354
V++ V + + PE+ D ++ L++ + P
Sbjct: 254 VRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
Query: 355 FPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
+ R P +R L+E R Q +
Sbjct: 313 ITKDAALGGSEWIF---RSCKNIPQ-----PVRALLEGFLRYPKEDRLLPLQAM 358
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 23/87 (26%), Positives = 37/87 (42%), Gaps = 2/87 (2%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
Y + ++ + LL++G N + LH AA T +V++LL G D D
Sbjct: 35 SYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFD 92
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
G+T L AV + +KL +
Sbjct: 93 DKGNTALYYAVDSGNMQTVKLFVKKNW 119
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 4e-23
Identities = 21/88 (23%), Positives = 31/88 (35%), Gaps = 1/88 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A D +K LL SG D + D TAL+ A G V+L + + +
Sbjct: 66 LHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYG 125
Query: 101 RWG-STPLADAVYYKHHDVIKLLEEHGA 127
+ G T AV ++
Sbjct: 126 KTGWKTSFYHAVMLNDVSIVSYFLSEIP 153
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 19/85 (22%), Positives = 31/85 (36%), Gaps = 3/85 (3%)
Query: 45 ANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGS 104
N +K L S D D+ +A + A +V LL+ GA + +
Sbjct: 7 INTWKSKQLKSFL-SSKDTFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE--NE 63
Query: 105 TPLADAVYYKHHDVIKLLEEHGAKP 129
PL A + ++K+L G
Sbjct: 64 FPLHQAATLEDTKIVKILLFSGLDD 88
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 3e-21
Identities = 14/88 (15%), Positives = 32/88 (36%), Gaps = 2/88 (2%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDID-KRTALHVAACQGRTDVVRLLLSRGADVDPE 99
L Y + G++ +K + + F +T+ + A +V LS +
Sbjct: 99 LYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPSTF-D 157
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ + + H D++ LL ++
Sbjct: 158 LAILLSCIHITIKNGHVDMMILLLDYMT 185
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 4e-21
Identities = 13/93 (13%), Positives = 32/93 (34%), Gaps = 2/93 (2%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
+ D+ + L + +H+ G D++ LLL + +
Sbjct: 133 FYHAVMLNDVSIVSYFLSEIPSTF-DLAILLSCIHITIKNGHVDMMILLLDYMTSTNTNN 191
Query: 101 RWGSTP-LADAVYYKHHDVIKLLEEHGAKPSTA 132
P + A+ K ++++ L ++ +A
Sbjct: 192 SLLFIPDIKLAIDNKDIEMLQALFKYDINIYSA 224
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 3e-20
Identities = 12/90 (13%), Positives = 31/90 (34%), Gaps = 8/90 (8%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRT-ALHVAACQGRTDVVRLLLSRGADVDPE 99
+ G +D + LLD T N + + +A ++++ L ++
Sbjct: 165 IHITIKNGHVDMMILLLDYMTSTNTNNSLLFIPDIKLAIDNKDIEMLQALFKYDINIY-- 222
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+ + V ++ K++ E +
Sbjct: 223 -----SANLENVLLDDAEIAKMIIEKHVEY 247
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 1e-12
Identities = 5/92 (5%), Positives = 29/92 (31%), Gaps = 11/92 (11%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
+ + D++ ++ L ++ +A ++ ++++ + + +
Sbjct: 199 IKLAIDNKDIEMLQALFKYDINIY-------SANLENVLLDDAEIAKMIIEKHVEYKSDS 251
Query: 101 RWGSTPLADAVYYK----HHDVIKLLEEHGAK 128
+ + ++L+ + K
Sbjct: 252 YTKDLDIVKNNKLDEIISKNKELRLMYVNCVK 283
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 98.3 bits (246), Expect = 7e-24
Identities = 26/93 (27%), Positives = 41/93 (44%), Gaps = 4/93 (4%)
Query: 41 LMYMANEGDLDGIKELLDS-GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADV--- 96
L E + ++ELL S + + +D D R LH + ++ LLS+ +V
Sbjct: 6 LHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLD 65
Query: 97 DPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
D D G TP A + +V+K L + KP
Sbjct: 66 DYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKP 98
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 95.2 bits (238), Expect = 9e-23
Identities = 24/89 (26%), Positives = 39/89 (43%), Gaps = 2/89 (2%)
Query: 41 LMYMANEGDLDGIKELLD--SGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDP 98
+ G+L+ +K L D D+N T LH+A + +V + L+ GA V
Sbjct: 76 FHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRI 135
Query: 99 EDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+D++ PL A +I+LL G
Sbjct: 136 KDKFNQIPLHRAASVGSLKLIELLCGLGK 164
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 89.4 bits (223), Expect = 1e-20
Identities = 26/92 (28%), Positives = 38/92 (41%), Gaps = 5/92 (5%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDI---DKRTALHVAACQGRTDVVRLLLSR--GAD 95
L + + + LL +VN D T H+A G +VV+ L R D
Sbjct: 40 LHWSVSFQAHEITSFLLSKMENVNLDDYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPD 99
Query: 96 VDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
++ G T L AV K +V + L E+GA
Sbjct: 100 LNKITNQGVTCLHLAVGKKWFEVSQFLIENGA 131
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 81.7 bits (203), Expect = 5e-18
Identities = 25/87 (28%), Positives = 37/87 (42%), Gaps = 5/87 (5%)
Query: 41 LMYMANEGDLDGIKELLDSGT-DVNFRDIDKRTALHVAACQGRTDVVRLLLSR-GADVDP 98
L A+ G L I+ L G VN++D T L A +G D LL+ + GA+ D
Sbjct: 144 LHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDL 203
Query: 99 EDRWGSTPLADAVYYKHHDVIKLLEEH 125
D G+ A+ + V K +
Sbjct: 204 VDNKGAKAEDVAL---NEQVKKFFLNN 227
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 72.5 bits (179), Expect = 9e-15
Identities = 14/58 (24%), Positives = 25/58 (43%), Gaps = 1/58 (1%)
Query: 71 RTALHVAACQGRTD-VVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
LH A + V LL S+ + + +D+ G PL +V ++ H++ L
Sbjct: 3 NYPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKME 60
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 97.1 bits (243), Expect = 8e-24
Identities = 27/87 (31%), Positives = 45/87 (51%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L++ L ++LL G++VN +D +T L + G +++ LL GA+V+ +
Sbjct: 72 LIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRN 131
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
G TPL A Y +++K L E GA
Sbjct: 132 LEGETPLIVASKYGRSEIVKKLLELGA 158
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 96.3 bits (241), Expect = 2e-23
Identities = 27/87 (31%), Positives = 47/87 (54%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
LM G + I +L+++ + +DI+ TAL A R + LLS+G++V+ +D
Sbjct: 39 LMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKD 98
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
G TPL ++ + + ++ L EHGA
Sbjct: 99 FSGKTPLMWSIIFGYSEMSYFLLEHGA 125
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 95.9 bits (240), Expect = 2e-23
Identities = 30/87 (34%), Positives = 46/87 (52%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
LM+ G + LL+ G +VN R+++ T L VA+ GR+++V+ LL GAD+ D
Sbjct: 105 LMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARD 164
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
G T A A + +VIK+ E
Sbjct: 165 LTGLTAEASARIFGRQEVIKIFTEVRR 191
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 86.7 bits (216), Expect = 4e-20
Identities = 20/87 (22%), Positives = 32/87 (36%), Gaps = 6/87 (6%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
+ + L N+RD RT L VA G + + L+ ++ +D
Sbjct: 12 EKIKDEKSINQNLDFL------RNYRDSYNRTPLMVACMLGMENAIDKLVENFDKLEDKD 65
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
GST L AV + + L G+
Sbjct: 66 IEGSTALIWAVKNNRLGIAEKLLSKGS 92
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 98.3 bits (246), Expect = 1e-23
Identities = 24/87 (27%), Positives = 41/87 (47%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L++ L ++ LL G +VN + +ALH A+ +G +VR L+ GAD ++
Sbjct: 154 LIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKN 213
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
TPL A + D+++ A
Sbjct: 214 CHNDTPLMVARSRRVIDILRGKATRPA 240
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 97.9 bits (245), Expect = 1e-23
Identities = 23/95 (24%), Positives = 43/95 (45%), Gaps = 4/95 (4%)
Query: 41 LMYMANEGDLDGIKELLD----SGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADV 96
L +G+L + L++ G +++ + ++T LH+A VVRLL++ GA
Sbjct: 13 LHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASP 72
Query: 97 DPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPST 131
DR G T A ++ ++ L + A +
Sbjct: 73 MALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTL 107
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 95.6 bits (239), Expect = 9e-23
Identities = 25/90 (27%), Positives = 41/90 (45%), Gaps = 1/90 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDI-DKRTALHVAACQGRTDVVRLLLSRGADVDPE 99
L N + ++ LL+ G D++ DI R+ L A +V+LLL GA+V+ +
Sbjct: 120 LHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQ 179
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
GS+ L A +++ L GA
Sbjct: 180 MYSGSSALHSASGRGLLPLVRTLVRSGADS 209
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 3e-21
Identities = 33/92 (35%), Positives = 45/92 (48%), Gaps = 5/92 (5%)
Query: 41 LMYMANEGDLDGIKELLDSG----TDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADV 96
++ LLDS D+ R+ D TALHVA + V+LLL RGAD+
Sbjct: 83 AHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADI 142
Query: 97 DPEDR-WGSTPLADAVYYKHHDVIKLLEEHGA 127
D D G +PL AV +++LL +HGA
Sbjct: 143 DAVDIKSGRSPLIHAVENNSLSMVQLLLQHGA 174
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 79.0 bits (196), Expect = 6e-17
Identities = 23/71 (32%), Positives = 31/71 (43%), Gaps = 4/71 (5%)
Query: 63 VNFRDIDKRTALHVAACQGRTDVVRLLLSR----GADVDPEDRWGSTPLADAVYYKHHDV 118
D D T LH+A QG V L++ G ++D + TPL AV V
Sbjct: 2 ATRADEDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSV 61
Query: 119 IKLLEEHGAKP 129
++LL GA P
Sbjct: 62 VRLLVTAGASP 72
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 1e-23
Identities = 42/183 (22%), Positives = 68/183 (37%), Gaps = 11/183 (6%)
Query: 41 LMYMANEGDLDGIKELLDS-GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPE 99
+ +A G LD +KE + + + D D RTALH A G T++V LL G V+ +
Sbjct: 10 ICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDK 69
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTA------PMHV---QNAREVPEYEIDPK 150
D G +PL A +++K L GA + P+H +N E+ ++
Sbjct: 70 DDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLE-G 128
Query: 151 ELDFSNSVEITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVV 210
+ A+ +G V L + + L L
Sbjct: 129 GANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEA 188
Query: 211 QFL 213
+FL
Sbjct: 189 KFL 191
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 7e-16
Identities = 19/155 (12%), Positives = 47/155 (30%), Gaps = 10/155 (6%)
Query: 68 IDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ ++A ++ +L+ + D+ T L A H ++++ L + G
Sbjct: 5 VSNIMICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGV 64
Query: 128 KPSTA------PMHV---QNAREVPEYEIDPKELDFSNSVEITKGTFRIASWRGTQVAVK 178
+ P+H+ E+ + + K + + A+ +
Sbjct: 65 PVNDKDDAGWSPLHIAASAGXDEIVKALLV-KGAHVNAVNQNGCTPLHYAASKNRHEIAV 123
Query: 179 TLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
L E + K + + +V L
Sbjct: 124 MLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHIL 158
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 8e-16
Identities = 29/120 (24%), Positives = 50/120 (41%), Gaps = 7/120 (5%)
Query: 36 DPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGAD 95
+ L Y A++ + LL+ G + + +D TA+H AA +G +V +LL A
Sbjct: 105 NGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKAS 164
Query: 96 VDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPST------APMHV-QNAREVPEYEID 148
+ +D G+TPL A + + K L GA P+ V + + +
Sbjct: 165 TNIQDTEGNTPLHLACDEERVEEAKFLVTQGASIYIENKEEKTPLQVAKGGLGLILKRLA 224
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 8e-16
Identities = 22/94 (23%), Positives = 40/94 (42%), Gaps = 2/94 (2%)
Query: 36 DPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGAD 95
+ A +G+L + LL N +D + T LH+A + R + + L+++GA
Sbjct: 138 YDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEAKFLVTQGAS 197
Query: 96 VDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+ E++ TPL A +I G +
Sbjct: 198 IYIENKEEKTPLQVAK--GGLGLILKRLAEGEEA 229
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 12/62 (19%), Positives = 26/62 (41%), Gaps = 2/62 (3%)
Query: 36 DPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGAD 95
+ L +E ++ K L+ G + + +++T L VA G ++ L+ G +
Sbjct: 171 EGNTPLHLACDEERVEEAKFLVTQGASIYIENKEEKTPLQVAK--GGLGLILKRLAEGEE 228
Query: 96 VD 97
Sbjct: 229 AS 230
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 53/202 (26%), Positives = 80/202 (39%), Gaps = 27/202 (13%)
Query: 171 RGTQVAVK--------TLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVT-QSTP 221
G VA+K + +D K + E+ LL HPN++ P
Sbjct: 45 EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEP 104
Query: 222 MM----IVTEYLPKGDLRAYLK-QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDL 276
M +VTE + DL + Q+ + P F I G++ LHE ++HRDL
Sbjct: 105 AMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDL 160
Query: 277 EPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCE-ETSWRYAAPEV-YKNEEYDT 334
P NIL D+ + + DF L A D T W Y APE+ + + +
Sbjct: 161 HPGNILLADNNDITICDFNL------AREDTADANKTHYVTHRW-YRAPELVMQFKGFTK 213
Query: 335 KVDVFSFALILQEMIEGCPPFP 356
VD++S ++ EM F
Sbjct: 214 LVDMWSAGCVMAEMFNRKALFR 235
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-23
Identities = 23/90 (25%), Positives = 40/90 (44%), Gaps = 1/90 (1%)
Query: 41 LMYMANEGDLDGIKELLD-SGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPE 99
L + + G D ++ L ++N ++ TALH AA +G D+V+LLL++GA D
Sbjct: 110 LYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGYADIVQLLLAKGARTDLR 169
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+ A ++K + A
Sbjct: 170 NIEKKLAFDMATNAACASLLKKKQGTDAVR 199
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-19
Identities = 20/88 (22%), Positives = 32/88 (36%), Gaps = 6/88 (6%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
++G I V + LH AA +G +R L V+ D
Sbjct: 49 WWKGTSKGRTGLIP-----SNYVAEQAESIDNPLHEAAKRGNLSWLRECLDNRVGVNGLD 103
Query: 101 RWGSTPLADAVYYKHHDVIK-LLEEHGA 127
+ GST L A + H D+++ L +
Sbjct: 104 KAGSTALYWACHGGHKDIVEMLFTQPNI 131
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 16/77 (20%), Positives = 29/77 (37%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A +G D ++ LL G + R+I+K+ A +A +++ A +
Sbjct: 144 LHAAAWKGYADIVQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVRTLSN 203
Query: 101 RWGSTPLADAVYYKHHD 117
D+ HH
Sbjct: 204 AEDYLDDEDSDLEHHHH 220
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 11/89 (12%), Positives = 25/89 (28%), Gaps = 5/89 (5%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
+ + EL D+ + T +GRT ++ V +
Sbjct: 16 VFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLI-----PSNYVAEQA 70
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
PL +A + ++ ++
Sbjct: 71 ESIDNPLHEAAKRGNLSWLRECLDNRVGV 99
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 5/57 (8%), Positives = 9/57 (15%)
Query: 71 RTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ + A L D+ T +I
Sbjct: 13 QVKVFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLIPSNYVAEQ 69
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 40/227 (17%)
Query: 144 EYEIDPKEL---DFSNSVEIT-KGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELA 199
+Y++ + L ++I K T + A+K L E+
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRT-------QEKFALKML--------QDCPKARREVE 106
Query: 200 LLQKI-RHPNVVQFLGA----VTQSTPMMIVTEYLPKGDLRAYLKQKGALKPT--LAVKF 252
L + + P++V+ + ++IV E L G+L + ++ +G T A +
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 253 ALDIARGMNYLHENRPEAIIHRDLEPSNIL---RDDSGHLKVADFGLSKLLKFANTVKED 309
I + YLH I HRD++P N+L + + LK+ DFG +K N++
Sbjct: 167 MKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT- 222
Query: 310 RPV-TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPF 355
P T Y APEV E+YD D++S +I+ ++ G PPF
Sbjct: 223 -PCYTPY-----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-23
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 6/93 (6%)
Query: 41 LMYMANEGDLDGIKELLDS-GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDP- 98
L+ A E D+ + +LL G +V+ R TALH+AA + +L+ ++
Sbjct: 7 LLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFE 66
Query: 99 ----EDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
E G T L AV ++ ++++ L GA
Sbjct: 67 PMTSELYEGQTALHIAVINQNVNLVRALLARGA 99
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 9e-19
Identities = 24/105 (22%), Positives = 39/105 (37%), Gaps = 17/105 (16%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDK-------------RTALHVAACQGRTDVVR 87
L +++ ++ LL G V+ R L AAC G ++VR
Sbjct: 79 LHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVR 138
Query: 88 LLLSRGADVDPEDRWGSTPLADAVYYKHHDV----IKLLEEHGAK 128
LL+ GAD+ +D G+T L + + LL +
Sbjct: 139 LLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGG 183
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-18
Identities = 27/105 (25%), Positives = 46/105 (43%), Gaps = 18/105 (17%)
Query: 41 LMYMANEGDLDGIKELLDSGTDV-----NFRDIDKRTALHVAACQGRTDVVRLLLSRGAD 95
L A +L+ L+++ ++ + +TALH+A ++VR LL+RGA
Sbjct: 41 LHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGAS 100
Query: 96 VDPEDR-------------WGSTPLADAVYYKHHDVIKLLEEHGA 127
V +G PL+ A ++++LL EHGA
Sbjct: 101 VSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGA 145
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-17
Identities = 20/97 (20%), Positives = 34/97 (35%), Gaps = 10/97 (10%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVR----LLLSRGADV 96
L + A G + ++ L++ G D+ +D T LH+ Q LLLS
Sbjct: 125 LSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGD 184
Query: 97 D------PEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ G TP A + + + L +
Sbjct: 185 HLKSLELVPNNQGLTPFKLAGVEGNIVMFQHLMQKRK 221
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 6e-14
Identities = 16/68 (23%), Positives = 27/68 (39%), Gaps = 1/68 (1%)
Query: 72 TALHVAACQGRTDVV-RLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPS 130
+ L +AA + + +LL G +V G T L A Y + + +L E +
Sbjct: 5 SPLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELV 64
Query: 131 TAPMHVQN 138
PM +
Sbjct: 65 FEPMTSEL 72
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-23
Identities = 31/260 (11%), Positives = 72/260 (27%), Gaps = 48/260 (18%)
Query: 170 WRGT------QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM 223
W+ QVA+ + + +D ++ + L +I P V + L V +
Sbjct: 48 WQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107
Query: 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR 283
+V E++ G L+ + P A++ +A + H + PS +
Sbjct: 108 VVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRV 162
Query: 284 DDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFAL 343
G + +A + + D+
Sbjct: 163 SIDGDVVLAYPA-------------------------TMPDA-------NPQDDIRGIGA 190
Query: 344 ILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA---YGLRELIEDCWSEEPFR 400
L ++ P P + + P + + + +
Sbjct: 191 SLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGI 250
Query: 401 RP--TFRQILMRLDDISDQL 418
R T ++ + ++D+
Sbjct: 251 RSASTLLNLMQQATAVADRT 270
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 54/192 (28%), Positives = 81/192 (42%), Gaps = 21/192 (10%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM------IV 225
VA+K L F ++ K EL L++ + H N++ L T + +V
Sbjct: 87 DRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145
Query: 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD 285
E + +L ++ + L + G+ +LH IIHRDL+PSNI+
Sbjct: 146 MELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 199
Query: 286 SGHLKVADFGLSKLLKFANTVKEDRPVTCE-ETSWRYAAPEVYKNEEYDTKVDVFSFALI 344
LK+ DFGL A T +T T + Y APEV Y VD++S I
Sbjct: 200 DCTLKILDFGL------ARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCI 252
Query: 345 LQEMIEGCPPFP 356
+ EM+ FP
Sbjct: 253 MGEMVRHKILFP 264
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 8e-23
Identities = 34/275 (12%), Positives = 71/275 (25%), Gaps = 53/275 (19%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR----------------------HPNV 209
G V + +K +E+ L+ +R P
Sbjct: 103 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162
Query: 210 VQFLGAVTQSTPMMIVTEYLPK-----------GDLRAYLKQKGALKPTLAVKFALDIAR 258
+ + M +++ + L ++ +L ++ L + R
Sbjct: 163 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 222
Query: 259 GMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS 318
+ LH ++H L P +I+ D G + + F + R E
Sbjct: 223 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPE-- 277
Query: 319 WRYAAPEVYKNEEYDTK-----VDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERP 373
A + ++ D ++ L + + P + I
Sbjct: 278 --TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW-IFRSCK 334
Query: 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
P +R L+E R Q +
Sbjct: 335 NIPQP-------VRALLEGFLRYPKEDRLLPLQAM 362
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 24/89 (26%), Positives = 47/89 (52%), Gaps = 1/89 (1%)
Query: 41 LMYMANEGDLDGIKELL-DSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPE 99
L Y A ++ +K L+ + G++ + +D D +T + +AA +GR +VV L+ +GA V+
Sbjct: 283 LHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAV 342
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGAK 128
D T A HH+++ + + +
Sbjct: 343 DATDHTARQLAQANNHHNIVDIFDRCRPE 371
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 21/95 (22%), Positives = 38/95 (40%), Gaps = 8/95 (8%)
Query: 41 LMYMANEGDLD--------GIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSR 92
L ++A+ + KE + +G DVN D D+ T L +A R +V L+
Sbjct: 129 LHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKA 188
Query: 93 GADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
GAD ++ + L A + ++ +
Sbjct: 189 GADPTIYNKSERSALHQAAANRDFGMMVYMLNSTK 223
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 28/99 (28%), Positives = 46/99 (46%), Gaps = 12/99 (12%)
Query: 41 LMYMANEGDLDGI---KELLDSGTDVNFR--------DIDKRTALHVAACQGRTDVVRLL 89
LM +A+ D + K L++ G V++ RTALH AA +V+ L
Sbjct: 239 LMIVAHNEGRDQVASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYL 298
Query: 90 LS-RGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ +G++ D +D G TP+ A +V+ L + GA
Sbjct: 299 VGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGA 337
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 12/88 (13%), Positives = 23/88 (26%), Gaps = 2/88 (2%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
G+ + + + LH A G + + ++ +
Sbjct: 65 NPQGYGNGNDFLGDFNHTNLQIPTEPEPESPIKLHTEA-AGSYAITEPITRESVNII-DP 122
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAK 128
R T L + + L H AK
Sbjct: 123 RHNRTVLHWIASNSSAEKSEDLIVHEAK 150
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 26/102 (25%), Positives = 40/102 (39%), Gaps = 15/102 (14%)
Query: 41 LMYMANEGDLDGIKELLD---SGTDVNFRDIDKRTALHVAACQGRTD---VVRLLLSRGA 94
L A D + +L+ D+ D + TAL + A D +LL+ +GA
Sbjct: 203 LHQAAANRDFGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGA 262
Query: 95 DVDP--------EDRWGSTPLADAVYYKHHDVIK-LLEEHGA 127
VD E G T L A + ++K L+ E G+
Sbjct: 263 KVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGS 304
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 6/88 (6%), Positives = 17/88 (19%), Gaps = 7/88 (7%)
Query: 46 NEGDLDGIKELLDSGTD------VNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPE 99
++ LL++ D N G + +
Sbjct: 31 HQSITSSQHSLLEASYDGYIKRQRNELQHYSLYPNPQGYGNGNDFLGDFNHTNLQIPTEP 90
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ L + + + +
Sbjct: 91 EPESPIKLHTEAAG-SYAITEPITRESV 117
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 12/57 (21%), Positives = 23/57 (40%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVD 97
+M A EG ++ + L+ G V D TA +A ++V + + +
Sbjct: 317 IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDRCRPERE 373
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 9/96 (9%), Positives = 22/96 (22%), Gaps = 17/96 (17%)
Query: 58 DSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHD 117
+ + + +L A+ G R L + P +
Sbjct: 25 EKNRKNHQSITSSQHSLLEASYDGYIKRQRNEL---------QHYSLYPNPQGYGNGNDF 75
Query: 118 VIKLLEEHGAKPSTA------PMHV--QNAREVPEY 145
+ + P+ +H + + E
Sbjct: 76 LGDFNHTNLQIPTEPEPESPIKLHTEAAGSYAITEP 111
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 59/194 (30%), Positives = 84/194 (43%), Gaps = 25/194 (12%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM------IV 225
G +VA+K L F E K EL LL+ +RH NV+ L T + +V
Sbjct: 50 GAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD 285
++ DL +K + L + +G+ Y+H IIHRDL+P N+ ++
Sbjct: 109 MPFMGT-DLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNE 163
Query: 286 SGHLKVADFGLSKLLKFANT--VKEDRPVTCEETSWRYAAPEV-YKNEEYDTKVDVFSFA 342
LK+ DFGL++ T V T W Y APEV Y VD++S
Sbjct: 164 DCELKILDFGLARQADSEMTGYV---------VTRW-YRAPEVILNWMRYTQTVDIWSVG 213
Query: 343 LILQEMIEGCPPFP 356
I+ EMI G F
Sbjct: 214 CIMAEMITGKTLFK 227
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 60/194 (30%), Positives = 87/194 (44%), Gaps = 25/194 (12%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM------IV 225
G +VAVK L F K EL LL+ ++H NV+ L T + + +V
Sbjct: 54 GLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112
Query: 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD 285
T + DL +K + L I RG+ Y+H IIHRDL+PSN+ ++
Sbjct: 113 THLMGA-DLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE 167
Query: 286 SGHLKVADFGLSKLLKFANT--VKEDRPVTCEETSWRYAAPEV-YKNEEYDTKVDVFSFA 342
LK+ DFGL++ T V T W Y APE+ Y+ VD++S
Sbjct: 168 DCELKILDFGLARHTADEMTGYV---------ATRW-YRAPEIMLNWMHYNQTVDIWSVG 217
Query: 343 LILQEMIEGCPPFP 356
I+ E++ G FP
Sbjct: 218 CIMAELLTGRTLFP 231
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 52/197 (26%), Positives = 84/197 (42%), Gaps = 20/197 (10%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM-----IVT 226
G VA+K + E F + E+ +L+ +H N++ + I+
Sbjct: 36 GEIVAIKKI--EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ 93
Query: 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286
E + DL + + L F R + LH + +IHRDL+PSN+L + +
Sbjct: 94 ELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSN 148
Query: 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEE------TSWRYAAPEV-YKNEEYDTKVDVF 339
LKV DFGL++++ + + T W Y APEV + +Y +DV+
Sbjct: 149 CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW-YRAPEVMLTSAKYSRAMDVW 207
Query: 340 SFALILQEMIEGCPPFP 356
S IL E+ P FP
Sbjct: 208 SCGCILAELFLRRPIFP 224
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-22
Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 1/89 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRD-IDKRTALHVAACQGRTDVVRLLLSRGADVDPE 99
L + G L ++ L+ G DVN ++ + RTALH+A D+V LLL GADV+
Sbjct: 121 LHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRV 180
Query: 100 DRWGSTPLADAVYYKHHDVIKLLEEHGAK 128
G +P + + L + +
Sbjct: 181 TYQGYSPYQLTWGRPSTRIQQQLGQLTLE 209
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-21
Identities = 19/87 (21%), Positives = 38/87 (43%)
Query: 47 EGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTP 106
++ I+++ +NF++ ++T LH+A + ++ LL G D + D G+TP
Sbjct: 22 ALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTP 81
Query: 107 LADAVYYKHHDVIKLLEEHGAKPSTAP 133
L A + +L + P
Sbjct: 82 LHLACEQGCLASVGVLTQSCTTPHLHS 108
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-21
Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 41 LMYMANEGDLDGIKELLDSGTD------VNFRDIDKRTALHVAACQGRTDVVRLLLSRGA 94
L +G L + L S T + + + T LH+A+ G +V LL+S GA
Sbjct: 82 LHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGA 141
Query: 95 DVD-PEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
DV+ E G T L AV ++ D++ LL + GA
Sbjct: 142 DVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADV 177
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 9e-19
Identities = 23/93 (24%), Positives = 35/93 (37%), Gaps = 6/93 (6%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGAD----- 95
L + + LL +G D RD T LH+A QG V +L
Sbjct: 49 LHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHS 108
Query: 96 -VDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+ + G T L A + + +++LL GA
Sbjct: 109 ILKATNYNGHTCLHLASIHGYLGIVELLVSLGA 141
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-14
Identities = 18/92 (19%), Positives = 32/92 (34%), Gaps = 13/92 (14%)
Query: 67 DIDKRTALHVAACQGRT----DVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLL 122
D + LH+A +V+R + A ++ ++ TPL AV ++ + L
Sbjct: 5 TEDGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEAL 64
Query: 123 EEHGAKPSTA------PMHV---QNAREVPEY 145
G P P+H+ Q
Sbjct: 65 LGAGCDPELRDFRGNTPLHLACEQGCLASVGV 96
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 5e-13
Identities = 10/78 (12%), Positives = 22/78 (28%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L + + D + LL G DVN + + + T + + L +
Sbjct: 155 LHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLENLQML 214
Query: 101 RWGSTPLADAVYYKHHDV 118
+ + +
Sbjct: 215 PESEDEESYDTESEFTEF 232
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 56/193 (29%), Positives = 91/193 (47%), Gaps = 19/193 (9%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM-----IVT 226
+VA+K + F + + + E+ +L + RH N++ + T IV
Sbjct: 52 KVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 109
Query: 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286
+ + DL LK + L F I RG+ Y+H ++HRDL+PSN+L + +
Sbjct: 110 DLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTT 164
Query: 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEE--TSWRYAAPEVYKN-EEYDTKVDVFSFAL 343
LK+ DFGL+++ A+ + E T W Y APE+ N + Y +D++S
Sbjct: 165 CDLKICDFGLARV---ADPDHDHTGFLTEYVATRW-YRAPEIMLNSKGYTKSIDIWSVGC 220
Query: 344 ILQEMIEGCPPFP 356
IL EM+ P FP
Sbjct: 221 ILAEMLSNRPIFP 233
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 52/222 (23%), Positives = 84/222 (37%), Gaps = 35/222 (15%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM-----IVT 226
VA+K + VF D K + E+A+L ++ H +VV+ L V +V
Sbjct: 78 KRVVAIKKILR-VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136
Query: 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286
E D + + L ++ G+ Y+H I+HRDL+P+N L +
Sbjct: 137 EIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQD 192
Query: 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEE-----------------------TSWRYAA 323
+KV DFGL++ + + P++ E T W Y A
Sbjct: 193 CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRW-YRA 251
Query: 324 PEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVP 364
PE+ E Y +DV+S I E++ P
Sbjct: 252 PELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-21
Identities = 16/102 (15%), Positives = 31/102 (30%), Gaps = 13/102 (12%)
Query: 41 LMYMANEGDLD------GIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVR------- 87
+ G D K L+ G D+ + + D
Sbjct: 79 FFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFKNIFNYFVDENEMIPLYKL 138
Query: 88 LLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+ G + +D+WG T L + +K++E++ K
Sbjct: 139 IFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIKKY 180
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-20
Identities = 21/106 (19%), Positives = 38/106 (35%), Gaps = 11/106 (10%)
Query: 32 SEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRT----ALHVAACQGRTDVVR 87
S A+ + A G + EL + G + + K L + R +
Sbjct: 1 SNAMSEYRTVSAAAMLGTYEDFLELFEKGYEDK-ESVLKSNILYDVLRNNNDEARYKISM 59
Query: 88 LLLSRGADVDPEDRWGSTPLADAVYYKHHDV------IKLLEEHGA 127
L+++GAD+ + G+T +D+ K+ E GA
Sbjct: 60 FLINKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGA 105
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-12
Identities = 7/67 (10%), Positives = 20/67 (29%), Gaps = 7/67 (10%)
Query: 41 LMYMANEGDLDGIKE-------LLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRG 93
+ +D + SG + +D TAL + ++++
Sbjct: 118 VFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYI 177
Query: 94 ADVDPED 100
+ ++
Sbjct: 178 KKYNLKE 184
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 8e-21
Identities = 43/190 (22%), Positives = 80/190 (42%), Gaps = 25/190 (13%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVT--QSTPMMIVTEY 228
+V VK L K K E+ +L+ +R PN++ V S +V E+
Sbjct: 61 NEKVVVKIL-----KPVKKKKI-KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114
Query: 229 LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD-DSG 287
+ D + + L + +I + ++Y H I+HRD++P N++ D +
Sbjct: 115 VNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHR 168
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCE-ETSWRYAAPEVYKN-EEYDTKVDVFSFALIL 345
L++ D+GL A + + + + PE+ + + YD +D++S +L
Sbjct: 169 KLRLIDWGL------AEFYHPGQEYNVRVASRY-FKGPELLVDYQMYDYSLDMWSLGCML 221
Query: 346 QEMIEGCPPF 355
MI PF
Sbjct: 222 ASMIFRKEPF 231
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 64/295 (21%), Positives = 114/295 (38%), Gaps = 44/295 (14%)
Query: 113 YKHHDVIKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNSVE------------I 160
+ HH + G T+ ++ + + + + + E +
Sbjct: 3 HHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVL 62
Query: 161 TKGTF------RIASWRGTQV--AVKTLGEEVFTDEDK-VKAFIDELALLQKIRH-PNVV 210
G + R S T A+K L + + K + E +L+ IR P +V
Sbjct: 63 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLV 122
Query: 211 QFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEA 270
A T + ++ +Y+ G+L +L Q+ + +I + +LH+
Sbjct: 123 TLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---G 179
Query: 271 IIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV-----TCEETSWRYAAPE 325
II+RD++ NIL D +GH+ + DFGLSK E T E Y AP+
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKE----FVADETERAYDFCGTIE-----YMAPD 230
Query: 326 VYKNEE--YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKA---YIANERPPF 375
+ + + +D VD +S +++ E++ G PF EK I PP+
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 285
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 30/203 (14%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM-------- 223
+VA+K + V TD VK + E+ +++++ H N+V+ + S +
Sbjct: 36 DKRVAIKKI---VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92
Query: 224 ------IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLE 277
IV EY+ DL L+Q G L A F + RG+ Y+H ++HRDL+
Sbjct: 93 ELNSVYIVQEYMET-DLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLK 147
Query: 278 PSNILRDDSG-HLKVADFGLSKLLKFANTVKEDRPVTCEE--TSWRYAAPEVYKN-EEYD 333
P+N+ + LK+ DFGL+++ + + E T W Y +P + + Y
Sbjct: 148 PANLFINTEDLVLKIGDFGLARI---MDPHYSHKGHLSEGLVTKW-YRSPRLLLSPNNYT 203
Query: 334 TKVDVFSFALILQEMIEGCPPFP 356
+D+++ I EM+ G F
Sbjct: 204 KAIDMWAAGCIFAEMLTGKTLFA 226
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 45/239 (18%), Positives = 86/239 (35%), Gaps = 81/239 (33%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFID------ELALLQKIRHPNVVQFLGAVTQSTPMM-- 223
G + A+K K D EL +++ + H N+++ + +
Sbjct: 32 GKRFALK-------------KVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78
Query: 224 ------------------------------------IVTEYLPKGDL----RAYLKQKGA 243
++ EY+P L +++++ +
Sbjct: 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRS 137
Query: 244 LKPTLAVK-FALDIARGMNYLHENRPEAIIHRDLEPSNILRD-DSGHLKVADFGLSKLLK 301
+ P + + + R + ++H I HRD++P N+L + LK+ DFG +K L
Sbjct: 138 I-PMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI 193
Query: 302 FANTVKEDRPVT---CEETSWRYAAPEV-YKNEEYDTKVDVFSFALILQEMIEGCPPFP 356
P C + + Y APE+ EY +D++S + E+I G P F
Sbjct: 194 ------PSEPSVAYIC--SRF-YRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS 243
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 48/217 (22%), Positives = 82/217 (37%), Gaps = 30/217 (13%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM-----IVT 226
VA+K + +F D K + E+ +L +++ +++ + + IV
Sbjct: 51 EKNVAIKKV-NRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109
Query: 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS 286
E DL+ K L ++ G N++HE+ IIHRDL+P+N L +
Sbjct: 110 EIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQD 165
Query: 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEE------------------TSWRYAAPEV-Y 327
+KV DFGL++ + + E T W Y APE+
Sbjct: 166 CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRW-YRAPELIL 224
Query: 328 KNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVP 364
E Y +D++S I E++ P
Sbjct: 225 LQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 49/226 (21%), Positives = 86/226 (38%), Gaps = 59/226 (26%)
Query: 144 EYEIDPKEL---DFSNSVEIT-KGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELA 199
+Y++ + L ++I K T + A+K L E+
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRT-------QEKFALKML--------QDCPKARREVE 62
Query: 200 LLQKI-RHPNVVQFLGA----VTQSTPMMIVTEYLPKGDLRAYLKQKGALKPT--LAVKF 252
L + + P++V+ + ++IV E L G+L + ++ +G T A +
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 253 ALDIARGMNYLHENRPEAIIHRDLEPSNIL---RDDSGHLKVADFGLSKLLKFANTVKED 309
I + YLH I HRD++P N+L + + LK+ DFG
Sbjct: 123 MKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF------------- 166
Query: 310 RPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPF 355
A E E+YD D++S +I+ ++ G PPF
Sbjct: 167 -------------AKETTG-EKYDKSCDMWSLGVIMYILLCGYPPF 198
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMM---IVTE 227
G VAVK + + F + + E+ +L ++ H N+V L V ++ +V +
Sbjct: 34 GEVVAVKKIFD-AFQNSTDAQRTFREIMILTELSGHENIVNLL-NVLRADNDRDVYLVFD 91
Query: 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
Y+ DL A ++ L+P + + + YLH ++HRD++PSNIL +
Sbjct: 92 YMET-DLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAEC 146
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEE-----------------TSWRYAAPEVYKN- 329
H+KVADFGLS+ V + P++ E T W Y APE+
Sbjct: 147 HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRW-YRAPEILLGS 205
Query: 330 EEYDTKVDVFSFALILQEMIEGCPPFP 356
+Y +D++S IL E++ G P FP
Sbjct: 206 TKYTKGIDMWSLGCILGEILCGKPIFP 232
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 8e-19
Identities = 20/96 (20%), Positives = 28/96 (29%), Gaps = 2/96 (2%)
Query: 45 ANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED--RW 102
LD + LL S V + A +AA G V+ L
Sbjct: 103 GCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAE 162
Query: 103 GSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQN 138
A H V+ L E +TA + +N
Sbjct: 163 NYHAFRLAAENGHLHVLNRLCELAPTEATAMIQAEN 198
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 21/113 (18%), Positives = 32/113 (28%), Gaps = 11/113 (9%)
Query: 28 DADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDK--RTALHVAACQGRTDV 85
A+ +A A G L + L + I A +AA G V
Sbjct: 125 QAENYQA------FRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHV 178
Query: 86 VRLLLSRGADVDPED--RWGSTPLADAVYYK-HHDVIKLLEEHGAKPSTAPMH 135
+ L A + HH+VI L + + A +H
Sbjct: 179 LNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYAEIH 231
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 18/106 (16%), Positives = 26/106 (24%), Gaps = 16/106 (15%)
Query: 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKR--TALHVAACQ-G 81
A A+ A A G L + L + I A AA G
Sbjct: 157 AMIQAENYHA------FRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRG 210
Query: 82 RTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+V+ LL + + Y V + H
Sbjct: 211 HHNVINFLLDCPVMLAYAEIHEFE-------YGEKYVNPFIARHVN 249
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 47/267 (17%), Positives = 74/267 (27%), Gaps = 40/267 (14%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAA---CQGRTDVVRLLLSRGADVD 97
L+ + K+L +D + + I VAA C D + LLL+ V
Sbjct: 66 LLCLYYAHYNRNAKQLW---SDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVK 122
Query: 98 PEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNS 157
A H V+ L E A + +N
Sbjct: 123 VIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENY--------HA-------- 166
Query: 158 VEITKGTFRIASWRG-TQVAVKTLGEEVFTDEDKVKAFIDELALL---QKIRHPNVVQFL 213
FR+A+ G V + L E T+ + + A H NV+ FL
Sbjct: 167 -------FRLAAENGHLHV-LNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFL 218
Query: 214 ---GAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEA 270
+ + + ++ + + F L G+ L
Sbjct: 219 LDCPVMLAYAEIHEFEYGEK--YVNPFIARHVNRLKEMHDAFKLSNPDGVFDLVTKSECL 276
Query: 271 IIHRDLEPSNILRDDSGHLKVADFGLS 297
L I R+D L F LS
Sbjct: 277 QGFYMLRN-LIRRNDEVLLDDIRFLLS 302
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 16/87 (18%), Positives = 25/87 (28%), Gaps = 8/87 (9%)
Query: 46 NEGDLDGIKEL-----LDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
+E LD I+ L + + D L +A G LLLS + +
Sbjct: 290 DEVLLDDIRFLLSIPGIKALAPTATIPGDANELLRLALRLGNQGACALLLSIPSVLALTK 349
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGA 127
D+ + EH
Sbjct: 350 A---NNYYINETGGRLDLRAVALEHHH 373
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 23/158 (14%), Positives = 37/158 (23%), Gaps = 61/158 (38%)
Query: 25 ADDDADGSEAIDPRVRLMYMANE-GDLDGIKELLDSGTDVNFRDI--------------- 68
A A+ A + A G + I LLD + + +I
Sbjct: 192 AMIQAENYYA------FRWAAVGRGHHNVINFLLDCPVMLAYAEIHEFEYGEKYVNPFIA 245
Query: 69 -------DKRTALHVAACQGRTDVV---------------------------RLLLS--- 91
+ A ++ G D+V R LLS
Sbjct: 246 RHVNRLKEMHDAFKLSNPDGVFDLVTKSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPG 305
Query: 92 --RGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
A + L A+ + LL +
Sbjct: 306 IKALAPTATIPGDANELLRLALRLGNQGACALLLSIPS 343
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 11/72 (15%), Positives = 21/72 (29%), Gaps = 6/72 (8%)
Query: 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTD 84
A +A + L G+ LL + + + K ++ GR D
Sbjct: 310 APTATIPGDANEL---LRLALRLGNQGACALLLSIPSVL---ALTKANNYYINETGGRLD 363
Query: 85 VVRLLLSRGADV 96
+ + L
Sbjct: 364 LRAVALEHHHHH 375
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 8e-18
Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 30/204 (14%)
Query: 171 RGTQVAVKTL-GEEVFTDEDKVKAFIDELALLQKIRH------PNVVQFLGAVTQSTPMM 223
VA+K + E+ F + +E+ +L+ +R NV+ L T +
Sbjct: 121 VHQHVALKMVRNEKRFH-----RQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175
Query: 224 IVTEYLPKGDLRAYLKQ---KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSN 280
+ E L +L +K+ +G L KFA I + ++ LH+NR IIH DL+P N
Sbjct: 176 MTFELLSM-NLYELIKKNKFQG-FSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPEN 230
Query: 281 IL--RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDV 338
IL + +KV DFG S E + V S Y APEV Y +D+
Sbjct: 231 ILLKQQGRSGIKVIDFGSS--------CYEHQRVYTYIQSRFYRAPEVILGARYGMPIDM 282
Query: 339 FSFALILQEMIEGCPPFPTKQEKE 362
+S IL E++ G P P + E +
Sbjct: 283 WSLGCILAELLTGYPLLPGEDEGD 306
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301 | Back alignment and structure |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 32/113 (28%), Positives = 51/113 (45%), Gaps = 3/113 (2%)
Query: 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTD 84
D A + V+ +AN+ L + ++ +G ++ + D TALH AA + D
Sbjct: 184 PDAQAPEELVLHLAVK---VANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPD 240
Query: 85 VVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQ 137
++LLL A V + G T L A H + +LLE+ A P+HV
Sbjct: 241 CLKLLLKGRALVGTVNEAGETALDIARKKHHKECEELLEQAQAGTFAFPLHVD 293
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 3e-17
Identities = 25/110 (22%), Positives = 39/110 (35%), Gaps = 25/110 (22%)
Query: 45 ANEGDLDGIKELLDSGTDVNF-----------RDIDKRTALHVAACQGRTDVVRLLLSRG 93
+ G D I LLD + +TALH+A + +V LL+ G
Sbjct: 65 LHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENG 124
Query: 94 ADVDPEDR--------------WGSTPLADAVYYKHHDVIKLLEEHGAKP 129
ADV +G PL+ A ++K L ++ +P
Sbjct: 125 ADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQP 174
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 25/112 (22%), Positives = 41/112 (36%), Gaps = 22/112 (19%)
Query: 38 RVRLMYMANEGDLDGIKELLDS-------GTDVNFRDIDK-RTALHVAAC---QGRTDVV 86
R + + + ++ LL TD F+D + +T L A G+ D +
Sbjct: 14 RRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTI 73
Query: 87 RLLLSRGADVDP-----------EDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
LLL D G T L A+ ++ ++ LL E+GA
Sbjct: 74 ALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGA 125
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 23/114 (20%), Positives = 37/114 (32%), Gaps = 26/114 (22%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDK--------------RTALHVAACQGRTDVV 86
L ++ + L+++G DV L +AAC + +V
Sbjct: 105 LHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIV 164
Query: 87 RLLLSRG---ADVDPEDRWGSTPLADAVYYKHHDV---------IKLLEEHGAK 128
+ LL AD+ D G+T L V + V + GAK
Sbjct: 165 KFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAK 218
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 26/115 (22%), Positives = 36/115 (31%), Gaps = 20/115 (17%)
Query: 41 LMYMANEGDLDGIKELLDSGT---DVNFRDIDKRTALHVAACQGRTDVVR---------L 88
L A L +K LL + D++ RD T LH V
Sbjct: 152 LSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNE 211
Query: 89 LLSRGADVDPE-------DRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHV 136
+L GA + P +R G TPLA A V+ + + H
Sbjct: 212 ILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPE-CRHA 265
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 12/64 (18%), Positives = 21/64 (32%), Gaps = 7/64 (10%)
Query: 54 KELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYY 113
+L + + T L +AA G+ V+ +L R A ++
Sbjct: 217 AKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIH-------EPECRHAAAHH 269
Query: 114 KHHD 117
HH
Sbjct: 270 HHHH 273
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 20/89 (22%), Positives = 31/89 (34%), Gaps = 12/89 (13%)
Query: 59 SGTDVNFRDIDKRTALHVAACQGRTDVVRLLL-------SRGADVDPEDR-WGSTPL--- 107
S + R D R ++ A Q + LL R D + +D G T L
Sbjct: 3 SAGEKPPRLYD-RRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKA 61
Query: 108 ADAVYYKHHDVIKLLEEHGAKPSTAPMHV 136
++ +D I LL + K + V
Sbjct: 62 MLNLHNGQNDTIALLLDVARKTDSLKQFV 90
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 9e-17
Identities = 26/121 (21%), Positives = 40/121 (33%), Gaps = 26/121 (21%)
Query: 42 MYMANEGDLDGIKELLDSG-----------TDVNFRDIDKRTALHVAACQGRTDVVRLLL 90
+ +G I LL +ALH+A + V+LL+
Sbjct: 51 VLNLQDGVNACIMPLLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLV 110
Query: 91 SRGADVDPEDR-------------WGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQ 137
GADV +G PL+ A K DV+ L E+ +P A +
Sbjct: 111 ENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQP--ASLEAT 168
Query: 138 N 138
+
Sbjct: 169 D 169
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 27/134 (20%), Positives = 42/134 (31%), Gaps = 38/134 (28%)
Query: 26 DDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDK-------------RT 72
D+ G A L + L +K L+++G DV+ R +
Sbjct: 85 DEFYQGHSA------LHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGEL 138
Query: 73 ALHVAACQGRTDVVRLLLSRG---ADVDPEDRWGSTPL----------------ADAVYY 113
L +AAC + DVV LL A ++ D G+T L +Y
Sbjct: 139 PLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENSALVIHMYD 198
Query: 114 KHHDVIKLLEEHGA 127
+ L
Sbjct: 199 GLLQMGARLCPTVQ 212
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 5e-15
Identities = 17/111 (15%), Positives = 31/111 (27%), Gaps = 19/111 (17%)
Query: 41 LMYMANEGDLDGIKELLDSGT---DVNFRDIDKRTALH----------------VAACQG 81
L A D + LL++ + D T LH + G
Sbjct: 140 LSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENSALVIHMYDG 199
Query: 82 RTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTA 132
+ L + + G TPL A ++ + + + + A
Sbjct: 200 LLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSGAAA 250
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 23/112 (20%), Positives = 35/112 (31%), Gaps = 22/112 (19%)
Query: 38 RVRLMYMANEGDLDGIKELLDS--------GTDVNFRDIDKRTALHVAAC---QGRTDVV 86
R RL + + G + + LL+ +T L A G +
Sbjct: 3 RDRLFSVVSRGVPEELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNACI 62
Query: 87 RLLLSRG-----------ADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
LL A E G + L A+ + +KLL E+GA
Sbjct: 63 MPLLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGA 114
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 49/203 (24%), Positives = 77/203 (37%), Gaps = 26/203 (12%)
Query: 171 RGTQVAVKTL-GEEVFTDEDKVKAFIDELALLQKIRHP------NVVQFLGAVTQSTPMM 223
VA+K + ++ F E+ LL+ + +V +
Sbjct: 78 EQEWVAIKIIKNKKAFL-----NQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132
Query: 224 IVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNI 281
+V E L +L L+ + L KFA + + +L IIH DL+P NI
Sbjct: 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENI 190
Query: 282 LRDDSGH--LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVF 339
L + +K+ DFG S + + + S Y +PEV YD +D++
Sbjct: 191 LLCNPKRSAIKIVDFGSS--------CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMW 242
Query: 340 SFALILQEMIEGCPPFPTKQEKE 362
S IL EM G P F E +
Sbjct: 243 SLGCILVEMHTGEPLFSGANEVD 265
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 40/219 (18%)
Query: 171 RGTQVAVKTL-GEEVFTDEDKVKAFIDELALLQKIR-----------HPNVVQFLGAVT- 217
T VA+K + G++V+T+ A DE+ LLQ++ ++++ L
Sbjct: 43 NNTHVAMKIVRGDKVYTE-----AAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97
Query: 218 ---QSTPMMIVTEYLPKGDLRAYLKQKGALK-PTLAVK-FALDIARGMNYLHENRPEAII 272
+++V E L +L A +K+ P + VK + + G++Y+H R II
Sbjct: 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGII 154
Query: 273 HRDLEPSNILRDDSGH------LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEV 326
H D++P N+L + +K+AD G N D T + Y +PEV
Sbjct: 155 HTDIKPENVLMEIVDSPENLIQIKIADLG--------NACWYDEHYTNSIQTREYRSPEV 206
Query: 327 YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPK 365
+ D++S A ++ E+I G F + K
Sbjct: 207 LLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-15
Identities = 23/114 (20%), Positives = 38/114 (33%), Gaps = 26/114 (22%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDK--------------RTALHVAACQGRTDVV 86
L ++ L++ G DV+ + + L +AAC + +V
Sbjct: 97 LHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIV 156
Query: 87 RLLLSRG---ADVDPEDRWGSTPLADAVYYKHH---------DVIKLLEEHGAK 128
L G AD+ +D G+T L V + + LL AK
Sbjct: 157 HYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAK 210
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 31/113 (27%), Positives = 44/113 (38%), Gaps = 25/113 (22%)
Query: 42 MYMANEGDLDGIKELLDSGTD---------VNFRDIDKR--TALHVAACQGRTDVVRLLL 90
+ + G D I LLD FRD+ R TALH+A + V LL+
Sbjct: 54 LLNLSAGRNDTIPILLDIAEKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLV 113
Query: 91 SRGADVDPEDR--------------WGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+GADV + R +G PL+ A ++ L E+G K
Sbjct: 114 EKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQ 166
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 5e-14
Identities = 24/112 (21%), Positives = 38/112 (33%), Gaps = 22/112 (19%)
Query: 38 RVRLMYMANEGDLDGIKE----LLDSGTDVNFRDIDK----RTALHVAA---CQGRTDVV 86
R L + + G DG++ LL + + + +T L A GR D +
Sbjct: 6 RPILFDIVSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAGRNDTI 65
Query: 87 RLLLSRGADVDP-----------EDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
+LL G T L A+ + ++LL E GA
Sbjct: 66 PILLDIAEKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGA 117
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 21/114 (18%), Positives = 36/114 (31%), Gaps = 19/114 (16%)
Query: 41 LMYMANEGDLDGIKELLDSGT---DVNFRDIDKRTALHVAACQG---------RTDVVRL 88
L A + L ++G D+ +D T LH T + L
Sbjct: 144 LSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDL 203
Query: 89 LLSRGADVDPE-------DRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMH 135
LL + A + P+ + G +PL A + + + + A H
Sbjct: 204 LLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIADAAAHHH 257
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 13/69 (18%), Positives = 23/69 (33%), Gaps = 11/69 (15%)
Query: 71 RTALHVAACQGRT----DVVRLLLSRGADVDPEDRW----GSTPL---ADAVYYKHHDVI 119
R L +G ++ LL+ + E+ G T L + +D I
Sbjct: 6 RPILFDIVSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAGRNDTI 65
Query: 120 KLLEEHGAK 128
+L + K
Sbjct: 66 PILLDIAEK 74
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 11/78 (14%), Positives = 23/78 (29%), Gaps = 18/78 (23%)
Query: 46 NEGDLDGIKELLDSGTDVN-------FRDIDKRTALHVAACQGRTDVVRLLLSRGADVDP 98
+ LL + + D + L +AA G+ + + ++ R
Sbjct: 194 TKFVTKMYDLLLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIADA- 252
Query: 99 EDRWGSTPLADAVYYKHH 116
A ++ HH
Sbjct: 253 ----------AAHHHHHH 260
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 3e-15
Identities = 21/93 (22%), Positives = 40/93 (43%)
Query: 44 MANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWG 103
+ L + L+ + +++ + TALH + ++LLL A ++ + G
Sbjct: 179 SVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESG 238
Query: 104 STPLADAVYYKHHDVIKLLEEHGAKPSTAPMHV 136
TPL A KH +LL + + + +HV
Sbjct: 239 ETPLDIAKRLKHEHCEELLTQALSGRFNSHVHV 271
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 24/121 (19%), Positives = 39/121 (32%), Gaps = 16/121 (13%)
Query: 21 QPLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNF------RDIDKRTAL 74
+ AD A + D+ G+ + G D+ TAL
Sbjct: 121 RKKHADTAAKLHSLCEA-------VKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETAL 173
Query: 75 HVAACQG---RTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPST 131
H+A +V L+ ++D + GST L + + +KLL A
Sbjct: 174 HLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEI 233
Query: 132 A 132
A
Sbjct: 234 A 234
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 21/135 (15%), Positives = 47/135 (34%), Gaps = 10/135 (7%)
Query: 3 SKSSARFTLGKQSSLAPDQPLPADDDADGS----EAIDPRVRLMYMANEGDLDGIKELL- 57
+ ++ Q +P + D S E + +++ + L + +
Sbjct: 58 EQKMKLEAFLQRLLFPEIQEMPTSLNNDSSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFP 117
Query: 58 DSGTDVNF-RDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHH 116
++ ++N D T LH ++V+ L+ G++ D G + L AV ++
Sbjct: 118 NTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNN 177
Query: 117 ----DVIKLLEEHGA 127
LL+
Sbjct: 178 YDSGTFEALLDYLYP 192
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 17/83 (20%), Positives = 31/83 (37%)
Query: 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTD 84
+ +E + L+ + +N +D + T L++AA G
Sbjct: 238 RPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAARLGNIS 297
Query: 85 VVRLLLSRGADVDPEDRWGSTPL 107
+V LL GAD ++ G P+
Sbjct: 298 IVDALLDYGADPFIANKSGLRPV 320
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 12/82 (14%), Positives = 28/82 (34%), Gaps = 4/82 (4%)
Query: 52 GIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSR----GADVDPEDRWGSTPL 107
+ ++ +++ + R D + L ++ +D G T L
Sbjct: 228 LMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCL 287
Query: 108 ADAVYYKHHDVIKLLEEHGAKP 129
A + ++ L ++GA P
Sbjct: 288 NIAARLGNISIVDALLDYGADP 309
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 14/103 (13%), Positives = 25/103 (24%), Gaps = 16/103 (15%)
Query: 41 LMYMA---NEGDLDGIKELLDS-GTDVNFRDIDKRTALHVAACQ----GRTDVVR----- 87
L+ N D + LLD + D RT LH G + +
Sbjct: 168 LVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILHHIIITSGMTGCSAAAKYYLDI 227
Query: 88 ---LLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
++ + + + D I +
Sbjct: 228 LMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKW 270
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368 | Back alignment and structure |
|---|
Score = 70.6 bits (172), Expect = 2e-13
Identities = 40/150 (26%), Positives = 56/150 (37%), Gaps = 11/150 (7%)
Query: 13 KQSSLAPDQPLPADDDADGSE------AIDPRVRLMYMANEGDLDGIKELLDSGTDVNFR 66
+ S P P AD A G++ D L+ L + LL +G +VN
Sbjct: 205 RASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQA 264
Query: 67 DIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHG 126
D R LH A G T + L L RGAD+ D G PL A+ + D++ LL
Sbjct: 265 DSAGRGPLHHATILGHTGLACLFLKRGADLGARDSEGRDPLTIAMETANADIVTLLRLAK 324
Query: 127 AKPSTAPMHVQNAREVPEYEIDPKELDFSN 156
+ + A + DFS
Sbjct: 325 MREAEAAQGQA-----GDETYLDIFRDFSL 349
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 48/225 (21%), Positives = 82/225 (36%), Gaps = 50/225 (22%)
Query: 171 RGTQVAVKTL-GEEVFTDEDKVKAFIDELALLQKIRH-----PNVVQFLGAVTQSTPMMI 224
AVK + + +T + E +L+KI++ N+V++ G M +
Sbjct: 59 NKKYYAVKVVRNIKKYTR-----SAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL 113
Query: 225 VTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL 282
+ E L L + + + ++I + +NYL + + H DL+P NIL
Sbjct: 114 IFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENIL 169
Query: 283 -------------------------RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEET 317
R S +K+ DFG +
Sbjct: 170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG--------CATFKSDYHGSIIN 221
Query: 318 SWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
+ +Y APEV N +D D++SF +L E+ G F T + E
Sbjct: 222 TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 46/211 (21%), Positives = 78/211 (36%), Gaps = 29/211 (13%)
Query: 172 GTQVAVKTL-GEEVFTDEDKVKAFIDELALLQKIRHP------NVVQFLGAVTQSTPMMI 224
+QVA+K + + + ++ E+ +L+KI+ V M I
Sbjct: 45 KSQVALKIIRNVGKYREAARL-----EINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI 99
Query: 225 VTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL 282
E L K + +LK+ A + + +LHEN+ + H DL+P NIL
Sbjct: 100 AFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENIL 155
Query: 283 RDDSGHLKVADFGLS-----------KLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEE 331
+S + + S ++ F + + T + Y PEV
Sbjct: 156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELG 215
Query: 332 YDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
+ DV+S IL E G F T + +E
Sbjct: 216 WAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 9e-12
Identities = 51/211 (24%), Positives = 84/211 (39%), Gaps = 29/211 (13%)
Query: 172 GTQVAVKTL-GEEVFTDEDKVKAFIDELALLQKIRHP------NVVQFLGAVTQSTPMMI 224
G VAVK + + + + + E+ +L+ + VQ L + I
Sbjct: 40 GRHVAVKIVKNVDRYCEAARS-----EIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI 94
Query: 225 VTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL 282
V E L ++K+ G + K A I + +N+LH N+ + H DL+P NIL
Sbjct: 95 VFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENIL 150
Query: 283 RDDSGHLKVADFGLS-----------KLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEE 331
S + + + + K++ F + +D + ++ Y APEV
Sbjct: 151 FVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALG 210
Query: 332 YDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362
+ DV+S IL E G FPT KE
Sbjct: 211 WSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 52/249 (20%), Positives = 81/249 (32%), Gaps = 64/249 (25%)
Query: 170 WRGTQVAVKTLGEEVFT-DEDKVKAFIDELALLQKIR-----HPN---VVQFLGAVTQST 220
VA+K V E + +DE+ LL+ +R PN VVQ L S
Sbjct: 60 QGKKFVAMK-----VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114
Query: 221 P----MMIVTEYL--PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHR 274
+ +V E L +G L K + +G++YLH IIH
Sbjct: 115 VNGTHICMVFEVLGHHLLKWIIKSNYQG-LPLPCVKKIIQQVLQGLDYLH--TKCRIIHT 171
Query: 275 DLEPSNIL-----------------------------------------RDDSGHLKVAD 293
D++P NIL + K A+
Sbjct: 172 DIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAE 231
Query: 294 FGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCP 353
K+ N + T + + +Y + EV Y+T D++S A + E+ G
Sbjct: 232 KLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDY 291
Query: 354 PFPTKQEKE 362
F +E
Sbjct: 292 LFEPHSGEE 300
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 2e-05
Identities = 27/203 (13%), Positives = 51/203 (25%), Gaps = 50/203 (24%)
Query: 149 PKELDFSNSVEITKGTFRI---ASWRGTQVAVKTLGEEVFTDED-----KVKAFIDELAL 200
+I +G F T VA+K + E + + + E+ +
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 201 LQKI---------RHPNVVQFLGA--VTQSTP---------------------------- 221
+++ R + V S P
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNI 281
+ IV E+ G ++ K A + + + HRDL N+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNV 193
Query: 282 LRDDSGHLKVADFGLSKLLKFAN 304
L + K+ K +
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPS 216
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 21/77 (27%), Positives = 39/77 (50%), Gaps = 6/77 (7%)
Query: 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL- 282
+V E L DL+ Q G K + ++ + + + Y+HEN +H D++ +N+L
Sbjct: 129 MVMERLGI-DLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLL 184
Query: 283 -RDDSGHLKVADFGLSK 298
+ + +AD+GLS
Sbjct: 185 GYKNPDQVYLADYGLSY 201
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 1e-04
Identities = 49/341 (14%), Positives = 92/341 (26%), Gaps = 99/341 (29%)
Query: 115 HHDVIKLLEEHGAKPSTAPMHVQNAREVPEYEID-PKELDFSNSVEITKGTFRIASWRGT 173
HH H T Q + +E D + ++ K +
Sbjct: 1 HH------HHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSIL-------S 47
Query: 174 QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQ-FLGAVTQS------TPMMIVT 226
+ + + L Q+ +VQ F+ V + +P I T
Sbjct: 48 KEEIDHIIMSK-DAVSGTLRLFWTLLSKQE----EMVQKFVEEVLRINYKFLMSP--IKT 100
Query: 227 EYL-PKGDLRAYLKQKGALKPTLAVKFALDIARGMNY------LHENRPEAIIHRDLEPS 279
E P R Y++Q+ L V +++R Y L E RP +
Sbjct: 101 EQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV------- 153
Query: 280 NILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCE---ETSW----RYAAPEVYKNEEY 332
++ G G + + A V V C+ + W +PE
Sbjct: 154 -LIDGVLG------SGKTWV---ALDVCLSYKVQCKMDFKIFWLNLKNCNSPE------- 196
Query: 333 DTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAP-TTHYAYG-LRELI 390
+L+ + + ++ + + H LR L
Sbjct: 197 ----------TVLEMLQKLL--------YQIDPNWTSRSDHSSNIKLRIHSIQAELRRL- 237
Query: 391 EDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVGPLRC 431
+ + L+ L ++ + + W L C
Sbjct: 238 --------LKSKPYENCLLVLLNVQN----AKAWNAFNLSC 266
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 11/48 (22%), Positives = 23/48 (47%), Gaps = 7/48 (14%)
Query: 262 YLHENRPEAIIHRDLEPSNIL--RDDSGHLKVADFGLSKLLKFANTVK 307
+LHEN +H ++ NI +D + +A +G + ++ + K
Sbjct: 174 FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF--RYCPSGK 216
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 11/39 (28%), Positives = 22/39 (56%), Gaps = 5/39 (12%)
Query: 262 YLHENRPEAIIHRDLEPSNIL--RDDSGHLKVADFGLSK 298
Y+HE+ +H D++ SN+L + + + D+GL+
Sbjct: 167 YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 38/142 (26%), Positives = 62/142 (43%), Gaps = 21/142 (14%)
Query: 233 DLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL---RDDSGHL 289
DL + +K +LK L A + + Y+H IHRD++P N L +
Sbjct: 93 DLFNFCSRKFSLKTVL--LLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLV 147
Query: 290 KVADFGLSKLLKFANT-----VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALI 344
+ DFGL+K + A T +E++ +T T+ RYA+ + E + D+ S +
Sbjct: 148 YIIDFGLAKKYRDARTHQHIPYRENKNLT--GTA-RYASINTHLGIEQSRRDDLESLGYV 204
Query: 345 LQEMIEGCPP-----FPTKQEK 361
L G P TK++K
Sbjct: 205 LMYFNLGSLPWQGLKAATKRQK 226
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 33/144 (22%), Positives = 60/144 (41%), Gaps = 23/144 (15%)
Query: 233 DLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL--RDDSGHLK 290
DL + +LK L A+ + M Y+H + +I+RD++P N L R + +
Sbjct: 93 DLFDLCDRTFSLKTVL--MIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQ 147
Query: 291 VA---DFGLSKLLKFANTVK-----EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFA 342
V DF L+K T K E + +T + RY + + +E + D+ +
Sbjct: 148 VIHIIDFALAKEYIDPETKKHIPYREHKSLT---GTARYMSINTHLGKEQSRRDDLEALG 204
Query: 343 LILQEMIEGCPPF-----PTKQEK 361
+ + G P+ T +E+
Sbjct: 205 HMFMYFLRGSLPWQGLKADTLKER 228
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 456 | |||
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1n0q_A | 93 | 3ANK, 3 ankyrin repeats; structural protein; 1.26A | 99.87 | |
| 4gpm_A | 169 | Engineered protein OR264; de novo protein, structu | 99.87 | |
| 4gpm_A | 169 | Engineered protein OR264; de novo protein, structu | 99.86 | |
| 2l6b_A | 115 | NR1C; ankyrin, consensus, repeat protein, ising mo | 99.84 | |
| 3c5r_A | 137 | BARD-1, BRCA1-associated ring domain protein 1; an | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 3aaa_C | 123 | Myotrophin, protein V-1; actin capping protein, ba | 99.82 | |
| 3twr_A | 165 | Tankyrase-2; ankyrin repeat, protein-protein inter | 99.82 | |
| 1awc_B | 153 | Protein (GA binding protein beta 1); complex (tran | 99.81 | |
| 1d9s_A | 136 | Cyclin-dependent kinase 4 inhibitor B; helix-turn- | 99.81 | |
| 3f6q_A | 179 | Integrin-linked protein kinase; ILK, integrin-link | 99.81 | |
| 3v30_A | 172 | DNA-binding protein rfxank; structural genomics co | 99.81 | |
| 2jab_A | 136 | H10-2-G3; HER2, darpin, ankyrin repeat protein, me | 99.8 | |
| 2zgd_A | 110 | 3 repeat synthetic ankyrin; ankyrin repeat, hydrox | 99.79 | |
| 2jab_A | 136 | H10-2-G3; HER2, darpin, ankyrin repeat protein, me | 99.79 | |
| 1bi7_B | 156 | P16INK4A, MTS1, multiple tumor suppressor; cyclin | 99.79 | |
| 2y1l_E | 169 | Darpin-8.4; hydrolase-inhibitor complex, DEVD darp | 99.79 | |
| 1d9s_A | 136 | Cyclin-dependent kinase 4 inhibitor B; helix-turn- | 99.79 | |
| 1n0r_A | 126 | 4ANK, 4 ankyrin repeats; structural protein; 1.50A | 99.78 | |
| 3v31_A | 167 | Ankyrin repeat family A protein 2; structural geno | 99.78 | |
| 2vge_A | 229 | RELA-associated inhibitor; iaspp, nucleus, apoptos | 99.78 | |
| 2rfm_A | 192 | Putative ankyrin repeat protein TV1425; ANK repeat | 99.78 | |
| 3t8k_A | 186 | Uncharacterized protein; structural genomics, PSI- | 99.77 | |
| 1n0r_A | 126 | 4ANK, 4 ankyrin repeats; structural protein; 1.50A | 99.77 | |
| 1dcq_A | 278 | PYK2-associated protein beta; zinc-binding module, | 99.77 | |
| 2vge_A | 229 | RELA-associated inhibitor; iaspp, nucleus, apoptos | 99.77 | |
| 4b93_B | 269 | Ankyrin repeat domain-containing protein 27; endoc | 99.77 | |
| 1bi7_B | 156 | P16INK4A, MTS1, multiple tumor suppressor; cyclin | 99.77 | |
| 3lvq_E | 497 | ARF-GAP with SH3 domain, ANK repeat and PH domain | 99.77 | |
| 3f6q_A | 179 | Integrin-linked protein kinase; ILK, integrin-link | 99.77 | |
| 1ihb_A | 162 | P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit | 99.77 | |
| 4b93_B | 269 | Ankyrin repeat domain-containing protein 27; endoc | 99.77 | |
| 1ycs_B | 239 | 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres | 99.77 | |
| 1ihb_A | 162 | P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit | 99.76 | |
| 1oy3_D | 282 | Transcription factor inhibitor I-kappa-B-beta; pro | 99.76 | |
| 3ehr_A | 222 | Osteoclast-stimulating factor 1; beta barrel, heli | 99.76 | |
| 3deo_A | 183 | Signal recognition particle 43 kDa protein; chloro | 99.76 | |
| 2b0o_E | 301 | UPLC1; arfgap, structural genomics, structural gen | 99.76 | |
| 3v30_A | 172 | DNA-binding protein rfxank; structural genomics co | 99.76 | |
| 1bd8_A | 156 | P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr | 99.76 | |
| 1ycs_B | 239 | 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres | 99.75 | |
| 3twr_A | 165 | Tankyrase-2; ankyrin repeat, protein-protein inter | 99.75 | |
| 2rfm_A | 192 | Putative ankyrin repeat protein TV1425; ANK repeat | 99.75 | |
| 3v31_A | 167 | Ankyrin repeat family A protein 2; structural geno | 99.75 | |
| 1yyh_A | 253 | HN1;, notch 1, ankyrin domain; ankyrin repeats, ce | 99.75 | |
| 1yyh_A | 253 | HN1;, notch 1, ankyrin domain; ankyrin repeats, ce | 99.74 | |
| 3ui2_A | 244 | Signal recognition particle 43 kDa protein, chlor; | 99.74 | |
| 2dzn_A | 228 | Probable 26S proteasome regulatory subunit P28; an | 99.74 | |
| 2f8y_A | 223 | Notch homolog 1, translocation-associated (drosoph | 99.74 | |
| 2y1l_E | 169 | Darpin-8.4; hydrolase-inhibitor complex, DEVD darp | 99.74 | |
| 3c5r_A | 137 | BARD-1, BRCA1-associated ring domain protein 1; an | 99.74 | |
| 1ikn_D | 236 | Protein (I-kappa-B-alpha), protein (NF-kappa-B P50 | 99.74 | |
| 2f8y_A | 223 | Notch homolog 1, translocation-associated (drosoph | 99.73 | |
| 1awc_B | 153 | Protein (GA binding protein beta 1); complex (tran | 99.73 | |
| 1bd8_A | 156 | P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr | 99.73 | |
| 1ikn_D | 236 | Protein (I-kappa-B-alpha), protein (NF-kappa-B P50 | 99.73 | |
| 3aaa_C | 123 | Myotrophin, protein V-1; actin capping protein, ba | 99.73 | |
| 3aji_A | 231 | 26S proteasome non-ATPase regulatory subunit 10; g | 99.73 | |
| 1sw6_A | 327 | Regulatory protein SWI6; transcription regulation, | 99.72 | |
| 3b7b_A | 237 | Euchromatic histone-lysine N-methyltransferase 1; | 99.72 | |
| 3aji_A | 231 | 26S proteasome non-ATPase regulatory subunit 10; g | 99.72 | |
| 3hra_A | 201 | Ankyrin repeat family protein; structural protein; | 99.72 | |
| 3ehr_A | 222 | Osteoclast-stimulating factor 1; beta barrel, heli | 99.72 | |
| 2etb_A | 256 | Transient receptor potential cation channel subfam | 99.72 | |
| 1k1a_A | 241 | B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa | 99.72 | |
| 2xai_A | 261 | ASB-9, ankyrin repeat and SOCS box protein 9; tran | 99.72 | |
| 2rfa_A | 232 | Transient receptor potential cation channel subfa | 99.72 | |
| 4hbd_A | 276 | KN motif and ankyrin repeat domain-containing Pro; | 99.72 | |
| 3utm_A | 351 | Tankyrase-1; tankyrase, TNKS, ankryin repeat clust | 99.72 | |
| 2dzn_A | 228 | Probable 26S proteasome regulatory subunit P28; an | 99.72 | |
| 4hbd_A | 276 | KN motif and ankyrin repeat domain-containing Pro; | 99.71 | |
| 3t8k_A | 186 | Uncharacterized protein; structural genomics, PSI- | 99.71 | |
| 3jxi_A | 260 | Vanilloid receptor-related osmotically activated p | 99.71 | |
| 3d9h_A | 285 | CDNA FLJ77766, highly similar to HOMO sapiens anky | 99.71 | |
| 2rfa_A | 232 | Transient receptor potential cation channel subfa | 99.71 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.71 | |
| 1s70_B | 299 | 130 kDa myosin-binding subunit of smooth muscle my | 99.71 | |
| 2etb_A | 256 | Transient receptor potential cation channel subfam | 99.71 | |
| 2xai_A | 261 | ASB-9, ankyrin repeat and SOCS box protein 9; tran | 99.71 | |
| 2pnn_A | 273 | Transient receptor potential cation channel subfa | 99.71 | |
| 2pnn_A | 273 | Transient receptor potential cation channel subfa | 99.71 | |
| 1k1a_A | 241 | B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa | 99.7 | |
| 3kea_A | 285 | K1L; tropism, ANK repeat, viral protein; 2.30A {Va | 99.7 | |
| 1oy3_D | 282 | Transcription factor inhibitor I-kappa-B-beta; pro | 99.7 | |
| 3deo_A | 183 | Signal recognition particle 43 kDa protein; chloro | 99.7 | |
| 1wdy_A | 285 | 2-5A-dependent ribonuclease; hydrolase, RNA-bindin | 99.7 | |
| 3ljn_A | 364 | Hypothetical protein; ankyrin, structural genomics | 99.7 | |
| 3jxi_A | 260 | Vanilloid receptor-related osmotically activated p | 99.7 | |
| 1s70_B | 299 | 130 kDa myosin-binding subunit of smooth muscle my | 99.69 | |
| 3jue_A | 368 | Arfgap with coiled-coil, ANK repeat and PH domain | 99.69 | |
| 3hra_A | 201 | Ankyrin repeat family protein; structural protein; | 99.69 | |
| 3d9h_A | 285 | CDNA FLJ77766, highly similar to HOMO sapiens anky | 99.69 | |
| 1wdy_A | 285 | 2-5A-dependent ribonuclease; hydrolase, RNA-bindin | 99.69 | |
| 3ui2_A | 244 | Signal recognition particle 43 kDa protein, chlor; | 99.69 | |
| 3b7b_A | 237 | Euchromatic histone-lysine N-methyltransferase 1; | 99.68 | |
| 1n11_A | 437 | Ankyrin; clathrin, BAND 3, anion exchanger, struct | 99.68 | |
| 4g8k_A | 337 | 2-5A-dependent ribonuclease; ankyrin-repeat domain | 99.68 | |
| 3utm_A | 351 | Tankyrase-1; tankyrase, TNKS, ankryin repeat clust | 99.68 | |
| 1n11_A | 437 | Ankyrin; clathrin, BAND 3, anion exchanger, struct | 99.68 | |
| 3kea_A | 285 | K1L; tropism, ANK repeat, viral protein; 2.30A {Va | 99.67 | |
| 2fo1_E | 373 | LIN-12 protein; beta-barrel, protein-DNA complex, | 99.66 | |
| 3ljn_A | 364 | Hypothetical protein; ankyrin, structural genomics | 99.66 | |
| 3jue_A | 368 | Arfgap with coiled-coil, ANK repeat and PH domain | 99.65 | |
| 2fo1_E | 373 | LIN-12 protein; beta-barrel, protein-DNA complex, | 99.64 | |
| 3eu9_A | 240 | Huntingtin-interacting protein 14; epigenetics, an | 99.61 | |
| 3eu9_A | 240 | Huntingtin-interacting protein 14; epigenetics, an | 99.61 | |
| 2b0o_E | 301 | UPLC1; arfgap, structural genomics, structural gen | 99.6 | |
| 3lvq_E | 497 | ARF-GAP with SH3 domain, ANK repeat and PH domain | 99.6 | |
| 1dcq_A | 278 | PYK2-associated protein beta; zinc-binding module, | 99.58 | |
| 4g8k_A | 337 | 2-5A-dependent ribonuclease; ankyrin-repeat domain | 99.54 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.53 | |
| 2l6b_A | 115 | NR1C; ankyrin, consensus, repeat protein, ising mo | 99.5 | |
| 1sw6_A | 327 | Regulatory protein SWI6; transcription regulation, | 99.49 | |
| 1n0q_A | 93 | 3ANK, 3 ankyrin repeats; structural protein; 1.26A | 99.49 | |
| 2aja_A | 376 | Ankyrin repeat family protein; NESG, Q5ZSV0, struc | 99.45 | |
| 2aja_A | 376 | Ankyrin repeat family protein; NESG, Q5ZSV0, struc | 99.41 | |
| 2zgd_A | 110 | 3 repeat synthetic ankyrin; ankyrin repeat, hydrox | 99.29 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.84 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.79 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.75 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.54 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.28 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.23 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.0 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.57 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.53 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.39 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.32 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.08 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.99 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.63 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.4 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.17 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.94 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.66 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.33 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.27 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 85.92 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.81 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 83.76 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 80.85 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 80.66 |
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-55 Score=424.19 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=219.6
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
..|...++||+|+||.| ..+|+.||||++..+.. ..+|+.+++.++|||||++++++.+++.+||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35778889999999977 24689999999976532 246999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-CEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG-HLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~-~vkl~Dfgls~~~~~~~~ 305 (456)
|||+||+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.+| .+||+|||+|+.+.....
T Consensus 130 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999999999899999999999999999999999999 99999999999999887 699999999987743322
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
...........||+.|||||++.+..++.++|||||||++|+|++|++||.+.+...+...+.... ++....+..+++.
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~s~~ 285 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP-PPIREIPPSCAPL 285 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC-CGGGGSCTTSCHH
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC-CCchhcCccCCHH
Confidence 222122234579999999999999999999999999999999999999999988888887775543 3333346789999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMRLDDISDQLS 419 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~ 419 (456)
+.+||.+||++||++|||+.|++++|........
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 9999999999999999999999999999988774
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-55 Score=424.22 Aligned_cols=246 Identities=24% Similarity=0.467 Sum_probs=211.7
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|++.+.||+|+||.| ..+|+.||||++.+... .....+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999976 24689999999987653 45567889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
||+||+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 999999999997643 4799999999999999999999999 9999999999999999999999999998763221
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.......||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+....+.....++. +..+|.+
T Consensus 180 ----~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~---~~~~s~~ 252 (350)
T 4b9d_A 180 ----ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV---SLHYSYD 252 (350)
T ss_dssp ----HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---CTTSCHH
T ss_pred ----ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC---CccCCHH
Confidence 112235699999999999999999999999999999999999999999888888777766655443 5678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.+||.+||+.||++|||++|++++
T Consensus 253 ~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 253 LRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999886
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=407.45 Aligned_cols=244 Identities=26% Similarity=0.443 Sum_probs=200.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|++.+.||+|+||.| ..+|+.||||++.+...........+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 6888999999999976 24689999999987655555556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|| +|+|.+++.+++.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~----- 164 (275)
T 3hyh_A 94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD----- 164 (275)
T ss_dssp CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC-----
Confidence 99 6899999999899999999999999999999999999 99999999999999999999999999986632
Q ss_pred CCCCcccCCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEY-DTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+... ...+ +..+|+++
T Consensus 165 -~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~-~~~~---p~~~s~~~ 239 (275)
T 3hyh_A 165 -GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG-VYTL---PKFLSPGA 239 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CCCC---CTTSCHHH
T ss_pred -CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-CCCC---CCCCCHHH
Confidence 122334679999999999998876 57999999999999999999999988777766666443 3332 46789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+||.+||+.||++|||++|+++|
T Consensus 240 ~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 240 AGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHccCChhHCcCHHHHHcC
Confidence 999999999999999999999886
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-55 Score=420.99 Aligned_cols=248 Identities=23% Similarity=0.398 Sum_probs=217.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.| ..+|+.||||++.+....++...+.+.+|+++|++++||||++++++|.+++.+|+|||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 6999999999999987 24689999999975433223345788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
||+||+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~--- 186 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--- 186 (311)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT---
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC---
Confidence 9999999999999899999999999999999999999999 9999999999999999999999999999763221
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
.........||+.|||||++.+..++.++|||||||++|+|++|++||.+.+..++...+.... ..+ +..+++++.
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~---p~~~s~~~~ 262 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE-YDF---PEKFFPKAR 262 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCC---CTTCCHHHH
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCC---CcccCHHHH
Confidence 1122345679999999999999999999999999999999999999999888877777775443 333 467899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+||.+||.+||++|||++|++.+
T Consensus 263 dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 263 DLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp HHHHHHSCSSGGGSTTSGGGTCH
T ss_pred HHHHHHccCCHhHCcChHHHcCC
Confidence 99999999999999999997654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=407.12 Aligned_cols=266 Identities=27% Similarity=0.433 Sum_probs=216.4
Q ss_pred CccccCccccccccceeeeccEEEEEeE--cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012777 143 PEYEIDPKELDFSNSVEITKGTFRIASW--RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST 220 (456)
Q Consensus 143 ~~~~~~~~~~~~~~~~~lg~G~fg~~~~--~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 220 (456)
..|||+.++ +...+.||+|+||.|.. ....||||+++... ...+..+.|.+|+.++++++|||||++++++.+ +
T Consensus 29 ~~Wei~~~~--l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 29 YYWEIEASE--VMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp CCCBCCTTS--CCEEEECCCCSSSEEEEEESSSEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred cCcEEcHHH--eEEeeEEeeCCCcEEEEEEECCcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 346777655 55677999999997732 34579999997653 456677899999999999999999999998864 5
Q ss_pred ceEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKL 299 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~ 299 (456)
.++||||||++|+|.+++... +.+++.++..|+.|++.||.|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 689999999999999999764 56999999999999999999999999 99999999999999999999999999986
Q ss_pred ccccccccCCCCcccCCCCcccccccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC--CCC
Q 012777 300 LKFANTVKEDRPVTCEETSWRYAAPEVYKN---EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE--RPP 374 (456)
Q Consensus 300 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~ 374 (456)
..... .........||+.|||||++.+ .+++.++|||||||++|||+||+.||.+.+.......+.... .+.
T Consensus 182 ~~~~~---~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~ 258 (307)
T 3omv_A 182 KSRWS---GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD 258 (307)
T ss_dssp ---------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC
T ss_pred cccCC---cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC
Confidence 53211 1122334679999999999864 368899999999999999999999998877655444443333 334
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 375 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
....+..+|.++.+||.+||+.||++|||+.++++.|+.+...+
T Consensus 259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 44456788999999999999999999999999999999876543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-54 Score=411.81 Aligned_cols=253 Identities=27% Similarity=0.451 Sum_probs=218.0
Q ss_pred ccccceeeeccEEEEEe----------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 153 DFSNSVEITKGTFRIAS----------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~----------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
+|...+.||+|+||.|. .++..||||+++.. .....+.|.+|+++|++++|||||++++++.+++.+
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 57788899999999762 24778999999753 566678899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCE
Q 012777 223 MIVTEYLPKGDLRAYLKQK-------------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~-------------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~v 289 (456)
++|||||++|+|.+++.+. ..+++.++..|+.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcE
Confidence 9999999999999999764 25999999999999999999999999 9999999999999999999
Q ss_pred EEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHH
Q 012777 290 KVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYI 368 (456)
Q Consensus 290 kl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~ 368 (456)
||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..++...+.
T Consensus 168 Ki~DFGla~~~~~~~~~---~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp EECCCSCHHHHTGGGCE---EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred EECCcccceecCCCCce---eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999865322111 11122358899999999999999999999999999999998 899999988888888776
Q ss_pred hcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 369 ANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
.+.+++. +..+|.++.+||.+||+.||++|||+++++..|+.+.+.
T Consensus 245 ~~~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 245 QGRVLQR---PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 6655543 567899999999999999999999999999999988654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-54 Score=417.03 Aligned_cols=245 Identities=22% Similarity=0.378 Sum_probs=214.2
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|+..++||+|+||.| ..+|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5888899999999977 2368999999997653322 3568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
||+||+|.+++.+ +.+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.+...
T Consensus 152 y~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~---- 223 (346)
T 4fih_A 152 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE---- 223 (346)
T ss_dssp CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS----
T ss_pred CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC----
Confidence 9999999999976 56999999999999999999999999 999999999999999999999999999876321
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
........||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+....+.....+.+ ..+..++.++.
T Consensus 224 -~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~-~~~~~~s~~~~ 301 (346)
T 4fih_A 224 -VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-KNLHKVSPSLK 301 (346)
T ss_dssp -SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-SCGGGSCHHHH
T ss_pred -CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-CccccCCHHHH
Confidence 1223456899999999999999999999999999999999999999999887777777755443333 23467899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+||.+||..||++|||++|+++|
T Consensus 302 dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 302 GFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999999876
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=411.84 Aligned_cols=253 Identities=27% Similarity=0.447 Sum_probs=214.1
Q ss_pred ccccceeeeccEEEEEeE----------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 153 DFSNSVEITKGTFRIASW----------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~~----------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
+|...++||+|+||.|.. +++.||||+++.. ++...+.|.+|+++|++++|||||+++++|.+...+
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 567778999999998732 4778999999753 566678899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC
Q 012777 223 MIVTEYLPKGDLRAYLKQK---------------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~---------------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~ 287 (456)
+||||||++|+|.+++.+. +++++.++..|+.|++.||.|||+++ ||||||||+|||++.++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCC
Confidence 9999999999999999753 35899999999999999999999999 99999999999999999
Q ss_pred CEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHH
Q 012777 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKA 366 (456)
Q Consensus 288 ~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~ 366 (456)
.+||+|||+++...... .........||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..+....
T Consensus 196 ~~Ki~DFGla~~~~~~~---~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTD---YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp EEEECCCC-------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred cEEEcccccceeccCCC---cceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999998663221 1112234568999999999999999999999999999999999 8999999888887777
Q ss_pred HHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 367 YIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
+..+.+++. +..+|+++.+||.+||+.||++|||++||+++|+.+.+.
T Consensus 273 i~~g~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 273 ITQGRELER---PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHTCCCCC---CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHcCCCCCC---cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 766655544 567899999999999999999999999999999988653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=407.77 Aligned_cols=256 Identities=28% Similarity=0.474 Sum_probs=216.9
Q ss_pred ccCccccccccceeeeccEEEEEe---E-------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeE
Q 012777 146 EIDPKELDFSNSVEITKGTFRIAS---W-------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGA 215 (456)
Q Consensus 146 ~~~~~~~~~~~~~~lg~G~fg~~~---~-------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 215 (456)
++...+ ++..++||+|+||.|. + +++.||||+++... .....+.|.+|+.++++++|||||+++++
T Consensus 22 ei~~~~--~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 22 EISLSA--VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp BCCGGG--EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCCHHH--CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 444444 4456789999999772 2 46789999997653 33345789999999999999999999999
Q ss_pred EEeCCceEEEEEccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 012777 216 VTQSTPMMIVTEYLPKGDLRAYLKQK----------------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPS 279 (456)
Q Consensus 216 ~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~ 279 (456)
+.++..+++|||||++|+|.+++... ..+++..+..|+.|++.||.|||+++ ||||||||+
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~ 174 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATR 174 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCcccc
Confidence 99999999999999999999999653 34899999999999999999999999 999999999
Q ss_pred CeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 012777 280 NILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTK 358 (456)
Q Consensus 280 Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~ 358 (456)
|||+++++.+||+|||+++....... ........||++|||||++.+..++.++|||||||++|||+| |..||.+.
T Consensus 175 NILl~~~~~~Ki~DFGlar~~~~~~~---~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~ 251 (308)
T 4gt4_A 175 NVLVYDKLNVKISDLGLFREVYAADY---YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 251 (308)
T ss_dssp GEEECGGGCEEECCSCCBCGGGGGGC---BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred ceEECCCCCEEECCcccceeccCCCc---eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999986643211 122334578999999999999999999999999999999998 89999998
Q ss_pred CccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 359 QEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
+..++...+..+.+++. +..+|..+.+|+.+||+.||++|||+++|+++|+.+
T Consensus 252 ~~~~~~~~i~~~~~~~~---p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 252 SNQDVVEMIRNRQVLPC---PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp CHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CHHHHHHHHHcCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 88888777765555543 568899999999999999999999999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=399.58 Aligned_cols=245 Identities=26% Similarity=0.448 Sum_probs=204.1
Q ss_pred ccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe----CCceEEE
Q 012777 155 SNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ----STPMMIV 225 (456)
Q Consensus 155 ~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----~~~~~lv 225 (456)
...++||+|+||.|. .++..||+|++.... ......+.|.+|+.++++++|||||+++++|.. +..+|+|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 556789999999872 358899999997654 345567889999999999999999999999865 3458999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-CCCCEEEeccCCcccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD-DSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~-~~~~vkl~Dfgls~~~~~~~ 304 (456)
||||+||+|.+++.+.+.+++..+..|+.||+.||.|||+++ .+|+||||||+|||++ .++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~--- 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 183 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC---
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC---
Confidence 999999999999999889999999999999999999999875 2499999999999998 47899999999997542
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
........||+.|||||++.+ .++.++|||||||++|+|++|+.||.+................+. ..+...++
T Consensus 184 ----~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~-~~~~~~~~ 257 (290)
T 3fpq_A 184 ----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA-SFDKVAIP 257 (290)
T ss_dssp ----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG-GGGGCCCH
T ss_pred ----CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC-CCCccCCH
Confidence 123345679999999999875 699999999999999999999999987655433333323332221 12456778
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.+||.+||..||++|||++|+++|
T Consensus 258 ~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 258 EVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 89999999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-53 Score=418.30 Aligned_cols=245 Identities=22% Similarity=0.378 Sum_probs=214.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|+..+.||+|+||.| ..+|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+.+.+|||||
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 5888999999999977 2368999999997653222 3568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
||+||+|.+++.. +.+++..+..|+.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++.+...
T Consensus 229 y~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~---- 300 (423)
T 4fie_A 229 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE---- 300 (423)
T ss_dssp CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS----
T ss_pred CCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC----
Confidence 9999999999875 56999999999999999999999999 999999999999999999999999999876321
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
........||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+....+.....+.+ ..+..++.++.
T Consensus 301 -~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~-~~~~~~s~~~~ 378 (423)
T 4fie_A 301 -VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-KNLHKVSPSLK 378 (423)
T ss_dssp -CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SCTTSSCHHHH
T ss_pred -CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-cccccCCHHHH
Confidence 1223456799999999999999999999999999999999999999999888777777755543333 23567899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+||.+||..||++|||++|+++|
T Consensus 379 dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 379 GFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999999886
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=408.33 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=205.6
Q ss_pred ccccceeeeccEEEEEe--------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 153 DFSNSVEITKGTFRIAS--------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~--------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
+|++.+.||+|+||.|. .+++.||||++.+..... .....+.+|+.+|++++||||+++++++.+++.+|+
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 69999999999999772 246789999997643221 112357889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 225 VTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
|||||+||+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH- 179 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCC-
Confidence 9999999999999999899999999999999999999999999 999999999999999999999999999865321
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
........||+.|||||++.+..++.++|||||||++|+|++|++||.+.+..+....+.... .++ +..+|+
T Consensus 180 ----~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~---p~~~s~ 251 (304)
T 3ubd_A 180 ----EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK-LGM---PQFLSP 251 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCC---CTTSCH
T ss_pred ----CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCC---CCcCCH
Confidence 122334679999999999999999999999999999999999999999988877777775443 332 467899
Q ss_pred HHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTF-----RQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~-----~ell~~ 410 (456)
++.+||.+||+.||++|||+ +|+++|
T Consensus 252 ~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 252 EAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 99999999999999999984 677654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=399.86 Aligned_cols=261 Identities=28% Similarity=0.484 Sum_probs=216.4
Q ss_pred ccccCccccccccceeeeccEEEEEeE----------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCC-Ccceee
Q 012777 144 EYEIDPKELDFSNSVEITKGTFRIASW----------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRH-PNVVQF 212 (456)
Q Consensus 144 ~~~~~~~~~~~~~~~~lg~G~fg~~~~----------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l 212 (456)
.|||+.+ +|...+.||+|+||.|.. .++.||||.+... ......+.|.+|+.+|+++.| ||||++
T Consensus 58 ~wEi~~~--~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~--~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 58 KWEFPRD--RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp HHBCCGG--GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccEecHH--HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc--cChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3555544 577888999999998732 2357999999865 345567889999999999965 999999
Q ss_pred eeEEEeC-CceEEEEEccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 012777 213 LGAVTQS-TPMMIVTEYLPKGDLRAYLKQK----------------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRD 275 (456)
Q Consensus 213 ~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~D 275 (456)
+++|.++ ..+++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999764 5789999999999999999753 23889999999999999999999999 99999
Q ss_pred CCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCC
Q 012777 276 LEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPP 354 (456)
Q Consensus 276 ikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p 354 (456)
|||+|||++.++.+||+|||+|+.+..... ........||+.|||||++.+..++.++|||||||++|||+| |+.|
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~---~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~P 287 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPD---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTT---SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCC---ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCC
Confidence 999999999999999999999986632211 111223468899999999999999999999999999999998 9999
Q ss_pred CCCCCccchH-HHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 355 FPTKQEKEVP-KAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 355 f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
|.+....+.. ..+..+.+++. +..+++++.++|.+||+.||++|||+++++++|+.+.+.
T Consensus 288 f~~~~~~~~~~~~i~~g~~~~~---p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 288 YPGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp STTCCCSHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 9987765544 44444444443 467899999999999999999999999999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=385.01 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=188.5
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC-------
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST------- 220 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~------- 220 (456)
+|+..+.||+|+||.|. .+|+.||||++... ..+...+.+.+|+.+|++++|||||+++++|.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP--NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC--SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 57888999999999772 36899999999754 35566678999999999999999999999987654
Q ss_pred -----ceEEEEEccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEe
Q 012777 221 -----PMMIVTEYLPKGDLRAYLKQKGA---LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVA 292 (456)
Q Consensus 221 -----~~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~ 292 (456)
.+|+|||||++|+|.+++...+. .++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 37999999999999999987655 445668899999999999999999 9999999999999999999999
Q ss_pred ccCCccccccccccc-------CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHH
Q 012777 293 DFGLSKLLKFANTVK-------EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPK 365 (456)
Q Consensus 293 Dfgls~~~~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 365 (456)
|||+|+......... .........||+.|||||++.+..++.++|||||||++|||++ ||.... +...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence 999998764321111 0112234579999999999999999999999999999999996 775432 1111
Q ss_pred HHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 366 AYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+.......++......++.+.+||.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111112211123445668899999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=381.66 Aligned_cols=262 Identities=27% Similarity=0.402 Sum_probs=195.1
Q ss_pred ccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC----ceEEE
Q 012777 153 DFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST----PMMIV 225 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~----~~~lv 225 (456)
++...+.||+|+||.| .++|+.||||++.... .....+..|+..+.+++||||+++++++.+++ .++||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 4667789999999865 6789999999997531 22222345666667789999999999998654 57999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENR-----PEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~-----~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
||||++|+|.+++.. ..+++..+..++.|++.||.|||++. ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 999999999999976 46999999999999999999999871 112999999999999999999999999999876
Q ss_pred cccccccCCCCcccCCCCcccccccccCCC------CCCCchhHHHHHHHHHHHHcCCCCCCCCCc----------c---
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNE------EYDTKVDVFSFALILQEMIEGCPPFPTKQE----------K--- 361 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~l~~g~~pf~~~~~----------~--- 361 (456)
....... ........||+.|||||++.+. .++.++|||||||++|||+||.+||..... .
T Consensus 159 ~~~~~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 159 DSATDTI-DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp ETTTTEE-SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred cCCCCce-eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 4321111 1122335799999999998764 466789999999999999999876543221 1
Q ss_pred --chHHHHHhcC-CCCCCCC--CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhcc
Q 012777 362 --EVPKAYIANE-RPPFRAP--TTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSI 420 (456)
Q Consensus 362 --~~~~~~~~~~-~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~ 420 (456)
.....+.... +|+++.. ....+..+.+|+.+||+.||++|||+.|+++.|+.+.++-++
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~i 301 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCC
Confidence 1112221222 3333211 112335688999999999999999999999999998876544
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=391.93 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=208.5
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe------CCc
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ------STP 221 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------~~~ 221 (456)
+|.+.+.||+|+||.| ..+|+.||||++.+.. ......+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5899999999999977 2469999999998654 345566788999999999999999999998764 357
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
+|+|||||+ |+|.+++.+.+.+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 899999995 689999988889999999999999999999999999 9999999999999999999999999998663
Q ss_pred ccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCC---
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFR--- 376 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~--- 376 (456)
.... ..........||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+....+.... .++..
T Consensus 210 ~~~~-~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 210 TSPA-EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred cCcc-ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 3211 122233457899999999998775 56899999999999999999999999887766655553321 11100
Q ss_pred -----------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 377 -----------------------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 377 -----------------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.....++.++.+||.+||..||++|||++|+++|
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0123578899999999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=401.96 Aligned_cols=246 Identities=24% Similarity=0.346 Sum_probs=204.2
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCC---CCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVF---TDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
--+|.+.+.||+|+||.| ..+|+.||||++.+... ...........++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 347999999999999987 24799999999975432 1222222233446677778999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++| ||||||||+|||++.+|.+||+|||+|+....
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999999999999899999999999999999999999999 99999999999999999999999999987632
Q ss_pred cccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccch---HHHHHhcCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV---PKAYIANERPPFRAP 378 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 378 (456)
. ......||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+.... ...+ ......+
T Consensus 345 ~-------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i-~~~~~~~--- 413 (689)
T 3v5w_A 345 K-------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVEL--- 413 (689)
T ss_dssp C-------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH-HHCCCCC---
T ss_pred C-------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh-cCCCCCC---
Confidence 1 1234579999999999965 5799999999999999999999999977554332 2222 2233332
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 012777 379 TTHYAYGLRELIEDCWSEEPFRRPT-----FRQILMR 410 (456)
Q Consensus 379 ~~~~~~~l~~li~~~l~~dp~~Rpt-----~~ell~~ 410 (456)
+..+|.++.+||.+||..||.+|++ ++|+++|
T Consensus 414 p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 414 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 5678999999999999999999998 6888776
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=398.92 Aligned_cols=246 Identities=22% Similarity=0.372 Sum_probs=214.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.| ..+|+.||+|++... .....+.+.+|+.+|+.++||||++++++|.+...+|+|||
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 6889999999999977 246899999999754 34556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC--CCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS--GHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~--~~vkl~Dfgls~~~~~~~ 304 (456)
||+||+|.+++.+ .+.+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+..
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~-- 309 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-- 309 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT--
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC--
Confidence 9999999999864 457999999999999999999999999 9999999999999854 8999999999987632
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
........||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+....+..............++.
T Consensus 310 ----~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 385 (573)
T 3uto_A 310 ----KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385 (573)
T ss_dssp ----TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCH
T ss_pred ----CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 2233445799999999999999999999999999999999999999999888887777754432222223467899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.+||.+||+.||.+|||++|+++|
T Consensus 386 ~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 386 DGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999999886
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=367.30 Aligned_cols=248 Identities=20% Similarity=0.270 Sum_probs=194.9
Q ss_pred cccccceeeeccEEEEEeE--------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCce
Q 012777 152 LDFSNSVEITKGTFRIASW--------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~~--------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 222 (456)
-.|++.+.||+|+||.|.. +++.||+|++.... . ...+.+|+++|+.+ +||||++++++|.+.+.+
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--H---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--C---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--C---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 3599999999999998721 36789999987542 2 24678999999998 699999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC-CCEEEeccCCccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS-GHLKVADFGLSKLLK 301 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~-~~vkl~Dfgls~~~~ 301 (456)
|+|||||++++|.+++. .+++.++..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+|+...
T Consensus 96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 99999999999999983 5999999999999999999999999 9999999999999876 799999999998653
Q ss_pred ccccc-----------------------cCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 012777 302 FANTV-----------------------KEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPT 357 (456)
Q Consensus 302 ~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~ 357 (456)
..... ..........||+.|+|||++.+. .++.++||||+||++|+|++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 21100 001122345799999999998775 588999999999999999999999965
Q ss_pred CCcc-chHHHHHh-------------------------------------cC---CCC----------CCCCCCCCcHHH
Q 012777 358 KQEK-EVPKAYIA-------------------------------------NE---RPP----------FRAPTTHYAYGL 386 (456)
Q Consensus 358 ~~~~-~~~~~~~~-------------------------------------~~---~~~----------~~~~~~~~~~~l 386 (456)
.+.. +....+.. .. .+. .......+++++
T Consensus 250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a 329 (361)
T 4f9c_A 250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA 329 (361)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence 4322 11111110 00 000 001235678899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+||.+||..||++|||++|+++|
T Consensus 330 ~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 330 YDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHCcCChhHCcCHHHHhcC
Confidence 999999999999999999999876
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=355.12 Aligned_cols=245 Identities=26% Similarity=0.466 Sum_probs=215.3
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
-+|.+.+.||+|+||.|. .+|+.||||++.... .+....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 368999999999999763 478999999997654 35566788999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||+++++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--- 167 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS---
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC---
Confidence 99999999999998889999999999999999999999999 999999999999999999999999999865321
Q ss_pred cCCCCcccCCCCcccccccccCCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYD-TKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+..... . .+..++.+
T Consensus 168 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~---~p~~~s~~ 240 (328)
T 3fe3_A 168 ---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-R---IPFYMSTD 240 (328)
T ss_dssp ---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-C---CCTTSCHH
T ss_pred ---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-C---CCCCCCHH
Confidence 223446789999999999888775 689999999999999999999999887777766644432 2 24568899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.++|.+||..||.+|||+++++++
T Consensus 241 ~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 241 CENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcC
Confidence 9999999999999999999999886
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=345.77 Aligned_cols=259 Identities=35% Similarity=0.580 Sum_probs=212.9
Q ss_pred ccccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 151 ELDFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
..+|.+.+.||+|+||.| ..+|+.||||++.... ......+.+.+|+.++++++||||+++++++......++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCC-CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 446888999999999865 5689999999998664 355667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQKGA---LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~---l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
|+++++|.+++...+. +++..++.++.|++.||.|||+++ .+|+||||||+|||++.++.+||+|||++......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~- 192 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST- 192 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc-
Confidence 9999999999987553 999999999999999999999986 24999999999999999999999999998754221
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
........||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+...... ...+..++.
T Consensus 193 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 266 (309)
T 3p86_A 193 ----FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR--LEIPRNLNP 266 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC--CCCCTTSCH
T ss_pred ----ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--CCCCccCCH
Confidence 11223456899999999999999999999999999999999999999988776666555333321 123568899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
.+.++|.+||..||++|||++++++.|+.+.+..
T Consensus 267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999988654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=352.80 Aligned_cols=257 Identities=29% Similarity=0.535 Sum_probs=220.0
Q ss_pred ccccccceeeeccEEEEEeE------------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEE
Q 012777 151 ELDFSNSVEITKGTFRIASW------------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVT 217 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~~------------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~ 217 (456)
..+|.+.+.||+|+||.|.. ++..||||++... ......+.+.+|+.+++++ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 34688899999999987631 2457999999765 3566678899999999999 8999999999999
Q ss_pred eCCceEEEEEccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 012777 218 QSTPMMIVTEYLPKGDLRAYLKQKG----------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNI 281 (456)
Q Consensus 218 ~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Ni 281 (456)
..+.+++||||+++++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhE
Confidence 9999999999999999999998753 3788999999999999999999999 99999999999
Q ss_pred EeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 012777 282 LRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQE 360 (456)
Q Consensus 282 l~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~ 360 (456)
|++.++.+||+|||++....... .........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNID---YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCC---TTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred EECCCCCEEEccccCCcccCccc---ceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999998653221 1112233456788999999999899999999999999999999 9999999887
Q ss_pred cchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 361 KEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
.+....+.....+.. +..++..+.++|.+||..||++|||+.++++.|+.+....
T Consensus 312 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 312 EELFKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp GGHHHHHHTTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 777766655444433 5678899999999999999999999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=352.81 Aligned_cols=246 Identities=25% Similarity=0.386 Sum_probs=212.3
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||+|+||.|. .+|+.||+|++.+...........+.+|+.+++.++||||+++++++.....+++|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 68889999999999762 3689999999975422122234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~----- 157 (337)
T 1o6l_A 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS----- 157 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc-----
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999875421
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
.........||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+.... .. .+..++.++.
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~---~p~~~s~~~~ 233 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IR---FPRTLSPEAK 233 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CC---CCTTSCHHHH
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC---CCCCCCHHHH
Confidence 1122334568999999999999999999999999999999999999999887766666664432 22 2467899999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rp-----t~~ell~~ 410 (456)
++|.+||..||++|| +++++++|
T Consensus 234 ~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 999999999999999 89999887
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=343.08 Aligned_cols=247 Identities=22% Similarity=0.422 Sum_probs=212.7
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
..+|+..+.||+|+||.| ..+|+.||+|++....... .+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 346899999999999976 2468899999997654333 35688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|||+++++|.+++.+. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 169 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169 (297)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc--
Confidence 9999999999999764 6999999999999999999999999 999999999999999999999999998865321
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
........||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.....+... .+..++..
T Consensus 170 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 245 (297)
T 3fxz_A 170 ---QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ-NPEKLSAI 245 (297)
T ss_dssp ---TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS-CGGGSCHH
T ss_pred ---ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-CccccCHH
Confidence 12233457899999999999999999999999999999999999999888776655555444443332 24678899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.++|.+||..||++|||+++++++
T Consensus 246 ~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 246 FRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHccCChhHCcCHHHHhhC
Confidence 9999999999999999999999876
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=360.43 Aligned_cols=249 Identities=19% Similarity=0.313 Sum_probs=214.9
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.|. .+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 68888999999999773 3689999999986543 34456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC---CCCCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD---DSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~---~~~~vkl~Dfgls~~~~~~~ 304 (456)
|+++++|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~- 166 (444)
T 3soa_A 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE- 166 (444)
T ss_dssp CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT-
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC-
Confidence 9999999999999888999999999999999999999999 99999999999998 4678999999999765321
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+..............++.
T Consensus 167 ----~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 242 (444)
T 3soa_A 167 ----QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242 (444)
T ss_dssp ----CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred ----CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence 1222345799999999999999999999999999999999999999998887777777755543322223467899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.+||.+||..||++|||+.+++++
T Consensus 243 ~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 243 EAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999999999999999999985
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=346.15 Aligned_cols=260 Identities=24% Similarity=0.363 Sum_probs=218.3
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|++.+.||+|+||.|. .+++.||+|++...........+.+.+|+.++++++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 368899999999999762 368899999997666667777889999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||+++++|.+++...+++++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 165 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-- 165 (294)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccc--
Confidence 99999999999998889999999999999999999999999 9999999999999999999999999998663211
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCC-CCCCCCCcHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPF-RAPTTHYAYG 385 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 385 (456)
........||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.............+.. ......++..
T Consensus 166 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T 4eqm_A 166 --LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred --ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence 1122234689999999999999999999999999999999999999988776655544444333322 1234678999
Q ss_pred HHHHHHHhcccCCCCCC-CHHHHHHHHHHHHHHh
Q 012777 386 LRELIEDCWSEEPFRRP-TFRQILMRLDDISDQL 418 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rp-t~~ell~~L~~~~~~~ 418 (456)
+.++|.+||..||.+|| +++++.+.|+.+..+-
T Consensus 244 l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 244 LSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp HHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred HHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 99999999999999998 8999999888765443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=355.19 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=212.8
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCH---HHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDE---DKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM 223 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 223 (456)
..|.+.+.||+|+||.|. .+|+.||+|++.+...... ...+.+.+|+.++++++||||+++++++.....++
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 368889999999999762 3589999999976543211 12467889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC----CEEEeccCCccc
Q 012777 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG----HLKVADFGLSKL 299 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~----~vkl~Dfgls~~ 299 (456)
+||||+++++|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999999999988888999999999999999999999999 99999999999998776 799999999986
Q ss_pred ccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCC
Q 012777 300 LKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPT 379 (456)
Q Consensus 300 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 379 (456)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+...........+
T Consensus 169 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 169 IEDG------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp CCTT------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred cCCC------CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 6321 2233456899999999999999999999999999999999999999988877776666443322111123
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 380 THYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..++..+.+||.+||..||++|||+++++++
T Consensus 243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 5788999999999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=352.39 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=214.0
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.|. .+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 68889999999999763 3588999999976543 45566789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC---CCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS---GHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~---~~vkl~Dfgls~~~~~~~ 304 (456)
|+++++|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.....
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~-- 183 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-- 183 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT--
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecC--
Confidence 9999999999988888999999999999999999999999 9999999999999865 4599999999986632
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+..............++.
T Consensus 184 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (362)
T 2bdw_A 184 ----SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 259 (362)
T ss_dssp ----CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCH
T ss_pred ----CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 1223345789999999999999999999999999999999999999998877777666654432221222357889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.+||.+||..||++|||+.+++++
T Consensus 260 ~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 260 EAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 99999999999999999999999987
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=344.58 Aligned_cols=274 Identities=28% Similarity=0.441 Sum_probs=222.1
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|...+.||+|+||.|. .+++.||+|++.. .+....+.+.+|+.++++++||||+++++++......++||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 368888999999999762 3588999999864 35667788999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
||+++++|.+++.. .+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999987 456999999999999999999999999 99999999999999999999999999986633211
Q ss_pred ccC---------CCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccch-----HHHHHhcC
Q 012777 306 VKE---------DRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV-----PKAYIANE 371 (456)
Q Consensus 306 ~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~ 371 (456)
... ........||+.|+|||++.+..++.++||||||+++|+|++|..||........ ........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY 243 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc
Confidence 110 0111245689999999999999999999999999999999999999876543321 11111111
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccccccCcchhhHHHHHhhhc
Q 012777 372 RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVGPLRCFQSLAALWKK 441 (456)
Q Consensus 372 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (456)
.+..++..+.++|.+||..||++|||++++++.|+.+...+... .+....++.....||.
T Consensus 244 ------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~----~~~~~~~~~~~~~~w~ 303 (310)
T 3s95_A 244 ------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH----LPLGPQLEQLDRGFWE 303 (310)
T ss_dssp ------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC----CCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc----ccCCcchhhccchHHH
Confidence 13567788999999999999999999999999999999887432 2222346666666664
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=345.57 Aligned_cols=259 Identities=28% Similarity=0.469 Sum_probs=219.1
Q ss_pred ccccccceeeeccEEEEEe---E-----cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 151 ELDFSNSVEITKGTFRIAS---W-----RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~---~-----~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
..+|.+.+.||+|+||.|. . .+..||||++... ......+.+.+|+.++++++||||+++++++......
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 4468889999999999762 2 3446999999864 3566678899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
++||||+++++|.+++... +.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999999764 56999999999999999999999999 9999999999999999999999999998763
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
..... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+......+. +.
T Consensus 203 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 277 (325)
T 3kul_A 203 DDPDA--AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA---PM 277 (325)
T ss_dssp ----C--CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CT
T ss_pred cCccc--eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC---CC
Confidence 32111 111222345778999999998889999999999999999999 9999999888777777755544433 46
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLS 419 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~ 419 (456)
.++..+.++|.+||..||++|||+.++++.|+.+.+...
T Consensus 278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 789999999999999999999999999999999987653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=355.37 Aligned_cols=246 Identities=26% Similarity=0.398 Sum_probs=209.7
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
+|.+.+.||+|+||.|. .+|+.||||++.+...........+.+|..+++.+ +||||+++++++.....+|+||
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~ 103 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence 68899999999999762 35889999999764333334456788999999988 7999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||+++++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 104 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~---- 176 (353)
T 3txo_A 104 EFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC---- 176 (353)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeeccc----
Confidence 99999999999998889999999999999999999999999 99999999999999999999999999875421
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... ..+ +..++.++
T Consensus 177 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~---p~~~~~~~ 251 (353)
T 3txo_A 177 -NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVY---PTWLHEDA 251 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCC---CTTSCHHH
T ss_pred -CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCC---CCCCCHHH
Confidence 1122334578999999999999899999999999999999999999999988877777775443 222 45688999
Q ss_pred HHHHHHhcccCCCCCCCH------HHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTF------RQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~------~ell~~ 410 (456)
.++|.+||..||.+||++ +++++|
T Consensus 252 ~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 252 TGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 999999999999999998 777765
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=353.42 Aligned_cols=247 Identities=22% Similarity=0.373 Sum_probs=206.3
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv 225 (456)
.+|...+.||+|+||.|. .+++.||+|++.+...........+.+|..++.++ +||||+++++++.....+++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 368899999999999772 35789999999877655666667788999999887 899999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|||+++++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~--- 205 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--- 205 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC---
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc---
Confidence 999999999999998889999999999999999999999999 99999999999999999999999999975321
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc--------c-hHHHHHhcCCCCCC
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK--------E-VPKAYIANERPPFR 376 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--------~-~~~~~~~~~~~~~~ 376 (456)
.........||+.|+|||++.+..++.++|||||||++|+|++|++||...... . ....+ ......+
T Consensus 206 --~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i-~~~~~~~- 281 (396)
T 4dc2_A 206 --PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-LEKQIRI- 281 (396)
T ss_dssp --TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH-HHCCCCC-
T ss_pred --CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH-hccccCC-
Confidence 122334467899999999999999999999999999999999999999643211 1 22233 2333332
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 012777 377 APTTHYAYGLRELIEDCWSEEPFRRPTF------RQILMR 410 (456)
Q Consensus 377 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~------~ell~~ 410 (456)
+..++.++.+||.+||+.||.+||++ +++++|
T Consensus 282 --p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 282 --PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp --CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred --CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 46789999999999999999999985 566654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=341.39 Aligned_cols=257 Identities=27% Similarity=0.501 Sum_probs=219.8
Q ss_pred cccccccceeeeccEEEEEe----------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC
Q 012777 150 KELDFSNSVEITKGTFRIAS----------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS 219 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~~----------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 219 (456)
...+|.+.+.||+|+||.|. .++..||+|++... ......+.+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 34568899999999998662 23478999999864 3566678899999999999999999999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQKGA------------------------LKPTLAVKFALDIARGMNYLHENRPEAIIHRD 275 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~~~------------------------l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~D 275 (456)
...++||||+++++|.+++..... +++..++.++.|++.||.|||+++ |+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccc
Confidence 999999999999999999987543 889999999999999999999999 99999
Q ss_pred CCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCC
Q 012777 276 LEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPP 354 (456)
Q Consensus 276 ikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p 354 (456)
|||+||+++.++.+||+|||++......... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSY---VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCE---ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cchheEEEcCCCCEEEccccccccccccccc---eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999865322111 11223456788999999988889999999999999999999 9999
Q ss_pred CCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 355 FPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 355 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
|...........+.....+. .+..++..+.++|.+||..||++|||+.+++++|+.+..+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTGHRME---RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp STTCCGGGHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHhhcCCcCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 99888877776665444333 2567899999999999999999999999999999999765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=345.40 Aligned_cols=243 Identities=25% Similarity=0.455 Sum_probs=211.0
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.|. .+|+.||+|++.+.........+.+.+|..+++.++||||+++++++.+...+++|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 68889999999998762 3689999999975422111234677899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----- 158 (318)
T 1fot_A 87 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD----- 158 (318)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-----
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-----
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999986521
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
......||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+.... ..+ +..++.++.
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~---p~~~~~~~~ 231 (318)
T 1fot_A 159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRF---PPFFNEDVK 231 (318)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCC---CTTSCHHHH
T ss_pred ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCC---CCCCCHHHH
Confidence 1223568999999999999999999999999999999999999999887777666664433 222 467889999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rp-----t~~ell~~ 410 (456)
++|.+||..||.+|| +++++++|
T Consensus 232 ~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 232 DLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 999999999999999 89998876
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=346.25 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=211.4
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCH---HHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDE---DKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM 223 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 223 (456)
..|...+.||+|+||.|. .+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 358889999999999762 3588999999976532211 12467889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC----CEEEeccCCccc
Q 012777 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG----HLKVADFGLSKL 299 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~----~vkl~Dfgls~~ 299 (456)
+||||+++++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 99999999999999988788999999999999999999999999 99999999999999877 899999999986
Q ss_pred ccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCC
Q 012777 300 LKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPT 379 (456)
Q Consensus 300 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 379 (456)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+............
T Consensus 168 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (326)
T 2y0a_A 168 IDFG------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241 (326)
T ss_dssp CCTT------SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCCC------CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc
Confidence 6321 1223456899999999999999999999999999999999999999887766666555433322111123
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 380 THYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..++..+.+||.+||..||++|||+.+++++
T Consensus 242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 5778899999999999999999999999985
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=344.35 Aligned_cols=246 Identities=23% Similarity=0.376 Sum_probs=209.8
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
+|...+.||+|+||.|. .+|+.||+|++.+.........+.+.+|..+++++ +||||+++++++.....+++||
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 68889999999999762 35889999999887666777788899999999988 8999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||+++++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~---- 162 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR---- 162 (345)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC----
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC----
Confidence 99999999999998888999999999999999999999999 99999999999999999999999999875321
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc---------cchHHHHHhcCCCCCCC
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE---------KEVPKAYIANERPPFRA 377 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~~~~~~~~ 377 (456)
.........||+.|+|||++.+..++.++|+|||||++|+|++|+.||..... ......+. .....+
T Consensus 163 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~-~~~~~~-- 238 (345)
T 3a8x_A 163 -PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRI-- 238 (345)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH-HCCCCC--
T ss_pred -CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH-cCCCCC--
Confidence 11223345789999999999999999999999999999999999999975321 12223332 233332
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 012777 378 PTTHYAYGLRELIEDCWSEEPFRRPTF------RQILMR 410 (456)
Q Consensus 378 ~~~~~~~~l~~li~~~l~~dp~~Rpt~------~ell~~ 410 (456)
+..++.++.++|.+||..||++||++ +++++|
T Consensus 239 -p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 239 -PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp -CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred -CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 46789999999999999999999995 666665
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=334.20 Aligned_cols=252 Identities=29% Similarity=0.580 Sum_probs=215.6
Q ss_pred cccccceeeeccEEEEEe---E-cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 152 LDFSNSVEITKGTFRIAS---W-RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~---~-~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.+|...+.||+|+||.|. . ++..||+|++...... . +.+.+|+.++++++||||+++++++.+....++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-E---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-H---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-H---HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 458888999999998762 2 6788999999865432 2 568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|+++++|.+++... +.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999999764 45999999999999999999999999 999999999999999999999999999865322111
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+....... .+..++..
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 235 (269)
T 4hcu_A 163 ----SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTH 235 (269)
T ss_dssp ----STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTSCHH
T ss_pred ----cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC---CCCcCCHH
Confidence 1223456778999999998899999999999999999999 999999888777776665443332 24667899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
+.+++.+||..||++|||+++++++|+.+.++
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 236 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 99999999999999999999999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=346.05 Aligned_cols=246 Identities=18% Similarity=0.295 Sum_probs=210.8
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.|. .+++.||+|++... ......+.+|+.+++.++||||+++++++.....+++|||
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 68888999999999773 35889999999753 2344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC--CCCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD--SGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~--~~~vkl~Dfgls~~~~~~~ 304 (456)
|+++++|.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-- 156 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence 999999999997654 6999999999999999999999999 999999999999997 78999999999986632
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
........+|+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+..............++.
T Consensus 157 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T 1tki_A 157 ----GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ----TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ----CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCH
Confidence 1222345688999999999998899999999999999999999999998877776666654433221112357889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
++.++|.+||..||++|||+.|++++-
T Consensus 233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 233 EAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 999999999999999999999999863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=335.04 Aligned_cols=254 Identities=27% Similarity=0.518 Sum_probs=214.0
Q ss_pred cccccccceeeeccEEEEEe---E-cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 150 KELDFSNSVEITKGTFRIAS---W-RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~~---~-~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
...+|...+.||+|+||.|. . ++..||+|++...... . +.+.+|+.++++++||||+++++++......++|
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-E---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-H---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-H---HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 34468889999999999762 2 4568999999865432 2 5688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 226 TEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999999986 456999999999999999999999999 9999999999999999999999999998663221
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
. .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+....... .+..++
T Consensus 175 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 247 (283)
T 3gen_A 175 Y----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---RPHLAS 247 (283)
T ss_dssp H----HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC---CCTTCC
T ss_pred c----ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC---CCCcCC
Confidence 1 11223446778999999998889999999999999999998 999999888777776665443333 246678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
..+.++|.+||..||++|||+++++++|+.+.++
T Consensus 248 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 248 EKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 8999999999999999999999999999999865
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=352.84 Aligned_cols=256 Identities=30% Similarity=0.505 Sum_probs=217.2
Q ss_pred cccccceeeeccEEEEE---eE--cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA---SW--RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~~--~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|...+.||+|+||.| .. +++.||||++... ........+.+|+.++++++||||+++++++......++||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 46888899999999976 23 5889999999754 34556678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
||+++++|.+++...+ .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 9999999999998754 5999999999999999999999999 99999999999999999999999999875422110
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
. .......+++.|+|||++....++.++||||||+++|+|++ |..||......+....+....+.+. +..++.
T Consensus 269 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 342 (377)
T 3cbl_A 269 A---ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC---PELCPD 342 (377)
T ss_dssp E---CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC---CTTCCH
T ss_pred e---ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCH
Confidence 0 01111224667999999988889999999999999999998 9999998877766666654444443 467889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
++.++|.+||..||++|||++++++.|+.+.++.
T Consensus 343 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 343 AVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 9999999999999999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=333.89 Aligned_cols=254 Identities=29% Similarity=0.548 Sum_probs=214.6
Q ss_pred cccccccceeeeccEEEEE---eE-cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 150 KELDFSNSVEITKGTFRIA---SW-RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~---~~-~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
...+|++.+.||+|+||.+ .. ++..||+|++...... .+.+.+|+.++++++||||+++++++......++|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 3456889999999999866 22 4558999999865432 25688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 226 TEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
|||+++++|.+++...+ .+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999998754 4999999999999999999999999 9999999999999999999999999998663221
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
. .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+....... .+..++
T Consensus 159 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 231 (268)
T 3sxs_A 159 Y----VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY---RPHLAS 231 (268)
T ss_dssp E----EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC---CCTTSC
T ss_pred h----hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCC---CCCcCh
Confidence 1 11223446778999999988889999999999999999999 999998887776666664443332 246678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
..+.++|.+||..||++|||+.+++++|+.+.++
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 232 DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 8999999999999999999999999999987543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=345.07 Aligned_cols=261 Identities=31% Similarity=0.544 Sum_probs=222.8
Q ss_pred ccccccceeeeccEEEEEeE------------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEE
Q 012777 151 ELDFSNSVEITKGTFRIASW------------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVT 217 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~~------------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~ 217 (456)
..+|.+.+.||+|+||.|.. .+..||+|++... ........+.+|+.+++++ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34688899999999997731 2257999999865 4566678899999999999 8999999999999
Q ss_pred eCCceEEEEEccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 012777 218 QSTPMMIVTEYLPKGDLRAYLKQKG----------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNI 281 (456)
Q Consensus 218 ~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Ni 281 (456)
..+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 9999999999999999999998754 4899999999999999999999999 99999999999
Q ss_pred EeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 012777 282 LRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQE 360 (456)
Q Consensus 282 l~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~ 360 (456)
|++.++.+||+|||++....... .........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHID---YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCC---TTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EEcCCCcEEEcccCccccccccc---ccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999998663221 1112233456788999999999999999999999999999999 9999998887
Q ss_pred cchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhcccc
Q 012777 361 KEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKR 422 (456)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~ 422 (456)
.+....+........ +..++.++.++|.+||..||++|||+++++++|+.+........
T Consensus 300 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 300 EELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp HHHHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred HHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 777766655444433 46789999999999999999999999999999999987764333
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=349.01 Aligned_cols=244 Identities=24% Similarity=0.402 Sum_probs=211.9
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|...+.||+|+||.|. .+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 368899999999998762 368999999996542212223467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||+++++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~---- 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC----
Confidence 99999999999998888999999999999999999999999 99999999999999999999999999986521
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.... ..+ +..++.++
T Consensus 194 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~---p~~~~~~~ 265 (350)
T 1rdq_E 194 ----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRF---PSHFSSDL 265 (350)
T ss_dssp ----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCC---CTTCCHHH
T ss_pred ----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-CCC---CCCCCHHH
Confidence 1123468999999999999999999999999999999999999999888777777665443 222 46789999
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPT-----FRQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt-----~~ell~~ 410 (456)
.++|.+||..||.+||+ +++++++
T Consensus 266 ~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 99999999999999998 8888876
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=333.51 Aligned_cols=255 Identities=25% Similarity=0.485 Sum_probs=207.5
Q ss_pred ccccccceeeeccEEEEEe---E-----cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 151 ELDFSNSVEITKGTFRIAS---W-----RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~---~-----~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
..+|...+.||+|+||.|. . .+..||+|++... ......+.+.+|+.++++++||||+++++++. ++..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 4468889999999998762 2 2457999998754 35666788999999999999999999999984 5678
Q ss_pred EEEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
++||||+++++|.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999999998654 5999999999999999999999999 9999999999999999999999999998663
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
.... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+......+. +.
T Consensus 168 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~---~~ 240 (281)
T 1mp8_A 168 DSTY----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM---PP 240 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CT
T ss_pred cccc----cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCC---CC
Confidence 2211 11223456778999999988889999999999999999997 9999998887777776655444333 56
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
.++..+.++|.+||..||++|||+.++++.|+.+.++.
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 78999999999999999999999999999999998764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=351.36 Aligned_cols=250 Identities=28% Similarity=0.420 Sum_probs=211.1
Q ss_pred ccccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCce
Q 012777 149 PKELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 149 ~~~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~ 222 (456)
....+|...+.||+|+||.|. .+|+.||+|++.+...........+..|..+++.+ +||||+++++++.....+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 334578999999999998762 35889999999754221122345678899999887 899999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
|+||||+++++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 999999999999999998888999999999999999999999999 99999999999999999999999999875421
Q ss_pred cccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (456)
. ........||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....+... .+.+ +..+
T Consensus 171 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~---p~~~ 241 (345)
T 1xjd_A 171 G-----DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-NPFY---PRWL 241 (345)
T ss_dssp T-----TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCC---CTTS
T ss_pred C-----CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC-CCCC---Cccc
Confidence 1 12233467899999999999999999999999999999999999999988877777666443 2332 4678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFR-QILMR 410 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~-ell~~ 410 (456)
+.++.++|.+||..||++||++. ++++|
T Consensus 242 s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 242 EKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp CHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 99999999999999999999997 66543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=335.32 Aligned_cols=265 Identities=26% Similarity=0.411 Sum_probs=217.8
Q ss_pred cccCccccccccce-eeeccEEEEEeE-------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEE
Q 012777 145 YEIDPKELDFSNSV-EITKGTFRIASW-------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV 216 (456)
Q Consensus 145 ~~~~~~~~~~~~~~-~lg~G~fg~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 216 (456)
.++.....+|.+.+ .||+|+||.|.. .++.||||++.... ......+.+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34444455788877 999999997622 36789999998653 2334467899999999999999999999999
Q ss_pred EeCCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCC
Q 012777 217 TQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGL 296 (456)
Q Consensus 217 ~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgl 296 (456)
.....++||||+++++|.+++...+.+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCc
Confidence 56778999999999999999998888999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCC
Q 012777 297 SKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPF 375 (456)
Q Consensus 297 s~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 375 (456)
+.......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+.....+..
T Consensus 164 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T 1xbb_A 164 SKALRADENYY--KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 241 (291)
T ss_dssp CEECCTTCSEE--EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred ceeeccCCCcc--cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 98663221111 11122346788999999988888999999999999999999 9999998877766666654444333
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 012777 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLS 419 (456)
Q Consensus 376 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~ 419 (456)
+..++..+.++|.+||..||++|||+.++++.|+.++....
T Consensus 242 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 242 ---PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 56789999999999999999999999999999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=331.34 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=215.2
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|.+.+.||+|+||.+. .+|+.||+|++.... ......+.+.+|+.++++++||||+++++++......++||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeeccc-CCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 368889999999999762 358899999997654 35556688999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC---EEEeccCCccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH---LKVADFGLSKLLKFA 303 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~---vkl~Dfgls~~~~~~ 303 (456)
||+++++|.+.+...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~- 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND- 160 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS-
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc-
Confidence 99999999999988888999999999999999999999999 999999999999986655 99999999976532
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
........+|+.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+..............++
T Consensus 161 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T 3kk8_A 161 -----SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 235 (284)
T ss_dssp -----SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred -----CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccC
Confidence 222234568999999999999999999999999999999999999999888777776665544322222346789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++.++|.+||..||++|||+++++++
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 236 PEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 999999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=332.35 Aligned_cols=273 Identities=27% Similarity=0.471 Sum_probs=225.6
Q ss_pred CCccccCccccccccceeeeccEEEEEeE-----cCc---EEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeee
Q 012777 142 VPEYEIDPKELDFSNSVEITKGTFRIASW-----RGT---QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213 (456)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~lg~G~fg~~~~-----~g~---~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 213 (456)
...+.++.....|...+.||+|+||.|.. ++. .||+|++... ......+.+.+|+.+++.++||||++++
T Consensus 11 ~~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 88 (298)
T 3pls_A 11 VKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALI 88 (298)
T ss_dssp TGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred hhheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 44555667777888889999999997621 222 7999999754 4566678899999999999999999999
Q ss_pred eEEEeCCce-EEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEE
Q 012777 214 GAVTQSTPM-MIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291 (456)
Q Consensus 214 ~~~~~~~~~-~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl 291 (456)
+++...+.. +++|||+.+++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl 165 (298)
T 3pls_A 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKV 165 (298)
T ss_dssp EEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEE
T ss_pred EEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEe
Confidence 999876555 9999999999999999863 45899999999999999999999999 999999999999999999999
Q ss_pred eccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhc
Q 012777 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIAN 370 (456)
Q Consensus 292 ~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~ 370 (456)
+|||++......... .........+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+...
T Consensus 166 ~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~ 244 (298)
T 3pls_A 166 ADFGLARDILDREYY-SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG 244 (298)
T ss_dssp CCTTSSCTTTTGGGG-CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT
T ss_pred CcCCCcccccCCccc-ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC
Confidence 999999865332211 1222334567889999999999999999999999999999999 56667776666666666444
Q ss_pred CCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccc
Q 012777 371 ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRH 423 (456)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~ 423 (456)
...+. +..++..+.++|.+||..||.+|||++++++.|+.+...+..+..
T Consensus 245 ~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~ 294 (298)
T 3pls_A 245 RRLPQ---PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY 294 (298)
T ss_dssp CCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCB
T ss_pred CCCCC---CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccch
Confidence 43332 567889999999999999999999999999999999998855543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=350.21 Aligned_cols=244 Identities=27% Similarity=0.442 Sum_probs=205.5
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.|. .+|+.||+|++.............+.+|+.+++.++||||+++++++......++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 68889999999999762 3788999999864321111123568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+ +|+|.+++.+.+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~---- 161 (336)
T 3h4j_B 90 YA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---- 161 (336)
T ss_dssp CC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS----
T ss_pred CC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC----
Confidence 99 7899999988889999999999999999999999999 999999999999999999999999999865321
Q ss_pred CCCCcccCCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEY-DTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
.......||+.|+|||++.+..+ ++++||||||+++|+|++|+.||...........+ .......+..++.++
T Consensus 162 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i----~~~~~~~p~~~s~~~ 235 (336)
T 3h4j_B 162 --NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV----NSCVYVMPDFLSPGA 235 (336)
T ss_dssp --BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC----CSSCCCCCTTSCHHH
T ss_pred --cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH----HcCCCCCcccCCHHH
Confidence 12234568999999999988776 67999999999999999999999876655443322 111122356789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++|.+||..||.+|||++|++++
T Consensus 236 ~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 236 QSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHHhC
Confidence 999999999999999999999987
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=344.16 Aligned_cols=258 Identities=23% Similarity=0.357 Sum_probs=208.6
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc----e
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP----M 222 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~----~ 222 (456)
.+|.+.+.||+|+||.|. .+++.||||++.............+.+|+.++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 368899999999999762 4688999999988766677777889999999999999999999999876654 4
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
++||||+++++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 999999999999999998888999999999999999999999999 99999999999999999999999999986633
Q ss_pred cccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (456)
.... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||..................+.......+
T Consensus 169 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 169 SGNS--VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred cccc--cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence 2111 11222346899999999999999999999999999999999999999888776665555444433222234568
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHH-HHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILM-RLDDI 414 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~-~L~~~ 414 (456)
+.++.++|.+||+.||++||++.+++. .+..+
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 899999999999999999996665554 44333
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=347.98 Aligned_cols=247 Identities=27% Similarity=0.407 Sum_probs=210.9
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv 225 (456)
.+|...+.||+|+||.|. .+|+.||+|++.+.........+.+..|..++..+ +||+|+++++++.....+|+|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 368899999999999762 24778999999754221222346788999999988 799999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|||++|++|.+++.+.+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--- 173 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--- 173 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC---
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccccc---
Confidence 999999999999998888999999999999999999999999 99999999999999999999999999885421
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.........||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+.... ..+ +..++.+
T Consensus 174 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~---p~~~s~~ 247 (353)
T 2i0e_A 174 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAY---PKSMSKE 247 (353)
T ss_dssp --TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCC---CTTSCHH
T ss_pred --CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCC---CCCCCHH
Confidence 1122334678999999999999999999999999999999999999999888777777765433 222 4678999
Q ss_pred HHHHHHHhcccCCCCCCC-----HHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPT-----FRQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt-----~~ell~~ 410 (456)
+.+||.+||..||++||+ ++++++|
T Consensus 248 ~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 999999999999999995 5777765
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=342.64 Aligned_cols=259 Identities=29% Similarity=0.442 Sum_probs=218.6
Q ss_pred ccccccccceeeeccEEEEE---eE-------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe
Q 012777 149 PKELDFSNSVEITKGTFRIA---SW-------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ 218 (456)
Q Consensus 149 ~~~~~~~~~~~lg~G~fg~~---~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 218 (456)
....+|.+.+.||+|+||.| .. +++.||+|++... ......+.+.+|+.++++++||||+++++++..
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 33457889999999999866 22 2378999999865 355667889999999999999999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 012777 219 STPMMIVTEYLPKGDLRAYLKQK------------------------GALKPTLAVKFALDIARGMNYLHENRPEAIIHR 274 (456)
Q Consensus 219 ~~~~~lv~e~~~~~sL~~~l~~~------------------------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~ 274 (456)
....++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 99999999999999999999863 46999999999999999999999999 9999
Q ss_pred CCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCC
Q 012777 275 DLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCP 353 (456)
Q Consensus 275 Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~ 353 (456)
||||+|||++.++.+||+|||++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |..
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADY---YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGC---BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCcc---ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999986532211 112233457889999999988889999999999999999999 999
Q ss_pred CCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 354 PFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 354 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
||......+....+.....+. .+..++..+.++|.+||..||++|||+.++++.|+.+..+.
T Consensus 276 p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred cCCCCChHHHHHHHhCCCcCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 999887777666665444333 35678899999999999999999999999999999887654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=352.19 Aligned_cols=247 Identities=32% Similarity=0.575 Sum_probs=214.0
Q ss_pred cccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC-ceEEEEE
Q 012777 152 LDFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST-PMMIVTE 227 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~-~~~lv~e 227 (456)
.+|...+.||+|+||.| ...|+.||||+++... ..+.+.+|+.++++++||||+++++++.... .+++|||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred HHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 35788899999999866 5679999999998653 2367899999999999999999999987765 7999999
Q ss_pred ccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLKQKGA--LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~--l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|+++++|.+++...+. +++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 9999999999987654 799999999999999999999999 999999999999999999999999998854211
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.....+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+..+.+.+. +..++.
T Consensus 343 ------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---p~~~~~ 413 (450)
T 1k9a_A 343 ------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA---PDGCPP 413 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCC---CTTCCH
T ss_pred ------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCH
Confidence 112346788999999999999999999999999999998 9999999888777777755544433 567899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
.+.++|.+||..||++|||+.++++.|+.+...
T Consensus 414 ~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 414 AVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999999998754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=334.41 Aligned_cols=270 Identities=27% Similarity=0.467 Sum_probs=222.8
Q ss_pred CCccccCccccccccceeeeccEEEEEe---E-----cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeee
Q 012777 142 VPEYEIDPKELDFSNSVEITKGTFRIAS---W-----RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213 (456)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~lg~G~fg~~~---~-----~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 213 (456)
.+...+.+....|...+.||+|+||.|. . ....||+|.+... ......+.+.+|+.++++++||||++++
T Consensus 15 ~~~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 92 (298)
T 3f66_A 15 VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLL 92 (298)
T ss_dssp HGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred hhheecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeee
Confidence 3455677778889999999999999762 1 1235899999764 4566778899999999999999999999
Q ss_pred eEEE-eCCceEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEE
Q 012777 214 GAVT-QSTPMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291 (456)
Q Consensus 214 ~~~~-~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl 291 (456)
+++. .+...++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||
T Consensus 93 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl 169 (298)
T 3f66_A 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKV 169 (298)
T ss_dssp EEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEE
T ss_pred eEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEE
Confidence 9864 456789999999999999999764 45899999999999999999999999 999999999999999999999
Q ss_pred eccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhc
Q 012777 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIAN 370 (456)
Q Consensus 292 ~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~ 370 (456)
+|||++......... .........+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+...
T Consensus 170 ~Dfg~a~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 3f66_A 170 ADFGLARDMYDKEYY-SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248 (298)
T ss_dssp CSCGGGCCCSCGGGC-BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT
T ss_pred Ccccccccccccchh-ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC
Confidence 999999866332211 1122334567788999999998899999999999999999999 67888887777766666544
Q ss_pred CCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhcc
Q 012777 371 ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSI 420 (456)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~ 420 (456)
.... .+..++..+.++|.+||..||++|||++++++.|+.+...+.-
T Consensus 249 ~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 249 RRLL---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred CCCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 4333 2467889999999999999999999999999999999987643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=338.05 Aligned_cols=269 Identities=29% Similarity=0.528 Sum_probs=222.0
Q ss_pred CCccccCccccccccceeeeccEEEEEe------------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCc
Q 012777 142 VPEYEIDPKELDFSNSVEITKGTFRIAS------------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPN 208 (456)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~lg~G~fg~~~------------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~ 208 (456)
.+.+++. ..+|.+.+.||+|+||.|. .++..||+|++... ........+.+|+.+++++ +|||
T Consensus 27 ~~~~~~~--~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~ 102 (334)
T 2pvf_A 27 DPKWEFP--RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKN 102 (334)
T ss_dssp CTTTBCC--GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT--CCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CccccCC--HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC--CcHHHHHHHHHHHHHHHHhhcCCC
Confidence 3444433 3468889999999998762 34678999999865 3566678899999999999 8999
Q ss_pred ceeeeeEEEeCCceEEEEEccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 012777 209 VVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG----------------ALKPTLAVKFALDIARGMNYLHENRPEAII 272 (456)
Q Consensus 209 iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~iv 272 (456)
|+++++++...+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+
T Consensus 103 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---iv 179 (334)
T 2pvf_A 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CI 179 (334)
T ss_dssp BCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 9999999999999999999999999999998653 3889999999999999999999999 99
Q ss_pred ecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-C
Q 012777 273 HRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-G 351 (456)
Q Consensus 273 H~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g 351 (456)
|+||||+||+++.++.+||+|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 180 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 256 (334)
T 2pvf_A 180 HRDLAARNVLVTENNVMKIADFGLARDINNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256 (334)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECTTTSSE---ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred CCCCccceEEEcCCCCEEEccccccccccccccc---cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999866322111 11223456788999999988889999999999999999999 9
Q ss_pred CCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccc
Q 012777 352 CPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRH 423 (456)
Q Consensus 352 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~ 423 (456)
..||.+....+....+........ +..++..+.++|.+||..||++|||+.++++.|+.+.........
T Consensus 257 ~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~~ 325 (334)
T 2pvf_A 257 GSPYPGIPVEELFKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEY 325 (334)
T ss_dssp CCSSTTCCHHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred CCCcCcCCHHHHHHHHhcCCCCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCcc
Confidence 999998877776666655443332 467889999999999999999999999999999999887654443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=347.63 Aligned_cols=261 Identities=29% Similarity=0.467 Sum_probs=220.3
Q ss_pred cccccceeeeccEEEEE---e-------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012777 152 LDFSNSVEITKGTFRIA---S-------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~-------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 221 (456)
.+|...+.||+|+||.| . .++..||||++... ........+.+|+.++++++||||+++++++.....
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 46888999999999855 2 24568999999754 355666789999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC---CEEE
Q 012777 222 MMIVTEYLPKGDLRAYLKQKG-------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG---HLKV 291 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~---~vkl 291 (456)
.++||||+++++|.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999998753 4899999999999999999999999 99999999999999554 5999
Q ss_pred eccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhc
Q 012777 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIAN 370 (456)
Q Consensus 292 ~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~ 370 (456)
+|||+++...... .........+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+...
T Consensus 226 ~DFG~a~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~ 302 (367)
T 3l9p_A 226 GDFGMARDIYRAG---YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302 (367)
T ss_dssp CCCHHHHHHHHHS---SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred CCCcccccccccc---ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999998653321 1122234557889999999988899999999999999999998 99999998877777766555
Q ss_pred CCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccc
Q 012777 371 ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRH 423 (456)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~ 423 (456)
..... +..++..+.+||.+||+.||++|||+.+++++|+.+.+.......
T Consensus 303 ~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~~~ 352 (367)
T 3l9p_A 303 GRMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINT 352 (367)
T ss_dssp CCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTC
T ss_pred CCCCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhccC
Confidence 44332 567889999999999999999999999999999999876654443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=350.91 Aligned_cols=245 Identities=24% Similarity=0.430 Sum_probs=205.0
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.| ..+++.||+|++.+...........+.+|+.+++.++||||+++++++.....+++|||
T Consensus 16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 95 (384)
T 4fr4_A 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95 (384)
T ss_dssp GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 6889999999999865 23688999999875432222234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~----- 167 (384)
T 4fr4_A 96 LLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR----- 167 (384)
T ss_dssp CCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT-----
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC-----
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999986632
Q ss_pred CCCCcccCCCCcccccccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchH---HHHHhcCCCCCCCCCCC
Q 012777 308 EDRPVTCEETSWRYAAPEVYKN---EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVP---KAYIANERPPFRAPTTH 381 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~ 381 (456)
........||+.|+|||++.. ..++.++|||||||++|+|++|+.||......... ..+ ...... .+..
T Consensus 168 -~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~---~p~~ 242 (384)
T 4fr4_A 168 -ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF-ETTVVT---YPSA 242 (384)
T ss_dssp -TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH-HHCCCC---CCTT
T ss_pred -CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH-hhcccC---CCCc
Confidence 223345679999999999864 45889999999999999999999999765443322 222 222222 2567
Q ss_pred CcHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPT-FRQILMR 410 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt-~~ell~~ 410 (456)
++..+.+||.+||..||++||+ +++++++
T Consensus 243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred CCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 8999999999999999999998 6766653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=338.14 Aligned_cols=267 Identities=27% Similarity=0.475 Sum_probs=204.2
Q ss_pred ccccccceeeeccEEEEEe-----EcC---cEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WRG---TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~g---~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
..+|.+.+.||+|+||.|. .++ ..||||++...... ....+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 4479999999999999762 122 27999999865433 34467899999999999999999999999877654
Q ss_pred ------EEEEEccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEE
Q 012777 223 ------MIVTEYLPKGDLRAYLKQKG------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLK 290 (456)
Q Consensus 223 ------~lv~e~~~~~sL~~~l~~~~------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vk 290 (456)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 99999999999999996543 5999999999999999999999999 99999999999999999999
Q ss_pred EeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHh
Q 012777 291 VADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIA 369 (456)
Q Consensus 291 l~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~ 369 (456)
|+|||++........ ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 178 l~Dfg~a~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 178 VADFGLSRKIYSGDY---YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp ECCCCC--------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred Eeecccccccccccc---ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 999999986633211 112223456778999999998899999999999999999999 9999999888887777655
Q ss_pred cCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccccccC
Q 012777 370 NERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVG 427 (456)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~ 427 (456)
...... +..++.++.++|.+||..||++|||++++++.|+++..+..+......+
T Consensus 255 ~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~p 309 (323)
T 3qup_A 255 GNRLKQ---PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP 309 (323)
T ss_dssp TCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------
T ss_pred CCCCCC---CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence 443333 5678899999999999999999999999999999999888655554333
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=333.34 Aligned_cols=267 Identities=15% Similarity=0.193 Sum_probs=220.6
Q ss_pred cccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEE
Q 012777 152 LDFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv 225 (456)
.+|.+.+.||+|+||.+ . .+|+.||+|++..... ...+.+|+.+++.+ +|++++++++++......++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 46889999999999866 2 4789999999865432 23578899999999 799999999999999999999
Q ss_pred EEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC-----EEEeccCCccc
Q 012777 226 TEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH-----LKVADFGLSKL 299 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~-----vkl~Dfgls~~ 299 (456)
|||+ +++|.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++..
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999 999999998754 5999999999999999999999999 999999999999987765 99999999987
Q ss_pred cccccccc--CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccch---HHHHHhcC-CC
Q 012777 300 LKFANTVK--EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV---PKAYIANE-RP 373 (456)
Q Consensus 300 ~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~-~~ 373 (456)
........ .........||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ...+.... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 64322111 11223446789999999999999999999999999999999999999988654332 22221111 12
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccccccC
Q 012777 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVG 427 (456)
Q Consensus 374 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~ 427 (456)
+.......++.++.++|.+||..||++|||++++++.|+.+.++.......+.+
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~d 294 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD 294 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCG
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccc
Confidence 222223578899999999999999999999999999999999999888888888
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=337.60 Aligned_cols=247 Identities=23% Similarity=0.367 Sum_probs=202.2
Q ss_pred cccccceeeeccEEEEEe--------EcCcEEEEEEeCCCCCC-CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 152 LDFSNSVEITKGTFRIAS--------WRGTQVAVKTLGEEVFT-DEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~--------~~g~~vAvK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
.+|...+.||+|+||.|. .+|+.||+|++.+.... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 468899999999999763 36889999999865322 223446678999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
++||||+++++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 999999999999999998888999999999999999999999999 99999999999999999999999999875422
Q ss_pred cccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (456)
. ........||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+.... ..+ +..+
T Consensus 174 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~---p~~~ 244 (327)
T 3a62_A 174 D-----GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-LNL---PPYL 244 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCC---CTTS
T ss_pred C-----CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CCC---CCCC
Confidence 1 112234568999999999999999999999999999999999999999887766666664432 222 4578
Q ss_pred cHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rp-----t~~ell~~ 410 (456)
+.++.++|.+||..||++|| ++.++++|
T Consensus 245 ~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 245 TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 89999999999999999999 78888876
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=346.29 Aligned_cols=244 Identities=27% Similarity=0.397 Sum_probs=201.0
Q ss_pred ccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHH-HhcCCCCcceeeeeEEEeCCceEE
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELAL-LQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
..+|...+.||+|+||.|. .+++.||+|++.+...........+..|..+ ++.++||||+++++++...+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 3479999999999998762 3588999999987665555556677888877 466799999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 225 VTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
||||+++++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~-- 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE-- 191 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC--
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc--
Confidence 9999999999999998888999999999999999999999999 99999999999999999999999999885421
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.........||+.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+.... .. .+..++.
T Consensus 192 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~---~~~~~~~ 264 (373)
T 2r5t_A 192 ---HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQ---LKPNITN 264 (373)
T ss_dssp ---CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-CC---CCSSSCH
T ss_pred ---CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-cC---CCCCCCH
Confidence 1122334678999999999999999999999999999999999999999888777777765432 22 2467899
Q ss_pred HHHHHHHHhcccCCCCCCCHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQ 406 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~e 406 (456)
++.++|.+||..||.+||++.+
T Consensus 265 ~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 265 SARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp HHHHHHHHHTCSSGGGSTTTTT
T ss_pred HHHHHHHHHcccCHHhCCCCCC
Confidence 9999999999999999999853
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=343.20 Aligned_cols=258 Identities=29% Similarity=0.496 Sum_probs=209.1
Q ss_pred ccccccceeeeccEEEEEeE--------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 151 ELDFSNSVEITKGTFRIASW--------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~~--------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
..+|.+.+.||+|+||.|.. ++..||||++... ..+...+.+.+|+.++++++||||+++++++......
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 34789999999999997732 4667999999764 3566678899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
++||||+++++|.+++.+.+ .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999998754 5999999999999999999999999 9999999999999999999999999998663
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
..... ........+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+......+. +.
T Consensus 199 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~---~~ 273 (373)
T 2qol_A 199 DDPEA--AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP---PM 273 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC---CT
T ss_pred cCCcc--ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---Cc
Confidence 32111 111112335678999999998899999999999999999998 9999988877766666644433332 45
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
.++..+.++|.+||..||++||+++++++.|+.+.+..
T Consensus 274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 78899999999999999999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=339.68 Aligned_cols=266 Identities=15% Similarity=0.212 Sum_probs=218.3
Q ss_pred cccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEE
Q 012777 152 LDFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv 225 (456)
.+|.+.+.||+|+||.| . .+|+.||||++...... +.+.+|+.+++++ +||||+++++++......++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 46889999999999755 2 57899999998754321 3578999999999 899999999999999999999
Q ss_pred EEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC-----EEEeccCCccc
Q 012777 226 TEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH-----LKVADFGLSKL 299 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~-----vkl~Dfgls~~ 299 (456)
|||+ +++|.+++... +.+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +||+|||++..
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999 89999999874 57999999999999999999999999 999999999999998876 99999999987
Q ss_pred ccccccc--cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHH---HHhcC-CC
Q 012777 300 LKFANTV--KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKA---YIANE-RP 373 (456)
Q Consensus 300 ~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~-~~ 373 (456)
....... ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+......... +.... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 6332111 111123456789999999999999999999999999999999999999988665544322 21111 11
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccccccC
Q 012777 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVG 427 (456)
Q Consensus 374 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~ 427 (456)
+.......+| ++.++|.+||..||.+||+++++.+.|+++.++.........+
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~d 292 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYD 292 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCT
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCcc
Confidence 1111123455 8999999999999999999999999999999999888887788
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=334.11 Aligned_cols=259 Identities=28% Similarity=0.457 Sum_probs=217.3
Q ss_pred cccccccceeeeccEEEEEe----------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEe
Q 012777 150 KELDFSNSVEITKGTFRIAS----------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQ 218 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~~----------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~ 218 (456)
...+|...+.||+|+||.|. .+++.||+|++... ......+.+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc--hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34568889999999999762 14578999999865 3455668899999999999 89999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 012777 219 STPMMIVTEYLPKGDLRAYLKQKG------------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSN 280 (456)
Q Consensus 219 ~~~~~lv~e~~~~~sL~~~l~~~~------------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~N 280 (456)
.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+|+||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence 999999999999999999998654 3899999999999999999999999 9999999999
Q ss_pred eEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 012777 281 ILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQ 359 (456)
Q Consensus 281 il~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~ 359 (456)
|+++.++.+||+|||++........ ........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSN---YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT---SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEEcCCCCEEEcccccccccccccc---ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999886632211 111223446778999999988899999999999999999998 999998877
Q ss_pred ccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 360 EKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
................ .+..++..+.++|.+||..||++|||++++++.|+.+..+.
T Consensus 253 ~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 253 VDSKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp SSHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred chhHHHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 6554444433332221 24678899999999999999999999999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=344.64 Aligned_cols=262 Identities=18% Similarity=0.314 Sum_probs=211.3
Q ss_pred cccCccccccccceeeecc--EEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE
Q 012777 145 YEIDPKELDFSNSVEITKG--TFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVT 217 (456)
Q Consensus 145 ~~~~~~~~~~~~~~~lg~G--~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 217 (456)
..+.+..-+|++.+.||+| +||.| ..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++.
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 96 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA-CSNEMVTFLQGELHVSKLFNHPNIVPYRATFI 96 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence 3445566689999999999 88866 2368999999998764 34566788899999999999999999999999
Q ss_pred eCCceEEEEEccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccC
Q 012777 218 QSTPMMIVTEYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFG 295 (456)
Q Consensus 218 ~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfg 295 (456)
..+.+++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg 173 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLR 173 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGG
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccc
Confidence 999999999999999999999875 56999999999999999999999999 9999999999999999999999999
Q ss_pred Cccccccccccc--CCCCcccCCCCcccccccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC
Q 012777 296 LSKLLKFANTVK--EDRPVTCEETSWRYAAPEVYKN--EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE 371 (456)
Q Consensus 296 ls~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 371 (456)
++.......... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 253 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 987553221111 1112233468899999999987 578999999999999999999999998876655443322111
Q ss_pred CC------------------------------------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012777 372 RP------------------------------------------PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILM 409 (456)
Q Consensus 372 ~~------------------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~ 409 (456)
.+ +....+..++..+.+||.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 10 000123567888999999999999999999999997
Q ss_pred H
Q 012777 410 R 410 (456)
Q Consensus 410 ~ 410 (456)
+
T Consensus 334 h 334 (389)
T 3gni_B 334 H 334 (389)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=327.99 Aligned_cols=253 Identities=30% Similarity=0.519 Sum_probs=201.4
Q ss_pred cccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCC-HHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 152 LDFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTD-EDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.+|+..+.||+|+||.| ...|+.||+|++....... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 46888899999999865 5679999999987643222 2335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC--------CCCEEEeccCCccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD--------SGHLKVADFGLSKL 299 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~--------~~~vkl~Dfgls~~ 299 (456)
|+++++|.+++. .+.+++..++.++.|++.||.|||+++..+|+||||||+||+++. ++.+||+|||++..
T Consensus 87 ~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~ 165 (271)
T 3dtc_A 87 FARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165 (271)
T ss_dssp CCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred cCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence 999999999885 457999999999999999999999997444789999999999986 77899999999986
Q ss_pred ccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCC
Q 012777 300 LKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPT 379 (456)
Q Consensus 300 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 379 (456)
.... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+...... ...+
T Consensus 166 ~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~ 236 (271)
T 3dtc_A 166 WHRT-------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA--LPIP 236 (271)
T ss_dssp -----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC--CCCC
T ss_pred cccc-------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC--CCCC
Confidence 5321 112346889999999999888999999999999999999999999887766655555433321 1235
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 380 THYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
..++..+.++|.+||..||++|||+.+++++|+.+
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 67889999999999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=328.67 Aligned_cols=261 Identities=24% Similarity=0.398 Sum_probs=219.0
Q ss_pred cccccce-eeeccEEEEEe-------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012777 152 LDFSNSV-EITKGTFRIAS-------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM 223 (456)
Q Consensus 152 ~~~~~~~-~lg~G~fg~~~-------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 223 (456)
.+|.+.. .||+|+||.|. .++..||+|++... ......+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 3455555 89999998762 25778999999865 3566678899999999999999999999999 556799
Q ss_pred EEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 224 IVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999999654 45999999999999999999999999 99999999999999999999999999986632
Q ss_pred cccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (456)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+.....+.. +..
T Consensus 163 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~ 237 (287)
T 1u59_A 163 DDSYY--TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPE 237 (287)
T ss_dssp CSCEE--CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC---CTT
T ss_pred Cccee--eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCC---CCC
Confidence 21111 11223456789999999988889999999999999999998 9999998887776666655444433 568
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccc
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRH 423 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~ 423 (456)
++..+.++|.+||..||++|||+.+++++|+.++.+......
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 899999999999999999999999999999999988755443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=333.11 Aligned_cols=257 Identities=28% Similarity=0.518 Sum_probs=207.5
Q ss_pred ccccccceeeeccEEEEEe---------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--
Q 012777 151 ELDFSNSVEITKGTFRIAS---------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS-- 219 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~---------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-- 219 (456)
..+|++.+.||+|+||.|. .+++.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 4578899999999999762 26889999999753 566678899999999999999999999998553
Q ss_pred CceEEEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
..+++||||+++++|.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 56899999999999999998754 4999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc----------------c
Q 012777 299 LLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK----------------E 362 (456)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----------------~ 362 (456)
........ ........+++.|+|||.+.+..++.++||||||+++|+|++|..||...... .
T Consensus 163 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 163 VLPQDKEF--FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp ---------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccCCcce--eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 76332111 11222345677899999999889999999999999999999999998653211 1
Q ss_pred hHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 363 VPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
....+......+ .+..++.++.++|.+||..||++|||++++++.|+.+.+++
T Consensus 241 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 241 LIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHhccCcCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 112222222222 25678999999999999999999999999999999998765
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=345.03 Aligned_cols=274 Identities=26% Similarity=0.454 Sum_probs=217.0
Q ss_pred CCccccCccccccccceeeeccEEEEEe---E--c---CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeee
Q 012777 142 VPEYEIDPKELDFSNSVEITKGTFRIAS---W--R---GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213 (456)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~lg~G~fg~~~---~--~---g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 213 (456)
.+...+.+....|...+.||+|+||.|. . + +..||+|.+... ......+.+.+|+.++++++||||++++
T Consensus 79 ~~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~ 156 (373)
T 3c1x_A 79 VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLL 156 (373)
T ss_dssp TTTTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCC
T ss_pred ccccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3445566677788889999999998763 1 2 236899998753 3445678899999999999999999999
Q ss_pred eEEEe-CCceEEEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEE
Q 012777 214 GAVTQ-STPMMIVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291 (456)
Q Consensus 214 ~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl 291 (456)
+++.. ++..++||||+++++|.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 157 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL 233 (373)
T 3c1x_A 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKV 233 (373)
T ss_dssp EEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred EEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEE
Confidence 98654 567899999999999999997654 4899999999999999999999999 999999999999999999999
Q ss_pred eccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhc
Q 012777 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIAN 370 (456)
Q Consensus 292 ~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~ 370 (456)
+|||++........ ..........+|+.|+|||++.+..++.++||||||+++|+|++ |.+||...+..+....+...
T Consensus 234 ~DFG~a~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~ 312 (373)
T 3c1x_A 234 ADFGLARDMYDKEF-DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312 (373)
T ss_dssp CCC----------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT
T ss_pred eecccccccccccc-ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC
Confidence 99999986532211 11112233457788999999998899999999999999999999 78899888877776666544
Q ss_pred CCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhcccccc
Q 012777 371 ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHW 424 (456)
Q Consensus 371 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~ 424 (456)
.... .+..++..+.++|.+||..||++|||++++++.|+.+...+..+...
T Consensus 313 ~~~~---~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~~ 363 (373)
T 3c1x_A 313 RRLL---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYV 363 (373)
T ss_dssp CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBC
T ss_pred CCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccccee
Confidence 4333 24678899999999999999999999999999999999988765544
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=345.51 Aligned_cols=246 Identities=19% Similarity=0.360 Sum_probs=210.5
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|.+.+.||+|+||.|. .+|+.||+|++... .......+.+|+.+++.++||||+++++++.....+++|||
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc---chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 68889999999999762 36889999999754 24445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC--CCCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD--SGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~--~~~vkl~Dfgls~~~~~~~ 304 (456)
|+++++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~-- 203 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-- 203 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT--
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC--
Confidence 999999999987654 6999999999999999999999999 999999999999984 56899999999986632
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..............++.
T Consensus 204 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 279 (387)
T 1kob_A 204 ----DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279 (387)
T ss_dssp ----TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ----CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCH
Confidence 1222344689999999999999999999999999999999999999998877666666644432222223467899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.+||.+||..||++|||+.+++++
T Consensus 280 ~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 280 EAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 99999999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=345.96 Aligned_cols=273 Identities=14% Similarity=0.195 Sum_probs=214.0
Q ss_pred ccccccceeeeccEEEEEeE----------cCcEEEEEEeCCCCCCCHHHH--------HHHHHHHHHHhcCCCCcceee
Q 012777 151 ELDFSNSVEITKGTFRIASW----------RGTQVAVKTLGEEVFTDEDKV--------KAFIDELALLQKIRHPNVVQF 212 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~~----------~g~~vAvK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~hp~iv~l 212 (456)
..+|.+.+.||+|+||.|.. .++.||||++........... ..+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 34799999999999997622 257899999875421000000 223455666777889999999
Q ss_pred eeEEEeC----CceEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC--C
Q 012777 213 LGAVTQS----TPMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD--D 285 (456)
Q Consensus 213 ~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~--~ 285 (456)
++++... ...++||||+ +++|.+++... +.+++..++.++.|++.||.|||+++ |+||||||+|||++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCC
Confidence 9998775 4589999999 99999999876 56999999999999999999999999 99999999999999 8
Q ss_pred CCCEEEeccCCccccccccccc--CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccch
Q 012777 286 SGHLKVADFGLSKLLKFANTVK--EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV 363 (456)
Q Consensus 286 ~~~vkl~Dfgls~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 363 (456)
++.+||+|||++..+....... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 8999999999998764332111 11122345699999999999999999999999999999999999999986433322
Q ss_pred HHH-HHhcCCCCCC------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccccccC
Q 012777 364 PKA-YIANERPPFR------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVG 427 (456)
Q Consensus 364 ~~~-~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~ 427 (456)
... .......... .....++.++.+++..||..||++||+++++++.|+.+.+....+.+.+.+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~d 340 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLD 340 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCC
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccc
Confidence 111 1111010000 012577899999999999999999999999999999999999999998998
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=333.33 Aligned_cols=249 Identities=27% Similarity=0.481 Sum_probs=202.1
Q ss_pred cccccceeeeccEEEEEe----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 152 LDFSNSVEITKGTFRIAS----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.+|++.+.||+|+||.|. .+|+.||+|++.... ........+.+|+.++++++||||+++++++......++|||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 368999999999998762 268899999997653 233345778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|++ ++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--- 172 (311)
T 3niz_A 100 FME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP--- 172 (311)
T ss_dssp CCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC---
T ss_pred CCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC---
Confidence 996 58888887654 4999999999999999999999999 999999999999999999999999999865321
Q ss_pred cCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCC--------
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFR-------- 376 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~-------- 376 (456)
........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.... .+...
T Consensus 173 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 173 --VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp --CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred --cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 122334567899999999876 568999999999999999999999998877766655543321 11100
Q ss_pred -----------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 377 -----------------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 377 -----------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.....++.++.+||.+||+.||++|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0123577889999999999999999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=356.50 Aligned_cols=247 Identities=25% Similarity=0.380 Sum_probs=203.9
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|.+.+.||+|+||.|. .+|+.||||++.............+.+|+.+++.++||||+++++++...+.+++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 368899999999999773 368899999997654344455677889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHE-NRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
||+++++|.+++...+.+++..+..++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||++.....
T Consensus 228 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--- 301 (446)
T 4ejn_A 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--- 301 (446)
T ss_dssp CCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred eeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC---
Confidence 999999999999988889999999999999999999998 88 99999999999999999999999999875421
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.... .. .+..++.+
T Consensus 302 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~---~p~~~~~~ 375 (446)
T 4ejn_A 302 --DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IR---FPRTLGPE 375 (446)
T ss_dssp -------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CC---CCTTSCHH
T ss_pred --CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CC---CCccCCHH
Confidence 1122334678999999999999999999999999999999999999999887777666664433 22 24678899
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rp-----t~~ell~~ 410 (456)
+.+||.+||..||++|| +++++++|
T Consensus 376 ~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 376 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 99999999999999999 99999876
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=341.89 Aligned_cols=256 Identities=28% Similarity=0.480 Sum_probs=213.3
Q ss_pred ccccccceeeeccEEEEEeE----------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC
Q 012777 151 ELDFSNSVEITKGTFRIASW----------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQS 219 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~~----------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~ 219 (456)
..+|.+.+.||+|+||.|.. +++.||||++... ......+.+.+|+.+++++ +||||+++++++...
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 45688999999999997622 3478999999765 3455667899999999999 799999999999875
Q ss_pred C-ceEEEEEccCCCCHHHHHHHcCC-------------------------------------------------------
Q 012777 220 T-PMMIVTEYLPKGDLRAYLKQKGA------------------------------------------------------- 243 (456)
Q Consensus 220 ~-~~~lv~e~~~~~sL~~~l~~~~~------------------------------------------------------- 243 (456)
+ ..++||||+++++|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 4 48999999999999999986533
Q ss_pred -----------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCc
Q 012777 244 -----------LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPV 312 (456)
Q Consensus 244 -----------l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~ 312 (456)
+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........ ....
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~ 252 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD---YVRK 252 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT---CEEC
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc---chhc
Confidence 889999999999999999999999 99999999999999999999999999986532211 1122
Q ss_pred ccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcC-CCCCCCCCCCCcHHHHHHH
Q 012777 313 TCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANE-RPPFRAPTTHYAYGLRELI 390 (456)
Q Consensus 313 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li 390 (456)
....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.............. ... .+..++.++.++|
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li 329 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---APDYTTPEMYQTM 329 (359)
T ss_dssp --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC---CCTTCCHHHHHHH
T ss_pred cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC---CCCCCCHHHHHHH
Confidence 23457888999999998899999999999999999998 999998877655443333333 333 2467889999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 391 EDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 391 ~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
.+||..||++|||+++++++|+.+...
T Consensus 330 ~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 330 LDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 999999999999999999999998864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=329.68 Aligned_cols=257 Identities=25% Similarity=0.458 Sum_probs=203.9
Q ss_pred ccccccceeeeccEEEEEe--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 151 ELDFSNSVEITKGTFRIAS--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
..+|++.+.||+|+||.|. .....||+|++.... ......+.+.+|+.++++++||||+++++++ .....++||||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~ 100 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW 100 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred ccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence 3468889999999999773 355679999998664 4566778899999999999999999999965 55678999999
Q ss_pred cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 229 LPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 229 ~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 174 (289)
T 3og7_A 101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS--- 174 (289)
T ss_dssp CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc---
Confidence 9999999999643 45999999999999999999999999 9999999999999999999999999987553211
Q ss_pred CCCCcccCCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC--CCCCCCCCCCC
Q 012777 308 EDRPVTCEETSWRYAAPEVYK---NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE--RPPFRAPTTHY 382 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 382 (456)
.........||+.|+|||++. +..++.++||||||+++|+|++|+.||......+......... .+........+
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence 111223356899999999986 5678889999999999999999999998876655444333332 33333445688
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
+..+.++|.+||..||++|||++++++.|+++.
T Consensus 255 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 255 PKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 999999999999999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=357.12 Aligned_cols=245 Identities=27% Similarity=0.432 Sum_probs=210.5
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||+|+||.|. .+|+.||||++........+....+.+|+.+++.++||||+++++++.....+++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68888999999998652 3689999999975422111234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~----- 168 (476)
T 2y94_A 97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD----- 168 (476)
T ss_dssp CCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT-----
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc-----
Confidence 9999999999988888999999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCCcccCCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEY-DTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..... . .+..++.++
T Consensus 169 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~---~p~~~s~~~ 243 (476)
T 2y94_A 169 -GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-Y---TPQYLNPSV 243 (476)
T ss_dssp -TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-C---CCTTCCHHH
T ss_pred -cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-C---CCccCCHHH
Confidence 122334568999999999988765 6799999999999999999999998877776666644332 1 245688999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++|.+||..||++|||+++++++
T Consensus 244 ~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 244 ISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHcCCCchhCcCHHHHHhC
Confidence 999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=334.78 Aligned_cols=258 Identities=19% Similarity=0.253 Sum_probs=208.7
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.+. .+++.||+|++.......+...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 2h34_A 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR 114 (309)
T ss_dssp CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence 68889999999998652 3688999999987655566667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++...+.+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--- 188 (309)
T 2h34_A 115 LINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEK--- 188 (309)
T ss_dssp CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccc---
Confidence 9999999999998888999999999999999999999999 9999999999999999999999999987653211
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
........+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+ ....+.....+..++..+.
T Consensus 189 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 189 -LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCGGGTSTTCCTHHH
T ss_pred -cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCccccCCCCCHHHH
Confidence 11223356889999999999999999999999999999999999999876654333333 3332222234567889999
Q ss_pred HHHHHhcccCCCCCC-CHHHHHHHHHHHHHHh
Q 012777 388 ELIEDCWSEEPFRRP-TFRQILMRLDDISDQL 418 (456)
Q Consensus 388 ~li~~~l~~dp~~Rp-t~~ell~~L~~~~~~~ 418 (456)
++|.+||..||++|| +++++++.|+.+....
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 999999999999999 9999999998776544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=357.37 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=211.2
Q ss_pred cccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 150 KELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
...+|...+.||+|+||.|. .+++.||+|++.+...........+.+|..+++.++||||++++++|.+...+++
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 34578999999999999772 3578999999965321111112347899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 225 VTEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
||||+++|+|.+++.+ .+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 9999999999999987 467999999999999999999999999 999999999999999999999999999765322
Q ss_pred ccccCCCCcccCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCCC
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYK-----NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRA 377 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~ 377 (456)
.. .......||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..+....+.... ...++.
T Consensus 229 ~~----~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 304 (437)
T 4aw2_A 229 GT----VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304 (437)
T ss_dssp SC----EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS
T ss_pred CC----cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc
Confidence 11 1122357999999999986 5578999999999999999999999999888777776664322 233333
Q ss_pred CCCCCcHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 012777 378 PTTHYAYGLRELIEDCWSEEPFR--RPTFRQILMR 410 (456)
Q Consensus 378 ~~~~~~~~l~~li~~~l~~dp~~--Rpt~~ell~~ 410 (456)
....++.++.+||.+||+.+|++ ||+++|+++|
T Consensus 305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 34678999999999999998888 9999999886
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=329.02 Aligned_cols=247 Identities=26% Similarity=0.352 Sum_probs=215.3
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|.+.+.||+|+||.+. .+++.||+|++...........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 478999999999999762 257899999998766566777788999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||+++++|.+++...+.+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 168 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--- 168 (294)
T ss_dssp ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCST---
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccC---
Confidence 99999999999988888999999999999999999999999 999999999999999999999999998865321
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
........+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+.... .. .+..++..+
T Consensus 169 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~ 242 (294)
T 2rku_A 169 --GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YS---IPKHINPVA 242 (294)
T ss_dssp --TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CC---CCTTSCHHH
T ss_pred --ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-CC---CccccCHHH
Confidence 112233568899999999999889999999999999999999999998877665555553322 22 246788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++|.+||..||++|||+++++++
T Consensus 243 ~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 243 ASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHHcccChhhCcCHHHHhhC
Confidence 999999999999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=341.29 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=204.7
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|++.+.||+|+||.|. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++......++|||
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc--ccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 68899999999999762 368899999996543 22334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++.....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-- 160 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-- 160 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE--
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc--
Confidence 9999999999987778999999999999999999999999 99999999999999999999999999986532211
Q ss_pred CCCCcccCCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEY-DTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.................. .......++..+
T Consensus 161 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (323)
T 3tki_A 161 -ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLNPWKKIDSAP 238 (323)
T ss_dssp -ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT-TSTTGGGSCHHH
T ss_pred -ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc-cCCccccCCHHH
Confidence 112234578999999999987765 67899999999999999999999876654333222222211 112246788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+||.+||..||++|||++|++++
T Consensus 239 ~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 239 LALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHccCChhhCcCHHHHhhC
Confidence 999999999999999999999876
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=343.93 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=203.2
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCC--CCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVF--TDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
.|.+.+.||+|+||.|. .+|+.||||++..... ......+.+.+|+.+++.++||||+++++++.....+++|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 58888999999999762 3689999999864211 0111246789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC---EEEeccCCcc
Q 012777 226 TEYLPKGDLRAYLKQK----GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH---LKVADFGLSK 298 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~---vkl~Dfgls~ 298 (456)
||||++++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++.
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999888653 24899999999999999999999999 999999999999986554 9999999998
Q ss_pred cccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCC
Q 012777 299 LLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAP 378 (456)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 378 (456)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. .+....+...........
T Consensus 182 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~ 255 (351)
T 3c0i_A 182 QLGES-----GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQ 255 (351)
T ss_dssp ECCTT-----SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHH
T ss_pred EecCC-----CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccc
Confidence 66321 112234568999999999999999999999999999999999999998743 333444433322211111
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 379 TTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 379 ~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
...++.++.+||.+||..||++|||+.+++++
T Consensus 256 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 256 WSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 25788999999999999999999999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=330.91 Aligned_cols=245 Identities=27% Similarity=0.428 Sum_probs=207.8
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|.+.+.||+|+||.| ..++..||+|++.............+.+|+.++++++||||+++++++......++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 36888999999999976 2357789999986542222223467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||+++++|.+++...+.+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 89 e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~---- 161 (279)
T 3fdn_A 89 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS---- 161 (279)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc----
Confidence 99999999999998888999999999999999999999999 99999999999999999999999998865421
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
.......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.... .. .+..++..+
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~ 234 (279)
T 3fdn_A 162 ---SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FT---FPDFVTEGA 234 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CC---CCTTSCHHH
T ss_pred ---ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-CC---CCCcCCHHH
Confidence 12233568899999999999999999999999999999999999999877666665554332 22 246688999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++|.+||..||++|||+++++++
T Consensus 235 ~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 235 RDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHhccChhhCCCHHHHhhC
Confidence 999999999999999999999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=337.46 Aligned_cols=250 Identities=24% Similarity=0.337 Sum_probs=211.2
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCH---HHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDE---DKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM 223 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 223 (456)
..|.+.+.||+|+||.|. .+|+.||+|++........ ...+.+.+|+.++++++||||+++++++......+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 468899999999999762 3588999999976532211 12467899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC----CEEEeccCCccc
Q 012777 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG----HLKVADFGLSKL 299 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~----~vkl~Dfgls~~ 299 (456)
+||||+++++|.+++...+.+++..++.++.|++.||.|||+++ |+|+||||+||+++.++ .+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 99999999999999998888999999999999999999999999 99999999999999887 799999999986
Q ss_pred ccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCC
Q 012777 300 LKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPT 379 (456)
Q Consensus 300 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 379 (456)
.... .......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+............
T Consensus 169 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (321)
T 2a2a_A 169 IEDG------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242 (321)
T ss_dssp CCTT------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred cCcc------ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhh
Confidence 6321 1223456899999999999999999999999999999999999999887766666555433221111113
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 380 THYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..++..+.++|.+||..||++|||+.+++++
T Consensus 243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 5788899999999999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=337.43 Aligned_cols=261 Identities=24% Similarity=0.378 Sum_probs=205.7
Q ss_pred cCccccccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc--
Q 012777 147 IDPKELDFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP-- 221 (456)
Q Consensus 147 ~~~~~~~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~-- 221 (456)
+.....+|+..+.||+|+||.| ...++.||||++... .........|+.++++++||||+++++++.....
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cccchhhchhhheecccCceEEEEEEECCCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 3444557999999999999865 667999999999754 2333456679999999999999999999987543
Q ss_pred --eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEecCCCCCCeEeCCCCCE
Q 012777 222 --MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHEN----------RPEAIIHRDLEPSNILRDDSGHL 289 (456)
Q Consensus 222 --~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~----------~~~~ivH~Dikp~Nil~~~~~~v 289 (456)
+++||||+++++|.+++.. ..+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCE
T ss_pred ceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeE
Confidence 6999999999999999976 4599999999999999999999999 8 9999999999999999999
Q ss_pred EEeccCCcccccccccccCCCCcccCCCCcccccccccCCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCccc--
Q 012777 290 KVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-----EYDTKVDVFSFALILQEMIEGCPPFPTKQEKE-- 362 (456)
Q Consensus 290 kl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-- 362 (456)
||+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.....
T Consensus 171 kL~DFg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 171 CIADFGLALKFEAGKS---AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp EECCCTTCEEECTTSC---CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred EEccCCcccccccccC---ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 9999999986643211 1122335689999999999873 45568899999999999999999997654321
Q ss_pred --------------hHHHHHhcC-CCCCCC--CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 363 --------------VPKAYIANE-RPPFRA--PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 363 --------------~~~~~~~~~-~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
....+.... .+.... .....+.++.++|.+||+.||++|||++++++.|+.+.+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111111111 121111 01223455999999999999999999999999999998754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=327.91 Aligned_cols=257 Identities=25% Similarity=0.446 Sum_probs=205.7
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|.+.+.||+|+||.+. .+|+.||+|++.............+.+|+.+++.++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 368999999999998762 368999999998765566777888999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 227 EYLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 227 e~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999875 355999999999999999999999999 99999999999999999999999999876532
Q ss_pred cccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc--chHHHHHhcCCCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK--EVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 380 (456)
.. .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.... .....+.....++. ...
T Consensus 189 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~ 261 (310)
T 2wqm_A 189 KT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL--PSD 261 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCC--CTT
T ss_pred CC-----ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCC--ccc
Confidence 11 1122346788999999999999999999999999999999999999765432 23333333222322 236
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
.++.++.++|.+||..||++|||++++++.|+.+....
T Consensus 262 ~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 262 HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 78899999999999999999999999999999997665
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=333.43 Aligned_cols=245 Identities=24% Similarity=0.392 Sum_probs=208.5
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|...+.||+|+||.|. .+|+.||||++...... ..+.+.+|+.++++++||||+++++++......++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 36666799999999762 26899999999754322 24678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++.+ ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---- 194 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---- 194 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS----
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccC----
Confidence 9999999998864 56999999999999999999999999 999999999999999999999999998865321
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
........||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.....+.. .....++..+.
T Consensus 195 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 272 (321)
T 2c30_A 195 -VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KNSHKVSPVLR 272 (321)
T ss_dssp -SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-TTGGGSCHHHH
T ss_pred -ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-CccccCCHHHH
Confidence 1122345789999999999999999999999999999999999999988777666655544433332 22456788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++|.+||..||++|||+++++++
T Consensus 273 ~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 273 DFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999886
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=327.08 Aligned_cols=245 Identities=22% Similarity=0.342 Sum_probs=209.2
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.|. .++..||+|++....... .+.+.+|+.++++++||||+++++++......++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 58888999999998762 246789999997654333 3678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe---CCCCCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR---DDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~---~~~~~vkl~Dfgls~~~~~~~ 304 (456)
|+++++|.+++...+.+++..++.++.|++.||.|||+++ |+|+||||+||++ +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~-- 161 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP-- 161 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT--
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC--
Confidence 9999999999998888999999999999999999999999 9999999999999 7888999999999986532
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
........+|+.|+|||++.+. ++.++||||||+++|+|++|+.||......+....+..............++.
T Consensus 162 ----~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 162 ----GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp ----TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred ----ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence 1223345689999999998764 89999999999999999999999998877776666654432221111236889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+.++|.+||..||++|||+.+++++
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=325.68 Aligned_cols=251 Identities=29% Similarity=0.560 Sum_probs=214.4
Q ss_pred cccccceeeeccEEEEEe----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 152 LDFSNSVEITKGTFRIAS----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.+|...+.||+|+||.+. .++..||+|++..... . .+.+.+|+.++++++||||+++++++......++|||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-S---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-C---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-C---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 458888999999998762 2677899999986542 2 2578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|+++++|.+++... +.+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 99999999999875 45999999999999999999999999 99999999999999999999999999886532111
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+....... .+..++..
T Consensus 160 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~ 233 (267)
T 3t9t_A 160 ---TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTH 233 (267)
T ss_dssp ---HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTSCHH
T ss_pred ---cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC---CCccCcHH
Confidence 11123456778999999988889999999999999999999 899999887776666664443332 24677899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMRLDDISD 416 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~ 416 (456)
+.+++.+||..||++|||+++++++|+.+.+
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=333.05 Aligned_cols=261 Identities=29% Similarity=0.477 Sum_probs=213.7
Q ss_pred ccccccceeeeccEEEEEe---Ec------CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012777 151 ELDFSNSVEITKGTFRIAS---WR------GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~---~~------g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 221 (456)
..+|...+.||+|+||.|. .. +..||+|++... ........+.+|+.++++++||||+++++++.....
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 4467888999999998662 11 235999999865 355666789999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
.++||||+++++|.+++... +.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999999865 56999999999999999999999999 999999999999999999999999999866
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCC
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPT 379 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 379 (456)
...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+......+. +
T Consensus 198 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~---~ 272 (333)
T 1mqb_A 198 EDDPEA--TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT---P 272 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---C
T ss_pred cccccc--ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC---c
Confidence 322111 111222345778999999998899999999999999999999 9999988877776666654444332 4
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccc
Q 012777 380 THYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIK 421 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~ 421 (456)
..++..+.++|.+||..||++||++.++++.|+.+.......
T Consensus 273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 314 (333)
T 1mqb_A 273 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314 (333)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence 678999999999999999999999999999999998766443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=340.96 Aligned_cols=244 Identities=22% Similarity=0.327 Sum_probs=202.7
Q ss_pred ccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEcc
Q 012777 155 SNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229 (456)
Q Consensus 155 ~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~ 229 (456)
...+.||+|+||.|. .+|+.||+|++... .....+.+.+|+.++++++||||+++++++.....+++||||+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc---ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 345679999998662 36889999999764 3345678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe--CCCCCEEEeccCCcccccccccc
Q 012777 230 PKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR--DDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 230 ~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~--~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~--- 242 (373)
T 2x4f_A 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--- 242 (373)
T ss_dssp TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT---
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc---
Confidence 999999988764 45999999999999999999999999 9999999999999 56778999999999866321
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..............++.++
T Consensus 243 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 243 ---EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp ---CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred ---cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 12233468999999999999899999999999999999999999999887776666665443222222246789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+||.+||..||.+|||+++++++
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHcCCChhhCCCHHHHhcC
Confidence 999999999999999999999985
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=342.20 Aligned_cols=248 Identities=27% Similarity=0.378 Sum_probs=196.3
Q ss_pred ccccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012777 149 PKELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM 223 (456)
Q Consensus 149 ~~~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 223 (456)
....+|.+.+.||+|+||.| ..+++.||+|++....... +.+.+|+.+++.++||||+++++++.....++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 33457999999999999855 2368899999997654333 46789999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC--EEEeccCCccccc
Q 012777 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH--LKVADFGLSKLLK 301 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~--vkl~Dfgls~~~~ 301 (456)
+||||+++++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +||+|||++....
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 99999999999999988888999999999999999999999999 999999999999987665 9999999987442
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCCCCc-hhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHh---cCCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTK-VDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIA---NERPPFRA 377 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~ 377 (456)
. ........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.............. .....++
T Consensus 170 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~- 242 (361)
T 3uc3_A 170 L------HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP- 242 (361)
T ss_dssp -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC-
T ss_pred c------cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC-
Confidence 1 112233568999999999988877665 8999999999999999999987665443332221 1111111
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 378 PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 378 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
....++..+.+||.+||..||++|||+.++++|
T Consensus 243 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 DDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 134678999999999999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=353.28 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=208.3
Q ss_pred cccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 150 KELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
...+|...+.||+|+||.| ..+|+.||+|++.+.........+.+.+|..++..++||||+++++++.+...+|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 3457899999999999876 23689999999975322122233457899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 225 VTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
||||+++++|.+++.+.+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 999999999999998754 6999999999999999999999999 999999999999999999999999999866322
Q ss_pred ccccCCCCcccCCCCcccccccccC-------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCC
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYK-------NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPF 375 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~ 375 (456)
.. .......||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..+....+.... ...+
T Consensus 216 ~~----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 291 (412)
T 2vd5_A 216 GT----VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291 (412)
T ss_dssp SC----EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred Cc----cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC
Confidence 11 1122357899999999987 4578999999999999999999999999888777766664322 2222
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 012777 376 RAPTTHYAYGLRELIEDCWSEEPFRR---PTFRQILMR 410 (456)
Q Consensus 376 ~~~~~~~~~~l~~li~~~l~~dp~~R---pt~~ell~~ 410 (456)
+.....++.++.+||.+||. +|.+| |+++++++|
T Consensus 292 p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 292 PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 22346789999999999999 99998 589999876
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=334.13 Aligned_cols=268 Identities=25% Similarity=0.419 Sum_probs=221.0
Q ss_pred ccccccccceeeeccEEEEEe----------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe
Q 012777 149 PKELDFSNSVEITKGTFRIAS----------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ 218 (456)
Q Consensus 149 ~~~~~~~~~~~lg~G~fg~~~----------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 218 (456)
....+|...+.||+|+||.|. .+++.||+|++... ........+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 334578999999999998662 24678999999754 345566789999999999999999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC
Q 012777 219 STPMMIVTEYLPKGDLRAYLKQK----------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288 (456)
Q Consensus 219 ~~~~~lv~e~~~~~sL~~~l~~~----------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~ 288 (456)
....++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCe
Confidence 99999999999999999999753 34789999999999999999999999 999999999999999999
Q ss_pred EEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHH
Q 012777 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAY 367 (456)
Q Consensus 289 vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~ 367 (456)
+||+|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+
T Consensus 177 ~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp EEECCTTCCCGGGGGGCE---EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred EEECcCcccccccccccc---ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 999999999865322111 11223346788999999988889999999999999999999 89999888776666666
Q ss_pred HhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccccccC
Q 012777 368 IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVG 427 (456)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~ 427 (456)
....... .+..++..+.++|.+||..||++|||+.+++++|+.+....-.+..+...
T Consensus 254 ~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~~~ 310 (322)
T 1p4o_A 254 MEGGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 310 (322)
T ss_dssp HTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTTS
T ss_pred HcCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccccccc
Confidence 4443332 35678999999999999999999999999999998875544333334333
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=339.16 Aligned_cols=245 Identities=26% Similarity=0.372 Sum_probs=194.0
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
..|.+.+.||+|+||.|. .+++.||||++.... ..+.+.+|+.++++++||||+++++++......++||
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 468889999999999762 257889999997542 2356789999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---CCCEEEeccCCccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD---SGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~---~~~vkl~Dfgls~~~~~~ 303 (456)
||+++++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||++......
T Consensus 128 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999999988888999999999999999999999999 999999999999975 889999999998865321
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc-hHHHHHhcCCCCCCCCCCCC
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE-VPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 382 (456)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+..............+
T Consensus 205 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 278 (349)
T 2w4o_A 205 ------VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred ------cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhC
Confidence 12234568999999999999999999999999999999999999998766554 33444333322222234678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.++.+||.+||..||++|||+.+++++
T Consensus 279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 279 SLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999999999885
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=326.00 Aligned_cols=255 Identities=27% Similarity=0.478 Sum_probs=212.9
Q ss_pred cccccccceeeeccEEEEEe---Ec-----CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012777 150 KELDFSNSVEITKGTFRIAS---WR-----GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~~---~~-----g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 221 (456)
...+|...+.||+|+||.|. .. +..||+|++... ......+.+.+|+.+++.++||||+++++++.. ..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT--SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc--cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 34568899999999998662 11 235999999865 345667889999999999999999999999865 45
Q ss_pred eEEEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
.++||||+++++|.+++...+ .+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++...
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 789999999999999997754 5999999999999999999999999 999999999999999999999999998866
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCC
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPT 379 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 379 (456)
.... ........+++.|+|||++.+..++.++||||||+++|+|++ |+.||...........+......+. +
T Consensus 164 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~---~ 236 (281)
T 3cc6_A 164 EDED----YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK---P 236 (281)
T ss_dssp -------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC---C
T ss_pred cccc----ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC---C
Confidence 3221 111223456788999999988889999999999999999998 9999988777777666655544333 4
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 380 THYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
..++..+.++|.+||..||++|||+.+++++|+.+...
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 67889999999999999999999999999999998754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=354.22 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=209.1
Q ss_pred cccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 150 KELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
...+|...+.||+|+||.|. .+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 34578999999999999772 3588999999864211111112347899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 225 VTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
||||++||+|.+++.+ ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 147 V~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 9999999999999976 56999999999999999999999999 9999999999999999999999999998653221
Q ss_pred cccCCCCcccCCCCcccccccccCCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCCCCC
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEE----YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRAPT 379 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~ 379 (456)
. .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+.... ...++ ..
T Consensus 223 ~----~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~ 297 (410)
T 3v8s_A 223 M----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP-DD 297 (410)
T ss_dssp E----EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-TT
T ss_pred c----ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCC-Cc
Confidence 1 1122457999999999997665 7889999999999999999999999888777777665432 11221 13
Q ss_pred CCCcHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 012777 380 THYAYGLRELIEDCWSEEPFR--RPTFRQILMR 410 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~--Rpt~~ell~~ 410 (456)
..++.++.+||.+||..+|.+ ||+++|+++|
T Consensus 298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 578999999999999999988 9999999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=330.24 Aligned_cols=260 Identities=27% Similarity=0.470 Sum_probs=209.2
Q ss_pred ccccccccceeeeccEEEEEe---E-----cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012777 149 PKELDFSNSVEITKGTFRIAS---W-----RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST 220 (456)
Q Consensus 149 ~~~~~~~~~~~lg~G~fg~~~---~-----~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 220 (456)
....+|...+.||+|+||.+. . ++..||+|++.... ......+.+.+|+.++++++||||+++++++....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 334578899999999998652 2 34489999997654 35566788999999999999999999999997654
Q ss_pred -----ceEEEEEccCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCE
Q 012777 221 -----PMMIVTEYLPKGDLRAYLKQ------KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289 (456)
Q Consensus 221 -----~~~lv~e~~~~~sL~~~l~~------~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~v 289 (456)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 45999999999999999853 245999999999999999999999999 9999999999999999999
Q ss_pred EEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHH
Q 012777 290 KVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYI 368 (456)
Q Consensus 290 kl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~ 368 (456)
||+|||++........ ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+.
T Consensus 187 kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 263 (313)
T 3brb_A 187 CVADFGLSKKIYSGDY---YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263 (313)
T ss_dssp EECSCSCC-------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred EEeecCcceecccccc---cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH
Confidence 9999999986632211 112223456788999999999899999999999999999999 999999888877777665
Q ss_pred hcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 369 ANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
....+.. +..++..+.++|.+||..||++|||+.+++++|+.+..++
T Consensus 264 ~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 264 HGHRLKQ---PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp TTCCCCC---BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCCCCC---CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 5444333 5678899999999999999999999999999999998765
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=329.65 Aligned_cols=248 Identities=24% Similarity=0.463 Sum_probs=200.3
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||+|+||.| ..+|+.||+|++.... ........+.+|+.++++++||||+++++++......++|||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC-CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5888899999999866 2368899999997654 334455778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|+++ +|.+.+.. .+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP--- 154 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC---
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc---
Confidence 9965 66666654 567999999999999999999999999 999999999999999999999999999865321
Q ss_pred cCCCCcccCCCCcccccccccCCCC-CCCchhHHHHHHHHHHHHcCCCC-CCCCCccchHHHHHhcC-CCC---------
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEE-YDTKVDVFSFALILQEMIEGCPP-FPTKQEKEVPKAYIANE-RPP--------- 374 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~-~~~--------- 374 (456)
........+|+.|+|||++.+.. ++.++|||||||++|+|++|..| |...+..+....+.... .+.
T Consensus 155 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp --CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred --cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 12233456889999999987765 79999999999999999988777 45544444443332211 110
Q ss_pred ---------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 ---------------FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.......++..+.+||.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 001124578899999999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=324.26 Aligned_cols=249 Identities=25% Similarity=0.419 Sum_probs=212.2
Q ss_pred ccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS--TPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~lv~e 227 (456)
+|...+.||+|+||.| ...|+.||+|++.... ......+.+.+|+.++++++||||+++++++... ...++|||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HhHHHHHhcCCCcceEEEEEECCeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 5888899999999865 5679999999998754 3456667899999999999999999999999877 78899999
Q ss_pred ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|+++++|.+++...+ .+++..++.++.|++.||.|||+++ ..++|+||||+||+++.++.++|.|||++....
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~---- 164 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ---- 164 (271)
T ss_dssp CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS----
T ss_pred ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec----
Confidence 999999999998765 4899999999999999999999875 349999999999999999999999988765331
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCC---chhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCCCCCCC
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDT---KVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRAPTTH 381 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~ 381 (456)
.....+|+.|+|||.+.+..++. ++||||||+++|+|++|+.||...........+.... .+. .+..
T Consensus 165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 235 (271)
T 3kmu_A 165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT---IPPG 235 (271)
T ss_dssp ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC---CCTT
T ss_pred ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC---CCCC
Confidence 12235788999999998765554 7999999999999999999999887766655554443 333 3567
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~ 416 (456)
++..+.++|.+||..||++|||++++++.|+.+.+
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 236 ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 89999999999999999999999999999998753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=330.76 Aligned_cols=259 Identities=29% Similarity=0.509 Sum_probs=220.2
Q ss_pred cccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 150 KELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
...+|...+.||+|+||.| ..++..||+|++.... ...+.+.+|+.++++++||||+++++++......++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 3456889999999999855 2348899999997542 235778999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 225 VTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
||||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 999999999999998743 4999999999999999999999999 99999999999999999999999999986532
Q ss_pred cccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (456)
.. ........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+....... .+..
T Consensus 164 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 236 (288)
T 3kfa_A 164 DT----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME---RPEG 236 (288)
T ss_dssp SS----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC---CCTT
T ss_pred Cc----cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC---CCCC
Confidence 11 111222345778999999998899999999999999999999 999999888777766665443333 2567
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhcccc
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKR 422 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~ 422 (456)
++..+.++|.+||..||.+|||++++++.|+.++.+.....
T Consensus 237 ~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~~~ 277 (288)
T 3kfa_A 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277 (288)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 89999999999999999999999999999999998765443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=337.40 Aligned_cols=258 Identities=27% Similarity=0.415 Sum_probs=210.5
Q ss_pred ccccccceeeeccEEEEEe---E-------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC
Q 012777 151 ELDFSNSVEITKGTFRIAS---W-------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQS 219 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~---~-------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~ 219 (456)
..+|...+.||+|+||.|. . ++..||+|++.... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3468889999999999762 1 35579999997542 334457899999999999 899999999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQKG-----------------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDL 276 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~~-----------------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Di 276 (456)
+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 99999999999999999998643 2789999999999999999999999 999999
Q ss_pred CCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 012777 277 EPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPF 355 (456)
Q Consensus 277 kp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf 355 (456)
||+|||++.++.+||+|||++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSN---YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTT---SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCcc---ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999986632211 111223446778999999988899999999999999999998 99999
Q ss_pred CCCCccchHHHHHhcC-CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 012777 356 PTKQEKEVPKAYIANE-RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLS 419 (456)
Q Consensus 356 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~ 419 (456)
................ .+. .+..++.++.++|.+||..||.+|||+.+++++|+.+.....
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 276 PGIPVDANFYKLIQNGFKMD---QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp TTCCCSHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred ccCCcHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 8877655544443433 222 246788999999999999999999999999999999876653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=353.30 Aligned_cols=249 Identities=24% Similarity=0.388 Sum_probs=208.3
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCH----------HHHHHHHHHHHHHhcCCCCcceeeeeEE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDE----------DKVKAFIDELALLQKIRHPNVVQFLGAV 216 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 216 (456)
.+|.+.+.||+|+||.|. .+++.||+|++........ ...+.+.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 468999999999999773 3678999999976542211 2346788999999999999999999999
Q ss_pred EeCCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC---CEEEec
Q 012777 217 TQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG---HLKVAD 293 (456)
Q Consensus 217 ~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~---~vkl~D 293 (456)
.....+++|||||++++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999999999988888999999999999999999999999 99999999999999776 699999
Q ss_pred cCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCC
Q 012777 294 FGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERP 373 (456)
Q Consensus 294 fgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 373 (456)
||++..... ........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+......
T Consensus 193 fg~a~~~~~------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 193 FGLSSFFSK------DYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp CTTCEECCT------TSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred CCCCEEcCC------CCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999986632 122334568999999999875 6899999999999999999999999998887777777544322
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.....+..++.++.+||.+||..||.+|||+++++++
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111235788999999999999999999999999876
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=358.09 Aligned_cols=248 Identities=25% Similarity=0.429 Sum_probs=213.5
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||+|+||.|. .+|+.||||++.............+.+|+.++++++||||+++++++......++|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 68889999999999762 3688999999976543333345788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe---CCCCCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR---DDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~---~~~~~vkl~Dfgls~~~~~~~ 304 (456)
|+.+++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 107 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~-- 181 (484)
T 3nyv_A 107 VYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-- 181 (484)
T ss_dssp CCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC--
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc--
Confidence 9999999999998888999999999999999999999999 9999999999999 4678999999999986632
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
........||+.|+|||++.+ .++.++|||||||++|+|++|++||.+.+..+....+...........+..++.
T Consensus 182 ----~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 256 (484)
T 3nyv_A 182 ----SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256 (484)
T ss_dssp ----CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred ----ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence 222334568999999999876 689999999999999999999999999888777777755442222222457889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.+||.+||..||.+|||+.+++++
T Consensus 257 ~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 257 SAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 99999999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=352.62 Aligned_cols=247 Identities=23% Similarity=0.402 Sum_probs=207.0
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|.+.+.||+|+||.|. .++..||+|++...... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 68899999999999762 36889999999765322 2224678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---CCCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD---SGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~---~~~vkl~Dfgls~~~~~~~ 304 (456)
||++++|.+++.....+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++......
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~- 192 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence 9999999999988888999999999999999999999999 999999999999976 445999999999866321
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+..............++.
T Consensus 193 -----~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 266 (494)
T 3lij_A 193 -----KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE 266 (494)
T ss_dssp -----BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCH
T ss_pred -----ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCH
Confidence 22234568999999999874 689999999999999999999999999888777777755443322223467899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+.++|.+||..||.+|||+.+++++
T Consensus 267 ~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 267 GAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHHHCCCChhhCccHHHHhcC
Confidence 99999999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=325.46 Aligned_cols=248 Identities=31% Similarity=0.571 Sum_probs=206.5
Q ss_pred ccccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-CceEEEE
Q 012777 151 ELDFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS-TPMMIVT 226 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~~lv~ 226 (456)
..+|...+.||+|+||.| ..+|+.||+|++.... ..+.+.+|+.++++++||||+++++++... ...++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 346889999999999865 5689999999997542 346789999999999999999999997554 5789999
Q ss_pred EccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 227 EYLPKGDLRAYLKQKGA--LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~--l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
||+++++|.+++...+. +++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 99999999999987543 899999999999999999999999 999999999999999999999999998755221
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.....+. .+..++
T Consensus 171 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 240 (278)
T 1byg_A 171 -------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---APDGCP 240 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC---CCTTCC
T ss_pred -------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---CcccCC
Confidence 112346788999999988889999999999999999998 999999887777666664433332 256789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
..+.++|.+||..||++|||+.++++.|+.+...
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 241 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 9999999999999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=335.26 Aligned_cols=255 Identities=27% Similarity=0.538 Sum_probs=207.5
Q ss_pred ccccccceeeeccEEEEEe---E--cCc----EEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012777 151 ELDFSNSVEITKGTFRIAS---W--RGT----QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~---~--~g~----~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 221 (456)
..+|...+.||+|+||.|. . +++ +||+|.+... ......+.+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 3468999999999999762 1 344 3588887643 23344578999999999999999999999998754
Q ss_pred eEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
.++++||+.+++|.+++... +.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 78999999999999999874 56999999999999999999999999 999999999999999999999999999876
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCC
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPT 379 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 379 (456)
.... .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+......+. +
T Consensus 168 ~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~ 241 (327)
T 3poz_A 168 GAEE---KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---P 241 (327)
T ss_dssp TTTC---C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---C
T ss_pred cCCc---ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC---C
Confidence 3321 1112223456789999999999999999999999999999999 9999998887777666654443332 4
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 380 THYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
..++..+.+++.+||+.||++|||+.+++++|+.+.+.
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 242 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 67888999999999999999999999999999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=336.60 Aligned_cols=245 Identities=29% Similarity=0.451 Sum_probs=209.9
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
..|...+.||+|+||.|. .+|+.||||++...........+.+.+|+.++++++||||+++++++......++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 358888999999999762 468899999997665455666788999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
||+. |+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC---
Confidence 9996 688888854 456999999999999999999999999 99999999999999999999999999876521
Q ss_pred ccCCCCcccCCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCC
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYK---NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (456)
.....||+.|+|||++. ...++.++|||||||++|+|++|+.||...+.......+.....+.. ....+
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 278 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHW 278 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--CCTTS
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCCCC
Confidence 12346899999999884 56789999999999999999999999988776665555555444333 24678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
+..+.++|.+||..||++|||+++++++.
T Consensus 279 ~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 279 SEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 89999999999999999999999998763
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=337.50 Aligned_cols=243 Identities=23% Similarity=0.404 Sum_probs=202.3
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
+|...+.||+|+||.|. .+|+.||+|++.+.... ..+|++++.++ +||||+++++++.+....|+||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 58888999999999762 35889999999765422 34688888887 7999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC-C---CEEEeccCCcccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS-G---HLKVADFGLSKLLKF 302 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~-~---~vkl~Dfgls~~~~~ 302 (456)
||+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||+..+ + .+||+|||++.....
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 99999999999998888999999999999999999999999 9999999999998543 2 499999999986632
Q ss_pred cccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC---ccchHHHHHhcCCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQ---EKEVPKAYIANERPPFRAPT 379 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~ 379 (456)
. ........+|+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+....+...........+
T Consensus 173 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 173 E-----NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp T-----TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred C-----CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 2 112234568999999999988888999999999999999999999998643 23344444433332222234
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 380 THYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..++.++.+||.+||..||++|||+.+++++
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 6789999999999999999999999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=333.54 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=216.0
Q ss_pred ccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
..+|.+.+.||+|+||.+. .+++.||+|++...........+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 3478999999999999762 35789999999876666677788899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|||+++++|.+++...+.+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||++......
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-- 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-- 194 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC--
Confidence 999999999999988888999999999999999999999999 999999999999999999999999999865321
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
........+|+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+.... .. .+..++..
T Consensus 195 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~---~~~~~~~~ 267 (335)
T 2owb_A 195 ---GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YS---IPKHINPV 267 (335)
T ss_dssp ---TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CC---CCTTSCHH
T ss_pred ---cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-CC---CCccCCHH
Confidence 112234568899999999998889999999999999999999999998877666555553332 22 24578899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.++|.+||..||++|||+++++++
T Consensus 268 ~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 268 AASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=335.89 Aligned_cols=268 Identities=24% Similarity=0.395 Sum_probs=214.5
Q ss_pred CCCccccCccccccccceeeeccEEEEEe----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEE
Q 012777 141 EVPEYEIDPKELDFSNSVEITKGTFRIAS----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV 216 (456)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~lg~G~fg~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 216 (456)
..+..++.....+|...+.||+|+||.|. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 104 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFC 104 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34455566666789999999999998762 258899999987642 23457889999999999999999999999
Q ss_pred EeCCceEEEEEccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEe
Q 012777 217 TQSTPMMIVTEYLPKGDLRAYLKQKG----ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVA 292 (456)
Q Consensus 217 ~~~~~~~lv~e~~~~~sL~~~l~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~ 292 (456)
...+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEEC
T ss_pred cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999986543 4899999999999999999999999 9999999999999999999999
Q ss_pred ccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHH-----
Q 012777 293 DFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAY----- 367 (456)
Q Consensus 293 Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~----- 367 (456)
|||++....... .........||+.|+|||++.+..++.++||||||+++|+|++|+.||....+.+.....
T Consensus 182 Dfg~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 258 (321)
T 2qkw_B 182 DFGISKKGTELD---QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258 (321)
T ss_dssp CCTTCEECSSSS---CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHH
T ss_pred eccccccccccc---ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhh
Confidence 999988653211 111222345788999999998889999999999999999999999999876554322111
Q ss_pred -HhcCC------CCC-CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 368 -IANER------PPF-RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 368 -~~~~~------~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
..... +.. ......++..+.+++.+||..||++|||+++++++|+.+.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp HHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 01110 111 111234556799999999999999999999999999988753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=329.01 Aligned_cols=245 Identities=24% Similarity=0.360 Sum_probs=208.5
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|...+.||+|+||.+. .+|+.||+|++.... ......+.+|+.++++++||||+++++++......++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 68888999999998762 368999999997542 2233568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe---CCCCCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR---DDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~---~~~~~vkl~Dfgls~~~~~~~ 304 (456)
|+++++|.+++...+.+++..++.++.|++.||.|||+++ |+|+||||+||++ +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-- 161 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-- 161 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--
Confidence 9999999999988888999999999999999999999999 9999999999999 7888999999999875421
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.......+++.|+|||++.+..++.++||||||+++|+|++|..||...........+..............++.
T Consensus 162 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 162 -----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp -----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred -----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCH
Confidence 112234578899999999999999999999999999999999999988777666666654443222233467899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+.++|.+||..||++|||+++++++
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=334.27 Aligned_cols=253 Identities=31% Similarity=0.529 Sum_probs=210.4
Q ss_pred cccccceeeeccEEEEE-----eEcCcEE--EEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQV--AVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMM 223 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~v--AvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~ 223 (456)
.+|...+.||+|+||.| ..+|..+ |+|.+... ......+.+.+|+.+++++ +||||+++++++...+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 36888999999999865 3456644 99998753 2344557789999999999 8999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC
Q 012777 224 IVTEYLPKGDLRAYLKQKG----------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~ 287 (456)
+||||+++++|.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+||+++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCC
Confidence 9999999999999997654 6999999999999999999999999 99999999999999999
Q ss_pred CEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHH
Q 012777 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKA 366 (456)
Q Consensus 288 ~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~ 366 (456)
.+||+|||++...... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....
T Consensus 180 ~~kL~Dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~ 253 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253 (327)
T ss_dssp CEEECCTTCEESSCEE------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred eEEEcccCcCcccccc------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence 9999999998744211 11223456788999999988889999999999999999998 9999998877666655
Q ss_pred HHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 367 YIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
+....... .+..++..+.++|.+||..||++|||+++++++|+.+..+.
T Consensus 254 ~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 254 LPQGYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp GGGTCCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred hhcCCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 54433332 24678899999999999999999999999999999998765
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=329.29 Aligned_cols=248 Identities=29% Similarity=0.482 Sum_probs=199.9
Q ss_pred ccccceeeeccEEEEEe----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 153 DFSNSVEITKGTFRIAS----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
+|...+.||+|+||.|. .+|+.||+|++..... .......+.+|+.++++++||||+++++++......++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57888999999999762 2588999999976532 222235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 229 LPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 229 ~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
++ ++|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 153 (288)
T 1ob3_A 82 LD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP---- 153 (288)
T ss_dssp CS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc----
Confidence 96 5999998764 56999999999999999999999999 999999999999999999999999998865321
Q ss_pred CCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CC------------
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RP------------ 373 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~------------ 373 (456)
........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+.... .+
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 154 -VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred -ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence 1122334678999999998764 58999999999999999999999998876655444432211 10
Q ss_pred ----CC--------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 ----PF--------RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 ----~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+ ......++.++.++|.+||..||++|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 01124678899999999999999999999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=330.17 Aligned_cols=247 Identities=26% Similarity=0.419 Sum_probs=199.3
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCC-----------------------HHHHHHHHHHHHHHhcC
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTD-----------------------EDKVKAFIDELALLQKI 204 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~l 204 (456)
+|...+.||+|+||.|. .+|+.||||++....... ....+.+.+|+.+++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 68889999999998762 358899999997543211 12245688999999999
Q ss_pred CCCcceeeeeEEEe--CCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeE
Q 012777 205 RHPNVVQFLGAVTQ--STPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL 282 (456)
Q Consensus 205 ~hp~iv~l~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil 282 (456)
+||||+++++++.. ...+++||||+++++|.+++. .+.+++..++.++.|++.||.|||+++ |+||||||+|||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil 169 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLL 169 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEE
Confidence 99999999999986 567999999999999988654 356999999999999999999999999 999999999999
Q ss_pred eCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCC---CCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 012777 283 RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEE---YDTKVDVFSFALILQEMIEGCPPFPTKQ 359 (456)
Q Consensus 283 ~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~l~~g~~pf~~~~ 359 (456)
++.++.+||+|||++...... ........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGS-----DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSS-----SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ECCCCCEEEecCCCccccccc-----cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999865321 11223456899999999998765 3678999999999999999999998876
Q ss_pred ccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 360 EKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.......+.... ..++ ....++.++.++|.+||..||++|||+++++++
T Consensus 245 ~~~~~~~~~~~~-~~~~-~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 IMCLHSKIKSQA-LEFP-DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHHHHCC-CCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHHHHhccc-CCCC-CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 655555553332 2221 235788999999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=332.14 Aligned_cols=248 Identities=27% Similarity=0.501 Sum_probs=190.9
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|...+.||+|+||.|. .+|+.||+|++.... .......+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 368888999999998762 358899999997543 2222356889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 227 EYLPKGDLRAYLKQK------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 227 e~~~~~sL~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
||++ ++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9996 6999998764 34899999999999999999999999 999999999999999999999999999865
Q ss_pred cccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCC----
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPP---- 374 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~---- 374 (456)
... ........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.... .++
T Consensus 159 ~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 159 GIP-----VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp TSC-----CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred CCC-----cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 321 1122335688999999998764 68999999999999999999999998877665554443211 110
Q ss_pred --------C----C-------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 --------F----R-------------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 --------~----~-------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+ . .....++.++.+||.+||..||++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 0 0123578899999999999999999999998875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=349.26 Aligned_cols=252 Identities=30% Similarity=0.516 Sum_probs=213.8
Q ss_pred ccccccceeeeccEEEEE---eE-cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 151 ELDFSNSVEITKGTFRIA---SW-RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~---~~-~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
..+|...+.||+|+||.| .. ++..||||++..... ..+.+.+|+.++++++||||+++++++. ....++||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 345788899999999976 22 477899999986532 2468999999999999999999999986 56789999
Q ss_pred EccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 227 EYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 227 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
||+++++|.+++... ..++...++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999999999754 36899999999999999999999999 9999999999999999999999999998663221
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
.. ......+|+.|+|||++....++.++||||||+++|+|++ |+.||.+.+..+....+....+.+. +..++
T Consensus 339 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~~~ 411 (454)
T 1qcf_A 339 YT----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR---PENCP 411 (454)
T ss_dssp HH----TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC---CTTSC
T ss_pred ee----ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCC
Confidence 11 1122346778999999988899999999999999999999 9999999887777777655544443 46789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
.++.++|.+||..||++|||++++++.|+.+...
T Consensus 412 ~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 412 EELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999887643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=327.02 Aligned_cols=245 Identities=24% Similarity=0.427 Sum_probs=201.8
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.|. .++..||+|++...... ...+.+.+|+.++++++||||+++++++......++|||
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 68899999999998762 36889999999765422 224678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe---CCCCCEEEeccCCcccc
Q 012777 228 YLPKGDLRAYLKQK----GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR---DDSGHLKVADFGLSKLL 300 (456)
Q Consensus 228 ~~~~~sL~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~---~~~~~vkl~Dfgls~~~ 300 (456)
|+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988643 56999999999999999999999999 9999999999999 45678999999999765
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
... .......+|+.|+|||++.+ .++.++||||||+++|+|++|+.||......+........ .+.+.....
T Consensus 178 ~~~------~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~ 249 (285)
T 3is5_A 178 KSD------EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK-EPNYAVECR 249 (285)
T ss_dssp ---------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCC--C
T ss_pred CCc------ccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC-CcccccccC
Confidence 321 12234568999999999864 6889999999999999999999999887766655554332 333333345
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+++.+.++|.+||..||++|||+.|++++
T Consensus 250 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 688999999999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=326.61 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=207.5
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCH---HHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDE---DKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
+|...+.||+|+||.+. .+|+.||+|++........ ...+.+.+|+.++++++||||+++++++......++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 58888999999998762 2588999999976533211 124678999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC----CEEEeccCCcccc
Q 012777 225 VTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG----HLKVADFGLSKLL 300 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~----~vkl~Dfgls~~~ 300 (456)
||||+++++|.+++...+.+++..++.++.|++.||.|||+++ ++|+||||+||+++.++ .+||+|||++...
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 86 ILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 9999999999999988888999999999999999999999999 99999999999999877 8999999998865
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
... .......+++.|+|||++.+..++.++||||||+++|+|++|..||......+....+.............
T Consensus 163 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T 3bhy_A 163 EAG------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS 236 (283)
T ss_dssp C--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred cCC------CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcc
Confidence 321 12233468899999999999999999999999999999999999998877666555553332211111235
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++..+.++|.+||..||++|||+.+++++
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp TCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 678899999999999999999999999985
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=331.78 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=203.0
Q ss_pred ccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC--ceE
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST--PMM 223 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~--~~~ 223 (456)
..+|.+.+.||+|+||.|. .+|+.||||++...... ...+.+.+|+.++++++||||+++++++.... ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 3468899999999999762 24889999999864322 22467789999999999999999999998765 789
Q ss_pred EEEEccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe----CCCCCEEEeccCC
Q 012777 224 IVTEYLPKGDLRAYLKQKGA---LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR----DDSGHLKVADFGL 296 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~----~~~~~vkl~Dfgl 296 (456)
+||||+++++|.+++..... +++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999999986543 999999999999999999999999 9999999999999 7778899999999
Q ss_pred cccccccccccCCCCcccCCCCcccccccccC--------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc----chH
Q 012777 297 SKLLKFANTVKEDRPVTCEETSWRYAAPEVYK--------NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK----EVP 364 (456)
Q Consensus 297 s~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~ 364 (456)
+...... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||...... +..
T Consensus 163 a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 163 ARELEDD------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp CEECCTT------CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred ceecCCC------CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 9866321 2223456899999999885 567889999999999999999999999754432 222
Q ss_pred HHHHhcCCCC------------------CC---CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 365 KAYIANERPP------------------FR---APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 365 ~~~~~~~~~~------------------~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
..+.....+. ++ .....++..+.++|.+||+.||++|||++|++++..+-
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 3332222110 00 11234556789999999999999999999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=327.52 Aligned_cols=244 Identities=24% Similarity=0.417 Sum_probs=208.5
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.+. .++..||+|++.............+.+|+.+++.++||||+++++++......++|||
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 68889999999998662 2577899999864321111223678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++...+.+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~----- 166 (284)
T 2vgo_A 95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS----- 166 (284)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS-----
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc-----
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999875521
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
.......+++.|+|||++.+..++.++||||||+++|+|++|..||......+....+... ... .+..++..+.
T Consensus 167 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~ 240 (284)
T 2vgo_A 167 --LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-DLK---FPPFLSDGSK 240 (284)
T ss_dssp --SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-CCC---CCTTSCHHHH
T ss_pred --cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-ccC---CCCcCCHHHH
Confidence 1122356889999999999999999999999999999999999999887766655555332 222 2467889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++|.+||..||++|||+++++++
T Consensus 241 ~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 241 DLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTC
T ss_pred HHHHHHhhcCHhhCCCHHHHhhC
Confidence 99999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.33 Aligned_cols=252 Identities=30% Similarity=0.499 Sum_probs=212.5
Q ss_pred cccccceeeeccEEEEEe---E-cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 152 LDFSNSVEITKGTFRIAS---W-RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~---~-~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.+|...+.||+|+||.|. . ++..||+|++..... . .+.+.+|+.+++.++||||+++++++. .+..++|||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-S---PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-C---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-c---HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 468889999999998762 2 456899999976532 2 357889999999999999999999986 456899999
Q ss_pred ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|+++++|.+++.... .+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999999999987543 6999999999999999999999999 99999999999999999999999999986632211
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+....... .+..++.
T Consensus 165 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 237 (279)
T 1qpc_A 165 ----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPDNCPE 237 (279)
T ss_dssp ----ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCH
T ss_pred ----ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC---CcccccH
Confidence 11123446778999999988889999999999999999999 999999887766666664443332 2467889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
.+.+++.+||..||++|||++++++.|+.++...
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999998765
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.56 Aligned_cols=261 Identities=26% Similarity=0.435 Sum_probs=216.4
Q ss_pred ccccccceeeeccEEEEEeE-----c-----CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC
Q 012777 151 ELDFSNSVEITKGTFRIASW-----R-----GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQS 219 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~~-----~-----g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~ 219 (456)
..+|...+.||+|+||.|.. + +..||+|++... ......+.+.+|+.+++++ +||||+++++++...
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc--cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 45688899999999997622 1 247999999765 3456678899999999999 899999999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQK--------------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD 285 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~--------------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~ 285 (456)
...++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 9999999999999999999753 35799999999999999999999999 999999999999999
Q ss_pred CCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchH
Q 012777 286 SGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVP 364 (456)
Q Consensus 286 ~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~ 364 (456)
++.+||+|||++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSN---YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTT---SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred CCeEEECccccccccccccc---eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 99999999999986532211 111223346778999999988889999999999999999998 99999887765555
Q ss_pred HHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccc
Q 012777 365 KAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIK 421 (456)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~ 421 (456)
..+....... ..+..++..+.++|.+||..||++|||++++++.|+.+..+...+
T Consensus 277 ~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 331 (333)
T 2i1m_A 277 YKLVKDGYQM--AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRE 331 (333)
T ss_dssp HHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCC--CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhcc
Confidence 4443333221 124567889999999999999999999999999999998766443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=358.66 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=207.8
Q ss_pred ccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
..+|...+.||+|+||.|. .+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+...+++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 3468999999999999772 36899999999654221122245688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGA--LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
|||++|++|.+++...+. +++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~- 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE- 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc-
Confidence 999999999999987544 999999999999999999999999 99999999999999999999999999986632
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc----hHHHHHhcCCCCCCCCC
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE----VPKAYIANERPPFRAPT 379 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~ 379 (456)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... +...+ ......+ +
T Consensus 339 -----~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i-~~~~~~~---p 409 (576)
T 2acx_A 339 -----GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVPEEY---S 409 (576)
T ss_dssp -----TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH-HHCCCCC---C
T ss_pred -----CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh-hcccccC---C
Confidence 122334579999999999999999999999999999999999999998765422 22222 2333332 4
Q ss_pred CCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 012777 380 THYAYGLRELIEDCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~Rp-----t~~ell~~ 410 (456)
..++.++.+||.+||..||.+|| +++|+++|
T Consensus 410 ~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 67899999999999999999999 78998876
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=323.56 Aligned_cols=251 Identities=30% Similarity=0.505 Sum_probs=204.2
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHH----HHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKV----KAFIDELALLQKIRHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~----~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 221 (456)
..+|...+.||+|+||.| ..+++.||+|++........... +.+.+|+.++++++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 346889999999999865 23688999999976543332222 67899999999999999999999986654
Q ss_pred eEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC-----EEEeccC
Q 012777 222 MMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH-----LKVADFG 295 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~-----vkl~Dfg 295 (456)
++||||+++++|.+++.+. ..+++..++.++.|++.||.|||+++ .+|+|+||||+|||++.++. +||+|||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 7999999999999988764 36999999999999999999999986 34999999999999988776 9999999
Q ss_pred CcccccccccccCCCCcccCCCCccccccccc--CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccch--HHHHHhcC
Q 012777 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVY--KNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV--PKAYIANE 371 (456)
Q Consensus 296 ls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~ 371 (456)
++..... ......+|+.|+|||++ ....++.++||||||+++|+|++|+.||........ ...+....
T Consensus 175 ~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 175 LSQQSVH--------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp TCBCCSS--------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred ccccccc--------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 9874421 23345688999999998 445678899999999999999999999987765544 22232222
Q ss_pred CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 372 RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 372 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
.. ...+..++..+.++|.+||..||++|||++++++.|+++
T Consensus 247 ~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 247 LR--PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CC--CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11 123568899999999999999999999999999999753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=329.63 Aligned_cols=249 Identities=23% Similarity=0.396 Sum_probs=202.5
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.|. .+|+.||+|++.... ......+.+.+|+.++++++||||+++++++......++|||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 58888999999999762 358899999997653 445556788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP---- 155 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc----
Confidence 9999999999887788999999999999999999999999 999999999999999999999999999865321
Q ss_pred CCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCC-------------
Q 012777 308 EDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERP------------- 373 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------- 373 (456)
........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+......
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 156 -SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred -ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 112233468889999999876 57899999999999999999999999887765544333221000
Q ss_pred -----CCC---------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 -----PFR---------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 -----~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..+ .....++..+.++|.+||..||++|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 0124678889999999999999999999999976
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=353.39 Aligned_cols=248 Identities=26% Similarity=0.406 Sum_probs=209.2
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|.+.+.||+|+||.|. .+|+.||||++....... .....+.+|+.++++++||||+++++++.....+++||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 368889999999998762 368899999986432111 12467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC---CCCCEEEeccCCccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD---DSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~---~~~~vkl~Dfgls~~~~~~ 303 (456)
|||++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99999999999988888999999999999999999999999 99999999999995 4567999999999865321
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
.......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+...........+..++
T Consensus 178 ------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 250 (486)
T 3mwu_A 178 ------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (486)
T ss_dssp ----------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSC
T ss_pred ------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCC
Confidence 22334568999999999876 58999999999999999999999999888777777765544322222246788
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++.++|.+||..||.+|||+.+++++
T Consensus 251 ~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 251 DDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=329.60 Aligned_cols=255 Identities=27% Similarity=0.499 Sum_probs=210.8
Q ss_pred cccceeeeccEEEEEe---------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--Cce
Q 012777 154 FSNSVEITKGTFRIAS---------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS--TPM 222 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~~---------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~ 222 (456)
|...+.||+|+||.|. .+|+.||||++... ......+.+.+|+.++++++||||+++++++... ..+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 4888999999999872 26889999999865 3566678899999999999999999999999874 678
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
++||||+++++|.+++... .+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 111 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 9999999999999999764 5999999999999999999999999 99999999999999999999999999987633
Q ss_pred cccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc---------------chHHHH
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK---------------EVPKAY 367 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---------------~~~~~~ 367 (456)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+
T Consensus 187 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 187 GHEYY--RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TCSEE--EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred ccccc--ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 21110 1123345788899999999888999999999999999999999998653221 011112
Q ss_pred HhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 012777 368 IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLS 419 (456)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~ 419 (456)
......+ .+..++..+.++|.+||..||++|||++++++.|+.+.+++.
T Consensus 265 ~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 265 ERGERLP---RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hcccCCC---CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 1122222 356789999999999999999999999999999999988774
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=327.74 Aligned_cols=254 Identities=24% Similarity=0.484 Sum_probs=204.7
Q ss_pred cccccceeeeccEEEEEe---------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--C
Q 012777 152 LDFSNSVEITKGTFRIAS---------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS--T 220 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~---------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~ 220 (456)
..|+..+.||+|+||.|. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 358889999999999762 268899999998653 233457789999999999999999999999876 6
Q ss_pred ceEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKL 299 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~ 299 (456)
.+++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++..
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 789999999999999999554 56999999999999999999999999 99999999999999999999999999986
Q ss_pred ccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-----------cc----chH
Q 012777 300 LKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQ-----------EK----EVP 364 (456)
Q Consensus 300 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----------~~----~~~ 364 (456)
....... ........+|+.|+|||++.+..++.++||||||+++|+|++|..|+.... .. ...
T Consensus 176 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 176 IETDKEY--YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp CCTTCCE--EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccCCCcc--eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 6332111 012233467888999999988889999999999999999999999864321 11 111
Q ss_pred HHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 365 KAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
..+......+ .+..++..+.++|.+||..||.+|||++++++.|+.+.
T Consensus 254 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 254 NTLKEGKRLP---CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhccCCCC---CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 2222222222 35678999999999999999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=353.54 Aligned_cols=254 Identities=29% Similarity=0.529 Sum_probs=215.5
Q ss_pred ccccccceeeeccEEEEE---eE--cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIA---SW--RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~---~~--~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
..+|...+.||+|+||.| .. ++..||||++..... ..+.+.+|+.++++++||||+++++++.....+++|
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 346888899999999855 22 478999999986532 246789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 226 TEYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
|||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999999864 34999999999999999999999999 999999999999999999999999999865321
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCC
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (456)
. ........+++.|+|||++....++.++||||||+++|+|++ |..||.+.+..+....+....+... +..+
T Consensus 372 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 444 (495)
T 1opk_A 372 T----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---PEGC 444 (495)
T ss_dssp C----EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC---CTTC
T ss_pred c----eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCC
Confidence 1 111223346778999999998889999999999999999999 9999999887777666644434332 5678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
+..+.+||.+||..||++|||+.++++.|+.++...
T Consensus 445 ~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 445 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 999999999999999999999999999998876443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=322.99 Aligned_cols=267 Identities=16% Similarity=0.202 Sum_probs=215.9
Q ss_pred cccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEE-EeCCceEEE
Q 012777 152 LDFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV-TQSTPMMIV 225 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-~~~~~~~lv 225 (456)
.+|...+.||+|+||.| . .+|+.||+|++...... ..+.+|+.+++.++|++++..+..+ ......++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 36889999999999866 2 46899999998765322 3578999999999888766655554 667788999
Q ss_pred EEccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC---CCCCEEEeccCCccccc
Q 012777 226 TEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD---DSGHLKVADFGLSKLLK 301 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~---~~~~vkl~Dfgls~~~~ 301 (456)
|||+ +++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999 8999999974 456999999999999999999999999 99999999999994 78899999999998764
Q ss_pred cccccc--CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc---chHHHHHhcC-CCCC
Q 012777 302 FANTVK--EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK---EVPKAYIANE-RPPF 375 (456)
Q Consensus 302 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~-~~~~ 375 (456)
...... .........||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+.... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 322111 111234457899999999999999999999999999999999999999875432 2333322211 1111
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccccccC
Q 012777 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVG 427 (456)
Q Consensus 376 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~ 427 (456)
......++.++.++|.+||+.||++|||++++++.|+.+..+.......+.+
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~d 291 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 291 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCG
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccc
Confidence 1123678899999999999999999999999999999999999888888888
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=334.64 Aligned_cols=255 Identities=25% Similarity=0.492 Sum_probs=209.1
Q ss_pred ccccccceeeeccEEEEEe-----EcCcE----EEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WRGTQ----VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~g~~----vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 221 (456)
..+|...+.||+|+||.|. .+++. ||+|.+.... .......+.+|+.+++.++||||+++++++. ...
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 3468889999999998762 23443 8888875432 1122345778999999999999999999886 467
Q ss_pred eEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
.++||||+++++|.+++... +.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 89999999999999999864 46999999999999999999999999 999999999999999999999999999876
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCC
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPT 379 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 379 (456)
.... .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+........ +
T Consensus 166 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~ 239 (325)
T 3kex_A 166 PPDD---KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ---P 239 (325)
T ss_dssp CCCT---TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC---C
T ss_pred Cccc---ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC---C
Confidence 4321 1122334567789999999998899999999999999999999 9999998887777666654443332 4
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 380 THYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
..++.++.++|.+||..||.+|||+++++++|+.+...
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 240 QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 56778899999999999999999999999999988644
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=327.06 Aligned_cols=247 Identities=25% Similarity=0.418 Sum_probs=184.6
Q ss_pred cccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|.+.+.||+|+||.+ . .+|+.||+|++...........+.+.+|+.++++++||||+++++++...+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 36888999999999866 2 368899999986432111122467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
||+++++|.+++... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH- 166 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC-
Confidence 999999999999875 56999999999999999999999999 9999999999999999999999999988653211
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+... .. ..+..++.+
T Consensus 167 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~-~~~~~~~~~ 238 (278)
T 3cok_A 167 ----EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA---DY-EMPSFLSIE 238 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS---CC-CCCTTSCHH
T ss_pred ----CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc---cc-CCccccCHH
Confidence 1122346889999999999988999999999999999999999999877655444333111 11 124668899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.++|.+||..||++|||+++++++
T Consensus 239 ~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 239 AKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHcccCHhhCCCHHHHhcC
Confidence 9999999999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=338.97 Aligned_cols=242 Identities=24% Similarity=0.354 Sum_probs=192.7
Q ss_pred ccccc-eeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEe----CCc
Q 012777 153 DFSNS-VEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQ----STP 221 (456)
Q Consensus 153 ~~~~~-~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~----~~~ 221 (456)
+|.+. +.||+|+||.|. .+|+.||||++... ..+.+|+.++.++ +||||+++++++.. ...
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 45555 689999999772 35889999998632 3567888887554 89999999999875 567
Q ss_pred eEEEEEccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---CCCEEEeccCC
Q 012777 222 MMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD---SGHLKVADFGL 296 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~---~~~vkl~Dfgl 296 (456)
+|+||||+++++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 899999999999999998754 4999999999999999999999999 999999999999997 78999999999
Q ss_pred cccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc----hHHHHHhcCC
Q 012777 297 SKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE----VPKAYIANER 372 (456)
Q Consensus 297 s~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~ 372 (456)
+..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+.....
T Consensus 211 a~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~ 284 (400)
T 1nxk_A 211 AKETTS------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284 (400)
T ss_dssp CEECC-----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC
T ss_pred ccccCC------CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc
Confidence 986532 112234568999999999999999999999999999999999999998765433 3333433322
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 373 PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 373 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
.........++.++.+||.+||..||++|||+++++++-
T Consensus 285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 111122367899999999999999999999999999873
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=338.03 Aligned_cols=256 Identities=22% Similarity=0.321 Sum_probs=205.1
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCC--CCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVF--TDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM 223 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 223 (456)
..+|...+.||+|+||.| ..++..||+|++..... ......+.+.+|+.++++++||||+++++++.+....+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 347899999999999866 24678999999865321 12344578999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHc----------------------------------------CCCCHHHHHHHHHHHHHHHHHH
Q 012777 224 IVTEYLPKGDLRAYLKQK----------------------------------------GALKPTLAVKFALDIARGMNYL 263 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~----------------------------------------~~l~~~~~~~i~~ql~~aL~~L 263 (456)
+||||+++++|.+++... ..+++..++.++.|++.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999988420 1146778889999999999999
Q ss_pred HhCCCCCeEecCCCCCCeEeCCCC--CEEEeccCCcccccccccccCCCCcccCCCCcccccccccCC--CCCCCchhHH
Q 012777 264 HENRPEAIIHRDLEPSNILRDDSG--HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN--EEYDTKVDVF 339 (456)
Q Consensus 264 H~~~~~~ivH~Dikp~Nil~~~~~--~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Diw 339 (456)
|+++ |+||||||+|||++.++ .+||+|||++........ ..........||+.|+|||++.+ ..++.++|||
T Consensus 185 H~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 185 HNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN-GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC-C--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCc-cccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 9999 99999999999998776 899999999986533211 11112334568999999999865 6788999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 340 SFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 340 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
|||+++|+|++|+.||......+....+..............++..+.++|.+||..||++|||+.+++++
T Consensus 261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999999999999888777666665544322222234578999999999999999999999999885
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=335.99 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=208.3
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCC-C----HHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCc
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFT-D----EDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~-~----~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~ 221 (456)
+|.+.+.||+|+||.|. .+|+.||||++...... . +...+.+.+|+.+++++ +||||+++++++.....
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 58888999999999762 25899999998654311 1 22356788999999999 79999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
.++||||+++++|.+++.....+++..+..++.|++.||.|||+.| |+|+||||+|||++.++.+||+|||++....
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 9999999999999999998888999999999999999999999999 9999999999999999999999999988663
Q ss_pred ccccccCCCCcccCCCCcccccccccCC------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKN------EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPF 375 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 375 (456)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+........
T Consensus 252 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 325 (365)
T 2y7j_A 252 PG------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS 325 (365)
T ss_dssp TT------CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred CC------cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 21 22334578999999998853 3688899999999999999999999988776665555544332211
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 376 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
......++..+.++|.+||..||++|||+.+++++
T Consensus 326 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 326 SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11125778899999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=329.20 Aligned_cols=257 Identities=28% Similarity=0.472 Sum_probs=213.5
Q ss_pred ccccccceeeeccEEEEEe----------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC
Q 012777 151 ELDFSNSVEITKGTFRIAS----------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQS 219 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~----------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~ 219 (456)
..+|.+.+.||+|+||.|. .+++.||||++... ........+.+|+.+++++ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC--CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 4578899999999999762 24578999999865 3455667899999999999 799999999998775
Q ss_pred C-ceEEEEEccCCCCHHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeE
Q 012777 220 T-PMMIVTEYLPKGDLRAYLKQKGA----------------LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL 282 (456)
Q Consensus 220 ~-~~~lv~e~~~~~sL~~~l~~~~~----------------l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil 282 (456)
+ .+++||||+++++|.+++..... +++..++.++.|++.||.|||+++ |+||||||+||+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil 180 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 180 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEE
Confidence 4 59999999999999999987543 889999999999999999999999 999999999999
Q ss_pred eCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCcc
Q 012777 283 RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEK 361 (456)
Q Consensus 283 ~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~ 361 (456)
++.++.+||+|||++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPD---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTT---SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ECCCCCEEECCCccccccccCcc---ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 99999999999999986532111 111223446788999999988899999999999999999998 99999887655
Q ss_pred chHHH-HHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 362 EVPKA-YIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 362 ~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
..... +....... .+..++..+.++|.+||..||.+|||+.+++++|+.+.+..
T Consensus 258 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 258 EEFCRRLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp HHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhccCccCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 44333 33332332 24668899999999999999999999999999999998654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=324.08 Aligned_cols=245 Identities=27% Similarity=0.424 Sum_probs=200.9
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.+. .+|+.||+|++........+..+.+.+|+.+++.++||||+++++++......++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 68889999999998662 2688999999864321112234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++...+.+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~---- 164 (276)
T 2h6d_A 92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---- 164 (276)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC----
Confidence 9999999999998888999999999999999999999999 999999999999999999999999998765321
Q ss_pred CCCCcccCCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEY-DTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
.......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+.... .. .+..++..+
T Consensus 165 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~---~~~~~~~~l 238 (276)
T 2h6d_A 165 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FY---IPEYLNRSV 238 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CC---CCTTSCHHH
T ss_pred --cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-cc---CchhcCHHH
Confidence 11223467889999999988765 579999999999999999999998877666655554332 22 246678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++|.+||..||++|||+++++++
T Consensus 239 ~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 239 ATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCChhhCCCHHHHHhC
Confidence 999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=330.65 Aligned_cols=255 Identities=26% Similarity=0.515 Sum_probs=207.0
Q ss_pred ccccccceeeeccEEEEEe-----EcCcE----EEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WRGTQ----VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~g~~----vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 221 (456)
..+|.+.+.||+|+||.|. .+++. ||+|.+.... .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 3469999999999999762 24554 5777776432 2233467899999999999999999999998754
Q ss_pred eEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
.+++++|+.+++|.+++... +.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 78999999999999999874 56999999999999999999999999 999999999999999999999999999876
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCC
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPT 379 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 379 (456)
.... .........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+......+. +
T Consensus 168 ~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~ 241 (327)
T 3lzb_A 168 GAEE---KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---P 241 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---C
T ss_pred cCcc---ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence 3321 1112223456788999999999999999999999999999999 9999999887777766654443333 5
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 380 THYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
..++.++.++|.+||..||++|||+.++++.|+.+...
T Consensus 242 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 242 PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 67889999999999999999999999999999999754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=356.86 Aligned_cols=251 Identities=27% Similarity=0.438 Sum_probs=211.2
Q ss_pred eeeeccEEEEEeE-------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccC
Q 012777 158 VEITKGTFRIASW-------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230 (456)
Q Consensus 158 ~~lg~G~fg~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~ 230 (456)
+.||+|+||.|.. .++.||||+++... ......+.+.+|+.++++++||||+++++++.. ...++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4799999997731 45789999998653 333445789999999999999999999999964 56899999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCC
Q 012777 231 KGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR 310 (456)
Q Consensus 231 ~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~ 310 (456)
+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........ ..
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~ 527 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YK 527 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc--cc
Confidence 9999999998888999999999999999999999999 999999999999999999999999999876332111 11
Q ss_pred CcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHH
Q 012777 311 PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLREL 389 (456)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 389 (456)
......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+....+....+........ +..++.++.+|
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~l 604 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAGCPREMYDL 604 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHH
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHH
Confidence 2223446788999999998899999999999999999998 9999999888777777755544443 56789999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 390 IEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 390 i~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
|.+||..||++|||++++++.|+.++..+
T Consensus 605 i~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 605 MNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 99999999999999999999999998765
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=323.46 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=206.4
Q ss_pred cccceeeeccEEEEE---eEcCcEEEEEEeCCCCC-CCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEcc
Q 012777 154 FSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVF-TDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~ 229 (456)
|...+.||+|+||.| ..+++.||+|++..... ..+...+.+.+|+.++++++||||+++++++......++||||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 334489999999866 45789999999975432 23445678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 230 PKGDLRAYLKQ---KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 230 ~~~sL~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
++++|.+++.. ...+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 187 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFA-- 187 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCS--
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeeccccccccccc--
Confidence 99999999974 345999999999999999999999999 9999999999999999999999999988653211
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHh---cC--------CCCC
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIA---NE--------RPPF 375 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~--------~~~~ 375 (456)
.........||+.|+|||.+.+ .++.++||||||+++|+|++|..||...........+.. .. ....
T Consensus 188 -~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (307)
T 2nru_A 188 -QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM 265 (307)
T ss_dssp -SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred -ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence 1111223468999999998876 478999999999999999999999987655433222211 11 1111
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 012777 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416 (456)
Q Consensus 376 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~ 416 (456)
......++..+.+++.+||..||.+|||+++++++|+.+..
T Consensus 266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 22234556779999999999999999999999999998753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=331.10 Aligned_cols=262 Identities=26% Similarity=0.409 Sum_probs=206.6
Q ss_pred CccccCccccccccceeeeccEEEEEe----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe
Q 012777 143 PEYEIDPKELDFSNSVEITKGTFRIAS----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ 218 (456)
Q Consensus 143 ~~~~~~~~~~~~~~~~~lg~G~fg~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 218 (456)
+.-++.....+|...+.||+|+||.|. .+|+.||||++..... ......+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp CTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred cHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC--chHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 334455556689999999999998763 2588999999976532 2222368899999999999999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCCeEecCCCCCCeEeCCCCCEEE
Q 012777 219 STPMMIVTEYLPKGDLRAYLKQKG----ALKPTLAVKFALDIARGMNYLHEN---RPEAIIHRDLEPSNILRDDSGHLKV 291 (456)
Q Consensus 219 ~~~~~lv~e~~~~~sL~~~l~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~~~~ivH~Dikp~Nil~~~~~~vkl 291 (456)
....++||||+++++|.+++.... .+++..++.++.|++.||.|||++ + |+||||||+|||++.++.+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEEE
T ss_pred CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999998643 399999999999999999999999 8 999999999999999999999
Q ss_pred eccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC----CCccchHHHH
Q 012777 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPT----KQEKEVPKAY 367 (456)
Q Consensus 292 ~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~----~~~~~~~~~~ 367 (456)
+|||++...... .........||+.|+|||++.+..++.++||||||+++|+|++|+.||.. ..........
T Consensus 176 ~Dfg~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 176 GDFGLAKLMDYK----DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp CCCSSCEECCSS----SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred ccCccccccCcc----cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 999999866321 11223334589999999999888899999999999999999999999952 1111111112
Q ss_pred HhcCCC--CC---------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 012777 368 IANERP--PF---------RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDD 413 (456)
Q Consensus 368 ~~~~~~--~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~ 413 (456)
...... .. .......+..+.+++.+||+.||.+|||+++++++|+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 111100 00 01122334679999999999999999999999999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=334.39 Aligned_cols=240 Identities=24% Similarity=0.399 Sum_probs=179.9
Q ss_pred ceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEEccC
Q 012777 157 SVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIVTEYLP 230 (456)
Q Consensus 157 ~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv~e~~~ 230 (456)
.+.||+|+||.|. .+|+.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 89 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence 3689999999762 35889999999643 2356788999999996 9999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC---CEEEeccCCccccccccccc
Q 012777 231 KGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG---HLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 231 ~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~---~vkl~Dfgls~~~~~~~~~~ 307 (456)
+++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++......
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~---- 162 (325)
T 3kn6_A 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD---- 162 (325)
T ss_dssp SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC----
Confidence 9999999999888999999999999999999999999 99999999999998765 7999999999865321
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc-------chHHHHHhcCCCCCCCCCC
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK-------EVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~ 380 (456)
........+|+.|+|||++.+..++.++||||||+++|+|++|+.||...+.. +....+.............
T Consensus 163 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (325)
T 3kn6_A 163 -NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK 241 (325)
T ss_dssp ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHH
T ss_pred -CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccccc
Confidence 11223456789999999999999999999999999999999999999875432 2233332221111111124
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++.++.+||.+||..||++|||+++++++
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 688999999999999999999999998865
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=322.79 Aligned_cols=267 Identities=16% Similarity=0.198 Sum_probs=213.8
Q ss_pred cccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEE-EeCCceEEE
Q 012777 152 LDFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV-TQSTPMMIV 225 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-~~~~~~~lv 225 (456)
.+|...+.||+|+||.| . .+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ......++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 36889999999999866 2 5788999998764422 23578899999999887766666554 667888999
Q ss_pred EEccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe---CCCCCEEEeccCCccccc
Q 012777 226 TEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR---DDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~---~~~~~vkl~Dfgls~~~~ 301 (456)
|||+ +++|.+++.. .+.+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999 8999999985 456999999999999999999999999 9999999999999 788999999999998764
Q ss_pred cccccc--CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc---hHHHHHhcC-CCCC
Q 012777 302 FANTVK--EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE---VPKAYIANE-RPPF 375 (456)
Q Consensus 302 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~-~~~~ 375 (456)
...... .........||+.|+|||.+.+..++.++|||||||++|+|++|+.||....... ....+.... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 322111 1122334678999999999999999999999999999999999999998755432 222221111 1111
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccccccC
Q 012777 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVG 427 (456)
Q Consensus 376 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~ 427 (456)
......++.++.++|.+||+.||++|||++++++.|+.+..+...+...+.+
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~d 291 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 291 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCG
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccc
Confidence 1123577899999999999999999999999999999999999888888888
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=335.78 Aligned_cols=266 Identities=14% Similarity=0.183 Sum_probs=215.2
Q ss_pred cccccccceeeeccEEEEEe---E----------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCccee-----
Q 012777 150 KELDFSNSVEITKGTFRIAS---W----------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQ----- 211 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~~---~----------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~----- 211 (456)
...+|.+.+.||+|+||.|. . .++.||+|++... ..+.+|+.++++++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhh
Confidence 34579999999999998762 1 3789999998753 35789999999999999988
Q ss_pred ----------eeeEEEe-CCceEEEEEccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 012777 212 ----------FLGAVTQ-STPMMIVTEYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEP 278 (456)
Q Consensus 212 ----------l~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp 278 (456)
+++++.. ....++||||+ +++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp 187 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTA 187 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCG
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCH
Confidence 5677766 67899999999 99999999875 67999999999999999999999999 99999999
Q ss_pred CCeEeCCCC--CEEEeccCCccccccccccc--CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCC
Q 012777 279 SNILRDDSG--HLKVADFGLSKLLKFANTVK--EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPP 354 (456)
Q Consensus 279 ~Nil~~~~~--~vkl~Dfgls~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p 354 (456)
+|||++.++ .+||+|||++.......... .........||+.|+|||++.+..++.++||||||+++|+|++|+.|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999988 89999999998664322111 11122345789999999999999999999999999999999999999
Q ss_pred CCCCCcc-chHHHHHh---cCCCCCC---CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccccccC
Q 012777 355 FPTKQEK-EVPKAYIA---NERPPFR---APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVG 427 (456)
Q Consensus 355 f~~~~~~-~~~~~~~~---~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~ 427 (456)
|...... ........ .....+. .....++..+.++|.+||..||++|||++++++.|+.+.++.......+.+
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~d 347 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIG 347 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCC
T ss_pred cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCcccc
Confidence 9876422 22211111 1111111 112357899999999999999999999999999999999999988888888
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=333.13 Aligned_cols=248 Identities=24% Similarity=0.414 Sum_probs=196.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.| ..+|+.||||++.... ........+.+|+.++++++||||+++++++......++|||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc-cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence 6899999999999866 3468899999997653 233445677899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-----CCCCEEEeccCCcccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD-----DSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~-----~~~~vkl~Dfgls~~~~~ 302 (456)
|++ ++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 114 ~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 114 YAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp CCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred cCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 996 599999998888999999999999999999999999 99999999999995 445599999999986632
Q ss_pred cccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCCCC--
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRAP-- 378 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~-- 378 (456)
. ........+|+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+.... .++....
T Consensus 190 ~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 190 P-----IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp ---------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred c-----ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 1 1122334578999999999875 58999999999999999999999998877665554443321 1110000
Q ss_pred -----------------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 379 -----------------------TTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 379 -----------------------~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
...++.++.+||.+||..||++|||++|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 01267889999999999999999999999875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=324.59 Aligned_cols=270 Identities=28% Similarity=0.433 Sum_probs=223.2
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|...+.||+|+||.| ..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 5888999999999865 23588999999976532 2345788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++.. +.+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--- 173 (303)
T ss_dssp CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB---
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc---
Confidence 9999999999864 57999999999999999999999999 9999999999999999999999999998653211
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
.......+++.|+|||++.+..++.++||||||+++|+|++|..||...........+.....+. ....++..+.
T Consensus 174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~ 248 (303)
T 3a7i_A 174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSKPLK 248 (303)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---CCSSCCHHHH
T ss_pred --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC---CccccCHHHH
Confidence 12234568899999999999999999999999999999999999998877666555554443333 3567899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccccccCcchhhHHHHHhhhcC
Q 012777 388 ELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVGPLRCFQSLAALWKKG 442 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (456)
++|.+||..||++|||+.+++++.. +..- ..+...+..+...-..|.+.
T Consensus 249 ~li~~~l~~dp~~Rps~~~ll~~~~--~~~~----~~~~~~~~~~~~~~~~~~~~ 297 (303)
T 3a7i_A 249 EFVEACLNKEPSFRPTAKELLKHKF--ILRN----AKKTSYLTELIDRYKRWKAE 297 (303)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTCHH--HHHH----CCCGGGGHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHhhChh--hhcC----CCccHHHHHHHHHHHHhhhh
Confidence 9999999999999999999999743 2222 22344555666666667653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=327.59 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=197.1
Q ss_pred ccccc-eeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEE
Q 012777 153 DFSNS-VEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 153 ~~~~~-~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv 225 (456)
.|.+. +.||+|+||.|. .+++.||||++...... ....+.+|+.+++++ +||||+++++++...+..++|
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 46653 679999999772 36889999999765322 246788999999985 799999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC---EEEeccCCcccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH---LKVADFGLSKLLKF 302 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~---vkl~Dfgls~~~~~ 302 (456)
|||+++++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999999998888999999999999999999999999 999999999999998765 99999999876532
Q ss_pred ccccc--CCCCcccCCCCcccccccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc-------------
Q 012777 303 ANTVK--EDRPVTCEETSWRYAAPEVYKN-----EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE------------- 362 (456)
Q Consensus 303 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------------- 362 (456)
..... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 21111 1112223458999999999865 568899999999999999999999998765322
Q ss_pred --hHHHHHhcCCCCCC-CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 363 --VPKAYIANERPPFR-APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 363 --~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
....+... ...++ .....++..+.+||.+||..||++|||+.+++++
T Consensus 247 ~~~~~~i~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 247 NMLFESIQEG-KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhcc-CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 22333222 22211 0124678899999999999999999999999886
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=332.16 Aligned_cols=245 Identities=27% Similarity=0.382 Sum_probs=199.6
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC------
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST------ 220 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~------ 220 (456)
.+|...+.||+|+||.| ..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46889999999999866 2368999999997653 45666788999999999999999999999997653
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
.+|+||||+ +++|.+++.. +.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 8899999876 57999999999999999999999999 999999999999999999999999999865
Q ss_pred cccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC--------
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-------- 371 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------- 371 (456)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 179 ~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 179 DS--------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CS--------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cc--------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 21 1234568999999999877 678999999999999999999999998876654443332211
Q ss_pred -------------------CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 -------------------RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 -------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
...+.......+..+.+||.+||..||++|||+++++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 111222235678899999999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=331.17 Aligned_cols=253 Identities=22% Similarity=0.320 Sum_probs=201.9
Q ss_pred CccccccccceeeeccEEEEEe----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCC--CcceeeeeEEEeCCc
Q 012777 148 DPKELDFSNSVEITKGTFRIAS----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRH--PNVVQFLGAVTQSTP 221 (456)
Q Consensus 148 ~~~~~~~~~~~~lg~G~fg~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~l~~~~~~~~~ 221 (456)
......|++.+.||+|+||.|. .+++.||||++.... ......+.+.+|+.++++++| |||+++++++.....
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 3345579999999999999773 358899999997654 456667889999999999976 999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
.++|||+ .+++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||++....
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 9999995 48899999999888999999999999999999999999 99999999999997 5789999999998663
Q ss_pred ccccccCCCCcccCCCCcccccccccCC-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc-hHHHHHh
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKN-----------EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE-VPKAYIA 369 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~ 369 (456)
... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+..
T Consensus 159 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 235 (343)
T 3dbq_A 159 PDT---TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235 (343)
T ss_dssp --------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred ccc---ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence 221 1112234568999999999854 678889999999999999999999997654322 2222211
Q ss_pred cCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 370 NERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
.. .. ...+...+..+.++|.+||..||++|||+.+++++-
T Consensus 236 ~~-~~-~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 236 PN-HE-IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp TT-SC-CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CC-cc-cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 11 11 123456678899999999999999999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=336.35 Aligned_cols=252 Identities=26% Similarity=0.437 Sum_probs=195.9
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCC--ceEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQST--PMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~--~~~l 224 (456)
+|.+.+.||+|+||.| ..+|+.||||++.... ........+.+|+.+++.+. ||||+++++++...+ .+|+
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 6888899999999966 2468999999997543 45666788899999999996 999999999997654 6899
Q ss_pred EEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 225 VTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
||||++ ++|.+++.. +.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 999996 699999876 57999999999999999999999999 9999999999999999999999999998653211
Q ss_pred cc----------------cCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHH
Q 012777 305 TV----------------KEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAY 367 (456)
Q Consensus 305 ~~----------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 367 (456)
.. ..........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 00 01122334679999999999876 57899999999999999999999999887765554444
Q ss_pred HhcC-CCC-----------------------------CC-------------CCCCCCcHHHHHHHHHhcccCCCCCCCH
Q 012777 368 IANE-RPP-----------------------------FR-------------APTTHYAYGLRELIEDCWSEEPFRRPTF 404 (456)
Q Consensus 368 ~~~~-~~~-----------------------------~~-------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~ 404 (456)
.... .+. .. .....++.++.+||.+||..||++|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 3211 110 00 0123678899999999999999999999
Q ss_pred HHHHHH
Q 012777 405 RQILMR 410 (456)
Q Consensus 405 ~ell~~ 410 (456)
+|+++|
T Consensus 324 ~e~l~H 329 (388)
T 3oz6_A 324 NDALKH 329 (388)
T ss_dssp HHHTTS
T ss_pred HHHhCC
Confidence 999987
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=325.55 Aligned_cols=247 Identities=32% Similarity=0.579 Sum_probs=202.1
Q ss_pred cccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 152 LDFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
.+|.+.+.||+|+||.| ...++.||+|++... ...+.+.+|+.++++++||||+++++++. +..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence 35888899999999865 567899999998643 23578899999999999999999999886 357999999
Q ss_pred cCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHh---CCCCCeEecCCCCCCeEeCCCCC-EEEeccCCccccc
Q 012777 229 LPKGDLRAYLKQKGA---LKPTLAVKFALDIARGMNYLHE---NRPEAIIHRDLEPSNILRDDSGH-LKVADFGLSKLLK 301 (456)
Q Consensus 229 ~~~~sL~~~l~~~~~---l~~~~~~~i~~ql~~aL~~LH~---~~~~~ivH~Dikp~Nil~~~~~~-vkl~Dfgls~~~~ 301 (456)
+++++|.+++..... ++...++.++.|++.||.|||+ ++ |+||||||+||+++.++. +||+|||++....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 999999999986543 7889999999999999999999 66 999999999999998886 7999999987552
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccch--HHHHHhcCCCCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV--PKAYIANERPPFRAPT 379 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~ 379 (456)
. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ...+.....++ ..
T Consensus 158 ~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 226 (307)
T 2eva_A 158 T--------HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP---LI 226 (307)
T ss_dssp ---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCC---CB
T ss_pred c--------ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCC---cc
Confidence 1 11234588999999999999999999999999999999999999986554332 22232222333 24
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 012777 380 THYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLS 419 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~ 419 (456)
..++..+.++|.+||..||++|||++++++.|+.+...+.
T Consensus 227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 6789999999999999999999999999999999987764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=328.00 Aligned_cols=249 Identities=28% Similarity=0.417 Sum_probs=200.3
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCC--HHHHHHHHHHHHHHhcC---CCCcceeeeeEEEeCC-
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTD--EDKVKAFIDELALLQKI---RHPNVVQFLGAVTQST- 220 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~--~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~~~- 220 (456)
.+|++.+.||+|+||.| ..+|+.||+|++....... ......+.+|+.+++++ +||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 46899999999999865 2468899999987432111 11113456677776666 5999999999998765
Q ss_pred ----ceEEEEEccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEecc
Q 012777 221 ----PMMIVTEYLPKGDLRAYLKQKGA--LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294 (456)
Q Consensus 221 ----~~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Df 294 (456)
..+++|||+. ++|.+++..... +++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSC
T ss_pred CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeC
Confidence 4899999995 699999987654 999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CC
Q 012777 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RP 373 (456)
Q Consensus 295 gls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~ 373 (456)
|++..... ........+|+.|+|||++.+..++.++|||||||++|+|++|++||...+..+....+.... .+
T Consensus 165 g~a~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 165 GLARIYSY------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp SCTTTSTT------CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccCC------CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99986532 222334568999999999999999999999999999999999999998887766655553321 11
Q ss_pred CCCC----------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 PFRA----------------------PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 ~~~~----------------------~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+... ....++.++.+||.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 1000 124678899999999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=344.31 Aligned_cols=253 Identities=33% Similarity=0.545 Sum_probs=209.1
Q ss_pred ccccccceeeeccEEEEE---eEc-CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 151 ELDFSNSVEITKGTFRIA---SWR-GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~---~~~-g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
..+|...+.||+|+||.| ... +..||||++..... . .+.+.+|+.++++++||||+++++++.. ...++||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-C---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-C---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 345788899999999876 333 46799999986532 2 3578999999999999999999999876 6789999
Q ss_pred EccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 227 EYLPKGDLRAYLKQ--KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 227 e~~~~~sL~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN- 333 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC-
Confidence 99999999999964 346999999999999999999999999 999999999999999999999999999866321
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
.........+++.|+|||++....++.++||||||+++|+|++ |+.||.+....+....+....+.+. +..++
T Consensus 334 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~~~ 407 (452)
T 1fmk_A 334 ---EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECP 407 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTSC
T ss_pred ---ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCC
Confidence 1112223456788999999988899999999999999999999 9999998887777776655544443 46789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
..+.++|.+||..||++|||++++++.|+.++...
T Consensus 408 ~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 99999999999999999999999999999876443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=321.72 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=209.7
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCC--C----HHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeC
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFT--D----EDKVKAFIDELALLQKIR-HPNVVQFLGAVTQS 219 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~--~----~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~ 219 (456)
.+|.+.+.||+|+||.|. .+|+.||||++...... . ....+.+.+|+.+++++. ||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 468889999999998762 36789999999754311 1 233567889999999995 99999999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccc
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKL 299 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~ 299 (456)
...++||||+++++|.+++.....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++..
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhh
Confidence 999999999999999999998888999999999999999999999999 99999999999999999999999999886
Q ss_pred ccccccccCCCCcccCCCCcccccccccC------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCC
Q 012777 300 LKFANTVKEDRPVTCEETSWRYAAPEVYK------NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERP 373 (456)
Q Consensus 300 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 373 (456)
... ........+++.|+|||++. ...++.++||||||+++|+|++|..||...+.......+......
T Consensus 174 ~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (298)
T 1phk_A 174 LDP------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 247 (298)
T ss_dssp CCT------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred cCC------CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc
Confidence 532 12223456889999999884 456888999999999999999999999887766666555444322
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
........++..+.++|.+||..||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 2222235788999999999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=328.62 Aligned_cols=259 Identities=29% Similarity=0.482 Sum_probs=214.0
Q ss_pred ccccccceeeeccEEEEE---e-------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012777 151 ELDFSNSVEITKGTFRIA---S-------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST 220 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~---~-------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 220 (456)
..+|.+.+.||+|+||.| . .++..||||++... ........+.+|+.++++++||||+++++++....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 447999999999999754 2 35678999999754 35566678999999999999999999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---CCCEE
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKG-------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD---SGHLK 290 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~---~~~vk 290 (456)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999998753 3889999999999999999999999 999999999999994 44699
Q ss_pred EeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHh
Q 012777 291 VADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIA 369 (456)
Q Consensus 291 l~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~ 369 (456)
|+|||++........ ........+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+..
T Consensus 184 l~Dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 184 IGDFGMARDIYRASY---YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp ECCCHHHHHHHC---------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred ECccccccccccccc---cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 999999875532211 112223457889999999988889999999999999999998 9999988877666666654
Q ss_pred cCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhcc
Q 012777 370 NERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSI 420 (456)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~ 420 (456)
...+. .+..++..+.++|.+||..||.+|||+.+++++|+.+......
T Consensus 261 ~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 308 (327)
T 2yfx_A 261 GGRMD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308 (327)
T ss_dssp TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred CCCCC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence 44333 2567889999999999999999999999999999999876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=348.37 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=196.3
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC------
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST------ 220 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~------ 220 (456)
.+|++.+.||+|+||.| ..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 36889999999999977 2368899999997653 45566788999999999999999999999996553
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
.+|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 141 ~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 46999999964 6777764 35999999999999999999999999 999999999999999999999999999865
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC--------
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER-------- 372 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------- 372 (456)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+....+.....
T Consensus 215 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 215 GT------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp --------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred CC------CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 32 2233446789999999999999999999999999999999999999988776554444332111
Q ss_pred -------------CCCCCC------CC-----------CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 373 -------------PPFRAP------TT-----------HYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 373 -------------~~~~~~------~~-----------~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.+... +. ..+.++.+||.+||..||++|||++|+++|
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 110000 00 015678999999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=353.03 Aligned_cols=254 Identities=23% Similarity=0.415 Sum_probs=210.8
Q ss_pred eeeccEEEEEe---E----cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012777 159 EITKGTFRIAS---W----RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 159 ~lg~G~fg~~~---~----~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
.||+|+||.|. . ++..||||+++... .....+.+.+|+.++++++||||+++++++.. +.+++||||+++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~ 419 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG 419 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence 79999998762 2 35679999998653 23345789999999999999999999999976 569999999999
Q ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCC
Q 012777 232 GDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR 310 (456)
Q Consensus 232 ~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~ 310 (456)
++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........ ..
T Consensus 420 g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~--~~ 494 (613)
T 2ozo_A 420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY--YT 494 (613)
T ss_dssp CBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce--ee
Confidence 9999999754 45999999999999999999999999 999999999999999999999999999866322111 11
Q ss_pred CcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHH
Q 012777 311 PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLREL 389 (456)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 389 (456)
......+++.|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+....+... +..++.++.+|
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~l 571 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPECPPELYAL 571 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCC---CTTCCHHHHHH
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCHHHHHH
Confidence 1122345678999999998899999999999999999998 9999999888777777755544443 46789999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHhccccc
Q 012777 390 IEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRH 423 (456)
Q Consensus 390 i~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~ 423 (456)
|.+||..||++||++.++++.|+.++.....+..
T Consensus 572 i~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~ 605 (613)
T 2ozo_A 572 MSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 605 (613)
T ss_dssp HHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCC
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHHHHHhccccC
Confidence 9999999999999999999999999988855443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=331.30 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=194.8
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC-------
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST------- 220 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~------- 220 (456)
+|++.+.||+|+||.|. .+|+.||||++.... .+...+.+.+|+.++++++||||+++++++.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 57888999999998762 368999999997653 3344578999999999999999999999986543
Q ss_pred --------------------------------------------------ceEEEEEccCCCCHHHHHHHcCC---CCHH
Q 012777 221 --------------------------------------------------PMMIVTEYLPKGDLRAYLKQKGA---LKPT 247 (456)
Q Consensus 221 --------------------------------------------------~~~lv~e~~~~~sL~~~l~~~~~---l~~~ 247 (456)
..++|||||++++|.+++..... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 28999999999999999987654 5556
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccC-------CCCcccCCCCcc
Q 012777 248 LAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKE-------DRPVTCEETSWR 320 (456)
Q Consensus 248 ~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~-------~~~~~~~~gt~~ 320 (456)
.++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........... ........||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999999999 99999999999999999999999999987643211100 112234568999
Q ss_pred cccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCC
Q 012777 321 YAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFR 400 (456)
Q Consensus 321 y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 400 (456)
|+|||++.+..++.++||||||+++|+|++|..|+... ......+.. ..++......++++.++|.+||..||++
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~ 316 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRN---LKFPLLFTQKYPQEHMMVQDMLSPSPTE 316 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHT---TCCCHHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhc---cCCCcccccCChhHHHHHHHHccCCCCc
Confidence 99999999999999999999999999999987765221 111222211 1221123455677899999999999999
Q ss_pred CCCHHHHHHH
Q 012777 401 RPTFRQILMR 410 (456)
Q Consensus 401 Rpt~~ell~~ 410 (456)
|||+++++++
T Consensus 317 Rps~~~~l~~ 326 (332)
T 3qd2_B 317 RPEATDIIEN 326 (332)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhhc
Confidence 9999999875
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=361.89 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=212.2
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv 225 (456)
.+|...+.||+|+||.| ..+++.||||++.+.........+.+..|..++..+ +||+|+++++++...+.+|+|
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 36888999999999866 236788999999754222222346788899999988 799999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|||+++++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~--- 494 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--- 494 (674)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCC---
T ss_pred EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecccc---
Confidence 999999999999998889999999999999999999999999 99999999999999999999999999985421
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHH
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (456)
.........||+.|+|||++.+..++.++||||||+++|||++|++||.+.+..+....+.... ..+ +..++.+
T Consensus 495 --~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~---p~~~s~~ 568 (674)
T 3pfq_A 495 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAY---PKSMSKE 568 (674)
T ss_dssp --TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC-CCC---CTTSCHH
T ss_pred --CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCC---CccCCHH
Confidence 1122344679999999999999999999999999999999999999999988877777775433 222 4678999
Q ss_pred HHHHHHHhcccCCCCCCCH-----HHHHHH
Q 012777 386 LRELIEDCWSEEPFRRPTF-----RQILMR 410 (456)
Q Consensus 386 l~~li~~~l~~dp~~Rpt~-----~ell~~ 410 (456)
+.+||.+||..||++||++ +++++|
T Consensus 569 ~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 569 AVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 9999999999999999997 777664
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=344.78 Aligned_cols=260 Identities=22% Similarity=0.340 Sum_probs=191.1
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----Cc
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS-----TP 221 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~ 221 (456)
.+|.+.+.||+|+||.| ..+|+.||||++.... .+....+.+.+|+.+|+.++||||+++++++... ..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36889999999999966 3468999999997653 4566678899999999999999999999998543 56
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
+|+||||+ +++|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 89999998 6799999988888999999999999999999999999 9999999999999999999999999998764
Q ss_pred cccccc----------------------CCCCcccCCCCccccccccc-CCCCCCCchhHHHHHHHHHHHHc--------
Q 012777 302 FANTVK----------------------EDRPVTCEETSWRYAAPEVY-KNEEYDTKVDVFSFALILQEMIE-------- 350 (456)
Q Consensus 302 ~~~~~~----------------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~l~~-------- 350 (456)
...... .........||+.|+|||++ .+..++.++|||||||++|+|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 221110 01123446789999999976 55679999999999999999998
Q ss_pred ---CCCCCCCCCcc--------------------chHHHHH-----------------------hcC----CCCCCCCCC
Q 012777 351 ---GCPPFPTKQEK--------------------EVPKAYI-----------------------ANE----RPPFRAPTT 380 (456)
Q Consensus 351 ---g~~pf~~~~~~--------------------~~~~~~~-----------------------~~~----~~~~~~~~~ 380 (456)
|+++|.+.... +....+. ... ...+.....
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 67777654311 0000000 000 001111234
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
..+.++.+||.+||..||++|||++|+++| .+++.+
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H--p~f~~~ 403 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAH--PFFKEV 403 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS--GGGTTT
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcC--Hhhhhc
Confidence 668899999999999999999999999986 444443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=327.33 Aligned_cols=255 Identities=24% Similarity=0.459 Sum_probs=190.4
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
..+|.+.+.||+|+||.+ ..+++.||||++.... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh--cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 457889999999999865 2368899999987543 233456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCc
Q 012777 226 TEYLPKGDLRAYLKQ--------KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLS 297 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~--------~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls 297 (456)
|||+++++|.+++.. .+.+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999974 345999999999999999999999999 999999999999999999999999998
Q ss_pred ccccccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCC
Q 012777 298 KLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFR 376 (456)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 376 (456)
...................+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.................+...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence 86643222222222334568999999999876 46889999999999999999999999887766655444333332221
Q ss_pred ------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 377 ------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 377 ------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.....++.++.++|.+||..||++|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1235788899999999999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=324.62 Aligned_cols=242 Identities=23% Similarity=0.253 Sum_probs=194.2
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv 225 (456)
.+|+..+.||+|+||.|. .+|+.||||++..... ..........|+..+.++ +||||+++++++.....+++|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 368899999999999762 2689999999876543 344445556666666555 899999999999999999999
Q ss_pred EEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 226 TEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
|||+ +++|.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~- 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA- 210 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC-
Confidence 9999 779999887654 5999999999999999999999999 999999999999999999999999998765321
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..|+.... ....+.....+ ...+..++.
T Consensus 211 -----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~ 279 (311)
T 3p1a_A 211 -----GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLP--PEFTAGLSS 279 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCC--HHHHTTSCH
T ss_pred -----CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCC--cccccCCCH
Confidence 12233568999999999876 78999999999999999999976654422 22223222111 112356889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.++|.+||+.||++|||+++++++
T Consensus 280 ~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 280 ELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 99999999999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=352.31 Aligned_cols=248 Identities=25% Similarity=0.379 Sum_probs=205.9
Q ss_pred ccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
..+|...+.||+|+||.|. .+|+.||+|++.+...........+.+|+.++++++||||+++++++.....+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 3468889999999998762 36899999999754322222346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 226 TEYLPKGDLRAYLKQK----GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
|||++|++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999764 35999999999999999999999999 9999999999999999999999999998663
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc----chHHHHHhcCCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK----EVPKAYIANERPPFRA 377 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~ 377 (456)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ++...+. .....
T Consensus 341 ~~-----~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~-~~~~~--- 411 (543)
T 3c4z_A 341 AG-----QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL-EQAVT--- 411 (543)
T ss_dssp TT-----CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH-HCCCC---
T ss_pred CC-----CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh-hcccC---
Confidence 21 11123357899999999999999999999999999999999999999876432 2333332 22222
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 012777 378 PTTHYAYGLRELIEDCWSEEPFRRPTF-----RQILMR 410 (456)
Q Consensus 378 ~~~~~~~~l~~li~~~l~~dp~~Rpt~-----~ell~~ 410 (456)
.+..++..+.++|.+||..||++||++ +++++|
T Consensus 412 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 412 YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 246789999999999999999999964 677654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=330.66 Aligned_cols=257 Identities=28% Similarity=0.482 Sum_probs=209.1
Q ss_pred ccccccceeeeccEEEEE---e------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE--eC
Q 012777 151 ELDFSNSVEITKGTFRIA---S------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVT--QS 219 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~---~------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~ 219 (456)
..+|...+.||+|+||.| . .+++.||+|++... .....+.+.+|+.++++++||||+++++++. ..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 446888999999999976 2 26789999999754 4566678999999999999999999999886 44
Q ss_pred CceEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
...++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||++.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 6689999999999999999873 45999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc---------------ch
Q 012777 299 LLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK---------------EV 363 (456)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---------------~~ 363 (456)
......... .......+|+.|+|||++.+..++.++||||||+++|+|++|+.||...... ..
T Consensus 176 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 176 LLPLDKDYY--VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp ECCTTCSEE--ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ecccCCccc--eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 663221111 1122345788899999998888999999999999999999999998653321 11
Q ss_pred HHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 364 PKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
...+......+ .+..++..+.++|.+||..||++|||+++++++|+.+....
T Consensus 254 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 254 LELLEEGQRLP---APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHhhcccCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 12222222222 25688999999999999999999999999999999987665
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=333.94 Aligned_cols=251 Identities=26% Similarity=0.463 Sum_probs=209.7
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|...+.||+|+||.|. .+|..||+|++... ......+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc--cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 468899999999998762 25889999999765 35666788999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHEN-RPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~-~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
||+++++|.+++...+.+++..+..++.|++.||.|||++ + |+|+||||+|||++.++.+||+|||++......
T Consensus 111 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 9999999999999888899999999999999999999996 8 999999999999999999999999998765321
Q ss_pred ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHH-------------------
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKA------------------- 366 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~------------------- 366 (456)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....
T Consensus 186 -----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 186 -----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp -----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred -----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 11234688999999999999999999999999999999999999987654332211
Q ss_pred -----------------------HHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 367 -----------------------YIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 367 -----------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
+.....+ ......++.++.+||.+||..||++|||+++++++ ..++..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~~~~~ 331 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPP--KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH--AFIKRS 331 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCC--CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS--HHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCC--CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC--hHhhcc
Confidence 1111111 12235678899999999999999999999999987 344443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=334.14 Aligned_cols=239 Identities=23% Similarity=0.362 Sum_probs=201.7
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCH-----HHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDE-----DKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
+|.+.+.||+|+||.| ..+|+.||||++........ .....+.+|+.++++++||||+++++++......
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 104 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF 104 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence 6888999999999855 34688999999976543221 1234577899999999999999999999999999
Q ss_pred EEEEEccCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 223 MIVTEYLPKG-DLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 223 ~lv~e~~~~~-sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
++||||+.++ +|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 105 ~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 105 QLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999998666 99999998888999999999999999999999999 9999999999999999999999999998663
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEY-DTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
. ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... . . .....+.
T Consensus 182 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~-~----~~~~~~~ 245 (335)
T 3dls_A 182 R------GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----V-E----AAIHPPY 245 (335)
T ss_dssp T------TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----T-T----TCCCCSS
T ss_pred C------CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----H-h----hccCCCc
Confidence 2 122234568999999999988876 77899999999999999999999763211 0 1 1111245
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++.++.++|.+||..||++|||+++++++
T Consensus 246 ~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 246 LVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 688999999999999999999999999987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=331.79 Aligned_cols=247 Identities=25% Similarity=0.431 Sum_probs=196.4
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.|. .+++.||+|++.... .......+.+|+.+++.++||||+++++++......++|||
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc--ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 58888999999999762 368899999997542 22222345679999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|++ ++|.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--- 153 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP--- 153 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC---
Confidence 996 69999988754 4999999999999999999999999 999999999999999999999999998755321
Q ss_pred cCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCC--------
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRA-------- 377 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------- 377 (456)
........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......+...
T Consensus 154 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 154 --TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred --ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 112233467899999999876 568999999999999999999999999887666554443321111000
Q ss_pred ------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 378 ------------------PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 378 ------------------~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
....++.++.+||.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 023578889999999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=317.79 Aligned_cols=251 Identities=25% Similarity=0.432 Sum_probs=205.9
Q ss_pred ccccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe----C
Q 012777 149 PKELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ----S 219 (456)
Q Consensus 149 ~~~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----~ 219 (456)
.....|...+.||+|+||.|. .++..||+|++.... ......+.+.+|+.+++.++||||+++++++.. .
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchh-hCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 334457888899999999762 357889999997654 345667889999999999999999999999875 3
Q ss_pred CceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-CCCCEEEeccCCcc
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD-DSGHLKVADFGLSK 298 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~-~~~~vkl~Dfgls~ 298 (456)
..+++||||+++++|.+++...+.+++..++.++.|++.||.|||+++ .+|+|+||||+||+++ .++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 558999999999999999998888999999999999999999999885 2499999999999998 78999999999987
Q ss_pred cccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCC
Q 012777 299 LLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAP 378 (456)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 378 (456)
... ........+|+.|+|||++.+ .++.++||||||+++|+|++|+.||..................+ ...
T Consensus 181 ~~~-------~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~ 251 (290)
T 1t4h_A 181 LKR-------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-ASF 251 (290)
T ss_dssp GCC-------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-GGG
T ss_pred ccc-------ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc-ccc
Confidence 542 122334568899999998875 58999999999999999999999998765544333332222221 122
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 379 TTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 379 ~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
....++++.++|.+||..||++|||+++++++
T Consensus 252 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 45667889999999999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=333.60 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=200.8
Q ss_pred ccccccceeeeccEEEEEe----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC--CCcceeeeeEEEeCCceEE
Q 012777 151 ELDFSNSVEITKGTFRIAS----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR--HPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~~~~~l 224 (456)
...|.+.+.||+|+||.|. .+++.||||++.... ......+.+.+|+.++++++ ||||+++++++.....+++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccc-ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 4469999999999999773 248899999997654 35666788999999999996 5999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 225 VTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
||| +.+++|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++.......
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 999 458899999998888999999999999999999999999 99999999999996 5799999999998663221
Q ss_pred cccCCCCcccCCCCcccccccccCC-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc-chHHHHHhcCC
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKN-----------EEYDTKVDVFSFALILQEMIEGCPPFPTKQEK-EVPKAYIANER 372 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~ 372 (456)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+....
T Consensus 209 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~- 284 (390)
T 2zmd_A 209 ---TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN- 284 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT-
T ss_pred ---ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc-
Confidence 1111234568999999999865 36888999999999999999999999775432 2222232211
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 373 PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 373 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
... ..+...+.++.+||.+||..||++|||+.+++++
T Consensus 285 ~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 285 HEI-EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp SCC-CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccC-CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111 1234557889999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=322.23 Aligned_cols=252 Identities=29% Similarity=0.475 Sum_probs=196.9
Q ss_pred cccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhc--CCCCcceeeeeEEEeC----Cce
Q 012777 152 LDFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQK--IRHPNVVQFLGAVTQS----TPM 222 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~l~~~~~~~----~~~ 222 (456)
.+|.+.+.||+|+||.| ..+|+.||||++... ....+..|.+++.. ++||||+++++++... ...
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46889999999999865 668999999999653 12455667776666 7899999999987543 458
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCeEeCCCCCEEEecc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLH--------ENRPEAIIHRDLEPSNILRDDSGHLKVADF 294 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH--------~~~~~~ivH~Dikp~Nil~~~~~~vkl~Df 294 (456)
++||||+++++|.++++. ..+++..++.++.|++.||.||| +++ |+||||||+|||++.++.+||+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCC
T ss_pred EEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeC
Confidence 999999999999999954 57999999999999999999999 888 999999999999999999999999
Q ss_pred CCcccccccccccCCCCcccCCCCcccccccccCCC------CCCCchhHHHHHHHHHHHHcC----------CCCCCCC
Q 012777 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE------EYDTKVDVFSFALILQEMIEG----------CPPFPTK 358 (456)
Q Consensus 295 gls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~l~~g----------~~pf~~~ 358 (456)
|++.......... ........||+.|+|||++.+. .++.++||||||+++|+|++| ..||...
T Consensus 158 g~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 158 GLAVMHSQSTNQL-DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp TTCEEEETTTTEE-ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCeeecccccccc-cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 9998653321111 1112234689999999999876 445689999999999999999 8888665
Q ss_pred Cccc----hHHHHHhcC--CCCCCC--CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 359 QEKE----VPKAYIANE--RPPFRA--PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 359 ~~~~----~~~~~~~~~--~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
.... ......... .+..+. .....+..+.++|.+||+.||++|||++++++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 4322 112221111 122110 1233557799999999999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=324.43 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=202.0
Q ss_pred ccccccceeeeccEEEEEe-----EcC-------cEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WRG-------TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ 218 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~g-------~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 218 (456)
..+|.+.+.||+|+||.|. .++ ..||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 3468888999999998662 233 579999997542 3344678999999999999999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC--------E
Q 012777 219 STPMMIVTEYLPKGDLRAYLKQKGA-LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH--------L 289 (456)
Q Consensus 219 ~~~~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~--------v 289 (456)
.+..++||||+++++|.+++...+. +++..++.++.|++.||.|||+++ |+||||||+|||++.++. +
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999987654 999999999999999999999999 999999999999998876 9
Q ss_pred EEeccCCcccccccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcC-CCCCCCCCccchHHHH
Q 012777 290 KVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEG-CPPFPTKQEKEVPKAY 367 (456)
Q Consensus 290 kl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~ 367 (456)
||+|||++...... ....+++.|+|||++.+ ..++.++||||||+++|+|++| .+||............
T Consensus 161 kl~Dfg~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 161 KLSDPGISITVLPK---------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp EECCCCSCTTTSCH---------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred eeccCcccccccCc---------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 99999998754211 12346778999999987 6789999999999999999995 5566554443333322
Q ss_pred HhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 368 IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
.. ... .+...+.++.++|.+||..||++|||+++++++|+.+....
T Consensus 232 -~~-~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 232 -ED-RHQ---LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp -HT-TCC---CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred -hc-cCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 22 222 13455778999999999999999999999999999887644
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=320.24 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=205.9
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|++.+.||+|+||.+. .+++.||+|++...... ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 58888999999998662 36899999999755322 345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++.....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 160 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-- 160 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE--
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc--
Confidence 9999999999987777999999999999999999999999 99999999999999999999999999986532211
Q ss_pred CCCCcccCCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEY-DTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
........+++.|+|||.+.+..+ +.++||||||+++|+|++|..||................... ......++..+
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 238 (276)
T 2yex_A 161 -ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKKIDSAP 238 (276)
T ss_dssp -ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT-STTGGGSCHHH
T ss_pred -hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc-cCchhhcCHHH
Confidence 112234568899999999987765 678999999999999999999998766543322222222111 12245788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++|.+||..||++|||+++++++
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 239 LALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHCCCCchhCCCHHHHhcC
Confidence 999999999999999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=324.20 Aligned_cols=251 Identities=24% Similarity=0.425 Sum_probs=207.6
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--CCceEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ--STPMMI 224 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~~l 224 (456)
.+|++.+.||+|+||.+ ..+|+.||+|++.... ......+.+.+|+.++++++||||+++++++.. ....++
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEccc-CCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46888999999999865 2368899999997654 345667889999999999999999999998854 567999
Q ss_pred EEEccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 225 VTEYLPKGDLRAYLKQK----GALKPTLAVKFALDIARGMNYLHENR--PEAIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~--~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
||||+++++|.+++... ..+++..++.++.|++.||.|||+++ ..+|+|+||||+||+++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999763 23999999999999999999999976 1239999999999999999999999999987
Q ss_pred cccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCC
Q 012777 299 LLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAP 378 (456)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 378 (456)
...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.....+..
T Consensus 165 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--- 236 (279)
T 2w5a_A 165 ILNHDT-----SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI--- 236 (279)
T ss_dssp HC---C-----HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---
T ss_pred eecccc-----ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC---
Confidence 653211 111234578899999999988899999999999999999999999998877666666655444333
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012777 379 TTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411 (456)
Q Consensus 379 ~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L 411 (456)
+..++.++.++|.+||..||++|||++++++++
T Consensus 237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 467899999999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=330.66 Aligned_cols=248 Identities=21% Similarity=0.348 Sum_probs=206.1
Q ss_pred ccccc-eeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEE
Q 012777 153 DFSNS-VEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 153 ~~~~~-~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv 225 (456)
.|.+. +.||+|+||.|. .+|+.||+|++..... .......+.+|+.+++.+ +||||+++++++......++|
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 35554 789999999762 3589999999976542 223346788999999999 579999999999999999999
Q ss_pred EEccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---CCCEEEeccCCcccc
Q 012777 226 TEYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD---SGHLKVADFGLSKLL 300 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~---~~~vkl~Dfgls~~~ 300 (456)
|||+++++|.+++... +.+++..++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||++...
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999999998543 56999999999999999999999999 999999999999997 789999999999866
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+.............
T Consensus 185 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 258 (327)
T 3lm5_A 185 GHA------CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS 258 (327)
T ss_dssp ---------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred CCc------cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhc
Confidence 321 12233568999999999999999999999999999999999999998887766666654444333333356
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++..+.++|.+||..||++|||+++++++
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 259 SVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 789999999999999999999999999876
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=341.64 Aligned_cols=239 Identities=13% Similarity=0.129 Sum_probs=192.1
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHH---HHhcCCCCcceeee-------eE
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELA---LLQKIRHPNVVQFL-------GA 215 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~---~l~~l~hp~iv~l~-------~~ 215 (456)
..+|.+.+.||+|+||.| ..+|+.||||++...........+.+.+|+. .++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 457888999999999976 2458999999997654445556688999994 55555799999998 66
Q ss_pred EEeCC-----------------ceEEEEEccCCCCHHHHHHHcCCCCH-------HHHHHHHHHHHHHHHHHHhCCCCCe
Q 012777 216 VTQST-----------------PMMIVTEYLPKGDLRAYLKQKGALKP-------TLAVKFALDIARGMNYLHENRPEAI 271 (456)
Q Consensus 216 ~~~~~-----------------~~~lv~e~~~~~sL~~~l~~~~~l~~-------~~~~~i~~ql~~aL~~LH~~~~~~i 271 (456)
+...+ ..+++|||+ +|+|.+++...+.+++ ..++.|+.|++.||.|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 65543 389999999 6899999987655665 788889999999999999999 9
Q ss_pred EecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCC-----------CCCCchhHHH
Q 012777 272 IHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-----------EYDTKVDVFS 340 (456)
Q Consensus 272 vH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Diws 340 (456)
+||||||+|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.++||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC--------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC--------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 9999999999999999999999999885421 2233456 889999999887 8999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 341 FALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 341 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
|||++|+|++|+.||...........+.. ....++.++.++|.+||..||++|||+.+++++
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHHHHSSCCC------CCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHHHHCCCCCcccccccchhhhhh--------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999999999987665443332211 125778999999999999999999999999974
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=341.96 Aligned_cols=248 Identities=24% Similarity=0.356 Sum_probs=195.4
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCC-----CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFT-----DEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
+|...+.||+|+||.|. .+++.||+|++...... .......+.+|+.+|++++||||+++++++.. ...
T Consensus 136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~ 214 (419)
T 3i6u_A 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDY 214 (419)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEE
T ss_pred cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cce
Confidence 68889999999998762 35789999999754321 12223457899999999999999999999854 558
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC---CEEEeccCCccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG---HLKVADFGLSKL 299 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~---~vkl~Dfgls~~ 299 (456)
++||||+++++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 215 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 215 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 999999999999999988788999999999999999999999999 99999999999997544 599999999986
Q ss_pred ccccccccCCCCcccCCCCcccccccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccch-HHHHHhcCCCCC
Q 012777 300 LKFANTVKEDRPVTCEETSWRYAAPEVYKN---EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV-PKAYIANERPPF 375 (456)
Q Consensus 300 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~ 375 (456)
... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+........
T Consensus 292 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~ 365 (419)
T 3i6u_A 292 LGE------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 365 (419)
T ss_dssp CC-----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCC
T ss_pred cCC------CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCC
Confidence 632 122234568999999999864 5677899999999999999999999987655433 344433322222
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 376 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.....++..+.++|.+||..||++|||+++++++
T Consensus 366 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 22235788999999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=331.63 Aligned_cols=261 Identities=24% Similarity=0.392 Sum_probs=207.2
Q ss_pred ccccccceeeeccEEEEEe--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 151 ELDFSNSVEITKGTFRIAS--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
..+|.+.+.||+|+||.+. ..+..||+|++..... .....+.+.+|+.++++++||||+++++++......++||||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 110 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL 110 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence 3468888999999998662 2345699999976532 222335677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 229 LPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 229 ~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
+++++|.+++...+ .+++..++.++.|++.||.|||+++ ++|+||||+||+++ ++.+||+|||++..........
T Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 111 CKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp CCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 99999999997754 5999999999999999999999999 99999999999998 6799999999987653222222
Q ss_pred CCCCcccCCCCcccccccccCC---------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCC
Q 012777 308 EDRPVTCEETSWRYAAPEVYKN---------EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAP 378 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 378 (456)
.........|++.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+.....+.. .
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~ 264 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL--S 264 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC--C
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC--C
Confidence 2223334568889999999875 3578899999999999999999999998877766666654444433 2
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 379 TTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 379 ~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
...++.++.++|.+||..||++|||+.++++.|+.+..+.
T Consensus 265 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 265 QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 3467889999999999999999999999999999988765
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=325.17 Aligned_cols=266 Identities=24% Similarity=0.386 Sum_probs=193.3
Q ss_pred cCccccccccceeeeccEEEEE---eE--cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEE---
Q 012777 147 IDPKELDFSNSVEITKGTFRIA---SW--RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVT--- 217 (456)
Q Consensus 147 ~~~~~~~~~~~~~lg~G~fg~~---~~--~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~--- 217 (456)
+.....+|++.+.||+|+||.| .. +|+.||+|++... .......+.+|+.+++++. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 3444568999999999999876 22 7889999998543 4556678899999999995 999999999984
Q ss_pred -----eCCceEEEEEccCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCE
Q 012777 218 -----QSTPMMIVTEYLPKGDLRAYLKQ---KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289 (456)
Q Consensus 218 -----~~~~~~lv~e~~~~~sL~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~v 289 (456)
....++++|||+. ++|.+++.. .+.+++..++.++.|++.||.|||+++ .+|+|+||||+|||++.++.+
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCE
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCE
Confidence 3345899999994 799998865 456999999999999999999999875 249999999999999999999
Q ss_pred EEeccCCcccccccccccC-------CCCcccCCCCccccccccc---CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 012777 290 KVADFGLSKLLKFANTVKE-------DRPVTCEETSWRYAAPEVY---KNEEYDTKVDVFSFALILQEMIEGCPPFPTKQ 359 (456)
Q Consensus 290 kl~Dfgls~~~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 359 (456)
||+|||++........... ........+|+.|+|||++ .+..++.++||||||+++|+|++|+.||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 9999999987643211100 0011134588999999998 56678889999999999999999999997755
Q ss_pred ccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccc
Q 012777 360 EKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRH 423 (456)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~ 423 (456)
........ ... ......+..+.+||.+||+.||++|||+++++++|+.+.........
T Consensus 258 ~~~~~~~~---~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~ 315 (337)
T 3ll6_A 258 KLRIVNGK---YSI---PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315 (337)
T ss_dssp -----------CCC---CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTT
T ss_pred HHHhhcCc---ccC---CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCC
Confidence 43322211 111 12356677899999999999999999999999999999877644433
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=322.16 Aligned_cols=258 Identities=26% Similarity=0.471 Sum_probs=203.2
Q ss_pred ccccccceeeeccEEEEE---eE---cCc--EEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 151 ELDFSNSVEITKGTFRIA---SW---RGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~---~~---~g~--~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
..+|.+.+.||+|+||.| .+ ++. .||+|++...........+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 447899999999999855 22 222 69999998665445566788999999999999999999999998764 8
Q ss_pred EEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
++||||+++++|.+++... +.+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++....
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence 9999999999999999764 56999999999999999999999999 9999999999999999999999999988663
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+....... ..+.
T Consensus 173 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~ 248 (291)
T 1u46_A 173 QNDDHY--VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--PRPE 248 (291)
T ss_dssp C-CCEE--EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--CCCT
T ss_pred ccccch--hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC--CCCc
Confidence 221110 11223456778999999988888999999999999999999 999999888776666664433221 1246
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~ 416 (456)
.++..+.++|.+||..||++|||+.++++.|+.+..
T Consensus 249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 789999999999999999999999999999988754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=331.96 Aligned_cols=246 Identities=26% Similarity=0.359 Sum_probs=194.5
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC------
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST------ 220 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~------ 220 (456)
.+|...+.||+|+||.| ..+|+.||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 36889999999999976 2358899999997643 45566778899999999999999999999997664
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
..++||||++ ++|.+++. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 104 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 6899999995 58988886 45999999999999999999999999 999999999999999999999999999865
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCC------
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPP------ 374 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------ 374 (456)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 178 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 178 GT------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred cc------ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 32 112234568899999999999999999999999999999999999998877655544443322111
Q ss_pred ---------------CCCC-----------C------CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 ---------------FRAP-----------T------THYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 ---------------~~~~-----------~------~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+... + ...+.++.+||.+||..||++|||+++++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000 0 0115678999999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=318.20 Aligned_cols=248 Identities=23% Similarity=0.422 Sum_probs=190.0
Q ss_pred cccccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 150 KELDFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
...+|+..+.||+|+||.| . .+|+.||+|++.... ........+.++...++.++||||+++++++......++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 3456889999999999976 2 378899999997653 223333445555566788899999999999999999999
Q ss_pred EEEccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEeCCCCCEEEeccCCccc
Q 012777 225 VTEYLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHEN-RPEAIIHRDLEPSNILRDDSGHLKVADFGLSKL 299 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~-~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~ 299 (456)
||||++ ++|.+++.. ...+++..++.++.|++.||.|||++ + |+||||||+||+++.++.+||+|||++..
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 999996 588877754 45799999999999999999999998 9 99999999999999999999999999986
Q ss_pred ccccccccCCCCcccCCCCccccccccc----CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc-cchHHHHHhcCCCC
Q 012777 300 LKFANTVKEDRPVTCEETSWRYAAPEVY----KNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE-KEVPKAYIANERPP 374 (456)
Q Consensus 300 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~ 374 (456)
.... .......+|+.|+|||++ .+..++.++||||||+++|+|++|+.||..... ............+.
T Consensus 160 ~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 233 (290)
T 3fme_A 160 LVDD------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ 233 (290)
T ss_dssp ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC
T ss_pred cccc------ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC
Confidence 6321 122234688999999996 556788899999999999999999999986443 23333333333332
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
. ....++.++.++|.+||..||++|||+++++++
T Consensus 234 ~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 234 L--PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp C--CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred c--ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 2 346789999999999999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=335.89 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=203.2
Q ss_pred cccccceeeeccEEEEEe--------EcCcEEEEEEeCCCCCC-CHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCc
Q 012777 152 LDFSNSVEITKGTFRIAS--------WRGTQVAVKTLGEEVFT-DEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~--------~~g~~vAvK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~ 221 (456)
.+|.+.+.||+|+||.|. .+|+.||||++...... .....+.+.+|+.+++++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 468999999999999763 27899999999753211 111224567899999999 69999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
.++||||+++++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999999999998888999999999999999999999999 9999999999999999999999999998653
Q ss_pred ccccccCCCCcccCCCCcccccccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHH---hcCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNE--EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYI---ANERPPFR 376 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~ 376 (456)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+. ....++
T Consensus 211 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 284 (355)
T 1vzo_A 211 ADET----ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP-- 284 (355)
T ss_dssp GGGG----GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC--
T ss_pred cCCC----CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC--
Confidence 2211 112234689999999999863 57889999999999999999999997654433222221 222333
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 012777 377 APTTHYAYGLRELIEDCWSEEPFRRP-----TFRQILMRL 411 (456)
Q Consensus 377 ~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~ell~~L 411 (456)
.+..++..+.+||.+||..||++|| ++++++++.
T Consensus 285 -~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 285 -YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 2567889999999999999999999 999998873
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=329.61 Aligned_cols=249 Identities=25% Similarity=0.423 Sum_probs=202.6
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||+|+||.| ..+|+.||+|++.... ......+.+.+|+.++++++||||+++++++......++|||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 6889999999999855 2358899999987653 455566778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++...+.+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 178 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--- 178 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc---
Confidence 9999899888877778999999999999999999999999 9999999999999999999999999998653221
Q ss_pred CCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC---------------
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE--------------- 371 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------------- 371 (456)
.......+|+.|+|||++.+. .++.++||||||+++|+|++|+.||......+....+....
T Consensus 179 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 179 --EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred --cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 122335688999999998875 78899999999999999999999998877654443332110
Q ss_pred ------CCCCC------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 ------RPPFR------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 ------~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+... .....++..+.+||.+||..||++|||++|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 0123678899999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=318.39 Aligned_cols=246 Identities=26% Similarity=0.426 Sum_probs=203.4
Q ss_pred ccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
..+|.+.+.||+|+||.+. .+|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++......++|
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 3468899999999998662 248999999997542 135688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 226 TEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 999999999999974 457999999999999999999999999 9999999999999999999999999997653211
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.......+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+.....+.+ ..+..++.
T Consensus 180 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 253 (314)
T 3com_A 180 -----AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF-RKPELWSD 253 (314)
T ss_dssp -----SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSGGGSCH
T ss_pred -----cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCccc-CCcccCCH
Confidence 122335688999999999999999999999999999999999999988776554444433333322 22456788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+.++|.+||..||.+|||+.+++++
T Consensus 254 ~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 254 NFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999999999999999999999885
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=333.53 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=197.2
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----Cc
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS-----TP 221 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~ 221 (456)
.+|.+.+.||+|+||.| ..+|+.||||++.... ......+.+.+|+.+|++++||||+++++++... ..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 36899999999999976 2358899999998653 4566678899999999999999999999999776 56
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
+|+||||++ ++|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 999999995 699999988778999999999999999999999999 9999999999999999999999999998764
Q ss_pred cccccc-----------------CCCCcccCCCCccccccccc-CCCCCCCchhHHHHHHHHHHHHcCCC----------
Q 012777 302 FANTVK-----------------EDRPVTCEETSWRYAAPEVY-KNEEYDTKVDVFSFALILQEMIEGCP---------- 353 (456)
Q Consensus 302 ~~~~~~-----------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~l~~g~~---------- 353 (456)
...... .........||+.|+|||++ ....++.++|||||||++|+|++|..
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 321110 00123556789999999986 55679999999999999999998544
Q ss_pred -CCCCCCcc-----------------ch-----------------------HHHHHhcCCCCCC----CCCCCCcHHHHH
Q 012777 354 -PFPTKQEK-----------------EV-----------------------PKAYIANERPPFR----APTTHYAYGLRE 388 (456)
Q Consensus 354 -pf~~~~~~-----------------~~-----------------------~~~~~~~~~~~~~----~~~~~~~~~l~~ 388 (456)
+|.+.+.. +. ............. .....++.++.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 44333210 00 0000010000000 012468899999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 012777 389 LIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 389 li~~~l~~dp~~Rpt~~ell~~ 410 (456)
||.+||..||++|||++|++++
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHHhcCCcccCCCHHHHhcC
Confidence 9999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=327.91 Aligned_cols=251 Identities=26% Similarity=0.423 Sum_probs=198.8
Q ss_pred ccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCC--HHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTD--EDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM 223 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 223 (456)
..+|.+.+.||+|+||.|. .+|+.||||++....... ......+.+|+.+++.++||||+++++++......+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 3468899999999998762 358899999997543221 112346789999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 224 IVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
+||||+++ +|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99999965 8998887653 5999999999999999999999999 99999999999999999999999999986532
Q ss_pred cccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCCC---
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFRA--- 377 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~--- 377 (456)
. ........+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+.... .+....
T Consensus 165 ~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 165 P-----NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp C-----CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred C-----cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 1 1223345689999999998764 57889999999999999999999998887666555543321 111000
Q ss_pred --------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 378 --------------------PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 378 --------------------~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
....++.++.+||.+||..||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 014567889999999999999999999999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=329.30 Aligned_cols=243 Identities=23% Similarity=0.302 Sum_probs=201.0
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-----CCcceeeeeEEEeCCc
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-----HPNVVQFLGAVTQSTP 221 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~l~~~~~~~~~ 221 (456)
-+|.+.+.||+|+||.|. .+++.||||++.. .......+..|+.+++.+. ||||+++++++...+.
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~ 110 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH 110 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence 479999999999999762 3688999999974 3455567888999999986 9999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC--------------
Q 012777 222 MMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD-------------- 285 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~-------------- 285 (456)
.++||||+ +++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccc
Confidence 99999999 899999998754 4999999999999999999999999 999999999999975
Q ss_pred -----------CCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCC
Q 012777 286 -----------SGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPP 354 (456)
Q Consensus 286 -----------~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p 354 (456)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSD--------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTS--------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ccccccccccCCCCEEEEeccCceecCC--------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 78999999999975421 12245689999999999999999999999999999999999999
Q ss_pred CCCCCccchHHHHHhcCCCC-------------------------CCCC-----------------CCCCcHHHHHHHHH
Q 012777 355 FPTKQEKEVPKAYIANERPP-------------------------FRAP-----------------TTHYAYGLRELIED 392 (456)
Q Consensus 355 f~~~~~~~~~~~~~~~~~~~-------------------------~~~~-----------------~~~~~~~l~~li~~ 392 (456)
|...+..+....+.....+. ++.. ....+..+.+||.+
T Consensus 259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 338 (360)
T 3llt_A 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS 338 (360)
T ss_dssp CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence 98876655444432221110 0000 01123668899999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 012777 393 CWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 393 ~l~~dp~~Rpt~~ell~~ 410 (456)
||+.||++|||++|++++
T Consensus 339 ~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 339 ILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HCCSSGGGSCCHHHHTTS
T ss_pred HhcCChhhCCCHHHHhcC
Confidence 999999999999999865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=322.48 Aligned_cols=259 Identities=28% Similarity=0.465 Sum_probs=201.5
Q ss_pred cccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC--CCCcceeeeeEEEeC----Cce
Q 012777 152 LDFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI--RHPNVVQFLGAVTQS----TPM 222 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~l~~~~~~~----~~~ 222 (456)
.+|.+.+.||+|+||.| ...|+.||||++.... ...+..|.+++... +||||+++++++... ...
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 36899999999999865 5679999999986431 23445566666655 899999999999887 789
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeEecCCCCCCeEeCCCCCEEEecc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHEN--------RPEAIIHRDLEPSNILRDDSGHLKVADF 294 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~--------~~~~ivH~Dikp~Nil~~~~~~vkl~Df 294 (456)
++||||+++++|.+++.. ..+++..++.++.|++.||.|||++ + |+||||||+|||++.++.+||+||
T Consensus 111 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeC
Confidence 999999999999999976 4699999999999999999999998 8 999999999999999999999999
Q ss_pred CCcccccccccccCCCCcccCCCCcccccccccCCCCCCCc------hhHHHHHHHHHHHHcC----------CCCCCCC
Q 012777 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTK------VDVFSFALILQEMIEG----------CPPFPTK 358 (456)
Q Consensus 295 gls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~~l~~g----------~~pf~~~ 358 (456)
|++......... .........||+.|+|||++.+...+.. +|||||||++|+|++| ..||...
T Consensus 187 g~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 187 GLAVKFISDTNE-VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp TTCEECC----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCceeecccccc-ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 999765322111 1111224568999999999988766665 9999999999999999 7777654
Q ss_pred Cccch----HHHHHhc-C-CCCCCC--CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccc
Q 012777 359 QEKEV----PKAYIAN-E-RPPFRA--PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIK 421 (456)
Q Consensus 359 ~~~~~----~~~~~~~-~-~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~ 421 (456)
..... ....... . .+.++. ....++.++.++|.+||+.||++|||+++++++|+.+.+...++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 336 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDIK 336 (337)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTCC
T ss_pred cCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcccC
Confidence 33221 1111111 1 222211 12356677999999999999999999999999999998876543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=314.76 Aligned_cols=240 Identities=22% Similarity=0.317 Sum_probs=199.6
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv 225 (456)
.+|.+.+.||+|+||.+. .+++.||+|++....... .....+.+|+..+..+ +||||+++++++...+..++|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 368888999999998762 268999999998654333 3457788999999999 899999999999999999999
Q ss_pred EEccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC---------------
Q 012777 226 TEYLPKGDLRAYLKQK----GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS--------------- 286 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~--------------- 286 (456)
|||+++++|.+++... +.+++..++.++.|++.||.|||+++ |+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999765 66999999999999999999999999 9999999999999844
Q ss_pred ----CCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCcc
Q 012777 287 ----GHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEK 361 (456)
Q Consensus 287 ----~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 361 (456)
..+||+|||++...... ....+|+.|+|||++.+. .++.++||||||+++|+|++|.+|+....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-- 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP---------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-- 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS---------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--
T ss_pred cCCceEEEEcccccccccCCc---------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--
Confidence 47999999998865321 123488999999999776 56679999999999999999998775432
Q ss_pred chHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 362 EVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
....+.....+. .+..++..+.++|.+||..||++|||+.+++++
T Consensus 236 -~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 -QWHEIRQGRLPR---IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -HHHHHHTTCCCC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -HHHHHHcCCCCC---CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 233343333333 356789999999999999999999999999876
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=329.45 Aligned_cols=253 Identities=22% Similarity=0.313 Sum_probs=201.6
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-------
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS------- 219 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------- 219 (456)
.+|.+.+.||+|+||.| ..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 47899999999999755 24688999999976542 222335678999999999999999999999773
Q ss_pred -CceEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCc
Q 012777 220 -TPMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLS 297 (456)
Q Consensus 220 -~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls 297 (456)
+.+++||||++ ++|.+.+... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 46899999996 5888777654 56999999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCC
Q 012777 298 KLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFR 376 (456)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 376 (456)
......... .........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.........
T Consensus 172 ~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 172 RAFSLAKNS-QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp EECCCCSSS-SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccccccccc-cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 866432111 1222344568999999999876 45799999999999999999999999987766555544332211111
Q ss_pred CCCCC----------------------------CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 377 APTTH----------------------------YAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 377 ~~~~~----------------------------~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..... .++.+.+||.+||..||++|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00111 26679999999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=325.12 Aligned_cols=251 Identities=25% Similarity=0.424 Sum_probs=206.0
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----C
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS-----T 220 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~ 220 (456)
.-+|++.+.||+|+||.| ..+++.||||++... ........+.+|+.++++++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 346999999999999976 236889999999753 3566668899999999999999999999999765 4
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
..++||||++ ++|.+++.. +.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 6899999995 699999876 56999999999999999999999999 999999999999999999999999999866
Q ss_pred cccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CC-----
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RP----- 373 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~----- 373 (456)
..... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... .+
T Consensus 179 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 179 DPDHD--HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp CGGGC--BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred CCCCC--ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 43211 1112234578999999998654 458999999999999999999999999887766655543211 10
Q ss_pred ---------------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 ---------------------PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 ---------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++......++.++.+||.+||..||++|||+++++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0001125678899999999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.35 Aligned_cols=256 Identities=20% Similarity=0.332 Sum_probs=202.3
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe----CCc
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ----STP 221 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----~~~ 221 (456)
..+|...+.||+|+||.| ..+|+.||||++... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 447999999999999876 247899999998653 45667889999999999999999999999873 347
Q ss_pred eEEEEEccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCc
Q 012777 222 MMIVTEYLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLS 297 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls 297 (456)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 8999999999999999976 356999999999999999999999999 999999999999999999999999998
Q ss_pred cccccccccc----CCCCcccCCCCcccccccccCCCC---CCCchhHHHHHHHHHHHHcCCCCCCCCC--ccchHHHHH
Q 012777 298 KLLKFANTVK----EDRPVTCEETSWRYAAPEVYKNEE---YDTKVDVFSFALILQEMIEGCPPFPTKQ--EKEVPKAYI 368 (456)
Q Consensus 298 ~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~ 368 (456)
.......... .........||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.... .......+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 261 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence 7542110000 000011234688999999987654 6889999999999999999999996421 112222222
Q ss_pred hcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 369 ANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
.....+ ....++..+.++|.+||..||++|||+++++++|+.+.
T Consensus 262 ~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 262 NQLSIP---QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp CC--CC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred ccCCCC---ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 211111 24578899999999999999999999999999998753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=325.76 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=198.2
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCC-----CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFT-----DEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
+|.+.+.||+|+||.|. .+++.||||++...... .......+.+|+.++++++||||+++++++.... .
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~ 89 (322)
T 2ycf_A 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y 89 (322)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence 68889999999999762 35789999999764321 1223356889999999999999999999987654 8
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC---EEEeccCCccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH---LKVADFGLSKL 299 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~---vkl~Dfgls~~ 299 (456)
++||||+++++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +||+|||++..
T Consensus 90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 999999999999999988788999999999999999999999999 999999999999987654 99999999886
Q ss_pred ccccccccCCCCcccCCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc-hHHHHHhcCCCCC
Q 012777 300 LKFANTVKEDRPVTCEETSWRYAAPEVYK---NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE-VPKAYIANERPPF 375 (456)
Q Consensus 300 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~ 375 (456)
.... .......||+.|+|||++. ...++.++||||||+++|+|++|..||....... ....+........
T Consensus 167 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T 2ycf_A 167 LGET------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240 (322)
T ss_dssp CCCC------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred cccc------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence 5321 1122345788999999863 5678899999999999999999999998766543 3333433322222
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 376 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.....++..+.++|.+||..||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 22235688999999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=319.10 Aligned_cols=247 Identities=26% Similarity=0.409 Sum_probs=206.5
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.+. .+++.||+|++...... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 68889999999998662 26889999999754322 2234678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC---CCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS---GHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~---~~vkl~Dfgls~~~~~~~ 304 (456)
|+++++|.+++...+.+++..++.++.|++.||.|||+++ ++|+||||+||+++.+ +.+||+|||++......
T Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~- 177 (287)
T 2wei_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (287)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC-
T ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCC-
Confidence 9999999999988888999999999999999999999999 9999999999999754 47999999998865321
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...+..+....+..............++.
T Consensus 178 -----~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 2wei_A 178 -----TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (287)
T ss_dssp -----SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred -----CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence 11122346788999999876 488999999999999999999999998877666666544432211112357889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.++|.+||..||++|||+++++++
T Consensus 252 ~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHcccChhhCcCHHHHhcC
Confidence 99999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=347.84 Aligned_cols=252 Identities=33% Similarity=0.550 Sum_probs=212.5
Q ss_pred ccccccceeeeccEEEEE---eEc-CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 151 ELDFSNSVEITKGTFRIA---SWR-GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~---~~~-g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
..+|...+.||+|+||.| .+. +..||||++..... . .+.+.+|+.+|++++||||+++++++.. ...++||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-C---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-C---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 345788899999999976 333 46799999986542 2 3578999999999999999999999876 6789999
Q ss_pred EccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 227 EYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 227 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 999999999999643 45999999999999999999999999 9999999999999999999999999998653211
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
. .......+++.|+|||++....++.++||||||+++|+|++ |+.||.+....+....+....+.+. +..++
T Consensus 418 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~~~ 490 (535)
T 2h8h_A 418 Y----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECP 490 (535)
T ss_dssp H----HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCC
T ss_pred e----ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCC
Confidence 1 11122346778999999988899999999999999999999 9999998887777776655444433 46788
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
..+.+||.+||..||++|||+++|++.|+.++..
T Consensus 491 ~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 491 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 9999999999999999999999999999887643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=323.40 Aligned_cols=258 Identities=28% Similarity=0.520 Sum_probs=209.7
Q ss_pred cccccccceeeeccEEEEEe---------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012777 150 KELDFSNSVEITKGTFRIAS---------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST 220 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~~---------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 220 (456)
...+|.+.+.||+|+||.|. .+|+.||+|++... .....+.+.+|+.++++++||||+++++++....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 34568889999999999762 25889999999763 3455678999999999999999999999986643
Q ss_pred --ceEEEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCc
Q 012777 221 --PMMIVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLS 297 (456)
Q Consensus 221 --~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls 297 (456)
..++||||+++++|.+++...+ .+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcch
Confidence 7899999999999999998754 5999999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc----------c------
Q 012777 298 KLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQE----------K------ 361 (456)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----------~------ 361 (456)
.......... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||..... .
T Consensus 193 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 193 KVLPQDKEYY--KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp EECCSSCSEE--ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred hhcccccccc--ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 8763221110 111234567789999999888889999999999999999999999864211 0
Q ss_pred chHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 362 EVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
.....+......+ .+..++.++.++|.+||..||++|||+.++++.|+.+.+++
T Consensus 271 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 271 HLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0111222222222 25678999999999999999999999999999999999876
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=319.33 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=201.0
Q ss_pred CccccccccceeeeccEEEEE---eE--cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEe---
Q 012777 148 DPKELDFSNSVEITKGTFRIA---SW--RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQ--- 218 (456)
Q Consensus 148 ~~~~~~~~~~~~lg~G~fg~~---~~--~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~--- 218 (456)
....-+|.+.+.||+|+||.+ .. +|+.||+|++...... ...+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 334457999999999999866 22 6889999999754322 25788999999999 79999999999977
Q ss_pred ---CCceEEEEEccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEec
Q 012777 219 ---STPMMIVTEYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293 (456)
Q Consensus 219 ---~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~D 293 (456)
....++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEee
Confidence 46799999999999999999864 46999999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccccccCCCCcccCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHH
Q 012777 294 FGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYK-----NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYI 368 (456)
Q Consensus 294 fgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 368 (456)
||++...... ........+++.|+|||++. ...++.++||||||+++|+|++|..||...........+.
T Consensus 173 fg~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (326)
T 2x7f_A 173 FGVSAQLDRT-----VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 247 (326)
T ss_dssp CTTTC------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CcCceecCcC-----ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence 9998865321 11123346889999999987 5578899999999999999999999998877655555444
Q ss_pred hcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 369 ANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 369 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
....+.. ....++..+.++|.+||..||++|||+++++++
T Consensus 248 ~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 248 RNPAPRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HSCCCCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cCccccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 4333322 346788999999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=326.59 Aligned_cols=261 Identities=17% Similarity=0.212 Sum_probs=200.2
Q ss_pred ccccccceeeeccEEEEE---eE-----cCcEEEEEEeCCCCCCCHH--------HHHHHHHHHHHHhcCCCCcceeeee
Q 012777 151 ELDFSNSVEITKGTFRIA---SW-----RGTQVAVKTLGEEVFTDED--------KVKAFIDELALLQKIRHPNVVQFLG 214 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~---~~-----~g~~vAvK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~l~~ 214 (456)
..+|.+.+.||+|+||.| .. ++..||+|++......... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 447999999999999865 22 6788999998764211111 1134667888999999999999999
Q ss_pred EEEe----CCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC--C
Q 012777 215 AVTQ----STPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG--H 288 (456)
Q Consensus 215 ~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~--~ 288 (456)
++.. ....++||||+ +++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCc
Confidence 9987 67899999999 9999999988778999999999999999999999999 99999999999999877 9
Q ss_pred EEEeccCCccccccccccc--CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccch-HH
Q 012777 289 LKVADFGLSKLLKFANTVK--EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV-PK 365 (456)
Q Consensus 289 vkl~Dfgls~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~ 365 (456)
+||+|||+++......... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ..
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 9999999998764332111 11222456789999999999998999999999999999999999999965332221 11
Q ss_pred HHHhcCCCCCC------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 366 AYIANERPPFR------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 366 ~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
..........+ .....++.++.++|.+||..||++|||++++++.|+.+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 11111111111 012378899999999999999999999999999988653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=329.00 Aligned_cols=244 Identities=23% Similarity=0.350 Sum_probs=195.8
Q ss_pred cccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe------
Q 012777 150 KELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ------ 218 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------ 218 (456)
...+|...+.||+|+||.| ..+|+.||||++..... ...+|+.+++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 3457999999999999977 23689999999865421 22479999999999999999999844
Q ss_pred --------------------------------CCceEEEEEccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHH
Q 012777 219 --------------------------------STPMMIVTEYLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNY 262 (456)
Q Consensus 219 --------------------------------~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~ 262 (456)
...+++||||++ ++|.+.+.. ...+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 334889999996 587777653 4679999999999999999999
Q ss_pred HHhCCCCCeEecCCCCCCeEeC-CCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHH
Q 012777 263 LHENRPEAIIHRDLEPSNILRD-DSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFS 340 (456)
Q Consensus 263 LH~~~~~~ivH~Dikp~Nil~~-~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diws 340 (456)
||++| |+||||||+|||++ .++.+||+|||++..... ........+|+.|+|||++.+. .++.++||||
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP------SEPSVAYICSRFYRAPELMLGATEYTPSIDLWS 227 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCT------TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCC------CCCCcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence 99999 99999999999998 688999999999986532 1222345678899999998775 5899999999
Q ss_pred HHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CC---------------CCC---------CCCCCCcHHHHHHHHHhcc
Q 012777 341 FALILQEMIEGCPPFPTKQEKEVPKAYIANE-RP---------------PFR---------APTTHYAYGLRELIEDCWS 395 (456)
Q Consensus 341 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~---------------~~~---------~~~~~~~~~l~~li~~~l~ 395 (456)
|||++|+|++|+.||.+.+..+....+.... .+ .++ ..+..++.++.+||.+||.
T Consensus 228 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 9999999999999999877665544443211 11 000 0235678899999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 012777 396 EEPFRRPTFRQILMR 410 (456)
Q Consensus 396 ~dp~~Rpt~~ell~~ 410 (456)
.||++|||+.|++++
T Consensus 308 ~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 308 YEPDLRINPYEAMAH 322 (383)
T ss_dssp SSGGGSCCHHHHHTS
T ss_pred CChhhCCCHHHHhcC
Confidence 999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=319.44 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=202.8
Q ss_pred cccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
..|++.+.||+|+||.+ . .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 36899999999999855 2 258899999997542 233567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 227 EYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 227 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 99999999999876 456999999999999999999999999 99999999999999999999999998764321111
Q ss_pred ccCCCCcccCCCCccccccccc-----CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 306 VKEDRPVTCEETSWRYAAPEVY-----KNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
......+++.|+|||++ ....++.++||||||+++|+|++|..||...+.......+.....+. ...+.
T Consensus 173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 246 (302)
T 2j7t_A 173 -----KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-LLTPS 246 (302)
T ss_dssp -----C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSSGG
T ss_pred -----ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-cCCcc
Confidence 11234688999999988 46678899999999999999999999999887766655554443332 22356
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++..+.++|.+||..||++|||+.+++++
T Consensus 247 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 247 KWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp GSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 788899999999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=329.38 Aligned_cols=245 Identities=28% Similarity=0.393 Sum_probs=187.0
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------C
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS------T 220 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------~ 220 (456)
.+|...+.||+|+||.| ..+|+.||||++.... ........+.+|+.+++.++||||+++++++... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46889999999999865 2468899999997653 4556677889999999999999999999998654 5
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
..++++|++ +++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 689999999 7899998875 57999999999999999999999999 999999999999999999999999998865
Q ss_pred cccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CC-----
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RP----- 373 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~----- 373 (456)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... .+
T Consensus 183 ~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 183 AD--------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cc--------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 21 1234568899999999877 678999999999999999999999998877654443332211 10
Q ss_pred ---------------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 ---------------------PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 ---------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.......+..+.+||.+||..||++|||+++++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000124567889999999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=347.48 Aligned_cols=255 Identities=25% Similarity=0.485 Sum_probs=214.0
Q ss_pred ccccccceeeeccEEEEEe---E-----cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 151 ELDFSNSVEITKGTFRIAS---W-----RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~---~-----~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
..+|...+.||+|+||.|. . .+..||+|.+... ......+.+.+|+.++++++||||+++++++. ++..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 3468888999999998662 2 2457999998754 35666788999999999999999999999985 4678
Q ss_pred EEEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
++||||+++++|.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 99999999999999998654 5999999999999999999999999 9999999999999999999999999998663
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+.....++. +.
T Consensus 543 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~---~~ 615 (656)
T 2j0j_A 543 DST----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM---PP 615 (656)
T ss_dssp C--------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCC---CT
T ss_pred CCc----ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC---Cc
Confidence 221 111223456788999999988899999999999999999997 9999998887777766655554443 56
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
.++..+.++|.+||..||++|||+.++++.|+.+.++.
T Consensus 616 ~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 616 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 78999999999999999999999999999999998654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=335.71 Aligned_cols=257 Identities=23% Similarity=0.353 Sum_probs=205.0
Q ss_pred ccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC--ceE
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST--PMM 223 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~--~~~ 223 (456)
..+|.+.+.||+|+||.|. .+|+.||||++...... ...+.+.+|+.++++++||||+++++++.... ..+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 3468899999999999762 34889999999864322 22467789999999999999999999998765 789
Q ss_pred EEEEccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe----CCCCCEEEeccCC
Q 012777 224 IVTEYLPKGDLRAYLKQKGA---LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR----DDSGHLKVADFGL 296 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~----~~~~~vkl~Dfgl 296 (456)
+||||+++++|.+++..... +++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 99999999999999976433 999999999999999999999999 9999999999999 7777899999999
Q ss_pred cccccccccccCCCCcccCCCCcccccccccCC--------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc----cchH
Q 012777 297 SKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN--------EEYDTKVDVFSFALILQEMIEGCPPFPTKQE----KEVP 364 (456)
Q Consensus 297 s~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~ 364 (456)
+....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+..
T Consensus 163 a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 163 ARELEDDE------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp CEECCCGG------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred ceEccCCC------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 98663221 1223568999999999865 4677899999999999999999999975432 2233
Q ss_pred HHHHhcCCCCC---------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 365 KAYIANERPPF---------------------RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 365 ~~~~~~~~~~~---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
..+.....+.. ......++..+.++|.+||..||++|||++++++.++.+.++.
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 33333221110 0111345567889999999999999999999999999987653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=316.58 Aligned_cols=242 Identities=26% Similarity=0.433 Sum_probs=201.0
Q ss_pred ccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe---------
Q 012777 153 DFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ--------- 218 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--------- 218 (456)
+|...+.||+|+||.+ . .+|+.||+|++.... ..+.+|+.++++++||||+++++++..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 6888999999999855 2 258999999997542 356789999999999999999998854
Q ss_pred -------CCceEEEEEccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCE
Q 012777 219 -------STPMMIVTEYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289 (456)
Q Consensus 219 -------~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~v 289 (456)
...+++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 34589999999999999999764 56999999999999999999999999 9999999999999999999
Q ss_pred EEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHh
Q 012777 290 KVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIA 369 (456)
Q Consensus 290 kl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 369 (456)
||+|||++...... .......+++.|+|||++.+..++.++||||||+++|+|++|..|+.... .....+..
T Consensus 162 kl~Dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~ 233 (284)
T 2a19_B 162 KIGDFGLVTSLKND------GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD 233 (284)
T ss_dssp EECCCTTCEESSCC------SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT
T ss_pred EECcchhheecccc------ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc
Confidence 99999998866321 12233468899999999999899999999999999999999998874321 12222211
Q ss_pred cCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 370 NERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
. . .+..++..+.++|.+||..||++|||+.+++++|+.+.+..
T Consensus 234 ~---~---~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 234 G---I---ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp T---C---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred c---c---ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 1 1 23568889999999999999999999999999999886544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=329.85 Aligned_cols=243 Identities=28% Similarity=0.385 Sum_probs=199.9
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC------CCCcceeeeeEEEeCC
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI------RHPNVVQFLGAVTQST 220 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~l~~~~~~~~ 220 (456)
.+|.+.+.||+|+||.|. .+++.||||++... ......+.+|+.+++.+ .|+||+++++++....
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 368899999999999773 35789999999753 44556778888888877 5779999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC--EEEeccCC
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH--LKVADFGL 296 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~--vkl~Dfgl 296 (456)
.+++||||+. ++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999995 69999998754 3999999999999999999999999 999999999999999887 99999999
Q ss_pred cccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC-CC-
Q 012777 297 SKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER-PP- 374 (456)
Q Consensus 297 s~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~- 374 (456)
+.... .......+|+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+..... ++
T Consensus 249 a~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 249 SCYEH--------QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp CEETT--------CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ceecC--------CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 87542 122345789999999999999999999999999999999999999988776554433322110 00
Q ss_pred --------------------CC---------------------------------CCCCCCcHHHHHHHHHhcccCCCCC
Q 012777 375 --------------------FR---------------------------------APTTHYAYGLRELIEDCWSEEPFRR 401 (456)
Q Consensus 375 --------------------~~---------------------------------~~~~~~~~~l~~li~~~l~~dp~~R 401 (456)
+. ......+..+.+||.+||..||++|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 00 0012346789999999999999999
Q ss_pred CCHHHHHHH
Q 012777 402 PTFRQILMR 410 (456)
Q Consensus 402 pt~~ell~~ 410 (456)
||++|++++
T Consensus 401 pta~e~L~H 409 (429)
T 3kvw_A 401 MTPGQALRH 409 (429)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhCC
Confidence 999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=321.99 Aligned_cols=258 Identities=28% Similarity=0.452 Sum_probs=193.9
Q ss_pred cccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHH--hcCCCCcceeeeeEEEe-----CCc
Q 012777 152 LDFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALL--QKIRHPNVVQFLGAVTQ-----STP 221 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l--~~l~hp~iv~l~~~~~~-----~~~ 221 (456)
.+|.+.+.||+|+||.| ..+++.||||++.... ...+..|.+++ ..++||||+++++.+.. ...
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred HHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 36888999999999865 5689999999996431 23444455544 45799999999986543 235
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEecCCCCCCeEeCCCCCEEEe
Q 012777 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHEN---------RPEAIIHRDLEPSNILRDDSGHLKVA 292 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---------~~~~ivH~Dikp~Nil~~~~~~vkl~ 292 (456)
+++||||+++++|.+++... ..++..++.++.|++.||.|||++ + |+||||||+|||++.++.+||+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEe
Confidence 78999999999999999764 468999999999999999999999 8 9999999999999999999999
Q ss_pred ccCCcccccccccc---cCCCCcccCCCCcccccccccCC-------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCc-c
Q 012777 293 DFGLSKLLKFANTV---KEDRPVTCEETSWRYAAPEVYKN-------EEYDTKVDVFSFALILQEMIEGCPPFPTKQE-K 361 (456)
Q Consensus 293 Dfgls~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~ 361 (456)
|||++......... ..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... .
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 99999876432111 11122234568999999999987 4566789999999999999999766533221 1
Q ss_pred ch----------------HHHHHh-c-CCCCCCCC---CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 012777 362 EV----------------PKAYIA-N-ERPPFRAP---TTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLS 419 (456)
Q Consensus 362 ~~----------------~~~~~~-~-~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~ 419 (456)
+. ...... . .++.++.. ...++.++.+||.+||..||++|||++++++.|+.+...+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 10 111111 1 12222211 12245579999999999999999999999999999987663
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=314.72 Aligned_cols=247 Identities=22% Similarity=0.342 Sum_probs=200.5
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCC-CHHHHHHHHHHHHHHhcCCCCcceeeeeEEE--eCCceEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFT-DEDKVKAFIDELALLQKIRHPNVVQFLGAVT--QSTPMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~~~~~l 224 (456)
+|.+.+.||+|+||.|. .+++.||+|++...... .......+.+|+.++++++||||+++++++. .....++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 68888999999998762 36789999999754211 1123567899999999999999999999984 4567999
Q ss_pred EEEccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 225 VTEYLPKGDLRAYLKQ--KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
||||++++ |.+++.. ...+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99999765 8888776 345999999999999999999999999 99999999999999999999999999986532
Q ss_pred cccccCCCCcccCCCCcccccccccCCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEE--YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
.. .........+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||...+.......+.... .. .+.
T Consensus 162 ~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~---~~~ 234 (305)
T 2wtk_C 162 FA---ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-YA---IPG 234 (305)
T ss_dssp TC---SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-CC---CCS
T ss_pred cc---cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-CC---CCC
Confidence 11 112223456899999999987643 3679999999999999999999999877666655554332 22 246
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++..+.++|.+||..||++|||+++++++
T Consensus 235 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 788999999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=333.45 Aligned_cols=267 Identities=16% Similarity=0.214 Sum_probs=214.5
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCC-CcceeeeeEEEeCCceEEE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRH-PNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~~~~~~~~lv 225 (456)
.+|.+.+.||+|+||.|. .+++.||||++...... ..+.+|+.+++.++| ++|..+..++......++|
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 368889999999998762 35899999998754322 347889999999976 5666666777788889999
Q ss_pred EEccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe---CCCCCEEEeccCCccccc
Q 012777 226 TEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR---DDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~---~~~~~vkl~Dfgls~~~~ 301 (456)
|||+ +++|.+++.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999 8999999986 456999999999999999999999999 9999999999999 588899999999998764
Q ss_pred cccccc--CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHH---HhcC-CCCC
Q 012777 302 FANTVK--EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAY---IANE-RPPF 375 (456)
Q Consensus 302 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~-~~~~ 375 (456)
...... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+ .... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 322111 112223567899999999999999999999999999999999999999886654332222 1111 1111
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccccccC
Q 012777 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVG 427 (456)
Q Consensus 376 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~ 427 (456)
......++.++.+||.+||..||++||++++|++.|+.++.+........++
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~d 289 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFD 289 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcC
Confidence 1123577899999999999999999999999999999999988766665555
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=328.50 Aligned_cols=248 Identities=12% Similarity=0.081 Sum_probs=184.2
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC--CCCcceeee-------eEE
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI--RHPNVVQFL-------GAV 216 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~l~-------~~~ 216 (456)
..+|...+.||+|+||.| ..+|+.||||++...........+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888999999999976 236889999999886554556677788885544444 699988755 444
Q ss_pred EeC-----------------CceEEEEEccCCCCHHHHHHHc-CCCCHHHH------HHHHHHHHHHHHHHHhCCCCCeE
Q 012777 217 TQS-----------------TPMMIVTEYLPKGDLRAYLKQK-GALKPTLA------VKFALDIARGMNYLHENRPEAII 272 (456)
Q Consensus 217 ~~~-----------------~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~------~~i~~ql~~aL~~LH~~~~~~iv 272 (456)
..+ ..+++||||++ ++|.+++... ..++...+ ..++.||+.||.|||+++ |+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 433 23799999997 8999999864 33555556 678899999999999999 99
Q ss_pred ecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCC--CCCCCchhHHHHHHHHHHHHc
Q 012777 273 HRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN--EEYDTKVDVFSFALILQEMIE 350 (456)
Q Consensus 273 H~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~ 350 (456)
||||||+|||++.++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE--------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC--------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 9999999999999999999999999865311 112345689999999987 679999999999999999999
Q ss_pred CCCCCCCCCccchH--HHH--HhcCCCCCC-CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 351 GCPPFPTKQEKEVP--KAY--IANERPPFR-APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 351 g~~pf~~~~~~~~~--~~~--~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
|+.||....+.... ... .......+. .....++..+.+||.+||..||++|||+.+++++
T Consensus 289 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp SSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 99999877543211 000 000111111 1235789999999999999999999999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=324.29 Aligned_cols=244 Identities=24% Similarity=0.389 Sum_probs=199.9
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce----
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM---- 222 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~---- 222 (456)
.+|...+.||+|+||.|. .+|+.||||++.... ..+.....+.+|+.+++.++||||+++++++......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 368889999999999762 358899999998654 4566678899999999999999999999999877654
Q ss_pred --EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 223 --MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 223 --~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
++||||+. ++|.+++. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999995 68988774 45999999999999999999999999 999999999999999999999999999855
Q ss_pred cccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CC-----
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RP----- 373 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~----- 373 (456)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... .+
T Consensus 195 ~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 195 DA--------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cc--------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence 21 1233567899999999887 688999999999999999999999998877655444432211 10
Q ss_pred ---------------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 ---------------------PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 ---------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+......++..+.+||.+||+.||++|||+.+++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0001124678899999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=319.47 Aligned_cols=254 Identities=17% Similarity=0.203 Sum_probs=206.7
Q ss_pred cccCccccccccceeeeccEEEEEe----------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC---CCccee
Q 012777 145 YEIDPKELDFSNSVEITKGTFRIAS----------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR---HPNVVQ 211 (456)
Q Consensus 145 ~~~~~~~~~~~~~~~lg~G~fg~~~----------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~ 211 (456)
.++.....+|.+.+.||+|+||.|. .+++.||+|++... .. ..+..|+.+++.++ |++|++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~---~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NP---WEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CH---HHHHHHHHHHHHSCGGGGGGBCC
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---Ch---hHHHHHHHHHHHhhhhhhhhhhh
Confidence 3444556679999999999998652 35789999999754 22 45677888888776 999999
Q ss_pred eeeEEEeCCceEEEEEccCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-
Q 012777 212 FLGAVTQSTPMMIVTEYLPKGDLRAYLKQ-----KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD- 285 (456)
Q Consensus 212 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~- 285 (456)
+++++...+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~ 208 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNG 208 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGG
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEeccc
Confidence 99999999999999999999999999974 356999999999999999999999999 999999999999998
Q ss_pred ----------CCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 012777 286 ----------SGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPF 355 (456)
Q Consensus 286 ----------~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf 355 (456)
++.+||+|||++...... ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 209 FLEQDDEDDLSAGLALIDLGQSIDMKLF---PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp GTCC------CTTEEECCCTTCEEGGGS---CTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccCccccccccCCEEEeeCchhhhhhcc---CCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcc
Confidence 899999999999765321 1122233456899999999999999999999999999999999999999
Q ss_pred CCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHHHHHh
Q 012777 356 PTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRR-PTFRQILMRLDDISDQL 418 (456)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R-pt~~ell~~L~~~~~~~ 418 (456)
......... ....+ .....++.+.+++..||+.+|.+| |+++++.+.|+.+..+.
T Consensus 286 ~~~~~~~~~------~~~~~--~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 286 VKNEGGECK------PEGLF--RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp EEEETTEEE------ECSCC--TTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccCCCCcee------echhc--cccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 654332111 01111 122457789999999999999999 68899999999988764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=319.74 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=204.2
Q ss_pred cccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhc--CCCCcceeeeeEEEeCC----ce
Q 012777 152 LDFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQK--IRHPNVVQFLGAVTQST----PM 222 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~l~~~~~~~~----~~ 222 (456)
.+|...+.||+|+||.| ..+|+.||||++... ....+.+|.++++. ++||||+++++++.... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 36889999999999865 568999999999643 12567788888887 68999999999998875 79
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCeEeCCCCCEEEecc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLH--------ENRPEAIIHRDLEPSNILRDDSGHLKVADF 294 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH--------~~~~~~ivH~Dikp~Nil~~~~~~vkl~Df 294 (456)
++||||+++++|.+++.+ ..+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+||+||
T Consensus 116 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp EEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEEC
Confidence 999999999999999976 46999999999999999999999 788 999999999999999999999999
Q ss_pred CCcccccccccccCCCCcccCCCCcccccccccCCCC------CCCchhHHHHHHHHHHHHcC----------CCCCCCC
Q 012777 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEE------YDTKVDVFSFALILQEMIEG----------CPPFPTK 358 (456)
Q Consensus 295 gls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~~l~~g----------~~pf~~~ 358 (456)
|++.......... ........||+.|+|||++.+.. ++.++||||||+++|+|++| ..||...
T Consensus 192 g~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 192 GLAVRHDSATDTI-DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp TTCEEEETTTTEE-EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCceecccccccc-ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 9998663321110 00123456899999999987762 33689999999999999999 7888765
Q ss_pred Cccc-----hHHHHHhcC-CCCCCC--CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccc
Q 012777 359 QEKE-----VPKAYIANE-RPPFRA--PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIK 421 (456)
Q Consensus 359 ~~~~-----~~~~~~~~~-~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~ 421 (456)
.... ....+.... ++..+. .....+..+.++|.+||..||++|||+++++++|+.+.++..++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~~ 341 (342)
T 1b6c_B 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 341 (342)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC--
T ss_pred CcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcCC
Confidence 4322 122221111 222211 11244567999999999999999999999999999998876543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=313.67 Aligned_cols=243 Identities=28% Similarity=0.463 Sum_probs=196.3
Q ss_pred cccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 154 FSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
|.....||+|+||.| ..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 445568999999866 2367899999997542 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-CCCEEEeccCCcccccccc
Q 012777 229 LPKGDLRAYLKQKG---ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD-SGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 229 ~~~~sL~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~-~~~vkl~Dfgls~~~~~~~ 304 (456)
+++++|.+++.... .+++..+..++.|++.||.|||+++ |+|+||||+||+++. ++.+||+|||++......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~- 176 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI- 176 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC-
Confidence 99999999998652 3678899999999999999999999 999999999999997 899999999998865321
Q ss_pred cccCCCCcccCCCCcccccccccCCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCccchH--HHHHhcCCCCCCCCCC
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEE--YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVP--KAYIANERPPFRAPTT 380 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~ 380 (456)
........+++.|+|||++.+.. ++.++||||||+++|+|++|+.||......... ........+. .+.
T Consensus 177 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~ 249 (295)
T 2clq_A 177 ----NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE---IPE 249 (295)
T ss_dssp --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCC---CCT
T ss_pred ----CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccc---ccc
Confidence 11123456889999999987653 788999999999999999999999765433221 1111222222 356
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++.++.++|.+||..||++|||+++++++
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 789999999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=318.19 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=201.2
Q ss_pred ccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----C
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS-----T 220 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~ 220 (456)
..+|...+.||+|+||.|. .+|+.||||++... ........+.+|+.++++++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 4478999999999999762 25889999999753 3556667889999999999999999999988654 6
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
..++||||+. ++|.+++.. +.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 7899999995 699999876 57999999999999999999999999 999999999999999999999999999866
Q ss_pred cccccccC-----CCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc-CCC
Q 012777 301 KFANTVKE-----DRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN-ERP 373 (456)
Q Consensus 301 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~ 373 (456)
........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+... ..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 43211110 011223568999999998754 67889999999999999999999999887654433322111 010
Q ss_pred C----------------------CC-----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 P----------------------FR-----APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 ~----------------------~~-----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
. .. .....++.++.++|.+||..||++|||+++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 00 0124688899999999999999999999999885
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=325.17 Aligned_cols=247 Identities=21% Similarity=0.384 Sum_probs=204.3
Q ss_pred ccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCH--------------HHHHHHHHHHHHHhcCCCCcceeeeeE
Q 012777 153 DFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDE--------------DKVKAFIDELALLQKIRHPNVVQFLGA 215 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~--------------~~~~~~~~E~~~l~~l~hp~iv~l~~~ 215 (456)
+|.+.+.||+|+||.| ..+|+.||+|++........ ...+.+.+|+.++++++||||++++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred ceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 7899999999999754 45899999999865322111 011678999999999999999999999
Q ss_pred EEeCCceEEEEEccCCCCHHHH------HHH--cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCC
Q 012777 216 VTQSTPMMIVTEYLPKGDLRAY------LKQ--KGALKPTLAVKFALDIARGMNYLHE-NRPEAIIHRDLEPSNILRDDS 286 (456)
Q Consensus 216 ~~~~~~~~lv~e~~~~~sL~~~------l~~--~~~l~~~~~~~i~~ql~~aL~~LH~-~~~~~ivH~Dikp~Nil~~~~ 286 (456)
+...+..++||||+++++|.++ +.. ...+++..++.++.|++.||.|||+ ++ |+|+||||+||+++.+
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKN 188 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTT
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCC
Confidence 9999999999999999999998 655 4669999999999999999999999 98 9999999999999999
Q ss_pred CCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCC-CCCC-chhHHHHHHHHHHHHcCCCCCCCCCc-cch
Q 012777 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDT-KVDVFSFALILQEMIEGCPPFPTKQE-KEV 363 (456)
Q Consensus 287 ~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~~l~~g~~pf~~~~~-~~~ 363 (456)
+.+||+|||++...... ......+++.|+|||++.+. .++. ++||||||+++|+|++|..||..... .+.
T Consensus 189 ~~~kl~dfg~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK-------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp SCEEECCCTTCEECBTT-------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred CcEEEeccccccccccc-------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 99999999999865321 23345688999999999887 6666 99999999999999999999988776 444
Q ss_pred HHHHHhcCCCCCCC----------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 364 PKAYIANERPPFRA----------------PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 364 ~~~~~~~~~~~~~~----------------~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
...+ ......++. ....++.++.++|.+||..||++|||+.+++++
T Consensus 262 ~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 FNNI-RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHH-TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHH-hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 4444 333222211 015688999999999999999999999999885
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=319.16 Aligned_cols=244 Identities=24% Similarity=0.383 Sum_probs=199.9
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc-----
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP----- 221 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~----- 221 (456)
.+|...+.||+|+||.| ..+|+.||||++.... ..+.....+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 36888999999999976 2358899999997653 456667889999999999999999999999987654
Q ss_pred -eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 222 -MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 222 -~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
.++||||+. ++|.+++. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 103 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999996 68888764 35999999999999999999999999 999999999999999999999999998765
Q ss_pred cccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc---------
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN--------- 370 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------- 370 (456)
.. ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+...
T Consensus 177 ~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 177 DA--------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp ---------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred CC--------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 21 1223467899999999877 67889999999999999999999999887654443333211
Q ss_pred ------------------CCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 371 ------------------ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 371 ------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
....+......++..+.++|.+||..||++|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0122223345788999999999999999999999999876
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=327.90 Aligned_cols=244 Identities=25% Similarity=0.361 Sum_probs=193.5
Q ss_pred cccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----
Q 012777 150 KELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS----- 219 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 219 (456)
...+|...+.||+|+||.|. .+|+.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 34578999999999999762 258999999986542 1234799999999999999999998542
Q ss_pred -CceEEEEEccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC-CCEEEec
Q 012777 220 -TPMMIVTEYLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS-GHLKVAD 293 (456)
Q Consensus 220 -~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~-~~vkl~D 293 (456)
..+++||||++ ++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 125 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 125 EVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp EEEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred ceeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEecc
Confidence 23779999996 477766643 456999999999999999999999999 9999999999999955 5689999
Q ss_pred cCCcccccccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc-C
Q 012777 294 FGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN-E 371 (456)
Q Consensus 294 fgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~ 371 (456)
||+++..... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+... +
T Consensus 201 FG~a~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg 274 (420)
T 1j1b_A 201 FGSAKQLVRG------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 274 (420)
T ss_dssp CTTCEECCTT------CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred chhhhhcccC------CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999865321 122345689999999998765 7899999999999999999999999887655444333221 0
Q ss_pred C----------CC---CCC-----------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 R----------PP---FRA-----------PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 ~----------~~---~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
. +. +.. ....++.++.+||.+||..||++|||+.|+++|
T Consensus 275 ~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 00 000 124568899999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=311.73 Aligned_cols=253 Identities=26% Similarity=0.442 Sum_probs=187.7
Q ss_pred cccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
.+|...+.||+|+||.+ . .+|+.||||++.... ......+.+.++..+++.++||||+++++++......++||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS-CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 36888899999999865 2 268999999997653 22333344455556788889999999999999999999999
Q ss_pred EccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 227 EYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHEN-RPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 227 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~-~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
||+ ++.+..+... .+.+++..++.++.|++.||.|||++ + |+|+||||+||+++.++.+||+|||++......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD- 178 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC-
Confidence 999 6677766654 45799999999999999999999995 8 999999999999999999999999998765321
Q ss_pred cccCCCCcccCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCc-cchHHHHHhcCCCCCCCC
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYK-----NEEYDTKVDVFSFALILQEMIEGCPPFPTKQE-KEVPKAYIANERPPFRAP 378 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~ 378 (456)
.......+++.|+|||++. ...++.++||||||+++|+|++|+.||..... .+....+.....+.. ..
T Consensus 179 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~ 252 (318)
T 2dyl_A 179 -----KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL-PG 252 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC-CS
T ss_pred -----ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC-Cc
Confidence 1222346888999999984 45688899999999999999999999987543 334444433333322 22
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 379 TTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 379 ~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
...++.++.++|.+||..||.+|||+++++++ .+++..
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h--~~~~~~ 290 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH--SFIKRY 290 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS--HHHHHH
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC--HHHHhc
Confidence 35688999999999999999999999999986 444444
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=310.84 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=200.3
Q ss_pred CccccccccceeeeccEEEEEe----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC--CCcceeeeeEEEeCCc
Q 012777 148 DPKELDFSNSVEITKGTFRIAS----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR--HPNVVQFLGAVTQSTP 221 (456)
Q Consensus 148 ~~~~~~~~~~~~lg~G~fg~~~----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~~~ 221 (456)
.....+|.+.+.||+|+||.|. .+++.||+|++.... ......+.+.+|+.++++++ ||||+++++++.....
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 3445579999999999999762 258899999997653 35666788999999999996 5999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
.++|||+ .+++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++. +.+||+|||++....
T Consensus 103 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 103 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 9999995 48899999998888999999999999999999999999 999999999999965 799999999998663
Q ss_pred ccccccCCCCcccCCCCcccccccccCC-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc-hHHHHHh
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKN-----------EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE-VPKAYIA 369 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~ 369 (456)
.... ........|++.|+|||++.+ ..++.++||||||+++|+|++|..||....... ....+..
T Consensus 178 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 254 (313)
T 3cek_A 178 PDTT---SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254 (313)
T ss_dssp ---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred Cccc---cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence 2211 111223468999999999875 467889999999999999999999997754332 2222221
Q ss_pred cCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 370 NERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 370 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.. .. ...+...+..+.++|.+||..||++|||+++++++
T Consensus 255 ~~-~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 255 PN-HE-IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp TT-SC-CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cc-cc-cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11 11 11245668899999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=315.05 Aligned_cols=252 Identities=27% Similarity=0.475 Sum_probs=181.9
Q ss_pred cCccccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHH-HHhcCCCCcceeeeeEEEeCC
Q 012777 147 IDPKELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELA-LLQKIRHPNVVQFLGAVTQST 220 (456)
Q Consensus 147 ~~~~~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~l~~~~~~~~ 220 (456)
......+|...+.||+|+||.|. .+|+.||||++.... .......+..|+. +++.++||||+++++++...+
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence 34445578889999999999762 358899999997652 3444556666666 677779999999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEeCCCCCEEEecc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQ-----KGALKPTLAVKFALDIARGMNYLHEN-RPEAIIHRDLEPSNILRDDSGHLKVADF 294 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~-~~~~ivH~Dikp~Nil~~~~~~vkl~Df 294 (456)
..++||||++ ++|.+++.. ...+++..+..++.|++.||.|||++ + |+||||||+||+++.++.+||+||
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 95 DCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp EEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCC
T ss_pred ceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccC
Confidence 9999999996 588888764 46699999999999999999999998 9 999999999999999999999999
Q ss_pred CCcccccccccccCCCCcccCCCCccccccccc----CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc-chHHHHHh
Q 012777 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVY----KNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEK-EVPKAYIA 369 (456)
Q Consensus 295 gls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~ 369 (456)
|++...... .......||+.|+|||++ .+..++.++||||||+++|+|++|+.||...... +....+..
T Consensus 171 g~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (327)
T 3aln_A 171 GISGQLVDS------IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244 (327)
T ss_dssp SSSCC------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC
T ss_pred CCceecccc------cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc
Confidence 999865321 112233688899999998 4567889999999999999999999999875432 11111111
Q ss_pred cCCCCCC-CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 370 NERPPFR-APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 370 ~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
...+.+. .....++..+.++|.+||..||++|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 1122221 1235688999999999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=315.76 Aligned_cols=250 Identities=28% Similarity=0.460 Sum_probs=200.6
Q ss_pred cccccccceeeeccEEEEE---e---EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC---CCCcceeeeeEEE---
Q 012777 150 KELDFSNSVEITKGTFRIA---S---WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI---RHPNVVQFLGAVT--- 217 (456)
Q Consensus 150 ~~~~~~~~~~lg~G~fg~~---~---~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~--- 217 (456)
...+|.+.+.||+|+||.| . .+|+.||+|++...... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457999999999999866 2 24788999998754321 11123456777777666 8999999999987
Q ss_pred --eCCceEEEEEccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEec
Q 012777 218 --QSTPMMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293 (456)
Q Consensus 218 --~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~D 293 (456)
.....++||||++ ++|.+++.... .+++..++.++.|++.||.|||++| |+|+||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999996 69999998754 3999999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-C
Q 012777 294 FGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-R 372 (456)
Q Consensus 294 fgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~ 372 (456)
||++...... .......+|+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.... .
T Consensus 164 fg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (326)
T 1blx_A 164 FGLARIYSFQ------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237 (326)
T ss_dssp CCSCCCCCGG------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred CcccccccCC------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence 9998865321 12233568899999999999999999999999999999999999998877655544443211 0
Q ss_pred C----------------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 373 P----------------------PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 373 ~----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+ +.......++..+.+||.+||..||++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 1111235688899999999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=310.34 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=191.6
Q ss_pred ccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe---------
Q 012777 153 DFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ--------- 218 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--------- 218 (456)
+|+..+.||+|+||.+ . .+|+.||+|++.. .....+.+.+|+.++++++||||+++++++..
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 5888899999999866 2 3689999999964 34556789999999999999999999998865
Q ss_pred ----CCceEEEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEec
Q 012777 219 ----STPMMIVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293 (456)
Q Consensus 219 ----~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~D 293 (456)
....++||||+++++|.+++...+ .+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 356899999999999999998654 4888999999999999999999999 99999999999999999999999
Q ss_pred cCCcccccccccc---------cCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC-ccc
Q 012777 294 FGLSKLLKFANTV---------KEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQ-EKE 362 (456)
Q Consensus 294 fgls~~~~~~~~~---------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~ 362 (456)
||++......... ..........+++.|+|||++.+. .++.++||||||+++|+|++ ||.... ...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 9998865321100 001122345688999999998764 68899999999999999998 554322 222
Q ss_pred hHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 363 VPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
....+...............+..+.++|.+||..||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 333332222111122346677889999999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=314.40 Aligned_cols=243 Identities=27% Similarity=0.363 Sum_probs=199.1
Q ss_pred cccccceeeeccEEEEEe------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCC------cceeeeeEEEeC
Q 012777 152 LDFSNSVEITKGTFRIAS------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHP------NVVQFLGAVTQS 219 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp------~iv~l~~~~~~~ 219 (456)
.+|.+.+.||+|+||.|. .+++.||+|++... ....+.+.+|+.+++.++|+ +++++++++...
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 368999999999999762 25789999999742 45567788999999988655 499999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC------------
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD------------ 285 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~------------ 285 (456)
+..++||||+ +++|.+++...+ ++++..++.++.|++.||.|||+++ |+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999999 889999998765 5899999999999999999999999 999999999999987
Q ss_pred -------CCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 012777 286 -------SGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTK 358 (456)
Q Consensus 286 -------~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 358 (456)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE--------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS--------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccCCCceEeeCcccccCcc--------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 66899999999875421 122356899999999999999999999999999999999999999887
Q ss_pred CccchHHHHHhcCCC-C---------------------------------------CCCCCCCCcHHHHHHHHHhcccCC
Q 012777 359 QEKEVPKAYIANERP-P---------------------------------------FRAPTTHYAYGLRELIEDCWSEEP 398 (456)
Q Consensus 359 ~~~~~~~~~~~~~~~-~---------------------------------------~~~~~~~~~~~l~~li~~~l~~dp 398 (456)
+..+....+.....+ + ........+.++.+||.+||..||
T Consensus 238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 655433332111100 0 001122345678999999999999
Q ss_pred CCCCCHHHHHHH
Q 012777 399 FRRPTFRQILMR 410 (456)
Q Consensus 399 ~~Rpt~~ell~~ 410 (456)
++|||++|++++
T Consensus 318 ~~Rpt~~ell~h 329 (339)
T 1z57_A 318 AKRITLREALKH 329 (339)
T ss_dssp TTSCCHHHHTTS
T ss_pred ccccCHHHHhcC
Confidence 999999999876
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=318.98 Aligned_cols=244 Identities=26% Similarity=0.367 Sum_probs=184.6
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc------
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP------ 221 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~------ 221 (456)
+|.+.+.||+|+||.|. .+|+.||||++....... ....+|+..++.++||||+++++++.....
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp TEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 68889999999999662 358899999986543222 355678888888999999999999976443
Q ss_pred -eEEEEEccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCCeEeCC-CCCEEEec
Q 012777 222 -MMIVTEYLPKGDLRAYLK----QKGALKPTLAVKFALDIARGMNYLH--ENRPEAIIHRDLEPSNILRDD-SGHLKVAD 293 (456)
Q Consensus 222 -~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH--~~~~~~ivH~Dikp~Nil~~~-~~~vkl~D 293 (456)
+++||||+++ +|.+.+. ....+++..+..++.|++.||.||| +++ |+||||||+|||++. ++.+||+|
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECC
T ss_pred eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEee
Confidence 8899999965 6655443 3456999999999999999999999 898 999999999999996 89999999
Q ss_pred cCCcccccccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-
Q 012777 294 FGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE- 371 (456)
Q Consensus 294 fgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~- 371 (456)
||++..... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+....
T Consensus 176 fg~a~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 176 FGSAKKLSP------SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp CTTCBCCCT------TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred CCCceecCC------CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 999986632 1222345689999999998665 48999999999999999999999999877665554443211
Q ss_pred CCC---------------------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 RPP---------------------------FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 ~~~---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++ +......++.++.+||.+||+.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 011123467889999999999999999999999976
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=323.22 Aligned_cols=243 Identities=27% Similarity=0.409 Sum_probs=192.6
Q ss_pred ccccccceeeeccEEEEEe---E-cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc-----
Q 012777 151 ELDFSNSVEITKGTFRIAS---W-RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP----- 221 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~---~-~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~----- 221 (456)
..+|...+.||+|+||.|. . .+..||+|++..... ...+|+.+++.++||||+++++++.....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 3469999999999999762 2 455699998865422 12379999999999999999999965433
Q ss_pred -eEEEEEccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-CCCCEEEeccC
Q 012777 222 -MMIVTEYLPKGDLRAYLK----QKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD-DSGHLKVADFG 295 (456)
Q Consensus 222 -~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~-~~~~vkl~Dfg 295 (456)
+++||||+++ ++.+.+. ....+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 8899999965 5544443 2456999999999999999999999999 99999999999999 79999999999
Q ss_pred CcccccccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CC
Q 012777 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RP 373 (456)
Q Consensus 296 ls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~ 373 (456)
+++..... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.... .+
T Consensus 188 ~a~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 261 (394)
T 4e7w_A 188 SAKILIAG------EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261 (394)
T ss_dssp TCEECCTT------CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred CcccccCC------CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99866321 222345689999999998765 58999999999999999999999999877655444432211 10
Q ss_pred ---------------CCC---------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 ---------------PFR---------APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 ---------------~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++ ..+..++.++.+||.+||..||.+|||+.++++|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000 1134578899999999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=320.42 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=195.9
Q ss_pred ccccccceeeeccEEEEEe----EcCcEEEEEEeCCCCC--------CCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe
Q 012777 151 ELDFSNSVEITKGTFRIAS----WRGTQVAVKTLGEEVF--------TDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ 218 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~----~~g~~vAvK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 218 (456)
..+|...+.||+|+||.|. .+|..||||++..... .+....+.+.+|+.++++++||||+++++++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 4468999999999999762 3588999999965432 234455789999999999999999999999854
Q ss_pred C-----CceEEEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEe
Q 012777 219 S-----TPMMIVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVA 292 (456)
Q Consensus 219 ~-----~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~ 292 (456)
. ..+++||||++ ++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp CCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred ccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEE
Confidence 3 35899999996 68888887543 5999999999999999999999999 9999999999999999999999
Q ss_pred ccCCcccccccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC
Q 012777 293 DFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE 371 (456)
Q Consensus 293 Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 371 (456)
|||++..... ........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+....
T Consensus 177 Dfg~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 250 (362)
T 3pg1_A 177 DFNLAREDTA------DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250 (362)
T ss_dssp CTTC---------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred ecCccccccc------ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 9999975422 122234568889999999877 678999999999999999999999998877655544442211
Q ss_pred -CC----------------------CCC-----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 -RP----------------------PFR-----APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 -~~----------------------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+ ... .....++..+.+||.+||..||++|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 10 000 1124667889999999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=324.02 Aligned_cols=246 Identities=23% Similarity=0.399 Sum_probs=179.0
Q ss_pred ccc-ceeeeccEEEEE---e----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--CCceE
Q 012777 154 FSN-SVEITKGTFRIA---S----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ--STPMM 223 (456)
Q Consensus 154 ~~~-~~~lg~G~fg~~---~----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~~ 223 (456)
|.+ .+.||+|+||.| . .+++.||||++..... . ..+.+|+.+|++++||||+++++++.. ...++
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-S----MSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-C----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-C----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 544 457999999976 2 2477899999976532 2 357899999999999999999999965 67899
Q ss_pred EEEEccCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe----CCCCCEE
Q 012777 224 IVTEYLPKGDLRAYLKQK---------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR----DDSGHLK 290 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~---------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~----~~~~~vk 290 (456)
+||||++ ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999995 6888887632 24999999999999999999999999 9999999999999 6778999
Q ss_pred EeccCCcccccccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCcc--------
Q 012777 291 VADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEK-------- 361 (456)
Q Consensus 291 l~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------- 361 (456)
|+|||++....... ..........||+.|+|||++.+. .++.++|||||||++|+|++|++||......
T Consensus 173 l~Dfg~a~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 173 IADMGFARLFNSPL--KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp ECCTTCCC------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEECCCceecCCCC--cccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 99999998663211 111223345789999999998874 5889999999999999999999999765432
Q ss_pred -chHHHHHhc-CCCCCCC---------------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHH
Q 012777 362 -EVPKAYIAN-ERPPFRA---------------------------------PTTHYAYGLRELIEDCWSEEPFRRPTFRQ 406 (456)
Q Consensus 362 -~~~~~~~~~-~~~~~~~---------------------------------~~~~~~~~l~~li~~~l~~dp~~Rpt~~e 406 (456)
+....+... +.+.... .....+..+.+||.+||..||.+|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 111222111 1111000 01122667899999999999999999999
Q ss_pred HHHH
Q 012777 407 ILMR 410 (456)
Q Consensus 407 ll~~ 410 (456)
++++
T Consensus 331 ~L~h 334 (405)
T 3rgf_A 331 AMQD 334 (405)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=314.50 Aligned_cols=249 Identities=22% Similarity=0.385 Sum_probs=194.2
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE---------
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVT--------- 217 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--------- 217 (456)
.+|.+.+.||+|+||.|. .+|+.||+|++... +....+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 368889999999998652 24889999998643 4666788999999999999999999999873
Q ss_pred -----eCCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-CCCCEEE
Q 012777 218 -----QSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD-DSGHLKV 291 (456)
Q Consensus 218 -----~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~-~~~~vkl 291 (456)
.....++||||++ ++|.+++.+ +.+++..++.++.|++.||.|||+++ |+||||||+||+++ .++.+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999996 699999864 67999999999999999999999999 99999999999997 5679999
Q ss_pred eccCCcccccccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc
Q 012777 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN 370 (456)
Q Consensus 292 ~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 370 (456)
+|||++........ .........+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....+...
T Consensus 163 ~Dfg~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 163 GDFGLARIMDPHYS--HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp CCCTTCBCC----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred ccCccccccCCCcc--cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999986532111 1112223456888999998765 67889999999999999999999999887765544443222
Q ss_pred CCC--------------------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 371 ERP--------------------------PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 371 ~~~--------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
... +.......++.++.++|.+||..||++|||+++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 110 0001124688999999999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=311.34 Aligned_cols=241 Identities=20% Similarity=0.321 Sum_probs=194.6
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEe--CCceE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQ--STPMM 223 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~--~~~~~ 223 (456)
.+|++.+.||+|+||.| ..+++.||+|++... . .+.+.+|+.++++++ ||||+++++++.. ....+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---K---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---C---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---c---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 36889999999999976 246889999999743 2 257889999999996 9999999999987 56789
Q ss_pred EEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-CEEEeccCCcccccc
Q 012777 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG-HLKVADFGLSKLLKF 302 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~-~vkl~Dfgls~~~~~ 302 (456)
+||||+++++|.+++. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++.....
T Consensus 110 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999999874 4899999999999999999999999 99999999999999776 899999999986532
Q ss_pred cccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCcc-chHHHHH------------
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEK-EVPKAYI------------ 368 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~------------ 368 (456)
. .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...... +....+.
T Consensus 184 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 184 G------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp T------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred C------CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHH
Confidence 1 22234568889999999877 67899999999999999999999999544322 1111110
Q ss_pred hcCCCCC---------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 369 ANERPPF---------------------RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 369 ~~~~~~~---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
....... ......++.++.+||.+||..||++|||++|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 00122378899999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=314.24 Aligned_cols=243 Identities=23% Similarity=0.354 Sum_probs=169.9
Q ss_pred ccccccce-eeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe----CC
Q 012777 151 ELDFSNSV-EITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ----ST 220 (456)
Q Consensus 151 ~~~~~~~~-~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----~~ 220 (456)
..+|.+.+ .||+|+||.|. .+|+.||||++... .... .+....++.++||||+++++++.. ..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 34688754 59999999762 35899999998643 2221 222234556699999999999876 45
Q ss_pred ceEEEEEccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---CCCEEEeccC
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD---SGHLKVADFG 295 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~---~~~vkl~Dfg 295 (456)
.+++||||+++++|.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 5899999999999999998754 5999999999999999999999999 999999999999986 4559999999
Q ss_pred CcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHh---cCC
Q 012777 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIA---NER 372 (456)
Q Consensus 296 ls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~ 372 (456)
++..... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||.............. ...
T Consensus 177 ~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (336)
T 3fhr_A 177 FAKETTQ-------NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 249 (336)
T ss_dssp TCEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred cceeccc-------cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc
Confidence 9876531 112234678899999999888899999999999999999999999977655433211111 111
Q ss_pred CCC-CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 373 PPF-RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 373 ~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..+ ......++.++.+||.+||..||++|||+++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111 11235789999999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=317.38 Aligned_cols=243 Identities=26% Similarity=0.327 Sum_probs=195.8
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CC-----cceeeeeEEEeCC
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HP-----NVVQFLGAVTQST 220 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----~iv~l~~~~~~~~ 220 (456)
.+|.+.+.||+|+||.|. .+++.||||++... ......+..|+.+++.++ |+ +|+++++++....
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 378899999999999762 35789999999743 445567788998888874 55 4999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeEecCCCCCCeEeC--CCCCEEEecc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHE--NRPEAIIHRDLEPSNILRD--DSGHLKVADF 294 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~--~~~~~ivH~Dikp~Nil~~--~~~~vkl~Df 294 (456)
..++||||++ ++|.+++... +.+++..+..++.|++.||.|||+ .+ |+||||||+|||++ .++.+||+||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCC
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999995 6999999875 359999999999999999999994 67 99999999999995 4778999999
Q ss_pred CCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC-C
Q 012777 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER-P 373 (456)
Q Consensus 295 gls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~ 373 (456)
|++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..... +
T Consensus 206 G~a~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 277 (382)
T 2vx3_A 206 GSSCQLGQ--------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277 (382)
T ss_dssp TTCEETTC--------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred cCceeccc--------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99986521 12345688999999999999999999999999999999999999998776655444432111 0
Q ss_pred C---------------------------------CCCC-CC-------------------------CCcHHHHHHHHHhc
Q 012777 374 P---------------------------------FRAP-TT-------------------------HYAYGLRELIEDCW 394 (456)
Q Consensus 374 ~---------------------------------~~~~-~~-------------------------~~~~~l~~li~~~l 394 (456)
+ +..+ .. ..+.++.+||.+||
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 357 (382)
T 2vx3_A 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML 357 (382)
T ss_dssp CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence 0 0000 00 00136899999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 012777 395 SEEPFRRPTFRQILMR 410 (456)
Q Consensus 395 ~~dp~~Rpt~~ell~~ 410 (456)
..||++|||++|++++
T Consensus 358 ~~dP~~Rpta~e~L~h 373 (382)
T 2vx3_A 358 DYDPKTRIQPYYALQH 373 (382)
T ss_dssp CSCTTTSCCHHHHTTS
T ss_pred CCChhhCCCHHHHhcC
Confidence 9999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=321.56 Aligned_cols=243 Identities=25% Similarity=0.322 Sum_probs=194.2
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC--------CCcceeeeeEEE-
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR--------HPNVVQFLGAVT- 217 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hp~iv~l~~~~~- 217 (456)
-+|.+.+.||+|+||.|. .+++.||||++.. .....+.+.+|+.+++.++ ||||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS----AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec----CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 368999999999999762 3588999999974 3455678899999999985 788999999987
Q ss_pred ---eCCceEEEEEccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEeCCCC----
Q 012777 218 ---QSTPMMIVTEYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHEN-RPEAIIHRDLEPSNILRDDSG---- 287 (456)
Q Consensus 218 ---~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~-~~~~ivH~Dikp~Nil~~~~~---- 287 (456)
....+++||||+ +++|.+.+... +.+++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 456799999999 66777777654 4599999999999999999999998 8 99999999999999775
Q ss_pred ---------------------------------------------CEEEeccCCcccccccccccCCCCcccCCCCcccc
Q 012777 288 ---------------------------------------------HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYA 322 (456)
Q Consensus 288 ---------------------------------------------~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~ 322 (456)
.+||+|||++..... ......||+.|+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--------~~~~~~gt~~y~ 260 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--------HFTEDIQTRQYR 260 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--------CSCSCCSCGGGC
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--------cCccCCCCCccc
Confidence 899999999986531 122346899999
Q ss_pred cccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchH------HHHHh-cCCCC---------------------
Q 012777 323 APEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVP------KAYIA-NERPP--------------------- 374 (456)
Q Consensus 323 aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~------~~~~~-~~~~~--------------------- 374 (456)
|||++.+..++.++|||||||++|+|++|+.||...+..... ..+.. ...++
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 999999999999999999999999999999999876543211 11100 00000
Q ss_pred -C---------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 -F---------------RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 -~---------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
. .......+..+.+||.+||..||++|||++|++++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0 00112334678899999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=324.20 Aligned_cols=249 Identities=25% Similarity=0.351 Sum_probs=190.6
Q ss_pred ccccccccceeeeccEEEEE----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceE
Q 012777 149 PKELDFSNSVEITKGTFRIA----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMM 223 (456)
Q Consensus 149 ~~~~~~~~~~~lg~G~fg~~----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~ 223 (456)
....+|...+.||+|+||.| ..+|+.||||++..... ..+.+|+.+|+.+ +||||+++++++......+
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 94 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQY 94 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence 33457889999999999853 45799999999975432 2356899999999 7999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-----CCCEEEeccCCc
Q 012777 224 IVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD-----SGHLKVADFGLS 297 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~-----~~~vkl~Dfgls 297 (456)
+|||||+ ++|.+++.... ..++..++.++.|++.||.|||+++ |+||||||+|||++. ...+||+|||++
T Consensus 95 lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 95 IAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9999995 69999998654 3666677899999999999999999 999999999999953 236889999999
Q ss_pred ccccccccccCCCCcccCCCCcccccccccC---CCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCC
Q 012777 298 KLLKFANTVKEDRPVTCEETSWRYAAPEVYK---NEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERP 373 (456)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 373 (456)
......... ........||+.|+|||++. ...++.++|||||||++|+|++ |..||......... .+......
T Consensus 171 ~~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~~~~~~ 247 (432)
T 3p23_A 171 KKLAVGRHS--FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILLGACSL 247 (432)
T ss_dssp ECC--------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHTTCCCC
T ss_pred eeccCCCcc--eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHhccCCc
Confidence 876322111 11223456899999999997 4567789999999999999999 99999665433322 22122222
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.........+..+.+||.+||+.||++|||+++++++
T Consensus 248 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 248 DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 2222234455668999999999999999999999954
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=310.95 Aligned_cols=243 Identities=25% Similarity=0.323 Sum_probs=196.4
Q ss_pred cccccceeeeccEEEEEe-----EcC-cEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCc------ceeeeeEEEeC
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRG-TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPN------VVQFLGAVTQS 219 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g-~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~------iv~l~~~~~~~ 219 (456)
.+|.+.+.||+|+||.|. .++ +.||+|++.. .....+.+.+|+.+++.++|++ ++.+++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN----VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc----cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 368999999999999763 234 6899999974 3455677889999999987655 89999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe--------------
Q 012777 220 TPMMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR-------------- 283 (456)
Q Consensus 220 ~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~-------------- 283 (456)
...++||||+ +++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 9999999999 678888877654 5999999999999999999999999 9999999999999
Q ss_pred -----CCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 012777 284 -----DDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTK 358 (456)
Q Consensus 284 -----~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 358 (456)
+.++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHE--------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTS--------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccCCCcEEEeecCccccccc--------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 5678999999999875421 123356899999999999999999999999999999999999999887
Q ss_pred CccchHHHHHhcCCC-C---------------------------------------CCCCCCCCcHHHHHHHHHhcccCC
Q 012777 359 QEKEVPKAYIANERP-P---------------------------------------FRAPTTHYAYGLRELIEDCWSEEP 398 (456)
Q Consensus 359 ~~~~~~~~~~~~~~~-~---------------------------------------~~~~~~~~~~~l~~li~~~l~~dp 398 (456)
+..+....+.....+ + ........+.++.+||.+||..||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 655443332211100 0 000112234578999999999999
Q ss_pred CCCCCHHHHHHH
Q 012777 399 FRRPTFRQILMR 410 (456)
Q Consensus 399 ~~Rpt~~ell~~ 410 (456)
++|||+.+++++
T Consensus 323 ~~Rpt~~e~l~h 334 (355)
T 2eu9_A 323 AQRITLAEALLH 334 (355)
T ss_dssp TTSCCHHHHTTS
T ss_pred hhCcCHHHHhcC
Confidence 999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=323.64 Aligned_cols=244 Identities=25% Similarity=0.378 Sum_probs=184.0
Q ss_pred cccceeeeccEEEEE----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEc
Q 012777 154 FSNSVEITKGTFRIA----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
|...+.||+|+||.| ..+|+.||||++..+. .+.+.+|+.+++++ +||||+++++++.....+++||||
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 555688999999865 4579999999986532 24578899999886 899999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCC-------CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC-------------CC
Q 012777 229 LPKGDLRAYLKQKGAL-------KPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDS-------------GH 288 (456)
Q Consensus 229 ~~~~sL~~~l~~~~~l-------~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~-------------~~ 288 (456)
|. ++|.+++...+.. ++..++.++.|++.||.|||+++ |+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 95 6999999865432 23345789999999999999999 9999999999999754 47
Q ss_pred EEEeccCCcccccccccccCCCCcccCCCCcccccccccCC-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCc
Q 012777 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-------EEYDTKVDVFSFALILQEMIE-GCPPFPTKQE 360 (456)
Q Consensus 289 vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~ 360 (456)
+||+|||++......... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.....
T Consensus 167 ~kL~DFG~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSS-FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEECCCTTCEECCC---------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEcccccceecCCCCcc-ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 999999999876432111 1111234568999999999875 578899999999999999999 9999976554
Q ss_pred cchHHHHHhcC-C-CCCC-CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 361 KEVPKAYIANE-R-PPFR-APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 361 ~~~~~~~~~~~-~-~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+ ..+.... . +... .....++.++.++|.+||..||.+|||+.+++++
T Consensus 246 ~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 246 RE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 33 2222222 1 1111 1123456789999999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=313.64 Aligned_cols=244 Identities=25% Similarity=0.388 Sum_probs=200.4
Q ss_pred cCccccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCH---HHHHHHHHHHHHHhcCC--CCcceeeeeEE
Q 012777 147 IDPKELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDE---DKVKAFIDELALLQKIR--HPNVVQFLGAV 216 (456)
Q Consensus 147 ~~~~~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--hp~iv~l~~~~ 216 (456)
......+|.+.+.||+|+||.|. .+|+.||||++........ .....+.+|+.++++++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 34445679999999999998662 3688999999976532221 11235678999999995 69999999999
Q ss_pred EeCCceEEEEEccCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-CCCCEEEecc
Q 012777 217 TQSTPMMIVTEYLPK-GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD-DSGHLKVADF 294 (456)
Q Consensus 217 ~~~~~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~-~~~~vkl~Df 294 (456)
......++|+|++.+ ++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999999975 899999998888999999999999999999999999 99999999999999 7889999999
Q ss_pred CCcccccccccccCCCCcccCCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCC
Q 012777 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEY-DTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERP 373 (456)
Q Consensus 295 gls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 373 (456)
|++..... .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.... .+... ..
T Consensus 195 g~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~-~~ 260 (320)
T 3a99_A 195 GSGALLKD-------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-QV 260 (320)
T ss_dssp TTCEECCS-------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-CC
T ss_pred cccccccc-------ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcc-cc
Confidence 99886632 12233568999999999877665 578999999999999999999996532 12121 11
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
. .+..++.++.++|.+||..||++|||+++++++
T Consensus 261 ~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 261 F---FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp C---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c---ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 246788999999999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=307.25 Aligned_cols=240 Identities=28% Similarity=0.412 Sum_probs=192.7
Q ss_pred ccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCH---HHHHHHHHHHHHHhcC----CCCcceeeeeEEEe
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDE---DKVKAFIDELALLQKI----RHPNVVQFLGAVTQ 218 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~hp~iv~l~~~~~~ 218 (456)
..+|.+.+.||+|+||.|. .+++.||||++........ .....+.+|+.+++++ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 3479999999999998762 3688999999976543221 1223456799999998 89999999999999
Q ss_pred CCceEEEEEc-cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-CCCCEEEeccCC
Q 012777 219 STPMMIVTEY-LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD-DSGHLKVADFGL 296 (456)
Q Consensus 219 ~~~~~lv~e~-~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~-~~~~vkl~Dfgl 296 (456)
.+..++|+|+ +.+++|.+++...+.+++..++.++.|++.||.|||+++ |+|+||||+||+++ .++.+||+|||+
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999 788999999998888999999999999999999999999 99999999999999 889999999999
Q ss_pred cccccccccccCCCCcccCCCCcccccccccCCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCC
Q 012777 297 SKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYD-TKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPF 375 (456)
Q Consensus 297 s~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 375 (456)
+...... ......+++.|+|||++.+..+. .++||||||+++|+|++|+.||.... .+.. ....
T Consensus 187 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~-~~~~- 251 (312)
T 2iwi_A 187 GALLHDE-------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILE-AELH- 251 (312)
T ss_dssp CEECCSS-------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH-TCCC-
T ss_pred hhhcccC-------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhh-hccC-
Confidence 8866321 22345688999999998776664 48999999999999999999996532 1211 1222
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 376 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+..++..+.++|.+||..||++|||+++++++
T Consensus 252 --~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 252 --FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 246788999999999999999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=300.51 Aligned_cols=229 Identities=13% Similarity=0.093 Sum_probs=189.3
Q ss_pred cccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012777 152 LDFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
-+|++.+.||+|+||.| . .+|+.||||++......++...+.+.+|+..+++++||||+++++++...+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 36999999999999866 2 248899999998876666777889999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||++|++|.+++.+ + ....++..++.|++.||.|||++| |+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999954 3 466678899999999999999999 9999999999999999999998543
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHH---HHHhcCCCCCCCCCCCCc
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPK---AYIANERPPFRAPTTHYA 383 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 383 (456)
|++ +++.++|||||||++|+|++|+.||...+...... .......+........++
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP 233 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSC
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCC
Confidence 333 36889999999999999999999998876543221 010111111111236788
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 384 YGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
.++.++|.+||+.||++| |+.++++.|+.+....
T Consensus 234 ~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 234 FQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred HHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 999999999999999999 9999999999987543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=313.92 Aligned_cols=243 Identities=21% Similarity=0.302 Sum_probs=191.7
Q ss_pred cccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-----------CCcceeeeeE
Q 012777 152 LDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-----------HPNVVQFLGA 215 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~iv~l~~~ 215 (456)
.+|.+.+.||+|+||.|. .+++.||||++.. .......+.+|+.+++++. ||||++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 479999999999999762 4688999999974 3445577889999999885 8999999999
Q ss_pred EEeCC----ceEEEEEccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeEeC----
Q 012777 216 VTQST----PMMIVTEYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHEN-RPEAIIHRDLEPSNILRD---- 284 (456)
Q Consensus 216 ~~~~~----~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~-~~~~ivH~Dikp~Nil~~---- 284 (456)
+.... .++++|||+ +++|.+++... ..+++..+..++.||+.||.|||++ + |+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 97654 789999999 89999999874 4499999999999999999999998 9 99999999999995
Q ss_pred --CCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccc
Q 012777 285 --DSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKE 362 (456)
Q Consensus 285 --~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 362 (456)
..+.+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 242 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE--------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB--------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred CcCcceEEEcccccccccCC--------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 344799999999986531 1223468999999999999999999999999999999999999998654221
Q ss_pred ------hHHHHHh-cCCCC-------------------------------------CCCCCCCCcHHHHHHHHHhcccCC
Q 012777 363 ------VPKAYIA-NERPP-------------------------------------FRAPTTHYAYGLRELIEDCWSEEP 398 (456)
Q Consensus 363 ------~~~~~~~-~~~~~-------------------------------------~~~~~~~~~~~l~~li~~~l~~dp 398 (456)
....+.. ....+ ....+..++.++.+||.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 1111110 00000 000123456789999999999999
Q ss_pred CCCCCHHHHHHH
Q 012777 399 FRRPTFRQILMR 410 (456)
Q Consensus 399 ~~Rpt~~ell~~ 410 (456)
++|||+++++++
T Consensus 323 ~~Rpt~~ell~h 334 (373)
T 1q8y_A 323 RKRADAGGLVNH 334 (373)
T ss_dssp TTCBCHHHHHTC
T ss_pred cccCCHHHHhhC
Confidence 999999999886
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.77 Aligned_cols=245 Identities=28% Similarity=0.368 Sum_probs=193.9
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe------CCc
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ------STP 221 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------~~~ 221 (456)
+|.+.+.||+|+||.| ..+|+.||||++... ......+.+.+|+.++++++||||+++++++.. ...
T Consensus 15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 6889999999999976 246889999999765 356667889999999999999999999998755 677
Q ss_pred eEEEEEccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC---EEEeccC
Q 012777 222 MMIVTEYLPKGDLRAYLKQKG---ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH---LKVADFG 295 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~---vkl~Dfg 295 (456)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999998744 5999999999999999999999999 999999999999997765 9999999
Q ss_pred CcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccch---------HHH
Q 012777 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV---------PKA 366 (456)
Q Consensus 296 ls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---------~~~ 366 (456)
++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||........ ...
T Consensus 170 ~a~~~~~~------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 170 YAKELDQG------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243 (676)
T ss_dssp CCCBTTSC------CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred cccccccc------cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence 99866321 222345789999999999999999999999999999999999999965421110 000
Q ss_pred HHh----cCC-------CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 012777 367 YIA----NER-------PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408 (456)
Q Consensus 367 ~~~----~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell 408 (456)
+.. ... +........++..+.++|.+||..||++|||+.+++
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 000 000 001112344678899999999999999999998844
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=290.66 Aligned_cols=220 Identities=24% Similarity=0.411 Sum_probs=175.3
Q ss_pred ccccc-eeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHH-hcCCCCcceeeeeEEEe----CCc
Q 012777 153 DFSNS-VEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALL-QKIRHPNVVQFLGAVTQ----STP 221 (456)
Q Consensus 153 ~~~~~-~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~iv~l~~~~~~----~~~ 221 (456)
+|.+. +.||+|+||.| ..+++.||+|++... ..+.+|+.++ +..+||||+++++++.. ...
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 56665 67999999876 236889999998642 3567888888 55589999999999977 677
Q ss_pred eEEEEEccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---CCCEEEeccCC
Q 012777 222 MMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD---SGHLKVADFGL 296 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~---~~~vkl~Dfgl 296 (456)
.++||||+++++|.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 999999999999999998764 5999999999999999999999999 999999999999997 78999999998
Q ss_pred cccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC-CCC
Q 012777 297 SKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER-PPF 375 (456)
Q Consensus 297 s~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~ 375 (456)
+.... +..++.++|||||||++|+|++|..||................. ...
T Consensus 167 a~~~~---------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 219 (299)
T 3m2w_A 167 AKETT---------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 219 (299)
T ss_dssp CEECT---------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC
T ss_pred ccccc---------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc
Confidence 76431 13467899999999999999999999977654332111111111 111
Q ss_pred CCC---CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 376 RAP---TTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 376 ~~~---~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
... ...++.++.++|.+||..||++|||+.+++++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111 15688999999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=307.06 Aligned_cols=247 Identities=13% Similarity=0.114 Sum_probs=186.4
Q ss_pred ccccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCC-Ccc---------eeee--
Q 012777 151 ELDFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRH-PNV---------VQFL-- 213 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~i---------v~l~-- 213 (456)
...|...+.||+|+||.| . .+|+.||||++...........+.+.+|+.+++.++| ++. +..+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345778889999999976 2 3589999999985543444446788999999999976 221 1111
Q ss_pred ----------eEEEe-----CCceEEEEEccCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 012777 214 ----------GAVTQ-----STPMMIVTEYLPKGDLRAYLKQ-------KGALKPTLAVKFALDIARGMNYLHENRPEAI 271 (456)
Q Consensus 214 ----------~~~~~-----~~~~~lv~e~~~~~sL~~~l~~-------~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~i 271 (456)
.++.. ....+++|+++ +++|.+++.. .+.+++..++.++.|++.||.|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11111 13467788877 7899999852 223778899999999999999999999 9
Q ss_pred EecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCccccccccc----------CCCCCCCchhHHHH
Q 012777 272 IHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVY----------KNEEYDTKVDVFSF 341 (456)
Q Consensus 272 vH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Diwsl 341 (456)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE--------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc--------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 99999999999999999999999998865321 223456 889999998 66678889999999
Q ss_pred HHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHHHh
Q 012777 342 ALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR--LDDISDQL 418 (456)
Q Consensus 342 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~--L~~~~~~~ 418 (456)
||++|+|++|+.||...+.......+.. ....+|..+.+||.+||..||++|||+.+++++ ++.+...+
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~~ 374 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 374 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCCcchhhhHHHHHh--------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHHH
Confidence 9999999999999988765544333311 124678899999999999999999999999775 44444433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.28 Aligned_cols=239 Identities=21% Similarity=0.297 Sum_probs=194.0
Q ss_pred cccccceeeeccEEEEEe---E---cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc----
Q 012777 152 LDFSNSVEITKGTFRIAS---W---RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP---- 221 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~---~---~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~---- 221 (456)
-+|.+.+.||+|+||.|. . +|+.||||++... ........+.+|+.++++++||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 379999999999998762 1 5789999998754 355667788999999999999999999999987765
Q ss_pred -eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 222 -MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 222 -~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
.|+||||+++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||++...
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999988764 7999999999999999999999999 9999999999999985 8999999999865
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||........ +. .....
T Consensus 232 ~~~---------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------~~-~~~~~ 291 (681)
T 2pzi_A 232 NSF---------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------PE-DDPVL 291 (681)
T ss_dssp TCC---------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------CT-TCHHH
T ss_pred ccC---------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc---------cc-ccccc
Confidence 311 335689999999998765 48899999999999999999999875322111 00 00112
Q ss_pred CCcHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHHHh
Q 012777 381 HYAYGLRELIEDCWSEEPFRRP-TFRQILMRLDDISDQL 418 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rp-t~~ell~~L~~~~~~~ 418 (456)
..+..+.++|.+||..||++|| +++++...|..+..+.
T Consensus 292 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 292 KTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp HHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 2456799999999999999999 5777888887776544
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=302.81 Aligned_cols=239 Identities=13% Similarity=0.146 Sum_probs=180.9
Q ss_pred cccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCC-----CHHHHHHHHHHHHHHhcCC---------CCcceeeee
Q 012777 152 LDFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFT-----DEDKVKAFIDELALLQKIR---------HPNVVQFLG 214 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------hp~iv~l~~ 214 (456)
.+|.+.+.||+|+||.| ..+|+.||||++...... .....+.+.+|+.+++.++ ||||+++++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~ 99 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS 99 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred ccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence 46889999999999866 568999999999865321 2223367888999888885 555555555
Q ss_pred E-----------------EEe-------------CCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 012777 215 A-----------------VTQ-------------STPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLH 264 (456)
Q Consensus 215 ~-----------------~~~-------------~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH 264 (456)
. +.. ...+++||||+++|++.+.+.+ +.+++..++.++.||+.||.|||
T Consensus 100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH 178 (336)
T 2vuw_A 100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAE 178 (336)
T ss_dssp EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHH
T ss_pred eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH
Confidence 4 433 6789999999999976666643 56899999999999999999999
Q ss_pred -hCCCCCeEecCCCCCCeEeCCCC--------------------CEEEeccCCcccccccccccCCCCcccCCCCccccc
Q 012777 265 -ENRPEAIIHRDLEPSNILRDDSG--------------------HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAA 323 (456)
Q Consensus 265 -~~~~~~ivH~Dikp~Nil~~~~~--------------------~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~a 323 (456)
+++ |+||||||+|||++.++ .+||+|||+++..... ...||+.|+|
T Consensus 179 ~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----------~~~gt~~y~a 245 (336)
T 2vuw_A 179 ASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----------IVVFCDVSMD 245 (336)
T ss_dssp HHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----------EEECCCCTTC
T ss_pred HhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----------cEEEeecccC
Confidence 999 99999999999999887 8999999999876321 2368899999
Q ss_pred ccccCCCCCCCchhHHHHHHH-HHHHHcCCCCCCCCCc-cchHHHHHhcC-CCC--CCCCCCCCcHHHHHHHHHhcccCC
Q 012777 324 PEVYKNEEYDTKVDVFSFALI-LQEMIEGCPPFPTKQE-KEVPKAYIANE-RPP--FRAPTTHYAYGLRELIEDCWSEEP 398 (456)
Q Consensus 324 PE~~~~~~~~~~~DiwslG~i-l~~l~~g~~pf~~~~~-~~~~~~~~~~~-~~~--~~~~~~~~~~~l~~li~~~l~~dp 398 (456)
||++.+.. +.++|||||+++ .+++++|..||..... ......+.... ... .......++.++.+||.+||+.|
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d- 323 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS- 323 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-
Confidence 99998776 889999998777 6778889999854211 11122222111 111 11112357788999999999876
Q ss_pred CCCCCHHHHH-HH
Q 012777 399 FRRPTFRQIL-MR 410 (456)
Q Consensus 399 ~~Rpt~~ell-~~ 410 (456)
|++|++ +|
T Consensus 324 ----sa~e~l~~H 332 (336)
T 2vuw_A 324 ----SATDLLCQH 332 (336)
T ss_dssp ----SHHHHHHHC
T ss_pred ----CHHHHHhcC
Confidence 999988 54
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=274.71 Aligned_cols=173 Identities=16% Similarity=0.104 Sum_probs=131.3
Q ss_pred eEcCcEEEEEEeCCCCCC-------CHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCCCCHHHHHHH
Q 012777 169 SWRGTQVAVKTLGEEVFT-------DEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQ 240 (456)
Q Consensus 169 ~~~g~~vAvK~~~~~~~~-------~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~ 240 (456)
.+.|+.||+|++.+.... .+...+.|.+|+++|+++ +|+||++++++++++..+|||||||+|++|.+++.+
T Consensus 256 ~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~ 335 (569)
T 4azs_A 256 YFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA 335 (569)
T ss_dssp EEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT
T ss_pred ccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh
Confidence 567999999999765321 133456799999999999 799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcc
Q 012777 241 KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWR 320 (456)
Q Consensus 241 ~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~ 320 (456)
.+++++. .|+.||+.||.|||++| ||||||||+|||++.+|.+||+|||+++..... ........||+.
T Consensus 336 ~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~-----~~~~~t~vGTp~ 404 (569)
T 4azs_A 336 GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD-----CSWPTNLVQSFF 404 (569)
T ss_dssp TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--------CCSHHHHHHHH
T ss_pred CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC-----CccccCceechh
Confidence 8888875 48899999999999999 999999999999999999999999999866321 112234568999
Q ss_pred cccccccCCCCCCCchhHHHHHHHHHHHHcCCC
Q 012777 321 YAAPEVYKNEEYDTKVDVFSFALILQEMIEGCP 353 (456)
Q Consensus 321 y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~ 353 (456)
|+|||++.+. +..++|+||+|++++++.++..
T Consensus 405 YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 405 VFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp HHHHHHC------------------CCCCTTHH
T ss_pred hccHHHhCCC-CCCcccccccccchhhhccccc
Confidence 9999998764 6678999999999887765533
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-25 Score=229.87 Aligned_cols=188 Identities=20% Similarity=0.216 Sum_probs=143.8
Q ss_pred cceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHH-----HHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 156 NSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDED-----KVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 156 ~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
..+.||+|+||.| ...+..+++|........... ..+.+.+|+.++++++||||+++..++......++|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 3468999999976 357899999997654433322 24568999999999999999966666667778899999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+++++|.+++.+ +..++.|+++||.|||+++ |+||||||+|||++. .+||+|||+++.........
T Consensus 420 ~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 420 YINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp CCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred CCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999875 5689999999999999999 999999999999999 99999999998763321100
Q ss_pred C--CCCcccCCCCcccccccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCC
Q 012777 308 E--DRPVTCEETSWRYAAPEVYKN--EEYDTKVDVFSFALILQEMIEGCPPFP 356 (456)
Q Consensus 308 ~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~ 356 (456)
. ........||+.|+|||++.. ..|+...|+|+..+-..+-+.++.+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 0 001123568899999999987 567778899999988888887776663
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-22 Score=158.21 Aligned_cols=93 Identities=46% Similarity=0.649 Sum_probs=89.5
Q ss_pred CCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccccccccc
Q 012777 36 DPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKH 115 (456)
Q Consensus 36 ~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~ 115 (456)
+|+||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||+|+|+..|+
T Consensus 1 ~g~t~L~~A~~~~~~~~v~~Ll~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~ 80 (93)
T 1n0q_A 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH 80 (93)
T ss_dssp --CCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred CCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCC
Confidence 58999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhhcCCC
Q 012777 116 HDVIKLLEEHGAK 128 (456)
Q Consensus 116 ~~~~~~L~~~~~~ 128 (456)
.+++++|++.|++
T Consensus 81 ~~~~~~Ll~~ga~ 93 (93)
T 1n0q_A 81 LEVVKLLLEAGAY 93 (93)
T ss_dssp HHHHHHHHHTTCC
T ss_pred HHHHHHHHHcCCC
Confidence 9999999999874
|
| >4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A | Back alignment and structure |
|---|
Probab=99.87 E-value=3e-22 Score=175.31 Aligned_cols=113 Identities=39% Similarity=0.535 Sum_probs=77.3
Q ss_pred CCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCC
Q 012777 24 PADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWG 103 (456)
Q Consensus 24 ~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 103 (456)
+.++|++. +|.+|+||||+|+..++.++++.|++.|+|++.+|.+|+||||+|+..|+.+++++|+++|+++|.+|.+|
T Consensus 25 ~~Gadvn~-~d~~g~t~l~~a~~~~~~~~~~~ll~~gad~~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gadvn~~d~~G 103 (169)
T 4gpm_A 25 ENGADVNA-SDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDG 103 (169)
T ss_dssp HTTCCTTC-CCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred HCCCCCCC-cCCCCCCHHHHHHHcCCHHHHHHHHhcccchhhhccCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCC
Confidence 34455443 34567777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred CcccccccccccchhhhhhhhcCCCCCCCccccc
Q 012777 104 STPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 104 ~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
+||||+|+..|+.+++++|++.|++++.++....
T Consensus 104 ~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~ 137 (169)
T 4gpm_A 104 RTPLHHAAENGHKEVVKLLISKGADVNTSDSDGR 137 (169)
T ss_dssp CCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred CCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCC
Confidence 7777777777777777777777777766655443
|
| >4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A | Back alignment and structure |
|---|
Probab=99.86 E-value=8.2e-22 Score=172.49 Aligned_cols=106 Identities=40% Similarity=0.538 Sum_probs=95.3
Q ss_pred CCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCC
Q 012777 24 PADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWG 103 (456)
Q Consensus 24 ~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 103 (456)
+.+.|++. ++.+|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|++++.+|.+|
T Consensus 58 ~~gad~~~-~d~~g~TpLh~A~~~g~~~~v~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G 136 (169)
T 4gpm_A 58 SKGADVNA-KDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNTSDSDG 136 (169)
T ss_dssp HTTCCTTC-CCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred hcccchhh-hccCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCC
Confidence 44556544 56789999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccchhhhhhhhcCCCCC
Q 012777 104 STPLADAVYYKHHDVIKLLEEHGAKPS 130 (456)
Q Consensus 104 ~t~l~~A~~~~~~~~~~~L~~~~~~~~ 130 (456)
.|||++|+..|+.+++++|+++||++.
T Consensus 137 ~TpL~~A~~~g~~~iv~~Ll~~GA~ie 163 (169)
T 4gpm_A 137 RTPLDLAREHGNEEVVKLLEKQGGWLE 163 (169)
T ss_dssp CCHHHHHHHTTCHHHHHHHHTC-----
T ss_pred CCHHHHHHHcCCHHHHHHHHHCCCCcC
Confidence 999999999999999999999999875
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-21 Score=159.05 Aligned_cols=105 Identities=36% Similarity=0.544 Sum_probs=99.8
Q ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccc
Q 012777 33 EAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVY 112 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~ 112 (456)
+|.+|+||||+||..|+.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus 5 ~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~~ 84 (115)
T 2l6b_A 5 GSKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKK 84 (115)
T ss_dssp CSCSSCCHHHHHHHHTCHHHHHHHTTTTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHHT
T ss_pred cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHH
Confidence 57889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccchhhhhhhhcCCCCCCCccccc
Q 012777 113 YKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 113 ~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
.|+.+++++|+++|++++.++....
T Consensus 85 ~~~~~~~~~Ll~~ga~~n~~~~~~~ 109 (115)
T 2l6b_A 85 NGHHEIVKLLDAKGADVNARSWGSS 109 (115)
T ss_dssp TTCHHHHHHHHTTSSSHHHHSCCCC
T ss_pred CCCHHHHHHHHHcCCCCCcCCcccc
Confidence 9999999999999999987655443
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.84 E-value=7.6e-21 Score=160.07 Aligned_cols=108 Identities=30% Similarity=0.360 Sum_probs=102.7
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccccc
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAV 111 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~ 111 (456)
.++.+|+||||+||..|+.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+
T Consensus 5 ~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~ 84 (137)
T 3c5r_A 5 FTNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAA 84 (137)
T ss_dssp CCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCHHHHHH
T ss_pred CcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCHHHHHH
Confidence 56889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchhhhhhhhcCCCCCCCccccccc
Q 012777 112 YYKHHDVIKLLEEHGAKPSTAPMHVQNA 139 (456)
Q Consensus 112 ~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 139 (456)
..|+.+++++|++.|++++.++....++
T Consensus 85 ~~~~~~~v~~Ll~~ga~~~~~~~~g~tp 112 (137)
T 3c5r_A 85 KNGHVDIVKLLLSYGASRNAVNIFGLRP 112 (137)
T ss_dssp HTTCHHHHHHHHHTTCCTTCCCTTSCCG
T ss_pred HcCCHHHHHHHHHcCCCCCCCCCCCCCH
Confidence 9999999999999999998887665544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.1e-21 Score=184.37 Aligned_cols=144 Identities=14% Similarity=0.057 Sum_probs=112.1
Q ss_pred ccccceeeeccEEEEE---eE-cCcEEEEEEeCCCCCCCH---------------HHHHHHHHHHHHHhcCCCCcceeee
Q 012777 153 DFSNSVEITKGTFRIA---SW-RGTQVAVKTLGEEVFTDE---------------DKVKAFIDELALLQKIRHPNVVQFL 213 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~-~g~~vAvK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~hp~iv~l~ 213 (456)
.|.+.+.||+|+||.| .. +|+.||+|++........ .....+.+|+.++++++ | ++++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 3556789999999866 22 588999999975321110 24567899999999998 4 6666
Q ss_pred eEEEeCCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEec
Q 012777 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293 (456)
Q Consensus 214 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~D 293 (456)
+++.. +..++||||++|++|.+ + .......++.|++.||.|||+++ |+||||||+|||++ ++.+||+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECC
T ss_pred eEEec-cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEE
Confidence 65544 56799999999999987 3 12345579999999999999999 99999999999999 99999999
Q ss_pred cCCcccccccccccCCCCcccCCCCcccccccccCC
Q 012777 294 FGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN 329 (456)
Q Consensus 294 fgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 329 (456)
||++... ..+.|||++.+
T Consensus 236 FG~a~~~------------------~~~~a~e~l~r 253 (282)
T 1zar_A 236 FPQSVEV------------------GEEGWREILER 253 (282)
T ss_dssp CTTCEET------------------TSTTHHHHHHH
T ss_pred CCCCeEC------------------CCCCHHHHHHH
Confidence 9998643 23678888754
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.5e-20 Score=155.15 Aligned_cols=106 Identities=32% Similarity=0.436 Sum_probs=97.6
Q ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccc
Q 012777 33 EAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVY 112 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~ 112 (456)
.+..|.||||+||..|+.++++.|++.|++++.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus 3 ~~~~~~~~l~~A~~~~~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~ 82 (123)
T 3aaa_C 3 LGSMCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVY 82 (123)
T ss_dssp ----CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHH
T ss_pred cccccchHHHHHHHcCCHHHHHHHHHcCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHH
Confidence 34668999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccchhhhhhhhcCCCCCCCcccccc
Q 012777 113 YKHHDVIKLLEEHGAKPSTAPMHVQN 138 (456)
Q Consensus 113 ~~~~~~~~~L~~~~~~~~~~~~~~~~ 138 (456)
.|+.+++++|++.|++++.++....+
T Consensus 83 ~~~~~~v~~Ll~~ga~~~~~~~~g~t 108 (123)
T 3aaa_C 83 EGHVSCVKLLLSKGADKTVKGPDGLT 108 (123)
T ss_dssp HTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence 99999999999999999887655443
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* | Back alignment and structure |
|---|
Probab=99.82 E-value=6.3e-20 Score=159.40 Aligned_cols=111 Identities=28% Similarity=0.365 Sum_probs=103.2
Q ss_pred CCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccc
Q 012777 29 ADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLA 108 (456)
Q Consensus 29 ~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~ 108 (456)
.....+.+|.||||+||..|+.+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||
T Consensus 34 ~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~ 113 (165)
T 3twr_A 34 NCRDIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLH 113 (165)
T ss_dssp TCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHH
T ss_pred CccccccCCCCHHHHHHHcChHHHHHHHHhcCCCCCccCCCCCCHHHHHHHcCcHHHHHHHHhCCCCCCCcCCCCCCHHH
Confidence 33455677999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchhhhhhhhcCCCCCCCccccccc
Q 012777 109 DAVYYKHHDVIKLLEEHGAKPSTAPMHVQNA 139 (456)
Q Consensus 109 ~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 139 (456)
+|+..|+.+++++|+++|++++.++....++
T Consensus 114 ~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~ 144 (165)
T 3twr_A 114 EAAAKGKYEICKLLLQHGADPTKKNRDGNTP 144 (165)
T ss_dssp HHHHTTCHHHHHHHHHTTCCTTCCCTTSCCT
T ss_pred HHHHcCCHHHHHHHHHcCCCCcccCCCCCCh
Confidence 9999999999999999999998887665544
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.81 E-value=3.3e-20 Score=159.26 Aligned_cols=105 Identities=30% Similarity=0.377 Sum_probs=99.9
Q ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccc
Q 012777 33 EAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVY 112 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~ 112 (456)
.+.+|.||||+||..|+.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus 30 ~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~ 109 (153)
T 1awc_B 30 TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATE 109 (153)
T ss_dssp CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHH
T ss_pred cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHHcCCCCCCCCCCCCCHHHHHHH
Confidence 47789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccchhhhhhhhcCCCCCCCccccc
Q 012777 113 YKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 113 ~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
.|+.+++++|++.|++++.++....
T Consensus 110 ~~~~~~v~~Ll~~ga~~~~~~~~g~ 134 (153)
T 1awc_B 110 HNHQEVVELLIKYGADVHTQSKFCK 134 (153)
T ss_dssp TTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred cCCHHHHHHHHHcCCCccccCCCCC
Confidence 9999999999999999988765543
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 | Back alignment and structure |
|---|
Probab=99.81 E-value=1.9e-20 Score=157.54 Aligned_cols=109 Identities=23% Similarity=0.277 Sum_probs=99.2
Q ss_pred CCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCC-CCc
Q 012777 27 DDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRW-GST 105 (456)
Q Consensus 27 ~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~-g~t 105 (456)
++++. .+.+|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+. |+.+++++|+++|++++.+|.. |.|
T Consensus 3 ~~~~~-~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t 80 (136)
T 1d9s_A 3 PGIHM-LGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTR 80 (136)
T ss_dssp CCCSC-CCCCCSCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBC
T ss_pred CCccC-CCCCCccHHHHHHHcCCHHHHHHHHHcCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCC
Confidence 44443 45679999999999999999999999999999999999999999999 9999999999999999999999 999
Q ss_pred ccccccccccchhhhhhhhcCCCCCCCccccc
Q 012777 106 PLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 106 ~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
|||+|+..|+.+++++|++.|++++.++....
T Consensus 81 ~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~ 112 (136)
T 1d9s_A 81 PVHDAAREGFLDTLVVLHRAGARLDVCDAWGR 112 (136)
T ss_dssp HHHHHHHHTCHHHHHHHHHTCCCCCCCSSSSS
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCCCccCCCCC
Confidence 99999999999999999999999988765543
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A | Back alignment and structure |
|---|
Probab=99.81 E-value=7.1e-20 Score=161.45 Aligned_cols=109 Identities=25% Similarity=0.312 Sum_probs=100.8
Q ss_pred CCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccc
Q 012777 30 DGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLAD 109 (456)
Q Consensus 30 ~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~ 109 (456)
....+.+|.||||+||..|+.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+
T Consensus 32 ~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~ 111 (179)
T 3f6q_A 32 LNQGDDHGFSPLHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHY 111 (179)
T ss_dssp TTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred ccccCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHH
Confidence 34567789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccchhhhhhhhcCCCCCCCcccccc
Q 012777 110 AVYYKHHDVIKLLEEHGAKPSTAPMHVQN 138 (456)
Q Consensus 110 A~~~~~~~~~~~L~~~~~~~~~~~~~~~~ 138 (456)
|+..|+.+++++|++.|++++.++....+
T Consensus 112 A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 140 (179)
T 3f6q_A 112 ACFWGQDQVAEDLVANGALVSICNKYGEM 140 (179)
T ss_dssp HHHTTCHHHHHHHHHTTCCSSBCCTTSCC
T ss_pred HHHcCCHHHHHHHHHCCCCcchhccCCCC
Confidence 99999999999999999998877655443
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A | Back alignment and structure |
|---|
Probab=99.81 E-value=6e-20 Score=160.70 Aligned_cols=114 Identities=28% Similarity=0.360 Sum_probs=104.8
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCC
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRW 102 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 102 (456)
++.+++.....+.+|.||||+||..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..
T Consensus 22 l~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~ 101 (172)
T 3v30_A 22 LRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYDWN 101 (172)
T ss_dssp HTTCSGGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTT
T ss_pred HHcCcccccCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCchhhcccCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCC
Confidence 34455555667789999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccchhhhhhhhcCCCCCCCcccc
Q 012777 103 GSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHV 136 (456)
Q Consensus 103 g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~ 136 (456)
|.||||+|+..|+.+++++|++.|++++.++...
T Consensus 102 g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 135 (172)
T 3v30_A 102 GGTPLLYAVRGNHVKCVEALLARGADLTTEADSG 135 (172)
T ss_dssp SCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred CCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCC
Confidence 9999999999999999999999999998775544
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C | Back alignment and structure |
|---|
Probab=99.80 E-value=4.8e-20 Score=155.01 Aligned_cols=107 Identities=31% Similarity=0.439 Sum_probs=94.1
Q ss_pred CCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 31 GSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 31 ~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
......|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|
T Consensus 8 ~~~~~~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A 87 (136)
T 2jab_A 8 HHHGSDLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLA 87 (136)
T ss_dssp ----CHHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHH
T ss_pred CcccccccHHHHHHHHhCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHH
Confidence 34456689999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccchhhhhhhhcCCCCCCCccccc
Q 012777 111 VYYKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
+..|+.+++++|+++|++++.++....
T Consensus 88 ~~~~~~~~v~~Ll~~g~~~~~~~~~g~ 114 (136)
T 2jab_A 88 AFIGHLEIAEVLLKHGADVNAQDKFGK 114 (136)
T ss_dssp HHHTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred HHcCCHHHHHHHHHcCCCCcCcCCCCC
Confidence 999999999999999999887765443
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.4e-19 Score=146.33 Aligned_cols=104 Identities=29% Similarity=0.425 Sum_probs=89.9
Q ss_pred CCCCCCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCC
Q 012777 19 PDQPLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDP 98 (456)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~ 98 (456)
+...-+..+......+.+|.|+||+||..|+.+++++|++.|+++|.+|..|.||||+||..|+.+++++|+++|++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~ 85 (110)
T 2zgd_A 6 HHHHSSGLVPRGSHMGSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXA 85 (110)
T ss_dssp CCCCCCC---------CCHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTC
T ss_pred cCCCCcCCCCcccccCCccchHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccc
Confidence 34444555666667788999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcccccccccccchhhhhh
Q 012777 99 EDRWGSTPLADAVYYKHHDVIKLL 122 (456)
Q Consensus 99 ~~~~g~t~l~~A~~~~~~~~~~~L 122 (456)
+|..|.||+|+|+..|+.+++++|
T Consensus 86 ~d~~g~tpl~~A~~~~~~~~~~~L 109 (110)
T 2zgd_A 86 QDKFGKTAFDISIDNGNEDLAEIL 109 (110)
T ss_dssp CCTTSCCHHHHHHHHTCHHHHHHH
T ss_pred cccCCCcHHHHHHHcCCHHHHHHh
Confidence 999999999999999999999987
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C | Back alignment and structure |
|---|
Probab=99.79 E-value=1.8e-19 Score=151.43 Aligned_cols=101 Identities=28% Similarity=0.419 Sum_probs=93.7
Q ss_pred CCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCC
Q 012777 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGS 104 (456)
Q Consensus 25 ~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 104 (456)
.+.+++. .+.+|.||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 36 ~g~~~~~-~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~ 114 (136)
T 2jab_A 36 NGADVNA-KDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQDKFGK 114 (136)
T ss_dssp TTCCTTC-CCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred cCCCCCC-cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcCcCCCCC
Confidence 3445443 467899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccchhhhhhhhcC
Q 012777 105 TPLADAVYYKHHDVIKLLEEHG 126 (456)
Q Consensus 105 t~l~~A~~~~~~~~~~~L~~~~ 126 (456)
||+|+|+..|+.+++++|+++|
T Consensus 115 tpl~~A~~~~~~~~~~~Ll~~G 136 (136)
T 2jab_A 115 TAFDISIGNGNEDLAEILQKLN 136 (136)
T ss_dssp CHHHHHHHTTCHHHHHHHHHC-
T ss_pred CHHHHHHHCCCHHHHHHHHHcC
Confidence 9999999999999999999875
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.5e-20 Score=159.03 Aligned_cols=110 Identities=25% Similarity=0.274 Sum_probs=72.5
Q ss_pred CCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcch-HHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCC
Q 012777 26 DDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRT-ALHVAACQGRTDVVRLLLSRGADVDPEDRWGS 104 (456)
Q Consensus 26 ~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T-~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 104 (456)
+.+++. .+.+|+||||+|+ .|+.+++++|+++|+++|.+|..|+| |||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 35 g~~~~~-~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~ 112 (156)
T 1bi7_B 35 GANPNA-PNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGR 112 (156)
T ss_dssp TCCTTC-CCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTCC
T ss_pred CCCCCC-CCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHHCCCHHHHHHHHHcCCCCcccCCCCC
Confidence 344433 3456777777764 77777777777777777777777777 77777777777777777777777777777777
Q ss_pred cccccccccccchhhhhhhhcCCCCCCCccccc
Q 012777 105 TPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 105 t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
||||+|+..|+.+++++|+++|++++.++....
T Consensus 113 tpl~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 145 (156)
T 1bi7_B 113 LPVDLAEELGHRDVARYLRAAAGGTRGSNHARI 145 (156)
T ss_dssp CHHHHHHHHTCHHHHHHHSSCC-----------
T ss_pred CHHHHHHHhCHHHHHHHHHHcCCCCCccCcCcC
Confidence 777777777777777777777777766654443
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.5e-19 Score=155.54 Aligned_cols=112 Identities=31% Similarity=0.434 Sum_probs=101.8
Q ss_pred CCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCC
Q 012777 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGS 104 (456)
Q Consensus 25 ~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 104 (456)
.+.+++ ..+.+|.||||+||..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 36 ~g~~~~-~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~ 114 (169)
T 2y1l_E 36 NGADVN-AEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGH 114 (169)
T ss_dssp TTCCTT-CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred CCCCCC-CCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCC
Confidence 344444 3467899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccchhhhhhhhcCCCCCCCccccc
Q 012777 105 TPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 105 t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
||||+|+..|+.+++++|++.|++++.++....
T Consensus 115 t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~ 147 (169)
T 2y1l_E 115 TPLHLAAMFGHLEIVEVLLKNGADVNAQDKFGK 147 (169)
T ss_dssp CHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred CHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCC
Confidence 999999999999999999999999887765443
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 | Back alignment and structure |
|---|
Probab=99.79 E-value=5.7e-20 Score=154.55 Aligned_cols=102 Identities=26% Similarity=0.295 Sum_probs=95.3
Q ss_pred CCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccC-cchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCC
Q 012777 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDID-KRTALHVAACQGRTDVVRLLLSRGADVDPEDRWG 103 (456)
Q Consensus 25 ~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~-g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 103 (456)
.+.+++. .+.+|+||||+||. |+.+++++|+++|++++.+|.. |+||||+|+..|+.+++++|+++|++++.+|..|
T Consensus 34 ~g~~~~~-~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g 111 (136)
T 1d9s_A 34 AGADPNA-LNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDAWG 111 (136)
T ss_dssp TTCCTTC-CCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBCHHHHHHHHTCHHHHHHHHHTCCCCCCCSSSS
T ss_pred cCCCcCC-cCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCC
Confidence 3445443 46789999999999 9999999999999999999999 9999999999999999999999999999999999
Q ss_pred CcccccccccccchhhhhhhhcCCC
Q 012777 104 STPLADAVYYKHHDVIKLLEEHGAK 128 (456)
Q Consensus 104 ~t~l~~A~~~~~~~~~~~L~~~~~~ 128 (456)
.||+|+|+..++.+++++|+++|++
T Consensus 112 ~tpl~~A~~~~~~~~~~~Ll~~Gad 136 (136)
T 1d9s_A 112 RLPVDLAEEQGHRDIARYLHAATGD 136 (136)
T ss_dssp SCHHHHHHHHTCHHHHHHHHHHHCC
T ss_pred CCHHHHHHHcCCHHHHHHHHHcCCC
Confidence 9999999999999999999999985
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.78 E-value=3.2e-19 Score=147.07 Aligned_cols=100 Identities=43% Similarity=0.608 Sum_probs=73.3
Q ss_pred CCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccccccccc
Q 012777 36 DPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKH 115 (456)
Q Consensus 36 ~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~ 115 (456)
+|+||||+||..|+.+++++|++.|++++..|..|.||||+|+..|+.+++++|+++|++++.+|..|.||+|+|+..|+
T Consensus 1 ~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~ 80 (126)
T 1n0r_A 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH 80 (126)
T ss_dssp CCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred CCccHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCh
Confidence 46777777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred chhhhhhhhcCCCCCCCccc
Q 012777 116 HDVIKLLEEHGAKPSTAPMH 135 (456)
Q Consensus 116 ~~~~~~L~~~~~~~~~~~~~ 135 (456)
.+++++|++.|++++.++..
T Consensus 81 ~~~~~~Ll~~g~~~~~~~~~ 100 (126)
T 1n0r_A 81 LEVVKLLLEAGADVNAKDKN 100 (126)
T ss_dssp HHHHHHHHHTTCCTTCCCTT
T ss_pred HHHHHHHHHcCCCCcccCCC
Confidence 77777777777776655443
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A | Back alignment and structure |
|---|
Probab=99.78 E-value=4e-19 Score=154.60 Aligned_cols=105 Identities=32% Similarity=0.450 Sum_probs=97.8
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccccc
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAV 111 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~ 111 (456)
..+.+|.||||+||..|+.+++++|++.|++++..|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+
T Consensus 31 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~ 110 (167)
T 3v31_A 31 HTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAV 110 (167)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCcCCCCCCCHHHHHH
Confidence 45678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchhhhhhhhcCCCCCCCcccc
Q 012777 112 YYKHHDVIKLLEEHGAKPSTAPMHV 136 (456)
Q Consensus 112 ~~~~~~~~~~L~~~~~~~~~~~~~~ 136 (456)
..|+.+++++|++.|++++.++...
T Consensus 111 ~~~~~~~v~~Ll~~g~~~~~~~~~g 135 (167)
T 3v31_A 111 HGNHVKCVKMLLESGADPTIETDSG 135 (167)
T ss_dssp HTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred HcCCHHHHHHHHHcCCCCCCcCCCC
Confidence 9999999999999999988775544
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.3e-19 Score=163.15 Aligned_cols=102 Identities=27% Similarity=0.375 Sum_probs=64.9
Q ss_pred CCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 31 GSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 31 ~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
...+.+|.||||+||..|+.+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|++++.+|..|.||||+|
T Consensus 15 ~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~tpLh~A 94 (229)
T 2vge_A 15 RRARLNPLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCA 94 (229)
T ss_dssp CCTTSCHHHHHHHHHHHTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHH
T ss_pred cccccchhHHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Confidence 34455566666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred cccccchhhhhhhhcCCCCCCC
Q 012777 111 VYYKHHDVIKLLEEHGAKPSTA 132 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~~~~~~~ 132 (456)
+..|+.+++++|++.|++++..
T Consensus 95 ~~~g~~~~v~~Ll~~ga~~~~~ 116 (229)
T 2vge_A 95 ASCNDTVICMALVQHGAAIFAT 116 (229)
T ss_dssp HHTTCHHHHHHHHTTTCCTTCC
T ss_pred HHcCCHHHHHHHHHcCCCcccc
Confidence 6666666666666666666554
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} | Back alignment and structure |
|---|
Probab=99.78 E-value=5.1e-19 Score=157.75 Aligned_cols=105 Identities=28% Similarity=0.399 Sum_probs=90.6
Q ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccc
Q 012777 33 EAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVY 112 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~ 112 (456)
.+.+|.||||+||..|+.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus 64 ~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~ 143 (192)
T 2rfm_A 64 KDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASK 143 (192)
T ss_dssp CCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHH
T ss_pred ccccCccHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Confidence 45678899999999999999999998888888888889999999999999999999998899998888889999999998
Q ss_pred cccchhhhhhhhcCCCCCCCccccc
Q 012777 113 YKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 113 ~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
.|+.+++++|++.|++++.++....
T Consensus 144 ~~~~~~v~~Ll~~ga~~~~~~~~g~ 168 (192)
T 2rfm_A 144 YGRSEIVKKLLELGADISARDLTGL 168 (192)
T ss_dssp HTCHHHHHHHHHTTCCTTCBCTTSC
T ss_pred cCCHHHHHHHHHCCCCCCCcCCCCC
Confidence 8888999999888888877654443
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.6e-19 Score=160.44 Aligned_cols=106 Identities=16% Similarity=0.134 Sum_probs=95.5
Q ss_pred CCCCchHHHHHHHcCCH----HHHHHHHHcCCCCCccccCcchHHHHHHHcCC------HHHHHHHHhCCCCCCCCCCCC
Q 012777 34 AIDPRVRLMYMANEGDL----DGIKELLDSGTDVNFRDIDKRTALHVAACQGR------TDVVRLLLSRGADVDPEDRWG 103 (456)
Q Consensus 34 ~~~g~t~Lh~a~~~~~~----~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~------~~~v~~Ll~~ga~~~~~~~~g 103 (456)
+..|+||||+||..|+. +++++|+++|+|+|.+|.+|+||||+|+..|+ .+++++|+++|+++|.+|..|
T Consensus 35 ~~~g~T~Lh~A~~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g 114 (186)
T 3t8k_A 35 SVLKSNILYDVLRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITALYKPY 114 (186)
T ss_dssp HHHTTTHHHHHTTCSCHHHHHHHHHHHHHTTCCSSCCCTTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCSSSCBGGG
T ss_pred ccCCCCHHHHHHHcCCcchHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCCCccCCCc
Confidence 36799999999999975 59999999999999999999999999999987 688999999999999999999
Q ss_pred C-cccccccccc-----cchhhhhhhh-cCCCCCCCccccccc
Q 012777 104 S-TPLADAVYYK-----HHDVIKLLEE-HGAKPSTAPMHVQNA 139 (456)
Q Consensus 104 ~-t~l~~A~~~~-----~~~~~~~L~~-~~~~~~~~~~~~~~~ 139 (456)
. ||||+|+..+ +.+++++|+. .|++++.++....++
T Consensus 115 ~ttpLh~A~~~~~~~~~~~~iv~~Ll~~~gad~~~~d~~G~Tp 157 (186)
T 3t8k_A 115 KIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTA 157 (186)
T ss_dssp TBCTTGGGGGCCSCHHHHHHHHHHHHTSTTCCTTCCCTTSCCH
T ss_pred CchHHHHHHHcCCChhhHHHHHHHHHHhcCCCCcccCCCCCCH
Confidence 9 9999999944 4569999999 999999987766543
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.77 E-value=7.3e-19 Score=144.87 Aligned_cols=96 Identities=45% Similarity=0.625 Sum_probs=93.2
Q ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccc
Q 012777 33 EAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVY 112 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~ 112 (456)
.+.+|.||||+|+..++.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||+++|+.
T Consensus 31 ~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~ 110 (126)
T 1n0r_A 31 KDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAAR 110 (126)
T ss_dssp CCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHH
T ss_pred cCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCcccCCCCCCHHHHHHH
Confidence 46789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccchhhhhhhhcCCC
Q 012777 113 YKHHDVIKLLEEHGAK 128 (456)
Q Consensus 113 ~~~~~~~~~L~~~~~~ 128 (456)
.|+.+++++|+++|++
T Consensus 111 ~~~~~~~~~Ll~~Gad 126 (126)
T 1n0r_A 111 NGHLEVVKLLLEAGAY 126 (126)
T ss_dssp TTCHHHHHHHHHHTCC
T ss_pred cCcHHHHHHHHHcCCC
Confidence 9999999999999985
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 | Back alignment and structure |
|---|
Probab=99.77 E-value=5.5e-19 Score=167.33 Aligned_cols=98 Identities=20% Similarity=0.217 Sum_probs=94.2
Q ss_pred CCCCCchHHHHHHHc---CCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccc
Q 012777 33 EAIDPRVRLMYMANE---GDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLAD 109 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~---~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~ 109 (456)
.+.+|.||||+||.. |+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+
T Consensus 165 ~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~g~tpL~~ 244 (278)
T 1dcq_A 165 GHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDI 244 (278)
T ss_dssp CSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred cccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCccCCCCCHHHH
Confidence 367899999999999 89999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccchhhhhhhhcCCCCC
Q 012777 110 AVYYKHHDVIKLLEEHGAKPS 130 (456)
Q Consensus 110 A~~~~~~~~~~~L~~~~~~~~ 130 (456)
|+..|+.+++++|+++|++..
T Consensus 245 A~~~~~~~~v~~Ll~~ga~~~ 265 (278)
T 1dcq_A 245 AKRLKHEHCEELLTQALSGRF 265 (278)
T ss_dssp HHHTTCHHHHHHHHHHHTTCC
T ss_pred HHHcCCHHHHHHHHHcCCCCC
Confidence 999999999999999998743
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=6.8e-19 Score=161.85 Aligned_cols=109 Identities=18% Similarity=0.134 Sum_probs=100.8
Q ss_pred CCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCC-CCCC
Q 012777 26 DDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED-RWGS 104 (456)
Q Consensus 26 ~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~-~~g~ 104 (456)
+.+++. .+.+|+||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.++ ..|.
T Consensus 44 g~~~~~-~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~ 122 (229)
T 2vge_A 44 MNDPSQ-PNEEGITALHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSDGA 122 (229)
T ss_dssp SSCTTC-CCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCSSTTC
T ss_pred CCCCCC-CCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCCCCC
Confidence 444443 56789999999999999999999999999999999999999999999999999999999999999987 5999
Q ss_pred cccccc--cccccchhhhhhhhcCCCCCCCccc
Q 012777 105 TPLADA--VYYKHHDVIKLLEEHGAKPSTAPMH 135 (456)
Q Consensus 105 t~l~~A--~~~~~~~~~~~L~~~~~~~~~~~~~ 135 (456)
||||+| +..|+.+++++|++.|++++..+..
T Consensus 123 tpL~~A~a~~~~~~~~v~~Ll~~ga~~~~~~~~ 155 (229)
T 2vge_A 123 TAFEKCDPYREGYADCATYLADVEQSMGLMNSG 155 (229)
T ss_dssp CTGGGCCTTSTTHHHHHHHHHHHHHHTTTSGGG
T ss_pred CHHHHHHHHhcChHHHHHHHHHcCCCcccccCC
Confidence 999999 9999999999999999999887644
|
| >4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=5.9e-19 Score=166.35 Aligned_cols=118 Identities=30% Similarity=0.332 Sum_probs=82.4
Q ss_pred CCCCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcC---------------------------------CCCCccc
Q 012777 21 QPLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSG---------------------------------TDVNFRD 67 (456)
Q Consensus 21 ~~~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g---------------------------------~~in~~d 67 (456)
..++.+.|++. .|.+|+||||+||..|+.+++++|++.| +++|.+|
T Consensus 71 ~Ll~~Gadvn~-~d~~G~TpLh~A~~~g~~~~v~~Ll~~~a~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d 149 (269)
T 4b93_B 71 KVPASGLGVNV-TSQDGSSPLHVAALHGRADLIPLLLKHGANAGARNADQAVPLHLACQQGHFQVVKCLLDSNAKPNKKD 149 (269)
T ss_dssp ----CCCCTTC-CCTTSCCHHHHHHHTTCTTHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCC
T ss_pred HHHHCCCCCCC-cCCCCCCHHHHHHHcCcHHHHHHHHhcCCCcCccCCCCCCccccccccChHHHHHHHHHCCCCCCCCC
Confidence 35566677654 4577888888888888877777666555 4556666
Q ss_pred cCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccccchhhhhhhhcCCCCCCCccccccc
Q 012777 68 IDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNA 139 (456)
Q Consensus 68 ~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 139 (456)
..|+||||+||..|+.+++++|+++|+++|.++..|.||||+|+..|+.++|++|+++|++++.++....++
T Consensus 150 ~~g~TpL~~A~~~g~~~~v~~Ll~~gadvn~~~~~g~t~Lh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~Tp 221 (269)
T 4b93_B 150 LSGNTPLIYACSGGHHELVALLLQHGASINASNNKGNTALHEAVIEKHVFVVELLLLHGASVQVLNKRQRTA 221 (269)
T ss_dssp TTCCCHHHHHHHTTCGGGHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCS
T ss_pred CCCCCHHHHHHHCCCHHHHHHHHHCCCCCCccccCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCH
Confidence 677777777777777777777777777777777777777777777777777777777777777665554443
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.7e-19 Score=155.34 Aligned_cols=107 Identities=25% Similarity=0.304 Sum_probs=97.7
Q ss_pred CCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCc-cccc
Q 012777 31 GSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGST-PLAD 109 (456)
Q Consensus 31 ~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t-~l~~ 109 (456)
...+.+|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+ .|+.+++++|+++|++++.+|..|.| |||+
T Consensus 6 ~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~ 84 (156)
T 1bi7_B 6 GSSMEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHD 84 (156)
T ss_dssp ----CCSTTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHH
T ss_pred cCCCccchHHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHH
Confidence 345678999999999999999999999999999999999999999996 99999999999999999999999999 9999
Q ss_pred ccccccchhhhhhhhcCCCCCCCcccccc
Q 012777 110 AVYYKHHDVIKLLEEHGAKPSTAPMHVQN 138 (456)
Q Consensus 110 A~~~~~~~~~~~L~~~~~~~~~~~~~~~~ 138 (456)
|+..|+.+++++|+++|++++.++....+
T Consensus 85 A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t 113 (156)
T 1bi7_B 85 AAREGFLDTLVVLHRAGARLDVRDAWGRL 113 (156)
T ss_dssp HHHHTCHHHHHHHHHHTCCSSCCCTTCCC
T ss_pred HHHCCCHHHHHHHHHcCCCCcccCCCCCC
Confidence 99999999999999999999987655443
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.2e-18 Score=153.54 Aligned_cols=110 Identities=21% Similarity=0.234 Sum_probs=101.9
Q ss_pred CCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCC
Q 012777 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGS 104 (456)
Q Consensus 25 ~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 104 (456)
.+.+++. .+.+|.||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 61 ~g~~~~~-~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 139 (179)
T 3f6q_A 61 RGARINV-MNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGE 139 (179)
T ss_dssp TTCCTTC-CCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSSBCCTTSC
T ss_pred cCCCCCC-cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcchhccCCC
Confidence 3444443 467899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccchhhhhhhhcCCCCCCCccc
Q 012777 105 TPLADAVYYKHHDVIKLLEEHGAKPSTAPMH 135 (456)
Q Consensus 105 t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~ 135 (456)
||+++|+..++.+++++|++.|++++..+..
T Consensus 140 tpl~~A~~~~~~~~~~~L~~~g~~~~~~~~~ 170 (179)
T 3f6q_A 140 MPVDKAKAPLRELLRERAEKMGQNLNRIPYK 170 (179)
T ss_dssp CGGGGSCHHHHHHHHHHHHHTTCCCSCBCCC
T ss_pred CcHHHHHHHHHHHHHHHHHHhhcCcccCCcc
Confidence 9999999999999999999999999877654
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A | Back alignment and structure |
|---|
Probab=99.77 E-value=8.1e-19 Score=151.72 Aligned_cols=110 Identities=26% Similarity=0.279 Sum_probs=97.3
Q ss_pred CCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCC
Q 012777 24 PADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWG 103 (456)
Q Consensus 24 ~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 103 (456)
+.+.+.+ ..+.+|+||||+|+. |+.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|
T Consensus 26 ~~~~~~~-~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g 103 (162)
T 1ihb_A 26 QNNVNVN-AQNGFGRTALQVMKL-GNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEG 103 (162)
T ss_dssp TSCCCTT-CCCTTSCCHHHHCCS-SCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred hCCCCcc-ccCccCccHHHHHHc-CcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCC
Confidence 4455554 346779999999999 99999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccchhhhhhhhcCCC-CCCCccc
Q 012777 104 STPLADAVYYKHHDVIKLLEEHGAK-PSTAPMH 135 (456)
Q Consensus 104 ~t~l~~A~~~~~~~~~~~L~~~~~~-~~~~~~~ 135 (456)
.||||+|+..|+.+++++|++.|++ ++..+..
T Consensus 104 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~ 136 (162)
T 1ihb_A 104 NLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHK 136 (162)
T ss_dssp CCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTT
T ss_pred CCHHHHHHHcCCHHHHHHHHHccCCCCCCcCCC
Confidence 9999999999999999999999987 4555443
|
| >4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=9.9e-19 Score=164.78 Aligned_cols=110 Identities=27% Similarity=0.333 Sum_probs=67.5
Q ss_pred CCCCCCCCCCchHHHHHHHcCCH-HHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcc
Q 012777 28 DADGSEAIDPRVRLMYMANEGDL-DGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTP 106 (456)
Q Consensus 28 ~~~~~~~~~g~t~Lh~a~~~~~~-~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~ 106 (456)
+.....+.+|.||||.|+..+.. .+++.|++.|+|+|.+|.+|+||||+||..|+.+++++|++.|++++.++..|.||
T Consensus 43 ~~~~~~~~~~~t~L~~a~~~~~~~~~v~~Ll~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~~a~~~~~~~~g~t~ 122 (269)
T 4b93_B 43 DTVSAADPEFCHPLCQCPKCAPAQKRLAKVPASGLGVNVTSQDGSSPLHVAALHGRADLIPLLLKHGANAGARNADQAVP 122 (269)
T ss_dssp --------------------------------CCCCTTCCCTTSCCHHHHHHHTTCTTHHHHHHHTTCCTTCCCTTCCCH
T ss_pred ccccccCccCCCHHHHHHHhCCHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHhcCCCcCccCCCCCCc
Confidence 34455678899999999998876 48899999999999999999999999999999999999999888888888788888
Q ss_pred cccccccccchhhhhhhhcCCCCCCCccccc
Q 012777 107 LADAVYYKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 107 l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
+++|+..++.+++++|++.|++++.++....
T Consensus 123 l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~ 153 (269)
T 4b93_B 123 LHLACQQGHFQVVKCLLDSNAKPNKKDLSGN 153 (269)
T ss_dssp HHHHHHHTCHHHHHHHHHTTCCSCCCCTTCC
T ss_pred cccccccChHHHHHHHHHCCCCCCCCCCCCC
Confidence 8777777777777777777777777655443
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B | Back alignment and structure |
|---|
Probab=99.77 E-value=4.3e-19 Score=164.21 Aligned_cols=114 Identities=26% Similarity=0.323 Sum_probs=91.2
Q ss_pred CCCCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCC
Q 012777 21 QPLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100 (456)
Q Consensus 21 ~~~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~ 100 (456)
..++.+.+++. +..|.||||.||..|+.++++.|++.|+++|.+|..|.||||+||..|+.+++++|+++|++++.+|
T Consensus 23 ~ll~~g~~~~~--~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d 100 (239)
T 1ycs_B 23 ERIAHGMRVKF--NPLPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAAD 100 (239)
T ss_dssp ----------------CHHHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCC
T ss_pred HHhccCCCccc--CchhhHHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccC
Confidence 44556666654 3568999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcccccccccccchhhhhhhhcCCCCCCCcccc
Q 012777 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHV 136 (456)
Q Consensus 101 ~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~ 136 (456)
..|.||||+|+..|+.+++++|+++|++++..+...
T Consensus 101 ~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~ 136 (239)
T 1ycs_B 101 SDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSD 136 (239)
T ss_dssp TTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCSSS
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHcCCCcceecCCC
Confidence 999999999999999999999999999988765443
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A | Back alignment and structure |
|---|
Probab=99.76 E-value=8.7e-19 Score=151.51 Aligned_cols=102 Identities=28% Similarity=0.379 Sum_probs=93.7
Q ss_pred CCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCC-CCCCCCCCC
Q 012777 26 DDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGAD-VDPEDRWGS 104 (456)
Q Consensus 26 ~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~-~~~~~~~g~ 104 (456)
+.+.+ ..+.+|.||||+|+..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++ ++.+|..|.
T Consensus 60 g~~~~-~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~ 138 (162)
T 1ihb_A 60 GANPD-LKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGD 138 (162)
T ss_dssp TCCTT-CCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSC
T ss_pred CCCCC-CCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHccCCCCCCcCCCCC
Confidence 44444 3467899999999999999999999999999999999999999999999999999999999998 699999999
Q ss_pred cccccccccccchhhhhhhhcCCC
Q 012777 105 TPLADAVYYKHHDVIKLLEEHGAK 128 (456)
Q Consensus 105 t~l~~A~~~~~~~~~~~L~~~~~~ 128 (456)
||+|+|+..|+.+++++|+++||+
T Consensus 139 t~l~~A~~~~~~~~~~~Ll~~GAd 162 (162)
T 1ihb_A 139 TACDLARLYGRNEVVSLMQANGAG 162 (162)
T ss_dssp CHHHHHHHTTCHHHHHHHHHTC--
T ss_pred cHHHHHHHcCCHHHHHHHHHhCCC
Confidence 999999999999999999999985
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-18 Score=164.70 Aligned_cols=108 Identities=29% Similarity=0.333 Sum_probs=98.1
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccC-cchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDID-KRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~-g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
..+.+|.||||+||..|+.+++++|+++|++++.++.. |+||||+|+..|+.+++++|+++|++++.+|..|.||||+|
T Consensus 153 ~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~A 232 (282)
T 1oy3_D 153 AENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSA 232 (282)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred CcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCcccccCCCCHHHHH
Confidence 45788999999999999999999999999999999855 99999999999999999999999999999999999999999
Q ss_pred cccccchhhhhhhhcCCCCCCCccccccc
Q 012777 111 VYYKHHDVIKLLEEHGAKPSTAPMHVQNA 139 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 139 (456)
+..|+.+++++|+++|++++.++....++
T Consensus 233 ~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp 261 (282)
T 1oy3_D 233 LLRPNPILARLLRAHGAPEPEDGGDKLSP 261 (282)
T ss_dssp HTSSCHHHHHHHHHTTCCCCCCC------
T ss_pred HHcCCcHHHHHHHHcCCCcCcCCCccccc
Confidence 99999999999999999999887766554
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A | Back alignment and structure |
|---|
Probab=99.76 E-value=4.6e-19 Score=161.86 Aligned_cols=105 Identities=27% Similarity=0.355 Sum_probs=99.1
Q ss_pred CCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhC-CCCCCCCCCCCCcccccccc
Q 012777 34 AIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSR-GADVDPEDRWGSTPLADAVY 112 (456)
Q Consensus 34 ~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~-ga~~~~~~~~g~t~l~~A~~ 112 (456)
+.+|.||||+||..|+.++++.|++.|+++|.+|..|+||||+||..|+.+++++|+++ |++++.+|..|.||||+|+.
T Consensus 70 ~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~ 149 (222)
T 3ehr_A 70 AESIDNPLHEAAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAW 149 (222)
T ss_dssp EEEESCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHH
T ss_pred ccccccccccccccCcHHHHHHHHhCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHH
Confidence 44678999999999999999999999999999999999999999999999999999998 99999999999999999999
Q ss_pred cccchhhhhhhhcCCCCCCCcccccc
Q 012777 113 YKHHDVIKLLEEHGAKPSTAPMHVQN 138 (456)
Q Consensus 113 ~~~~~~~~~L~~~~~~~~~~~~~~~~ 138 (456)
.|+.+++++|+..|++++.++....+
T Consensus 150 ~~~~~~v~~Ll~~ga~~~~~~~~g~t 175 (222)
T 3ehr_A 150 KGYADIVQLLLAKGARTDLRNIEKKL 175 (222)
T ss_dssp HTCHHHHHHHHHHTCCSCCCCTTSCC
T ss_pred cCCHHHHHHHHHcCCCCccccCCCCC
Confidence 99999999999999999887665544
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A | Back alignment and structure |
|---|
Probab=99.76 E-value=5.6e-19 Score=156.40 Aligned_cols=104 Identities=32% Similarity=0.345 Sum_probs=98.1
Q ss_pred CCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCC-CCCCcccccccc
Q 012777 34 AIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED-RWGSTPLADAVY 112 (456)
Q Consensus 34 ~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~-~~g~t~l~~A~~ 112 (456)
+.+|.||||+||..|+.++++.|++ |+++|.+|..|+||||+|+..|+.+++++|+++|++++.++ ..|.||||+|+.
T Consensus 41 ~~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~ 119 (183)
T 3deo_A 41 VSEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAG 119 (183)
T ss_dssp HHHHHHHHHHHHHTTCHHHHHHHTT-TSCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHh-cCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHh
Confidence 4579999999999999999999999 99999999999999999999999999999999999999998 889999999999
Q ss_pred cccchhhhhhhhcCCCCCCCcccccc
Q 012777 113 YKHHDVIKLLEEHGAKPSTAPMHVQN 138 (456)
Q Consensus 113 ~~~~~~~~~L~~~~~~~~~~~~~~~~ 138 (456)
.|+.+++++|+++|++++.++....+
T Consensus 120 ~~~~~~v~~Ll~~ga~~~~~d~~g~t 145 (183)
T 3deo_A 120 YVRPEVVEALVELGADIEVEDERGLT 145 (183)
T ss_dssp TTCHHHHHHHHHHTCCTTCCCTTSCC
T ss_pred cCcHHHHHHHHHcCCCCcCCCCCCCC
Confidence 99999999999999999887665543
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=5.1e-19 Score=169.50 Aligned_cols=115 Identities=25% Similarity=0.300 Sum_probs=104.0
Q ss_pred CCCCCCCCCC-----CCCCCchHHHHHHHc---CCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCC
Q 012777 23 LPADDDADGS-----EAIDPRVRLMYMANE---GDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGA 94 (456)
Q Consensus 23 ~~~~~~~~~~-----~~~~g~t~Lh~a~~~---~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga 94 (456)
+..++|++.. .+.+|+||||+||.. |+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|+
T Consensus 171 l~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~ga 250 (301)
T 2b0o_E 171 FANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRA 250 (301)
T ss_dssp HHTTCCTTSCEECSSSCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTC
T ss_pred HhcCCcccccCCCcccCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCC
Confidence 3455666554 678899999999997 89999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcccccccccccchhhhhhhhcCCCCCCCccccc
Q 012777 95 DVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 95 ~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
+++.+|..|.|||++|+..|+.+++++|++.|++.+..|++..
T Consensus 251 d~~~~d~~G~TpL~~A~~~~~~~iv~~Ll~~ga~~g~tpLh~A 293 (301)
T 2b0o_E 251 LVGTVNEAGETALDIARKKHHKECEELLEQAQAGTFAFPLHVD 293 (301)
T ss_dssp CCSCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHHTTSSCCC--
T ss_pred CCCCcCCCCCCHHHHHHHcCCHHHHHHHHHhcCCCCCChhHHH
Confidence 9999999999999999999999999999999998777766653
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=7.2e-19 Score=153.76 Aligned_cols=110 Identities=27% Similarity=0.270 Sum_probs=98.7
Q ss_pred CCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCc
Q 012777 26 DDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGST 105 (456)
Q Consensus 26 ~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 105 (456)
+.+.+. .+.+|.||||+||..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 59 g~~~~~-~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 137 (172)
T 3v30_A 59 GADPHI-LAKERESALSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGNHVKCVEALLARGADLTTEADSGYT 137 (172)
T ss_dssp TCCTTC-CCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred CCCchh-hcccCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCC
Confidence 344333 4577999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccchhhhhhhhcCCCCCCCcccc
Q 012777 106 PLADAVYYKHHDVIKLLEEHGAKPSTAPMHV 136 (456)
Q Consensus 106 ~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~ 136 (456)
|+++|+..|+.+++++|+++++++..++...
T Consensus 138 ~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~ 168 (172)
T 3v30_A 138 PMDLAVALGYRKVQQVIENHILKLFQSNLVP 168 (172)
T ss_dssp HHHHHHHHTCHHHHHHHHHHHHHHSCC----
T ss_pred HHHHHHHhCcHHHHHHHHHHHHHHhcccCCC
Confidence 9999999999999999999999877665443
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B | Back alignment and structure |
|---|
Probab=99.76 E-value=1.5e-18 Score=149.16 Aligned_cols=104 Identities=25% Similarity=0.262 Sum_probs=96.5
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccccc
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAV 111 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~ 111 (456)
..+.+|.||||+ |..|+.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+
T Consensus 31 ~~~~~g~t~L~~-~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~ 109 (156)
T 1bd8_A 31 ALNRFGKTALQV-MMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAV 109 (156)
T ss_dssp CCCTTSCCHHHH-SCTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHH
T ss_pred ccCCCCCcHHHH-HHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHH
Confidence 346779999999 9999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchhhhhhhhcCCCCCCCccccc
Q 012777 112 YYKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 112 ~~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
..|+.+++++|++. ++++.++....
T Consensus 110 ~~~~~~~v~~Ll~~-~~~~~~~~~g~ 134 (156)
T 1bd8_A 110 QEGHTAVVSFLAAE-SDLHRRDARGL 134 (156)
T ss_dssp HHTCHHHHHHHHTT-SCTTCCCTTSC
T ss_pred HhChHHHHHHHHhc-cCCCCcCCCCC
Confidence 99999999999988 88877655443
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B | Back alignment and structure |
|---|
Probab=99.75 E-value=1.6e-18 Score=160.27 Aligned_cols=110 Identities=22% Similarity=0.146 Sum_probs=100.7
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCC
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRW 102 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 102 (456)
++.++|++. .+.+|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.++..
T Consensus 57 l~~g~~~~~-~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 135 (239)
T 1ycs_B 57 IYEVDDPSL-PNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYS 135 (239)
T ss_dssp TSTTSSCCC-CCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCSS
T ss_pred HHcCCCCCC-cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcceecCC
Confidence 455565554 4678999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred CC-cccccc--cccccchhhhhhhhcCCCCCCCc
Q 012777 103 GS-TPLADA--VYYKHHDVIKLLEEHGAKPSTAP 133 (456)
Q Consensus 103 g~-t~l~~A--~~~~~~~~~~~L~~~~~~~~~~~ 133 (456)
|. ||+|+| +..|+.+++++|+..|++++..+
T Consensus 136 ~~~t~l~~a~~~~~g~~~~~~~Ll~~~a~~~~~~ 169 (239)
T 1ycs_B 136 DMQTAADKCEEMEEGYTQCSQFLYGVQEKMGIMN 169 (239)
T ss_dssp SCCCHHHHCCSSSTTCCCHHHHHHHHHHHTTTTG
T ss_pred CCcchHHHHHHhhhccHHHHHHHHHhhhcccccc
Confidence 87 999999 78899999999999999988753
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* | Back alignment and structure |
|---|
Probab=99.75 E-value=3.3e-18 Score=148.46 Aligned_cols=100 Identities=31% Similarity=0.389 Sum_probs=91.3
Q ss_pred CCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCc
Q 012777 26 DDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGST 105 (456)
Q Consensus 26 ~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 105 (456)
+.+++ ..+.+|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 65 g~~~~-~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 143 (165)
T 3twr_A 65 GADVH-AKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNT 143 (165)
T ss_dssp TCCTT-CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred CCCCC-ccCCCCCCHHHHHHHcCcHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCC
Confidence 44443 34568999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccchhhhhhhhcCC
Q 012777 106 PLADAVYYKHHDVIKLLEEHGA 127 (456)
Q Consensus 106 ~l~~A~~~~~~~~~~~L~~~~~ 127 (456)
|+++|+. |+.+++++|+..|+
T Consensus 144 ~l~~a~~-~~~~i~~~L~~~gA 164 (165)
T 3twr_A 144 PLDLVKD-GDTDIQDLLRGDAA 164 (165)
T ss_dssp TGGGSCT-TCHHHHHHHHTC--
T ss_pred hhHhHhc-CChHHHHHHhhccc
Confidence 9999887 88999999998876
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} | Back alignment and structure |
|---|
Probab=99.75 E-value=9.8e-19 Score=155.88 Aligned_cols=106 Identities=26% Similarity=0.323 Sum_probs=100.5
Q ss_pred CCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 31 GSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 31 ~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
..+|.+|+||||+||..|+.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|
T Consensus 29 n~~d~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A 108 (192)
T 2rfm_A 29 NYRDSYNRTPLMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWS 108 (192)
T ss_dssp TCCCTTCCCHHHHHHHHTCGGGHHHHHHHHCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHH
T ss_pred hCcCCCCCCHHHHHHHcCCHHHHHHHHHhccccccccccCccHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHH
Confidence 35678899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccchhhhhhhhcCCCCCCCcccc
Q 012777 111 VYYKHHDVIKLLEEHGAKPSTAPMHV 136 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~~~~~~~~~~~ 136 (456)
+..|+.+++++|++.|++++.++...
T Consensus 109 ~~~~~~~~v~~Ll~~g~~~~~~~~~g 134 (192)
T 2rfm_A 109 IIFGYSEMSYFLLEHGANVNDRNLEG 134 (192)
T ss_dssp HHHTCHHHHHHHHHTTCCSSCCCTTC
T ss_pred HHcCCHHHHHHHHHCCCCCCCCCCCC
Confidence 99999999999999999998775543
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.1e-18 Score=150.08 Aligned_cols=101 Identities=22% Similarity=0.255 Sum_probs=96.7
Q ss_pred CCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccccccccc
Q 012777 36 DPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKH 115 (456)
Q Consensus 36 ~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~ 115 (456)
+|.||||.||..|+.++++.|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.++..|.||||+|+..|+
T Consensus 2 ~~~t~L~~A~~~g~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~ 81 (167)
T 3v31_A 2 ANSLSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGY 81 (167)
T ss_dssp TTCCCHHHHHHTTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTC
T ss_pred CCcchHHHHHHCCCHHHHHHHHHcCCCcCCCCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCC
Confidence 68999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhhcCCCCCCCcccc
Q 012777 116 HDVIKLLEEHGAKPSTAPMHV 136 (456)
Q Consensus 116 ~~~~~~L~~~~~~~~~~~~~~ 136 (456)
.+++++|++.|++++..+...
T Consensus 82 ~~~v~~Ll~~g~~~~~~~~~g 102 (167)
T 3v31_A 82 TDIVKMLLDCGVDVNEYDWNG 102 (167)
T ss_dssp HHHHHHHHHHTCCTTCCCTTS
T ss_pred HHHHHHHHHCCCCCCcCCCCC
Confidence 999999999999998775443
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.5e-18 Score=161.82 Aligned_cols=107 Identities=26% Similarity=0.238 Sum_probs=85.9
Q ss_pred CCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 31 GSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 31 ~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
...+.+|.||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|
T Consensus 118 ~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A 197 (253)
T 1yyh_A 118 DARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLA 197 (253)
T ss_dssp TCCCTTCCCHHHHHHHHTCSSHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred cccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHH
Confidence 34456788888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred cccccchhhhhhhhcCCCCCCCccccc
Q 012777 111 VYYKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
+..|+.+++++|+++|++++.++....
T Consensus 198 ~~~~~~~~v~~Ll~~ga~~~~~d~~g~ 224 (253)
T 1yyh_A 198 AREGSYETAKVLLDHFANRDITDHMDR 224 (253)
T ss_dssp HHHTCHHHHHHHHHTTCCTTCCCTTCC
T ss_pred HHCCCHHHHHHHHHcCCCccccccCCC
Confidence 888888888888888888776655443
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A | Back alignment and structure |
|---|
Probab=99.74 E-value=3.2e-18 Score=159.60 Aligned_cols=119 Identities=22% Similarity=0.209 Sum_probs=99.7
Q ss_pred CCCCCCCCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCC-C
Q 012777 17 LAPDQPLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGA-D 95 (456)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga-~ 95 (456)
.--...++.+++.+...+.+|.||||+||..|+.+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|+ +
T Consensus 37 ~~v~~Ll~~g~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~ 116 (253)
T 1yyh_A 37 AVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATD 116 (253)
T ss_dssp ---------------CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHSTTSC
T ss_pred HHHHHHHHccCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCC
Confidence 334456778888888889999999999999999999999999999999999999999999999999999999999987 8
Q ss_pred CCCCCCCCCcccccccccccchhhhhhhhcCCCCCCCccc
Q 012777 96 VDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMH 135 (456)
Q Consensus 96 ~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~ 135 (456)
++.++..|.||||+|+..|+.+++++|++.|++++.++..
T Consensus 117 ~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~ 156 (253)
T 1yyh_A 117 LDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDL 156 (253)
T ss_dssp TTCCCTTCCCHHHHHHHHTCSSHHHHHHHTTCCTTCBCTT
T ss_pred ccccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCCCcCCC
Confidence 9999999999999999999999999999999998877543
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.1e-18 Score=162.11 Aligned_cols=104 Identities=32% Similarity=0.345 Sum_probs=97.9
Q ss_pred CCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCC-CCCCcccccccc
Q 012777 34 AIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED-RWGSTPLADAVY 112 (456)
Q Consensus 34 ~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~-~~g~t~l~~A~~ 112 (456)
+.+|.||||+||..|+.++++.|++ |+++|.+|..|+||||+||..|+.+++++|+++|++++.++ ..|.||||+|+.
T Consensus 42 ~~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~ 120 (244)
T 3ui2_A 42 VSEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAG 120 (244)
T ss_dssp HHHHHHHHHHHHTTTCHHHHHHTTT-TCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHH
T ss_pred ccCCCCHHHHHHHcCCHHHHHHHHc-CCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHH
Confidence 3579999999999999999999999 99999999999999999999999999999999999999998 789999999999
Q ss_pred cccchhhhhhhhcCCCCCCCcccccc
Q 012777 113 YKHHDVIKLLEEHGAKPSTAPMHVQN 138 (456)
Q Consensus 113 ~~~~~~~~~L~~~~~~~~~~~~~~~~ 138 (456)
.|+.+++++|+++|++++.++....+
T Consensus 121 ~g~~~~v~~Ll~~ga~~~~~d~~g~t 146 (244)
T 3ui2_A 121 YVRPEVVEALVELGADIEVEDERGLT 146 (244)
T ss_dssp TTCHHHHHHHHHTTCCTTCCCTTCCC
T ss_pred cCCHHHHHHHHHCCCCCCCCCCCCCc
Confidence 99999999999999999987665543
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A | Back alignment and structure |
|---|
Probab=99.74 E-value=5.7e-18 Score=154.75 Aligned_cols=107 Identities=25% Similarity=0.255 Sum_probs=86.2
Q ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCC-CCCCCCCCCCCccccccc
Q 012777 33 EAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRG-ADVDPEDRWGSTPLADAV 111 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~g-a~~~~~~~~g~t~l~~A~ 111 (456)
.+.+|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++| ++++.+|..|.||||+|+
T Consensus 103 ~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~d~~g~t~L~~A~ 182 (228)
T 2dzn_A 103 ITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHAL 182 (228)
T ss_dssp CCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHH
T ss_pred CCcCCCCHHHHHHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhcCcccccCcCCCCCCHHHHHH
Confidence 3566888888888888888888888888888888888888888888888888888888887 888888888888888888
Q ss_pred ccccchhhhhhh-hcCCCCCCCccccccc
Q 012777 112 YYKHHDVIKLLE-EHGAKPSTAPMHVQNA 139 (456)
Q Consensus 112 ~~~~~~~~~~L~-~~~~~~~~~~~~~~~~ 139 (456)
..|+.+++++|+ +.|++++.++....++
T Consensus 183 ~~~~~~~v~~Ll~~~ga~~~~~~~~g~t~ 211 (228)
T 2dzn_A 183 AEGHGDAAVLLVEKYGAEYDLVDNKGAKA 211 (228)
T ss_dssp HTTCHHHHHHHHHHHCCCSCCBCTTSCBG
T ss_pred HcCCHHHHHHHHHhcCCCCCccCCCCCcH
Confidence 888888888888 7788887766554433
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A | Back alignment and structure |
|---|
Probab=99.74 E-value=4.3e-18 Score=155.11 Aligned_cols=104 Identities=27% Similarity=0.249 Sum_probs=79.1
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccccc
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAV 111 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~ 111 (456)
..+.+|.||||+||..|+.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||+|+|+
T Consensus 87 ~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~ 166 (223)
T 2f8y_A 87 ARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAA 166 (223)
T ss_dssp CCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHH
T ss_pred cCCCCCCcHHHHHHHhCcHHHHHHHHHcCCCCcCcCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCcCHHHHHH
Confidence 34566777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred ccccchhhhhhhhcCCCCCCCccc
Q 012777 112 YYKHHDVIKLLEEHGAKPSTAPMH 135 (456)
Q Consensus 112 ~~~~~~~~~~L~~~~~~~~~~~~~ 135 (456)
..|+.+++++|+++|++++.++..
T Consensus 167 ~~~~~~~v~~Ll~~ga~~~~~~~~ 190 (223)
T 2f8y_A 167 REGSYETAKVLLDHFANRDITDHM 190 (223)
T ss_dssp HHTCHHHHHHHHHTTCCTTCCCTT
T ss_pred HcCCHHHHHHHHHcCCCCcccccc
Confidence 777777777777777777665443
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* | Back alignment and structure |
|---|
Probab=99.74 E-value=4.9e-18 Score=148.17 Aligned_cols=100 Identities=30% Similarity=0.469 Sum_probs=92.8
Q ss_pred CCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCc
Q 012777 26 DDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGST 105 (456)
Q Consensus 26 ~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 105 (456)
+.+.+ ..+.+|.||||+||..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 70 g~~~~-~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t 148 (169)
T 2y1l_E 70 GADVN-AVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQDKFGKT 148 (169)
T ss_dssp TCCTT-CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred CCCCC-ccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence 34443 34678999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccchhhhhhhhcC
Q 012777 106 PLADAVYYKHHDVIKLLEEHG 126 (456)
Q Consensus 106 ~l~~A~~~~~~~~~~~L~~~~ 126 (456)
|+++|+..|+.+++++|++.|
T Consensus 149 ~l~~A~~~~~~~~~~~L~~~G 169 (169)
T 2y1l_E 149 AFDISIDNGNEDLAEILQKLN 169 (169)
T ss_dssp HHHHHHHTTCHHHHHHHHTC-
T ss_pred HHHHHHHhCCHHHHHHHHHcC
Confidence 999999999999999999875
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.74 E-value=5e-18 Score=142.67 Aligned_cols=101 Identities=26% Similarity=0.313 Sum_probs=90.2
Q ss_pred CCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCc
Q 012777 26 DDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGST 105 (456)
Q Consensus 26 ~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 105 (456)
+.+++ ..+.+|.||||+||..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 33 g~~~~-~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 111 (137)
T 3c5r_A 33 GSDPN-VKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVNIFGLR 111 (137)
T ss_dssp TCCSC-CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred CCCCC-cCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCC
Confidence 44444 35678999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccchhhhhhhhcCC
Q 012777 106 PLADAVYYKHHDVIKLLEEHGA 127 (456)
Q Consensus 106 ~l~~A~~~~~~~~~~~L~~~~~ 127 (456)
|+++|+..+..+++++|.+.+.
T Consensus 112 pl~~A~~~~~~~~l~~l~~~~~ 133 (137)
T 3c5r_A 112 PVDYTDDESMKSLLLLPEKNES 133 (137)
T ss_dssp GGGGCCCHHHHHHHSCC-----
T ss_pred HHHHHhhccHHHHHhhcccccc
Confidence 9999999999999998886654
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E | Back alignment and structure |
|---|
Probab=99.74 E-value=8.9e-18 Score=154.65 Aligned_cols=98 Identities=27% Similarity=0.277 Sum_probs=65.6
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCcccc-CcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDI-DKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~-~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
..+.+|.||||+||..|+.+++++|+++|++++.+|. .|.||||+|+..|+.+++++|+++|++++.+|..|.||+++|
T Consensus 112 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A 191 (236)
T 1ikn_D 112 ATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLT 191 (236)
T ss_dssp CCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGGC
T ss_pred ccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccCCCCCHHHHH
Confidence 4455566666666666666666666666666666665 666666666666666666666666666666666666666666
Q ss_pred cccccchhhhhhhhcCCCC
Q 012777 111 VYYKHHDVIKLLEEHGAKP 129 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~~~~ 129 (456)
+..|+.+++++|+++|++.
T Consensus 192 ~~~~~~~~~~~Ll~~ga~~ 210 (236)
T 1ikn_D 192 WGRPSTRIQQQLGQLTLEN 210 (236)
T ss_dssp TTSSCHHHHHHHHTTSCGG
T ss_pred HccCchHHHHHHHHcchhh
Confidence 6666666666666666654
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A | Back alignment and structure |
|---|
Probab=99.73 E-value=6.7e-18 Score=153.84 Aligned_cols=114 Identities=23% Similarity=0.225 Sum_probs=106.9
Q ss_pred CCCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCC-CCCCCC
Q 012777 22 PLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGA-DVDPED 100 (456)
Q Consensus 22 ~~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga-~~~~~~ 100 (456)
.++.+++++...+.+|.||||+||..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++++ +++.++
T Consensus 10 Ll~~g~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~ 89 (223)
T 2f8y_A 10 FIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDARM 89 (223)
T ss_dssp TEETTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHBTTSCTTCCC
T ss_pred HHHcCCCcccccCCCCCchHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCC
Confidence 4567888888889999999999999999999999999999999999999999999999999999999999987 899999
Q ss_pred CCCCcccccccccccchhhhhhhhcCCCCCCCccc
Q 012777 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMH 135 (456)
Q Consensus 101 ~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~ 135 (456)
..|.||||+|+..|+.+++++|++.|++++..+..
T Consensus 90 ~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~ 124 (223)
T 2f8y_A 90 HDGTTPLILAARLAVEGMLEDLINSHADVNAVDDL 124 (223)
T ss_dssp TTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTT
T ss_pred CCCCcHHHHHHHhCcHHHHHHHHHcCCCCcCcCCC
Confidence 99999999999999999999999999998876543
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.73 E-value=5.9e-18 Score=145.08 Aligned_cols=97 Identities=32% Similarity=0.428 Sum_probs=90.6
Q ss_pred CCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCC
Q 012777 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGS 104 (456)
Q Consensus 25 ~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 104 (456)
.+.+.+ ..+.+|.||||+||..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 56 ~g~~~~-~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 134 (153)
T 1awc_B 56 AGVSRD-ARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCK 134 (153)
T ss_dssp TTCCTT-CCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred cCCCCC-CCCCCCCCHHHHHHHcChHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCC
Confidence 344544 3567799999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccchhhhhh
Q 012777 105 TPLADAVYYKHHDVIKLL 122 (456)
Q Consensus 105 t~l~~A~~~~~~~~~~~L 122 (456)
||+++|+..|+.+++++|
T Consensus 135 t~l~~A~~~~~~~i~~~L 152 (153)
T 1awc_B 135 TAFDISIDNGNEDLAEIL 152 (153)
T ss_dssp CHHHHHHHTTCHHHHHHH
T ss_pred CHHHHHHHcCCHHHHHHh
Confidence 999999999999999987
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B | Back alignment and structure |
|---|
Probab=99.73 E-value=6.6e-18 Score=145.04 Aligned_cols=99 Identities=28% Similarity=0.405 Sum_probs=91.6
Q ss_pred CCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCC
Q 012777 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGS 104 (456)
Q Consensus 25 ~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 104 (456)
.+.+.+ ..+.+|.||||+||..|+.+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++ ++++.+|..|.
T Consensus 57 ~g~~~~-~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~-~~~~~~~~~g~ 134 (156)
T 1bd8_A 57 QGASPN-VQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRRDARGL 134 (156)
T ss_dssp TTCCTT-CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTT-SCTTCCCTTSC
T ss_pred CCCCCC-CcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHhChHHHHHHHHhc-cCCCCcCCCCC
Confidence 344444 3457899999999999999999999999999999999999999999999999999999999 99999999999
Q ss_pred cccccccccccchhhhhhhhc
Q 012777 105 TPLADAVYYKHHDVIKLLEEH 125 (456)
Q Consensus 105 t~l~~A~~~~~~~~~~~L~~~ 125 (456)
||+++|+..|+.+++++|+++
T Consensus 135 t~l~~A~~~~~~~~v~~Ll~~ 155 (156)
T 1bd8_A 135 TPLELALQRGAQDLVDILQGH 155 (156)
T ss_dssp CHHHHHHHSCCHHHHHHHHTT
T ss_pred CHHHHHHHcCcHHHHHHHHhh
Confidence 999999999999999999863
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-17 Score=154.15 Aligned_cols=102 Identities=28% Similarity=0.381 Sum_probs=61.9
Q ss_pred CCCCchHHHHHHHcCCHHHHHHHHHcCCC------CCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCC-CCCcc
Q 012777 34 AIDPRVRLMYMANEGDLDGIKELLDSGTD------VNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDR-WGSTP 106 (456)
Q Consensus 34 ~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~------in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~-~g~t~ 106 (456)
+.+|.||||+||..|+.+++++|++.|++ ++..|..|.||||+|+..|+.+++++|+++|++++.++. .|.||
T Consensus 75 ~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~tp 154 (236)
T 1ikn_D 75 DFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTA 154 (236)
T ss_dssp CTTCCCHHHHHHHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCH
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHhcccchhHHHHhhccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCCH
Confidence 34556666666666666666666665543 344555566666666666666666666666666666665 66666
Q ss_pred cccccccccchhhhhhhhcCCCCCCCccc
Q 012777 107 LADAVYYKHHDVIKLLEEHGAKPSTAPMH 135 (456)
Q Consensus 107 l~~A~~~~~~~~~~~L~~~~~~~~~~~~~ 135 (456)
||+|+..|+.+++++|+++|++++.++..
T Consensus 155 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 183 (236)
T 1ikn_D 155 LHLAVDLQNPDLVSLLLKCGADVNRVTYQ 183 (236)
T ss_dssp HHHHHHTTCHHHHHHHHTTTCCSCCCCTT
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCCcccCC
Confidence 66666666666666666666666555433
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A | Back alignment and structure |
|---|
Probab=99.73 E-value=5.9e-18 Score=139.50 Aligned_cols=94 Identities=29% Similarity=0.347 Sum_probs=84.3
Q ss_pred CCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCC
Q 012777 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGS 104 (456)
Q Consensus 25 ~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 104 (456)
.+++++ ..+.+|+||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 29 ~~~~~~-~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 107 (123)
T 3aaa_C 29 KGEDVN-RTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGL 107 (123)
T ss_dssp TTCCTT-SCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred cCCCcC-ccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCC
Confidence 445544 3467899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccchhh
Q 012777 105 TPLADAVYYKHHDVI 119 (456)
Q Consensus 105 t~l~~A~~~~~~~~~ 119 (456)
||+++|...+..+++
T Consensus 108 t~l~~A~~~~~~~ll 122 (123)
T 3aaa_C 108 TAFEATDNQAIKALL 122 (123)
T ss_dssp CHHHHCCCHHHHHHH
T ss_pred CHHHHhCCHHHHHHh
Confidence 999999665555543
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-17 Score=153.26 Aligned_cols=99 Identities=25% Similarity=0.292 Sum_probs=52.3
Q ss_pred CCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccc
Q 012777 35 IDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYK 114 (456)
Q Consensus 35 ~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~ 114 (456)
.+|.||||+||..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++.++..|.||||+|+..|
T Consensus 71 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~ 150 (231)
T 3aji_A 71 DAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKG 150 (231)
T ss_dssp TTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHT
T ss_pred CCCCCHHHHHHHcCHHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcC
Confidence 34555555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred cchhhhhhhhcCCCCCCCc
Q 012777 115 HHDVIKLLEEHGAKPSTAP 133 (456)
Q Consensus 115 ~~~~~~~L~~~~~~~~~~~ 133 (456)
+.+++++|++.|++++.++
T Consensus 151 ~~~~v~~Ll~~g~~~~~~~ 169 (231)
T 3aji_A 151 NLKMVHILLFYKASTNIQD 169 (231)
T ss_dssp CHHHHHHHHHTTCCSCCCC
T ss_pred CHHHHHHHHhcCCCccccC
Confidence 5555555555555554443
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.72 E-value=8.3e-18 Score=163.08 Aligned_cols=118 Identities=16% Similarity=0.123 Sum_probs=98.0
Q ss_pred CCCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCC-------------------
Q 012777 22 PLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGR------------------- 82 (456)
Q Consensus 22 ~~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~------------------- 82 (456)
.++.+.|++...+.+|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+
T Consensus 116 l~~~g~dvn~~~d~~g~TpLh~Aa~~g~~~~v~~Ll~~Gad~n~~d~~g~TpLh~A~~~g~~~~~~~~~~ll~~~~~~~~ 195 (327)
T 1sw6_A 116 FPNTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLI 195 (327)
T ss_dssp CTTSCCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGG
T ss_pred HHhcCCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhcccccHHHHHHHHHhhhcccc
Confidence 3456788888788999999999999999999999999999999999999999999988554
Q ss_pred ----------------------HHHHHHHHhCCC---------------------------------------------C
Q 012777 83 ----------------------TDVVRLLLSRGA---------------------------------------------D 95 (456)
Q Consensus 83 ----------------------~~~v~~Ll~~ga---------------------------------------------~ 95 (456)
.+++++|++.++ +
T Consensus 196 ~~d~~g~tpLh~A~~~~~~~g~~~~v~~Ll~~~~~~~~~~~~~~i~~~~~~~g~~~~~~~~~g~t~L~~a~~~~~Ll~~~ 275 (327)
T 1sw6_A 196 LEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANM 275 (327)
T ss_dssp EECTTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHT
T ss_pred CCCCCCCCHHHHHHHHccccccHHHHHHHHHHHHHHHhcccchHHHhhhhcccCCcccccccCCChhHHHHHHHHHHHhC
Confidence 455555555422 5
Q ss_pred CCCCCCCCCcccccccccccchhhhhhhhcCCCCCCCccccccc
Q 012777 96 VDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNA 139 (456)
Q Consensus 96 ~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 139 (456)
++.+|..|.||||+|+..|+.++|++|+++|++++.++....++
T Consensus 276 ~n~~d~~G~TpLh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~Tp 319 (327)
T 1sw6_A 276 LNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRP 319 (327)
T ss_dssp TTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCG
T ss_pred CCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCH
Confidence 77888889999999999999999999999999998877665443
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.3e-17 Score=153.37 Aligned_cols=104 Identities=23% Similarity=0.331 Sum_probs=73.8
Q ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccc
Q 012777 33 EAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVY 112 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~ 112 (456)
.+..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus 107 ~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~ 186 (237)
T 3b7b_A 107 QDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLHIAAR 186 (237)
T ss_dssp CCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHH
Confidence 44567777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred cccchhhhhhhhcCCCCCCCcccc
Q 012777 113 YKHHDVIKLLEEHGAKPSTAPMHV 136 (456)
Q Consensus 113 ~~~~~~~~~L~~~~~~~~~~~~~~ 136 (456)
.|+.+++++|+++|++++.++...
T Consensus 187 ~~~~~~v~~Ll~~gad~~~~d~~g 210 (237)
T 3b7b_A 187 ENRYDCVVLFLSRDSDVTLKNKEG 210 (237)
T ss_dssp TTCHHHHHHHHTTTCCTTCCCTTS
T ss_pred hCCHhHHHHHHHcCCCCCccCCCC
Confidence 777777777777777766654443
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A | Back alignment and structure |
|---|
Probab=99.72 E-value=5.5e-18 Score=155.31 Aligned_cols=110 Identities=30% Similarity=0.437 Sum_probs=101.9
Q ss_pred CCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCc
Q 012777 26 DDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGST 105 (456)
Q Consensus 26 ~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 105 (456)
+++.....+.+|.||||+||..|+.+++++|++.|++++.+|..|+||||+|+..|+.+++++|+++|++++.++..|.|
T Consensus 29 ~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t 108 (231)
T 3aji_A 29 DKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCT 108 (231)
T ss_dssp CGGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred chhhhhcCCCCCCCHHHHHHHcCcHHHHHHHHHhCCCCCCcCCCCCCHHHHHHHcCHHHHHHHHHHcCCCCCCCCCCCCC
Confidence 33445566788999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccchhhhhhhhcCCCCCCCccc
Q 012777 106 PLADAVYYKHHDVIKLLEEHGAKPSTAPMH 135 (456)
Q Consensus 106 ~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~ 135 (456)
|||+|+..|+.+++++|++.|++++..+..
T Consensus 109 ~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~ 138 (231)
T 3aji_A 109 PLHYAASKNRHEIAVMLLEGGANPDAKDHY 138 (231)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCCCCcCCC
Confidence 999999999999999999999998776543
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.6e-17 Score=148.70 Aligned_cols=105 Identities=25% Similarity=0.361 Sum_probs=97.6
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHH-hCCCCCCCCCCCCCcccccc
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLL-SRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll-~~ga~~~~~~~~g~t~l~~A 110 (456)
..+.+|.||||+||..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+ ..+++++.++..|.||||+|
T Consensus 34 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A 113 (201)
T 3hra_A 34 EVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPA 113 (201)
T ss_dssp CCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCSHHHH
T ss_pred CCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhccCcccccccCCCCcHHHHH
Confidence 45678999999999999999999999999999999999999999999999999999999 57889999999999999999
Q ss_pred cccccchhhhhhhhcC-CCCCCCcccc
Q 012777 111 VYYKHHDVIKLLEEHG-AKPSTAPMHV 136 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~-~~~~~~~~~~ 136 (456)
+..|+.+++++|++.| ++++.++...
T Consensus 114 ~~~~~~~~v~~Ll~~g~~~~~~~~~~g 140 (201)
T 3hra_A 114 AEKGHIDNVKLLLEDGREDIDFQNDFG 140 (201)
T ss_dssp HHTTCHHHHHHHHHHCCCCTTCCCTTS
T ss_pred HHcCCHHHHHHHHHcCCCCcCCCCCCC
Confidence 9999999999999998 8887765543
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A | Back alignment and structure |
|---|
Probab=99.72 E-value=3.4e-18 Score=156.04 Aligned_cols=110 Identities=21% Similarity=0.222 Sum_probs=89.8
Q ss_pred CCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHc-CCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCC
Q 012777 24 PADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDS-GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRW 102 (456)
Q Consensus 24 ~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~-g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 102 (456)
+.+.+++ ..+.+|+||||+||..|+.+++++|++. |+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..
T Consensus 94 ~~g~~~~-~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 172 (222)
T 3ehr_A 94 DNRVGVN-GLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGYADIVQLLLAKGARTDLRNIE 172 (222)
T ss_dssp HTTCCTT-CCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCSCCCCTT
T ss_pred hCCCCcc-ccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCccccCC
Confidence 3455554 4467899999999999999999999998 9999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccchhhhhhhhcCCCCCCCcc
Q 012777 103 GSTPLADAVYYKHHDVIKLLEEHGAKPSTAPM 134 (456)
Q Consensus 103 g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~ 134 (456)
|.||+++|+..++.++++.|+..++.....+.
T Consensus 173 g~t~l~~A~~~~~~~~l~~l~~~~~~~~~~~~ 204 (222)
T 3ehr_A 173 KKLAFDMATNAACASLLKKKQGTDAVRTLSNA 204 (222)
T ss_dssp SCCHHHHCCSHHHHHHHC--------------
T ss_pred CCCHHHHhcchhHHHHHHHHhccchhhhccch
Confidence 99999999999999999999999998765543
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A | Back alignment and structure |
|---|
Probab=99.72 E-value=5.8e-18 Score=157.92 Aligned_cols=97 Identities=28% Similarity=0.369 Sum_probs=92.6
Q ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccC-------------cchHHHHHHHcCCHHHHHHHHh---CCCCC
Q 012777 33 EAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDID-------------KRTALHVAACQGRTDVVRLLLS---RGADV 96 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~-------------g~T~Lh~A~~~~~~~~v~~Ll~---~ga~~ 96 (456)
.+.+|.||||+||..|+.+++++|+++|+++|.+|.. |.||||+|+..|+.+++++|++ +|+++
T Consensus 86 ~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~ 165 (256)
T 2etb_A 86 EFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASL 165 (256)
T ss_dssp TTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCT
T ss_pred ccccCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCc
Confidence 3567999999999999999999999999999999886 9999999999999999999999 99999
Q ss_pred CCCCCCCCcccccccc--cccch-------hhhhhhhcCCCC
Q 012777 97 DPEDRWGSTPLADAVY--YKHHD-------VIKLLEEHGAKP 129 (456)
Q Consensus 97 ~~~~~~g~t~l~~A~~--~~~~~-------~~~~L~~~~~~~ 129 (456)
+.+|..|.||||+|+. .++.+ ++++|++.|+++
T Consensus 166 n~~d~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~Ll~~ga~~ 207 (256)
T 2etb_A 166 EATDSLGNTVLHALVMIADNSPENSALVIHMYDGLLQMGARL 207 (256)
T ss_dssp TCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred CccCCCCCCHHHHHHHcccCCchhhHHHHHHHHHHHHcCCCc
Confidence 9999999999999998 77888 999999999998
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.4e-17 Score=153.36 Aligned_cols=107 Identities=25% Similarity=0.283 Sum_probs=96.3
Q ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccc-cCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccccc
Q 012777 33 EAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRD-IDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAV 111 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d-~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~ 111 (456)
.+.+|.||||+|+..|+.+++++|++.|++++..+ ..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+
T Consensus 112 ~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~ 191 (241)
T 1k1a_A 112 RNYDGLTALHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSAS 191 (241)
T ss_dssp CCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHH
T ss_pred cCcCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHH
Confidence 45779999999999999999999999999999988 78999999999999999999999999999999999999999999
Q ss_pred ccccchhhhhhhhcCCCCCCCccccccc
Q 012777 112 YYKHHDVIKLLEEHGAKPSTAPMHVQNA 139 (456)
Q Consensus 112 ~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 139 (456)
..|+.+++++|+++|++++.++....++
T Consensus 192 ~~~~~~~v~~Ll~~ga~~~~~~~~g~tp 219 (241)
T 1k1a_A 192 GRGLLPLVRTLVRSGADSSLKNCHNDTP 219 (241)
T ss_dssp HHTCHHHHHHHHHTTCCTTCCCTTSCCT
T ss_pred HcCCHHHHHHHHhcCCCCCCcCCCCCCH
Confidence 9999999999999999988876655443
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.72 E-value=1e-17 Score=153.75 Aligned_cols=111 Identities=24% Similarity=0.342 Sum_probs=96.4
Q ss_pred CCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCC-----CccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCC
Q 012777 26 DDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDV-----NFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100 (456)
Q Consensus 26 ~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~i-----n~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~ 100 (456)
+.+++. .+.+|+||||+||..|+.+++++|++.|+++ +.+|..|.||||+|+..|+.+++++|+++|++++.++
T Consensus 27 g~~~~~-~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~ 105 (232)
T 2rfa_A 27 GCEVHQ-RGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARA 105 (232)
T ss_dssp CSCTTC-CCTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred CCCccc-CCCCCCCHHHHHHHcCCHHHHHHHHHcCchhccccccccCCCCcCHHHHHHHcCCHHHHHHHHhCCCCCCccc
Confidence 444443 4678999999999999999999999999886 6778899999999999999999999999999999876
Q ss_pred C-------------CCCcccccccccccchhhhhhhhcCCCCCCCccccc
Q 012777 101 R-------------WGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 101 ~-------------~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
. .|.||||+|+..|+.+++++|++.|++++.++....
T Consensus 106 ~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~ 155 (232)
T 2rfa_A 106 TGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGN 155 (232)
T ss_dssp CSGGGSCCTTCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred CCcceeecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Confidence 6 799999999999999999999999999887765543
|
| >4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=9.6e-18 Score=158.62 Aligned_cols=94 Identities=31% Similarity=0.404 Sum_probs=64.0
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHh-CCCCCCCCCCCCCcccccc
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLS-RGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~-~ga~~~~~~~~g~t~l~~A 110 (456)
..+.+|+||||+||..|+.+++++|++.|+|+|.+|..|+||||+|+..|+.+++++|++ .|++++.+|..|.|||++|
T Consensus 178 ~~~~~g~tpLh~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~TpL~~A 257 (276)
T 4hbd_A 178 KASQAGQTALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDRDGSTALMVA 257 (276)
T ss_dssp CCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTTCCCTTSCCHHHHH
T ss_pred ccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCcCcCCCCCCHHHHH
Confidence 344556677777777777777777776677776666667777777777777777777766 5666666666677777777
Q ss_pred cccccchhhhhhhhc
Q 012777 111 VYYKHHDVIKLLEEH 125 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~ 125 (456)
+..|+.+++++|+++
T Consensus 258 ~~~g~~~iv~~Ll~~ 272 (276)
T 4hbd_A 258 LDAGQSEIASMLYSR 272 (276)
T ss_dssp HHHTCHHHHHHHHHH
T ss_pred HHcCCHHHHHHHHhc
Confidence 766666776666654
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.8e-17 Score=161.23 Aligned_cols=106 Identities=31% Similarity=0.392 Sum_probs=99.8
Q ss_pred CCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 31 GSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 31 ~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
...+.+|.||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|
T Consensus 52 ~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A 131 (351)
T 3utm_A 52 HASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEA 131 (351)
T ss_dssp CCSSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHH
T ss_pred ccCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Confidence 34567899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccchhhhhhhhcCCCCCCCcccc
Q 012777 111 VYYKHHDVIKLLEEHGAKPSTAPMHV 136 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~~~~~~~~~~~ 136 (456)
+..|+.+++++|++.|++++..+...
T Consensus 132 ~~~~~~~~v~~Ll~~g~~~~~~~~~g 157 (351)
T 3utm_A 132 ASKNRVEVCSLLLSHGADPTLVNCHG 157 (351)
T ss_dssp HHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred HHcCCHHHHHHHHHcCCCCccccCCC
Confidence 99999999999999999988765443
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.6e-17 Score=151.70 Aligned_cols=100 Identities=24% Similarity=0.286 Sum_probs=50.5
Q ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHcC--CCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 33 EAIDPRVRLMYMANEGDLDGIKELLDSG--TDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g--~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
.+..|.||||+||..|+.+++++|+++| ++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|
T Consensus 68 ~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A 147 (228)
T 2dzn_A 68 PDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRA 147 (228)
T ss_dssp CCTTSCCHHHHHHHHCCHHHHHHHHSSSSCCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHhCCCCcccccCCcCCCCHHHHHHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHH
Confidence 3444555555555555555555555444 44444555555555555555555555555555555555555555555555
Q ss_pred cccccchhhhhhhhcC-CCCCCC
Q 012777 111 VYYKHHDVIKLLEEHG-AKPSTA 132 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~-~~~~~~ 132 (456)
+..|+.+++++|++.| ++++.+
T Consensus 148 ~~~~~~~~v~~Ll~~g~~~~~~~ 170 (228)
T 2dzn_A 148 ASVGSLKLIELLCGLGKSAVNWQ 170 (228)
T ss_dssp HHTTCHHHHHHHHTTTCCCSCCC
T ss_pred HHcCCHHHHHHHHhcCcccccCc
Confidence 5555555555555544 444443
|
| >4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.7e-17 Score=156.98 Aligned_cols=106 Identities=30% Similarity=0.358 Sum_probs=88.6
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHHHHHcCC-CCCccc--------------------------------------cCcch
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKELLDSGT-DVNFRD--------------------------------------IDKRT 72 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~-~in~~d--------------------------------------~~g~T 72 (456)
..|.+|+||||+||..|+.+++++|++.|+ +++..| ..|+|
T Consensus 106 ~~d~~g~T~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~a~~~~~~~~~~~~~v~~Ll~~g~~~~~~~~~g~t 185 (276)
T 4hbd_A 106 IADSNGNTALHYSVSHANFPVVQQLLDSGVCKVDKQNRAGYSPIMLTALATLKTQDDIETVLQLFRLGNINAKASQAGQT 185 (276)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHGGGCCCCSHHHHHHHHHHHHHSCTTCCCTTTCCC
T ss_pred CCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCcCCCCCCCCCCHHHHHHHHHhhhhhhHHHHHHHHHcCCCccccCCCCCC
Confidence 456778888888888888888888888886 655544 45778
Q ss_pred HHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccccchhhhhhhh-cCCCCCCCccccc
Q 012777 73 ALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEE-HGAKPSTAPMHVQ 137 (456)
Q Consensus 73 ~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~-~~~~~~~~~~~~~ 137 (456)
|||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+. .|++++.++....
T Consensus 186 pLh~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~ 251 (276)
T 4hbd_A 186 ALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDRDGS 251 (276)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTTCCCTTSC
T ss_pred HHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCcCcCCCCC
Confidence 8888889999999999999999999999999999999999999999999998 8998887765543
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.3e-18 Score=154.62 Aligned_cols=109 Identities=16% Similarity=0.172 Sum_probs=96.9
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHcCC------HHHHHHHHHcCCCCCccccCcc-hHHHHHHHcC-----CHHHHHHHH
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANEGD------LDGIKELLDSGTDVNFRDIDKR-TALHVAACQG-----RTDVVRLLL 90 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~~~------~~~~~~Ll~~g~~in~~d~~g~-T~Lh~A~~~~-----~~~~v~~Ll 90 (456)
++.++|++... .+|+||||+|+..++ .+++++|+++|+|+|.+|..|+ ||||+|+..+ +.+++++|+
T Consensus 62 l~~Gadvn~~d-~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~ttpLh~A~~~~~~~~~~~~iv~~Ll 140 (186)
T 3t8k_A 62 INKGADIKSRT-KEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFKNIFNYFVDENEMIPLYKLIF 140 (186)
T ss_dssp HHTTCCSSCCC-TTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCSSSCBGGGTBCTTGGGGGCCSCHHHHHHHHHHHH
T ss_pred HHCCCCCCCCC-CCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCCCccCCCcCchHHHHHHHcCCChhhHHHHHHHHH
Confidence 45677877654 889999999999987 6889999999999999999999 9999999944 467999999
Q ss_pred h-CCCCCCCCCCCCCcccccccccccchhhhhhhhcCCCCCCC
Q 012777 91 S-RGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTA 132 (456)
Q Consensus 91 ~-~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~ 132 (456)
+ +|++++.+|..|.||||+|+..|+.+++++|.++..+.+.+
T Consensus 141 ~~~gad~~~~d~~G~TpL~~A~~~~~~~~v~~L~~~~~~~~~~ 183 (186)
T 3t8k_A 141 SQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIKKYNLK 183 (186)
T ss_dssp TSTTCCTTCCCTTSCCHHHHHHTTTCHHHHHHHHHHHHHHTCC
T ss_pred HhcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHHHHHHhcc
Confidence 9 99999999999999999999999999999999876655544
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=5.8e-18 Score=158.23 Aligned_cols=99 Identities=22% Similarity=0.226 Sum_probs=93.1
Q ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccc--------------cCcchHHHHHHHcCCHHHHHHHHh---CCCC
Q 012777 33 EAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRD--------------IDKRTALHVAACQGRTDVVRLLLS---RGAD 95 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d--------------~~g~T~Lh~A~~~~~~~~v~~Ll~---~ga~ 95 (456)
.+.+|+||||+||..|+.+++++|+++|+++|.+| ..|.||||+|+..|+.+++++|++ +|++
T Consensus 89 ~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~ga~ 168 (260)
T 3jxi_A 89 VYYRGQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQAD 168 (260)
T ss_dssp SSEESBCHHHHHHHTTCHHHHHHHHHTTCCTTCCCEECCCSSSCCCCSCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCC
T ss_pred cccCCCCHHHHHHHcCCHHHHHHHHhCCCCcCccccccccCcccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCC
Confidence 34589999999999999999999999999999998 689999999999999999999999 9999
Q ss_pred CCCCCCCCCccccccccccc---------chhhhhhhhcCCCCCC
Q 012777 96 VDPEDRWGSTPLADAVYYKH---------HDVIKLLEEHGAKPST 131 (456)
Q Consensus 96 ~~~~~~~g~t~l~~A~~~~~---------~~~~~~L~~~~~~~~~ 131 (456)
++.+|..|.||||+|+..++ .+++++|++.|++++.
T Consensus 169 ~~~~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~~~ 213 (260)
T 3jxi_A 169 LRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKLFP 213 (260)
T ss_dssp TTCCCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHHHHHHHHCT
T ss_pred CcccCCCCCcHHHHHHHhccCchhHHHHHHHHHHHHHHhCccccc
Confidence 99999999999999998777 6999999999999853
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.1e-17 Score=156.93 Aligned_cols=102 Identities=27% Similarity=0.338 Sum_probs=97.8
Q ss_pred CCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 31 GSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 31 ~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
..++.+|+||||+||..|+.+++++|++.|+++|.+|.+|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|
T Consensus 53 ~~~~~~g~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~~A 132 (285)
T 3d9h_A 53 MGDAVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNA 132 (285)
T ss_dssp CSSSCCSCCHHHHHHHTTCHHHHHHHHHTTCCSCEECTTCCCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHHHH
T ss_pred cCCCccCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Confidence 45788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccchhhhhhhhcCCCCCCC
Q 012777 111 VYYKHHDVIKLLEEHGAKPSTA 132 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~~~~~~~ 132 (456)
+..|+.+++++|++.|++++..
T Consensus 133 ~~~~~~~~v~~Ll~~g~~~~~~ 154 (285)
T 3d9h_A 133 CVSGSWDCVNLLLQHGASVQPE 154 (285)
T ss_dssp HHHTCHHHHHHHHHTTCCSSCS
T ss_pred HHcCHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999987643
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.5e-17 Score=151.12 Aligned_cols=101 Identities=26% Similarity=0.367 Sum_probs=94.7
Q ss_pred CCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCcccc-------------CcchHHHHHHHcCCHHHHHHHHhCCCCCC
Q 012777 31 GSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDI-------------DKRTALHVAACQGRTDVVRLLLSRGADVD 97 (456)
Q Consensus 31 ~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~-------------~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~ 97 (456)
...+.+|.||||+||..|+.+++++|+++|++++.++. .|.||||+|+..|+.+++++|+++|++++
T Consensus 69 ~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~ 148 (232)
T 2rfa_A 69 TSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIR 148 (232)
T ss_dssp CSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCTTCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTT
T ss_pred cccCCCCcCHHHHHHHcCCHHHHHHHHhCCCCCCcccCCcceeecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCC
Confidence 44567899999999999999999999999999998865 79999999999999999999999999999
Q ss_pred CCCCCCCcccccccccccchhh----hhhhhcCCCCCC
Q 012777 98 PEDRWGSTPLADAVYYKHHDVI----KLLEEHGAKPST 131 (456)
Q Consensus 98 ~~~~~g~t~l~~A~~~~~~~~~----~~L~~~~~~~~~ 131 (456)
.+|..|.||||+|+..|+.+++ ++|++.|++++.
T Consensus 149 ~~d~~g~t~L~~A~~~~~~~~~~~i~~~Ll~~g~~~~~ 186 (232)
T 2rfa_A 149 AQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDHL 186 (232)
T ss_dssp CCCTTSCCHHHHHHTCSCHHHHHHHHHHHHHTTCSCSS
T ss_pred CCCCCCCCHHHHHHHcCChHHHHHHHHHHHhcCCchhh
Confidence 9999999999999999999988 999999998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.7e-17 Score=155.29 Aligned_cols=135 Identities=21% Similarity=0.192 Sum_probs=102.2
Q ss_pred cccceeeeccEEEEE---e--EcCcE--EEEEEeCCCCCCC---------------------HHHHHHHHHHHHHHhcCC
Q 012777 154 FSNSVEITKGTFRIA---S--WRGTQ--VAVKTLGEEVFTD---------------------EDKVKAFIDELALLQKIR 205 (456)
Q Consensus 154 ~~~~~~lg~G~fg~~---~--~~g~~--vAvK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~ 205 (456)
|.+.+.||+|+||.| . .+|+. ||||++......- ......+.+|+.+|+++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 566789999999866 2 37888 9999976532110 112246788999999998
Q ss_pred CCcc--eeeeeEEEeCCceEEEEEccCC-C----CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCC
Q 012777 206 HPNV--VQFLGAVTQSTPMMIVTEYLPK-G----DLRAYLKQKGALKPTLAVKFALDIARGMNYLH-ENRPEAIIHRDLE 277 (456)
Q Consensus 206 hp~i--v~l~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH-~~~~~~ivH~Dik 277 (456)
|+++ +.+++. ...++||||+++ | +|.++... .++..+..++.|++.+|.||| +.+ |+|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE---LVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCC
Confidence 7754 444432 356899999942 3 77766432 345678899999999999999 999 9999999
Q ss_pred CCCeEeCCCCCEEEeccCCcccc
Q 012777 278 PSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 278 p~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
|+|||++. .++|+|||++...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 8999999998754
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.71 E-value=1.5e-17 Score=158.50 Aligned_cols=106 Identities=26% Similarity=0.418 Sum_probs=99.4
Q ss_pred CCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 31 GSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 31 ~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
...+.+|.|+||.||..|+.+++++|+++|+++|.+|..|.||||+||..|+.+++++|+++|++++.+|..|.||||+|
T Consensus 34 ~~~~~~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A 113 (299)
T 1s70_B 34 TKVKFDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAA 113 (299)
T ss_dssp CCCEECHHHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred cccccCCccHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHH
Confidence 33456799999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccchhhhhhhhcCCCCCCCcccc
Q 012777 111 VYYKHHDVIKLLEEHGAKPSTAPMHV 136 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~~~~~~~~~~~ 136 (456)
+..|+.+++++|++.|++++..+...
T Consensus 114 ~~~g~~~~v~~Ll~~g~~~~~~~~~g 139 (299)
T 1s70_B 114 ASCGYLDIAEYLISQGAHVGAVNSEG 139 (299)
T ss_dssp HHHTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred HHcCCHHHHHHHHhCCCCCCCcCCCC
Confidence 99999999999999999988765443
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A | Back alignment and structure |
|---|
Probab=99.71 E-value=7.1e-18 Score=157.32 Aligned_cols=113 Identities=26% Similarity=0.229 Sum_probs=101.1
Q ss_pred CCCCCCC---CCCCCCchHHHHHHHc---CCHHHHHHHHHcCCCCCc-----------cccCcchHHHHHHHcCCHHHHH
Q 012777 25 ADDDADG---SEAIDPRVRLMYMANE---GDLDGIKELLDSGTDVNF-----------RDIDKRTALHVAACQGRTDVVR 87 (456)
Q Consensus 25 ~~~~~~~---~~~~~g~t~Lh~a~~~---~~~~~~~~Ll~~g~~in~-----------~d~~g~T~Lh~A~~~~~~~~v~ 87 (456)
.+.+++. ..+.+|+||||+||.. |+.+++++|++.|++++. +|..|.||||+|+..|+.++++
T Consensus 28 ~g~~i~~~~~~~d~~g~t~L~~A~~~~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~ 107 (256)
T 2etb_A 28 NSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNACIMPLLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVK 107 (256)
T ss_dssp HTCCTTSGGGSBTTTTBCHHHHHHHTCBTTBCTTHHHHHHHHHHTTCSSCGGGCCCCSTTTTTCCHHHHHHHTTCHHHHH
T ss_pred cCCCcccccccCCCCCCCHHHHHHHccccchHHHHHHHHhcCCcccchhhhcccccccccccCCCHHHHHHHcCCHHHHH
Confidence 4566665 5788999999999999 999999999999987763 3478999999999999999999
Q ss_pred HHHhCCCCCCCCCCC-------------CCcccccccccccchhhhhhhh---cCCCCCCCccccc
Q 012777 88 LLLSRGADVDPEDRW-------------GSTPLADAVYYKHHDVIKLLEE---HGAKPSTAPMHVQ 137 (456)
Q Consensus 88 ~Ll~~ga~~~~~~~~-------------g~t~l~~A~~~~~~~~~~~L~~---~~~~~~~~~~~~~ 137 (456)
+|+++|++++.++.. |.||||+|+..|+.+++++|++ .|++++.++....
T Consensus 108 ~Ll~~ga~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~n~~d~~g~ 173 (256)
T 2etb_A 108 LLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGN 173 (256)
T ss_dssp HHHHTTCCTTCCCCSGGGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSC
T ss_pred HHHHcCCCCCcccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCcCccCCCCC
Confidence 999999999999886 9999999999999999999999 9999988765543
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=5e-18 Score=160.00 Aligned_cols=99 Identities=25% Similarity=0.231 Sum_probs=89.8
Q ss_pred CCCchHHHHHHHcCCHHHHHHHHH---cCCCCCccccCcchHHHHHHHcCC---------HHHHHHHHhCCCCCC-----
Q 012777 35 IDPRVRLMYMANEGDLDGIKELLD---SGTDVNFRDIDKRTALHVAACQGR---------TDVVRLLLSRGADVD----- 97 (456)
Q Consensus 35 ~~g~t~Lh~a~~~~~~~~~~~Ll~---~g~~in~~d~~g~T~Lh~A~~~~~---------~~~v~~Ll~~ga~~~----- 97 (456)
.+|.||||+||..|+.+++++|++ .|+++|.+|..|+||||+|+..|+ .+++++|+++|++++
T Consensus 146 ~~g~tpL~~A~~~g~~~~v~~Ll~~~~~gad~~~~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~n~~~~~ 225 (273)
T 2pnn_A 146 YFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKL 225 (273)
T ss_dssp CSCBSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHCTTCCG
T ss_pred cCCCCHHHHHHHcCCHHHHHHHHhcccCCCCceeeCCCCCcHHHHHHHccCcchhHHHHHHHHHHHHHHhhhhccccccc
Confidence 479999999999999999999999 999999999999999999999998 899999999999997
Q ss_pred --CCCCCCCcccccccccccchhhhhhhhcCC-CCCCCc
Q 012777 98 --PEDRWGSTPLADAVYYKHHDVIKLLEEHGA-KPSTAP 133 (456)
Q Consensus 98 --~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~-~~~~~~ 133 (456)
.+|..|.||||+|+..|+.+++++|+++|+ ++...+
T Consensus 226 ~~~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga~dp~~~~ 264 (273)
T 2pnn_A 226 EEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRH 264 (273)
T ss_dssp GGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHTC------
T ss_pred ccccCCCCCCHHHHHHHhChHHHHHHHHHCCCCCchhhh
Confidence 489999999999999999999999999999 555443
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.2e-17 Score=157.26 Aligned_cols=99 Identities=22% Similarity=0.273 Sum_probs=94.3
Q ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCcccc--------------CcchHHHHHHHcCCHHHHHHHHh---CCCC
Q 012777 33 EAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDI--------------DKRTALHVAACQGRTDVVRLLLS---RGAD 95 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~--------------~g~T~Lh~A~~~~~~~~v~~Ll~---~ga~ 95 (456)
.+.+|.||||+||..|+.+++++|+++|++++.++. .|.||||+|+..|+.+++++|++ +|++
T Consensus 97 ~d~~g~tpL~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~gad 176 (273)
T 2pnn_A 97 SYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPAD 176 (273)
T ss_dssp TTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBCSGGGSSCSSSCCCCSCBSHHHHHHHTTCHHHHHHHHHCSSCCCC
T ss_pred ccCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCccccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhcccCCCC
Confidence 456899999999999999999999999999999987 79999999999999999999999 9999
Q ss_pred CCCCCCCCCccccccccccc---------chhhhhhhhcCCCCCC
Q 012777 96 VDPEDRWGSTPLADAVYYKH---------HDVIKLLEEHGAKPST 131 (456)
Q Consensus 96 ~~~~~~~g~t~l~~A~~~~~---------~~~~~~L~~~~~~~~~ 131 (456)
++.+|..|.||||+|+..|+ .+++++|+..|++++.
T Consensus 177 ~~~~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~n~ 221 (273)
T 2pnn_A 177 ISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHP 221 (273)
T ss_dssp TTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHCT
T ss_pred ceeeCCCCCcHHHHHHHccCcchhHHHHHHHHHHHHHHhhhhccc
Confidence 99999999999999999888 7999999999999875
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.8e-17 Score=152.63 Aligned_cols=104 Identities=26% Similarity=0.309 Sum_probs=92.9
Q ss_pred CCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCC
Q 012777 24 PADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWG 103 (456)
Q Consensus 24 ~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 103 (456)
+.+++.+...+.+|.||||+|+..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|
T Consensus 137 ~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 216 (241)
T 1k1a_A 137 ERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHN 216 (241)
T ss_dssp HTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred HcCCCcccccccCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCcCCCC
Confidence 45566666666889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccchhhhhhhhcCC
Q 012777 104 STPLADAVYYKHHDVIKLLEEHGA 127 (456)
Q Consensus 104 ~t~l~~A~~~~~~~~~~~L~~~~~ 127 (456)
.||+++|+..|+.++++.|...++
T Consensus 217 ~tpl~~A~~~~~~~i~~~l~~~~a 240 (241)
T 1k1a_A 217 DTPLMVARSRRVIDILRGKATRPA 240 (241)
T ss_dssp CCTTTTCSSHHHHHHHTC------
T ss_pred CCHHHHHHhcCcHHHHhhhccCCC
Confidence 999999999999999999987654
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} | Back alignment and structure |
|---|
Probab=99.70 E-value=8.2e-18 Score=159.85 Aligned_cols=104 Identities=22% Similarity=0.200 Sum_probs=97.3
Q ss_pred CCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 31 GSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 31 ~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
...|.+|.||||+||..|+.+++++|++.|+++|.+| |+||||+|+..|+.+++++|+++|++++.+|..|.||||+|
T Consensus 25 ~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~--g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A 102 (285)
T 3kea_A 25 FKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYA 102 (285)
T ss_dssp TCCCTTSCCHHHHHHHTTCHHHHHHHHHTTGGGSCCT--TCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred CccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCC--CCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHH
Confidence 4567889999999999999999999999999999884 99999999999999999999999999999999999999999
Q ss_pred cccccchhhhhhhhcCCCCCCCcccc
Q 012777 111 VYYKHHDVIKLLEEHGAKPSTAPMHV 136 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~~~~~~~~~~~ 136 (456)
+..|+.+++++|++.|++++..+...
T Consensus 103 ~~~g~~~~v~~Ll~~ga~~~~~~~~g 128 (285)
T 3kea_A 103 VDSGNMQTVKLFVKKNWRLMFYGKTG 128 (285)
T ss_dssp HHTTCHHHHHHHHHHCGGGGGCSSSG
T ss_pred HHcCCHHHHHHHHhcCCCCCccCCCC
Confidence 99999999999999999988665443
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D | Back alignment and structure |
|---|
Probab=99.70 E-value=2.4e-17 Score=155.44 Aligned_cols=101 Identities=24% Similarity=0.196 Sum_probs=95.8
Q ss_pred CCCCCCCchHHHHHHHcCCHHHHHHHHHcCCC---CCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccc
Q 012777 31 GSEAIDPRVRLMYMANEGDLDGIKELLDSGTD---VNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPL 107 (456)
Q Consensus 31 ~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~---in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l 107 (456)
...|.+|+||||+||..|+.+++++|++.|++ +|.+|..|+||||+|+..|+.+++++|+++|++++.++..|.|||
T Consensus 3 ~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL 82 (282)
T 1oy3_D 3 GYVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTAL 82 (282)
T ss_dssp CCCCTTCCCHHHHHHHTTCHHHHHHHHHHHTTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHH
T ss_pred CccCCCCCcHHHHHHHcCCHHHHHHHHhcCCCcccccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHH
Confidence 45688999999999999999999999999988 889999999999999999999999999999999999999999999
Q ss_pred ccccccccchhhhhhhhcCCCCCC
Q 012777 108 ADAVYYKHHDVIKLLEEHGAKPST 131 (456)
Q Consensus 108 ~~A~~~~~~~~~~~L~~~~~~~~~ 131 (456)
|+|+..|+.+++++|+..|++.+.
T Consensus 83 ~~A~~~~~~~~v~~Ll~~~~~~~~ 106 (282)
T 1oy3_D 83 HLACRVRAHTCACVLLQPRPSHPR 106 (282)
T ss_dssp HHHTTTTCHHHHHHHSSSCCSSCC
T ss_pred HHHHHcCCcchhHhhhccCCCCch
Confidence 999999999999999999887543
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.2e-17 Score=147.71 Aligned_cols=102 Identities=31% Similarity=0.378 Sum_probs=91.5
Q ss_pred CCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccc-cCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCC
Q 012777 26 DDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRD-IDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGS 104 (456)
Q Consensus 26 ~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d-~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 104 (456)
+.+++. .+.+|+||||+||..|+.+++++|+++|+++|.+| ..|+||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 66 ~~~~~~-~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~ 144 (183)
T 3deo_A 66 DRDVDA-VDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERGL 144 (183)
T ss_dssp TSCTTC-CCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSC
T ss_pred cCCCCC-cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHhcCcHHHHHHHHHcCCCCcCCCCCCC
Confidence 445544 56789999999999999999999999999999998 8899999999999999999999999999999999999
Q ss_pred cccccccccccchhhhhhhhcCCC
Q 012777 105 TPLADAVYYKHHDVIKLLEEHGAK 128 (456)
Q Consensus 105 t~l~~A~~~~~~~~~~~L~~~~~~ 128 (456)
||+|+|+..++.+.++.++..+++
T Consensus 145 tpl~~A~~~~~~~~~~~~l~~a~~ 168 (183)
T 3deo_A 145 TALELAREILKTTPKGNPMQFGRR 168 (183)
T ss_dssp CHHHHHHHHHHTCCCCSHHHHHHH
T ss_pred CHHHHHHHhccCcccccHHHHHHH
Confidence 999999998877777766666554
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.70 E-value=3.1e-17 Score=154.62 Aligned_cols=111 Identities=26% Similarity=0.339 Sum_probs=102.8
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCC
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRW 102 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 102 (456)
++.+++++...+..|.||||+||..|+.+++++|+++|++++.+|.+|.||||+|+..|+.+++++|+++|++++.++..
T Consensus 25 l~~g~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~ 104 (285)
T 1wdy_A 25 LEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFY 104 (285)
T ss_dssp HHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTT
T ss_pred HHcCCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCcc
Confidence 34567777777888999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccchhhhhhhhcCCCCCCCc
Q 012777 103 GSTPLADAVYYKHHDVIKLLEEHGAKPSTAP 133 (456)
Q Consensus 103 g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~ 133 (456)
|.||||+|+..|+.+++++|++.|++++...
T Consensus 105 g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~ 135 (285)
T 1wdy_A 105 GFTAFMEAAVYGKVKALKFLYKRGANVNLRR 135 (285)
T ss_dssp CCBHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred cCCHHHHHHHhCCHHHHHHHHHhCCCccccc
Confidence 9999999999999999999999999887653
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.9e-17 Score=162.78 Aligned_cols=105 Identities=19% Similarity=0.200 Sum_probs=98.2
Q ss_pred CCCCCchHHHHHHHcC--CHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCC-----CCCCCCCCCc
Q 012777 33 EAIDPRVRLMYMANEG--DLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGAD-----VDPEDRWGST 105 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~--~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~-----~~~~~~~g~t 105 (456)
.+.+|.||||+||..| +.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++ ++.+|..|.|
T Consensus 134 ~~~~g~t~L~~A~~~g~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g~t 213 (364)
T 3ljn_A 134 KHCKGQTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNS 213 (364)
T ss_dssp EEESCCCHHHHHHHSCGGGHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTCCC
T ss_pred CCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCCCCCc
Confidence 5678999999999999 99999999999999999999999999999999999999999999999 9999999999
Q ss_pred ccccccccccchhhhhhhhcCCCCCCCccccc
Q 012777 106 PLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 106 ~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
|||+|+..|+.+++++|+++|++++.++....
T Consensus 214 ~L~~A~~~g~~~~v~~Ll~~gad~~~~d~~g~ 245 (364)
T 3ljn_A 214 HLHWAILINWEDVAMRFVEMGIDVNMEDNEHT 245 (364)
T ss_dssp TTHHHHTTTCHHHHHHHHTTTCCTTCCCTTSC
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCC
Confidence 99999999999999999999999988765443
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=3.5e-18 Score=159.71 Aligned_cols=98 Identities=18% Similarity=0.145 Sum_probs=92.0
Q ss_pred CCCchHHHHHHHcCCHHHHHHHHH---cCCCCCccccCcchHHHHHHHcCC---------HHHHHHHHhCCCCC------
Q 012777 35 IDPRVRLMYMANEGDLDGIKELLD---SGTDVNFRDIDKRTALHVAACQGR---------TDVVRLLLSRGADV------ 96 (456)
Q Consensus 35 ~~g~t~Lh~a~~~~~~~~~~~Ll~---~g~~in~~d~~g~T~Lh~A~~~~~---------~~~v~~Ll~~ga~~------ 96 (456)
.+|.||||+||..|+.+++++|++ .|+++|.+|..|+||||+|+..++ .+++++|+++|+++
T Consensus 138 ~~g~tpL~~A~~~g~~~~v~~Ll~~~~~ga~~~~~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~~~~~~~ 217 (260)
T 3jxi_A 138 YFGELPLSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKLFPDTNL 217 (260)
T ss_dssp CSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHHHHHHHHCTTCCG
T ss_pred cCCCCHHHHHHHcCCHHHHHHHHhccccCCCCcccCCCCCcHHHHHHHhccCchhHHHHHHHHHHHHHHhCcccccccch
Confidence 679999999999999999999999 999999999999999999999888 79999999999999
Q ss_pred -CCCCCCCCcccccccccccchhhhhhhhcCCCCCCC
Q 012777 97 -DPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTA 132 (456)
Q Consensus 97 -~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~ 132 (456)
+.+|..|.||||+|+..|+.+++++|+++|++....
T Consensus 218 ~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~~~~ 254 (260)
T 3jxi_A 218 EALLNNDGLSPLMMAAKTGKIGIFQHIIRREIADAAA 254 (260)
T ss_dssp GGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHHHHHC-
T ss_pred hhcccCCCCCHHHHHHHcCCHHHHHHHHHhCCCcccc
Confidence 679999999999999999999999999999875443
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.69 E-value=5.4e-17 Score=154.66 Aligned_cols=66 Identities=29% Similarity=0.413 Sum_probs=37.9
Q ss_pred CCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCC
Q 012777 34 AIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPE 99 (456)
Q Consensus 34 ~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~ 99 (456)
+.+|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++..
T Consensus 70 ~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~~~~ 135 (299)
T 1s70_B 70 NVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAV 135 (299)
T ss_dssp CTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCC
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCCc
Confidence 344555555555555555555555555555555555555555555555555555555555555443
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A | Back alignment and structure |
|---|
Probab=99.69 E-value=2.5e-17 Score=161.61 Aligned_cols=105 Identities=25% Similarity=0.341 Sum_probs=65.5
Q ss_pred CCCCCchHHHHHHHc-CCHHHHHHHHHcCCCCCccc--cCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccc
Q 012777 33 EAIDPRVRLMYMANE-GDLDGIKELLDSGTDVNFRD--IDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLAD 109 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~-~~~~~~~~Ll~~g~~in~~d--~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~ 109 (456)
.+.++.|+||.||.. |++++++.|++.|+|+|..| ..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+
T Consensus 195 ~~~~~~t~L~~Aa~~~g~~~~v~~LL~~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~ 274 (368)
T 3jue_A 195 GSLHPGALLFRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHH 274 (368)
T ss_dssp --CCHHHHHHHHTSSSCCHHHHHHHHHTTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred ccCCCCcHHHHHHHccCCHHHHHHHHHcCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHH
Confidence 334556666666666 66666666666666666665 556666666666666666666666666666666666666666
Q ss_pred ccccccchhhhhhhhcCCCCCCCccccc
Q 012777 110 AVYYKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 110 A~~~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
|+..|+.+++++|+.+|++++.++....
T Consensus 275 A~~~g~~~~v~~LL~~Gad~~~~d~~G~ 302 (368)
T 3jue_A 275 ATILGHTGLACLFLKRGADLGARDSEGR 302 (368)
T ss_dssp HHHHTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred HHHcCcHHHHHHHHHCcCCCCCcCCCCC
Confidence 6666666666666666666665554433
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} | Back alignment and structure |
|---|
Probab=99.69 E-value=4.2e-17 Score=146.02 Aligned_cols=112 Identities=29% Similarity=0.374 Sum_probs=100.5
Q ss_pred CCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHH-HcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCC-CCCCCCCCC
Q 012777 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELL-DSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRG-ADVDPEDRW 102 (456)
Q Consensus 25 ~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll-~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~g-a~~~~~~~~ 102 (456)
.+++.+. .+.+|.||||+|+..|+.+++++|+ ..+++++.+|..|.||||+|+..|+.+++++|+++| ++++.+|..
T Consensus 61 ~g~~~~~-~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~ 139 (201)
T 3hra_A 61 RGADINL-QNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQNDF 139 (201)
T ss_dssp TTCCTTC-CCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCSHHHHHHTTCHHHHHHHHHHCCCCTTCCCTT
T ss_pred cCCCCCC-CCCCCCCHHHHHHHcCCHHHHHHHHhccCcccccccCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcCCCCCC
Confidence 3445443 5678999999999999999999999 667899999999999999999999999999999998 999999999
Q ss_pred CCccccccccccc-----chhhhhhhhcCCCCCCCccccc
Q 012777 103 GSTPLADAVYYKH-----HDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 103 g~t~l~~A~~~~~-----~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
|.||||+|+..++ .+++++|++.|++++.++....
T Consensus 140 g~t~L~~A~~~~~~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 179 (201)
T 3hra_A 140 GYTALIEAVGLREGNQLYQDIVKLLMENGADQSIKDNSGR 179 (201)
T ss_dssp SCCHHHHHHHSSCCSHHHHHHHHHHHHTTCCTTCCCTTSC
T ss_pred CCCHHHHHHHhccchhhHHHHHHHHHHCCCCCCccCCCCC
Confidence 9999999999887 8999999999999988765543
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=4.8e-17 Score=154.52 Aligned_cols=104 Identities=21% Similarity=0.290 Sum_probs=82.6
Q ss_pred CCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccc
Q 012777 35 IDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYK 114 (456)
Q Consensus 35 ~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~ 114 (456)
.+|.||||+|+..|+.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++. +..|.||||+|+..|
T Consensus 155 ~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~-~~~g~t~L~~A~~~~ 233 (285)
T 3d9h_A 155 SDLASPIHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVNQ-GKGQDSPLHAVVRTA 233 (285)
T ss_dssp CTTSCHHHHHHHHTCHHHHHHHHHTTCCTTCCBTTTBCHHHHHHHTTCHHHHHHHHHTTCCTTC-CBTTBCHHHHHHHTT
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHCCCCCCC-CCCCCCHHHHHHHcC
Confidence 3478888888888888888888888888888888888888888888888888888888888874 677888888888888
Q ss_pred cchhhhhhhhcCCCCCCCccccccc
Q 012777 115 HHDVIKLLEEHGAKPSTAPMHVQNA 139 (456)
Q Consensus 115 ~~~~~~~L~~~~~~~~~~~~~~~~~ 139 (456)
+.+++++|+++|++++.++....++
T Consensus 234 ~~~~v~~Ll~~gad~~~~d~~g~t~ 258 (285)
T 3d9h_A 234 SEELACLLMDFGADTQAKNAEGKRP 258 (285)
T ss_dssp CHHHHHHHHHTTCCTTCCCTTSCCG
T ss_pred CHHHHHHHHHCCCCCCCcCCCCCCH
Confidence 8888888888888887776655443
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.69 E-value=6.9e-17 Score=152.20 Aligned_cols=101 Identities=28% Similarity=0.255 Sum_probs=88.1
Q ss_pred CCCCCchHHHHHHHcCC----HHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHh-CCCCCCCCCCCCCccc
Q 012777 33 EAIDPRVRLMYMANEGD----LDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLS-RGADVDPEDRWGSTPL 107 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~----~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~-~ga~~~~~~~~g~t~l 107 (456)
.+..|.||||+|+..++ .+++++|+++|+++|.+|..|.||||+|+..|+.+++++|++ .|++++.+|..|.||+
T Consensus 178 ~~~~g~t~l~~a~~~~~~~~~~~i~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~~~~g~t~l 257 (285)
T 1wdy_A 178 CDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTAL 257 (285)
T ss_dssp CCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCCTTSCCHH
T ss_pred cCCCCCCHHHHHHHccccchHHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhccCCCccccCCCCCcHH
Confidence 45678888888888888 888888888888888888888999999999899999999888 7888888888889999
Q ss_pred ccccccccchhhhhhhhcCCCCCCCc
Q 012777 108 ADAVYYKHHDVIKLLEEHGAKPSTAP 133 (456)
Q Consensus 108 ~~A~~~~~~~~~~~L~~~~~~~~~~~ 133 (456)
|+|+..|+.+++++|+++|++++.++
T Consensus 258 ~~A~~~~~~~i~~~Ll~~Ga~~~~~d 283 (285)
T 1wdy_A 258 LLAVELKLKKIAELLCKRGASTDCGD 283 (285)
T ss_dssp HHHHHTTCHHHHHHHHHHSSCSCCSS
T ss_pred HHHHHcCcHHHHHHHHHcCCCCCccc
Confidence 99988888899999998888888765
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A | Back alignment and structure |
|---|
Probab=99.69 E-value=3.5e-17 Score=151.83 Aligned_cols=102 Identities=34% Similarity=0.431 Sum_probs=91.7
Q ss_pred CCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccc-cCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCC
Q 012777 26 DDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRD-IDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGS 104 (456)
Q Consensus 26 ~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d-~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 104 (456)
+.+++. .+.+|+||||+||..|+.+++++|+++|+++|.+| ..|+||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 67 ~~~~~~-~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~ 145 (244)
T 3ui2_A 67 DRDVDA-VDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERGL 145 (244)
T ss_dssp TCCTTC-BCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCC
T ss_pred CCCCCC-cCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Confidence 455554 56789999999999999999999999999999998 8899999999999999999999999999999999999
Q ss_pred ccccccc----------------ccccchhhhhhhhcCCC
Q 012777 105 TPLADAV----------------YYKHHDVIKLLEEHGAK 128 (456)
Q Consensus 105 t~l~~A~----------------~~~~~~~~~~L~~~~~~ 128 (456)
||+|+|+ ..|+.+++++|+..+.+
T Consensus 146 t~l~~A~~~~~~~~~~~~l~~a~~~g~~~iv~~L~~~~~~ 185 (244)
T 3ui2_A 146 TALELAREILKTTPKGNPMQFGRRIGLEKVINVLEGQVFE 185 (244)
T ss_dssp CHHHHHHHHHTTCCCSSHHHHHHHHHHHHHHHHHHHHHEE
T ss_pred cHHHHHHHHHhccCCCCHHHHHHHcChHHHHHHHHHhccc
Confidence 9999988 56778888888876543
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=8.3e-17 Score=147.96 Aligned_cols=102 Identities=30% Similarity=0.357 Sum_probs=95.7
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccccc
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAV 111 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~ 111 (456)
.++.+|.||||+||..|+.+++++|+++|++++..|..|.||||+|+..|+.+++++|+++|++++.++..|.||||+|+
T Consensus 6 ~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~ 85 (237)
T 3b7b_A 6 MEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAA 85 (237)
T ss_dssp CSSCCSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCCCCCCTTSCCHHHHHH
T ss_pred cccCCCCCHHHHHHHcCcHHHHHHHHHcCCCcCccCCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCcHHHHHH
Confidence 35678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchhhhhhhhcC-CCCCCCc
Q 012777 112 YYKHHDVIKLLEEHG-AKPSTAP 133 (456)
Q Consensus 112 ~~~~~~~~~~L~~~~-~~~~~~~ 133 (456)
..|+.+++++|+..| ++++..+
T Consensus 86 ~~~~~~~~~~Ll~~~~~~~~~~~ 108 (237)
T 3b7b_A 86 KKGHYEVVQYLLSNGQMDVNCQD 108 (237)
T ss_dssp HTTCHHHHHHHHTTTCCCTTCCC
T ss_pred HcCCHHHHHHHHhCCCCCcccCC
Confidence 999999999999988 6666553
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.68 E-value=4.9e-17 Score=163.74 Aligned_cols=104 Identities=29% Similarity=0.395 Sum_probs=79.0
Q ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccc
Q 012777 33 EAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVY 112 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~ 112 (456)
.+.+|.||||+|+..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus 274 ~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~gad~n~~~~~g~t~L~~A~~ 353 (437)
T 1n11_A 274 GNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQ 353 (437)
T ss_dssp CCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCSSCCCHHHHHHHSSCSHHHHHHHHTTCCTTCCCTTSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHhCCccCCCCCCCCCCHHHHHHHcCcHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Confidence 35667777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred cccchhhhhhhhcCCCCCCCcccc
Q 012777 113 YKHHDVIKLLEEHGAKPSTAPMHV 136 (456)
Q Consensus 113 ~~~~~~~~~L~~~~~~~~~~~~~~ 136 (456)
.|+.++|++|+++|++++.++...
T Consensus 354 ~g~~~iv~~Ll~~ga~~~~~~~~g 377 (437)
T 1n11_A 354 QGHTDIVTLLLKNGASPNEVSSDG 377 (437)
T ss_dssp TTCHHHHHHHHHTTCCSCCCCSSS
T ss_pred CChHHHHHHHHHCcCCCCCCCCCC
Confidence 777777777777777777665443
|
| >4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=3.1e-17 Score=159.42 Aligned_cols=100 Identities=26% Similarity=0.314 Sum_probs=64.7
Q ss_pred CCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHc-CCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCC
Q 012777 26 DDDADGSEAIDPRVRLMYMANEGDLDGIKELLDS-GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGS 104 (456)
Q Consensus 26 ~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~-g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 104 (456)
++|++. ++.+|+||||+||..|+.++++.|++. |+++|.+|.+|+||||+|+..|+.++|++||++||++|.+
T Consensus 229 gad~n~-~d~~g~t~L~~a~~~~~~~~v~~Ll~~~~~~vn~~d~~G~TpL~~A~~~g~~~iv~~Ll~~GAd~n~~----- 302 (337)
T 4g8k_A 229 GADVNV-RGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCG----- 302 (337)
T ss_dssp TCCTTC-CCGGGCCHHHHHHHTTCHHHHHHHHTSTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHTTSCSSTTC-----
T ss_pred CCCCCC-cCCCCCCHHHHHHHhhhhHHHHHHHHhcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC-----
Confidence 344433 345567777777777777777766653 6677777777777777777777777777777777666543
Q ss_pred cccccccccccchhhhhhhhcCCCCCC
Q 012777 105 TPLADAVYYKHHDVIKLLEEHGAKPST 131 (456)
Q Consensus 105 t~l~~A~~~~~~~~~~~L~~~~~~~~~ 131 (456)
+||++|+..|+.++|++|+++||++|.
T Consensus 303 ~~L~~A~~~~~~~iv~~Ll~~GA~~d~ 329 (337)
T 4g8k_A 303 DLVMTARRNYDHSLVKVLLSHGAKEDF 329 (337)
T ss_dssp CHHHHHHHTTCHHHHHHHHHTTCCC--
T ss_pred CHHHHHHHcCCHHHHHHHHHCcCCCCC
Confidence 467777777777777777777776654
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.68 E-value=8.2e-17 Score=156.53 Aligned_cols=111 Identities=27% Similarity=0.307 Sum_probs=102.6
Q ss_pred CCCCCCCCCchHHHHHHHc---CCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCc
Q 012777 29 ADGSEAIDPRVRLMYMANE---GDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGST 105 (456)
Q Consensus 29 ~~~~~~~~g~t~Lh~a~~~---~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 105 (456)
.+...+.+|.||||+|+.. ++.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 203 ~~~~~~~~~~t~L~~A~~~~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~t 282 (351)
T 3utm_A 203 INFKQPQSHETALHCAVASLHPKRKQVAELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSLGQT 282 (351)
T ss_dssp TTCCCTTTCCCHHHHHHHCCSTTHHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred ccccCCCCCCCHHHHHHHHhCccHHHHHHHHHHcCCCcCCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCC
Confidence 3445677899999999999 6689999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccchhhhhhhhcCCCCCCCccccccc
Q 012777 106 PLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNA 139 (456)
Q Consensus 106 ~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 139 (456)
|||+|+..|+.+++++|+++|++++..+....++
T Consensus 283 ~L~~A~~~~~~~~v~~Ll~~gad~~~~~~~g~ta 316 (351)
T 3utm_A 283 ALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTA 316 (351)
T ss_dssp HHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred HHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCCh
Confidence 9999999999999999999999999887665543
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.68 E-value=4.8e-17 Score=163.85 Aligned_cols=109 Identities=29% Similarity=0.359 Sum_probs=94.3
Q ss_pred CCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcc
Q 012777 27 DDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTP 106 (456)
Q Consensus 27 ~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~ 106 (456)
++++ ..+.+|.||||+||..|+.+++++|+++|+++|..|..|.||||+|+..|+.+++++|+++|++++.++.+|.||
T Consensus 5 ~~~~-~~~~~g~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~ 83 (437)
T 1n11_A 5 ISGG-GGGESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTP 83 (437)
T ss_dssp -----------CCHHHHHHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCH
T ss_pred CCcc-ccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCH
Confidence 3443 456889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccchhhhhhhhcCCCCCCCcccc
Q 012777 107 LADAVYYKHHDVIKLLEEHGAKPSTAPMHV 136 (456)
Q Consensus 107 l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~ 136 (456)
||+|+..|+.+++++|++.|++++..+...
T Consensus 84 L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g 113 (437)
T 1n11_A 84 LHCAARIGHTNMVKLLLENNANPNLATTAG 113 (437)
T ss_dssp HHHHHHHTCHHHHHHHHHHTCCTTCCCTTC
T ss_pred HHHHHHCCCHHHHHHHHhCCCCCCCCCCCC
Confidence 999999999999999999999988765543
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.2e-17 Score=156.85 Aligned_cols=102 Identities=22% Similarity=0.134 Sum_probs=94.2
Q ss_pred CCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCC-
Q 012777 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWG- 103 (456)
Q Consensus 25 ~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g- 103 (456)
.+++++.. +|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.++..|
T Consensus 53 ~g~~~~~~---~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~ 129 (285)
T 3kea_A 53 AGALKNLL---ENEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGW 129 (285)
T ss_dssp TTGGGSCC---TTCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCSSSGG
T ss_pred CCCCCCCC---CCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCCCccCCCCC
Confidence 34444444 59999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccchhhhhhhhcCCCC
Q 012777 104 STPLADAVYYKHHDVIKLLEEHGAKP 129 (456)
Q Consensus 104 ~t~l~~A~~~~~~~~~~~L~~~~~~~ 129 (456)
.||||+|+..|+.+++++|++.|+++
T Consensus 130 ~t~L~~A~~~~~~~~v~~Ll~~g~~~ 155 (285)
T 3kea_A 130 KTSFYHAVMLNDVSIVSYFLSEIPST 155 (285)
T ss_dssp GSHHHHHHHTTCHHHHHHHHTTSCTT
T ss_pred CCHHHHHHHcCCHHHHHHHHhCCCcc
Confidence 79999999999999999999998765
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.66 E-value=1.4e-16 Score=157.32 Aligned_cols=97 Identities=27% Similarity=0.388 Sum_probs=91.7
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHHHHHcC-CCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKELLDSG-TDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g-~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
..+.+|.||||+||..|+.+++++|++.| +++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||+++|
T Consensus 274 ~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~~~~~~n~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gad~~~~d~~g~t~l~~A 353 (373)
T 2fo1_E 274 SEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLA 353 (373)
T ss_dssp SSSCCCCCTHHHHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCHHHHH
T ss_pred cccccCCCHHHHHHHhCCHHHHHHHHHhcCCCccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccCCCCCCCCHHHHH
Confidence 46778999999999999999999999876 99999999999999999999999999999999999999999999999999
Q ss_pred cccccchhhhhhhhcCCC
Q 012777 111 VYYKHHDVIKLLEEHGAK 128 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~~~ 128 (456)
+..|+.+++++|+.++++
T Consensus 354 ~~~g~~~iv~~Ll~~~a~ 371 (373)
T 2fo1_E 354 QANNHHNIVDIFDRCRPE 371 (373)
T ss_dssp HHTTCHHHHHHHHTTC--
T ss_pred HHcCCHHHHHHHHhcCcc
Confidence 999999999999998875
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.66 E-value=6.9e-17 Score=158.69 Aligned_cols=105 Identities=17% Similarity=0.145 Sum_probs=97.6
Q ss_pred CCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCC-----CCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCC
Q 012777 26 DDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTD-----VNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100 (456)
Q Consensus 26 ~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~-----in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~ 100 (456)
+.|++ ..+.+|.||||+||..|+.+++++|+++|++ +|.+|..|+||||+|+..|+.+++++|+++|++++.+|
T Consensus 163 ga~~~-~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~gad~~~~d 241 (364)
T 3ljn_A 163 GASPT-AKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAILINWEDVAMRFVEMGIDVNMED 241 (364)
T ss_dssp TCCTT-CCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTCCCTTHHHHTTTCHHHHHHHHTTTCCTTCCC
T ss_pred CCCCc-ccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCC
Confidence 44444 3467899999999999999999999999998 99999999999999999999999999999999999999
Q ss_pred CCCCcccccccccccchhhhhhhhcCCCCCC
Q 012777 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKPST 131 (456)
Q Consensus 101 ~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~ 131 (456)
..|.||||+|+..|+.+++++|++.|++++.
T Consensus 242 ~~g~tpL~~A~~~g~~~~v~~Ll~~~~~~~~ 272 (364)
T 3ljn_A 242 NEHTVPLYLSVRAAMVLLTKELLQKTDVFLI 272 (364)
T ss_dssp TTSCCHHHHHHHTCCHHHHHHHHHHSCHHHH
T ss_pred CCCCCHHHHHHHhChHHHHHHHHHcCCchhh
Confidence 9999999999999999999999999988643
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.2e-16 Score=156.72 Aligned_cols=106 Identities=29% Similarity=0.371 Sum_probs=97.4
Q ss_pred CCCCCCCCCCC-CCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCC
Q 012777 23 LPADDDADGSE-AIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDR 101 (456)
Q Consensus 23 ~~~~~~~~~~~-~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~ 101 (456)
++.++|++... +.+|.||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|.
T Consensus 220 L~~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~LL~~Gad~~~~d~ 299 (368)
T 3jue_A 220 LAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHTGLACLFLKRGADLGARDS 299 (368)
T ss_dssp HHTTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCT
T ss_pred HHcCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHCcCCCCCcCC
Confidence 34556666544 37899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcccccccccccchhhhhhhhcCCC
Q 012777 102 WGSTPLADAVYYKHHDVIKLLEEHGAK 128 (456)
Q Consensus 102 ~g~t~l~~A~~~~~~~~~~~L~~~~~~ 128 (456)
.|.||||+|+..|+.+++++|+..+..
T Consensus 300 ~G~TpL~~A~~~g~~~iv~lLl~~~~~ 326 (368)
T 3jue_A 300 EGRDPLTIAMETANADIVTLLRLAKMR 326 (368)
T ss_dssp TSCCHHHHHHHTTCHHHHHHHHHHHC-
T ss_pred CCCCHHHHHHHCCCHHHHHHHHHcCCC
Confidence 999999999999999999999988754
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.64 E-value=6.9e-17 Score=159.52 Aligned_cols=109 Identities=19% Similarity=0.267 Sum_probs=97.4
Q ss_pred CCCCCCCCCCCchHHHHHHHcCCHHHHHHHH--------HcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCC
Q 012777 27 DDADGSEAIDPRVRLMYMANEGDLDGIKELL--------DSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDP 98 (456)
Q Consensus 27 ~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll--------~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~ 98 (456)
.+++...+.+|+||||+||..|+.+++++|+ +.|+++|.+|.+|.||||+|+..|+.+++++|+++|++++.
T Consensus 115 ~~~n~~d~~~g~t~Lh~Aa~~g~~~~v~~Ll~~~~~~ll~~ga~vn~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga~~~~ 194 (373)
T 2fo1_E 115 ESVNIIDPRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTI 194 (373)
T ss_dssp TTTTTCCCSSCCCHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCC
T ss_pred ccccccCCcCCCCHHHHHHHCCCHHHHHHHHHHHHHHHHhcCCCCcCCCCCCCCHHHHHHHcChHHHHHHHHHCCCCCcc
Confidence 4556555678999999999999988777776 78999999999999999999999999999999999999999
Q ss_pred CCCCCCcccccccccccchhhhhhhhcC---CCCCCCccc
Q 012777 99 EDRWGSTPLADAVYYKHHDVIKLLEEHG---AKPSTAPMH 135 (456)
Q Consensus 99 ~~~~g~t~l~~A~~~~~~~~~~~L~~~~---~~~~~~~~~ 135 (456)
+|..|.||||+|+..|+.+++++|+..+ ++++..+..
T Consensus 195 ~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~d~~ 234 (373)
T 2fo1_E 195 YNKSERSALHQAAANRDFGMMVYMLNSTKLKGDIEELDRN 234 (373)
T ss_dssp CCTTCCCHHHHHHHTTCHHHHHHHTTSHHHHHTTSCCCTT
T ss_pred cCCCCCCHHHHHHHCCCHHHHHHHHhcCccccChhhcCCC
Confidence 9999999999999999999999999887 677665443
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.4e-15 Score=139.54 Aligned_cols=112 Identities=22% Similarity=0.200 Sum_probs=98.4
Q ss_pred CCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccc-cCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCC
Q 012777 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRD-IDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWG 103 (456)
Q Consensus 25 ~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d-~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 103 (456)
.+.+++. .+.+|.||||+||..|+.+++++|++.|++++..+ ..|.||||+|+..|+.+++++|+++|++++.++..|
T Consensus 31 ~g~~~~~-~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g 109 (240)
T 3eu9_A 31 AGYDVRQ-PDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEG 109 (240)
T ss_dssp TTCCTTC-CCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBTTTTBCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred cCCCcCC-CCCCCCCHHHHHHHhCCHHHHHHHHHcCCcchhhcCCcCCChhHHHHHcCCHHHHHHHHHcCCCCcccCCCC
Confidence 4455443 45779999999999999999999999999988665 449999999999999999999999999999999999
Q ss_pred CcccccccccccchhhhhhhhcCCCCCCCccccc
Q 012777 104 STPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 104 ~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
.||+|+|+..|+.+++++|++.|++++..+....
T Consensus 110 ~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~g~ 143 (240)
T 3eu9_A 110 CSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGM 143 (240)
T ss_dssp CCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred CCHHHHHHHcCHHHHHHHHHhcCCCccccCCCCC
Confidence 9999999999999999999999999987765543
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.8e-15 Score=138.67 Aligned_cols=105 Identities=30% Similarity=0.290 Sum_probs=93.8
Q ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCC-CCCccccccc
Q 012777 33 EAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDR-WGSTPLADAV 111 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~-~g~t~l~~A~ 111 (456)
.|..|.|+||.||..|+.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++..+. .|.||||+|+
T Consensus 5 ~d~~~~~~l~~A~~~g~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~t~L~~A~ 84 (240)
T 3eu9_A 5 IDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWAT 84 (240)
T ss_dssp CSCGGGCCHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBTTTTBCHHHHHH
T ss_pred cccccchHHHHHHHcCChHHHHHHHHcCCCcCCCCCCCCCHHHHHHHhCCHHHHHHHHHcCCcchhhcCCcCCChhHHHH
Confidence 456789999999999999999999999999999999999999999999999999999999999886554 4999999999
Q ss_pred ccccchhhhhhhhcCCCCCCCccccc
Q 012777 112 YYKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 112 ~~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
..|+.+++++|++.|++++..+....
T Consensus 85 ~~~~~~~v~~Ll~~g~~~~~~~~~g~ 110 (240)
T 3eu9_A 85 RQGHLSMVVQLMKYGADPSLIDGEGC 110 (240)
T ss_dssp HHTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred HcCCHHHHHHHHHcCCCCcccCCCCC
Confidence 99999999999999999887655433
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.2e-15 Score=145.99 Aligned_cols=103 Identities=23% Similarity=0.268 Sum_probs=95.6
Q ss_pred CCchHHHHHHHcCCHHHHHHHHHcCCCCCc------cccCcchHHHHHHHc---CCHHHHHHHHhCCCCCCCCCCCCCcc
Q 012777 36 DPRVRLMYMANEGDLDGIKELLDSGTDVNF------RDIDKRTALHVAACQ---GRTDVVRLLLSRGADVDPEDRWGSTP 106 (456)
Q Consensus 36 ~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~------~d~~g~T~Lh~A~~~---~~~~~v~~Ll~~ga~~~~~~~~g~t~ 106 (456)
.+.++||.|+..|+++.++.|++.|++++. .|..|.||||+|+.. |+.+++++|+++|++++.+|..|.||
T Consensus 150 ~~~~~L~~A~~~g~~~~v~~ll~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~Tp 229 (301)
T 2b0o_E 150 PEPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTA 229 (301)
T ss_dssp -CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCEECSSSCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCH
T ss_pred chHHHHhhhhhccCHHHHHHHHhcCCcccccCCCcccCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCH
Confidence 356889999999999999999999999998 699999999999997 89999999999999999999999999
Q ss_pred cccccccccchhhhhhhhcCCCCCCCcccccc
Q 012777 107 LADAVYYKHHDVIKLLEEHGAKPSTAPMHVQN 138 (456)
Q Consensus 107 l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~ 138 (456)
||+|+..|+.+++++|+++|++++.++....+
T Consensus 230 Lh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~T 261 (301)
T 2b0o_E 230 LHYAALYNQPDCLKLLLKGRALVGTVNEAGET 261 (301)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCCSCCCTTSCC
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence 99999999999999999999999888765443
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.2e-15 Score=156.33 Aligned_cols=103 Identities=25% Similarity=0.291 Sum_probs=96.3
Q ss_pred CchHHHHHHHcCCHHHHHHHHHcCCCCCcc------ccCcchHHHHHHH---cCCHHHHHHHHhCCCCCCCCCCCCCccc
Q 012777 37 PRVRLMYMANEGDLDGIKELLDSGTDVNFR------DIDKRTALHVAAC---QGRTDVVRLLLSRGADVDPEDRWGSTPL 107 (456)
Q Consensus 37 g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~------d~~g~T~Lh~A~~---~~~~~~v~~Ll~~ga~~~~~~~~g~t~l 107 (456)
..+.||.|+..|+.++++.|++.|+|+|.. |..|+||||+||. .|+.+++++||++|+++|.+|..|.|||
T Consensus 132 ~~~~L~~A~~~g~~~~v~~ll~~g~~~n~~~~~~~~~~~g~t~Lh~A~~~a~~g~~~~v~~Ll~~ga~vn~~d~~g~TpL 211 (497)
T 3lvq_E 132 EPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTAL 211 (497)
T ss_dssp CHHHHHHHHHHTCHHHHHHHHHTTCCSSSCBCCSSSCCSCBCHHHHHHHTCCTTTHHHHHHHHHHSCCTTCCCSSSCCHH
T ss_pred cHHHHHHHHhccCHHHHHHHHhhcccccCCCCCcccccccchHHHHHHHhcccccHHHHHHHHHcCCCCCccCCCCCcHH
Confidence 457899999999999999999999999988 8899999999977 8999999999999999999999999999
Q ss_pred ccccccccchhhhhhhhcCCCCCCCccccccc
Q 012777 108 ADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNA 139 (456)
Q Consensus 108 ~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 139 (456)
|+|+..|+.+++++|+++|++++.++....++
T Consensus 212 h~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 243 (497)
T 3lvq_E 212 HYAALYNQPDCLKLLLKGRALVGTVNEAGETA 243 (497)
T ss_dssp HHHTTTTCHHHHHHHHHTCCCCSCCCTTCCCH
T ss_pred HHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence 99999999999999999999999987765543
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 | Back alignment and structure |
|---|
Probab=99.58 E-value=2.8e-15 Score=141.71 Aligned_cols=102 Identities=22% Similarity=0.229 Sum_probs=94.0
Q ss_pred CchHHHHHHHcCCHHHHHHHHHcCCCCC------ccccCcchHHHHHHHc---CCHHHHHHHHhCCCCCCCCCCCCCccc
Q 012777 37 PRVRLMYMANEGDLDGIKELLDSGTDVN------FRDIDKRTALHVAACQ---GRTDVVRLLLSRGADVDPEDRWGSTPL 107 (456)
Q Consensus 37 g~t~Lh~a~~~~~~~~~~~Ll~~g~~in------~~d~~g~T~Lh~A~~~---~~~~~v~~Ll~~ga~~~~~~~~g~t~l 107 (456)
..++||.|+..|+++.++.++..|++++ ..|..|.||||+|+.. |+.+++++|+++|+++|.+|..|.|||
T Consensus 130 ~l~~l~~a~~~~d~~~~~~ll~~g~~~~~~~~l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpL 209 (278)
T 1dcq_A 130 KLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTAL 209 (278)
T ss_dssp HHHHHHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHH
T ss_pred hhhhhhhHhhhcccHHHHHHHHhhcchhhhccccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCHH
Confidence 4578999999999999999999999954 4588999999999999 899999999999999999999999999
Q ss_pred ccccccccchhhhhhhhcCCCCCCCcccccc
Q 012777 108 ADAVYYKHHDVIKLLEEHGAKPSTAPMHVQN 138 (456)
Q Consensus 108 ~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~ 138 (456)
|+|+..|+.+++++|+++|++++.++....+
T Consensus 210 h~A~~~g~~~~v~~Ll~~gad~~~~d~~g~t 240 (278)
T 1dcq_A 210 HYCCLTDNAECLKLLLRGKASIEIANESGET 240 (278)
T ss_dssp HHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred HHHHHcCCHHHHHHHHHcCCCCCCccCCCCC
Confidence 9999999999999999999999988765543
|
| >4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=9.7e-15 Score=141.73 Aligned_cols=100 Identities=32% Similarity=0.464 Sum_probs=84.8
Q ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCcccc-CcchHHHHHHHcCCHHHHHHHHhCCCCCCC-------------
Q 012777 33 EAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDI-DKRTALHVAACQGRTDVVRLLLSRGADVDP------------- 98 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~-~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~------------- 98 (456)
.+.+|+|+||.||..|++++|++|+++|+|+|.++. .|+||||+||..|+.++|++||++|++++.
T Consensus 21 ~~~~~~t~L~~Av~~g~~~~V~~LL~~Gadvn~~~~~~g~TpLh~A~~~g~~~iv~~Ll~~ga~~~~~~~~~~~~~~~~~ 100 (337)
T 4g8k_A 21 AAVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFILAA 100 (337)
T ss_dssp CHHHHHHHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHH
T ss_pred CCCCCChHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCcCHHHHHHHcCCHHHHHHHHHcCCchhhhccCCCchhHHHH
Confidence 355689999999999999999999999999999875 499999999999999999999999987654
Q ss_pred --------------------CCCCCCcccccccccccchhhhhhhhcCCCCCCC
Q 012777 99 --------------------EDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTA 132 (456)
Q Consensus 99 --------------------~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~ 132 (456)
+|..|.||+++|+..|+.+++++|+..|++++..
T Consensus 101 ~~~~~~~~~~~~~~~~~~~~~d~~g~t~l~~A~~~~~~~~~~~ll~~ga~~~~~ 154 (337)
T 4g8k_A 101 IAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLR 154 (337)
T ss_dssp HHTCHHHHHHHHTTTCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred hcccchhhHHhhhccchhhhhccCCCCHHHHHHHcCcHHHHHHHHHcCCCcchh
Confidence 4556677777777777777777777777776654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.4e-15 Score=148.52 Aligned_cols=136 Identities=17% Similarity=0.113 Sum_probs=93.5
Q ss_pred ccccceeeeccEEEEEe----EcCcEEEEEEeCCCCCC--------------CH-HH----HHHHHHHHHHHhcCCCCcc
Q 012777 153 DFSNSVEITKGTFRIAS----WRGTQVAVKTLGEEVFT--------------DE-DK----VKAFIDELALLQKIRHPNV 209 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~----~~g~~vAvK~~~~~~~~--------------~~-~~----~~~~~~E~~~l~~l~hp~i 209 (456)
-|++...||.|+||.|. .+|+.||||+++..... .. .. .-....|...|.++.++++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 37888999999999762 36899999997642110 00 00 0112346666666644433
Q ss_pred eeeeeEEEeCCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC-
Q 012777 210 VQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH- 288 (456)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~- 288 (456)
.- ...+.. ...++||||++|.+|.++. .......++.|++.+|.+||+.| ||||||||.|||+++++.
T Consensus 176 ~v-p~p~~~-~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 176 PV-PEPIAQ-SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp SC-CCEEEE-ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECS
T ss_pred CC-Ceeeec-cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCc
Confidence 21 111111 1347999999988876542 22345678999999999999999 999999999999997763
Q ss_pred ---------EEEeccCCccc
Q 012777 289 ---------LKVADFGLSKL 299 (456)
Q Consensus 289 ---------vkl~Dfgls~~ 299 (456)
+.|+||+-+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 88999997653
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.1e-14 Score=118.15 Aligned_cols=84 Identities=32% Similarity=0.425 Sum_probs=74.3
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCC
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRW 102 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 102 (456)
++.+.+++. .+.+|.||||+||..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++.++..
T Consensus 29 l~~g~~~~~-~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~~~~~~~~~~~Ll~~ga~~n~~~~~ 107 (115)
T 2l6b_A 29 LSKGADVNA-RSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKKNGHHEIVKLLDAKGADVNARSWG 107 (115)
T ss_dssp TTTTCCSSC-CCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHHTTTCHHHHHHHHTTSSSHHHHSCC
T ss_pred HHcCCCCCC-cCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCcc
Confidence 344555544 4678999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccc
Q 012777 103 GSTPL 107 (456)
Q Consensus 103 g~t~l 107 (456)
|.+|-
T Consensus 108 ~~~~~ 112 (115)
T 2l6b_A 108 SSHHH 112 (115)
T ss_dssp CC---
T ss_pred ccccc
Confidence 99874
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.49 E-value=3e-14 Score=137.96 Aligned_cols=83 Identities=27% Similarity=0.201 Sum_probs=75.3
Q ss_pred CCCCCCchHHHHHHH----cCCHHHHHHHHHcCC---------------------------------------------C
Q 012777 32 SEAIDPRVRLMYMAN----EGDLDGIKELLDSGT---------------------------------------------D 62 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~----~~~~~~~~~Ll~~g~---------------------------------------------~ 62 (456)
..+.+|+||||+||. .|+.+++++|++.++ +
T Consensus 196 ~~d~~g~tpLh~A~~~~~~~g~~~~v~~Ll~~~~~~~~~~~~~~i~~~~~~~g~~~~~~~~~g~t~L~~a~~~~~Ll~~~ 275 (327)
T 1sw6_A 196 LEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANM 275 (327)
T ss_dssp EECTTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHT
T ss_pred CCCCCCCCHHHHHHHHccccccHHHHHHHHHHHHHHHhcccchHHHhhhhcccCCcccccccCCChhHHHHHHHHHHHhC
Confidence 457889999999999 899999999997743 6
Q ss_pred CCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccc
Q 012777 63 VNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYK 114 (456)
Q Consensus 63 in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~ 114 (456)
+|.+|..|+||||+|+..|+.++|++|+++|++++.+|..|.||||+|+..|
T Consensus 276 ~n~~d~~G~TpLh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~TpL~~A~~~g 327 (327)
T 1sw6_A 276 LNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGAGLE 327 (327)
T ss_dssp TTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTCC--
T ss_pred CCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHhcC
Confidence 8889999999999999999999999999999999999999999999998764
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.49 E-value=7.7e-14 Score=108.56 Aligned_cols=70 Identities=41% Similarity=0.603 Sum_probs=63.9
Q ss_pred CCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCC
Q 012777 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGAD 95 (456)
Q Consensus 25 ~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~ 95 (456)
.+.+++ .++.+|+||||+||..|+.+++++|+++|++++.+|.+|+||||+|+..|+.+++++|+++|++
T Consensus 24 ~g~~~n-~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~~~~Ll~~ga~ 93 (93)
T 1n0q_A 24 AGADVN-AKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGAY 93 (93)
T ss_dssp TTCCTT-CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCC
T ss_pred cCCCCc-ccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCC
Confidence 345544 3567899999999999999999999999999999999999999999999999999999999985
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 | Back alignment and structure |
|---|
Probab=99.45 E-value=4.2e-15 Score=146.31 Aligned_cols=90 Identities=18% Similarity=0.145 Sum_probs=50.7
Q ss_pred CCchHHHHHHHcCCHHHHHHHHHcCCCC---CccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCC--CCCCCCcccccc
Q 012777 36 DPRVRLMYMANEGDLDGIKELLDSGTDV---NFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDP--EDRWGSTPLADA 110 (456)
Q Consensus 36 ~g~t~Lh~a~~~~~~~~~~~Ll~~g~~i---n~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~--~~~~g~t~l~~A 110 (456)
.|.||||+||..|+.+++++|+++|+|+ +..+.+ +||||+||..|+.++|++|+++|++++. .|..|.||||+|
T Consensus 127 ~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~TpLh~Aa~~G~~eiv~~Ll~~ga~~~~~~~d~~g~TpL~~A 205 (376)
T 2aja_A 127 ENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN-YHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRWA 205 (376)
T ss_dssp HHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH-HHHHHHHHHTTCHHHHHHHHHSCGGGHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC-CCHHHHHHHCCCHHHHHHHHHcCCccchhccCCCCCCHHHHH
Confidence 4555666666666666666666666442 112222 5666666666666666666666665554 555556666666
Q ss_pred c-ccccchhhhhhhhcC
Q 012777 111 V-YYKHHDVIKLLEEHG 126 (456)
Q Consensus 111 ~-~~~~~~~~~~L~~~~ 126 (456)
+ ..|+.++|++|++.|
T Consensus 206 a~~~G~~eiv~~Ll~~g 222 (376)
T 2aja_A 206 AVGRGHHNVINFLLDCP 222 (376)
T ss_dssp HSTTCCHHHHHHHTTSH
T ss_pred HHHCCCHHHHHHHHhCC
Confidence 6 666666666665544
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 | Back alignment and structure |
|---|
Probab=99.41 E-value=2.1e-14 Score=141.35 Aligned_cols=98 Identities=19% Similarity=0.103 Sum_probs=80.7
Q ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHcCCC---CCccccCcchHHHHHHHcCCHHHHHHHHhCCCCC---CCCCCCCCcc
Q 012777 33 EAIDPRVRLMYMANEGDLDGIKELLDSGTD---VNFRDIDKRTALHVAACQGRTDVVRLLLSRGADV---DPEDRWGSTP 106 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~---in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~---~~~~~~g~t~ 106 (456)
.+.+++||||+||..|+.+++++|++.|+. .+..|..|.||||+||..|+.++|++|+++|+++ +..+.+ .||
T Consensus 88 ~g~~~~T~Lh~Aa~~G~~e~v~~Ll~~ga~~~~~~~~~~~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~Tp 166 (376)
T 2aja_A 88 KGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN-YHA 166 (376)
T ss_dssp HTCCHHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH-HHH
T ss_pred cCCCcCCHHHHHHHcCCHHHHHHHHHcCCcHHHHHHhccCCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC-CCH
Confidence 356778999999999999999999999972 2244567899999999999999999999999752 233223 899
Q ss_pred cccccccccchhhhhhhhcCCCCCC
Q 012777 107 LADAVYYKHHDVIKLLEEHGAKPST 131 (456)
Q Consensus 107 l~~A~~~~~~~~~~~L~~~~~~~~~ 131 (456)
||+|+..|+.++|++|++.|++++.
T Consensus 167 Lh~Aa~~G~~eiv~~Ll~~ga~~~~ 191 (376)
T 2aja_A 167 FRLAAENGHLHVLNRLCELAPTEAT 191 (376)
T ss_dssp HHHHHHTTCHHHHHHHHHSCGGGHH
T ss_pred HHHHHHCCCHHHHHHHHHcCCccch
Confidence 9999999999999999999998654
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A | Back alignment and structure |
|---|
Probab=99.29 E-value=2.1e-12 Score=103.79 Aligned_cols=75 Identities=37% Similarity=0.426 Sum_probs=66.3
Q ss_pred CCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccccchhhhhhhhcCCCCCCCccccc
Q 012777 63 VNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 63 in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
++-.|.+|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|++.|++++.++....
T Consensus 17 ~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~ 91 (110)
T 2zgd_A 17 GSHMGSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGK 91 (110)
T ss_dssp -----CCHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred ccccCCccchHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCC
Confidence 445678999999999999999999999999999999999999999999999999999999999999988765543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=1.4e-10 Score=108.19 Aligned_cols=137 Identities=12% Similarity=-0.025 Sum_probs=99.7
Q ss_pred cccceeeeccEEE---EEeEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEcc
Q 012777 154 FSNSVEITKGTFR---IASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYL 229 (456)
Q Consensus 154 ~~~~~~lg~G~fg---~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~e~~ 229 (456)
|.....++.|+.+ .+...+..+++|+........ ...+.+|+.+++.+ .+..+.++++++...+..|+||||+
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 4444444443332 334457899999987532111 13578899999988 4677889999999888999999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 012777 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENR------------------------------------------ 267 (456)
Q Consensus 230 ~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~------------------------------------------ 267 (456)
+|.+|.+.+ .+......++.++..+|..||+..
T Consensus 93 ~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 93 DGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp SSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred CCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 999987752 122334578899999999999811
Q ss_pred --------------CCCeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 268 --------------PEAIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 268 --------------~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
+..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1239999999999999876666799999754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.84 E-value=7.4e-09 Score=101.14 Aligned_cols=138 Identities=14% Similarity=0.176 Sum_probs=98.0
Q ss_pred eeeeccEEE---EEeEcCcEEEEEEeC--CCCCCCHHHHHHHHHHHHHHhcCC--CCcceeeeeEEEeC---CceEEEEE
Q 012777 158 VEITKGTFR---IASWRGTQVAVKTLG--EEVFTDEDKVKAFIDELALLQKIR--HPNVVQFLGAVTQS---TPMMIVTE 227 (456)
Q Consensus 158 ~~lg~G~fg---~~~~~g~~vAvK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~---~~~~lv~e 227 (456)
+.|+.|.++ .+...+..+++|+.. ... .......+.+|..+++.+. +..+++++.++.+. +..++|||
T Consensus 44 ~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~--~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSK--LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EECCC-CCSCEEEEECSSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEcCCcccceEEEEEECCceEEEEeCCCCCCC--CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 356656543 344456789999876 321 1122356788999999986 45678888888766 44899999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENR---------------------------------------- 267 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~---------------------------------------- 267 (456)
|++|..+.+. ....++......++.++..+|..||+..
T Consensus 122 ~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 122 FVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp CCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred ecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 9998777431 1134778888899999999999999731
Q ss_pred ---------------CCCeEecCCCCCCeEeCCCCC--EEEeccCCccc
Q 012777 268 ---------------PEAIIHRDLEPSNILRDDSGH--LKVADFGLSKL 299 (456)
Q Consensus 268 ---------------~~~ivH~Dikp~Nil~~~~~~--vkl~Dfgls~~ 299 (456)
+..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 135999999999999997653 68999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.79 E-value=2.6e-09 Score=99.05 Aligned_cols=114 Identities=21% Similarity=0.162 Sum_probs=84.0
Q ss_pred cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCc--ceeeeeEEEeCCceEEEEEccCCCCHHHHHHHcCCCCHHH
Q 012777 171 RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPN--VVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTL 248 (456)
Q Consensus 171 ~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~ 248 (456)
+|..+++|+..... ...+..|+.+++.+.+.+ +.+++++....+..++||||++|.+|. . ...+
T Consensus 43 ~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~---~~~~--- 108 (264)
T 1nd4_A 43 GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S---SHLA--- 108 (264)
T ss_dssp TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T---SCCC---
T ss_pred CCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c---CcCC---
Confidence 46789999986531 135678999998885333 566888888878899999999998874 1 1122
Q ss_pred HHHHHHHHHHHHHHHHhCC-------------------------------------------------------CCCeEe
Q 012777 249 AVKFALDIARGMNYLHENR-------------------------------------------------------PEAIIH 273 (456)
Q Consensus 249 ~~~i~~ql~~aL~~LH~~~-------------------------------------------------------~~~ivH 273 (456)
...++.+++..|..||+.. +..++|
T Consensus 109 ~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~H 188 (264)
T 1nd4_A 109 PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTH 188 (264)
T ss_dssp HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEEC
T ss_pred HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEEC
Confidence 2356677777788887643 112999
Q ss_pred cCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 274 RDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 274 ~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
+|++|.||+++.++.+.|+||+.+.
T Consensus 189 gDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 189 GDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp SSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999877667799999765
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.75 E-value=9.9e-09 Score=97.83 Aligned_cols=185 Identities=18% Similarity=0.114 Sum_probs=120.4
Q ss_pred eeeeccEEEEEeEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCc--ceeeeeEEEeCC---ceEEEEEccCC
Q 012777 158 VEITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPN--VVQFLGAVTQST---PMMIVTEYLPK 231 (456)
Q Consensus 158 ~~lg~G~fg~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~--iv~l~~~~~~~~---~~~lv~e~~~~ 231 (456)
+.++.|....+..-+..+++|+... ......+.+|..+++.+ .+.. +.+++....... ..|+||++++|
T Consensus 26 ~~~~~G~~n~v~~v~~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEINRDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEESTTSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEECCEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 3577887776655567899998643 24457788999999887 3332 445555443332 35889999999
Q ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 012777 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENR-------------------------------------------- 267 (456)
Q Consensus 232 ~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~-------------------------------------------- 267 (456)
.+|.+... ..++..+...++.+++..|..||+..
T Consensus 101 ~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 178 (304)
T 3sg8_A 101 VPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR 178 (304)
T ss_dssp EECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred eECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence 88875433 34778888888999999998888621
Q ss_pred -----------CCCeEecCCCCCCeEeCC--CCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccC----CC
Q 012777 268 -----------PEAIIHRDLEPSNILRDD--SGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYK----NE 330 (456)
Q Consensus 268 -----------~~~ivH~Dikp~Nil~~~--~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~ 330 (456)
+..++|+|++|.||+++. ...+.++||+.+......... ........-..|+... ..
T Consensus 179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl------~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF------ISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH------HTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH------HHHHhhccccCHHHHHHHHHHc
Confidence 124899999999999998 556889999987654211000 0000000001222110 00
Q ss_pred -CCC---------CchhHHHHHHHHHHHHcCCCCC
Q 012777 331 -EYD---------TKVDVFSFALILQEMIEGCPPF 355 (456)
Q Consensus 331 -~~~---------~~~DiwslG~il~~l~~g~~pf 355 (456)
..+ ...+.|+++.+++.+.+|..+|
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 1258999999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=7.6e-06 Score=77.83 Aligned_cols=135 Identities=18% Similarity=0.151 Sum_probs=91.4
Q ss_pred eeeeccEEEEEeEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCC---cceeeeeEEE-eCCceEEEEEccCCCC
Q 012777 158 VEITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHP---NVVQFLGAVT-QSTPMMIVTEYLPKGD 233 (456)
Q Consensus 158 ~~lg~G~fg~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---~iv~l~~~~~-~~~~~~lv~e~~~~~s 233 (456)
+.++.|....+..-|..+++|+.. .......+..|..+|+.+.+. .+.+.+.+.. ..+..+++||+++|.+
T Consensus 25 ~~l~~G~~n~v~~vg~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILVNGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEETTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEECCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 356666655443337889999853 234557889999999998642 3566666664 3456789999999988
Q ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q 012777 234 LRAYLKQKGALKPTLAVKFALDIARGMNYLHENR---------------------------------------------- 267 (456)
Q Consensus 234 L~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~---------------------------------------------- 267 (456)
|.+..- ..++......++.++...|..||+..
T Consensus 100 l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 177 (306)
T 3tdw_A 100 LGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ 177 (306)
T ss_dssp CHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred Cchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence 766321 23455555555666666665555432
Q ss_pred -----------CCCeEecCCCCCCeEeCC---CCC-EEEeccCCccc
Q 012777 268 -----------PEAIIHRDLEPSNILRDD---SGH-LKVADFGLSKL 299 (456)
Q Consensus 268 -----------~~~ivH~Dikp~Nil~~~---~~~-vkl~Dfgls~~ 299 (456)
+..++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 123799999999999997 455 48999997653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=6.3e-06 Score=76.64 Aligned_cols=118 Identities=14% Similarity=0.159 Sum_probs=89.3
Q ss_pred cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEEccCCCCHHHHHHHcCCCCHHHH
Q 012777 171 RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLA 249 (456)
Q Consensus 171 ~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~ 249 (456)
.+..+++|+-.. .....+.+|...|+.+. +--+.+++.++...+..++|||+++|.++.+..... ....
T Consensus 49 ~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~ 118 (272)
T 4gkh_A 49 NAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSG 118 (272)
T ss_dssp TCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGH
T ss_pred CCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHH
Confidence 456899998642 23467888999998884 434778899999889999999999998888765431 2334
Q ss_pred HHHHHHHHHHHHHHHhCC-------------------------------------------------------CCCeEec
Q 012777 250 VKFALDIARGMNYLHENR-------------------------------------------------------PEAIIHR 274 (456)
Q Consensus 250 ~~i~~ql~~aL~~LH~~~-------------------------------------------------------~~~ivH~ 274 (456)
..+..++...|..||... +..++|+
T Consensus 119 ~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HG 198 (272)
T 4gkh_A 119 ENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHG 198 (272)
T ss_dssp HHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECS
T ss_pred HHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcC
Confidence 457777778888888631 1138999
Q ss_pred CCCCCCeEeCCCCCEEEeccCCcc
Q 012777 275 DLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 275 Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
|+.+.|||++.++.+-|+||+.+.
T Consensus 199 Dl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 199 DFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCCCeEEEECCeEEEEEECcccc
Confidence 999999999987777799999765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.57 E-value=7.8e-05 Score=72.22 Aligned_cols=60 Identities=5% Similarity=-0.005 Sum_probs=40.0
Q ss_pred CcEEEEEEeCCCC---CCCHHHHHHHHHHHHHHhcCC-C--CcceeeeeEEEeC---CceEEEEEccCCCCH
Q 012777 172 GTQVAVKTLGEEV---FTDEDKVKAFIDELALLQKIR-H--PNVVQFLGAVTQS---TPMMIVTEYLPKGDL 234 (456)
Q Consensus 172 g~~vAvK~~~~~~---~~~~~~~~~~~~E~~~l~~l~-h--p~iv~l~~~~~~~---~~~~lv~e~~~~~sL 234 (456)
+..+++|+..... ... ...+..|..+++.+. + ..+.+++.++... +..++|||+++|..+
T Consensus 52 ~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 52 QQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp EEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCC
T ss_pred CceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCCh
Confidence 6789999875432 100 134677888888873 3 3577788777654 356899999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.56 E-value=0.0011 Score=58.70 Aligned_cols=137 Identities=11% Similarity=0.038 Sum_probs=89.9
Q ss_pred CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCC
Q 012777 233 DLRAYLKQK-GALKPTLAVKFALDIARGMNYLHE-NRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR 310 (456)
Q Consensus 233 sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~-~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~ 310 (456)
||.++|+.. .+++++++|.++.|.+.+|.-+-. .. -..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~---~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ---PRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc---CCceecCCcceEEecCCceeccc-cccc------------
Confidence 799999764 579999999999999999988732 11 11233447889999999987764 2110
Q ss_pred CcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHH
Q 012777 311 PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELI 390 (456)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 390 (456)
.....+.|||... ...+.+.=|||||+++|.-+--..|-. .+..+++.+.+||
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~---------------------eE~eLS~~LE~LL 150 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN---------------------EERELSPPLEQLI 150 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT---------------------EEECCCHHHHHHH
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc---------------------cchhhCHHHHHHH
Confidence 0112377888764 234567889999999999884222210 1356778889999
Q ss_pred HHhcccC-------------------------CCCCCCHHHHHHHHH
Q 012777 391 EDCWSEE-------------------------PFRRPTFRQILMRLD 412 (456)
Q Consensus 391 ~~~l~~d-------------------------p~~Rpt~~ell~~L~ 412 (456)
..|.... +..|+++++|++.=.
T Consensus 151 ~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~ 197 (229)
T 2yle_A 151 DHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA 197 (229)
T ss_dssp HHHTTCCC--------------------CCSCCCCCCSHHHHHHHHH
T ss_pred HHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence 8887652 457889888876543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0033 Score=59.97 Aligned_cols=29 Identities=21% Similarity=0.334 Sum_probs=26.1
Q ss_pred CeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 270 AIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 270 ~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 223 NLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred ceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 49999999999999888899999999754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00047 Score=67.76 Aligned_cols=73 Identities=18% Similarity=0.121 Sum_probs=40.9
Q ss_pred eeeeccEEEEE-----eEcCcEEEEEEeCCCCC-CCH---HHHHHHHHHHHHHhcCC-C-Cc-ceeeeeEEEeCCceEEE
Q 012777 158 VEITKGTFRIA-----SWRGTQVAVKTLGEEVF-TDE---DKVKAFIDELALLQKIR-H-PN-VVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 158 ~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~-h-p~-iv~l~~~~~~~~~~~lv 225 (456)
+.||.|..+.+ ...+..|+||....... ..+ .....+..|.++++.+. . |. +.+++.+ +....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46777765533 23467899998653211 000 01235677888888773 2 33 4455544 34556899
Q ss_pred EEccCCC
Q 012777 226 TEYLPKG 232 (456)
Q Consensus 226 ~e~~~~~ 232 (456)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0018 Score=61.37 Aligned_cols=71 Identities=18% Similarity=0.109 Sum_probs=51.7
Q ss_pred eeeeccEEE---EEeEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC---CCcceeeeeEEEeCCceEEEEEccCC
Q 012777 158 VEITKGTFR---IASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR---HPNVVQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 158 ~~lg~G~fg---~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~l~~~~~~~~~~~lv~e~~~~ 231 (456)
+.|+.|... .+...+..+++|+.... ....+..|...|+.+. ...+++++......+..++|||++++
T Consensus 42 ~~l~gG~~n~~y~v~~~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDEVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEECCSSSSEEEEEESSSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred EEeCCccceeeeEEEECCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 456666432 33446778999987532 2456788999888883 36688888888877889999999988
Q ss_pred CCH
Q 012777 232 GDL 234 (456)
Q Consensus 232 ~sL 234 (456)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0039 Score=61.71 Aligned_cols=30 Identities=27% Similarity=0.332 Sum_probs=26.5
Q ss_pred CeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 270 AIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 270 ~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
.++|+|++|.|||++.++ +.++||+.+...
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 499999999999999876 999999987654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0054 Score=58.50 Aligned_cols=32 Identities=31% Similarity=0.418 Sum_probs=27.1
Q ss_pred CCeEecCCCCCCeEeCCC----CCEEEeccCCcccc
Q 012777 269 EAIIHRDLEPSNILRDDS----GHLKVADFGLSKLL 300 (456)
Q Consensus 269 ~~ivH~Dikp~Nil~~~~----~~vkl~Dfgls~~~ 300 (456)
..++|+|+.+.|||++.+ +.+.++||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 359999999999999874 67999999987644
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.40 E-value=0.018 Score=53.56 Aligned_cols=72 Identities=18% Similarity=0.064 Sum_probs=44.6
Q ss_pred ccceeeeccEEEE---E-eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-C--CcceeeeeEEEeCCceEEEEE
Q 012777 155 SNSVEITKGTFRI---A-SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-H--PNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 155 ~~~~~lg~G~fg~---~-~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--p~iv~l~~~~~~~~~~~lv~e 227 (456)
...+.+|.|..+. + ..+|+.|++|+........ ...+..|...|+.+. . --+++.+... .-++|||
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 3445677665442 2 3478999999876432221 235678999988873 2 2345555542 3478999
Q ss_pred ccCCCC
Q 012777 228 YLPKGD 233 (456)
Q Consensus 228 ~~~~~s 233 (456)
|++++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 987664
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.17 E-value=0.012 Score=55.08 Aligned_cols=29 Identities=28% Similarity=0.330 Sum_probs=24.4
Q ss_pred CeEecCCCCCCeEeCCCCCEEEeccCCccc
Q 012777 270 AIIHRDLEPSNILRDDSGHLKVADFGLSKL 299 (456)
Q Consensus 270 ~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~ 299 (456)
.++|+|+.|.||+ ..++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5566789999987653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.94 E-value=0.033 Score=52.66 Aligned_cols=27 Identities=22% Similarity=0.256 Sum_probs=23.9
Q ss_pred CeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 270 AIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 270 ~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
.++|+|+++.|||++ + .+.++||+.+.
T Consensus 196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp EECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 489999999999999 4 89999998765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.66 E-value=0.011 Score=57.66 Aligned_cols=119 Identities=19% Similarity=0.276 Sum_probs=70.8
Q ss_pred CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEEccCCCCHH--------------H
Q 012777 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIVTEYLPKGDLR--------------A 236 (456)
Q Consensus 172 g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv~e~~~~~sL~--------------~ 236 (456)
+..|++|+.... . .....+.+|..+++.+. +.-..++++.+.. .+||||++|.+|. +
T Consensus 82 ~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~ 153 (379)
T 3feg_A 82 PREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIAT 153 (379)
T ss_dssp CSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHH
T ss_pred CCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHH
Confidence 478999986321 1 12345668999998884 3334667776643 2999999875442 1
Q ss_pred HHHH--cC--C----C--CHHHHHHHHHHHHH-------------------HHHH----HHhC-CCCCeEecCCCCCCeE
Q 012777 237 YLKQ--KG--A----L--KPTLAVKFALDIAR-------------------GMNY----LHEN-RPEAIIHRDLEPSNIL 282 (456)
Q Consensus 237 ~l~~--~~--~----l--~~~~~~~i~~ql~~-------------------aL~~----LH~~-~~~~ivH~Dikp~Nil 282 (456)
.+.+ .- + . -..++.++..++.. .+.. |... .+..++|+|+.+.||+
T Consensus 154 ~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil 233 (379)
T 3feg_A 154 KMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNIL 233 (379)
T ss_dssp HHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEE
T ss_pred HHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEE
Confidence 1111 10 1 1 12344445444322 1222 2222 1234999999999999
Q ss_pred eCCC----CCEEEeccCCcc
Q 012777 283 RDDS----GHLKVADFGLSK 298 (456)
Q Consensus 283 ~~~~----~~vkl~Dfgls~ 298 (456)
++.+ +.+.++||..+.
T Consensus 234 ~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 234 LLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EESCC---CCEEECCCTTCE
T ss_pred EcCCCCccCcEEEEecccCC
Confidence 9876 789999998765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.33 E-value=0.047 Score=51.48 Aligned_cols=29 Identities=24% Similarity=0.272 Sum_probs=25.1
Q ss_pred CeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 270 AIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 270 ~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
.++|+|+.+.|||++.++.+.++||+.+.
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 49999999999999987666899998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=85.92 E-value=0.48 Score=45.00 Aligned_cols=30 Identities=20% Similarity=0.426 Sum_probs=26.8
Q ss_pred CeEecCCCCCCeEeCCCCCEEEeccCCccc
Q 012777 270 AIIHRDLEPSNILRDDSGHLKVADFGLSKL 299 (456)
Q Consensus 270 ~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~ 299 (456)
.++|+|+.+.||+++.++.+.++||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 499999999999999888899999987654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.81 E-value=1.7 Score=38.28 Aligned_cols=113 Identities=10% Similarity=0.086 Sum_probs=74.8
Q ss_pred CCCcceeeeeEEEeCCceEEEEEccCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEecCCCCCCeE
Q 012777 205 RHPNVVQFLGAVTQSTPMMIVTEYLPKG-DLRAYLKQKGALKPTLAVKFALDIARGMN-YLHENRPEAIIHRDLEPSNIL 282 (456)
Q Consensus 205 ~hp~iv~l~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~l~~~~~~~i~~ql~~aL~-~LH~~~~~~ivH~Dikp~Nil 282 (456)
.||++ --..-..++.+.+.++.-+++ +... + ..++....++++.+|+.... ++++ -+|--+.|+|++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i---~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I---RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H---HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H---HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence 68887 233345666667766654332 3332 3 34888999999999988876 4543 478899999999
Q ss_pred eCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchh-HHHHHHHHHHHHcCCCCCC
Q 012777 283 RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVD-VFSFALILQEMIEGCPPFP 356 (456)
Q Consensus 283 ~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-iwslG~il~~l~~g~~pf~ 356 (456)
++.++.+++.-.|+-. -++|.-+. ..| +-..=|++..++.++..|.
T Consensus 117 f~~~~~p~i~hRGi~~----------------------~lpP~e~~------ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 117 FNRALEPFFLHVGVKE----------------------SLPPDEWD------DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp ECTTCCEEESCCEETT----------------------TBSSCSCC------HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EeCCCcEEEEEcCCcc----------------------cCCCCCCC------HHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999887522 22332211 122 2356678888887777763
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=83.76 E-value=0.47 Score=45.49 Aligned_cols=28 Identities=32% Similarity=0.572 Sum_probs=23.7
Q ss_pred CeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 270 AIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 270 ~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
.++|+|+.+.|||++.++ +.++||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 499999999999998654 8999998765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=80.85 E-value=0.57 Score=46.12 Aligned_cols=53 Identities=11% Similarity=0.182 Sum_probs=33.7
Q ss_pred CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEEccCCCC
Q 012777 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIVTEYLPKGD 233 (456)
Q Consensus 172 g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv~e~~~~~s 233 (456)
+..+++|+.... .. ...+..|..+++.+. +.-.+++++.+.. .+|+||++|.+
T Consensus 105 ~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~ 158 (429)
T 1nw1_A 105 PNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP 158 (429)
T ss_dssp CSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred CceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcc
Confidence 578999988432 12 134557998888884 3223667766542 38899987643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=80.66 E-value=0.79 Score=45.55 Aligned_cols=69 Identities=12% Similarity=0.003 Sum_probs=38.1
Q ss_pred eeeeccEEE---EEeEcC--cEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcc-eeeeeEEEeCCceEEEEEccCC
Q 012777 158 VEITKGTFR---IASWRG--TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNV-VQFLGAVTQSTPMMIVTEYLPK 231 (456)
Q Consensus 158 ~~lg~G~fg---~~~~~g--~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~l~~~~~~~~~~~lv~e~~~~ 231 (456)
+.|+.|-.. .+...+ ..+++|+.......- -...+|..+++.+...++ +++++.+. + .+|+||++|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~----idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI----INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC----SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh----cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 345544322 334444 789999875321000 011478888888854333 56777763 2 359999976
Q ss_pred CCH
Q 012777 232 GDL 234 (456)
Q Consensus 232 ~sL 234 (456)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 456 | ||||
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-62 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-51 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-51 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-45 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-26 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 1e-23 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 3e-17 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 2e-15 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 1e-13 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 3e-13 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 8e-13 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 3e-12 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-21 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 3e-19 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 5e-14 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 6e-11 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 1e-10 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 2e-07 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 6e-17 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 8e-11 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 2e-10 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 1e-06 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 2e-06 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 0.001 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 3e-16 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 3e-14 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 4e-12 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 1e-08 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 3e-07 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 1e-05 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 8e-16 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 2e-10 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 3e-10 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 7e-09 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 4e-14 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 5e-13 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 2e-12 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 3e-11 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 3e-08 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 9e-14 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 4e-13 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 1e-10 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 3e-09 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 1e-13 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 9e-09 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 4e-07 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 8e-07 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 2e-06 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 2e-13 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 9e-05 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 3e-13 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 7e-11 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 4e-09 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 4e-07 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 9e-13 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 6e-09 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 3e-06 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 2e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-10 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 4e-10 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 1e-09 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 3e-08 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 1e-07 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 2e-05 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 6e-10 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 9e-09 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 5e-08 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 0.002 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 7e-08 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 1e-06 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 6e-05 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 0.002 | |
| d1bd8a_ | 156 | d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma | 1e-07 | |
| d1bd8a_ | 156 | d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma | 1e-04 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 1e-07 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 2e-05 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 2e-05 | |
| d1ycsb1 | 130 | d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) | 4e-07 | |
| d1ycsb1 | 130 | d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) | 3e-05 | |
| d1ycsb1 | 130 | d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) | 0.002 | |
| d1bi7b_ | 125 | d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Huma | 6e-04 | |
| d1bi7b_ | 125 | d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Huma | 8e-04 |
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-62
Identities = 81/277 (29%), Positives = 136/277 (49%), Gaps = 28/277 (10%)
Query: 145 YEIDPKELDFSNSVEITKGTF---RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALL 201
+ ++ KEL I KG F + +RG +VAVK + ++ +AF+ E +++
Sbjct: 2 WALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVM 54
Query: 202 QKIRHPNVVQFLGAVTQS-TPMMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIAR 258
++RH N+VQ LG + + + IVTEY+ KG L YL+ +G L +KF+LD+
Sbjct: 55 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 259 GMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS 318
M YL N +HRDL N+L + KV+DFGL+K +
Sbjct: 115 AMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA--------SSTQDTGKLP 163
Query: 319 WRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRA 377
++ APE + +++ TK DV+SF ++L E+ G P+P K+V +
Sbjct: 164 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA-- 221
Query: 378 PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
+ E++++CW + RP+F Q+ +L+ I
Sbjct: 222 -PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 7e-62
Identities = 72/284 (25%), Positives = 134/284 (47%), Gaps = 20/284 (7%)
Query: 144 EYEIDPKELDFSNSVEITKGTF---RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELAL 200
++EI ++ I G+F W G VAVK L T + ++AF +E+ +
Sbjct: 2 DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQ-LQAFKNEVGV 57
Query: 201 LQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL-KQKGALKPTLAVKFALDIARG 259
L+K RH N++ F+G T + IVT++ L +L + + + A A+G
Sbjct: 58 LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 260 MNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSW 319
M+YLH IIHRDL+ +NI + +K+ DFGL+ + + + ++ S
Sbjct: 117 MDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG---SI 170
Query: 320 RYAAPEVYKNEE---YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE--RPP 374
+ APEV + ++ Y + DV++F ++L E++ G P+ ++ + P
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230
Query: 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418
++ ++ L+ +C ++ RP F QIL ++ ++ L
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 3e-59
Identities = 67/270 (24%), Positives = 116/270 (42%), Gaps = 23/270 (8%)
Query: 144 EYEIDPKELDFSNSVEITKGTF---RIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDEL 198
++ ++ DF + KG F +A + +A+K L + E+
Sbjct: 2 QWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 57
Query: 199 ALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIAR 258
+ +RHPN+++ G +T + ++ EY P G + L++ + ++A
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 117
Query: 259 GMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS 318
++Y H R +IHRD++P N+L +G LK+ADFG S T +
Sbjct: 118 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA-------PSSRRTTLCGT 167
Query: 319 WRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAP 378
Y PE+ + +D KVD++S ++ E + G PPF +E K I+ F
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-ISRVEFTFPD- 225
Query: 379 TTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
G R+LI P +RP R++L
Sbjct: 226 --FVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (493), Expect = 4e-59
Identities = 76/278 (27%), Positives = 121/278 (43%), Gaps = 25/278 (8%)
Query: 141 EVPE--YEIDPKELDFSNSVEITKGTF---RIASWR--GTQVAVKTLGEEVFTDEDKVKA 193
+V E ++ DP++L FS+ EI G+F A VA+K + +K +
Sbjct: 3 DVAELFFKDDPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 194 FIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFA 253
I E+ LQK+RHPN +Q+ G + +V EY K L+
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT 121
Query: 254 LDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT 313
+G+ YLH + +IHRD++ NIL + G +K+ DFG + ++ AN+
Sbjct: 122 HGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------ 172
Query: 314 CEETSWRYAAPEVY---KNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN 370
+ + APEV +YD KVDV+S + E+ E PP N
Sbjct: 173 ---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229
Query: 371 ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
E P ++ H++ R ++ C + P RPT +L
Sbjct: 230 ESPALQSG--HWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 6e-58
Identities = 72/274 (26%), Positives = 127/274 (46%), Gaps = 22/274 (8%)
Query: 147 IDPKELDFSNSVEITKGTF---RIASWR-GTQVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
IDPK+L F E+ G F + WR VA+K + E ++++ FI+E ++
Sbjct: 1 IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL-KQKGALKPTLAVKFALDIARGMN 261
+ H +VQ G T+ P+ I+TEY+ G L YL + + + ++ D+ M
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114
Query: 262 YLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRY 321
YL + +HRDL N L +D G +KV+DFGLS+ + + R+
Sbjct: 115 YLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS----SVGSKFPVRW 167
Query: 322 AAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANERPPFRAPTT 380
+ PEV ++ +K D+++F +++ E+ G P+ E + R
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PH 224
Query: 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
+ + ++ CW E+ RPTF+ +L + D+
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 1e-57
Identities = 64/287 (22%), Positives = 123/287 (42%), Gaps = 21/287 (7%)
Query: 144 EYEIDPKELDFSNSVEITKGTF-------RIASWRGTQVAVKTLGEEVFTDEDKVKAFID 196
+ + L ++ +E+ G F + VA+K L + T++ + +
Sbjct: 2 KLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMR 58
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL-KQKGALKPTLAVKFALD 255
E ++ ++ +P +V+ +G V Q+ +M+V E G L +L ++ + + +
Sbjct: 59 EAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117
Query: 256 IARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCE 315
++ GM YL E +HRDL N+L + + K++DFGLSK L ++ R
Sbjct: 118 VSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK- 173
Query: 316 ETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANERPP 374
++ APE ++ ++ DV+S+ + + E + G P+ + EV +R
Sbjct: 174 -WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 232
Query: 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIK 421
L L+ DCW + RP F + R+ L+ K
Sbjct: 233 CPP---ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-57
Identities = 61/263 (23%), Positives = 117/263 (44%), Gaps = 22/263 (8%)
Query: 159 EITKGTF---RIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
I G++ + + G + K L T+ +K + + E+ LL++++HPN+V++
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHPNIVRYY 69
Query: 214 GAVTQST--PMMIVTEYLPKGDLRAYL----KQKGALKPTLAVKFALDIARGMNYLHENR 267
+ T + IV EY GDL + + K++ L ++ + + H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 268 PEA--IIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPE 325
++HRDL+P+N+ D ++K+ DFGL+++L + + T Y +PE
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT-----PYYMSPE 184
Query: 326 VYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG 385
Y+ K D++S +L E+ PPF +KE+ + Y+
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY---RYSDE 241
Query: 386 LRELIEDCWSEEPFRRPTFRQIL 408
L E+I + + + RP+ +IL
Sbjct: 242 LNEIITRMLNLKDYHRPSVEEIL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-57
Identities = 67/269 (24%), Positives = 118/269 (43%), Gaps = 14/269 (5%)
Query: 146 EIDPKELDFSNSVEITKGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELAL 200
+++P++ + E+ G F A + T A K + + E++++ ++ E+ +
Sbjct: 7 DLNPED-FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDI 62
Query: 201 LQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL-KQKGALKPTLAVKFALDIARG 259
L HPN+V+ L A + I+ E+ G + A + + + L +
Sbjct: 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122
Query: 260 MNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSW 319
+NYLH+N+ IIHRDL+ NIL G +K+ADFG+S ++ T +
Sbjct: 123 LNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 179
Query: 320 RYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPT 379
E K+ YD K DV+S + L EM E PP V +E P P
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP- 238
Query: 380 THYAYGLRELIEDCWSEEPFRRPTFRQIL 408
+ ++ ++ ++ C + R T Q+L
Sbjct: 239 SRWSSNFKDFLKKCLEKNVDARWTTSQLL 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-57
Identities = 82/279 (29%), Positives = 131/279 (46%), Gaps = 24/279 (8%)
Query: 143 PEYEIDPKELDFSNSVEITKGTF---RIASWR-GTQVAVKTLGEEVFTDEDKVKAFIDEL 198
E+E+ + L + G F + + T+VAVK+L + AF+ E
Sbjct: 6 DEWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLKQ----GSMSPDAFLAEA 59
Query: 199 ALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTL--AVKFALDI 256
L+++++H +V+ VTQ P+ I+TEY+ G L +LK +K T+ + A I
Sbjct: 60 NLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 257 ARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEE 316
A GM ++ E IHRDL +NIL D+ K+ADFGL++L++ E +
Sbjct: 119 AEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED----NEYTAREGAK 171
Query: 317 TSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANERPPF 375
++ APE + K DV+SF ++L E++ G P+P EV + R
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
+ L +L+ CW E P RPTF + L+D
Sbjct: 232 ---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 6e-57
Identities = 70/276 (25%), Positives = 120/276 (43%), Gaps = 19/276 (6%)
Query: 147 IDPKELDFSNSVEITKGTF---RIASWR----GTQVAVKTLGEEVFTDEDKVKAFIDELA 199
+D K L + E+ G F + ++ VAVK L E D + E
Sbjct: 3 LDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEAN 60
Query: 200 LLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARG 259
++Q++ +P +V+ +G M+V E G L YL+Q +K ++ ++ G
Sbjct: 61 VMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 119
Query: 260 MNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSW 319
M YL E+ +HRDL N+L + K++DFGLSK L+ + +
Sbjct: 120 MKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK--WPV 174
Query: 320 RYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANERPPFRAP 378
++ APE ++ +K DV+SF +++ E G P+ + EV ER A
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA- 233
Query: 379 TTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
+ +L+ CW+ + RP F + +RL +
Sbjct: 234 --GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-56
Identities = 82/276 (29%), Positives = 137/276 (49%), Gaps = 22/276 (7%)
Query: 147 IDPKELDFSNSVEITKGTF---RIASWR-GTQVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
IDP EL F EI G F + W +VA+KT+ E ++ED FI+E ++
Sbjct: 2 IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMM 55
Query: 203 KIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKP-TLAVKFALDIARGMN 261
K+ HP +VQ G + P+ +V E++ G L YL+ + L + LD+ GM
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 262 YLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRY 321
YL E +IHRDL N L ++ +KV+DFG+++ + + T + ++
Sbjct: 116 YLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSSTGTKFPVKW 168
Query: 322 AAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANERPPFRAPTT 380
A+PEV+ Y +K DV+SF +++ E+ EG P+ + EV + R
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PR 225
Query: 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416
+ + +++ CW E P RP F ++L +L +I++
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-55
Identities = 70/307 (22%), Positives = 118/307 (38%), Gaps = 56/307 (18%)
Query: 147 IDPKELDFSNSVEITKGTF---RIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALL 201
++ K+ DF E+ G S + G +A K + E+ I EL +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVL 58
Query: 202 QKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMN 261
+ P +V F GA + I E++ G L LK+ G + + K ++ + +G+
Sbjct: 59 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT 118
Query: 262 YLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRY 321
YL E I+HRD++PSNIL + G +K+ DFG+S L D + Y
Sbjct: 119 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSY 169
Query: 322 AAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER--------- 372
+PE + Y + D++S L L EM G P P KE+ +
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229
Query: 373 -------------------------------PPFRAPTTHYAYGLRELIEDCWSEEPFRR 401
PP + P+ ++ ++ + C + P R
Sbjct: 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 289
Query: 402 PTFRQIL 408
+Q++
Sbjct: 290 ADLKQLM 296
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-55
Identities = 74/299 (24%), Positives = 118/299 (39%), Gaps = 42/299 (14%)
Query: 159 EITKGTF---RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGA 215
I KG F WRG +VAVK + E++ E+ +RH N++ F+ A
Sbjct: 10 SIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 216 VTQS----TPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEA- 270
+ T + +V++Y G L YL + + +K AL A G+ +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 271 ----IIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEV 326
I HRDL+ NIL +G +AD GL+ A + P T RY APEV
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT-KRYMAPEV 183
Query: 327 Y------KNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERP------- 373
K+ E + D+++ L+ E+ C ++ ++P + P
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 374 -----------PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIK 421
P R + + +++ +CW R T +I L +S Q IK
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (466), Expect = 3e-55
Identities = 82/277 (29%), Positives = 135/277 (48%), Gaps = 16/277 (5%)
Query: 146 EIDPKELDFSNSV------EITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELA 199
EID + + E+ G ++ R VA+KTL E + + F+ E +
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEAS 79
Query: 200 LLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIAR 258
++ + HPNV+ G VT+STP+MI+TE++ G L ++L+Q G V IA
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 259 GMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETS 318
GM YL + +HRDL NIL + + KV+DFGLS+ L+ + +
Sbjct: 140 GMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196
Query: 319 WRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANERPPFRA 377
R+ APE + ++ + DV+S+ +++ E++ G P+ ++V A + R P
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP--- 253
Query: 378 PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
P L +L+ DCW ++ RP F QI+ LD +
Sbjct: 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 1e-54
Identities = 55/237 (23%), Positives = 107/237 (45%), Gaps = 13/237 (5%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G +VA++ + + K + I+E+ ++++ ++PN+V +L + + +V EYL
Sbjct: 45 GQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
G L + + + + + +LH N+ +IHRD++ NIL G +K+
Sbjct: 102 GSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG 351
DFG + E + + + APEV + Y KVD++S ++ EMIEG
Sbjct: 158 TDFGFCAQITP-----EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
Query: 352 CPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
PP+ + N P + P + R+ + C + +R + +++L
Sbjct: 213 EPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDFLNRCLDMDVEKRGSAKELL 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 1e-54
Identities = 68/260 (26%), Positives = 119/260 (45%), Gaps = 21/260 (8%)
Query: 159 EITKGTF---RIASWRGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
EI +G+F T +VA L + T ++ + F +E +L+ ++HPN+V+F
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQHPNIVRFY 74
Query: 214 GA----VTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPE 269
+ V +++VTE + G L+ YLK+ +K + + I +G+ +LH P
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP- 133
Query: 270 AIIHRDLEPSNIL-RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYK 328
IIHRDL+ NI +G +K+ D GL+ L + T + APE+Y+
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK------RASFAKAVIGTPE-FMAPEMYE 186
Query: 329 NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRE 388
+YD VDV++F + + EM P+ Q + + P ++E
Sbjct: 187 E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD-KVAIPEVKE 244
Query: 389 LIEDCWSEEPFRRPTFRQIL 408
+IE C + R + + +L
Sbjct: 245 IIEGCIRQNKDERYSIKDLL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-54
Identities = 65/255 (25%), Positives = 106/255 (41%), Gaps = 10/255 (3%)
Query: 162 KGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221
+G + S + VAVK L +V + + + FI E+ + + H N+++ G V + P
Sbjct: 26 RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPP 84
Query: 222 MMIVTEYLPKGDLRAY-LKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSN 280
M +VTE P G L K +G ++A+ +A GM YL R IHRDL N
Sbjct: 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARN 141
Query: 281 ILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFS 340
+L +K+ DFGL + L + + + + APE K + D +
Sbjct: 142 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK--VPFAWCAPESLKTRTFSHASDTWM 199
Query: 341 FALILQEMI-EGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPF 399
F + L EM G P+ ++ R + ++ CW+ +P
Sbjct: 200 FGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE--DCPQDIYNVMVQCWAHKPE 257
Query: 400 RRPTFRQILMRLDDI 414
RPTF + L +
Sbjct: 258 DRPTFVALRDFLLEA 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 3e-54
Identities = 63/256 (24%), Positives = 112/256 (43%), Gaps = 15/256 (5%)
Query: 159 EITKGTF---RIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
+ +G + ++A R VAVK + ++ D + E+ + + + H NVV+F
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIH 273
G + + EY G+L ++ + A +F + G+ YLH I H
Sbjct: 70 GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITH 126
Query: 274 RDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYD 333
RD++P N+L D+ +LK++DFGL+ + ++ N +R + + Y APE+ K E+
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNN---RERLLNKMCGTLPYVAPELLKRREFH 183
Query: 334 T-KVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIED 392
VDV+S ++L M+ G P+ + + E+ + P L+
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 393 CWSEEPFRRPTFRQIL 408
E P R T I
Sbjct: 243 ILVENPSARITIPDIK 258
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-53
Identities = 74/305 (24%), Positives = 124/305 (40%), Gaps = 47/305 (15%)
Query: 143 PEYEIDPKELDFSNSVEITKGTF---RIASWRGT-------QVAVKTLGEEVFTDEDKVK 192
++E + L+F + G F A+ G QVAVK L E+ D + +
Sbjct: 30 LKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSERE 85
Query: 193 AFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQK---------- 241
A + EL ++ ++ H N+V LGA T S P+ ++ EY GDL YL+ K
Sbjct: 86 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145
Query: 242 -------------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288
L + FA +A+GM +L +HRDL N+L
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKV 202
Query: 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEM 348
+K+ DFGL++ + + ++ APE Y K DV+S+ ++L E+
Sbjct: 203 VKICDFGLARDI---MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 259
Query: 349 I-EGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQI 407
G P+P I N + + + +++ CW+ + +RP+F +
Sbjct: 260 FSLGVNPYPGIPVDANFYKLIQNGFKMDQPF--YATEEIYIIMQSCWAFDSRKRPSFPNL 317
Query: 408 LMRLD 412
L
Sbjct: 318 TSFLG 322
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-53
Identities = 86/278 (30%), Positives = 132/278 (47%), Gaps = 24/278 (8%)
Query: 144 EYEIDPKELDFSNSVEITKGTF---RIASWRGT-QVAVKTLGEEVFTDEDKVKAFIDELA 199
+EI + L ++ +G F + +W GT +VA+KTL + E F+ E
Sbjct: 11 AWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQ 64
Query: 200 LLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTL--AVKFALDIA 257
+++K+RH +VQ V++ P+ IVTEY+ KG L +LK + L V A IA
Sbjct: 65 VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 123
Query: 258 RGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEET 317
GM Y+ +HRDL +NIL ++ KVADFGL++L+ E +
Sbjct: 124 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKF 176
Query: 318 SWRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANERPPFR 376
++ APE + K DV+SF ++L E+ +G P+P +EV R P
Sbjct: 177 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 236
Query: 377 APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
L +L+ CW +EP RPTF + L+D
Sbjct: 237 P---ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (446), Expect = 2e-52
Identities = 78/289 (26%), Positives = 134/289 (46%), Gaps = 24/289 (8%)
Query: 141 EVPEYEIDPKELDFSNSVEITKGTF---RIASWR--GTQVAVKTLGEEVFTDEDKVKAFI 195
++E++ ++ + ++ G + W+ VAVKTL E D +V+ F+
Sbjct: 8 NYDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFL 61
Query: 196 DELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYL--KQKGALKPTLAVKFA 253
E A++++I+HPN+VQ LG T+ P I+TE++ G+L YL + + + + A
Sbjct: 62 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121
Query: 254 LDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVT 313
I+ M YL + IHRDL N L ++ +KVADFGLS+L+
Sbjct: 122 TQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 314 CEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANER 372
++ APE ++ K DV++F ++L E+ G P+P +V + + R
Sbjct: 179 P----IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 234
Query: 373 PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIK 421
+ EL+ CW P RP+F +I + + + SI
Sbjct: 235 MERPE---GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 280
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 2e-52
Identities = 53/252 (21%), Positives = 102/252 (40%), Gaps = 17/252 (6%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
+ A+K L + E+KV E ++ ++ HP V+ + Y
Sbjct: 33 SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 92
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
G+L Y+++ G+ T + +I + YLH IIHRDL+P NIL ++ H+++
Sbjct: 93 GELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQI 149
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG 351
DFG + K + + + +Y +PE+ + D+++ I+ +++ G
Sbjct: 150 TDFGTA---KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206
Query: 352 CPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411
PPF E + + I F + R+L+E + +R ++
Sbjct: 207 LPPFRAGNEYLIFQK-IIKLEYDF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 262
Query: 412 DDISDQLSIKRH 423
+K H
Sbjct: 263 P-------LKAH 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-52
Identities = 65/282 (23%), Positives = 133/282 (47%), Gaps = 21/282 (7%)
Query: 144 EYEIDPKELDFSNSV------EITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDE 197
+YEI + ++ + ++ +G + VA+KT + T + + F+ E
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQE 58
Query: 198 LALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAY-LKQKGALKPTLAVKFALDI 256
+++ HP++V+ +G +T++ P+ I+ E G+LR++ +K +L + +A +
Sbjct: 59 ALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 257 ARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEE 316
+ + YL R +HRD+ N+L + +K+ DFGLS+ ++ + K + +
Sbjct: 118 STALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK----ASKGK 170
Query: 317 TSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANERPPF 375
++ APE + + DV+ F + + E++ G PF + +V ER P
Sbjct: 171 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 230
Query: 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417
+ L L+ CW+ +P RRP F ++ +L I ++
Sbjct: 231 PP---NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 176 bits (446), Expect = 1e-51
Identities = 52/240 (21%), Positives = 101/240 (42%), Gaps = 15/240 (6%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G A K + E + E+ + +RHP +V A M+++ E++
Sbjct: 51 GNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107
Query: 232 GDLRAYL-KQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL--RDDSGH 288
G+L + + + AV++ + +G+ ++HEN +H DL+P NI+ S
Sbjct: 108 GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNE 164
Query: 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEM 348
LK+ DFGL+ L + V + +AAPEV + + D++S ++ +
Sbjct: 165 LKLIDFGLTAHLD------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 218
Query: 349 IEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
+ G PF + + E + + + + + + ++ I +P R T Q L
Sbjct: 219 LSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQAL 278
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (441), Expect = 2e-51
Identities = 63/258 (24%), Positives = 116/258 (44%), Gaps = 19/258 (7%)
Query: 159 EITKGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
+ G F +A + TQ VA+K + ++ E K + +E+A+L KI+HPN+V
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIH 273
+ ++ + + G+L + +KG A + + + YLH+ I+H
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVH 130
Query: 274 RDLEPSNIL---RDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNE 330
RDL+P N+L D+ + ++DFGLSK+ ++ + Y APEV +
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKME------DPGSVLSTACGTPGYVAPEVLAQK 184
Query: 331 EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELI 390
Y VD +S +I ++ G PPF + + ++ + + E + ++ I
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244
Query: 391 EDCWSEEPFRRPTFRQIL 408
++P +R T Q L
Sbjct: 245 RHLMEKDPEKRFTCEQAL 262
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 7e-51
Identities = 73/295 (24%), Positives = 132/295 (44%), Gaps = 20/295 (6%)
Query: 140 REVPEYEIDPKELDFSNSVEITKGTF--------RIASWRGTQVAVKTLGEEVFTDEDKV 191
+ V I P L + I +G F + AVK+L TD +V
Sbjct: 15 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEV 72
Query: 192 KAFIDELALLQKIRHPNVVQFLGAVTQS-TPMMIVTEYLPKGDLRAYLKQKGA-LKPTLA 249
F+ E +++ HPNV+ LG +S ++V Y+ GDLR +++ +
Sbjct: 73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 132
Query: 250 VKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKED 309
+ F L +A+GM +L + +HRDL N + D+ +KVADFGL++ + +
Sbjct: 133 IGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSV 188
Query: 310 RPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYI 368
T + ++ A E + +++ TK DV+SF ++L E++ G PP+P ++ +
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 248
Query: 369 ANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRH 423
R + L E++ CW + RP+F +++ R+ I + +
Sbjct: 249 QGRRLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 300
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (440), Expect = 9e-51
Identities = 45/240 (18%), Positives = 100/240 (41%), Gaps = 15/240 (6%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G K + D+ +E++++ ++ HP ++ A M+++ E+L
Sbjct: 54 GRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110
Query: 232 GDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL--RDDSGH 288
G+L + + + + + G+ ++HE+ I+H D++P NI+ +
Sbjct: 111 GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASS 167
Query: 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEM 348
+K+ DFGL+ L D V + +AAPE+ E D+++ ++ +
Sbjct: 168 VKIIDFGLATKLN------PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVL 221
Query: 349 IEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
+ G PF + + E + + + + ++ I++ +EP +R T L
Sbjct: 222 LSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 281
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 171 bits (433), Expect = 1e-50
Identities = 56/244 (22%), Positives = 107/244 (43%), Gaps = 10/244 (4%)
Query: 172 GTQVAVKTL------GEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMI 224
+ AVK + ++ +A + E+ +L+K+ HPN++Q +T +
Sbjct: 28 CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87
Query: 225 VTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD 284
V + + KG+L YL +K L K + + LH+ I+HRDL+P NIL D
Sbjct: 88 VFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLD 144
Query: 285 DSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALI 344
D ++K+ DFG S L ++E + Y +VD++S +I
Sbjct: 145 DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 204
Query: 345 LQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTF 404
+ ++ G PPF +++ + + ++ Y+ +++L+ +P +R T
Sbjct: 205 MYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA 264
Query: 405 RQIL 408
+ L
Sbjct: 265 EEAL 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (434), Expect = 1e-50
Identities = 74/268 (27%), Positives = 111/268 (41%), Gaps = 36/268 (13%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
T VAVK L EE D F E AL+ + +PN+V+ LG PM ++ EY+
Sbjct: 43 FTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAY 100
Query: 232 GDLRAYLKQKG------------------------ALKPTLAVKFALDIARGMNYLHENR 267
GDL +L+ L + A +A GM YL E +
Sbjct: 101 GDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 160
Query: 268 PEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVY 327
+HRDL N L ++ +K+ADFGLS+ + A+ K D + R+ PE
Sbjct: 161 ---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAD---GNDAIPIRWMPPESI 214
Query: 328 KNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386
Y T+ DV+++ ++L E+ G P+ +EV + L
Sbjct: 215 FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACP---ENCPLEL 271
Query: 387 RELIEDCWSEEPFRRPTFRQILMRLDDI 414
L+ CWS+ P RP+F I L +
Sbjct: 272 YNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 3e-50
Identities = 75/301 (24%), Positives = 122/301 (40%), Gaps = 40/301 (13%)
Query: 143 PEYEIDPKELDFSNSVEITKGTF----------RIASWRGTQVAVKTLGEEVFTDEDKVK 192
++E L F + G F I S VAVK L + + +
Sbjct: 16 HKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTERE 71
Query: 193 AFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG--------- 242
A + EL +L + H N+V LGA T P +++TEY GDL +L++K
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 243 ---------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293
AL + F+ +A+GM +L IHRDL NIL K+ D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 188
Query: 294 FGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCP 353
FGL++ +K + ++ APE N Y + DV+S+ + L E+
Sbjct: 189 FGLARDIKNDSN---YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
Query: 354 PFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDD 413
+ + E +P H + ++++ CW +P +RPTF+QI+ ++
Sbjct: 246 SPYPGMPVDSKFYKMIKEGFRMLSP-EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
Query: 414 I 414
Sbjct: 305 Q 305
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-49
Identities = 84/302 (27%), Positives = 136/302 (45%), Gaps = 43/302 (14%)
Query: 143 PEYEIDPKELDFSNSVEITKGTF------------RIASWRGTQVAVKTLGEEVFTDEDK 190
P +E+ L + +G F + R T+VAVK L + E
Sbjct: 6 PRWELPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKD 61
Query: 191 VKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG------- 242
+ I E+ +++ I +H N++ LGA TQ P+ ++ EY KG+LR YL+ +
Sbjct: 62 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121
Query: 243 ---------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVAD 293
L V A +ARGM YL + IHRDL N+L + +K+AD
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIAD 178
Query: 294 FGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGC 352
FGL++ + + + + T ++ APE + Y + DV+SF ++L E+ G
Sbjct: 179 FGLARDI---HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
Query: 353 PPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412
P+P +E+ K R ++ L ++ DCW P +RPTF+Q++ LD
Sbjct: 236 SPYPGVPVEELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 413 DI 414
I
Sbjct: 293 RI 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-49
Identities = 42/240 (17%), Positives = 92/240 (38%), Gaps = 16/240 (6%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
K V E+++L RH N++ + ++++ E++
Sbjct: 30 KKTYMAK----FVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85
Query: 232 GDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNIL--RDDSGH 288
D+ + L V + + + +LH + I H D+ P NI+ S
Sbjct: 86 LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSST 142
Query: 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEM 348
+K+ +FG ++ LK + T+ Y APEV++++ T D++S ++ +
Sbjct: 143 IKIIEFGQARQLKPGDNF------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVL 196
Query: 349 IEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
+ G PF + +++ + + E + + ++ +E R T + L
Sbjct: 197 LSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEAL 256
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 5e-49
Identities = 69/258 (26%), Positives = 118/258 (45%), Gaps = 18/258 (6%)
Query: 159 EITKGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQK-IRHPNVVQF 212
+ KG+F +A ++ T A+K L ++V +D V+ + E +L HP +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 213 LGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAII 272
+ V EYL GDL +++ + A +A +I G+ +LH I+
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IV 125
Query: 273 HRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEY 332
+RDL+ NIL D GH+K+ADFG+ K + T Y APE+ ++Y
Sbjct: 126 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT-----PDYIAPEILLGQKY 180
Query: 333 DTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIED 392
+ VD +SF ++L EM+ G PF + E+E+ I + P + ++L+
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH-SIRMDNPFYPR---WLEKEAKDLLVK 236
Query: 393 CWSEEPFRRPTFRQILMR 410
+ EP +R R + +
Sbjct: 237 LFVREPEKRLGVRGDIRQ 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 5e-49
Identities = 66/275 (24%), Positives = 113/275 (41%), Gaps = 21/275 (7%)
Query: 150 KELDFSNSVEITKGTF---RIASWRGT------QVAVKTLGEEVFTDEDKVKAFIDELAL 200
KE +F + G F W VA+K L E T K +DE +
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYV 64
Query: 201 LQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGM 260
+ + +P+V + LG ST +I L + K + + + + IA+GM
Sbjct: 65 MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 261 NYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWR 320
NYL + R ++HRDL N+L H+K+ DFGL+KLL + + +
Sbjct: 125 NYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPIK 178
Query: 321 YAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANERPPFRAPT 379
+ A E + Y + DV+S+ + + E++ G P+ E+ ER P
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP-- 236
Query: 380 THYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
+ ++ CW + RP FR++++ +
Sbjct: 237 -ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-48
Identities = 78/294 (26%), Positives = 130/294 (44%), Gaps = 41/294 (13%)
Query: 146 EIDPKELDFSNSVEITKGTF---RIASWRGT----QVAVKTLGEEVFTDEDKVKAFIDEL 198
+D ++ F + I +G F A + A+K + + + +D + F EL
Sbjct: 6 VLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGEL 61
Query: 199 ALLQKI-RHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQK---------------- 241
+L K+ HPN++ LGA + + EY P G+L +L++
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 242 GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301
L + FA D+ARGM+YL + + IHRDL NIL ++ K+ADFGLS+
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRG-- 176
Query: 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQE 360
+ T R+ A E Y T DV+S+ ++L E++ G P+
Sbjct: 177 ----QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232
Query: 361 KEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
E+ + R + + +L+ CW E+P+ RP+F QIL+ L+ +
Sbjct: 233 AELYEKLPQGYRLEKPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 3e-48
Identities = 76/280 (27%), Positives = 124/280 (44%), Gaps = 23/280 (8%)
Query: 146 EIDPKELDFSNSVEITKGTF---RIASWRGTQ------VAVKTLGEEVFTDEDKVKAFID 196
EI P + I G F + + VA+KTL E + F+
Sbjct: 3 EIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLG 58
Query: 197 ELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGD-LRAYLKQKGALKPTLAVKFALD 255
E ++ + H N+++ G +++ PMMI+TEY+ G + ++ G V
Sbjct: 59 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 256 IARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCE 315
IA GM YL +HRDL NIL + + KV+DFGLS++L+ + + +
Sbjct: 119 IAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEATYTTSGG 173
Query: 316 ETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI-EGCPPFPTKQEKEVPKAYIANERPP 374
+ R+ APE ++ + DV+SF +++ E++ G P+ EV KA R P
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 233
Query: 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414
+ +L+ CW +E RRP F I+ LD +
Sbjct: 234 TPM---DCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (415), Expect = 5e-48
Identities = 61/248 (24%), Positives = 106/248 (42%), Gaps = 13/248 (5%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP----MMIVTE 227
VAVK L ++ D F E + HP +V TP IV E
Sbjct: 32 HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 91
Query: 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
Y+ LR + +G + P A++ D + +N+ H+N IIHRD++P+NI+ +
Sbjct: 92 YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATN 148
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQE 347
+KV DFG+++ + + + +Y +PE + + D + DV+S +L E
Sbjct: 149 AVKVMDFGIARAIADSGNSVTQTAAVI--GTAQYLSPEQARGDSVDARSDVYSLGCVLYE 206
Query: 348 MIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPT---- 403
++ G PPF V ++ + P A + L ++ ++ P R
Sbjct: 207 VLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 266
Query: 404 FRQILMRL 411
R L+R+
Sbjct: 267 MRADLVRV 274
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-47
Identities = 68/294 (23%), Positives = 136/294 (46%), Gaps = 34/294 (11%)
Query: 144 EYEIDPKELDFSNSVEITKGTF----------RIASWRGTQVAVKTLGEEVFTDEDKVKA 193
E+E+ +++ S E+ +G+F + T+VA+KT+ E +
Sbjct: 14 EWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIE 69
Query: 194 FIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG----------A 243
F++E +++++ +VV+ LG V+Q P +++ E + +GDL++YL+
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 244 LKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303
+ ++ A +IA GM YL+ N+ +HRDL N + + +K+ DFG+++ +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186
Query: 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGC-PPFPTKQEKE 362
+ R R+ +PE K+ + T DV+SF ++L E+ P+ ++
Sbjct: 187 DYY---RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243
Query: 363 VPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416
V + + + L EL+ CW P RP+F +I+ + + +
Sbjct: 244 VLRFVMEGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (402), Expect = 4e-45
Identities = 54/238 (22%), Positives = 99/238 (41%), Gaps = 13/238 (5%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDE---LALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228
G A+K L ++ + ++E L+L+ P +V A + + +
Sbjct: 29 GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 88
Query: 229 LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288
+ GDL +L Q G +A +I G+ ++H +++RDL+P+NIL D+ GH
Sbjct: 89 MNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGH 145
Query: 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEM 348
++++D GL+ + +P T A + K YD+ D FS +L ++
Sbjct: 146 VRISDLGLACDF------SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 199
Query: 349 IEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQ 406
+ G PF + K+ + P ++ LR L+E + RR
Sbjct: 200 LRGHSPFRQHKTKDKHEIDRMTLTMAVELP-DSFSPELRSLLEGLLQRDVNRRLGCLG 256
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-45
Identities = 60/262 (22%), Positives = 112/262 (42%), Gaps = 21/262 (8%)
Query: 159 EITKGTF---RIASWR--GTQVAVKTLGEEVFTDEDK---VKAFIDELALLQKIRHPNVV 210
E+ G F + + G Q A K + + + + E+++L++I+HPNV+
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 211 QFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEA 270
T ++++ E + G+L +L +K +L A +F I G+ YLH +
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--- 133
Query: 271 IIHRDLEPSNILRDDSG----HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEV 326
I H DL+P NI+ D +K+ DFGL+ + F N + + APE+
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF------KNIFGTPEFVAPEI 187
Query: 327 YKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386
E + D++S +I ++ G PF ++E A ++ +
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 247
Query: 387 RELIEDCWSEEPFRRPTFRQIL 408
++ I ++P +R T + L
Sbjct: 248 KDFIRRLLVKDPKKRMTIQDSL 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-44
Identities = 59/251 (23%), Positives = 103/251 (41%), Gaps = 31/251 (12%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGA----VTQSTPMMIVT 226
+ A+K L E+ L + + P++V+ + ++IV
Sbjct: 37 QEKFALKML--------QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88
Query: 227 EYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD 284
E L G+L + ++ +G A A + I + YLH I HRD++P N+L
Sbjct: 89 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYT 145
Query: 285 ---DSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSF 341
+ LK+ DFG +K +T + Y APEV E+YD D++S
Sbjct: 146 SKRPNAILKLTDFGFAKETT------SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 199
Query: 342 ALILQEMIEGCPPFPTKQEKEVP---KAYIANERPPFRAP-TTHYAYGLRELIEDCWSEE 397
+I+ ++ G PPF + + K I + F P + + ++ LI + E
Sbjct: 200 GVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 259
Query: 398 PFRRPTFRQIL 408
P +R T + +
Sbjct: 260 PTQRMTITEFM 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (388), Expect = 1e-43
Identities = 59/235 (25%), Positives = 109/235 (46%), Gaps = 15/235 (6%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G A+K L +E+ +V+ DE +L + HP +++ G + + ++ +Y+
Sbjct: 29 GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 88
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
G+L + L++ +A +A ++ + YLH II+RDL+P NIL D +GH+K+
Sbjct: 89 GELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKI 145
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG 351
DFG +K + P Y APEV + Y+ +D +SF +++ EM+ G
Sbjct: 146 TDFGFAKYVPDVTYTLCGTP--------DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 197
Query: 352 CPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQ 406
PF + + I N F + +++L+ + + +R Q
Sbjct: 198 YTPFYDSNTMKTYEK-ILNAELRFP---PFFNEDVKDLLSRLITRDLSQRLGNLQ 248
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (383), Expect = 3e-43
Identities = 41/260 (15%), Positives = 83/260 (31%), Gaps = 18/260 (6%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV-TQSTPMMIVTEYLP 230
G +VA+K + + K E + + ++ + + + ++V E L
Sbjct: 32 GEEVAIK-----LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86
Query: 231 KGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH-- 288
+ + A + + Y+H IHRD++P N L
Sbjct: 87 PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGN 143
Query: 289 -LKVADFGLSKLLKFANTVKEDRPVTCEET--SWRYAAPEVYKNEEYDTKVDVFSFALIL 345
+ + DFGL+K + A T + + + RYA+ + E + D+ S +L
Sbjct: 144 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 203
Query: 346 QEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYG----LRELIEDCWSEEPFRR 401
G P+ + + Y P G + C S +
Sbjct: 204 MYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDK 263
Query: 402 PTFRQILMRLDDISDQLSIK 421
P + + ++ +
Sbjct: 264 PDYSYLRQLFRNLFHRQGFS 283
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 4e-42
Identities = 63/245 (25%), Positives = 109/245 (44%), Gaps = 28/245 (11%)
Query: 172 GTQVAVKTLGEEVFTDEDKV---KAFIDELALLQKIR--HPNVVQFLGAVTQSTPMMIVT 226
VA+K + ++ +D ++ E+ LL+K+ V++ L + +++
Sbjct: 29 NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 88
Query: 227 EYL-PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD- 284
E P DL ++ ++GAL+ LA F + + + H ++HRD++ NIL D
Sbjct: 89 ERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDL 145
Query: 285 DSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTK-VDVFSFAL 343
+ G LK+ DFG LLK D T + + Y+ PE + Y + V+S +
Sbjct: 146 NRGELKLIDFGSGALLK-------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 198
Query: 344 ILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPT 403
+L +M+ G PF +E I + FR + + LI C + P RPT
Sbjct: 199 LLYDMVCGDIPFEHDEE-------IIRGQVFFR---QRVSSECQHLIRWCLALRPSDRPT 248
Query: 404 FRQIL 408
F +I
Sbjct: 249 FEEIQ 253
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-41
Identities = 78/303 (25%), Positives = 129/303 (42%), Gaps = 41/303 (13%)
Query: 141 EVPEYEIDPKELDFSNSVEITKGTF---RIASWRGT-------QVAVKTLGEEVFTDEDK 190
+ ++E L + +G F A G VAVK L E +
Sbjct: 4 DASKWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSE 59
Query: 191 VKAFIDELALLQKIRH-PNVVQFLGAVTQ-STPMMIVTEYLPKGDLRAYLKQKG------ 242
+A + EL +L I H NVV LGA T+ P+M++ E+ G+L YL+ K
Sbjct: 60 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119
Query: 243 ----------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVA 292
L + ++ +A+GM +L + IHRDL NIL + +K+
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKIC 176
Query: 293 DFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGC 352
DFGL++ + + ++ APE + Y + DV+SF ++L E+
Sbjct: 177 DFGLARDI---YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 233
Query: 353 -PPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRL 411
P+P + E + E RAP + + + + DCW EP +RPTF +++ L
Sbjct: 234 ASPYPGVKIDEEFCRRL-KEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
Query: 412 DDI 414
++
Sbjct: 292 GNL 294
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-40
Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 33/263 (12%)
Query: 172 GTQVAVKTL--GEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229
VA+K + G + + + E+ LLQ++ HPN++ L A + + +V +++
Sbjct: 23 NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82
Query: 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHL 289
L P+ + L +G+ YLH++ I+HRDL+P+N+L D++G L
Sbjct: 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVL 139
Query: 290 KVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI 349
K+ADFGL+K N + V T W A ++ Y VD+++ IL E++
Sbjct: 140 KLADFGLAKSFGSPNRAYTHQVV----TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 195
Query: 350 EGCPPFPTKQEKEVPKAYIAN------------------------ERPPFRAPTTHYAYG 385
P P + + P +
Sbjct: 196 LRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDD 255
Query: 386 LRELIEDCWSEEPFRRPTFRQIL 408
L +LI+ + P R T Q L
Sbjct: 256 LLDLIQGLFLFNPCARITATQAL 278
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-40
Identities = 59/235 (25%), Positives = 102/235 (43%), Gaps = 12/235 (5%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G A+K L +EV +D+V + E +LQ RHP + A + V EY
Sbjct: 30 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
G+L +L ++ A + +I + YLH +++RD++ N++ D GH+K+
Sbjct: 90 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKI 146
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG 351
DFGL K + T E Y APEV ++ +Y VD + +++ EM+ G
Sbjct: 147 TDFGLCKEGISDGATMKTFCGTPE-----YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
Query: 352 CPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQ 406
PF + + + + I E F + + L+ ++P +R
Sbjct: 202 RLPFYNQDHERLFEL-ILMEEIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGP 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (363), Expect = 2e-40
Identities = 36/261 (13%), Positives = 82/261 (31%), Gaps = 18/261 (6%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
QVA+K +D +++ LL V + G + ++V + L
Sbjct: 30 NQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFG--QEGLHNVLVIDLLGP 85
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD-----S 286
A + + +HE +++RD++P N L +
Sbjct: 86 SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNA 142
Query: 287 GHLKVADFGLSKLLKFANTVKEDRPVTCEET--SWRYAAPEVYKNEEYDTKVDVFSFALI 344
+ V DFG+ K + T + + + RY + + E + D+ + +
Sbjct: 143 NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHV 202
Query: 345 LQEMIEGCPPFPTKQEKEVPKAYI----ANERPPFRAPTTHYAYGLRELIEDCWSEEPFR 400
+ G P+ + + Y + P R + + + +
Sbjct: 203 FMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDA 262
Query: 401 RPTFRQILMRLDDISDQLSIK 421
P + + + ++L+
Sbjct: 263 TPDYDYLQGLFSKVLERLNTT 283
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 139 bits (351), Expect = 1e-38
Identities = 66/279 (23%), Positives = 119/279 (42%), Gaps = 37/279 (13%)
Query: 159 EITKGTF---RIASWR-GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLG 214
+I +GT+ A G A+K + E DE I E+++L++++H N+V+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLE-KEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 215 AVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHR 274
+ +++V E+L + + +G L+ A F L + G+ Y H+ R ++HR
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHR 124
Query: 275 DLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDT 334
DL+P N+L + G LK+ADFGL++ + + T W A + +++Y T
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAF----GIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 335 KVDVFSFALILQEMIEGCPPFPTKQEKEV-------------------------PKAYIA 369
+D++S I EM+ G P FP E + +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 370 NERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
E P+ + +L+ +P +R T +Q L
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (355), Expect = 1e-38
Identities = 57/242 (23%), Positives = 114/242 (47%), Gaps = 20/242 (8%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPK 231
G A+K L ++ +++ ++E +LQ + P +V+ + ++ + +V EY+
Sbjct: 66 GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 232 GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKV 291
G++ ++L++ G A +A I YLH +I+RDL+P N+L D G+++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 182
Query: 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG 351
DFG +K +K P APE+ ++ Y+ VD ++ +++ EM G
Sbjct: 183 TDFGFAKRVKGRTWTLCGTP--------EALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 352 CPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRR-----PTFRQ 406
PPF Q ++ + I + + F +H++ L++L+ + + +R
Sbjct: 235 YPPFFADQPIQIYE-KIVSGKVRFP---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVND 290
Query: 407 IL 408
I
Sbjct: 291 IK 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-37
Identities = 62/300 (20%), Positives = 110/300 (36%), Gaps = 55/300 (18%)
Query: 149 PKELDFSNSVEITKGTF---RIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQK 203
P+E+ ++++ I G+F A G VA+K + + EL +++K
Sbjct: 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRK 69
Query: 204 IRHPNVVQFLGAVTQSTP------MMIVTEYLPKG---DLRAYLKQKGALKPTLAVKFAL 254
+ H N+V+ S + +V +Y+P+ R Y + K L +
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 255 DIARGMNYLHENRPEAIIHRDLEPSNI-LRDDSGHLKVADFGLSKLLKFANTVKEDRPVT 313
+ R + Y+H I HRD++P N+ L D+ LK+ DFG +K L V+ + V+
Sbjct: 130 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVS 181
Query: 314 CEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERP 373
+ + A ++ +Y + +DV+S +L E++ G P FP + I
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 374 PFRAPTTHYAYG-------------------------LRELIEDCWSEEPFRRPTFRQIL 408
P R L P R T +
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 1e-36
Identities = 55/291 (18%), Positives = 98/291 (33%), Gaps = 45/291 (15%)
Query: 159 EITKGTF---RIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
+I +GTF A R G +VA+K + E E + E+ +LQ ++H NVV +
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLME-NEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 214 GAVTQSTP--------MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHE 265
+ +V ++ + + + G+ Y+H
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135
Query: 266 NRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPE 325
N+ I+HRD++ +N+L G LK+ADFGL++ A + +R T W
Sbjct: 136 NK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 326 VYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIA---------------- 369
+ +Y +D++ I+ EM P E+
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252
Query: 370 ------------NERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
+ R +LI+ +P +R L
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-36
Identities = 65/288 (22%), Positives = 116/288 (40%), Gaps = 41/288 (14%)
Query: 153 DFSNSVEITKGTF---RIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHP 207
+F +I +GT+ A + G VA+K + + E I E++LL+++ HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD-TETEGVPSTAIREISLLKELNHP 61
Query: 208 NVVQFLGAVTQSTPMMIVTEYLPKGDLR-AYLKQKGALKPTLAVKFALDIARGMNYLHEN 266
N+V+ L + + +V E+L + + + L + + +G+ + H +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 267 RPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEV 326
R ++HRDL+P N+L + G +K+ADFGL++ R T E + Y APE+
Sbjct: 122 R---VLHRDLKPQNLLINTEGAIKLADFGLARAFG-----VPVRTYTHEVVTLWYRAPEI 173
Query: 327 YKNEEY-DTKVDVFSFALILQEMIEGCPPFPTKQEKEV---------------------- 363
+Y T VD++S I EM+ FP E +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 364 ---PKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
++ R F R L+ +P +R + + L
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-36
Identities = 55/258 (21%), Positives = 100/258 (38%), Gaps = 15/258 (5%)
Query: 159 EITKGTF--------RIASWRGTQVAVKTLGEEVFTDEDK-VKAFIDELALLQKIRH-PN 208
+ G + G A+K L + + K + E +L+ IR P
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 209 VVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRP 268
+V A T + ++ +Y+ G+L +L Q+ + +I + +LH+
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG- 149
Query: 269 EAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYK 328
II+RD++ NIL D +GH+ + DFGLSK +F E C +
Sbjct: 150 --IIYRDIKLENILLDSNGHVVLTDFGLSK--EFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 329 NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRE 388
+ +D VD +S +++ E++ G PF EK + ++
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKD 265
Query: 389 LIEDCWSEEPFRRPTFRQ 406
LI+ ++P +R
Sbjct: 266 LIQRLLMKDPKKRLGCGP 283
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 9e-36
Identities = 69/287 (24%), Positives = 113/287 (39%), Gaps = 46/287 (16%)
Query: 159 EITKGTF------RIASWRGTQVAVKTLGEEVFTDEDKVKAF--IDELALLQKIRHPNVV 210
EI +G + R G VA+K + + + + + L L+ HPNVV
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 211 QFLGAVTQS-----TPMMIVTEYLPKGDLRAYLKQKGALKPTLAVK-FALDIARGMNYLH 264
+ T S T + +V E++ + K PT +K + RG+++LH
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133
Query: 265 ENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAP 324
+R ++HRDL+P NIL SG +K+ADFGL+++ +T + Y AP
Sbjct: 134 SHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS------FQMALTSVVVTLWYRAP 184
Query: 325 EVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV--------------------- 363
EV Y T VD++S I EM P F + +
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 364 --PKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
+A+ + P T ++L+ C + P +R + L
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-35
Identities = 63/301 (20%), Positives = 117/301 (38%), Gaps = 48/301 (15%)
Query: 145 YEIDPKELDFSNSVEITKGTF---RIASWR--GTQVAVKTLGEEVFTDEDKVKAFIDELA 199
+++ P+ ++N I +G + A +VA+K + F + + + E+
Sbjct: 4 FDVGPR---YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIK 58
Query: 200 LLQKIRHPNVVQFLGAVTQST----PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALD 255
+L + RH N++ + T + + +L DL LK + L F
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQ 117
Query: 256 IARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCE 315
I RG+ Y+H ++HRDL+PSN+L + + LK+ DFGL+++ +
Sbjct: 118 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV- 173
Query: 316 ETSWRYAAPEVYKNEEYDT-KVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIA----- 369
+ Y APE+ N + T +D++S IL EM+ P FP K + +
Sbjct: 174 -ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232
Query: 370 ----------------------NERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQI 407
+ P+ + +L++ + P +R Q
Sbjct: 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
Query: 408 L 408
L
Sbjct: 293 L 293
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-34
Identities = 60/282 (21%), Positives = 113/282 (40%), Gaps = 41/282 (14%)
Query: 159 EITKGTF---RIASWRGTQ--VAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
+I +GT+ A R T VA+K + + DE + + E+ LL++++H N+V+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLD-DDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIH 273
+ + +V E+ + + + G L P + F + +G+ + H ++H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLH 124
Query: 274 RDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEE-Y 332
RDL+P N+L + +G LK+A+FGL++ R + E + Y P+V + Y
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFG-----IPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 333 DTKVDVFSFALILQEMIEGC-PPFPTKQEKEVPKAYIANERPP----------------- 374
T +D++S I E+ P FP + K P
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 375 --------FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
R+L+++ P +R + + L
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-32
Identities = 61/270 (22%), Positives = 96/270 (35%), Gaps = 46/270 (17%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS------TPMMIV 225
G +VA+K L F E K EL LL+ +RH NV+ L T T +V
Sbjct: 43 GAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 101
Query: 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD 285
++ G L + L + +G+ Y+H IHRDL+P N+ ++
Sbjct: 102 MPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNE 156
Query: 286 SGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALIL 345
LK+ DFGL++ + T W A + Y VD++S I+
Sbjct: 157 DCELKILDFGLARQA-------DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 209
Query: 346 QEMIEGCPPFPTKQEKEVPKAYIAN---------------------------ERPPFRAP 378
EMI G F + K + E+ F +
Sbjct: 210 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI 269
Query: 379 TTHYAYGLRELIEDCWSEEPFRRPTFRQIL 408
T+ + L+E + +R T + L
Sbjct: 270 LTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 114 bits (286), Expect = 4e-29
Identities = 58/335 (17%), Positives = 115/335 (34%), Gaps = 70/335 (20%)
Query: 126 GAKPSTA--PMHVQNAREVPEYEIDPKELDFSNS------VEITKGTF---RIASWR--G 172
G PS A V R ++ + +++ N ++ +G + A
Sbjct: 1 GPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNN 60
Query: 173 TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTP--MMIVTEYL 229
+V VK L K K E+ +L+ +R PN++ V +V E++
Sbjct: 61 EKVVVKIL------KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114
Query: 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD-DSGH 288
D + + L + +I + ++Y H I+HRD++P N++ D +
Sbjct: 115 NNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRK 168
Query: 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEE-YDTKVDVFSFALILQE 347
L++ D+GL++ + S + PE+ + + YD +D++S +L
Sbjct: 169 LRLIDWGLAEFYH------PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 222
Query: 348 MIEGCPPFP-----------------TKQEKEVPKAYIANERPPFRAPTTHYAYG----- 385
MI PF T+ + Y P F ++
Sbjct: 223 MIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF 282
Query: 386 ------------LRELIEDCWSEEPFRRPTFRQIL 408
+ ++ + R T R+ +
Sbjct: 283 VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 1e-28
Identities = 61/268 (22%), Positives = 93/268 (34%), Gaps = 42/268 (15%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL-- 229
G +VAVK L F K EL LL+ ++H NV+ L T + + +
Sbjct: 43 GLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101
Query: 230 --PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG 287
G + + L I RG+ Y+H IIHRDL+PSN+ ++
Sbjct: 102 THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC 158
Query: 288 HLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQE 347
LK+ DFGL++ T T W A + Y+ VD++S I+ E
Sbjct: 159 ELKILDFGLARHTDDEMT-------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 348 MIEGCPPFPTKQEKEVPKAYIANERPP---------------------------FRAPTT 380
++ G FP + K + P F
Sbjct: 212 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 271
Query: 381 HYAYGLRELIEDCWSEEPFRRPTFRQIL 408
+L+E + +R T Q L
Sbjct: 272 GANPLAVDLLEKMLVLDSDKRITAAQAL 299
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 3e-26
Identities = 63/286 (22%), Positives = 102/286 (35%), Gaps = 29/286 (10%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM------IV 225
VA+K L F ++ K EL L++ + H N++ L T + +V
Sbjct: 42 DRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 100
Query: 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD 285
E + + + + G+ +LH IHRDL+PSNI+
Sbjct: 101 MELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKS 154
Query: 286 SGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALIL 345
LK+ DFGL++ T +T + Y APEV Y VD++S I+
Sbjct: 155 DCTLKILDFGLAR------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 208
Query: 346 QEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFR 405
EM+ FP + + I P +R +E+ P
Sbjct: 209 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP--- 265
Query: 406 QILMRLDDISDQLSIKRHWKVGPLRCFQSLAALWKKGHADPSSRSS 451
+L S + H K+ + L+ + DP+ R S
Sbjct: 266 ----KLFPDSLFPADSEHNKLKASQARDLLSKMLVI---DPAKRIS 304
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (248), Expect = 1e-23
Identities = 32/99 (32%), Positives = 47/99 (47%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L + G L +K LL G N ++ T LH+AA G T+V + LL A V+ +
Sbjct: 4 LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKA 63
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNA 139
+ TPL A H +++KLL E+ A P+ A
Sbjct: 64 KDDQTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTP 102
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.8 bits (198), Expect = 3e-17
Identities = 33/104 (31%), Positives = 50/104 (48%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L ++ G++ +K LL DVN + + LH AA QG TD+V LLL GA +
Sbjct: 301 LHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVS 360
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNAREVPE 144
G+TPLA A + V +L+ + S + ++ PE
Sbjct: 361 SDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSDKHRMSFPE 404
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.4 bits (184), Expect = 2e-15
Identities = 22/58 (37%), Positives = 30/58 (51%)
Query: 72 TALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
T LHVA+ G +V+ LL RGA + + TPL A H +V K L ++ AK
Sbjct: 2 TPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKV 59
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.0 bits (170), Expect = 1e-13
Identities = 34/125 (27%), Positives = 44/125 (35%), Gaps = 33/125 (26%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSR-------- 92
L A G + K LL + VN + D +T LH AA G T++V+LLL
Sbjct: 37 LHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLAT 96
Query: 93 -------------------------GADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGA 127
A + G TPL A Y V +LL E A
Sbjct: 97 TAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDA 156
Query: 128 KPSTA 132
P+ A
Sbjct: 157 HPNAA 161
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.8 bits (167), Expect = 3e-13
Identities = 43/199 (21%), Positives = 77/199 (38%), Gaps = 16/199 (8%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A + ++ + LL G N + T LH+AA +G ++V LLLS+ A+ + +
Sbjct: 202 LHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGN 261
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKPS-------TAPMHVQNAREVPEYEIDPKELD 153
+ G TPL H V +L +HG T + + + +
Sbjct: 262 KSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQA 321
Query: 154 FSNSVEITKGT-FRIASWRGTQVAVKTL---GEEV-FTDEDKVKAFIDELALLQKIRHPN 208
N+ + A+ +G V L G D LA+ +++ + +
Sbjct: 322 DVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTP----LAIAKRLGYIS 377
Query: 209 VVQFLGAVTQSTPMMIVTE 227
V L VT T ++V++
Sbjct: 378 VTDVLKVVTDETSFVLVSD 396
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.7 bits (164), Expect = 8e-13
Identities = 25/85 (29%), Positives = 35/85 (41%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A G + + LL+ N + T LHVA D+V+LLL RG
Sbjct: 136 LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPA 195
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEH 125
G TPL A +V + L ++
Sbjct: 196 WNGYTPLHIAAKQNQVEVARSLLQY 220
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.8 bits (159), Expect = 3e-12
Identities = 41/164 (25%), Positives = 64/164 (39%), Gaps = 8/164 (4%)
Query: 58 DSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHD 117
+ T LHVAA G+ V LLL R A + + G TPL AV++ + D
Sbjct: 120 EKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLD 179
Query: 118 VIKLLEEHGAKPSTA------PMHVQNAREVPEYEIDPKELDFSNSVEITKGT--FRIAS 169
++KLL G P + P+H+ + E + S + E +G +A+
Sbjct: 180 IVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAA 239
Query: 170 WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
G V L + K+ + L L+ + H V L
Sbjct: 240 QEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVL 283
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 91.6 bits (226), Expect = 6e-21
Identities = 49/272 (18%), Positives = 90/272 (33%), Gaps = 32/272 (11%)
Query: 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQ---------------FLGAV 216
T VA+K + D+ +A DE+ LLQ++ + + F
Sbjct: 38 NTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93
Query: 217 TQSTPMMIVTEYLPKGDLRAYLKQKGALKP-TLAVKFALDIARGMNYLHENRPEAIIHRD 275
+++V E L + L K + P + + + G++Y+H IIH D
Sbjct: 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTD 151
Query: 276 LEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTK 335
++P N+L + + K+ N D T + Y +PEV +
Sbjct: 152 IKPENVLMEIVDS--PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCG 209
Query: 336 VDVFSFALILQEMIEGCPPFPTKQEKEVPKAY--------IANERPPFRAPTTHYAYGLR 387
D++S A ++ E+I G F + K + E P + Y
Sbjct: 210 ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFF 269
Query: 388 ELIEDCWSEEPFRRPTFRQILMRLDDISDQLS 419
+ + +L S +
Sbjct: 270 NSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.4 bits (210), Expect = 3e-19
Identities = 30/108 (27%), Positives = 45/108 (41%), Gaps = 2/108 (1%)
Query: 24 PADDDA-DGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGR 82
AD +A D L+ + LLD G DVN R +T L +A +
Sbjct: 172 GADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKH 231
Query: 83 TDVVRLLLSR-GADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+V+ LL + +++ D G T L AV K + +LL + GA
Sbjct: 232 LGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGAST 279
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.0 bits (170), Expect = 5e-14
Identities = 18/61 (29%), Positives = 28/61 (45%), Gaps = 1/61 (1%)
Query: 41 LMYMANEGDLDGIKELLDS-GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPE 99
L+ + L ++ LL+ ++N D D +TAL +A + LL RGA D
Sbjct: 223 LILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCG 282
Query: 100 D 100
D
Sbjct: 283 D 283
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.7 bits (146), Expect = 6e-11
Identities = 35/95 (36%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 41 LMYMANEGDLDGIKELLDS-GTDVNFRDIDKRTALHVAACQGRT----DVVRLLLSRGAD 95
LM A +G ++ +K LLD G DVN D R AL A + LLL GAD
Sbjct: 152 LMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGAD 211
Query: 96 VDPEDRWGSTPLADAVYYKHHDVIK-LLEEHGAKP 129
V+ G TPL AV KH +++ LLE+ +
Sbjct: 212 VNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEI 246
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.6 bits (143), Expect = 1e-10
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 1/94 (1%)
Query: 34 AIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDID-KRTALHVAACQGRTDVVRLLLSR 92
A++ L+ D+D +++LL+ G +VNF++ + T LH A R D+V LLL
Sbjct: 2 AVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRH 61
Query: 93 GADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHG 126
GAD + G+TP A ++KL G
Sbjct: 62 GADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKG 95
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.3 bits (119), Expect = 2e-07
Identities = 22/72 (30%), Positives = 31/72 (43%), Gaps = 5/72 (6%)
Query: 63 VNFRDIDKRTALHVAACQGRTDVVRLLLSR-GADVDPEDRWGSTPLADAVYYKHH----D 117
TAL AA +G +V+++LL GADV+ D G L A+
Sbjct: 141 QERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEA 200
Query: 118 VIKLLEEHGAKP 129
+ LL +HGA
Sbjct: 201 ITHLLLDHGADV 212
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 78.6 bits (192), Expect = 6e-17
Identities = 19/65 (29%), Positives = 36/65 (55%)
Query: 60 GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVI 119
G++ + +D D +T + +AA +GR +VV L+ +GA V+ D T A HH+++
Sbjct: 211 GSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIV 270
Query: 120 KLLEE 124
+ +
Sbjct: 271 DIFDR 275
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 60.5 bits (145), Expect = 8e-11
Identities = 21/86 (24%), Positives = 29/86 (33%), Gaps = 10/86 (11%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRD-IDKRTALHVAACQGRTDVVRLLL--------S 91
+ I E + VN D RT LH A + L+ +
Sbjct: 4 IKLHTEAAGSYAITEPITR-ESVNIIDPRHNRTVLHWIASNSSAEKSEDLIVHEAKECIA 62
Query: 92 RGADVDPEDRWGSTPLADAVYYKHHD 117
GADV+ D +TPL AV +
Sbjct: 63 AGADVNAMDCDENTPLMLAVLARRRR 88
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 59.4 bits (142), Expect = 2e-10
Identities = 12/50 (24%), Positives = 21/50 (42%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLL 90
+M A EG ++ + L+ G V D TA +A ++V +
Sbjct: 225 IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFD 274
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 47.4 bits (111), Expect = 1e-06
Identities = 20/71 (28%), Positives = 32/71 (45%), Gaps = 1/71 (1%)
Query: 60 GTDVNFRDIDKRTALHVAACQGRTDVVRLLLS-RGADVDPEDRWGSTPLADAVYYKHHDV 118
+ RTALH AA +V+ L+ +G++ D +D G TP+ A +V
Sbjct: 177 AARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEV 236
Query: 119 IKLLEEHGAKP 129
+ L + GA
Sbjct: 237 VMYLIQQGASV 247
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 47.0 bits (110), Expect = 2e-06
Identities = 11/57 (19%), Positives = 18/57 (31%), Gaps = 2/57 (3%)
Query: 72 TALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAK 128
LH A G + + ++ + R T L + + L H AK
Sbjct: 4 IKLHTEAA-GSYAITEPITRESVNI-IDPRHNRTVLHWIASNSSAEKSEDLIVHEAK 58
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 38.6 bits (88), Expect = 0.001
Identities = 22/106 (20%), Positives = 40/106 (37%), Gaps = 8/106 (7%)
Query: 41 LMYMANEGDLD--------GIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSR 92
L ++A+ + KE + +G DVN D D+ T L +A R +V L+
Sbjct: 37 LHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKA 96
Query: 93 GADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQN 138
GAD ++ + L A + ++ + +N
Sbjct: 97 GADPTIYNKSERSALHQAAANRDFGMMVYMLNSTKLKGDIEELDRN 142
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 77.2 bits (189), Expect = 3e-16
Identities = 20/103 (19%), Positives = 28/103 (27%), Gaps = 5/103 (4%)
Query: 41 LMYMANEGDLDGIK---ELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVD 97
A G + LL S V + A +AA G V+ L
Sbjct: 94 CFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEI 153
Query: 98 PEDR--WGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQN 138
A H V+ L E +TA + +N
Sbjct: 154 MAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQAEN 196
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 71.5 bits (174), Expect = 3e-14
Identities = 17/93 (18%), Positives = 27/93 (29%), Gaps = 3/93 (3%)
Query: 49 DLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDV---VRLLLSRGADVDPEDRWGST 105
+ +D + + I VAA G + + LLL+ V
Sbjct: 69 YAHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQ 128
Query: 106 PLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQN 138
A H V+ L E A + +N
Sbjct: 129 AFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN 161
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 64.9 bits (157), Expect = 4e-12
Identities = 32/191 (16%), Positives = 56/191 (29%), Gaps = 20/191 (10%)
Query: 28 DADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDK--RTALHVAACQGRTDV 85
A+ +A A G L + L + I A +AA G V
Sbjct: 123 QAENYQA------FRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHV 176
Query: 86 VRLLLSRGADVD---PEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNAREV 142
+ L + AV HH+VI L + + A +H E
Sbjct: 177 LNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYAEIH---EFEY 233
Query: 143 PEYEIDPKELDFSNSVEITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQ 202
E ++P N ++ F++++ G V + + L
Sbjct: 234 GEKYVNPFIARHVNRLKEMHDAFKLSNPDGVFDLVTKSE------CLQGFYMLRNLIRRN 287
Query: 203 KIRHPNVVQFL 213
+ ++FL
Sbjct: 288 DEVLLDDIRFL 298
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 54.1 bits (129), Expect = 1e-08
Identities = 17/79 (21%), Positives = 24/79 (30%), Gaps = 5/79 (6%)
Query: 18 APDQPLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSG-----TDVNFRDIDKRT 72
PD ++ + L+ +E LD I+ LL D
Sbjct: 260 NPDGVFDLVTKSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANE 319
Query: 73 ALHVAACQGRTDVVRLLLS 91
L +A G LLLS
Sbjct: 320 LLRLALRLGNQGACALLLS 338
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 49.9 bits (118), Expect = 3e-07
Identities = 13/81 (16%), Positives = 23/81 (28%), Gaps = 7/81 (8%)
Query: 47 EGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRW---- 102
+ DG+ +L+ + L + D +R LLS
Sbjct: 258 LSNPDGVFDLVTK--SECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPG 315
Query: 103 -GSTPLADAVYYKHHDVIKLL 122
+ L A+ + LL
Sbjct: 316 DANELLRLALRLGNQGACALL 336
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 44.9 bits (105), Expect = 1e-05
Identities = 19/183 (10%), Positives = 43/183 (23%), Gaps = 21/183 (11%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVN---FRDIDKRTALHVAACQGRTDVVRLLLSRGADVD 97
A G L + L + + + A +G +V+ LL +
Sbjct: 165 FRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLA 224
Query: 98 PEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNAREVPEYEIDPKELDFSNS 157
Y V + H + + + +++ K
Sbjct: 225 -------YAEIHEFEYGEKYVNPFIARHVNRLKEMHDAFKLSNPDGVFDLVTKSECLQGF 277
Query: 158 VEIT-------KGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVV 210
+ + + + +K L D + L L ++ +
Sbjct: 278 YMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANEL----LRLALRLGNQGAC 333
Query: 211 QFL 213
L
Sbjct: 334 ALL 336
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 75.5 bits (184), Expect = 8e-16
Identities = 26/88 (29%), Positives = 42/88 (47%), Gaps = 4/88 (4%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A +G + +K L+ + DVN +D D T LH AA G+ + R+L+ D++ +
Sbjct: 203 LHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVN 262
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAK 128
+ G T D++ LEE K
Sbjct: 263 KVGQTAF----DVADEDILGYLEELQKK 286
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 59.3 bits (142), Expect = 2e-10
Identities = 23/75 (30%), Positives = 37/75 (49%)
Query: 56 LLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKH 115
L + TALHVAA +G T+V++LL+ DV+ +D G TPL A ++
Sbjct: 185 LNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGK 244
Query: 116 HDVIKLLEEHGAKPS 130
+ ++L E+
Sbjct: 245 EEACRILVENLCDME 259
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 58.6 bits (140), Expect = 3e-10
Identities = 25/97 (25%), Positives = 37/97 (38%), Gaps = 9/97 (9%)
Query: 53 IKELLDSGTDVNFR---------DIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWG 103
+K + S TD+ D A G T+ V LL RGAD++ + G
Sbjct: 14 LKRWIGSETDLEPPVVKRKKTKVKFDDGAVFLAACSSGDTEEVLRLLERGADINYANVDG 73
Query: 104 STPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNAR 140
T L A + D++K L E+GA +
Sbjct: 74 LTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPL 110
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 54.7 bits (130), Expect = 7e-09
Identities = 36/180 (20%), Positives = 67/180 (37%), Gaps = 2/180 (1%)
Query: 36 DPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGAD 95
D + + GD + + LL+ G D+N+ ++D TALH A D+V+ L+ GA+
Sbjct: 39 DDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGAN 98
Query: 96 VDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPM--HVQNAREVPEYEIDPKELD 153
++ D G PL A + D+ + L GA E + + +
Sbjct: 99 INQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNE 158
Query: 154 FSNSVEITKGTFRIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213
+ + + + A + L D K+ L + + V++ L
Sbjct: 159 VNRQGVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLL 218
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.2 bits (168), Expect = 4e-14
Identities = 32/123 (26%), Positives = 49/123 (39%), Gaps = 34/123 (27%)
Query: 41 LMYMANEGDLDGIKELLDS-GTDVNFRDIDKRTALHVAACQG------------------ 81
+ +A G L+ +KE + + + D D RTALH A G
Sbjct: 7 VCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDK 66
Query: 82 ---------------RTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHG 126
R ++V+ LL +GA V+ ++ G TPL A H++ +L E G
Sbjct: 67 DDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGG 126
Query: 127 AKP 129
A P
Sbjct: 127 ANP 129
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.8 bits (159), Expect = 5e-13
Identities = 27/89 (30%), Positives = 45/89 (50%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L Y A++ + LL+ G + + +D + TA+H AA +G ++ +LL A + +D
Sbjct: 107 LHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQD 166
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
G+TPL A + + KLL GA
Sbjct: 167 TEGNTPLHLACDEERVEEAKLLVSQGASI 195
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.2 bits (155), Expect = 2e-12
Identities = 25/84 (29%), Positives = 42/84 (50%), Gaps = 1/84 (1%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
+ A +G+L I LL N +D + T LH+A + R + +LL+S+GA + E+
Sbjct: 140 MHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIEN 199
Query: 101 RWGSTPLADAVYYKHHDVIKLLEE 124
+ TPL A ++K + E
Sbjct: 200 KEEKTPLQVAK-GGLGLILKRMVE 222
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.8 bits (146), Expect = 3e-11
Identities = 25/85 (29%), Positives = 43/85 (50%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L A+ G + +K LL G VN + + T LH AA + R ++ +LL GA+ D +D
Sbjct: 74 LHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKD 133
Query: 101 RWGSTPLADAVYYKHHDVIKLLEEH 125
+ +T + A + +I +L +
Sbjct: 134 HYEATAMHRAAAKGNLKMIHILLYY 158
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (123), Expect = 3e-08
Identities = 10/51 (19%), Positives = 24/51 (47%), Gaps = 1/51 (1%)
Query: 40 RLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLL 90
L +E ++ K L+ G + + +++T L VA G +++ ++
Sbjct: 172 PLHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVAK-GGLGLILKRMV 221
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 68.6 bits (166), Expect = 9e-14
Identities = 22/58 (37%), Positives = 28/58 (48%)
Query: 71 RTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAK 128
RT LH+A V+ LLL GAD G TPL A+ + + +LL HGA
Sbjct: 193 RTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAP 250
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 67.0 bits (162), Expect = 4e-13
Identities = 17/59 (28%), Positives = 24/59 (40%), Gaps = 1/59 (1%)
Query: 42 MYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
++ LL +G D R RT L A + + RLL + GA +PED
Sbjct: 197 HLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAP-EPED 254
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 59.7 bits (143), Expect = 1e-10
Identities = 14/56 (25%), Positives = 20/56 (35%), Gaps = 3/56 (5%)
Query: 64 NFRDIDKRTALHVAACQGRTDVVRLLLSRGAD---VDPEDRWGSTPLADAVYYKHH 116
+ D TALH+A + LL A +D ++ G T L A
Sbjct: 3 GYVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEA 58
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 55.5 bits (132), Expect = 3e-09
Identities = 22/92 (23%), Positives = 34/92 (36%), Gaps = 3/92 (3%)
Query: 41 LMYMANEGDLDGIKELLDSGTD---VNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVD 97
L + LL ++ ++ +TALH+AA G V L + GA V
Sbjct: 13 LHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVL 72
Query: 98 PEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+R G T L A + H +L +
Sbjct: 73 VAERGGHTALHLACRVRAHTCACVLLQPRPSH 104
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 67.9 bits (164), Expect = 1e-13
Identities = 21/83 (25%), Positives = 38/83 (45%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED 100
L + A + + + LL + + +D T L +AA +G + + LL A+ + D
Sbjct: 127 LHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANREITD 186
Query: 101 RWGSTPLADAVYYKHHDVIKLLE 123
P A HHD+++LL+
Sbjct: 187 HMDRLPRDVASERLHHDIVRLLD 209
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 53.3 bits (126), Expect = 9e-09
Identities = 17/50 (34%), Positives = 23/50 (46%)
Query: 40 RLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLL 89
L A EG + K LLD+ + D R VA+ + D+VRLL
Sbjct: 159 PLFLAAREGSYEASKALLDNFANREITDHMDRLPRDVASERLHHDIVRLL 208
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 48.2 bits (113), Expect = 4e-07
Identities = 14/38 (36%), Positives = 20/38 (52%), Gaps = 1/38 (2%)
Query: 53 IKELLDSGTDVNFR-DIDKRTALHVAACQGRTDVVRLL 89
I +LL G ++N D T+LH+AA R D + L
Sbjct: 5 ISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRL 42
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.5 bits (111), Expect = 8e-07
Identities = 25/88 (28%), Positives = 41/88 (46%)
Query: 42 MYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDR 101
+ A +++L+ + D+N D +TALH AA T+ V +LL A+ D +D
Sbjct: 95 ILAARLAIEGMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDD 154
Query: 102 WGSTPLADAVYYKHHDVIKLLEEHGAKP 129
TPL A ++ K L ++ A
Sbjct: 155 KDETPLFLAAREGSYEASKALLDNFANR 182
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.7 bits (109), Expect = 2e-06
Identities = 13/42 (30%), Positives = 22/42 (52%), Gaps = 1/42 (2%)
Query: 85 VVRLLLSRGADVD-PEDRWGSTPLADAVYYKHHDVIKLLEEH 125
V+ LL++GA+++ D+ G T L A + D K L +
Sbjct: 4 VISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRLLDA 45
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 65.4 bits (158), Expect = 2e-13
Identities = 25/151 (16%), Positives = 46/151 (30%), Gaps = 45/151 (29%)
Query: 29 ADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFR------DIDKRTALHVAA---C 79
AD + + L D+ G+ + G D+ + TALH+A
Sbjct: 1 ADTAAKLHS---LCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVD 57
Query: 80 QGRTDVVRLLLSRGADV---------------------------------DPEDRWGSTP 106
+ +V L+ ++ + + G TP
Sbjct: 58 RTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETP 117
Query: 107 LADAVYYKHHDVIKLLEEHGAKPSTAPMHVQ 137
L A KH +LL + + + +HV+
Sbjct: 118 LDIAKRLKHEHCEELLTQALSGRFNSHVHVE 148
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 40.3 bits (93), Expect = 9e-05
Identities = 9/79 (11%), Positives = 19/79 (24%), Gaps = 9/79 (11%)
Query: 69 DKRTALHVAACQGRTDVVRLLLSRGADVDPE------DRWGSTPL---ADAVYYKHHDVI 119
K +L A + + G D+ + T L +V ++
Sbjct: 5 AKLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIV 64
Query: 120 KLLEEHGAKPSTAPMHVQN 138
L ++
Sbjct: 65 DFLVQNSGNLDKQTGKGST 83
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 67.8 bits (164), Expect = 3e-13
Identities = 21/93 (22%), Positives = 34/93 (36%), Gaps = 4/93 (4%)
Query: 23 LPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDS----GTDVNFRDIDKRTALHVAA 78
+ + + + N D I E LD +N +D + T L++AA
Sbjct: 208 IVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAA 267
Query: 79 CQGRTDVVRLLLSRGADVDPEDRWGSTPLADAV 111
G +V LL GAD ++ G P+
Sbjct: 268 RLGNISIVDALLDYGADPFIANKSGLRPVDFGA 300
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 60.8 bits (146), Expect = 7e-11
Identities = 19/105 (18%), Positives = 38/105 (36%), Gaps = 2/105 (1%)
Query: 23 LPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLD-SGTDVNFR-DIDKRTALHVAACQ 80
L D SE + +++ + L + + + ++N D T LH
Sbjct: 58 LNNDSSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSI 117
Query: 81 GRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEH 125
++V+ L+ G++ D G + L AV ++ E
Sbjct: 118 ANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEAL 162
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 55.4 bits (132), Expect = 4e-09
Identities = 14/93 (15%), Positives = 34/93 (36%), Gaps = 5/93 (5%)
Query: 42 MYMANEGDLDGIKELLDS--GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSR---GADV 96
A + LD + + + +K + + + + ++ L + +
Sbjct: 193 CSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANML 252
Query: 97 DPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+ +D G T L A + ++ L ++GA P
Sbjct: 253 NAQDSNGDTCLNIAARLGNISIVDALLDYGADP 285
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 49.3 bits (116), Expect = 4e-07
Identities = 19/118 (16%), Positives = 41/118 (34%), Gaps = 2/118 (1%)
Query: 14 QSSLAPDQPLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTA 73
S L + LP+ D + + L + + L + ++ N
Sbjct: 16 SSPLKIMKALPSPVVNDNEQKMKLEAFLQRLLFPEIQEMPTSLNNDSSNRNSEGGSSNQQ 75
Query: 74 LHVAACQGRT-DVVRLLLSRGADVD-PEDRWGSTPLADAVYYKHHDVIKLLEEHGAKP 129
+ +V + +++ P D G+TPL + +++K L +HG+
Sbjct: 76 QQHVSFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNR 133
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.3 bits (157), Expect = 9e-13
Identities = 27/98 (27%), Positives = 45/98 (45%)
Query: 23 LPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGR 82
L D D + R L++ L ++ LL G +VN + +ALH A+ +G
Sbjct: 130 LERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGL 189
Query: 83 TDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIK 120
+VR L+ GAD ++ TPL A + D+++
Sbjct: 190 LPLVRTLVRSGADSSLKNCHNDTPLMVARSRRVIDILR 227
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.1 bits (128), Expect = 6e-09
Identities = 16/52 (30%), Positives = 22/52 (42%), Gaps = 4/52 (7%)
Query: 69 DKRTALHVAACQGRTDVVRLLLS----RGADVDPEDRWGSTPLADAVYYKHH 116
D T LH+A QG V L++ G ++D + TPL AV
Sbjct: 2 DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLP 53
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (107), Expect = 3e-06
Identities = 23/102 (22%), Positives = 43/102 (42%), Gaps = 4/102 (3%)
Query: 41 LMYMANEGDLDGIKELLD----SGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADV 96
L +G+L + L++ G +++ + ++T LH+A VVRLL++ GA
Sbjct: 7 LHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASP 66
Query: 97 DPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQN 138
DR G T A ++ ++ L + A +
Sbjct: 67 MALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNY 108
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (93), Expect = 2e-04
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 1/96 (1%)
Query: 36 DPRVRLMYMANEGDLDGIKELLDSGTDVNFRDI-DKRTALHVAACQGRTDVVRLLLSRGA 94
D L N + ++ LL+ G D++ DI R+ L A +V+LLL GA
Sbjct: 109 DGLTALHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGA 168
Query: 95 DVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPS 130
+V+ + GS+ L A +++ L GA S
Sbjct: 169 NVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSS 204
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 57.5 bits (138), Expect = 2e-10
Identities = 31/202 (15%), Positives = 62/202 (30%), Gaps = 43/202 (21%)
Query: 165 FRIASWRGTQVAVKTL----------------GEEVFTDEDKVKAFIDELALLQKIRHPN 208
F S + + VK G+ F+ ++ +E LQK++
Sbjct: 17 FNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAI-RSARNEFRALQKLQGLA 75
Query: 209 VVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRP 268
V + ++ E + +L + + I + +
Sbjct: 76 VPKVYAWEG----NAVLMELIDAKELYRVRVENPD-------EVLDMILEEVAKFYHRG- 123
Query: 269 EAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYK 328
I+H DL N+L + G + + DF S V+ E Y
Sbjct: 124 --IVHGDLSQYNVLVSEEG-IWIIDFPQS--------VEVGEEGWREILERDVRNIITYF 172
Query: 329 NEEYDTKVDVFSFALILQEMIE 350
+ Y T+ D+ S + +++
Sbjct: 173 SRTYRTEKDINS---AIDRILQ 191
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 57.5 bits (137), Expect = 4e-10
Identities = 14/68 (20%), Positives = 28/68 (41%), Gaps = 1/68 (1%)
Query: 72 TALHVAACQGRTDVVRLLL-SRGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPS 130
LH A + V+ LL S+ + + +D+ G PL +V ++ H++ L +
Sbjct: 2 YPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVN 61
Query: 131 TAPMHVQN 138
+
Sbjct: 62 LDDYPDDS 69
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 56.0 bits (133), Expect = 1e-09
Identities = 18/66 (27%), Positives = 28/66 (42%), Gaps = 4/66 (6%)
Query: 63 VNFRDIDKRTALHVAACQGRTDVVRLLLSR-GADVDPEDRWGSTPLADAVYYKHHDVIKL 121
VN++D T L A +G D LL+ + GA+ D D G+ A+ + V K
Sbjct: 165 VNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVAL---NEQVKKF 221
Query: 122 LEEHGA 127
+
Sbjct: 222 FLNNVV 227
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 52.1 bits (123), Expect = 3e-08
Identities = 12/55 (21%), Positives = 19/55 (34%), Gaps = 4/55 (7%)
Query: 42 MYMANEGDLDGIKELLDS-GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGAD 95
+ EG D L++ G + + D A VA V + L+ D
Sbjct: 177 FHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVAL---NEQVKKFFLNNVVD 228
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 50.2 bits (118), Expect = 1e-07
Identities = 16/77 (20%), Positives = 30/77 (38%), Gaps = 1/77 (1%)
Query: 41 LMYMANEGDLDGIKELLDS-GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPE 99
L E + ++ELL S + + +D D R LH + ++ LLS+ +V+ +
Sbjct: 4 LHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLD 63
Query: 100 DRWGSTPLADAVYYKHH 116
D +
Sbjct: 64 DYPDDSGWTPFHIACSV 80
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 43.7 bits (101), Expect = 2e-05
Identities = 27/115 (23%), Positives = 50/115 (43%), Gaps = 8/115 (6%)
Query: 42 MYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGAD-VDPED 100
+ + + L+++G V +D + LH AA G ++ LL G V+ +D
Sbjct: 110 HLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQD 169
Query: 101 RWGSTPLADAVYYKHHDVIK-LLEEHGAKPSTA------PMHVQNAREVPEYEID 148
+ G TPL A+ H D L+E++GA+ V +V ++ ++
Sbjct: 170 KQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVALNEQVKKFFLN 224
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.8 bits (135), Expect = 6e-10
Identities = 18/66 (27%), Positives = 27/66 (40%)
Query: 64 NFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVIKLLE 123
+ RTALH+A D+V LLL GADV+ G +P + + L
Sbjct: 139 AQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLG 198
Query: 124 EHGAKP 129
+ +
Sbjct: 199 QLTLEN 204
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 9e-09
Identities = 10/55 (18%), Positives = 19/55 (34%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGAD 95
L + + D + LL G DVN + + + T + + L +
Sbjct: 149 LHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLE 203
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.0 bits (120), Expect = 5e-08
Identities = 12/52 (23%), Positives = 20/52 (38%), Gaps = 4/52 (7%)
Query: 69 DKRTALHVAACQGRTD----VVRLLLSRGADVDPEDRWGSTPLADAVYYKHH 116
D + LH+A V+R + A ++ ++ TPL AV
Sbjct: 1 DGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQP 52
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.002
Identities = 8/44 (18%), Positives = 17/44 (38%), Gaps = 4/44 (9%)
Query: 41 LMYMANEGDLDGIKELL----DSGTDVNFRDIDKRTALHVAACQ 80
L + E++ +NF++ ++T LH+A
Sbjct: 6 LHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVIT 49
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.5 bits (116), Expect = 7e-08
Identities = 10/45 (22%), Positives = 18/45 (40%)
Query: 72 TALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHH 116
L AA +G + + LL +V+ ++ +G T L
Sbjct: 3 NELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMKLGNPE 47
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.4 bits (108), Expect = 1e-06
Identities = 11/31 (35%), Positives = 16/31 (51%)
Query: 63 VNFRDIDKRTALHVAACQGRTDVVRLLLSRG 93
V R+ TA +A GR +VV L+ + G
Sbjct: 126 VGHRNHKGDTACDLARLYGRNEVVSLMQANG 156
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 6e-05
Identities = 8/31 (25%), Positives = 15/31 (48%)
Query: 96 VDPEDRWGSTPLADAVYYKHHDVIKLLEEHG 126
V + G T A Y ++V+ L++ +G
Sbjct: 126 VGHRNHKGDTACDLARLYGRNEVVSLMQANG 156
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (83), Expect = 0.002
Identities = 10/31 (32%), Positives = 16/31 (51%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKR 71
L A GDL+ + LL + +VN ++ R
Sbjct: 5 LASAAARGDLEQLTSLLQNNVNVNAQNGFGR 35
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.0 bits (115), Expect = 1e-07
Identities = 22/66 (33%), Positives = 33/66 (50%), Gaps = 1/66 (1%)
Query: 60 GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVI 119
G DVN D +H+A +G T VV L + +D+ D G TPL A+ D++
Sbjct: 91 GADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRRDARGLTPLELALQRGAQDLV 149
Query: 120 KLLEEH 125
+L+ H
Sbjct: 150 DILQGH 155
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (93), Expect = 1e-04
Identities = 14/46 (30%), Positives = 19/46 (41%), Gaps = 1/46 (2%)
Query: 72 TALHVAACQGRTDVVRLLLSR-GADVDPEDRWGSTPLADAVYYKHH 116
L AA +G VR LL R D +R+G T L ++
Sbjct: 4 DRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMMFGSTA 49
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 48.7 bits (114), Expect = 1e-07
Identities = 22/64 (34%), Positives = 36/64 (56%)
Query: 60 GTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDVI 119
G DVN +D+ K TALH A +VV LL+ GADV + ++ T ++ + D+
Sbjct: 90 GADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLA 149
Query: 120 KLLE 123
++L+
Sbjct: 150 EILQ 153
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.5 bits (98), Expect = 2e-05
Identities = 18/48 (37%), Positives = 24/48 (50%), Gaps = 1/48 (2%)
Query: 69 DKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHH 116
D L AA G+ D VR+L++ GA D G++PL A Y H
Sbjct: 1 DLGKKLLEAARAGQDDEVRILMANGAPFTT-DWLGTSPLHLAAQYGHF 47
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.5 bits (98), Expect = 2e-05
Identities = 10/49 (20%), Positives = 22/49 (44%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLL 89
L + + ++ L+ G DV+ + +TA ++ G D+ +L
Sbjct: 104 LHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (109), Expect = 4e-07
Identities = 20/124 (16%), Positives = 35/124 (28%), Gaps = 36/124 (29%)
Query: 41 LMYMANEGDLDGIKELLDSGTDVN---------------------------------FRD 67
L+ + EG+ D ++ ++ D + D
Sbjct: 5 LLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAAD 64
Query: 68 IDKRTALHVAACQGRTDVVRLLLSRGADV---DPEDRWGSTPLADAVYYKHHDVIKLLEE 124
D T LH AA V + L+ GA V D + + + + + L
Sbjct: 65 SDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYG 124
Query: 125 HGAK 128
K
Sbjct: 125 VQEK 128
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 3e-05
Identities = 11/47 (23%), Positives = 17/47 (36%), Gaps = 3/47 (6%)
Query: 53 IKELLDSGTDVNFRDI-DKRTA--LHVAACQGRTDVVRLLLSRGADV 96
K L++SG V D +TA +G T + L +
Sbjct: 83 CKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKM 129
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.2 bits (82), Expect = 0.002
Identities = 11/45 (24%), Positives = 20/45 (44%)
Query: 72 TALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHH 116
L ++ +G D+V+ ++ D + G T L +AV H
Sbjct: 3 ALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHT 47
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} Length = 125 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 6e-04
Identities = 11/31 (35%), Positives = 17/31 (54%)
Query: 72 TALHVAACQGRTDVVRLLLSRGADVDPEDRW 102
L AA +GR + VR LL GA+ + + +
Sbjct: 5 DWLATAAARGRVEEVRALLEAGANPNAPNSY 35
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} Length = 125 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (84), Expect = 8e-04
Identities = 9/28 (32%), Positives = 13/28 (46%)
Query: 64 NFRDIDKRTALHVAACQGRTDVVRLLLS 91
+ RD R + +A G DV R L +
Sbjct: 96 DVRDAWGRLPVDLAEELGHRDVARYLRA 123
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 456 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1myoa_ | 118 | Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116] | 99.85 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1ycsb1 | 130 | 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | 99.83 | |
| d1dcqa1 | 154 | Pyk2-associated protein beta {Mouse (Mus musculus) | 99.81 | |
| d1ycsb1 | 130 | 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | 99.78 | |
| d1myoa_ | 118 | Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116] | 99.78 | |
| d1bi7b_ | 125 | Cell cycle inhibitor p16ink4A {Human (Homo sapiens | 99.75 | |
| d1bi7b_ | 125 | Cell cycle inhibitor p16ink4A {Human (Homo sapiens | 99.74 | |
| d1oy3d_ | 255 | Transcription factor inhibitor I-kappa-B-beta, IKB | 99.74 | |
| d1uoha_ | 223 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.72 | |
| d1oy3d_ | 255 | Transcription factor inhibitor I-kappa-B-beta, IKB | 99.7 | |
| d1sw6a_ | 301 | Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch | 99.68 | |
| d1wdya_ | 285 | RNase L, 2-5a-dependent ribonuclease {Human (Homo | 99.67 | |
| d1ot8a_ | 209 | Neurogenic locus notch receptor domain {Fruit fly | 99.66 | |
| d2fo1e1 | 277 | Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | 99.66 | |
| d1awcb_ | 153 | GA bindinig protein (GABP) beta 1 {Mouse (Mus musc | 99.65 | |
| d1n11a_ | 408 | Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | 99.65 | |
| d1bd8a_ | 156 | Cell cycle inhibitor p19ink4D {Human (Homo sapiens | 99.64 | |
| d1uoha_ | 223 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.64 | |
| d1ixva_ | 229 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.63 | |
| d1s70b_ | 291 | Myosin phosphatase targeting subunit 1, MYPT1 {Chi | 99.62 | |
| d1ot8a_ | 209 | Neurogenic locus notch receptor domain {Fruit fly | 99.62 | |
| d1ihba_ | 156 | p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606] | 99.61 | |
| d1bd8a_ | 156 | Cell cycle inhibitor p19ink4D {Human (Homo sapiens | 99.61 | |
| d2ajaa1 | 346 | Hypothetical protein LPG2416 {Legionella pneumophi | 99.61 | |
| d1dcqa1 | 154 | Pyk2-associated protein beta {Mouse (Mus musculus) | 99.6 | |
| d1iknd_ | 221 | I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606 | 99.6 | |
| d1awcb_ | 153 | GA bindinig protein (GABP) beta 1 {Mouse (Mus musc | 99.59 | |
| d1n11a_ | 408 | Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | 99.59 | |
| d2ajaa1 | 346 | Hypothetical protein LPG2416 {Legionella pneumophi | 99.58 | |
| d1iknd_ | 221 | I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606 | 99.58 | |
| d1s70b_ | 291 | Myosin phosphatase targeting subunit 1, MYPT1 {Chi | 99.57 | |
| d2fo1e1 | 277 | Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | 99.56 | |
| d1k1aa_ | 228 | bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | 99.55 | |
| d1k1aa_ | 228 | bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | 99.54 | |
| d1ihba_ | 156 | p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606] | 99.53 | |
| d1ixva_ | 229 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.5 | |
| d1wdya_ | 285 | RNase L, 2-5a-dependent ribonuclease {Human (Homo | 99.37 | |
| d1sw6a_ | 301 | Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch | 99.32 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.07 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.6 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.17 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.16 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.17 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 90.98 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=400.47 Aligned_cols=244 Identities=27% Similarity=0.448 Sum_probs=213.4
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|++.+.||+|+||.| ..+|+.||+|++.+....+......+.+|+.+++.++||||+++++++.+++.+++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 5888899999999977 23688999999875432222334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
||++|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~----- 158 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS----- 158 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-----
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC-----
Confidence 9999999999998889999999999999999999999999 99999999999999999999999999986531
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+... ...+ +..+|+++.
T Consensus 159 --~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-~~~~---p~~~s~~~~ 232 (263)
T d2j4za1 159 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTF---PDFVTEGAR 232 (263)
T ss_dssp --CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-CCCC---CTTSCHHHH
T ss_pred --CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCC---CccCCHHHH
Confidence 1223457999999999999999999999999999999999999999988777766666433 3332 467899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+||.+||+.||++|||++|+++|
T Consensus 233 ~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 233 DLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHHHccCCHhHCcCHHHHHcC
Confidence 99999999999999999999876
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-52 Score=392.78 Aligned_cols=265 Identities=26% Similarity=0.438 Sum_probs=214.4
Q ss_pred ccccCccccccccceeeeccEEEEEe--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012777 144 EYEIDPKELDFSNSVEITKGTFRIAS--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTP 221 (456)
Q Consensus 144 ~~~~~~~~~~~~~~~~lg~G~fg~~~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 221 (456)
.|||+... |...+.||+|+||.|. ..+..||||++..... ++...+.|.+|+.++++++||||+++++++.. ..
T Consensus 2 dwei~~~~--~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~ 77 (276)
T d1uwha_ 2 DWEIPDGQ--ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQ 77 (276)
T ss_dssp CCBCCTTC--CCCCSEEEECSSCEEEEEESSSEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred Cccccccc--EEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cE
Confidence 35555444 6777899999999772 2455799999986543 34556889999999999999999999998754 56
Q ss_pred eEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
+++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeec
Confidence 89999999999999999764 56999999999999999999999999 999999999999999999999999999866
Q ss_pred cccccccCCCCcccCCCCcccccccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC--CCCC
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNE---EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE--RPPF 375 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~ 375 (456)
.... .........||+.|+|||++... .++.++|||||||++|||++|+.||.+.+............ .+..
T Consensus 155 ~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~ 231 (276)
T d1uwha_ 155 SRWS---GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL 231 (276)
T ss_dssp --------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG
T ss_pred cccC---CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcc
Confidence 3221 11223345789999999998643 57889999999999999999999999877655444443333 3333
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 376 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
...+..+|+++.+||.+||..||++|||+++++++|+.+.+.+
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 3446788999999999999999999999999999999988653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-52 Score=395.42 Aligned_cols=245 Identities=22% Similarity=0.425 Sum_probs=213.7
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|+..+.||+|+||.| ..+|+.||||++....... .+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 6888999999999977 2469999999997654333 3678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
||++|+|.+++.+ +.+++.+++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 y~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~---- 169 (293)
T d1yhwa1 98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 169 (293)
T ss_dssp CCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST----
T ss_pred ecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc----
Confidence 9999999998875 56999999999999999999999999 999999999999999999999999999876321
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.....+.+. .+..++.++.
T Consensus 170 -~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~ 247 (293)
T d1yhwa1 170 -QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ-NPEKLSAIFR 247 (293)
T ss_dssp -TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS-SGGGSCHHHH
T ss_pred -cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC-CcccCCHHHH
Confidence 12234457999999999999999999999999999999999999999888776666666555544432 3467899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+||.+||..||++|||++|+++|
T Consensus 248 ~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 248 DFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTC
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999876
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-53 Score=396.81 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=207.2
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|++.+.||+|+||.| ..+|+.||||++.... ..+..+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh--cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 6888999999999977 2368999999997653 23344678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
||++|+|.+++...+.+++.+++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~--- 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN--- 157 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT---
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC---
Confidence 9999999999988788999999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCCCcccCCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEY-DTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|++||................ .........++.++
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~ 236 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTYLNPWKKIDSAP 236 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT-CTTSTTGGGSCHHH
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCCCCccccCCHHH
Confidence 1122344679999999999988776 467999999999999999999998766544333332222 22223346789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+||.+||+.||++|||++|++++
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999999765
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-51 Score=393.89 Aligned_cols=257 Identities=31% Similarity=0.517 Sum_probs=208.8
Q ss_pred ccccceeeeccEEEEEe---E--cC---cEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 153 DFSNSVEITKGTFRIAS---W--RG---TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~---~--~g---~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
+|...+.||+|+||.|. . +| ..||||.+... ..+...+.|.+|+.+|++++||||+++++++..++.+++
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 47778899999999772 2 22 25899998764 356667889999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 225 VTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
|||||++|+|.+++... +.+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999988774 46999999999999999999999999 999999999999999999999999999876433
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCC
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (456)
.............+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....+....+....+++. +..+
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~ 258 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP---PMDC 258 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTC
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---Cccc
Confidence 22222222333567899999999999999999999999999999998 8999999888777777765555443 5678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
+.++.+||.+||+.||++|||++++++.|+++.+.
T Consensus 259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 259 PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 99999999999999999999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-52 Score=389.91 Aligned_cols=249 Identities=24% Similarity=0.440 Sum_probs=203.3
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--CCceEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ--STPMMIV 225 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~~lv 225 (456)
+|++.+.||+|+||.| ..+|+.||+|++..... ++...+.+.+|++++++++||||+++++++.+ +..+|+|
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5888899999999976 23688999999987643 56667889999999999999999999999864 4668999
Q ss_pred EEccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCC--CCeEecCCCCCCeEeCCCCCEEEeccCCccc
Q 012777 226 TEYLPKGDLRAYLKQ----KGALKPTLAVKFALDIARGMNYLHENRP--EAIIHRDLEPSNILRDDSGHLKVADFGLSKL 299 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~~--~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~ 299 (456)
||||++|+|.+++.+ .+.+++..++.++.|++.||.|||+++. .+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999864 3569999999999999999999998641 2399999999999999999999999999987
Q ss_pred ccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCC
Q 012777 300 LKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPT 379 (456)
Q Consensus 300 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 379 (456)
.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.....+. .+
T Consensus 164 ~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~---~~ 235 (269)
T d2java1 164 LNHD-----TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IP 235 (269)
T ss_dssp C----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CC
T ss_pred cccC-----CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC---CC
Confidence 6322 112234678999999999999999999999999999999999999999888777777775554433 35
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 380 THYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 380 ~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..+|+++.+||.+||+.||++|||++|+++|
T Consensus 236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 236 YRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 6889999999999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-52 Score=397.33 Aligned_cols=247 Identities=23% Similarity=0.387 Sum_probs=199.2
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|.+.+.||+|+||.| ..+|+.||||++.+.... .....+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4888899999999865 236899999999765432 234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC---CCCCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD---DSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~---~~~~vkl~Dfgls~~~~~~~ 304 (456)
||+|++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||+. .++.+||+|||+++.....
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~- 163 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 163 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence 9999999999998888999999999999999999999999 99999999999995 5789999999999866321
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..............+|+
T Consensus 164 -----~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 238 (307)
T d1a06a_ 164 -----SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred -----CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCH
Confidence 222345799999999999999999999999999999999999999998887777777755443332233568899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.+||.+||..||++|||++|+++|
T Consensus 239 ~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 239 SAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 99999999999999999999999886
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=398.59 Aligned_cols=248 Identities=23% Similarity=0.395 Sum_probs=212.3
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|++.+.||+|+||.| ..+|+.||||++.+.....+...+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 5889999999999976 23688999999975432223345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
||++|+|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~--- 162 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--- 162 (288)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCC---
Confidence 9999999999999899999999999999999999999999 9999999999999999999999999998763221
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... ...+ +..+++++.
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-~~~~---p~~~s~~~~ 238 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EYDF---PEKFFPKAR 238 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-CCCC---CTTCCHHHH
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC-CCCC---CccCCHHHH
Confidence 112223457999999999999999999999999999999999999999988877777766433 3332 467899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+||.+||+.||++|||++|++++
T Consensus 239 ~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 239 DLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHHHTTSCSSGGGSTTSGGGTCH
T ss_pred HHHHHHccCCHhHCcCHHHHcCC
Confidence 99999999999999999998765
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-52 Score=393.93 Aligned_cols=246 Identities=26% Similarity=0.386 Sum_probs=211.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|++.+.||+|+||.| ..+|+.||||++.... ....+.+.+|+++|++++||||+++++++.+++.+++|||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 4788899999999977 2368899999997542 3345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 228 YLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 228 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
||++|+|.+++.+. +.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~- 165 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 165 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence 99999999997654 56999999999999999999999999 99999999999999999999999999986532211
Q ss_pred cCCCCcccCCCCcccccccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCC
Q 012777 307 KEDRPVTCEETSWRYAAPEVYK-----NEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTH 381 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (456)
......||+.|+|||++. ...++.++|||||||++|+|++|+.||.+.+..+....+.....+.. ..+..
T Consensus 166 ----~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~ 240 (288)
T d2jfla1 166 ----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-AQPSR 240 (288)
T ss_dssp ----HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-SSGGG
T ss_pred ----cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-Ccccc
Confidence 122457899999999984 45688999999999999999999999999888888777765544333 23467
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 382 YAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 382 ~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.++.+||.+||+.||++|||++|+++|
T Consensus 241 ~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 89999999999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-51 Score=395.13 Aligned_cols=244 Identities=28% Similarity=0.434 Sum_probs=214.9
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|+..+.||+|+||.|. .+|+.||||++...........+.+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 48889999999999762 4688999999987665566677889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
||.+|+|..++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence 9999999888888788999999999999999999999999 99999999999999999999999999986521
Q ss_pred CCCCcccCCCCcccccccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKN---EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....+.. ....+|.
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~ 241 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSE 241 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SCTTSCH
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCCCH
Confidence 223569999999999864 4688999999999999999999999998887776666655554443 2467899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.+||.+||+.||++|||++|+++|
T Consensus 242 ~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 242 YFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 99999999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=384.69 Aligned_cols=251 Identities=29% Similarity=0.570 Sum_probs=206.1
Q ss_pred ccccceeeeccEEEEE---eE-cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 153 DFSNSVEITKGTFRIA---SW-RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~-~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
+|...+.||+|+||.| .. +++.||||++..... . .+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-S---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-C---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-c---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 4777889999999866 22 577899999986542 2 25789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 229 LPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 229 ~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~--- 155 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--- 155 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC---
Confidence 9999999998764 45899999999999999999999999 9999999999999999999999999998663321
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
........||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+....+....++.. +...+.++
T Consensus 156 -~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l 231 (263)
T d1sm2a_ 156 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHV 231 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCHHH
T ss_pred -ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCHHH
Confidence 112233568899999999999999999999999999999999 5777777776666666655544443 46788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
.+||.+||+.||++|||+++++++|+++.++
T Consensus 232 ~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 232 YQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=387.63 Aligned_cols=251 Identities=27% Similarity=0.439 Sum_probs=210.9
Q ss_pred eeeeccEEEEEeE-------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccC
Q 012777 158 VEITKGTFRIASW-------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 230 (456)
Q Consensus 158 ~~lg~G~fg~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~~ 230 (456)
++||+|+||.|.. .++.||||+++... .++...+.+.+|+.+|++++||||+++++++.. +..++|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 5799999997722 24579999997654 334456789999999999999999999999865 56789999999
Q ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCC
Q 012777 231 KGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDR 310 (456)
Q Consensus 231 ~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~ 310 (456)
+|+|.+++.+...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......... .
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~--~ 165 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--K 165 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE--E
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc--c
Confidence 9999999998888999999999999999999999999 9999999999999999999999999998663221111 1
Q ss_pred CcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHH
Q 012777 311 PVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLREL 389 (456)
Q Consensus 311 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 389 (456)
......||+.|+|||.+.+..++.++|||||||++|||++ |+.||.+.+..+....+..+.+++. +..+|.++.+|
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~~~~l 242 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAGCPREMYDL 242 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHH
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC---CcccCHHHHHH
Confidence 2233568999999999999999999999999999999998 8999999887777777765555544 56789999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 390 IEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 390 i~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
|.+||+.||++|||++++++.|++.+...
T Consensus 243 i~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 243 MNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 99999999999999999999999886543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=384.49 Aligned_cols=257 Identities=23% Similarity=0.403 Sum_probs=217.8
Q ss_pred ccccce-eeeccEEEEEeE-------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 153 DFSNSV-EITKGTFRIASW-------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 153 ~~~~~~-~lg~G~fg~~~~-------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
++.... +||+|+||.|.. ++..||||+++.. ......+.|.+|+.+|++++||||+++++++.. +.+++
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 355555 599999997622 3457999999765 456667889999999999999999999999865 56899
Q ss_pred EEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 225 VTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
|||||++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999998654 56999999999999999999999999 999999999999999999999999999876432
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCC
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHY 382 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (456)
.... .......||+.|+|||++....++.++|||||||++|||+| |+.||.+.+..+....+..+.+++. +..+
T Consensus 163 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~ 237 (285)
T d1u59a_ 163 DSYY--TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPEC 237 (285)
T ss_dssp SCEE--CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC---CTTC
T ss_pred cccc--ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCcC
Confidence 2111 12223468899999999998899999999999999999998 9999999887777777765555544 5678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhcc
Q 012777 383 AYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSI 420 (456)
Q Consensus 383 ~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~ 420 (456)
|+++.+||.+||..||++|||+.++++.|+..+.++..
T Consensus 238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence 99999999999999999999999999999998876633
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=380.90 Aligned_cols=245 Identities=26% Similarity=0.452 Sum_probs=203.3
Q ss_pred ccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe----CCceEEE
Q 012777 155 SNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ----STPMMIV 225 (456)
Q Consensus 155 ~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----~~~~~lv 225 (456)
...++||+|+||.|. .+++.||+|++..... .....+.+.+|+++|++++||||+++++++.. ...+++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 455689999999772 3578999999976543 45667889999999999999999999999865 3458999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-CCCCEEEeccCCcccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD-DSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~-~~~~vkl~Dfgls~~~~~~~ 304 (456)
||||++|+|.+++.+.+.+++..+..++.||+.||.|||+++ .+|+||||||+|||++ .++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~--- 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 166 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC---
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc---
Confidence 999999999999998889999999999999999999999875 3499999999999997 57899999999997542
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
........||+.|+|||++.+ .++.++|||||||++|+|++|+.||..................+. ..+...++
T Consensus 167 ----~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~-~~~~~~~~ 240 (270)
T d1t4ha_ 167 ----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA-SFDKVAIP 240 (270)
T ss_dssp ----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG-GGGGCCCH
T ss_pred ----CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc-ccCccCCH
Confidence 122335679999999999876 599999999999999999999999987655443333323332221 12456788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.+||.+||..||++|||++|+++|
T Consensus 241 ~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 241 EVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 89999999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=382.35 Aligned_cols=260 Identities=30% Similarity=0.483 Sum_probs=216.1
Q ss_pred CCCccccCccccccccceeeeccEEEEE---eE-cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEE
Q 012777 141 EVPEYEIDPKELDFSNSVEITKGTFRIA---SW-RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV 216 (456)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~lg~G~fg~~---~~-~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 216 (456)
....|||+.. +|+..+.||+|+||.| .. +++.||||++..... . .+.|.+|+.++++++||||+++++++
T Consensus 4 ~~~~wei~~~--~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~---~~~~~~E~~~l~~l~HpnIv~~~g~~ 77 (272)
T d1qpca_ 4 WEDEWEVPRE--TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-S---PDAFLAEANLMKQLQHQRLVRLYAVV 77 (272)
T ss_dssp TTCTTBCCGG--GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-C---HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCeecCHH--HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-C---HHHHHHHHHHHHhCCCCCEeEEEeee
Confidence 3456667654 5788889999999976 33 467899999976532 2 35789999999999999999999987
Q ss_pred EeCCceEEEEEccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEecc
Q 012777 217 TQSTPMMIVTEYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADF 294 (456)
Q Consensus 217 ~~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Df 294 (456)
.+ +.+++|||||++|+|.+++... .++++..+..|+.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 78 ~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DF 153 (272)
T d1qpca_ 78 TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADF 153 (272)
T ss_dssp CS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred cc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccc
Confidence 54 5679999999999999977543 35999999999999999999999999 999999999999999999999999
Q ss_pred CCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCccchHHHHHhcCCC
Q 012777 295 GLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG-CPPFPTKQEKEVPKAYIANERP 373 (456)
Q Consensus 295 gls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~ 373 (456)
|+++...... ........||+.|+|||++....++.++|||||||++|||+|| .+||...+..+....+....++
T Consensus 154 Gla~~~~~~~----~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~ 229 (272)
T d1qpca_ 154 GLARLIEDNE----YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM 229 (272)
T ss_dssp TTCEECSSSC----EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred cceEEccCCc----cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC
Confidence 9998764321 1122345688899999999988999999999999999999995 6666666666666666544444
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 374 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
.. +..++.++.+||.+||+.||++|||++++++.|++++..
T Consensus 230 ~~---p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 230 VR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC---cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 43 567899999999999999999999999999999998864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-51 Score=394.36 Aligned_cols=246 Identities=25% Similarity=0.393 Sum_probs=215.3
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.| ..+|+.||||++.+.........+.+.+|+.+|++++||||+++++++.+.+.+|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 5889999999999977 24689999999976432223345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
||+||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~---- 158 (337)
T d1o6la_ 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---- 158 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT----
T ss_pred ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC----
Confidence 9999999999999999999999999999999999999999 999999999999999999999999999865321
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
........||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..++...+... ...+ +..+++++.
T Consensus 159 -~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~-~~~~---p~~~s~~~~ 233 (337)
T d1o6la_ 159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRF---PRTLSPEAK 233 (337)
T ss_dssp -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCC---CTTSCHHHH
T ss_pred -CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC-CCCC---CccCCHHHH
Confidence 12233467899999999999999999999999999999999999999998887777666443 3333 567899999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHHHH
Q 012777 388 ELIEDCWSEEPFRRPT-----FRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rpt-----~~ell~~ 410 (456)
+||.+||++||.+||+ ++++++|
T Consensus 234 dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHhhccCCchhhcccccccHHHHHcC
Confidence 9999999999999994 8888875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.8e-51 Score=396.11 Aligned_cols=246 Identities=22% Similarity=0.379 Sum_probs=213.7
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.|. .+|+.||||++... .....+.+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 68999999999999772 36899999999764 34556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC--CCCCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD--DSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~--~~~~vkl~Dfgls~~~~~~~ 304 (456)
||+||+|.+++.+ .+.+++..+..|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~--- 177 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--- 177 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECC---
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecc---
Confidence 9999999999854 457999999999999999999999999 99999999999996 46789999999998763
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..............++.
T Consensus 178 ---~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 254 (350)
T d1koaa2 178 ---PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254 (350)
T ss_dssp ---TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred ---cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 22233456789999999999999999999999999999999999999998887777777754442222223457889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.+||.+||..||++|||++|+++|
T Consensus 255 ~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 255 DGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999999886
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=395.32 Aligned_cols=254 Identities=26% Similarity=0.473 Sum_probs=209.4
Q ss_pred ccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 225 (456)
+-+|++.+.||+|+||.|. .+|+.||+|+++... .+.....+.+|+.+|++++||||++++++|.++..+++|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3468999999999999762 368999999997653 334457889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHE-NRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~-~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
|||+++|+|.+++.+.+.+++..+..++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||+|......
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999999999988899999999999999999999997 48 999999999999999999999999999976322
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc--------------
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN-------------- 370 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------------- 370 (456)
......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+........
T Consensus 159 ------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 159 ------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp ------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred ------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 112357999999999999999999999999999999999999999776543221110000
Q ss_pred --------------------------CCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 371 --------------------------ERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 371 --------------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
..++...+...++.++.+||.+||..||++|||++|+++| .++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H--pf~~~~ 304 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH--AFIKRS 304 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS--HHHHHH
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC--HhhCcC
Confidence 0001111224567899999999999999999999999997 455544
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-51 Score=389.83 Aligned_cols=259 Identities=28% Similarity=0.491 Sum_probs=214.5
Q ss_pred CccccCccccccccceeeeccEEEEE---e--EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE
Q 012777 143 PEYEIDPKELDFSNSVEITKGTFRIA---S--WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVT 217 (456)
Q Consensus 143 ~~~~~~~~~~~~~~~~~lg~G~fg~~---~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 217 (456)
..|||+.. +|+..+.||+|+||.| . .+|+.||||+++.+.. ..+.+.+|+.+|++++||||+++++++.
T Consensus 10 ~~wei~~~--~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (287)
T d1opja_ 10 DKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCT 83 (287)
T ss_dssp CTTBCCGG--GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccEecHH--HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEe
Confidence 34666654 4777889999999865 2 2588999999976532 2357899999999999999999999999
Q ss_pred eCCceEEEEEccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccC
Q 012777 218 QSTPMMIVTEYLPKGDLRAYLKQK--GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFG 295 (456)
Q Consensus 218 ~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfg 295 (456)
+.+.+++|||||++|+|.+++.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred eCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcccc
Confidence 999999999999999999999764 45899999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCC-CCCCCccchHHHHHhcCCCC
Q 012777 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPP-FPTKQEKEVPKAYIANERPP 374 (456)
Q Consensus 296 ls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~ 374 (456)
+++...... ........|++.|+|||++.+..++.++|||||||++|||++|..| |...+.......+....+++
T Consensus 161 ~a~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~ 236 (287)
T d1opja_ 161 LSRLMTGDT----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236 (287)
T ss_dssp CTTTCCSSS----SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred ceeecCCCC----ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCC
Confidence 998763221 1112233478889999999999999999999999999999996555 55555555545454443444
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 375 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
. +..+++++.+||.+||+.||++|||++++++.|+.++++
T Consensus 237 ~---~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 237 R---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp C---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred C---CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 3 567899999999999999999999999999988876543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-51 Score=387.62 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=213.9
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCC---HHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTD---EDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
.|.+.+.||+|+||.| ..+|+.||||++.+..... ....+.+.+|+.+|++++||||+++++++.+...+|+
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 5889999999999977 2368999999997543322 1235778999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC----CEEEeccCCcccc
Q 012777 225 VTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG----HLKVADFGLSKLL 300 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~----~vkl~Dfgls~~~ 300 (456)
|||||++|+|.+++.+.+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++...
T Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999999999998889999999999999999999999999 99999999999999776 5999999999876
Q ss_pred cccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...........+.
T Consensus 168 ~~~------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 168 DFG------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp TTS------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred CCC------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence 322 22334578999999999999999999999999999999999999999888777776664443222122236
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+|.++.+||.+||..||++|||++|+++|
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 788999999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.2e-50 Score=381.72 Aligned_cols=258 Identities=23% Similarity=0.353 Sum_probs=217.0
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC----ceE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST----PMM 223 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~----~~~ 223 (456)
+|.+.+.||+|+||.| ..+|+.||||++..+...+......+.+|+.+++.++||||+++++++...+ .+|
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 5888899999999976 2468999999999877677777889999999999999999999999997654 389
Q ss_pred EEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
+|||||+|++|.+++...+.+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.++++|||.+......
T Consensus 88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccc
Confidence 99999999999999998889999999999999999999999999 999999999999999999999999998755322
Q ss_pred ccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
.. .........||+.|+|||++.+..+++++|||||||++|+|++|++||.+.+..+....+......+.......+|
T Consensus 165 ~~--~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 165 GN--SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred cc--cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence 11 1122334578999999999999999999999999999999999999999888777766665555433333457889
Q ss_pred HHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRP-TFRQILMRLDDIS 415 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rp-t~~ell~~L~~~~ 415 (456)
.++.++|.+||+.||++|| |++++++.|.++.
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 9999999999999999999 8999999988765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=375.91 Aligned_cols=247 Identities=27% Similarity=0.510 Sum_probs=214.7
Q ss_pred ccccceeeeccEEEEEe---E-cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 153 DFSNSVEITKGTFRIAS---W-RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~---~-~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
+|+..+.||+|+||.|. + ++..||||++++... . .+.+.+|+.++++++||||+++++++.+++.+++||||
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-S---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-C---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-C---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 57788899999999773 2 566899999986543 2 25789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 229 LPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 229 ~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
+++|+|.+++... ..+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~---- 153 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---- 153 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS----
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCC----
Confidence 9999999997653 56999999999999999999999999 999999999999999999999999999866322
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
.........+|+.|+|||.+.+..++.++|||||||++|||+| |+.||...+..+....+....+++. +...+.++
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l 230 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKV 230 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHH
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC---cccccHHH
Confidence 1122334568999999999999999999999999999999998 8999999988888777765544443 56788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFRQILMRLDD 413 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~ell~~L~~ 413 (456)
.+||.+||+.||++|||+++++++|.+
T Consensus 231 ~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 231 YTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-50 Score=393.32 Aligned_cols=246 Identities=19% Similarity=0.360 Sum_probs=214.1
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
.|++.+.||+|+||.|. .+|+.||||++... .......+.+|+.+|++++||||++++++|.+++.+|+|||
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc---chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 58899999999999772 36899999999764 33445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC--CCCCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRD--DSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~--~~~~vkl~Dfgls~~~~~~~ 304 (456)
||+||+|.+++...+ ++++.+++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~-- 181 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-- 181 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT--
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC--
Confidence 999999999876544 5999999999999999999999999 99999999999998 678999999999987632
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..............++.
T Consensus 182 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 257 (352)
T d1koba_ 182 ----DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257 (352)
T ss_dssp ----TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ----CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 2233446789999999999999999999999999999999999999998887777777755443322233568899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.+||.+||+.||++|||++|+++|
T Consensus 258 ~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 258 EAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999999876
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-50 Score=377.37 Aligned_cols=259 Identities=25% Similarity=0.496 Sum_probs=211.4
Q ss_pred cccCccccccccceeeeccEEEEEe---E-----cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEE
Q 012777 145 YEIDPKELDFSNSVEITKGTFRIAS---W-----RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV 216 (456)
Q Consensus 145 ~~~~~~~~~~~~~~~lg~G~fg~~~---~-----~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 216 (456)
|||+.+ +|...+.||+|+||.|. . .+..||||.+... ..+...+.+.+|+.++++++||||+++++++
T Consensus 2 ~ei~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 2 YEIQRE--RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVI 77 (273)
T ss_dssp CBCCGG--GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCcCHH--HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 555544 58888999999999762 2 2346899998654 4566678899999999999999999999998
Q ss_pred EeCCceEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccC
Q 012777 217 TQSTPMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFG 295 (456)
Q Consensus 217 ~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfg 295 (456)
. ++.+++||||+++|+|.+++... +.+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 78 ~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 78 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--
T ss_pred e-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccch
Confidence 5 46789999999999999987654 46999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCC
Q 012777 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPP 374 (456)
Q Consensus 296 ls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 374 (456)
+++..... .........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+....+++
T Consensus 154 ~a~~~~~~----~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~ 229 (273)
T d1mp8a_ 154 LSRYMEDS----TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 229 (273)
T ss_dssp ---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred hheeccCC----cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99876322 1122234568899999999999999999999999999999998 899999998888888776655554
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 375 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
. +.++|.++.+||.+||..||++|||+++|+++|+.+.++-
T Consensus 230 ~---~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 230 M---PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp C---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C---CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 4 5788999999999999999999999999999999987653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-49 Score=375.27 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=213.2
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCC------HHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCC
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTD------EDKVKAFIDELALLQKIR-HPNVVQFLGAVTQST 220 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~ 220 (456)
+|+..+.||+|+||.|. .+|+.||||++.+..... +...+.+.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 58888999999999762 378899999997654322 223456889999999996 999999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
..|+|||||++|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999999998899999999999999999999999999 999999999999999999999999999876
Q ss_pred cccccccCCCCcccCCCCcccccccccCC------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCC
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKN------EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPP 374 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 374 (456)
.. ........||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+..+....+.......
T Consensus 161 ~~------~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~ 234 (277)
T d1phka_ 161 DP------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234 (277)
T ss_dssp CT------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred cC------CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 32 222344678999999998853 356889999999999999999999999988777766665544322
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
......++|+++.+||.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 222345899999999999999999999999999876
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.9e-50 Score=386.15 Aligned_cols=243 Identities=25% Similarity=0.455 Sum_probs=213.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|++.+.||+|+||.| ..+|+.||||++.+.........+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 6888999999999876 24689999999975432222335778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
||+|++|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++....
T Consensus 85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~----- 156 (316)
T d1fota_ 85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD----- 156 (316)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-----
T ss_pred ecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc-----
Confidence 9999999999999889999999999999999999999999 99999999999999999999999999987632
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.... ..+ +..++.++.
T Consensus 157 ---~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~---p~~~s~~~~ 229 (316)
T d1fota_ 157 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRF---PPFFNEDVK 229 (316)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCC---CTTSCHHHH
T ss_pred ---ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCC---CCCCCHHHH
Confidence 1224579999999999999999999999999999999999999999988877777765443 222 467899999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rp-----t~~ell~~ 410 (456)
++|.+||..||.+|+ |++++++|
T Consensus 230 ~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 230 DLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 999999999999996 89999886
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=374.87 Aligned_cols=260 Identities=30% Similarity=0.497 Sum_probs=210.5
Q ss_pred ccCccccccccceeeeccEEEEEe---Ec--C----cEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEE
Q 012777 146 EIDPKELDFSNSVEITKGTFRIAS---WR--G----TQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAV 216 (456)
Q Consensus 146 ~~~~~~~~~~~~~~lg~G~fg~~~---~~--g----~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 216 (456)
||.++ .|+..+.||+|+||.|. +. + ..||||++... ..+.....|.+|+.++++++||||+++++++
T Consensus 3 ei~~~--~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~ 78 (283)
T d1mqba_ 3 EIHPS--CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 78 (283)
T ss_dssp BCCTT--TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCCHH--HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc--cChHHHHHHHHHHHHHHhcCCCCEeeeeEEE
Confidence 34444 37788899999998762 22 1 36999999764 3455667899999999999999999999999
Q ss_pred EeCCceEEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccC
Q 012777 217 TQSTPMMIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFG 295 (456)
Q Consensus 217 ~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfg 295 (456)
.+....++||||+.++++.+++... +.+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 79 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred ecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccc
Confidence 9999999999999999999988765 56999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCccchHHHHHhcCCCC
Q 012777 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG-CPPFPTKQEKEVPKAYIANERPP 374 (456)
Q Consensus 296 ls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~ 374 (456)
+++........ ........||+.|+|||++.+..++.++|||||||++|||++| .+|+......+....+....+++
T Consensus 156 la~~~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~ 233 (283)
T d1mqba_ 156 LSRVLEDDPEA--TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 233 (283)
T ss_dssp C-------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred hhhcccCCCcc--ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC
Confidence 99876432111 1122234688999999999999999999999999999999995 55666666666666665555555
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 375 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
. +..++..+.+||.+||..||++|||++++++.|+.+.+.
T Consensus 234 ~---~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 234 T---PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp C---CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred C---chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 4 467899999999999999999999999999999988764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-50 Score=385.76 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=210.0
Q ss_pred ccccCccccccccceeeeccEEEEEe---Ec--C-----cEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceee
Q 012777 144 EYEIDPKELDFSNSVEITKGTFRIAS---WR--G-----TQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQF 212 (456)
Q Consensus 144 ~~~~~~~~~~~~~~~~lg~G~fg~~~---~~--g-----~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l 212 (456)
.||++.+ +|...+.||+|+||.|. .. + ..||+|.+.... .......+.+|+.+++++ +||||+++
T Consensus 31 kwei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l 106 (325)
T d1rjba_ 31 KWEFPRE--NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNL 106 (325)
T ss_dssp GGBCCGG--GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHH--HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEE
Confidence 3455544 57778999999999772 21 2 269999987643 344457889999999998 89999999
Q ss_pred eeEEEeCCceEEEEEccCCCCHHHHHHHc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 012777 213 LGAVTQSTPMMIVTEYLPKGDLRAYLKQK-----------------------GALKPTLAVKFALDIARGMNYLHENRPE 269 (456)
Q Consensus 213 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----------------------~~l~~~~~~~i~~ql~~aL~~LH~~~~~ 269 (456)
++++.+.+.+++|||||++|+|.+++... +.+++..++.++.|++.||.|||+++
T Consensus 107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-- 184 (325)
T d1rjba_ 107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-- 184 (325)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 99999999999999999999999999754 24889999999999999999999999
Q ss_pred CeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHH
Q 012777 270 AIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMI 349 (456)
Q Consensus 270 ~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 349 (456)
|+||||||+|||++.++.+||+|||+|+...... .........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 185 -IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~eml 260 (325)
T d1rjba_ 185 -CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS---NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260 (325)
T ss_dssp -EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCT---TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred -eeeccCchhccccccCCeEEEeeccccccccCCC---ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHH
Confidence 9999999999999999999999999998663221 111222345789999999999999999999999999999999
Q ss_pred c-CCCCCCCCCccchHHHHHhcC-CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012777 350 E-GCPPFPTKQEKEVPKAYIANE-RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLD 412 (456)
Q Consensus 350 ~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~ 412 (456)
+ |++||.+.+.......+.... +++. +..+|+++.+||.+||+.||++|||++||+++|.
T Consensus 261 t~g~~Pf~~~~~~~~~~~~~~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 261 SLGVNPYPGIPVDANFYKLIQNGFKMDQ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTSCCSSTTCCCSHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHhcCCCCCC---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 7 899999877766555554444 3333 5678999999999999999999999999999985
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.9e-50 Score=388.86 Aligned_cols=243 Identities=23% Similarity=0.396 Sum_probs=213.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|++.+.||+|+||.| ..+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.....+++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 6899999999999977 23699999999875432222335678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
|+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~----- 193 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----- 193 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS-----
T ss_pred cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc-----
Confidence 9999999999998889999999999999999999999999 99999999999999999999999999987631
Q ss_pred CCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHH
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLR 387 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 387 (456)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.... +. .+..+++++.
T Consensus 194 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~---~p~~~s~~~~ 266 (350)
T d1rdqe_ 194 ---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VR---FPSHFSSDLK 266 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CC---CCTTCCHHHH
T ss_pred ---ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC-CC---CCccCCHHHH
Confidence 1223568999999999999999999999999999999999999999888777777665443 22 2467899999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHHH
Q 012777 388 ELIEDCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 388 ~li~~~l~~dp~~Rp-----t~~ell~~ 410 (456)
++|.+||..||.+|+ |++++++|
T Consensus 267 ~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHHhhhCHHhccccccccHHHHHcC
Confidence 999999999999994 89999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=369.59 Aligned_cols=252 Identities=32% Similarity=0.578 Sum_probs=210.3
Q ss_pred cccCccccccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe-CC
Q 012777 145 YEIDPKELDFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ-ST 220 (456)
Q Consensus 145 ~~~~~~~~~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 220 (456)
|+|+..+ |+..+.||+|+||.| ..+|+.||||+++.+. ..+.+.+|+.++++++||||+++++++.+ .+
T Consensus 2 w~i~~~~--~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKE--LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGG--EEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHH--eEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 4555554 666789999999865 6789999999997542 23678999999999999999999999865 46
Q ss_pred ceEEEEEccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
.+++||||+++|+|.+++.+.+ .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 151 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccce
Confidence 6899999999999999997643 4999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCC
Q 012777 299 LLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRA 377 (456)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 377 (456)
.... ......+|+.|+|||++.+..+++++||||||+++|||++ |++||...+..+....+....++++
T Consensus 152 ~~~~--------~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~-- 221 (262)
T d1byga_ 152 EASS--------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA-- 221 (262)
T ss_dssp ------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC--
T ss_pred ecCC--------CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence 6521 1223456788999999998999999999999999999998 7999998888888877755555554
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 378 PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 378 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
+..+++++.+||.+||..||++|||+.+++++|+++..+
T Consensus 222 -~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 222 -PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 567889999999999999999999999999999998653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.5e-49 Score=384.73 Aligned_cols=247 Identities=24% Similarity=0.337 Sum_probs=204.3
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCC---CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFT---DEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 224 (456)
+|.+.+.||+|+||.| ..+|+.||||++.+.... ..........|+.+++.++||||+++++++..++.+|+
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 6888999999999977 236899999998643321 12222223345677778889999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccc
Q 012777 225 VTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~ 304 (456)
|||||++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 vmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp EECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred EEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence 9999999999999999889999999999999999999999999 999999999999999999999999999866321
Q ss_pred cccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCc
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYA 383 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (456)
......||+.|+|||++.. ..++.++|||||||++|+|++|+.||......+...........+ ...+..++
T Consensus 161 ------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~s 233 (364)
T d1omwa3 161 ------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-VELPDSFS 233 (364)
T ss_dssp ------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC-CCCCSSSC
T ss_pred ------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC-CCCCCCCC
Confidence 2234579999999999865 568999999999999999999999998876655443332222222 22356799
Q ss_pred HHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 012777 384 YGLRELIEDCWSEEPFRRPT-----FRQILMR 410 (456)
Q Consensus 384 ~~l~~li~~~l~~dp~~Rpt-----~~ell~~ 410 (456)
+++.+||.+||..||++||| ++++++|
T Consensus 234 ~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 99999999999999999999 7898876
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=370.40 Aligned_cols=263 Identities=32% Similarity=0.569 Sum_probs=218.9
Q ss_pred CCCccccCccccccccceeeeccEEEEEe---E---------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCC
Q 012777 141 EVPEYEIDPKELDFSNSVEITKGTFRIAS---W---------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHP 207 (456)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~lg~G~fg~~~---~---------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp 207 (456)
..|.|+|+.+ +|.+.+.||+|+||.|. . ++..||||++..+ ........+.+|...++++ +||
T Consensus 4 ~~~~~~i~~~--~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~e~~~l~~~~~Hp 79 (299)
T d1fgka_ 4 EDPRWELPRD--RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHK 79 (299)
T ss_dssp CCTTTBCCGG--GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT--CCHHHHHHHHHHHHHHHHHCCCT
T ss_pred cCCcCcccHH--HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc--cChHHHHHHHHHHHHHHHhcCCC
Confidence 4566766655 57778899999999662 1 2247999999865 3556678899999999888 799
Q ss_pred cceeeeeEEEeCCceEEEEEccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 012777 208 NVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKG----------------ALKPTLAVKFALDIARGMNYLHENRPEAI 271 (456)
Q Consensus 208 ~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~i 271 (456)
||+++++++.++..+++|||||++|+|.+++.... .+++.++..++.||+.||+|||+++ |
T Consensus 80 nIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---i 156 (299)
T d1fgka_ 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---C 156 (299)
T ss_dssp TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---E
Confidence 99999999999999999999999999999997542 4899999999999999999999999 9
Q ss_pred EecCCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-
Q 012777 272 IHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE- 350 (456)
Q Consensus 272 vH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 350 (456)
+||||||+|||++.++.+||+|||++......... .......+|+.|+|||.+.+..++.++||||||+++|+|++
T Consensus 157 vHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~ 233 (299)
T d1fgka_ 157 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 233 (299)
T ss_dssp CCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTT---CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred EeeeecccceeecCCCCeEeccchhhccccccccc---cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccC
Confidence 99999999999999999999999999877433211 22334568889999999999999999999999999999998
Q ss_pred CCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 012777 351 GCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416 (456)
Q Consensus 351 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~ 416 (456)
|.+||.+.+.......+....+++. +..+++++.+||.+||+.||.+|||++|+++.|+++..
T Consensus 234 g~~p~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 234 GGSPYPGVPVEELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp SCCSSTTCCHHHHHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCC---CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 7999998887777766655545544 56789999999999999999999999999999998864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=382.13 Aligned_cols=246 Identities=28% Similarity=0.436 Sum_probs=210.2
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHh-cCCCCcceeeeeEEEeCCceEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQ-KIRHPNVVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~l~~~~~~~~~~~lv~ 226 (456)
+|.+.+.||+|+||.| ..+|+.||||++.+.....+...+.+..|..++. .++||||+++++++.+++.+|+||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 5888899999999876 2368999999997543222223456677777665 579999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccc
Q 012777 227 EYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTV 306 (456)
Q Consensus 227 e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~ 306 (456)
|||++|+|.+++...+.+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~---- 155 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML---- 155 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC----
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc----
Confidence 99999999999999889999999999999999999999999 99999999999999999999999999986532
Q ss_pred cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcHHH
Q 012777 307 KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAYGL 386 (456)
Q Consensus 307 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 386 (456)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+... .+.+ +..+|+++
T Consensus 156 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-~~~~---p~~~s~~~ 230 (320)
T d1xjda_ 156 -GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-NPFY---PRWLEKEA 230 (320)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCC---CTTSCHHH
T ss_pred -ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCC---CccCCHHH
Confidence 122333457999999999999999999999999999999999999999998887777776433 3333 56789999
Q ss_pred HHHHHHhcccCCCCCCCHH-HHHHH
Q 012777 387 RELIEDCWSEEPFRRPTFR-QILMR 410 (456)
Q Consensus 387 ~~li~~~l~~dp~~Rpt~~-ell~~ 410 (456)
.+||.+||..||++|||+. ++++|
T Consensus 231 ~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 231 KDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHHhcccCCCCCcCHHHHHHhC
Confidence 9999999999999999995 77653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=369.16 Aligned_cols=259 Identities=32% Similarity=0.535 Sum_probs=210.4
Q ss_pred CCccccCccccccccceeeeccEEEEE---eE-cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE
Q 012777 142 VPEYEIDPKELDFSNSVEITKGTFRIA---SW-RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVT 217 (456)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~lg~G~fg~~---~~-~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 217 (456)
...|+|+.+ +|++.+.||+|+||.| .. ++..||||++..... . .+.|.+|+.++++++||||+++++++.
T Consensus 9 ~~~~~i~~~--~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~---~~~~~~E~~~l~~l~h~nIv~~~g~~~ 82 (285)
T d1fmka3 9 KDAWEIPRE--SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-S---PEAFLQEAQVMKKLRHEKLVQLYAVVS 82 (285)
T ss_dssp TTCSBCCGG--GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-C---HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CcceEcCHH--HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-C---HHHHHHHHHHHHhcccCCEeEEEEEEe
Confidence 345666654 5888899999999976 22 456899999976542 2 257899999999999999999999985
Q ss_pred eCCceEEEEEccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccC
Q 012777 218 QSTPMMIVTEYLPKGDLRAYLKQ--KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFG 295 (456)
Q Consensus 218 ~~~~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfg 295 (456)
++.+++||||+++|+|.+++.. .+.+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 83 -~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfG 158 (285)
T d1fmka3 83 -EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFG 158 (285)
T ss_dssp -SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred -cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccc
Confidence 4568999999999999988854 356999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCccchHHHHHhcCCCC
Q 012777 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG-CPPFPTKQEKEVPKAYIANERPP 374 (456)
Q Consensus 296 ls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~ 374 (456)
+++..... .........||+.|+|||++..+.++.++||||||+++|||++| .+|+......+....+....+++
T Consensus 159 la~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~ 234 (285)
T d1fmka3 159 LARLIEDN----EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 234 (285)
T ss_dssp TTC------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred hhhhccCC----CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 99866322 11222345689999999999999999999999999999999995 55566666666666665554544
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 375 FRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 375 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
. +..++.++.+||.+||+.||++|||+++|++.|++.+..
T Consensus 235 ~---~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 235 C---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp C---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred C---CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 3 567899999999999999999999999999998887654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=378.90 Aligned_cols=245 Identities=18% Similarity=0.296 Sum_probs=210.3
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|.+.+.||+|+||.|. .+|+.||||++.... .....+.+|+.+|+.++||||+++++++.+++.+|+|||
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 48888999999999772 368899999998642 223568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC--CCCEEEeccCCcccccccc
Q 012777 228 YLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD--SGHLKVADFGLSKLLKFAN 304 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~--~~~vkl~Dfgls~~~~~~~ 304 (456)
||+|++|.+++.+.+ .+++.+++.++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++.....
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-- 156 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc--
Confidence 999999999998655 6999999999999999999999999 999999999999984 45899999999986522
Q ss_pred cccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCCCCcH
Q 012777 305 TVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTTHYAY 384 (456)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (456)
........+|+.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+..............++.
T Consensus 157 ----~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T d1tkia_ 157 ----GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp ----TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ----CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCH
Confidence 2223345688999999999999999999999999999999999999999888777777754432221112357899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 385 GLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 385 ~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
++.+||.+||..||++|||++|+++|
T Consensus 233 ~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 233 EAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=371.04 Aligned_cols=260 Identities=28% Similarity=0.468 Sum_probs=204.7
Q ss_pred ccccCccccccccceeeeccEEEEEeE----------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceee
Q 012777 144 EYEIDPKELDFSNSVEITKGTFRIASW----------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQF 212 (456)
Q Consensus 144 ~~~~~~~~~~~~~~~~lg~G~fg~~~~----------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l 212 (456)
.|+++.+ +|...+.||+|+||.|.. +++.||||++... ......+.+.+|...+.++ +|+||+++
T Consensus 7 ~wei~~~--~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 7 KWEFPRD--RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHBCCGG--GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccHH--HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc--cCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 4455543 588889999999997732 3468999999754 3455567788888888887 68999999
Q ss_pred eeEEEeC-CceEEEEEccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 012777 213 LGAVTQS-TPMMIVTEYLPKGDLRAYLKQK----------------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRD 275 (456)
Q Consensus 213 ~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~D 275 (456)
++++..+ ..+++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++ |+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 9988664 4689999999999999999753 23889999999999999999999999 99999
Q ss_pred CCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcC-CCC
Q 012777 276 LEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG-CPP 354 (456)
Q Consensus 276 ikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g-~~p 354 (456)
|||+|||++.++.+||+|||+|+...... .........||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p 236 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDP---DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCT---TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCccceeECCCCcEEEccCcchhhccccc---cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCC
Confidence 99999999999999999999998653221 11223345789999999999999999999999999999999986 678
Q ss_pred CCCCCccchHHHH-HhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 012777 355 FPTKQEKEVPKAY-IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISD 416 (456)
Q Consensus 355 f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~ 416 (456)
|......+..... ....+++. +..+++++.++|.+||+.||++|||++|++++|+.+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 237 YPGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp STTCCCSHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCCCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 8877665544443 33334433 56788999999999999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=372.67 Aligned_cols=254 Identities=26% Similarity=0.529 Sum_probs=209.8
Q ss_pred cccccceeeeccEEEEEe---E--cCc----EEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 152 LDFSNSVEITKGTFRIAS---W--RGT----QVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~~---~--~g~----~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
.+|+..+.||+|+||.|. . +|+ +||+|.+.... .....+.+.+|+.++++++||||+++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 368999999999999772 2 333 68999887542 333457899999999999999999999999865 56
Q ss_pred EEEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
++++||+.+++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 7888999999999988765 46999999999999999999999999 9999999999999999999999999998764
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
... .........||+.|+|||++.++.++.++|||||||++|||+| |.+||.+.+..++...+..+.+++. +.
T Consensus 163 ~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~---p~ 236 (317)
T d1xkka_ 163 AEE---KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PP 236 (317)
T ss_dssp TTC---C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC---CT
T ss_pred ccc---ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---Cc
Confidence 221 1112233468999999999999999999999999999999998 8999998888777777755555544 46
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
.++.++.+||.+||..||++|||+++++++|+.+.+.
T Consensus 237 ~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 7899999999999999999999999999999988653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-48 Score=369.21 Aligned_cols=252 Identities=29% Similarity=0.447 Sum_probs=215.7
Q ss_pred ccccceeeeccEEEEEe---E-------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012777 153 DFSNSVEITKGTFRIAS---W-------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~---~-------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 222 (456)
+|+..+.||+|+||.|. + +++.||||++... ...+..+.|.+|+.++++++||||+++++++......
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh--cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 58889999999999762 2 3468999999764 3566678899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 012777 223 MIVTEYLPKGDLRAYLKQKG------------------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEP 278 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~------------------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp 278 (456)
+++|||+++++|.+++.... .+++..+..|+.|++.||.|||+++ |+||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence 99999999999999997532 3788999999999999999999999 99999999
Q ss_pred CCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCC
Q 012777 279 SNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG-CPPFPT 357 (456)
Q Consensus 279 ~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~ 357 (456)
+|||++.++.+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++| .+||..
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADY---YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGC---BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cceEECCCCcEEEccchhheeccCCcc---ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 999999999999999999986633221 1122345678899999999999999999999999999999998 478988
Q ss_pred CCccchHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 358 KQEKEVPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
.+..+....+.....++. +..+++++.+||.+||+.||++|||++||++.|+++.
T Consensus 246 ~~~~e~~~~v~~~~~~~~---p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp SCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCHHHHHHHHHcCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 888887777765554443 5678999999999999999999999999999998763
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-48 Score=368.96 Aligned_cols=268 Identities=25% Similarity=0.413 Sum_probs=215.1
Q ss_pred cCccccccccceeeeccEEEEEe---E---c--CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe
Q 012777 147 IDPKELDFSNSVEITKGTFRIAS---W---R--GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ 218 (456)
Q Consensus 147 ~~~~~~~~~~~~~lg~G~fg~~~---~---~--g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 218 (456)
+......+...+.||+|+||.|. . + ...||||++... .+....+.|.+|+.+|++++||||+++++++..
T Consensus 22 ~~~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 99 (311)
T d1r0pa_ 22 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 99 (311)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred eChHHceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe
Confidence 33344433445789999999772 2 1 236999999753 467778899999999999999999999999876
Q ss_pred -CCceEEEEEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCC
Q 012777 219 -STPMMIVTEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGL 296 (456)
Q Consensus 219 -~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgl 296 (456)
+..+++|||||++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 100 ~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~ 176 (311)
T d1r0pa_ 100 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 176 (311)
T ss_dssp TTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGG
T ss_pred cCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccc
Confidence 467999999999999999987544 4788899999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC-CCCccchHHHHHhcCCCCC
Q 012777 297 SKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFP-TKQEKEVPKAYIANERPPF 375 (456)
Q Consensus 297 s~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~ 375 (456)
++........ .........||+.|+|||.+....++.++||||||+++|||++|..||. ..+..+....+..+.++..
T Consensus 177 ~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~ 255 (311)
T d1r0pa_ 177 ARDMYDKEFD-SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 255 (311)
T ss_dssp GCCTTTTTCC-CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC
T ss_pred hhhccccccc-cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9876433221 1222334568999999999999999999999999999999999666554 4445555666655544443
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccc
Q 012777 376 RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRH 423 (456)
Q Consensus 376 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~ 423 (456)
+..+++++.+||.+||..||++|||++|++++|+.+.+.+..+..
T Consensus 256 ---p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~ 300 (311)
T d1r0pa_ 256 ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 300 (311)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred ---cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhc
Confidence 567889999999999999999999999999999999987765543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=368.41 Aligned_cols=254 Identities=27% Similarity=0.489 Sum_probs=203.1
Q ss_pred cccccceeeeccEEEEE---eEc-----CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012777 152 LDFSNSVEITKGTFRIA---SWR-----GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMM 223 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~---~~~-----g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 223 (456)
.+|+..+.||+|+||.| ... ...||||++.+.....++..+.|.+|+.+|++++||||+++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45888899999999865 222 23799999987665556667889999999999999999999999965 4678
Q ss_pred EEEEccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 224 IVTEYLPKGDLRAYLKQK-GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
+||||+++++|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999999887654 46999999999999999999999999 99999999999999999999999999997633
Q ss_pred cccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCccchHHHHHhcC-CCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCPPFPTKQEKEVPKAYIANE-RPPFRAPTT 380 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~ 380 (456)
.... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+....+.... +++ .+.
T Consensus 164 ~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~---~~~ 238 (273)
T d1u46a_ 164 NDDH--YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP---RPE 238 (273)
T ss_dssp -CCE--EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC---CCT
T ss_pred CCCc--ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC---Ccc
Confidence 2111 112233457889999999999999999999999999999998 899999988887777775544 332 256
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDI 414 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~ 414 (456)
.+|.++.+||.+||..||++|||+.+|++.|++.
T Consensus 239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 7899999999999999999999999999888764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-48 Score=369.95 Aligned_cols=252 Identities=31% Similarity=0.513 Sum_probs=209.5
Q ss_pred ccccceeeeccEEEEEe-----EcCc--EEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGT--QVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQSTPMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~--~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~l 224 (456)
+|+..+.||+|+||.|. .+|. .||||.+... ...+..+.+.+|+.+|+++ +||||+++++++.+.+.+++
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 46667899999999762 2444 4778887543 2344567899999999998 79999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCC
Q 012777 225 VTEYLPKGDLRAYLKQK----------------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGH 288 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~ 288 (456)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence 99999999999999753 45999999999999999999999999 999999999999999999
Q ss_pred EEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCccchHHHH
Q 012777 289 LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG-CPPFPTKQEKEVPKAY 367 (456)
Q Consensus 289 vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~ 367 (456)
+||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..++...+
T Consensus 166 ~kl~DfG~a~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i 239 (309)
T d1fvra_ 166 AKIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239 (309)
T ss_dssp EEECCTTCEESSCEE------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred eEEcccccccccccc------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 999999999755321 111234588899999999999999999999999999999996 5689888877777776
Q ss_pred HhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 012777 368 IANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQL 418 (456)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~ 418 (456)
..+.+++. +..+++++.+||.+||..||++|||+++++++|+.+.++.
T Consensus 240 ~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 240 PQGYRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp GGTCCCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HhcCCCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 55545443 5678999999999999999999999999999999987643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=371.68 Aligned_cols=241 Identities=24% Similarity=0.387 Sum_probs=195.6
Q ss_pred ccccce-eeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEe----CCc
Q 012777 153 DFSNSV-EITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQFLGAVTQ----STP 221 (456)
Q Consensus 153 ~~~~~~-~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~----~~~ 221 (456)
+|.+.. .||+|+||.| ..+|+.||||++... ..+.+|+.++.++ +||||++++++|.+ ...
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 577764 5999999977 246899999998642 3567899887655 89999999999875 466
Q ss_pred eEEEEEccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---CCCEEEeccCC
Q 012777 222 MMIVTEYLPKGDLRAYLKQKG--ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD---SGHLKVADFGL 296 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~---~~~vkl~Dfgl 296 (456)
+|+|||||+||+|.+++.+.+ .+++.+++.|+.||+.||.|||+++ |+||||||+|||++. .+.+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 899999999999999998753 5999999999999999999999999 999999999999985 56799999999
Q ss_pred cccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCC
Q 012777 297 SKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPF 375 (456)
Q Consensus 297 s~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~ 375 (456)
++.... ........||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+.... ...+
T Consensus 161 a~~~~~------~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~ 234 (335)
T d2ozaa1 161 AKETTS------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234 (335)
T ss_dssp CEECCC------CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS
T ss_pred eeeccC------CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC
Confidence 986632 222344679999999999999999999999999999999999999998876655544432222 1111
Q ss_pred CCC---CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 376 RAP---TTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 376 ~~~---~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
..+ ...+|+++.+||.+||+.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111 23678899999999999999999999999886
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=368.64 Aligned_cols=246 Identities=26% Similarity=0.388 Sum_probs=198.1
Q ss_pred ceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCC--HHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEcc
Q 012777 157 SVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTD--EDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 229 (456)
Q Consensus 157 ~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~~ 229 (456)
.+.||+|+||.| ..+|+.||||++....... +...+.+.+|+.++++++||||+++++++..++.+++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999987 2468999999997643221 122356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccCC
Q 012777 230 PKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKED 309 (456)
Q Consensus 230 ~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~ 309 (456)
.++++..+......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-----~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-----N 154 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-----C
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC-----c
Confidence 88777776666667999999999999999999999999 999999999999999999999999999865321 1
Q ss_pred CCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCCCC-----------
Q 012777 310 RPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPPFR----------- 376 (456)
Q Consensus 310 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~----------- 376 (456)
.......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+.... .+...
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 223345789999999998654 57899999999999999999999999887766655553321 11000
Q ss_pred ----C--------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 377 ----A--------PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 377 ----~--------~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
. ....+++++.+||.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0 013567899999999999999999999999876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-47 Score=362.46 Aligned_cols=261 Identities=29% Similarity=0.478 Sum_probs=218.6
Q ss_pred ccccCccccccccceeeeccEEEEEeE----------cCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceee
Q 012777 144 EYEIDPKELDFSNSVEITKGTFRIASW----------RGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI-RHPNVVQF 212 (456)
Q Consensus 144 ~~~~~~~~~~~~~~~~lg~G~fg~~~~----------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l 212 (456)
.|+++.+ +|+..+.||+|+||.|.. +++.||||++... ........+.+|+.+++++ +||||+++
T Consensus 17 ~~~~~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 17 KWEFPRN--RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp GGBCCGG--GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHH--HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc--cCHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 4566655 566678999999997731 3458999999865 3456667899999999999 69999999
Q ss_pred eeEEEeCCceEEEEEccCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 012777 213 LGAVTQSTPMMIVTEYLPKGDLRAYLKQKG------------------ALKPTLAVKFALDIARGMNYLHENRPEAIIHR 274 (456)
Q Consensus 213 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~ 274 (456)
++++.+...+++|||||++|+|.+++.... .+++..+..++.||+.||.|||+++ ++||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHr 169 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHR 169 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 999999999999999999999999997543 4889999999999999999999999 9999
Q ss_pred CCCCCCeEeCCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHc-CCC
Q 012777 275 DLEPSNILRDDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIE-GCP 353 (456)
Q Consensus 275 Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~ 353 (456)
||||+||+++.++.+|++|||+++....... ........||+.|+|||.+.+..++.++|||||||++|+|++ |.+
T Consensus 170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p 246 (311)
T d1t46a_ 170 DLAARNILLTHGRITKICDFGLARDIKNDSN---YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246 (311)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTT---SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccccccccccccCcccccccchheeccCCCc---ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCC
Confidence 9999999999999999999999987643211 112233568899999999999999999999999999999998 677
Q ss_pred CCCCCCccchHHHHHhcC-CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 012777 354 PFPTKQEKEVPKAYIANE-RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQ 417 (456)
Q Consensus 354 pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~ 417 (456)
||...+..+....+.... ++. .+...+..+.+||.+||+.||++|||++++++.|+++...
T Consensus 247 ~~~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 247 PYPGMPVDSKFYKMIKEGFRML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SSTTCCSSHHHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhcCCCCC---CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 787777666655554444 333 2467889999999999999999999999999999987654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=359.84 Aligned_cols=259 Identities=26% Similarity=0.455 Sum_probs=218.9
Q ss_pred ccccCccccccccceeeeccEEEEEe----------EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeee
Q 012777 144 EYEIDPKELDFSNSVEITKGTFRIAS----------WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFL 213 (456)
Q Consensus 144 ~~~~~~~~~~~~~~~~lg~G~fg~~~----------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 213 (456)
.+||+++ +|...+.||+|+||.|. .+++.||||++... ........+.+|+.++++++||||++++
T Consensus 14 ~~ei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 14 EWEVARE--KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp TTBCCGG--GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred ceeecHH--HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 3566654 56778899999998762 23578999999754 3556667899999999999999999999
Q ss_pred eEEEeCCceEEEEEccCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe
Q 012777 214 GAVTQSTPMMIVTEYLPKGDLRAYLKQK----------GALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILR 283 (456)
Q Consensus 214 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~ 283 (456)
+++..+...++||||+++|+|.+++... ..++...+..++.|++.||.|||+++ |+||||||+|||+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 166 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceee
Confidence 9999999999999999999999998642 23788999999999999999999999 9999999999999
Q ss_pred CCCCCEEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCccc
Q 012777 284 DDSGHLKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEG-CPPFPTKQEKE 362 (456)
Q Consensus 284 ~~~~~vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~ 362 (456)
+.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++| .+||.+.+..+
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~---~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~ 243 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDY---YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGC---EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred cCCceEEEeecccceeccCCcc---eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999986643221 1112234578999999999999999999999999999999997 68898888877
Q ss_pred hHHHHHhcCCCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 012777 363 VPKAYIANERPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDIS 415 (456)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~ 415 (456)
....+.....++. +..++..+.++|.+||+.||++|||++++++.|+...
T Consensus 244 ~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 244 VLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHHHhCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 7777765554443 5678899999999999999999999999999987653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-47 Score=360.87 Aligned_cols=248 Identities=27% Similarity=0.488 Sum_probs=198.7
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|++.+.||+|+||.| ..+|+.||||++.... ..+...+.+.+|+++|++++||||+++++++.++..+|+|||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6888999999999876 2468999999997653 233345788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccc
Q 012777 228 YLPKGDLRAYLKQ--KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANT 305 (456)
Q Consensus 228 ~~~~~sL~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~ 305 (456)
|+.+ ++.+++.. .+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-- 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-- 155 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC--
Confidence 9954 55555543 345999999999999999999999999 999999999999999999999999999866321
Q ss_pred ccCCCCcccCCCCcccccccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-CCC---------
Q 012777 306 VKEDRPVTCEETSWRYAAPEVYKNEE-YDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-RPP--------- 374 (456)
Q Consensus 306 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~--------- 374 (456)
........||+.|+|||.+.... ++.++|||||||++|+|++|+.||.+.+..+....+.... .+.
T Consensus 156 ---~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 156 ---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp ---SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ---cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 22333456899999999877665 5789999999999999999999998877655444432211 110
Q ss_pred -------CCC--------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 375 -------FRA--------PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 375 -------~~~--------~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.. ....++.++.+||.+||..||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 023667889999999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=360.01 Aligned_cols=240 Identities=25% Similarity=0.379 Sum_probs=199.5
Q ss_pred ccccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHH---HHHHHHHHHHHHhcCC--CCcceeeeeEEEeCC
Q 012777 151 ELDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDED---KVKAFIDELALLQKIR--HPNVVQFLGAVTQST 220 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~---~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~~ 220 (456)
..+|++.+.||+|+||.| ..+|+.||||++.+....+.. ....+.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 346899999999999977 236899999999765432211 1234678999999986 899999999999999
Q ss_pred ceEEEEEccCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-CCCEEEeccCCcc
Q 012777 221 PMMIVTEYLPK-GDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD-SGHLKVADFGLSK 298 (456)
Q Consensus 221 ~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~-~~~vkl~Dfgls~ 298 (456)
..++||||+.+ +++.+++.+.+.+++..++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||++.
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccce
Confidence 99999999965 688999988889999999999999999999999999 999999999999985 4789999999998
Q ss_pred cccccccccCCCCcccCCCCcccccccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCC
Q 012777 299 LLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEY-DTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRA 377 (456)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 377 (456)
.... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+ .+... ...
T Consensus 160 ~~~~-------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~-~~~--- 222 (273)
T d1xwsa_ 160 LLKD-------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-QVF--- 222 (273)
T ss_dssp ECCS-------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-CCC---
T ss_pred eccc-------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-ccC---
Confidence 6521 12334679999999999987765 467899999999999999999997532 23222 222
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 378 PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 378 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+..+|+++.+||.+||..||++|||++|++++
T Consensus 223 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 223 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 246789999999999999999999999999876
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-46 Score=356.57 Aligned_cols=249 Identities=28% Similarity=0.466 Sum_probs=201.9
Q ss_pred ccccceeeeccEEEEE----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012777 153 DFSNSVEITKGTFRIA----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEY 228 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e~ 228 (456)
+|...+.||+|+||.| ..+|+.||||++..... .+...+.+.+|+.+|++++||||+++++++..++..++++|+
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5888899999999977 23588999999976532 233357899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccccccccC
Q 012777 229 LPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVKE 308 (456)
Q Consensus 229 ~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~~ 308 (456)
+.++.+..+....+.+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+......
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~----- 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP----- 153 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC-----
Confidence 977666666666777999999999999999999999999 999999999999999999999999999876321
Q ss_pred CCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc-CCC-------------
Q 012777 309 DRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN-ERP------------- 373 (456)
Q Consensus 309 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~------------- 373 (456)
........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+... ..+
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 1222334678899999998764 5689999999999999999999999887665544443221 110
Q ss_pred -----------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 -----------PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 -----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.......++.++.+||.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011235678899999999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=358.12 Aligned_cols=250 Identities=27% Similarity=0.408 Sum_probs=198.1
Q ss_pred ccccccceeeeccEEEEEe-----Ec-CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcC---CCCcceeeeeEEEe---
Q 012777 151 ELDFSNSVEITKGTFRIAS-----WR-GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKI---RHPNVVQFLGAVTQ--- 218 (456)
Q Consensus 151 ~~~~~~~~~lg~G~fg~~~-----~~-g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~--- 218 (456)
+.+|++.+.||+|+||.|. .+ ++.||||++...... +.....+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 4579999999999999772 22 567999998654322 12223456777776665 79999999999853
Q ss_pred --CCceEEEEEccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccC
Q 012777 219 --STPMMIVTEYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFG 295 (456)
Q Consensus 219 --~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfg 295 (456)
...++++|||+.++++...... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 3468999999977666544433 345999999999999999999999999 9999999999999999999999999
Q ss_pred CcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-C--
Q 012777 296 LSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-R-- 372 (456)
Q Consensus 296 ls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~-- 372 (456)
++...... .......||+.|+|||++.+.+++.++|||||||++|+|++|++||.+.+..+....+.... .
T Consensus 162 ~~~~~~~~------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 162 LARIYSFQ------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235 (305)
T ss_dssp SCCCCCGG------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hhhhhccc------ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence 98765322 23345679999999999999999999999999999999999999999887666555443211 0
Q ss_pred --------------------CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 373 --------------------PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 373 --------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.+.......++..+.+||.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 01111245678899999999999999999999999886
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.5e-45 Score=346.11 Aligned_cols=267 Identities=15% Similarity=0.187 Sum_probs=219.9
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEE
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIV 225 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv 225 (456)
-+|.+.+.||+|+||.| ..+|+.||||++...... ..+.+|++.++.++ |++++.+++++......++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 46889999999999976 246889999998654321 34678999999996 58999999999999999999
Q ss_pred EEccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-----CCCEEEeccCCccc
Q 012777 226 TEYLPKGDLRAYLKQKG-ALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD-----SGHLKVADFGLSKL 299 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~-----~~~vkl~Dfgls~~ 299 (456)
|||+ +++|.+++...+ .++..++..++.|++.||.|||++| |+||||||+|||++. ++.+||+|||+++.
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999 789999987754 5999999999999999999999999 999999999999974 57899999999997
Q ss_pred cccccc--ccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHH---HHHhcC-CC
Q 012777 300 LKFANT--VKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPK---AYIANE-RP 373 (456)
Q Consensus 300 ~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~-~~ 373 (456)
...... ...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+........ .+.... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 643221 122223345679999999999999999999999999999999999999998765543322 221111 11
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccccccC
Q 012777 374 PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVG 427 (456)
Q Consensus 374 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~ 427 (456)
+.......+|+++.+++..|+..+|++||+++.+.+.|+++.++.....+.++|
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~D 289 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD 289 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCG
T ss_pred ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 212224678899999999999999999999999999999999999998888888
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=353.11 Aligned_cols=245 Identities=27% Similarity=0.379 Sum_probs=197.8
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC------
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST------ 220 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~------ 220 (456)
.+|++.+.||+|+||.| ..+|+.||||++.... .++...+.+.+|+.+|+.++||||++++++|...+
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46999999999999976 2359999999998654 45666788999999999999999999999997654
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccc
Q 012777 221 PMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLL 300 (456)
Q Consensus 221 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~ 300 (456)
.+|+||||| +.+|.++++. +.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|++|||++...
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceecc
Confidence 479999999 6788887754 67999999999999999999999999 999999999999999999999999999865
Q ss_pred cccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC--------
Q 012777 301 KFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-------- 371 (456)
Q Consensus 301 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------- 371 (456)
.. ......||+.|+|||.+.+. .++.++||||+||++|+|++|++||.+.+.......+....
T Consensus 172 ~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 172 DS--------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CS--------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CC--------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 21 22346789999999998664 57889999999999999999999998876544332221110
Q ss_pred -------------------CCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 372 -------------------RPPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 372 -------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
...+.....+.++++.+||.+||..||++|||++|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111122235678899999999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-45 Score=348.85 Aligned_cols=260 Identities=26% Similarity=0.394 Sum_probs=196.4
Q ss_pred ccccceeeeccEEEEE---eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC----ceEEE
Q 012777 153 DFSNSVEITKGTFRIA---SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST----PMMIV 225 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~---~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~----~~~lv 225 (456)
+|...+.||+|+||.| ..+|+.||||++.... ........|+..+++++||||+++++++..++ .+++|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 4566788999999865 6789999999996531 22222334555556779999999999997654 58999
Q ss_pred EEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--------CCCCCeEecCCCCCCeEeCCCCCEEEeccCCc
Q 012777 226 TEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHE--------NRPEAIIHRDLEPSNILRDDSGHLKVADFGLS 297 (456)
Q Consensus 226 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~--------~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls 297 (456)
|||+++|+|.+++++. .+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~---IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---eeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999864 69999999999999999999997 46 999999999999999999999999999
Q ss_pred ccccccccccCCCCcccCCCCcccccccccCCCC------CCCchhHHHHHHHHHHHHcCCCCCCCCCccc---------
Q 012777 298 KLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEE------YDTKVDVFSFALILQEMIEGCPPFPTKQEKE--------- 362 (456)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--------- 362 (456)
......... .........||+.|+|||++.... ++.++|||||||++|||++|..||.......
T Consensus 156 ~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 156 VRHDSATDT-IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp EEEETTTTE-ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred ccccCCCcc-eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 877432211 112233467999999999987643 5668999999999999999988774322111
Q ss_pred -----hHHHHHh-cC-CCCCCCC--CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccc
Q 012777 363 -----VPKAYIA-NE-RPPFRAP--TTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIK 421 (456)
Q Consensus 363 -----~~~~~~~-~~-~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~ 421 (456)
....... .. +++.+.. ....+..+.+++.+||+.||++|||+.|+++.|+++.++-.++
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~ 302 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCCC
Confidence 1111111 11 2322111 1123345889999999999999999999999999998876554
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-45 Score=347.08 Aligned_cols=266 Identities=17% Similarity=0.191 Sum_probs=210.0
Q ss_pred ccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCc-ceeeeeEEEeCCceEEEE
Q 012777 153 DFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPN-VVQFLGAVTQSTPMMIVT 226 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~l~~~~~~~~~~~lv~ 226 (456)
+|++.+.||+|+||.|. .+|+.||||++..+... ..+..|+++++.++|++ |+.+.+++......++||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 58899999999998772 35889999998764322 35778999999997666 455566677888899999
Q ss_pred EccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---CCCEEEeccCCcccccc
Q 012777 227 EYLPKGDLRAYLKQ-KGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDD---SGHLKVADFGLSKLLKF 302 (456)
Q Consensus 227 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~---~~~vkl~Dfgls~~~~~ 302 (456)
||+ +++|.+.+.. .+.+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+|+....
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 999 5677776655 456999999999999999999999999 999999999999863 55799999999997744
Q ss_pred cccc--cCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc----CCCCCC
Q 012777 303 ANTV--KEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN----ERPPFR 376 (456)
Q Consensus 303 ~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~~~~~ 376 (456)
.... ..........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+... ...+.+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 3211 1122334567999999999999999999999999999999999999999876654433222111 112222
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccccccccC
Q 012777 377 APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMRLDDISDQLSIKRHWKVG 427 (456)
Q Consensus 377 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~L~~~~~~~~~~~~~~~~ 427 (456)
....++|+++.++|.+||..||++||+++++.+.|++++.+...+.+.++|
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~D 289 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 289 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCH
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 234678999999999999999999999999999999999888777777887
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=356.26 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=207.2
Q ss_pred ccccceeeeccEEEEEeE--------cCcEEEEEEeCCCCCC-CHHHHHHHHHHHHHHhcCCC-CcceeeeeEEEeCCce
Q 012777 153 DFSNSVEITKGTFRIASW--------RGTQVAVKTLGEEVFT-DEDKVKAFIDELALLQKIRH-PNVVQFLGAVTQSTPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~~~--------~g~~vAvK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~~~~~~~ 222 (456)
+|++.+.||+|+||.|.. +|+.||||++++.... +....+.+.+|+.++++++| |||+++++++.....+
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 599999999999998722 4789999999754321 12223567899999999965 8999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
+++|||+.+++|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred eeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 999999999999999999899999999999999999999999999 99999999999999999999999999986633
Q ss_pred cccccCCCCcccCCCCcccccccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCCCCCCCCC
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNE--EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERPPFRAPTT 380 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (456)
.. ........|++.|++||.+.+. .++.++|||||||++|+|++|+.||...+.......+...........+.
T Consensus 182 ~~----~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (322)
T d1vzoa_ 182 DE----TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257 (322)
T ss_dssp GG----GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred cc----cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence 21 1122335688899999998764 46789999999999999999999998887776655554433111122356
Q ss_pred CCcHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 012777 381 HYAYGLRELIEDCWSEEPFRRP-----TFRQILMR 410 (456)
Q Consensus 381 ~~~~~l~~li~~~l~~dp~~Rp-----t~~ell~~ 410 (456)
.++.++.+||.+||..||++|| |++|+++|
T Consensus 258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 7999999999999999999999 47888764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=349.59 Aligned_cols=254 Identities=21% Similarity=0.286 Sum_probs=196.7
Q ss_pred cccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--------
Q 012777 152 LDFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQ-------- 218 (456)
Q Consensus 152 ~~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-------- 218 (456)
.+|++.+.||+|+||.| ..+|+.||||++..... .+.....+.+|+.+|++++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999876 23689999999876532 23344678899999999999999999998855
Q ss_pred CCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 219 STPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 219 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
...++++|||+.++.+..+......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceee
Confidence 3468999999977666655555567999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC-CCCC
Q 012777 299 LLKFANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER-PPFR 376 (456)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~ 376 (456)
........ .........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+..... ++..
T Consensus 166 ~~~~~~~~-~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 166 AFSLAKNS-QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp ECCC------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eccccccc-ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 66432211 11223345789999999998765 688999999999999999999999988776555444432211 1000
Q ss_pred C--C----------------C---------CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 377 A--P----------------T---------THYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 377 ~--~----------------~---------~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
. . . ...++.+.+||.+||..||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 0 0 0125567899999999999999999999976
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=350.11 Aligned_cols=250 Identities=24% Similarity=0.394 Sum_probs=197.4
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC----ceE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQST----PMM 223 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~----~~~ 223 (456)
+|++.+.||+|+||.| ..+|+.||||++.+. ......+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh--cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 5889999999999976 246999999999764 35666788999999999999999999999997653 234
Q ss_pred EEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccc
Q 012777 224 IVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFA 303 (456)
Q Consensus 224 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~ 303 (456)
++++|+.+++|.+++.. +.+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 87 ~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 44455668999999976 46999999999999999999999999 999999999999999999999999999866432
Q ss_pred ccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcC-C---------
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANE-R--------- 372 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~--------- 372 (456)
... ........||+.|+|||++... .++.++||||+||++|+|++|+.||...+..+......... .
T Consensus 163 ~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 163 HDH--TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GCB--CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred Ccc--ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 211 1223346789999999998554 67889999999999999999999998776543332221110 0
Q ss_pred -----------------CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 373 -----------------PPFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 373 -----------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.++.....+++.++.+||.+||..||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011134677889999999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=351.69 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=195.1
Q ss_pred CccccccccceeeeccEEEEEe-----EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC---
Q 012777 148 DPKELDFSNSVEITKGTFRIAS-----WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS--- 219 (456)
Q Consensus 148 ~~~~~~~~~~~~lg~G~fg~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--- 219 (456)
.+.+.+|...+.||+|+||.|. .+|+.||||++..+.. .+.+|+.+|++++||||++++++|...
T Consensus 16 ~~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp CCEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred CcccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence 3445679999999999999772 3689999999976532 234799999999999999999998543
Q ss_pred ---CceEEEEEccCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-CEEE
Q 012777 220 ---TPMMIVTEYLPKGDLRAYL----KQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG-HLKV 291 (456)
Q Consensus 220 ---~~~~lv~e~~~~~sL~~~l----~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~-~vkl 291 (456)
..+++|||||+++ +.+.+ .....+++.+++.++.||+.||+|||++| |+||||||+|||++.++ .+||
T Consensus 89 ~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl 164 (350)
T d1q5ka_ 89 KDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKL 164 (350)
T ss_dssp CSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEE
T ss_pred CCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeE
Confidence 3478999999755 43333 23456999999999999999999999999 99999999999999765 8999
Q ss_pred eccCCcccccccccccCCCCcccCCCCcccccccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhc
Q 012777 292 ADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKN-EEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIAN 370 (456)
Q Consensus 292 ~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 370 (456)
+|||++..... ........||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+..+....+...
T Consensus 165 ~DFG~a~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~ 238 (350)
T d1q5ka_ 165 CDFGSAKQLVR------GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238 (350)
T ss_dssp CCCTTCEECCT------TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred ecccchhhccC------CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHH
Confidence 99999986632 222334578899999998765 57899999999999999999999999887655544433211
Q ss_pred C----------------CCCC---------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 371 E----------------RPPF---------RAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 371 ~----------------~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
. ...+ .......++++.+||.+||..||++|||++|+++|
T Consensus 239 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000 01134678899999999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=337.68 Aligned_cols=249 Identities=22% Similarity=0.404 Sum_probs=205.0
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQSTPMMIVTE 227 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~e 227 (456)
+|++.+.||+|+||.| ..+|+.||||+++... ..+.....+.+|+.+|+.++||||+++++++......+++++
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5888999999999876 2468899999997654 344556889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccccccccc
Q 012777 228 YLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKFANTVK 307 (456)
Q Consensus 228 ~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~~~~~~ 307 (456)
++.+++|..++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||.+......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~---- 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP---- 154 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC----
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC----
Confidence 9999999988888888999999999999999999999999 999999999999999999999999999876322
Q ss_pred CCCCcccCCCCcccccccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCC-CCccchHHHHHhcC-CC-----------
Q 012777 308 EDRPVTCEETSWRYAAPEVYKNEE-YDTKVDVFSFALILQEMIEGCPPFPT-KQEKEVPKAYIANE-RP----------- 373 (456)
Q Consensus 308 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~-~~----------- 373 (456)
........+++.|+|||.+.... ++.++|||||||++|+|++|+.||.. .+..+....+.... .+
T Consensus 155 -~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp -CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred -CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 22233345778899999887664 68899999999999999999988644 33333333322111 00
Q ss_pred -------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 -------------PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 -------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
........++..+.+||.+||+.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111235677889999999999999999999999876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=343.89 Aligned_cols=245 Identities=25% Similarity=0.357 Sum_probs=190.5
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------Cc
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS------TP 221 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------~~ 221 (456)
+|++.+.||+|+||.| ..+|+.||||++.... .+......+.+|+.++++++||||++++++|... ..
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5889999999999976 2369999999998764 3566667899999999999999999999999643 67
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCccccc
Q 012777 222 MMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLK 301 (456)
Q Consensus 222 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~ 301 (456)
+|+|||||.+ ++.+.+. ..+++..++.++.|++.||.|||++| |+||||||+|||++.++.+|++|||++....
T Consensus 97 ~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccc
Confidence 8999999965 5555553 56999999999999999999999999 9999999999999999999999999988653
Q ss_pred ccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCC---------
Q 012777 302 FANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANER--------- 372 (456)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------- 372 (456)
. ........+|+.|+|||++.+..+++++||||+||++++|++|+.||.+.+.......+.....
T Consensus 171 ~------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 171 T------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred c------ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 2 2233445688999999999999999999999999999999999999987765544333321110
Q ss_pred ------------CCCCC-----------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 373 ------------PPFRA-----------------PTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 373 ------------~~~~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
+.... .....+.++.+||.+||..||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 001235678999999999999999999999987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.6e-43 Score=337.15 Aligned_cols=240 Identities=20% Similarity=0.314 Sum_probs=192.5
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeC--CceEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQS--TPMMI 224 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~--~~~~l 224 (456)
+|++.+.||+|+||.| ..+|+.||||+++... .+.+.+|+.+|++++ ||||++++++|... ..+++
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 6999999999999977 2468999999997532 356889999999995 99999999999754 56999
Q ss_pred EEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-CEEEeccCCccccccc
Q 012777 225 VTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSG-HLKVADFGLSKLLKFA 303 (456)
Q Consensus 225 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~-~vkl~Dfgls~~~~~~ 303 (456)
|||||.+++|.++. +.+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||++......
T Consensus 110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999987753 46999999999999999999999999 99999999999998655 6999999999866322
Q ss_pred ccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccch-HHHHHh------------
Q 012777 304 NTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV-PKAYIA------------ 369 (456)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~------------ 369 (456)
.......+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||........ ...+..
T Consensus 184 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 184 ------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp ------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred ------CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 223445688999999998765 578999999999999999999999976554221 111100
Q ss_pred -cC---CC-----------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 370 -NE---RP-----------------PFRAPTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 370 -~~---~~-----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
.. .+ ........+++++.+||.+||..||++|||++|+++|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00 0001124567889999999999999999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=343.49 Aligned_cols=245 Identities=27% Similarity=0.354 Sum_probs=196.8
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----Cce
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPNVVQFLGAVTQS-----TPM 222 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~~ 222 (456)
+|++.+.||+|+||.| ..+|+.||||++.+.. .+....+.+.+|+.+|++++||||+++++++... ...
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 5889999999999865 3468999999998654 4555667899999999999999999999998643 334
Q ss_pred EEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccCCcccccc
Q 012777 223 MIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFGLSKLLKF 302 (456)
Q Consensus 223 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~~~~ 302 (456)
+++++|+.+++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|++|||++.....
T Consensus 98 ~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred EEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCc
Confidence 566677779999999864 56999999999999999999999999 99999999999999999999999999875521
Q ss_pred cccccCCCCcccCCCCcccccccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCccchHHHHHhcCCC--------
Q 012777 303 ANTVKEDRPVTCEETSWRYAAPEVYKNE-EYDTKVDVFSFALILQEMIEGCPPFPTKQEKEVPKAYIANERP-------- 373 (456)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 373 (456)
......|++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+.......+......
T Consensus 174 --------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 174 --------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp --------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred --------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 22345688899999987665 4678999999999999999999999887655544443222110
Q ss_pred --------------CCC-----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012777 374 --------------PFR-----APTTHYAYGLRELIEDCWSEEPFRRPTFRQILMR 410 (456)
Q Consensus 374 --------------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ell~~ 410 (456)
... ......+.++.+||.+||..||.+|||++|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000 0124678889999999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-36 Score=296.21 Aligned_cols=243 Identities=20% Similarity=0.295 Sum_probs=180.1
Q ss_pred ccccceeeeccEEEEE-----eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-----------CCcceeeeeEE
Q 012777 153 DFSNSVEITKGTFRIA-----SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-----------HPNVVQFLGAV 216 (456)
Q Consensus 153 ~~~~~~~lg~G~fg~~-----~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~iv~l~~~~ 216 (456)
+|++.+.||+|+||.| ..+|+.||||+++++ ....+.+.+|+.+++.+. |+||+++++++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4889999999999977 246899999999754 344567788998888774 57899999988
Q ss_pred EeC--CceEEEEEccCCCC-HHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCCC--
Q 012777 217 TQS--TPMMIVTEYLPKGD-LRAYLKQ--KGALKPTLAVKFALDIARGMNYLHE-NRPEAIIHRDLEPSNILRDDSGH-- 288 (456)
Q Consensus 217 ~~~--~~~~lv~e~~~~~s-L~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~-~~~~~ivH~Dikp~Nil~~~~~~-- 288 (456)
... ...+++++++..+. ....... ...+++..++.++.|++.||.|||+ .| |+||||||+|||++.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccc
Confidence 643 45666666654443 3333322 3459999999999999999999998 87 999999999999986653
Q ss_pred ----EEEeccCCcccccccccccCCCCcccCCCCcccccccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCccch-
Q 012777 289 ----LKVADFGLSKLLKFANTVKEDRPVTCEETSWRYAAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFPTKQEKEV- 363 (456)
Q Consensus 289 ----vkl~Dfgls~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~- 363 (456)
++++|||.+..... ......||+.|+|||++....++.++|+||+||++++|++|+.||........
T Consensus 167 ~~~~~kl~dfg~s~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE--------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp TEEEEEECCCTTCEETTB--------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeeEeeccccccccc--------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 99999999875521 12335689999999999999999999999999999999999999975432110
Q ss_pred -----HHH-HHh-cCC---------------------CCC---------------CCCCCCCcHHHHHHHHHhcccCCCC
Q 012777 364 -----PKA-YIA-NER---------------------PPF---------------RAPTTHYAYGLRELIEDCWSEEPFR 400 (456)
Q Consensus 364 -----~~~-~~~-~~~---------------------~~~---------------~~~~~~~~~~l~~li~~~l~~dp~~ 400 (456)
... +.. +.. ... .......+.++.+||.+||..||.+
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~ 318 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 318 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence 000 000 000 000 0012334667999999999999999
Q ss_pred CCCHHHHHHH
Q 012777 401 RPTFRQILMR 410 (456)
Q Consensus 401 Rpt~~ell~~ 410 (456)
|||++|+++|
T Consensus 319 Rpta~e~L~H 328 (362)
T d1q8ya_ 319 RADAGGLVNH 328 (362)
T ss_dssp CBCHHHHHTC
T ss_pred CcCHHHHhcC
Confidence 9999999875
|
| >d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myotrophin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.85 E-value=4.8e-22 Score=161.24 Aligned_cols=103 Identities=34% Similarity=0.482 Sum_probs=98.5
Q ss_pred chHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccccch
Q 012777 38 RVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHD 117 (456)
Q Consensus 38 ~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~ 117 (456)
+|||++||..|+++++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|++++.+|.+|.||||+|+..|+.+
T Consensus 3 ~tpL~~A~~~g~~~~v~~Ll~~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~ 82 (118)
T d1myoa_ 3 DKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVS 82 (118)
T ss_dssp HHHHHHHHHTTCHHHHHHHHTTTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCH
T ss_pred ChHHHHHHHCCCHHHHHHHHHhhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchh
Confidence 68999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCcccccccc
Q 012777 118 VIKLLEEHGAKPSTAPMHVQNAR 140 (456)
Q Consensus 118 ~~~~L~~~~~~~~~~~~~~~~~~ 140 (456)
++++|+++|++++.++....++-
T Consensus 83 ~v~~Ll~~Gad~~~~d~~G~t~l 105 (118)
T d1myoa_ 83 CVKLLLSKGADKTVKGPDGLTAL 105 (118)
T ss_dssp HHHHHHTTCCCSSSSSSSTCCCC
T ss_pred hhhhhhcccccceeeCCCCCCHH
Confidence 99999999999998877766543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=2.3e-21 Score=171.16 Aligned_cols=162 Identities=16% Similarity=0.104 Sum_probs=116.4
Q ss_pred ccceeeeccEEEEE----eEcCcEEEEEEeCCCCCC---------------CHHHHHHHHHHHHHHhcCCCCcceeeeeE
Q 012777 155 SNSVEITKGTFRIA----SWRGTQVAVKTLGEEVFT---------------DEDKVKAFIDELALLQKIRHPNVVQFLGA 215 (456)
Q Consensus 155 ~~~~~lg~G~fg~~----~~~g~~vAvK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 215 (456)
.+.+.||+|+||.| ..+|+.||||++...... .......+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999976 347899999987632110 01122445678899999999999988766
Q ss_pred EEeCCceEEEEEccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCCEEEeccC
Q 012777 216 VTQSTPMMIVTEYLPKGDLRAYLKQKGALKPTLAVKFALDIARGMNYLHENRPEAIIHRDLEPSNILRDDSGHLKVADFG 295 (456)
Q Consensus 216 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~~~~~ivH~Dikp~Nil~~~~~~vkl~Dfg 295 (456)
. ..+++|||+++..+. .++...+..++.|++.+|.|||+++ |+||||||+|||+++++ ++|+|||
T Consensus 83 ~----~~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liDFG 147 (191)
T d1zara2 83 E----GNAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFP 147 (191)
T ss_dssp E----TTEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECCCT
T ss_pred c----CCEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEECC
Confidence 4 237999999775442 2566777889999999999999999 99999999999999764 8999999
Q ss_pred CcccccccccccCCCCcccCCCCccccc------ccccCCCCCCCchhHHHHHHHH
Q 012777 296 LSKLLKFANTVKEDRPVTCEETSWRYAA------PEVYKNEEYDTKVDVFSFALIL 345 (456)
Q Consensus 296 ls~~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DiwslG~il 345 (456)
+|.....+.. ..|.. .+.+ ...|+.++|+||+.--+
T Consensus 148 ~a~~~~~~~~-------------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGW-------------REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTH-------------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCc-------------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9875521110 01111 1112 24678889999976544
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=2.8e-21 Score=159.45 Aligned_cols=97 Identities=30% Similarity=0.403 Sum_probs=92.3
Q ss_pred chHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccccch
Q 012777 38 RVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHD 117 (456)
Q Consensus 38 ~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~ 117 (456)
-++||.||..|++++++.|+++|+|+|.+|.+|+||||+||..|+.+++++|+++|++++.+|.+|+||||+|+..|+.+
T Consensus 2 l~lL~~A~~~G~~~~v~~Ll~~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~ 81 (130)
T d1ycsb1 2 LALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQ 81 (130)
T ss_dssp HHHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHH
T ss_pred hHHHHHHHHcCCHHHHHHHHHcCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHH
Confidence 37899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCcc
Q 012777 118 VIKLLEEHGAKPSTAPM 134 (456)
Q Consensus 118 ~~~~L~~~~~~~~~~~~ 134 (456)
++++|+++|++++..+.
T Consensus 82 ~v~~Ll~~ga~v~~~~~ 98 (130)
T d1ycsb1 82 VCKFLVESGAAVFAMTY 98 (130)
T ss_dssp HHHHHHHTTCCTTCCCS
T ss_pred HHHHHHHcCCCcccccC
Confidence 99999999999987654
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.81 E-value=2.2e-20 Score=158.43 Aligned_cols=97 Identities=21% Similarity=0.222 Sum_probs=91.5
Q ss_pred CCCCchHHHHHHHc---CCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 34 AIDPRVRLMYMANE---GDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 34 ~~~g~t~Lh~a~~~---~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
+..|+||||+|+.. ++.+++++|+++|+|+|.+|.+|+||||+||..|+.+++++|+++|++++.+|..|.||+|+|
T Consensus 42 ~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~A 121 (154)
T d1dcqa1 42 HEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIA 121 (154)
T ss_dssp SSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred CCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhccccccccccccccccccccccCccccccCCCCCCHHHHH
Confidence 56699999999985 678999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccchhhhhhhhcCCCCC
Q 012777 111 VYYKHHDVIKLLEEHGAKPS 130 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~~~~~ 130 (456)
+..|+.+++++|++.++...
T Consensus 122 ~~~~~~~i~~~L~~~~~~~~ 141 (154)
T d1dcqa1 122 KRLKHEHCEELLTQALSGRF 141 (154)
T ss_dssp HHTTCHHHHHHHHHHHTTCC
T ss_pred HHcCCHHHHHHHHHhCCCCC
Confidence 99999999999999877643
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=2.3e-19 Score=147.82 Aligned_cols=105 Identities=22% Similarity=0.151 Sum_probs=92.2
Q ss_pred CCCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCC
Q 012777 22 PLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDR 101 (456)
Q Consensus 22 ~~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~ 101 (456)
.++.+.|++ .+|.+|+||||+||..|+.+++++|++.|+++|.+|.+|+||||+|+..|+.+++++|+++|++++..+.
T Consensus 20 Ll~~g~d~n-~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~v~~~~~ 98 (130)
T d1ycsb1 20 IIYEVDDPS-LPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTY 98 (130)
T ss_dssp HTSTTSSCC-CCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCS
T ss_pred HHHcCCCcc-ccccccccccccccccccccccccccccccccccccccCcccccccchhhHHHHHHHHHHcCCCcccccC
Confidence 356677765 4577899999999999999999999999999999999999999999999999999999999999998765
Q ss_pred -CCCccc--ccccccccchhhhhhhhcCC
Q 012777 102 -WGSTPL--ADAVYYKHHDVIKLLEEHGA 127 (456)
Q Consensus 102 -~g~t~l--~~A~~~~~~~~~~~L~~~~~ 127 (456)
+|.||+ +.|+..|+.+++++|+..+.
T Consensus 99 ~~~~~~~~~~~a~~~g~~eiv~~L~~~~~ 127 (130)
T d1ycsb1 99 SDMQTAADKCEEMEEGYTQCSQFLYGVQE 127 (130)
T ss_dssp SSCCCHHHHCCSSSTTCCCHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHcChHHHHHHHHhHHH
Confidence 577875 55567899999999986543
|
| >d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myotrophin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.78 E-value=1.5e-19 Score=146.21 Aligned_cols=96 Identities=32% Similarity=0.378 Sum_probs=85.6
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCC
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRW 102 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 102 (456)
++.+.|++. .+.+|+||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|.+
T Consensus 22 l~~g~d~n~-~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~~v~~Ll~~Gad~~~~d~~ 100 (118)
T d1myoa_ 22 VAKGEDVNR-TLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPD 100 (118)
T ss_dssp HTTTCCCCC-CSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCHHHHHHHTTCCCSSSSSSS
T ss_pred HHhhhcccc-ccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchhhhhhhhcccccceeeCCC
Confidence 345566554 4678999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccchhhhhhh
Q 012777 103 GSTPLADAVYYKHHDVIKLLE 123 (456)
Q Consensus 103 g~t~l~~A~~~~~~~~~~~L~ 123 (456)
|.||+|+|.. +.++.|+
T Consensus 101 G~t~l~~a~~----~~i~~LL 117 (118)
T d1myoa_ 101 GLTALEATDN----QAIKALL 117 (118)
T ss_dssp TCCCCCTCSS----TTTGGGG
T ss_pred CCCHHHHHhH----HHHHHhc
Confidence 9999999843 4555554
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=2.5e-19 Score=146.48 Aligned_cols=100 Identities=24% Similarity=0.310 Sum_probs=77.5
Q ss_pred CchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCC-ccccccccccc
Q 012777 37 PRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGS-TPLADAVYYKH 115 (456)
Q Consensus 37 g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~-t~l~~A~~~~~ 115 (456)
+.++||+||..|+++++++|+++|+|+|.+|..|.||||+|+ .|+.+++++|+++|++++.++..|. ||||+|+..|+
T Consensus 3 ~~~~L~~Aa~~G~~~~v~~Ll~~gad~n~~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~ 81 (125)
T d1bi7b_ 3 SADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGF 81 (125)
T ss_dssp STTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTC
T ss_pred ChhHHHHHHHCCCHHHHHHHHHcCCccccccccccccccccc-ccccccccccccccccccccccccccccccccccccc
Confidence 457788888888888888888888888888888888887664 6788888888888888887777665 47888888888
Q ss_pred chhhhhhhhcCCCCCCCccccc
Q 012777 116 HDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 116 ~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
.+++++|++.|++++.++....
T Consensus 82 ~~~v~~Ll~~ga~~~~~d~~G~ 103 (125)
T d1bi7b_ 82 LDTLVVLHRAGARLDVRDAWGR 103 (125)
T ss_dssp HHHHHHHHHHTCCSSCCCTTCC
T ss_pred ccccccccccccccccccCCCC
Confidence 8888888888888776655443
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=3.8e-19 Score=145.42 Aligned_cols=100 Identities=28% Similarity=0.340 Sum_probs=90.4
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcc-hHHHHHHHcCCHHHHHHHHhCCCCCCCCCC
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKR-TALHVAACQGRTDVVRLLLSRGADVDPEDR 101 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~-T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~ 101 (456)
++.+.|.+ .++.+|.||||+|+ .|+.+++++|+++|+++|.+|..|. ||||+|+..|+.+++++|+++|++++.+|.
T Consensus 23 l~~gad~n-~~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~ 100 (125)
T d1bi7b_ 23 LEAGANPN-APNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDA 100 (125)
T ss_dssp HTTTCCTT-CCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCT
T ss_pred HHcCCccc-cccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccC
Confidence 34556655 45678999999775 7999999999999999999998876 699999999999999999999999999999
Q ss_pred CCCcccccccccccchhhhhhhh
Q 012777 102 WGSTPLADAVYYKHHDVIKLLEE 124 (456)
Q Consensus 102 ~g~t~l~~A~~~~~~~~~~~L~~ 124 (456)
.|.||+|+|+..|+.+++++|+.
T Consensus 101 ~G~T~l~~A~~~g~~~~v~~Lls 123 (125)
T d1bi7b_ 101 WGRLPVDLAEELGHRDVARYLRA 123 (125)
T ss_dssp TCCCHHHHHHHHTCHHHHHHHSS
T ss_pred CCCCHHHHHHHcCCHHHHHHHHh
Confidence 99999999999999999999985
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.74 E-value=2e-18 Score=158.46 Aligned_cols=97 Identities=32% Similarity=0.380 Sum_probs=92.6
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCcc-ccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFR-DIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~-d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
.++.+|.||||+||..++.+++++|++.+++++.. +..|.||||+||..|+.+++++|+++|++++.+|..|.||||+|
T Consensus 153 ~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~TpL~~A~~~~~~~~v~~Ll~~gadin~~d~~g~t~L~~A 232 (255)
T d1oy3d_ 153 AENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSA 232 (255)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred cccccCcccccccccccccccccchhcccccccccccccccccccccccccHHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Confidence 46789999999999999999999999999998864 67899999999999999999999999999999999999999999
Q ss_pred cccccchhhhhhhhcCCC
Q 012777 111 VYYKHHDVIKLLEEHGAK 128 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~~~ 128 (456)
+..++.+++++|+++||+
T Consensus 233 ~~~~~~~i~~~Ll~~Ga~ 250 (255)
T d1oy3d_ 233 LLRPNPILARLLRAHGAP 250 (255)
T ss_dssp HTSSCHHHHHHHHHTTCC
T ss_pred HHCCCHHHHHHHHHcCCC
Confidence 999999999999999996
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=6.8e-18 Score=152.19 Aligned_cols=114 Identities=24% Similarity=0.270 Sum_probs=104.5
Q ss_pred CCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCC
Q 012777 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGS 104 (456)
Q Consensus 25 ~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 104 (456)
.+++++ ..|.+|.||||+||..|+.+++++|+++|++++.+|..|.||||+|+..++.+++++|++.+++++.+|.+|.
T Consensus 92 ~~~d~~-~~d~~g~tpL~~A~~~~~~e~~~~Ll~~g~d~~~~~~~~~t~L~~a~~~~~~~~~~~L~~~~~~i~~~d~~g~ 170 (223)
T d1uoha_ 92 KGAQVN-AVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGN 170 (223)
T ss_dssp TTCCTT-CCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTCC
T ss_pred cCceeE-eeCCCCCchhhHHHHcCCHHHHHHHHHCCCCCCCcCCCCCccchhhhhcCCcchhhhhccccceeeeccCCCC
Confidence 344443 4577899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccchhhhhhhhcCCCCCCCccccccc
Q 012777 105 TPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNA 139 (456)
Q Consensus 105 t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 139 (456)
||||+|+..|+.++|++|++.|++++.++....++
T Consensus 171 TpL~~Aa~~g~~~~v~~LL~~Gad~~~~d~~g~tp 205 (223)
T d1uoha_ 171 TPLHLACDEERVEEAKLLVSQGASIYIENKEEKTP 205 (223)
T ss_dssp CHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCH
T ss_pred ceeccccccCcHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 99999999999999999999999999887665443
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.70 E-value=9.6e-18 Score=153.84 Aligned_cols=96 Identities=24% Similarity=0.193 Sum_probs=90.0
Q ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHcCCC---CCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccc
Q 012777 33 EAIDPRVRLMYMANEGDLDGIKELLDSGTD---VNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLAD 109 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~---in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~ 109 (456)
.+.+|+||||+||..|+.+++++|+++|++ ++.+|..|.||||+||..|+.+++++|+++|++++.+|.+|.||||+
T Consensus 5 i~~~G~t~Lh~A~~~~~~~~v~~Ll~~~a~~~~i~~~~~~g~TpL~~A~~~g~~~iv~~Ll~~ga~i~~~d~~g~tpL~~ 84 (255)
T d1oy3d_ 5 VTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHL 84 (255)
T ss_dssp CCTTCCCHHHHHHHTTCHHHHHHHHHHHTTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHHHH
T ss_pred CCcCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCcCCCCCCccchHHhhcccccccccccccccccccccccchhhhh
Confidence 368899999999999999999999999988 66788999999999999999999999999999999999999999999
Q ss_pred ccccccchhhhhhhhcCCC
Q 012777 110 AVYYKHHDVIKLLEEHGAK 128 (456)
Q Consensus 110 A~~~~~~~~~~~L~~~~~~ 128 (456)
|+..++.+++++|+..+..
T Consensus 85 A~~~~~~~~~~~Ll~~~~~ 103 (255)
T d1oy3d_ 85 ACRVRAHTCACVLLQPRPS 103 (255)
T ss_dssp HTTTTCHHHHHHHSSSCCS
T ss_pred hhccCchHHHHHHHhhccc
Confidence 9999999999999876543
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.68 E-value=3.5e-17 Score=154.44 Aligned_cols=114 Identities=17% Similarity=0.174 Sum_probs=93.8
Q ss_pred CCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCH-------HHHHHH---------
Q 012777 26 DDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRT-------DVVRLL--------- 89 (456)
Q Consensus 26 ~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~-------~~v~~L--------- 89 (456)
+.|++...|.+|+||||+||..|+.++|++|+++|+|++.+|..|+||||.||..++. +++++|
T Consensus 96 ~~dvn~~~D~~G~T~LH~Aa~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~~~~~~~~ll~~l~~~~~~~d~ 175 (301)
T d1sw6a_ 96 QLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILEDS 175 (301)
T ss_dssp CCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEECT
T ss_pred CCCcCcCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcCCcccccHHHHhhhcccchhhhhHHHHHHHHhhhhhhccc
Confidence 4466665588999999999999999999999999999999999999999999976541 232222
Q ss_pred ---------------------------------HhCCC-------------------------------------CCCCC
Q 012777 90 ---------------------------------LSRGA-------------------------------------DVDPE 99 (456)
Q Consensus 90 ---------------------------------l~~ga-------------------------------------~~~~~ 99 (456)
+..+. .+|.+
T Consensus 176 ~g~t~lh~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~in~~ 255 (301)
T d1sw6a_ 176 MNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQ 255 (301)
T ss_dssp TCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTCC
T ss_pred ccCCHHHHHHHHhCccccHHHHHHHHHHHHHHHHhcCCcchhcccccccchhHHHHhcchHHHHHHHhhHHHHhcCccCC
Confidence 22211 16889
Q ss_pred CCCCCcccccccccccchhhhhhhhcCCCCCCCccccccc
Q 012777 100 DRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNA 139 (456)
Q Consensus 100 ~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 139 (456)
|..|.||||+|+..|+.++|++|++.||+++.++....++
T Consensus 256 D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tp 295 (301)
T d1sw6a_ 256 DSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRP 295 (301)
T ss_dssp CTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCG
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 9999999999999999999999999999999887665543
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=6.4e-17 Score=150.50 Aligned_cols=83 Identities=30% Similarity=0.350 Sum_probs=74.6
Q ss_pred HHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHh-CCCCCCCCCCCCCcccccccccccchhhhhhhhcCCCCC
Q 012777 52 GIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLS-RGADVDPEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPS 130 (456)
Q Consensus 52 ~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~-~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~ 130 (456)
++++|+++|+++|.+|..|.||||+|+..|+.+++++||+ .|++++.+|.+|.||||+|+..|+.+++++|+++||++|
T Consensus 201 i~~~Li~~ga~~n~~~~~g~t~L~~a~~~~~~~~v~~lL~~~g~din~~d~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n 280 (285)
T d1wdya_ 201 ITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTD 280 (285)
T ss_dssp HHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSC
T ss_pred HHHHHHHCCCCCCccCCCCCCccchhhhcCcHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCC
Confidence 4445555666777788899999999999999999999998 599999999999999999999999999999999999999
Q ss_pred CCcc
Q 012777 131 TAPM 134 (456)
Q Consensus 131 ~~~~ 134 (456)
+++.
T Consensus 281 ~~d~ 284 (285)
T d1wdya_ 281 CGDL 284 (285)
T ss_dssp CSSC
T ss_pred cccC
Confidence 9863
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.66 E-value=7.3e-17 Score=143.21 Aligned_cols=91 Identities=23% Similarity=0.292 Sum_probs=87.8
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccccc
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAV 111 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~ 111 (456)
..+..|+||||+|+..+..++++.+++.+.++|.+|.+|.||||+||..|+.+++++||++|++++.+|..|+||||+|+
T Consensus 118 ~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gad~n~~d~~g~Tpl~~A~ 197 (209)
T d1ot8a_ 118 AADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANREITDHMDRLPRDVAS 197 (209)
T ss_dssp CBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred ccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhccccHHHHHHHHHHCCCCCCCcCCCCCCHHHHHH
Confidence 34677999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchhhhhh
Q 012777 112 YYKHHDVIKLL 122 (456)
Q Consensus 112 ~~~~~~~~~~L 122 (456)
..|+.++|++|
T Consensus 198 ~~~~~~iv~lL 208 (209)
T d1ot8a_ 198 ERLHHDIVRLL 208 (209)
T ss_dssp HTTCHHHHHHH
T ss_pred HcCCHHHHhhc
Confidence 99999999987
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.66 E-value=1.6e-17 Score=153.93 Aligned_cols=98 Identities=21% Similarity=0.305 Sum_probs=88.6
Q ss_pred CCCCCCCCCCchHHHHHHHcCCHHHHHHH--------HHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCC
Q 012777 28 DADGSEAIDPRVRLMYMANEGDLDGIKEL--------LDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPE 99 (456)
Q Consensus 28 ~~~~~~~~~g~t~Lh~a~~~~~~~~~~~L--------l~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~ 99 (456)
+++...+.+|+||||+||..|+.++++.| ++.|+|||.+|.+|+||||+|+..|+.+++++|+++|++++.+
T Consensus 24 ~~n~~~~~~g~T~Lh~A~~~g~~~~v~~Ll~~~~~~~l~~Gadvn~~d~~G~TpLh~A~~~g~~~iv~~Ll~~Gad~n~~ 103 (277)
T d2fo1e1 24 SVNIIDPRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIY 103 (277)
T ss_dssp TTTTCCCSSCCCHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCC
T ss_pred CCCcCCCCCCccHHHHHHHcCCHHHHHHHHhcchhHHHHcCCCccccCCCCCeeeccccccccccccccccccccccccc
Confidence 34444555799999999999999988776 5679999999999999999999999999999999999999999
Q ss_pred CCCCCcccccccccccchhhhhhhhc
Q 012777 100 DRWGSTPLADAVYYKHHDVIKLLEEH 125 (456)
Q Consensus 100 ~~~g~t~l~~A~~~~~~~~~~~L~~~ 125 (456)
|.+|.||+++|+..++.+++.++...
T Consensus 104 ~~~g~t~l~~a~~~~~~~~~~~l~~~ 129 (277)
T d2fo1e1 104 NKSERSALHQAAANRDFGMMVYMLNS 129 (277)
T ss_dssp CTTCCCHHHHHHHTTCHHHHHHHTTS
T ss_pred cccccccccchhhhcchhhhhhhhhc
Confidence 99999999999999999999888754
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.65 E-value=8.3e-17 Score=135.63 Aligned_cols=102 Identities=31% Similarity=0.384 Sum_probs=51.5
Q ss_pred CCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccccccc
Q 012777 34 AIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYY 113 (456)
Q Consensus 34 ~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~ 113 (456)
+..|+||||+|+..++.++++.++......+..+..+.++++.++...+.+++++|+.+|++++.+|.+|+||||+|+..
T Consensus 31 ~~~g~t~L~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~T~L~~A~~~ 110 (153)
T d1awcb_ 31 DWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEH 110 (153)
T ss_dssp CTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHT
T ss_pred ccCCCccccccccccccccccccccccccccccccccccccccccccccceeeecccccCCccccccccCchHHHhhhhc
Confidence 45555666665555555444333322222222222222222222233344455555566666666666666666666666
Q ss_pred ccchhhhhhhhcCCCCCCCccc
Q 012777 114 KHHDVIKLLEEHGAKPSTAPMH 135 (456)
Q Consensus 114 ~~~~~~~~L~~~~~~~~~~~~~ 135 (456)
|+.+++++|++.|++++..+..
T Consensus 111 g~~~iv~~ll~~gad~~~~d~~ 132 (153)
T d1awcb_ 111 NHQEVVELLIKYGADVHTQSKF 132 (153)
T ss_dssp TCHHHHHHHHHTTCCTTCCCTT
T ss_pred chhheeeeccccccCCcccCCC
Confidence 6666666666666666555443
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=6.5e-17 Score=158.34 Aligned_cols=95 Identities=34% Similarity=0.450 Sum_probs=90.4
Q ss_pred chHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccccch
Q 012777 38 RVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHD 117 (456)
Q Consensus 38 ~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~ 117 (456)
-||||.||..|++++|++|+++|+++|.+|..|+||||+||..|+.+++++||++|++++.++..|.||+++|+..|+.+
T Consensus 1 ~TpL~~Aa~~g~~~~v~~Ll~~g~~in~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gadi~~~~~~g~t~L~~A~~~g~~~ 80 (408)
T d1n11a_ 1 LTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTN 80 (408)
T ss_dssp CCHHHHHHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCHHHHHHHHTCHH
T ss_pred CChHHHHHHCcCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCHH
Confidence 39999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCC
Q 012777 118 VIKLLEEHGAKPSTA 132 (456)
Q Consensus 118 ~~~~L~~~~~~~~~~ 132 (456)
++++|+..+.++...
T Consensus 81 ~~~~Ll~~~~~~~~~ 95 (408)
T d1n11a_ 81 MVKLLLENNANPNLA 95 (408)
T ss_dssp HHHHHHHHTCCTTCC
T ss_pred HHHHHHHhhhccccc
Confidence 999999887765443
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=1.9e-16 Score=134.11 Aligned_cols=104 Identities=26% Similarity=0.276 Sum_probs=75.2
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccccc
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAV 111 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~ 111 (456)
..|..|+||||+|+ .|+.+++++|++++++++..+..|.+|++.|+..++.+++++++++|++++.+|.+|.||||+|+
T Consensus 31 ~~d~~g~t~L~~A~-~~~~~~v~~Ll~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~n~~~~~~~t~L~~A~ 109 (156)
T d1bd8a_ 31 ALNRFGKTALQVMM-FGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAV 109 (156)
T ss_dssp CCCTTSCCHHHHSC-TTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHH
T ss_pred ccCCCCCccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccCCCCeeecccc
Confidence 34566777777765 46777777777777777777777777777777777777777777777777777777777777777
Q ss_pred ccccchhhhhhhhcCCCCCCCccccc
Q 012777 112 YYKHHDVIKLLEEHGAKPSTAPMHVQ 137 (456)
Q Consensus 112 ~~~~~~~~~~L~~~~~~~~~~~~~~~ 137 (456)
..|+.+++++|+ .|++++.++....
T Consensus 110 ~~~~~~i~~~L~-~~~~~~~~d~~G~ 134 (156)
T d1bd8a_ 110 QEGHTAVVSFLA-AESDLHRRDARGL 134 (156)
T ss_dssp HHTCHHHHHHHH-TTSCTTCCCTTSC
T ss_pred cccccccccccc-ccccccccCCCCC
Confidence 777777777666 5667666655443
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=9.4e-17 Score=144.56 Aligned_cols=112 Identities=31% Similarity=0.450 Sum_probs=103.2
Q ss_pred CCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCC
Q 012777 24 PADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWG 103 (456)
Q Consensus 24 ~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 103 (456)
..++......|.+|+||||+||..|+.+++++|+..+.+....+..+.++++.|+..++.+++++|+++|++++.+|..|
T Consensus 24 ~~~~~~~~~~D~~G~TpLh~Aa~~g~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~Ll~~~~d~~~~d~~g 103 (223)
T d1uoha_ 24 LADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNG 103 (223)
T ss_dssp HHCGGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCSCCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTC
T ss_pred HhCCCcCcCcCCCCCCHHHHHHHhhhhcccccccccccccccccccccccccccccccccchhHHHhccCceeEeeCCCC
Confidence 44555666788999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccchhhhhhhhcCCCCCCCccc
Q 012777 104 STPLADAVYYKHHDVIKLLEEHGAKPSTAPMH 135 (456)
Q Consensus 104 ~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~ 135 (456)
.||||+|+..|+.+++++|+++|++++.++..
T Consensus 104 ~tpL~~A~~~~~~e~~~~Ll~~g~d~~~~~~~ 135 (223)
T d1uoha_ 104 CTPLHYAASKNRHEIAVMLLEGGANPDAKDHY 135 (223)
T ss_dssp CCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTT
T ss_pred CchhhHHHHcCCHHHHHHHHHCCCCCCCcCCC
Confidence 99999999999999999999999998766443
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.63 E-value=3.5e-16 Score=140.76 Aligned_cols=93 Identities=27% Similarity=0.284 Sum_probs=58.3
Q ss_pred CCCCCchHHHHHHHcCCHHHHHHHHHcC-CCCCccccCcchHHHHHHHcCCHHHHHHHHh-CCCCCCCCCCCCCcccccc
Q 012777 33 EAIDPRVRLMYMANEGDLDGIKELLDSG-TDVNFRDIDKRTALHVAACQGRTDVVRLLLS-RGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 33 ~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g-~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~-~ga~~~~~~~~g~t~l~~A 110 (456)
.+.+|+||||+|+..|+.++++.|++.| .++|.+|.+|+||||+|+..|+.+++++|++ .|++++.+|..|.||||+|
T Consensus 134 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~gad~~~~d~~g~t~l~~A 213 (229)
T d1ixva_ 134 KDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVA 213 (229)
T ss_dssp CCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHHHCCCSCCCCTTSCCTGGGC
T ss_pred cCCCCCCccchhhhcccccccccccccccccccccccccCCchhhhcccccHHHHHHHHHhcCCCCCCcCCCCCCHHHHH
Confidence 3455666666666666666666666554 4566666666666666666666666666664 3666666666666666666
Q ss_pred cccccchhhhhhhhcCCC
Q 012777 111 VYYKHHDVIKLLEEHGAK 128 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~~~ 128 (456)
+. .+++++|++.|+|
T Consensus 214 ~~---~~~~~~Ll~~g~d 228 (229)
T d1ixva_ 214 LN---EQVKKFFLNNVVD 228 (229)
T ss_dssp SC---HHHHHHHHHHCCC
T ss_pred hh---HHHHHHHHHcCCC
Confidence 53 3566666666654
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.62 E-value=4.7e-16 Score=145.22 Aligned_cols=93 Identities=29% Similarity=0.357 Sum_probs=85.4
Q ss_pred CCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 31 GSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 31 ~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
...+.+|.||||.|+..|+.++++.|++.|+|+|.+|.+|+||||+||..|+.++|++|+++|++++.+|..|.||||+|
T Consensus 193 ~~~~~~g~t~L~~a~~~~~~~~~~~Ll~~g~din~~~~~g~TpL~~A~~~g~~~iv~lLl~~Gadv~~~d~~G~TaL~~A 272 (291)
T d1s70b_ 193 VRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVA 272 (291)
T ss_dssp CCCTTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTTTSC
T ss_pred ccccCCCCChhhHHHHcCChhhhcccccceecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHH
Confidence 34567899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccchhhhhhhhcCC
Q 012777 111 VYYKHHDVIKLLEEHGA 127 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~~ 127 (456)
+. +++++|....+
T Consensus 273 ~e----~~~~~L~~~~~ 285 (291)
T d1s70b_ 273 DE----DILGYLEELQK 285 (291)
T ss_dssp CS----GGGHHHHHHHH
T ss_pred HH----HHHHHHHHHhh
Confidence 75 67777765443
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.62 E-value=4.4e-17 Score=144.64 Aligned_cols=114 Identities=27% Similarity=0.249 Sum_probs=99.5
Q ss_pred CCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCcccc------------------------------------
Q 012777 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDI------------------------------------ 68 (456)
Q Consensus 25 ~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~------------------------------------ 68 (456)
.++|++...|.+|.||||+||..|+.+++++|++.|+++|.++.
T Consensus 11 ~g~din~~~d~~G~t~L~~A~~~g~~e~v~~Ll~~g~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (209)
T d1ot8a_ 11 QGAELNATMDKTGETSLHLAARFARADAAKRLLDAGADANSQDNTGRTPLHAAVAADAMGVFQILLRNRATNLNARMHDG 90 (209)
T ss_dssp HHHHHHHHHHHHCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTCTTCCTTCCCTTC
T ss_pred CCCCcCcCcCCCCCCHHHHHHHcCCHHHHHHHHhhccccccccccccccccccccccccccccccccccccccccccccc
Confidence 34555566678899999999999999999888888776655433
Q ss_pred -------------------------------CcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccccch
Q 012777 69 -------------------------------DKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHD 117 (456)
Q Consensus 69 -------------------------------~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~ 117 (456)
.|+|||+.|+..+...+++.|++++++++.+|..|.||||+|+..|+.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~L~~~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~ 170 (209)
T d1ot8a_ 91 TTPLILAARLAIEGMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYE 170 (209)
T ss_dssp CCHHHHHHHTTCTTHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHH
T ss_pred cccccccccccchhhhhhhhhhcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhccccHHH
Confidence 6899999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCcccccc
Q 012777 118 VIKLLEEHGAKPSTAPMHVQN 138 (456)
Q Consensus 118 ~~~~L~~~~~~~~~~~~~~~~ 138 (456)
++++|++.|++++.++....+
T Consensus 171 ~v~~Ll~~gad~n~~d~~g~T 191 (209)
T d1ot8a_ 171 ASKALLDNFANREITDHMDRL 191 (209)
T ss_dssp HHHHHHHTTCCTTCCCTTSCC
T ss_pred HHHHHHHCCCCCCCcCCCCCC
Confidence 999999999999887655443
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=2.3e-16 Score=133.32 Aligned_cols=97 Identities=32% Similarity=0.360 Sum_probs=85.0
Q ss_pred hHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccccchh
Q 012777 39 VRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYKHHDV 118 (456)
Q Consensus 39 t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~ 118 (456)
++||+||..|++++++.|+++|+|+|.+|..|.||||+|+ .|+.+++++|+++|++++.++..|.++++.++..++.++
T Consensus 3 ~~Lh~Aa~~g~~~~v~~Ll~~g~d~n~~d~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~ 81 (156)
T d1ihba_ 3 NELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDT 81 (156)
T ss_dssp HHHHHHHHHTCHHHHHHHTTSCCCTTCCCTTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHH
T ss_pred HHHHHHHHcCCHHHHHHHHHCCCCcCccCCcccccccccc-cccccccccccccccccccccccCccccccccccccccc
Confidence 7899999999999999999999999999999999999886 688999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCcccc
Q 012777 119 IKLLEEHGAKPSTAPMHV 136 (456)
Q Consensus 119 ~~~L~~~~~~~~~~~~~~ 136 (456)
++.|+..+.+++..+...
T Consensus 82 ~~~l~~~~~~~~~~~~~~ 99 (156)
T d1ihba_ 82 LQTLLEFQADVNIEDNEG 99 (156)
T ss_dssp HHHHHHTTCCTTCCCTTS
T ss_pred cccccccccccccccccc
Confidence 999988888876654443
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=4e-16 Score=132.11 Aligned_cols=101 Identities=29% Similarity=0.391 Sum_probs=90.1
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCC
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRW 102 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~ 102 (456)
++.+.+.+. .+.+|.+||+.++..++.++++.++++|+++|.+|.+|+||||+||..|+.+++++|+ .|++++.+|..
T Consensus 55 l~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~n~~~~~~~t~L~~A~~~~~~~i~~~L~-~~~~~~~~d~~ 132 (156)
T d1bd8a_ 55 LKQGASPNV-QDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLA-AESDLHRRDAR 132 (156)
T ss_dssp HHTTCCTTC-CCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHH-TTSCTTCCCTT
T ss_pred ccccccccc-cccccccccccccccccccccccccccccccccccCCCCeeecccccccccccccccc-ccccccccCCC
Confidence 344555554 3567999999999999999999999999999999999999999999999999999887 68999999999
Q ss_pred CCcccccccccccchhhhhhhhc
Q 012777 103 GSTPLADAVYYKHHDVIKLLEEH 125 (456)
Q Consensus 103 g~t~l~~A~~~~~~~~~~~L~~~ 125 (456)
|.||||+|+..|+.+++++|+++
T Consensus 133 G~TpL~~A~~~g~~~iv~~Ll~h 155 (156)
T d1bd8a_ 133 GLTPLELALQRGAQDLVDILQGH 155 (156)
T ss_dssp SCCHHHHHHHSCCHHHHHHHHTT
T ss_pred CCCHHHHHHHcCCHHHHHHHHhh
Confidence 99999999999999999999864
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Probab=99.61 E-value=2e-17 Score=159.36 Aligned_cols=98 Identities=19% Similarity=0.109 Sum_probs=84.1
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHH---HHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCC--CCCCcc
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKE---LLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPED--RWGSTP 106 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~---Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~--~~g~t~ 106 (456)
.++..|.||||+||.+|+.+++++ |++.|+++|.+|.+|+||||+||..|+.++|++|+++|++++..+ .+|.||
T Consensus 85 ~~~~~~~t~L~~Aa~~g~~~~~~~~~~L~~~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~ 164 (346)
T d2ajaa1 85 KKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHA 164 (346)
T ss_dssp HHTCCHHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHH
T ss_pred hccCCCCcHHHHHHHhCCHHHHHHHHHHHhCCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCCh
Confidence 346789999999999999877665 789999999999999999999999999999999999999998765 468999
Q ss_pred cccccccccchhhhhhhhcCCCC
Q 012777 107 LADAVYYKHHDVIKLLEEHGAKP 129 (456)
Q Consensus 107 l~~A~~~~~~~~~~~L~~~~~~~ 129 (456)
||+|+..|+.++|++|++.|+..
T Consensus 165 L~~Aa~~g~~~iv~~Ll~~~~~~ 187 (346)
T d2ajaa1 165 FRLAAENGHLHVLNRLCELAPTE 187 (346)
T ss_dssp HHHHHHTTCHHHHHHHHHSCGGG
T ss_pred hHHHHHHhhHHHHHHHHHcCCcc
Confidence 99999999999999999988754
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.60 E-value=7.8e-16 Score=129.92 Aligned_cols=99 Identities=22% Similarity=0.262 Sum_probs=88.8
Q ss_pred HHHHHHHcCCHHHHHHHHHcCCCCCcc------ccCcchHHHHHHHc---CCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 40 RLMYMANEGDLDGIKELLDSGTDVNFR------DIDKRTALHVAACQ---GRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 40 ~Lh~a~~~~~~~~~~~Ll~~g~~in~~------d~~g~T~Lh~A~~~---~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
.|+.|+..+++..+..++..|+|++.. +..|+||||+|+.. ++.+++++|+++|++++.+|.+|.||||+|
T Consensus 9 ~L~~Av~~~dl~~l~~~~~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A 88 (154)
T d1dcqa1 9 SLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYC 88 (154)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHH
T ss_pred HHHHHHHhCCHHHHHHHHHcCCCcCCCCCcccCCCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhccccccc
Confidence 345778899999999999999988765 77899999999974 688999999999999999999999999999
Q ss_pred cccccchhhhhhhhcCCCCCCCcccccc
Q 012777 111 VYYKHHDVIKLLEEHGAKPSTAPMHVQN 138 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~~~~~~~~~~~~~ 138 (456)
+..|+.+++++|+++|++++.++....+
T Consensus 89 ~~~~~~~~v~~Ll~~gad~~~~d~~g~t 116 (154)
T d1dcqa1 89 CLTDNAECLKLLLRGKASIEIANESGET 116 (154)
T ss_dssp HHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cccccccccccccccCccccccCCCCCC
Confidence 9999999999999999999988665543
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=1.7e-15 Score=135.79 Aligned_cols=101 Identities=26% Similarity=0.259 Sum_probs=90.2
Q ss_pred CCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccc-cCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcc
Q 012777 28 DADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRD-IDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTP 106 (456)
Q Consensus 28 ~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d-~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~ 106 (456)
........+|.||||.|+..++.+++++|+..|++++..+ .+|.||||+|+..|+.+++++|+++|+|++.+|.+|.||
T Consensus 102 ~~~~~~~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tp 181 (221)
T d1iknd_ 102 SILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSP 181 (221)
T ss_dssp CGGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCG
T ss_pred ccccccccccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCCH
Confidence 3444556678999999999999999999999999988765 579999999999999999999999999999999999999
Q ss_pred cccccccccchhhhhhhhcCCC
Q 012777 107 LADAVYYKHHDVIKLLEEHGAK 128 (456)
Q Consensus 107 l~~A~~~~~~~~~~~L~~~~~~ 128 (456)
||+|+..++.+++++|++.+.+
T Consensus 182 l~~A~~~~~~~~~~~l~~~~~~ 203 (221)
T d1iknd_ 182 YQLTWGRPSTRIQQQLGQLTLE 203 (221)
T ss_dssp GGGCTTSSCHHHHHHHHTTSCG
T ss_pred HHHHHHCCCHHHHHHHHHcCCc
Confidence 9999999999999999987665
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.59 E-value=1.6e-15 Score=127.63 Aligned_cols=91 Identities=32% Similarity=0.440 Sum_probs=87.2
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccccc
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAV 111 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~ 111 (456)
..+.++.++++.++...+.++++.++..|++++.+|.+|+||||+||..|+.+++++|+++|++++.+|.+|.||+|+|+
T Consensus 62 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~~g~Tpl~~A~ 141 (153)
T d1awcb_ 62 ARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISI 141 (153)
T ss_dssp CCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred ccccccccccccccccccceeeecccccCCccccccccCchHHHhhhhcchhheeeeccccccCCcccCCCCCCHHHHHH
Confidence 44567889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchhhhhh
Q 012777 112 YYKHHDVIKLL 122 (456)
Q Consensus 112 ~~~~~~~~~~L 122 (456)
..|+.|++++|
T Consensus 142 ~~g~~eiv~lL 152 (153)
T d1awcb_ 142 DNGNEDLAEIL 152 (153)
T ss_dssp HTTCHHHHHHH
T ss_pred HcCCHHHHHhC
Confidence 99999999987
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=1.4e-15 Score=148.80 Aligned_cols=88 Identities=34% Similarity=0.332 Sum_probs=67.7
Q ss_pred CCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccccccc
Q 012777 35 IDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYYK 114 (456)
Q Consensus 35 ~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~ 114 (456)
.++.||||.|+..++.++++.+++.|+++|.+|.+|.||||+|+..|+.++|++|+++||+++.+|.+|.||||+|+..|
T Consensus 295 ~~~~t~L~~~~~~~~~~~~~~ll~~g~~in~~d~~G~T~Lh~A~~~g~~~iv~~Ll~~GAd~n~~d~~G~t~L~~A~~~~ 374 (408)
T d1n11a_ 295 RMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIAKRLG 374 (408)
T ss_dssp SSCCCHHHHHHHSSCSHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCSSSCCHHHHHHHTT
T ss_pred ccccccchhhcccCcceeeeeeccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcC
Confidence 45677777777777777777777777777777777888888888888888888888888888877777888888887777
Q ss_pred cchhhhhh
Q 012777 115 HHDVIKLL 122 (456)
Q Consensus 115 ~~~~~~~L 122 (456)
+.++|++|
T Consensus 375 ~~~iv~~L 382 (408)
T d1n11a_ 375 YISVTDVL 382 (408)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 77777655
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Probab=99.58 E-value=3e-17 Score=157.99 Aligned_cols=110 Identities=18% Similarity=0.100 Sum_probs=92.4
Q ss_pred CCCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccc--cCcchHHHHHHHcCCHHHHHHHHhCCCCCC--
Q 012777 22 PLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRD--IDKRTALHVAACQGRTDVVRLLLSRGADVD-- 97 (456)
Q Consensus 22 ~~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d--~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~-- 97 (456)
.+..+++++. .+.+|+||||+||.+|+.++|++|++.|++++..+ .+|+||||+||..|+.++|++|++.|++..
T Consensus 112 L~~~~~~in~-~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~L~~Aa~~g~~~iv~~Ll~~~~~~~~~ 190 (346)
T d2ajaa1 112 LLTSDEIVKV-IQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATA 190 (346)
T ss_dssp C--CCSSCC---CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHHHHHHHHTTCHHHHHHHHHSCGGGHHH
T ss_pred HHhCCCcccc-cCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCChhHHHHHHhhHHHHHHHHHcCCccccc
Confidence 4555666665 45789999999999999999999999999999876 459999999999999999999999998653
Q ss_pred -CCCCCCCcccccccccccchhhhhhhhcCCCCCCC
Q 012777 98 -PEDRWGSTPLADAVYYKHHDVIKLLEEHGAKPSTA 132 (456)
Q Consensus 98 -~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~ 132 (456)
..+.+|.||++.|+..|+.++|++|++.|++++.+
T Consensus 191 ~~~~~~~~t~l~~A~~~g~~~iv~~Ll~~ga~~~~~ 226 (346)
T d2ajaa1 191 MIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYA 226 (346)
T ss_dssp HHHHHHHHHHHHHHSTTCCHHHHHHHTTSHHHHHHH
T ss_pred ccccCCCcchhhHHhhcCHHHHHHHHHhCCCCcchH
Confidence 34456778889999999999999999999887544
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=1.3e-15 Score=136.52 Aligned_cols=114 Identities=26% Similarity=0.271 Sum_probs=92.9
Q ss_pred CCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHH---------------
Q 012777 25 ADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLL--------------- 89 (456)
Q Consensus 25 ~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~L--------------- 89 (456)
.+.+++ ..|.+|+||||+||..|+.+++++|++.|+|++.+|..|.||||+|+..++.++++.|
T Consensus 28 ~~~~in-~~d~~g~TpLh~A~~~~~~~iv~~L~~~g~d~~~~d~~g~t~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 106 (221)
T d1iknd_ 28 DLAFLN-FQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKA 106 (221)
T ss_dssp -CCCCC-CCCTTCCCHHHHHHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHHHHHHHTCHHHHHHHHHSTTTTSSSCGGGC
T ss_pred CCCCcc-cCCCCCCccccccccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccc
Confidence 344544 5677999999999999999999999999999999999898888888877766666555
Q ss_pred ------------------------HhCCCCCCCCC-CCCCcccccccccccchhhhhhhhcCCCCCCCccccccc
Q 012777 90 ------------------------LSRGADVDPED-RWGSTPLADAVYYKHHDVIKLLEEHGAKPSTAPMHVQNA 139 (456)
Q Consensus 90 ------------------------l~~ga~~~~~~-~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~~ 139 (456)
+..|+.++.++ ..|.||||+|+..|+.+++++|+++|++++.++....++
T Consensus 107 ~~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tp 181 (221)
T d1iknd_ 107 TNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSP 181 (221)
T ss_dssp CCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCG
T ss_pred cccccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCCH
Confidence 45566666544 469999999999999999999999999999887665544
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.57 E-value=1.4e-15 Score=142.04 Aligned_cols=101 Identities=28% Similarity=0.457 Sum_probs=95.1
Q ss_pred CCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccccccc
Q 012777 34 AIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAVYY 113 (456)
Q Consensus 34 ~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~ 113 (456)
+.+|.|+||.||..|++++|++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|++.+..+..+.+|++.|+..
T Consensus 37 ~~~~~t~l~~A~~~G~~~~v~~Ll~~Gadvn~~d~~G~T~L~~A~~~g~~eiv~~Ll~~~~~~~~~~~~~~~~L~~a~~~ 116 (291)
T d1s70b_ 37 KFDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASC 116 (291)
T ss_dssp EECHHHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHH
T ss_pred CCCCchHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCcHHHHHHhcCCceeeeeecccccccccccccccccccccccc
Confidence 35678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhhhhcCCCCCCCcc
Q 012777 114 KHHDVIKLLEEHGAKPSTAPM 134 (456)
Q Consensus 114 ~~~~~~~~L~~~~~~~~~~~~ 134 (456)
++.++++.|+..|+..+..+.
T Consensus 117 ~~~~~~~~l~~~~~~~~~~~~ 137 (291)
T d1s70b_ 117 GYLDIAEYLISQGAHVGAVNS 137 (291)
T ss_dssp TCHHHHHHHHHTTCCTTCCCT
T ss_pred cccchhhcccccCcccccccc
Confidence 999999999999988766543
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.56 E-value=2.5e-15 Score=138.94 Aligned_cols=94 Identities=29% Similarity=0.439 Sum_probs=88.6
Q ss_pred CCCCCCCchHHHHHHHcCCHHHHHHHH-HcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccc
Q 012777 31 GSEAIDPRVRLMYMANEGDLDGIKELL-DSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLAD 109 (456)
Q Consensus 31 ~~~~~~g~t~Lh~a~~~~~~~~~~~Ll-~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~ 109 (456)
...+.+|.|+||+++..++.+++++++ ..+.+++.+|..|+||||+||..|+.+++++|+++|++++.+|.+|.||||+
T Consensus 181 ~~~~~~g~t~L~~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~tpL~~A~~~g~~~iv~~Ll~~gadin~~d~~G~T~L~~ 260 (277)
T d2fo1e1 181 DSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQL 260 (277)
T ss_dssp SSSSCCCCCTHHHHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCHHHH
T ss_pred cccccCCCCccccccccccccccccccccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCcCCCCCCHHHH
Confidence 445778999999999999999999866 6789999999999999999999999999999999999999999999999999
Q ss_pred ccccccchhhhhhhh
Q 012777 110 AVYYKHHDVIKLLEE 124 (456)
Q Consensus 110 A~~~~~~~~~~~L~~ 124 (456)
|+..|+.++|++|++
T Consensus 261 A~~~~~~~iv~lL~~ 275 (277)
T d2fo1e1 261 AQANNHHNIVDIFDR 275 (277)
T ss_dssp HHHTTCHHHHHHHHT
T ss_pred HHHcCCHHHHHHHHH
Confidence 999999999999985
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=6.9e-15 Score=130.30 Aligned_cols=94 Identities=28% Similarity=0.363 Sum_probs=88.0
Q ss_pred CCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcc
Q 012777 27 DDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTP 106 (456)
Q Consensus 27 ~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~ 106 (456)
.+........|.++||.|+..+...+++.+++.|.+++.+|.+|.||||+|+..|+.+++++|+++|+|++.+|.+|.||
T Consensus 134 ~~~~~~~~~~~~~~l~~a~~~~~~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~Gad~n~~d~~G~Tp 213 (228)
T d1k1aa_ 134 ADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTP 213 (228)
T ss_dssp CCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCT
T ss_pred cccccccccchhhHHHHHHHhhhhhhhhhhhhhccccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 34455567789999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccchhhh
Q 012777 107 LADAVYYKHHDVIK 120 (456)
Q Consensus 107 l~~A~~~~~~~~~~ 120 (456)
||+|+..|+.++|+
T Consensus 214 L~~A~~~~~~divk 227 (228)
T d1k1aa_ 214 LMVARSRRVIDILR 227 (228)
T ss_dssp TTTCSSHHHHHHHT
T ss_pred HHHHHhCCCccccC
Confidence 99999999998875
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=6.7e-15 Score=130.39 Aligned_cols=93 Identities=26% Similarity=0.348 Sum_probs=86.6
Q ss_pred CCCchHHHHHHHcCCHHHHHHHHH----cCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCcccccc
Q 012777 35 IDPRVRLMYMANEGDLDGIKELLD----SGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADA 110 (456)
Q Consensus 35 ~~g~t~Lh~a~~~~~~~~~~~Ll~----~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 110 (456)
.||+||||+||.+|+.++++.|++ .|+++|.+|.+|+||||+|+..|+.+++++|+++|++.+..+..|.++++.|
T Consensus 1 ~dG~TpLh~A~~~g~~~~v~~Ll~~~~~~g~~in~~d~~g~TpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~a 80 (228)
T d1k1aa_ 1 EDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLA 80 (228)
T ss_dssp CTTCCHHHHHHHTTCHHHHHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred CCCccHHHHHHHcCCHHHHHHHHHHHHHCCCCCCccCCCCCccceehhcccccccccccccccccccccccccccccccc
Confidence 479999999999999999999884 7999999999999999999999999999999999999999999999999999
Q ss_pred cccccchhhhhhhhcCC
Q 012777 111 VYYKHHDVIKLLEEHGA 127 (456)
Q Consensus 111 ~~~~~~~~~~~L~~~~~ 127 (456)
...++.++++.+.....
T Consensus 81 ~~~~~~~~~~~~~~~~~ 97 (228)
T d1k1aa_ 81 CEHRSPTCLRALLDSAA 97 (228)
T ss_dssp HHTTCHHHHHHHHHHSC
T ss_pred cccccccchhhhhhccc
Confidence 99999999988776543
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=1.2e-14 Score=122.42 Aligned_cols=113 Identities=27% Similarity=0.268 Sum_probs=100.1
Q ss_pred CCCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCC
Q 012777 22 PLPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDR 101 (456)
Q Consensus 22 ~~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~ 101 (456)
.++.++|++. .|.+|.||||+|+ .|+.+++++|+++|++++.++..|.|+++.++..++.+++++|+.++.+++..+.
T Consensus 20 Ll~~g~d~n~-~d~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~ 97 (156)
T d1ihba_ 20 LLQNNVNVNA-QNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDN 97 (156)
T ss_dssp HTTSCCCTTC-CCTTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCT
T ss_pred HHHCCCCcCc-cCCcccccccccc-cccccccccccccccccccccccCccccccccccccccccccccccccccccccc
Confidence 3556777654 5788999999886 7899999999999999999999999999999999999999999999999999999
Q ss_pred CCCcccccccccccchhhhhhhhcCC-CCCCCcccc
Q 012777 102 WGSTPLADAVYYKHHDVIKLLEEHGA-KPSTAPMHV 136 (456)
Q Consensus 102 ~g~t~l~~A~~~~~~~~~~~L~~~~~-~~~~~~~~~ 136 (456)
.|.+|+++|+..++.+++++|+.+++ +++.++...
T Consensus 98 ~~~~~l~~a~~~~~~~~~~~Ll~~~~~~~~~~d~~g 133 (156)
T d1ihba_ 98 EGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKG 133 (156)
T ss_dssp TSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTS
T ss_pred ccccccccccccccccccccccccccccccccCCCC
Confidence 99999999999999999999998876 666665543
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.50 E-value=2.7e-14 Score=128.09 Aligned_cols=108 Identities=26% Similarity=0.260 Sum_probs=99.0
Q ss_pred CCCCCCchHHHHHHHcCCHHHHHHHHHcCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCC-CCCCCCCCCCCcccccc
Q 012777 32 SEAIDPRVRLMYMANEGDLDGIKELLDSGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRG-ADVDPEDRWGSTPLADA 110 (456)
Q Consensus 32 ~~~~~g~t~Lh~a~~~~~~~~~~~Ll~~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~g-a~~~~~~~~g~t~l~~A 110 (456)
..+..+.|+++.++..++.++++.|++.|.+.+.+|..|+||||+|+..|+.+++++|++.+ .+++.+|.+|.||||+|
T Consensus 100 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpLh~A 179 (229)
T d1ixva_ 100 KITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHA 179 (229)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHH
T ss_pred ccccccccccccccccchhhhhhhhhhhcccccccCCCCCCccchhhhcccccccccccccccccccccccccCCchhhh
Confidence 45567899999999999999999999999999999999999999999999999999999986 78899999999999999
Q ss_pred cccccchhhhhhhh-cCCCCCCCccccccc
Q 012777 111 VYYKHHDVIKLLEE-HGAKPSTAPMHVQNA 139 (456)
Q Consensus 111 ~~~~~~~~~~~L~~-~~~~~~~~~~~~~~~ 139 (456)
+..|+.++|++|++ .|++++.++....++
T Consensus 180 ~~~~~~~~v~~Ll~~~gad~~~~d~~g~t~ 209 (229)
T d1ixva_ 180 LAEGHGDAAVLLVEKYGAEYDLVDNKGAKA 209 (229)
T ss_dssp HHTTCHHHHHHHHHHHCCCSCCCCTTSCCT
T ss_pred cccccHHHHHHHHHhcCCCCCCcCCCCCCH
Confidence 99999999999996 699999887665544
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=3.2e-13 Score=124.91 Aligned_cols=78 Identities=26% Similarity=0.304 Sum_probs=70.1
Q ss_pred CCCCCCCCCCCCCCCchHHHHHHHcCCHHHHHHHHH-cCCCCCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCC
Q 012777 23 LPADDDADGSEAIDPRVRLMYMANEGDLDGIKELLD-SGTDVNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDR 101 (456)
Q Consensus 23 ~~~~~~~~~~~~~~g~t~Lh~a~~~~~~~~~~~Ll~-~g~~in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~ 101 (456)
++.+++++. .+.+|.||||+||..|+.+++++|++ .|+|+|.+|.+|.||||+|+..|+.+++++||++||++|.+|.
T Consensus 206 i~~ga~~n~-~~~~g~t~L~~a~~~~~~~~v~~lL~~~g~din~~d~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~d~ 284 (285)
T d1wdya_ 206 LDHGADVNV-RGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGDL 284 (285)
T ss_dssp HHTTCCSSC-CCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSSC
T ss_pred HHCCCCCCc-cCCCCCCccchhhhcCcHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcccC
Confidence 345566554 46789999999999999999999997 5899999999999999999999999999999999999999874
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.32 E-value=1.1e-12 Score=123.10 Aligned_cols=49 Identities=31% Similarity=0.377 Sum_probs=47.6
Q ss_pred CCccccCcchHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCccccccc
Q 012777 63 VNFRDIDKRTALHVAACQGRTDVVRLLLSRGADVDPEDRWGSTPLADAV 111 (456)
Q Consensus 63 in~~d~~g~T~Lh~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~ 111 (456)
+|.+|.+|+||||+||..|+.++|++|+++||+++.+|..|.|||++|+
T Consensus 252 in~~D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tpl~~A~ 300 (301)
T d1sw6a_ 252 LNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA 300 (301)
T ss_dssp TTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTC
T ss_pred ccCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHcC
Confidence 6889999999999999999999999999999999999999999999996
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.07 E-value=8.5e-06 Score=73.08 Aligned_cols=125 Identities=14% Similarity=-0.004 Sum_probs=86.7
Q ss_pred EEEeEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEEccCCCCHHHHHHHcCCC
Q 012777 166 RIASWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGAL 244 (456)
Q Consensus 166 g~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l 244 (456)
.++...+..+++|+........ ...+.+|...+..+. +--+.+++.+...++..++||++++|.++.+...
T Consensus 31 ~rv~~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~----- 102 (263)
T d1j7la_ 31 YKLVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE----- 102 (263)
T ss_dssp EEEECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT-----
T ss_pred EEEEeCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc-----
Confidence 4556677889999986543222 234677888887773 4446788888888889999999999888765432
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------------------C
Q 012777 245 KPTLAVKFALDIARGMNYLHENR--------------------------------------------------------P 268 (456)
Q Consensus 245 ~~~~~~~i~~ql~~aL~~LH~~~--------------------------------------------------------~ 268 (456)
+......++.++...+..||+.. +
T Consensus 103 ~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 182 (263)
T d1j7la_ 103 DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEE 182 (263)
T ss_dssp TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCC
T ss_pred ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCC
Confidence 11223345566666666666521 1
Q ss_pred CCeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 269 EAIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 269 ~~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
..++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 183 ~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cEEEEeeccCcceeecCCceEEEeechhcc
Confidence 127999999999999987666799998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.60 E-value=8e-05 Score=66.08 Aligned_cols=115 Identities=22% Similarity=0.172 Sum_probs=73.9
Q ss_pred EcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC--CCcceeeeeEEEeCCceEEEEEccCCCCHHHHHHHcCCCCHH
Q 012777 170 WRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR--HPNVVQFLGAVTQSTPMMIVTEYLPKGDLRAYLKQKGALKPT 247 (456)
Q Consensus 170 ~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~ 247 (456)
..+..+++|....... ..+..|...++.+. .-.+.+++.+..+++..++||++++|.++.+. ..+..
T Consensus 33 ~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~-----~~~~~ 101 (255)
T d1nd4a_ 33 QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSS-----HLAPA 101 (255)
T ss_dssp TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTS-----CCCHH
T ss_pred CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccc-----cccHH
Confidence 3466788998765432 24667888777763 33367788888888889999999987665320 11111
Q ss_pred HHHHHHHHHHHHHHHHHh---------------------------------------------------CC----CCCeE
Q 012777 248 LAVKFALDIARGMNYLHE---------------------------------------------------NR----PEAII 272 (456)
Q Consensus 248 ~~~~i~~ql~~aL~~LH~---------------------------------------------------~~----~~~iv 272 (456)
.++.++...|.-||+ .. +..++
T Consensus 102 ---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~li 178 (255)
T d1nd4a_ 102 ---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVT 178 (255)
T ss_dssp ---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEE
T ss_pred ---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEE
Confidence 112233333333332 11 12389
Q ss_pred ecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 273 HRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 273 H~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
|+|+.|.|||++.+..+-|+||+.+.
T Consensus 179 HgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 179 HGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eCCCCCcceEEeCCceEEEEEchhcc
Confidence 99999999999987667899998654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.17 E-value=0.0005 Score=65.18 Aligned_cols=29 Identities=28% Similarity=0.416 Sum_probs=25.0
Q ss_pred CeEecCCCCCCeEeCCCCCEEEeccCCccc
Q 012777 270 AIIHRDLEPSNILRDDSGHLKVADFGLSKL 299 (456)
Q Consensus 270 ~ivH~Dikp~Nil~~~~~~vkl~Dfgls~~ 299 (456)
.++|+|+.|.|||++++ .++++||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCC-ceEEechhhccc
Confidence 49999999999999976 489999987653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.16 E-value=0.0054 Score=56.12 Aligned_cols=125 Identities=14% Similarity=0.129 Sum_probs=68.3
Q ss_pred eEcCcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCCCCc--ceeee-----eEEEeCCceEEEEEccCCCCH-----HH
Q 012777 169 SWRGTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIRHPN--VVQFL-----GAVTQSTPMMIVTEYLPKGDL-----RA 236 (456)
Q Consensus 169 ~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~l~-----~~~~~~~~~~lv~e~~~~~sL-----~~ 236 (456)
..+|+.|++|+...... + .+.+..|...+..+.... ++..+ ..+......+.++++++|..+ ..
T Consensus 43 ~~dg~~~VlK~~rp~~~-s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~ 118 (325)
T d1zyla1 43 DEDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQ 118 (325)
T ss_dssp CTTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHH
T ss_pred cCCCCEEEEEEeCCCCC-C---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHH
Confidence 34788999999875432 2 245777887777763111 12212 123456678889999865432 11
Q ss_pred ------HHH---H----------------------------cCCCCHH---HHHHHHHHHHHHHHHHH-hCCCCCeEecC
Q 012777 237 ------YLK---Q----------------------------KGALKPT---LAVKFALDIARGMNYLH-ENRPEAIIHRD 275 (456)
Q Consensus 237 ------~l~---~----------------------------~~~l~~~---~~~~i~~ql~~aL~~LH-~~~~~~ivH~D 275 (456)
.+. . ...++.. .....+.++...+.-+- +..+..+||+|
T Consensus 119 ~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgD 198 (325)
T d1zyla1 119 MEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGD 198 (325)
T ss_dssp HHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSS
T ss_pred HHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCC
Confidence 110 0 0111111 11222333333333221 12234589999
Q ss_pred CCCCCeEeCCCCCEEEeccCCccc
Q 012777 276 LEPSNILRDDSGHLKVADFGLSKL 299 (456)
Q Consensus 276 ikp~Nil~~~~~~vkl~Dfgls~~ 299 (456)
+.+.|||++.+ ..++||+-+..
T Consensus 199 lh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 199 CHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSGGGEEESSS--EEECCCTTCCE
T ss_pred CCcccEEEeCC--ceEEechhccc
Confidence 99999999743 56899997653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.17 E-value=0.03 Score=52.40 Aligned_cols=54 Identities=15% Similarity=0.237 Sum_probs=35.3
Q ss_pred CcEEEEEEeCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012777 172 GTQVAVKTLGEEVFTDEDKVKAFIDELALLQKIR-HPNVVQFLGAVTQSTPMMIVTEYLPKGDL 234 (456)
Q Consensus 172 g~~vAvK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv~e~~~~~sL 234 (456)
+..|.+++.-.. ... ....+|..+++.+. +.-..++++++.. .+|+||++|.+|
T Consensus 74 ~~~vllRi~g~~--~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 74 PNKVLLRVYFNP--ETE---SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp CSEEEEEEECSC--CCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred CCcEEEEecCCc--chh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 456777776532 222 34568999988884 4445678887753 688999976543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=90.98 E-value=0.027 Score=50.76 Aligned_cols=29 Identities=24% Similarity=0.272 Sum_probs=26.1
Q ss_pred CeEecCCCCCCeEeCCCCCEEEeccCCcc
Q 012777 270 AIIHRDLEPSNILRDDSGHLKVADFGLSK 298 (456)
Q Consensus 270 ~ivH~Dikp~Nil~~~~~~vkl~Dfgls~ 298 (456)
++||+|+.++||+++.+...-++||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 49999999999999988777899999765
|